human O B-DNA 0.6644490361213684
cDNA B-DNA I-DNA 0.6243647933006287
clone E-DNA E-DNA 0.9952948689460754
encoding O O 0.997297465801239
a O O 0.9999431371688843
protein O O 0.8617571592330933
that O O 0.9990701079368591
was O O 0.9999632835388184
identical O O 0.999937891960144
to O O 0.9999929666519165
the O O 0.9999526739120483
mammalian B-protein B-protein 0.6609298586845398
27-kDa I-protein I-protein 0.8212396502494812

alpha I-DNA I-DNA 0.25107863545417786
enhancers E-DNA E-DNA 0.9961103796958923
. O O 0.9998393058776855
CD3 S-protein S-protein 0.8718299269676208
-epsilon O O 0.8129895329475403
gene O O 0.6290438175201416
expression O O 0.9975079298019409
is O O 0.9999934434890747
confined O O 0.9999716281890869
to O O 0.999995231628418
the O O 0.9999120235443115
T B-cell_line B-cell_type 0.4733482599258423
cell I-cell_line I-cell_type 0.42143169045448303
lineage E-cell_line E-cell_type 0.7819437980651855

studies O O 0.9965870380401611
have O O 0.9999992847442627
shown O O 0.9999986886978149
this O O 0.9999840259552002
integrin S-protein O 0.7356157302856445
to O O 0.9997672438621521
be O O 0.9999809265136719
particularly O O 0.9998069405555725
prone O O 0.9991760849952698
to O O 0.9999855756759644
proteolytic O O 0.9667145013809204
regulation O O 0.9996629953384399
of O O 0.9999970197677612
its O O 0.9999902248382568
function O O 0.9992153644561768
. O O 0.9999979734420776
Second O O 0.9960287809371948
, O O 0.9999823570251465
we O O 0.9999673366546631
found O O 0.9999954700469971
that O O 0.999998927116394
the O O 0.9999862909317017
potentiating O O 0.9848123788833618
activity O O 0.9996590614318848
of O O 0.9999974966049194
NE S-protein S-protein 0.8724976778030396
on O O 0.9995278120040894
the O O 0.9999922513961792
threshold O O 0.9993233680725098
of O O 0.9999939203262329
cathepsin B-protein B-protein 0.5969784259796143
G E-protein E-protein 0.9985671043395996
-induced O O 0.9982580542564392
platelet O O 0.4501837193965912
aggregation O O 0.9928887486457825
was O O 0.9999902248382568
strictly O O 0.9979355335235596
dependent O O 0.99997878074646
on O O 0.9999960660934448
the O O 0.9999949932098389
presence O O 0.9997387528419495
of O O 0.9999904632568359
exogenous B-protein O 0.8278806805610657
fibrinogen E-protein O 0.653863251209259
. O O 0.9995976090431213
Using O O 0.9999063014984131
flow O O 0.96509850025177
cytometry O O 0.9815303683280945

gene O O 0.8200121521949768
expression O O 0.9935811758041382
as O O 0.9999954700469971
the O O 0.9999327659606934
cells O O 0.9825945496559143
mature O O 0.999464213848114
along O O 0.9999779462814331
the O O 0.9999321699142456
DC S-cell_type S-cell_type 0.9942574501037598
and O O 0.9936593174934387
macrophage B-cell_type O 0.8150689601898193
pathways E-cell_type O 0.9950879216194153
. O O 0.9999980926513672
A O O 0.999993085861206
distinctive O O 0.9746954441070557
pattern O O 0.9919684529304504
of O O 0.9999263286590576
differentially O O 0.7736263275146484
expressed O O 0.9210416674613953
cDNAs S-DNA S-DNA 0.9444339871406555
is O O 0.9998039603233337
evident O O 0.9999966621398926
where O O 0.9999979734420776

These O O 0.9996473789215088
results O O 0.9999854564666748
suggest O O 0.9999995231628418
that O O 0.999998927116394
CMV O O 0.9703409075737
activates O O 0.999681830406189
these O O 0.9999816417694092
transcriptional B-protein B-protein 0.5984633564949036
factors E-protein E-protein 0.9759404063224792
, O O 0.9995377063751221
resulting O O 0.9999969005584717
in O O 0.9999963045120239
IL-8 S-protein B-DNA 0.7753207087516785
gene O E-DNA 0.9086865186691284
expression O O 0.9986581802368164
. O O 0.9999979734420776
Construction O O 0.9969342947006226

In O O 0.999721348285675
many O O 0.9996861219406128
chronic O O 0.9119902849197388
inflammatory O O 0.9699994921684265
disorders O O 0.998601496219635
, O O 0.999997615814209
glucocorticoid O O 0.8449327349662781
( O O 0.9881783127784729
GC O O 0.9546285271644592
) O O 0.9960734844207764
insensitivity O O 0.9998711347579956
is O O 0.9999994039535522
a O O 0.9999992847442627
challenging O O 0.9935763478279114
clinical O O 0.9939561486244202
problem O O 0.999717652797699
associated O O 0.9999345541000366
with O O 0.999996542930603
life-threatening O O 0.9813084006309509
disease O O 0.9972135424613953
progression O O 0.9999444484710693
. O O 0.9999995231628418
The O O 0.999998927116394
molecular O O 0.9404253363609314
basis O O 0.9981212019920349
of O O 0.9999934434890747
GC O O 0.7650556564331055
insensitivity O O 0.9940406680107117
, O O 0.9999182224273682
however O O 0.9999791383743286
, O O 0.9999861717224121
is O O 0.9999953508377075
unknown O O 0.9999666213989258
. O O 0.9999980926513672
Alternative O O 0.9911195635795593
splicing O O 0.995307981967926
of O O 0.9999704360961914
the O O 0.9999548196792603
GC B-RNA B-protein 0.44962769746780396
receptor I-RNA E-protein 0.8539062738418579
( I-RNA O 0.8309987187385559
R I-RNA O 0.30781927704811096

factor E-protein E-protein 0.9411775469779968
to O O 0.9982789754867554
induce O O 0.9997667670249939
erythroid B-cell_type B-cell_type 0.5768461227416992
progenitors E-cell_type E-cell_type 0.9826546311378479
to O O 0.999071478843689
undergo O O 0.9999608993530273
15 O O 0.9876556992530823
to O O 0.9994899034500122
22 O O 0.9970383644104004
cell O O 0.9810912609100342
divisions O O 0.9455034732818604
, O O 0.9999918937683105
corresponding O O 0.9999628067016602
to O O 0.9999549388885498
a O O 0.9999827146530151
10 O O 0.9215225577354431
( O O 0.9938271641731262
5 O O 0.9923920035362244
) O O 0.9945057034492493
- O O 0.9986667633056641
to O O 0.9991311430931091
10 O O 0.987304151058197
( O O 0.9992297887802124

binding O O 0.8499341607093811
affinity O O 0.9724417328834534
of O O 0.9998726844787598
these O O 0.9999873638153076
receptors O O 0.4701251685619354
in O O 0.9993048906326294
squirrel B-cell_type B-cell_type 0.4893554747104645
monkey I-cell_type I-cell_type 0.8195164203643799
cells E-cell_type E-cell_type 0.9555696845054626
. O O 0.9999029636383057
Rather O O 0.9999908208847046
, O O 0.9999951124191284
the O O 0.9999914169311523
binding O O 0.9656761884689331
affinity O O 0.9976087808609009
is O O 0.9999831914901733
probably O O 0.9999278783798218
influenced O O 0.9999628067016602
by O O 0.9999994039535522
the O O 0.9999980926513672
expression O O 0.9991495609283447

suppression O O 0.9931076169013977
of O O 0.9999829530715942
TNF S-protein S-protein 0.9656471610069275
translation O O 0.9936157464981079
efficiency O O 0.999862551689148
. O O 0.9999955892562866
CNI-1493 O O 0.40754789113998413
blocked O O 0.9947527647018433
neither O O 0.9999654293060303
the O O 0.9999686479568481
lipopolysaccharide O O 0.8558844923973083
( O O 0.980525553226471
LPS O O 0.8974843621253967
) O O 0.9676708579063416
-induced O O 0.9971580505371094
increases O O 0.9998611211776733
in O O 0.999984860420227

, O O 0.9651855230331421
sensitive O O 0.9792503118515015
( O O 0.9974631071090698
IC50 O O 0.8709501624107361
< O O 0.9970763921737671
381 O O 0.9945077300071716
ng/mL O O 0.9927216172218323
) O O 0.9994370341300964
and O O 0.9999220371246338
resistant O O 0.8336032629013062
( O O 0.9889975786209106
IC50 O O 0.8382384181022644
> O O 0.9988440275192261
381 O O 0.9963332414627075
ng/mL O O 0.9874594211578369
) O O 0.999263346195221
groups O O 0.9986284971237183
. O O 0.9999992847442627
In O O 0.9999809265136719
healthy O O 0.9890794157981873
subjects O O 0.999277651309967
, O O 0.999994158744812

transient O O 0.8503178358078003
transfection O O 0.9578948616981506
experiments O O 0.9969059824943542
. O O 0.9999973773956299
In O O 0.9999814033508301
addition O O 0.9999805688858032
, O O 0.9999856948852539
BSAP S-protein S-protein 0.9221892952919006
was O O 0.9998137354850769
found O O 0.9999532699584961
to O O 0.9999942779541016
be O O 0.999997615814209
the O O 0.9999966621398926
only O O 0.9997269511222839
abundant O O 0.9259445667266846
DNA-binding O O 0.5069218873977661
activity O O 0.8621934652328491
of O O 0.999745786190033
B-cell O O 0.3335971534252167
nuclear O O 0.4665285050868988
extracts O O 0.5754448175430298
that O O 0.999756395816803
interacts O O 0.9999287128448486
with O O 0.9999655485153198
the O O 0.9998137354850769
CD19 B-DNA B-DNA 0.5065019130706787
promoter E-DNA E-DNA 0.9883517622947693
. O O 0.9997965693473816
Together O O 0.999771773815155

young O O 0.9701219797134399

clinical O O 0.8007308840751648
course O O 0.9425541162490845
. O O 0.999955415725708
RESULTS O O 0.9987995624542236
: O O 0.9999946355819702
All O O 0.9999911785125732
the O O 0.9999886751174927
tumors O O 0.9395001530647278
exhibited O O 0.998989999294281
strong O O 0.9977561831474304
expression O O 0.9996756315231323
of O O 0.9999912977218628
vimentin S-protein S-protein 0.9689516425132751
, O O 0.9934687614440918
but O O 0.9999085664749146
most O O 0.9999390840530396
other O O 0.9997379183769226
antigens O S-protein 0.7236470580101013
( O O 0.9716274738311768
including O O 0.9977303147315979
smooth B-protein B-protein 0.8638064861297607
muscle I-protein I-protein 0.7302356362342834
actin E-protein E-protein 0.7741171717643738
) O O 0.9786223769187927
were O O 0.9999798536300659

we O O 0.9982550740242004
have O O 0.9999963045120239
examined O O 0.9999302625656128
induction O O 0.9954791069030762
of O O 0.9999603033065796
the O O 0.9999712705612183
transcription B-protein B-protein 0.5245662331581116
factors E-protein E-protein 0.9839956164360046
OCT-1 S-protein S-protein 0.9650260806083679
, O O 0.9898189902305603
AP-1 S-protein S-protein 0.9910003542900085
and O O 0.9968137145042419
NF-kappa B-protein B-protein 0.9397358894348145
B E-protein E-protein 0.9935060739517212
which O O 0.9990849494934082
are O O 0.9999518394470215
known O O 0.9998873472213745
to O O 0.999980092048645
be O O 0.999984622001648
transcriptional B-protein B-protein 0.5546737313270569
regulators E-protein E-protein 0.951353907585144
of O O 0.9995437264442444
several O O 0.9952414035797119
cytokine S-protein B-DNA 0.5117916464805603
and O I-DNA 0.5523816347122192
cytokine S-protein I-DNA 0.7823969125747681
receptor O I-DNA 0.9096336364746094
genes O E-DNA 0.989774227142334
, O O 0.9977464079856873
including O O 0.9999862909317017
the O O 0.9998258948326111
IL-2 B-DNA B-DNA 0.6634492874145508
and I-DNA I-DNA 0.8655041456222534
IL-2R I-DNA I-DNA 0.9072728753089905
genes E-DNA E-DNA 0.9962553977966309
. O O 0.9999439716339111
Co-ligation O O 0.9834823608398438
of O O 0.9997362494468689
the O O 0.9999080896377563
A6H S-protein B-protein 0.5647032260894775
antigen O E-protein 0.9645044803619385
and O O 0.9895440340042114
the O O 0.9997091889381409
CD3 B-protein B-protein 0.7188131809234619
complex E-protein E-protein 0.9909532070159912
induced O O 0.9936228394508362
expression O O 0.9950509667396545

cells O E-cell_type 0.5823438167572021
. O O 0.9999148845672607
Two O O 0.9999076128005981
groups O O 0.9945666790008545
of O O 0.9999854564666748
U937 B-cell_line B-cell_line 0.8532297611236572
promonocytic I-cell_line I-cell_line 0.9235869646072388
cells E-cell_line E-cell_line 0.9918642044067383
were O O 0.9996191263198853
obtained O O 0.9999090433120728
by O O 0.9999939203262329
limiting O O 0.9988219141960144
dilution O O 0.989140510559082
cloning O O 0.9983927607536316
which O O 0.9999935626983643
differed O O 0.999769389629364
strikingly O O 0.9997953772544861
in O O 0.9999892711639404
their O O 0.9999754428863525
ability O O 0.9999247789382935
to O O 0.9999866485595703
support O O 0.9999431371688843
human O O 0.8860080242156982
immunodeficiency O O 0.9697917103767395
virus O O 0.9772720336914062
1 O O 0.9822167158126831
( O O 0.9993822574615479
HIV-1 O O 0.9929048418998718
) O O 0.9994568228721619
replication O O 0.9995402097702026
. O O 0.9999985694885254
`` B-cell_line B-cell_line 0.7159943580627441
Plus I-cell_line I-cell_line 0.5043945908546448
'' I-cell_line I-cell_line 0.7411193251609802
clones E-cell_line E-cell_line 0.9966374635696411
replicated O O 0.9993436932563782
the O O 0.9999858140945435
virus O O 0.9235280156135559

mice O O 0.9815523028373718
following O O 0.9999672174453735
LPS O O 0.9839694499969482
injection O O 0.9981484413146973
. O O 0.9999972581863403
Thus O O 0.9987999200820923
antioxidants O O 0.9489927291870117
vary O O 0.9999030828475952
widely O O 0.9999879598617554
in O O 0.9999268054962158
potency O O 0.9634108543395996
as O O 0.9998445510864258
inhibitors O O 0.9740327596664429
of O O 0.9994454979896545
the O O 0.9999517202377319
activation O O 0.9743273854255676
of O O 0.9993915557861328
transcription B-protein B-protein 0.7990046143531799
factors E-protein E-protein 0.9966602325439453
and O O 0.9988742470741272
of O O 0.9999864101409912
the O O 0.9999901056289673
transcription O O 0.7152817249298096
of O O 0.989608108997345
genes S-DNA O 0.45199280977249146
for O O 0.9969571828842163
pro-inflammatory B-protein B-protein 0.5740758776664734
cytokines E-protein E-protein 0.9881753921508789
. O O 0.9999747276306152
Coordinate O O 0.9894104599952698
inhibition O O 0.9982398748397827
of O O 0.9999793767929077
the O O 0.9999669790267944
transcription O O 0.7798683643341064
of O O 0.9941792488098145
genes O O 0.45079582929611206
for O O 0.9983955025672913
inflammatory O B-protein 0.49959930777549744
cytokines S-protein E-protein 0.9860237836837769
could O O 0.9999169111251831
provide O O 0.9999980926513672
a O O 0.9999954700469971
strategy O O 0.9993236064910889
for O O 0.9999885559082031
therapy O O 0.9996931552886963
of O O 0.9999905824661255
diseases O O 0.9948669672012329
with O O 0.9999927282333374
inflammatory O O 0.9500296711921692
pathogenesis O O 0.9940443634986877
and O O 0.99992835521698
for O O 0.999987006187439
septic O O 0.9023808240890503
shock O O 0.958287239074707
. O O 0.9999814033508301
An O O 0.999964714050293
interleukin-4-induced B-protein B-protein 0.44406524300575256
transcription I-protein I-protein 0.7398858070373535
factor E-protein E-protein 0.9962791800498962
: O O 0.9784843325614929
IL-4 B-protein B-protein 0.5392431020736694
Stat E-protein E-protein 0.9962934851646423
. O O 0.9992627501487732
Interleukin-4 S-protein S-protein 0.9684017896652222
( O O 0.9842734336853027
IL-4 S-protein S-protein 0.994125485420227
) O O 0.9827436208724976
is O O 0.9999957084655762
an O O 0.9999815225601196
immunomodulatory O B-protein 0.5907689929008484
cytokine O E-protein 0.9900516867637634
secreted O O 0.9983354210853577
by O O 0.9999711513519287

. O O 0.9989663362503052
When O O 0.9999850988388062
endothelial O B-cell_type 0.6108118891716003
cells O E-cell_type 0.9380584359169006
are O O 0.9995185136795044
incubated O O 0.999862790107727
with O O 0.999997615814209
this O O 0.9999306201934814
lipoprotein O O 0.5282903909683228
in O O 0.9976667165756226
pathophysiologic O O 0.7820945978164673
amounts O O 0.9814961552619934
, O O 0.9999634027481079
the O O 0.9999604225158691
cells O O 0.9693235158920288
are O O 0.9999805688858032
activated O O 0.9906099438667297
. O O 0.9999916553497314
Among O O 0.9999970197677612
the O O 0.9999967813491821
documented O O 0.9657790660858154
cellular O O 0.9343184232711792
responses O O 0.9965155124664307
to O O 0.9999816417694092
LDL S-protein O 0.3374252915382385
is O O 0.9987239241600037
increased O O 0.9997674822807312
recruitment O O 0.9994839429855347
of O O 0.9999849796295166
monocytes S-cell_type S-cell_type 0.9949170351028442
, O O 0.9943234920501709
which O O 0.9997087121009827
are O O 0.9999665021896362
believed O O 0.9999401569366455
to O O 0.9999877214431763
play O O 0.9999823570251465
a O O 0.999994158744812
major O O 0.9996026158332825
role O O 0.9999898672103882
in O O 0.9999946355819702
promoting O O 0.9992159605026245
intimal O O 0.9774157404899597
plaque O O 0.9558937549591064
formation O O 0.9996101260185242
. O O 0.9999997615814209
The O O 0.9999995231628418
findings O O 0.9999017715454102
presented O O 0.9999940395355225
here O O 0.9999974966049194
link O O 0.9999676942825317
an O O 0.9999877214431763
atheogenic B-protein B-protein 0.5389567613601685
lipoprotein E-protein E-protein 0.9850168228149414
, O O 0.9961626529693604
LDL S-protein S-protein 0.9199848771095276
, O O 0.9962798953056335
with O O 0.9999924898147583
the O O 0.9999973773956299
induction O O 0.9961578249931335

mRNA E-RNA E-RNA 0.8058429956436157

which O O 0.9979058504104614
EBNA-2 S-protein S-protein 0.8829643130302429
mediates O O 0.977817714214325
trans-activation O O 0.9434381723403931
. O O 0.9998843669891357
To O O 0.9999864101409912
determine O O 0.9999953508377075
whether O O 0.999994158744812
EBNA-2 S-protein S-protein 0.9520235657691956
also O O 0.9979379773139954
trans-activates O O 0.9976049661636353
the O O 0.9999215602874756
LMP B-DNA B-DNA 0.6873871684074402
promoter E-DNA E-DNA 0.9929893016815186
by O O 0.9998522996902466
protein-protein O O 0.6695464253425598
interactions O O 0.8913338780403137
, O O 0.9999624490737915
we O O 0.9999830722808838
performed O O 0.9999752044677734
a O O 0.9999982118606567
series O O 0.9899579882621765
of O O 0.9999561309814453
gel O O 0.6339606642723083
retardation O O 0.8728749752044678
assays O O 0.9956896901130676

sites E-DNA O 0.7572605013847351
showed O O 0.9999780654907227
either O O 0.9999935626983643
no O O 0.99937504529953
or O O 0.9994487166404724
only O O 0.999866247177124
weak O O 0.9768614172935486
activity O O 0.996887743473053
compared O O 0.9999861717224121
to O O 0.9999619722366333
Jurkat B-cell_line B-cell_line 0.8045937418937683
T I-cell_line I-cell_line 0.7635159492492676
cells E-cell_line E-cell_line 0.9955624341964722
. O O 0.9999481439590454
An O O 0.9999885559082031
IL-2 B-DNA B-DNA 0.49593085050582886
promoter E-DNA E-DNA 0.9899448752403259
bearing O O 0.9985378980636597
a O O 0.999941349029541
defective O O 0.6821292042732239
NF-chi B-DNA B-DNA 0.8023557066917419
B I-DNA I-DNA 0.7410276532173157
site E-DNA E-DNA 0.9907459020614624
was O O 0.9997460246086121
completely O O 0.9972556233406067
inactive O O 0.9995608925819397
in O O 0.9999791383743286
EBV-transformed B-cell_line B-cell_line 0.6766910552978516
B I-cell_line I-cell_line 0.6554784178733826
cells E-cell_line E-cell_line 0.8246026039123535
, O O 0.9902653098106384
while O O 0.9999850988388062
it O O 0.9996832609176636
still O O 0.9996947050094604
had O O 0.9999556541442871
activity O O 0.9996102452278137
in O O 0.9999918937683105
Jurkat B-cell_line B-cell_line 0.6574791669845581
T I-cell_line I-cell_line 0.709770143032074
cells E-cell_line E-cell_line 0.9935291409492493
. O O 0.9999297857284546
In O O 0.999956488609314
seven O O 0.9996507167816162

human I-DNA B-DNA 0.5175560712814331
cDNA E-DNA E-DNA 0.9180925488471985
that O O 0.9867951273918152
potentially O O 0.9999486207962036
encodes O O 0.9999352693557739
the O O 0.9998804330825806
65-kD B-protein B-protein 0.8978515267372131
subunit E-protein E-protein 0.9817909002304077
of O O 0.9985445737838745
NF-kappa B-protein B-protein 0.8422646522521973
B E-protein E-protein 0.9961548447608948
[ O O 0.9957044720649719
published O O 0.9489141702651978
erratum O O 0.8338263034820557
appears O O 0.9997127652168274
in O O 0.9999916553497314
Science O O 0.9957601428031921
1991 O O 0.9998013377189636
Oct O O 0.9994990825653076
4 O O 0.9996787309646606
; O O 0.9999828338623047
254 O O 0.9974111914634705
( O O 0.9999376535415649
5028 O O 0.9967144727706909
) O O 0.9998440742492676
: O O 0.9998480081558228
11 O O 0.9973853230476379
] O O 0.999789297580719
A O O 0.9991447925567627

work O O 0.9902722239494324
towards O O 0.9999287128448486
redefining O O 0.9924927353858948
the O O 0.9998914003372192
identity O O 0.9925918579101562
and O O 0.9997944235801697
the O O 0.9999959468841553
differentiative O O 0.9710860252380371
fate O O 0.9965824484825134
of O O 0.9999891519546509
these O O 0.9999295473098755
primitive B-cell_type B-cell_type 0.5532987117767334
cells E-cell_type E-cell_type 0.8655229806900024
. O O 0.9999103546142578
Molecular O O 0.9441673755645752
cues O O 0.8978824019432068
delivered O O 0.9995477795600891
by O O 0.999984860420227
the O O 0.999940037727356
microenvironment O O 0.7949234247207642
frequently O O 0.9980827569961548
act O O 0.9999170303344727
in O O 0.9999829530715942
an O O 0.9999833106994629
instructive O O 0.9855512380599976
fashion O O 0.9989271759986877
by O O 0.9999963045120239
initiating O O 0.9992152452468872
intracellular O O 0.954176127910614
signaling O O 0.9833434820175171
pathways O O 0.999099612236023
that O O 0.9999970197677612
ultimately O O 0.9999884366989136
target O O 0.9999743700027466
a O O 0.9999948740005493
select O O 0.9730175137519836
group O O 0.9793420433998108

demonstrate O O 0.9973860383033752

IL-5 B-DNA B-DNA 0.7804082036018372
gene E-DNA E-DNA 0.9861876964569092
. O O 0.9998981952667236
Selective O O 0.9976205229759216
regulation O O 0.9998430013656616
of O O 0.9999971389770508
IL-5 S-protein B-DNA 0.6537134647369385
gene O E-DNA 0.9465570449829102
transcription O O 0.982669472694397
may O O 0.9999822378158569
be O O 0.9999980926513672
useful O O 0.99991774559021
for O O 0.9999908208847046
treating O O 0.9972119927406311
eosinophlic O O 0.7084811329841614
inflammation O O 0.9952868223190308
. O O 0.9999977350234985
Defining O O 0.9871653318405151
therapeutic O O 0.9683094620704651
targets O O 0.9487120509147644
by O O 0.9999899864196777
using O O 0.9990873336791992
adenovirus O O 0.8551415801048279
: O O 0.9842244386672974
blocking O O 0.961725115776062
NF-kappaB S-protein S-protein 0.9180812239646912
inhibits O O 0.999924898147583
both O O 0.9999734163284302
inflammatory O O 0.7640281915664673

to O O 0.994802713394165
25-fold O O 0.9827205538749695
increase O O 0.9999380111694336
in O O 0.9999924898147583
the O O 0.9999943971633911
nuclear O O 0.8940361738204956
level O O 0.9868823885917664
of O O 0.9999098777770996
the O O 0.9999892711639404
DNA B-protein B-protein 0.6296077966690063
polymerase-associated I-protein I-protein 0.5428382158279419
processivity I-protein I-protein 0.6156875491142273
factor I-protein E-protein 0.94528728723526
PCNA E-protein S-protein 0.7706353664398193
and O O 0.9768244624137878
of O O 0.9992744326591492
the O O 0.9999563694000244
proliferation-specific B-protein B-protein 0.5884919166564941
transcription I-protein I-protein 0.58721524477005
factor I-protein E-protein 0.9242190718650818
E2F1 E-protein S-protein 0.7122172117233276
. O O 0.9997465014457703
In O O 0.9998884201049805
contrast O O 0.9997245669364929
, O O 0.9999693632125854
induction O O 0.9942571520805359
of O O 0.9996600151062012
differentiation O O 0.9732163548469543
but O O 0.9981213212013245
not O O 0.9985507130622864
of O O 0.9996933937072754
proliferation O O 0.9940459728240967
was O O 0.9999808073043823
followed O O 0.9999853372573853
by O O 0.9999984502792358
a O O 0.9999967813491821
25- O O 0.9184287786483765
to O O 0.992116391658783
30-fold O O 0.9931043982505798
increase O O 0.9998792409896851
in O O 0.9999887943267822
the O O 0.9999829530715942
nuclear O O 0.8727836012840271
level O O 0.9788573980331421
of O O 0.999815046787262
the O O 0.9999667406082153
tumor B-protein B-protein 0.6172271966934204
suppressor I-protein I-protein 0.7509104013442993
proteins I-protein E-protein 0.983038067817688
p53 E-protein B-protein 0.731830894947052
( O I-protein 0.8238931894302368
wild O I-protein 0.4786006510257721
type O I-protein 0.587349534034729
) O E-protein 0.7368298172950745
, O O 0.8197855353355408
pRb S-protein S-protein 0.9805079102516174
, O O 0.9718234539031982
and O O 0.9835258722305298
p130/Rb2 S-protein S-protein 0.9882683753967285
and O O 0.9862564206123352
of O O 0.9991260170936584

. O O 0.9992648959159851
In O O 0.9999935626983643
this O O 0.9999994039535522
study O O 0.9998024106025696
, O O 0.9999969005584717
we O O 0.9999072551727295
cloned O O 0.9989872574806213
two O O 0.9886524081230164
cDNAs S-DNA S-DNA 0.9642501473426819
encoding O O 0.983242928981781
proteins O O 0.8330826163291931
which O O 0.9997038245201111
bind O O 0.9996776580810547
to O O 0.9999774694442749
an O O 0.9999198913574219
oligonucleotide O O 0.45132070779800415
in O O 0.9919984936714172
silencer B-DNA O 0.6929337978363037
I E-DNA O 0.5941761136054993
containing O O 0.8205605149269104
a O O 0.9795020222663879

. O O 0.999321699142456
In O O 0.9997578263282776
6 O O 0.9513797163963318
of O O 0.9998558759689331
14 O O 0.9978394508361816
patients O O 0.9994978904724121
, O O 0.9999765157699585
T B-cell_type B-cell_type 0.5158987045288086
lymphocytes E-cell_type E-cell_type 0.9875191450119019
displayed O O 0.9998859167098999
an O O 0.9999933242797852
impaired O O 0.9928910732269287
ability O O 0.9997679591178894
to O O 0.9999901056289673
translocate O O 0.9961750507354736
NFeB B-protein B-protein 0.5606892704963684
p65 E-protein E-protein 0.9816396832466125
( O O 0.9779290556907654
Rel-A S-protein S-protein 0.9862014651298523
) O O 0.9748091697692871
following O O 0.999983549118042
activation O O 0.9995195865631104
by O O 0.999998927116394
anti-CD3 O B-protein 0.4784051775932312

basis O O 0.8012386560440063

2 I-DNA I-DNA 0.4698287844657898
( I-DNA I-DNA 0.5742945075035095
Il-2 I-DNA I-DNA 0.9192345142364502
) I-DNA I-DNA 0.5862501859664917
genes E-DNA E-DNA 0.9965043067932129
contain O O 0.9999632835388184
the O O 0.999971866607666
kB-like B-DNA B-DNA 0.9141860008239746
sequence E-DNA E-DNA 0.9773578643798828
GGGATTTCACC O S-DNA 0.630685031414032
as O O 0.9999103546142578
an O O 0.9999905824661255
essential B-DNA O 0.9624887108802795
cis-acting I-DNA B-DNA 0.6850048899650574
enhancer I-DNA I-DNA 0.6076791882514954
motif E-DNA E-DNA 0.9852449297904968
. O O 0.9998970031738281
When O O 0.9999861717224121
cloned O O 0.8618639707565308
in O O 0.9987730383872986
multiple O O 0.8682430982589722
copies O O 0.9655367136001587
this O O 0.9999849796295166
so-called O O 0.9949069619178772
TCEd S-DNA B-DNA 0.6815984845161438
( O I-DNA 0.934825599193573
distal B-DNA I-DNA 0.6857482194900513
T I-DNA I-DNA 0.5532702803611755
cell I-DNA I-DNA 0.5722601413726807
element E-DNA E-DNA 0.8573422431945801
) O O 0.8879817128181458
acts O O 0.9951936602592468
as O O 0.9999936819076538

; O O 0.9818629622459412
SH O O 0.9536600112915039
, O O 0.9992455244064331
0.6 O O 0.9990577101707458
+/- O O 0.9999822378158569
0.4 O O 0.999736487865448
( O O 0.9999724626541138
0.2-1.2 O O 0.999392032623291
) O O 0.99969482421875
x O O 0.9992088675498962
10 O O 0.9990763664245605
( O O 0.9999673366546631
-10 O O 0.9992101192474365
) O O 0.9997510313987732
M O O 0.9973738193511963
; O O 0.9998846054077148
RT O O 0.9751395583152771
, O O 0.9997162222862244

induction O O 0.9702633619308472
of O O 0.9997766613960266
NF-AT S-protein S-protein 0.9841841459274292
, O O 0.9901049733161926
AP-1 S-protein S-protein 0.9809399247169495
, O O 0.9870004653930664
and O O 0.9972918629646301
NF-kappaB S-protein S-protein 0.9978850483894348
as O O 0.9992166757583618
well O O 0.9992921352386475
as O O 0.9999879598617554
IL-2 S-protein S-protein 0.9233198165893555
production O O 0.9933034777641296
. O O 0.9999948740005493
Using O O 0.9999467134475708
selective O O 0.924856960773468
inhibitors O O 0.9260780215263367
, O O 0.9999659061431885
we O O 0.99996018409729
investigated O O 0.9999914169311523
the O O 0.9999967813491821
signaling O O 0.9571182131767273

different O O 0.9754002690315247
hIL-5-responsive B-cell_line B-cell_line 0.7569882869720459
cell I-cell_line I-cell_line 0.7907790541648865
lines E-cell_line E-cell_line 0.9996945858001709
, O O 0.9993937015533447
hIL-5 B-cell_line B-protein 0.27305519580841064
receptor I-cell_line I-protein 0.5723695755004883
alpha-subunit I-cell_line E-protein 0.5077027678489685

identify O O 0.9995051622390747
a O O 0.9999672174453735
cDNA O S-DNA 0.9082821607589722
encoding O O 0.9888004064559937
a O O 0.9999127388000488
novel O O 0.8836291432380676
component O O 0.7023199200630188
of O O 0.9983841180801392
the O O 0.999855637550354
NB O S-protein 0.9081401824951172
, O O 0.9893954396247864
a O O 0.9991655349731445
140-kDa B-protein B-protein 0.9425133466720581
protein E-protein E-protein 0.9682656526565552
designated O O 0.9492629170417786
Sp140 S-protein S-protein 0.9478987455368042
. O O 0.9997904896736145
The O O 0.9999966621398926
predicted O O 0.9934053421020508
amino O B-protein 0.8915976285934448
acid O I-protein 0.6826134324073792
sequence O E-protein 0.9139268398284912
of O O 0.9995484948158264
the O O 0.9999897480010986
amino-terminal B-protein B-protein 0.8340996503829956
portion E-protein E-protein 0.885420560836792
of O O 0.9774295091629028
Sp140 S-protein S-protein 0.8576074242591858
was O O 0.9997923970222473
similar O O 0.9999078512191772

The O O 0.9993647933006287
two O O 0.996452808380127
most O O 0.9927433729171753
active O O 0.9892446994781494
NFAT-like B-DNA B-DNA 0.597500205039978
elements E-DNA E-DNA 0.993624210357666
were O O 0.9997239708900452
located O O 0.9993801116943359
at O O 0.9999115467071533
the O O 0.9999608993530273
center O O 0.9633933901786804
of O O 0.9987602233886719
the O O 0.9998019337654114
DNase B-DNA B-DNA 0.8514149785041809
I-hypersensitive I-DNA I-DNA 0.9789490103721619
site E-DNA E-DNA 0.9933405518531799
. O O 0.9997912049293518
One O O 0.9999966621398926
of O O 0.999996542930603
these O O 0.9999309778213501
NFAT-like B-DNA B-DNA 0.8361242413520813
elements E-DNA E-DNA 0.993225634098053
encompassed O O 0.9997010827064514
overlapping O O 0.6681891679763794
Oct- B-DNA B-DNA 0.38209670782089233
and I-DNA I-DNA 0.748258113861084
NFATp/c-binding I-DNA I-DNA 0.9200820326805115
sites E-DNA E-DNA 0.9869349002838135
, O O 0.9964532852172852
which O O 0.9999167919158936
functioned O O 0.9997828602790833

by O O 0.9994487166404724
using O O 0.9999446868896484
a O O 0.9999724626541138
radioligand O O 0.8630353808403015
binding O O 0.9260542988777161
assay O O 0.9935815334320068
and O O 0.9997959733009338
Scatchard O O 0.9049109816551208
analysis O O 0.9979244470596313
. O O 0.9999957084655762
RESULTS O O 0.9839892983436584
: O O 0.9998698234558105
Dose-dependent O O 0.9563989639282227
inhibition O O 0.996095597743988
was O O 0.9999902248382568
demonstrated O O 0.9999635219573975
for O O 0.9999947547912598
all O O 0.9998216032981873
glucocorticoids O O 0.8891964554786682
in O O 0.9998859167098999
both O O 0.9999555349349976
patient O O 0.9435750842094421
groups O O 0.9803540110588074
, O O 0.9999251365661621
with O O 0.9999945163726807
the O O 0.9999910593032837
steroid-resistant O O 0.6838350296020508
group O O 0.6853988766670227
requiring O O 0.9997565150260925
approximately O O 0.9994032382965088
2 O O 0.980627715587616
log-fold O O 0.9556331634521484
more O O 0.9984412789344788

2D3 O O 0.4639892280101776
degradation O O 0.9829022884368896
through O O 0.999975323677063
enhancement O O 0.9912025928497314
of O O 0.9998811483383179
24-hydroxylase S-protein B-RNA 0.7937787175178528
mRNA O E-RNA 0.9894793629646301
levels O O 0.9946762323379517
and O O 0.9999313354492188
activity O O 0.9981036186218262
. O O 0.9999985694885254
The O O 0.9999958276748657

gamma-IFN S-protein S-protein 0.785894513130188
inducible O O 0.9178866147994995
DNA O O 0.8150019645690918
binding O O 0.8883254528045654
activity O O 0.9926843047142029
to O O 0.9999667406082153
three O O 0.9974512457847595
potential O O 0.9650851488113403
STATI B-DNA B-DNA 0.8670477271080017
DNA I-DNA I-DNA 0.5270190238952637

data O O 0.9827415347099304
show O O 0.9999969005584717
that O O 0.9999996423721313
neither O O 0.999887228012085
NF-kappa B-protein B-protein 0.8454113006591797
B E-protein E-protein 0.9979019165039062
nor O O 0.998986542224884
AP-1 S-protein S-protein 0.9661263823509216
activation O O 0.9931168556213379
is O O 0.9999723434448242
required O O 0.999956488609314
for O O 0.9999840259552002
IL-2 S-protein S-protein 0.999038577079773
-mediated O O 0.9952558875083923
survival O O 0.9886088371276855
or O O 0.9995137453079224
cell O O 0.9274739623069763
cycle O O 0.9489040374755859
progression O O 0.9979084730148315
in O O 0.9999812841415405
activated O O 0.6071029305458069
primary B-cell_type B-cell_type 0.42308223247528076
human I-cell_type I-cell_type 0.6144024729728699
T I-cell_type I-cell_type 0.8763786554336548
cells E-cell_type E-cell_type 0.957449734210968
. O O 0.9998003840446472
Estrone O O 0.6199581623077393
potentiates O O 0.9887403845787048
myeloid O O 0.48882001638412476
cell O O 0.7127493619918823
differentiation O O 0.9607191681861877
: O O 0.9997168183326721
a O O 0.9999942779541016
role O O 0.9932706952095032
for O O 0.9998636245727539
17 B-protein O 0.9435861110687256
beta-hydroxysteroid I-protein O 0.8508581519126892
dehydrogenase E-protein O 0.817625105381012
in O O 0.9994632601737976
modulating O O 0.8028609752655029
hemopoiesis O O 0.8416973948478699
. O O 0.9998301267623901
Hormones O O 0.9457274079322815
such O O 0.9997746348381042
as O O 0.9999709129333496
1 O O 0.9787065386772156
alpha O O 0.8794634938240051
, O O 0.9987804293632507
25-dihydroxy O O 0.9367877244949341
vitamin O O 0.9729188084602356
D3 O O 0.96625816822052
( O O 0.9979889392852783
D3 O O 0.9698709845542908
) O O 0.9972034692764282
, O O 0.9999316930770874

activation O O 0.9863060712814331
of O O 0.9998949766159058
NF-kappa B-protein B-protein 0.899499773979187
B E-protein E-protein 0.997337281703949
in O O 0.9997777342796326
PBL S-cell_type S-cell_type 0.8194090127944946
, O O 0.9644140005111694
HM O S-protein 0.5926601886749268
and O O 0.9842405915260315
HF S-cell_type S-protein 0.506923258304596
. O O 0.9995508790016174
These O O 0.9999958276748657
results O O 0.9999327659606934
appear O O 0.9999909400939941
to O O 0.9999959468841553
indicate O O 0.9999990463256836
that O O 0.9999939203262329
suppression O O 0.9982839226722717

recognized O O 0.9714647531509399
peptides O O 0.9202126860618591
by O O 0.999988317489624
patients O O 0.9891078472137451
' O O 0.9952183365821838
PBMC S-cell_type S-cell_type 0.9976645708084106
before O O 0.9998801946640015
RAI O O 0.9571996927261353
and O O 0.9993770718574524
surgery O O 0.9978128671646118
may O O 0.9999939203262329
reflect O O 0.9999991655349731
the O O 0.9999994039535522
effect O O 0.9999960660934448
of O O 0.9999971389770508
long O O 0.9532334804534912
term O O 0.978465735912323
therapy O O 0.9996163845062256
with O O 0.9999982118606567
ATD O O 0.9508134722709656
in O O 0.9999881982803345
the O O 0.9999947547912598
patients O O 0.9991924166679382

are O O 0.9987473487854004
present O O 0.9998447895050049
in O O 0.999901533126831
VCAM-1 B-DNA S-protein 0.7729201912879944
and I-DNA O 0.9829696416854858
intercellular I-DNA B-DNA 0.7954089045524597
adhesion I-DNA I-DNA 0.7186850905418396
molecule-1 I-DNA I-DNA 0.8316827416419983
( I-DNA I-DNA 0.6089415550231934
ICAM-1 I-DNA I-DNA 0.6489777565002441
) I-DNA I-DNA 0.7950488328933716
promoters E-DNA E-DNA 0.9934794902801514
, O O 0.9990631937980652
we O O 0.999909520149231
used O O 0.9999582767486572
PDTC O O 0.8776019215583801
to O O 0.9998292922973633
study O O 0.9999923706054688
the O O 0.9999938011169434
regulatory O O 0.9482343196868896
mechanisms O O 0.9984534978866577
of O O 0.9999955892562866
VCAM-1 S-protein S-protein 0.8407115340232849
and O O 0.9908106327056885
ICAM-1 S-protein S-protein 0.9604930281639099
induction O O 0.9980190992355347
and O O 0.9999768733978271
subsequent O O 0.9930340051651001
monocyte S-cell_type O 0.8701804280281067
adhesion O O 0.9887834191322327
in O O 0.9999744892120361
TNF-treated B-cell_line B-cell_line 0.6694402098655701
human I-cell_line I-cell_line 0.789387047290802

ATGCAAAT O S-DNA 0.5966557264328003
is O O 0.9998518228530884
a O O 0.9999974966049194
critical O O 0.9931690692901611
determinant O O 0.9969289898872375
of O O 0.9999911785125732
the O O 0.9999983310699463
lymphoid-specific O O 0.6601179838180542
expression O O 0.9411337971687317
of O O 0.9992319345474243
immunoglobulin B-DNA B-DNA 0.7638133764266968
genes E-DNA E-DNA 0.9984042048454285
. O O 0.9999806880950928
Ectopic O O 0.9826276898384094
expression O O 0.9982420206069946
of O O 0.9999798536300659
cloned B-DNA O 0.44203245639801025
Oct2 I-DNA B-DNA 0.46267715096473694
cDNA E-DNA E-DNA 0.9958399534225464
was O O 0.9997265934944153
shown O O 0.9999849796295166
to O O 0.9999945163726807
be O O 0.9999881982803345
sufficient O O 0.9999408721923828
to O O 0.9999849796295166
reconstitute O O 0.9999393224716187
at O O 0.9999817609786987
least O O 0.999925971031189
some O O 0.9999967813491821
aspects O O 0.9998688697814941
of O O 0.9999966621398926
this O O 0.9999978542327881

primary O O 0.4664902091026306
tumor O O 0.6286002397537231
and O O 0.9928280711174011
a O O 0.9999768733978271
positive O O 0.9737576842308044
reaction O O 0.9981610178947449
with O O 0.9999938011169434
the O O 0.9999642372131348
isolated O B-cell_type 0.7816454768180847
tumor B-cell_type I-cell_type 0.5154787302017212
cells E-cell_type E-cell_type 0.9345995187759399
from O O 0.999954342842102
the O O 0.9999961853027344
pleural O O 0.8874288201332092
effusions O O 0.9937410950660706
. O O 0.999998927116394
These O O 0.9999990463256836
results O O 0.9999628067016602
indicate O O 0.9999984502792358
that O O 0.9999978542327881
the O O 0.9999895095825195
demonstration O O 0.9992503523826599
of O O 0.9999927282333374
hormone B-protein B-protein 0.6349290609359741
receptor I-protein I-protein 0.6092562079429626
proteins E-protein E-protein 0.9938598871231079
in O O 0.9989826083183289
cells O O 0.9496753811836243
from O O 0.9999179840087891
malignant O O 0.5809300541877747

a O O 0.9964210987091064
non-fusion B-protein B-protein 0.48447152972221375
protein E-protein E-protein 0.9866090416908264
. O O 0.9998132586479187
The O O 0.9999958276748657
protein O O 0.9113098382949829
from O O 0.9995827078819275
E. O O 0.8014169335365295
coli O O 0.8569256663322449
specifically O O 0.998923122882843
converted O O 0.9982889294624329
dUTP O S-protein 0.7059758901596069
to O O 0.9887626767158508
dUMP O O 0.3744848072528839
and O O 0.8184765577316284
did O O 0.9904740452766418
not O O 0.99934321641922
react O O 0.9999709129333496
with O O 0.9999943971633911
other O O 0.9999074935913086
dNTPs O S-protein 0.5066049695014954
or O O 0.9952488541603088
NTPs O O 0.41430482268333435

-183/-166 O O 0.9184833765029907
NXS O O 0.897513747215271
) O O 0.9970335960388184
were O O 0.9999915361404419
not O O 0.9998965263366699
predicted O O 0.9999897480010986
by O O 0.9999991655349731
their O O 0.9999871253967285
effects O O 0.9998635053634644
in O O 0.999985933303833
transfection O O 0.9912200570106506
. O O 0.9999901056289673
In O O 0.9999618530273438
addition O O 0.999975323677063
, O O 0.999996542930603
we O O 0.9998096823692322

Two O O 0.9930676221847534
chronically B-cell_line B-cell_line 0.5875511765480042
HIV-1-infected I-cell_line I-cell_line 0.5966535210609436
cell I-cell_line I-cell_line 0.881988525390625
lines E-cell_line E-cell_line 0.9989898800849915
, O O 0.9984809756278992
U1 S-cell_line S-cell_line 0.9870784282684326
( O O 0.9793785214424133
monocytic O S-cell_line 0.8399903178215027
) O O 0.37321409583091736
and O O 0.9892295002937317
ACH-2 S-cell_line S-cell_line 0.9775240421295166
( O O 0.9481335878372192
T O B-cell_type 0.8951528668403625
lymphocytic O E-cell_type 0.6476308107376099
) O O 0.40692391991615295
, O O 0.976253867149353

. O O 0.9992883801460266
The O O 0.9999581575393677
T B-protein B-protein 0.43134820461273193
cell I-protein I-protein 0.5786280632019043
surface I-protein I-protein 0.8297938704490662
molecule E-protein E-protein 0.9767558574676514
CD28 S-protein S-protein 0.9375898838043213
binds O O 0.9988147020339966
to O O 0.9997767806053162
ligands O O 0.8543398976325989
on O O 0.9996287822723389
accessory B-cell_type B-cell_type 0.5838949680328369
cells E-cell_type E-cell_type 0.9807987809181213
and O O 0.9946107864379883
APCs S-cell_type S-cell_type 0.992715060710907
, O O 0.9969989061355591
playing O O 0.9995707869529724
an O O 0.9999897480010986
important O O 0.9984024167060852
costimulatory O O 0.9055103659629822
role O O 0.9896529316902161

cells E-cell_line E-cell_type 0.5692815184593201
increased O O 0.9995852112770081
rapidly O O 0.9997397065162659
( O O 0.9998531341552734
within O O 0.9999849796295166
5 O O 0.9995666146278381
h O O 0.9961254000663757
) O O 0.9996294975280762
, O O 0.999944806098938
and O O 0.999990701675415
the O O 0.9999973773956299
level O O 0.9992932081222534
of O O 0.9996261596679688
GATA-1 B-RNA B-RNA 0.9900240302085876
mRNA E-RNA E-RNA 0.9989812970161438
increased O O 0.9995176792144775
. O O 0.9999963045120239
In O O 0.9995402097702026

kinase I-protein E-protein 0.9331799149513245

in O O 0.9983307719230652
PHA S-protein S-protein 0.9897232055664062
-induced O O 0.9943654537200928
proliferation O O 0.9983921647071838
of O O 0.9999812841415405
PBMCs S-cell_type S-cell_type 0.9867796897888184
depended O O 0.9998714923858643
upon O O 0.9999877214431763
the O O 0.9999933242797852
tumour O O 0.8841873407363892
burden O O 0.9955847859382629
as O O 0.9999967813491821

, O O 0.9959278702735901
we O O 0.9999920129776001
demonstrate O O 0.9999974966049194
that O O 0.9999963045120239
NK B-cell_line B-cell_type 0.7473940253257751
cells E-cell_line E-cell_type 0.9560061693191528
induce O O 0.999816358089447
HLA-DR S-protein S-protein 0.7809930443763733
on O O 0.9992715716362
the O O 0.9999923706054688
surface O O 0.9978833794593811
of O O 0.9999781847000122
a O O 0.999929666519165
mutant B-cell_line B-cell_line 0.6937762498855591
cell I-cell_line I-cell_line 0.8218302726745605
line E-cell_line E-cell_line 0.9929566383361816
that O O 0.9992730021476746
is O O 0.9999850988388062
defective O O 0.9973108768463135
in O O 0.9999693632125854
IFN-gamma S-protein S-protein 0.9961554408073425
-induced O O 0.9988446235656738
MHC B-protein B-protein 0.3363698720932007
class I-protein I-protein 0.4117695987224579
II E-protein E-protein 0.8828898072242737
expression O O 0.9830520153045654
. O O 0.9999604225158691
RNA O O 0.4775558114051819
analysis O O 0.9592248201370239
in O O 0.9999691247940063
these O O 0.999663233757019
cells O O 0.9791907668113708
and O O 0.9997879862785339
in O O 0.9998273849487305
a O O 0.9996521472930908
cell O O 0.7343502640724182
line O O 0.8788065910339355
that O O 0.9980119466781616
is O O 0.9999786615371704
defective O O 0.992752194404602
in O O 0.9998492002487183
class B-protein B-cell_line 0.5168871879577637
II I-protein I-cell_line 0.8220357894897461

negative O O 0.7480902671813965
regulatory O O 0.6762045621871948
effect O O 0.9931498169898987
of O O 0.9999849796295166
the O O 0.9999914169311523
beta B-DNA B-DNA 0.5895673036575317
globin I-DNA I-DNA 0.8537273406982422
gene I-DNA I-DNA 0.9554541110992432
upstream I-DNA I-DNA 0.42477983236312866
element E-DNA E-DNA 0.9966461062431335
( O O 0.9939751029014587
s O O 0.49115562438964844
) O O 0.8402456641197205
. O O 0.9998596906661987
Fusion O O 0.682420551776886
of O O 0.9969683289527893
the O O 0.9998049139976501
upstream B-DNA B-DNA 0.9210104942321777
portion E-DNA E-DNA 0.9801172614097595
of O O 0.9973036050796509
the O O 0.9998290538787842
delta B-DNA B-DNA 0.9090621471405029
promoter E-DNA E-DNA 0.9935292601585388
to O O 0.9995601773262024
the O O 0.9999558925628662
truncated O B-DNA 0.705005407333374
beta B-DNA I-DNA 0.42098814249038696
globin I-DNA I-DNA 0.8370173573493958
promoter E-DNA E-DNA 0.9866726398468018
yielded O O 0.9996299743652344
a O O 0.9999555349349976
modest O O 0.987224817276001
increase O O 0.9997721314430237
in O O 0.9997308850288391
promoter O O 0.6969140768051147
strength O O 0.8731582760810852
relative O O 0.9985575079917908
to O O 0.9999946355819702
the O O 0.9999889135360718
truncated B-DNA B-DNA 0.6251921057701111
beta I-DNA I-DNA 0.628410279750824
gene I-DNA I-DNA 0.5505512356758118
promoter E-DNA E-DNA 0.9908614158630371
, O O 0.9915245175361633

IL-2 S-protein S-protein 0.9643669724464417
, O O 0.986348032951355
IL-4 S-protein S-protein 0.994729220867157
, O O 0.9908561706542969
IL-7 S-protein S-protein 0.998256504535675
, O O 0.9918985366821289
IL-13 S-protein S-protein 0.9987351298332214
, O O 0.9888736009597778
and O O 0.9960318207740784
IL-15 S-protein S-protein 0.9988189339637756
. O O 0.9999125003814697
To O O 0.9999809265136719
understand O O 0.9999890327453613
the O O 0.9999958276748657
molecular O O 0.8768011331558228
bases O O 0.6381106376647949
for O O 0.9999526739120483
cytokine O S-protein 0.8489846587181091
redundancy O O 0.9938850998878479
and O O 0.9998571872711182
pleiotropy O O 0.9371793270111084
, O O 0.9998881816864014
we O O 0.9999864101409912
have O O 0.9999985694885254
compared O O 0.99998939037323
the O O 0.9999767541885376
Stat B-protein B-protein 0.8146997094154358
proteins E-protein E-protein 0.9976229071617126
activated O O 0.9971494078636169
in O O 0.9999239444732666

has O O 0.9860242009162903
been O O 0.9998730421066284
called O O 0.9993840456008911
anergy O O 0.9824367761611938
. O O 0.9999707937240601
During O O 0.9999874830245972
the O O 0.9999973773956299
induction O O 0.9981383085250854
of O O 0.9999240636825562
anergy O O 0.7449123859405518
, O O 0.9910134673118591
T B-cell_type B-cell_type 0.8129664659500122
cells E-cell_type E-cell_type 0.9883562922477722
are O O 0.9997439980506897
phenotypically O O 0.9663025736808777
similar O O 0.998193085193634
to O O 0.9998544454574585
cells O O 0.973003089427948
responding O O 0.9999358654022217
to O O 0.9999955892562866
an O O 0.9999775886535645
immunogenic O O 0.9307094216346741
stimulus O O 0.9884178042411804
. O O 0.9999949932098389

proliferation O O 0.9846715331077576
in O O 0.9999837875366211
these O O 0.9999216794967651
cell B-cell_line B-cell_line 0.6915206909179688
lines E-cell_line E-cell_line 0.9895402789115906
. O O 0.999900221824646
Tissue-specific O O 0.9173698425292969
activity O O 0.9966260194778442
of O O 0.9999871253967285
the O O 0.9999892711639404
gammac B-DNA B-DNA 0.41342970728874207
chain I-DNA I-DNA 0.3183755874633789
gene I-DNA I-DNA 0.47368323802948
promoter E-DNA E-DNA 0.990990400314331
depends O O 0.9999052286148071
upon O O 0.9999934434890747
an O O 0.9999492168426514
Ets B-DNA B-DNA 0.8397256135940552
binding I-DNA I-DNA 0.9468321204185486
site E-DNA E-DNA 0.9706867337226868
and O O 0.9947094917297363
is O O 0.999916672706604
regulated O O 0.9996789693832397
by O O 0.999984622001648
GA-binding B-protein B-protein 0.8368744850158691
protein E-protein E-protein 0.9782667756080627
. O O 0.9989320635795593

) O O 0.676188588142395
mol/L O O 0.4195903539657593
for O O 0.9878888726234436
hydrocortisone O O 0.904800295829773
, O O 0.9992652535438538
whereas O O 0.999998927116394
the O O 0.9999961853027344
mean O O 0.9741140007972717
IC50s O O 0.3640345335006714
for O O 0.9997290968894958
the O O 0.9999901056289673
steroid-resistant O O 0.7425423860549927
group O O 0.7451549172401428
ranged O O 0.9999219179153442
from O O 0.9999711513519287
approximately O O 0.998955488204956
2 O O 0.9717789888381958
x O O 0.9924305081367493
10 O O 0.9964955449104309
( O O 0.9998663663864136
-8 O O 0.9974007606506348
) O O 0.9994553923606873
mol/L O O 0.9769161343574524
for O O 0.9999363422393799
budesonide O O 0.9533767700195312
to O O 0.9984727501869202
greater O O 0.9998252987861633
than O O 0.9999815225601196
10 O O 0.957037627696991

NF-IL6 S-protein S-protein 0.8142495155334473
. O O 0.9998817443847656
Neither O O 0.9998621940612793
IL-10 S-protein S-protein 0.9928705096244812
nor O O 0.998701810836792
IL-4 S-protein S-protein 0.9825191497802734
inhibited O O 0.9997126460075378
LPS-induced O O 0.9618741273880005
NF-kappa B-protein B-protein 0.5574677586555481
B E-protein E-protein 0.9979391694068909
binding O O 0.9889808893203735
activity O O 0.9996296167373657
. O O 0.9999991655349731
In O O 0.9999765157699585
agreement O O 0.9997020363807678
with O O 0.9999995231628418
this O O 0.9999978542327881
finding O O 0.9994105100631714
, O O 0.9999961853027344
Northern O O 0.9856756925582886
experiments O O 0.9996997117996216
where O O 0.9999972581863403
p65 O S-protein 0.5664024949073792
and O O 0.6247122287750244
p105 O B-RNA 0.38641417026519775
mRNA O E-RNA 0.9676743149757385
levels O O 0.9984309077262878
were O O 0.9999933242797852
determined O O 0.999976634979248
, O O 0.9999896287918091
demonstrated O O 0.9999653100967407
that O O 0.9999967813491821
expression O O 0.9998800754547119
of O O 0.9999985694885254
these O O 0.9999828338623047
components O O 0.9867779016494751
of O O 0.9997895359992981
the O O 0.9999276399612427

in O O 0.9973679184913635
platelets S-cell_type S-cell_type 0.9974834322929382
is O O 0.9998037219047546
an O O 0.9999985694885254
important O O 0.9994175434112549
common O O 0.9931893348693848
event O O 0.9997803568840027
in O O 0.9999970197677612
early O O 0.8116163611412048
agonist-induced O O 0.9491016268730164
signalling O O 0.9756669402122498
, O O 0.9998040795326233
and O O 0.9999864101409912
that O O 0.9999995231628418
this O O 0.9999146461486816
activation O O 0.9978081583976746
is O O 0.9999911785125732
mediated O O 0.9999622106552124
by O O 0.9999997615814209
an O O 0.9999957084655762
increased O O 0.9973264932632446
intracellular O O 0.9087973237037659
Ca2+ O O 0.8804702162742615
concentration O O 0.9898638129234314
Physical O O 0.9644365906715393
interactions O O 0.9970135688781738
between O O 0.9997932314872742
Ets B-protein B-protein 0.7072795629501343
and I-protein I-protein 0.7687828540802002
NF-kappaB/NFAT I-protein I-protein 0.7561727166175842
proteins E-protein E-protein 0.9780746698379517
play O O 0.9998918771743774
an O O 0.999995231628418
important O O 0.9996134638786316
role O O 0.9994550347328186

cis B-DNA I-DNA 0.22308620810508728
element E-DNA E-DNA 0.9785067439079285
binds O O 0.9992899894714355
a O O 0.9999887943267822
protein O B-protein 0.5883600115776062
complex O E-protein 0.9751594066619873
referred O O 0.9994211196899414
to O O 0.9999772310256958
as O O 0.9996895790100098
HRF S-protein S-protein 0.9639093279838562
( O O 0.9875802993774414
heme-responsive B-protein B-protein 0.7865419387817383
factor E-protein E-protein 0.9066376686096191
) O O 0.7908692955970764
, O O 0.998059093952179
which O O 0.999942421913147
is O O 0.9999550580978394
greatly O O 0.999812662601471
enhanced O O 0.9999090433120728
both O O 0.9999934434890747
in O O 0.9995930790901184
heme-treated O B-cell_line 0.6671118140220642
FLCs S-cell_line E-cell_line 0.8296999335289001
and O O 0.9946863651275635
during O O 0.9991301894187927
monocyte-to-macrophage O O 0.6318605542182922
differentiation O O 0.9943015575408936

they O O 0.9995054006576538
mount O O 0.9999668598175049
a O O 0.9999949932098389
high-titer O O 0.826447069644928
antibody O O 0.5016834139823914
response O O 0.9882034659385681
to O O 0.9999492168426514
the O O 0.9999693632125854
fusion B-protein B-protein 0.5224899053573608
protein E-protein E-protein 0.9914942979812622
, O O 0.9986361861228943
Maltose B-protein B-protein 0.6418249011039734
Binding I-protein I-protein 0.9302146434783936
Protein E-protein E-protein 0.972842276096344
( O O 0.9775696396827698
MBP S-protein S-protein 0.9819656014442444
) O O 0.9729430675506592
. O O 0.9999916553497314
Subsequently O O 0.9999681711196899
, O O 0.9999626874923706
TCF-1-specific B-cell_line B-protein 0.6431805491447449
hybridomas E-cell_line E-protein 0.7114177942276001

chimeric B-DNA O 0.38146647810935974

. O O 0.9983067512512207
In O O 0.9999845027923584
contrast O O 0.9999895095825195
to O O 0.9999974966049194
PMA O O 0.993351936340332
, O O 0.9999871253967285
RA O O 0.9625523090362549
did O O 0.9998279809951782
not O O 0.9999929666519165
induce O O 0.9999943971633911
any O O 0.9999967813491821
CAT S-protein S-protein 0.9933682084083557
activity O O 0.9988620281219482
in O O 0.9999951124191284
these O O 0.99982750415802
cells O O 0.9830526113510132
, O O 0.9999394416809082
thus O O 0.999984622001648
suggesting O O 0.9999878406524658
that O O 0.9999978542327881
the O O 0.9999754428863525
RA-induced O O 0.8511636853218079
changes O O 0.997183084487915
in O O 0.9999934434890747
the O O 0.9999817609786987
expression O O 0.9992156028747559
of O O 0.9999945163726807
those O O 0.9999681711196899
genes O O 0.6886898279190063
described O O 0.9998564720153809
above O O 0.9991236329078674
were O O 0.999992847442627
not O O 0.999942421913147

the O O 0.998314380645752
ability O O 0.9998093247413635
to O O 0.9999711513519287
isolate O O 0.9956568479537964
adenovirus O O 0.8549343347549438
from O O 0.999332845211029
tonsils O O 0.7643840909004211
and O O 0.998571515083313
to O O 0.9999445676803589
detect O O 0.9997500777244568
adenovirus O B-DNA 0.6829615235328674
DNA O E-DNA 0.9979189038276672
by O O 0.9999871253967285
Southern O O 0.8841509222984314
blot O O 0.8362388014793396
hybridization O O 0.980195164680481
in O O 0.9999525547027588
peripheral B-cell_type B-cell_type 0.5050082206726074
blood I-cell_type I-cell_type 0.8110425472259521
mononuclear I-cell_type I-cell_type 0.9812657237052917
cells E-cell_type E-cell_type 0.9867069125175476
( O O 0.9922406673431396
PBMC S-cell_type S-cell_type 0.9989410042762756
) O O 0.9826524257659912
. O O 0.9999840259552002
To O O 0.9999903440475464
test O O 0.9999096393585205
this O O 0.9999570846557617
hypothesis O O 0.9983458518981934
, O O 0.9999924898147583
a O O 0.9999973773956299
more O O 0.9991952776908875
sensitive O O 0.9961722493171692

induce O O 0.9969053864479065
time- O O 0.9440116882324219
and O O 0.9903788566589355
dose-dependent O O 0.9914449453353882
increases O O 0.9998316764831543
in O O 0.999890923500061
aP2 B-RNA B-RNA 0.9768620133399963
mRNA E-RNA E-RNA 0.9982497096061707
in O O 0.9997146725654602
both O O 0.9995973706245422
primary B-cell_type B-cell_type 0.5495601892471313
human I-cell_type I-cell_type 0.7745181918144226
monocytes E-cell_type E-cell_type 0.9748355150222778
and O O 0.9986911416053772
the O O 0.9997674822807312
monocytic B-cell_line B-cell_line 0.6521967649459839
cell I-cell_line I-cell_line 0.8686054348945618
line E-cell_line E-cell_line 0.9900389313697815
, O O 0.9913889765739441
THP-1 S-cell_line S-cell_line 0.9987745881080627
. O O 0.9997865557670593
These O O 0.9999970197677612
data O O 0.9997833371162415
suggest O O 0.9999990463256836
that O O 0.9999977350234985
PPARgamma S-protein S-protein 0.9838696122169495
activation O O 0.9993569254875183
may O O 0.9999933242797852
play O O 0.9999897480010986
a O O 0.9999986886978149
role O O 0.9999806880950928
in O O 0.9999866485595703
monocyte S-cell_type O 0.759207010269165
differentiation O O 0.9955631494522095
and O O 0.9998351335525513
function O O 0.9994055032730103
analogous O O 0.9991457462310791
to O O 0.9999724626541138
its O O 0.9999583959579468
well-characterized O O 0.9828373193740845
role O O 0.9975699782371521
in O O 0.9999395608901978
adipocytes B-cell_type S-cell_type 0.9437807202339172

1999 O O 0.967903733253479
Academic O O 0.9950439929962158
Press O O 0.9944873452186584
. O O 0.9999957084655762
Immortalization O O 0.9982964396476746
of O O 0.9999672174453735
CD4 B-cell_type B-cell_type 0.4603264331817627
( I-cell_type I-cell_type 0.6458060145378113
+ I-cell_type I-cell_type 0.9269313216209412
) I-cell_type I-cell_type 0.8939602971076965
and I-cell_type I-cell_type 0.9500831365585327
CD8 I-cell_type I-cell_type 0.9699246883392334
( I-cell_type I-cell_type 0.984185516834259
+ I-cell_type I-cell_type 0.9958114624023438
) I-cell_type I-cell_type 0.9950864911079407
T I-cell_type I-cell_type 0.9975932240486145
lymphocytes E-cell_type E-cell_type 0.998537540435791
by O O 0.9999866485595703
human O B-protein 0.721404492855072
T-cell O I-protein 0.6607149839401245
leukemia O I-protein 0.5237061381340027
virus O I-protein 0.41411441564559937
type O I-protein 0.6352813243865967
1 O I-protein 0.7517760396003723
Tax B-protein I-protein 0.6828387379646301
mutants E-protein E-protein 0.9484373927116394
expressed O O 0.9993686079978943
in O O 0.9999896287918091
a O O 0.999943733215332
functional B-cell_line B-cell_line 0.859734296798706
molecular I-cell_line I-cell_line 0.6655825972557068
clone E-cell_line E-cell_line 0.9075329899787903
. O O 0.9999241828918457
The O O 0.9999957084655762
human B-protein B-protein 0.518638014793396
T-cell I-protein I-protein 0.4115122854709625
leukemia I-protein I-protein 0.3820195198059082
virus I-protein I-protein 0.614640474319458
type I-protein I-protein 0.8280113935470581
1 I-protein I-protein 0.8594703078269958
( I-protein I-protein 0.8990282416343689
HTLV-1 I-protein I-protein 0.9723950624465942
) I-protein I-protein 0.974531352519989
transcriptional I-protein I-protein 0.9132826328277588
trans-activator E-protein E-protein 0.8873851299285889
Tax S-protein S-protein 0.6828133463859558
has O O 0.9998977184295654
been O O 0.9999526739120483
demonstrated O O 0.999945878982544
to O O 0.9999841451644897
have O O 0.999982476234436
transforming O O 0.9411835670471191
activity O O 0.9982781410217285
in O O 0.9999880790710449
multiple B-cell_line O 0.8386898040771484
cell I-cell_line O 0.8278732895851135
culture E-cell_line O 0.6327844858169556
and O O 0.9929308891296387
transgenic-mouse O O 0.7879635095596313
models O O 0.4559444487094879
. O O 0.9999791383743286
In O O 0.999950647354126
addition O O 0.9998900890350342

and I-DNA I-DNA 0.9308977127075195
fos I-DNA I-DNA 0.9197980761528015
early I-DNA I-DNA 0.7294692993164062
response I-DNA I-DNA 0.6537442803382874
genes E-DNA E-DNA 0.9969293475151062
. O O 0.9999691247940063
Low O O 0.9921888113021851
levels O O 0.9993771910667419
of O O 0.9999661445617676
c-jun B-protein B-RNA 0.6063368320465088
transcripts E-protein E-RNA 0.9899076223373413
were O O 0.9997562766075134
detectable O O 0.9986978769302368
in O O 0.9999535083770752
resting B-cell_type B-cell_type 0.5418055653572083
human I-cell_type I-cell_type 0.5926802754402161
peripheral I-cell_type I-cell_type 0.8510874509811401
blood I-cell_type I-cell_type 0.9496906399726868
monocytes E-cell_type E-cell_type 0.9346098899841309
. O O 0.9997912049293518
Treatment O O 0.9982185959815979
of O O 0.9999817609786987
these O O 0.9996455907821655
cells O O 0.9760178327560425
with O O 0.9999698400497437
10 O O 0.9865427017211914
( O O 0.9989655017852783
3 O O 0.997162401676178
) O O 0.9990635514259338
units/ml O O 0.90899258852005
human B-protein O 0.7800938487052917
recombinant I-protein O 0.7181743383407593
M-CSF E-protein S-protein 0.5995111465454102
was O O 0.9993038177490234
associated O O 0.9998708963394165
with O O 0.9999985694885254

TNF B-protein B-protein 0.5024968981742859
alpha E-protein E-protein 0.993022620677948
. O O 0.9995380640029907
Thus O O 0.9998751878738403
, O O 0.9999678134918213
stimulation O O 0.999381422996521
of O O 0.9999901056289673
monocyte B-cell_line B-cell_line 0.4016372263431549
cell I-cell_line I-cell_line 0.4565379023551941
lines E-cell_line E-cell_line 0.9962788224220276
by O O 0.9999353885650635
phorbol O O 0.9164073467254639
esters O O 0.9688110947608948
or O O 0.9999476671218872
TNF B-protein B-protein 0.720567524433136
alpha E-protein E-protein 0.9965270161628723
induces O O 0.9989702701568604
cell O O 0.9608829617500305
differentiation O O 0.9984448552131653
and O O 0.9999511241912842
activates O O 0.9993358254432678
HIV O O 0.7132130861282349
transcription O O 0.9527322053909302
. O O 0.9999785423278809
Such O O 0.9999986886978149
a O O 0.9999970197677612
process O O 0.999919056892395
may O O 0.9999983310699463
have O O 0.9999985694885254
fundamental O O 0.997197151184082

cell I-cell_line I-cell_line 0.4802936911582947
line I-cell_line I-cell_line 0.9435659646987915
Jurkat E-cell_line E-cell_line 0.6866852045059204
as O O 0.9977895021438599
well O O 0.9986028075218201
as O O 0.9999676942825317
human B-cell_type B-cell_type 0.5602643489837646
aortic I-cell_type I-cell_type 0.571845293045044
endothelial I-cell_type I-cell_type 0.7181600332260132
cells E-cell_type E-cell_type 0.812197744846344
. O O 0.9999316930770874
HLA B-protein B-protein 0.7317683100700378
class I-protein I-protein 0.9197565913200378
I E-protein E-protein 0.8197139501571655
-mediated O O 0.7070677280426025

% O O 0.6168800592422485
) O O 0.9435088634490967
in O O 0.9999401569366455
a O O 0.9999915361404419
resting B-cell_line O 0.6991192698478699
B-cell I-cell_line O 0.3548128008842468
preparation E-cell_line O 0.839204728603363
from O O 0.9999650716781616
hepatitis O O 0.824712336063385
B O O 0.748714029788971
patients O O 0.9770088791847229
decreased O O 0.999614953994751
to O O 0.9999319314956665

IC50s O O 0.19001473486423492
) O O 0.9449681639671326
for O O 0.9998024106025696
the O O 0.9999951124191284
steroid-sensitive O O 0.7233673930168152
group O O 0.650420069694519
ranged O O 0.9999198913574219
from O O 0.999942421913147
2 O O 0.9009944796562195
x O O 0.9705480337142944
10 O O 0.9902456998825073
( O O 0.999849796295166
-10 O O 0.9951039552688599
) O O 0.9991514682769775
mol/L O O 0.9883376955986023
for O O 0.9999154806137085
budesonide O O 0.913114070892334
to O O 0.9968811273574829
7 O O 0.988628625869751
x O O 0.9946436882019043
10 O O 0.9851336479187012
( O O 0.9995927214622498
-8 O O 0.9582586884498596

in O O 0.9981430768966675
T B-cell_type B-cell_type 0.6522325873374939
effector I-cell_type I-cell_type 0.8587601780891418
cells E-cell_type E-cell_type 0.9593552350997925
. O O 0.9999324083328247
The O O 0.999998927116394
relative O O 0.9896689057350159
low O O 0.9849967956542969
binding O O 0.9671047925949097
affinity O O 0.9915356636047363
of O O 0.9999616146087646
cleavage B-protein B-protein 0.5900043845176697
stimulation I-protein I-protein 0.7205527424812317
factor E-protein E-protein 0.9223970174789429
CstF-64 S-protein S-protein 0.7387149930000305
to O O 0.9993278980255127
the O O 0.999953031539917
proximal B-DNA B-DNA 0.7375308275222778
polyA I-DNA I-DNA 0.8995387554168701
site E-DNA E-DNA 0.9801718592643738
seems O O 0.9995796084403992
to O O 0.9999960660934448
contribute O O 0.9999984502792358

larger O O 0.9664468765258789
number O O 0.9959742426872253
of O O 0.9999507665634155
mutants O O 0.5963425636291504
studied O O 0.993950366973877
. O O 0.9999914169311523
However O O 0.9999774694442749
, O O 0.9999901056289673
the O O 0.9999861717224121
ES O O 0.3380306661128998
cell O O 0.37244755029678345
system O O 0.7072762250900269
can O O 0.9992326498031616
be O O 0.9999804496765137
used O O 0.9999397993087769
as O O 0.999994158744812
an O O 0.9999796152114868
alternative O O 0.9947998523712158
until O O 0.9999666213989258
targeted B-cell_line O 0.9505727887153625
erythroleukemia I-cell_line B-cell_type 0.38535329699516296
cells E-cell_line E-cell_type 0.7877631783485413
become O O 0.9993547797203064
available O O 0.9999223947525024
. O O 0.9999983310699463
Other O O 0.9999842643737793
applications O O 0.998418927192688
involve O O 0.9999991655349731
the O O 0.9999990463256836
introduction O O 0.9999297857284546
of O O 0.9999974966049194
other O O 0.9992414712905884
GATA-binding B-protein B-protein 0.845534086227417
protein I-protein I-protein 0.7009293437004089
family I-protein E-protein 0.8527988791465759

that O O 0.9996551275253296
the O O 0.9999972581863403
emergence O O 0.999735414981842
of O O 0.9999935626983643
CTLs S-cell_type S-cell_type 0.7829617857933044
against O O 0.9982379674911499
immunorecessive B-protein B-protein 0.715680718421936
epitopes E-protein E-protein 0.9355155825614929
following O O 0.9999428987503052
multiple O O 0.9936111569404602
administrations O O 0.9993810653686523
of O O 0.9999946355819702
Ad O O 0.6937029957771301
vectors O O 0.3979661464691162
lacking O O 0.9997197985649109
immunodominant O B-protein 0.8158883452415466
antigens O E-protein 0.9317551255226135
is O O 0.9998723268508911
dependent O O 0.9999508857727051
on O O 0.9999645948410034
haplotype O O 0.6733644604682922
and O O 0.9766191840171814
could O O 0.9996923208236694

( I-protein O 0.8732247948646545
gamma I-protein B-protein 0.3607374131679535
( I-protein I-protein 0.7093272805213928
c I-protein I-protein 0.9088257551193237
) I-protein E-protein 0.9915887713432312
) E-protein O 0.8662042617797852
. O O 0.9999876022338867
Genetic O O 0.9886628985404968
inactivation O O 0.9988561868667603
of O O 0.9999861717224121
JAK3 S-protein S-protein 0.9630885124206543

, O O 0.8252921104431152
and O O 0.9241973161697388
STAT3 S-protein S-protein 0.9952020645141602
, O O 0.9717499613761902
and O O 0.9946138262748718
induced O B-protein 0.9104143381118774
complexes O E-protein 0.9725359678268433
containing O O 0.9968439340591431
STAT4 S-protein S-protein 0.9921833872795105
only O O 0.9963906407356262
, O O 0.9994978904724121
STAT4 S-protein S-protein 0.9984670281410217
with O O 0.9997089505195618
STAT1 B-protein B-protein 0.6149778366088867
alpha E-protein E-protein 0.9949136972427368
, O O 0.9943655729293823
STAT3 S-protein S-protein 0.9937520623207092
with O O 0.9996782541275024
STAT1 B-protein B-protein 0.8621989488601685
alpha E-protein E-protein 0.9749532341957092
, O O 0.972978949546814
or O O 0.9973347783088684

P O O 0.9384257197380066
= O O 0.9988200068473816
0.045 O O 0.9996999502182007
; O O 0.9999439716339111
P O O 0.9948953986167908
= O O 0.9998001456260681
0.029 O O 0.9993314743041992
) O O 0.9998810291290283
. O O 0.9999942779541016
CONCLUSIONS O O 0.9992592930793762
: O O 0.999991774559021
The O O 0.9999966621398926
increased O O 0.9978272318840027
number O O 0.9949239492416382
and O O 0.9998728036880493
apparent O O 0.9979389309883118
dissociation O O 0.9880149960517883
constant O O 0.9952393770217896
of O O 0.9999876022338867
glucocorticoid B-protein B-protein 0.8828176856040955
receptor E-protein E-protein 0.9952366352081299
are O O 0.9997871518135071
closely O O 0.9914389848709106
associated O O 0.999734103679657
with O O 0.9999977350234985
the O O 0.9999967813491821
effectiveness O O 0.9996126294136047
of O O 0.9999910593032837
glucocorticoid O O 0.7592090368270874
therapy O O 0.990801990032196
. O O 0.9999967813491821
The O O 0.9999984502792358
measurement O O 0.9847299456596375
of O O 0.9998353719711304
the O O 0.9999909400939941
number O O 0.9423085451126099
and O O 0.9944329857826233
apparent O O 0.9948791265487671
dissociation O O 0.9555131793022156
constant O O 0.9725354909896851
of O O 0.9998606443405151
glucocorticoid B-protein B-protein 0.9058250188827515
receptor E-protein E-protein 0.9896281957626343
may O O 0.9984110593795776

apoptosis O O 0.9739523530006409
. O O 0.9999719858169556
We O O 0.9999688863754272
have O O 0.9999978542327881
found O O 0.9999949932098389
that O O 0.999997615814209
Bcl-2 S-protein S-protein 0.9795113801956177
overexpression O O 0.9982174038887024
leads O O 0.9999896287918091
to O O 0.9999951124191284
the O O 0.9999961853027344
prevention O O 0.9998770952224731
of O O 0.9999918937683105
chemotherapy O O 0.958746075630188
( O O 0.9969655871391296
paclitaxel O O 0.848073422908783
) O O 0.9578583240509033
-induced O O 0.9893430471420288
expression O O 0.9991200566291809

contrast O O 0.9928414821624756
, O O 0.9999691247940063
ICRF-193 O S-protein 0.6689233779907227
only O O 0.9995899796485901
provoked O O 0.99996018409729
a O O 0.9999943971633911
late O O 0.9825016856193542
activation O O 0.9971831440925598
( O O 0.9999691247940063
from O O 0.999981164932251
hours O O 0.9978201389312744
72 O O 0.9951565265655518
to O O 0.9997212290763855

responses O O 0.9860332608222961
. O O 0.9999935626983643
The O O 0.9999945163726807
antigens O O 0.5642751455307007
recognized O O 0.9982039928436279
by O O 0.9999970197677612
many O O 0.9977031350135803
HSV-specific B-cell_type B-cell_line 0.5215373039245605
CD4 I-cell_type I-cell_line 0.5367660522460938
T I-cell_type I-cell_line 0.629869282245636
cells E-cell_type E-cell_line 0.7299906611442566
localizing O O 0.9980971217155457
to O O 0.9999639987945557
genital O O 0.8583849668502808
HSV-2 O O 0.498692125082016
lesions O O 0.786842942237854
are O O 0.9999748468399048

functional O O 0.8933383822441101
role O O 0.9878124594688416
of O O 0.9998520612716675
specific O B-protein 0.8715389966964722
nuclear B-protein I-protein 0.6629815697669983
factor-DNA I-protein I-protein 0.6556350588798523
complexes E-protein E-protein 0.998297393321991
. O O 0.9999576807022095
We O O 0.999974250793457
studied O O 0.9999657869338989
the O O 0.9999958276748657
functional O O 0.9886019825935364
interaction O O 0.9985688924789429
between O O 0.99977046251297
human B-DNA B-DNA 0.6349601149559021
embryonic I-DNA I-DNA 0.5855681300163269
zeta I-DNA I-DNA 0.5768237113952637
2 I-DNA I-DNA 0.7847192287445068
globin I-DNA I-DNA 0.8957220315933228

binding O O 0.8851998448371887
affinity O O 0.9837127923965454
of O O 0.9998934268951416
the O O 0.9999721050262451
GR S-protein S-protein 0.9413261413574219
in O O 0.9994440674781799
lymphocytes O S-cell_type 0.9916366934776306
and O O 0.9929695725440979
regulatory O O 0.9238293766975403
function O O 0.9985471367835999
at O O 0.999998927116394
the O O 0.9999983310699463
hypothalamic O O 0.7317329049110413
level O O 0.9945211410522461
, O O 0.9999788999557495

and O O 0.9813288450241089
to O O 0.999930739402771
study O O 0.9999938011169434
the O O 0.9999971389770508
maturation O O 0.9529529809951782
defects O O 0.986577033996582
occurring O O 0.9999983310699463
when O O 0.9999982118606567
NF-kappa B-protein B-protein 0.777984619140625
B E-protein E-protein 0.9964207410812378
activation O O 0.9975712895393372

a O O 0.9966853260993958
part O O 0.9943332672119141
of O O 0.9998970031738281
this O O 0.9999942779541016
complex O O 0.9551862478256226
. O O 0.9999674558639526
The O O 0.9999905824661255
EBV-encoded B-protein B-protein 0.35471510887145996
latent I-protein I-protein 0.4815465211868286
membrane I-protein I-protein 0.6205855011940002
protein I-protein I-protein 0.498918741941452
1 E-protein E-protein 0.9711828231811523
is O O 0.9975304007530212
capable O O 0.999028205871582
of O O 0.9999454021453857
transactivating O O 0.9910950660705566
the O O 0.9998428821563721
isolated O O 0.6901326179504395
CD48 S-protein B-DNA 0.7245460152626038
NF-kappa B-DNA I-DNA 0.30638250708580017
B I-DNA I-DNA 0.4997365176677704
site E-DNA E-DNA 0.9694337248802185
but O O 0.9981129169464111
not O O 0.9998281002044678
the O O 0.9999781847000122
intact B-DNA B-DNA 0.6113919615745544
element E-DNA E-DNA 0.9261123538017273
, O O 0.994676947593689
suggesting O O 0.9999886751174927
that O O 0.9999986886978149
the O O 0.9999240636825562
latent B-protein B-protein 0.5482709407806396
membrane I-protein I-protein 0.5915341973304749
protein I-protein I-protein 0.5749484300613403
1 E-protein E-protein 0.995271623134613
-driven O O 0.9855027198791504
activation O O 0.9689435958862305

class B-DNA I-DNA 0.2986520528793335
II I-DNA I-DNA 0.41766005754470825
major I-DNA I-DNA 0.5355811715126038
histocompatibility I-DNA I-DNA 0.8241968750953674
complex I-DNA I-DNA 0.6609942317008972
promoters E-DNA E-DNA 0.9967713952064514
plays O O 0.9998732805252075
an O O 0.9999463558197021
important O O 0.9997414946556091
role O O 0.9999747276306152
in O O 0.9999953508377075
influencing O O 0.9991118311882019
differential O O 0.9957380294799805
expression O O 0.9998279809951782
of O O 0.9999922513961792

anti-TCF-1 B-protein B-protein 0.5282059907913208
antibodies E-protein E-protein 0.9968664050102234
. O O 0.9999350309371948
By O O 0.9999102354049683
immunization O O 0.9971025586128235
with O O 0.9999953508377075
a O O 0.9999805688858032
recombinant B-protein B-protein 0.5558106899261475
fusion I-protein I-protein 0.7280065417289734
protein E-protein E-protein 0.9865100979804993
, O O 0.9996931552886963
we O O 0.9999722242355347
show O O 0.9999985694885254
that O O 0.9999971389770508
TCF-1 S-protein S-protein 0.9512764811515808

in O O 0.9988711476325989
Group O O 0.6137645244598389
C O O 0.5327864289283752
had O O 0.9997828602790833
a O O 0.9999947547912598
normal O O 0.9813977479934692
profile O O 0.9944285154342651
of O O 0.9999618530273438
p16 S-protein S-protein 0.8739956021308899
, O O 0.9876667261123657
p15 S-protein S-protein 0.9525237679481506
and O O 0.9957056641578674
CDK4 S-protein S-protein 0.9130363464355469
at O O 0.9975206255912781
presentation O O 0.9983604550361633
. O O 0.9999963045120239
Upon O O 0.9997864365577698
recurrence O O 0.9993390440940857
, O O 0.999993085861206
however O O 0.999996542930603
, O O 0.999998927116394
the O O 0.9999923706054688
tumors O O 0.962427020072937
sustained O O 0.9997913241386414
either O O 0.9999948740005493
deletion O O 0.99945467710495
of O O 0.9999750852584839
p16 S-protein S-protein 0.6251505017280579
alone O O 0.9649725556373596
or O O 0.9982573390007019
codeletion O O 0.9248793721199036
of O O 0.9979631900787354

been O O 0.9970638155937195
used O O 0.9998732805252075
to O O 0.9999707937240601
study O O 0.9999951124191284
the O O 0.9999923706054688

NF-kappa B-DNA B-DNA 0.8074585199356079
B I-DNA I-DNA 0.8073486685752869
site E-DNA E-DNA 0.9969232678413391
( O O 0.9990866184234619
-223 B-DNA B-DNA 0.9488518834114075
bases E-DNA E-DNA 0.9929878115653992
from O O 0.9991520643234253
the O O 0.9999251365661621
translation B-DNA B-DNA 0.7675989270210266
start I-DNA I-DNA 0.6274909973144531
site E-DNA E-DNA 0.9899370670318604
) O O 0.9917423725128174
prevented O O 0.9999880790710449
the O O 0.9999973773956299
activation O O 0.9976199269294739
of O O 0.9999498128890991
ICAM-1 B-DNA B-DNA 0.5148730278015137
promoter E-DNA E-DNA 0.994485080242157
, O O 0.9929251670837402
indicating O O 0.9999961853027344
that O O 0.9999995231628418
the O O 0.9999336004257202
downstream O B-DNA 0.5020405054092407
NF-kappa B-DNA I-DNA 0.5844365358352661
B I-DNA I-DNA 0.8310658931732178
site E-DNA E-DNA 0.9969450831413269
is O O 0.9999414682388306
critical O O 0.9997732043266296
for O O 0.9999862909317017
thrombin S-protein S-protein 0.9317271709442139
inducibility O O 0.9985464215278625
. O O 0.9999957084655762
NF-kappa B-protein B-protein 0.8876701593399048
B E-protein E-protein 0.9599573016166687

underlying O O 0.9814456105232239
IL-2 S-protein S-protein 0.8727436065673828
transcriptional O O 0.8646204471588135
blockade O O 0.7445193529129028
in O O 0.9998934268951416
anergic B-cell_line B-cell_line 0.4308791160583496
T I-cell_line I-cell_line 0.5011880397796631
cell I-cell_line I-cell_line 0.7113929986953735
clones E-cell_line E-cell_line 0.9981405735015869
is O O 0.9994879961013794
not O O 0.9997372031211853
fully O O 0.994239091873169
understood O O 0.9998593330383301
. O O 0.9999983310699463
To O O 0.9999948740005493
examine O O 0.999995231628418
whether O O 0.999997615814209
an O O 0.9999644756317139
active O O 0.8319323658943176
negative O O 0.7969591617584229
regulatory O O 0.5267775654792786
process O O 0.7667563557624817
occurs O O 0.9997329115867615
, O O 0.9999969005584717
we O O 0.9999947547912598
created O O 0.9999915361404419
a O O 0.9999967813491821
reporter B-DNA O 0.8607587814331055
construct E-DNA O 0.514603316783905
containing O O 0.9986653327941895
as O O 0.999970555305481
an O O 0.9998589754104614
enhancer S-DNA O 0.5185733437538147
four O O 0.9740144610404968
copies O O 0.9520025849342346
of O O 0.9996989965438843
the O O 0.9998334646224976
NF-AT B-DNA B-DNA 0.8911451697349548
site E-DNA E-DNA 0.9832639098167419
and O O 0.9929012060165405
one O O 0.9994943141937256
copy O O 0.9173270463943481
of O O 0.996487021446228
the O O 0.9998220801353455
octamer B-DNA B-DNA 0.898179829120636
site E-DNA E-DNA 0.9945911169052124
( O O 0.997914731502533
4X B-DNA B-DNA 0.7522796392440796
NF-AT-Oct E-DNA E-DNA 0.6915624737739563
) O O 0.5173953175544739
. O O 0.9994162321090698
This O O 0.9999929666519165
construct O O 0.9946995973587036

in O O 0.9987832903862
human B-cell_type B-cell_type 0.6243352890014648
primary I-cell_type I-cell_type 0.7742242813110352
B-lymphocytes E-cell_type E-cell_type 0.9771425724029541
. O O 0.9999266862869263
The O O 0.9999922513961792
pocket B-protein B-protein 0.7797133922576904
protein-E2F I-protein I-protein 0.31413519382476807
complexes E-protein E-protein 0.9935483336448669
are O O 0.9999325275421143
convergence O O 0.8636215925216675
points O O 0.6550805568695068
for O O 0.9999330043792725
cell O O 0.9132167100906372
cycle O O 0.9310729503631592
signaling O O 0.9890011548995972
. O O 0.9999955892562866
In O O 0.9999909400939941
the O O 0.9999992847442627
present O O 0.9970576763153076
report O O 0.9995757937431335
, O O 0.9999897480010986
we O O 0.9999607801437378
identified O O 0.9999380111694336
and O O 0.9998164772987366
monitored O O 0.9997702240943909
the O O 0.9999886751174927

Egr-1 S-protein S-protein 0.46618708968162537

form O O 0.4894722104072571
of O O 0.9922521710395813
the O O 0.9998916387557983
helix-loop-helix B-protein B-protein 0.8013625144958496
protein E-protein E-protein 0.9866070747375488
, O O 0.9856849908828735
Id-3 S-protein S-protein 0.9884350299835205
, O O 0.9969026446342468
generated O O 0.9996675252914429
by O O 0.9999947547912598
an O O 0.9999908208847046
alternative O O 0.9110562801361084
splicing O O 0.888988196849823
mechanism O O 0.9776973128318787
. O O 0.9999947547912598
The O O 0.9999821186065674
Id O B-protein 0.7362588047981262
family O E-protein 0.8402259945869446
of O O 0.9546401500701904
helix-loop-helix B-protein B-protein 0.6423010230064392
proteins E-protein E-protein 0.994926929473877
function O O 0.9998399019241333
as O O 0.9999905824661255
negative O O 0.8209744691848755
regulators O O 0.8013819456100464
of O O 0.995060384273529
DNA O O 0.6298062801361084
binding O O 0.5099297761917114
, O O 0.9314151406288147
basic O B-protein 0.6556756496429443
helix-loop-helix B-protein I-protein 0.8856589198112488
proteins E-protein E-protein 0.9962963461875916
in O O 0.9999122619628906
the O O 0.999972939491272
regulation O O 0.9903610944747925
of O O 0.9998382329940796
cell O O 0.9281023740768433
growth O O 0.97407466173172
and O O 0.998581051826477
differentiation O O 0.9987491369247437
. O O 0.9999977350234985
We O O 0.9999635219573975
report O O 0.9999912977218628
here O O 0.9999632835388184
on O O 0.9999910593032837
the O O 0.9999974966049194
identification O O 0.998763918876648
of O O 0.9999872446060181
a O O 0.9999430179595947
17 B-protein B-protein 0.5579378008842468
kDa I-protein I-protein 0.7673044204711914
variant E-protein E-protein 0.71486896276474
of O O 0.9682571291923523
the O O 0.9992761015892029
14 B-protein B-protein 0.540177047252655
kDa I-protein I-protein 0.8297439813613892
Id-3 E-protein I-protein 0.9212938547134399
protein O E-protein 0.9815804362297058
termed O O 0.996894359588623
Id-3L S-protein B-protein 0.37302225828170776

glucocorticoid O O 0.6000389456748962
treatment O O 0.9767730236053467
. O O 0.9999954700469971
A O O 0.9997889399528503
single O O 0.9562049508094788
point O O 0.9599072933197021
assay O O 0.9946936964988708
of O O 0.9999475479125977
glucocorticoid B-protein B-protein 0.924760639667511
receptors E-protein E-protein 0.9986512064933777
( O O 0.9943521022796631
GR S-protein S-protein 0.9981403350830078
) O O 0.995819091796875
in O O 0.9999604225158691
human O B-cell_type 0.8171564936637878
lymphocytes S-cell_type E-cell_type 0.9797061085700989
based O O 0.9978553652763367
on O O 0.999984860420227
the O O 0.9999943971633911
measurement O O 0.9962958693504333
of O O 0.9999496936798096

but O O 0.9838396906852722
not O O 0.9953076243400574
Stat1 S-protein S-protein 0.9976739287376404
and O O 0.998216450214386
blocked O O 0.9748042821884155
IL-10 S-protein S-protein 0.9977272152900696
-induced O O 0.9989497065544128
Stat3 S-protein S-protein 0.9955714344978333
phosphorylation O O 0.9976595640182495
in O O 0.9999967813491821
a O O 0.9999610185623169
cell-free O O 0.6385536789894104
system O O 0.5637403726577759
. O O 0.9999856948852539
In O O 0.9999914169311523
contrast O O 0.9998829364776611
, O O 0.9999380111694336
tyrosine-phosphorylated O O 0.7703229188919067
peptides O O 0.6272072792053223
containing O O 0.9996129870414734
Tyr374 O O 0.4322524666786194
or O O 0.9579129815101624
Tyr396 O O 0.4574567675590515
did O O 0.9980227947235107
not O O 0.9999732971191406
interact O O 0.9997757077217102

CD36 S-protein S-protein 0.7315527200698853
is O O 0.9994908571243286
involved O O 0.9999923706054688
in O O 0.9999842643737793
phagocytosis O O 0.8917859792709351
of O O 0.9992641806602478
apoptotic B-cell_type B-cell_type 0.8213822841644287
cells E-cell_type E-cell_type 0.9729709029197693
, O O 0.9952282905578613
and O O 0.9992973804473877
foam O O 0.6128338575363159
cell O O 0.45068785548210144
formation O O 0.9906975626945496
by O O 0.9999973773956299
uptake O O 0.991905689239502
of O O 0.9998736381530762
oxidized B-protein O 0.9058558344841003
low I-protein B-protein 0.8466632962226868
density I-protein I-protein 0.850233793258667
lipoprotein E-protein E-protein 0.9502052664756775
. O O 0.9997866749763489
To O O 0.9999960660934448
study O O 0.9999862909317017
the O O 0.9999940395355225
molecular O O 0.9578474760055542
mechanisms O O 0.9969632029533386
that O O 0.9999974966049194
control O O 0.999991774559021
the O O 0.9999918937683105
transcription O O 0.9762001633644104
of O O 0.9994774460792542

elements E-DNA E-DNA 0.9711295366287231
and O O 0.9997642636299133
a O O 0.9998960494995117
promoter B-DNA B-DNA 0.6176513433456421
proximal I-DNA I-DNA 0.48418769240379333
region E-DNA E-DNA 0.9813226461410522
upstream O O 0.9516488909721375
of O O 0.9999825954437256
the O O 0.9999634027481079

gamma B-cell_type B-cell_line 0.41739505529403687
delta I-cell_type I-cell_line 0.46288686990737915
T I-cell_type I-cell_line 0.6730800867080688
cell I-cell_type I-cell_line 0.5561151504516602
receptor-bearing I-cell_type I-cell_line 0.808967649936676
lymphocytes E-cell_type E-cell_line 0.8623521327972412
. O O 0.9998723268508911
The O O 0.9999991655349731
binding O O 0.9892917275428772
of O O 0.999910831451416
these O O 0.9999011754989624
gamma B-cell_type B-cell_line 0.3549409508705139
delta I-cell_type I-cell_line 0.3199668526649475
T I-cell_type I-cell_line 0.34034767746925354
cells E-cell_type E-cell_line 0.5545247793197632
serves O O 0.9952587485313416
as O O 0.9999889135360718
a O O 0.9999963045120239
signal O O 0.9989860653877258
for O O 0.999988317489624
abrogation O O 0.9996248483657837
of O O 0.9999868869781494
oral O O 0.3880268335342407

on O O 0.9984524250030518
tumor O B-protein 0.6752912998199463
necrosis O I-protein 0.6388660669326782
factor O I-protein 0.4099637567996979
alpha O E-protein 0.981084406375885
( O O 0.9933470487594604
TNF-alpha S-protein S-protein 0.9199599623680115
) O O 0.9868592023849487
- O O 0.9993265867233276
and O O 0.9998975992202759
phorbol O O 0.9546667337417603
12-myristate O O 0.9939773082733154
13-acetate O O 0.9956120252609253
( O O 0.9998704195022583
PMA O O 0.9964979887008667
) O O 0.9996895790100098
-induced O O 0.9997856020927429
HIV-1 O O 0.9562768936157227
replication O O 0.9945331811904907
in O O 0.9999861717224121
chronically B-cell_line B-cell_line 0.5001522302627563
infected I-cell_line I-cell_line 0.4994543194770813
cell I-cell_line I-cell_line 0.8292796611785889
lines E-cell_line E-cell_line 0.9987980127334595
. O O 0.9998974800109863

human O O 0.5363266468048096
immunodeficiency O O 0.7544673085212708
virus O O 0.8637423515319824
type O O 0.9166303873062134
1 O O 0.9021949768066406
( O O 0.9973527193069458
HIV-1 O O 0.9765484929084778
) O O 0.9984777569770813
containing O O 0.9999276399612427
a O O 0.9999699592590332
deletion O O 0.9976351261138916
of O O 0.9999890327453613
the O O 0.9999802112579346
long B-DNA B-DNA 0.6653838157653809
terminal I-DNA I-DNA 0.9154215455055237
repeat E-DNA E-DNA 0.8400471806526184
( O O 0.523221492767334
LTR S-DNA S-DNA 0.9342959523200989
) O O 0.7173827886581421
NF-kappa B-protein B-DNA 0.4983299970626831
B E-protein I-DNA 0.5891137719154358
sites O E-DNA 0.9964022636413574
. O O 0.9999227523803711

and O O 0.9414116740226746
cell O O 0.912898600101471
proliferation O O 0.9985215067863464
. O O 0.9999991655349731
In O O 0.9999942779541016
the O O 0.9999994039535522
present O O 0.9989694356918335
study O O 0.9997907280921936
, O O 0.9999980926513672
the O O 0.9999991655349731
role O O 0.9982798099517822
of O O 0.9999827146530151
IL-2R S-protein S-protein 0.9453309774398804
signaling O O 0.9873673915863037
in O O 0.9999771118164062
the O O 0.9999866485595703
growth O O 0.9951207041740417
of O O 0.9999690055847168
CD8+ B-cell_line O 0.709715723991394
T I-cell_line O 0.7108340859413147
cell I-cell_line O 0.33753836154937744
prolymphocytic I-cell_line O 0.5408846139907837
leukemia I-cell_line O 0.7368865609169006
( I-cell_line O 0.9604440927505493
T-PLL I-cell_line O 0.8305690884590149
) I-cell_line O 0.9865430593490601

cell O O 0.5262224674224854
activation O O 0.9814388155937195
. O O 0.9999834299087524
The O O 0.9999964237213135
distribution O O 0.998427152633667
of O O 0.9999895095825195
this O O 0.9999741315841675
integral B-protein B-protein 0.603106677532196
membrane I-protein I-protein 0.6426692605018616
protein E-protein E-protein 0.9936238527297974
is O O 0.9997953772544861
restricted O O 0.9996966123580933
to O O 0.9999960660934448
certain O O 0.9988518953323364
tissues O O 0.9783284664154053
where O O 0.9999301433563232
its O O 0.9999847412109375
level O O 0.9993652701377869
of O O 0.9998451471328735
expression O O 0.9973742961883545
is O O 0.9999855756759644
modulated O O 0.9996945858001709
by O O 0.9999982118606567
multiple O O 0.9587224721908569
exogenous O O 0.8863354921340942
stimuli O O 0.9300866723060608
. O O 0.9999735355377197
To O O 0.9999922513961792
identify O O 0.9999942779541016
the O O 0.9999881982803345
molecular O O 0.6989471316337585

( O O 0.8854368329048157
EBNA2 S-protein S-protein 0.9588307738304138
) O O 0.9424603581428528
, O O 0.9997673630714417
a O O 0.9999840259552002
protein O O 0.8609076738357544
required O O 0.998049259185791
for O O 0.9999402761459351
B B-cell_type B-cell_type 0.5349602103233337
lymphocyte E-cell_type E-cell_type 0.83812415599823
immortalization O O 0.9634077548980713
, O O 0.9995660185813904
induces O O 0.9999806880950928
the O O 0.9999901056289673
synthesis O O 0.9850921034812927
of O O 0.9998109936714172
type B-protein B-protein 0.781919538974762
I I-protein I-protein 0.8977739810943604
interferon E-protein E-protein 0.9547863602638245
in O O 0.9983458518981934

organism O O 0.5202561020851135
. O O 0.999871015548706
Activation O O 0.9950417876243591
of O O 0.999889612197876
NF-kappa B-protein B-protein 0.9538165926933289
B E-protein E-protein 0.9994596838951111
correlates O O 0.9987817406654358
with O O 0.9999167919158936
phosphorylation O O 0.9764016270637512
of O O 0.9998233914375305
I B-protein B-protein 0.8078968524932861
kappa I-protein I-protein 0.8999978303909302
B-alpha E-protein E-protein 0.9775451421737671
and O O 0.9951169490814209
requires O O 0.9999828338623047
the O O 0.9999936819076538
proteolysis O O 0.894431471824646
of O O 0.9986618757247925
this O O 0.9999566078186035
inhibitor O O 0.9366834163665771
. O O 0.9998798370361328
When O O 0.9999148845672607

study O O 0.9960476756095886
, O O 0.9999631643295288
analysis O O 0.9998871088027954
of O O 0.9999977350234985
the O O 0.9999909400939941
interleukin-2 B-DNA B-DNA 0.38190358877182007
( I-DNA I-DNA 0.5202661752700806
IL-2 I-DNA I-DNA 0.7826057076454163
) I-DNA I-DNA 0.8324664831161499
gene E-DNA E-DNA 0.9654924869537354
activation O O 0.9443715810775757
shows O O 0.9990307092666626
that O O 0.9999886751174927
naive B-cell_type B-cell_type 0.4847528338432312
human I-cell_type I-cell_type 0.5067282319068909
helper I-cell_type I-cell_type 0.8125895857810974
T I-cell_type I-cell_type 0.9472532868385315
cells E-cell_type E-cell_type 0.9771488904953003
( O O 0.9949049949645996
cord B-cell_type B-cell_type 0.9600573778152466
blood I-cell_type I-cell_type 0.9709495306015015
CD4+ I-cell_type I-cell_type 0.9772431254386902
T I-cell_type I-cell_type 0.985228955745697
cells E-cell_type E-cell_type 0.9659472107887268
, O O 0.9886807203292847

from O O 0.9982178807258606
adherent B-cell_type B-cell_type 0.7062392830848694
cells E-cell_type E-cell_type 0.9666678309440613
. O O 0.9999566078186035
This O O 0.9999980926513672
study O O 0.9999703168869019
shows O O 0.9999994039535522
that O O 0.9999984502792358
human O B-cell_type 0.6035951375961304
peripheral O I-cell_type 0.7772616744041443
blood O I-cell_type 0.9602150917053223
monocytes S-cell_type E-cell_type 0.9906021356582642
( O O 0.9960122108459473
PBMo S-cell_type S-cell_type 0.9781461954116821
) O O 0.9724120497703552
also O O 0.9997394680976868
respond O O 0.9999136924743652
to O O 0.9999885559082031
MDHM O O 0.6034418344497681
with O O 0.9999291896820068
increases O O 0.9997797608375549
in O O 0.9999852180480957
IL-1 B-protein B-protein 0.41506239771842957
beta E-protein E-protein 0.7574808597564697
, O O 0.9598448276519775
IL-6 S-protein O 0.5059634447097778
and O O 0.9788864850997925
TNF B-protein B-protein 0.337468683719635
alpha E-protein E-protein 0.982833206653595
expression O O 0.9956586360931396
, O O 0.9999879598617554
both O O 0.9999974966049194
at O O 0.9999977350234985
the O O 0.9999947547912598
mRNA O O 0.9354345202445984
and O O 0.9835995435714722
protein O O 0.8479753732681274
level O O 0.9939475059509277
. O O 0.9999939203262329
The O O 0.9999986886978149
induced O O 0.9896357655525208
expression O O 0.9984667897224426
of O O 0.9999889135360718
IL-1 B-RNA B-RNA 0.8358607888221741
beta I-RNA I-RNA 0.5647575259208679
and I-RNA I-RNA 0.6057319641113281
TNF I-RNA I-RNA 0.6147654056549072
alpha I-RNA I-RNA 0.9865684509277344
mRNA E-RNA E-RNA 0.9907196760177612
in O O 0.9996228218078613
the O O 0.9998737573623657
monocytic O B-cell_line 0.7750527262687683
THP-1 B-cell_line I-cell_line 0.9262133836746216
cell I-cell_line I-cell_line 0.8158836364746094
line E-cell_line E-cell_line 0.9950843453407288
increased O O 0.9995131492614746
as O O 0.9999843835830688
quickly O O 0.9997817873954773
as O O 0.999997615814209
in O O 0.999206006526947
primary B-cell_type B-cell_type 0.6923340559005737
cells E-cell_type E-cell_type 0.9834157228469849
. O O 0.99989914894104
In O O 0.9998842477798462
contrast O O 0.9996750354766846

of O O 0.9962908029556274
tumor B-RNA B-RNA 0.4864083528518677
necrosis I-RNA I-RNA 0.5888968110084534
factor I-RNA I-RNA 0.9063591957092285
alpha I-RNA I-RNA 0.8801648020744324
( I-RNA I-RNA 0.8526428937911987
TNF-alpha I-RNA I-RNA 0.9239913821220398
) I-RNA I-RNA 0.9712858200073242
and I-RNA I-RNA 0.9445705413818359
IL-6 I-RNA I-RNA 0.9808298349380493
mRNAs E-RNA E-RNA 0.9944808483123779
. O O 0.9998199343681335
In O O 0.999995231628418
this O O 0.9999982118606567
study O O 0.9991402626037598
, O O 0.9999958276748657
the O O 0.9999983310699463
effect O O 0.999944806098938
of O O 0.9999945163726807
anti-E. B-protein B-protein 0.5413239598274231
chaffeensis I-protein I-protein 0.7809016704559326
antibody E-protein E-protein 0.987463116645813
complexed O O 0.9948098659515381
with O O 0.9999816417694092
E. O O 0.7618683576583862

and O O 0.9702234268188477
during O O 0.9998329877853394
the O O 0.9999990463256836
rescue O O 0.9991405010223389
of O O 0.9999842643737793
immature B-cell_type B-cell_type 0.6979208588600159
B I-cell_type I-cell_type 0.9251136779785156
cells E-cell_type E-cell_type 0.9768393635749817
from O O 0.9996548891067505
apoptosis O O 0.9950904846191406
. O O 0.9999918937683105
It O O 0.9999887943267822
is O O 0.9999983310699463
possible O O 0.9999949932098389
that O O 0.9999992847442627
the O O 0.9998598098754883
CRE B-DNA B-DNA 0.7859302163124084
site E-DNA E-DNA 0.9803494215011597
is O O 0.9998155236244202
responsible O O 0.9999301433563232
for O O 0.9999936819076538
induction O O 0.9994654059410095
of O O 0.9999876022338867

to O O 0.9977443218231201
activating O O 0.974148154258728
transcription O O 0.9488255977630615
from O O 0.9999262094497681
the O O 0.9999706745147705
viral B-DNA B-DNA 0.9145183563232422
long I-DNA I-DNA 0.98421311378479
terminal I-DNA I-DNA 0.991661548614502
repeat E-DNA E-DNA 0.9982695579528809
( O O 0.9957243204116821
LTR S-DNA S-DNA 0.99918133020401
) O O 0.9777137637138367
through O O 0.9999866485595703
the O O 0.9999885559082031
cyclic B-protein B-protein 0.5462247729301453
AMP I-protein I-protein 0.37091782689094543
response I-protein I-protein 0.45121926069259644
element I-protein I-protein 0.4068886339664459
binding I-protein I-protein 0.661811113357544
protein/activating I-protein I-protein 0.7075158953666687
transcription I-protein I-protein 0.7995022535324097
factor I-protein E-protein 0.9523252844810486
( I-protein O 0.8291122913360596
CREB/ATF I-protein S-protein 0.7417556643486023
) I-protein O 0.6969025135040283

less O O 0.9948410391807556
RT-PCR B-DNA B-protein 0.3162844777107239
product E-DNA E-protein 0.8962680101394653
derived O O 0.9980936646461487
from O O 0.9999938011169434
the O O 0.9999455213546753
small B-RNA B-RNA 0.6214833855628967
t I-RNA I-RNA 0.48575830459594727
allele I-RNA I-RNA 0.9288724660873413
mRNA E-RNA E-RNA 0.9846606850624084
in O O 0.9991886019706726
steady O O 0.9154935479164124
state O O 0.9873879551887512
, O O 0.9999698400497437
a O O 0.9999986886978149
finding O O 0.9991181492805481
which O O 0.9999891519546509
also O O 0.9999650716781616
speaks O O 0.9996606111526489
against O O 0.9999589920043945

scanning O O 0.9894802570343018
confocal O O 0.8225364685058594
microscopy O O 0.935577929019928
in O O 0.9999340772628784
human B-cell_line B-cell_line 0.3753558099269867
CD14-transfected I-cell_line I-cell_line 0.4596571624279022
Chinese I-cell_line I-cell_line 0.7014275789260864
hamster I-cell_line I-cell_line 0.7783417701721191
ovary I-cell_line I-cell_line 0.7716761231422424
fibroblasts E-cell_line E-cell_line 0.9050472974777222
( O O 0.9813449382781982
CHO-CD14 B-cell_line B-cell_line 0.6949604749679565
cells E-cell_line E-cell_line 0.9707184433937073
) O O 0.9870370626449585
and O O 0.9998420476913452

. O O 0.9985442161560059
Deoxycorticosterone O O 0.8778228163719177
acetate O O 0.9885215759277344
had O O 0.99998939037323
an O O 0.9999947547912598
intermediate O O 0.9473708868026733
activity O O 0.9966384172439575
with O O 0.9999959468841553
an O O 0.9999856948852539
apparent O O 0.9940599203109741
Kd O O 0.9072816371917725
of O O 0.9957270622253418
100 O O 0.9838130474090576
nM O O 0.9929835796356201
. O O 0.9999918937683105
These O O 0.9999991655349731
findings O O 0.999669075012207
are O O 0.9999988079071045
the O O 0.9999977350234985
first O O 0.9999628067016602
to O O 0.9999904632568359
demonstrate O O 0.9999940395355225

of O O 0.9954842329025269
cells O O 0.9772405028343201
with O O 0.9999728202819824
1 O O 0.9680877327919006
, O O 0.9980140924453735
25- O O 0.9988162517547607
( O O 0.9998089671134949
OH O O 0.994295060634613
) O O 0.9994279742240906
2D3 O O 0.9980102181434631
had O O 0.9999954700469971
no O O 0.9999934434890747
effect O O 0.9999955892562866
on O O 0.9999983310699463
the O O 0.9999946355819702
time O O 0.9960772395133972
course O O 0.9982783794403076
of O O 0.9999790191650391
IL-1 B-RNA B-RNA 0.8804942965507507
beta I-RNA I-RNA 0.7120206952095032
mRNA E-RNA E-RNA 0.9405122995376587
appearance O O 0.9789506793022156
in O O 0.9999886751174927
response O O 0.9976738095283508
to O O 0.9999868869781494
LPS O O 0.9964951872825623
. O O 0.9999953508377075
However O O 0.9999814033508301
, O O 0.9999804496765137
exposure O O 0.9996005892753601
of O O 0.9999769926071167
U-937 B-cell_line B-cell_line 0.9543669819831848
cells E-cell_line E-cell_line 0.9988211989402771
to O O 0.9970218539237976
1 O O 0.9240235090255737
, O O 0.997057318687439
25- O O 0.9987173080444336
( O O 0.9998538494110107
OH O O 0.9946204423904419
) O O 0.999559223651886
2D3 O O 0.9914332628250122
increased O O 0.9999904632568359
by O O 0.9999977350234985
200 O O 0.9904824495315552

postactivation O O 0.7928815484046936
death O O 0.9486454725265503
. O O 0.9999463558197021
Proximal O O 0.9448885321617126
signal O O 0.9815635681152344
transduction O O 0.9920387268066406
events O O 0.9998200535774231
and O O 0.9999839067459106
immediate B-DNA O 0.9457482099533081
early I-DNA O 0.9154033660888672
gene E-DNA O 0.6718992590904236
transcription O O 0.9759983420372009
were O O 0.9999887943267822
unaffected O O 0.9998654127120972
. O O 0.9999973773956299
However O O 0.9999901056289673
, O O 0.999987006187439
the O O 0.9999951124191284
transcription O O 0.8987365365028381
and O O 0.9905491471290588

a O O 0.9965341091156006
characteristic O O 0.9973177313804626
of O O 0.9999791383743286
breast O O 0.9201129078865051
cancer O O 0.9961147308349609
. O O 0.9999978542327881
Out O O 0.9999648332595825
current O O 0.998984158039093
findings O O 0.9999721050262451
suggest O O 0.9999994039535522
that O O 0.9999961853027344
further O O 0.9991729855537415
investigations O O 0.9999428987503052
are O O 0.9999990463256836
warranted O O 0.9999810457229614
to O O 0.9999977350234985
elucidate O O 0.9999560117721558
the O O 0.999997615814209
possible O O 0.999541163444519
linkage O O 0.9998397827148438
of O O 0.999997615814209
ER B-DNA O 0.3518872857093811
codon I-DNA O 0.27183815836906433
10 E-DNA O 0.44326192140579224
polymorphism O O 0.6471871137619019
to O O 0.9995161294937134
physiological O O 0.9662494659423828
and O O 0.9901590943336487
pathological O O 0.9937385320663452
conditions O O 0.999860405921936
. O O 0.9999971389770508
USF/c-Myc S-protein S-protein 0.4110761284828186
enhances O O 0.8628852367401123
, O O 0.9957731366157532
while O O 0.9999703168869019

granules O O 0.6559232473373413

LKLF S-protein S-protein 0.9414426684379578
, O O 0.99227374792099
and O O 0.999292254447937
GATA3 B-protein B-protein 0.5627052783966064
zinc-finger I-protein I-protein 0.8476425409317017
proteins E-protein E-protein 0.9981157779693604
; O O 0.999454915523529
the O O 0.9998986721038818
Ets S-protein S-protein 0.46718257665634155
, O O 0.6405305862426758

studied O O 0.9971902966499329
the O O 0.9999959468841553
regulation O O 0.9998101592063904
of O O 0.9999934434890747
corticosteroid B-protein B-protein 0.5530232191085815
receptors E-protein E-protein 0.9928075075149536
in O O 0.9999188184738159

prior O O 0.99016273021698
to O O 0.999829888343811
treatment O O 0.9996108412742615
with O O 0.9999909400939941
PAO O O 0.8188884258270264
and O O 0.9994024038314819
TNF S-protein S-protein 0.8622953295707703
abolishes O O 0.9992998838424683
the O O 0.9999868869781494
inhibition O O 0.991870641708374
induced O O 0.999889612197876
by O O 0.9999936819076538
PAO O O 0.5839248895645142
, O O 0.9989989399909973
in O O 0.9997594952583313
T B-cell_type B-cell_type 0.9250215888023376
cells E-cell_type E-cell_type 0.9970824122428894
from O O 0.9997677206993103
both O O 0.9999864101409912
young O O 0.9882094860076904
and O O 0.99798583984375
old O O 0.994306743144989
donors O O 0.9964715242385864
, O O 0.9999103546142578
alike O O 0.9979864358901978
. O O 0.9999898672103882
Finally O O 0.9999678134918213
, O O 0.9999897480010986
we O O 0.9999369382858276

with O O 0.9980613589286804
dexamethasone O O 0.9660182595252991
. O O 0.999953031539917
The O O 0.999998927116394
ability O O 0.9999442100524902
of O O 0.9999929666519165
Jun B-protein B-protein 0.525903046131134
proteins E-protein E-protein 0.9819363951683044
to O O 0.9985646605491638
cooperate O O 0.999901294708252
with O O 0.9999637603759766
GR S-protein S-protein 0.992998480796814
in O O 0.9998379945755005
T B-cell_type B-cell_type 0.9368506073951721
cells E-cell_type E-cell_type 0.9914804697036743
has O O 0.9997609257698059
been O O 0.9999943971633911
investigated O O 0.9999922513961792
after O O 0.9999982118606567
transfection O O 0.9977832436561584
of O O 0.9999771118164062
c-jun B-DNA S-DNA 0.4842986762523651
, I-DNA O 0.7987391948699951
jun-B I-DNA S-protein 0.3527469038963318
, I-DNA O 0.5508552193641663

of O O 0.9983371496200562
patients O O 0.9957286715507507

Fc I-protein B-protein 0.576404333114624
receptor I-protein I-protein 0.7897130250930786
type I-protein I-protein 0.618634819984436
I E-protein E-protein 0.8719738125801086
( O O 0.9418609142303467
Fc B-protein B-protein 0.5097254514694214
gamma I-protein I-protein 0.8006524443626404
RI E-protein E-protein 0.9318042397499084
) O O 0.9342924952507019
on O O 0.9999388456344604
myeloid B-cell_type B-cell_type 0.670219898223877
cells E-cell_type E-cell_type 0.9808448553085327
is O O 0.9997569918632507
dramatically O O 0.9985597729682922
increased O O 0.9999563694000244
by O O 0.9999972581863403
treatment O O 0.9996271133422852
with O O 0.9999953508377075
interferon-gamma S-protein S-protein 0.6239897012710571

sulfate O O 0.5786681771278381
( O O 0.9899929165840149
T3SO4 O O 0.7357392311096191
) O O 0.9471908211708069
. O O 0.9999712705612183
We O O 0.9999510049819946
, O O 0.9999680519104004
therefore O O 0.9999552965164185
, O O 0.999957799911499
wished O O 0.9999547004699707
to O O 0.9999679327011108
determine O O 0.9999974966049194
whether O O 0.9999939203262329
T3SO4 O S-protein 0.711066722869873
could O O 0.9994706511497498
mimic O O 0.9998922348022461
the O O 0.999994158744812
action O O 0.9994551539421082
of O O 0.999990701675415
thyroid O O 0.7444658875465393
hormone O O 0.8576338887214661
in O O 0.9990262985229492
vitro O O 0.9964132905006409
. O O 0.9999891519546509
T3SO4 O S-protein 0.5446152091026306
had O O 0.9976153373718262
no O O 0.9999672174453735
thyromimetic O O 0.8270809054374695
effect O O 0.9979174733161926
on O O 0.9999959468841553

contain O O 0.9974296689033508
PPARgamma S-protein S-protein 0.8752930164337158
: O O 0.9821001291275024
differentiation-dependent B-protein O 0.9375860691070557
peroxisomal I-protein B-protein 0.6338095664978027
proliferator-activated I-protein I-protein 0.6695858836174011
receptor I-protein I-protein 0.37340354919433594
gamma E-protein E-protein 0.9622794985771179
( O O 0.9696049690246582
PPARgamma S-protein S-protein 0.9794527292251587
) O O 0.9809030294418335
expression O O 0.9988744854927063
and O O 0.9999839067459106
reduction O O 0.9964237809181213
of O O 0.9999780654907227
MMP-9 S-protein S-protein 0.9398252964019775
activity O O 0.9978231191635132
through O O 0.999995231628418
PPARgamma S-protein S-protein 0.9556379318237305
activation O O 0.9968032836914062
in O O 0.9999449253082275
mononuclear O B-cell_type 0.8040245175361633
phagocytes O E-cell_type 0.9967876672744751
in O O 0.999866247177124
vitro O O 0.9922824501991272
. O O 0.9999896287918091
Mononuclear B-cell_type O 0.724750816822052

recombinant O O 0.6276146769523621
IFN-gamma S-protein S-protein 0.6503071188926697
could O O 0.9999370574951172
activate O O 0.9999706745147705
the O O 0.9999850988388062
factor O O 0.9600925445556641
in O O 0.9996436834335327
naive B-cell_type B-cell_type 0.790746808052063
cells E-cell_type E-cell_type 0.9645325541496277
. O O 0.9997226595878601
Therefore O O 0.9999923706054688
, O O 0.999992847442627
a O O 0.9999872446060181
STAT1 S-protein B-protein 0.9537286162376404
transcription B-protein I-protein 0.7726680040359497
factor E-protein E-protein 0.9894711971282959
is O O 0.9996150732040405
activated O O 0.9961686730384827
by O O 0.9999774694442749
IFN-gamma S-protein S-protein 0.9813337922096252
synthesized O O 0.9900230765342712
and O O 0.9989321827888489
released O O 0.999330997467041
upon O O 0.9998266100883484
stimulation O O 0.9988117218017578
of O O 0.9999690055847168
T B-cell_type B-cell_type 0.8559442758560181

gene E-DNA E-DNA 0.9662237763404846
in O O 0.9996321201324463
primary B-cell_type B-cell_type 0.8024978041648865
B I-cell_type I-cell_type 0.9497231245040894
lymphocytes E-cell_type E-cell_type 0.9953603148460388
from O O 0.9998881816864014
transgenic O O 0.8733962178230286
mice O O 0.9948877692222595
. O O 0.9999988079071045
Analyses O O 0.9998940229415894
of O O 0.9999942779541016
nuclear O O 0.699536919593811
translocation O O 0.8485625982284546
of O O 0.9951381087303162
individual O O 0.7932010293006897

a O O 0.9947671890258789
given O O 0.994825005531311
differentiated O O 0.9776645302772522
phenotype O O 0.893746554851532
and O O 0.9964509010314941
suppress O O 0.9948720335960388
transcriptional B-protein B-protein 0.6988627314567566
activators E-protein E-protein 0.8237757086753845
that O O 0.9979744553565979
might O O 0.9999836683273315
typically O O 0.9999812841415405
be O O 0.9999872446060181
associated O O 0.9996188879013062
with O O 0.9999916553497314
proliferation O O 0.9996224641799927
. O O 0.9999982118606567
Ectopic O O 0.965385913848877
expression O O 0.9986622333526611
of O O 0.99998939037323
a O O 0.9998806715011597
conditional O O 0.49396705627441406
GATA-2/estrogen B-protein S-protein 0.2770169675350189

that O O 0.9995189905166626
cross-linking O O 0.9935644268989563
of O O 0.9999439716339111
MHC B-protein B-protein 0.5630689263343811
class I-protein I-protein 0.9243212342262268
II I-protein I-protein 0.5058730244636536
molecules E-protein E-protein 0.9931569695472717

the O O 0.9982247948646545
HSV-2 B-protein B-protein 0.5351796746253967
VP16 I-protein I-protein 0.4461008906364441
protein E-protein E-protein 0.9866349101066589
were O O 0.9998383522033691
utilized O O 0.9999105930328369
for O O 0.9999957084655762
studies O O 0.9997188448905945
of O O 0.9999951124191284
peptide O O 0.821313202381134
binding O O 0.93115234375
to O O 0.998701810836792
DQ0302 O B-protein 0.33403438329696655
molecules O E-protein 0.9830588102340698
and O O 0.99864262342453
T O O 0.4630146026611328
cell O O 0.3799959421157837
activation O O 0.9701029062271118
at O O 0.9999816417694092
both O O 0.9998787641525269
neutral O O 0.8411312699317932
and O O 0.9816709756851196
acidic O O 0.7638498544692993
pH O O 0.41353267431259155
. O O 0.9996873140335083
The O O 0.9999897480010986

therefore O O 0.9992145299911499
an O O 0.9999953508377075
effective O O 0.9960982799530029
strategy O O 0.9996474981307983
to O O 0.9999943971633911
target O O 0.9994932413101196
expression O O 0.9991194605827332
of O O 0.999995231628418
a O O 0.9999220371246338
retroviral B-DNA O 0.6366375088691711
transgene E-DNA O 0.7064761519432068
to O O 0.9966515898704529
a O O 0.9999701976776123
specific O O 0.9772336483001709
progeny O O 0.9659062623977661
of O O 0.9998346567153931
transduced B-cell_line B-cell_line 0.6037307977676392
hematopoietic I-cell_line I-cell_line 0.7980290055274963
stem I-cell_line I-cell_line 0.9176246523857117
cells E-cell_line E-cell_line 0.9331833124160767
. O O 0.9999316930770874
Regulation O O 0.9997933506965637
of O O 0.9999951124191284
Fas B-protein B-protein 0.7402716875076294
ligand E-protein E-protein 0.9640593528747559
expression O O 0.9979507327079773
and O O 0.9999493360519409
cell O O 0.9677470922470093
death O O 0.9961303472518921
by O O 0.9999957084655762
apoptosis-linked B-DNA O 0.70820152759552

( I-protein I-protein 0.8798015713691711
alpha I-protein I-protein 0.3652813732624054
) E-protein E-protein 0.8658878207206726
levels O O 0.99666827917099
and O O 0.9999887943267822
the O O 0.9999979734420776
enhancing O O 0.9981708526611328
effect O O 0.9999595880508423
of O O 0.9999977350234985
the O O 0.9999911785125732
cytokine S-protein S-protein 0.8337651491165161
on O O 0.9992325305938721
retinoid-dependent B-protein O 0.6008052825927734

fraction E-cell_type O 0.9385988712310791
of O O 0.999713122844696
human B-cell_type B-cell_type 0.4922596216201782
peripheral I-cell_type I-cell_type 0.690851092338562
blood I-cell_type I-cell_type 0.9270862936973572
cells E-cell_type E-cell_type 0.9821605682373047
. O O 0.9998931884765625
As O O 0.9999719858169556
neutrophils S-cell_type S-cell_type 0.9972792267799377
occupy O O 0.9992431402206421
approximately O O 0.9999399185180664
92 O O 0.9964753985404968
% O O 0.9990363121032715
of O O 0.9999951124191284
the O O 0.9998621940612793
cells O O 0.9760044813156128
in O O 0.9999377727508545
granulocyte B-cell_type O 0.656505286693573
fraction E-cell_type O 0.8499734401702881
of O O 0.998399555683136
human B-cell_type B-cell_type 0.4870087504386902
peripheral I-cell_type I-cell_type 0.7123985290527344
blood I-cell_type I-cell_type 0.9173758029937744
cells E-cell_type E-cell_type 0.9862393736839294

cells E-cell_type E-cell_type 0.5078182220458984
and O O 0.9932367205619812
dendritic B-cell_type B-cell_type 0.871986448764801
cells E-cell_type E-cell_type 0.987966001033783
. O O 0.9999624490737915
Its O O 0.9999839067459106
cognate B-protein O 0.9175599217414856
ligand E-protein O 0.8500745296478271
( O O 0.9897580146789551
RANKL S-protein S-protein 0.9870720505714417
) O O 0.9915549159049988
plays O O 0.9999774694442749
significant O O 0.999323844909668
roles O O 0.9998950958251953
in O O 0.9999979734420776
the O O 0.9999964237213135
activation O O 0.9941609501838684
of O O 0.9997630715370178

role O O 0.9818065166473389
in O O 0.9999836683273315
the O O 0.9999969005584717
apoptotic O O 0.8744971752166748
process O O 0.9919067621231079
of O O 0.9999779462814331
human B-cell_type B-cell_type 0.6429203152656555
hematopoietic I-cell_type I-cell_type 0.7729564905166626
cells E-cell_type E-cell_type 0.9766913652420044
. O O 0.999942421913147
Overexpression O O 0.9985538125038147
of O O 0.9999873638153076
protein B-protein B-protein 0.6495410799980164
kinase I-protein I-protein 0.9161161184310913
C-zeta E-protein E-protein 0.9201051592826843
stimulates O O 0.9992997646331787
leukemic B-cell_type O 0.6135036945343018
cell E-cell_type O 0.6471512913703918
differentiation O O 0.9946814179420471
. O O 0.999996542930603
A O O 0.9997743964195251
function O O 0.9989884495735168
for O O 0.9999537467956543
protein B-protein B-protein 0.6398360729217529
kinase I-protein I-protein 0.9038084745407104
C-zeta E-protein E-protein 0.8249616622924805
( O O 0.9917160868644714
PKC-zeta S-protein S-protein 0.998023509979248
) O O 0.9849280118942261
, O O 0.9998595714569092
a O O 0.9998997449874878

if O O 0.9997619986534119
the O O 0.9999889135360718
Ad5-induced O O 0.8751453757286072
inhibition O O 0.9841371774673462
of O O 0.9997674822807312
IFN S-protein S-protein 0.9689486622810364
-MCP O O 0.5646795034408569
was O O 0.9999717473983765
independent O O 0.9999333620071411
of O O 0.9999954700469971
adenovirus O O 0.844821035861969
( O O 0.9926626682281494
Ad O O 0.9465919733047485
) O O 0.9912760257720947
infection O O 0.9993352293968201
and O O 0.9999849796295166
secondary O O 0.9956262111663818
only O O 0.9999593496322632
to O O 0.9999947547912598
the O O 0.9999960660934448
expression O O 0.9993485808372498
of O O 0.9999969005584717
the O O 0.9998509883880615
Ad B-DNA B-DNA 0.7166645526885986
early I-DNA I-DNA 0.8888604640960693
region I-DNA I-DNA 0.9056373238563538
1A I-DNA I-DNA 0.5669066905975342
gene E-DNA E-DNA 0.9708890914916992

manic O O 0.8237061500549316
, O O 0.9906293749809265
and O O 0.9982035160064697
depressed O O 0.962320864200592
patients O O 0.9980295300483704
with O O 0.9999845027923584
bipolar O O 0.9877705574035645
disorder O O 0.9992664456367493
and O O 0.9999719858169556
healthy O O 0.9927318692207336
subjects O O 0.9975653886795044
. O O 0.9999973773956299
METHODS O O 0.9417294859886169

or O O 0.9454183578491211
HEB S-protein S-protein 0.8045950531959534
and O O 0.9407820105552673
E2A B-protein B-protein 0.45216062664985657
proteins E-protein E-protein 0.9935067892074585
. O O 0.9999568462371826
The O O 0.9999915361404419
Id1 O B-protein 0.5440471172332764
protein O E-protein 0.9612846374511719
was O O 0.9993020296096802
found O O 0.9999904632568359
to O O 0.9999897480010986
repress O O 0.9999258518218994
ALF1 S-protein S-protein 0.9801411032676697
activity O O 0.9990471005439758
in O O 0.9999825954437256
vitro O O 0.9863444566726685
and O O 0.9991229176521301
in O O 0.9998470544815063
vivo O O 0.9958664178848267
. O O 0.9999911785125732
Moreover O O 0.994100034236908
, O O 0.999747097492218
ectopic B-protein O 0.8752880096435547
Id1 E-protein S-protein 0.5701351165771484
repressed O O 0.9215013384819031
E B-DNA O 0.328174352645874
( I-DNA O 0.6286991238594055

( O O 0.9458017349243164
HTLV-I O O 0.4685211479663849
) O O 0.6410609483718872
is O O 0.9997400641441345
a O O 0.9999964237213135
potent O O 0.9580704569816589
transcriptional B-protein B-protein 0.7925029993057251
activator E-protein E-protein 0.8438639044761658
that O O 0.9990130662918091
both O O 0.9999814033508301
stimulates O O 0.9966044425964355
viral O O 0.7389472126960754
gene O O 0.6903506517410278
expression O O 0.9906546473503113
and O O 0.9998834133148193
activates O O 0.9996019005775452
an O O 0.9999806880950928
array O O 0.9910858273506165
of O O 0.9998786449432373
cellular B-DNA B-DNA 0.4156270921230316
genes E-DNA E-DNA 0.9482308626174927
involved O O 0.9994206428527832

that O O 0.9996551275253296
the O O 0.9999938011169434
interaction O O 0.9982319474220276
between O O 0.999904990196228
Cbl S-protein S-protein 0.9928395748138428
and O O 0.9972448348999023
PI3-K S-protein S-protein 0.9915083646774292
is O O 0.9997497200965881
not O O 0.9999295473098755
required O O 0.999969482421875
in O O 0.9999986886978149
the O O 0.9999936819076538
70Z/3 S-protein S-protein 0.781866729259491
-mediated O O 0.9956732392311096
induction O O 0.9993405938148499
of O O 0.9999924898147583
NFAT S-protein S-protein 0.9899862408638
. O O 0.9999744892120361
Additional O O 0.9996106028556824
mapping O O 0.9707118272781372
studies O O 0.9991342425346375
indicated O O 0.9999940395355225
that O O 0.9999977350234985

previous O O 0.9970508813858032
studies O O 0.9996250867843628
in O O 0.9999853372573853
human B-cell_type B-cell_type 0.4752744436264038
monocytes E-cell_type E-cell_type 0.945586085319519
have O O 0.9999527931213379
demonstrated O O 0.9999946355819702
that O O 0.9999990463256836
interleukin B-protein B-protein 0.6782768368721008
( I-protein I-protein 0.7777310013771057
IL I-protein I-protein 0.9779269099235535
) I-protein I-protein 0.9126559495925903
-10 E-protein I-protein 0.5710058212280273

10 O O 0.8241451978683472
% O O 0.9723936915397644
of O O 0.9999117851257324
the O O 0.9999821186065674
TBP7 S-protein B-DNA 0.5994196534156799
sequence O E-DNA 0.9708186388015747
, O O 0.998515784740448
and O O 0.9999867677688599
the O O 0.9999990463256836
fact O O 0.999845027923584
that O O 0.9999986886978149
the O O 0.9999921321868896
migration O O 0.9929866194725037
of O O 0.9998650550842285

to O O 0.9965227842330933
IFN-gamma S-protein S-protein 0.988934338092804
. O O 0.9999412298202515
When O O 0.9999676942825317
freshly O O 0.7456651329994202
isolated O O 0.9186521768569946
, O O 0.9925299286842346
highly O O 0.7769768238067627
enriched O O 0.8107224106788635
( O O 0.9623430967330933
> O O 0.9953853487968445
98 O O 0.9949924349784851
% O O 0.9986673593521118
) O O 0.9975534081459045
T B-cell_type B-cell_type 0.7326449751853943
cells E-cell_type E-cell_type 0.9736723303794861
are O O 0.9998576641082764
examined O O 0.9998582601547241
for O O 0.9999929666519165
IFN-gamma S-protein S-protein 0.9859224557876587
responsiveness O O 0.9978659749031067
; O O 0.999982476234436
these O O 0.9999344348907471
cells O O 0.9792024493217468
can O O 0.9999650716781616
respond O O 0.9999690055847168
to O O 0.9999655485153198
IFN-gamma S-protein S-protein 0.9954079985618591
and O O 0.9988070726394653

, O O 0.9373978972434998

effusions O O 0.9604623317718506
is O O 0.9999862909317017
possible O O 0.9999810457229614
and O O 0.9999948740005493
that O O 0.9999996423721313
there O O 0.9999970197677612
is O O 0.9999985694885254
a O O 0.9999992847442627
correlation O O 0.9998213648796082
with O O 0.9999991655349731
the O O 0.9999979734420776
status O O 0.9983739852905273
of O O 0.9999873638153076
the O O 0.9999908208847046
primary O O 0.5706830620765686
site O O 0.4968859851360321
of O O 0.9959549903869629
cancer O O 0.9941344857215881
. O O 0.9999960660934448
Constitutive O O 0.9925222992897034
activation O O 0.9970955848693848
of O O 0.9999536275863647
NF-kB S-protein S-protein 0.9947696328163147
in O O 0.9998290538787842
human B-cell_type B-cell_type 0.7775201797485352
thymocytes E-cell_type E-cell_type 0.9838236570358276
. O O 0.9997392296791077
NF-kB S-protein S-protein 0.979259729385376
is O O 0.9998036026954651

IL-1 B-protein B-protein 0.6307497024536133
receptor-associated I-protein I-protein 0.46874919533729553
kinase E-protein E-protein 0.9848806858062744
on O O 0.9996148347854614
NFkappaB S-protein S-protein 0.9861897826194763
activation O O 0.9970620274543762
, O O 0.9999418258666992
IL-2 S-protein S-protein 0.9346535205841064
production O O 0.9962906837463379

of O O 0.9947364926338196
c-Rel S-protein S-protein 0.9906800389289856
correlate O O 0.999626874923706
with O O 0.9999805688858032
its O O 0.9999042749404907
DNA-binding O O 0.5498911738395691
activity O O 0.9355136752128601
but O O 0.9983966946601868
not O O 0.9997105002403259
with O O 0.9999536275863647
its O O 0.9999257326126099
ability O O 0.9996688365936279
to O O 0.9999330043792725
heterodimerize O O 0.9430860280990601
with O O 0.9994924068450928
p50 S-protein S-protein 0.9552106261253357
, O O 0.9935897588729858
suggesting O O 0.9999409914016724
that O O 0.9999915361404419
c-Rel S-protein S-protein 0.9876283407211304
inhibition O O 0.9986060261726379
involves O O 0.9999990463256836

or O O 0.9460419416427612
control B-cell_type O 0.7267680764198303
cells E-cell_type O 0.5710699558258057
, O O 0.9925069212913513
while O O 0.9999736547470093
treatment O O 0.9930251836776733
of O O 0.9999271631240845
ER- B-cell_line B-cell_line 0.49229520559310913
cells E-cell_line E-cell_line 0.73966383934021
with O O 0.9990929365158081
either O O 0.9999403953552246
E2 O O 0.35110440850257874
or O O 0.9400122165679932
TAM O O 0.37087541818618774
alone O O 0.943191647529602
did O O 0.9994712471961975
not O O 0.9999712705612183
alter O O 0.9999545812606812
from O O 0.9999772310256958
control O O 0.9943084120750427
their O O 0.9999361038208008
susceptibility O O 0.9995728135108948
to O O 0.999997615814209
this O O 0.9999903440475464
immune-mediated O O 0.984703779220581
lysis O O 0.9984550476074219
. O O 0.9999994039535522
All O O 0.9998583793640137
ER+ B-cell_line B-cell_line 0.7405734658241272
and I-cell_line I-cell_line 0.5747503042221069
ER- I-cell_line I-cell_line 0.4511547088623047
cells E-cell_line E-cell_line 0.8992303609848022
tested O O 0.9971224665641785
remained O O 0.9999744892120361
sensitive O O 0.9997676014900208
after O O 0.9999959468841553
treatment O O 0.9999212026596069
with O O 0.999997615814209
TAM O O 0.9332812428474426
to O O 0.999923586845398
lysis O O 0.9990178346633911
by O O 0.9999986886978149
LAK B-cell_type S-protein 0.6631890535354614

of O O 0.9979392886161804
a O O 0.9999653100967407
luciferase B-DNA B-DNA 0.6345098614692688
reporter I-DNA I-DNA 0.6818122863769531
gene E-DNA E-DNA 0.9930688142776489
, O O 0.9983922839164734
this O O 0.9999309778213501
promoter O S-DNA 0.8717822432518005
is O O 0.9990180730819702
able O O 0.9996005892753601
to O O 0.9999550580978394
direct O O 0.9999343156814575
a O O 0.9999642372131348
high O O 0.8774389624595642
luciferase S-protein S-protein 0.7284772396087646
activity O O 0.9949811100959778
in O O 0.9999967813491821
a O O 0.9999387264251709
human B-cell_line B-cell_line 0.6992154121398926
B-LCL E-cell_line E-cell_line 0.7255626320838928
. O O 0.9880366325378418
In O O 0.9998014569282532
contrast O O 0.9996144771575928

lymphocytes E-cell_type E-cell_type 0.6342547535896301
during O O 0.9998118281364441
aging O O 0.9936593174934387
: O O 0.9998613595962524
evidence O O 0.9999053478240967
for O O 0.9999957084655762
altered O O 0.9779019355773926
IkappaB-alpha S-protein S-protein 0.9919852018356323
phosphorylation O O 0.9982129335403442
and O O 0.9999809265136719
degradation O O 0.9963030815124512
. O O 0.999991774559021
Nuclear B-protein B-protein 0.5512890815734863
Factor I-protein I-protein 0.5832207202911377
kappa I-protein I-protein 0.8528591394424438
B E-protein E-protein 0.9931938648223877
( O O 0.9911593794822693
NFkappaB S-protein S-protein 0.9980418682098389
) O O 0.9945112466812134
is O O 0.999997615814209
a O O 0.9999973773956299
critical O O 0.9612619280815125
regulator O O 0.8901283740997314

cell O O 0.3733727037906647
proliferation O O 0.9934780597686768
. O O 0.9999991655349731
Further O O 0.9999498128890991
Northern O O 0.9979798197746277
analyses O O 0.9997401833534241
indicated O O 0.9999934434890747
that O O 0.9999985694885254
there O O 0.9999914169311523
was O O 0.9999969005584717
no O O 0.9999980926513672
significant O O 0.9999134540557861
change O O 0.999987006187439
in O O 0.9999897480010986
17beta-HSD B-protein B-protein 0.47354525327682495
IV E-protein E-protein 0.8311695456504822
or O O 0.9961599111557007
DNA-PK B-RNA O 0.6452862620353699
( I-RNA O 0.9633250832557678

these O O 0.9979912042617798
agents O O 0.9908254742622375
was O O 0.9999725818634033
independent O O 0.9998964071273804
of O O 0.999994158744812
the O O 0.9999920129776001
inhibition O O 0.9822351932525635
of O O 0.9969419836997986
proliferation O O 0.9960983991622925
. O O 0.9999922513961792
In O O 0.9999192953109741
addition O O 0.999904990196228
, O O 0.9999215602874756
IL-2 S-protein S-protein 0.9956645369529724
but O O 0.9975907802581787
not O O 0.9987756609916687
IL-12 S-protein S-protein 0.9916280508041382
induced O O 0.9918560981750488
nuclear B-protein B-protein 0.6491591930389404
factors E-protein E-protein 0.9561939239501953
NF-kappa B-protein B-protein 0.576867938041687

choice O O 0.921796977519989
between O O 0.9995083808898926
T B-cell_type B-cell_type 0.6714820861816406
and I-cell_type I-cell_type 0.8644870519638062
B I-cell_type I-cell_type 0.9811320900917053
lymphocytes E-cell_type E-cell_type 0.9918692111968994
. O O 0.9999308586120605
Transgenic O O 0.9656602740287781
mice O O 0.9961621761322021
with O O 0.9999948740005493
human B-DNA B-DNA 0.6693122386932373
CD3epsilon I-DNA I-DNA 0.6596261858940125
gene E-DNA E-DNA 0.9903534650802612
have O O 0.9996887445449829
been O O 0.9999107122421265
shown O O 0.9999649524688721
to O O 0.9999887943267822
exhibit O O 0.9999229907989502
early O O 0.963498055934906
arrest O O 0.9993773102760315
of O O 0.9999912977218628

enhancer I-DNA I-DNA 0.5896711945533752
motifs E-DNA E-DNA 0.9501371383666992
, O O 0.9981526732444763
5'NF-E2/AP1 S-DNA S-DNA 0.9627887606620789
, O O 0.9898902177810669
GT B-DNA B-DNA 0.7406769394874573
II E-DNA E-DNA 0.9674878120422363
, O O 0.9806240200996399
and O O 0.9954699277877808
GATA-1 B-DNA B-DNA 0.44621679186820984
( I-DNA I-DNA 0.49927666783332825
c I-DNA I-DNA 0.7962861061096191
) E-DNA E-DNA 0.7889042496681213
, O O 0.95163893699646
positively O O 0.9917497038841248
regulate O O 0.999927282333374
the O O 0.999832034111023
zeta B-DNA B-DNA 0.7279713153839111
2-globin I-DNA I-DNA 0.5035092234611511
promoter E-DNA E-DNA 0.9205429553985596
activity O O 0.9410972595214844
in O O 0.9999361038208008
embryonic/fetal B-cell_line B-cell_line 0.4511052966117859
erythroid I-cell_line I-cell_line 0.5870703458786011
K562 I-cell_line I-cell_line 0.6148030757904053
cells E-cell_line E-cell_line 0.9843319654464722
and O O 0.9983671307563782
the O O 0.9999874830245972
adult B-DNA O 0.6397969722747803

in O O 0.9987496137619019
the O O 0.9999510049819946
B B-cell_type B-cell_type 0.6927035450935364
cells E-cell_type E-cell_type 0.9788691401481628
of O O 0.9996559619903564
both O O 0.9999645948410034
humans O O 0.9755409955978394
and O O 0.9992679953575134
mice O O 0.9919596314430237
, O O 0.9999945163726807
a O O 0.9999940395355225
functional B-DNA B-DNA 0.9276652932167053
promoter I-DNA I-DNA 0.6397365927696228
region E-DNA E-DNA 0.9869129657745361
( O O 0.9979584217071533

to O O 0.9992185831069946
the O O 0.9999977350234985
study O O 0.9995166063308716
of O O 0.9999938011169434
different O O 0.9969493746757507
aspects O O 0.9991171956062317
of O O 0.9999775886535645
T O O 0.7395493984222412
cell O O 0.6811633110046387
biology O O 0.9789262413978577
, O O 0.9998764991760254
but O O 0.9998611211776733
will O O 0.9999872446060181
also O O 0.9999960660934448

. O O 0.9991379976272583
Comparison O O 0.9996984004974365
of O O 0.9999960660934448
a O O 0.9999903440475464
nearly B-DNA O 0.9865655303001404
full-length I-DNA O 0.8499585390090942
cDNA I-DNA B-DNA 0.256009042263031
sequence E-DNA E-DNA 0.9874474406242371
with O O 0.9999589920043945
the O O 0.9999858140945435
corresponding O O 0.930044412612915
genomic B-DNA O 0.828302264213562
sequence E-DNA O 0.7649884223937988
reveals O O 0.9999505281448364
one O O 0.9998019337654114
small O B-DNA 0.7760190963745117
intron O E-DNA 0.6511000990867615
and O O 0.976904571056366
an O O 0.9994285702705383
open B-DNA B-DNA 0.7579540014266968
reading I-DNA I-DNA 0.929140567779541

3 I-DNA I-DNA 0.5453969836235046
' I-DNA I-DNA 0.40245914459228516
enhancer E-DNA E-DNA 0.9906450510025024
activity O O 0.9761481285095215
and O O 0.9996787309646606
c-myc S-DNA S-DNA 0.9504292011260986
expression O O 0.9933708906173706
in O O 0.9999953508377075
a O O 0.9999538660049438
plasmacytoma O B-cell_line 0.455209344625473
x O I-cell_line 0.7667285203933716
fibroblast O I-cell_line 0.8197799324989319
environment O E-cell_line 0.7860628366470337
: O O 0.9749770760536194
implications O O 0.9999271631240845

it O O 0.9964027404785156
prevents O O 0.9999842643737793
high O O 0.9874125719070435
level O O 0.9968358874320984
induction O O 0.9992058873176575
of O O 0.9999803304672241
IL-2R S-protein S-protein 0.9693908095359802
. O O 0.9998268485069275
The O O 0.9999988079071045
presence O O 0.9985894560813904
of O O 0.9999783039093018
TN S-protein S-protein 0.8089844584465027
in O O 0.9983912110328674
culture O O 0.9351648092269897
medium O O 0.9778467416763306
does O O 0.9999253749847412
not O O 0.9999792575836182
detectably O O 0.9999078512191772
alter O O 0.9999566078186035
the O O 0.999996542930603
pattern O O 0.9994175434112549
of O O 0.9999926090240479
tyrosine O O 0.7872321605682373
phosphorylation O O 0.9534140825271606

influx O O 0.954591691493988
into O O 0.9999849796295166
the O O 0.9999814033508301
E. O O 0.7046645879745483
histolytica-infected O O 0.8691931366920471
intestinal O O 0.7839133143424988
xenografts O O 0.872438907623291
. O O 0.9999719858169556
Inhibition O O 0.9979349374771118
of O O 0.9999858140945435
the O O 0.9999936819076538
gut O O 0.7245442271232605
inflammatory O O 0.8309507966041565
response O O 0.9849908947944641
by O O 0.9999946355819702
the O O 0.9999868869781494
antisense O O 0.7363373637199402
oligonucleotide O O 0.7230913639068604
or O O 0.9978783130645752
the O O 0.9999772310256958
depletion O O 0.9963048696517944
of O O 0.9999737739562988
neutrophils S-cell_type S-cell_type 0.9967165589332581
from O O 0.9998369216918945
SCID-HU- O O 0.6627414226531982
INT O O 0.40725353360176086
mice O O 0.9355584383010864
blocked O O 0.9998528957366943
the O O 0.9999991655349731
increase O O 0.9999532699584961
in O O 0.9999704360961914
intestinal O O 0.8588325381278992
permeability O O 0.9919158816337585
observed O O 0.9998117089271545
with O O 0.9999463558197021
amebic O O 0.9059080481529236
infection O O 0.998202919960022
. O O 0.9999974966049194
CONCLUSIONS O O 0.999570906162262
: O O 0.9999858140945435
Intestinal B-cell_type B-cell_type 0.6186708211898804
epithelial I-cell_type I-cell_type 0.946534276008606
cells E-cell_type E-cell_type 0.9936368465423584
initiate O O 0.9999003410339355
an O O 0.9999943971633911
inflammatory O O 0.9233372807502747
response O O 0.9952690005302429
with O O 0.9999904632568359
resulting O O 0.99811851978302
neutrophil-mediated O O 0.9144147038459778
tissue O O 0.9595133662223816

and O O 0.9779137969017029
healthy O O 0.975680947303772
controls O O 0.996946394443512
were O O 0.999997615814209
7.03 O O 0.9332702159881592
( O O 0.9997546076774597
range O O 0.9974215030670166
, O O 0.9999527931213379
5.66-10 O O 0.9987289309501648
) O O 0.9998483657836914
, O O 0.9999855756759644
4.27 O O 0.9837474226951599
( O O 0.9999542236328125
range O O 0.9984577894210815
, O O 0.9999425411224365
4-5.13 O O 0.9979725480079651
) O O 0.9998111128807068
, O O 0.9999806880950928
and O O 0.9999221563339233
6.18 O O 0.9489604234695435
( O O 0.9997252821922302
range O O 0.9980643391609192
, O O 0.9999326467514038
5.86-6.74 O O 0.9995267391204834
) O O 0.9998024106025696
nM O O 0.9981846213340759
, O O 0.9999676942825317
respectively O O 0.9999936819076538
. O O 0.9999940395355225
Nonresponders O O 0.7957936525344849
had O O 0.9999778270721436
a O O 0.9999897480010986
significant O O 0.9987390637397766
increase O O 0.9999778270721436

blood O O 0.5475591421127319

not O O 0.9719743132591248
maintain O O 0.9921929240226746
v-Abl S-protein S-protein 0.9501367211341858
-mediated O O 0.9963638186454773
differentiation O O 0.9974328875541687
arrest O O 0.9999433755874634
of O O 0.999996542930603
the O O 0.9999736547470093
pre-B B-cell_type B-cell_type 0.5831714272499084
cells E-cell_type E-cell_type 0.8541497588157654
, O O 0.9951413869857788
as O O 0.999998927116394
activation O O 0.9958617687225342
of O O 0.9999635219573975
NF-kappaB S-protein S-protein 0.9222915768623352
and O O 0.990036129951477
RAG B-DNA B-DNA 0.4233076572418213
gene E-DNA E-DNA 0.8734123110771179
transcription O O 0.8967136144638062
was O O 0.9998854398727417
unaffected O O 0.9999817609786987
by O O 0.9999971389770508
IL-7 S-protein S-protein 0.9963255524635315
. O O 0.9999701976776123
These O O 0.9999982118606567
results O O 0.9999105930328369
identify O O 0.999997615814209
a O O 0.9999973773956299
potential O O 0.9931893348693848
role O O 0.9993743300437927
for O O 0.9999837875366211

RNAs E-RNA E-RNA 0.49710777401924133
. O O 0.9994083642959595
Nuclear O O 0.9287140965461731
run-on O O 0.9342371821403503
experiments O O 0.9971621632575989
showed O O 0.9999995231628418
that O O 0.9999992847442627
THP O O 0.3839728832244873
inhibited O O 0.9619858264923096
transcription O O 0.963538646697998
of O O 0.9997568726539612
the O O 0.9999780654907227
IL-1 B-DNA B-DNA 0.7683504819869995
beta I-DNA I-DNA 0.480232834815979
gene E-DNA E-DNA 0.9922637939453125
. O O 0.9994540810585022
THP O O 0.47968590259552
decreased O O 0.9958025813102722
the O O 0.9999858140945435
concentration O O 0.998749852180481
of O O 0.9999926090240479
the O O 0.999983549118042
transcription B-protein B-protein 0.5790061950683594
factors E-protein E-protein 0.9868876338005066
NF-kappa B-protein B-protein 0.9280558824539185
B E-protein E-protein 0.9962666630744934
and O O 0.9970505237579346
AP-1 S-protein S-protein 0.9809069037437439
detected O O 0.9994656443595886
in O O 0.9999732971191406
nuclear O O 0.5953919887542725

by O O 0.9997312426567078
a O O 0.9999842643737793
cell-intrinsic O O 0.8824019432067871
mechanism O O 0.9810519218444824
that O O 0.9999868869781494
is O O 0.99998939037323
not O O 0.9998127818107605
dependent O O 0.9999746084213257
on O O 0.999983549118042
IL-4 S-protein S-protein 0.9732259511947632
and O O 0.9954884648323059
that O O 0.9999200105667114
may O O 0.9999665021896362
involve O O 0.9999979734420776
repression O O 0.9991801381111145
of O O 0.9999914169311523
IL-12 S-protein S-protein 0.9767773747444153
signaling O O 0.9927425384521484
. O O 0.9999940395355225
Thus O O 0.999721348285675
, O O 0.9996935129165649
GATA-3 S-protein S-protein 0.9923005104064941
expression O O 0.999799907207489
and O O 0.9999792575836182

control O O 0.9865582585334778
the O O 0.9999333620071411
expression O O 0.9991556406021118
of O O 0.9999957084655762
a O O 0.9999585151672363
number O O 0.9952474236488342
of O O 0.9999539852142334
cellular B-DNA B-DNA 0.4628938138484955
and I-DNA I-DNA 0.5258715152740479
viral I-DNA I-DNA 0.900615394115448
genes E-DNA E-DNA 0.990128219127655
. O O 0.9999284744262695
These O O 0.9999988079071045
two O O 0.9949946403503418

exhibits O O 0.9702929854393005
similar O O 0.9997891783714294
but O O 0.9995239973068237
not O O 0.99930739402771
identical O O 0.9421189427375793
sensitivities O O 0.9831936359405518
to O O 0.9999969005584717
a O O 0.9999713897705078
proteasome O O 0.3838115632534027
inhibitor O O 0.51617431640625
. O O 0.9998267292976379
Together O O 0.9999727010726929
, O O 0.9999904632568359
these O O 0.999994158744812
results O O 0.9999587535858154
suggest O O 0.9999991655349731
that O O 0.9999967813491821
phosphorylation O O 0.9905086755752563
of O O 0.999921441078186
I B-protein B-protein 0.8968687653541565
kappa I-protein I-protein 0.8994362354278564
B I-protein I-protein 0.7497350573539734
alpha E-protein E-protein 0.9934459328651428
, O O 0.9980340600013733
mediated O O 0.9971966743469238
through O O 0.999983549118042
both O O 0.9999949932098389
the O O 0.9999762773513794

activated O O 0.9180986881256104
upon O O 0.9981155395507812
hemin O S-protein 0.8144398331642151
treatment O O 0.997495174407959
. O O 0.9999959468841553
In O O 0.999902606010437
contrast O O 0.9999499320983887
, O O 0.9999816417694092
when O O 0.9999403953552246
HSF2-beta S-protein S-protein 0.9769605398178101
is O O 0.9996122717857361
expressed O O 0.9997351765632629
at O O 0.9999847412109375
levels O O 0.9997479319572449
exceeding O O 0.9999730587005615
those O O 0.9999951124191284
of O O 0.9999909400939941
endogenous B-protein B-protein 0.43214595317840576
HSF2-alpha E-protein E-protein 0.8848482966423035
, O O 0.9940662384033203
the O O 0.9999493360519409

and O O 0.9774121046066284
in O O 0.9998401403427124
identifying O O 0.9982140064239502
potential O O 0.990847110748291
therapeutic O O 0.9678100943565369
targets O O 0.9451351761817932
. O O 0.9999986886978149
The O O 0.9999836683273315
Epstein-Barr B-protein B-protein 0.4524717926979065
virus I-protein I-protein 0.7646705508232117
oncoprotein I-protein I-protein 0.936128556728363
latent I-protein I-protein 0.6714914441108704
membrane I-protein I-protein 0.5478968620300293
protein I-protein I-protein 0.4822673797607422
1 E-protein E-protein 0.9969798922538757
engages O O 0.9991579055786133
the O O 0.9999333620071411
tumor B-protein B-protein 0.7109789848327637
necrosis I-protein I-protein 0.8890146613121033
factor I-protein I-protein 0.6479745507240295

In O O 0.9987647533416748
electrophoretic O O 0.8603183627128601
mobility O O 0.9867537617683411
shift O O 0.9982901215553284
assays O O 0.9996552467346191
using O O 0.9999853372573853
the O O 0.9999709129333496
E1 S-DNA B-DNA 0.6488093137741089
oligonucleotide O E-DNA 0.8761063814163208
as O O 0.996487021446228
probe O O 0.9371732473373413

of O O 0.9970153570175171
the O O 0.9999442100524902
5'-UTR S-DNA S-DNA 0.921376645565033
was O O 0.9986220598220825
localized O O 0.9990732669830322
to O O 0.9999639987945557
tandem O B-DNA 0.7743422985076904
GATA-like B-DNA I-DNA 0.35529598593711853
sites E-DNA E-DNA 0.8423369526863098
, O O 0.997519314289093
which O O 0.9999656677246094
appear O O 0.9999408721923828
to O O 0.9999885559082031
bind O O 0.9999504089355469
a O O 0.9999903440475464
complex O O 0.9183930158615112
of O O 0.9979202151298523
two O O 0.9910449981689453
proteins O O 0.8612081408500671
, O O 0.9966854453086853

cytopathic O O 0.7342545986175537
effects O O 0.9990872144699097
in O O 0.9999914169311523
HIV-infected B-cell_type B-cell_type 0.5057919025421143
human I-cell_type I-cell_type 0.3256828486919403
T I-cell_type I-cell_type 0.5950915813446045
cells E-cell_type E-cell_type 0.7601996064186096
. O O 0.9999059438705444
This O O 0.9999988079071045
study O O 0.999956488609314
examines O O 0.9999961853027344
the O O 0.9999959468841553
regions O O 0.9928746223449707
of O O 0.9999810457229614
the O O 0.999915599822998
HIV B-DNA B-DNA 0.8374300599098206
promoter E-DNA E-DNA 0.993419349193573
required O O 0.9991718530654907
for O O 0.9999892711639404
HHV-6 O O 0.39252030849456787
transactivation O O 0.9741766452789307
in O O 0.9999833106994629
a O O 0.9999610185623169
heterogeneous O O 0.6206681728363037
population O O 0.4107570946216583
of O O 0.9943932294845581

transfected O O 0.6416491866111755

and O O 0.9735528230667114
signalling O O 0.9976775050163269
in O O 0.9997839331626892
peripheral B-cell_type B-cell_type 0.4928557574748993
blood I-cell_type I-cell_type 0.8790449500083923
mononuclear I-cell_type I-cell_type 0.9924477338790894
cells E-cell_type E-cell_type 0.9966762065887451
from O O 0.999944806098938
patients O O 0.9996557235717773
with O O 0.9999483823776245
thalassaemia O O 0.9909668564796448
or O O 0.9999072551727295
sickle O O 0.9134148359298706
cell O O 0.8646438121795654

actual O O 0.9090814590454102
target O O 0.8855113983154297
of O O 0.9989597797393799
the O O 0.9999843835830688
silencing O O 0.9842490553855896
. O O 0.9999747276306152
To O O 0.9999886751174927
gain O O 0.9999735355377197
further O O 0.9998730421066284
insight O O 0.9999446868896484
into O O 0.9999978542327881
the O O 0.9999934434890747
suppression O O 0.927705705165863
phenomenon O O 0.9426310062408447
we O O 0.9999880790710449
performed O O 0.9998636245727539
luciferase O O 0.6751199960708618
assays O O 0.9784219264984131
which O O 0.9999880790710449
show O O 0.9999988079071045
that O O 0.9999979734420776
silencing O O 0.9961578249931335
affects O O 0.9999939203262329
the O O 0.9999966621398926
activity O O 0.9995251893997192
of O O 0.9999951124191284
the O O 0.9993541836738586
B-cell-specific B-DNA B-DNA 0.575519859790802
promoter E-DNA E-DNA 0.90326988697052
of O O 0.9634494781494141
CIITA S-protein S-protein 0.7028976082801819
. O O 0.9999395608901978
These O O 0.9999966621398926
results O O 0.9995228052139282
therefore O O 0.9999955892562866

the O O 0.9987358450889587
anti-AIM B-protein B-protein 0.6855078339576721
mAb E-protein E-protein 0.9948928356170654
was O O 0.9994595646858215
added O O 0.9999828338623047
to O O 0.9999934434890747
the O O 0.9999887943267822
culture O O 0.9374165534973145
medium O O 0.9562873244285583
in O O 0.9999831914901733
the O O 0.9999971389770508
presence O O 0.99887615442276
of O O 0.999984622001648
cycloheximide O O 0.9075443148612976
, O O 0.9984843134880066
suggesting O O 0.9999908208847046
that O O 0.9999973773956299
de O O 0.9937599301338196
novo O O 0.9964627623558044
protein O O 0.9260629415512085
synthesis O O 0.9896998405456543

paracrine O O 0.6220148205757141
effect O O 0.9967144727706909
on O O 0.9999860525131226
IL-2R-alpha S-protein S-protein 0.964876115322113
expression O O 0.9983566403388977
. O O 0.9999974966049194
These O O 0.9999971389770508
changes O O 0.9993820190429688
appear O O 0.9999905824661255
to O O 0.9999948740005493
be O O 0.9999945163726807
mediated O O 0.9998810291290283
by O O 0.9999974966049194
RAR-alpha S-protein S-protein 0.9949126243591309
. O O 0.9998866319656372
Thus O O 0.9999680519104004
, O O 0.9998766183853149
IL-2 S-protein S-protein 0.9962933659553528
may O O 0.9998620748519897
be O O 0.9999985694885254
another O O 0.9999990463256836
important O O 0.9987190961837769
cytokine S-protein S-protein 0.8913547992706299
modulated O O 0.9943727254867554
by O O 0.9999638795852661

oligo O O 0.5654445290565491
stimulation O O 0.9927380681037903
in O O 0.9999910593032837
patients O O 0.9974589943885803
, O O 0.9999724626541138
while O O 0.9999960660934448
it O O 0.9996381998062134
increased O O 0.9999279975891113
form O O 0.9984654188156128
4.7 O O 0.9987974166870117
% O O 0.9998028874397278
to O O 0.9999592304229736
48.6 O O 0.998915433883667
% O O 0.9998733997344971
in O O 0.999984622001648
healthy O O 0.9403995871543884
controls O O 0.9944977164268494
. O O 0.9999995231628418
The O O 0.9999982118606567
sense O O 0.9383131861686707
sequence O O 0.834299623966217
( O O 0.9966872334480286
sequence O O 0.8496972322463989
III O O 0.7126942276954651
) O O 0.9071094393730164
of O O 0.9994500279426575
the O O 0.999916672706604
X B-DNA B-DNA 0.9551044702529907
gene E-DNA E-DNA 0.9572743773460388

) I-DNA O 0.6721069812774658
chromosomal I-DNA O 0.6310099363327026
translocation E-DNA O 0.9689262509346008
in O O 0.9999563694000244
pro-B-cell O O 0.5282081961631775
acute O O 0.8529872894287109
lymphoblastic O O 0.8768109083175659
leukemia O O 0.9388875365257263
, O O 0.9992392063140869
incorporates O O 0.9999474287033081
the O O 0.9999904632568359
transactivation B-protein B-protein 0.6265649795532227
domains E-protein E-protein 0.9424224495887756
of O O 0.9996126294136047
E2A S-protein S-protein 0.961682915687561
and O O 0.9948370456695557
the O O 0.9997983574867249
basic B-protein B-protein 0.4989117383956909
leucine I-protein I-protein 0.7961835265159607
zipper I-protein I-protein 0.6728401780128479
( I-protein I-protein 0.6312975883483887
bZIP I-protein I-protein 0.8264865875244141
) I-protein I-protein 0.7497615218162537
DNA-binding I-protein E-protein 0.7831422090530396
and I-protein O 0.643265962600708
protein I-protein B-protein 0.48262882232666016
dimerization I-protein I-protein 0.9321314692497253
domain E-protein E-protein 0.9718868136405945
of O O 0.9916541576385498
HLF S-protein S-protein 0.980929970741272
( O O 0.9958578944206238
hepatic B-protein B-protein 0.6111953258514404
leukemic I-protein I-protein 0.8570042848587036
factor E-protein E-protein 0.9746871590614319
) O O 0.97320955991745
. O O 0.9999881982803345
The O O 0.9999985694885254
ability O O 0.999920129776001
of O O 0.9999874830245972
E2A-HLF S-protein S-protein 0.9288793206214905
to O O 0.997660756111145
prolong O O 0.999826967716217
the O O 0.9999657869338989
survival O O 0.9997283816337585
of O O 0.9999911785125732

gene I-protein I-protein 0.3874293565750122
product E-protein E-protein 0.8397736549377441
in O O 0.9997146725654602
a O O 0.99980229139328
variety O O 0.9925336837768555
of O O 0.9999421834945679
species O O 0.9805752038955688
, O O 0.9998887777328491
has O O 0.9999175071716309
been O O 0.9999402761459351
found O O 0.9999616146087646
to O O 0.9999760389328003
be O O 0.9999853372573853
inversely O O 0.9916159510612488
associated O O 0.9995636343955994

the O O 0.9989742040634155
respiratory O O 0.9566328525543213
burst O O 0.991111695766449
. O O 0.9999957084655762
The O O 0.9999985694885254
effects O O 0.9998718500137329
of O O 0.9999899864196777

generated O O 0.9838788509368896
from O O 0.999927282333374
lymphoblastoid B-cell_line B-cell_line 0.5587450861930847
cell I-cell_line I-cell_line 0.7207292914390564
lines E-cell_line E-cell_line 0.998454213142395
, O O 0.9991785883903503
translated O O 0.9869753122329712
into O O 0.9997373223304749
35S-methionine B-protein B-protein 0.3427809476852417
labelled I-protein I-protein 0.5987244248390198
protein E-protein E-protein 0.9502304792404175
, O O 0.9941856861114502
and O O 0.9998531341552734
analysed O O 0.9978703260421753
by O O 0.9999754428863525
SDS-PAGE O S-protein 0.9144397974014282
. O O 0.9997530579566956
PCR B-DNA B-protein 0.523106038570404
products E-DNA E-protein 0.8928446173667908
showing O O 0.9991917014122009

those O O 0.9995408058166504

, O O 0.9674880504608154
has O O 0.9994962215423584
been O O 0.999871015548706
shown O O 0.9999305009841919
to O O 0.9999814033508301
be O O 0.9999188184738159
activated O O 0.9973948001861572
by O O 0.9999852180480957
LMP-1 S-protein S-protein 0.990847110748291
. O O 0.9999492168426514
The O O 0.9999940395355225
mechanism O O 0.9928885102272034
( O O 0.9996441602706909
s O O 0.9975312352180481
) O O 0.9998181462287903
regulating O O 0.9985230565071106
this O O 0.9997912049293518
activation O O 0.9940909743309021
remains O O 0.9999762773513794
unknown O O 0.9999784231185913
. O O 0.9999986886978149
Our O O 0.9999992847442627
data O O 0.9996086955070496
indicate O O 0.9999988079071045
that O O 0.9999979734420776
increased O O 0.9975348711013794
NF-kappa B-protein B-protein 0.6857629418373108
B E-protein E-protein 0.9928054213523865
DNA O O 0.9542558193206787
binding O O 0.9937779903411865
and O O 0.999897837638855

by O O 0.9996044039726257
an O O 0.9999951124191284
ELISA O O 0.8392820954322815
. O O 0.9995272159576416
NF-kappaB S-protein S-protein 0.9466521143913269
DNA O O 0.8727703094482422
binding O O 0.994565486907959
was O O 0.9999873638153076
evaluated O O 0.999993085861206
by O O 0.9999973773956299
electrophoretic O O 0.7616693377494812
mobility O O 0.9084990620613098
shift O O 0.9751483201980591
assay O O 0.9994157552719116
. O O 0.9999929666519165
RESULTS O O 0.9893690347671509
: O O 0.999882698059082
LPS O O 0.9842627048492432
increased O O 0.9998003840446472
NF-kappaB S-protein S-protein 0.9208588600158691

that O O 0.9988420605659485
HL60 S-cell_line S-cell_line 0.8554056286811829
and O O 0.8887239694595337
normal B-cell_type B-cell_type 0.5218712091445923
cells E-cell_type E-cell_type 0.8088583946228027
are O O 0.999828577041626
able O O 0.9999133348464966
to O O 0.9999698400497437
generate O O 0.9999058246612549
estrone O O 0.44165536761283875
( O O 0.9646316170692444
E1 O O 0.41720378398895264
) O O 0.866892397403717
from O O 0.9998984336853027
estradiol O O 0.6851227283477783
( O O 0.9760518074035645
E2 O O 0.8176215291023254
) O O 0.979738712310791
. O O 0.9999767541885376
Neither O O 0.999128520488739
cell O O 0.9120416641235352
population O O 0.70932537317276
generated O O 0.9999700784683228
significant O O 0.9997178912162781
amounts O O 0.9999293088912964
of O O 0.9999926090240479
E2 O S-protein 0.501454770565033
from O O 0.9954387545585632
E1 O S-protein 0.24426718056201935
. O O 0.999091386795044
Reverse O B-protein 0.8609511852264404
transcriptase O E-protein 0.8174853324890137

factors E-protein E-protein 0.9923861026763916
or O O 0.9991913437843323
is O O 0.9999438524246216
maintained O O 0.9999767541885376
entirely O O 0.999996542930603
by O O 0.9999984502792358
an O O 0.9999902248382568
autoregulatory O O 0.7561830282211304
loop O O 0.6471118330955505
, O O 0.9998428821563721
we O O 0.9999809265136719
have O O 0.9999974966049194
used O O 0.9999138116836548

from O O 0.9993864297866821
recombination O O 0.970112144947052
between O O 0.9993334412574768
a O O 0.9999176263809204
gene O O 0.9814436435699463
that O O 0.9999579191207886
encoded O O 0.9999600648880005
a O O 0.9999144077301025
soluble B-protein B-protein 0.6209636926651001
nuclear I-protein I-protein 0.5012537240982056
protein E-protein E-protein 0.9805611968040466
and O O 0.9979097247123718
a O O 0.9999603033065796
membrane B-DNA B-DNA 0.5064244270324707
protein I-DNA I-DNA 0.4848802089691162
gene E-DNA E-DNA 0.8882028460502625
similar O O 0.9924582839012146
to O O 0.9999428987503052
those O O 0.9999513626098633
in O O 0.9998303651809692
yeast O O 0.6243605613708496
. O O 0.998885452747345
These O O 0.999996542930603
results O O 0.9999113082885742
are O O 0.9999966621398926
the O O 0.9999945163726807
first O O 0.9999148845672607
to O O 0.9999675750732422
demonstrate O O 0.9999951124191284
the O O 0.9999936819076538

, O O 0.9856221079826355
a O O 0.9999518394470215
guanine B-protein B-protein 0.7230662107467651
nucleotide I-protein I-protein 0.5988394618034363
exchange I-protein I-protein 0.5026365518569946
factor E-protein E-protein 0.9847288727760315
for O O 0.9944011569023132
Rho-family B-protein B-protein 0.39884528517723083
GTPases E-protein E-protein 0.8655828833580017
. O O 0.9994370341300964
The O O 0.9999974966049194
assembly O O 0.9980005621910095
of O O 0.999968409538269
this O O 0.999971866607666
tri-molecular B-protein B-protein 0.5866239666938782
complex E-protein E-protein 0.9830617904663086
permits O O 0.9996367692947388
the O O 0.9999814033508301
activated O O 0.8373331427574158
Rho-family B-protein B-protein 0.5496088862419128
GTPases E-protein E-protein 0.8979106545448303
to O O 0.9971132278442383
regulate O O 0.9990931749343872
target O O 0.7920105457305908
effectors O O 0.7700242400169373
that O O 0.999733030796051
interact O O 0.9998596906661987
through O O 0.9998750686645508
nck S-protein S-protein 0.9426893591880798
. O O 0.999347984790802
In O O 0.999778687953949
turn O O 0.997188150882721
, O O 0.9999719858169556
assembly O O 0.9912746548652649
of O O 0.9999016523361206
this O O 0.9999798536300659
complex O O 0.7467288970947266
mediates O O 0.984150230884552
the O O 0.999953031539917

production O O 0.9850972890853882
, O O 0.9999204874038696
since O O 0.999995231628418
the O O 0.9999994039535522
addition O O 0.999872088432312
of O O 0.9999938011169434
anti-IFN-alpha/beta B-protein B-protein 0.8481701612472534
antibody E-protein E-protein 0.9895301461219788
to O O 0.9988362193107605
the O O 0.9997530579566956
cells O O 0.9626646637916565
decreased O O 0.9993289709091187
PKR S-protein S-protein 0.9722567796707153
expression O O 0.9998108744621277
. O O 0.9999988079071045
Furthermore O O 0.9999929666519165
, O O 0.9999973773956299
the O O 0.9999991655349731
analysis O O 0.9999822378158569
of O O 0.9999954700469971
IkappaBalpha S-protein S-protein 0.890540361404419

expression O O 0.9696245789527893
in O O 0.9999008178710938
transplant O O 0.8563432097434998
recipients O O 0.854056715965271
was O O 0.9999186992645264
shown O O 0.9999924898147583
to O O 0.9999966621398926
be O O 0.9999959468841553
adversely O O 0.9984245300292969
affected O O 0.9999842643737793
by O O 0.9999988079071045
treatment O O 0.9997655749320984
with O O 0.9999964237213135
CsA O O 0.9953354001045227
: O O 0.999778687953949
TF S-protein S-protein 0.8255683779716492
induction O O 0.9990598559379578
was O O 0.9999973773956299
markedly O O 0.9997735619544983
reduced O O 0.9999822378158569
by O O 0.9999990463256836
CsA O O 0.8632140755653381
serum O O 0.8469200134277344
concentrations O O 0.9906125068664551
reaching O O 0.9999808073043823
peak O O 0.9886885285377502
CsA O O 0.8500230312347412
drug O O 0.986510694026947
levels O O 0.9998966455459595
. O O 0.9999990463256836
Inhibition O O 0.9972571730613708
of O O 0.9999617338180542
TF S-protein S-protein 0.9256060123443604
induction O O 0.9990370273590088
in O O 0.9999897480010986
the O O 0.9999797344207764
presence O O 0.9975245594978333
of O O 0.9999830722808838
high O O 0.9357567429542542
CsA O O 0.8331030011177063
blood O O 0.6961849927902222

an O O 0.9993352293968201
important O O 0.9993698000907898
role O O 0.9998701810836792
in O O 0.9999896287918091
inducible O O 0.9656159281730652
TNF-alpha S-protein S-protein 0.9773505926132202
expression O O 0.9994578957557678
. O O 0.9999929666519165
E3330 O O 0.331620991230011
decreased O O 0.9913457632064819
activated O O 0.9494892954826355
NF-kappa B-protein B-protein 0.8472740650177002
B E-protein E-protein 0.9974654912948608
in O O 0.9997966885566711
nuclei O O 0.45724576711654663
, O O 0.9244670867919922
suggesting O O 0.9997077584266663
that O O 0.9999973773956299
E3330 O O 0.8650509119033813
inhibits O O 0.9995384216308594
NF-kappa B-protein B-protein 0.7769306302070618
B E-protein E-protein 0.9976644515991211
activation O O 0.9941754937171936
and/or O O 0.9786515831947327
translocation O O 0.9968397617340088
of O O 0.9999866485595703
the O O 0.999985933303833
nuclei O O 0.7315356731414795
. O O 0.9993925094604492
Western O O 0.9780994057655334
blotting O O 0.9824419617652893
analysis O O 0.9998694658279419
with O O 0.9999969005584717
anti-I B-protein B-protein 0.8069245219230652
kappa I-protein I-protein 0.9082295298576355
B-alpha I-protein I-protein 0.5216144323348999
antibody E-protein E-protein 0.9876322746276855
indicated O O 0.9997033476829529
that O O 0.9999992847442627
E3330 O O 0.682847797870636
inhibited O O 0.995622456073761
degradation O O 0.999226450920105
of O O 0.9999911785125732
I B-protein B-protein 0.79245525598526
kappa I-protein I-protein 0.8003413081169128
B-alpha E-protein E-protein 0.8330842852592468

, O O 0.9942576885223389
the O O 0.999984860420227
recruitment O O 0.9992297887802124
of O O 0.9999897480010986
a O O 0.9999680519104004
specific O O 0.9100058674812317
Stat B-protein B-protein 0.7520328760147095
protein E-protein E-protein 0.9956229329109192
is O O 0.9996581077575684
dictated O O 0.9999810457229614
by O O 0.9999973773956299
amino O O 0.7741090059280396
acid O O 0.6405439972877502
residues O O 0.6650493144989014
C-terminal O O 0.39177069067955017
to O O 0.9911966323852539
the O O 0.9997791647911072

, O O 0.9729633927345276
including O O 0.9996623992919922
butylated O O 0.8833966255187988
hydroxyanisole O O 0.7023094892501831
( O O 0.9942459464073181
BHA O O 0.660978376865387
) O O 0.9890021085739136
, O O 0.999841570854187
tetrahydropapaveroline O O 0.778332531452179
( O O 0.9916440844535828
THP O O 0.8484848141670227
) O O 0.9846230149269104
, O O 0.9998283386230469
nordihydroguiauretic O O 0.8983059525489807
acid O O 0.924731969833374
, O O 0.9970864653587341
and O O 0.9996459484100342
10 O O 0.9927156567573547
, O O 0.9994773268699646
11-dihydroxyaporphine O O 0.985893726348877
( O O 0.9996843338012695
DHA O O 0.9276694655418396
) O O 0.997927188873291

MCP-1 S-protein S-protein 0.9231970906257629
. O O 0.9999430179595947
These O O 0.9999914169311523
activities O O 0.9987589120864868
may O O 0.9999951124191284
contribute O O 0.9999991655349731
to O O 0.999998927116394
the O O 0.9999979734420776
immunomodulatory O O 0.964178204536438
properties O O 0.9955626726150513
of O O 0.9999970197677612
heparin O O 0.8015361428260803
. O O 0.9995531439781189
[ O O 0.9981512427330017
Molecular-biologic O O 0.9728677868843079
aspects O O 0.9979791045188904
of O O 0.9999620914459229
interaction O O 0.9833937287330627
between O O 0.9997828602790833

role O O 0.9798662066459656
of O O 0.9999258518218994
different O O 0.9924853444099426
transcription O B-protein 0.669746458530426
factors O E-protein 0.9977754950523376
and O O 0.9989888072013855
transcriptional O O 0.8605275750160217
mechanisms O O 0.9664795994758606
in O O 0.9999715089797974
T O O 0.6213142275810242
cell O O 0.48908039927482605
differentiation O O 0.9921914935112
and O O 0.9998890161514282
the O O 0.9999915361404419
immune O O 0.9700683951377869
response O O 0.9988040924072266
. O O 0.9999839067459106
Tcf-1 S-protein S-protein 0.986390233039856
-mediated O O 0.992466151714325
transcription O O 0.960135281085968
in O O 0.999545156955719
T B-cell_type B-cell_type 0.8198584318161011
lymphocytes E-cell_type E-cell_type 0.9899853467941284
: O O 0.9912105798721313
differential O O 0.9865095019340515
role O O 0.994183361530304
for O O 0.9999228715896606
glycogen B-protein B-protein 0.6164159774780273
synthase I-protein I-protein 0.5171366930007935
kinase-3 E-protein E-protein 0.9839463233947754
in O O 0.9974576830863953
fibroblasts S-cell_type S-cell_type 0.9846296906471252
and O O 0.9878966808319092
T B-cell_type B-cell_type 0.8754094839096069
cells E-cell_type E-cell_type 0.9822174906730652
. O O 0.9997727274894714
Beta-catenin O S-protein 0.8595162630081177
is O O 0.9998243451118469
the O O 0.9999947547912598
vertebrate O O 0.7842158675193787
homolog O O 0.616450309753418
of O O 0.9903832077980042
the O O 0.9997685551643372
Drosophila B-DNA B-DNA 0.4506872892379761
segment I-DNA I-DNA 0.31494855880737305
polarity I-DNA I-DNA 0.35129693150520325
gene E-DNA E-DNA 0.8855447769165039
Armadillo S-DNA O 0.3244047164916992
and O O 0.8263494372367859
plays O O 0.9956263303756714
roles O O 0.9991056323051453
in O O 0.999996542930603
both O O 0.9998966455459595
cell-cell O O 0.8485121726989746
adhesion O O 0.9710018038749695
and O O 0.999234676361084
transduction O O 0.9865022897720337
of O O 0.9998030066490173
the O O 0.9999643564224243
Wnt O O 0.4288818836212158
signaling O O 0.6409253478050232
cascade O O 0.3330489993095398
. O O 0.998588502407074
Recently O O 0.9997771382331848
, O O 0.9999911785125732
members O O 0.9971164464950562
of O O 0.999920129776001
the O O 0.9998936653137207
Lef/Tcf B-protein S-protein 0.5281837582588196

promoter E-DNA E-DNA 0.948714554309845
. O O 0.9998940229415894
To O O 0.999991774559021
examine O O 0.9999970197677612
the O O 0.9999972581863403
role O O 0.9990928173065186
of O O 0.9999759197235107
EKLF S-protein S-protein 0.9802124500274658
in O O 0.99992835521698
the O O 0.9999914169311523
developmental O O 0.9830551147460938
regulation O O 0.9989272952079773
of O O 0.9999910593032837
the O O 0.9999793767929077
human B-DNA B-DNA 0.711862325668335
gamma-globin I-DNA I-DNA 0.9195183515548706
gene E-DNA E-DNA 0.9121734499931335

growth O O 0.9636335968971252
in O O 0.9998583793640137
culture O O 0.9272466897964478
. O O 0.999975323677063
Thus O O 0.9999334812164307
, O O 0.9999018907546997
c-erbA/TR S-protein S-protein 0.9360788464546204
appears O O 0.9984726309776306
to O O 0.999941349029541
act O O 0.9999244213104248
as O O 0.9999986886978149
a O O 0.9999955892562866
binary O O 0.8478904962539673
switch O O 0.7845860123634338
affecting O O 0.9996378421783447
erythroid B-cell_type O 0.4826655685901642
cell I-cell_type O 0.45715591311454773
fate E-cell_type O 0.6826412081718445
: O O 0.99710613489151
unliganded O B-protein 0.6328871846199036
c-erbA/TR S-protein E-protein 0.7166044116020203
supports O O 0.9993212223052979
growth O O 0.9660370945930481
while O O 0.9999146461486816
ligand-activated O O 0.8078356981277466
c-erbA/TR S-protein S-protein 0.6257362365722656
induces O O 0.9995170831680298
differentiation O O 0.9982016086578369
. O O 0.9999959468841553
Additionally O O 0.9998310804367065
, O O 0.9999510049819946
to O O 0.9998949766159058
determine O O 0.9999916553497314
the O O 0.9999902248382568

aging O O 0.9517834186553955
. O O 0.9999730587005615
The O O 0.999995231628418
activation O O 0.9958493709564209
of O O 0.999864935874939
transcriptional B-protein B-protein 0.7024946212768555
factor E-protein E-protein 0.8997424244880676
c-Fos/c-Jun O S-protein 0.8200135827064514
AP-1 S-protein S-protein 0.6547861695289612
is O O 0.9998151659965515
essential O O 0.9999786615371704
for O O 0.9999855756759644
normal O O 0.86954665184021
T B-cell_type O 0.7640211582183838
cell E-cell_type O 0.7451229691505432
responsiveness O O 0.9859638214111328
and O O 0.9996871948242188
is O O 0.999964714050293
often O O 0.9999263286590576
impaired O O 0.9998494386672974
in O O 0.9998531341552734
T B-cell_type B-cell_type 0.9449666738510132
cells E-cell_type E-cell_type 0.9937950372695923
during O O 0.999468982219696
aging O O 0.9993552565574646
. O O 0.9999986886978149
In O O 0.9999839067459106
the O O 0.9999985694885254
present O O 0.9996256828308105
study O O 0.9998828172683716
, O O 0.9999822378158569

those O O 0.9985324144363403
obtained O O 0.9998925924301147
by O O 0.9999995231628418
the O O 0.999997615814209
Scatchard O O 0.6762475967407227
analysis O O 0.9929904937744141
. O O 0.9999984502792358
The O O 0.9999995231628418
single O O 0.9773154258728027
point O O 0.9590549468994141
assay O O 0.9970927238464355
has O O 0.9999738931655884
been O O 0.9999741315841675
also O O 0.9999526739120483
applied O O 0.9999494552612305
for O O 0.9999967813491821
determination O O 0.9996935129165649
of O O 0.9999955892562866
GH O O 0.4047568738460541
in O O 0.9977420568466187
10 O O 0.9986805319786072
children O O 0.9957283139228821
treated O O 0.9999326467514038
with O O 0.9999979734420776

monocyte B-cell_line O 0.39521756768226624

neutrophils E-cell_type E-cell_type 0.5372655391693115
. O O 0.9998939037322998
In O O 0.999984860420227
contrast O O 0.9999860525131226
to O O 0.9999927282333374
PU.1 S-protein S-protein 0.9618072509765625
, O O 0.9997357726097107
significant O O 0.998126208782196
levels O O 0.9996304512023926
of O O 0.9999483823776245
Spi-B B-RNA B-RNA 0.9536948204040527
mRNA E-RNA E-RNA 0.9932090640068054
and O O 0.9910679459571838
protein O O 0.7920668125152588
are O O 0.9985504746437073
found O O 0.9999305009841919
only O O 0.9999889135360718
in O O 0.9998745918273926
some O O 0.9994462132453918
B-cell B-cell_line B-cell_line 0.7187367081642151
lines E-cell_line E-cell_line 0.996997594833374
and O O 0.9937167763710022
spleen O O 0.4953067898750305
but O O 0.8025898933410645
are O O 0.9923779964447021
not O O 0.9908263087272644
found O O 0.9994342923164368
in O O 0.999933123588562
myeloid B-cell_line B-cell_line 0.42481932044029236
cell I-cell_line I-cell_line 0.4901711642742157
lines E-cell_line E-cell_line 0.9945855736732483
, O O 0.9957091808319092
neutrophils S-cell_type S-cell_type 0.9894338250160217
, O O 0.9883409142494202
or O O 0.9960208535194397
macrophages S-cell_type S-cell_type 0.9985767602920532
. O O 0.9998555183410645
In O O 0.9995446801185608
vitro O O 0.971836268901825
translated O O 0.9821013808250427

with O O 0.9995785355567932
a O O 0.9999823570251465
synthetic O O 0.9130949378013611
ceramide O O 0.8225653171539307
analog O O 0.9165423512458801
results O O 0.9995037317276001
in O O 0.9999933242797852
JNK S-protein S-protein 0.9534796476364136
activation O O 0.9957379102706909
as O O 0.9999697208404541
well O O 0.9999078512191772
as O O 0.9999903440475464
apoptosis O O 0.9891035556793213
, O O 0.9999650716781616
suggesting O O 0.9999713897705078
ceramide O O 0.7750893235206604
release O O 0.9931206107139587
occurs O O 0.999992847442627
proximal O O 0.9022247791290283

of O O 0.9976946711540222
the O O 0.9999878406524658
reporter B-DNA B-DNA 0.5242436528205872
gene E-DNA E-DNA 0.9814049601554871
was O O 0.9987154006958008
induced O O 0.9999792575836182
by O O 0.9999973773956299
coexpression O O 0.9895361661911011
of O O 0.9994038343429565
Tax S-protein S-protein 0.9976298809051514
and O O 0.9971305727958679
CREB S-protein S-protein 0.9322757720947266
. O O 0.999847412109375
This O O 0.9999923706054688
effect O O 0.9999476671218872
was O O 0.9999958276748657
stronger O O 0.9999792575836182
with O O 0.9999992847442627
the O O 0.9999904632568359
GAD-CREB B-protein S-protein 0.5671875476837158

production O O 0.9930919408798218
by O O 0.9999923706054688
HUVECs S-cell_line S-cell_type 0.49244484305381775
is O O 0.9994431138038635
increased O O 0.9999473094940186
after O O 0.9999990463256836
the O O 0.9999988079071045
second O O 0.984862208366394
A/R O O 0.8145819902420044
challenge O O 0.9306674003601074
, O O 0.9998304843902588
but O O 0.9999440908432007
not O O 0.9998949766159058
after O O 0.9999929666519165
the O O 0.9999967813491821
first O O 0.9831915497779846
A/R O O 0.7442854642868042
challenge O O 0.9587931632995605
. O O 0.9999958276748657
Inhibition O O 0.9988127946853638
of O O 0.9999843835830688
NO B-protein B-protein 0.44827577471733093
synthase E-protein E-protein 0.9940754175186157
( O O 0.9911502599716187
NOS S-protein S-protein 0.9631766676902771
) O O 0.9823410511016846
during O O 0.9999903440475464
the O O 0.9999973773956299
second O O 0.9774797558784485
A/R O O 0.6916723251342773
challenge O O 0.9570301175117493
prevents O O 0.9999816417694092
the O O 0.9999954700469971
development O O 0.999935507774353
of O O 0.9999966621398926
A/R O O 0.48529064655303955
tolerance O O 0.9961684346199036
with O O 0.9999967813491821
respect O O 0.9995613694190979
to O O 0.9999936819076538
PMN O S-cell_type 0.9644719958305359
adhesion O O 0.9945982694625854
. O O 0.9999948740005493
However O O 0.9999383687973022
, O O 0.9999613761901855
while O O 0.9999879598617554

of O O 0.9977825284004211
HIV-1 B-DNA B-DNA 0.5204059481620789
long I-DNA I-DNA 0.6422131657600403
terminal I-DNA I-DNA 0.9546986818313599
repeat E-DNA E-DNA 0.9971023201942444
( O O 0.9963474869728088
LTR S-DNA S-DNA 0.9979273080825806
) O O 0.9473552107810974
. O O 0.9999094009399414
S9a O S-protein 0.8530303835868835
was O O 0.9981479644775391
superior O O 0.9990317821502686
to O O 0.9999903440475464
the O O 0.9999692440032959
first O O 0.6845358610153198
generation O O 0.42448535561561584
compound O O 0.32732418179512024
Canventol O O 0.29868361353874207
, O O 0.9725676774978638
which O O 0.9998810291290283
was O O 0.9999607801437378
superior O O 0.9995806813240051
to O O 0.9999943971633911
the O O 0.9999620914459229
natural O O 0.5374623537063599
compound O O 0.6108390688896179
sarcophytol O O 0.6781718730926514
A O O 0.7945593595504761
, O O 0.9924048781394958
demonstrating O O 0.9999469518661499
that O O 0.9999974966049194
further O O 0.9976521134376526
structure-based O O 0.9911086559295654
enhancement O O 0.9990699887275696
of O O 0.999982476234436
potency O O 0.9973621964454651
of O O 0.9999854564666748
these O O 0.999969482421875
compounds O O 0.943209171295166
is O O 0.999868631362915
feasible O O 0.9999253749847412
. O O 0.999998927116394
This O O 0.9999979734420776
study O O 0.9999531507492065
suggests O O 0.9999977350234985
a O O 0.9999984502792358
therapeutic O O 0.9941457509994507
approach O O 0.9999489784240723
against O O 0.9999911785125732
AIDS O O 0.9970158338546753
by O O 0.9999988079071045
application O O 0.9966012239456177
of O O 0.9999779462814331
two O O 0.999454915523529
drugs O O 0.9733619093894958
, O O 0.9997245669364929
one O O 0.999920129776001
against O O 0.9999063014984131
a O O 0.9998929500579834
cellular O O 0.6882694363594055
and O O 0.9064134359359741
the O O 0.9862669706344604
other O O 0.9990839958190918
a O O 0.9996259212493896
viral O O 0.5488962531089783
target O O 0.37847864627838135
, O O 0.989081859588623
which O O 0.9999077320098877
may O O 0.9999903440475464
provide O O 0.9999970197677612
an O O 0.9999958276748657
approach O O 0.9999340772628784
to O O 0.9999986886978149
the O O 0.9999973773956299
problem O O 0.9994864463806152
of O O 0.9999959468841553
frequent O O 0.9938583970069885
emergence O O 0.9994482398033142
of O O 0.9999939203262329
resistant O O 0.7478370070457458
variants O O 0.5512080788612366
to O O 0.999941349029541
combinations O O 0.9925588369369507
of O O 0.9999066591262817
drugs O O 0.9748007655143738
that O O 0.9999443292617798
target O O 0.9999245405197144
only O O 0.9995892643928528
HIV B-DNA B-DNA 0.5575575232505798
genes E-DNA E-DNA 0.9962835907936096
. O O 0.9999855756759644
Highly O O 0.9735845327377319
polarized O O 0.9855048060417175
HLA B-protein B-protein 0.5449862480163574
class I-protein I-protein 0.806515634059906
II I-protein I-protein 0.6255568265914917
antigen E-protein E-protein 0.9499940276145935
processing O O 0.9749265313148499
and O O 0.9991993308067322

GATA-3 S-protein S-protein 0.9645145535469055
-dependent O O 0.9947499632835388
enhancer O O 0.8091553449630737
activity O O 0.9993904829025269
in O O 0.9999858140945435
IL-4 B-DNA B-DNA 0.5011312961578369
gene E-DNA E-DNA 0.972434937953949
regulation O O 0.9959535598754883
. O O 0.9999983310699463
Previously O O 0.9999579191207886
, O O 0.9999963045120239
we O O 0.9999545812606812
analyzed O O 0.9999772310256958
the O O 0.9999345541000366
proximal B-DNA B-DNA 0.6115230321884155
IL-4 I-DNA I-DNA 0.4940429925918579
promoter E-DNA E-DNA 0.992874264717102
in O O 0.9998273849487305
directing O O 0.9738406538963318
Th2-specific O O 0.6161795854568481
activity O O 0.9897985458374023
. O O 0.9999977350234985
An O O 0.9999839067459106
800-base B-DNA B-DNA 0.5020809173583984
pair I-DNA I-DNA 0.47663405537605286
proximal I-DNA I-DNA 0.55771404504776
promoter E-DNA E-DNA 0.9823083877563477
conferred O O 0.9992976188659668
some O O 0.999958872795105
Th2-selective O S-DNA 0.5419344902038574
expression O O 0.6910797953605652
in O O 0.9983892440795898
transgenic O O 0.8681731224060059
mice O O 0.9816691279411316
. O O 0.9999921321868896
However O O 0.9999939203262329
, O O 0.9999951124191284
this O O 0.9999921321868896
region O O 0.9892030358314514
directed O O 0.9999004602432251
extremely O O 0.9940451383590698
low O O 0.9325218796730042
reporter O B-RNA 0.6387927532196045
mRNA O E-RNA 0.881071150302887

In O O 0.9991530179977417
contrast O O 0.9999430179595947
, O O 0.9999785423278809
AP-1 S-protein S-protein 0.9784080982208252
from O O 0.9998090863227844
PHA-activated B-cell_type B-cell_line 0.556410551071167
cells E-cell_type E-cell_line 0.8697084784507751
contains O O 0.999534010887146
c-Jun S-protein S-protein 0.8718677163124084
and O O 0.9667527079582214
low O O 0.9652295112609863
levels O O 0.9991796612739563

we O O 0.9926983714103699
have O O 0.9999852180480957
utilized O O 0.9998873472213745
a O O 0.9999133348464966
mutant B-cell_line B-cell_line 0.6281676888465881
Jak1-deficient I-cell_line I-cell_line 0.654000461101532
HeLa I-cell_line I-cell_line 0.9208681583404541
cell I-cell_line I-cell_line 0.6472317576408386
line E-cell_line E-cell_line 0.99832683801651
, O O 0.9956068396568298
E1C3 S-cell_line S-cell_line 0.9961502552032471
, O O 0.7474114894866943
and O O 0.9994810223579407
its O O 0.9985313415527344
parental B-cell_line O 0.7017728090286255
Jak1-expressing I-cell_line B-cell_line 0.5870791673660278
counterpart E-cell_line E-cell_line 0.8400528430938721
, O O 0.8376880288124084
1D4 S-cell_line S-cell_line 0.9551578760147095
, O O 0.9754980206489563
to O O 0.9996234178543091

. O O 0.9980740547180176
CD8+ B-cell_type B-cell_type 0.849755585193634
T I-cell_type I-cell_type 0.950352668762207
lymphocytes E-cell_type E-cell_type 0.9927902221679688
of O O 0.999355137348175
HIV-1 O O 0.6406998634338379
infected O O 0.8573134541511536
individuals O O 0.9702920913696289
produce O O 0.9999706745147705
a O O 0.9999946355819702
soluble B-protein O 0.9055595993995667
factor E-protein O 0.8023445010185242
that O O 0.999701201915741
efficiently O O 0.9996204376220703
suppresses O O 0.9998607635498047
HIV-1 O O 0.8214099407196045
replication O O 0.985632061958313
at O O 0.999996542930603
the O O 0.9999992847442627
transcriptional O O 0.9238648414611816
level O O 0.999071478843689
. O O 0.999998927116394
We O O 0.9999958276748657
show O O 0.9999983310699463
here O O 0.9999945163726807
that O O 0.9999990463256836
the O O 0.9999946355819702
response O O 0.9982923865318298
of O O 0.9999686479568481

NF-kappa B-protein B-protein 0.788408637046814
B E-protein E-protein 0.9977399110794067
binding O O 0.9870224595069885
activity O O 0.9987358450889587
was O O 0.9999945163726807
inducible O O 0.9998065829277039
by O O 0.9999867677688599
tumor B-protein B-protein 0.602785050868988
necrosis I-protein I-protein 0.6606918573379517
factor E-protein E-protein 0.9702572226524353
and O O 0.996810257434845
phorbol O O 0.9097239375114441
myristate O O 0.9366533160209656
acetate O O 0.9930703043937683
in O O 0.9999879598617554
PLB-985 S-cell_line S-cell_line 0.7353545427322388
. O O 0.9934927821159363
However O O 0.9999749660491943
, O O 0.9999744892120361
in O O 0.9998596906661987
PLB-IIIB B-cell_line B-cell_line 0.7669307589530945
cells E-cell_line E-cell_line 0.9826885461807251
, O O 0.9991870522499084
constitutive O O 0.9351189732551575
expression O O 0.9968507885932922
of O O 0.9999816417694092
a O O 0.9999912977218628
novel O O 0.7040950655937195
NF-kappa B-protein B-protein 0.8369042277336121
B I-protein E-protein 0.8255200386047363

similar O O 0.9949743747711182
to O O 0.9997180104255676
IL-6 B-RNA B-RNA 0.9819017052650452
mRNA E-RNA E-RNA 0.9985462427139282
. O O 0.9997784495353699
In O O 0.9993147850036621
situ O O 0.9574280977249146
DNA O O 0.9537489414215088
binding O O 0.9882857799530029
assay O O 0.999570906162262
determined O O 0.9999220371246338
Stat3 S-protein S-protein 0.9985248446464539
activation O O 0.9994164705276489
predominantly O O 0.9999679327011108
within O O 0.9999450445175171
alveoli O O 0.615419328212738
. O O 0.999508261680603
Intratracheal O O 0.8025601506233215
instillation O O 0.9491899013519287
of O O 0.9995174407958984
IL-6 S-protein S-protein 0.9614781141281128
alone O O 0.9943033456802368
into O O 0.9999135732650757
normal O O 0.8002395629882812
rats O O 0.8269264101982117
resulted O O 0.9998107552528381
in O O 0.9999969005584717
PMN O O 0.7240719795227051
infiltration O O 0.9959250688552856
into O O 0.9999539852142334
lung O O 0.4119538962841034
interstitium O O 0.46572571992874146
and O O 0.9371657371520996
alveoli O O 0.5286672115325928
, O O 0.9741642475128174
marked O O 0.9834122657775879
elevation O O 0.9942449927330017
of O O 0.999954104423523
bronchoalveolar O O 0.6409218907356262
lavage O O 0.5025310516357422
cellularity O O 0.8218390941619873

cells E-cell_type E-cell_type 0.5342748165130615
. O O 0.9999083280563354
Here O O 0.9999874830245972
we O O 0.9999946355819702
summarize O O 0.9999803304672241
studies O O 0.9992369413375854
which O O 0.9999967813491821
investigate O O 0.9999957084655762
the O O 0.9999966621398926
mechanism O O 0.9985888600349426
by O O 0.9999960660934448
which O O 0.9999986886978149
these O O 0.9999817609786987
cytokines S-protein S-protein 0.9932219982147217
selectively O O 0.9990252256393433
reprogramme O O 0.9477694630622864
gene O O 0.7356664538383484
expression O O 0.9965173006057739
in O O 0.9999116659164429
T-lymphocytes S-cell_type S-cell_type 0.9984065890312195
. O O 0.9994587302207947
Cytokine S-protein S-protein 0.612457275390625
stimulation O O 0.9913875460624695
leads O O 0.9999752044677734
to O O 0.9999972581863403
the O O 0.9999949932098389
phosphorylation O O 0.9770848751068115
of O O 0.9998857975006104
specific O O 0.9120690226554871
tyrosine O O 0.4675959646701813
residues O O 0.8410300612449646
within O O 0.9996764659881592
the O O 0.9999867677688599
intracellular B-protein B-protein 0.6554995775222778
domain E-protein E-protein 0.9604408144950867
of O O 0.9899294972419739
the O O 0.9996005892753601
corresponding O O 0.8054845929145813
cytokine B-protein B-protein 0.542328953742981
receptor E-protein E-protein 0.8998088240623474

on O O 0.999235987663269
UT-7 B-cell_line B-cell_line 0.7654945850372314
Epo I-cell_line I-cell_line 0.9349623322486877
cells E-cell_line E-cell_line 0.9983358979225159
was O O 0.9999063014984131
one-sixth O O 0.9996869564056396
the O O 0.9999990463256836
number O O 0.9998493194580078
of O O 0.9999933242797852
UT-7 B-cell_line B-cell_line 0.8583922982215881
cells E-cell_line E-cell_line 0.9911023378372192
( O O 0.9986956715583801
2400 O O 0.9664779305458069
+/- O O 0.9998321533203125
3 O O 0.9993478655815125
vs. O O 0.9998658895492554
13 O O 0.9897727370262146
, O O 0.9999351501464844
800 O O 0.999765932559967
+/- O O 0.9999536275863647
300 O O 0.9983150959014893
) O O 0.9999605417251587
. O O 0.9999984502792358
This O O 0.9999978542327881
difference O O 0.9999755620956421
in O O 0.9999974966049194
the O O 0.9999959468841553
number O O 0.9993067979812622
of O O 0.9999886751174927
binding O B-protein 0.5141288042068481
sites O E-protein 0.8205133080482483
could O O 0.9999330043792725
be O O 0.9999969005584717
due O O 0.999968409538269
to O O 0.9999971389770508
differences O O 0.9998375177383423
in O O 0.9999545812606812
cell O O 0.9169194102287292
surface O O 0.9690240025520325
( O O 0.9976382255554199
UT-7 B-cell_line B-cell_line 0.4734785556793213
cells E-cell_line E-cell_line 0.985135018825531
are O O 0.9997643828392029
20 O O 0.997901439666748
% O O 0.9997590184211731
smaller O O 0.999144434928894
than O O 0.9999903440475464
the O O 0.9998602867126465
parental O B-cell_line 0.5320968627929688
UT-7 B-cell_line I-cell_line 0.34474486112594604
cells E-cell_line E-cell_line 0.9477466344833374

regulatory O I-DNA 0.4197693169116974
elements O E-DNA 0.9973052740097046
in O O 0.9999536275863647
the O O 0.9999823570251465
proximal O B-DNA 0.8467757105827332
promoter B-DNA I-DNA 0.5955350399017334
region E-DNA E-DNA 0.9989421963691711
. O O 0.9999692440032959
Nuclear B-protein B-protein 0.7230209112167358
factor I-protein I-protein 0.5499399304389954
of I-protein I-protein 0.7557595372200012
activated I-protein I-protein 0.9343361258506775
T I-protein I-protein 0.9724335074424744
cell I-protein E-protein 0.840299129486084
( I-protein O 0.8355215787887573
NFAT I-protein S-protein 0.6133705973625183

expressing O O 0.7640954256057739
CD40L S-protein S-protein 0.9643741846084595
, O O 0.9974628686904907
consistent O O 0.999685525894165
with O O 0.9999964237213135
the O O 0.9999990463256836
observation O O 0.9980714917182922
that O O 0.9999929666519165
CD40 S-protein S-protein 0.9730467796325684
signaling O O 0.9891588091850281
downregulates O O 0.9992668032646179
BCL-6 S-protein S-protein 0.934035062789917
expression O O 0.9987159967422485
. O O 0.9999986886978149
These O O 0.9999985694885254
data O O 0.9996933937072754
indicate O O 0.9999980926513672
that O O 0.9999922513961792
tumor B-cell_type B-cell_type 0.6373904943466187
cells E-cell_type E-cell_type 0.9737382531166077
of O O 0.9987629652023315
NLPHD O S-protein 0.4865129590034485
uniformly O O 0.9496669769287109
display O O 0.9994551539421082
a O O 0.9999877214431763
GC O O 0.614815354347229
B-cell O O 0.3753131031990051
phenotype O O 0.282039612531662
, O O 0.9808825850486755
whereas O O 0.9999853372573853
the O O 0.9999936819076538
phenotype O O 0.9306332468986511
of O O 0.9992175102233887
tumor B-cell_type B-cell_type 0.7307873964309692
cells E-cell_type E-cell_type 0.9808796048164368
of O O 0.9990220069885254
CHD O O 0.3971952795982361
appears O O 0.9471049308776855
to O O 0.9989217519760132
be O O 0.9999390840530396
modulated O O 0.998554527759552
by O O 0.9999949932098389
the O O 0.9999885559082031
surrounding O O 0.9836124777793884
cellular O O 0.91745525598526
background O O 0.9745231866836548
, O O 0.999904990196228
particularly O O 0.9999576807022095
CD40L+ B-cell_type B-cell_type 0.3658052980899811
reactive I-cell_type I-cell_type 0.5350766181945801
T I-cell_type I-cell_type 0.7562499642372131
cells E-cell_type E-cell_type 0.7556153535842896

pain O O 0.977724015712738
. O O 0.9999936819076538
Recently O O 0.9999686479568481
, O O 0.9999905824661255
fibromyalgia O O 0.9833989143371582
( O O 0.9996529817581177
FMS O O 0.9957991242408752
) O O 0.9998905658721924
was O O 0.9999914169311523
shown O O 0.9999953508377075
to O O 0.9999978542327881
be O O 0.9999966621398926
a O O 0.9999903440475464
disorder O O 0.9992976188659668
associated O O 0.9998725652694702
with O O 0.9999934434890747
an O O 0.9999505281448364
altered O O 0.9747102856636047
functioning O O 0.9955272078514099

gamma B-RNA I-RNA 0.7738274931907654
mRNA E-RNA E-RNA 0.9973180890083313
were O O 0.9996370077133179
determined O O 0.9999839067459106
. O O 0.999998927116394
The O O 0.9999994039535522
effects O O 0.9999463558197021
of O O 0.9999963045120239
RA O O 0.993180513381958
on O O 0.9999022483825684
IL-2-alpha O B-protein 0.9348646998405457
receptor O E-protein 0.8711307048797607
expression O O 0.9981845021247864
was O O 0.9999957084655762
determined O O 0.9999836683273315
by O O 0.999994158744812

chaffeensis O O 0.520983874797821
on O O 0.999692440032959
the O O 0.9999969005584717
expression O O 0.9978317618370056
of O O 0.9999945163726807
major B-protein B-protein 0.4793444871902466
proinflammatory I-protein I-protein 0.4927200376987457
cytokines E-protein E-protein 0.9931597709655762
in O O 0.9998776912689209
human B-cell_type B-cell_type 0.6661804914474487
monocytes E-cell_type E-cell_type 0.9717439413070679
was O O 0.9998716115951538

pathogen O O 0.35824885964393616
invasion O O 0.973802924156189
. O O 0.9999765157699585
Thus O O 0.9998855590820312
, O O 0.9999533891677856
it O O 0.999962568283081
is O O 0.9999829530715942
not O O 0.9997507929801941
unexpected O O 0.9998836517333984
that O O 0.999997615814209
this O O 0.9999667406082153
versatile O O 0.9105892777442932
cellular O O 0.9132280945777893
homeostatic O O 0.8993335366249084
switch O O 0.9575262665748596
would O O 0.9999898672103882
be O O 0.9999955892562866
affected O O 0.9999418258666992
by O O 0.9999984502792358
a O O 0.9999905824661255
variety O O 0.9964166879653931
of O O 0.999982476234436
viral O O 0.7542098760604858
pathogens O O 0.44711166620254517
, O O 0.9985017776489258
which O O 0.999950647354126
have O O 0.9999866485595703
evolved O O 0.9998031258583069

it O O 0.9934281706809998
has O O 0.9999589920043945
been O O 0.9999939203262329
proposed O O 0.9999747276306152
that O O 0.9999992847442627
reactivation O O 0.9940389394760132
of O O 0.9999490976333618
latent O O 0.5255875587463379
HIV-1 O O 0.3899611830711365
harbored O O 0.9283137917518616
in O O 0.9995725750923157
chronically B-cell_type B-cell_type 0.5554433465003967
infected I-cell_type I-cell_type 0.4840148091316223
T I-cell_type I-cell_type 0.4765406548976898
lymphocytes E-cell_type E-cell_type 0.6466928124427795
, O O 0.9755876660346985
monocytes S-cell_type S-cell_type 0.9915779829025269
, O O 0.9746131896972656
or O O 0.9958921670913696

Jun S-protein S-protein 0.8746766448020935
with O O 0.999313235282898
respect O O 0.9997346997261047
to O O 0.9999876022338867
GR S-protein S-protein 0.8301041126251221
; O O 0.9968035221099854
high O O 0.9796287417411804
basal O O 0.9400138258934021
expression O O 0.9974002838134766
of O O 0.9999668598175049
c-fos S-protein S-DNA 0.9472885727882385
as O O 0.9885728359222412
well O O 0.9954081177711487
as O O 0.9999099969863892
AP-1 S-protein S-protein 0.8435673117637634
DNA O O 0.8594141006469727
binding O O 0.9513477683067322
and O O 0.9973819851875305
transcriptional O O 0.8950208425521851
activity O O 0.9947276711463928
were O O 0.9999973773956299

significantly O O 0.9945764541625977
different O O 0.9999581575393677
from O O 0.9999921321868896
those O O 0.9999434947967529
measured O O 0.9964950680732727
with O O 0.9999806880950928
threshold O O 0.9958508014678955
of O O 0.9999765157699585
cathepsin B-protein B-protein 0.6036006212234497
G E-protein E-protein 0.9920694828033447
alone O O 0.9991496801376343
( O O 0.9999372959136963
p O O 0.9988632202148438
> O O 0.9998176693916321
0.05 O O 0.9978330731391907
) O O 0.9998860359191895
, O O 0.9999911785125732
indicating O O 0.9999929666519165
that O O 0.9999996423721313
the O O 0.9999783039093018
phospholipase B-protein B-protein 0.515404462814331
C E-protein E-protein 0.9523841142654419
/protein B-protein O 0.9324845671653748

derived O O 0.9938269257545471
from O O 0.9999927282333374
indigenous O O 0.7976481318473816
bacteria O O 0.7885487079620361
that O O 0.9994055032730103
can O O 0.9999918937683105
activate O O 0.9999606609344482
the O O 0.9999560117721558
HIV-1 B-DNA B-DNA 0.46344512701034546
LTR E-DNA E-DNA 0.9978347420692444
, O O 0.997902512550354

alpha E-protein E-protein 0.9654872417449951
expression O O 0.9912335276603699
correlated O O 0.9998149275779724
with O O 0.999994158744812
occupancy O O 0.9997366070747375
of O O 0.9999974966049194
the O O 0.9999897480010986
GASd B-DNA B-DNA 0.7152826189994812
element E-DNA E-DNA 0.9912023544311523
. O O 0.999950647354126
Our O O 0.9999985694885254
data O O 0.9984954595565796
demonstrate O O 0.9999961853027344
a O O 0.9999856948852539
major O O 0.9961035251617432
role O O 0.9997313618659973
of O O 0.9999948740005493
the O O 0.999990701675415
GASd/EBSd B-DNA B-DNA 0.6199509501457214
element E-DNA E-DNA 0.9738779664039612
in O O 0.9995112419128418
IL-2R B-protein B-protein 0.3607783615589142
alpha E-protein E-protein 0.9909921884536743
regulation O O 0.9970815777778625
and O O 0.9999562501907349
suggest O O 0.9999957084655762
that O O 0.9999983310699463
the O O 0.9999619722366333
T-cell-specific B-protein O 0.3008434772491455

not O O 0.7461329102516174
, O O 0.9323028922080994
and O O 0.9911980032920837
the O O 0.9998890161514282
constitutive O B-cell_type 0.6790509223937988
B B-cell_line I-cell_type 0.669927179813385
cells E-cell_line E-cell_type 0.9653759002685547
. O O 0.9998294115066528
These O O 0.9999990463256836
results O O 0.9999850988388062
suggest O O 0.9999994039535522
that O O 0.9999992847442627
both O O 0.9999468326568604
common O O 0.9802636504173279
mechanisms O O 0.9974761605262756
, O O 0.9999741315841675
such O O 0.9999884366989136
as O O 0.9999947547912598
the O O 0.9999948740005493
one O O 0.9995717406272888
mediated O O 0.9990461468696594
by O O 0.9999963045120239
the O O 0.9998874664306641
CIITA B-protein B-protein 0.6418034434318542
trans-activator E-protein E-protein 0.8133689761161804
, O O 0.991643488407135
and O O 0.9996554851531982
distinct O O 0.9924517273902893
tissue-specific O O 0.6778921484947205
constraints O O 0.9689327478408813
contribute O O 0.9999980926513672
to O O 0.9999974966049194
the O O 0.9999916553497314
transcriptional O O 0.9081344604492188

was O O 0.9950543642044067
obtained O O 0.9998917579650879
by O O 0.9999995231628418
the O O 0.9999980926513672
observation O O 0.981894314289093
that O O 0.9999698400497437
coexpression O O 0.9807139039039612
of O O 0.9995125532150269
the O O 0.9997389912605286
N-terminal B-protein B-protein 0.9608893394470215
domain E-protein E-protein 0.9624502658843994
of O O 0.9823342561721802
PKCalpha S-protein S-protein 0.9945151805877686
blocked O O 0.9998019337654114
the O O 0.9999932050704956
effects O O 0.9996219873428345
of O O 0.9999827146530151
activated O O 0.9475025534629822
Rho S-protein S-protein 0.9652736186981201
plus O O 0.9990953207015991
PMA O O 0.8420000076293945
on O O 0.9998389482498169
AP-1 S-protein S-protein 0.9104375839233398
transcriptional O O 0.9548627734184265
activity O O 0.998627781867981
. O O 0.9999990463256836
These O O 0.9999991655349731
data O O 0.9997467398643494
suggest O O 0.9999988079071045
that O O 0.9999921321868896
Rho S-protein S-protein 0.992066502571106
potentiates O O 0.9990445971488953
AP-1 S-protein S-protein 0.8101706504821777

Moreover O O 0.9986141920089722
we O O 0.9999880790710449
present O O 0.9999926090240479
evidence O O 0.9999895095825195
that O O 0.999998927116394
the O O 0.9999630451202393
component O O 0.9655702710151672
that O O 0.9998008608818054
forms O O 0.9999440908432007
the O O 0.999929666519165
faster-migrating O O 0.44532039761543274
( O O 0.8808501958847046
`` O O 0.8695316314697266
lower O O 0.7410846948623657
'' O O 0.7891737818717957
) O O 0.9651901125907898
nuclear B-protein B-protein 0.7077382802963257
NF-AT I-protein E-protein 0.9618232846260071

receptor E-protein E-protein 0.9779452681541443
and O O 0.9952378273010254
its O O 0.9998098015785217
partner O O 0.7365235686302185
, O O 0.9934536218643188
the O O 0.9997245669364929
retinoid B-protein B-protein 0.664297878742218
X I-protein I-protein 0.9234791994094849
receptor E-protein E-protein 0.9845356345176697
. O O 0.9997321963310242
These O O 0.9999949932098389
data O O 0.9990466237068176
demonstrate O O 0.9999955892562866
that O O 0.9999979734420776
VitD3 O S-protein 0.8499534726142883
induces O O 0.9991777539253235
CD14 S-protein S-protein 0.9856583476066589
indirectly O O 0.9997758269309998
through O O 0.9999932050704956
some O O 0.9999039173126221
intermediary B-protein B-protein 0.6454827785491943
factor E-protein E-protein 0.9184849262237549
, O O 0.9152244925498962
and O O 0.9903026223182678

glucocorticoid B-protein B-protein 0.5453703999519348
receptor E-protein E-protein 0.9970152378082275
( O O 0.9922950267791748
GR S-protein S-protein 0.9946916699409485
) O O 0.9953274726867676
. O O 0.9999951124191284
In O O 0.9999452829360962
humans O O 0.8784639835357666
, O O 0.9976966977119446
alternative O O 0.9782481789588928
splicing O O 0.9887794256210327
of O O 0.9999105930328369
the O O 0.999954104423523

monocytic O O 0.8281306028366089
differentiation O O 0.9925205707550049
and O O 0.9998130202293396
EGR-1 S-DNA S-protein 0.46904000639915466
transcription O O 0.9313750267028809
through O O 0.999984860420227
the O O 0.9999834299087524
5'-most B-DNA B-DNA 0.48547932505607605
CArG I-DNA I-DNA 0.6294464468955994
element E-DNA E-DNA 0.9900897741317749
. O O 0.9998581409454346
Since O O 0.9999974966049194
these O O 0.9999959468841553
findings O O 0.9994494318962097
supported O O 0.999976396560669
the O O 0.9999988079071045
involvement O O 0.9999743700027466
of O O 0.9999974966049194
serine/threonine O B-protein 0.6917612552642822
protein O E-protein 0.8528488278388977
phosphorylation O O 0.8316671252250671
in O O 0.9996697902679443
the O O 0.9999856948852539
regulation O O 0.9980987906455994
of O O 0.9999837875366211
EGR-1 S-DNA S-protein 0.8642553091049194
expression O O 0.9986489415168762
, O O 0.9999982118606567
we O O 0.9999816417694092
studied O O 0.999832272529602
activation O O 0.998755931854248
of O O 0.9999741315841675
the O O 0.9998910427093506
40S B-protein B-protein 0.8093962669372559
ribosomal I-protein I-protein 0.9180310368537903
protein I-protein E-protein 0.9491252303123474

, O O 0.9373978972434998

is O O 0.9945998191833496
preceded O O 0.9999322891235352
by O O 0.9999979734420776
cleavage O O 0.977390468120575
of O O 0.9994710087776184
Bcl-2 S-protein S-protein 0.9642965793609619
. O O 0.9999512434005737
Expression O O 0.9997896552085876
of O O 0.9999982118606567
the O O 0.9999772310256958
human B-protein O 0.43211767077445984
immunodeficiency I-protein O 0.49431636929512024
virus I-protein O 0.5160849094390869
type I-protein O 0.5732892751693726
1 I-protein O 0.6887502074241638
( I-protein O 0.6407873630523682
HIV I-protein O 0.6025302410125732
) I-protein O 0.5189042091369629

such O O 0.9971234202384949
phenomena O O 0.9854933619499207
. O O 0.9999852180480957
Using O O 0.9997977614402771
reporter B-DNA B-DNA 0.6595264077186584
gene I-DNA I-DNA 0.5734277963638306
constructs E-DNA E-DNA 0.9716909527778625
driven O O 0.9996525049209595
by O O 0.9999970197677612
the O O 0.999882698059082
CD4 B-DNA B-DNA 0.6771295070648193
promoter E-DNA E-DNA 0.9885450005531311
, O O 0.9991586208343506
we O O 0.9999924898147583
report O O 0.9999974966049194
that O O 0.9999904632568359
HHV-6 O S-protein 0.7526114583015442
can O O 0.9989099502563477
efficiently O O 0.9996246099472046
transactivate O O 0.9884029030799866

or I-DNA O 0.9586186408996582
jun-D I-DNA B-DNA 0.3800094723701477
expression I-DNA I-DNA 0.47727009654045105
vectors E-DNA E-DNA 0.9828842878341675
, O O 0.9987117052078247
which O O 0.9999889135360718
augmented O O 0.9972174167633057
GR S-protein S-protein 0.7559285163879395
-dependent O O 0.996799111366272
transcription O O 0.9817227721214294
from O O 0.999988317489624
either O O 0.999900221824646
MMTV B-DNA B-DNA 0.9202309250831604
LTR E-DNA E-DNA 0.998465895652771
or O O 0.9984442591667175
GRE S-DNA S-DNA 0.9969411492347717
. O O 0.9998345375061035
Conversely O O 0.9992032647132874
, O O 0.9993106126785278
c-jun S-protein S-DNA 0.8336551785469055
and O O 0.9729537963867188
jun-B S-protein O 0.22896282374858856
transfection O O 0.49046629667282104
blunted O O 0.9954624772071838
GR S-protein S-protein 0.3013595938682556

, O O 0.8954664468765259
interleukin-2 B-protein B-protein 0.8745747804641724
( I-protein I-protein 0.9402298927307129
IL-2 I-protein I-protein 0.7105168700218201
) I-protein I-protein 0.5438084602355957
R I-protein I-protein 0.5988672971725464
alpha E-protein E-protein 0.9913192391395569
, O O 0.9922342300415039
IL-2R B-protein B-protein 0.8606955409049988
beta E-protein E-protein 0.9821098446846008
and O O 0.9822491407394409
IL-2R B-protein B-protein 0.7635143995285034
gamma E-protein E-protein 0.9863573312759399
, O O 0.9968512654304504
while O O 0.9999972581863403
no O O 0.9998513460159302
corresponding O O 0.985736072063446
up-regulation O O 0.9947726130485535
of O O 0.999984622001648
these O O 0.9999595880508423
cell B-protein B-protein 0.6577057242393494
surface I-protein I-protein 0.5229280591011047
molecules E-protein E-protein 0.9865763187408447
was O O 0.9998842477798462
seen O O 0.9999949932098389
in O O 0.9998310804367065
CD8+ B-cell_type B-cell_type 0.9062545299530029
T I-cell_type I-cell_type 0.9658035039901733
cells E-cell_type E-cell_type 0.8955259919166565
. O O 0.9997013211250305
In O O 0.9999885559082031
order O O 0.9999436140060425
to O O 0.999996542930603
investigate O O 0.9999978542327881
the O O 0.9999984502792358
nature O O 0.9998038411140442
of O O 0.999996542930603
the O O 0.9999821186065674
A6H B-protein B-protein 0.49060365557670593
mAb E-protein E-protein 0.886544942855835
costimulus O O 0.6493756771087646
at O O 0.999967098236084
the O O 0.9999991655349731
transcriptional O O 0.9053992033004761
level O O 0.9969958066940308

genes E-DNA E-DNA 0.9400023221969604
and O O 0.9988389611244202
has O O 0.9999163150787354
been O O 0.9999914169311523
attributed O O 0.9999678134918213
to O O 0.9999978542327881
some O O 0.9999923706054688
aspect O O 0.9962155222892761
of O O 0.9999175071716309
the O O 0.9999957084655762
isolation O O 0.9639511108398438
procedure O O 0.9966384172439575
. O O 0.999997615814209
In O O 0.9984365105628967
cells O O 0.9734611511230469
that O O 0.9999926090240479

of O O 0.9961821436882019
I-factor/nm23 B-protein B-protein 0.7117553949356079
protein E-protein E-protein 0.9887095093727112
is O O 0.9995310306549072
not O O 0.9997711777687073
restricted O O 0.9994612336158752
to O O 0.9999871253967285
monocytic O O 0.5849881768226624
differentiation O O 0.9773863554000854
of O O 0.9998719692230225
M1 B-cell_line B-cell_line 0.6410032510757446
cells E-cell_line E-cell_line 0.9231722950935364
, O O 0.9981514811515808
( O O 0.9994400143623352
2 O O 0.9967693090438843
) O O 0.9997190833091736
the O O 0.999985933303833
inhibitory O O 0.870097279548645
activity O O 0.9962511658668518
is O O 0.999987006187439
exhibited O O 0.9998359680175781
without O O 0.9999786615371704
species O O 0.9714169502258301
specificity O O 0.9980220794677734
, O O 0.9999812841415405
and O O 0.9999574422836304
( O O 0.9998064637184143
3 O O 0.9989338517189026
) O O 0.9997931122779846
the O O 0.9999933242797852
differentiation O O 0.9636985063552856
inhibitory O O 0.9672397375106812
activity O O 0.9994379878044128
of O O 0.9999899864196777

Class O I-DNA 0.5034055113792419
II O I-DNA 0.5300779938697815
transactivator-independent O I-DNA 0.3464353680610657
endothelial O I-DNA 0.5836467146873474
cell O I-DNA 0.5019278526306152
MHC B-protein I-DNA 0.4462936222553253
class I-protein I-DNA 0.890060544013977
II E-protein I-DNA 0.907520055770874
gene O E-DNA 0.9919120073318481
activation O O 0.9903138279914856
induced O O 0.9998657703399658
by O O 0.9999773502349854
lymphocyte O S-cell_type 0.8888972997665405
adhesion O O 0.9829176068305969
. O O 0.9999761581420898
NK O B-cell_type 0.8079230189323425
cells O E-cell_type 0.9875184893608093
induce O O 0.9999463558197021
MHC B-protein B-protein 0.7115252614021301
class I-protein I-protein 0.9610874652862549
II E-protein I-protein 0.7941724061965942
molecules O E-protein 0.9991297125816345
on O O 0.9999312162399292
the O O 0.999981164932251
surface O O 0.9971970319747925
of O O 0.9999605417251587
allogeneic O B-cell_type 0.588050127029419
endothelial O I-cell_type 0.8024077415466309
cells O E-cell_type 0.9482673406600952
in O O 0.999925971031189
an O O 0.9999921321868896
adhesion-dependent O O 0.9384945631027222
, O O 0.9916467070579529
IFN-gamma S-protein S-protein 0.993448793888092
-independent O O 0.9912019968032837
manner O O 0.9996346235275269
. O O 0.9999994039535522
Here O O 0.9999696016311646

) O O 0.7523679137229919
is O O 0.9992889165878296
associated O O 0.9999150037765503
with O O 0.9999977350234985
reciprocal O O 0.9332450032234192
chromosomal O O 0.8531125783920288
translocations O O 0.8754045367240906
involving O O 0.9999912977218628
the O O 0.9999706745147705
retinoic B-DNA B-DNA 0.4533180594444275
acid I-DNA I-DNA 0.6479862928390503
receptor I-DNA I-DNA 0.5265728235244751
alpha I-DNA I-DNA 0.8365424275398254
( I-DNA I-DNA 0.5663398504257202
RARalpha I-DNA I-DNA 0.7564143538475037
) I-DNA I-DNA 0.9140968918800354
locus E-DNA E-DNA 0.9834907054901123
on O O 0.999670147895813
chromosome B-DNA B-DNA 0.794036865234375
17 E-DNA E-DNA 0.995175838470459
. O O 0.9997138381004333
In O O 0.9999631643295288
the O O 0.9999914169311523
majority O O 0.9819590449333191

with O O 0.9979113936424255
activation O O 0.9940047860145569
of O O 0.999752938747406
pp90rsk S-protein S-protein 0.9501996636390686
. O O 0.998907208442688
Antioxidants O O 0.9928058981895447
inhibit O O 0.9998770952224731
monocyte S-cell_type O 0.5004155039787292
adhesion O O 0.9935423135757446
by O O 0.9999908208847046
suppressing O O 0.9955214262008667
nuclear B-protein B-protein 0.7277237176895142
factor-kappa I-protein I-protein 0.48681944608688354
B E-protein E-protein 0.9866558313369751
mobilization O O 0.988996148109436

in O O 0.9985468983650208
productively O B-cell_type 0.753010630607605
infected O I-cell_type 0.5933762192726135
cells O E-cell_type 0.8569393157958984
. O O 0.9999102354049683
Expression O O 0.9790615439414978
levels O O 0.9996435642242432
of O O 0.9999969005584717
the O O 0.9999427795410156
thyrotropin B-DNA B-DNA 0.41188904643058777
receptor I-DNA I-DNA 0.43478190898895264
gene E-DNA E-DNA 0.9939753413200378
in O O 0.9999185800552368
autoimmune O O 0.7706603407859802
thyroid O O 0.7869482040405273
disease O O 0.984632134437561
: O O 0.9996232986450195
coregulation O O 0.9755266308784485

tyrosine I-protein B-protein 0.4394252598285675
kinases E-protein E-protein 0.9920028448104858
and O O 0.998802900314331
the O O 0.9997946619987488
STATs S-protein S-protein 0.9487187266349792
( O O 0.9717042446136475
signal B-protein B-protein 0.7626925706863403
transducers I-protein I-protein 0.49688461422920227
and I-protein I-protein 0.7858520150184631
activators I-protein I-protein 0.8800117373466492
of I-protein I-protein 0.9914078116416931
transcription E-protein E-protein 0.9675766229629517
) O O 0.9405120015144348
have O O 0.9999645948410034
been O O 0.9999240636825562
shown O O 0.9999740123748779
to O O 0.999970555305481
be O O 0.9999427795410156
activated O O 0.9937432408332825
in O O 0.9999059438705444
response O O 0.9986411929130554
to O O 0.9999915361404419
a O O 0.999984622001648
number O O 0.9988787770271301
of O O 0.9999842643737793
cytokines S-protein S-protein 0.9970914125442505
and O O 0.9978613257408142
growth B-protein B-protein 0.5455473065376282
factors E-protein E-protein 0.9957314133644104
. O O 0.9999390840530396
In O O 0.9999924898147583
this O O 0.9999991655349731
study O O 0.9999068975448608
, O O 0.9999959468841553
we O O 0.9996862411499023

activated O B-cell_type 0.44299745559692383
T B-cell_type I-cell_type 0.6423724293708801
lymphocytes E-cell_type E-cell_type 0.9559783935546875
, O O 0.9902984499931335
basophils S-cell_type S-cell_type 0.9903337359428406
, O O 0.9841780066490173
and O O 0.9946708083152771
mast B-cell_type B-cell_type 0.886491060256958
cells E-cell_type E-cell_type 0.9838252663612366
. O O 0.9998451471328735
It O O 0.9999793767929077
plays O O 0.9999862909317017
an O O 0.9999773502349854
important O O 0.9998290538787842
role O O 0.9999829530715942
in O O 0.9999916553497314
modulating O O 0.9929706454277039

be O O 0.997965931892395
related O O 0.9999150037765503
to O O 0.9999967813491821
the O O 0.9999847412109375
pathogenesis O O 0.9385378360748291
of O O 0.9994627833366394
type O O 0.8281769156455994
II O O 0.5873262286186218
diabetes O O 0.9421517252922058
in O O 0.9999352693557739
menopausal O O 0.7608374357223511
period O O 0.948663592338562
. O O 0.9999717473983765
Lymphocyte O B-protein 0.605647087097168
glucocorticoid B-protein I-protein 0.8001383543014526
receptor E-protein E-protein 0.9703598022460938
number O O 0.7706232666969299
in O O 0.9997566342353821
posttraumatic O O 0.7830324769020081
stress O O 0.966961681842804
disorder O O 0.9985547661781311
. O O 0.9999963045120239
OBJECTIVE O O 0.9688913226127625
: O O 0.9998019337654114
The O O 0.9999896287918091
authors O O 0.9415187239646912
' O O 0.9759484529495239
objective O O 0.9936821460723877
was O O 0.9999954700469971
to O O 0.9999849796295166

B I-DNA I-DNA 0.5291141271591187
promoter E-DNA E-DNA 0.9895394444465637
demonstrated O O 0.9997336268424988
that O O 0.9999986886978149
both O O 0.999794065952301
sites O O 0.982319176197052
participate O O 0.9999948740005493
in O O 0.9999831914901733
dexamethasone-mediated O O 0.980872631072998
inhibition O O 0.9983384609222412
of O O 0.9999912977218628
the O O 0.9999555349349976
granzyme B-DNA B-DNA 0.6481885313987732
B I-DNA I-DNA 0.5165930986404419
promoter E-DNA E-DNA 0.970560610294342
activity O O 0.9879172444343567
. O O 0.9999911785125732
Electromobility O O 0.9229632616043091
shift O O 0.9837333559989929
assay O O 0.9948500990867615

cold O O 0.6530558466911316
aldosterone O O 0.7505282759666443
, O O 0.9917689561843872
but O O 0.9997395873069763
not O O 0.9997484087944031
cortisol O O 0.9697821736335754
in O O 0.9999703168869019
the O O 0.9999915361404419
binding O O 0.9670965671539307
media O O 0.9943935871124268
. O O 0.9999983310699463
This O O 0.9999885559082031
aldosterone-selectivity O O 0.7841033935546875
is O O 0.9993124008178711
typical O O 0.9999215602874756
and O O 0.9998981952667236
discriminatory O O 0.9967585206031799
for O O 0.9999849796295166
the O O 0.9999909400939941
new O O 0.9747511744499207
aldosterone B-protein O 0.7132734656333923

of O O 0.9925521612167358

< O O 0.9062431454658508
0.05 O O 0.8746248483657837
) O O 0.960533082485199
and O O 0.9995123147964478
by O O 0.9999499320983887
enhancing O O 0.9997513890266418
its O O 0.9999347925186157
inactivation O O 0.9926637411117554
through O O 0.9999289512634277
binding O O 0.8993133902549744
to O O 0.9969582557678223
soluble O O 0.8615508675575256
TNF-alpha S-protein B-protein 0.5506335496902466
receptor O I-protein 0.7053961753845215
type O I-protein 0.5702434778213501
II O E-protein 0.9921446442604065
( O O 0.9971907734870911
P O O 0.947860062122345
< O O 0.9975215792655945
0.05 O O 0.9962533712387085
) O O 0.9998507499694824
. O O 0.9999978542327881
We O O 0.9999963045120239
also O O 0.9999984502792358
show O O 0.9999990463256836
that O O 0.9999986886978149
DFX O O 0.48768532276153564
treatment O O 0.9931992888450623
limits O O 0.9999762773513794
the O O 0.9999957084655762
in O O 0.9997571110725403

, O O 0.9373978972434998

suggesting O O 0.9890450239181519
expression O O 0.9989253878593445
in O O 0.999996542930603
the O O 0.999993085861206
germ O B-cell_line 0.5170471668243408
line O E-cell_line 0.9879531860351562
. O O 0.9999431371688843
An O O 0.9999825954437256
upstream B-DNA B-DNA 0.6428722143173218
segment E-DNA E-DNA 0.9865380525588989
contains O O 0.9998939037322998
tandem B-DNA B-DNA 0.6081120371818542
dinucleotide I-DNA I-DNA 0.5346209406852722
repeats E-DNA E-DNA 0.9374033808708191
( B-DNA O 0.9897817373275757
CT I-DNA O 0.8557882905006409
) I-DNA O 0.953729510307312
19/ I-DNA O 0.9843988418579102
( I-DNA O 0.9996092915534973
CA I-DNA O 0.8936765789985657
) I-DNA O 0.977559506893158
16 E-DNA O 0.8466630578041077
. O O 0.999872088432312
There O O 0.9999902248382568
is O O 0.9999973773956299
a O O 0.9999974966049194
suitably O O 0.9619078636169434
located O O 0.9892483949661255
TATA B-DNA B-DNA 0.6319091320037842
box E-DNA E-DNA 0.9899923205375671
, O O 0.9983115196228027

to I-DNA O 0.9700666666030884
+15 E-DNA O 0.39470750093460083
. O O 0.9981256127357483
Electromobility O O 0.9269158840179443
shift O O 0.9836907982826233
assays O O 0.9983876943588257
utilizing O O 0.9999212026596069
this O O 0.9999545812606812
sequence O O 0.9633204340934753
demonstrated O O 0.9994558691978455
binding O O 0.9913766384124756
of O O 0.9998151659965515
a O O 0.9999276399612427
fetal B-protein B-protein 0.39799222350120544
and I-protein I-protein 0.5823530554771423
erythroid-specific I-protein I-protein 0.7609007954597473
protein E-protein E-protein 0.9848184585571289
. O O 0.9997603297233582
The O O 0.999996542930603
repressor O O 0.5277118682861328
activity O O 0.9721447825431824

have O O 0.9976498484611511
been O O 0.9999552965164185
isolated O O 0.996745228767395
only O O 0.9999830722808838
from O O 0.9998564720153809
T B-cell_type B-cell_type 0.9224503040313721
cells E-cell_type E-cell_type 0.9861739873886108
. O O 0.9997889399528503
To O O 0.9999914169311523
further O O 0.9999496936798096
characterize O O 0.9997667670249939
NFAT S-protein S-protein 0.9849986433982849
function O O 0.9992189407348633
in O O 0.9998878240585327
human B-cell_type B-cell_type 0.5111066102981567
B I-cell_type I-cell_type 0.786472737789154
cells E-cell_type E-cell_type 0.9752458930015564
and O O 0.9965338706970215
to O O 0.9999580383300781
demonstrate O O 0.9999344348907471
cytokine O B-DNA 0.4674849510192871
gene O E-DNA 0.9561906456947327

previously O O 0.9910252094268799
established O O 0.9400711059570312
murine B-cell_line B-cell_line 0.36282843351364136
T I-cell_line I-cell_line 0.3837019205093384
cell I-cell_line I-cell_line 0.295849472284317
hybridoma I-cell_line E-cell_line 0.8003367781639099
model E-cell_line O 0.7838113903999329
A1.1 S-cell_line S-cell_line 0.5621901154518127
, O O 0.9862791299819946
we O O 0.9999748468399048
show O O 0.9999995231628418
that O O 0.9999996423721313
specific O O 0.9595181941986084
protein B-protein B-protein 0.7518762946128845
kinase I-protein I-protein 0.5161014795303345
C E-protein E-protein 0.9790674448013306
( O O 0.9831506609916687
PKC S-protein S-protein 0.9831224083900452
) O O 0.9706963300704956
inhibitors O O 0.9882227778434753
could O O 0.9999963045120239
block O O 0.9997746348381042
activation-induced O O 0.9510406255722046
Fas S-protein S-protein 0.874123215675354
expression O O 0.9997052550315857
and O O 0.999987006187439
apoptosis O O 0.9987443685531616
. O O 0.9999982118606567
The O O 0.9999955892562866

abolished O O 0.9897448420524597
by O O 0.9999853372573853
co-treatment O O 0.9834302663803101
with O O 0.9999681711196899
phenylarsine O O 0.9355897307395935
oxide O O 0.9475787878036499
( O O 0.9995966553688049
PAO O O 0.9828806519508362
) O O 0.999656081199646
, O O 0.9999921321868896
a O O 0.9999946355819702
specific O O 0.9831891059875488
inhibitor O O 0.9364970922470093
of O O 0.9994465708732605
PTPase S-protein S-protein 0.9928129315376282
. O O 0.9999732971191406
The O O 0.9999970197677612
induction O O 0.9983489513397217
of O O 0.999969482421875
ICAM-1 S-protein S-protein 0.9055948257446289
, O O 0.9820257425308228
VCAM-1 S-protein S-protein 0.9848260879516602
, O O 0.9914805889129639

may O O 0.9950284361839294
be O O 0.9999866485595703
involved O O 0.9999871253967285
in O O 0.999997615814209
the O O 0.9999945163726807
pathogenesis O O 0.9949896931648254
of O O 0.9999240636825562
inflammation O O 0.9990562796592712
, O O 0.9999901056289673
including O O 0.9999905824661255
RA O O 0.9810456037521362
synovitis O O 0.9964572787284851
. O O 0.999980092048645
NF-kappaB S-protein S-protein 0.9973114728927612
activation O O 0.9995731711387634
is O O 0.9999983310699463
a O O 0.9999985694885254
critical O O 0.9914671182632446
regulator O O 0.9819316864013672
of O O 0.9998849630355835

on O O 0.9992607235908508
the O O 0.9999819993972778
CRE B-DNA B-DNA 0.5551587343215942
site E-DNA E-DNA 0.9932321310043335
. O O 0.9999403953552246
These O O 0.9999974966049194
stimuli O O 0.9918813109397888
result O O 0.9999932050704956
in O O 0.9999979734420776
phosphorylation O O 0.9922665953636169
of O O 0.9999243021011353
CREB S-protein S-protein 0.9108433127403259
at O O 0.9998714923858643

molar O O 0.6298344731330872
amounts O O 0.997603714466095
of O O 0.9999865293502808
TATA-binding B-protein B-protein 0.8269702196121216
protein E-protein E-protein 0.9891784191131592
( O O 0.9776122570037842
TBP S-protein S-protein 0.9848191738128662
) O O 0.9531054496765137
and O O 0.9992052912712097
TFIIIB90 S-protein S-protein 0.9940111041069031
can O O 0.9995967745780945
weakly O O 0.9996693134307861
associate O O 0.9999402761459351
with O O 0.9999916553497314
PTF S-protein S-protein 0.953222393989563
at O O 0.9999853372573853
low O O 0.978383481502533
salt O O 0.9636523127555847
conditions O O 0.9989350438117981
, O O 0.9999905824661255
but O O 0.9999939203262329
this O O 0.9999991655349731
association O O 0.9995453953742981
is O O 0.9999971389770508
dramatically O O 0.99993896484375

CAEV B-DNA B-DNA 0.6811730265617371
LTR E-DNA E-DNA 0.9983363747596741
is O O 0.9998339414596558
essential O O 0.9999557733535767
for O O 0.9999969005584717
the O O 0.9999963045120239
response O O 0.9978005290031433
to O O 0.9999524354934692
IFN-gamma S-protein S-protein 0.9958184361457825
and O O 0.999249279499054
a O O 0.9999642372131348
STAT1-like B-protein B-protein 0.4124157726764679

-101 B-DNA B-DNA 0.586591362953186
to I-DNA I-DNA 0.8618009090423584
-92 E-DNA E-DNA 0.9739813208580017
) O O 0.8880230188369751
. O O 0.9999570846557617
We O O 0.9999868869781494
show O O 0.9999974966049194
in O O 0.9999969005584717
this O O 0.999997615814209
work O O 0.9997673630714417
that O O 0.9999984502792358
mutations O O 0.994175374507904
in O O 0.9999916553497314
either O O 0.9999842643737793
the O O 0.9995493292808533
purine-rich B-DNA B-DNA 0.5794377326965332
region E-DNA E-DNA 0.9045811295509338
of O O 0.9953417778015137
the O O 0.9996554851531982
CLEO B-DNA B-DNA 0.8533436059951782
element E-DNA E-DNA 0.9965715408325195
or O O 0.9988214373588562
the O O 0.999718964099884
NF-kappa B-DNA B-DNA 0.9332088828086853
B I-DNA I-DNA 0.7988876104354858
site E-DNA E-DNA 0.9912354946136475
result O O 0.9999680519104004
in O O 0.9999984502792358
reduced O O 0.9968200922012329
PMA/Ca2+ O S-protein 0.5729082226753235
activation O O 0.9835051894187927
of O O 0.9999568462371826
a O O 0.9999784231185913
620-bp B-DNA B-DNA 0.6748848557472229
human I-DNA I-DNA 0.7560754418373108
GM-CSF I-DNA I-DNA 0.9133096933364868
promoter-luciferase I-DNA I-DNA 0.9625536799430847
reporter I-DNA I-DNA 0.8422139883041382
construct E-DNA E-DNA 0.9987658262252808
in O O 0.9999024868011475
Jurkat B-cell_line B-cell_line 0.7285902500152588
T I-cell_line I-cell_line 0.7279428243637085
cells E-cell_line E-cell_line 0.9924197793006897
by O O 0.9998880624771118
65 O O 0.9854958653450012
% O O 0.9984159469604492
and O O 0.9997765421867371
50 O O 0.9981701374053955
% O O 0.9997459053993225
, O O 0.9999758005142212
respectively O O 0.9999864101409912
. O O 0.9999982118606567
The O O 0.9999971389770508
major O B-protein 0.8075574636459351
inducible B-protein I-protein 0.8268486857414246
protein I-protein I-protein 0.39568957686424255
complex E-protein E-protein 0.9756009578704834

RESULTS O O 0.9564847946166992
: O O 0.9999839067459106
There O O 0.9999924898147583
were O O 0.9999982118606567
no O O 0.9999955892562866
significant O O 0.9997816681861877
differences O O 0.9999616146087646
in O O 0.9999991655349731
the O O 0.9999967813491821
number O O 0.9641361236572266
( O O 0.9998204112052917
6500+/-1001 O O 0.983755350112915
sites/cell O O 0.9922000765800476
and O O 0.9999779462814331
6352+/-1697 O O 0.9931939840316772
sites/cell O O 0.989367663860321
, O O 0.999977707862854
respectively O O 0.9999948740005493
; O O 0.9999741315841675
P O O 0.9974193572998047
> O O 0.9998249411582947
0.05 O O 0.9990769624710083
) O O 0.999948263168335
and O O 0.999991774559021
affinity O O 0.9616343975067139
( O O 0.9998782873153687
3.93+/-0.89 O O 0.9976045489311218
nM O O 0.9996138215065002
and O O 0.9999475479125977
4.49+/-0.71 O O 0.997904896736145
nM O O 0.9990394711494446
, O O 0.9999297857284546
respectively O O 0.9999829530715942
; O O 0.999964714050293

activation O O 0.9624622464179993
. O O 0.9997777342796326
ISG15-LTR-IFN B-DNA B-DNA 0.4890405237674713
hybrid I-DNA I-DNA 0.42310506105422974
gene E-DNA E-DNA 0.988711953163147
inserted O O 0.9950272440910339
into O O 0.9999762773513794
the O O 0.9998266100883484
retrovirus B-DNA B-DNA 0.5634542107582092
vector E-DNA E-DNA 0.9537717700004578
was O O 0.999471127986908
transduced O O 0.9979034662246704
into O O 0.9999022483825684
Jurkat S-cell_line S-cell_line 0.9766533970832825
and O O 0.9688917994499207
U937 B-cell_line B-cell_line 0.8734148144721985
cells E-cell_line E-cell_line 0.9996533393859863
. O O 0.9999189376831055
Selected O O 0.9444030523300171
transfected B-cell_line B-cell_line 0.5286040902137756
clones E-cell_line E-cell_line 0.9925082325935364
produced O O 0.9996194839477539
low O O 0.9903476238250732
levels O O 0.9997661709785461
of O O 0.9999722242355347
IFN B-protein B-protein 0.6288167834281921
A E-protein E-protein 0.768444836139679
( O O 0.8988535404205322
IFNA S-protein S-protein 0.46541228890419006

17 O O 0.3959902226924896

the O O 0.9986091256141663
class B-protein B-protein 0.7437835335731506
II-peptide I-protein I-protein 0.5445737242698669
complex E-protein E-protein 0.9869224429130554
, O O 0.9982357025146484
in O O 0.9999943971633911
which O O 0.9999984502792358
the O O 0.9999845027923584
substituted O O 0.9292037487030029
peptide O O 0.9585659503936768
abolished O O 0.9964258074760437
T O O 0.7504115700721741
cell O O 0.6709911227226257
reactivity O O 0.9407253861427307
, O O 0.9997078776359558
which O O 0.9999874830245972
was O O 0.999948263168335
directed O O 0.9999624490737915

down-regulation O O 0.9920145273208618
of O O 0.9999855756759644
many O O 0.9982625842094421
erythroid B-DNA B-DNA 0.5703774094581604
cell-specific I-DNA I-DNA 0.7726564407348633
genes E-DNA E-DNA 0.9873959422111511
, O O 0.9958781003952026
including O O 0.9999551773071289
alpha- B-DNA B-DNA 0.646713137626648
and I-DNA I-DNA 0.5919650197029114
beta-globin E-DNA I-DNA 0.2815445363521576
, O I-DNA 0.6850156784057617
band O I-DNA 0.4109916388988495
3 O E-DNA 0.9618668556213379
, O O 0.9688953757286072
band O B-DNA 0.49026525020599365
4.1 O E-DNA 0.9849507808685303
, O O 0.9903203845024109
and O O 0.9993019104003906
the O O 0.9998151659965515
erythroid B-protein B-DNA 0.49548497796058655
cell-specific I-protein I-DNA 0.5926501154899597
histone E-protein I-DNA 0.7537093758583069
H5 S-protein E-DNA 0.7210192084312439
. O O 0.9910506010055542
We O O 0.9999799728393555
show O O 0.9999967813491821
here O O 0.9999922513961792
that O O 0.9999978542327881
estrogens O O 0.888701856136322

multiple O O 0.8967069983482361
malignancies O O 0.9841474294662476
and O O 0.9998531341552734
in O O 0.9999486207962036
normal O O 0.9666566848754883
tissues O O 0.9858470559120178
and O O 0.9997639060020447
mimics O O 0.9969261288642883
alterations O O 0.9964834451675415
previously O O 0.9999535083770752
described O O 0.9999921321868896
in O O 0.9999140501022339
tumours O O 0.6298858523368835
. O O 0.9995660185813904
Intragenic O O 0.9151042699813843
deletions O O 0.8420323729515076
of O O 0.9999792575836182
TSG101 S-DNA S-DNA 0.9430325031280518
, O O 0.9946609139442444
the O O 0.9999884366989136
human O B-DNA 0.418302983045578
homolog O E-DNA 0.4649515748023987
of O O 0.6913132071495056
a O O 0.9885791540145874
mouse B-DNA B-DNA 0.7075233459472656
gene E-DNA E-DNA 0.8447908163070679

part O O 0.9037899971008301
of O O 0.9996787309646606
the O O 0.9999992847442627
anti-atherogenic O O 0.8836331963539124
effect O O 0.9984731078147888
of O O 0.9999845027923584
aspirin O O 0.9766759276390076
may O O 0.9999568462371826
be O O 0.9999972581863403
due O O 0.9999843835830688
to O O 0.9999966621398926
the O O 0.9999958276748657
prevention O O 0.9999344348907471
of O O 0.9999973773956299
the O O 0.999982476234436
adhesion O O 0.9936851859092712
of O O 0.999897837638855
sensitized B-cell_type B-cell_type 0.5404300093650818
T I-cell_type I-cell_type 0.44807949662208557
cells E-cell_type E-cell_type 0.8015422224998474
to O O 0.9992424249649048
stressed O O 0.8851590156555176
EC S-cell_type S-cell_type 0.9621337056159973
; O O 0.9960874319076538
( O O 0.9984409213066101
2 O O 0.9967105388641357
) O O 0.9988190531730652
that O O 0.9999974966049194
part O O 0.9988682270050049

that O O 0.9997624754905701
cytoplasmic O O 0.8613710999488831
acidification O O 0.9812532067298889
facilitated O O 0.9994431138038635
NF-kappa B-protein B-protein 0.7971898317337036
B E-protein E-protein 0.9988532066345215
activation O O 0.9990919828414917
by O O 0.9999995231628418
both O O 0.9999395608901978
TNF B-protein B-protein 0.7113891243934631
alpha E-protein E-protein 0.9853286147117615
and O O 0.9931784868240356
PKC S-protein S-protein 0.9042832255363464
, O O 0.9989323019981384
by O O 0.999996542930603
a O O 0.9999914169311523
mechanism O O 0.9951505661010742
that O O 0.999995231628418
increases O O 0.9999803304672241
NF-kappa B-protein B-protein 0.5235034227371216
B E-protein E-protein 0.995037853717804
/I B-protein O 0.9332270622253418
kappa I-protein O 0.9812237024307251
B E-protein O 0.6139336228370667
dissociation O O 0.9991279244422913
without O O 0.9999935626983643
affecting O O 0.999940037727356
the O O 0.99998939037323

were O O 0.9990863800048828
detected O O 0.999825656414032
in O O 0.9999843835830688
the O O 0.9999436140060425
peripheral B-cell_type B-cell_type 0.6007239818572998
blood I-cell_type I-cell_type 0.6428566575050354
T I-cell_type I-cell_type 0.9278270602226257
cells E-cell_type E-cell_type 0.9918015599250793
in O O 0.9998636245727539
27 O O 0.9959297776222229
of O O 0.9999936819076538
29 O O 0.9986779093742371
patients O O 0.999527096748352
, O O 0.9999535083770752
and O O 0.9999563694000244
overall O O 0.999413013458252
, O O 0.9999140501022339
reduced O O 0.9989733695983887

naive I-cell_type B-cell_type 0.3713237941265106
( I-cell_type I-cell_type 0.6274325847625732
CD45RA+ I-cell_type I-cell_type 0.9116854071617126
) I-cell_type I-cell_type 0.9285976886749268
T I-cell_type I-cell_type 0.9694594740867615
cell I-cell_type I-cell_type 0.7903972864151001
subsets E-cell_type E-cell_type 0.9937365055084229
from O O 0.9999709129333496
young O O 0.9842785000801086
and O O 0.997880220413208
elderly O O 0.9919122457504272
donors O O 0.9967314004898071
has O O 0.9999923706054688
demonstrated O O 0.9999874830245972
that O O 0.9999985694885254
, O O 0.9999681711196899
regardless O O 0.999996542930603
of O O 0.9999841451644897
donor O O 0.863707423210144
age O O 0.9896490573883057
, O O 0.9999898672103882

early O O 0.827053964138031
treatment O O 0.9964815378189087
( O O 0.9999282360076904
day O O 0.9949626922607422
0 O O 0.9988129138946533
HPCs S-cell_type O 0.6437023878097534
) O O 0.998641312122345
with O O 0.9999914169311523
alpha-PML S-protein O 0.39331570267677307
reduced O O 0.9986236095428467
the O O 0.9999955892562866
number O O 0.9996123909950256
of O O 0.9999923706054688
both O O 0.9990091323852539
erythroid B-cell_line B-cell_line 0.391865074634552
and I-cell_line I-cell_line 0.5063741207122803
granulocytic I-cell_line I-cell_line 0.6411287188529968
colonies E-cell_line E-cell_line 0.9008522033691406
, O O 0.9945202469825745
whereas O O 0.999985933303833
late O O 0.8808301687240601
treatment O O 0.9960516095161438
( O O 0.9998952150344849
day O O 0.9928207993507385
5 O O 0.9974193572998047
culture O O 0.9757677316665649
) O O 0.9998082518577576

after O O 0.999087929725647
the O O 0.9999983310699463
initiation O O 0.9988250136375427
of O O 0.9999910593032837
the O O 0.9999982118606567
viral O O 0.7807273268699646
lytic O O 0.7691767811775208
cycle O O 0.8522496223449707
, O O 0.9995793700218201
while O O 0.9999979734420776
the O O 0.9999983310699463
amount O O 0.9999070167541504
of O O 0.9999935626983643
circular O B-DNA 0.5519415736198425
DNA O E-DNA 0.914189338684082
remained O O 0.9992930889129639
approximately O O 0.9997362494468689
constant O O 0.9998237490653992
. O O 0.9999973773956299
We O O 0.9999836683273315
propose O O 0.999996542930603
from O O 0.9999990463256836
these O O 0.9999958276748657
results O O 0.9998261332511902
that O O 0.9999995231628418
the O O 0.9999974966049194
source O O 0.9929503202438354

the O O 0.998673677444458
thymus O O 0.8312466740608215
, O O 0.9975520968437195
the O O 0.9999868869781494
white O O 0.8770288228988647
pulp O O 0.8770564198493958
of O O 0.9985412359237671
the O O 0.9999754428863525
spleen O O 0.7439213395118713
, O O 0.9928960204124451
and O O 0.9996123909950256
the O O 0.9999808073043823
germinal O O 0.7171074748039246
centers O O 0.7705820202827454
of O O 0.9990779161453247
lymph O O 0.5870474576950073
nodes O O 0.7958449125289917
. O O 0.999691367149353
Spi-B S-protein S-protein 0.943658709526062
expression O O 0.9988541603088379
is O O 0.9999924898147583
very O O 0.9999266862869263
abundant O O 0.9958460927009583
in O O 0.9997749924659729
B B-cell_type B-cell_type 0.8062575459480286
cells E-cell_type E-cell_type 0.9831790924072266
and O O 0.9985139966011047
both O O 0.999956488609314
Spi-B B-RNA B-RNA 0.7101830840110779
mRNA E-RNA E-RNA 0.9956738352775574
and O O 0.9968782663345337

has O O 0.9888082146644592
been O O 0.9998921155929565
used O O 0.9997995495796204
to O O 0.9999302625656128
protect O O 0.999953031539917
against O O 0.9998408555984497
acetaminophen- O O 0.7448960542678833
and O O 0.954087495803833
CCl4-induced O O 0.9701160192489624
hepatotoxicity O O 0.9969448447227478
, O O 0.9999830722808838
lipid O O 0.9841407537460327
peroxidation O O 0.9986242055892944
, O O 0.999983549118042
radiation O O 0.9693459272384644
injury O O 0.9983702301979065
, O O 0.9999608993530273
and O O 0.9998981952667236
also O O 0.9998644590377808
has O O 0.999940037727356
been O O 0.9999752044677734
used O O 0.9998431205749512
clinically O O 0.9998718500137329
as O O 0.9999943971633911
an O O 0.9999663829803467
anti-choleretic O O 0.8062423467636108

. O O 0.9991347193717957
The O O 0.9999819993972778
M-CSF B-DNA B-DNA 0.4961318373680115
gene E-DNA E-DNA 0.9912430047988892
was O O 0.9995347261428833
expressed O O 0.9999784231185913
in O O 0.9999948740005493
6 O O 0.9260978102684021
cases O O 0.9904526472091675
and O O 0.9999397993087769
the O O 0.9999896287918091
FMS S-DNA S-DNA 0.6910698413848877
and O O 0.8347477316856384
the O O 0.9575608968734741
EGR-1 B-DNA B-DNA 0.6422407031059265
genes E-DNA E-DNA 0.9912449717521667
were O O 0.9998838901519775
expressed O O 0.9999150037765503
in O O 0.9999942779541016
2 O O 0.9827495813369751
of O O 0.9999794960021973
the O O 0.9999916553497314
latter O O 0.9990946054458618
cases O O 0.9995731711387634
. O O 0.999998927116394
An O O 0.9999741315841675
autocrine O O 0.5797839164733887

required O O 0.9926570057868958
for O O 0.9999111890792847
erythroid O O 0.6726683974266052
differentiation O O 0.9919773936271667
. O O 0.9999951124191284
Interaction O O 0.9921205043792725
between O O 0.9992170333862305
PU.1 S-protein S-protein 0.9713463187217712
and O O 0.9947229623794556
GATA-1 S-protein S-protein 0.9936145544052124
requires O O 0.9998838901519775
intact O O 0.9664188027381897
DNA-binding B-protein B-protein 0.742870569229126
domains E-protein E-protein 0.972115695476532
in O O 0.9999082088470459
both O O 0.9998248219490051
proteins O O 0.9356332421302795
. O O 0.9998884201049805
PU.1 S-protein S-protein 0.7128286957740784

a O O 0.9828090071678162

able O O 0.9867161512374878
to O O 0.9998747110366821
protect O O 0.999971866607666
the O O 0.9998682737350464
cells O O 0.9762071967124939
from O O 0.9999892711639404
apoptosis O O 0.996281087398529
induced O O 0.9999610185623169
by O O 0.9999971389770508
IL-3 S-protein S-protein 0.988854169845581
deprivation O O 0.9997479319572449
. O O 0.9999994039535522
Surprisingly O O 0.9997875094413757
, O O 0.9999899864196777
different O O 0.9994636178016663
combinations O O 0.9977995753288269
of O O 0.9999732971191406
disabling O O 0.6236833930015564

CREB/ATF S-protein S-protein 0.9835819005966187
and O O 0.9982897639274597
AP-1 S-protein S-protein 0.9924219250679016
. O O 0.9998983144760132
Peptidoglycan O O 0.8972604274749756
( O O 0.9970248341560364
PGN O O 0.5185948610305786
) O O 0.9845713376998901
, O O 0.9998862743377686
the O O 0.9999947547912598
major O O 0.89854896068573
cell O O 0.9005737900733948
wall O O 0.8206827044487
component O O 0.707014262676239
of O O 0.9998878240585327
Gram-positive O O 0.6404973864555359
bacteria O O 0.48876938223838806
, O O 0.9968258142471313
induces O O 0.999936580657959
secretion O O 0.9953382015228271
of O O 0.9999591112136841
cytokines S-protein S-protein 0.9955536723136902
in O O 0.9998807907104492
macrophages S-cell_type S-cell_type 0.9985671043395996
through O O 0.9989058971405029
CD14 S-protein S-protein 0.9682623744010925
, O O 0.9994111061096191
the O O 0.9999951124191284
pattern O B-protein 0.7459587454795837
recognition O I-protein 0.5867710709571838
receptor O E-protein 0.9529245495796204
that O O 0.999724805355072

1 B-protein I-protein 0.4240938127040863
, I-protein I-protein 0.7938774824142456
25 I-protein I-protein 0.6517850756645203
( I-protein I-protein 0.5646430850028992
OH I-protein I-protein 0.9608992338180542
) I-protein I-protein 0.9468040466308594
2D3 I-protein I-protein 0.9853779077529907
receptors E-protein E-protein 0.9979264736175537
. O O 0.9999772310256958
The O O 0.9999991655349731
percentage O O 0.9990676045417786
of O O 0.9999935626983643
lavage B-cell_type B-cell_type 0.5715702176094055
T-lymphocytes E-cell_type E-cell_type 0.9585494995117188

cohort O O 0.3704788088798523
. O O 0.9997007846832275
Activation O O 0.9985130429267883
of O O 0.999972939491272
NFkappaB S-protein S-protein 0.9983990788459778
in O O 0.9998916387557983
peripheral B-cell_type B-cell_type 0.6566860675811768
blood I-cell_type I-cell_type 0.874255895614624
T I-cell_type I-cell_type 0.9806690812110901
cells E-cell_type E-cell_type 0.9893577694892883
was O O 0.9998107552528381
inducible O O 0.9996243715286255

transfectants E-cell_line O 0.3591318130493164
with O O 0.9993103742599487
Tax S-protein S-protein 0.998749852180481
. O O 0.999980092048645
Human O B-protein 0.7964984178543091
T-cell O I-protein 0.7672854065895081
leukemia O I-protein 0.8206295371055603
virus O I-protein 0.7472363710403442
type O I-protein 0.5478394031524658
1 O I-protein 0.7796183824539185
( O I-protein 0.49789559841156006
HTLV-1 O I-protein 0.9621738791465759
) O I-protein 0.9616817831993103
Tax S-protein E-protein 0.9946179986000061
is O O 0.9994221925735474
thought O O 0.9998993873596191
to O O 0.999990701675415
play O O 0.9999909400939941
a O O 0.9999982118606567
pivotal O O 0.9991752505302429
role O O 0.9999669790267944
in O O 0.9999935626983643
immortalization O O 0.9992275238037109
of O O 0.9999607801437378
T B-cell_type B-cell_type 0.9193849563598633
cells E-cell_type E-cell_type 0.9953699707984924
. O O 0.9998051524162292
We O O 0.9999926090240479
have O O 0.9999940395355225
recently O O 0.9999411106109619
shown O O 0.9999972581863403
that O O 0.9999983310699463
the O O 0.9999814033508301
expression O O 0.9980547428131104
of O O 0.9998923540115356
Tax S-protein S-protein 0.9948632121086121
protected O O 0.9983583092689514
the O O 0.9999207258224487
mouse B-cell_line B-cell_line 0.37738269567489624
T-cell I-cell_line I-cell_line 0.5836938619613647

the O O 0.9983574748039246
control O O 0.9944900274276733
of O O 0.9999145269393921
the O O 0.9999898672103882
entire O O 0.9870285987854004
IL2 B-DNA B-DNA 0.57806396484375
regulatory I-DNA I-DNA 0.870561420917511
region E-DNA E-DNA 0.9810011982917786
or O O 0.9978844523429871
of O O 0.9999321699142456
multimers O S-DNA 0.8422421216964722
of O O 0.9585070013999939
individual O B-DNA 0.8634052276611328
enhancer B-DNA I-DNA 0.5494676828384399
sequences E-DNA E-DNA 0.9864878058433533
. O O 0.9999436140060425
CAT O S-protein 0.8661379218101501
expression O O 0.9967309236526489
directed O O 0.9999713897705078
by O O 0.9999991655349731
the O O 0.9999558925628662
IL2 B-DNA B-DNA 0.46738526225090027
regulatory I-DNA I-DNA 0.7366170287132263

gene E-DNA E-DNA 0.9653123617172241
to O O 0.9994428753852844
different O O 0.9990606904029846
regions O O 0.9693147540092468
of O O 0.9997058510780334
the O O 0.9993396401405334
IRF-1 S-protein B-DNA 0.7436860799789429
5'-flanking S-DNA I-DNA 0.7055845856666565
and O I-DNA 0.5384628772735596
promoter B-DNA I-DNA 0.4798668920993805
DNA E-DNA E-DNA 0.9986905455589294
. O O 0.9999678134918213
The O O 0.9999991655349731
0.2-kb O B-DNA 0.4310877323150635
IRF-CAT B-DNA I-DNA 0.7274179458618164
construct E-DNA E-DNA 0.9875324368476868
was O O 0.9999207258224487
induced O O 0.9999898672103882
by O O 0.9999984502792358
PRL S-protein S-protein 0.5388884544372559

monocyte-endothelial O O 0.3668464124202728

formation O O 0.9521865248680115
in O O 0.9999731779098511
the O O 0.999995231628418
liver O O 0.9504390954971313
of O O 0.9997197985649109
patients O O 0.9981978535652161
with O O 0.9999886751174927
chronic O O 0.9782892465591431
hepatitis O O 0.9959220886230469
C O O 0.9939224123954773
were O O 0.9999918937683105
similar O O 0.9999840259552002
to O O 0.9999960660934448
those O O 0.9999949932098389
of O O 0.9999806880950928
lymph O O 0.46232709288597107
nodes O O 0.501457691192627
, O O 0.9779568910598755
indicating O O 0.9997443556785583
that O O 0.9999862909317017
B B-cell_type B-cell_type 0.8237804174423218
cells E-cell_type E-cell_type 0.9871925115585327
are O O 0.9997465014457703
activated O O 0.9234308004379272
, O O 0.9883212447166443
proliferated O O 0.9266431927680969
, O O 0.9945026636123657
and O O 0.9993770718574524
differentiated O O 0.9968532919883728
in O O 0.9999569654464722
the O O 0.9999152421951294
ILFs O S-cell_type 0.8737625479698181
with O O 0.9996070265769958
GC O O 0.8281054496765137
formation O O 0.9972475171089172
in O O 0.9999947547912598
patients O O 0.9991672039031982
with O O 0.9999728202819824
chronic O O 0.9876696467399597
hepatitis O O 0.9975504279136658
C O O 0.9958947896957397
. O O 0.9999973773956299
Oligoclonal O O 0.9614949822425842
expansion O O 0.9995001554489136
of O O 0.9999866485595703
B B-cell_type B-cell_type 0.7943008542060852
cells E-cell_type E-cell_type 0.98869788646698

that O O 0.9995726943016052
both O O 0.9999573230743408
stimuli O O 0.9009230732917786
activate O O 0.997428834438324
NF-kappa B-protein B-protein 0.8197214603424072
B E-protein E-protein 0.9914974570274353
. O O 0.9997017979621887
Characterization O O 0.998353123664856
of O O 0.999984622001648
the O O 0.9999428987503052
NF-kappa B-DNA B-DNA 0.5947733521461487
B1 I-DNA I-DNA 0.38853904604911804
promoter E-DNA E-DNA 0.9893139004707336
identified O O 0.9997712969779968
an O O 0.9999886751174927
Egr-1 B-DNA B-DNA 0.7530671954154968
site E-DNA E-DNA 0.9781825542449951
which O O 0.9990794658660889
was O O 0.9999350309371948
found O O 0.9999524354934692
to O O 0.9999885559082031
be O O 0.9999896287918091
essential O O 0.9999337196350098
for O O 0.9999911785125732
both O O 0.9999935626983643
the O O 0.9999104738235474
PMA/ O B-DNA 0.42195817828178406
PHA S-protein I-DNA 0.28731292486190796

suggesting O O 0.9976765513420105
that O O 0.9999920129776001
protein-protein O O 0.7878319621086121
interactions O O 0.9771692156791687
might O O 0.999982476234436
functionally O O 0.9999691247940063
coordinate O O 0.9999934434890747
the O O 0.9999972581863403
actions O O 0.9997205138206482
of O O 0.9999980926513672
the O O 0.9999872446060181
upstream B-DNA B-DNA 0.8603020906448364
and I-DNA I-DNA 0.7402077317237854
downstream I-DNA I-DNA 0.806876540184021
positive I-DNA I-DNA 0.9148577451705933
regulatory I-DNA I-DNA 0.9832893013954163
elements E-DNA E-DNA 0.9986446499824524
. O O 0.9999675750732422
This O O 0.9999973773956299
is O O 0.999995231628418
the O O 0.9999992847442627
first O O 0.9998241066932678
report O O 0.9994320273399353
of O O 0.9999914169311523
a O O 0.9999904632568359
physical O O 0.9668198823928833
interaction O O 0.9970104694366455
between O O 0.9999358654022217

of O O 0.9925521612167358

but O O 0.9839175939559937
lacking O O 0.9990774393081665
immunophilins S-protein S-protein 0.9671208262443542
and O O 0.9975782036781311
p23 S-protein S-protein 0.9494068026542664
. O O 0.9983086585998535
We O O 0.9999735355377197
have O O 0.9999971389770508
studied O O 0.9999736547470093
two O O 0.9993106126785278
pre-formed B-protein O 0.981467068195343
hsp90 I-protein B-protein 0.5469791293144226
complexes E-protein E-protein 0.9888706803321838
that O O 0.9996997117996216
may O O 0.9999902248382568
participate O O 0.9999910593032837
in O O 0.999994158744812
the O O 0.9999974966049194
assembly O O 0.9980602860450745
of O O 0.9999442100524902
PR B-protein B-protein 0.45684531331062317
complexes E-protein E-protein 0.995732843875885
. O O 0.9999361038208008
One O O 0.9996408224105835
contains O O 0.9998156428337097
hsp90 S-protein S-protein 0.5032867789268494
bound O O 0.7080116271972656
to O O 0.9839402437210083
hsp70 S-protein S-protein 0.5675010681152344
and O O 0.9411457180976868

affect O O 0.9996125102043152
basal O O 0.8206582069396973
LTR S-DNA S-DNA 0.56015944480896
function O O 0.9918671250343323
and O O 0.9997363686561584
transcription B-protein B-protein 0.6375776529312134
factor E-protein E-protein 0.9807571172714233
recruitment O O 0.987942636013031
, O O 0.9999057054519653
which O O 0.9999576807022095
may O O 0.9999895095825195
, O O 0.9999179840087891
in O O 0.9999887943267822
turn O O 0.9998257756233215
, O O 0.9999765157699585

promoters E-DNA E-DNA 0.7672033905982971
of O O 0.9991697072982788
certain O O 0.9940298795700073
growth- B-DNA B-DNA 0.4545205235481262
and I-DNA I-DNA 0.699673593044281
cell I-DNA I-DNA 0.5055636167526245
cycle-controlling I-DNA I-DNA 0.8531509041786194
genes E-DNA E-DNA 0.9759443998336792
and O O 0.9904181361198425
forms O O 0.9981195330619812
distinct O O 0.998346209526062
heteromeric B-protein B-protein 0.4726833403110504
complexes E-protein E-protein 0.9840611815452576
with O O 0.9999560117721558
other O O 0.9990542531013489
nuclear B-protein B-protein 0.4772404432296753
proteins E-protein E-protein 0.9864073991775513
. O O 0.9997041821479797
It O O 0.9999008178710938
has O O 0.9999220371246338
therefore O O 0.99988853931427
been O O 0.9999910593032837
proposed O O 0.999970555305481
that O O 0.9999961853027344
E2F S-protein S-protein 0.9935657382011414
is O O 0.9997943043708801
involved O O 0.9999805688858032
in O O 0.999984860420227
cellular O O 0.9425298571586609
proliferation O O 0.9889329671859741
control O O 0.999539852142334
. O O 0.9999980926513672
Human O O 0.674170732498169
T-cell O O 0.3991401791572571

activating O O 0.9017814993858337
interleukin-2 B-DNA S-protein 0.7159910798072815
( I-DNA O 0.9088452458381653
IL-2 I-DNA S-protein 0.9082115888595581
) I-DNA O 0.8331624865531921
gene E-DNA O 0.7809688448905945
expression O O 0.997514009475708
. O O 0.9999948740005493
It O O 0.9999665021896362
has O O 0.9999929666519165
been O O 0.9999829530715942

jun/fos B-DNA I-protein 0.2795976996421814
family E-DNA E-protein 0.8368836045265198
and O O 0.9941267967224121
that O O 0.999991774559021
expression O O 0.9990342855453491
of O O 0.9999946355819702
these O O 0.9999614953994751
genes O O 0.6039861440658569
could O O 0.999792754650116
contribute O O 0.9999986886978149
to O O 0.9999961853027344
nuclear O O 0.9415633082389832
signaling O O 0.9735758304595947
mechanisms O O 0.9975426197052002
that O O 0.9999978542327881
regulate O O 0.999990701675415
a O O 0.9999902248382568
specific O O 0.9904374480247498
program O O 0.9979536533355713
of O O 0.9999555349349976
monocyte O O 0.842682421207428
differentiation O O 0.9967021346092224
. O O 0.9999964237213135
Glucocorticoid B-protein B-protein 0.7819725275039673
receptors E-protein E-protein 0.9985999464988708
in O O 0.9998410940170288
systemic O O 0.8717133402824402
lupus O O 0.7965699434280396
erythematosus O O 0.8101798892021179
. O O 0.9998770952224731
Glucocorticosteroids O O 0.980362594127655
remain O O 0.999954104423523
the O O 0.9999949932098389
major O O 0.975166916847229
treatment O O 0.9897275567054749
modality O O 0.9981302618980408
for O O 0.9999855756759644
systemic O O 0.9642482995986938

not O O 0.9104796051979065
required O O 0.9984577894210815
for O O 0.99994957447052
TCR S-protein S-protein 0.9992423057556152
-induced O O 0.998555600643158
tyrosine O O 0.8566668033599854
phosphorylation O O 0.94491046667099
of O O 0.9996520280838013
most O O 0.9977633953094482
proteins O O 0.8989541530609131
, O O 0.9975563287734985
but O O 0.9999256134033203
was O O 0.9999390840530396
required O O 0.999962568283081
for O O 0.9999876022338867
optimal O O 0.927122175693512
tyrosine O O 0.8446627855300903
phosphorylation O O 0.9794151782989502
and O O 0.9993058443069458
activation O O 0.9834776520729065
of O O 0.9995935559272766
phospholipase B-protein B-protein 0.5581860542297363
C-gamma1 E-protein E-protein 0.9933949112892151
( O O 0.9929935336112976
PLC-gamma1 S-protein S-protein 0.9905357956886292
) O O 0.9885590076446533
, O O 0.9997532963752747
as O O 0.9999816417694092
well O O 0.9998444318771362
as O O 0.999984860420227
Ras S-protein S-protein 0.9562654495239258
pathway O O 0.9497843980789185
activation O O 0.9907621741294861
. O O 0.9999011754989624
TCR S-protein S-protein 0.9941381216049194
-inducible O O 0.9708721041679382
gene O O 0.8268709182739258
expression O O 0.999710738658905
was O O 0.9999983310699463

possibility O O 0.9793171882629395
directly O O 0.9998831748962402
using O O 0.9999555349349976
TAP-deficient B-cell_line B-cell_line 0.7806834578514099
cell I-cell_line I-cell_line 0.8401865363121033
lines E-cell_line E-cell_line 0.9990045428276062
lacking O O 0.9996101260185242
antigenic O O 0.8498831987380981
ER O O 0.34976333379745483
peptides O O 0.4123150110244751
derived O O 0.9997575879096985
from O O 0.9999963045120239
two O O 0.9949889779090881
model O O 0.9050494432449341
Ags S-protein S-protein 0.49295371770858765
, O O 0.9953367114067078
the O O 0.999947190284729
human B-protein B-DNA 0.5068071484565735
adenovirus I-protein I-DNA 0.3490482568740845
type I-protein I-DNA 0.4342360198497772
5 I-protein I-DNA 0.48043227195739746
early I-protein I-DNA 0.5567799210548401
regions I-protein E-DNA 0.6702796220779419
E1A I-protein S-DNA 0.8386698961257935
and I-protein O 0.9925113916397095
E1B E-protein S-DNA 0.8728750944137573
. O O 0.9995612502098083
Although O O 0.9999414682388306

out O O 0.9977872371673584
to O O 0.9999635219573975
characterize O O 0.9990600943565369
genes O O 0.5661768317222595
up-regulated O O 0.9986613988876343
by O O 0.9999781847000122
IL-12 S-protein S-protein 0.994987964630127
, O O 0.9996157884597778
first O O 0.9958949089050293
by O O 0.9999690055847168
contrasting O O 0.9792516231536865
IL-12 S-DNA S-protein 0.9803707599639893
-and O O 0.9970760345458984
IFN-alpha-inducible B-DNA O 0.32957923412323

and O O 0.9440383911132812
Oct B-protein B-protein 0.3882363736629486
binding I-protein I-protein 0.7063517570495605
proteins E-protein E-protein 0.9945163130760193
after O O 0.9998897314071655
SEA S-protein S-protein 0.8413047790527344
stimulation O O 0.9965533018112183
. O O 0.9999959468841553
Resolution O O 0.9802694916725159
of O O 0.9997683167457581
the O O 0.9999724626541138
NF-kappa B-protein B-protein 0.8721531629562378
B I-protein I-protein 0.703967809677124
complex E-protein E-protein 0.9861463904380798
demonstrated O O 0.9997326731681824
predominant O O 0.9786287546157837
expression O O 0.9974794983863831
of O O 0.9999830722808838
p50-p65 B-protein B-protein 0.7501621246337891
heterodimers E-protein E-protein 0.9888228178024292
in O O 0.9996311664581299
activated B-cell_type O 0.6238306760787964
CD4+ I-cell_type B-cell_type 0.6601420640945435
T I-cell_type I-cell_type 0.9482304453849792
cells E-cell_type E-cell_type 0.8676332831382751
, O O 0.9930250644683838
while O O 0.999984622001648
anergic O B-cell_type 0.6523807048797607
cells O E-cell_type 0.9610657095909119
mainly O O 0.9991984963417053
expressed O O 0.9999492168426514
the O O 0.9999884366989136
transcriptionally O O 0.6374349594116211
inactive O O 0.5679377913475037
p50 B-protein B-protein 0.49334457516670227
homodimer E-protein E-protein 0.9899227023124695
. O O 0.999796450138092
These O O 0.9999929666519165
alterations O O 0.9963780045509338
of O O 0.999906063079834
transcription B-protein B-protein 0.6005454063415527
factors E-protein E-protein 0.9950738549232483
are O O 0.9998706579208374
likely O O 0.999954104423523
to O O 0.9999951124191284
be O O 0.9999942779541016
responsible O O 0.999947190284729
for O O 0.9999938011169434
repression O O 0.9993271827697754
of O O 0.9999890327453613
IL-2 S-protein S-protein 0.989068329334259
in O O 0.999902606010437
anergic B-cell_type B-cell_type 0.6401212215423584
T I-cell_type I-cell_type 0.793502688407898
cells E-cell_type E-cell_type 0.9095841646194458

gC2- B-cell_line B-cell_line 0.2597775459289551
and I-cell_line I-cell_line 0.5200040340423584
gD2-specific I-cell_line I-cell_line 0.6175748705863953
CD4+ I-cell_line I-cell_line 0.7171655297279358
clones E-cell_line E-cell_line 0.9982707500457764
had O O 0.9998214840888977
cytotoxic O O 0.9085076451301575
activity O O 0.9975711703300476
. O O 0.999998927116394
The O O 0.9999990463256836
approximate O O 0.991644561290741
locations O O 0.9787386059761047
of O O 0.9999911785125732
the O O 0.999975323677063
HSV-2 O B-DNA 0.677922248840332
genes O E-DNA 0.9927132725715637
encoding O O 0.9968839287757874
HSV-2 O B-protein 0.3028779923915863
type-specific O I-protein 0.5937313437461853
CD4+ B-protein I-protein 0.7885164022445679
antigens E-protein E-protein 0.9873851537704468
have O O 0.9997391104698181
been O O 0.9999706745147705
determined O O 0.9999856948852539
by O O 0.9999972581863403
using O O 0.9996267557144165
HSV-1 O O 0.7622853517532349
x O O 0.8649114370346069
HSV-2 O O 0.9015032649040222
intertypic O O 0.9636958241462708
recombinant O O 0.9787952303886414
virus O O 0.9909371733665466
and O O 0.9998643398284912

sequence E-DNA O 0.5343647003173828

prevented O O 0.9943276047706604
the O O 0.999985933303833
activation O O 0.9989668130874634
of O O 0.9999750852584839
NF-kappa B-protein B-protein 0.9357941746711731
B E-protein E-protein 0.9976375102996826
by O O 0.9999003410339355
H2O2 O O 0.6623611450195312
. O O 0.9991911053657532
NAC O O 0.7787107229232788
and O O 0.99490886926651
other O O 0.9990898370742798
thiol O O 0.7967092990875244
compounds O O 0.7693462371826172
also O O 0.9994694590568542
blocked O O 0.999942421913147
the O O 0.9999955892562866
activation O O 0.9972018003463745
of O O 0.9999635219573975
NF-kappa B-protein B-protein 0.9279558062553406
B E-protein E-protein 0.9971426129341125
by O O 0.9999247789382935
cycloheximide O B-RNA 0.506541907787323
, O I-RNA 0.7519036531448364
double-stranded B-RNA I-RNA 0.4202045798301697
RNA E-RNA E-RNA 0.8403961062431335
, O O 0.9943071007728577
calcium O O 0.6464020013809204

CHO/CD14 S-protein S-protein 0.4522518515586853
) O O 0.9392029643058777
. O O 0.9999707937240601
Nuclear O O 0.9535635113716125
translocation O O 0.9935058355331421
of O O 0.9999606609344482
cytosolic O B-protein 0.6233338117599487
NF-kappa O I-protein 0.7075139284133911
B O E-protein 0.9982549548149109
is O O 0.9995803236961365
correlated O O 0.9991482496261597
with O O 0.9999967813491821
a O O 0.9999860525131226
number O O 0.9994639754295349
of O O 0.9999926090240479
LPS-inducible O O 0.4378073215484619
responses O O 0.8265649080276489
. O O 0.9999456405639648
We O O 0.9999117851257324
sought O O 0.9997199177742004
to O O 0.9999701976776123
determine O O 0.9999929666519165

chloramphenicol I-DNA I-DNA 0.3703633248806
acetyltransferase I-DNA I-DNA 0.869313657283783
( I-DNA I-DNA 0.8747041821479797
CAT I-DNA I-DNA 0.4890030026435852
) I-DNA I-DNA 0.5899196267127991
plasmids E-DNA E-DNA 0.9583784341812134
. O O 0.9999508857727051
In O O 0.9998589754104614
erythroid B-cell_line B-cell_line 0.6072770357131958
K562 I-cell_line I-cell_line 0.7678743600845337
cells E-cell_line E-cell_line 0.983089804649353
in O O 0.9995548129081726
which O O 0.9999983310699463
the O O 0.9999682903289795
HS2 B-DNA B-DNA 0.5326220989227295
enhancer E-DNA E-DNA 0.9952736496925354
is O O 0.9993581175804138
active O O 0.9977940320968628
, O O 0.9999924898147583
the O O 0.9999866485595703
HS2 B-DNA B-DNA 0.4845426678657532
sequence E-DNA E-DNA 0.9830567240715027
directs O O 0.9993841648101807
the O O 0.9999921321868896
synthesis O O 0.9750964045524597
of O O 0.9992874264717102

this O O 0.999664306640625
study O O 0.9999854564666748
the O O 0.9999994039535522
effect O O 0.9999830722808838
of O O 0.9999948740005493
IL-10 S-protein S-protein 0.9913060069084167
on O O 0.9999426603317261
the O O 0.9999926090240479
expression O O 0.9987737536430359
of O O 0.9999951124191284
the O O 0.9999668598175049
protooncogene B-DNA B-DNA 0.6042055487632751
c-fos E-DNA E-DNA 0.9774925112724304
was O O 0.9993898868560791
investigated O O 0.999871015548706
, O O 0.9999825954437256
because O O 0.9999940395355225
Fos O S-protein 0.9913243055343628
plays O O 0.9998464584350586
a O O 0.9999927282333374
potential O O 0.9969694018363953
role O O 0.9999088048934937
in O O 0.9999969005584717
the O O 0.9999959468841553
regulation O O 0.999606192111969
of O O 0.9999879598617554
B O O 0.43921083211898804
cell O O 0.7771240472793579
proliferation O O 0.9747722148895264
and O O 0.9994215965270996
differentiation O O 0.9984973669052124
. O O 0.9999938011169434
B B-cell_type B-cell_type 0.5586892366409302

significantly O O 0.994968831539154
increased O O 0.9999322891235352
in O O 0.9999051094055176
transgenic O O 0.7654202580451965
mice O O 0.9653056859970093
overexpressing O O 0.9961560368537903
ICSAT S-protein S-protein 0.8761466145515442
. O O 0.9991281628608704
ICSAT S-protein S-protein 0.823201060295105
overexpression O O 0.9924629926681519
in O O 0.9995478987693787
lymphocytes S-cell_type S-cell_type 0.9948404431343079
seems O O 0.999028205871582

T B-cell_type B-cell_type 0.2498694807291031
cells E-cell_type E-cell_type 0.8306176662445068
uses O O 0.999864935874939
the O O 0.9999915361404419
CD28 S-protein S-protein 0.9327953457832336
costimulatory O O 0.8375401496887207
pathway O O 0.9973986148834229
. O O 0.9999874830245972
IL-8 S-protein S-protein 0.987739622592926
, O O 0.9991362690925598
a O O 0.9999837875366211
potent O O 0.9636214375495911
chemotactic B-protein O 0.8750784397125244
factor E-protein O 0.7840835452079773
for O O 0.9959555864334106
neutrophil B-cell_type B-cell_type 0.6614128351211548
granulocytes E-cell_type E-cell_type 0.9461156725883484
and O O 0.9933428168296814
lymphocytes S-cell_type S-cell_type 0.9903548955917358
, O O 0.9950553178787231
is O O 0.9999901056289673
a O O 0.9999896287918091
proinflammatory O B-protein 0.6201872825622559
cytokine O E-protein 0.9981237053871155
secreted O O 0.9995636343955994
by O O 0.9999978542327881
a O O 0.9999501705169678
variety O O 0.9925684928894043
of O O 0.9999510049819946
cell O O 0.8097067475318909
types O O 0.5430715084075928
, O O 0.9982882142066956
including O O 0.9996533393859863
T B-cell_type B-cell_type 0.8783755898475647
cells E-cell_type E-cell_type 0.9957427382469177
. O O 0.99989914894104
Stimulation O O 0.9970061182975769
of O O 0.9999631643295288
the O O 0.9999402761459351
CD28 B-protein B-protein 0.5660244226455688
cell I-protein I-protein 0.5169079899787903
surface I-protein I-protein 0.7090184092521667
molecule E-protein E-protein 0.9933716058731079
delivers O O 0.9999079704284668
costimulatory O O 0.7756572961807251
signals O O 0.9735915660858154
essential O O 0.9998921155929565
for O O 0.9999599456787109
lymphokine S-protein S-protein 0.6638361215591431
production O O 0.9877135753631592
in O O 0.999934196472168
activated B-cell_type B-cell_type 0.5847288370132446
T I-cell_type I-cell_type 0.585893452167511
cells E-cell_type E-cell_type 0.9749566316604614
via O O 0.9997844099998474
a O O 0.9999686479568481
conserved B-DNA B-DNA 0.8322184681892395
sequence I-DNA I-DNA 0.6364080905914307
element E-DNA E-DNA 0.978833019733429
found O O 0.9994268417358398
in O O 0.9999886751174927
the O O 0.9997174143791199
promoter S-DNA S-DNA 0.9590831995010376
of O O 0.9968990087509155
several O O 0.9928123354911804
lymphokine B-DNA B-DNA 0.8184671401977539
genes E-DNA E-DNA 0.9956631064414978
. O O 0.9999525547027588
Anti-CD28-stimulated B-cell_line B-cell_line 0.49354931712150574
T I-cell_line I-cell_line 0.6079201698303223
cells E-cell_line E-cell_line 0.684710681438446
produced O O 0.9991406202316284
significant O O 0.9993313550949097
amounts O O 0.9999029636383057
of O O 0.9999831914901733
IL-8 S-protein S-protein 0.973207414150238
; O O 0.9991506338119507
additionally O O 0.9998972415924072
, O O 0.99996018409729
costimulation O O 0.9878706336021423
with O O 0.9999750852584839
anti-CD3 S-protein S-protein 0.9304648637771606
and O O 0.981419563293457
anti-CD28 B-protein B-protein 0.6672548055648804
Abs E-protein E-protein 0.9997835755348206
resulted O O 0.9998753070831299
in O O 0.9999970197677612
a O O 0.9999979734420776
synergistic O O 0.9824309945106506
induction O O 0.9989116191864014
of O O 0.999990701675415
IL-8 S-protein S-protein 0.900457501411438
secretion O O 0.9653435945510864
. O O 0.9999841451644897
Sequence O O 0.8715740442276001
homology O O 0.8510625958442688
, O O 0.9989759922027588
single O O 0.9155914783477783
nucleotide O O 0.7277553677558899
mutations O O 0.5064164400100708
, O O 0.9995498061180115
and O O 0.9999151229858398
anti-CD28 B-protein B-protein 0.33115318417549133
Ab E-protein E-protein 0.9366734027862549
stimulation O O 0.9404472708702087
studies O O 0.9904414415359497
established O O 0.9999910593032837
that O O 0.9999992847442627
the O O 0.9998934268951416
NF-kappa B-DNA B-DNA 0.7436390519142151
B-like I-DNA I-DNA 0.8718041181564331
sequence E-DNA E-DNA 0.987727165222168
in O O 0.9999145269393921
the O O 0.9998936653137207
promoter S-DNA S-DNA 0.8108418583869934
of O O 0.9799205660820007

new O O 0.9702061414718628
era O O 0.9228646755218506
in O O 0.9999034404754639
biomedical O O 0.9478172063827515
research O O 0.9987277388572693
. O O 0.9999990463256836
Elucidation O O 0.9979776740074158
of O O 0.9999891519546509
the O O 0.9999934434890747
biochemical O O 0.89548259973526
nature O O 0.9894038438796997
of O O 0.9999510049819946
the O O 0.9999927282333374
signal O O 0.8184967041015625
transduction O O 0.9157446026802063
pathway O O 0.9965717792510986
that O O 0.9999922513961792
regulate O O 0.9996832609176636
transcription O O 0.9225817918777466
and O O 0.9929980039596558
replication O O 0.988815426826477
is O O 0.9999855756759644
the O O 0.9999988079071045
focus O O 0.9998552799224854
of O O 0.9999879598617554
attention O O 0.9994499087333679
in O O 0.9999722242355347
molecular O O 0.8814513683319092
biology O O 0.9907138347625732
. O O 0.9999958276748657
This O O 0.9999980926513672
research O O 0.9997304081916809
may O O 0.9999985694885254
make O O 0.999997615814209
feasible O O 0.9958233833312988
manipulation O O 0.9998273253440857
of O O 0.9999942779541016

differentiation O O 0.9701410531997681
. O O 0.9998898506164551
Thymocytes S-cell_type S-cell_type 0.8485940098762512
, O O 0.9929139614105225
activated B-cell_type B-cell_type 0.6435440182685852
peripheral I-cell_type I-cell_type 0.39216381311416626
T I-cell_type I-cell_type 0.8286120891571045
lymphocytes E-cell_type E-cell_type 0.6756511926651001
, O O 0.9712830185890198
or O O 0.9995242357254028
an O O 0.9992469549179077
activated B-cell_line B-cell_line 0.7095869183540344
T-cell I-cell_line I-cell_line 0.5016129016876221
clone E-cell_line E-cell_line 0.9965156316757202
were O O 0.9998890161514282
used O O 0.9999356269836426

IL-2 S-protein S-protein 0.8796454071998596
. O O 0.9999343156814575
Following O O 0.9999619722366333
T O O 0.7798559069633484
cell O O 0.7702679634094238
activation O O 0.9870852828025818
, O O 0.9999631643295288
the O O 0.9999924898147583
genes O O 0.6262075901031494
encoding O O 0.9971873164176941
IL-2 S-protein S-protein 0.6526616811752319

of O O 0.9963884353637695
celiac O O 0.9163726568222046
disease O O 0.9960636496543884
( O O 0.9999278783798218
CD O O 0.9887944459915161
) O O 0.9997226595878601
. O O 0.9999963045120239
It O O 0.9999971389770508
is O O 0.9999994039535522
our O O 0.9999996423721313
contention O O 0.9999978542327881
that O O 0.9999994039535522
CD O O 0.6823880076408386
is O O 0.9994089603424072
triggered O O 0.9999443292617798
by O O 0.9999986886978149
the O O 0.9999960660934448
binding O O 0.9866577982902527
of O O 0.999913215637207
one O O 0.9989646673202515
or O O 0.9998352527618408
more O O 0.9987791180610657
gliadin O O 0.4632508158683777
peptides O O 0.5304224491119385
to O O 0.9997236132621765
CD-associated B-protein B-protein 0.5362249612808228
HLA I-protein I-protein 0.5054288506507874
class I-protein I-protein 0.8429345488548279
II I-protein I-protein 0.5466430187225342
molecules E-protein E-protein 0.9986611604690552
. O O 0.9999746084213257
Furthermore O O 0.9999892711639404
, O O 0.9999947547912598
we O O 0.9999808073043823
propose O O 0.9999982118606567
that O O 0.9999990463256836
these O O 0.9999822378158569
putative O O 0.9216083288192749
CD O O 0.3765306770801544
peptides O O 0.7632037401199341
bind O O 0.998846173286438

transient O O 0.6618407964706421

have O O 0.9980477094650269
been O O 0.999946117401123
preincubated O O 0.9992077946662903
to O O 0.9999923706054688
lower O O 0.9904131293296814
mRNA O O 0.7397885918617249
levels O O 0.998650848865509
, O O 0.9999957084655762
there O O 0.9999984502792358
is O O 0.9999988079071045
a O O 0.9999991655349731
transient O O 0.9511996507644653
increase O O 0.9998338222503662
in O O 0.9999105930328369
G0S2 B-RNA B-RNA 0.9685199856758118
mRNA E-RNA E-RNA 0.9920796751976013

Therefore O O 0.9989336133003235
, O O 0.999991774559021
this O O 0.9999910593032837
pathway O O 0.999336302280426
appears O O 0.999987006187439
as O O 0.9999982118606567
a O O 0.9999991655349731
crucial O O 0.9997335076332092
step O O 0.9999717473983765
in O O 0.9999991655349731
the O O 0.9999990463256836
initiation O O 0.9997346997261047
of O O 0.9999960660934448
early O O 0.7561893463134766
T O O 0.7509488463401794
cell O O 0.6903855800628662
activation O O 0.9886214137077332
events O O 0.9999295473098755
. O O 0.9999974966049194
Gangliosides O O 0.49072596430778503
suppress O O 0.9990041851997375
tumor B-protein B-protein 0.5775468349456787
necrosis I-protein I-protein 0.8454043865203857
factor E-protein E-protein 0.9729612469673157
production O O 0.9916087985038757
in O O 0.9999852180480957

1 I-DNA I-DNA 0.3048349618911743
gene E-DNA E-DNA 0.9886230826377869
by O O 0.9996705055236816
80-90 O O 0.9815871119499207
% O O 0.9968744516372681
. O O 0.9999898672103882
In O O 0.9998196959495544
gel-shift O O 0.7526988983154297
assays O O 0.9783695340156555
, O O 0.9999594688415527

interferon B-protein B-protein 0.5209758281707764
alpha E-protein E-protein 0.9627369046211243
treatment O O 0.9940378665924072
. O O 0.9999979734420776
The O O 0.9999988079071045
effects O O 0.9999380111694336
of O O 0.9999943971633911
phorbol O O 0.9122451543807983
ester O O 0.9559506177902222
on O O 0.9999520778656006
MNDA B-RNA B-RNA 0.9820598363876343
mRNA E-RNA E-RNA 0.9986554384231567
appeared O O 0.9993243217468262
to O O 0.999992847442627
be O O 0.9999932050704956
associated O O 0.9995701909065247
with O O 0.9999949932098389
induced O O 0.9893400073051453
differentiation O O 0.9981369972229004
since O O 0.9999963045120239
inhibiting O O 0.9880335330963135
cell O O 0.9714319109916687
proliferation O O 0.9995378255844116
did O O 0.9999957084655762
not O O 0.9999922513961792
alter O O 0.9999922513961792
the O O 0.9999961853027344
level O O 0.9996789693832397
of O O 0.9998881816864014
MNDA B-RNA B-RNA 0.970048725605011
mRNA E-RNA E-RNA 0.9963093400001526
and O O 0.9937408566474915
cell O O 0.9448878169059753
cycle O O 0.9818577766418457

kinase E-protein E-protein 0.982028603553772
dependent O O 0.968936562538147
and O O 0.9986883997917175
protein B-protein B-protein 0.490152508020401
kinase I-protein I-protein 0.7696215510368347
C E-protein E-protein 0.9885949492454529
independent O O 0.8888668417930603
. O O 0.9998975992202759
BACKGROUND O O 0.9368461966514587
: O O 0.9985260367393494
Tumor B-protein B-protein 0.7372350096702576
necrosis I-protein I-protein 0.937195897102356
factor I-protein I-protein 0.5474877953529358
alpha E-protein E-protein 0.9956307411193848
( O O 0.9928256273269653
TNF-alpha S-protein S-protein 0.9954871535301208
) O O 0.992942214012146
is O O 0.9999946355819702
an O O 0.9999982118606567
important O O 0.9989745616912842
mediator O O 0.9738689064979553
of O O 0.9992546439170837
septic O O 0.4498365521430969

in O O 0.9994701743125916
both O O 0.9999086856842041
patient O O 0.9420785903930664
and O O 0.9920467138290405
normal O O 0.9606737494468689
individuals O O 0.9981354475021362
. O O 0.9999986886978149
Our O O 0.9999991655349731
results O O 0.9999821186065674
, O O 0.9999974966049194
although O O 0.9999853372573853
limited O O 0.9993828535079956
, O O 0.9999927282333374
suggest O O 0.9999990463256836
that O O 0.9999948740005493
normal O O 0.888973593711853
individuals O O 0.9921714067459106
can O O 0.9999774694442749
express O O 0.9999969005584717
both O O 0.9999911785125732
the O O 0.999974250793457
wild-type O O 0.5145275592803955
and O O 0.5717891454696655
truncated O O 0.47651612758636475
version O O 0.466782808303833
at O O 0.9999806880950928
the O O 0.9999998807907104
same O O 0.999998927116394
time O O 0.9998685121536255

domain E-protein E-protein 0.6524599194526672

NFkappaB S-protein S-protein 0.9773778319358826
nuclear O O 0.9904414415359497
translocation O O 0.9985130429267883
. O O 0.9999974966049194
In O O 0.999927282333374
human B-cell_type B-cell_type 0.528502881526947
monocytes E-cell_type E-cell_type 0.9411004185676575
, O O 0.9990267753601074
interleukin B-protein B-protein 0.4535251557826996
1beta E-protein I-protein 0.8980305790901184
protein O E-protein 0.8853292465209961
production O O 0.984210729598999
and O O 0.9995625615119934
steady O O 0.9851991534233093
state O O 0.9952089190483093

of O O 0.9962357878684998
GATA-1 S-protein S-protein 0.9859073162078857
during O O 0.9998809099197388
erythroid O O 0.7741073966026306
ontogeny O O 0.7194541692733765
. O O 0.9996242523193359
How O O 0.9999793767929077
does O O 0.9999951124191284
GATA-1 S-protein S-protein 0.9869611263275146
regulate O O 0.9990391731262207
red B-DNA B-DNA 0.40949925780296326
cell I-DNA I-DNA 0.3876810073852539
genes E-DNA E-DNA 0.9083476662635803
like O O 0.9974830746650696
globin S-DNA S-protein 0.5191750526428223
or O O 0.910529613494873
the O O 0.993821382522583
Epo B-protein B-protein 0.4279431402683258
receptor E-protein E-protein 0.841309666633606
? O O 0.9831328988075256
Once O O 0.9998612403869629
we O O 0.9999411106109619
identify O O 0.9999960660934448
the O O 0.9999904632568359
functional O O 0.9172438979148865
domains O O 0.4998071789741516
of O O 0.9988335967063904

the O O 0.9988133907318115
NF-kappa B-protein B-protein 0.7753556966781616
B I-protein E-protein 0.9750081300735474
inhibitors E-protein O 0.805067241191864
blocked O O 0.9971298575401306
SP-A S-protein S-protein 0.9750358462333679
-dependent O O 0.9944724440574646
increases O O 0.9998350143432617
in O O 0.9999822378158569
tumor B-RNA B-protein 0.7269156575202942
necrosis I-RNA I-protein 0.7117007374763489
factor-alpha I-RNA E-protein 0.7986358404159546
mRNA E-RNA O 0.8276146054267883
levels O O 0.9987291693687439
. O O 0.9999985694885254
These O O 0.9999982118606567
observations O O 0.9991195797920227
suggest O O 0.9999994039535522
a O O 0.9999988079071045
mechanism O O 0.9985721111297607
by O O 0.9999958276748657
which O O 0.9999911785125732
SP-A S-protein S-protein 0.9775522947311401
plays O O 0.9998383522033691
a O O 0.9999978542327881
role O O 0.9999563694000244
in O O 0.9999970197677612
the O O 0.999995231628418
pathogenesis O O 0.9990255832672119
of O O 0.999991774559021
some O O 0.9999624490737915
lung O O 0.6213487386703491
conditions O O 0.9800096154212952
and O O 0.999818742275238
point O O 0.9947498440742493

inhibitors O O 0.7545315027236938
suggests O O 0.9999712705612183
that O O 0.9999972581863403
components O O 0.9947264790534973
of O O 0.9999300241470337
the O O 0.9999910593032837
signal O O 0.9009087085723877
transduction O O 0.9641352295875549
pathway O O 0.9993340373039246
are O O 0.9999973773956299
shared O O 0.9999697208404541
by O O 0.9999991655349731
all O O 0.9999098777770996
three O O 0.9853668212890625
cytokines S-protein S-protein 0.992588996887207
. O O 0.9999796152114868
Encephalomyocarditis O O 0.8237967491149902
virus O O 0.9145618081092834
internal O O 0.9629744291305542
ribosomal O O 0.9294066429138184
entry O O 0.9611305594444275
site O O 0.8678944706916809
RNA-protein O O 0.6517470479011536
interactions O O 0.959070086479187
. O O 0.999991774559021
Translational O O 0.8982264995574951

Ig O O 0.3583605885505676
mutation O O 0.7725046873092651
, O O 0.9998214840888977
represent O O 0.9999961853027344
an O O 0.9999977350234985
inherent O O 0.9870626330375671
feature O O 0.9955902099609375
of O O 0.999991774559021
the O O 0.999946117401123
lymphoma B-cell_type B-cell_type 0.5484912395477295
precursor I-cell_type I-cell_type 0.5565171837806702
cells E-cell_type E-cell_type 0.853095531463623
. O O 0.9998875856399536
Therefore O O 0.9999935626983643
, O O 0.9999967813491821
we O O 0.9999723434448242
investigated O O 0.9999611377716064
their O O 0.9999854564666748
normal O O 0.8537871241569519
cell O O 0.8263954520225525
counterparts O O 0.553936243057251
microdissected O O 0.9983768463134766
from O O 0.9999982118606567
a O O 0.9999788999557495
reactive O O 0.8958008289337158
tonsil O O 0.8816813230514526
. O O 0.9997218251228333
Bcl6 O S-protein 0.4544619023799896
mutation O O 0.6503643989562988
was O O 0.9999443292617798
found O O 0.9999943971633911
in O O 0.9999936819076538
13 O O 0.9976189732551575
of O O 0.9999887943267822
24 O O 0.9768341183662415
( O O 0.9986066222190857
54 O O 0.9987138509750366
% O O 0.9992245435714722
) O O 0.9984184503555298
clones O O 0.886483371257782
from O O 0.9999984502792358
the O O 0.9999958276748657
germinal O O 0.621441662311554
centre O O 0.7143388390541077
but O O 0.9980271458625793
only O O 0.9999732971191406
in O O 0.9999599456787109
1 O O 0.9810482263565063
of O O 0.9999455213546753
24 O O 0.9767835140228271
( O O 0.9984790682792664
4 O O 0.999286949634552
% O O 0.999077558517456
) O O 0.9987208247184753
clones O O 0.8769850730895996
from O O 0.9999953508377075
the O O 0.9999769926071167
naive B-cell_type B-cell_type 0.5871017575263977
B I-cell_type I-cell_type 0.5542420148849487
cells E-cell_type E-cell_type 0.8862759470939636
of O O 0.9994150400161743
the O O 0.9999891519546509
mantle O O 0.6928578019142151
zone O O 0.9147645831108093
. O O 0.9999881982803345
The O O 0.9999980926513672
frequency O O 0.9983362555503845
, O O 0.9998782873153687
distribution O O 0.9974609613418579
, O O 0.9998382329940796
and O O 0.9999150037765503
nature O O 0.9959623217582703
of O O 0.9999488592147827
these O O 0.9999517202377319
mutations O O 0.9873271584510803
were O O 0.999984860420227
similar O O 0.9999771118164062
to O O 0.9999908208847046
those O O 0.999990701675415
resulting O O 0.9999916553497314
from O O 0.999998927116394
the O O 0.9999818801879883
Ig O O 0.3394722640514374
hypermutation O O 0.669995129108429
process O O 0.9913197159767151
. O O 0.999998927116394
The O O 0.9999997615814209
results O O 0.9999685287475586
show O O 0.9999958276748657
unequivocal O O 0.9976014494895935

ICRF-193 O S-protein 0.5173578858375549
, O O 0.9947106838226318
two O O 0.9989351630210876
antitumour O B-protein 0.6841257214546204
DNA B-protein I-protein 0.6520731449127197
topoisomerase I-protein I-protein 0.7017961740493774
II E-protein E-protein 0.6993201971054077
inhibitors O O 0.5923614501953125
with O O 0.9999476671218872
different O O 0.9961302280426025
mechanisms O O 0.9703882932662964
of O O 0.9981392621994019
action O O 0.9991679191589355
. O O 0.9999966621398926
We O O 0.9999890327453613
have O O 0.9999982118606567
compared O O 0.9999843835830688
the O O 0.9999979734420776
action O O 0.9986899495124817
on O O 0.9999622106552124
U-937 B-cell_line B-cell_line 0.7833230495452881
human I-cell_line I-cell_line 0.917733371257782
promonocytic I-cell_line I-cell_line 0.969751238822937

indicating O O 0.9973533153533936
that O O 0.9999967813491821
the O O 0.9999955892562866
actions O O 0.9994590878486633
of O O 0.9999966621398926
these O O 0.9999964237213135
two O O 0.9979636669158936
molecules O O 0.9823656678199768
are O O 0.9999889135360718
mediated O O 0.9999212026596069
by O O 0.9999982118606567
a O O 0.9997329115867615
G B-protein B-protein 0.5002332925796509
protein E-protein E-protein 0.9959369897842407
-coupled O O 0.9865018725395203
pathway O O 0.9985906481742859
. O O 0.9999978542327881
Furthermore O O 0.9999899864196777
, O O 0.9999935626983643
we O O 0.9999054670333862
investigated O O 0.9999884366989136
the O O 0.9999978542327881
effects O O 0.9997937083244324
of O O 0.9999741315841675
C3a S-protein S-protein 0.9267804026603699
and O O 0.9814890027046204
C3a B-protein B-protein 0.5063397288322449
( I-protein I-protein 0.5227510333061218
desArg I-protein I-protein 0.9279667735099792
) E-protein E-protein 0.9596516489982605
on O O 0.9996702671051025
induction O O 0.9895469546318054
of O O 0.9999454021453857
NF-kappaB S-protein S-protein 0.9930852651596069
and O O 0.9992671608924866
activating B-protein O 0.8599729537963867
protein-1 E-protein O 0.6294375061988831
binding O O 0.6823290586471558
. O O 0.9994627833366394
Both O O 0.9999191761016846
molecules O O 0.9603685736656189
enhanced O O 0.9966455101966858

The O O 0.9993034601211548
recently O O 0.977856457233429
cloned O O 0.9741724729537964
TCL1 B-DNA B-DNA 0.3568495810031891
gene E-DNA E-DNA 0.9931192398071289
, O O 0.9846140146255493
also O O 0.9998065829277039
involved O O 0.9998854398727417
in O O 0.9999548196792603
translocations O O 0.9016715288162231
and O O 0.9977940320968628
inversions O O 0.9837065935134888
associated O O 0.9995012283325195
with O O 0.9999817609786987
T-cell O O 0.30904555320739746
proliferations O O 0.6181803941726685
, O O 0.9993512034416199
codes O O 0.9799854755401611
for O O 0.9999778270721436
a O O 0.9999786615371704
14-kD B-protein B-protein 0.791431725025177
protein E-protein E-protein 0.9612782597541809
that O O 0.9995751976966858

site E-DNA E-DNA 0.9025324583053589
was O O 0.999821126461029
active O O 0.9996993541717529
in O O 0.9999946355819702
the O O 0.9999352693557739
LT-producing B-cell_line B-cell_line 0.7126893997192383
C81-66-45 I-cell_line I-cell_line 0.8473672866821289
cell I-cell_line I-cell_line 0.8028027415275574
line E-cell_line E-cell_line 0.9982123374938965
, O O 0.9728626012802124
which O O 0.9998700618743896
contains O O 0.9999037981033325
defective O O 0.7082125544548035
HTLV-I O O 0.27539536356925964
but O O 0.8323698043823242
expresses O O 0.9981712102890015
tax S-protein S-protein 0.981979489326477
. O O 0.9999184608459473
The O O 0.9999985694885254
observation O O 0.9990377426147461
that O O 0.9999988079071045
a O O 0.99993896484375
mutated B-DNA O 0.790863037109375
LT-kappa I-DNA B-DNA 0.5646911859512329
B I-DNA I-DNA 0.4601089060306549
construct E-DNA E-DNA 0.9730071425437927
( O O 0.9969925880432129
M1-CAT S-DNA S-protein 0.620293915271759
) O O 0.9552909731864929
was O O 0.9998785257339478
inactive O O 0.9997425675392151
in O O 0.9999831914901733
C81-66-45 S-cell_line S-cell_line 0.8028069734573364
, O O 0.9073395133018494
confirmed O O 0.9995203018188477
the O O 0.9999943971633911

used O O 0.9932873845100403
most O O 0.9999071359634399
frequently O O 0.9997524619102478
. O O 0.999996542930603
These O O 0.9999983310699463
observations O O 0.9990535378456116
imply O O 0.9999988079071045
that O O 0.9999983310699463
during O O 0.9998862743377686
persistent O O 0.9858778715133667
infection O O 0.99569171667099
Ad5 O O 0.9147827625274658
underwent O O 0.9999803304672241
spontaneous O O 0.9597826600074768
mutations O O 0.9043834805488586
by O O 0.9999983310699463
sequence-specific O O 0.8597143888473511
breakage O O 0.8919910192489624
and O O 0.9978050589561462
nonhomologous O O 0.7297499179840088
end-end O O 0.5509225726127625
joining O O 0.9380955696105957

) O O 0.8385958075523376
. O O 0.9998873472213745
The O O 0.9999964237213135
maximal O O 0.9706233143806458
stimulation O O 0.9982560276985168
of O O 0.9999901056289673
the O O 0.9999525547027588
lymphocytes S-cell_type S-cell_type 0.9653641581535339
, O O 0.988587498664856
as O O 0.9999542236328125
measured O O 0.9987195730209351
by O O 0.9999970197677612
the O O 0.9999938011169434
maximal O O 0.9721431732177734
thymidine O O 0.7668675184249878
incorporation O O 0.9855043292045593
( O O 0.9997413754463196
in O O 0.9999420642852783

EBV O O 0.6060760617256165
latency O O 0.9190039038658142
resided O O 0.9994338154792786
primarily O O 0.9998751878738403
in O O 0.9999901056289673
its O O 0.9999674558639526
ability O O 0.9992151260375977
to O O 0.9999604225158691
activate O O 0.9993959665298462
transcription O O 0.9255131483078003
of O O 0.9986261129379272
genes O O 0.5961344242095947
that O O 0.9994180202484131
encode O O 0.9982900023460388
products O O 0.907663106918335
required O O 0.9997598528862
for O O 0.999985933303833
lytic O O 0.8164839744567871
replication O O 0.9763566255569458
. O O 0.9999841451644897
We O O 0.999948263168335
generated O O 0.9999051094055176
a O O 0.9999829530715942
point O O 0.9943904280662537

transcriptional O O 0.46045804023742676
regulator O O 0.6676651835441589
of O O 0.8442562818527222
inflammatory O O 0.7323909401893616
responses O O 0.9544531106948853
. O O 0.9999761581420898
We O O 0.9999877214431763
demonstrate O O 0.9999978542327881
that O O 0.999998927116394
a O O 0.9999758005142212
fusion O B-protein 0.5857597589492798
protein O E-protein 0.9202993512153625
composed O O 0.9986164569854736
of O O 0.9999861717224121
a O O 0.99989914894104
C-terminal O B-protein 0.8473900556564331
Hsp70 S-protein I-protein 0.8392924666404724
peptide O E-protein 0.5090689063072205
and O O 0.9349055886268616
the O O 0.9995647072792053
p50 B-protein B-protein 0.8271968364715576
subunit E-protein E-protein 0.9768383502960205
of O O 0.9956764578819275
NF-kappaB S-protein S-protein 0.9961984753608704
was O O 0.999911904335022
directed O O 0.9999631643295288
into O O 0.9999958276748657
the O O 0.9999275207519531

study O O 0.9967665672302246
is O O 0.9999963045120239
the O O 0.9999991655349731
first O O 0.999962329864502
to O O 0.9999938011169434
demonstrate O O 0.9999970197677612
the O O 0.9999980926513672
expression O O 0.9997093081474304
of O O 0.9999935626983643
CD14 S-protein S-protein 0.9794816374778748
in O O 0.9998123049736023
human B-cell_type B-cell_type 0.5096312761306763
gingival I-cell_type I-cell_type 0.8136188387870789
fibroblasts E-cell_type E-cell_type 0.9400683641433716
and O O 0.9984226226806641
to O O 0.9999641180038452
show O O 0.9999924898147583
that O O 0.9999994039535522
the O O 0.9999864101409912
signal-transducing O O 0.8888631463050842
pathway O O 0.9917373061180115
of O O 0.9999542236328125
P-LPS O S-protein 0.8540351986885071
in O O 0.9997023940086365
the O O 0.9998763799667358
cells O O 0.9701953530311584
is O O 0.9999712705612183
mediated O O 0.9997617602348328
by O O 0.9999896287918091
CD14 S-protein S-protein 0.9638660550117493
. O O 0.9997476935386658
rel S-protein S-protein 0.7901061177253723
Is O O 0.9967170357704163
rapidly O O 0.9494357109069824
tyrosine-phosphorylated O O 0.8751397132873535
following O O 0.997669517993927
granulocyte-colony B-protein O 0.8706678748130798

with O O 0.9995155334472656
the O O 0.9999370574951172
5 B-DNA B-DNA 0.6545103192329407
' I-DNA I-DNA 0.8713449835777283
flanking I-DNA I-DNA 0.9262022376060486
regions E-DNA E-DNA 0.9981582760810852
of O O 0.999808132648468
the O O 0.9999622106552124
IL-2 B-DNA B-DNA 0.5952219367027283
and I-DNA I-DNA 0.7313923835754395
IL-2-R I-DNA I-DNA 0.8775389194488525
alpha I-DNA I-DNA 0.879872739315033
genes E-DNA E-DNA 0.9967986345291138
using O O 0.9999722242355347
both O O 0.9999722242355347
DNase B-protein B-protein 0.37168022990226746
I E-protein E-protein 0.6524030566215515
footprinting O O 0.7798677086830139
and O O 0.9933699369430542
gel O O 0.8629500269889832
retardation O O 0.9490901231765747
techniques O O 0.9930232763290405
. O O 0.9999955892562866
We O O 0.9999866485595703
have O O 0.999995231628418
found O O 0.9999910593032837
that O O 0.9999973773956299
a O O 0.999968409538269
region O O 0.9651970863342285
in O O 0.9996594190597534
both O O 0.9999053478240967
genes O O 0.8054037094116211

alter O O 0.9899613857269287
the O O 0.9999657869338989
course O O 0.9982495903968811
of O O 0.9999707937240601
viral O O 0.9317193031311035
replication O O 0.9896456003189087
in O O 0.9999362230300903
cells O O 0.9654972553253174

cells E-cell_line E-cell_type 0.5622199773788452
. O O 0.9996411800384521
Neutrophils O S-cell_type 0.973791241645813
pretreated O O 0.9992369413375854
with O O 0.9999706745147705
NH2Cl O O 0.636654257774353
( O O 0.9968516230583191
30-50 O O 0.9467521905899048
microM O O 0.8649768829345703
) O O 0.9971734285354614
showed O O 0.9999986886978149
a O O 0.9999984502792358
marked O O 0.9977825284004211
decrease O O 0.9999505281448364
in O O 0.9999971389770508
the O O 0.9999885559082031
respiratory O O 0.9451335072517395
burst O O 0.9787946939468384
activity O O 0.999427080154419
induced O O 0.9999916553497314
by O O 0.9999964237213135
phorbol O O 0.9489671587944031
12-myristate O O 0.9932108521461487
13-acetate O O 0.9947133660316467
( O O 0.9999217987060547
PMA O O 0.9976033568382263
) O O 0.9998410940170288
, O O 0.9999818801879883
which O O 0.9999921321868896
is O O 0.9999958276748657
a O O 0.9999960660934448
potent O O 0.993424654006958
PKC S-protein S-protein 0.9287705421447754
activator O O 0.5812023282051086
. O O 0.999932050704956
These O O 0.9999839067459106
cells O O 0.9849222302436829
, O O 0.9990891218185425
however O O 0.9999138116836548
, O O 0.9999523162841797
were O O 0.9999927282333374
viable O O 0.999367892742157
and O O 0.9999719858169556
showed O O 0.9999964237213135

STAT B-protein B-protein 0.6048675179481506
proteins E-protein E-protein 0.9969058632850647
. O O 0.9997020363807678
Interferon-gamma S-protein S-protein 0.9619469046592712
modulates O O 0.999619722366333
the O O 0.9999912977218628
lipopolysaccharide-induced O O 0.7969075441360474
expression O O 0.9778589606285095
of O O 0.9998127818107605
AP-1 S-protein S-protein 0.9119155406951904
and O O 0.9819484353065491
NF-kappa B-protein B-protein 0.9330825209617615
B E-protein E-protein 0.996820330619812
at O O 0.999936580657959
the O O 0.9999514818191528

for O O 0.9955073595046997
provirus O O 0.7439484596252441
induction O O 0.9903382658958435
. O O 0.9999868869781494
U1 B-cell_line B-cell_line 0.7414072155952454
lines E-cell_line E-cell_line 0.9990900754928589
overexpressing O O 0.9387218356132507
C/EBP B-protein B-protein 0.5076267123222351
activator E-protein I-protein 0.6648938655853271
NF-IL-6 S-protein E-protein 0.9404693841934204
produced O O 0.9986993074417114
more O O 0.9992191791534424
viral B-RNA B-RNA 0.6558770537376404
mRNA E-RNA E-RNA 0.9772117137908936
and O O 0.988415002822876
virus O O 0.8758633732795715
particles O O 0.8157497644424438
following O O 0.9998917579650879
cellular O O 0.9654157161712646

as O O 0.9993796348571777
surface O O 0.9705186486244202
expression O O 0.9963595271110535
of O O 0.9999774694442749
the O O 0.9997420907020569
CD69 O B-protein 0.6673199534416199
antigen O E-protein 0.9880837798118591
and O O 0.9926658272743225
the O O 0.9998290538787842
interleukin O B-protein 0.7412325143814087
2 O I-protein 0.6180983185768127
receptor O I-protein 0.5992943644523621
alpha-chain O E-protein 0.9806086421012878
( O O 0.9649389386177063
CD25 O S-protein 0.9771448969841003
) O O 0.9577158093452454
. O O 0.9999382495880127
Pervanadate O O 0.45323699712753296
synergized O O 0.964884877204895
with O O 0.999735414981842
signals O O 0.9466250538825989
delivered O O 0.9987701773643494
by O O 0.9999500513076782

sequences E-DNA E-DNA 0.8528841733932495

HL60 S-cell_line S-protein 0.44787001609802246
to O O 0.9952351450920105
radiolabeled O O 0.8144744038581848
hormone O O 0.9311146140098572
for O O 0.9991975426673889
3 O O 0.9953035116195679
h O O 0.9684544205665588
followed O O 0.9996291399002075
by O O 0.9999852180480957
culture O O 0.9144986867904663
in O O 0.9998167157173157
medium O O 0.8105461001396179
without O O 0.9919323325157166
serum O O 0.905786395072937
and O O 0.9913867115974426
calcitriol O O 0.9631682634353638
lead O O 0.9997873902320862
to O O 0.9999837875366211
nuclear O O 0.9456095099449158
retention O O 0.9961233735084534
of O O 0.9999784231185913
approximately O O 0.997896671295166
1600 B-protein O 0.9231218695640564
radiolabeled I-protein O 0.9797179698944092
VDR E-protein O 0.3953312933444977

release O O 0.9677846431732178
by O O 0.9999618530273438
PBMC S-cell_type S-cell_type 0.9963005781173706
in O O 0.9996607303619385
a O O 0.9999649524688721
dose-dependent O O 0.9265884160995483
manner O O 0.9950140118598938
. O O 0.999995231628418
Since O O 0.999945878982544
C3a S-protein S-protein 0.8969191908836365
has O O 0.9984721541404724
been O O 0.9998451471328735
shown O O 0.9999552965164185
to O O 0.9999839067459106
induce O O 0.9999395608901978
PGE2 O S-protein 0.7166212797164917
production O O 0.9908512234687805
by O O 0.9999912977218628
monocytes S-cell_type S-cell_type 0.9952681660652161
, O O 0.9929313659667969

B I-cell_type B-cell_type 0.2853604257106781
cells E-cell_type E-cell_type 0.8893336653709412
. O O 0.9998422861099243
The O O 0.9999954700469971
activation O O 0.9895257949829102
is O O 0.9999061822891235
rapid O O 0.998525083065033
and O O 0.9997499585151672
transient O O 0.993904173374176
and O O 0.999882698059082
is O O 0.9999810457229614
mediated O O 0.99982750415802
through O O 0.9999963045120239
a O O 0.9999884366989136
cyclosporin O O 0.6581276059150696
A-insensitive O O 0.6279088854789734
pathway O O 0.9903514981269836
. O O 0.9999969005584717
Furthermore O O 0.9999955892562866
, O O 0.9999947547912598
this O O 0.9999940395355225
signaling O O 0.9536393284797668
pathway O O 0.9985682964324951
appears O O 0.9999842643737793
not O O 0.9999717473983765
to O O 0.9999902248382568
rely O O 0.9999927282333374
on O O 0.9999274015426636
protein B-protein O 0.6364035606384277

) I-DNA I-DNA 0.41266095638275146
gene E-DNA E-DNA 0.9814698696136475
and O O 0.997227132320404
the O O 0.9999877214431763
function O O 0.9998137354850769
of O O 0.9999954700469971
the O O 0.9999735355377197
TF B-protein B-protein 0.5535898804664612
protein E-protein E-protein 0.9839041233062744
. O O 0.9998644590377808
The O O 0.9999991655349731
enhanced O O 0.9872094392776489
initiation O O 0.9836087822914124

contrast O O 0.9930810332298279
, O O 0.9999921321868896
the O O 0.9999992847442627
addition O O 0.9998804330825806
of O O 0.9999969005584717
GM-CSF S-protein S-protein 0.9926360249519348
to O O 0.9999303817749023
the O O 0.9999254941940308
M-TAT/EPO B-cell_line B-cell_line 0.8124105930328369
cell I-cell_line I-cell_line 0.6646659970283508
culture E-cell_line E-cell_line 0.9986018538475037
decreased O O 0.9998041987419128
the O O 0.9999994039535522
amount O O 0.9999525547027588
of O O 0.9999902248382568
hemoglobin O S-protein 0.685967206954956
, O O 0.988292396068573
even O O 0.9996079802513123
in O O 0.9999829530715942
the O O 0.9999929666519165
presence O O 0.999292254447937
of O O 0.999982476234436
EPO S-protein S-protein 0.9218790531158447
, O O 0.9987488985061646
indicating O O 0.9999825954437256
that O O 0.9999988079071045
the O O 0.9999549388885498
EPO S-protein S-protein 0.9677776098251343
signal O O 0.9969136714935303
for O O 0.9999829530715942
erythroid O O 0.7350749373435974
differentiation O O 0.9966185092926025
is O O 0.9999948740005493
suppressed O O 0.9999603033065796
by O O 0.9999985694885254
GM-CSF S-protein S-protein 0.8940739035606384

invariant B-protein I-protein 0.43647944927215576
( I-protein I-protein 0.7736291885375977
Ii I-protein I-protein 0.792752742767334
) I-protein I-protein 0.4746265709400177
chains E-protein E-protein 0.9903653860092163
were O O 0.9998261332511902
equivalent O O 0.9976387023925781
in O O 0.9988271594047546
control B-cell_type O 0.98149174451828
and I-cell_type O 0.9978774785995483
infected I-cell_type B-cell_type 0.5517846345901489
cells E-cell_type E-cell_type 0.9461047053337097
. O O 0.9998664855957031
Metabolic O O 0.9458572864532471
labeling O O 0.9856799840927124
combined O O 0.9999223947525024
with O O 0.9999966621398926
pulse-chase O O 0.739196240901947
experiments O O 0.9750731587409973
and O O 0.9998513460159302
biochemical O O 0.9779746532440186
analysis O O 0.9997820258140564
showed O O 0.9999995231628418
that O O 0.9999988079071045
the O O 0.9999942779541016
majority O O 0.998900294303894
of O O 0.9999960660934448
class B-protein B-protein 0.5021533966064453
II I-protein I-protein 0.7284247875213623
molecules E-protein E-protein 0.9954118132591248
in O O 0.9998464584350586
infected O B-cell_type 0.5464085340499878
cells O E-cell_type 0.952518880367279

alpha E-protein E-protein 0.44583553075790405
) O O 0.2055361121892929
-induced O O 0.8565302491188049
changes O O 0.9818335175514221
of O O 0.9998346567153931
gcRs S-protein S-protein 0.5263510346412659
. O O 0.999242901802063

IgG B-protein B-protein 0.6721094846725464
Fc I-protein I-protein 0.8436532616615295
receptors E-protein E-protein 0.9970678687095642
in O O 0.9995966553688049
B B-cell_type B-cell_type 0.8913117051124573
lymphocytes E-cell_type E-cell_type 0.9937303066253662
. O O 0.9998875856399536
B B-cell_type B-cell_type 0.8317689895629883
lymphocytes E-cell_type E-cell_type 0.991717517375946
and O O 0.9982277750968933
macrophages O S-cell_type 0.9993830919265747
express O O 0.9994761347770691
closely O O 0.9370365738868713
related O O 0.9912506341934204
immunoglobulin B-protein B-protein 0.6830888390541077
G I-protein E-protein 0.9165652990341187

transcription I-protein I-protein 0.4611828923225403
factor E-protein E-protein 0.9894763231277466
, O O 0.9941176176071167
Elf-1 S-protein S-protein 0.9558930993080139
, O O 0.99581378698349
binds O O 0.999011754989624
specifically O O 0.9991092085838318
to O O 0.9999750852584839
two B-DNA O 0.9963269829750061
purine-rich I-DNA B-DNA 0.6163267493247986
motifs E-DNA E-DNA 0.9585896134376526
in O O 0.9997832179069519
the O O 0.9999617338180542
HIV-2 B-DNA B-DNA 0.7316921353340149
enhancer E-DNA E-DNA 0.9942640662193298
. O O 0.9998192191123962
Mutagenesis O O 0.9710524082183838
experiments O O 0.9988110065460205
demonstrated O O 0.9999966621398926
that O O 0.9999991655349731
these O O 0.9999790191650391
Elf-1 B-DNA B-DNA 0.5261769890785217
binding I-DNA I-DNA 0.5510382652282715

N O O 0.6518012881278992
supine O O 0.9737228751182556
: O O 0.9989481568336487
1.120 O O 0.9925958514213562
) O O 0.9998860359191895
, O O 0.9999837875366211
aldosterone O O 0.9684716463088989
( O O 0.9998384714126587
> O O 0.9999189376831055
2000 O O 0.9995492100715637
pg/ml O O 0.9996758699417114
; O O 0.9999703168869019
N O O 0.9807847738265991
supine O O 0.9941264390945435
< O O 0.9996341466903687
150 O O 0.9939531683921814
) O O 0.9998303651809692

stimulation O O 0.9887802600860596
was O O 0.9999784231185913
shown O O 0.9999982118606567
to O O 0.9999969005584717
enhance O O 0.9998170733451843
transcription O O 0.9799901843070984
by O O 0.999984860420227
two- O O 0.9911031723022461
to O O 0.9979544878005981
threefold O O 0.9970833659172058
. O O 0.9999569654464722
IL-4 S-protein S-protein 0.9707080125808716
stimulated O O 0.9978761672973633
nuclear B-protein B-protein 0.7591454982757568
factor-kappaB E-protein E-protein 0.9956806898117065
nuclear O O 0.9667016863822937
translocation O O 0.9943724870681763
and O O 0.9998676776885986
binding O O 0.9734373688697815
before O O 0.9998911619186401
enhancement O O 0.9992488026618958
of O O 0.9999912977218628
HIV B-RNA B-RNA 0.4158264398574829
RNA E-RNA E-RNA 0.9009552001953125
expression O O 0.9837546944618225

suggest O O 0.9985501170158386
that O O 0.999993085861206
p2l B-protein B-protein 0.5016319155693054
( I-protein I-protein 0.6223849058151245
ras I-protein I-protein 0.9214972853660583
) E-protein E-protein 0.9777601361274719
is O O 0.9996793270111084
an O O 0.9999963045120239
essential O O 0.9971998929977417
mediator O O 0.9820948243141174
in O O 0.9998658895492554
generating O O 0.9811174273490906
not O O 0.9962201714515686
only O O 0.9998214840888977
positive O O 0.9508827924728394
but O O 0.9957926273345947
also O O 0.9999445676803589
negative O O 0.9693961143493652
modulatory O O 0.9515472054481506
mechanisms O O 0.9983805418014526
controlling O O 0.9999639987945557
the O O 0.9999953508377075
competence O O 0.9994043111801147
of O O 0.9999854564666748
T B-cell_type B-cell_type 0.8361153602600098
cells E-cell_type E-cell_type 0.9948910474777222
in O O 0.9998359680175781
response O O 0.998559296131134
to O O 0.9999821186065674
inductive O O 0.9778408408164978
stimulations O O 0.998324453830719
. O O 0.9999986886978149
Calcineurin S-protein S-protein 0.767313539981842

of O O 0.9925521612167358

from O O 0.9990309476852417
stat3 S-protein S-protein 0.93658447265625
, O O 0.9998539686203003
another O O 0.9999940395355225
cytoplasmic B-protein B-protein 0.5251237750053406
protein E-protein E-protein 0.9683913588523865
was O O 0.999117910861969
tyrosine O O 0.917262613773346
phosphorylated O O 0.9136384725570679
and O O 0.9978320002555847
subsequently O O 0.9997230172157288
translocated O O 0.9992468357086182
to O O 0.9999868869781494
the O O 0.9999165534973145

consistent O O 0.991357684135437
with O O 0.9999938011169434
a O O 0.9999967813491821
causal O O 0.9815422892570496
linkage O O 0.9998108744621277
between O O 0.9999507665634155
the O O 0.9999743700027466
phosphorylation O O 0.8752514719963074
status O O 0.9907192587852478
and O O 0.9998229146003723
proteolytic O O 0.9549198746681213
stability O O 0.9986695051193237
of O O 0.9999963045120239
this O O 0.9999551773071289
cytoplasmic B-protein O 0.5155013203620911
inhibitor E-protein O 0.5797936916351318
. O O 0.9998432397842407
Together O O 0.9999852180480957
, O O 0.9999934434890747
these O O 0.9999853372573853
in O O 0.9995354413986206
vivo O O 0.9965447783470154
studies O O 0.9997296929359436
define O O 0.9999868869781494
a O O 0.9999942779541016
critical O O 0.9620174169540405
signal O O 0.916857898235321
response O O 0.9212680459022522
domain O O 0.6602827906608582
in O O 0.9999439716339111
I B-protein B-protein 0.8000295758247375
kappa I-protein I-protein 0.8403628468513489
B I-protein I-protein 0.7032844424247742
alpha E-protein E-protein 0.9950751662254333
that O O 0.9997819066047668
coordinately O O 0.9997904896736145
controls O O 0.9999256134033203
the O O 0.9999912977218628
biologic O O 0.9680024981498718
activities O O 0.9983296990394592
of O O 0.9999963045120239
I B-protein B-protein 0.8196465373039246
kappa I-protein I-protein 0.8265274167060852
B I-protein I-protein 0.6618998050689697
alpha E-protein E-protein 0.9907744526863098
and O O 0.99747234582901
NF-kappa B-protein B-protein 0.9160141944885254
B E-protein E-protein 0.996454119682312
in O O 0.9997971653938293

13-acetate O O 0.3441404104232788
led O O 0.9911878108978271
to O O 0.9999668598175049
a O O 0.9999974966049194
dramatic O O 0.997637152671814
inhibition O O 0.9994671940803528
of O O 0.9999839067459106
thrombin B-RNA B-RNA 0.5560576319694519
receptor I-RNA I-RNA 0.4613073170185089
mRNA E-RNA E-RNA 0.9642043709754944
expression O O 0.9964103102684021
and O O 0.9999889135360718
to O O 0.999996542930603
a O O 0.9999960660934448
concomitant O O 0.9677819609642029
loss O O 0.9979633092880249
of O O 0.9999908208847046
the O O 0.9999918937683105
thrombin S-protein S-protein 0.4399730861186981

B I-DNA I-DNA 0.3052082657814026
sequence E-DNA E-DNA 0.9918419122695923
located O O 0.9989805817604065
within O O 0.999994158744812
the O O 0.9999688863754272
TNF B-DNA B-DNA 0.8019123673439026
promoter E-DNA E-DNA 0.9934404492378235
. O O 0.9995798468589783
PMA O O 0.8969197869300842
induction O O 0.9917036294937134
increases O O 0.9999784231185913

mRNA E-RNA E-RNA 0.9482792615890503
was O O 0.998455286026001
detected O O 0.9999576807022095
in O O 0.999992847442627
three O O 0.9999462366104126
of O O 0.999976634979248
seven O O 0.9985160231590271
cases O O 0.997534990310669
; O O 0.9999709129333496
however O O 0.9999935626983643
, O O 0.9999877214431763
neither B-RNA O 0.9998995065689087
LMP1 I-RNA S-protein 0.9076669216156006
nor I-RNA O 0.8116700053215027
LMP2B I-RNA B-RNA 0.5798743367195129
mRNA E-RNA E-RNA 0.9982006549835205
was O O 0.9995778203010559
detected O O 0.9998905658721924
in O O 0.9999973773956299
any O O 0.9999947547912598

macrophages S-cell_type S-cell_type 0.9365201592445374
, O O 0.9921991229057312
and O O 0.9984933137893677
endothelial B-cell_type B-cell_type 0.6811644434928894
cells E-cell_type E-cell_type 0.9441981911659241
, O O 0.9940453767776489
play O O 0.9999635219573975
an O O 0.9999890327453613
important O O 0.9999366998672485
role O O 0.9999877214431763
in O O 0.9999986886978149
the O O 0.9999971389770508
pathogenesis O O 0.9978678226470947
of O O 0.9999918937683105
Gram-negative O O 0.9024320840835571
bacteria-induced O O 0.9807063341140747
sepsis O O 0.9933197498321533
syndrome O O 0.9997583031654358
. O O 0.9999982118606567

regulatory I-DNA I-DNA 0.4189344346523285
region E-DNA E-DNA 0.9720779657363892
from O O 0.9999802112579346
the O O 0.999977707862854
ER-positive B-cell_line B-cell_line 0.7159374952316284
MCF-7 E-cell_line E-cell_line 0.739350438117981
and O O 0.5757389068603516
the O O 0.977035641670227
ER-negative B-cell_line B-cell_line 0.4775044023990631
MDA-MB-231 I-cell_line I-cell_line 0.6638358235359192
breast I-cell_line I-cell_line 0.955471396446228
cancer I-cell_line I-cell_line 0.9864489436149597
cell I-cell_line I-cell_line 0.9620879292488098
lines E-cell_line E-cell_line 0.9991908669471741
to O O 0.9994156360626221
determine O O 0.9999855756759644

Furthermore O O 0.9986024498939514
, O O 0.9999270439147949
CD40 S-protein S-protein 0.9752496480941772
ligation O O 0.9914108514785767
of O O 0.9999527931213379
a O O 0.9997265934944153
HLA-A2+ B-cell_line B-cell_line 0.5629640221595764
, I-cell_line I-cell_line 0.5682141780853271
MelanA/MART1+ I-cell_line I-cell_line 0.5709000825881958
MM I-cell_line I-cell_line 0.9190936088562012
cell I-cell_line I-cell_line 0.6338624358177185
line E-cell_line E-cell_line 0.9965662360191345
enhanced O O 0.999207079410553
its O O 0.9999825954437256
susceptibility O O 0.9993261098861694
to O O 0.9999949932098389
specific O O 0.9944755434989929
lysis O O 0.9988468885421753
by O O 0.9999992847442627
a O O 0.999840497970581
HLA-A2-restricted B-cell_line B-cell_line 0.6997511386871338
, I-cell_line I-cell_line 0.8104118704795837
MelanA/MART-1-specific I-cell_line I-cell_line 0.913914144039154
CTL I-cell_line I-cell_line 0.7980871796607971
clone E-cell_line E-cell_line 0.9986448884010315
. O O 0.9999291896820068
Finally O O 0.9998629093170166
, O O 0.9999468326568604
CD40 S-protein S-protein 0.9745511412620544
ligation O O 0.9856294989585876
induced O O 0.9994354844093323
growth O O 0.8598717451095581
inhibition O O 0.9835668802261353
and O O 0.9996322393417358
apoptosis O O 0.9952836632728577
in O O 0.9999655485153198
MM O O 0.5478514432907104
. O O 0.9997337460517883
These O O 0.9999971389770508
results O O 0.9999803304672241
indicate O O 0.9999986886978149
that O O 0.9999969005584717
CD40 S-protein S-protein 0.9976092576980591
-CD40L S-protein S-protein 0.9067922234535217
interactions O O 0.9968054294586182
may O O 0.999996542930603
play O O 0.9999932050704956
an O O 0.9999955892562866
important O O 0.9999574422836304
role O O 0.9999924898147583
in O O 0.9999958276748657
augmenting O O 0.9989820122718811
antitumor O O 0.9666101336479187
immunity O O 0.9992861151695251
and O O 0.9999916553497314
inducing O O 0.9993281364440918
apoptosis O O 0.9991648197174072
in O O 0.9999959468841553
some O O 0.9998818635940552
CD40 S-protein S-protein 0.8440721035003662
-positive O O 0.913989245891571
immunogenic O O 0.7454674243927002
human O O 0.5274104475975037
MMs O O 0.490963876247406
. O O 0.9993067979812622
Human O O 0.9265721440315247
immunodeficiency O O 0.9859145879745483
virus-associated O O 0.9947016835212708
Hodgkin O O 0.990839421749115
's O O 0.9989686012268066
disease O O 0.9997850060462952
derives O O 0.9999397993087769

patients O O 0.9759396314620972
. O O 0.9999866485595703
Further O O 0.9989838004112244
, O O 0.9999700784683228
M. O O 0.9271472096443176
tuberculosis O O 0.9940788745880127
and O O 0.999864935874939
its O O 0.9999767541885376
tuberculin S-protein O 0.5249640345573425
, O O 0.9865921139717102
purified B-protein O 0.917631983757019
protein I-protein O 0.6931349635124207
derivative E-protein O 0.9619529843330383
, O O 0.9994105100631714
induced O O 0.9997474551200867
the O O 0.9999910593032837
degradation O O 0.9968736171722412
of O O 0.9999855756759644
I B-protein B-protein 0.9417604804039001
kappa I-protein I-protein 0.9628843665122986
B-alpha E-protein E-protein 0.9636817574501038
and O O 0.9864199757575989
the O O 0.9997257590293884

p38 S-protein S-protein 0.8938836455345154
and O O 0.9585261940956116
p63 S-protein S-protein 0.8988633155822754
is O O 0.9971171617507935
also O O 0.9999654293060303
observed O O 0.9999157190322876
in O O 0.9999650716781616
platelets S-cell_type S-cell_type 0.9743502140045166
stimulated O O 0.998573899269104
by O O 0.9999979734420776
the O O 0.9999240636825562
tyrosine B-protein B-protein 0.6570397019386292
kinase E-protein E-protein 0.9936016201972961
-linked O O 0.9705103039741516
receptor O O 0.7364367842674255
agonist O O 0.9489893913269043
collagen S-protein O 0.7783080339431763
and O O 0.999382495880127
by O O 0.9999815225601196
the O O 0.9999279975891113
G B-protein B-protein 0.751845121383667
protein E-protein E-protein 0.9897691011428833
-coupled O O 0.9513362646102905
receptor O O 0.6082466244697571
agonist O O 0.9594678282737732
thrombin S-protein S-protein 0.8237410187721252
, O O 0.99955815076828
although O O 0.9999887943267822
phosphorylation O O 0.975753664970398
of O O 0.999301552772522
SLP-76 S-protein S-protein 0.9742575883865356
is O O 0.9997771382331848
only O O 0.9999847412109375
observed O O 0.9992332458496094

the O O 0.9992566704750061
long O B-DNA 0.7300237417221069
terminal O I-DNA 0.5693469643592834
repeat O E-DNA 0.9690495133399963
of O O 0.9985455274581909
type O O 0.6610771417617798
1 O O 0.7356076836585999
human O O 0.7575749754905701
immunodeficiency O O 0.8548216819763184
virus O O 0.8860560655593872
. O O 0.9999427795410156
The O O 0.9999983310699463
long B-DNA B-DNA 0.7020588517189026
terminal I-DNA I-DNA 0.9421244263648987
repeat E-DNA E-DNA 0.9957146048545837
( O O 0.9915609955787659
LTR S-DNA S-DNA 0.9988911747932434
) O O 0.9792491793632507
of O O 0.99993896484375
the O O 0.9999618530273438
type O O 0.6704935431480408
1 O O 0.7024192810058594
human O O 0.5486561059951782
immunodeficiency O O 0.564375102519989
virus O O 0.7340396642684937
( O O 0.8594266176223755
HIV-1 O O 0.7104893922805786
) O O 0.9587013721466064
and O O 0.9984991550445557
the O O 0.9999089241027832
5 B-DNA B-DNA 0.7152777314186096
' I-DNA I-DNA 0.5044192671775818
regulatory I-DNA I-DNA 0.7942001223564148
region E-DNA E-DNA 0.9952636957168579
of O O 0.9991820454597473

. O O 0.9988880753517151
Further O O 0.9996850490570068
characterization O O 0.999717652797699
of O O 0.9999960660934448
these O O 0.9999213218688965
cells O O 0.9701850414276123
should O O 0.9999665021896362
identify O O 0.9999562501907349
factors O O 0.9587368369102478
involved O O 0.9997678399085999
in O O 0.999984860420227
the O O 0.9999850988388062
growth O O 0.9763184189796448
, O O 0.9992409944534302
terminal O O 0.9632008671760559
differentiation O O 0.9949953556060791
and O O 0.9996899366378784
activation O O 0.9972646236419678
of O O 0.9999490976333618
osteoclasts S-cell_type S-cell_type 0.9508093595504761
. O O 0.9996826648712158
Oleic O O 0.8933343887329102
acid O O 0.9578717947006226
inhibits O O 0.9992454051971436
endothelial O O 0.8339143395423889
activation O O 0.9943385720252991
: O O 0.999941349029541
A O O 0.998782217502594
direct O O 0.9831273555755615
vascular O O 0.8792043924331665

LPS-induced O O 0.762413740158081
NF-kappaB S-protein S-protein 0.6847177147865295
and O O 0.999637246131897
activating B-protein O 0.918157696723938
protein-1 E-protein O 0.5536513328552246
binding O O 0.6718549132347107
activity O O 0.9813880920410156
. O O 0.9999885559082031
These O O 0.999997615814209
results O O 0.9999163150787354
demonstrate O O 0.9999985694885254
the O O 0.9999980926513672
capacity O O 0.999504566192627
of O O 0.9999866485595703
intact O O 0.8285516500473022
C3a S-protein S-protein 0.7560528516769409
and O O 0.9682084321975708
its O O 0.9992762207984924
circulating O O 0.9274947047233582
des-Arg B-protein O 0.48720353841781616

previously O O 0.9901464581489563
characterized O O 0.978283166885376
factors O O 0.5413258075714111
J B-protein B-protein 0.720507800579071
kappa E-protein E-protein 0.8826075196266174
, O O 0.9417662024497986
PU.1 S-protein S-protein 0.9747602343559265
, O O 0.9940442442893982
and O O 0.9993915557861328
AML1 S-protein S-protein 0.9853304624557495
bind O O 0.9949034452438354
to O O 0.9999762773513794
the O O 0.999945878982544
LMP-1 B-DNA B-DNA 0.6681546568870544
E2RE E-DNA E-DNA 0.8467788696289062
, O O 0.9361345171928406
along O O 0.9992861151695251
with O O 0.9999916553497314
six O O 0.9984577894210815
other O O 0.9994753003120422
unidentified O B-protein 0.6665331721305847
factors O E-protein 0.9750102758407593
( O O 0.9832894802093506
LBF2 S-protein S-protein 0.9612044095993042
to O O 0.9884746670722961

+/- O O 0.9913374185562134
SEM O O 0.9893108606338501
, O O 0.9999363422393799
n O O 0.9989560842514038
= O O 0.9999244213104248
6 O O 0.9991004467010498
) O O 0.999940037727356
in O O 0.9999992847442627
the O O 0.9999957084655762
CS O O 0.8991597890853882
group O O 0.986446738243103
and O O 0.9999921321868896
1.6 O O 0.9963132739067078
+/- O O 0.9999511241912842
0.35 O O 0.9998953342437744
nM O O 0.9995463490486145
( O O 0.9999816417694092
mean O O 0.9997081160545349
+/- O O 0.9999176263809204
SEM O O 0.9974718689918518
, O O 0.9999685287475586
n O O 0.9993557333946228
= O O 0.9999181032180786
6 O O 0.9986612796783447
) O O 0.9999215602874756
in O O 0.999998927116394
the O O 0.9999994039535522
CR O O 0.7923831939697266
group O O 0.8800564408302307
of O O 0.9999282360076904
patients O O 0.9981498718261719
( O O 0.999889612197876

consequence O O 0.9909867644309998
of O O 0.9999785423278809
the O O 0.9999984502792358
activation O O 0.9987393021583557
of O O 0.9999754428863525
PKC S-protein S-protein 0.9732517600059509
can O O 0.9999501705169678
be O O 0.9999982118606567
increased O O 0.9999524354934692
expression O O 0.9997366070747375
of O O 0.9999939203262329
mitogen-activated B-protein B-protein 0.5287564396858215
protein I-protein I-protein 0.7777175903320312
( I-protein I-protein 0.5899029970169067
MAP I-protein I-protein 0.8564921021461487
) I-protein I-protein 0.7321953177452087
kinase E-protein E-protein 0.9884045124053955
pathways O O 0.9974499344825745
. O O 0.9999970197677612
Therefore O O 0.999983549118042
, O O 0.9999891519546509
we O O 0.9999237060546875
also O O 0.9999856948852539
evaluated O O 0.9999217987060547
activation O O 0.9980589747428894
of O O 0.999962568283081
the O O 0.9998867511749268
MAP B-protein B-protein 0.8743239045143127
kinase I-protein I-protein 0.8577276468276978
extracellular I-protein I-protein 0.4857591688632965
signal-regulated I-protein I-protein 0.8209241032600403
kinase I-protein I-protein 0.9023624062538147
( I-protein I-protein 0.7746764421463013
ERK I-protein I-protein 0.7981926202774048
) I-protein I-protein 0.9012992978096008
2 E-protein E-protein 0.9809769988059998
by O O 0.9999363422393799
the O O 0.9999691247940063
phorbol O O 0.8651358485221863
ester O O 0.9631600975990295
phorbol O O 0.9831574559211731
12-myristate O O 0.9922952651977539
13-acetate O O 0.9917286038398743
( O O 0.9995918869972229
PMA O O 0.9867138266563416

also O O 0.9989156723022461
reduce O O 0.9999923706054688
the O O 0.9999977350234985
number O O 0.9997113347053528
of O O 0.9999814033508301
erythroid B-cell_type B-cell_type 0.847594678401947
progenitor I-cell_type I-cell_type 0.9521369338035583
cells E-cell_type E-cell_type 0.9929721355438232
in O O 0.99991774559021
primary B-cell_line B-cell_line 0.5296131372451782
human I-cell_line I-cell_line 0.4945835471153259
bone I-cell_line I-cell_line 0.6348637938499451
marrow I-cell_line I-cell_line 0.8373029828071594
cultures E-cell_line E-cell_line 0.6882862448692322
. O O 0.9994997978210449
To O O 0.9999984502792358
address O O 0.9999940395355225
potential O O 0.9983618855476379
mechanisms O O 0.9996324777603149
by O O 0.9999985694885254

In O O 0.9993348717689514
an O O 0.9999755620956421
aged O O 0.9928178787231445
population O O 0.9946801066398621
the O O 0.9999980926513672
mean O O 0.9985484480857849

. O O 0.9994255304336548
One O O 0.9998416900634766
hour O O 0.9556060433387756
pulse-treatment O O 0.9836795926094055
with O O 0.9999814033508301
3 O O 0.9662985801696777
microM O O 0.956707239151001
etoposide O O 0.9731263518333435
caused O O 0.9998741149902344
topoisomerase S-protein O 0.8227226138114929
associated O O 0.9859733581542969
, O O 0.9997343420982361
primary O O 0.8358467221260071
DNA O O 0.7952477335929871
breakage O O 0.9311986565589905
, O O 0.9996763467788696
which O O 0.9999116659164429
was O O 0.9999485015869141
rapidly O O 0.9998738765716553
followed O O 0.9999914169311523
by O O 0.9999960660934448
apoptosis O O 0.9969563484191895
. O O 0.9999955892562866
By O O 0.999985933303833
contrast O O 0.9999732971191406
, O O 0.9999964237213135
these O O 0.999984622001648
effects O O 0.9998533725738525
were O O 0.999990701675415
not O O 0.9997629523277283
observed O O 0.9997971653938293
upon O O 0.999941349029541
pulse-treatment O O 0.967985212802887
with O O 0.9999797344207764
6 O O 0.9948928356170654
microM O O 0.9807526469230652
ICRF-193 O O 0.8143759369850159
. O O 0.9999727010726929
However O O 0.9999798536300659
, O O 0.9998918771743774
continuous O O 0.9667156934738159
treatments O O 0.9967995882034302
with O O 0.999995231628418
subcytotoxic O O 0.9053677320480347
concentrations O O 0.9934529066085815

mononuclear B-cell_type I-cell_type 0.45674118399620056
phagocytes E-cell_type E-cell_type 0.9807558655738831
. O O 0.9999369382858276
Soluble O O 0.5567532777786255
interleukin-2 B-protein B-protein 0.24313503503799438
receptor-alpha E-protein E-protein 0.9938021898269653
( O O 0.9823381900787354
IL-2Ralpha S-protein S-protein 0.997668445110321
) O O 0.989201545715332
has O O 0.9999668598175049
been O O 0.9999092817306519
reported O O 0.999919056892395
to O O 0.9999262094497681
be O O 0.9999532699584961
increased O O 0.9999585151672363
in O O 0.9999902248382568
the O O 0.9999732971191406

interleukin B-protein B-protein 0.3988477289676666
3 E-protein E-protein 0.9897441267967224
-mediated O O 0.9880169630050659
survival O O 0.9976612329483032
of O O 0.9999808073043823
pro-B B-cell_type B-cell_type 0.7383795976638794
lymphocytes E-cell_type E-cell_type 0.9611420035362244
. O O 0.999946117401123
The O O 0.9999529123306274
E2A-HLF B-protein S-protein 0.8377964496612549
( I-protein O 0.9451990723609924
hepatic I-protein B-protein 0.677217423915863
leukemia I-protein I-protein 0.43940651416778564
factor I-protein E-protein 0.801863968372345
) I-protein O 0.6388642191886902
oncoprotein E-protein S-protein 0.6304284930229187
, O O 0.9943242073059082
generated O O 0.9988133907318115
in O O 0.9998424053192139
pro-B B-cell_type B-cell_type 0.821709930896759
lymphocytes E-cell_type E-cell_type 0.9768749475479126
by O O 0.9999299049377441
fusion O O 0.9127212166786194
of O O 0.9973447918891907
the O O 0.999797523021698
trans-activation B-protein B-protein 0.7004674077033997
domain E-protein E-protein 0.969689130783081
of O O 0.99299156665802
E2A S-protein S-protein 0.8648829460144043

. O O 0.999038815498352
In O O 0.9999909400939941
this O O 0.9999988079071045
review O O 0.9992109537124634
, O O 0.9999960660934448
we O O 0.9999911785125732
describe O O 0.9999958276748657
the O O 0.9999938011169434
host-cell B-protein B-protein 0.5090590715408325
transcription I-protein I-protein 0.6635430455207825
factors E-protein E-protein 0.9950070381164551
that O O 0.9997926354408264
interact O O 0.9999229907989502
with O O 0.999976634979248
the O O 0.9998635053634644
5'-UTR S-DNA S-protein 0.48577025532722473
and O O 0.9332794547080994
discuss O O 0.998969316482544
their O O 0.99997878074646
role O O 0.9998635053634644
in O O 0.9999942779541016
the O O 0.9999936819076538
transcriptional O O 0.9801256060600281
regulation O O 0.999241828918457
of O O 0.9999946355819702
HIV-1 O O 0.6826664209365845
gene O O 0.8147671818733215
expression O O 0.9970267415046692
. O O 0.9999982118606567
Regulation O O 0.9996904134750366
of O O 0.9999949932098389
PAK O S-protein 0.9691036939620972
activation O O 0.9966938495635986
and O O 0.9999686479568481
the O O 0.9999874830245972
T O O 0.5997379422187805
cell O O 0.47556883096694946
cytoskeleton O O 0.4609500765800476
by O O 0.9982035160064697
the O O 0.9999574422836304

containing O O 0.9910905361175537
a O O 0.9997175335884094
PXQXT/S B-DNA B-DNA 0.5369661450386047
sequence E-DNA E-DNA 0.973166286945343
are O O 0.9998995065689087
highly O O 0.9862924814224243
conserved O O 0.9994339346885681
in O O 0.9999897480010986
human O B-cell_line 0.4880492389202118
and O I-cell_line 0.8600030541419983
simian O I-cell_line 0.7942976355552673
EBV O I-cell_line 0.5745052695274353
LMP1 S-protein E-cell_line 0.8398277163505554
but O O 0.9681915640830994
do O O 0.9998998641967773

results O O 0.9987851977348328
demonstrate O O 0.9999991655349731
that O O 0.9999955892562866
multidrug-resistant B-cell_line B-cell_line 0.44379013776779175
HL-60 I-cell_line I-cell_line 0.6820909976959229
cells E-cell_line E-cell_line 0.9948603510856628
, O O 0.9936968684196472
designated O O 0.921444296836853
HL-60/vinc O S-cell_line 0.9785606265068054
, O O 0.9321343302726746
fail O O 0.9974154233932495
to O O 0.9999319314956665
respond O O 0.9999735355377197
to O O 0.9999879598617554
TPA O O 0.9609728455543518
with O O 0.9999810457229614
an O O 0.9999936819076538
increase O O 0.9999393224716187
in O O 0.9999688863754272
c-jun B-RNA B-RNA 0.7118817567825317
transcripts E-RNA E-RNA 0.9568037986755371
or O O 0.9977319240570068
other O O 0.9993277788162231
phenotypic O O 0.7462204694747925
characteristics O O 0.9422574639320374
of O O 0.9992982149124146
monocytic O O 0.7378085851669312
differentiation O O 0.9930520057678223
. O O 0.9999963045120239
By O O 0.9999731779098511
contrast O O 0.9998248219490051

were O O 0.9991927742958069
completely O O 0.9950752854347229
blocked O O 0.9999657869338989
by O O 0.9999982118606567
tyrosine B-protein B-protein 0.8425124883651733
kinase E-protein E-protein 0.893913745880127
inhibitors O O 0.5424524545669556
. O O 0.999984860420227
In O O 0.999977707862854
contrast O O 0.9999747276306152
, O O 0.9999915361404419
expression O O 0.9991705417633057
of O O 0.9999922513961792
dominant B-protein B-protein 0.4148639142513275
negative I-protein I-protein 0.6001111268997192
mutants E-protein E-protein 0.9411919116973877
of O O 0.9926275610923767
Ras S-protein S-protein 0.980138897895813
and O O 0.9831740260124207
Raf-1 S-protein S-protein 0.994510293006897
, O O 0.9985268115997314
in O O 0.9999715089797974
these O O 0.999546229839325
cells O O 0.9816224575042725
, O O 0.9997764229774475
did O O 0.9999717473983765
not O O 0.9999731779098511
have O O 0.9999841451644897
any O O 0.9999899864196777
effect O O 0.9999759197235107
on O O 0.999995231628418

, O O 0.9697594046592712
but O O 0.9993045330047607
they O O 0.9999898672103882
also O O 0.9999980926513672
explain O O 0.9999523162841797
effects O O 0.9997407793998718
of O O 0.9999858140945435
Nef S-protein S-protein 0.998046875
in O O 0.999957799911499
HIV O O 0.9501005411148071
infection O O 0.9986618757247925
and O O 0.9999847412109375
progression O O 0.9997161030769348
to O O 0.9999958276748657
AIDS O O 0.9990655779838562
. O O 0.9999994039535522
An O O 0.9999992847442627
intricate O O 0.9414454102516174
arrangement O O 0.9971098303794861
of O O 0.9999641180038452

differ O O 0.9987034797668457
significantly O O 0.9999897480010986
between O O 0.9999252557754517
the O O 0.9999974966049194
groups O O 0.9965537786483765
. O O 0.9999969005584717
Responses O O 0.9994655251502991
to O O 0.999970555305481
jun-B S-protein S-protein 0.8322888016700745
were O O 0.9996938705444336
not O O 0.9995700716972351
related O O 0.9999276399612427
to O O 0.9999676942825317
age O O 0.9957706332206726
, O O 0.9999364614486694
sex O O 0.9745451807975769
, O O 0.9996534585952759
or O O 0.9998266100883484
human B-protein O 0.7903776168823242
leukocyte I-protein O 0.5809847116470337

stability O O 0.9921168684959412
of O O 0.9999645948410034
its O O 0.999984622001648
message O O 0.9854623079299927
is O O 0.9999436140060425
regulated O O 0.9995566010475159
. O O 0.9999969005584717
Although O O 0.9999924898147583
a O O 0.9999942779541016
number O O 0.9998249411582947
of O O 0.9999943971633911
transcription B-protein B-protein 0.8499829769134521
factors E-protein E-protein 0.998914361000061
involved O O 0.9998730421066284
in O O 0.9999481439590454
the O O 0.9999914169311523
control O O 0.9960361123085022
of O O 0.9999699592590332
the O O 0.9999232292175293
cell O O 0.8084883689880371
cycle O O 0.884694516658783
or O O 0.9966259002685547

proteins O E-protein 0.9050273299217224
of O O 0.9916327595710754
about O O 0.9989981055259705
65-75 B-protein O 0.49141883850097656
and I-protein O 0.9797077775001526
120-125 I-protein O 0.9184006452560425
kDa E-protein O 0.49583300948143005
. O O 0.9998806715011597
In O O 0.9999511241912842
addition O O 0.9999531507492065
, O O 0.9999791383743286
integrin S-protein S-protein 0.9807958006858826
ligation O O 0.9958121180534363
leads O O 0.9999587535858154
to O O 0.9999724626541138
nuclear O O 0.7853808999061584
translocation O O 0.8143824338912964
of O O 0.9942893981933594
the O O 0.9994934797286987
p50 S-protein S-protein 0.9291085600852966
and O O 0.9096533060073853
p65 B-protein B-protein 0.602287232875824
subunits E-protein E-protein 0.9908283948898315
of O O 0.9991115927696228
the O O 0.9998999834060669
NF-kappa B-protein B-protein 0.8289064764976501
B I-protein E-protein 0.9497972130775452
transcription I-protein B-protein 0.36205926537513733
factor E-protein E-protein 0.9698254466056824
, O O 0.9947263598442078
to O O 0.9999371767044067
activation O O 0.9910599589347839
of O O 0.9998243451118469
a O O 0.9999822378158569
reporter B-DNA B-DNA 0.5596944689750671
gene E-DNA E-DNA 0.8764302730560303
driven O O 0.9912171363830566
by O O 0.9999934434890747
a O O 0.999969482421875
promoter S-DNA O 0.516258955001831
containing O O 0.9936971068382263
NF-kappa B-DNA B-protein 0.6961467862129211

a O O 0.9982142448425293
regulator O O 0.9205307364463806
of O O 0.9965420365333557
lymphocyte-specific O B-DNA 0.5513516664505005
gene O E-DNA 0.8701958656311035
expression O O 0.9799345135688782
. O O 0.9999918937683105
Early B-protein B-protein 0.7822723984718323
B-cell I-protein I-protein 0.48640111088752747
factor E-protein E-protein 0.9927224516868591
( O O 0.988271176815033
EBF S-protein S-protein 0.9957914352416992
) O O 0.9912751913070679
was O O 0.9999665021896362
identified O O 0.9999759197235107
previously O O 0.9999916553497314
as O O 0.9999970197677612
a O O 0.9999871253967285
tissue-specific O B-protein 0.6119211912155151
and O I-protein 0.8478538393974304
differentiation O I-protein 0.7599069476127625
stage-specific O I-protein 0.7423851490020752
DNA-binding B-protein I-protein 0.6086789965629578
protein E-protein E-protein 0.9827691912651062
that O O 0.9995012283325195
participates O O 0.999873161315918
in O O 0.9999582767486572
the O O 0.9999927282333374
regulation O O 0.9991092085838318
of O O 0.9999909400939941
the O O 0.9999699592590332
pre-B B-DNA B-DNA 0.39866334199905396
and I-DNA I-DNA 0.6161083579063416
B I-DNA I-DNA 0.4615964889526367
lymphocyte-specific I-DNA I-DNA 0.8047896027565002
mb-1 I-DNA I-DNA 0.9321557879447937
gene E-DNA E-DNA 0.9956205487251282
. O O 0.9999470710754395
Partial O O 0.98055100440979
amino O B-protein 0.6834351420402527
acid O I-protein 0.45794352889060974
sequences O E-protein 0.7248502373695374
obtained O O 0.9996811151504517
from O O 0.9999974966049194
purified O O 0.6622593998908997
EBF S-protein B-DNA 0.4882037043571472

genomes E-DNA E-DNA 0.9418478012084961
and O O 0.99908447265625
reinfection O O 0.8618652820587158
kinetics O O 0.884976863861084
showed O O 0.9999947547912598
no O O 0.9999974966049194
evidence O O 0.9999940395355225
of O O 0.999997615814209
wild-type O O 0.7038446664810181
reversion O O 0.977112352848053
even O O 0.9998875856399536
after O O 0.9999951124191284
prolonged O O 0.9881086945533752
infection O O 0.9998887777328491
with O O 0.9999992847442627
the O O 0.9999711513519287
Tat S-protein S-protein 0.5666940808296204
-virus O O 0.5201718807220459
. O O 0.9994983673095703
The O O 0.9999992847442627
implications O O 0.9999760389328003

E.Ramazzotti O O 0.9584716558456421
, O O 0.999779999256134
M.C.Re O O 0.9832866191864014
, O O 0.9999023675918579
G.Visani O O 0.9983932375907898
, O O 0.9999849796295166
and O O 0.9999810457229614
M.LaPlaca O O 0.9983000159263611
, O O 0.9999880790710449
Blood O O 0.9967069029808044
87 O O 0.9993621706962585
: O O 0.9999748468399048
4737-4745 O O 0.9997820258140564
, O O 0.9999743700027466
1996 O O 0.9991794228553772
) O O 0.999967098236084
. O O 0.9999990463256836
Our O O 0.9999985694885254
objective O O 0.9995809197425842
was O O 0.9999967813491821
to O O 0.9999964237213135
identify O O 0.9999983310699463
the O O 0.9999977350234985
mechanisms O O 0.9976933598518372
underlying O O 0.999845027923584

growth O O 0.9390619993209839

BR3 S-DNA S-protein 0.44713178277015686

of O O 0.993394672870636
Itk S-protein S-protein 0.9854340553283691
, O O 0.9964300990104675
which O O 0.9997782111167908
was O O 0.9993947744369507
maximal O O 0.9965548515319824
as O O 0.9999814033508301
early O O 0.9935050010681152
as O O 0.9999799728393555
1 O O 0.9997230172157288
min O O 0.9981291890144348
after O O 0.9999769926071167
stimulation O O 0.999417781829834
. O O 0.9999986886978149
The O O 0.9999978542327881
tyrosine O B-protein 0.7693195939064026
kinase O E-protein 0.8309468626976013
activity O O 0.9849737882614136
in O O 0.9999920129776001
the O O 0.9999850988388062
anti- O O 0.6583983898162842
Itk S-protein S-protein 0.7283906936645508
immunoprecipitate O O 0.9459000825881958
was O O 0.9999088048934937
significantly O O 0.9998835325241089
activated O O 0.9996774196624756
upon O O 0.9999959468841553
these O O 0.9999898672103882
stimulations O O 0.9936787486076355
. O O 0.9999819993972778
Interleukin-2 O S-protein 0.8710634708404541
( O O 0.9500541687011719
IL-2 S-protein S-protein 0.9412932991981506
) O O 0.874818742275238
promoter O O 0.7956171035766602
activity O O 0.9924278855323792
stimulated O O 0.9996978044509888
by O O 0.9999895095825195
cross-linking O O 0.9732744693756104
of O O 0.9995959401130676
CD2 S-protein S-protein 0.7882043123245239
, O O 0.9812340140342712

participation O O 0.992845356464386
of O O 0.9999761581420898
at O O 0.9997742772102356
least O O 0.999825656414032
two O O 0.9996052384376526
separate O O 0.9787799119949341
cis-acting B-DNA B-DNA 0.6494303345680237
regulatory I-DNA I-DNA 0.8189275860786438
elements E-DNA E-DNA 0.9960325360298157
. O O 0.9999576807022095
Rescue O O 0.9943976402282715
by O O 0.9999822378158569
cytokines S-protein S-protein 0.9257890582084656
of O O 0.9978469610214233
apoptotic O O 0.5853452682495117
cell O O 0.3616243898868561
death O O 0.5387629270553589
induced O O 0.9842650890350342
by O O 0.999757707118988

newly O O 0.890460193157196
synthesized O O 0.9491095542907715
nuclear B-protein O 0.768083930015564
component E-protein O 0.7899104952812195
of O O 0.9663935303688049
NF-AT S-protein S-protein 0.9546266794204712
is O O 0.9999470710754395
the O O 0.999991774559021
transcription B-protein B-protein 0.6718764305114746
factor E-protein E-protein 0.9718701839447021
AP-1 S-protein S-protein 0.7155711054801941
. O O 0.9999294281005859
We O O 0.999981164932251
show O O 0.9999985694885254
that O O 0.9999992847442627
the O O 0.9999796152114868
inducible O O 0.8210688829421997
nuclear O O 0.6229709982872009
form O O 0.5887806415557861
of O O 0.9488470554351807
NF-AT S-protein S-protein 0.8121520280838013
contains O O 0.9997848868370056
Fos S-protein S-protein 0.9708979725837708
and O O 0.9637362360954285
Jun S-protein B-protein 0.8282490968704224
proteins O E-protein 0.8995355367660522

specificity O O 0.9851319193840027
between O O 0.9999498128890991
all O O 0.9987490177154541
candidates O O 0.9881497621536255
of O O 0.9999250173568726
c-jun S-DNA B-DNA 0.641754686832428
AS O I-DNA 0.25735193490982056
oligonucleotides O E-DNA 0.8114821910858154
and O O 0.9918830394744873
the O O 0.999962329864502
whole O O 0.9873983860015869
sequences O O 0.9276493787765503
in O O 0.999992847442627
GenBank O O 0.5718977451324463
database O O 0.7001765370368958
, O O 0.999537467956543
using O O 0.9999793767929077
a O O 0.9999853372573853
computer O O 0.8955998420715332
program O O 0.9844054579734802
. O O 0.9999984502792358
Among O O 0.9999988079071045
the O O 0.9999986886978149
20 O O 0.9581880569458008
selected O O 0.9889193177223206
oligonucleotides O O 0.5888657569885254
, O O 0.99915611743927
two O O 0.9991474151611328
potent O O 0.9979715943336487
15-mer O O 0.9193379878997803
AS O O 0.8875465393066406
oligonucleotides O O 0.8806965351104736
( O O 0.9993522763252258
C-JUN O O 0.7811582684516907
AS O O 0.9037230610847473
oligonucleotides O O 0.9760714769363403

IL-1 S-DNA S-protein 0.9715776443481445
, O O 0.9928503036499023
and O O 0.9992223978042603
IL-6 S-DNA S-protein 0.9968336224555969
. O O 0.9999425411224365
Electrophoretic O O 0.9529109001159668
mobility O O 0.9931328892707825
shift O O 0.9996682405471802
assays O O 0.9998419284820557
showed O O 0.9999991655349731
that O O 0.9999990463256836
both O O 0.9998420476913452
surfactants O O 0.9352688789367676
decreased O O 0.9997205138206482
activation O O 0.9987784028053284
of O O 0.999974250793457
NF-kappa B-protein B-protein 0.952268123626709
B E-protein E-protein 0.9974417686462402
. O O 0.9998757839202881
The O O 0.9999980926513672
presence O O 0.9988692402839661
of O O 0.9999901056289673
both O O 0.9998102784156799
p65 S-protein S-protein 0.7948130369186401
and O O 0.9384315013885498
p50 S-protein S-protein 0.8339471220970154
NF-kappa B-protein B-protein 0.45531466603279114
B I-protein E-protein 0.9449909329414368
components E-protein O 0.5101141333580017
in O O 0.999968409538269
LPS-activated O B-cell_line 0.8036558628082275
THP-1 B-cell_line I-cell_line 0.9030013680458069
cells E-cell_line E-cell_line 0.9971033930778503

of O O 0.9975734353065491
kappa B-DNA B-DNA 0.8371887803077698
B I-DNA I-DNA 0.5002629160881042
response I-DNA I-DNA 0.7134929299354553
elements E-DNA E-DNA 0.9975011944770813
. O O 0.9999586343765259
Two O O 0.9998599290847778
explanations O O 0.9995624423027039
for O O 0.9999755620956421
hyporesponsiveness O O 0.9768452644348145
of O O 0.999840497970581
the O O 0.9999443292617798
human B-DNA B-DNA 0.6328526139259338
iNOS I-DNA I-DNA 0.8035954833030701
promoter E-DNA E-DNA 0.9956367611885071
to O O 0.9996576309204102
LPS O O 0.5478337407112122
+/- O O 0.8938602805137634
IFN-gamma S-protein S-protein 0.6918041110038757
were O O 0.999045193195343
found O O 0.9999698400497437
: O O 0.9999512434005737
( O O 0.9995961785316467
1 O O 0.9978724718093872
) O O 0.9985978007316589
multiple O O 0.9343152046203613
inactivating O O 0.8539906144142151
nucleotide O O 0.5985476970672607
substitutions O O 0.6651002764701843
in O O 0.9999723434448242
the O O 0.9999891519546509
human O O 0.4791877567768097
counterpart O O 0.507617712020874
of O O 0.8629905581474304
the O O 0.9935442209243774
enhancer B-DNA B-DNA 0.49450576305389404
element E-DNA E-DNA 0.9493997097015381
that O O 0.995866060256958
has O O 0.9999305009841919
been O O 0.9999814033508301
shown O O 0.9999817609786987

NRE-II S-DNA S-DNA 0.5091326236724854
, O O 0.9630502462387085
respectively O O 0.9992029070854187
, O O 0.9996849298477173
were O O 0.9999781847000122
identified O O 0.9998939037322998
. O O 0.9999905824661255
Furthermore O O 0.9999922513961792
, O O 0.9999963045120239
a O O 0.9999964237213135
positive B-DNA B-DNA 0.8453140258789062
regulatory I-DNA I-DNA 0.5385354161262512
element E-DNA E-DNA 0.9954050779342651
was O O 0.9999420642852783
found O O 0.9999744892120361
45 B-DNA O 0.7362455725669861
bp I-DNA O 0.6933528780937195
downstream E-DNA O 0.6693699359893799
of O O 0.9990131855010986
the O O 0.9998878240585327
NRE S-DNA S-DNA 0.9913871884346008
. O O 0.999528169631958
The O O 0.9999858140945435
enhancer O O 0.6544107794761658
activity O O 0.9563881754875183
of O O 0.9997522234916687
the O O 0.9998704195022583
PRE S-DNA S-DNA 0.967041015625
was O O 0.9897922277450562
completely O O 0.9948698282241821
suppressed O O 0.9998955726623535
when O O 0.9999984502792358
the O O 0.9999252557754517

promoter I-DNA I-DNA 0.6670306921005249
serum I-DNA I-DNA 0.6961999535560608
response I-DNA I-DNA 0.6272652745246887
element E-DNA E-DNA 0.9748461842536926
, O O 0.9901682138442993
together O O 0.9999408721923828
with O O 0.9999929666519165
differences O O 0.9954836368560791
in O O 0.9999494552612305
the O O 0.9999604225158691
spacing O O 0.9683306813240051
between O O 0.9983508586883545
the O O 0.9998173117637634
SRF B-DNA B-DNA 0.5067281126976013
and I-DNA I-DNA 0.6664490103721619
ETS I-DNA I-DNA 0.8644387722015381
motifs E-DNA E-DNA 0.9887058734893799
, O O 0.9982700347900391
appear O O 0.999908447265625
to O O 0.999987006187439
account O O 0.9999978542327881
for O O 0.9999985694885254
the O O 0.9999992847442627
inability O O 0.9998956918716431
of O O 0.9999973773956299
the O O 0.9999604225158691
SCMV B-DNA B-DNA 0.39871323108673096
SNEs E-DNA E-DNA 0.9354904890060425
to O O 0.9986010193824768
respond O O 0.99994957447052
to O O 0.9999725818634033
serum O O 0.9077401161193848
induction O O 0.9974620342254639
. O O 0.9999892711639404
T-cell S-cell_type O 0.45670217275619507
-directed O O 0.8977924585342407

diamide O O 0.600954532623291
, O O 0.9951338171958923
also O O 0.9998451471328735
blocked O O 0.9983410835266113
TNF S-protein S-protein 0.9994333386421204
-dependent O O 0.9981997013092041
NF-kappa B-protein B-protein 0.6445578932762146
B E-protein E-protein 0.9990782737731934
activation O O 0.995919406414032
and O O 0.9999449253082275
induction O O 0.9807735085487366
of O O 0.9998795986175537
all O O 0.9999821186065674
the O O 0.9999302625656128
three O O 0.9246049523353577
adhesion B-protein B-protein 0.7243866920471191
proteins E-protein E-protein 0.9946990013122559
. O O 0.9999104738235474
Consistent O O 0.999778687953949
with O O 0.9999886751174927
these O O 0.9999823570251465
results O O 0.999599039554596
, O O 0.9999974966049194
the O O 0.9999972581863403
attachment O O 0.9873521327972412
of O O 0.999774158000946
monocytes O S-cell_type 0.9964098334312439
to O O 0.998145341873169
MVEC S-cell_line S-cell_type 0.7330479621887207
was O O 0.9964756369590759
also O O 0.9999380111694336
blocked O O 0.9999768733978271
by O O 0.9999991655349731
the O O 0.9999827146530151
PTPase S-protein S-protein 0.916769802570343
inhibitors O O 0.6867488026618958
. O O 0.9999686479568481

of O O 0.9981147050857544
heavy B-DNA B-DNA 0.8033024668693542
and I-DNA I-DNA 0.9437819719314575
light I-DNA I-DNA 0.8971061110496521
chain I-DNA I-DNA 0.6877260804176331
genes E-DNA E-DNA 0.97806316614151
in O O 0.9998862743377686
B-lymphoid B-cell_type B-cell_type 0.512701690196991
cells E-cell_type E-cell_type 0.7533150911331177
showed O O 0.9999490976333618
that O O 0.9999996423721313
the O O 0.9999879598617554
three O O 0.983194887638092
Ig B-DNA B-DNA 0.8380364775657654
genes E-DNA E-DNA 0.9954655766487122
are O O 0.9999023675918579
differentially O O 0.9971109628677368
and O O 0.9996782541275024
nonrandomly O O 0.9348010420799255
distributed O O 0.9993897676467896
in O O 0.9999799728393555
different O O 0.9977084398269653
nuclear O O 0.7772718667984009
subvolumes O O 0.5735660791397095

, O O 0.9636452198028564
which O O 0.9995821118354797
did O O 0.9999819993972778
not O O 0.9999936819076538
affect O O 0.9999986886978149
the O O 0.9999961853027344
GR S-protein S-protein 0.9655531644821167
count O O 0.9843087792396545
. O O 0.999998927116394
The O O 0.9999995231628418
patients O O 0.995546817779541
' O O 0.9990955591201782
plasma O O 0.7366136312484741
cortisol O O 0.909339427947998
concentrations O O 0.9908490180969238
were O O 0.9999985694885254
normal O O 0.9996041655540466

NFAT B-protein B-protein 0.5398213267326355
complex E-protein E-protein 0.9947974681854248
in O O 0.9999074935913086
both O O 0.9998047947883606
cell O O 0.9369809031486511
types O O 0.8974372744560242
. O O 0.9999977350234985
An O O 0.9999439716339111
NFAT S-protein B-DNA 0.3745814561843872
oligonucleotide O E-DNA 0.6676375865936279
carrying O O 0.5866457223892212
mutations O O 0.6906144618988037
in O O 0.9999574422836304
the O O 0.9998300075531006
5 B-DNA B-DNA 0.662733793258667
' I-DNA I-DNA 0.8025737404823303
purine-rich I-DNA I-DNA 0.9152088761329651
part E-DNA E-DNA 0.6032743453979492
of O O 0.609127402305603
the O O 0.8240574598312378
NFAT B-DNA B-DNA 0.4654673933982849
sequence E-DNA E-DNA 0.9321021437644958
failed O O 0.9992941617965698
to O O 0.999970555305481
form O O 0.9999642372131348
a O O 0.9999899864196777
complex O O 0.8094581961631775
and O O 0.945101261138916

GPX S-protein S-protein 0.33390605449676514

showed O O 0.9981241822242737

Apart O O 0.9877808094024658

essential O O 0.9595316052436829
for O O 0.9995989203453064
the O O 0.9999926090240479
induction O O 0.9968722462654114
and O O 0.9997472167015076
were O O 0.9999819993972778
required O O 0.9998347759246826
to O O 0.9999822378158569
generate O O 0.9999932050704956
a O O 0.9999954700469971
synergistic O O 0.9828905463218689
increase O O 0.9998188614845276
in O O 0.9999707937240601
virus O O 0.8377189636230469
expression O O 0.9955867528915405
. O O 0.9999983310699463
The O O 0.9999991655349731
effects O O 0.9999531507492065
of O O 0.9999964237213135
the O O 0.9999970197677612
two O O 0.9984985589981079
cytokines S-protein S-protein 0.9923050999641418
were O O 0.9999797344207764
distinguishable O O 0.9958765506744385

in O O 0.9981774091720581
another O O 0.999985933303833
. O O 0.9999810457229614
Different O O 0.9990604519844055
elements O O 0.9211235642433167
thus O O 0.9999512434005737
contribute O O 0.9999983310699463
to O O 0.9999812841415405
IL-2 B-DNA B-DNA 0.7359145879745483
promoter E-DNA E-DNA 0.9825658798217773
activity O O 0.9973711967468262
in O O 0.9999878406524658
different O O 0.9956091046333313
cells O O 0.9116336107254028
. O O 0.9999958276748657
Regulation O O 0.9994006156921387
of O O 0.9999926090240479
I B-protein B-protein 0.8128761649131775
kappa I-protein I-protein 0.8301194906234741
B I-protein I-protein 0.7865309119224548
alpha E-protein E-protein 0.9633097052574158
and O O 0.9834165573120117
p105 S-protein S-protein 0.7287197113037109
in O O 0.995882511138916
monocytes S-cell_type S-cell_type 0.9974780678749084
and O O 0.9865628480911255
macrophages S-cell_type S-cell_type 0.9934993982315063
persistently O O 0.995643138885498
infected O O 0.9997937083244324
with O O 0.9999698400497437
human O O 0.8883894085884094
immunodeficiency O O 0.9420492053031921
virus O O 0.9586092233657837
. O O 0.99997878074646
The O O 0.9999997615814209
mechanisms O O 0.9989394545555115
regulating O O 0.9996219873428345
human O O 0.7617801427841187
immunodeficiency O O 0.7969933748245239

wild-type O B-protein 0.4775756001472473
endotoxin O E-protein 0.9536707401275635
, O O 0.9978089928627014
it O O 0.9997344613075256
failed O O 0.9998190999031067
to O O 0.9999796152114868
induce O O 0.9999945163726807
significant O O 0.9987743496894836
production O O 0.9998800754547119
of O O 0.9999920129776001
tumor B-protein B-protein 0.6479166746139526
necrosis I-protein I-protein 0.8874009847640991
factor-alpha E-protein E-protein 0.9790799021720886
and O O 0.9880707263946533
macrophage B-protein O 0.4347475469112396

megakaryocytes S-cell_type O 0.4784962236881256

that O O 0.9985365867614746

in O O 0.996475875377655
cell O O 0.8653205633163452
membrane O O 0.8696635961532593
phospholipids O O 0.6951061487197876
and O O 0.9996623992919922
a O O 0.9999955892562866
consequent O O 0.9853925108909607
modulation O O 0.9935210347175598
of O O 0.9999581575393677
gene O O 0.9009443521499634
expression O O 0.9929606318473816
for O O 0.9999334812164307
molecules O O 0.9286230802536011
involved O O 0.9995680451393127
in O O 0.9999693632125854
monocyte O O 0.6309041976928711
recruitment O O 0.9949701428413391
. O O 0.9999973773956299
Both O O 0.9994140863418579
Stat3 S-protein S-protein 0.9996486902236938
-activation O O 0.9991926550865173
and O O 0.9999533891677856
Stat3 S-protein S-protein 0.9991819262504578
-independent O O 0.9982728958129883
BCL2 S-protein S-protein 0.6495513916015625
downregulation O O 0.998512327671051
are O O 0.9999985694885254
important O O 0.9999881982803345
for O O 0.9999890327453613
interleukin-6 S-protein S-protein 0.9996708631515503
-induced O O 0.9978169202804565
apoptosis O O 0.9987391829490662
of O O 0.9999743700027466
1A9-M B-cell_line B-cell_line 0.6503292918205261
cells E-cell_line E-cell_line 0.970100998878479
. O O 0.9999066591262817
A O O 0.9998685121536255

B-cell-specific I-protein B-protein 0.4461134374141693
transcription I-protein I-protein 0.7113189101219177
factor E-protein E-protein 0.983323872089386
PU.1/Spi-1 S-protein S-protein 0.6602382659912109
. O O 0.9999208450317383
In O O 0.99994957447052
most O O 0.9994518160820007
HIV-1 O O 0.5934375524520874
isolates O O 0.5865236520767212
in O O 0.999937891960144
which O O 0.9990399479866028

the O O 0.9990146160125732
arterial O O 0.8082951307296753
intima O O 0.46674561500549316
beneath O O 0.9957841038703918
stressed O O 0.6309338808059692
EC S-cell_type S-cell_type 0.5941310524940491
. O O 0.9997820258140564
In O O 0.9993911981582642
vivo O O 0.9906398057937622
modulation O O 0.9959534406661987
of O O 0.9999692440032959
glucocorticoid B-RNA B-RNA 0.6127980351448059
receptor I-RNA I-RNA 0.6674728989601135
mRNA E-RNA E-RNA 0.8879849314689636
by O O 0.9997807145118713
inhaled O O 0.7581350803375244
fluticasone O O 0.3795599341392517
propionate O O 0.6063120365142822
in O O 0.9990979433059692
bronchial O B-cell_type 0.5021666288375854
mucosa O I-cell_type 0.45044299960136414
and O I-cell_type 0.7922379970550537
blood B-cell_type I-cell_type 0.4932982623577118
lymphocytes E-cell_type E-cell_type 0.9803783297538757
in O O 0.9997609257698059
subjects O O 0.9976111650466919
with O O 0.9999890327453613
mild O O 0.9893503785133362
asthma O O 0.998773992061615
. O O 0.9999986886978149

activator O I-protein 0.48711156845092773
protein-1 S-protein E-protein 0.9413883686065674
-dependent O O 0.9823957085609436
transcription O O 0.986229419708252
. O O 0.9999923706054688
In O O 0.9999783039093018
this O O 0.9999901056289673
report O O 0.9605517387390137
expression O O 0.9355133771896362
profiles O O 0.9671973586082458
and O O 0.9997557997703552
activation O O 0.994652271270752
of O O 0.9999189376831055
PKC S-protein S-protein 0.8540779948234558
were O O 0.9998481273651123
analyzed O O 0.9998164772987366
in O O 0.9999428987503052
human B-cell_line B-cell_line 0.5714871883392334
Raji I-cell_line I-cell_line 0.6804501414299011
B I-cell_line I-cell_line 0.9524469375610352
lymphoblastoid I-cell_line I-cell_line 0.9630226492881775
cells E-cell_line E-cell_line 0.9850871562957764
. O O 0.9999396800994873
Transient O O 0.9584748148918152
transfection O O 0.9702020883560181
analysis O O 0.9997201561927795

the O O 0.9993366599082947
production O O 0.9996861219406128
of O O 0.9999942779541016
several O O 0.9981316924095154
cytokines S-protein S-protein 0.9953421354293823
in O O 0.9998651742935181
T B-cell_type B-cell_type 0.7643798589706421
lymphocytes E-cell_type E-cell_type 0.9926044940948486
. O O 0.9999198913574219
We O O 0.9999841451644897
observed O O 0.9999754428863525
that O O 0.9999985694885254
FK506 O O 0.9289586544036865
suppressed O O 0.9996042847633362
the O O 0.9999954700469971
transcription O O 0.9761199355125427
of O O 0.9997164607048035
a O O 0.9999003410339355
chemotactic B-protein B-protein 0.6274011731147766
cytokine E-protein E-protein 0.9828376770019531
, O O 0.9924389123916626
interleukin-8 S-protein S-protein 0.9555785059928894
( O O 0.9636020660400391

produced O O 0.9886640906333923
by O O 0.9999626874923706
resident B-cell_type B-cell_type 0.7257545590400696
and I-cell_type I-cell_type 0.896780252456665
inflammatory I-cell_type I-cell_type 0.4608866572380066
cells E-cell_type E-cell_type 0.9717821478843689
during O O 0.9997976422309875
connective O O 0.9882166981697083
tissue O O 0.9849531054496765
turnover O O 0.9972163438796997
, O O 0.999984622001648
cleaves O O 0.9502320885658264
type B-protein O 0.9427472949028015
I I-protein B-protein 0.7570793032646179
collagen I-protein I-protein 0.561665415763855
fibrils E-protein E-protein 0.7757852077484131
. O O 0.9998213648796082
This O O 0.9999923706054688
catalytic O O 0.9253159165382385
event O O 0.9971898198127747
is O O 0.999991774559021
rate O O 0.9993245601654053
limiting O O 0.9992306232452393
in O O 0.9998862743377686
remodeling O O 0.9272536635398865
of O O 0.999268114566803
tissues O O 0.9632987976074219
rich O O 0.9992820620536804
in O O 0.9996907711029053
fibrillar B-protein O 0.8059709072113037
collagen E-protein O 0.6271252632141113
such O O 0.994494616985321
as O O 0.9999257326126099
the O O 0.9999133348464966
skin O O 0.9308035373687744
and O O 0.9953118562698364
lungs O O 0.9862935543060303

human O B-cell_type 0.44872841238975525
endothelial B-cell_type I-cell_type 0.8503014445304871
cells E-cell_type E-cell_type 0.9718939065933228
demonstrated O O 0.9999010562896729
that O O 0.9999994039535522
overexpression O O 0.9988707900047302
of O O 0.9999842643737793
CBP S-protein S-protein 0.9558437466621399
rescued O O 0.9992002844810486
cAMP O O 0.7095257043838501
inhibition O O 0.9755237698554993
of O O 0.9998513460159302
NF-kappaB S-protein S-protein 0.9983760118484497
-mediated O O 0.9959000945091248
transcription O O 0.9108428955078125
and O O 0.9925020933151245
transcription O O 0.8871164917945862
mediated O O 0.9953287839889526
by O O 0.9999949932098389
a O O 0.9998792409896851
chimeric B-protein B-protein 0.7939683198928833
protein E-protein E-protein 0.9849936962127686
, O O 0.997495174407959
GAL4-p65 B-protein S-protein 0.6794155836105347
( I-protein O 0.8188230395317078
286-551 I-protein S-protein 0.839533269405365
) E-protein O 0.8022588491439819
, O O 0.9982750415802002
which O O 0.999990701675415
contained O O 0.9999873638153076
the O O 0.9999618530273438
GAL4 B-protein B-protein 0.5167402625083923
DNA I-protein I-protein 0.6032231450080872
binding I-protein I-protein 0.8180487155914307

. O O 0.9975379705429077
By O O 0.9998645782470703
contrast O O 0.9997804760932922
, O O 0.9999769926071167
the O O 0.9999908208847046
monocyte-macrophage B-protein B-protein 0.5005515813827515
colony I-protein I-protein 0.49165990948677063
stimulating I-protein I-protein 0.7040995359420776
factor I-protein E-protein 0.9791432619094849
( I-protein O 0.9694849252700806
M-CSF I-protein S-protein 0.9050886631011963

and O O 0.9829527139663696
decreased O O 0.9964828491210938
plasma O O 0.7428003549575806
bicarbonates O O 0.5245490074157715
level O O 0.9990549683570862
( O O 0.9999219179153442
HCO3- O O 0.9853657484054565
: O O 0.9996065497398376
16 O O 0.999674916267395
mmol/l O O 0.9977476000785828
; O O 0.9999489784240723
N O O 0.9979268312454224
: O O 0.9997698664665222
27-30 O O 0.9973868727684021
) O O 0.9999178647994995
. O O 0.9999974966049194
However O O 0.9999934434890747
, O O 0.9999960660934448
the O O 0.9999970197677612
plasma O O 0.810951292514801
cortisol O O 0.8976013660430908
was O O 0.9999810457229614
high O O 0.9998931884765625
( O O 0.9991911053657532
66 O O 0.997191846370697
microg/100 O O 0.9971605539321899
ml O O 0.9980282187461853
at O O 0.9999964237213135
10 O O 0.98800128698349
: O O 0.9997547268867493
00 O O 0.999913215637207
h O O 0.9996039271354675
; O O 0.9999550580978394
N O O 0.9872353672981262
: O O 0.9990134239196777
8-15 O O 0.997002899646759
) O O 0.9998526573181152
and O O 0.9999922513961792
the O O 0.9999947547912598
ACTH O O 0.4095451235771179
was O O 0.9998239874839783
normal O O 0.998776376247406
( O O 0.9997618794441223
13 O O 0.998909592628479
pg/ml O O 0.9977160692214966
, O O 0.9998422861099243
N O O 0.9910263419151306

supramaximal O O 0.5931909084320068
dose O O 0.8207870721817017
of O O 0.9993064403533936
cerulein O O 0.5124306678771973
( O O 0.9614855051040649
5 O O 0.9597977995872498
( O O 0.9942781925201416
g/kg/h O O 0.9414013624191284
) O O 0.9845343828201294
for O O 0.9999504089355469
6 O O 0.9991616010665894
h O O 0.9965978264808655
. O O 0.9999936819076538
The O O 0.9999980926513672
effects O O 0.9999080896377563
of O O 0.9999934434890747
GDSP O O 0.8615275621414185
were O O 0.9999234676361084
also O O 0.9999921321868896
measured O O 0.9999164342880249
on O O 0.9999655485153198
superoxide O O 0.8672508597373962
formation O O 0.9932861924171448
by O O 0.9999959468841553
activated B-cell_type B-cell_type 0.5502694249153137
human I-cell_type I-cell_type 0.6935105919837952
neutrophils E-cell_type E-cell_type 0.9931161999702454
. O O 0.9999521970748901
The O O 0.9999988079071045
effects O O 0.9999251365661621
of O O 0.9999911785125732

alpha E-protein E-protein 0.8747615218162537
, O O 0.9588635563850403
were O O 0.999900221824646
markedly O O 0.9983291029930115
decreased O O 0.9999358654022217
in O O 0.9999731779098511
in B-cell_line O 0.919609010219574
vitro I-cell_line O 0.8793792724609375
monocyte-derived I-cell_line B-cell_type 0.44136694073677063
macrophages E-cell_line E-cell_type 0.9008523225784302
( O O 0.9989042282104492
MDMac S-cell_line S-cell_line 0.8219271898269653
) O O 0.9530724287033081
, O O 0.999049723148346
and O O 0.9999321699142456
with O O 0.9999840259552002
increasing O O 0.9967646598815918
time O O 0.9959821701049805
of O O 0.999947190284729
monocytes S-cell_type S-cell_type 0.9875056743621826
in O O 0.9991600513458252
culture O O 0.9007816314697266
correlated O O 0.9985018968582153
with O O 0.9999966621398926

to O O 0.9956401586532593
IgE S-protein S-protein 0.9789687395095825
. O O 0.9998151659965515
Pathogenesis O O 0.9987331032752991
. O O 0.9999945163726807
There O O 0.9999979734420776
are O O 0.9999986886978149
many O O 0.9999741315841675
hypotheses O O 0.9801964163780212
concerning O O 0.9999116659164429
the O O 0.9999943971633911
pathogenesis O O 0.9816675186157227
of O O 0.9997038245201111
endometriosis O O 0.997510552406311

) I-DNA I-DNA 0.5136771202087402
binding I-DNA I-DNA 0.6988772749900818
site E-DNA E-DNA 0.9897171258926392
( O O 0.9985535740852356
located O O 0.9978970289230347
between O O 0.9780845642089844
the O O 0.9984073042869568
LEF-1 B-DNA S-protein 0.5810375213623047
and I-DNA O 0.8542786240577698
distal I-DNA B-DNA 0.5083101987838745
NF-kappaB I-DNA I-DNA 0.3709839880466461
transcription I-DNA I-DNA 0.5160185694694519
factor I-DNA I-DNA 0.7194010019302368
binding I-DNA I-DNA 0.6045652031898499
sites E-DNA E-DNA 0.9538202881813049
) O O 0.9964277148246765
that O O 0.9999918937683105
we O O 0.9999186992645264
identified O O 0.999972939491272
in O O 0.9999966621398926
previous O O 0.9994032382965088
studies O O 0.9968814849853516
of O O 0.9999760389328003
the O O 0.9999611377716064
HIV-1 B-DNA B-DNA 0.7901692390441895
LTR E-DNA E-DNA 0.9991303086280823
. O O 0.9999489784240723
These O O 0.9999979734420776
findings O O 0.9999490976333618
suggest O O 0.9999990463256836
that O O 0.9999924898147583
LTR B-DNA S-DNA 0.9546338319778442
sequence E-DNA O 0.7890686988830566
changes O O 0.9985741376876831
can O O 0.9999932050704956
significantly O O 0.999957799911499

( O O 0.8954167366027832
iNOS S-protein S-protein 0.8706362247467041
) O O 0.9050794839859009
activity O O 0.9964920878410339
with O O 0.9999947547912598
N O B-protein 0.47471895813941956
omega-monomethyl-L-arginine O E-protein 0.6993972063064575
in O O 0.990199863910675
endothelial-RAW264.7 B-cell_line B-cell_line 0.5753147602081299
cocultures E-cell_line E-cell_line 0.9297676086425781
, O O 0.9953514337539673
stimulated O O 0.9419751167297363
with O O 0.9997022747993469

a O O 0.9984939098358154
high O O 0.9863333106040955
level O O 0.9995800852775574
of O O 0.9999847412109375
HIV O O 0.9119623303413391
replication O O 0.9906283020973206
in O O 0.9998632669448853
thymocytes S-cell_type S-cell_type 0.9975651502609253
, O O 0.9899510741233826
is O O 0.999955415725708
regulated O O 0.9997572302818298
in O O 0.9999920129776001
a O O 0.9999912977218628
specific O O 0.9915651082992554
manner O O 0.9994491934776306
in O O 0.9999979734420776
the O O 0.9999814033508301
thymic O O 0.6736856698989868
microenvironment O O 0.7375314235687256
which O O 0.9994857311248779
provides O O 0.999994158744812
the O O 0.9999954700469971
necessary O O 0.998036801815033
cytokines O S-protein 0.9883925318717957
: O O 0.9923284649848938
TNF S-protein S-protein 0.9960468411445618
, O O 0.988243043422699
IL-1 S-protein S-protein 0.9972597360610962
, O O 0.9916338920593262
and O O 0.9991229176521301
IL-7 S-protein S-protein 0.9980008006095886
. O O 0.9999604225158691
Imbalanced O O 0.9718937277793884
expression O O 0.9965292811393738
of O O 0.9999867677688599
the O O 0.9999433755874634
glucocorticoid B-protein B-protein 0.9193456768989563
receptor I-protein I-protein 0.8131608366966248
isoforms E-protein E-protein 0.9561497569084167
in O O 0.9997803568840027
cultured B-cell_type B-cell_type 0.5632957816123962
lymphocytes E-cell_type E-cell_type 0.5753165483474731
from O O 0.9993343949317932

with O O 0.9993712306022644
high O O 0.9393748641014099
cell O O 0.9574699997901917
turnover O O 0.998924195766449
such O O 0.9999911785125732
as O O 0.9999923706054688
the O O 0.9999710321426392
lymphoid O O 0.6393958926200867
system O O 0.547480583190918
. O O 0.9999769926071167
We O O 0.9999798536300659
have O O 0.9999957084655762

and O O 0.9838046431541443
suggest O O 0.9999781847000122
that O O 0.9999994039535522
different O O 0.9982155561447144
species O O 0.9886325001716614
of O O 0.9998564720153809
heterodimers S-protein O 0.4992435574531555
involving O O 0.9967495203018188
RXR-alpha S-protein S-protein 0.9863036274909973
may O O 0.9998332262039185
control O O 0.9999781847000122
the O O 0.9999802112579346
acquisition O O 0.9997331500053406
of O O 0.9999966621398926
different O O 0.9967663288116455
features O O 0.9896374940872192
of O O 0.9998531341552734
mature O O 0.879535973072052
monocyte/macrophage O O 0.5840137600898743
function O O 0.9957668781280518
. O O 0.999996542930603
Transcriptional O O 0.9331014156341553
activation O O 0.9956129789352417
of O O 0.9999749660491943
the O O 0.9999734163284302
vascular B-DNA B-DNA 0.5044754147529602
cell I-DNA I-DNA 0.6188180446624756
adhesion I-DNA I-DNA 0.4846199154853821
molecule-1 I-DNA I-DNA 0.5062845945358276
gene E-DNA E-DNA 0.9903684854507446
in O O 0.9997256398200989
T B-cell_type B-cell_type 0.8437260389328003
lymphocytes E-cell_type E-cell_type 0.9914119243621826
expressing O O 0.9957681894302368
human B-protein B-protein 0.6919594407081604
T-cell I-protein I-protein 0.46182042360305786
leukemia I-protein I-protein 0.5339169502258301
virus I-protein I-protein 0.7959926128387451
type I-protein I-protein 0.9307116866111755
1 I-protein I-protein 0.9644848704338074
Tax I-protein I-protein 0.6756021976470947
protein E-protein E-protein 0.9962632060050964
. O O 0.9999172687530518
Recruitment O O 0.9966346621513367
and O O 0.9997143149375916
extravasation O O 0.9874525666236877
of O O 0.9995071887969971
T B-cell_type B-cell_type 0.9131297469139099
cells E-cell_type E-cell_type 0.9960491061210632
through O O 0.9999324083328247
the O O 0.9999905824661255

surface O O 0.8551024198532104
recognition O O 0.9631485939025879
events O O 0.9980522394180298
. O O 0.9999979734420776
Since O O 0.9999783039093018
CLs S-cell_type O 0.5823329091072083
can O O 0.9982182383537292
induce O O 0.9999663829803467
either O O 0.9998499155044556
apoptotic O O 0.663690447807312
or O O 0.9462039470672607
necrotic O O 0.7692206501960754
cell O O 0.6810417771339417
death O O 0.9781874418258667
, O O 0.9999847412109375
we O O 0.9999921321868896
asked O O 0.999997615814209
whether O O 0.9999990463256836
E1A S-protein S-protein 0.8120980262756348
sensitization O O 0.9934273958206177
to O O 0.9999608993530273
injury-induced O O 0.9623478055000305
apoptosis O O 0.9977795481681824
is O O 0.9999935626983643
sufficient O O 0.9999769926071167
to O O 0.9999942779541016
explain O O 0.9999587535858154
E1A S-protein S-protein 0.9949657320976257
-induced O O 0.9972788691520691
cytolytic O O 0.8824746608734131

recognition O O 0.9954437017440796
of O O 0.9999769926071167
a O O 0.999988317489624
nuclear B-protein B-protein 0.7045428156852722
localization I-protein I-protein 0.6358770132064819
sequence E-protein E-protein 0.680468738079071
( O O 0.9946900606155396
NLS S-protein S-protein 0.5062260031700134
) O O 0.9803344011306763
within O O 0.9999569654464722
the O O 0.9999889135360718
karyophilic B-protein B-protein 0.6688679456710815
protein E-protein E-protein 0.9900586009025574
by O O 0.9998910427093506
a O O 0.9999313354492188
cytoplasmic B-protein B-protein 0.8183220624923706
receptor E-protein E-protein 0.9227586388587952
such O O 0.9726530313491821
as O O 0.999599039554596
the O O 0.9991293549537659
importin B-protein B-protein 0.7503854632377625
( I-protein I-protein 0.6200904250144958
karyopherin I-protein I-protein 0.901914656162262
) I-protein I-protein 0.9256948828697205
-alpha I-protein I-protein 0.6131349802017212
subunit E-protein E-protein 0.9910978674888611

. O O 0.9954484105110168

mitogenic O O 0.5075038075447083
for O O 0.9730282425880432
mature O O 0.6505414843559265
, O O 0.5132710933685303
but O O 0.5840007066726685
not O O 0.6470432877540588
immature O O 0.6591506600379944
, O O 0.563193678855896
T B-cell_type B-cell_type 0.5060229301452637
cells E-cell_type E-cell_type 0.9945505261421204
. O O 0.9996163845062256
However O O 0.9999761581420898
, O O 0.9999744892120361
during O O 0.9999450445175171
infection O O 0.998931348323822
by O O 0.9999984502792358
EBV O O 0.9949721097946167
, O O 0.9999779462814331
ligation O O 0.9895350337028503
of O O 0.9998056292533875
CD2 S-protein S-protein 0.9247233867645264
caused O O 0.9946948885917664
thymocytes S-cell_type S-cell_type 0.9815171360969543
to O O 0.9973516464233398
proliferate O O 0.9998854398727417
in O O 0.9999758005142212
the O O 0.9999964237213135
absence O O 0.9998844861984253
of O O 0.9999910593032837
exogenous B-protein B-protein 0.7514206767082214
cytokines E-protein E-protein 0.9428482055664062
. O O 0.9999555349349976
This O O 0.9999899864196777
function O O 0.9995830655097961
was O O 0.9999946355819702
a O O 0.9999971389770508
result O O 0.9999908208847046
of O O 0.9999990463256836
the O O 0.9999985694885254

promoter E-DNA I-DNA 0.6542902588844299
fragment O E-DNA 0.9831866025924683
led O O 0.9995042085647583
to O O 0.9999741315841675
complete O O 0.996033251285553
extinction O O 0.9994655251502991
of O O 0.999972939491272
transcription O O 0.5681113004684448
activity O O 0.9257840514183044
, O O 0.9995388984680176
consistent O O 0.9990566372871399
with O O 0.9999867677688599
a O O 0.9990928173065186

to O O 0.9959348440170288
efficiently O O 0.9988659620285034
induce O O 0.999988317489624
the O O 0.9999868869781494
binding O O 0.9928981065750122
of O O 0.9997063279151917
Rel O S-protein 0.9855735898017883
, O O 0.9977138042449951
whereas O O 0.9999866485595703
PMA O O 0.7842470407485962
is O O 0.9993628859519958
not O O 0.9997400641441345
. O O 0.999982476234436
This O O 0.9998376369476318
established O O 0.9955587387084961
a O O 0.9997125267982483

minor O O 0.8510982990264893
importance O O 0.9997156262397766
after O O 0.9999982118606567
influenza O O 0.8556225299835205
infection O O 0.9961995482444763
since O O 0.999997615814209
in O O 0.9999421834945679
apoptosisprone B-cell_type B-cell_type 0.399916410446167
cells E-cell_type E-cell_type 0.6586419343948364
an O O 0.9999520778656006
immediate O O 0.9953813552856445
availability O O 0.9993662238121033
of O O 0.9999732971191406
transcription B-protein B-protein 0.5776626467704773
factor I-protein E-protein 0.9481867551803589

disease-free O O 0.9031401872634888
or O O 0.9955184459686279
overall O O 0.9941502213478088
survival O O 0.9996131062507629
was O O 0.9999958276748657
observed O O 0.9999346733093262
. O O 0.9999926090240479
BASH S-protein S-protein 0.8072863817214966
, O O 0.9970595240592957
a O O 0.9999916553497314
novel B-protein O 0.9128288626670837
signaling I-protein B-protein 0.5200230479240417
molecule E-protein E-protein 0.9727689623832703
preferentially O O 0.9863714575767517
expressed O O 0.9996916055679321
in O O 0.9997912049293518
B B-cell_type B-cell_type 0.8722281455993652
cells E-cell_type E-cell_type 0.9904733300209045

. O O 0.9992239475250244
A O O 0.9996445178985596
negative O B-DNA 0.7440361380577087
regulatory O I-DNA 0.6031858325004578
region O E-DNA 0.9550622701644897
containing O O 0.9994001388549805
a O O 0.9999027252197266
glucocorticosteroid B-DNA B-DNA 0.6108813285827637
response I-DNA I-DNA 0.8850851058959961
element E-DNA E-DNA 0.9946146607398987
( O O 0.9927345514297485
nGRE S-DNA S-DNA 0.9991936087608337
) O O 0.9895493984222412
in O O 0.999995231628418
the O O 0.9999480247497559
human B-DNA B-DNA 0.6916853785514832
interleukin-1beta I-DNA I-DNA 0.933266282081604
gene E-DNA E-DNA 0.9441262483596802

development O O 0.9935431480407715
of O O 0.9999831914901733
rat O O 0.4544972777366638
cerulein O O 0.6260644197463989
pancreatitis O O 0.9858086109161377
. O O 0.9999932050704956
A O O 0.9999241828918457
novel O O 0.9328365325927734
lipopolysaccharide-induced B-protein B-protein 0.5714809894561768
transcription I-protein I-protein 0.5439844727516174
factor E-protein E-protein 0.9866443276405334
regulating O O 0.9897682070732117
tumor B-protein B-DNA 0.48264679312705994
necrosis I-protein I-DNA 0.6678751707077026
factor I-protein I-DNA 0.6417062878608704
alpha E-protein I-DNA 0.8555693626403809
gene O E-DNA 0.8956676125526428
expression O O 0.9539045691490173
: O O 0.9997339844703674
molecular O O 0.867929220199585
cloning O O 0.9088864922523499
, O O 0.9980092644691467
sequencing O O 0.7878785729408264
, O O 0.9602976441383362
characterization O O 0.9617306590080261
, O O 0.9975638389587402
and O O 0.9993709921836853
chromosomal O O 0.9226244688034058
assignment O O 0.9933544397354126
. O O 0.9999933242797852
Lipopolysaccharide O O 0.9634055495262146
( O O 0.9984960556030273
LPS O O 0.9885885715484619
) O O 0.9994391798973083
is O O 0.999996542930603
a O O 0.9999960660934448
potent O O 0.9930598735809326
stimulator O O 0.9870229959487915
of O O 0.9999241828918457
monocytes S-cell_type S-cell_type 0.9960506558418274
and O O 0.9859943389892578

strain O O 0.9191662669181824
. O O 0.9999785423278809
Both O O 0.9999990463256836
the O O 0.9999896287918091
mutant O O 0.7632172107696533
and O O 0.9682435989379883
wild-type O O 0.8874804377555847
strains O O 0.9362227320671082
were O O 0.9999918937683105
more O O 0.999889612197876
resistant O O 0.9994402527809143
to O O 0.9999896287918091
stress O O 0.9995191097259521
when O O 0.9999988079071045
in O O 0.9996100068092346
stationary O O 0.9818505644798279
phase O O 0.9950085878372192
than O O 0.9999363422393799
when O O 0.9999322891235352
in O O 0.9998903274536133
the O O 0.9999921321868896
logarithmic O O 0.9441863894462585
phase O O 0.9928602576255798
of O O 0.9997954964637756

have O O 0.9973118305206299
not O O 0.9994103908538818
been O O 0.9999527931213379
elucidated O O 0.9921932816505432
. O O 0.9999804496765137
We O O 0.9999884366989136
have O O 0.9999887943267822
generated O O 0.9994418025016785
transgenic O O 0.8383744359016418
mice O O 0.9563310742378235
in O O 0.9999310970306396
which O O 0.9999991655349731
the O O 0.9999793767929077
PML/RARalpha B-protein B-protein 0.5483897924423218
fusion I-protein I-protein 0.8394054174423218
protein E-protein E-protein 0.9913852214813232
is O O 0.9995524287223816
specifically O O 0.9988344311714172
expressed O O 0.9999072551727295
in O O 0.9999597072601318
the O O 0.9998171925544739
myeloid-promyelocytic B-cell_type B-cell_type 0.6069744229316711
lineage E-cell_type E-cell_type 0.980387806892395
. O O 0.9999254941940308
During O O 0.9999957084655762
their O O 0.9999977350234985
first O O 0.9984114170074463

. O O 0.999303936958313
A O O 0.999977707862854
single O O 0.9748080968856812
BCS S-DNA O 0.30110371112823486
had O O 0.9994750618934631
little O O 0.9998459815979004
effect O O 0.9999939203262329
either O O 0.9999977350234985
on O O 0.9999860525131226
the O O 0.999945878982544
minimal O B-DNA 0.6574798226356506
B29 B-DNA I-DNA 0.27850860357284546
promoter E-DNA E-DNA 0.9874042272567749
or O O 0.997867226600647
on O O 0.9999192953109741
a O O 0.9998787641525269
heterologous O B-DNA 0.7488378286361694
promoter O E-DNA 0.9876989126205444
. O O 0.9990814924240112
Instead O O 0.9998782873153687
, O O 0.9999420642852783

SM S-protein S-protein 0.7068790197372437
was O O 0.9970097541809082
shown O O 0.9999343156814575
to O O 0.999977707862854
transactivate O O 0.9882494211196899

Inhibition O O 0.9933358430862427
of O O 0.9999773502349854
HIV-1 O O 0.8613938093185425
replication O O 0.9943618774414062
by O O 0.9999963045120239
combination O O 0.9947910308837891
of O O 0.9999732971191406
a O O 0.9999872446060181
novel O O 0.9047114849090576
inhibitor O O 0.8411284685134888
of O O 0.9967821836471558
TNF-alpha S-protein S-protein 0.9917594790458679
with O O 0.9997746348381042
AZT O S-protein 0.8731655478477478
. O O 0.9999178647994995
The O O 0.9999963045120239
small O B-protein 0.6961784958839417
molecule O I-protein 0.5280770063400269
S9a O E-protein 0.8961399793624878
was O O 0.998424768447876
derived O O 0.9999678134918213
from O O 0.9999983310699463
an O O 0.999941349029541
established O O 0.9610460996627808
tumor B-protein B-protein 0.42851176857948303
necrosis I-protein I-protein 0.6190602779388428
factor-alpha E-protein E-protein 0.9249866008758545
( O O 0.8953242301940918
TNF-alpha S-protein S-protein 0.7249274849891663
) O O 0.6488032341003418
inhibitor O O 0.6344875693321228
( O O 0.9977776408195496
Canventol O O 0.9227021336555481
) O O 0.9962387084960938
by O O 0.9999905824661255
replacement O O 0.9755651950836182
of O O 0.9997826218605042
the O O 0.9999693632125854
isopropylidine O O 0.6744495034217834
group O O 0.7068567276000977
with O O 0.9999570846557617
a O O 0.9999710321426392
phenyl O O 0.737725019454956
ring O O 0.6663591861724854
. O O 0.9997342228889465
S9a O O 0.644509494304657
at O O 0.9994352459907532
10 O O 0.9886019825935364
to O O 0.9989499449729919
100 O O 0.9990830421447754
nM O O 0.9981514811515808
inhibited O O 0.9994269609451294
HIV O O 0.9053826928138733
production O O 0.9989778995513916
as O O 0.9999992847442627
potently O O 0.9993346333503723
as O O 0.9999837875366211
3'-azido-3'-deoxythymidine O O 0.6705711483955383
( O O 0.9252275824546814
AZT O O 0.7908164858818054
) O O 0.9819445610046387

surface I-protein I-protein 0.42169031500816345
receptor E-protein E-protein 0.9956212639808655
( O O 0.9890356659889221
EpoR S-protein S-protein 0.9954824447631836
) O O 0.9891324639320374
on O O 0.9999455213546753
erythroid B-cell_type B-cell_type 0.6505464911460876
progenitors E-cell_type E-cell_type 0.9912374019622803
. O O 0.9998393058776855
We O O 0.9999747276306152
used O O 0.9999111890792847
deletion O O 0.9273423552513123
analysis O O 0.997052788734436
and O O 0.9999649524688721
transfection O O 0.8601787686347961
assays O O 0.9845625758171082
with O O 0.9999955892562866
reporter B-DNA B-DNA 0.5147165656089783
gene I-DNA I-DNA 0.7605203986167908
constructs E-DNA E-DNA 0.9765307307243347
to O O 0.9999459981918335
examine O O 0.9999908208847046
the O O 0.9999475479125977
transcription B-DNA B-DNA 0.5450343489646912
control I-DNA I-DNA 0.46317246556282043
elements E-DNA E-DNA 0.9875904321670532
in O O 0.9998738765716553
the O O 0.9998700618743896
5 B-DNA B-DNA 0.9050907492637634
' I-DNA I-DNA 0.9252419471740723

five O O 0.9747368693351746
amino-acid O B-protein 0.4636465609073639
motif O E-protein 0.5534127354621887
and O O 0.9646982550621033
are O O 0.9997174143791199
shown O O 0.9999701976776123
to O O 0.999992847442627
be O O 0.999983549118042
phosphorylated O O 0.9537959694862366
upon O O 0.9994427561759949
TCR S-protein S-protein 0.9913197159767151
ligation O O 0.9974125027656555
. O O 0.9999967813491821
Although O O 0.9999054670333862
mutation O O 0.9954376816749573
of O O 0.9999558925628662
either O O 0.9997755885124207
Y113 O O 0.31734520196914673
and O O 0.9347655177116394
Y128 O O 0.6051861643791199
has O O 0.9993405938148499
a O O 0.9999926090240479
minimal O O 0.9948380589485168
effect O O 0.9999769926071167
on O O 0.9999936819076538
SLP-76 S-protein S-protein 0.9149324893951416
function O O 0.9963829517364502
, O O 0.9999606609344482
mutation O O 0.9887757301330566
of O O 0.9998021721839905

Oct-2 S-protein S-protein 0.9623319506645203
. O O 0.9999797344207764
The O O 0.9999985694885254
strategy O O 0.9993547797203064
described O O 0.999994158744812
here O O 0.9997863173484802
provides O O 0.9999974966049194
a O O 0.9999959468841553
new O O 0.9988252520561218
approach O O 0.9999098777770996
for O O 0.9999881982803345
studying O O 0.999530553817749
protein-protein O O 0.8834848999977112
interactions O O 0.9798988103866577
that O O 0.9999817609786987
govern O O 0.9999920129776001
the O O 0.9999938011169434
complex O O 0.9819990396499634
regulation O O 0.9987469911575317
of O O 0.9999802112579346
gene O O 0.9610452055931091
expression O O 0.9986534118652344
. O O 0.9999943971633911
Tap S-protein S-protein 0.980836033821106
: O O 0.9934186935424805
a O O 0.9998915195465088
novel O O 0.8644416928291321
cellular B-protein B-protein 0.5569828748703003
protein E-protein E-protein 0.9637031555175781
that O O 0.9990200996398926
interacts O O 0.9999074935913086
with O O 0.9999552965164185

and O O 0.9630019664764404
spontaneous O O 0.9625425934791565
expression O O 0.9971573352813721
in O O 0.9999895095825195
human O O 0.7539148926734924
SLE O O 0.3248695135116577
of O O 0.9538136720657349
polyomavirus B-protein O 0.7602257132530212
T-antigen E-protein O 0.4009569585323334
. O O 0.9987276196479797
A O O 0.9998842477798462
molecular O O 0.9136999249458313
basis O O 0.998176097869873
for O O 0.999984622001648
induction O O 0.9968944787979126
of O O 0.999974250793457
antibodies S-protein S-protein 0.7353207468986511
to O O 0.9803255200386047
DNA O O 0.7435758113861084
and O O 0.9687519073486328
eukaryotic B-protein B-protein 0.7211286425590515
transcription I-protein I-protein 0.5657719969749451
factors E-protein E-protein 0.9899265766143799
. O O 0.9999167919158936
We O O 0.9999755620956421
have O O 0.9999946355819702
previously O O 0.9999569654464722
demonstrated O O 0.9999885559082031
that O O 0.9999977350234985
experimental O O 0.9748758673667908
expression O O 0.998405396938324
of O O 0.9999864101409912
the O O 0.9999507665634155
polyomavirus B-protein B-protein 0.5246223211288452
transcription I-protein I-protein 0.7833759188652039
factor I-protein E-protein 0.9514855742454529
T-antigen E-protein S-protein 0.6497471332550049
has O O 0.9996218681335449
the O O 0.9999815225601196
potential O O 0.9997883439064026
to O O 0.9999923706054688
induce O O 0.9999691247940063

] O O 0.7667261362075806
i O O 0.6407936811447144
) O O 0.934162974357605
from O O 0.9999567270278931
the O O 0.9999905824661255
intracellular O O 0.6019706726074219
pool O O 0.7332327365875244
and O O 0.9951100945472717
little O O 0.9703244566917419
or O O 0.9961240887641907
no O O 0.9984114170074463
protein O O 0.8036479353904724
tyrosine O O 0.5851427316665649
phosphorylation O O 0.622276782989502
, O O 0.9986067414283752
phosphatidyl O O 0.4636979401111603

two O O 0.9950129389762878
of O O 0.9999520778656006
these O O 0.9999740123748779
appear O O 0.9987025260925293
to O O 0.9999898672103882
be O O 0.9999964237213135
novel O O 0.9255815148353577
transcription B-protein B-DNA 0.40044596791267395
factor E-protein I-DNA 0.840042233467102
binding B-DNA I-DNA 0.44672465324401855
sites E-DNA E-DNA 0.9368600249290466
, O O 0.9984045624732971
whereas O O 0.999996542930603
the O O 0.999945878982544
third O O 0.6792802214622498
was O O 0.8948694467544556
identified O O 0.9969011545181274
as O O 0.9999661445617676
a O O 0.9999860525131226
cyclic B-DNA B-protein 0.4113529920578003

complex E-protein E-protein 0.9786646962165833
. O O 0.999907374382019
We O O 0.9999865293502808
have O O 0.9999943971633911
previously O O 0.9999692440032959
shown O O 0.9999936819076538
that O O 0.9999971389770508
prolonged O O 0.9427592754364014
treatment O O 0.9979128241539001
of O O 0.9999929666519165
the O O 0.9998703002929688
untransformed O B-cell_line 0.46493101119995117
T B-cell_line I-cell_line 0.573630154132843
cell I-cell_line I-cell_line 0.8291269540786743
clone I-cell_line I-cell_line 0.9856833815574646
Ar-5 E-cell_line E-cell_line 0.6676343679428101
with O O 0.999262273311615
phorbol O O 0.8619836568832397
esters O O 0.9196401238441467
results O O 0.9999487400054932

the O O 0.9986211061477661
expression O O 0.9805786609649658
level O O 0.9994000196456909
on O O 0.9999821186065674
basal O O 0.4858560562133789
cell O O 0.4576300084590912
epitheliomas O O 0.3636675477027893
was O O 0.9997056126594543
low O O 0.9999208450317383
. O O 0.9999960660934448
Peculiarly O O 0.9976502060890198
, O O 0.9998960494995117
eccrine O O 0.9145872592926025
poromas O O 0.6652133464813232
and O O 0.999219536781311
undifferentiated O B-cell_line 0.6299923062324524
spindle-shaped O I-cell_line 0.4798576831817627
basal O I-cell_line 0.5099939703941345
cell O I-cell_line 0.699627161026001
epitheliomas O E-cell_line 0.799042284488678
were O O 0.9984170198440552
totally O O 0.9983304142951965
unstained O O 0.9997853636741638
. O O 0.999997615814209
Squamous O O 0.88688725233078
cell O O 0.9350694417953491
carcinomas O O 0.9850316047668457
showed O O 0.9999966621398926
a O O 0.9999970197677612
variety O O 0.9978411197662354
of O O 0.9999631643295288
expression O O 0.9584086537361145
levels O O 0.9995700716972351
, O O 0.9999932050704956
while O O 0.9999977350234985
two O O 0.9990214109420776
undifferentiated O O 0.7086055278778076
spindle-shaped O O 0.41825535893440247
carcinomas O O 0.5793431997299194
and O O 0.9932072758674622
one O O 0.9997404217720032
undifferentiated O B-cell_line 0.5159307718276978
SCC B-cell_line I-cell_line 0.5043820738792419
cell I-cell_line I-cell_line 0.8142292499542236
line E-cell_line E-cell_line 0.9947237968444824
remained O O 0.9990799427032471
unstained O O 0.9987658262252808
. O O 0.9999977350234985
These O O 0.999998927116394
results O O 0.9999898672103882
suggest O O 0.999998927116394
that O O 0.9999980926513672

translocation O O 0.9520429968833923
of O O 0.9997519850730896
the O O 0.999987006187439
IL-4/IL-13-inducible B-protein B-protein 0.48123231530189514
transcription I-protein I-protein 0.8450549840927124
factor E-protein E-protein 0.9880282878875732
, O O 0.9959866404533386
Stat6 S-protein S-protein 0.9972525238990784
, O O 0.9991459846496582
suggesting O O 0.9999891519546509
a O O 0.9999974966049194
potential O O 0.9948315024375916
mechanism O O 0.9991607666015625
by O O 0.9999958276748657
which O O 0.9999974966049194
IFN-gamma S-protein S-protein 0.9947474598884583
and O O 0.9958528280258179
IL-10 S-protein S-protein 0.9950503706932068
may O O 0.9998592138290405
mediate O O 0.9999206066131592
their O O 0.9999961853027344
suppressive O O 0.9856897592544556
effects O O 0.9998373985290527
. O O 0.9999988079071045
These O O 0.9999992847442627
findings O O 0.9999563694000244
demonstrate O O 0.9999983310699463
that O O 0.9999984502792358
certain O O 0.9985577464103699
cytokines O S-protein 0.9933164119720459
, O O 0.9989919066429138

P/CAF S-protein S-protein 0.9489081501960754
. O O 0.9999029636383057
However O O 0.9999879598617554
, O O 0.9999912977218628
its O O 0.9999954700469971
interactions O O 0.9995087385177612
with O O 0.9999980926513672
these O O 0.9999299049377441
histone B-protein B-protein 0.35757413506507874
acetyltransferases E-protein E-protein 0.8135942816734314
are O O 0.9987861514091492
not O O 0.9998260140419006
equivalent O O 0.9973920583724976
, O O 0.9999878406524658
as O O 0.9999990463256836
CBP S-protein S-protein 0.8663650155067444

sites E-DNA E-DNA 0.8675846457481384
for O O 0.999626874923706
NF-kappa B-protein B-protein 0.5208563208580017
B E-protein E-protein 0.8743686676025391
located O O 0.9927484393119812
from O O 0.999126136302948
-571 O B-DNA 0.9594093561172485
bp O I-DNA 0.708405613899231
to O I-DNA 0.498258113861084
-459 O I-DNA 0.4954027831554413
bp O E-DNA 0.9931622743606567
. O O 0.9999017715454102
These O O 0.9999985694885254
findings O O 0.9999481439590454
suggest O O 0.9999995231628418
a O O 0.9999980926513672
molecular O O 0.9497262239456177
mechanism O O 0.9983558058738708
of O O 0.9999830722808838
positive O O 0.9734689593315125
regulation O O 0.9994403719902039
of O O 0.999988317489624

secreted O O 0.9096900820732117
alkaline B-protein B-protein 0.5886000394821167
phosphatase E-protein E-protein 0.9669345617294312
activity O O 0.9968036413192749
in O O 0.9999909400939941
transient O O 0.8932557106018066
assays O O 0.9940316081047058
showed O O 0.9999915361404419
that O O 0.9999983310699463
, O O 0.9998979568481445
unlike O O 0.9999964237213135
human O O 0.7615882158279419
immunodeficiency O O 0.8379889726638794
virus O O 0.8389818668365479
type O O 0.8557435274124146
1 O O 0.8132330775260925

humans O O 0.9147583842277527

diseases O O 0.8652374744415283
like O O 0.9999468326568604
bronchitis O O 0.9919486045837402
or O O 0.9997573494911194
asthma O O 0.9800655245780945
bronchiale O O 0.9846699237823486
are O O 0.9999834299087524
mediated O O 0.9999297857284546
by O O 0.9999988079071045
inflammatory O O 0.8505978584289551
mechanisms O O 0.9485839605331421
in O O 0.9999845027923584
bronchial B-cell_type B-cell_type 0.6391170620918274
epithelial I-cell_type I-cell_type 0.9478257894515991
cells E-cell_type E-cell_type 0.991119921207428
. O O 0.9999191761016846
Alveolar B-cell_type B-cell_type 0.57467120885849
macrophages E-cell_type E-cell_type 0.9379645586013794
are O O 0.9997795224189758
located O O 0.999804675579071
directly O O 0.999658465385437
in O O 0.999971866607666
the O O 0.999975323677063
surrounding O O 0.9976863861083984
of O O 0.9999271631240845
these O O 0.9991894364356995
cells O O 0.9799655675888062
, O O 0.9998571872711182
so O O 0.999995231628418
that O O 0.9999837875366211
we O O 0.9999432563781738
suppose O O 0.9999972581863403

in O O 0.9986814856529236
murine B-cell_type B-cell_type 0.4399893283843994
haemopoietic I-cell_type I-cell_type 0.7704586982727051
cells E-cell_type E-cell_type 0.8737363219261169
was O O 0.9998657703399658
examined O O 0.9999710321426392
by O O 0.9999990463256836
indirect O O 0.9701943397521973
immunofluorescence O O 0.9903224110603333
. O O 0.9999980926513672
Specific O O 0.9963447451591492
bright O O 0.936500608921051
foci O O 0.831620454788208
of O O 0.9974467754364014
GATA-1 S-protein S-protein 0.3916425406932831
fluorescence O O 0.5075291395187378
were O O 0.9995480179786682
observed O O 0.9994899034500122
in O O 0.9998496770858765
erythroleukaemia B-cell_type B-cell_type 0.6313348412513733
cells E-cell_type E-cell_type 0.8043341636657715
and O O 0.9985387325286865
primary B-cell_type B-cell_type 0.7821570634841919
murine I-cell_type I-cell_type 0.9457604885101318
erythroblasts E-cell_type E-cell_type 0.9298959374427795
and O O 0.9633318781852722
megakaryocytes S-cell_type S-cell_type 0.9844671487808228
, O O 0.9907888770103455
in O O 0.9999592304229736
addition O O 0.9998522996902466
to O O 0.9999885559082031
diffuse O O 0.980813205242157
nucleoplasmic O O 0.8961438536643982
localization O O 0.9963662624359131
. O O 0.9999986886978149
These O O 0.9999823570251465
foci O O 0.2862165868282318
, O O 0.862217128276825
which O O 0.995090126991272
were O O 0.9999120235443115
preferentially O O 0.9977647066116333
found O O 0.9999792575836182
adjacent O O 0.9996415376663208
to O O 0.9999181032180786
nucleoli O O 0.2986847162246704
or O O 0.3553217649459839
at O O 0.9738266468048096

The O O 0.9996170997619629
action O O 0.9980708956718445
of O O 0.9999735355377197
adenoviral B-protein B-protein 0.7481873035430908
E1A I-protein I-protein 0.2587636113166809
oncoprotein E-protein E-protein 0.9723296761512756
on O O 0.9996819496154785
host B-DNA B-DNA 0.8103886842727661
immune-response I-DNA I-DNA 0.4251942038536072
genes E-DNA E-DNA 0.9831468462944031
has O O 0.9999278783798218
been O O 0.9999967813491821
attributed O O 0.9999948740005493
to O O 0.9999973773956299
interaction O O 0.9978801012039185
with O O 0.9999878406524658
p300/CBP-type B-protein B-protein 0.5746604204177856
transcriptional I-protein I-protein 0.8098639249801636
coactivators E-protein E-protein 0.9382138848304749
in O O 0.9998968839645386
competition O O 0.9914344549179077
with O O 0.9999661445617676

associated O O 0.9714449644088745
with O O 0.9999315738677979
As2O3-induced O O 0.9704241156578064
apoptosis O O 0.9991779923439026
. O O 0.9999980926513672
As2O3 O O 0.7979007363319397
induced O O 0.9965732097625732
PML O O 0.35658183693885803
( O O 0.9709877371788025
promyelocytic O O 0.8691229820251465
leukemia O O 0.8163729310035706
) O O 0.9693922996520996
protein O O 0.786518394947052
degradation O O 0.993904173374176
but O O 0.999913215637207
did O O 0.9999736547470093
not O O 0.9999396800994873
modulate O O 0.9963240623474121
expression O O 0.9997194409370422
of O O 0.9999902248382568

rescues O O 0.9871680736541748
IFN-gamma-induced O B-DNA 0.844109833240509
class B-DNA I-DNA 0.6004312634468079
II I-DNA I-DNA 0.5336270928382874
gene E-DNA E-DNA 0.964540958404541
expression O O 0.9884516000747681
. O O 0.9999889135360718
However O O 0.9999963045120239
, O O 0.9999974966049194
the O O 0.9999988079071045
molecular O O 0.9693901538848877
mechanism O O 0.9990492463111877
of O O 0.9999951124191284
Rb S-protein O 0.3307856023311615
rescue O O 0.9677057862281799
of O O 0.9999234676361084
the O O 0.9999852180480957
class B-DNA B-DNA 0.6044068336486816
II I-DNA I-DNA 0.8673155903816223
genes E-DNA E-DNA 0.9967734217643738
is O O 0.9999474287033081
unknown O O 0.9999498128890991
. O O 0.9999969005584717
We O O 0.999993085861206
have O O 0.9999978542327881
examined O O 0.9999884366989136
the O O 0.9999982118606567
effect O O 0.9999383687973022
of O O 0.9999929666519165
Rb S-protein S-protein 0.8519795536994934
expression O O 0.9992745518684387
on O O 0.9999969005584717
the O O 0.9999585151672363
activation O O 0.9876026511192322
of O O 0.9999122619628906
the O O 0.9997448325157166
promoter O O 0.3593697249889374

The O O 0.9980267882347107
PML B-DNA B-DNA 0.4030735492706299
gene E-DNA E-DNA 0.9970992803573608
is O O 0.9996009469032288
fused O O 0.9995080232620239
to O O 0.9999947547912598
the O O 0.9999680519104004
retinoic B-DNA B-DNA 0.37064385414123535
acid I-DNA I-DNA 0.4790762662887573
receptor I-DNA I-DNA 0.5324432253837585
alpha I-DNA I-DNA 0.875920295715332
gene E-DNA E-DNA 0.989510178565979
( O O 0.9857351183891296

a O O 0.9983880519866943
relation O O 0.9990205764770508
between O O 0.9997761845588684
the O O 0.9999758005142212
functionality O O 0.9984548091888428
of O O 0.9999773502349854
the O O 0.9999499320983887
GR S-protein S-protein 0.9244914650917053
and O O 0.9950284361839294
the O O 0.9998146891593933
development O O 0.999542236328125
of O O 0.9999908208847046
NRDS O O 0.3942370116710663
. O O 0.9998553991317749
Inefficient O O 0.9912559986114502
termination O O 0.9954574108123779
of O O 0.9999611377716064
antigen O O 0.7317788600921631

the O O 0.9988718628883362
transformed B-protein O 0.8206226229667664
MR I-protein O 0.33792686462402344
state E-protein O 0.6311046481132507
. O O 0.9999485015869141
By O O 0.9999749660491943
using O O 0.9999395608901978
several O O 0.9998551607131958
HBD B-protein O 0.5419941544532776
subfragments E-protein O 0.624092698097229
, O O 0.9999173879623413
the O O 0.9999843835830688
mAb B-protein B-protein 0.586264967918396
18C7 I-protein I-protein 0.46016567945480347
epitope E-protein E-protein 0.8101024627685547

region O O 0.5003281235694885
of O O 0.9985597729682922
Stat5b S-protein S-protein 0.9195279479026794
as O O 0.9999172687530518
the O O 0.9999654293060303
bait O O 0.484785258769989
in O O 0.998989999294281
a O O 0.9999707937240601
yeast O O 0.9086626172065735
two-hybrid O O 0.8649529814720154
screen O O 0.7217078804969788
, O O 0.9998561143875122
we O O 0.9999639987945557
identified O O 0.999983549118042
the O O 0.9999560117721558

We O O 0.9968921542167664
also O O 0.999975323677063
demonstrated O O 0.9999864101409912
that O O 0.9999996423721313
the O O 0.9999947547912598
CMV B-protein B-DNA 0.6426622867584229
immediate I-protein I-DNA 0.8026866912841797
early I-protein I-DNA 0.5643157362937927
1 I-protein I-DNA 0.3994525074958801
gene I-protein E-DNA 0.9054045081138611
product E-protein O 0.5533900260925293
increased O O 0.998548686504364
expression O O 0.9991222023963928
of O O 0.9999954700469971
the O O 0.9999141693115234
IL-6 B-DNA B-DNA 0.6975252032279968
promoter E-DNA E-DNA 0.996896505355835
. O O 0.9999215602874756
This O O 0.9999970197677612
effect O O 0.9999828338623047
of O O 0.9999973773956299
the O O 0.9999780654907227
CMV B-protein B-protein 0.3896613121032715
immediate I-protein I-protein 0.49743834137916565
early I-protein I-protein 0.4636232554912567
1 I-protein I-protein 0.6093412041664124
gene I-protein I-protein 0.8309668898582458
product E-protein E-protein 0.6860463619232178
was O O 0.9996930360794067
dependent O O 0.9999716281890869
upon O O 0.9999960660934448
the O O 0.9999977350234985
presence O O 0.9997747540473938
of O O 0.9999951124191284
specific O O 0.8896337747573853
transcription B-DNA B-DNA 0.48536285758018494
factor I-DNA I-DNA 0.8390865921974182
binding I-DNA I-DNA 0.4644286036491394
sites E-DNA E-DNA 0.9591330289840698
in O O 0.9999349117279053
the O O 0.9999159574508667
IL-6 B-DNA B-DNA 0.8237680792808533
promoter E-DNA E-DNA 0.9933395981788635
. O O 0.9990952014923096

One O O 0.9977285265922546
of O O 0.9999880790710449
the O O 0.9999880790710449
induced O B-RNA 0.7966650128364563
transcripts O E-RNA 0.8224801421165466
( O O 0.9803210496902466
MAD-3 S-RNA S-DNA 0.6321473717689514
) O O 0.9608166813850403
encodes O O 0.9999167919158936
a O O 0.9999595880508423
protein O O 0.8165038824081421
of O O 0.9851736426353455
317 O O 0.8563602566719055
amino O O 0.8569967150688171
acids O O 0.662462055683136
with O O 0.9998646974563599
one O O 0.9998109936714172
domain O O 0.86884605884552
containing O O 0.9930496215820312
five B-protein O 0.9391005635261536
tandem I-protein O 0.46048274636268616
repeats E-protein O 0.5039581060409546
of O O 0.9630796909332275
the O O 0.9983832836151123
cdc10/ankyrin B-protein B-protein 0.5037189722061157
motif E-protein E-protein 0.5359673500061035

. O O 0.9980589747428894
We O O 0.9998619556427002
developed O O 0.9981173276901245
retroviral O O 0.8159798979759216
vectors O O 0.7911884784698486
in O O 0.999697208404541
which O O 0.9999978542327881
the O O 0.9999226331710815
constitutive B-DNA B-DNA 0.5046864748001099
viral I-DNA I-DNA 0.7548269629478455
enhancer E-DNA E-DNA 0.9871079325675964
in O O 0.9995195865631104
the O O 0.9998507499694824

calcium O O 0.8226876854896545
. O O 0.9994878768920898
CAML S-protein S-protein 0.8545177578926086
appears O O 0.9980316758155823
to O O 0.9999884366989136
be O O 0.9999992847442627
a O O 0.999997615814209
new O O 0.998178243637085
participant O O 0.9947840571403503
in O O 0.9999889135360718
the O O 0.9999970197677612
calcium-signal O O 0.7401067018508911
transduction O O 0.9458249807357788
pathway O O 0.9986233711242676
, O O 0.9999958276748657
implicating O O 0.9999294281005859
cyclophilin B-protein B-protein 0.42988336086273193
B E-protein E-protein 0.993261992931366
in O O 0.9999107122421265
calcium O O 0.4394684135913849
signalling O O 0.8018743991851807

, O O 0.9907912015914917
we O O 0.9998492002487183
generated O O 0.9967358708381653
stably O O 0.8175170421600342
transfected O B-cell_line 0.6927887797355652
cell O I-cell_line 0.514246940612793
lines O E-cell_line 0.9925956130027771
which O O 0.9997689127922058
expressed O O 0.999930739402771
either O O 0.9999653100967407
increased O O 0.9992101192474365
or O O 0.9993048906326294
decreased O O 0.9985645413398743
levels O O 0.9994059801101685
of O O 0.9999399185180664
RXR-alpha S-protein S-protein 0.8817468285560608
, O O 0.9909634590148926
respectively O O 0.9998908042907715
. O O 0.9999947547912598
The O O 0.9999957084655762
sense B-cell_line O 0.9732578992843628
cell I-cell_line B-cell_line 0.7781944870948792
lines E-cell_line E-cell_line 0.9723033308982849
( O O 0.9971755743026733
U B-cell_line B-cell_line 0.382669061422348

IL-1beta S-protein B-protein 0.6795657873153687
receptor O I-protein 0.5430082082748413
type O I-protein 0.5218753814697266
1 O E-protein 0.6940529942512512
, O O 0.8212277293205261
which O O 0.9986810088157654
transduces O O 0.9991508722305298
IL-1beta S-protein S-protein 0.968052327632904
signal O O 0.9108405113220215
. O O 0.9999902248382568
Our O O 0.9999994039535522
findings O O 0.9999076128005981
reveal O O 0.9999992847442627
that O O 0.9999954700469971
monocyte-derived B-protein B-protein 0.503196656703949
IL-1beta E-protein E-protein 0.7631446123123169

G B-protein B-protein 0.2891016900539398
( I-protein I-protein 0.7289402484893799
S I-protein I-protein 0.8648678064346313
) I-protein I-protein 0.6584786772727966
alpha E-protein E-protein 0.9973502159118652
expression O O 0.9994291663169861
in O O 0.9999886751174927
certain O O 0.9987139701843262
tissues O O 0.9860580563545227
compared O O 0.9999561309814453
with O O 0.9999949932098389
the O O 0.9999765157699585
offspring O O 0.9736701846122742
of O O 0.9998520612716675
nonalcoholics O O 0.6358398199081421
. O O 0.9998255372047424
The O O 0.999998927116394
aim O O 0.9997238516807556
of O O 0.9999970197677612
this O O 0.9999983310699463
research O O 0.9996053576469421
was O O 0.9999980926513672
to O O 0.9999974966049194
test O O 0.9999887943267822
the O O 0.9999979734420776
hypothesis O O 0.9992563128471375
that O O 0.9999982118606567
a O O 0.9999845027923584
causal O O 0.9632161259651184
relationship O O 0.9981383085250854
exists O O 0.9999979734420776
between O O 0.9995582699775696
the O O 0.9999837875366211
level O O 0.9991550445556641
of O O 0.9999395608901978
expression O O 0.9979357719421387
of O O 0.9999703168869019
G B-protein B-protein 0.5157557725906372
( I-protein I-protein 0.4778500497341156
S I-protein I-protein 0.9518505930900574
) I-protein I-protein 0.7830470204353333
alpha E-protein E-protein 0.9826315641403198
and O O 0.9964976906776428
induction O O 0.989860475063324
of O O 0.9999445676803589
the O O 0.9999840259552002
adenylyl B-protein O 0.6609655022621155
cyclase E-protein O 0.7850190997123718
( O O 0.9223803877830505
AC O S-protein 0.38545048236846924
) O O 0.4947948753833771
cascade O O 0.7815627455711365
. O O 0.9998663663864136
The O O 0.9999994039535522
methodology O O 0.9940482378005981
employed O O 0.99986732006073
transient O O 0.9268186688423157
transfection O O 0.9947939515113831
of O O 0.9999887943267822
HEK B-cell_line B-cell_line 0.7197974920272827
293 I-cell_line I-cell_line 0.8003669381141663
cells E-cell_line E-cell_line 0.9983066320419312
with O O 0.9999167919158936
a O O 0.9999405145645142
cDNA O S-DNA 0.7952297925949097
for O O 0.994081437587738
the O O 0.9998133778572083
52-kDa O B-protein 0.6223965287208557
form O E-protein 0.6898923516273499

cytokines S-protein S-protein 0.9034083485603333
or O O 0.9987635612487793
growth B-protein B-protein 0.7230923175811768
factors E-protein E-protein 0.9973946809768677
. O O 0.9999712705612183
Recent O O 0.9999732971191406
studies O O 0.9999269247055054
suggest O O 0.9999990463256836
that O O 0.999998927116394
one O O 0.9998351335525513
or O O 0.9998762607574463
more O O 0.9990696310997009
cytoplasmic B-protein B-protein 0.6916397213935852
serine I-protein I-protein 0.9185017943382263
kinases E-protein E-protein 0.9937208890914917
also O O 0.9992160797119141
phosphorylate O O 0.7441428899765015
STAT3 S-protein S-protein 0.9352645874023438
and O O 0.9973815083503723

probe O E-DNA 0.8835357427597046
from O O 0.9999526739120483
the O O 0.9999599456787109
DNA B-protein B-DNA 0.7054184675216675
binding I-protein I-DNA 0.6287574768066406
domain E-protein E-DNA 0.5754961967468262
of O O 0.927544355392456
Ets-1 S-protein S-protein 0.9866917729377747
and O O 0.9901755452156067
isolated O O 0.8521436452865601
a O O 0.9949585795402527
novel B-protein O 0.6753057241439819
Ets I-protein B-protein 0.6884346604347229
family I-protein I-protein 0.491359144449234
member E-protein E-protein 0.9871075749397278
, O O 0.993829071521759
Elf-1 S-protein S-protein 0.9952297210693359
. O O 0.9997414946556091
Elf-1 S-protein S-protein 0.9905741810798645
contains O O 0.9999334812164307
a O O 0.9999728202819824
DNA B-protein B-protein 0.5049768686294556
binding I-protein I-protein 0.8499714732170105
domain E-protein E-protein 0.8426994681358337
that O O 0.9963441491127014
is O O 0.9999158382415771
nearly O O 0.9997773766517639
identical O O 0.9997159838676453
to O O 0.9999850988388062
that O O 0.9999847412109375
of O O 0.9999148845672607
E74 S-protein S-protein 0.9777947664260864
, O O 0.9982712268829346
the O O 0.9999641180038452
ecdysone-inducible B-protein B-protein 0.6697733998298645
Drosophila I-protein I-protein 0.718546986579895
transcription I-protein I-protein 0.9484142065048218
factor E-protein E-protein 0.992205798625946
required O O 0.9992157220840454
for O O 0.9999896287918091
metamorphosis O O 0.8746421337127686

plays O O 0.995606005191803
a O O 0.9998296499252319
major O O 0.998482882976532
role O O 0.9999783039093018
in O O 0.9999988079071045
the O O 0.9999971389770508
stimulation O O 0.998892605304718
of O O 0.9999774694442749
bone O O 0.873092770576477
growth O O 0.9821075797080994
, O O 0.999672532081604
mineralization O O 0.9739512205123901
, O O 0.9990456700325012
and O O 0.9998414516448975

Challenges O O 0.9665457606315613
in O O 0.9999339580535889
developing O O 0.9887774586677551
new O O 0.9972087740898132
therapeutic O O 0.9653360247612
strategies O O 0.9959583878517151
include O O 0.9999978542327881
not O O 0.9998623132705688
only O O 0.9999786615371704
identifying O O 0.9978752136230469
novel O O 0.9419292211532593
agents O O 0.9829319715499878
, O O 0.9999334812164307
but O O 0.9999622106552124
also O O 0.9999861717224121
improving O O 0.9999665021896362
the O O 0.99998939037323
definitions O O 0.9992644190788269
of O O 0.9999926090240479
clinical O O 0.9116819500923157
endpoints O O 0.9889523386955261
and O O 0.9999798536300659
defining O O 0.9902578592300415
efficacy O O 0.9990621209144592
at O O 0.9999990463256836
the O O 0.9999985694885254
biologic O O 0.9618284702301025
level O O 0.9994543194770813
. O O 0.9999986886978149
Only O O 0.9999964237213135
through O O 0.9999908208847046
considered O O 0.9995008707046509
evaluation O O 0.999836802482605
of O O 0.9999934434890747
clinical O O 0.9372187256813049
evidence O O 0.9983363747596741
may O O 0.999997615814209

B4 O O 0.5559123754501343
( O O 0.7997687458992004
LTB4 O O 0.3443084955215454
) O O 0.3206949234008789
enhanced O O 0.919827401638031
degradation O O 0.996292769908905
of O O 0.9999839067459106
this O O 0.999958872795105
eicosanoid O O 0.3233356177806854
, O O 0.9161048531532288
offersuggesting O O 0.9918917417526245
a O O 0.9999476671218872
new O O 0.9983348250389099
aspect O O 0.9991644620895386
of O O 0.9999382495880127
down-regulation O O 0.9981818199157715
of O O 0.9999449253082275
inflammation O O 0.9892604351043701
. O O 0.9999825954437256
Here O O 0.9999687671661377
, O O 0.9999921321868896
we O O 0.9999911785125732
studied O O 0.9999852180480957
whether O O 0.9999983310699463
PPARalpha S-protein S-protein 0.9932718873023987
activation O O 0.9987610578536987

. O O 0.9992285966873169
The O O 0.9999713897705078
class B-protein B-protein 0.4241039752960205
II I-protein I-protein 0.3413344919681549
transactivator E-protein E-protein 0.8332579731941223
CIITA S-protein S-protein 0.7487546801567078
is O O 0.9998883008956909
required O O 0.9998332262039185
for O O 0.999981164932251
transcriptional O O 0.939851701259613
activation O O 0.9955663084983826
of O O 0.9999833106994629
the O O 0.9999845027923584
major B-DNA B-DNA 0.5162392258644104
histocompatibility I-DNA I-DNA 0.6697080731391907
complex I-DNA I-DNA 0.5355567932128906
( I-DNA I-DNA 0.9158719778060913
MHC I-DNA I-DNA 0.9801688194274902
) I-DNA I-DNA 0.9855347871780396
class I-DNA I-DNA 0.9934816360473633
II I-DNA I-DNA 0.954054594039917
genes E-DNA E-DNA 0.9985789060592651
. O O 0.9999805688858032
Aside O O 0.9996943473815918
from O O 0.9999991655349731
an O O 0.9999027252197266
N-terminal B-DNA B-protein 0.646834135055542
acidic I-DNA I-protein 0.8045081496238708
transcriptional I-DNA I-protein 0.8714796900749207
activation I-DNA I-protein 0.9353423714637756
domain E-DNA E-protein 0.9913199543952942
, O O 0.999762237071991
little O O 0.999625563621521
is O O 0.9999606609344482
known O O 0.9999979734420776
about O O 0.9999958276748657
how O O 0.999998927116394
this O O 0.9999572038650513
factor O O 0.9191410541534424
functions O O 0.9995180368423462
. O O 0.9999979734420776
Extensive O O 0.9904723167419434
mutagenesis O O 0.9801411032676697
of O O 0.999790608882904
CIITA S-protein S-protein 0.576758623123169
was O O 0.9996689558029175

higher O O 0.9849956631660461
than O O 0.999881386756897
that O O 0.9999916553497314
of O O 0.99998939037323
an O O 0.9998291730880737
LTR S-DNA S-DNA 0.9934984445571899
from O O 0.9998432397842407
a O O 0.9999724626541138
non-acutely O O 0.7217650413513184
pathogenic O O 0.8107789158821106
strain O O 0.665595293045044
. O O 0.999990701675415
These O O 0.999994158744812
LTRs S-DNA S-DNA 0.9689444899559021
differ O O 0.9998351335525513
by O O 0.9999948740005493
five O O 0.9932541251182556
point O O 0.9867364764213562
mutations O O 0.9339371919631958
and O O 0.999994158744812
a O O 0.9999843835830688
22-bp B-DNA O 0.8377707004547119
duplication E-DNA O 0.548754870891571
in O O 0.9948732256889343
SIVsmmPBj14 O S-DNA 0.6760361790657043
, O O 0.9430453181266785
which O O 0.9998806715011597
includes O O 0.9999845027923584
a O O 0.9998044371604919
nuclear B-DNA B-DNA 0.5279110074043274
factor I-DNA I-DNA 0.3729999363422394
kappa I-DNA I-DNA 0.8672165870666504
B I-DNA I-DNA 0.6671510338783264
( I-DNA I-DNA 0.8643596768379211
NF I-DNA I-DNA 0.9620954990386963
kappa I-DNA I-DNA 0.9888086915016174
B I-DNA I-DNA 0.9671363234519958
) I-DNA I-DNA 0.9328840374946594
site E-DNA E-DNA 0.9977042078971863
. O O 0.9999719858169556
Transcriptional O O 0.9512673020362854
differences O O 0.9983533620834351

molecules E-protein E-protein 0.8923895359039307
. O O 0.9998959302902222
T B-cell_type B-cell_type 0.5481650829315186
lymphocytes E-cell_type E-cell_type 0.9938352108001709
from O O 0.9998160004615784
6 O O 0.9888690710067749
of O O 0.9999690055847168
the O O 0.9999964237213135
14 O O 0.994782030582428
patients O O 0.9992626309394836
also O O 0.9999427795410156
exhibited O O 0.9999536275863647
an O O 0.9999980926513672
increased O O 0.9980408549308777
expression O O 0.9995977282524109
of O O 0.9999963045120239
the O O 0.9999332427978516
dual O B-protein 0.4464758038520813
specificity B-protein I-protein 0.7238213419914246
phosphatase E-protein E-protein 0.9964852333068848
, O O 0.9969139099121094
map B-protein B-protein 0.9815871119499207
kinase I-protein I-protein 0.8670666813850403
phosphatase-1 E-protein E-protein 0.9641383290290833
( O O 0.9869036674499512
MKP-1 S-protein S-protein 0.9992400407791138
) O O 0.9887033104896545
. O O 0.9999797344207764
MKP-1 S-protein S-protein 0.9896491765975952
inactivates O O 0.9995170831680298
MAP B-protein B-protein 0.8666996955871582
kinase E-protein E-protein 0.9346750974655151
and O O 0.9776498079299927
therefore O O 0.9998606443405151
may O O 0.9999887943267822
interfere O O 0.9999854564666748
with O O 0.9999946355819702

data O O 0.9794968366622925
suggest O O 0.9999958276748657
that O O 0.9999994039535522
transcriptional O O 0.9324508905410767
activation O O 0.9973612427711487
of O O 0.9999908208847046
human B-DNA B-DNA 0.6016483306884766
embryonic I-DNA I-DNA 0.7186930775642395
zeta I-DNA I-DNA 0.6981820464134216
2 I-DNA I-DNA 0.9240641593933105
globin I-DNA I-DNA 0.9628890156745911
gene E-DNA E-DNA 0.9962664246559143
and O O 0.9989539384841919
the O O 0.9999834299087524
fetal/adult B-DNA B-DNA 0.525105893611908
alpha I-DNA I-DNA 0.6205234527587891
globin I-DNA I-DNA 0.9177329540252686
genes E-DNA E-DNA 0.9984005093574524
is O O 0.999967098236084
mediated O O 0.999953031539917
by O O 0.9999966621398926
erythroid O O 0.5616843700408936

phosphatase I-DNA I-DNA 0.6152861714363098
( I-DNA I-DNA 0.5696442723274231
PLAP I-DNA I-DNA 0.9086597561836243
) I-DNA I-DNA 0.9419627785682678
reporter I-DNA I-DNA 0.8638635873794556
gene E-DNA E-DNA 0.9946186542510986
whose O O 0.9989157915115356
transcription O O 0.8880199790000916
is O O 0.9989983439445496
controlled O O 0.9987369179725647
by O O 0.9999969005584717
a O O 0.9999613761901855
1.4-kb B-DNA B-DNA 0.6220420002937317
human I-DNA I-DNA 0.6990727782249451

like O O 0.9905170798301697
TNF-alpha S-protein S-protein 0.9771797060966492
and O O 0.9964026212692261
EBV O O 0.5139184594154358
. O O 0.9975981116294861
In O O 0.9998887777328491
contrast O O 0.9999817609786987
to O O 0.9999958276748657
induction O O 0.9988825917243958
of O O 0.9999874830245972
STATs S-protein S-protein 0.9418330192565918
by O O 0.9998366832733154
cytokines S-protein S-protein 0.9820287227630615
, O O 0.9998472929000854
the O O 0.9999680519104004
IRF-1 B-DNA B-protein 0.5392515659332275
GAS E-DNA I-protein 0.6818665862083435
-binding O I-protein 0.7943761944770813
complex O E-protein 0.9448568224906921
activated O O 0.9980289340019226
by O O 0.9999853372573853
CD40 S-protein S-protein 0.9396534562110901

expressed O O 0.9911875128746033
during O O 0.9999829530715942
the O O 0.9999958276748657
lectin S-protein S-protein 0.9950864911079407
-induced O O 0.9965869188308716
switch O O 0.9934815168380737
of O O 0.9999364614486694
lymphocytes S-cell_type S-cell_type 0.9961483478546143
from O O 0.9996515512466431
the O O 0.9999769926071167
G0 O O 0.8285461664199829
to O O 0.99888676404953
the O O 0.9999769926071167
G1 O O 0.8649123311042786
phases O O 0.9546593427658081
of O O 0.9998230338096619
the O O 0.9999947547912598
cell O O 0.9524139761924744
cycle O O 0.9911465048789978
. O O 0.9999985694885254
This O O 0.999998927116394
paper O O 0.9978396892547607
presents O O 0.9999933242797852
studies O O 0.9996211528778076
of O O 0.999990701675415
G0S2 S-DNA S-DNA 0.7331200838088989
, O O 0.9934117197990417
a O O 0.9999768733978271
member O O 0.9741816520690918

induction O O 0.9725399017333984
of O O 0.9996837377548218
CD20 B-RNA B-RNA 0.9851617813110352
mRNA E-RNA E-RNA 0.9992138147354126
was O O 0.9990523457527161
temporally O O 0.9945242404937744
associated O O 0.9998160004615784
with O O 0.9999974966049194
induction O O 0.9958251714706421

glucocorticoid B-protein B-protein 0.4233125150203705
receptor E-protein E-protein 0.9867256879806519
( O O 0.9765992760658264
GR S-protein S-protein 0.963468611240387
) O O 0.9574540257453918
expression O O 0.9928470253944397
seen O O 0.9999791383743286
in O O 0.9998959302902222
most O O 0.9950580596923828
cells O O 0.92955082654953
and O O 0.9994334578514099
tissues O O 0.9882348775863647
, O O 0.999977707862854
GR S-protein S-protein 0.9677755832672119
expression O O 0.9988362193107605
is O O 0.9999929666519165
positively O O 0.9965595602989197
autoregulated O O 0.9992995262145996
in O O 0.9999421834945679
human B-cell_type B-cell_type 0.5727904438972473
leukemic I-cell_type I-cell_type 0.6863251328468323
T I-cell_type I-cell_type 0.901826798915863
cells E-cell_type E-cell_type 0.9683591723442078
and O O 0.9975679516792297
in O O 0.9998488426208496
other O O 0.9968982934951782
cells O O 0.9431389570236206
sensitive O O 0.9987179040908813
to O O 0.9999657869338989
glucocorticoid-induced O O 0.7495061159133911
cell O O 0.650911808013916
death O O 0.9774691462516785
. O O 0.9999872446060181
To O O 0.9999920129776001
determine O O 0.9999866485595703

using O O 0.9964213371276855
cDNA O O 0.6138898134231567
microarray O O 0.8287181258201599
technology O O 0.9562357664108276
. O O 0.9999961853027344
Simultaneous O O 0.9997243285179138
analysis O O 0.9998257756233215
of O O 0.9999964237213135
close O O 0.9870031476020813
to O O 0.9984601736068726
600 B-DNA O 0.9684988260269165
genes E-DNA O 0.5056532025337219
indicated O O 0.9999698400497437
highest O O 0.9977644681930542
increase O O 0.9997889399528503
in O O 0.9999945163726807
the O O 0.9999511241912842
expression O O 0.9975274205207825

This O O 0.997418999671936
expression O O 0.999642014503479
may O O 0.9999985694885254
in O O 0.9999985694885254
part O O 0.9999687671661377
reflect O O 0.999997615814209
expression O O 0.9998586177825928
of O O 0.9999966621398926
A-myb S-DNA S-DNA 0.669079601764679
by O O 0.9999005794525146
the O O 0.9999779462814331
normal O B-cell_type 0.704386830329895
germinal O I-cell_type 0.5129120945930481
center O I-cell_type 0.56712406873703
B B-cell_type I-cell_type 0.8318042755126953
cells E-cell_type E-cell_type 0.93551105260849
that O O 0.9991341233253479
are O O 0.9999963045120239
the O O 0.999995231628418
normal O O 0.9710936546325684
counterpart O O 0.987995445728302
of O O 0.9999510049819946
these O O 0.9999336004257202
transformed B-cell_line B-cell_type 0.46500125527381897
B I-cell_line I-cell_type 0.45417967438697815
cells E-cell_line E-cell_type 0.6128775477409363
. O O 0.9998865127563477
The O O 0.9999990463256836
data O O 0.9974291920661926
presented O O 0.9999560117721558
strongly O O 0.9999569654464722
support O O 0.9999909400939941
a O O 0.9999985694885254
role O O 0.9996448755264282
for O O 0.9999942779541016
this O O 0.9999375343322754
transcription B-protein B-protein 0.5595869421958923
factor E-protein E-protein 0.9802061319351196
in O O 0.9992438554763794
B-cell O O 0.701651930809021
differentiation O O 0.9555503129959106
and O O 0.999402642250061
perhaps O O 0.9998421669006348
in O O 0.9999192953109741

induction O O 0.9868580102920532
with O O 0.9999850988388062
phorbol O O 0.9081529378890991
esters O O 0.9717473387718201
resulted O O 0.9999876022338867
in O O 0.9999983310699463
the O O 0.9999990463256836
appearance O O 0.9995642304420471
of O O 0.9999963045120239
new O O 0.9626471400260925
DNA B-protein B-protein 0.45989203453063965
binding I-protein I-protein 0.8903780579566956
proteins E-protein E-protein 0.9831732511520386
of O O 0.9873195886611938
85 B-protein B-protein 0.3853701055049896
, I-protein I-protein 0.6168777346611023
75 I-protein I-protein 0.6165505051612854
, I-protein I-protein 0.7382318377494812
and I-protein I-protein 0.5172722935676575
54 I-protein I-protein 0.5156151056289673
kDa E-protein E-protein 0.909985363483429
, O O 0.9810799360275269
whereas O O 0.999940037727356
in O O 0.9987190961837769
Tax B-cell_line S-protein 0.9501554369926453
expressing I-cell_line O 0.8248082399368286
cells E-cell_line O 0.5574193596839905
the O O 0.9998112320899963
85-kDa B-protein B-protein 0.9153605103492737
protein E-protein E-protein 0.9853604435920715
and O O 0.9943422079086304

the O O 0.9995670914649963
influence O O 0.9988129138946533
of O O 0.9999897480010986
the O O 0.9999922513961792
sequences O O 0.8731738924980164
located O O 0.9997722506523132
between B-DNA O 0.9997788071632385
-3134 I-DNA O 0.6216925978660583
and I-DNA O 0.8120176196098328
-2987 E-DNA O 0.7227426171302795
on O O 0.9965745210647583
the O O 0.9999847412109375
transcriptional O O 0.9512273669242859
activity O O 0.9947726130485535
of O O 0.9999728202819824
the O O 0.9999786615371704
proIL-1beta B-DNA B-DNA 0.4572566747665405
gene E-DNA E-DNA 0.9898937344551086
in O O 0.9998784065246582
LPS-stimulated B-cell_line B-cell_line 0.6952317357063293
Raw I-cell_line I-cell_line 0.7015116214752197
264.7 I-cell_line I-cell_line 0.856627881526947
cells E-cell_line E-cell_line 0.9990863800048828
was O O 0.9997993111610413
examined O O 0.9999076128005981
in O O 0.9999798536300659

in O O 0.9989217519760132
glucocorticoid O O 0.6583412289619446
mediated O O 0.9350394010543823
apoptosis O O 0.9960448145866394
, O O 0.9999856948852539
establishing O O 0.999478280544281
that O O 0.9999951124191284
NF-kappaB S-protein S-protein 0.9948493838310242
also O O 0.9991937279701233
functions O O 0.9999390840530396
as O O 0.9999872446060181
an O O 0.9999557733535767
antiapoptotic O B-protein 0.8067665696144104
factor O E-protein 0.8904904723167419
. O O 0.9975917339324951

) O O 0.7746245265007019
was O O 0.99935382604599
examined O O 0.9999740123748779
in O O 0.9999880790710449
detail O O 0.9996198415756226
against O O 0.9999808073043823
HIV-1 O O 0.403497576713562
laboratory O O 0.4689522385597229
isolates O O 0.5046340227127075
( O O 0.9992996454238892
HTLV-IIIB O O 0.33315590023994446
, O O 0.9761843681335449
JRFL O S-protein 0.30697667598724365
, O O 0.9587981104850769
and O O 0.9959064722061157
MN O S-protein 0.4388361871242523
) O O 0.9868264198303223
, O O 0.9998277425765991
primary O O 0.6440476775169373
isolates O O 0.4022426903247833
( O O 0.9967664480209351
KMT O O 0.5110277533531189
and O O 0.9971386194229126
KMO O O 0.5493453145027161
) O O 0.9955737590789795
, O O 0.9999434947967529
and O O 0.999976396560669

definition O O 0.9862943291664124
of O O 0.9999531507492065
this O O 0.999984622001648
pathway O O 0.9989616870880127
will O O 0.9999973773956299
yield O O 0.9999978542327881
new O O 0.9997864365577698
insights O O 0.9992270469665527
into O O 0.999996542930603
inflammation O O 0.9948925971984863
initiated O O 0.9999704360961914
by O O 0.9999979734420776
TNFalpha S-protein S-protein 0.9743636846542358

effects O O 0.9982962012290955
of O O 0.9999915361404419
LSF S-protein S-protein 0.9544629454612732
previously O O 0.9993859529495239
observed O O 0.999964714050293
in O O 0.9999322891235352
vitro O O 0.9911491870880127
and O O 0.9994004964828491
in O O 0.9997231364250183
vivo O O 0.9965941309928894
. O O 0.9999920129776001
Thus O O 0.9998593330383301
, O O 0.999982476234436
the O O 0.9999974966049194
cooperation O O 0.9999548196792603
of O O 0.9999980926513672
two O O 0.9996985197067261
general O B-protein 0.8599212765693665
cellular O I-protein 0.6911288499832153
transcription O I-protein 0.4963907301425934
factors O E-protein 0.9903733730316162
may O O 0.999829888343811
allow O O 0.9999973773956299
for O O 0.9999942779541016
the O O 0.9999973773956299

, O O 0.9936650991439819
the O O 0.9999669790267944
macrophage O B-protein 0.4482678174972534
transcription B-protein I-protein 0.7126375436782837
factor E-protein E-protein 0.9818582534790039
PU.1 O S-protein 0.6217062473297119
binds O O 0.9997519850730896
the O O 0.999956488609314
CD11b B-DNA B-DNA 0.798749566078186
promoter E-DNA E-DNA 0.9960160851478577
in O O 0.99974125623703
vitro O O 0.9801927208900452
and O O 0.999099850654602
in O O 0.9997377991676331
vivo O O 0.9926846027374268
close O O 0.9958903193473816
to O O 0.9999592304229736
the O O 0.9999525547027588
Sp1 B-DNA B-DNA 0.6722784042358398
site E-DNA E-DNA 0.9876595139503479
. O O 0.9994831085205078

' I-DNA I-DNA 0.5919435024261475
flanking I-DNA I-DNA 0.6810164451599121
region E-DNA E-DNA 0.9878330230712891
augments O O 0.9990099668502808
alpha-globin B-DNA B-DNA 0.74442458152771
promoter E-DNA E-DNA 0.9873348474502563
activity O O 0.9960338473320007
in O O 0.9999929666519165
a O O 0.999964714050293
chromatin S-DNA S-DNA 0.8604171872138977
-dependent O O 0.971756100654602
manner O O 0.9991956353187561
. O O 0.9999986886978149
We O O 0.9999970197677612
further O O 0.9999960660934448
show O O 0.9999988079071045
that O O 0.9999996423721313
this O O 0.9999679327011108
G B-DNA B-DNA 0.5186615586280823
+ I-DNA I-DNA 0.4715573787689209
C-rich I-DNA I-DNA 0.8132399916648865
region E-DNA E-DNA 0.9724982976913452
is O O 0.9999107122421265
required O O 0.9999637603759766
for O O 0.9999982118606567
the O O 0.9999957084655762
activation O O 0.9918033480644226
of O O 0.9999337196350098
alpha-globin B-DNA B-DNA 0.7579079866409302
gene E-DNA E-DNA 0.9639750123023987
expression O O 0.9936274290084839
during O O 0.9999798536300659

type O O 0.5169728994369507
1 O O 0.33925873041152954
( O O 0.8334439992904663
HIV-1 O O 0.6189124584197998
) O O 0.5019534826278687
is O O 0.9991299510002136
a O O 0.9999969005584717
potent O O 0.9916530251502991
activator O O 0.8867332935333252
of O O 0.9978487491607666
long B-DNA B-DNA 0.5630085468292236
terminal I-DNA I-DNA 0.6444987654685974
repeat E-DNA E-DNA 0.9054604768753052

Y I-protein I-protein 0.3673029839992523
) E-protein E-protein 0.5587568879127502
, O O 0.5214142203330994
and O O 0.8028133511543274
NF-kappa B-protein B-protein 0.6996927857398987
B I-protein I-protein 0.7377844452857971
family I-protein I-protein 0.51694655418396
proteins E-protein E-protein 0.9978629946708679
. O O 0.9999781847000122
The O O 0.9999970197677612
interleukin B-DNA B-DNA 0.3850003480911255
2 I-DNA I-DNA 0.4359409213066101
receptor I-DNA I-DNA 0.6830810308456421
alpha-chain I-DNA I-DNA 0.6177430152893066
( I-DNA I-DNA 0.9141265749931335
IL-2R I-DNA I-DNA 0.9817059636116028
alpha I-DNA I-DNA 0.9442909955978394
) I-DNA I-DNA 0.9681646227836609
gene E-DNA E-DNA 0.9968620538711548
is O O 0.9997439980506897
rapidly O O 0.9997476935386658
and O O 0.9998719692230225
potently O O 0.9986685514450073
induced O O 0.9998815059661865
in O O 0.9997963309288025
T B-cell_type B-cell_type 0.9596987962722778
cells E-cell_type E-cell_type 0.9965932965278625
in O O 0.9998329877853394
response O O 0.9936816692352295
to O O 0.9999370574951172
mitogenic O O 0.7162614464759827

procedure O O 0.8298747539520264
suitable O O 0.9993473887443542
for O O 0.9999517202377319
cloning B-RNA B-RNA 0.5936813354492188
labile I-RNA I-RNA 0.958080530166626
mRNAs E-RNA E-RNA 0.9504238367080688
that O O 0.9992621541023254
contain O O 0.9999871253967285
AU O B-DNA 0.483148455619812
motifs O E-DNA 0.9470006823539734
is O O 0.9997053742408752
presented O O 0.999818742275238
( O O 0.99977046251297
AU-DD O S-DNA 0.5789461731910706
) O O 0.9737980365753174
. O O 0.9999732971191406
These O O 0.9999974966049194
motifs O O 0.9187042117118835
are O O 0.9999595880508423
regulatory B-DNA B-DNA 0.6598849892616272
sequences E-DNA E-DNA 0.9428157806396484
within O O 0.999893307685852
the O O 0.9999880790710449
so-called O O 0.9302629232406616
AU-rich B-DNA B-DNA 0.6610009074211121
elements E-DNA E-DNA 0.9947382807731628
( O O 0.9967081546783447
AREs S-DNA S-DNA 0.9936192631721497
) O O 0.9856987595558167
often O O 0.9998718500137329
found O O 0.9999719858169556
in O O 0.9999704360961914
3 B-DNA O 0.5358924865722656
' I-DNA O 0.40585145354270935
untranslated I-DNA O 0.45059189200401306

in O O 0.9988614320755005
PMN S-cell_type S-cell_type 0.9987385869026184
. O O 0.9998841285705566
In O O 0.9999938011169434
the O O 0.9999997615814209
present O O 0.9993603825569153
study O O 0.9999336004257202
we O O 0.999991774559021
demonstrate O O 0.9999938011169434
that O O 0.9999955892562866
also O O 0.999984622001648
the O O 0.9999934434890747
signal B-protein B-protein 0.506713330745697
transducers I-protein I-protein 0.45671746134757996
and I-protein I-protein 0.5528243184089661
activators I-protein I-protein 0.8179205060005188
of I-protein I-protein 0.9630122184753418
transcription I-protein I-protein 0.6583222150802612
( I-protein I-protein 0.746502161026001
STAT I-protein I-protein 0.9758172631263733
) I-protein I-protein 0.9367268085479736
family I-protein I-protein 0.6077215671539307
members E-protein E-protein 0.9793593883514404
STAT1 B-protein B-protein 0.7946012616157532
p91 E-protein E-protein 0.8219411969184875
and O O 0.9634206891059875
STAT3 B-protein B-protein 0.6855122447013855
p92 E-protein E-protein 0.9356343746185303
and O O 0.9835118055343628
the O O 0.9995874762535095

in O O 0.9982715845108032
Wurzburg B-cell_line B-cell_line 0.6966347694396973
cells E-cell_line E-cell_line 0.9938485026359558
was O O 0.9997183680534363
remarkably O O 0.9987863898277283
inhibited O O 0.9999731779098511
by O O 0.9999986886978149
ADT O O 0.7406935691833496
pretreatment O O 0.9971134662628174
. O O 0.9999938011169434
ADT O O 0.5412376523017883
, O O 0.9976624250411987
a O O 0.9999582767486572
pro-glutathione O O 0.7226627469062805
antioxidant O O 0.5030014514923096
, O O 0.9951679706573486
was O O 0.9999557733535767
observed O O 0.9999494552612305
to O O 0.9999880790710449
be O O 0.9999747276306152
capable O O 0.9998192191123962
of O O 0.9999768733978271
modulating O O 0.9861006140708923
NF-kappa B-protein B-protein 0.8279051184654236
B E-protein E-protein 0.9990755319595337
activation O O 0.9991002082824707
. O O 0.9999990463256836
Involvement O O 0.9998894929885864
of O O 0.9999966621398926
tyrosine O O 0.7994590401649475
phosphorylation O O 0.9674707651138306
in O O 0.9999421834945679
endothelial B-protein B-protein 0.7490899562835693
adhesion I-protein I-protein 0.8138750791549683
molecule E-protein E-protein 0.8902863264083862
induction O O 0.9963629841804504
. O O 0.9999969005584717
Induction O O 0.993239164352417
of O O 0.9999641180038452
endothelial B-protein B-protein 0.6178631782531738
adhesion I-protein I-protein 0.848344624042511
molecules E-protein E-protein 0.9990760087966919
by O O 0.9999840259552002
the O O 0.9999797344207764
cytokine S-protein B-protein 0.7512871026992798
tumor B-protein I-protein 0.8022817373275757

MDS1/EVI1 S-DNA S-protein 0.5622771382331848
and O O 0.9676111340522766
AML1/MDS1/EVI1 S-protein S-protein 0.7602377533912659
) O O 0.902381420135498
physically O O 0.9995057582855225
interacts O O 0.9999176263809204
with O O 0.9999798536300659
SMAD3 S-protein S-protein 0.9485887289047241
, O O 0.9963240623474121
which O O 0.9999535083770752
is O O 0.9999922513961792
an O O 0.999994158744812
intracellular O O 0.794047474861145
mediator O O 0.4951746463775635
of O O 0.9960882663726807
TGF-beta1 S-protein S-protein 0.834417998790741
signaling O O 0.9641529321670532
. O O 0.9999556541442871
Finally O O 0.999768078327179
, O O 0.9999645948410034
we O O 0.9999383687973022
have O O 0.9999887943267822
correlated O O 0.9997592568397522
the O O 0.9999786615371704
response O O 0.9883561730384827

( O O 0.9319785833358765
IKKalpha S-protein S-protein 0.9851704239845276
) O O 0.9722229838371277
and O O 0.9997405409812927
IKKbeta S-protein S-protein 0.9526447653770447
, O O 0.986458957195282
which O O 0.9999226331710815
normally O O 0.9984696507453918
phosphorylate O O 0.8860670924186707
IkappaB B-protein B-protein 0.5848578810691833
alpha E-protein E-protein 0.9798199534416199
on O O 0.9997959733009338
both O O 0.9998884201049805
of O O 0.9999939203262329
its O O 0.9999581575393677
N-terminal O B-protein 0.6971356868743896
regulatory O I-protein 0.8407452702522278
serines O E-protein 0.9270638823509216
in O O 0.9997425675392151
response O O 0.9976062774658203
to O O 0.9999804496765137
tumor B-protein B-protein 0.6581112146377563
necrosis I-protein I-protein 0.5602344870567322
factor I-protein I-protein 0.3901212215423584
alpha E-protein E-protein 0.989314079284668
( O O 0.9932854175567627
TNF-alpha S-protein S-protein 0.993067741394043
) O O 0.9943159222602844
and O O 0.999922513961792
interleukin-1 S-protein S-protein 0.9212864637374878
( O O 0.9885953068733215
IL-1 S-protein S-protein 0.9709509015083313
) O O 0.9863779544830322
stimulation O O 0.9989321827888489
. O O 0.9999972581863403

cleavage O I-protein 0.43206706643104553
products O E-protein 0.8838240504264832
as O O 0.9999147653579712
those O O 0.9999889135360718
observed O O 0.9993612170219421
in O O 0.9999397993087769
vivo O O 0.9944643378257751
. O O 0.9999902248382568
Recombinant B-protein B-protein 0.7703621983528137
caspase I-protein I-protein 0.5021604299545288
6 E-protein E-protein 0.9490028023719788
( O O 0.9853437542915344
Mch B-protein O 0.6857494711875916
2 E-protein O 0.5076894164085388
) O O 0.8841978907585144
primarily O O 0.9996922016143799
generates O O 0.9999912977218628
a O O 0.9999910593032837
68-kDa O B-protein 0.7868548035621643
cleavage O I-protein 0.9396190643310547
product O E-protein 0.9784079790115356

has O O 0.9971218705177307
the O O 0.9999778270721436
potential O O 0.9995100498199463
to O O 0.9999850988388062
reconstitute O O 0.9997377991676331
NF B-protein B-protein 0.9618234038352966
( I-protein I-protein 0.9769838452339172
P I-protein I-protein 0.9454750418663025
) E-protein E-protein 0.9760161638259888
whereas O O 0.9996089339256287
NF-kappa B-protein B-protein 0.9389352202415466
B E-protein E-protein 0.9917247295379639
alone O O 0.9860287308692932
can O O 0.9999790191650391
not O O 0.9999796152114868
account O O 0.9999688863754272
for O O 0.9999788999557495
NF B-protein B-protein 0.9351532459259033
( I-protein I-protein 0.9744378328323364
P I-protein I-protein 0.917503833770752
) E-protein E-protein 0.9878609776496887
in O O 0.9997723698616028
crude O O 0.8428848385810852
extracts O O 0.962151050567627
. O O 0.9999945163726807
Unlike O O 0.9999896287918091
NF-AT S-protein S-protein 0.9853774905204773
, O O 0.9994365572929382
NF B-protein B-protein 0.9150430560112
( I-protein I-protein 0.9587315917015076
P I-protein I-protein 0.9564483761787415
) E-protein E-protein 0.9862020611763
does O O 0.9994087219238281
not O O 0.9999915361404419
contain O O 0.9999953508377075
AP1 S-protein S-protein 0.9946804642677307
as O O 0.9999784231185913
its O O 0.9999814033508301
DNA B-protein O 0.7982628345489502
binding I-protein O 0.6349737644195557
component E-protein O 0.755246639251709
. O O 0.9999756813049316
Activation O O 0.9991511106491089
of O O 0.9999836683273315
early B-DNA O 0.5942761301994324
growth I-DNA O 0.4310095012187958
response I-DNA O 0.5024300813674927

demonstrate O O 0.9985030889511108
that O O 0.9999946355819702
the O O 0.9998747110366821
IL-10R S-protein S-protein 0.9567723870277405
, O O 0.9943943023681641
unlike O O 0.9999865293502808
other O O 0.9995728135108948
members O O 0.9918025135993958
of O O 0.9999209642410278
the O O 0.9999743700027466
interferon O B-protein 0.7712172865867615
receptor O I-protein 0.6981501579284668
family O E-protein 0.9727789163589478
, O O 0.9975019097328186

cytolytic O O 0.490801602602005
programs O O 0.9112376570701599
and O O 0.9998539686203003
that O O 0.9999994039535522
engagement O O 0.9986684322357178
of O O 0.9999911785125732
NK B-protein B-protein 0.412770539522171
cell I-protein I-protein 0.3328478932380676
inhibitory I-protein I-protein 0.4555608332157135
receptors E-protein E-protein 0.9898089170455933
for O O 0.9995922446250916
MHC B-protein B-protein 0.5718043446540833
class I-protein I-protein 0.9362682700157166
I I-protein I-protein 0.7774661183357239
molecules E-protein E-protein 0.9991777539253235
impairs O O 0.9999550580978394
the O O 0.9999983310699463
very O O 0.9956203103065491
early O O 0.9653503894805908
activation O O 0.9938575625419617
of O O 0.9998742341995239

. O O 0.9989956021308899
Remixing O O 0.9976142644882202
of O O 0.9999092817306519
purified B-cell_type B-cell_type 0.5817906856536865
T I-cell_type I-cell_type 0.5421584248542786
cells E-cell_type E-cell_type 0.8687812089920044
showed O O 0.9999039173126221
that O O 0.9999958276748657
naive B-cell_type B-cell_type 0.47998589277267456
T I-cell_type I-cell_type 0.8379740715026855
cells E-cell_type E-cell_type 0.9488872289657593
do O O 0.9996705055236816
not O O 0.9999871253967285
suppress O O 0.9999549388885498
LAI O O 0.5167220234870911
replication O O 0.9299798607826233
in O O 0.9999197721481323
memory B-cell_type B-cell_type 0.8205466270446777
T I-cell_type I-cell_type 0.9524611234664917
cells E-cell_type E-cell_type 0.9888816475868225
and O O 0.9981998205184937
that O O 0.9999910593032837
memory B-cell_type B-cell_type 0.8764536380767822
T I-cell_type I-cell_type 0.9755727052688599
cells E-cell_type E-cell_type 0.9859031438827515
do O O 0.9998195767402649
not O O 0.9999947547912598
restore O O 0.9998383522033691
LAI O S-protein 0.4399116635322571
expression O O 0.9946954846382141
in O O 0.9999750852584839
naive B-cell_type B-cell_type 0.646769106388092
T I-cell_type I-cell_type 0.826978862285614
cells E-cell_type E-cell_type 0.9706704616546631
. O O 0.9999313354492188
The O O 0.9999964237213135

expression O O 0.9734975695610046

enhancer O I-protein 0.27904894948005676
region O E-protein 0.5269008874893188
of O O 0.9450300335884094
the O O 0.9966741800308228
IL-2 B-DNA B-protein 0.5311442017555237
receptor I-DNA I-protein 0.33578118681907654
alpha I-DNA I-protein 0.6387342214584351
chain E-DNA E-protein 0.986372172832489
( O O 0.9793499112129211
p55 S-protein S-protein 0.9835729002952576
) O O 0.9487254023551941
. O O 0.9999887943267822
Similarly O O 0.9998716115951538
, O O 0.9999046325683594
IL-2 S-protein S-protein 0.9797321557998657
activates O O 0.9994182586669922
NF-kappa B-protein B-protein 0.7563584446907043
B E-protein E-protein 0.9881438612937927
in O O 0.999852180480957
the O O 0.999955415725708
human B-cell_line B-cell_line 0.6413921117782593
monocytic I-cell_line I-cell_line 0.8840892314910889
cell I-cell_line I-cell_line 0.9672053456306458
line I-cell_line I-cell_line 0.7627349495887756
U I-cell_line I-cell_line 0.8410918712615967
937 E-cell_line E-cell_line 0.9972062706947327
, O O 0.9787014722824097
but O O 0.9993626475334167
not O O 0.9976104497909546
in O O 0.9967267513275146
resting B-cell_type B-cell_type 0.6993486285209656
human I-cell_type I-cell_type 0.8729170560836792
T-cells E-cell_type E-cell_type 0.9478580355644226
. O O 0.9998526573181152
This O O 0.9999935626983643
effect O O 0.9998831748962402
is O O 0.9999909400939941
detectable O O 0.9985430240631104
within O O 0.9999943971633911
15 O O 0.9931555390357971
min O O 0.9972766041755676
and O O 0.999915361404419
peaks O O 0.9916533827781677
1 O O 0.9975574016571045
h O O 0.995917022228241
after O O 0.9999749660491943
exposure O O 0.9981912970542908
to O O 0.9999465942382812
IL-2 S-protein S-protein 0.984451413154602
. O O 0.9999593496322632
Enhanced O O 0.9898697733879089
NF-kappa B-protein B-protein 0.8773362040519714
B E-protein E-protein 0.9700376391410828

PEBP2 B-DNA B-DNA 0.43315303325653076
site E-DNA E-DNA 0.9872904419898987
within O O 0.9999209642410278
the O O 0.9999786615371704
mouse B-DNA B-DNA 0.7960584759712219
GM-CSF I-DNA I-DNA 0.8983848094940186
promoter E-DNA E-DNA 0.9969151020050049
. O O 0.9996260404586792
PEBP2 B-protein B-protein 0.4882160425186157
alpha I-protein I-protein 0.8037434220314026
A1 E-protein E-protein 0.9409295320510864
and O O 0.990071177482605
alpha B-protein B-protein 0.427094042301178
B1 E-protein E-protein 0.9442119002342224
enhanced O O 0.9982239603996277
the O O 0.9999769926071167
expression O O 0.9993932247161865
of O O 0.9999964237213135
the O O 0.9999051094055176
GM-CSF B-DNA B-DNA 0.4624827206134796
promoter-driven I-DNA I-DNA 0.5833540558815002

mRNA E-RNA E-RNA 0.9126654267311096
, O O 0.9874609112739563
indicating O O 0.9997614026069641
specificity O O 0.999782383441925
. O O 0.9999991655349731
To O O 0.9999966621398926
examine O O 0.9999899864196777
transcriptional O O 0.9630895256996155
regulation O O 0.9991294741630554
of O O 0.999994158744812
cytokine B-DNA B-DNA 0.7077991962432861
genes E-DNA E-DNA 0.9960240125656128
by O O 0.9999526739120483
CD15 O S-protein 0.9012632966041565
engagement O O 0.9868524670600891
, O O 0.9999970197677612
a O O 0.9999959468841553
CAT O B-DNA 0.6547441482543945
plasmid O I-DNA 0.6622809171676636
reporter O I-DNA 0.8877302408218384
construct O E-DNA 0.9936926364898682
containing O O 0.9981852173805237
IL-1 B-DNA B-DNA 0.8638863563537598
beta I-DNA I-DNA 0.5988882184028625
promoter/enhancer I-DNA I-DNA 0.9591629505157471
sequences E-DNA E-DNA 0.9947479367256165
was O O 0.9999290704727173
introduced O O 0.9999539852142334
into O O 0.9999806880950928
MM6 S-cell_line S-cell_line 0.8742398023605347
. O O 0.9989114999771118
Subsequent O O 0.9998800754547119
cross-linking O O 0.9946619868278503
of O O 0.9999370574951172
CD15 O S-protein 0.8964046835899353
increased O O 0.9995717406272888

is O O 0.9932218790054321
also O O 0.9999572038650513
an O O 0.9999958276748657
effector O O 0.9643273949623108
of O O 0.9995310306549072
non-cytotoxic O O 0.8158475160598755
LMP-1 S-protein S-protein 0.5300167798995972
signaling O O 0.9864197373390198
in O O 0.9998927116394043
B B-cell_type B-cell_type 0.9026217460632324
cells E-cell_type E-cell_type 0.9905417561531067
, O O 0.9976723790168762
the O O 0.9999884366989136
physiological O O 0.9033914804458618

Oct-2 S-protein S-protein 0.9904190897941589
-harboring O O 0.9955470561981201
tester O O 0.9873428344726562
strain O O 0.9972188472747803
at O O 0.9999992847442627
the O O 0.9999988079071045
transcriptional O O 0.9117515087127686
level O O 0.997825562953949
. O O 0.9999974966049194
In O O 0.9998205304145813
gel O O 0.883472740650177
mobility O O 0.9731963276863098
shift O O 0.9957301020622253
assays O O 0.9993705153465271
, O O 0.9999911785125732
hT86 O O 0.43190377950668335
attenuated O O 0.984611451625824
the O O 0.9999861717224121
intensity O O 0.9988594055175781
of O O 0.9999940395355225
the O O 0.9999855756759644
retarded O O 0.8388673663139343
band O O 0.8426125049591064
composed O O 0.9950843453407288
of O O 0.9999700784683228
the O O 0.9999740123748779
octamer B-DNA B-DNA 0.7101896405220032
probe E-DNA E-DNA 0.9716145396232605
and O O 0.9954272508621216
Oct-2 S-protein S-protein 0.9298068881034851
, O O 0.9996472597122192
suggesting O O 0.9999868869781494
a O O 0.9999773502349854
dominant O O 0.9607064127922058
negative O O 0.9718884229660034
effect O O 0.9999361038208008
on O O 0.9999992847442627
the O O 0.9999953508377075
DNA-binding O O 0.6249698400497437
activity O O 0.9648193120956421
of O O 0.9995561242103577

homeostasis O O 0.8209811449050903
, O O 0.9989408850669861
while O O 0.9999959468841553
interleukin-15 S-protein S-protein 0.9881767630577087
promotes O O 0.9995425939559937
extrathymic O O 0.9307350516319275
development O O 0.9976758360862732
of O O 0.9999809265136719
T B-cell_type B-cell_type 0.5958855152130127
and I-cell_type I-cell_type 0.6789830327033997
NK I-cell_type I-cell_type 0.9462193250656128
cells E-cell_type E-cell_type 0.962141215801239
. O O 0.9999043941497803
The O O 0.9999978542327881
IL-4 B-protein B-protein 0.886946976184845
receptor I-protein I-protein 0.559967041015625
alpha-chain I-protein I-protein 0.37161895632743835
cytoplasmic I-protein I-protein 0.6093748807907104
domain E-protein E-protein 0.9781342148780823
is O O 0.9998218417167664
sufficient O O 0.9999454021453857

decline O O 0.9686629772186279
in O O 0.9999661445617676
chymotryptic O O 0.680157482624054
activity O O 0.9933748841285706
. O O 0.9999939203262329

mRNA O E-RNA 0.8058428168296814

epsilon O O 0.45885393023490906
germline S-DNA S-DNA 0.617714524269104
transcription O O 0.8201724886894226
: O O 0.9914423823356628
role O O 0.9585991501808167
of O O 0.9993211030960083
B-cell-specific B-protein B-protein 0.669307291507721
activator I-protein I-protein 0.7009303569793701
protein E-protein E-protein 0.9907547831535339
. O O 0.999505877494812
Germline B-protein B-RNA 0.6951367259025574
transcripts E-protein E-RNA 0.9785088896751404
initiate O O 0.9702982902526855
from O O 0.9998745918273926
promoters S-DNA S-DNA 0.8978223204612732
upstream O O 0.9280500411987305
of O O 0.9997041821479797
the O O 0.9999700784683228
immunoglobulin B-DNA B-DNA 0.6464796662330627
switch I-DNA I-DNA 0.7176070213317871
region E-DNA E-DNA 0.9426596164703369
, O O 0.9964816570281982
and O O 0.9996914863586426
are O O 0.9999706745147705

of O O 0.9925521612167358

of O O 0.9986200332641602
human O O 0.6749826073646545
T-cell O O 0.7278560400009155
lymphotropic O O 0.7736884355545044
virus O O 0.7075085043907166
type O O 0.5307236313819885
1 O O 0.5567592978477478
( O O 0.9004912972450256
HTLV-1 O O 0.60797518491745
) O O 0.7918645739555359
is O O 0.9993752837181091
a O O 0.9999837875366211
40-kDa B-protein B-protein 0.8455743193626404
transcriptional I-protein I-protein 0.8933939337730408
activator E-protein E-protein 0.9833146333694458
which O O 0.999441921710968
is O O 0.9999933242797852
critical O O 0.999870777130127
for O O 0.999985933303833
HTLV-1 O B-DNA 0.4811334013938904
gene O E-DNA 0.9750794172286987
regulation O O 0.9936590790748596
and O O 0.9998745918273926
virus-induced O O 0.9426250457763672
cellular O O 0.9765483736991882
transformation O O 0.9992793202400208
. O O 0.9999974966049194
Tax S-protein S-protein 0.9915590286254883
is O O 0.9999169111251831
localized O O 0.9984215497970581
to O O 0.999992847442627
the O O 0.9998942613601685
DNA O O 0.6968268752098083
through O O 0.9994857311248779
its O O 0.9999711513519287
interaction O O 0.9968097805976868
with O O 0.9999908208847046
the O O 0.9999512434005737
site-specific B-protein B-protein 0.4969939589500427
activators E-protein I-protein 0.636603832244873
cyclic B-protein I-protein 0.5567843317985535
AMP-responsive I-protein I-protein 0.8732274770736694
element-binding I-protein I-protein 0.9725229144096375
protein E-protein E-protein 0.9734382629394531
, O O 0.9580305218696594
NF-kappaB S-protein S-protein 0.9964203834533691
, O O 0.9960712194442749
and O O 0.9991706609725952
serum B-protein B-protein 0.8272542357444763
response I-protein I-protein 0.9171445965766907
factor E-protein E-protein 0.9519874453544617
. O O 0.9956458210945129
It O O 0.9997935891151428
has O O 0.9999767541885376
been O O 0.9999895095825195
suggested O O 0.9999871253967285
that O O 0.9999971389770508

targeting O O 0.9678367376327515
Ras S-protein S-protein 0.8854301571846008
expressing O O 0.968421995639801
tumors O O 0.7515863180160522
. O O 0.999383807182312
Modulation O O 0.986134946346283
of O O 0.9996883869171143
E2F B-protein B-protein 0.6926954984664917
complexes E-protein E-protein 0.98689204454422
during O O 0.9999173879623413
G0 O O 0.8071677088737488
to O O 0.9961540102958679
S O O 0.9417608976364136
phase O O 0.9835320711135864
transition O O 0.9875975251197815

. O O 0.9993544220924377
Human B-protein B-protein 0.8072463870048523
immunodeficiency I-protein I-protein 0.8383581042289734
virus I-protein I-protein 0.8024967312812805
type I-protein I-protein 0.6390908360481262
1 I-protein I-protein 0.4903034269809723
Tat E-protein E-protein 0.9429570436477661
upregulates O O 0.9961792230606079
interleukin-2 S-protein S-protein 0.8929358124732971
secretion O O 0.9538015127182007
in O O 0.9998428821563721
activated B-cell_type B-cell_type 0.5464666485786438
T I-cell_type I-cell_type 0.7015964388847351
cells E-cell_type E-cell_type 0.9556333422660828
. O O 0.999882698059082
Dysregulation O O 0.9977073669433594
of O O 0.999983549118042
cytokines S-protein S-protein 0.9954419136047363
secreted O O 0.9992425441741943
by O O 0.9999526739120483
T B-cell_type B-cell_type 0.869408130645752
cells E-cell_type E-cell_type 0.9889178276062012
may O O 0.9995737671852112
play O O 0.999992847442627
an O O 0.9999961853027344
important O O 0.999962329864502
role O O 0.9999872446060181
in O O 0.9999984502792358
the O O 0.9999955892562866
pathogenesis O O 0.9979477524757385

a O O 0.9992939233779907
significant O O 0.99967360496521
decrease O O 0.9998629093170166
in O O 0.9999960660934448
the O O 0.9999908208847046
switch O O 0.9920044541358948
from O O 0.9999767541885376
the O O 0.9999526739120483
membrane B-RNA O 0.5982660055160522
forms E-RNA O 0.6174681782722473
of O O 0.9963636994361877
mu S-RNA B-protein 0.39217233657836914
and O I-protein 0.4689790606498718
gamma S-RNA E-protein 0.929896354675293
to O O 0.983082115650177
their O O 0.9998315572738647
respective O O 0.994322657585144
secreted B-RNA O 0.8233389854431152
forms E-RNA O 0.5790314078330994
was O O 0.9999403953552246
noted O O 0.9999929666519165
in O O 0.9999641180038452

the O O 0.9978005290031433

B O E-protein 0.9536277055740356
. O O 0.9994333386421204
The O O 0.9999864101409912
oligo O B-DNA 0.4160121977329254
sequence O E-DNA 0.8228405714035034
I O O 0.709794282913208
stimulated O O 0.969170868396759
proliferation O O 0.9956843852996826
of O O 0.9999818801879883
both O O 0.9995115995407104
T B-cell_type O 0.7929683923721313
and I-cell_type O 0.6946010589599609
, I-cell_type O 0.607093095779419
to I-cell_type O 0.9949867725372314
a I-cell_type O 0.9999834299087524
lesser I-cell_type O 0.9996800422668457
extent I-cell_type O 0.9993240833282471
, I-cell_type O 0.9999346733093262
B I-cell_type B-cell_type 0.8357309699058533
cells E-cell_type E-cell_type 0.9904730916023254
. O O 0.9995439648628235

rapidly O O 0.8319161534309387
up-regulated O O 0.9916770458221436
following O O 0.9999035596847534
infection O O 0.9992781281471252
. O O 0.9999980926513672
These O O 0.9999980926513672
results O O 0.9999600648880005
support O O 0.999998927116394
our O O 0.9999982118606567
hypothesis O O 0.9992202520370483
that O O 0.9999990463256836
HCMV O O 0.8500961661338806
initiates O O 0.9995560050010681
a O O 0.9999921321868896
signal O O 0.934408962726593
transduction O O 0.9657943844795227
pathway O O 0.9992730021476746
that O O 0.9999967813491821
leads O O 0.9999732971191406
to O O 0.999981164932251
monocyte O O 0.6744903922080994
activation O O 0.9818689227104187
and O O 0.9995136260986328

molecules E-protein E-protein 0.9263460040092468
but O O 0.9986843466758728
also O O 0.9999679327011108
NF-kappa B-protein B-protein 0.9417157769203186
B E-protein I-protein 0.909407377243042
molecules O E-protein 0.9835013747215271
. O O 0.9999592304229736
In O O 0.999990701675415
fact O O 0.999727189540863
, O O 0.9999845027923584
cellular O O 0.8258436918258667
NF-kappa B-protein B-protein 0.628665566444397
B E-protein E-protein 0.9977433681488037
activity O O 0.9976820945739746
was O O 0.9999896287918091
phosphorylation-dependent O O 0.9777390360832214
and O O 0.999625563621521

in O O 0.9984003901481628
GR S-protein S-protein 0.8083471655845642
. O O 0.9998401403427124
Gender O O 0.9902201294898987
difference O O 0.9998563528060913
in O O 0.9999977350234985
the O O 0.9999969005584717
number O O 0.9981721639633179
of O O 0.9999756813049316

. O O 0.9991292357444763
Surprisingly O O 0.999930739402771
, O O 0.9999949932098389
overexpression O O 0.9987828135490417
of O O 0.9999814033508301
GRbeta S-protein S-protein 0.9760156869888306
in O O 0.9999147653579712
Jurkat B-cell_line B-cell_line 0.8064171075820923
cells E-cell_line E-cell_line 0.9896494150161743
did O O 0.9997077584266663
not O O 0.9999954700469971
cause O O 0.9999943971633911
significant O O 0.9997259974479675
inhibition O O 0.999840259552002
of O O 0.9999905824661255
GRalpha S-protein S-protein 0.9980465173721313
-induced O O 0.9984886646270752
transactivation O O 0.9970619082450867
of O O 0.9999856948852539
a O O 0.9999550580978394
GRE-dependent B-DNA B-DNA 0.49333882331848145
luciferase I-DNA I-DNA 0.6590483784675598
reporter I-DNA I-DNA 0.8370267748832703
gene E-DNA E-DNA 0.994304358959198
either O O 0.9994500279426575
. O O 0.9999970197677612
We O O 0.9978146553039551

of O O 0.9981228709220886
the O O 0.9999821186065674
interleukin-1 B-DNA B-DNA 0.5339692234992981
genes E-DNA E-DNA 0.9953877329826355
. O O 0.9999645948410034
Stimulation O O 0.9985326528549194
of O O 0.9999828338623047
interleukin-1 B-DNA B-DNA 0.38054758310317993
gene E-DNA E-DNA 0.968864381313324
transcription O O 0.9419183731079102
may O O 0.9999692440032959
be O O 0.9999974966049194

intact O O 0.868126630783081
E B-DNA B-DNA 0.3114556074142456
( I-DNA I-DNA 0.7285540103912354
gre I-DNA I-DNA 0.804375946521759
) I-DNA I-DNA 0.49699267745018005
motifs E-DNA E-DNA 0.9818114638328552
for O O 0.9996556043624878
mediating O O 0.983007550239563
transcriptional O O 0.9294191002845764
activation O O 0.9909408688545227
. O O 0.9999511241912842
ALF1 S-protein S-protein 0.8879250288009644
transactivated O O 0.954502522945404
transcription O O 0.9266204833984375
of O O 0.9995532631874084
Akv O B-DNA 0.3810851275920868
MLV O E-DNA 0.7603083252906799
through O O 0.9989405274391174
the O O 0.9999904632568359
two O O 0.989562451839447
E B-DNA B-DNA 0.6560418009757996
( I-DNA I-DNA 0.6348910331726074
gre I-DNA I-DNA 0.9528277516365051
) I-DNA I-DNA 0.5833659768104553
motifs E-DNA E-DNA 0.9937376976013184
equally O O 0.99980229139328
, O O 0.999985933303833
whereas O O 0.9999964237213135
E2A B-protein B-protein 0.3466785252094269
protein E-protein E-protein 0.9409533739089966
required O O 0.9995222091674805
the O O 0.9999933242797852
promoter-proximal O B-DNA 0.6196775436401367
E B-DNA I-DNA 0.3005739152431488
( I-DNA I-DNA 0.5499916672706604
gre I-DNA I-DNA 0.8521845936775208
) E-DNA I-DNA 0.6787046194076538
motif O E-DNA 0.9829734563827515
. O O 0.9999570846557617
In O O 0.9991427659988403
T- B-cell_line B-cell_line 0.6473561525344849
and I-cell_line I-cell_line 0.8122612833976746
B-cell I-cell_line I-cell_line 0.8850986957550049
lines E-cell_line E-cell_line 0.9984551668167114
, O O 0.9999103546142578
the O O 0.9999887943267822
E B-DNA B-DNA 0.5995894074440002
( I-DNA I-DNA 0.6387860774993896
gre I-DNA I-DNA 0.9613858461380005
) I-DNA I-DNA 0.5425323843955994
motifs E-DNA E-DNA 0.9941241145133972
were O O 0.9999595880508423
of O O 0.9999951124191284
major O O 0.9934321045875549
importance O O 0.9999239444732666
for O O 0.9999970197677612
Akv O O 0.5755459666252136
MLV O O 0.349544495344162
transcriptional O O 0.9220898151397705
activity O O 0.996394693851471
, O O 0.9999916553497314
while O O 0.9999967813491821
the O O 0.9999784231185913
EA/S B-DNA B-DNA 0.46199795603752136
motif E-DNA E-DNA 0.8965911269187927
had O O 0.99968421459198
some O O 0.9999908208847046
effect O O 0.9999775886535645
. O O 0.9999963045120239
In O O 0.9999556541442871
contrast O O 0.9999251365661621
, O O 0.9999843835830688
neither O O 0.99962317943573

and O O 0.9603224992752075
inflammatory O O 0.9440644383430481
responses O O 0.9980498552322388
, O O 0.9999985694885254
the O O 0.999996542930603
authors O O 0.9955161213874817
have O O 0.9999908208847046
analysed O O 0.9999818801879883
the O O 0.9999973773956299
activation O O 0.9964154958724976
of O O 0.9999570846557617
NF-kappa B-protein B-protein 0.9298524260520935
B E-protein E-protein 0.9989225268363953
in O O 0.9998805522918701
human B-cell_type B-cell_type 0.6093550324440002
umbilical I-cell_type I-cell_type 0.7337548136711121
cord I-cell_type I-cell_type 0.5939244031906128
T I-cell_type I-cell_type 0.6976097822189331
lymphocytes E-cell_type E-cell_type 0.6448525786399841
. O O 0.9999250173568726
The O O 0.9999986886978149
activity O O 0.998690664768219
was O O 0.9999903440475464
tested O O 0.9999611377716064
by O O 0.9999977350234985
quantitating O O 0.9756479263305664
the O O 0.9997586607933044

receptor-alpha E-protein E-protein 0.9867095351219177
( O O 0.982311487197876
PPARalpha S-protein S-protein 0.9998910427093506
) O O 0.9788854718208313
, O O 0.999911904335022
a O O 0.9999110698699951
member O O 0.9405409693717957
of O O 0.9985066056251526
the O O 0.9998331069946289
nuclear B-protein B-protein 0.514534056186676
receptor I-protein I-protein 0.6914843320846558
family E-protein E-protein 0.9715180993080139
, O O 0.9941934943199158
regulates O O 0.9988607168197632
gene O O 0.9670754671096802
expression O O 0.9992774128913879
in O O 0.9999918937683105
response O O 0.9965807795524597
to O O 0.9999861717224121
certain O O 0.998830258846283
fatty O O 0.9295032620429993
acids O O 0.9097070693969727
and O O 0.9995837807655334
fibric O O 0.9554541110992432
acid O O 0.9661210775375366
derivatives O O 0.9517499804496765
. O O 0.9999954700469971
The O O 0.9999994039535522
present O O 0.9908487796783447

Although O O 0.9995130300521851
this O O 0.9999932050704956
reversal O O 0.9997492432594299
by O O 0.9999958276748657
IL-2 S-protein S-protein 0.9943963289260864
was O O 0.9999144077301025
pronounced O O 0.9999418258666992
, O O 0.9999951124191284
it O O 0.9999886751174927
was O O 0.9999756813049316
not O O 0.9999666213989258
complete O O 0.9999697208404541
, O O 0.9999971389770508
suggesting O O 0.9999959468841553
that O O 0.9999942779541016
IL-10 S-protein S-protein 0.9940184354782104
may O O 0.9998975992202759

M-CSF B-protein I-RNA 0.4976770877838135
receptor E-protein I-RNA 0.7093895673751831
, O I-RNA 0.7957709431648254
cfms B-RNA I-RNA 0.8697054386138916
mRNA E-RNA E-RNA 0.9918901920318604
, O O 0.9878368973731995
and O O 0.9996181726455688
aborting O O 0.9472895264625549
the O O 0.9986248016357422
potential O O 0.9967781901359558
to O O 0.9999045133590698
convert O O 0.9994126558303833
to O O 0.9996384382247925
macrophages S-cell_type S-cell_type 0.9976876974105835
. O O 0.9997261166572571
In O O 0.9999328851699829
contrast O O 0.999969482421875
to O O 0.9999781847000122
IL-4 S-protein S-protein 0.9946880340576172
, O O 0.9995996356010437
interferon-gamma S-protein S-protein 0.9844967126846313
( O O 0.9928522706031799
IFN-gamma S-protein S-protein 0.9972162246704102
) O O 0.9921205043792725
had O O 0.9999842643737793
no O O 0.9999756813049316
demonstrable O O 0.9990779161453247
effect O O 0.9999942779541016
on O O 0.9999935626983643
the O O 0.999987006187439
differentiation O O 0.9980558156967163
of O O 0.9999783039093018
monocytes S-cell_type S-cell_type 0.9986108541488647
. O O 0.9998088479042053
Rather O O 0.9999687671661377
, O O 0.9999788999557495
IFN-gamma S-protein S-protein 0.9946441650390625
antagonized O O 0.9997853636741638
the O O 0.999997615814209
effect O O 0.9999661445617676
of O O 0.9999853372573853
IL-4 S-protein S-protein 0.966361939907074
and O O 0.999302864074707
suppressed O O 0.9939982891082764
the O O 0.9994282126426697
DC S-cell_type S-cell_type 0.9860460162162781
and O O 0.994536817073822
MGC S-cell_type O 0.5664187669754028
formation O O 0.977788507938385
induced O O 0.9993915557861328

both O O 0.9993714690208435
a O O 0.9999892711639404
rapid O O 0.971295952796936
and O O 0.995909571647644
concentration-dependent O O 0.9948518872261047
manner O O 0.9998767375946045
by O O 0.9999996423721313
the O O 0.9999818801879883
fungal O B-protein 0.7002638578414917
metabolite O I-protein 0.6622553467750549
gliotoxin O E-protein 0.8653913736343384
, O O 0.9954472184181213
but O O 0.9999319314956665
not O O 0.9997462630271912
by O O 0.999990701675415
its O O 0.9999784231185913
inactive O O 0.8809707760810852
analog O O 0.7726424932479858
methylthiogliotoxin O O 0.7648753523826599
. O O 0.9998013377189636
This O O 0.9999816417694092
induction O O 0.9989997744560242
of O O 0.9999840259552002
apoptosis O O 0.9667246341705322
was O O 0.9999105930328369
abolished O O 0.9999046325683594
by O O 0.999998927116394
the O O 0.9999473094940186
caspase O S-protein 0.6024355888366699
inhibitor O O 0.6019351482391357
zVAD-fmk O S-protein 0.6732627749443054
, O O 0.9970874190330505
correlated O O 0.999377429485321
with O O 0.9999949932098389
the O O 0.9999910593032837
inhibition O O 0.9851586222648621
of O O 0.9998078942298889
nuclear B-protein B-protein 0.6559527516365051
factor-kappa I-protein I-protein 0.9077219367027283
B E-protein E-protein 0.9748710989952087
( O O 0.9192171096801758

significantly O O 0.9964054822921753
higher O O 0.9999079704284668
in O O 0.9997772574424744
transplant O O 0.9293168783187866
recipients O O 0.9242910742759705
than O O 0.999984860420227
in O O 0.9990110397338867
control O O 0.9835972189903259
subjects O O 0.9728859663009644
( O O 0.9999754428863525
P O O 0.9881243109703064
< O O 0.9993940591812134
.05 O O 0.9994155168533325
) O O 0.9999275207519531
. O O 0.9999991655349731
Increased O O 0.9996870756149292
monocyte O O 0.7365572452545166
TF S-protein S-protein 0.3377969264984131

the O O 0.9978005290031433

in O O 0.9995112419128418
most O O 0.9994962215423584
cases O O 0.9983249306678772
of O O 0.9999935626983643
Hodgkin O O 0.9641817808151245
's O O 0.9969402551651001
disease O O 0.999853253364563
( O O 0.9999771118164062
HD O O 0.9847559332847595
) O O 0.9997101426124573
have O O 0.999993085861206
been O O 0.9999829530715942
recently O O 0.9995867609977722
recognized O O 0.9999195337295532
to O O 0.9999614953994751
originate O O 0.9998136162757874
from O O 0.9999215602874756
the O O 0.9995166063308716
B-cell B-cell_type B-cell_type 0.6321699023246765
lineage E-cell_type E-cell_type 0.9707284569740295
, O O 0.9973875880241394
but O O 0.9999872446060181
their O O 0.999997615814209
precise O O 0.9885687828063965
differentiation O O 0.9905005693435669
stage O O 0.9992228746414185

contribute O O 0.997077226638794

-induced O O 0.9222040772438049

AP-1 S-protein S-protein 0.9436329007148743
and O O 0.9842960834503174
nuclear O B-protein 0.7459688782691956
factor B-protein I-protein 0.46412786841392517
of I-protein I-protein 0.7087477445602417
activated I-protein I-protein 0.9284787774085999
T I-protein I-protein 0.9778351187705994
cells E-protein E-protein 0.996485710144043
( O O 0.9957188963890076
NF-AT-1 S-protein S-protein 0.9846512079238892
) O O 0.9956075549125671
. O O 0.9999916553497314
The O O 0.9999985694885254
ability O O 0.9999476671218872
of O O 0.9999943971633911
PKC-epsilon S-protein S-protein 0.9313233494758606
to O O 0.9983969330787659
induce O O 0.999936580657959
transactivation O O 0.9919571876525879
of O O 0.9997838139533997
NF-AT-1 S-protein S-protein 0.9792637228965759
and O O 0.993245542049408
AP-1 S-protein S-protein 0.9902433753013611
was O O 0.9999256134033203
similar O O 0.9999868869781494
to O O 0.9999958276748657
the O O 0.9999939203262329
stimulatory O O 0.8693263530731201

) O O 0.8105065226554871
such O O 0.9989998936653137
as O O 0.9999899864196777
hydrogen O O 0.8639049530029297
peroxide O O 0.983881950378418
serve O O 0.9998966455459595
as O O 0.9999926090240479
second O O 0.9469205141067505
messengers O O 0.7848144769668579
in O O 0.9999755620956421
the O O 0.9999943971633911
induction O O 0.9934420585632324
of O O 0.9999395608901978
the O O 0.9999349117279053
transcription B-protein B-protein 0.8259769678115845
factor E-protein E-protein 0.9358770847320557
NF-kappaB S-protein S-protein 0.954089343547821
, O O 0.9971517324447632
and O O 0.999752938747406
hence O O 0.9992897510528564
in O O 0.9999786615371704
the O O 0.9999741315841675
activation O O 0.9822074770927429
and O O 0.9987553358078003
replication O O 0.9886773824691772
of O O 0.9998842477798462
human O B-cell_type 0.3963179290294647

PKC B-protein B-protein 0.44304054975509644
isotypes E-protein E-protein 0.9797465801239014
in O O 0.9996892213821411
T B-cell_type B-cell_type 0.9299885034561157
cells E-cell_type E-cell_type 0.9954231381416321
. O O 0.9998687505722046
Moreover O O 0.999982476234436
, O O 0.9999961853027344
the O O 0.999998927116394
data O O 0.999761164188385
comparing O O 0.9999929666519165
the O O 0.9999985694885254
effects O O 0.9998960494995117
of O O 0.9999902248382568
activated B-protein O 0.8903817534446716
Ras E-protein S-protein 0.5330668091773987
and O O 0.8625006675720215
PKC B-protein S-protein 0.6880464553833008
mutants E-protein O 0.8434621095657349
suggest O O 0.999951958656311
that O O 0.9999982118606567
PKC-alpha S-protein S-protein 0.9802890419960022
, O O 0.9875938296318054

Sp1 B-DNA B-DNA 0.7133831977844238
binding I-DNA I-DNA 0.5690723657608032
sites E-DNA E-DNA 0.9890456199645996
. O O 0.9999891519546509
The O O 0.9999988079071045
effects O O 0.9999405145645142
of O O 0.9999979734420776
these O O 0.9999979734420776
substitutions O O 0.9977346658706665
on O O 0.9999685287475586
viral O O 0.8317490220069885
replication O O 0.9607143402099609
in O O 0.9999750852584839
transfected O B-cell_line 0.5378035306930542
HeLa B-cell_line I-cell_line 0.6815657019615173
cells E-cell_line E-cell_line 0.9970209002494812
and O O 0.9985733032226562
on O O 0.9999295473098755
HIV O O 0.9564116597175598
infection O O 0.9993017911911011

interacts O O 0.9345150589942932
with O O 0.9999988079071045
the O O 0.9999064207077026
HTLV-I B-DNA B-DNA 0.7349159121513367
promoter E-DNA I-DNA 0.9719622731208801
central O I-DNA 0.888329029083252
21 B-DNA I-DNA 0.6654103398323059
bp I-DNA I-DNA 0.5142539143562317
repeat E-DNA E-DNA 0.9974599480628967
. O O 0.9998681545257568
Characterization O O 0.9886310696601868

subset O O 0.34343254566192627
of O O 0.9972885847091675
CD8+ B-cell_type B-cell_type 0.9027889370918274
T I-cell_type I-cell_type 0.9704331159591675
cells E-cell_type E-cell_type 0.9435322284698486
( O O 0.9879223704338074
CD8+CD18bright S-cell_type S-protein 0.391745388507843
) O O 0.8785948753356934
is O O 0.9992958307266235
strongly O O 0.9983271956443787
activated O O 0.9997034668922424
by O O 0.9999991655349731
the O O 0.9999942779541016
combination O O 0.9808381199836731
of O O 0.9995007514953613
IL-12 S-protein S-protein 0.96490478515625
and O O 0.9957385063171387

proteins E-protein E-protein 0.9362958669662476
are O O 0.9999120235443115
a O O 0.999991774559021
family O O 0.9712001085281372
of O O 0.9994151592254639
transcription B-protein B-protein 0.7957186698913574
factors E-protein E-protein 0.9959346055984497
that O O 0.9999088048934937
include O O 0.9999806880950928
proteins O O 0.8869938850402832
critical O O 0.9950916767120361
to O O 0.9998551607131958
differentiation O O 0.994695246219635
and O O 0.999497652053833
development O O 0.998898983001709
in O O 0.999974250793457
species O O 0.9643999338150024
ranging O O 0.9994879961013794
from O O 0.9999791383743286
plants O O 0.7744734883308411
to O O 0.999422550201416
mammals O O 0.748184323310852
. O O 0.9999384880065918
Five O O 0.9986359477043152
members O O 0.9975680708885193
of O O 0.9999761581420898
this O O 0.9999890327453613
family O O 0.9207819700241089
( O O 0.9969310164451599
MYC S-protein S-protein 0.7346535921096802
, O O 0.9747319221496582
SCL S-protein S-protein 0.8738311529159546
, O O 0.983086109161377
TAL-2 S-protein S-protein 0.6403995752334595

, O O 0.8869097828865051
and O O 0.9658350944519043
transcription B-protein B-protein 0.45831918716430664
factors E-protein E-protein 0.9997296929359436
( O O 0.995826780796051
EKLF S-protein S-protein 0.9905625581741333
, O O 0.9953011274337769
GATA-1 S-protein S-protein 0.9938662648200989
, O O 0.995232880115509
GATA-2 S-protein S-protein 0.9943165183067322
, O O 0.9962324500083923
p45 B-protein B-protein 0.8587242960929871
NF-E2 E-protein E-protein 0.9789110422134399
, O O 0.9938399195671082
PU.1 S-protein S-protein 0.9942740797996521
, O O 0.9918014407157898
and O O 0.9983829259872437
SCL/Tal1 S-protein S-protein 0.9957154393196106
) O O 0.9931106567382812
at O O 0.9999916553497314
discrete O O 0.9671753644943237
stages O O 0.9985910058021545
of O O 0.9999591112136841
erythropoietic O O 0.964205801486969
development O O 0.9993066787719727
. O O 0.999998927116394

cytokine S-protein O 0.24315330386161804

Oct2b B-protein S-protein 0.6246007680892944
's I-protein O 0.9770391583442688
carboxy I-protein B-DNA 0.6537154912948608
terminal I-protein I-DNA 0.5770263075828552
insert E-protein E-DNA 0.9451608657836914
( O O 0.9981132745742798
exon B-DNA B-DNA 0.575538694858551
13 E-DNA E-DNA 0.4550897181034088
) O O 0.6691880226135254
was O O 0.9995003938674927
found O O 0.9999927282333374
that O O 0.9999966621398926
created O O 0.9999797344207764
a O O 0.9999929666519165
novel O O 0.9278151988983154
large O O 0.8924535512924194
isoform O O 0.41230860352516174
, O O 0.9942155480384827
Oct2ab S-protein S-protein 0.9914321899414062
. O O 0.9998624324798584
More O O 0.9996836185455322

promoters E-DNA E-DNA 0.870912492275238
and O O 0.9991384744644165
the O O 0.9999772310256958
ISRE O B-DNA 0.6432678699493408
probe O E-DNA 0.99591463804245
to O O 0.9998424053192139
detect O O 0.9999184608459473
STAT B-protein B-protein 0.7243683934211731
proteins E-protein E-protein 0.9960405826568604
in O O 0.9999033212661743
nuclear O O 0.9440170526504517
extracts O O 0.9892233610153198
from O O 0.9999831914901733
acute B-cell_type B-cell_type 0.5099014639854431
leukemia I-cell_type I-cell_type 0.8352584838867188
cells E-cell_type E-cell_type 0.9761183857917786
in O O 0.999957799911499
bandshift O O 0.9113379716873169
assays O O 0.9953018426895142
. O O 0.999998927116394
Specific O O 0.9924772381782532
DNA O B-protein 0.6329633593559265
protein B-protein I-protein 0.350718230009079
complex E-protein E-protein 0.967877209186554
formation O O 0.9738209843635559
was O O 0.9999604225158691
observed O O 0.9998575448989868
with O O 0.999996542930603
the O O 0.9999954700469971
probes O O 0.9275261759757996
from O O 0.9999819993972778
the O O 0.9999455213546753
beta-casein O B-DNA 0.711816132068634
and O I-DNA 0.6987231373786926
IRF-1 B-DNA I-DNA 0.9046393036842346
gene I-DNA I-DNA 0.5567808151245117
promoters E-DNA E-DNA 0.9944566488265991
, O O 0.9902455806732178
but O O 0.9999102354049683
not O O 0.9998359680175781
with O O 0.9996187686920166
the O O 0.9998154044151306
ISRE O B-DNA 0.5115925073623657

the O O 0.9990912675857544
patients O O 0.9966753721237183
did O O 0.9999855756759644
not O O 0.999962329864502
. O O 0.9999955892562866
These O O 0.9999983310699463
data O O 0.9997249245643616
suggest O O 0.9999988079071045
that O O 0.9999983310699463
the O O 0.999976396560669
physiological O O 0.9881860017776489
relationship O O 0.999713122844696
between O O 0.9998382329940796
binding O O 0.9572086334228516
and O O 0.9925187826156616
function O O 0.9980594515800476
of O O 0.9999761581420898
the O O 0.9999603033065796
glucocorticoid B-protein B-protein 0.8742632865905762
receptor E-protein E-protein 0.9896652102470398
is O O 0.999667763710022
disturbed O O 0.999605119228363
in O O 0.9999692440032959
MS O O 0.6284646391868591
. O O 0.9983981251716614
Phorbol O O 0.830576479434967
ester-induced O O 0.9577532410621643
mononuclear O O 0.7320855855941772
cell O O 0.6027984023094177
differentiation O O 0.9971494078636169
is O O 0.9999916553497314
blocked O O 0.9999006986618042
by O O 0.9999994039535522
the O O 0.9999867677688599
mitogen-activated B-protein B-protein 0.6373788714408875
protein I-protein I-protein 0.44231951236724854
kinase I-protein I-protein 0.6358599066734314
kinase E-protein I-protein 0.9033395648002625
( O I-protein 0.7367205023765564
MEK S-protein I-protein 0.5311993956565857
) O I-protein 0.38861796259880066
inhibitor O E-protein 0.7860281467437744

not O O 0.982781708240509
result O O 0.9998679161071777
in O O 0.9999978542327881
enhanced O O 0.9889616370201111
p50 S-protein S-protein 0.9372483491897583
and O O 0.9892347455024719
p65 B-protein S-protein 0.9495413303375244
protein E-protein O 0.6431598663330078
expression O O 0.9991440773010254
. O O 0.9999990463256836
The O O 0.9999990463256836
effects O O 0.9998337030410767
of O O 0.9999924898147583
IFN-gamma S-protein S-protein 0.9909522533416748
on O O 0.9999312162399292
the O O 0.9999454021453857
transcription B-protein B-protein 0.6024460792541504
factors E-protein E-protein 0.9936072826385498
were O O 0.9998601675033569
specific O O 0.9997312426567078
, O O 0.9999810457229614
since O O 0.9999971389770508
no O O 0.9999767541885376
change O O 0.9999454021453857
was O O 0.9999964237213135
observed O O 0.9999352693557739
in O O 0.9999961853027344
the O O 0.9999963045120239
expression O O 0.9993982315063477
of O O 0.9999889135360718
NF-IL-6 S-protein S-protein 0.8248665928840637
or O O 0.9882670044898987
I B-protein B-protein 0.9615748524665833
kappa I-protein I-protein 0.9038525819778442

considered O O 0.9976269602775574
as O O 0.9999947547912598
an O O 0.9999656677246094
oxidative O O 0.9388481378555298
species O O 0.9575964212417603
capable O O 0.9997377991676331
of O O 0.9999797344207764
inducing O O 0.9991397857666016
NF-kappaB S-protein S-protein 0.9982126951217651
in O O 0.9999716281890869
a O O 0.9998465776443481
T-lymphocytic B-cell_line B-cell_line 0.8791913390159607
cell I-cell_line I-cell_line 0.9152311682701111
line E-cell_line E-cell_line 0.99672532081604
through O O 0.9999179840087891
a O O 0.9999960660934448
transduction O O 0.9119778275489807
mechanism O O 0.988416850566864
involving O O 0.9999852180480957
ROS O O 0.5128756761550903
, O O 0.9758066534996033
and O O 0.9985995888710022
having O O 0.9997405409812927
a O O 0.999958872795105
long-distance O O 0.9219017624855042
effect O O 0.9989297986030579
through O O 0.9999960660934448
subsequent O O 0.9973679184913635
TNF-alpha S-protein S-protein 0.9920416474342346
release O O 0.9963733553886414
. O O 0.9999990463256836
Rapid O O 0.9268873929977417
Ca2+-mediated O O 0.8402098417282104
activation O O 0.9856083393096924
of O O 0.9997970461845398
Rap1 S-protein S-protein 0.9950882792472839
in O O 0.9998244643211365
human B-cell_type B-cell_type 0.7270840406417847
platelets E-cell_type E-cell_type 0.9894794821739197
. O O 0.9998955726623535
Rap1 S-protein S-protein 0.9819502830505371
is O O 0.999910831451416

the O O 0.9987921118736267
MBC O S-cell_type 0.9150011539459229
over O O 0.985031008720398
baseline O O 0.9236767888069153
and O O 0.9990230798721313
a O O 0.999983549118042
fivefold O O 0.9946061968803406
increase O O 0.9999685287475586
over O O 0.9999924898147583
placebo-treated O O 0.8684566617012024
subjects O O 0.8821326494216919
. O O 0.9999978542327881
The O O 0.999996542930603
T3 O O 0.48793473839759827
-group O O 0.3655773401260376
showed O O 0.9998683929443359
no O O 0.999996542930603
change O O 0.9999960660934448
in O O 0.999997615814209
MBC O S-cell_type 0.9570412039756775
over O O 0.9993723034858704
the O O 0.9999990463256836
study O O 0.9999254941940308

c-Fos S-protein S-protein 0.8983309268951416
) O O 0.9480320811271667
or O O 0.9989604949951172
decrease O O 0.9971217513084412
( O O 0.9951192140579224
Jun S-protein S-protein 0.6916153430938721
) O O 0.8820724487304688
protein O O 0.728706419467926
levels O O 0.9994412064552307
as O O 0.999996542930603
well O O 0.9999816417694092
as O O 0.9999991655349731
increasing O O 0.9991875290870667
AP-1 S-protein S-protein 0.9437292218208313
binding O O 0.9495522975921631

affinities O O 0.8900945782661438
were O O 0.9999788999557495
then O O 0.9999778270721436
indirectly O O 0.9992547631263733
estimated O O 0.9999939203262329
by O O 0.9999971389770508
blocking O O 0.9873499274253845
CD8 S-protein S-protein 0.968992292881012
interaction O O 0.9991899132728577
with O O 0.999998927116394
an O O 0.9999786615371704
anti-CD8 B-protein B-protein 0.7576467990875244
mAb E-protein E-protein 0.9954867959022522
. O O 0.9997251629829407
We O O 0.999990701675415
found O O 0.9999982118606567
a O O 0.9999984502792358
wide O O 0.9920616149902344
range O O 0.9995056390762329
of O O 0.9999871253967285
TCR S-protein S-protein 0.4932129979133606
affinities O O 0.8306701183319092
among O O 0.9998958110809326
the O O 0.999993085861206
different O O 0.9974628686904907
clonotypes O O 0.5474732518196106

of O O 0.997289776802063
c-Rel S-protein S-protein 0.9736762046813965
and O O 0.9965248703956604
Rel B-protein B-protein 0.3904978632926941
A E-protein E-protein 0.986801028251648
were O O 0.9997451901435852
normal O O 0.976858377456665
in O O 0.9998971223831177
freshly O O 0.5582209825515747
isolated O O 0.8726872205734253
tumor-draining O B-protein 0.3997170329093933
LN O E-protein 0.2673894762992859
, O O 0.8235970139503479
as O O 0.9998431205749512
was O O 0.9999451637268066
nuclear O B-protein 0.8114164471626282
kappaB S-protein E-protein 0.8957303762435913
DNA-binding O O 0.9358976483345032
activity O O 0.9987875819206238
induced O O 0.9999908208847046
by O O 0.9999972581863403
anti-CD3 B-protein B-protein 0.46659526228904724

of O O 0.99896240234375
these O O 0.9999774694442749
cleaved O O 0.7312561273574829
products O O 0.5962932109832764
( O O 0.9997199177742004
band O O 0.9786237478256226
1 O O 0.9917144179344177
pk O O 0.9496579766273499
) O O 0.9951657056808472
correlates O O 0.9996556043624878
with O O 0.999984622001648
RFX S-protein S-protein 0.9618251323699951
activity O O 0.9982826709747314
. O O 0.9999985694885254
A O O 0.9999971389770508
similar O O 0.9998801946640015
comparison O O 0.9996321201324463
with O O 0.9999963045120239
protease-treated O O 0.7142202258110046
extracts O O 0.7259554862976074
prepared O O 0.999758780002594
from O O 0.9999817609786987
Jurkat B-cell_line B-cell_line 0.9219585061073303
cells E-cell_line E-cell_line 0.9985576272010803
demonstrated O O 0.9998646974563599
the O O 0.9999995231628418
presence O O 0.999901533126831
of O O 0.9999974966049194
the O O 0.9999042749404907
band O B-protein 0.4990629255771637
1pk O E-protein 0.487178236246109
activity O O 0.9420915246009827
despite O O 0.999976396560669
an O O 0.9999984502792358
absence O O 0.9999840259552002
of O O 0.9999990463256836
the O O 0.9999973773956299
native O O 0.7101787328720093
RFX S-protein S-protein 0.764995813369751
activity O O 0.9812532067298889
. O O 0.9999830722808838

strand O O 0.7802401781082153
competition O O 0.9819823503494263
between O O 0.9997649788856506
identical O O 0.9256974458694458
sequences O O 0.7755244970321655
of O O 0.9998007416725159
biotin- O O 0.5970328450202942
and O O 0.9019273519515991
fluorescein-labeled O O 0.875977098941803
amplicon O O 0.49842318892478943
( O O 0.9739744067192078
probe O O 0.6419205665588379
) O O 0.9766085147857666
and O O 0.9994633793830872
unlabeled O O 0.9060777425765991
amplicon O O 0.4171619713306427
( O O 0.9486056566238403
target O O 0.5128676891326904
) O O 0.9307252168655396
during O O 0.9991675615310669
hybridization O O 0.9943996071815491
. O O 0.9999974966049194
As O O 0.9999982118606567
the O O 0.999990701675415
target O O 0.7574458122253418
quantity O O 0.8826814293861389
increased O O 0.9997953772544861
, O O 0.9999951124191284
that O O 0.9999978542327881
of O O 0.9999933242797852
the O O 0.999992847442627
double-labeled O B-DNA 0.5879502892494202
probe O E-DNA 0.9197288751602173
decreased O O 0.9998145699501038
in O O 0.9999699592590332
accordance O O 0.9999573230743408
with O O 0.999996542930603
the O O 0.9999958276748657
mass O O 0.8795737028121948

revealing O O 0.9914495348930359
predominant O O 0.9530020356178284
expression O O 0.9928561449050903
of O O 0.999957799911499
the O O 0.99998939037323
Ah B-DNA B-DNA 0.476614773273468
receptor I-DNA I-DNA 0.46019259095191956
gene E-DNA E-DNA 0.9909597635269165
in O O 0.999895453453064
the O O 0.9999784231185913
monocyte B-cell_type O 0.39181438088417053
fraction E-cell_type O 0.42727985978126526
. O O 0.9995535016059875
Then O O 0.9999778270721436
the O O 0.9999880790710449
expression O O 0.9700930714607239
levels O O 0.9996887445449829

. O O 0.9966340661048889
IL-4 S-protein S-protein 0.9321608543395996
and O O 0.9871097803115845
IL-13 S-protein S-protein 0.9806766510009766
induced O O 0.9975827932357788
dose- O O 0.908714771270752
and O O 0.9799587726593018
time-dependent O O 0.979698896408081
increases O O 0.9996395111083984
in O O 0.9999814033508301
IL-1RI O S-protein 0.8129695653915405
and O O 0.9902392625808716

binds O O 0.9635489583015442
to O O 0.9998183846473694
interferon B-DNA B-DNA 0.4442839026451111
consensus I-DNA I-DNA 0.8077084422111511
sequences E-DNA E-DNA 0.9946010112762451
( O O 0.9992759823799133
ICSs S-DNA S-DNA 0.958676815032959
) O O 0.9940980672836304
found O O 0.9999818801879883
in O O 0.9999923706054688
many O O 0.9996218681335449
promoters O S-DNA 0.9929785132408142
of O O 0.9993652701377869
the O O 0.9999480247497559
IFN-regulated B-DNA B-DNA 0.861487627029419
genes E-DNA E-DNA 0.9966416358947754
. O O 0.9999582767486572
Among O O 0.9999847412109375
T-cell B-cell_line B-cell_line 0.8156887888908386
lines E-cell_line E-cell_line 0.9988549947738647
investigated O O 0.9994276165962219
, O O 0.9999748468399048
ICSAT S-protein S-protein 0.5602453947067261
was O O 0.9997268319129944
abundantly O O 0.9522157907485962
expressed O O 0.9990925788879395
in O O 0.9999676942825317

Raf1/MEK1/ O O 0.7016243934631348
ERK1/2 S-protein S-protein 0.7444303035736084
pathway O O 0.9810671806335449
did O O 0.9999419450759888
not O O 0.9999982118606567
affect O O 0.9999996423721313
the O O 0.999997615814209
DNA O O 0.9625082612037659
binding O O 0.990757167339325
of O O 0.9999054670333862
NF-kappa B-protein B-protein 0.9564725756645203
B E-protein E-protein 0.9955273270606995
but O O 0.9979593753814697
, O O 0.9998874664306641
rather O O 0.999915599822998
, O O 0.999861478805542
acted O O 0.9932108521461487
at O O 0.9999915361404419
the O O 0.9999966621398926
level O O 0.999337375164032
of O O 0.9999699592590332
transcriptional O O 0.8928076028823853
activity O O 0.9953953623771667
of O O 0.999950647354126

sites E-DNA E-DNA 0.837126612663269
in O O 0.9999064207077026
the O O 0.9999287128448486
5 B-DNA B-DNA 0.6126285791397095
' I-DNA I-DNA 0.8251497149467468
flank E-DNA E-DNA 0.982884407043457
and O O 0.9750423431396484
encodes O O 0.989469051361084
a O O 0.9998089671134949
small B-protein O 0.899772047996521
basic I-protein B-protein 0.8356916904449463
potential I-protein I-protein 0.9070354700088501
phosphoprotein E-protein E-protein 0.7447925209999084
of O O 0.97864830493927
unknown O O 0.8218339085578918
function O O 0.9922143816947937
. O O 0.9999871253967285
Using O O 0.9999068975448608
a O O 0.9998857975006104
sensitive O O 0.868955135345459
, O O 0.9685311317443848
reverse O O 0.753399133682251

. O O 0.9981916546821594
METHODS O O 0.9778397083282471
: O O 0.999911904335022
During O O 0.999988317489624
a O O 0.9999934434890747
double-blind O O 0.8218045234680176
placebo-controlled O O 0.9335158467292786
crossover O O 0.9311909079551697
study O O 0.9924376606941223
, O O 0.9999953508377075
200 O O 0.9899113774299622
micrograms O O 0.9921351671218872
fluticasone O O 0.950053334236145
propionate O O 0.9775727987289429
aqueous O O 0.962594211101532
nasal O O 0.9676946401596069
spray O O 0.9913169145584106
( O O 0.9997764229774475
in O O 0.9999854564666748
the O O 0.9999939203262329
active O O 0.9123470783233643
treatment O O 0.9785293340682983
period O O 0.9973022937774658
) O O 0.9998278617858887
and O O 0.9999444484710693

CD14 S-protein S-protein 0.8312004804611206
expression O O 0.9986752867698669
. O O 0.9999979734420776
This O O 0.9999936819076538
region O O 0.995015561580658
contains O O 0.9999972581863403
two O O 0.9970494508743286
binding B-DNA B-DNA 0.6484083533287048
sites E-DNA E-DNA 0.9498323798179626
for O O 0.9994481205940247
the O O 0.9999394416809082
Sp1 B-protein S-protein 0.8486871719360352
transcription I-protein B-protein 0.3652710020542145
factor E-protein E-protein 0.9735147356987
. O O 0.999627947807312
A O O 0.9983421564102173
3-bp O B-DNA 0.9350935220718384

an O O 0.9977986216545105

in O O 0.9993910789489746
healthy O O 0.9782132506370544
women O O 0.9993758797645569
( O O 0.9999845027923584
mean O O 0.9993395209312439
+/- O O 0.9995286464691162
S.D. O O 0.9991883635520935
( O O 0.9999442100524902
range O O 0.999129593372345
) O O 0.9998838901519775
: O O 0.9999202489852905
PHP O O 0.9709069728851318
, O O 0.999874472618103
1.2 O O 0.9961479902267456
+/- O O 0.9999792575836182
1.0 O O 0.9993414282798767
( O O 0.9999505281448364
0.2-4 O O 0.9995205402374268
) O O 0.9996477365493774
x O O 0.9987127780914307
10 O O 0.9963979721069336
( O O 0.9996825456619263
-10 O O 0.994046688079834
) O O 0.9994706511497498

IL-5 S-protein S-protein 0.9663936495780945
production O O 0.9987832903862
by O O 0.9999903440475464
helper B-cell_type B-cell_type 0.45846518874168396
T I-cell_type I-cell_type 0.7828274965286255
cells E-cell_type E-cell_type 0.9437189102172852
seems O O 0.9993624091148376
to O O 0.9999942779541016
cause O O 0.9999960660934448
the O O 0.9999960660934448
eosinophilic O O 0.9435017704963684
inflammation O O 0.9990344047546387
of O O 0.9999938011169434
both O O 0.9998205304145813
atopic O O 0.9105352163314819
and O O 0.98811274766922
nonatopic O O 0.9830374121665955
asthma O O 0.99854975938797
. O O 0.9999988079071045
Elucidation O O 0.9971919655799866
of O O 0.999901294708252

LMP1 S-protein S-protein 0.9849590063095093
expression O O 0.9993140697479248
induces O O 0.9999841451644897
phenotypic O O 0.9414882063865662
changes O O 0.9936338663101196
resembling O O 0.999776303768158
B O O 0.5932680368423462
cell O O 0.43316909670829773
activation O O 0.9394789934158325
, O O 0.9993021488189697
such O O 0.9999864101409912
as O O 0.9999775886535645
cell O O 0.8786150813102722
size O O 0.935259997844696
increase O O 0.9981796741485596
and O O 0.999861478805542
up-regulation O O 0.9986248016357422
of O O 0.9999806880950928
cell B-protein B-protein 0.6351704001426697
surface I-protein I-protein 0.5191200375556946
activation I-protein I-protein 0.5391355156898499
markers E-protein E-protein 0.9666491150856018

Human O B-protein 0.4593196511268616
T O I-protein 0.5783435702323914
cell O I-protein 0.4293663799762726
leukemia O I-protein 0.5498748421669006
virus-I O I-protein 0.4884503483772278
( O I-protein 0.7922660708427429
HTLV-I O I-protein 0.40579479932785034
) O I-protein 0.38640499114990234
Tax S-protein E-protein 0.8518291115760803
-mediated O O 0.9959619641304016
apoptosis O O 0.9979923963546753
in O O 0.9998979568481445
activated B-cell_type B-cell_type 0.5115480422973633
T I-cell_type I-cell_type 0.5896991491317749
cells E-cell_type E-cell_type 0.9588785171508789
requires O O 0.9998700618743896
an O O 0.9999963045120239
enhanced O O 0.9941046833992004
intracellular O O 0.8823859691619873
prooxidant O O 0.8697791695594788
state O O 0.9706291556358337
. O O 0.9999970197677612
We O O 0.9999943971633911
have O O 0.9999954700469971
shown O O 0.9999953508377075
that O O 0.9999988079071045
an O O 0.9999639987945557

interact O O 0.9861646294593811
with O O 0.9999687671661377
DNA-binding B-protein B-protein 0.5915690660476685
nuclear I-protein I-protein 0.7805072665214539
factors E-protein E-protein 0.9882811903953552
. O O 0.9998595714569092
A O O 0.9997636675834656
fragment O O 0.7741310596466064
extending O O 0.9956230521202087
from O O 0.9994742274284363
-643 B-DNA B-DNA 0.693851113319397
to I-DNA I-DNA 0.6345090866088867
+33 E-DNA E-DNA 0.9339482188224792
is O O 0.9962742328643799
capable O O 0.999666690826416
of O O 0.9999798536300659
controlling O O 0.9992965459823608
the O O 0.9999737739562988
tissue-specific O O 0.718002438545227
expression O O 0.9616830945014954
of O O 0.9996079802513123
the O O 0.9999171495437622
CAT B-DNA B-DNA 0.731228232383728

pmol/L O O 0.472153902053833
; O O 0.9939454197883606
in O O 0.9999573230743408
normal O O 0.9811681509017944
pregnant O O 0.9937566518783569
women O O 0.9997910857200623
it O O 0.9999951124191284
was O O 0.9999959468841553
697 O O 0.9972736239433289
+/- O O 0.9999566078186035
172 O O 0.9992294311523438
pmol/L O O 0.9973245859146118
( O O 0.9998517036437988
P O O 0.9983479976654053
less O O 0.9999184608459473
than O O 0.9999669790267944
0.025 O O 0.9899047017097473
) O O 0.9999037981033325
. O O 0.9999964237213135
Plasma O O 0.7984665632247925
18-hydroxycorticosterone O O 0.7643008232116699
was O O 0.9990885257720947
also O O 0.9999934434890747
significantly O O 0.9999904632568359
( O O 0.9998332262039185
P O O 0.9953560829162598
less O O 0.9999504089355469
than O O 0.9999816417694092
0.025 O O 0.9427709579467773

a O O 0.998485267162323
conditional O B-DNA 0.8434171080589294
tyrosine B-DNA I-DNA 0.5695949196815491
kinase I-DNA I-DNA 0.7601283192634583
oncogene E-DNA E-DNA 0.9781864285469055
. O O 0.99983811378479
When O O 0.9999656677246094
added O O 0.9790342450141907
pulsewise O O 0.9799140095710754
to O O 0.9997567534446716
immature B-cell_type B-cell_type 0.6241152882575989
cells E-cell_type E-cell_type 0.8935545682907104
, O O 0.9986498951911926
differentiation O O 0.9946275353431702
was O O 0.9999712705612183
accelerated O O 0.9998127818107605
while O O 0.9999972581863403
more O O 0.9995830655097961
mature B-cell_type B-cell_type 0.5938100814819336
cells E-cell_type E-cell_type 0.8865583539009094
underwent O O 0.9994737505912781
premature O O 0.9436008930206299
cell O O 0.862210214138031
death O O 0.9970021843910217
. O O 0.999997615814209
Thyroid O O 0.711419403553009
hormone O O 0.7548314332962036
( O O 0.9841399192810059
T3 O O 0.8665708899497986
) O O 0.9831188321113586
alone O O 0.9998146891593933
caused O O 0.9999834299087524

Ca2+- O O 0.2659797668457031
signaling O O 0.8384400606155396
pathways O O 0.9876169562339783
downstream O O 0.9993575215339661
of O O 0.9999912977218628
T O O 0.6298074722290039
cell O O 0.4942447245121002
activation O O 0.9813825488090515
. O O 0.999984860420227
Nonpituitary B-DNA O 0.9114687442779541
human I-DNA B-DNA 0.7704561352729797
prolactin I-DNA I-DNA 0.35551267862319946
gene E-DNA E-DNA 0.9685215353965759
transcription O O 0.9417083263397217
is O O 0.999935507774353
independent O O 0.9998821020126343
of O O 0.9999872446060181

inhibit O O 0.9942938685417175
HIV-1 O O 0.868694543838501
replication O O 0.9880799651145935
in O O 0.9999854564666748
persistently O O 0.6302937269210815
infected O O 0.790179431438446
Molt-4 S-cell_line S-cell_line 0.8395372033119202
and O O 0.7926971912384033
U937 B-cell_line B-cell_line 0.7782055735588074
cells E-cell_line E-cell_line 0.9991674423217773
. O O 0.9998812675476074
However O O 0.9999886751174927
, O O 0.9999885559082031
inhibition O O 0.9993785619735718
of O O 0.999991774559021
HIV-1 O O 0.7798612117767334
replication O O 0.9899035692214966
appears O O 0.9999825954437256
not O O 0.9998657703399658
to O O 0.999969482421875
be O O 0.9999760389328003
directly O O 0.9962917566299438
correlated O O 0.9998371601104736
with O O 0.9999943971633911
GSH O O 0.486982524394989
levels O O 0.9995875954627991
. O O 0.9999978542327881
Cysteine O O 0.8922114968299866
and O O 0.9964937567710876
NAC O O 0.9463918209075928
also O O 0.9999518394470215
inhibit O O 0.999904990196228
NF-kappa B-protein B-protein 0.7387761473655701
B E-protein E-protein 0.9993671774864197
activity O O 0.999136745929718
as O O 0.9999985694885254
determined O O 0.9999023675918579
by O O 0.9999967813491821
electrophoretic O O 0.8947128653526306
mobility O O 0.9828363060951233
shift O O 0.9973430037498474
assays O O 0.9993484616279602
and O O 0.9999814033508301
chloramphenicol B-protein B-protein 0.6900443434715271
acetyl-transferase E-protein E-protein 0.8774360418319702

: O O 0.9856341481208801
In O O 0.9998620748519897
patients O O 0.9994305968284607
with O O 0.9999918937683105
AMI O O 0.9957215785980225
, O O 0.9999912977218628
leukocyte-platelet O O 0.8597816824913025
adhesion O O 0.9946605563163757
is O O 0.9999897480010986
increased O O 0.999967098236084
. O O 0.9999977350234985
Binding O O 0.9823141098022461
of O O 0.9997544884681702
activated B-cell_type B-cell_type 0.6672429442405701
platelets E-cell_type E-cell_type 0.9420011639595032
induces O O 0.9999065399169922
IL-1 B-protein B-protein 0.49523216485977173
beta E-protein E-protein 0.90690016746521
, O O 0.9604178071022034
IL-8 S-protein S-protein 0.930304229259491
, O O 0.992298424243927
and O O 0.9991568326950073
MCP-1 S-protein S-protein 0.9871915578842163
in O O 0.9997356534004211
leukocytes S-cell_type S-cell_type 0.9976091384887695
. O O 0.9998680353164673
Our O O 0.9999995231628418
findings O O 0.9999724626541138
suggest O O 0.9999991655349731
that O O 0.999997615814209
leukocyte-platelet O O 0.8381359577178955
adhesion O O 0.9927207827568054
contributes O O 0.9999889135360718
to O O 0.999997615814209
the O O 0.9999971389770508
regulation O O 0.9998332262039185
of O O 0.9999953508377075
inflammatory O O 0.5791000723838806

enhancer- O O 0.893509566783905
zeta B-DNA B-DNA 0.5095557570457458
2 I-DNA I-DNA 0.49812090396881104
globin I-DNA I-DNA 0.7725360989570618
promoter E-DNA E-DNA 0.9856431484222412
interaction O O 0.9862602353096008
is O O 0.999972939491272
mediated O O 0.9999450445175171
by O O 0.9999990463256836
the O O 0.9999872446060181
two O O 0.9715525507926941
GATA-1 O B-DNA 0.3965507745742798
factor O I-DNA 0.5757730007171631
binding O I-DNA 0.5878753066062927
motifs O E-DNA 0.9373818039894104
located O O 0.9990332126617432
at O O 0.9996770620346069
-230 O B-DNA 0.9013535380363464
and O I-DNA 0.7696406245231628
-104 O E-DNA 0.8139810562133789
, O O 0.8589795827865601
respectively O O 0.9973114728927612
. O O 0.9999947547912598
The O O 0.9999955892562866
functional O O 0.8747736811637878
domains O O 0.37105679512023926
of O O 0.9979653358459473
HS-40 S-DNA S-protein 0.3985974192619324

H2O2 O O 0.27453121542930603
treatment O O 0.891144335269928
of O O 0.9983692765235901
cells O O 0.9625429511070251
from O O 0.999982476234436
its O O 0.9999681711196899
inactive B-protein O 0.9447912573814392
cytoplasmic I-protein O 0.8069730997085571
form E-protein O 0.48993566632270813
. O O 0.9999328851699829
N-acetyl-L-cysteine O O 0.8417719602584839
( O O 0.9910109043121338
NAC O O 0.9326958656311035
) O O 0.9918338060379028
, O O 0.9998559951782227
a O O 0.9999704360961914

the O O 0.9992051720619202
induction O O 0.9982938170433044
of O O 0.9999736547470093
CD36 S-protein S-protein 0.9500445127487183
, O O 0.9939467906951904
Tal1 S-protein S-protein 0.977088451385498
, O O 0.9970071911811829
EKLF S-protein S-protein 0.9927041530609131
, O O 0.9961472749710083
NF-E2 S-protein S-protein 0.9896265268325806
, O O 0.994899332523346
and O O 0.9989074468612671
GATA-1 S-protein S-protein 0.9920452833175659
that O O 0.9998517036437988
preceeded O O 0.9924076795578003
expression O O 0.9962762594223022
of O O 0.9999608993530273
EpoR S-protein S-protein 0.8297274708747864
. O O 0.9990772008895874
In O O 0.9998742341995239
late O O 0.9968036413192749
stages O O 0.9995867609977722
of O O 0.9999762773513794
erythroid O O 0.809858500957489
maturation O O 0.9963384866714478
, O O 0.9999929666519165
GPA S-protein S-protein 0.5577511787414551
was O O 0.999390721321106
upregulated O O 0.9982931017875671
, O O 0.999869704246521
whereas O O 0.9999701976776123
CD34 S-protein S-protein 0.9220624566078186
, O O 0.9626021385192871
c-kit S-protein S-protein 0.900521993637085
, O O 0.991650402545929
PU.1 S-protein S-protein 0.9719655513763428
, O O 0.9877064824104309
and O O 0.9981899857521057
GATA-2 S-protein S-protein 0.986977756023407
were O O 0.9998674392700195

acquisition O O 0.9771472811698914

Bcl-x B-cell_type B-cell_type 0.29079312086105347
protected I-cell_type I-cell_type 0.5444733500480652
B I-cell_type I-cell_type 0.363158255815506
cells E-cell_type E-cell_type 0.7062839269638062
from O O 0.9999667406082153
Fas-mediated O O 0.852249801158905
apoptosis O O 0.9922124743461609
in O O 0.999992847442627
the O O 0.999998927116394
absence O O 0.9999324083328247
of O O 0.9999939203262329
NF-kappaB S-protein S-protein 0.9873864054679871
signaling O O 0.989386796951294
. O O 0.9999855756759644

factor E-protein E-protein 0.9519098997116089
, O O 0.9871706366539001
activator B-protein B-protein 0.6397725343704224
protein-1 E-protein E-protein 0.9987782835960388
( O O 0.9897364377975464
AP-1 S-protein S-protein 0.9968717694282532
) O O 0.9922159314155579
. O O 0.9999897480010986
PMA O O 0.8399757742881775
treatment O O 0.9978159666061401
caused O O 0.999993085861206
a O O 0.9999957084655762
concentration- O O 0.8597103357315063
and O O 0.964599072933197
time-dependent O O 0.9727492332458496
increase O O 0.9998492002487183
in O O 0.9999959468841553
both O O 0.9998924732208252

nervous O O 0.8915970921516418
and O O 0.9898326396942139
immune O O 0.9869333505630493
systems O O 0.9991017580032349
] O O 0.9999929666519165
The O O 0.9999977350234985
problem O O 0.9995003938674927
of O O 0.9999988079071045
the O O 0.9999972581863403
neuro-immuno O O 0.7473831176757812
interactions O O 0.9779624938964844
on O O 0.9999899864196777
the O O 0.9999923706054688
level O O 0.9992495179176331
of O O 0.9999903440475464
the O O 0.9999728202819824
protein B-protein O 0.7424983978271484
trans-factors E-protein O 0.605311930179596

these O O 0.9979178309440613
agents O O 0.994766116142273
is O O 0.9999572038650513
not O O 0.9996054768562317
merely O O 0.9995905756950378
governed O O 0.998727023601532
by O O 0.9999974966049194
the O O 0.9999953508377075
expression O O 0.9994688630104065
of O O 0.9999942779541016
their O O 0.9998935461044312
receptors O O 0.540039598941803
and O O 0.9957414865493774
the O O 0.999968409538269
availability O O 0.9991570711135864
of O O 0.999983549118042
ligand O O 0.43612927198410034

sites O E-DNA 0.7039664387702942
as O O 0.9998801946640015
seen O O 0.9999704360961914
in O O 0.9999853372573853
the O O 0.9999914169311523
estrogen O O 0.5686492919921875
target O O 0.6234660148620605
organ O O 0.5759483575820923
. O O 0.9999152421951294
A O O 0.9998915195465088
microtitre O O 0.747931957244873
assay O O 0.9024228453636169
system O O 0.9663144946098328
for O O 0.9999246597290039
glucocorticoid B-protein B-protein 0.865708589553833
receptors E-protein E-protein 0.9914020895957947
: O O 0.9969210624694824
decreased O O 0.9945800304412842
receptor O O 0.811637818813324
concentration O O 0.9937031865119934
in O O 0.9999803304672241
myocardial O O 0.7772086262702942
infarction O O 0.9687252044677734
. O O 0.9999641180038452
A O O 0.9999943971633911
major O O 0.9976237416267395
difficulty O O 0.9999052286148071
in O O 0.9999955892562866
determination O O 0.9996399879455566
of O O 0.9999946355819702
glucocorticoid O B-protein 0.7827692031860352
receptor O I-protein 0.9521660804748535
sites O E-protein 0.7200679779052734
is O O 0.9999872446060181
the O O 0.9999992847442627

is O O 0.9966534972190857
the O O 0.9999908208847046
only O O 0.9986404776573181
CsA-sensitive B-protein B-protein 0.48922282457351685
component E-protein E-protein 0.8857055902481079
limiting O O 0.9892760515213013
signaling O O 0.9935439825057983
from O O 0.999983549118042
the O O 0.9999191761016846
T B-protein B-cell_line 0.3691609799861908
cell I-protein I-cell_line 0.4907670319080353

in O O 0.9990712404251099
hypotonic O O 0.7672260403633118
extracts O O 0.9609698057174683
of O O 0.9998904466629028
unstimulated B-cell_type B-cell_type 0.39269787073135376
T I-cell_type I-cell_type 0.6208646893501282
cells E-cell_type E-cell_type 0.8314733505249023
. O O 0.9997568726539612
On O O 0.9999911785125732
the O O 0.9999990463256836
basis O O 0.9996218681335449
of O O 0.9999911785125732
binding O O 0.9326561689376831
, O O 0.9957204461097717
reconstitution O O 0.968162477016449
and O O 0.9980091452598572
cotransfection O O 0.8954887390136719
experiments O O 0.9615405797958374
, O O 0.9999977350234985
we O O 0.9999793767929077
propose O O 0.9999982118606567
that O O 0.9999990463256836
activation O O 0.9937930107116699
of O O 0.9996821880340576
NF-AT S-protein S-protein 0.9896793365478516
occurs O O 0.9999208450317383
in O O 0.9999676942825317
at O O 0.9999752044677734
least O O 0.9998194575309753
two O O 0.9999545812606812
stages O O 0.9990019202232361
: O O 0.999988317489624
a O O 0.9999953508377075
CsA-sensitive O O 0.4918467700481415
stage O O 0.6697903275489807
involving O O 0.9951707720756531
modification O O 0.9708445072174072
and/or O O 0.9438154101371765

mRNA O E-RNA 0.9379804730415344
levels O O 0.9961897730827332
are O O 0.9999927282333374
increased O O 0.9999833106994629
in O O 0.9999898672103882
response O O 0.9997978806495667
to O O 0.9999949932098389
lipopolysaccharide O O 0.942558228969574
, O O 0.999663233757019
predominantly O O 0.9999465942382812
as O O 0.9999971389770508
a O O 0.9999973773956299
result O O 0.999995231628418
of O O 0.999998927116394
increased O O 0.9997003078460693
transcription O O 0.991951584815979
of O O 0.9999538660049438
the O O 0.9999891519546509
interleukin B-protein B-DNA 0.6451975703239441
1beta E-protein I-DNA 0.6810517311096191
gene O E-DNA 0.9946921467781067
. O O 0.9999136924743652
Expression O O 0.9994377493858337
of O O 0.9999924898147583
interleukin B-protein B-protein 0.8610489368438721
1beta E-protein E-protein 0.9866942167282104
and O O 0.9882020354270935
other O O 0.9937291145324707
cytokines S-protein S-protein 0.9946460723876953
, O O 0.9991744160652161
such O O 0.9999821186065674
as O O 0.999962568283081
interleukin B-protein B-protein 0.886419415473938
6 E-protein E-protein 0.9823809862136841
and O O 0.9893593788146973
tumor B-protein B-protein 0.9738343358039856

of O O 0.9972848892211914
SS B-cell_type B-cell_type 0.8438464403152466
RBC E-cell_type E-cell_type 0.988893449306488
to O O 0.9994971752166748
endothelial B-cell_type B-cell_type 0.7127580046653748
cells E-cell_type E-cell_type 0.969653844833374
in O O 0.9999147653579712
large O O 0.9759568572044373
vessel O O 0.9185512065887451
can O O 0.9975600242614746
generate O O 0.9999709129333496
enhanced O O 0.9904643297195435
oxidant O O 0.8890395164489746
stress O O 0.9869778752326965
leading O O 0.9998025298118591
to O O 0.9999942779541016
increased O O 0.998513400554657
adhesion O O 0.958489179611206
and O O 0.9971387386322021
diapedesis O O 0.9472981095314026
of O O 0.9966849684715271
monocytes S-cell_type S-cell_type 0.9951381087303162
, O O 0.9936922788619995
as O O 0.9999181032180786
well O O 0.9998831748962402
as O O 0.9999939203262329
heightened O O 0.9758630990982056
adherence O O 0.9986695051193237
of O O 0.9999842643737793
SS B-cell_type B-cell_type 0.699150025844574
reticulocytes E-cell_type E-cell_type 0.940065324306488
, O O 0.9982352256774902
indicating O O 0.999976634979248
that O O 0.999997615814209
injury/activation O O 0.9841370582580566
of O O 0.999789297580719
endothelium O O 0.7949150204658508
can O O 0.9973846077919006

nuclear O O 0.8969582915306091
extracts O O 0.9964410662651062
to O O 0.9999924898147583
the O O 0.9999943971633911
consensus B-DNA B-DNA 0.5394582748413086
heat I-DNA I-DNA 0.5788707137107849
shock I-DNA I-DNA 0.9182713627815247
element E-DNA E-DNA 0.997669517993927
. O O 0.9999537467956543
Interestingly O O 0.9998738765716553
, O O 0.9999966621398926
the O O 0.9999983310699463
progressive O O 0.9751128554344177
decline O O 0.998691976070404
in O O 0.9999986886978149
the O O 0.9999947547912598
heat O O 0.8324297666549683
shock O O 0.9338939189910889

lactate O O 0.5525511503219604
concentrations O O 0.964893639087677
during O O 0.9999755620956421
MPE O O 0.7486574649810791
. O O 0.9999680519104004
After O O 0.9999886751174927
exercise O O 0.9993458390235901
following O O 0.9999966621398926
placebo O O 0.962804913520813
administration O O 0.9993839263916016
we O O 0.999997615814209
observed O O 0.9997345805168152
increases O O 0.9999591112136841
in O O 0.9999808073043823
concentrations O O 0.9981120824813843
of O O 0.9999548196792603
blood O O 0.6835833191871643
substrates O O 0.4112299084663391
, O O 0.9996271133422852
plasma B-protein O 0.5817974209785461
adrenocorticotropin E-protein O 0.7015056610107422
( O O 0.9406111240386963
ACTH S-protein O 0.4798285961151123
) O O 0.8233367204666138
, O O 0.9963753819465637

transcription B-protein B-protein 0.4267101585865021
factors E-protein E-protein 0.9983022212982178
are O O 0.999891996383667
thought O O 0.999934196472168
to O O 0.999987006187439
play O O 0.9999961853027344
an O O 0.9999979734420776
important O O 0.999955415725708
role O O 0.9999879598617554
in O O 0.9999978542327881
the O O 0.9999984502792358
control O O 0.999711811542511
of O O 0.99997878074646
cell O O 0.9242285490036011
cycle O O 0.925645649433136
progression O O 0.9921586513519287

acid I-protein O 0.8445436358451843

< O O 0.7828878164291382

of O O 0.9979780316352844
the O O 0.9999867677688599
BOX1 B-protein B-DNA 0.31516891717910767
motif E-protein E-DNA 0.889408528804779
abrogated O O 0.99261474609375
IL-9 S-protein S-protein 0.9948979020118713
-induced O O 0.997007429599762
cell O O 0.9744122624397278
proliferation O O 0.9983319640159607
and O O 0.9999531507492065
signal O O 0.9643505811691284
transduction O O 0.9942920207977295
. O O 0.9999926090240479
However O O 0.999983549118042
, O O 0.9999852180480957
substitution O O 0.9992092847824097
of O O 0.9999878406524658
the O O 0.9999222755432129
Pro-X-Pro S-protein S-protein 0.5361023545265198
in O O 0.9970663189888
the O O 0.9999227523803711
BOX1 B-protein B-DNA 0.2729005515575409
motif E-protein E-DNA 0.5753341317176819
with O O 0.9998013377189636
Ala-X-Ala S-protein S-protein 0.8258166313171387
failed O O 0.9941986799240112
to O O 0.9998575448989868
abolish O O 0.9997090697288513
IL-9 S-protein S-protein 0.9986441731452942
-induced O O 0.9938967823982239
cell O O 0.9689504504203796
proliferation O O 0.9990170001983643
but O O 0.9999889135360718

1 I-DNA I-DNA 0.30146145820617676
( I-DNA I-DNA 0.7948058247566223
HIV-1 I-DNA I-DNA 0.7072507739067078
) I-DNA I-DNA 0.501030683517456
genome E-DNA E-DNA 0.9975711703300476
has O O 0.9998636245727539
previously O O 0.9999948740005493
revealed O O 0.999998927116394
a O O 0.9999982118606567
major B-DNA O 0.7086349129676819
constitutive I-DNA O 0.7340372800827026
DNase I-DNA B-DNA 0.42833417654037476
I-hypersensitive I-DNA I-DNA 0.9087449908256531
site E-DNA E-DNA 0.9765214323997498
associated O O 0.9985393285751343
with O O 0.999996542930603

to O O 0.9990741014480591
the O O 0.9999898672103882
consensus B-DNA B-DNA 0.5355727076530457
DNA I-DNA I-DNA 0.7373713850975037
sequence E-DNA E-DNA 0.9933682084083557
in O O 0.9999004602432251
the O O 0.9999790191650391
cis-acting B-DNA B-DNA 0.8542369604110718
elements E-DNA E-DNA 0.9967103004455566
of O O 0.9993185997009277
various B-DNA O 0.9539141058921814
genes E-DNA O 0.5247755646705627
. O O 0.9999452829360962
Although O O 0.9999815225601196
NF-kappa B-protein B-protein 0.7752507925033569
B E-protein E-protein 0.9950548410415649
activates O O 0.9990265369415283
the O O 0.9999755620956421
expression O O 0.9927142262458801
of O O 0.9999686479568481
many O O 0.9983946681022644
genes O O 0.6821840405464172
involved O O 0.997955322265625
in O O 0.9999372959136963
immune O O 0.883660078048706
and O O 0.9767999053001404
inflammatory O O 0.9677301049232483
responses O O 0.9984197616577148
, O O 0.9999971389770508
little O O 0.9999486207962036
is O O 0.9999938011169434
known O O 0.9999986886978149
about O O 0.9999979734420776
the O O 0.9999966621398926

not O O 0.9589053988456726

in O O 0.9988757967948914
this O O 0.9999946355819702
context O O 0.9997923970222473
. O O 0.9999992847442627
Conversely O O 0.9999839067459106
, O O 0.999988317489624
inhibition O O 0.9973088502883911
of O O 0.9999455213546753
NF-kappaB S-protein S-protein 0.9914662837982178
confers O O 0.9994519352912903
a O O 0.9999940395355225
tenfold O O 0.9745767712593079

4.3 O O 0.9762396812438965
+/- O O 0.999625563621521
0.2 O O 0.9997727274894714
nmol/L O O 0.9953659772872925
, O O 0.9999532699584961
respectively O O 0.999992847442627
; O O 0.9999619722366333
n O O 0.9772597551345825
= O O 0.9994683861732483
3 O O 0.997068464756012
) O O 0.9997841715812683
, O O 0.9999799728393555
consistent O O 0.9998144507408142
with O O 0.9999983310699463
previous O O 0.9998632669448853
studies O O 0.9980827569961548
in O O 0.9999595880508423
mononuclear B-cell_type B-cell_type 0.8582059741020203
leukocytes E-cell_type E-cell_type 0.9937346577644348
isolated O O 0.9961828589439392
from O O 0.9999953508377075
the O O 0.9999916553497314
two O O 0.9985841512680054
species O O 0.9918000102043152
. O O 0.9999946355819702
As O O 0.9999940395355225
a O O 0.9999973773956299
first O O 0.9954386353492737
step O O 0.9999269247055054
in O O 0.9999978542327881
understanding O O 0.9999631643295288
the O O 0.9999955892562866
mechanism O O 0.9994674324989319
of O O 0.9999958276748657
decreased O O 0.9922768473625183
binding O O 0.985745906829834
affinity O O 0.9991738200187683
in O O 0.9999973773956299
New O O 0.8647333383560181

( O O 0.9122505187988281
D584AQPQAGR O S-DNA 0.7998771071434021
) O O 0.8338626027107239
, O O 0.999154806137085
generating O O 0.9999170303344727
a O O 0.9999721050262451
22-kDa O B-protein 0.8459354639053345
C-terminal O I-protein 0.8693603873252869
SP1 S-protein I-protein 0.7381500601768494
protein O I-protein 0.5506268739700317
fragment O E-protein 0.9596269726753235
which O O 0.9991999268531799
still O O 0.9998019337654114
contains O O 0.9999799728393555
the O O 0.9998444318771362
DNA O B-DNA 0.4994424879550934
binding O I-DNA 0.47850531339645386

macrophage B-cell_line I-cell_line 0.40456920862197876
cell I-cell_line I-cell_line 0.7435592412948608
line E-cell_line I-cell_line 0.8550612330436707
U937 S-cell_line E-cell_line 0.982181191444397
is O O 0.999176561832428
different O O 0.999981164932251
from O O 0.9999926090240479
that O O 0.9998869895935059
in O O 0.9994990825653076
Jurkat B-cell_line B-cell_line 0.873123824596405
cells E-cell_line E-cell_line 0.9979628324508667
. O O 0.9998446702957153

( O O 0.8706297278404236
1-4 O O 0.4661208987236023
) O O 0.7267976999282837
. O O 0.977788507938385
ATF/CREB S-protein S-protein 0.8062132596969604
and O O 0.986254096031189
Sp B-protein B-protein 0.5056169629096985
family I-protein I-protein 0.4257398247718811
members E-protein E-protein 0.8857177495956421
interacted O O 0.9990659356117249
with O O 0.9999898672103882
the O O 0.9998195767402649
21 B-DNA B-DNA 0.8995749950408936
bp I-DNA I-DNA 0.938746452331543

control O O 0.9509785175323486
of O O 0.9994351267814636
the O O 0.9999903440475464
early O O 0.5173996090888977
and O O 0.8483026623725891
the O O 0.9766407012939453
late O O 0.8769458532333374
IL-6 S-protein S-protein 0.9760382771492004
-induced O O 0.998155415058136
junB S-DNA O 0.45823729038238525
transcription O O 0.780023455619812
waves O O 0.7794965505599976
. O O 0.9999924898147583
First O O 0.9979879856109619
, O O 0.9999852180480957
cycloheximide O O 0.9644838571548462
strongly O O 0.9980809688568115
potentiated O O 0.9999440908432007
the O O 0.9999974966049194
transcription O O 0.9530765414237976
of O O 0.999478280544281
the O O 0.9999529123306274
second O O 0.7738441228866577

a O O 0.9973188042640686
hydrolase S-protein O 0.34472760558128357
required O O 0.990705668926239
for O O 0.9999531507492065
the O O 0.9999881982803345
cleavage O O 0.9491171836853027
of O O 0.9996582269668579
cholesteryl O O 0.8179832696914673
esters O O 0.8474968075752258
and O O 0.9954480528831482
triglycerides O O 0.7220926880836487
derived O O 0.9982714653015137
from O O 0.9999909400939941
plasma O B-protein 0.5404604077339172
lipoproteins O E-protein 0.9804195761680603
. O O 0.9998517036437988
It O O 0.9999334812164307
is O O 0.9999864101409912
shown O O 0.9999970197677612
here O O 0.9999979734420776
that O O 0.9999990463256836
during O O 0.9990087747573853
monocyte O O 0.8108049035072327
to O O 0.9976500868797302
macrophage O O 0.5764662027359009
differentiation O O 0.9967005848884583
, O O 0.999992847442627
the O O 0.9999966621398926

express O O 0.9863082766532898

of O O 0.9983112812042236
wild B-protein B-protein 0.5227153897285461
type I-protein I-protein 0.8160489797592163
p53 E-protein E-protein 0.6134425401687622
in O O 0.9396985173225403
concert O O 0.9748728275299072
with O O 0.9999809265136719
the O O 0.9999430179595947
nuclear B-protein B-protein 0.5274940729141235
transcription I-protein I-protein 0.7605874538421631
factor E-protein E-protein 0.9858435988426208
, O O 0.9950119256973267
NF-kappa B-protein B-protein 0.9576027989387512
B E-protein E-protein 0.9957798719406128
. O O 0.9995372295379639
Both O O 0.9999423027038574
TNF-alpha S-protein S-protein 0.979914128780365
and O O 0.9918087124824524
NF-kappa B-protein B-protein 0.9419280886650085
B E-protein E-protein 0.9964810609817505
are O O 0.9992462396621704
also O O 0.9999215602874756
involved O O 0.9999831914901733
in O O 0.9999974966049194
the O O 0.9999953508377075

, O O 0.9916150569915771
we O O 0.999968409538269
can O O 0.9999966621398926
conclude O O 0.9999996423721313
that O O 0.9999992847442627
electrostatic O O 0.9727200269699097
interactions O O 0.9991994500160217

by O O 0.9995869994163513
the O O 0.9999984502792358
inhibition O O 0.9965481162071228
of O O 0.9997555613517761
transcription O O 0.9492248892784119
of O O 0.999396800994873
certain O O 0.9971791505813599
pro-inflammatory B-protein B-protein 0.5516274571418762
mediators E-protein E-protein 0.9744817614555359
and O O 0.9859607219696045
adhesion B-protein B-protein 0.6610332131385803
molecules E-protein E-protein 0.9976722598075867
. O O 0.9999502897262573
Generation O O 0.9790332913398743
of O O 0.9998469352722168
cytotoxic B-cell_type B-cell_type 0.8243474960327148
T I-cell_type I-cell_type 0.949428915977478
lymphocytes E-cell_type E-cell_type 0.9888356328010559
against O O 0.9997180104255676
immunorecessive B-protein O 0.7096763253211975

than O O 0.9828793406486511
previously O O 0.9990021586418152
thought O O 0.999708354473114
. O O 0.9999973773956299
Monitoring O O 0.9995222091674805
DPD S-protein S-protein 0.9260669350624084
activity O O 0.9993353486061096
may O O 0.9999979734420776
be O O 0.9999994039535522
important O O 0.9999934434890747
in O O 0.9999978542327881
the O O 0.9999969005584717

average O O 0.9858074188232422
GR S-protein O 0.3149872422218323
concentration O O 0.8951907753944397
7131 O O 0.9572723507881165
+/- O O 0.9997560381889343
1256 O O 0.9955845475196838
sites/cell O O 0.9872481226921082
) O O 0.9998376369476318
correlated O O 0.9997202754020691
excellently O O 0.9999834299087524
with O O 0.9999992847442627

with O O 0.9992011189460754
a O O 0.9999808073043823
role O O 0.9956592917442322
for O O 0.9997527003288269
bcl-xL S-protein S-protein 0.9875498414039612
in O O 0.9997850060462952
mediating O O 0.9544103145599365
GATA-1 S-protein S-protein 0.9970355033874512
-induced O O 0.9979363679885864
erythroid O O 0.6286273002624512
cell O O 0.6001952290534973
survival O O 0.9740312099456787
, O O 0.9998103976249695
in O O 0.9999080896377563
vitro-differentiated B-cell_line B-cell_line 0.7751296162605286
bcl-xL-/- I-cell_line I-cell_line 0.7817111611366272
embryonic I-cell_line I-cell_line 0.9747705459594727
stem I-cell_line I-cell_line 0.991245687007904
cells E-cell_line E-cell_line 0.9961267113685608
fail O O 0.9966357350349426
to O O 0.9999672174453735
generate O O 0.9998830556869507
viable O O 0.9608328342437744
mature O B-cell_type 0.6115471124649048
definitive O I-cell_type 0.7182117700576782
erythroid B-cell_type I-cell_type 0.649722158908844
cells E-cell_type E-cell_type 0.9498479962348938
, O O 0.9986978769302368
a O O 0.9999890327453613
phenotype O O 0.7436672449111938
resembling O O 0.9963558912277222
that O O 0.9999891519546509
of O O 0.9999860525131226
GATA-1 B-DNA B-DNA 0.5316491723060608
gene E-DNA E-DNA 0.9353685975074768
disruption O O 0.9929728507995605
. O O 0.9999954700469971
In O O 0.9999791383743286
addition O O 0.999961256980896
, O O 0.9999959468841553
we O O 0.9999817609786987
show O O 0.9999991655349731
that O O 0.9999971389770508
erythropoietin S-protein S-protein 0.984086811542511
, O O 0.9983031749725342
which O O 0.9999388456344604
is O O 0.9999572038650513
also O O 0.9999369382858276
required O O 0.9999736547470093
for O O 0.9999889135360718
erythroid O O 0.4679173529148102

, O O 0.996566116809845
we O O 0.9999921321868896
demonstrate O O 0.9999979734420776
that O O 0.9999994039535522
GC-insensitive O O 0.8709274530410767
asthma O O 0.9820579290390015
is O O 0.999958872795105
associated O O 0.9999103546142578
with O O 0.9999985694885254
a O O 0.9999974966049194
significantly O O 0.999276340007782
higher O O 0.9998236298561096
number O O 0.9988767504692078
of O O 0.99997878074646
GCR-beta-immunoreactive B-cell_type B-protein 0.3554937541484833

differentiation O O 0.9854098558425903
. O O 0.9999942779541016
Similar O O 0.9999744892120361
results O O 0.9998897314071655
were O O 0.9999955892562866
obtained O O 0.9999887943267822
when O O 0.9999856948852539
HL60 B-cell_line B-cell_line 0.9010788798332214
cells E-cell_line E-cell_line 0.9993463158607483
were O O 0.9998192191123962
treated O O 0.9999638795852661
with O O 0.9999988079071045
5 O O 0.984882652759552
x O O 0.988810122013092
10 O O 0.9937164187431335
( O O 0.9998711347579956
-7 O O 0.9970487952232361
) O O 0.9997699856758118
all-trans O O 0.99793541431427
RA O O 0.9903968572616577
together O O 0.9999830722808838
with O O 0.9999994039535522
a O O 0.9999741315841675
wide O O 0.9820231795310974
range O O 0.9968057870864868
of O O 0.9998725652694702
concentrations O O 0.9867931008338928
of O O 0.9998644590377808
D3 O O 0.33829349279403687
. O O 0.99750816822052
Cross O O 0.9725590944290161
titration O O 0.989547610282898
analyses O O 0.9984326958656311

via O O 0.9865656495094299
activation O O 0.9920083284378052
of O O 0.9998513460159302
Jun B-protein B-protein 0.5082836151123047
kinase E-protein E-protein 0.9801859855651855
in O O 0.9990548491477966
cell O B-cell_line 0.6398666501045227
lines O E-cell_line 0.988012433052063
lacking O O 0.9992857575416565
p56 S-protein S-protein 0.8239911198616028
. O O 0.9941331744194031
Jun B-protein B-protein 0.4595978260040283
kinase E-protein E-protein 0.9583139419555664

, O O 0.9456976652145386
cGATA-3 S-protein S-protein 0.9726648330688477
, O O 0.9950670003890991
is O O 0.9999758005142212
most O O 0.99970942735672
abundantly O O 0.984095573425293
expressed O O 0.999750554561615
in O O 0.9999752044677734
the O O 0.9997747540473938
T-lymphocyte B-cell_type B-cell_type 0.4852656126022339
cell I-cell_type I-cell_type 0.3435182273387909
lineage E-cell_type E-cell_type 0.7691330909729004
. O O 0.9999788999557495
Analysis O O 0.9999892711639404
of O O 0.9999977350234985
human B-protein B-protein 0.5339593887329102
and I-protein I-protein 0.8551830649375916
murine I-protein I-protein 0.6526628732681274
GATA-3 I-protein I-protein 0.34955236315727234
factors E-protein E-protein 0.9788858294487
shows O O 0.9997895359992981

. O O 0.9964838027954102
Since O O 0.9999375343322754
CIITA S-protein S-protein 0.908780574798584
overexpression O O 0.9956165552139282
in O O 0.9998695850372314
normal B-cell_type B-cell_type 0.6368944644927979
cells E-cell_type E-cell_type 0.8585825562477112
did O O 0.9990012049674988
not O O 0.9999772310256958
increase O O 0.9998849630355835
class O O 0.9048822522163391
II O O 0.5323012471199036
expression O O 0.9950044751167297
, O O 0.9999966621398926
we O O 0.999967098236084
propose O O 0.9999984502792358
that O O 0.9999986886978149
initiation O O 0.9895346760749817
of O O 0.9998928308486938
CIITA S-protein S-protein 0.7331172823905945
expression O O 0.9845814108848572
serves O O 0.9993964433670044
as O O 0.9999982118606567
the O O 0.9999973773956299
on-off O O 0.9374287128448486
switch O O 0.900691568851471
, O O 0.999889612197876
while O O 0.999994158744812
availability O O 0.9987726807594299
of O O 0.9999716281890869
downstream O O 0.9641475081443787

c-fos O S-DNA 0.7724361419677734
and O O 0.9615228176116943
c-jun O O 0.5337516665458679
gene O O 0.732941746711731
expression O O 0.9910365343093872
. O O 0.9999936819076538
( O O 0.9997112154960632
ABSTRACT O O 0.9984886646270752
TRUNCATED O O 0.99972003698349
AT O O 0.9999964237213135
250 O O 0.9983742237091064
WORDS O O 0.999316930770874
) O O 0.9999732971191406
Kappa B-protein O 0.9655714631080627
B-specific I-protein O 0.9504181146621704

In O O 0.9697746634483337
promoter B-DNA B-DNA 0.7153008580207825
regions E-DNA E-DNA 0.9828790426254272
, O O 0.9999078512191772
the O O 0.9999707937240601
actively B-DNA O 0.8579199314117432
transcribed I-DNA O 0.9346122741699219
genes E-DNA O 0.5944849848747253
demonstrated O O 0.9999109506607056
extensive O O 0.9949617385864258
and O O 0.9974367022514343
consistent O O 0.9894652366638184
footprints O O 0.9036732316017151
over O O 0.9999381303787231
the O O 0.9999852180480957
canonical O B-DNA 0.6840358972549438
elements O E-DNA 0.9850063920021057
, O O 0.9982454776763916
such O O 0.9999650716781616
as O O 0.9999821186065674
CACCC B-DNA B-DNA 0.8842054009437561
and I-DNA I-DNA 0.9044419527053833
CCAAT I-DNA I-DNA 0.4538254737854004
motifs E-DNA E-DNA 0.9897290468215942
. O O 0.9999722242355347
The O O 0.9999969005584717
adult B-cell_type O 0.8122554421424866
globin I-cell_type O 0.42981019616127014
expressing I-cell_type O 0.4574449062347412
cells E-cell_type O 0.5770548582077026
displayed O O 0.9989373087882996
more O O 0.9996923208236694
extensive O O 0.977150559425354
footprints O O 0.9570180773735046

. O O 0.9977300763130188
We O O 0.9999433755874634
have O O 0.9999929666519165
developed O O 0.9999361038208008
a O O 0.9999924898147583
computational O O 0.962601363658905
approach O O 0.9996128678321838
to O O 0.9999918937683105
identify O O 0.9999628067016602
potential O O 0.9781449437141418
NFAT B-DNA B-DNA 0.6164863109588623
target I-DNA I-DNA 0.5572986602783203
genes E-DNA E-DNA 0.9908740520477295
which O O 0.9994550347328186
( O O 0.9993975162506104
a O O 0.9975534081459045
) O O 0.9973945617675781
comprises O O 0.9998830556869507
an O O 0.999972939491272
improved O O 0.9833588004112244
method O O 0.9822652339935303
to O O 0.9999346733093262
scan O O 0.9992806315422058
for O O 0.9998414516448975
individual O O 0.9421435594558716
NFAT B-DNA B-DNA 0.3444119095802307
composite I-DNA I-DNA 0.6713777780532837
elements E-DNA E-DNA 0.9821760058403015
; O O 0.999122679233551
( O O 0.9989581108093262
b O O 0.9767056107521057
) O O 0.9957376718521118
considers O O 0.9999508857727051
positional O O 0.88640958070755
effects O O 0.9990319013595581
relative O O 0.9998904466629028
to O O 0.9999703168869019

. O O 0.9992339611053467
These O O 0.9999986886978149
data O O 0.9998018145561218
suggest O O 0.9999994039535522
that O O 0.9999996423721313
the O O 0.9999631643295288
B29 B-DNA B-DNA 0.5626722574234009
gene E-DNA E-DNA 0.9907762408256531
is O O 0.9999408721923828
a O O 0.9999971389770508
genetic O O 0.968192994594574
target O O 0.9799925684928894
for O O 0.9999760389328003
EBF S-protein S-protein 0.9773632287979126
in O O 0.9999159574508667
early O O 0.7372006773948669
B-cell O O 0.5200046896934509
development O O 0.9925035238265991
. O O 0.9999969005584717
Delta-opioid O B-protein 0.572905957698822
receptors O E-protein 0.9837957620620728

for O O 0.9913456439971924
RANTES S-protein S-protein 0.9702947735786438
in O O 0.9998043179512024
T B-cell_type B-cell_type 0.9138875603675842
cells E-cell_type E-cell_type 0.9944685697555542
. O O 0.9998750686645508
Fas B-protein B-protein 0.45268872380256653
ligand E-protein E-protein 0.8883197903633118
induction O O 0.9931926131248474
in O O 0.999920129776001
human B-cell_type B-cell_type 0.47821828722953796
NK I-cell_type I-cell_type 0.8820472359657288
cells E-cell_type E-cell_type 0.9834370613098145
is O O 0.9995701909065247
regulated O O 0.9998902082443237
by O O 0.9999982118606567
redox O O 0.9620254635810852
through O O 0.9999394416809082

c-Rel S-protein B-protein 0.8001781105995178
NF-kappaB B-protein I-protein 0.4660831391811371
subunits E-protein E-protein 0.9857102632522583
was O O 0.999847412109375
present O O 0.9999843835830688
in O O 0.9999768733978271
nuclei O O 0.6524627804756165
of O O 0.9957547187805176
CD40-stimulated B-cell_line B-cell_type 0.4566228687763214
B I-cell_line I-cell_type 0.5855964422225952
cells E-cell_line E-cell_type 0.49263763427734375
. O O 0.9997166991233826
These O O 0.9999971389770508
results O O 0.9999268054962158
confirm O O 0.9999972581863403
at O O 0.9999988079071045
a O O 0.9999980926513672
molecular O O 0.9656943082809448
level O O 0.9997232556343079
the O O 0.9999979734420776
ability O O 0.9999794960021973
of O O 0.9999942779541016
HIV-1 O O 0.6419754028320312
to O O 0.9925243258476257

Expression O O 0.992233157157898
of O O 0.9999614953994751
the O O 0.9999730587005615
IL-2 B-DNA B-DNA 0.6508092284202576
gene E-DNA E-DNA 0.9861414432525635
requires O O 0.9998020529747009
activation O O 0.9986401200294495
of O O 0.9999574422836304
T B-cell_type B-cell_type 0.8486801385879517
cells E-cell_type E-cell_type 0.9891300201416016
through O O 0.9997434020042419
stimulation O O 0.9983585476875305
of O O 0.999982476234436
the O O 0.9999768733978271
TCR S-protein S-protein 0.7684135437011719
and O O 0.9668694734573364
costimulation O O 0.9332450032234192
through O O 0.9993690848350525
accessory B-protein B-protein 0.6002029180526733
receptors E-protein E-protein 0.9598734974861145

To O O 0.9658364057540894

) O O 0.7475271821022034
is O O 0.9993534684181213
essential O O 0.999967098236084
for O O 0.9999823570251465
viral O O 0.9385666847229004
replication O O 0.9937673807144165
and O O 0.9999525547027588
also O O 0.9999421834945679
shows O O 0.9999961853027344
pleiotropic O O 0.941421627998352
activities O O 0.998102605342865
on O O 0.9999963045120239
various O O 0.9841715693473816
cell O O 0.9271660447120667
functions O O 0.9898945689201355
. O O 0.9999973773956299
To O O 0.999988317489624
get O O 0.9999775886535645
further O O 0.999202311038971

stimuli O O 0.8173983097076416
that O O 0.9998358488082886
mimic O O 0.9998471736907959
the O O 0.9999810457229614
CD40 S-protein S-protein 0.9120329022407532
signaling O O 0.8709461092948914
cascade O O 0.9463872313499451
, O O 0.9998165965080261

kinase E-protein E-protein 0.9932804703712463
( O O 0.9900029897689819
MEK S-protein S-protein 0.9984819293022156
) O O 0.9819676876068115
, O O 0.9998812675476074
inhibited O O 0.9985004663467407
TPA-induced O O 0.7304612398147583
ERK2 S-protein S-protein 0.8292878270149231
activity O O 0.9996646642684937
. O O 0.9999994039535522
Furthermore O O 0.999996542930603
, O O 0.9999868869781494
PD98059 O O 0.9725286364555359
completely O O 0.9987490177154541
blocked O O 0.9999731779098511
the O O 0.9999957084655762
TPA-induced O O 0.9511904120445251
differentiation O O 0.9924531579017639
of O O 0.9998667240142822

lipoproteins E-protein E-protein 0.8357881903648376
decrease O O 0.9998908042907715
early O O 0.9932011961936951
production O O 0.9998194575309753
of O O 0.999996542930603
interleukin B-protein B-protein 0.7515285015106201
2 E-protein E-protein 0.9929803013801575
and O O 0.9969046711921692
nuclear B-protein B-protein 0.6420655846595764
factor I-protein I-protein 0.6731939315795898
kappaB E-protein E-protein 0.9593030214309692
binding O O 0.9700533151626587
to O O 0.9998083710670471
DNA O O 0.6681081056594849
in O O 0.9977726340293884
activated B-cell_type B-cell_type 0.6445944309234619
T-lymphocytes E-cell_type E-cell_type 0.6118202805519104
. O O 0.9997854828834534
Activated O B-cell_type 0.5653765797615051
T-lymphocytes O E-cell_type 0.7180505990982056
are O O 0.9995290040969849
found O O 0.9999804496765137
early O O 0.9995803236961365
in O O 0.9999889135360718

therapy O O 0.9528486728668213
and O O 0.9996415376663208
its O O 0.999985933303833
clinical O O 0.9923275113105774
significance O O 0.9999077320098877
. O O 0.9999967813491821
C-fos S-DNA S-protein 0.6220095157623291
has O O 0.9976544976234436
been O O 0.9999477863311768
reported O O 0.9998576641082764
to O O 0.9999847412109375
be O O 0.9999940395355225
one O O 0.9999816417694092
of O O 0.9999977350234985
the O O 0.9999988079071045
immediate B-DNA B-DNA 0.826614499092102
early I-DNA I-DNA 0.5270431637763977
genes E-DNA E-DNA 0.9818320274353027
in O O 0.9999063014984131
signal O O 0.8215157389640808
transduction O O 0.855126678943634
systems O O 0.873557984828949
after O O 0.9999932050704956

receptor E-protein E-protein 0.9885106086730957
( O O 0.9914759397506714
TCDD B-protein B-protein 0.592910647392273
receptor E-protein E-protein 0.9855542182922363
) O O 0.9577094912528992
during O O 0.9998764991760254
human O O 0.6190446019172668
monocytic O O 0.6705148816108704
differentiation O O 0.9802210330963135
. O O 0.9999772310256958
We O O 0.9999638795852661
have O O 0.9999960660934448
previously O O 0.9999667406082153
found O O 0.9999958276748657
a O O 0.999997615814209
high O O 0.9673542976379395
expression O O 0.9945271611213684
of O O 0.999970555305481
human B-RNA B-RNA 0.5151122808456421
Ah I-RNA I-RNA 0.9269964694976807
receptor I-RNA I-RNA 0.9038833379745483
( I-RNA I-RNA 0.9387362599372864
TCDD I-RNA I-RNA 0.9962612986564636
receptor I-RNA I-RNA 0.9980401396751404
) I-RNA I-RNA 0.986013650894165
mRNA E-RNA E-RNA 0.9097508788108826
in O O 0.998488187789917
peripheral B-cell_type B-cell_type 0.8290838003158569
blood I-cell_type I-cell_type 0.9702191352844238
cells E-cell_type E-cell_type 0.9873973727226257
of O O 0.998480498790741
individuals O O 0.996997594833374
. O O 0.999995231628418
In O O 0.9999926090240479
this O O 0.9999939203262329
paper O O 0.9959322810173035
, O O 0.9999918937683105
the O O 0.9999921321868896

is O O 0.9944868683815002

the O O 0.9987733960151672
HIV-1 O B-DNA 0.7100045680999756
NF-kB S-protein I-DNA 0.3467687666416168
probe O E-DNA 0.9130637645721436
and O O 0.99849534034729
nuclear O O 0.843854546546936
extracts O O 0.9789271950721741
from O O 0.9999345541000366
PMA-treated B-cell_type B-cell_line 0.6721956729888916
cells E-cell_type E-cell_line 0.9118786454200745
, O O 0.9771423935890198
showed O O 0.9999963045120239
significantly O O 0.9998946189880371
reduced O O 0.999739944934845
induction O O 0.9992054104804993
of O O 0.9999899864196777
nuclear B-protein B-protein 0.6412986516952515
NF-kB I-protein I-protein 0.5728167295455933
binding I-protein I-protein 0.8600415587425232
proteins E-protein E-protein 0.9976025223731995
in O O 0.9999747276306152
these O O 0.9999890327453613
two O O 0.9976063966751099
subclones O O 0.9717777371406555

which O O 0.993747353553772

genes E-DNA E-DNA 0.918839156627655
induced O O 0.9996002316474915
by O O 0.9999862909317017
interferon-alpha B-cell_line S-protein 0.9584154486656189
in I-cell_line O 0.9995802044868469
U937 I-cell_line B-cell_line 0.9507655501365662
cells E-cell_line E-cell_line 0.9987784028053284
. O O 0.9999136924743652
Binding O O 0.9880176782608032
of O O 0.9997143149375916
type B-protein B-protein 0.5225945711135864
I I-protein I-protein 0.8636589646339417
interferon I-protein E-protein 0.9882232546806335
( I-protein O 0.986809492111206
IFN-alpha/beta I-protein S-protein 0.9973294734954834
) I-protein O 0.9917566776275635
to I-protein O 0.9999774694442749
specific I-protein O 0.9290359020233154
receptors E-protein O 0.8243929743766785
results O O 0.9998852014541626
in O O 0.9999970197677612
the O O 0.9999970197677612
rapid O O 0.9892767667770386
transcriptional O O 0.9842628836631775
activation O O 0.9988609552383423
, O O 0.9999881982803345
independent O O 0.9963780045509338
of O O 0.9999629259109497
protein O O 0.5584743618965149
synthesis O O 0.7987031936645508
, O O 0.9978837370872498
of O O 0.9999655485153198
IFN-alpha-stimulated B-DNA B-DNA 0.4882931709289551
genes E-DNA E-DNA 0.9905903339385986
( O O 0.9961613416671753

cells O E-cell_type 0.5205051898956299

and O O 0.9376595616340637

these O O 0.9979313611984253
glucocorticoid B-protein B-protein 0.7929618954658508
receptors E-protein E-protein 0.9977838397026062
. O O 0.9999517202377319
In B-protein B-protein 0.9912885427474976
vitro I-protein I-protein 0.9329650402069092
translated I-protein I-protein 0.8787077069282532
hGR E-protein E-protein 0.7639766335487366
was O O 0.9997884631156921
capable O O 0.9998286962509155
of O O 0.999983549118042
selective O O 0.9338743090629578
DNA O O 0.874652087688446
binding O O 0.9824934005737305
even O O 0.9996384382247925
in O O 0.9999256134033203

-mediated O O 0.9711105227470398
activation O O 0.9981369972229004
of O O 0.9999862909317017
NF-kappa B-protein B-protein 0.8943511843681335
B E-protein E-protein 0.9934425354003906
and O O 0.9966585636138916
cytotoxicity O O 0.9402172565460205
involves O O 0.9999240636825562
the O O 0.9999959468841553
intracellular O O 0.9381631016731262
formation O O 0.9960086345672607
of O O 0.9999843835830688
reactive O O 0.8983667492866516
oxygen O O 0.8834583759307861
intermediates O O 0.8801457285881042
. O O 0.9999922513961792
Therefore O O 0.9999921321868896
, O O 0.9999841451644897
Tat S-protein S-protein 0.9985802173614502
-mediated O O 0.9975160360336304
effects O O 0.9999293088912964
on O O 0.9999961853027344
the O O 0.9999914169311523
cellular O O 0.8641166090965271
redox O O 0.8651363849639893
state O O 0.9177497625350952
were O O 0.9998632669448853
analyzed O O 0.9996551275253296
. O O 0.9999978542327881
In O O 0.9999402761459351
both O O 0.9987396597862244
T B-cell_type B-cell_type 0.7412109971046448
cells E-cell_type E-cell_type 0.9716192483901978
and O O 0.9990377426147461
HeLa B-cell_line B-cell_line 0.9290788173675537
cells E-cell_line E-cell_line 0.9963309168815613
HIV-1 B-protein O 0.5887546539306641

experimentally O O 0.791767418384552
derived O O 0.9113500118255615
B-lymphoblastoid B-cell_line B-cell_line 0.3543408215045929
cell I-cell_line I-cell_line 0.6031787395477295
line E-cell_line E-cell_line 0.9913842678070068
, O O 0.996504545211792
clone B-cell_line B-cell_line 0.4919794499874115
13 E-cell_line E-cell_line 0.9940302968025208
, O O 0.9888644218444824
expresses O O 0.9995899796485901
high O O 0.9748124480247498
levels O O 0.9992850422859192
of O O 0.9999827146530151
HLADQ S-protein S-protein 0.5679407715797424
in O O 0.9994995594024658
the O O 0.9999923706054688
absence O O 0.9997588992118835
of O O 0.9999856948852539
HLA-DR S-DNA S-protein 0.715354323387146
and O O 0.964863121509552
HLA-DP S-DNA S-protein 0.615821123123169
, O O 0.9963584542274475
despite O O 0.9999953508377075
its O O 0.9999961853027344
mapping O O 0.9936313033103943
by O O 0.9999699592590332

as O O 0.9982006549835205

level O O 0.9717193245887756
of O O 0.9996161460876465
CREB S-protein B-protein 0.8614129424095154
protein O E-protein 0.9423432946205139
was O O 0.9995444416999817
observed O O 0.9998171925544739
. O O 0.9999970197677612
Phosphorylation O O 0.9917436242103577
of O O 0.9999253749847412
CREB S-protein S-protein 0.9162229895591736
occurred O O 0.999870777130127
through O O 0.9999957084655762
a O O 0.9999880790710449
herbimycin O O 0.8262783885002136
A O O 0.8867052793502808
and O O 0.9958230257034302
Rp-cAMP- O O 0.9501017332077026
sensitive O O 0.9758648872375488
pathway O O 0.9990411400794983
, O O 0.9999942779541016
suggesting O O 0.9999905824661255
phosphorylation O O 0.997769832611084
required O O 0.9999687671661377
antecedent O O 0.9791958332061768
activation O O 0.9984242916107178
of O O 0.9999922513961792
both O O 0.9998472929000854
protein B-protein B-protein 0.7681505680084229
tyrosine I-protein I-protein 0.9543101787567139
kinases E-protein E-protein 0.9905675053596497

days O O 0.9688522815704346
of O O 0.9991138577461243
adherence O O 0.9978341460227966
to O O 0.9999314546585083
plastic O O 0.74022376537323
. O O 0.9947490096092224
IL-4 S-protein S-protein 0.9677353501319885
had O O 0.9998900890350342
no O O 0.9999850988388062
significant O O 0.9995396137237549
effect O O 0.9999918937683105
on O O 0.9999927282333374
HIV O O 0.8043982982635498
reverse O O 0.783321738243103
transcription O O 0.9920376539230347
. O O 0.9999961853027344
The O O 0.9999994039535522
effect O O 0.9999690055847168
of O O 0.9999977350234985
both O O 0.9998593330383301
cytokines S-protein S-protein 0.9852258563041687
on O O 0.9999730587005615
the O O 0.9998811483383179
monocyte O O 0.3155764043331146
maturation/differentiation O O 0.5769528150558472
( O O 0.8924834132194519
CD11b S-protein S-protein 0.9492406845092773
, O O 0.9831574559211731
CD13 S-protein S-protein 0.9826915860176086
, O O 0.991204023361206
and O O 0.9987316727638245
CD26 S-protein S-protein 0.9771510362625122

to O O 0.9993324875831604
our O O 0.9999743700027466
understanding O O 0.9998986721038818
of O O 0.9999890327453613
neutrophil B-cell_type O 0.7879988551139832
biology E-cell_type O 0.9891344308853149
. O O 0.9999984502792358
Two O O 0.9998695850372314
distinct O O 0.9996117949485779
pathways O O 0.9941806197166443
of O O 0.9999510049819946
interleukin-5 S-protein S-protein 0.7793234586715698
synthesis O O 0.961451530456543
in O O 0.9999566078186035
allergen-specific B-cell_line B-cell_line 0.6242730617523193
human I-cell_line I-cell_line 0.804843544960022
T-cell I-cell_line I-cell_line 0.9001860618591309
clones E-cell_line E-cell_line 0.9984846711158752
are O O 0.9996780157089233
suppressed O O 0.9994489550590515
by O O 0.9999969005584717
glucocorticoids O O 0.9693509340286255
. O O 0.999963641166687
Glucocorticoids O O 0.978317379951477
( O O 0.9984567165374756
GC O O 0.9773106575012207
) O O 0.999420166015625
have O O 0.9999991655349731

the O O 0.9989113807678223
observed O O 0.9620786309242249
repertoire O O 0.8905400633811951
heterogeneity O O 0.8617950677871704
, O O 0.9995847344398499
all O O 0.9998898506164551
clones O O 0.9335036873817444
displayed O O 0.9999498128890991
a O O 0.9999890327453613
narrow O O 0.9307402968406677
range O O 0.9927466511726379
of O O 0.9999332427978516
MHC S-protein S-protein 0.34951433539390564
/peptide O O 0.5583551526069641
density O O 0.8975210785865784
requirements O O 0.9914786219596863
in O O 0.9999957084655762
cytotoxicity O O 0.8779898881912231
assays O O 0.9944449067115784
( O O 0.9999498128890991
ED50 O O 0.936829149723053
between O O 0.9998670816421509
9 O O 0.998680055141449
and O O 0.999953031539917
36 O O 0.9995817542076111
nM O O 0.9991589784622192
) O O 0.9999241828918457
. O O 0.9999958276748657
TCR S-protein S-protein 0.5546265244483948

total B-protein O 0.9460768699645996
IgG-AECA E-protein S-protein 0.8966639041900635
from O O 0.9997987151145935
the O O 0.9999804496765137
Takayasu O O 0.6731448769569397
arteritis O O 0.7497146129608154
patient O O 0.7695239186286926
. O O 0.9999200105667114
The O O 0.999997615814209
binding O O 0.9245565533638
of O O 0.9966818690299988
the O O 0.9997130036354065
mAECA S-protein S-protein 0.31772446632385254
to O O 0.7028101086616516

important O O 0.9851710200309753

. O O 0.9981198906898499
By O O 0.9999228715896606
isolating O O 0.9868361949920654
Daudi B-cell_line B-cell_line 0.33435097336769104
x I-cell_line I-cell_line 0.4434505105018616
HeLa I-cell_line I-cell_line 0.6778145432472229
heterokaryons E-cell_line E-cell_line 0.9813775420188904
a O O 0.9990755319595337
few O O 0.9996298551559448
hours O O 0.999745786190033
after O O 0.999981164932251
fusion O O 0.9937312006950378
, O O 0.9999876022338867
we O O 0.9999915361404419
have O O 0.9999970197677612
studied O O 0.9998810291290283
the O O 0.9999895095825195

pregnant O O 0.8864715695381165

which O O 0.9954133629798889
was O O 0.9998639822006226
shown O O 0.9999837875366211
to O O 0.9999947547912598
contain O O 0.999951958656311
E2F-4 S-protein S-protein 0.9741308689117432
, O O 0.9928060173988342
DP-1 S-protein S-protein 0.9935399889945984
and O O 0.9965453743934631
p130 S-protein S-protein 0.9807931184768677
, O O 0.9975934624671936
indicating O O 0.9999866485595703
that O O 0.9999979734420776
all O O 0.9986031651496887
quiescent B-cell_type B-cell_type 0.69472736120224
haemopoietic I-cell_type I-cell_type 0.37152811884880066
cells E-cell_type E-cell_type 0.6169410347938538
have O O 0.9998308420181274
the O O 0.9999983310699463
same O O 0.9999771118164062
complex O O 0.880047619342804
. O O 0.9998465776443481
Examination O O 0.9999508857727051
of O O 0.9999973773956299
18 O O 0.9578148126602173
AML O O 0.5262532234191895
samples O O 0.6635380387306213
by O O 0.9999964237213135
EMSA O O 0.9493686556816101
revealed O O 0.9999351501464844
the O O 0.9999988079071045
presence O O 0.9997239708900452
of O O 0.9999932050704956
E2F S-protein S-protein 0.8792332410812378
binding O O 0.9795834422111511
and O O 0.9998748302459717
no O O 0.9998818635940552
gross O O 0.9590175747871399
abnormalities O O 0.9865728616714478
were O O 0.9999946355819702
detected O O 0.9999605417251587
. O O 0.9999986886978149
An O O 0.9997910857200623
E2F-4/p130 B-protein B-protein 0.3216214179992676
complex E-protein E-protein 0.9789888858795166
was O O 0.9998273849487305
detected O O 0.999976396560669
in O O 0.9999713897705078
representative O O 0.9699020385742188

, O O 0.9373978972434998

in O O 0.9987697005271912
Callithrix O O 0.6156032085418701
jacchus O O 0.625261127948761
. O O 0.9993773102760315
These O O 0.9999842643737793
are O O 0.9999345541000366
: O O 0.9997698664665222
helper-inducer B-cell_type B-cell_type 0.4855302572250366
( I-cell_type I-cell_type 0.792195737361908
memory I-cell_type I-cell_type 0.3850804567337036
) I-cell_type I-cell_type 0.5198251605033875
T I-cell_type I-cell_type 0.743326723575592
cells E-cell_type E-cell_type 0.7605687379837036
( O O 0.9945034980773926
CD4+CD45R0+CD45RA-CD29highCD11a+ S-cell_type S-cell_line 0.9062595963478088
) O O 0.6579961776733398
, O O 0.9516106843948364
CD20+ B-cell_type B-cell_type 0.8919525742530823
B I-cell_type I-cell_type 0.9650593996047974
cells E-cell_type E-cell_type 0.9080238938331604
, O O 0.9728398323059082
and O O 0.9980366826057434
cytotoxic B-cell_type B-cell_type 0.8412793278694153
T I-cell_type I-cell_type 0.9256940484046936
cells E-cell_type E-cell_type 0.9528574347496033
( O O 0.9929012060165405
CD8+CD56+/CD57+ S-cell_type S-cell_type 0.5590580105781555
) O O 0.8338788151741028
. O O 0.9997732043266296
Furthermore O O 0.9999878406524658
, O O 0.9999898672103882
68 O O 0.7144349813461304
triple-labellings O O 0.43451881408691406
with O O 0.9996215105056763
mAbs S-protein S-protein 0.907629132270813
were O O 0.9995738863945007
performed O O 0.9998745918273926
on O O 0.9999264478683472
the O O 0.9998527765274048
cells O O 0.9690866470336914
of O O 0.999921441078186
each O O 0.9996129870414734

VDR B-RNA B-RNA 0.8636041879653931
mRNA E-RNA E-RNA 0.9979738593101501
, O O 0.9845725297927856
and O O 0.9998843669891357
to O O 0.9999644756317139
use O O 0.9999592304229736
these O O 0.9999561309814453
to O O 0.999735414981842
examine O O 0.999990701675415
the O O 0.9999860525131226
role O O 0.997642457485199
of O O 0.9996819496154785
1 O B-protein 0.7484526038169861
, O I-protein 0.8738085031509399
25 O I-protein 0.8739068508148193

The O O 0.9997122883796692
maximum O O 0.9927974343299866
levels O O 0.9999057054519653
of O O 0.9999966621398926
these O O 0.9999721050262451
markers O O 0.9465674161911011
induced O O 0.9998632669448853
by O O 0.9999879598617554
ML-9 O S-protein 0.879470705986023
were O O 0.9997549653053284
comparable O O 0.9998175501823425
to O O 0.9999909400939941
those O O 0.9999847412109375
induced O O 0.9997758269309998
by O O 0.9999915361404419
VD3 O O 0.49411290884017944
, O O 0.9920090436935425
but O O 0.9998928308486938
after O O 0.9999943971633911
removal O O 0.9998877048492432
of O O 0.9999936819076538
ML-9 O S-protein 0.6326674818992615
from O O 0.9982287287712097

treatment O O 0.9847961664199829
of O O 0.999819815158844
T B-cell_type B-cell_type 0.8897978067398071
cells E-cell_type E-cell_type 0.9915127158164978
with O O 0.9998457431793213
calcium O O 0.9047019481658936
ionophores O O 0.8636674880981445
alone O O 0.9962371587753296
, O O 0.9999395608901978
via O O 0.999993085861206
a O O 0.9999655485153198
calcineurin S-protein S-protein 0.9925204515457153
-dependent O O 0.9927687644958496
process O O 0.9997803568840027

in O O 0.9995071887969971
the O O 0.9999867677688599
TCR-alpha B-DNA B-DNA 0.4865206182003021
and I-DNA I-DNA 0.6613981127738953
CD3-epsilon I-DNA I-DNA 0.6690798997879028
enhancers E-DNA E-DNA 0.9971901774406433
imply O O 0.9999057054519653
an O O 0.9999912977218628
important O O 0.9991570711135864
role O O 0.9994179010391235
for O O 0.9999516010284424
TCF-1 S-protein S-protein 0.9899560213088989
in O O 0.9999500513076782
the O O 0.9999953508377075
establishment O O 0.9989707469940186
of O O 0.9999916553497314
the O O 0.9999666213989258
mature B-cell_type O 0.6859455704689026
T I-cell_type O 0.6335596442222595
cell I-cell_type O 0.467362642288208
phenotype E-cell_type O 0.37856969237327576
. O O 0.9995020627975464
Cloning O O 0.9703007340431213
of O O 0.999823272228241
a O O 0.9999468326568604
human B-DNA B-cell_line 0.48898449540138245

immune O O 0.8678154349327087
function O O 0.9970530271530151
and O O 0.9999204874038696
impaired O O 0.9936304688453674
activation O O 0.9944394826889038
of O O 0.9999072551727295
the O O 0.9999821186065674
transcription B-protein B-protein 0.7060971856117249
factor E-protein E-protein 0.9887463450431824
, O O 0.9969522953033447
NF-kappaB S-protein S-protein 0.9987927675247192
. O O 0.9999375343322754
We O O 0.9999071359634399
determined O O 0.9999935626983643
the O O 0.9999988079071045
mechanism O O 0.998955488204956
of O O 0.9999895095825195
NF-kappaB S-protein S-protein 0.9973946809768677
suppression O O 0.9995543360710144
in O O 0.9999511241912842
T B-cell_type B-cell_type 0.8926935195922852
cells E-cell_type E-cell_type 0.9943195581436157

activity O O 0.9920004606246948

cells E-cell_type E-cell_type 0.5372753143310547
. O O 0.9999227523803711
Differential O O 0.9966716766357422
regulation O O 0.999049723148346
of O O 0.9999918937683105
coproporphyrinogen B-DNA B-DNA 0.511971652507782
oxidase I-DNA I-DNA 0.6986008882522583
gene E-DNA E-DNA 0.9754675030708313
between O O 0.9986360669136047
erythroid B-cell_type B-protein 0.42386555671691895

, O O 0.9148140549659729
and O O 0.9872401356697083
potentially O O 0.9721248149871826
novel B-protein B-protein 0.9306306838989258
proteins E-protein E-protein 0.9409509897232056
( O O 0.9968820810317993
around O O 0.9964058995246887
35 B-protein B-protein 0.6752185821533203
kDa E-protein E-protein 0.827612042427063
) O O 0.8763540983200073
can O O 0.9998513460159302
bind O O 0.9998599290847778
to O O 0.999996542930603
this O O 0.9999920129776001
important O O 0.9857800602912903
sequence O O 0.8307783007621765
. O O 0.9999885559082031
Mutations O O 0.998293936252594
at O O 0.9999954700469971
different O O 0.9992374181747437
sites O O 0.9728007912635803
within O O 0.9999570846557617
this O O 0.9999692440032959
proximal B-DNA B-DNA 0.7617248296737671
promoter I-DNA I-DNA 0.5180646777153015
region E-DNA E-DNA 0.9980790615081787
abolished O O 0.9998354911804199
the O O 0.9999290704727173
promoter O O 0.5271745324134827
activity O O 0.9476284384727478
as O O 0.9997543692588806
well O O 0.999841570854187
as O O 0.9999959468841553

IL-13 S-protein S-protein 0.8667884469032288

interleukin-2 I-DNA B-DNA 0.5015311241149902
receptor I-DNA I-DNA 0.3610825836658478
beta-chain I-DNA I-DNA 0.6082743406295776
promoter E-DNA E-DNA 0.9957144856452942
through O O 0.9998113512992859
noncanonical B-DNA O 0.633608877658844
Egr I-DNA S-protein 0.24116690456867218

seven O O 0.996792733669281
cases O O 0.9992372989654541
with O O 0.9999967813491821
TMD O O 0.9878119826316833
in O O 0.999997615814209
this O O 0.9999978542327881
study O O 0.9992091059684753
. O O 0.9999946355819702
Erythroid-specific B-RNA B-RNA 0.5368410348892212
mRNAs E-RNA E-RNA 0.8372170925140381
encoding O O 0.9752680063247681
gamma-globin S-protein S-protein 0.8803092837333679
and O O 0.9861672520637512
erythroid B-protein B-protein 0.7451227903366089
delta-aminolevulinate I-protein I-protein 0.49152088165283203
synthase E-protein E-protein 0.9634212255477905
were O O 0.9998666048049927

Differential O O 0.9385072588920593
interaction O O 0.9969456791877747
of O O 0.9999830722808838
nuclear O B-protein 0.6544519066810608
factors O E-protein 0.9860779047012329
with O O 0.9998111128807068
the O O 0.9999887943267822
PRE-I B-DNA B-DNA 0.33692851662635803
enhancer I-DNA I-DNA 0.29406872391700745
element E-DNA E-DNA 0.9690631628036499
of O O 0.9976874589920044
the O O 0.9999157190322876
human B-DNA B-DNA 0.7733954191207886
IL-4 I-DNA I-DNA 0.8585168123245239
promoter E-DNA E-DNA 0.977822482585907

are O O 0.9978353381156921
only O O 0.9998948574066162
present O O 0.9996696710586548
in O O 0.9998693466186523
megakaryocytic B-cell_line B-cell_type 0.6085909008979797
cells E-cell_line E-cell_type 0.8101841807365417
. O O 0.9998961687088013
In O O 0.999985933303833
addition O O 0.999984860420227
, O O 0.9999964237213135
deletion O O 0.9950547218322754
of O O 0.9999598264694214
the O O 0.9999922513961792
region O O 0.9644043445587158
containing O O 0.9995198249816895
these O O 0.9999570846557617
two O O 0.9912715554237366
domains O O 0.9380689263343811
results O O 0.9999929666519165
in O O 0.9999940395355225
a O O 0.9999955892562866
significant O O 0.9996108412742615
decrease O O 0.9999521970748901
of O O 0.9999961853027344
the O O 0.9999781847000122
promoter S-DNA O 0.8199728727340698
activity O O 0.9959847927093506
. O O 0.9999958276748657
It O O 0.9999866485595703
is O O 0.9999960660934448
very O O 0.999992847442627
likely O O 0.9999980926513672
that O O 0.9999991655349731
these O O 0.9999270439147949
domains O O 0.9565494656562805
bind O O 0.9977422952651978
megakaryocyte-specific B-protein B-protein 0.47069618105888367
nuclear I-protein I-protein 0.8162460327148438
proteins E-protein E-protein 0.996645987033844
acting O O 0.9974915981292725
as O O 0.99998939037323
positive B-protein B-protein 0.6187179088592529
transcription I-protein I-protein 0.4600765109062195
factors E-protein E-protein 0.9951444268226624
. O O 0.999923825263977
Lymphocyte O B-protein 0.672934353351593
glucocorticoid B-protein I-protein 0.8303218483924866
receptor E-protein E-protein 0.9884136319160461
binding O O 0.9759767651557922
during O O 0.9998964071273804
depression O O 0.9949900507926941
and O O 0.9999747276306152
after O O 0.9999711513519287
clinical O O 0.9937065243721008
recovery O O 0.9997995495796204

These O O 0.9988698363304138
stimuli O O 0.9936738014221191
also O O 0.9999858140945435
induced O O 0.9999936819076538
the O O 0.9999970197677612
stress-activated O O 0.9193562269210815
kinase O O 0.7610548138618469
pathway O O 0.9278749823570251
( O O 0.9989470839500427
SAPK S-protein S-protein 0.8368765711784363
/JNK S-protein O 0.6955903172492981
) O O 0.989568293094635
, O O 0.9999086856842041
which O O 0.999983549118042
was O O 0.9999822378158569
required O O 0.999988317489624
for O O 0.9999971389770508
the O O 0.9999949932098389
maximal O O 0.98646080493927
induction O O 0.9991662502288818
of O O 0.9999873638153076
apoptosis O O 0.9934699535369873
. O O 0.9999951124191284
A O O 0.9998902082443237
1.2 O B-DNA 0.5438463091850281
kb O I-DNA 0.5889021754264832
FasL B-DNA I-DNA 0.5479284524917603
promoter E-DNA E-DNA 0.993232011795044
responded O O 0.9997027516365051
to O O 0.9997984766960144

nuclear B-protein B-protein 0.587081253528595
factor E-protein E-protein 0.8708229660987854
recruitment O O 0.9500262141227722
in O O 0.9999009370803833
human B-cell_type B-cell_type 0.47843053936958313
glial I-cell_type I-cell_type 0.8678914308547974
cells I-cell_type E-cell_type 0.9795798063278198
and I-cell_type O 0.9896931052207947
lymphocytes E-cell_type S-cell_type 0.9946512579917908
. O O 0.9998629093170166
The O O 0.9999964237213135
generation O O 0.9913079142570496
of O O 0.9998652935028076
genomic O O 0.8517895936965942
diversity O O 0.9953546524047852
during O O 0.9999823570251465
the O O 0.9999977350234985
course O O 0.999572217464447
of O O 0.9999861717224121
infection O O 0.9988100528717041

in O O 0.9965315461158752
vivo O O 0.9981511235237122
. O O 0.9999908208847046
Thus O O 0.999678373336792
, O O 0.9999282360076904
STAT1 S-protein S-protein 0.9969345331192017
may O O 0.9999090433120728
be O O 0.9999983310699463
a O O 0.999996542930603
useful O O 0.9964307546615601
target O O 0.9937213659286499
in O O 0.9999905824661255
the O O 0.9999969005584717
development O O 0.999906063079834
of O O 0.9999983310699463
new O O 0.9873878359794617
immunosuppressive O O 0.8991225361824036
and O O 0.9871560335159302
antineoplastic O O 0.967261016368866
agents O O 0.9934712648391724
. O O 0.9999985694885254
Studies O O 0.9999524354934692
into O O 0.9999966621398926
the O O 0.9999966621398926
effect O O 0.9999407529830933
of O O 0.9999940395355225
tyrosine B-protein B-protein 0.7669995427131653
phosphatase E-protein E-protein 0.9532846212387085
inhibitor O O 0.9112383723258972
phenylarsine O O 0.9607462286949158
oxide O O 0.970130205154419
on O O 0.9999126195907593
NFkappaB S-protein S-protein 0.9828574657440186
activation O O 0.9991149306297302
in O O 0.9999881982803345

lines E-cell_line E-cell_line 0.9924101829528809
correlates O O 0.9990270137786865
with O O 0.9999877214431763
the O O 0.9999914169311523
proliferative O O 0.9651529788970947
status O O 0.9990749359130859
of O O 0.999993085861206
the O O 0.9999624490737915
cells O O 0.9701029062271118
, O O 0.9999606609344482
members O O 0.9984000325202942
of O O 0.9999831914901733
the O O 0.9999872446060181
EB1-like B-DNA B-protein 0.49334049224853516
gene I-DNA I-protein 0.5564436912536621
family E-DNA E-protein 0.6722635626792908
may O O 0.9993351101875305
not O O 0.9999849796295166
only O O 0.9999923706054688
be O O 0.9999903440475464

at O O 0.9995138645172119
the O O 0.9999974966049194
G2/M O O 0.34402114152908325
interphase O O 0.4586787521839142
was O O 0.9956929087638855
not O O 0.9997581839561462
observed O O 0.9998548030853271
. O O 0.9999972581863403
These O O 0.9999964237213135
features O O 0.9942871928215027
are O O 0.999992847442627
very O O 0.9999608993530273
different O O 0.9999923706054688
from O O 0.9999947547912598
those O O 0.9999655485153198
observed O O 0.9994193315505981
in O O 0.9999438524246216
B104 B-cell_line O 0.8368436694145203
cell E-cell_line O 0.7614855170249939
death O O 0.5252465605735779
induced O O 0.9992928504943848
by O O 0.999992847442627
anti-IgM B-protein B-protein 0.756925106048584
Ab E-protein E-protein 0.9991956353187561
. O O 0.9999362230300903
Neither O O 0.9999884366989136
DNA O O 0.8439309597015381
fragmentation O O 0.9722253084182739

Oct-2 S-protein S-protein 0.9522202610969543
and O O 0.9903349876403809
nuclear B-protein B-protein 0.6033836603164673
factor I-protein I-protein 0.7493531107902527
( I-protein I-protein 0.6909679770469666
NF I-protein I-protein 0.8898305892944336
) I-protein I-protein 0.907245934009552
kappa I-protein I-protein 0.8701075911521912
B E-protein E-protein 0.988350510597229
, O O 0.9961887001991272
known O O 0.9999711513519287
to O O 0.9999871253967285
be O O 0.9999947547912598
important O O 0.9998860359191895
in O O 0.9999358654022217
Ig S-protein B-DNA 0.4459973871707916
gene O E-DNA 0.9801187515258789
transcription O O 0.9756046533584595
were O O 0.9999954700469971
examined O O 0.9999040365219116
. O O 0.9999918937683105
Oct-2 B-RNA B-RNA 0.9571744799613953
mRNA E-RNA E-RNA 0.9874513745307922

human O O 0.6086307168006897
immunodeficiency O O 0.8504267930984497
virus O O 0.9254075288772583
type O O 0.9455611109733582
1 O O 0.9469829797744751
. O O 0.9998548030853271
Therefore O O 0.9999746084213257
, O O 0.9999852180480957
the O O 0.9999980926513672
surprisingly O O 0.9850836396217346
high O O 0.9942558407783508
replicative O O 0.9853801131248474
capacity O O 0.9991074204444885
of O O 0.9999897480010986
NF-kappaB O S-protein 0.9596108198165894
and O O 0.9944065809249878

. O O 0.9985141158103943
Thus O O 0.9999579191207886
, O O 0.9999905824661255
the O O 0.9999949932098389
RAR-RXR S-protein S-protein 0.9185794591903687
response O O 0.969131588935852
pathway O O 0.9991266131401062
can O O 0.9999967813491821
signal O O 0.9998599290847778
growth O O 0.9973847270011902
inhibition O O 0.9997343420982361
of O O 0.9999918937683105
normal B-cell_type O 0.5089504718780518
bone I-cell_type O 0.530739426612854

evaluated O O 0.9960530996322632
the O O 0.9999887943267822
activation O O 0.9974736571311951
of O O 0.9999191761016846
JAK S-protein S-protein 0.9984660148620605
/STAT S-protein S-protein 0.9991133809089661
pathway O O 0.9986771941184998
upon O O 0.9999537467956543
human B-protein B-protein 0.8303264379501343
interleukin-5 E-protein E-protein 0.7309460639953613
( O O 0.927897572517395
hIL-5 S-protein S-protein 0.8074348568916321
) O O 0.8640621304512024
stimulation O O 0.9872170090675354
of O O 0.9999337196350098
two O O 0.9809102416038513

Cell-mediated O O 0.8784883618354797
immunity O O 0.9983384609222412
plays O O 0.999997615814209
an O O 0.9999978542327881
essential O O 0.9999446868896484
role O O 0.9999853372573853
in O O 0.9999986886978149
the O O 0.9999982118606567
control O O 0.999396800994873
of O O 0.9999793767929077
infection O O 0.9983583092689514
with O O 0.9999969005584717
the O O 0.9999854564666748
human O O 0.8310955166816711
cytomegalovirus O O 0.8301594853401184
( O O 0.9952227473258972
HCMV O O 0.9851603507995605
) O O 0.999300479888916
. O O 0.9999972581863403
However O O 0.9999872446060181
, O O 0.9999921321868896
only O O 0.9999834299087524
a O O 0.9999779462814331
few O O 0.9993484616279602
CD8 B-protein B-cell_type 0.4540838897228241
( I-protein I-cell_type 0.6854636073112488
+ I-protein I-cell_type 0.9170602560043335
) I-protein I-cell_type 0.9107926487922668
-T-cell I-protein I-cell_type 0.8929271101951599
epitopes E-protein E-cell_type 0.47066110372543335
are O O 0.9946656227111816
known O O 0.9998551607131958
, O O 0.999961256980896
with O O 0.9999955892562866
the O O 0.9999932050704956
majority O O 0.9940220713615417
being O O 0.9999583959579468
contained O O 0.9998862743377686
in O O 0.9999940395355225
the O O 0.999972939491272

markedly O O 0.9960529804229736
inhibited O O 0.9943558573722839
LPS-stimulated O O 0.7464969158172607
accumulation O O 0.9945599436759949
of O O 0.999958872795105
mRNA O S-RNA 0.9834122657775879
for O O 0.992746889591217
ELAM-1 S-protein S-protein 0.9649680256843567
and O O 0.9973269701004028
expression O O 0.9955577254295349
of O O 0.9999568462371826
ELAM-1 S-protein S-protein 0.9345034956932068
and O O 0.997056245803833
ICAM-1 S-protein S-protein 0.9677467942237854
( O O 0.9970728158950806
IC50 O S-protein 0.8242985010147095
< O O 0.9936374425888062
10 O O 0.9784631133079529
nM O O 0.9576878547668457
, O O 0.9999337196350098
both O O 0.9998494386672974
P O O 0.630844235420227
< O O 0.9934939742088318
0.001 O O 0.9736496210098267
, O O 0.9999135732650757
n O O 0.9546417593955994
= O O 0.9984368681907654
4-9 O O 0.9928374886512756
) O O 0.9998445510864258
; O O 0.9999573230743408
inhibition O O 0.9884529709815979
of O O 0.9995107650756836
expression O O 0.9956738352775574
by O O 0.9999947547912598
dexamethasone O O 0.7071433067321777
was O O 0.9960410594940186
reversed O O 0.9998878240585327
by O O 0.9999964237213135
RU-486 O O 0.4425850212574005
( O O 0.9355620741844177
both O O 0.9977141618728638

populations O O 0.31779855489730835
in O O 0.9999734163284302
atopic O O 0.8601662516593933
patients O O 0.9930341243743896
predicts O O 0.9999932050704956
a O O 0.9999991655349731
limited O O 0.9991624355316162
skewing O O 0.970176637172699
potential O O 0.9946507811546326
of O O 0.999983549118042
IL-12 S-protein S-protein 0.9772929549217224
in O O 0.9999414682388306
the O O 0.9999964237213135
case O O 0.9990346431732178

of O O 0.9878789782524109
binding O B-DNA 0.70814448595047
DNA O E-DNA 0.9592143893241882
. O O 0.9999221563339233
These O O 0.9999983310699463
results O O 0.9999669790267944
indicate O O 0.9999990463256836
that O O 0.9999971389770508
IL-6 S-protein S-protein 0.9995602965354919
-induced O O 0.9967886209487915
B-cell O O 0.7935704588890076
differentiation O O 0.9877046346664429
, O O 0.9999439716339111
as O O 0.9999966621398926
measured O O 0.9995180368423462
by O O 0.9999972581863403
IgM S-protein S-protein 0.895148754119873
production O O 0.9980946183204651

HLA O B-protein 0.14846116304397583

In O O 0.9993081092834473
addition O O 0.999980092048645
, O O 0.9999974966049194
we O O 0.9999699592590332
evaluated O O 0.9999827146530151
the O O 0.9999988079071045
effect O O 0.9999532699584961
of O O 0.9999924898147583
dexamethasone O O 0.9687528014183044
on O O 0.9996520280838013
phorbolmyristate-acetate-stimulated O B-protein 0.7134326696395874
IL-1 B-protein I-protein 0.5126599669456482
receptor E-protein E-protein 0.7773146033287048
antagonist O O 0.5273580551147461

for O O 0.9948549270629883

by O O 0.9996015429496765
nuclear O O 0.9388957023620605
extracts O O 0.9909084439277649
from O O 0.9999345541000366
B B-cell_type B-cell_type 0.7811486124992371
cells E-cell_type E-cell_type 0.97655189037323
, O O 0.9961307048797607
T B-cell_type B-cell_type 0.9205595254898071
cells E-cell_type E-cell_type 0.9895695447921753
, O O 0.9514040946960449
or O O 0.9991361498832703
HeLa O B-cell_line 0.9109367728233337
cells O E-cell_line 0.9900320768356323
. O O 0.999847412109375
Gel O O 0.8998040556907654
mobility O O 0.9867109656333923
shift O O 0.9975747466087341
assays O O 0.9996465444564819
using O O 0.9999953508377075
a O O 0.999980092048645
synthetic B-DNA B-DNA 0.8442325592041016
E6 I-DNA I-DNA 0.3943958580493927
motif E-DNA E-DNA 0.6080389618873596
detected O O 0.9997193217277527
a O O 0.9999932050704956
B-cell-specific B-protein B-protein 0.5937302112579346
complex E-protein E-protein 0.9897660613059998
in O O 0.999834418296814
addition O O 0.9997456669807434
to O O 0.9999958276748657
a O O 0.999981164932251
ubiquitous O O 0.7332718372344971
band O O 0.6745009422302246
found O O 0.9965080618858337

blood O O 0.7627520561218262
from O O 0.9994186162948608
ten O O 0.9974397420883179
healthy O O 0.9957770109176636
male O O 0.9942935109138489
volunteers O O 0.9975988268852234
. O O 0.9999988079071045
In O O 0.9999674558639526
parallel O O 0.998941957950592
, O O 0.9999969005584717
the O O 0.9999977350234985
inhibitory O O 0.938051700592041
effect O O 0.9997504353523254
of O O 0.999995231628418
dexamethasone O O 0.9626761674880981
on O O 0.9996778964996338
3-O-methyl-D-glucose O O 0.3642118275165558
uptake O O 0.9479165077209473
was O O 0.9999845027923584

immune O O 0.6960615515708923
system O O 0.9097638726234436
, O O 0.9991540908813477
most O O 0.9997982382774353
notably O O 0.9999316930770874
of O O 0.9999240636825562
T B-cell_type B-cell_type 0.932972252368927
cells E-cell_type E-cell_type 0.9901832938194275
. O O 0.9992198944091797
They O O 0.999969482421875
act O O 0.9988415837287903
at O O 0.9999969005584717
a O O 0.9999929666519165
point O O 0.9932677745819092
in O O 0.999872088432312
activation O O 0.9949126243591309
that O O 0.9999784231185913
lies O O 0.9999790191650391
between O O 0.9979689717292786
receptor O O 0.8560479283332825
ligation O O 0.9750211238861084
and O O 0.9996968507766724
the O O 0.9999954700469971
transcription O O 0.9393233060836792
of O O 0.9995598196983337
early B-DNA B-DNA 0.5377523899078369
genes E-DNA E-DNA 0.9762077927589417
. O O 0.9999426603317261
Here O O 0.9999812841415405
, O O 0.9999938011169434
Stuart O O 0.9884021878242493
Schreiber O O 0.9961004257202148
and O O 0.9999258518218994
Gerald O O 0.9832434058189392
Crabtree O O 0.9837990999221802
review O O 0.9999747276306152
recent O O 0.9969520568847656
findings O O 0.9994487166404724
that O O 0.9999995231628418

of O O 0.9925521612167358

activation O O 0.9863758683204651
by O O 0.9999849796295166
the O O 0.9999701976776123
transcription B-protein B-protein 0.6720118522644043
factor E-protein E-protein 0.9474844932556152
VP16 S-protein S-protein 0.8150466680526733
. O O 0.9997593760490417
Taken O O 0.9999814033508301
together O O 0.9999057054519653
, O O 0.999994158744812
these O O 0.9999957084655762
data O O 0.9996415376663208
suggest O O 0.9999985694885254

tumor O B-protein 0.58921879529953
necrosis O I-protein 0.9125356674194336
factor O E-protein 0.9612982869148254
in O O 0.9969971179962158
murine O B-cell_type 0.8515940308570862
cells O E-cell_type 0.951949954032898
, O O 0.9623364806175232
but O O 0.999630331993103
with O O 0.9999622106552124
inhibition O O 0.9963021278381348
in O O 0.9999535083770752
human B-cell_type B-cell_type 0.6855507493019104
monocytes E-cell_type E-cell_type 0.9732175469398499
. O O 0.9999555349349976
The O O 0.9999991655349731
posttranscriptional O O 0.9309673309326172
effect O O 0.999792754650116
of O O 0.9999971389770508
antioxidants O O 0.9683206081390381
on O O 0.9999516010284424
TF S-protein S-protein 0.7415271997451782
expression O O 0.9651374816894531
data O O 0.9982761144638062
suggests O O 0.9999977350234985

, O O 0.9725821018218994
and O O 0.9992393255233765
the O O 0.9999982118606567
recent O O 0.9993823766708374
demonstration O O 0.9998440742492676
of O O 0.9999964237213135
JAK S-protein S-protein 0.8939582109451294
phosphorylation O O 0.9673996567726135
by O O 0.9999691247940063
IL-12 S-protein S-protein 0.9839460849761963
, O O 0.9996331930160522
identify O O 0.999993085861206
a O O 0.9999973773956299
rapid O O 0.9664533138275146
signal-transduction O O 0.9819298386573792
pathway O O 0.9993106126785278
likely O O 0.9999871253967285
to O O 0.9999957084655762
mediate O O 0.999100923538208
IL-12 S-protein S-protein 0.9981576800346375
-induced O O 0.9985951781272888
gene O O 0.9849611520767212
expression O O 0.9998891353607178
. O O 0.9999991655349731
Temperature-induced O O 0.976269006729126
down-regulation O O 0.9945476651191711
of O O 0.999930739402771
the O O 0.9999666213989258
glucocorticoid B-protein B-protein 0.8896211385726929
receptor E-protein E-protein 0.9181689023971558

) O O 0.7863357663154602
human B-cell_type B-cell_type 0.5404795408248901
red I-cell_type I-cell_type 0.5330855846405029
blood I-cell_type I-cell_type 0.8998119235038757
cells E-cell_type E-cell_type 0.9830020070075989
( O O 0.9966731071472168
HRBC S-cell_type S-cell_type 0.8811880350112915
) O O 0.973831295967102
or O O 0.999659538269043
gram-negative O B-protein 0.5529941916465759
bacterial O I-protein 0.6056402325630188
endotoxin O E-protein 0.9869938492774963
( O O 0.9983713030815125
Escherichia O O 0.8263483047485352
coli O O 0.8988699913024902
LPS O O 0.9140839576721191
: O O 0.9983704686164856
30 O O 0.9984859824180603
micrograms/kg O O 0.9908360242843628
) O O 0.9998916387557983
. O O 0.999998927116394
The O O 0.999998927116394
adult O O 0.9230191111564636
male O O 0.983772337436676

into O O 0.9987909197807312
those O O 0.9998918771743774
encoding O O 0.8971295356750488
cytokines S-protein S-protein 0.8455023765563965
, O O 0.9990432858467102
cell B-protein B-protein 0.644522488117218
surface I-protein I-protein 0.6087943911552429
receptors E-protein E-protein 0.996618390083313
, O O 0.9984985589981079
acute B-protein B-protein 0.5929742455482483
phase I-protein I-protein 0.7366968393325806
proteins E-protein E-protein 0.9775157570838928
and O O 0.990856945514679
viral B-DNA B-DNA 0.5671404004096985
genomes E-DNA E-DNA 0.9229891300201416
, O O 0.9980462789535522
such O O 0.9999750852584839
as O O 0.9999918937683105
that O O 0.9999821186065674
of O O 0.9999872446060181
human O O 0.6871763467788696
immunodeficiency O O 0.7816736102104187
virus O O 0.7631321549415588
type O O 0.7731484174728394
1 O O 0.6811872124671936
( O O 0.9714593887329102
HIV-1 O O 0.9418874382972717

mitogen O S-protein 0.5038427114486694
activation O O 0.9940162897109985
. O O 0.9999922513961792
In O O 0.9999865293502808
contrast O O 0.9999749660491943
, O O 0.9999927282333374
the O O 0.9999603033065796
human B-cell_line B-cell_line 0.5689568519592285
T I-cell_line I-cell_line 0.6820117831230164
cell I-cell_line I-cell_line 0.9126709699630737
line E-cell_line E-cell_line 0.9909532070159912
, O O 0.9977182149887085
IARC B-cell_line B-cell_line 0.5301250219345093
301 E-cell_line E-cell_line 0.9973976612091064
, O O 0.9950136542320251
expresses O O 0.9999812841415405
these O O 0.9999902248382568
two O O 0.9981333613395691
genes O O 0.7760850191116333
constitutively O O 0.9988020658493042
and O O 0.9999288320541382

, O O 0.98307204246521
usually O O 0.9997517466545105
, O O 0.9993901252746582
STAT3 S-protein S-protein 0.9987941980361938
and O O 0.9948922395706177
STAT5 S-protein S-protein 0.99709153175354
was O O 0.9998714923858643
detected O O 0.9999732971191406
in O O 0.9999951124191284
all O O 0.9998977184295654
four O O 0.9847164154052734
IL-2-independent B-cell_line B-cell_line 0.7489959001541138
cell I-cell_line I-cell_line 0.7000886797904968
lines E-cell_line E-cell_line 0.9988752007484436
tested O O 0.9981733560562134
, O O 0.9999794960021973
but O O 0.999884843826294

compared O O 0.9983829259872437
to O O 0.9999972581863403
the O O 0.9999988079071045
effects O O 0.9998602867126465
of O O 0.9999908208847046
LPS O O 0.9962424039840698
alone O O 0.9999481439590454
. O O 0.9999942779541016
Not O O 0.9999889135360718
only O O 0.9999980926513672
was O O 0.9999881982803345
this O O 0.9999897480010986
effect O O 0.9999197721481323
observed O O 0.9999549388885498
at O O 0.9999996423721313
the O O 0.9999963045120239
mRNA O O 0.8676859140396118
level O O 0.9961287975311279
, O O 0.9999878406524658
but O O 0.9999569654464722
activator B-protein B-protein 0.7159222960472107
protein-1 E-protein E-protein 0.9893151521682739
( O O 0.9642019271850586
AP-1 S-protein S-protein 0.974414050579071
) O O 0.9782530665397644

to O O 0.9993934631347656
multiple O O 0.9873301982879639
pathways O O 0.9996237754821777
for O O 0.9999903440475464
NF-kappa B-protein B-protein 0.7886117100715637
B E-protein E-protein 0.9986169338226318
activation O O 0.9983003735542297
. O O 0.9999985694885254
The O O 0.9999933242797852
eukaryotic B-protein B-protein 0.5593602061271667
transcription I-protein I-protein 0.5178672075271606
factor E-protein E-protein 0.9680087566375732
NF-kappa B-protein B-protein 0.8080342411994934
B E-protein E-protein 0.9995135068893433
plays O O 0.9997772574424744
a O O 0.9999932050704956
central O O 0.9978570342063904
role O O 0.9999649524688721
in O O 0.9999974966049194
the O O 0.9999954700469971
induced O O 0.995771586894989
expression O O 0.9994094371795654
of O O 0.9999964237213135
human O O 0.7805284261703491
immunodeficiency O O 0.8580430150032043
virus O O 0.8793022632598877
type O O 0.8580021262168884
1 O O 0.6895906329154968
and O O 0.9496341943740845
in O O 0.9993274211883545
many O O 0.9997431635856628
aspects O O 0.999775230884552
of O O 0.9999854564666748

to O O 0.9955873489379883
three O O 0.99906986951828
yeast O O 0.9498262405395508
polypeptides O O 0.7461013793945312
, O O 0.9998273849487305
suggesting O O 0.9999810457229614
that O O 0.9999984502792358
this O O 0.9999591112136841
higher B-DNA O 0.9461159110069275
eukaryotic I-DNA B-DNA 0.6180235147476196
gene E-DNA E-DNA 0.9588592648506165
could O O 0.9998739957809448
have O O 0.9999969005584717
evolved O O 0.9998680353164673

with O O 0.9990403056144714
anti-Ig B-protein B-protein 0.699172854423523
antibody E-protein E-protein 0.9934129118919373
in O O 0.9991899132728577
B B-cell_type B-cell_type 0.8371636271476746
cells E-cell_type E-cell_type 0.979568362236023
, O O 0.9972892999649048
even O O 0.9999120235443115
in O O 0.9999701976776123
the O O 0.9999949932098389
absence O O 0.9998772144317627
of O O 0.9999959468841553
other O O 0.9989262223243713
viral O B-DNA 0.5419636964797974
genes O E-DNA 0.9902378916740417
. O O 0.9999523162841797
We O O 0.9999871253967285
identified O O 0.9999891519546509
several O O 0.9997715353965759
anti-Ig O B-DNA 0.6430078148841858
response O I-DNA 0.8372644782066345
elements O E-DNA 0.9957536458969116
within O O 0.9989091157913208
Zp S-DNA S-DNA 0.9980111122131348
, O O 0.9910506010055542
which O O 0.9997929930686951
were O O 0.9999488592147827
originally O O 0.9990888833999634
defined O O 0.9997602105140686
as O O 0.9999866485595703
12-O-tetradecanoylphorbol-13-acetate B-DNA B-DNA 0.31276053190231323
( I-DNA I-DNA 0.7734014987945557
TPA I-DNA I-DNA 0.593845784664154
) I-DNA I-DNA 0.7180268168449402
response I-DNA I-DNA 0.9422239065170288
elements E-DNA E-DNA 0.9990057349205017
( O O 0.9984723925590515
ZI O B-DNA 0.9243379235267639
repeats O E-DNA 0.9745527505874634
and O O 0.9992554783821106
ZII S-DNA S-DNA 0.9934306740760803
, O O 0.9973238706588745
an O O 0.9999223947525024
AP-1-like B-DNA B-DNA 0.9601808786392212

Three O O 0.9689584970474243

as O O 0.9984732270240784
shown O O 0.9999864101409912
by O O 0.9999957084655762
pulsed O O 0.8762145042419434
field O O 0.9471411108970642
gel O O 0.9413964748382568
electrophoresis O O 0.9832791090011597
analysis O O 0.9991859793663025
, O O 0.9999940395355225
at O O 0.9999500513076782
most O O 0.9997230172157288
400 O O 0.7970994710922241
kb O O 0.789995014667511
or O O 0.9861103296279907
690 O O 0.8915714025497437
kb O O 0.8769896626472473
from O O 0.9994651675224304
SOX9 S-DNA S-DNA 0.9172988533973694
. O O 0.9997208714485168
By O O 0.9999610185623169
using O O 0.9999327659606934
a O O 0.9998866319656372
SOX9 B-DNA B-DNA 0.6009852886199951
coding I-DNA I-DNA 0.7537542581558228
sequence I-DNA E-DNA 0.9375781416893005
polymorphism E-DNA O 0.5713972449302673
, O O 0.999627947807312
expression O O 0.998931348323822
of O O 0.9999828338623047
both O O 0.9998923540115356

in O O 0.999362051486969
low O O 0.9802526235580444
numbers O O 0.99257493019104
in O O 0.9999496936798096
peripheral B-cell_type B-cell_type 0.5265794992446899
blood I-cell_type I-cell_type 0.8903064727783203
lymphocytes E-cell_type E-cell_type 0.9902676939964294
( O O 0.9981650710105896
PBL S-cell_type S-cell_type 0.9965001344680786
) O O 0.9870539307594299
. O O 0.9999722242355347
HL60 B-cell_line B-cell_line 0.8377037048339844
cells E-cell_line E-cell_line 0.9971697926521301
, O O 0.997036337852478
expressing O O 0.9942914247512817
some O O 0.9999173879623413
characteristics O O 0.995033860206604
of O O 0.9999285936355591
promyelocytes S-cell_line S-cell_type 0.9935193657875061
, O O 0.9977768063545227
can O O 0.999963641166687
be O O 0.9999845027923584
induced O O 0.9997944235801697
to O O 0.9999923706054688
monocytoid O O 0.9037743806838989
differentiation O O 0.9973217844963074
by O O 0.9999948740005493

of O O 0.9969136714935303
the O O 0.999966025352478
virus O O 0.9657066464424133
, O O 0.9989732503890991
are O O 0.9999536275863647
unknown O O 0.9995502829551697
. O O 0.999994158744812
Transient O O 0.9022132158279419
expression O O 0.9930880665779114
assays O O 0.9997431635856628
with O O 0.9999767541885376
plasmids O S-DNA 0.9490800499916077
containing O O 0.998410701751709
deleted O O 0.8988633155822754
parts O O 0.5355364084243774
of O O 0.9987573623657227
the O O 0.999903678894043
LTR B-DNA B-DNA 0.6936156749725342
region E-DNA E-DNA 0.9575502276420593
linked O O 0.9995050430297852
to O O 0.999996542930603
a O O 0.9999771118164062
reporter O B-DNA 0.5191911458969116
gene O E-DNA 0.9399139285087585
showed O O 0.9998593330383301
that O O 0.9999991655349731
the O O 0.9998219609260559
NF-kappaB B-DNA B-DNA 0.7654138803482056

targeting O O 0.991446852684021
the O O 0.9998121857643127
GATA-1 B-DNA B-DNA 0.6419141888618469
gene E-DNA E-DNA 0.9879580140113831
. O O 0.9998704195022583
If O O 0.9999589920043945
GATA-1 B-cell_line S-protein 0.9786964654922485
-red I-cell_line O 0.9390840530395508
cells E-cell_line O 0.5492585301399231
were O O 0.9998934268951416
available O O 0.9999414682388306
, O O 0.9999978542327881
the O O 0.9999977350234985
analyses O O 0.9991098046302795
would O O 0.999998927116394
involve O O 0.9999996423721313
the O O 0.999998927116394
actual O O 0.9977712631225586
transcription O O 0.9776526689529419
of O O 0.9997931122779846
or O O 0.9946576952934265
chromatin O S-DNA 0.7690141797065735
structure O O 0.46882855892181396

was O O 0.9986128807067871
no O O 0.999974250793457
detectable O O 0.993444561958313
activation O O 0.9935949444770813
of O O 0.9999066591262817
pp70S6K S-protein S-protein 0.9299687147140503
during O O 0.999840259552002
TPA- O O 0.7349623441696167
or O O 0.9562185406684875
okadaic O O 0.9376735091209412
acid-induced O O 0.9690147042274475
monocytic O O 0.92208331823349
differentiation O O 0.9985465407371521
. O O 0.999998927116394
Moreover O O 0.9990549683570862
, O O 0.9999123811721802

IcsA I-protein B-protein 0.5596825480461121
protein E-protein E-protein 0.9650972485542297
and O O 0.9954197406768799
in O O 0.9957000017166138
vitro O O 0.9825106263160706
analysis O O 0.9994315505027771
of O O 0.9999867677688599
reconstituted O O 0.5930673480033875
systems O O 0.41386568546295166
from O O 0.9996787309646606
purified B-protein B-cell_type 0.5538303852081299

to O O 0.9969436526298523
alter O O 0.9994214773178101
NF-kappaB S-protein S-protein 0.9931604862213135
directly O O 0.9998021721839905
as O O 0.9999982118606567
pre-incubation O O 0.9835710525512695
of O O 0.9997667670249939
nuclear O O 0.8508262038230896
extracts O O 0.9751682877540588
with O O 0.9999630451202393
DMDTC O O 0.577718198299408
does O O 0.9993723034858704
not O O 0.9999874830245972
diminish O O 0.9999618530273438
binding O O 0.9822449684143066
activity O O 0.9987142086029053
of O O 0.9999923706054688
this O O 0.9999734163284302
protein O O 0.6853200793266296
. O O 0.9954341053962708

stimulated O O 0.9452043175697327
with O O 0.9997324347496033
TNF-alpha S-protein S-protein 0.9785434603691101
or O O 0.9990079998970032
PMA O O 0.8059913516044617
and O O 0.9745026230812073
cultured O O 0.9164611101150513
in O O 0.9997169375419617
the O O 0.9999942779541016
presence O O 0.9985151886940002

of O O 0.9952547550201416
ZAP-70 S-protein S-protein 0.9600386023521423
and O O 0.9852783679962158
Syk S-protein S-protein 0.9939051270484924
as O O 0.9996646642684937
substrates O O 0.7792627811431885
in O O 0.9989529848098755
intact O B-cell_type 0.5380359888076782
cells O E-cell_type 0.9408396482467651
. O O 0.9996236562728882
Therefore O O 0.9999902248382568
, O O 0.9999898672103882
we O O 0.9999842643737793
suggest O O 0.9999966621398926
that O O 0.9999974966049194

clones E-cell_line O 0.8247175812721252
during O O 0.999954342842102
an O O 0.9999884366989136
EBV O O 0.8960636258125305
chronic O O 0.9787798523902893
response O O 0.9954600930213928
are O O 0.9999890327453613
determined O O 0.9999661445617676
by O O 0.9999974966049194
avidity O O 0.9822167158126831
, O O 0.9998289346694946
CD8 S-protein S-protein 0.7987464070320129
variable O O 0.9561439156532288
contribution O O 0.9954758286476135
compensating O O 0.9980804920196533
for O O 0.9999755620956421
differences O O 0.9992489218711853
in O O 0.9999790191650391
TCR S-protein S-protein 0.9142646789550781
affinities O O 0.9441410303115845
. O O 0.9999990463256836
Recent O O 0.999970555305481
studies O O 0.9999339580535889
have O O 0.9999996423721313
suggested O O 0.9999971389770508
that O O 0.9999991655349731
the O O 0.9999915361404419
diversity O O 0.9991330504417419
of O O 0.9999918937683105
TCR S-protein S-protein 0.4172656536102295
repertoire O O 0.44947129487991333
after O O 0.9997822642326355
primary O O 0.9235635995864868
immunization O O 0.9964897036552429
is O O 0.9999889135360718
conserved O O 0.9997586607933044
in O O 0.9999617338180542
memory B-cell_type B-cell_type 0.8593901991844177
T I-cell_type I-cell_type 0.9569496512413025
cells E-cell_type E-cell_type 0.9903494119644165
and O O 0.9983735084533691
that O O 0.999997615814209
a O O 0.9999964237213135
progressive O O 0.9748492240905762
narrowing O O 0.9951456189155579
of O O 0.9999830722808838
this O O 0.9999850988388062
repertoire O O 0.9297730922698975
may O O 0.9999301433563232
take O O 0.9999949932098389
place O O 0.9999253749847412
during O O 0.9999939203262329
recall O O 0.9766191840171814
infections O O 0.9983077049255371
. O O 0.9999980926513672
It O O 0.9999778270721436
now O O 0.9999884366989136
remains O O 0.9999817609786987
to O O 0.999991774559021
be O O 0.9999979734420776
investigated O O 0.9999874830245972
which O O 0.9999872446060181
parameters O O 0.9963896870613098
determine O O 0.9999972581863403
the O O 0.9999977350234985
repertoire O O 0.9921706318855286
of O O 0.9999693632125854
the O O 0.9999755620956421
memory O O 0.46488717198371887
response O O 0.8790894150733948
and O O 0.9966313242912292
possibly O O 0.9998157620429993

located O O 0.995136559009552
on O O 0.9997941851615906
human B-DNA B-DNA 0.6899814009666443
chromosome I-DNA I-DNA 0.7331819534301758
11 E-DNA E-DNA 0.9901455044746399
at O O 0.9991528987884521
band B-DNA B-DNA 0.5349122285842896
11p13 E-DNA E-DNA 0.9922211766242981
, O O 0.9979143738746643
where O O 0.9999831914901733
a O O 0.9999769926071167
cluster O O 0.9801743030548096
of O O 0.9996534585952759
T-cell B-DNA O 0.4368632435798645
leukemia-specific I-DNA O 0.47791358828544617
translocations E-DNA O 0.5826212167739868
occur O O 0.9989655017852783
; O O 0.9999796152114868
all O O 0.9997733235359192
translocation O O 0.6584143042564392
breakpoints O O 0.8546094298362732
at O O 0.9995507597923279
11p13 S-DNA S-DNA 0.9802743792533875
are O O 0.9970535039901733
upstream O O 0.7858763337135315
of O O 0.9947406649589539
the O O 0.999198853969574
Rhom-2 B-DNA B-DNA 0.6242780089378357
gene E-DNA E-DNA 0.9936457872390747
. O O 0.9998117089271545
Human B-DNA O 0.7199274897575378
and I-DNA O 0.9285753965377808
mouse I-DNA O 0.6012502312660217
Rhom-2 E-DNA O 0.2716384530067444
are O O 0.9567599296569824

we O O 0.9989860653877258
analyzed O O 0.9999840259552002
the O O 0.9999872446060181
expression O O 0.9973965883255005
of O O 0.9999697208404541
GATA-1 S-protein B-DNA 0.42214012145996094
, O I-DNA 0.6757641434669495
Epo-R S-protein I-DNA 0.48051485419273376
and O I-DNA 0.5012625455856323
globin B-DNA I-DNA 0.8807706236839294
genes E-DNA E-DNA 0.9927142262458801
in O O 0.9999325275421143
an O O 0.999840497970581
Epo-dependent O B-cell_line 0.8260349631309509
human O I-cell_line 0.9455280900001526
cell O I-cell_line 0.9565849304199219
line O E-cell_line 0.9977023005485535
, O O 0.9967246651649475
UT-7 S-cell_line B-cell_line 0.9116805791854858
Epo O E-cell_line 0.9192129969596863
. O O 0.9994602799415588
The O O 0.9999978542327881
results O O 0.9998051524162292
were O O 0.9999947547912598
compared O O 0.9999847412109375
to O O 0.9999829530715942
those O O 0.9999840259552002
obtained O O 0.9997628331184387
with O O 0.9999923706054688
the O O 0.9999607801437378
parental B-cell_line B-cell_line 0.7130389213562012
granulocyte-macrophage I-cell_line I-cell_line 0.5543323755264282
colony-stimulating I-cell_line I-cell_line 0.3956011235713959
factor I-cell_line I-cell_line 0.8086977601051331
( I-cell_line I-cell_line 0.7668895125389099
GM-CSF I-cell_line I-cell_line 0.46248742938041687
) I-cell_line I-cell_line 0.587627112865448
-dependent I-cell_line I-cell_line 0.7236037850379944
cell I-cell_line I-cell_line 0.862050473690033
line E-cell_line E-cell_line 0.9960402250289917
, O O 0.9915350675582886
UT-7 S-cell_line S-cell_line 0.9963198900222778
, O O 0.6890976428985596
which O O 0.9985184073448181
has O O 0.9999785423278809

[ O O 0.904541552066803
corrected O O 0.7920650243759155
] O O 0.8901726603507996
CD45RA B-cell_type S-protein 0.2791944146156311
and I-cell_type O 0.8234211802482605
CD45R0 I-cell_type B-cell_type 0.3432588577270508
T I-cell_type I-cell_type 0.8483096361160278
helper I-cell_type I-cell_type 0.9663771390914917
subsets E-cell_type E-cell_type 0.9731925129890442
[ O O 0.9989153146743774
published O O 0.9877411723136902
erratum O O 0.9573918581008911
appears O O 0.9999489784240723
in O O 0.9999920129776001
Eur O O 0.4789435863494873
J O O 0.6223984956741333
Immunol O O 0.8837329745292664
1997 O O 0.9736550450325012
Jul O O 0.9258890151977539

the O O 0.9992108345031738
variant O O 0.8879828453063965
peptide O O 0.9486514329910278
in O O 0.9998818635940552
dictating O O 0.8263231515884399
specificities O O 0.9659572839736938
. O O 0.999995231628418
Since O O 0.9999954700469971
the O O 0.9999961853027344
AES B-protein B-protein 0.2938108742237091
proteins E-protein E-protein 0.9875696301460266
are O O 0.9999407529830933
part O O 0.9996367692947388
of O O 0.9999953508377075
a O O 0.9999935626983643
set O O 0.9877834916114807
of O O 0.9997768998146057
transcriptional O B-protein 0.47369441390037537
repressors O E-protein 0.9570019245147705
encoded O O 0.9993005990982056
by O O 0.999956488609314

protein B-protein B-protein 0.5663626790046692
kinase I-protein I-protein 0.48776954412460327
C E-protein E-protein 0.9660377502441406
pathways O O 0.9883205890655518
inhibits O O 0.9999754428863525
the O O 0.9999595880508423
CD3 S-protein S-protein 0.991746187210083
-dependent O O 0.9945014715194702
T O O 0.9470565319061279
cell O O 0.8994690775871277
activation O O 0.9941892623901367
and O O 0.9999070167541504
leads O O 0.9999066591262817
to O O 0.9999935626983643
a O O 0.9999969005584717
persistent O O 0.9880974888801575
expression O O 0.9988445043563843
of O O 0.9999914169311523
the O O 0.9999806880950928
AP-1 B-protein B-protein 0.8292034864425659
transcription I-protein I-protein 0.4310697019100189
factor E-protein E-protein 0.9679149389266968
. O O 0.9996370077133179
The O O 0.999994158744812
effects O O 0.9997319579124451
mediated O O 0.9998502731323242
by O O 0.9999982118606567
a O O 0.9999909400939941
combined O O 0.9901008605957031
stimulation O O 0.9989684820175171
of O O 0.9999938011169434
cAMP O O 0.6122124195098877
-and O O 0.9900522828102112
protein B-protein B-protein 0.7799488306045532
kinase I-protein I-protein 0.6012993454933167
C E-protein E-protein 0.9568497538566589
( O O 0.9812582731246948
PKC S-protein S-protein 0.9801595211029053
) O O 0.9574682116508484
-dependent O O 0.9959355592727661
pathways O O 0.9996271133422852
have O O 0.9999982118606567
been O O 0.9999904632568359
investigated O O 0.9999901056289673
in O O 0.9999923706054688
different O O 0.9966482520103455
cellular O O 0.7268482446670532
systems O O 0.7334267497062683
, O O 0.999579131603241
and O O 0.999958872795105
it O O 0.999936580657959
has O O 0.9999818801879883
been O O 0.9999840259552002
shown O O 0.9999920129776001
that O O 0.9999909400939941
they O O 0.9999027252197266
may O O 0.9999840259552002
complement O O 0.9999771118164062
each O O 0.999993085861206
other O O 0.9999041557312012
in O O 0.9998112320899963
activating O O 0.6808807253837585
cell O O 0.546830415725708
proliferation O O 0.9940280914306641
and O O 0.9998588562011719
differentiation O O 0.9995088577270508
. O O 0.9999991655349731
In O O 0.9999947547912598
this O O 0.9999995231628418
report O O 0.9999336004257202

for O O 0.9951667785644531
16p13.3 B-DNA O 0.6798264384269714
markers E-DNA O 0.4173288643360138
. O O 0.9999685287475586
Three O O 0.9997674822807312
overlapping O B-protein 0.8787651658058167
PCR B-DNA I-protein 0.25828632712364197
products E-DNA E-protein 0.7680841684341431
, O O 0.9984785914421082
covering O O 0.9999406337738037
the O O 0.9999945163726807
complete O O 0.9062215089797974
coding O O 0.7547561526298523
sequence O O 0.4394929111003876
of O O 0.9993414282798767
mRNA S-RNA S-RNA 0.9828478097915649
, O O 0.9837031364440918
were O O 0.9999752044677734

-1alpha E-protein E-protein 0.8164669871330261
and O O 0.990082323551178
MIP-1beta S-protein S-protein 0.9338898062705994
, O O 0.9846615195274353
but O O 0.9994331002235413
did O O 0.9999591112136841
not O O 0.9999730587005615
stimulate O O 0.9999786615371704
the O O 0.9999935626983643
release O O 0.9983124732971191
of O O 0.9999855756759644
either O O 0.9990692734718323
chemokine S-protein S-protein 0.7854693531990051
. O O 0.9997040629386902
These O O 0.9999991655349731
findings O O 0.999969482421875
indicate O O 0.999998927116394
that O O 0.9999974966049194
MBP S-protein S-protein 0.9881637692451477
is O O 0.9998903274536133
selective O O 0.9997339844703674
among O O 0.9999927282333374
the O O 0.9999386072158813
eosinophil B-protein B-protein 0.5178148746490479
granule I-protein I-protein 0.7271121144294739
proteins E-protein E-protein 0.9984521865844727
as O O 0.9999722242355347
a O O 0.9999971389770508
stimulus O O 0.9631562232971191
for O O 0.9995840191841125

suggest O O 0.9988055229187012
that O O 0.9999979734420776
the O O 0.999967098236084
AhR S-protein S-protein 0.7907140851020813
could O O 0.9981369972229004
interfere O O 0.9999802112579346
with O O 0.9999747276306152
BSAP S-protein S-protein 0.993252694606781
-stimulated O O 0.9951226115226746
CD19 B-DNA B-DNA 0.646329402923584
gene E-DNA E-DNA 0.9625362157821655
transcription O O 0.9866735935211182
by O O 0.9999961853027344
competition O O 0.9865390658378601
for O O 0.9999250173568726
a O O 0.9999895095825195
common O O 0.9000216126441956
DNA B-DNA B-DNA 0.5760201811790466
binding I-DNA I-DNA 0.3941803276538849
site E-DNA E-DNA 0.8175554871559143
. O O 0.999940037727356
Inhibitory O O 0.9145355820655823
action O O 0.9809540510177612
of O O 0.9996711015701294
nm23 B-protein B-protein 0.6701710820198059
proteins E-protein E-protein 0.996213972568512
on O O 0.9998934268951416
induction O O 0.9911826848983765
of O O 0.9999175071716309
erythroid O O 0.47531741857528687
differentiation O O 0.9472410678863525
of O O 0.9997201561927795
human B-cell_type B-cell_type 0.5374026894569397
leukemia I-cell_type I-cell_type 0.7880975604057312
cells E-cell_type E-cell_type 0.9588945508003235
. O O 0.9999219179153442
We O O 0.9999817609786987
recently O O 0.9999698400497437
identified O O 0.999993085861206
a O O 0.9999977350234985
differentiation B-protein O 0.8435582518577576
inhibitory I-protein O 0.9228401780128479

mRNA E-RNA E-RNA 0.9469823241233826
by O O 0.9997649788856506
competitive O O 0.8294603824615479
polymerase O O 0.6940083503723145
chain O O 0.692838191986084
reaction O O 0.9945414662361145
in O O 0.9999474287033081
PBMC S-cell_type S-cell_type 0.9959905743598938
: O O 0.9858354330062866
lack O O 0.9995187520980835
of O O 0.9999427795410156

vitro O O 0.7539640069007874
by O O 0.9990416169166565
IL-2 S-protein S-protein 0.9940947890281677
. O O 0.9999184608459473
Activated B-cell_type B-cell_type 0.6113754510879517
platelets E-cell_type E-cell_type 0.9146013855934143
induce O O 0.999935507774353
monocyte B-protein B-protein 0.6559839248657227
chemotactic I-protein I-protein 0.6469612121582031
protein-1 E-protein E-protein 0.9619133472442627
secretion O O 0.9614506363868713
and O O 0.9996299743652344
surface O O 0.9500491619110107
expression O O 0.9934781789779663
of O O 0.9999464750289917
intercellular B-cell_type B-protein 0.5724329948425293
adhesion I-cell_type I-protein 0.7698512077331543
molecule-1 E-cell_type E-protein 0.9961243271827698
on O O 0.999203622341156
endothelial B-cell_type B-cell_type 0.8963910937309265
cells E-cell_type E-cell_type 0.9952823519706726
[ O O 0.9966368675231934
see O O 0.9999104738235474
comments O O 0.9982559084892273

significantly O O 0.999264657497406
from O O 0.9999781847000122
Spi-B S-protein S-protein 0.9767122864723206
and O O 0.9972821474075317
PU.1 S-protein S-protein 0.9544552564620972
within O O 0.9996993541717529
helix B-protein B-protein 0.5974612236022949
1 E-protein E-protein 0.832675039768219
of O O 0.9776304364204407
the O O 0.9992770552635193
Ets B-protein B-DNA 0.750658392906189
domain E-protein E-DNA 0.8080801963806152
. O O 0.9985992312431335
Spi-C S-protein S-protein 0.9525867104530334
was O O 0.9997950196266174
encoded O O 0.9999442100524902
by O O 0.9999988079071045
a O O 0.9999665021896362
single-copy B-DNA B-DNA 0.520926833152771
gene E-DNA E-DNA 0.9715718626976013
that O O 0.9965315461158752
was O O 0.9999607801437378
mapped O O 0.9984503984451294
to O O 0.9994052648544312
chromosome B-DNA B-DNA 0.930682897567749
10 E-DNA E-DNA 0.9938456416130066
, O O 0.9916799664497375
region B-DNA B-DNA 0.687641441822052
C E-DNA E-DNA 0.9916266202926636
. O O 0.9925210475921631

receptor E-protein E-protein 0.9040319323539734
in O O 0.9991503953933716
aged O O 0.8693838119506836
long-distance O O 0.8246963024139404
runner O O 0.77751225233078
] O O 0.9928750991821289
For O O 0.9999434947967529
the O O 0.9999988079071045
study O O 0.9997424483299255
of O O 0.9999964237213135
the O O 0.9999977350234985
changes O O 0.998137354850769
in O O 0.9999439716339111

% O O 0.8648521304130554
but O O 0.9960476756095886
decreased O O 0.9991077780723572
CREB S-protein S-protein 0.9203205704689026
binding O O 0.9881080985069275
( O O 0.9998639822006226
38 O O 0.9996693134307861
% O O 0.9992315769195557
) O O 0.9997925162315369
over O O 0.9999951124191284
a O O 0.999995231628418
60-min O O 0.7997761368751526
time O O 0.9109839200973511
course O O 0.9667065739631653
. O O 0.9999786615371704
Dexamethasone O O 0.9067202210426331
produced O O 0.9995489716529846
a O O 0.9999899864196777
rapid O O 0.9872689247131348
and O O 0.999068558216095
sustained O O 0.9988775849342346
increase O O 0.9999746084213257
in O O 0.9999814033508301
glucocorticoid B-DNA O 0.5680042505264282
response I-DNA O 0.8856964111328125

regulatory I-protein I-protein 0.44126448035240173
factor I-protein I-protein 0.46470868587493896
1 E-protein E-protein 0.9272597432136536
not O O 0.9772177338600159
only O O 0.9998906850814819
triggers O O 0.9999489784240723
the O O 0.9999959468841553
activation O O 0.9994563460350037
of O O 0.9999933242797852
the O O 0.9999948740005493
interferon S-protein S-protein 0.38123780488967896
signal O O 0.3817330002784729
transduction O O 0.6990943551063538
pathway O O 0.9883906841278076
, O O 0.99993896484375
but O O 0.9999607801437378
also O O 0.9999555349349976
may O O 0.9999815225601196
play O O 0.9999881982803345
a O O 0.9999986886978149
role O O 0.9999861717224121
in O O 0.9999949932098389
limiting O O 0.9993292093276978

the O O 0.998723566532135
presence O O 0.9966403245925903
of O O 0.9999234676361084
thapsigargin O O 0.4565941393375397
) O O 0.9927703738212585
in O O 0.9999855756759644
Ca2+-free O O 0.7012805342674255
medium O O 0.9092285633087158
. O O 0.9999476671218872
SERCA S-protein O 0.41683393716812134
activity O O 0.9791175127029419
was O O 0.9999748468399048
measured O O 0.999950647354126
as O O 0.999998927116394
the O O 0.9999918937683105
thapsigargin O O 0.4972374141216278
sensitive O O 0.7600460648536682
, O O 0.9953067898750305
Ca2+ O O 0.8786634802818298
dependent O O 0.979505181312561
and O O 0.9988259673118591
ouabain O O 0.9215041399002075
resistant O O 0.8855862021446228
, O O 0.9998316764831543
ATP O O 0.5803129076957703
hydrolyses O O 0.7639316320419312
in O O 0.9998787641525269
platelet O O 0.7128968238830566
membranes O O 0.6571535468101501
. O O 0.9999470710754395
Relative O O 0.9952778816223145
expressions O O 0.9988231062889099
of O O 0.999990701675415
SERCA S-protein B-protein 0.5062982439994812
2 O I-protein 0.41233527660369873
and O I-protein 0.6954476833343506
3 O I-protein 0.6614920496940613
isoforms O E-protein 0.9529042840003967
and O O 0.9873350858688354

low O O 0.9326679110527039
shear-induced O O 0.9817554950714111
activation O O 0.9988406300544739
of O O 0.9999908208847046
NF-kappaB S-protein S-protein 0.9892942905426025
, O O 0.9981945157051086
expression O O 0.9947852492332458
of O O 0.9999395608901978
VCAM-1 S-protein S-protein 0.8510661125183105
, O O 0.9864120483398438
and O O 0.9990662932395935
EC-Mn O S-protein 0.8714828491210938
adhesion O O 0.9911155700683594
. O O 0.999993085861206
Paradoxically O O 0.9999022483825684
, O O 0.999984860420227
NAC O O 0.8354129791259766
exerted O O 0.9993040561676025
a O O 0.9999876022338867
positive O O 0.9851110577583313
effect O O 0.9999626874923706
on O O 0.9999959468841553
low O O 0.9789733290672302
shear-induced O O 0.9745885133743286
VCAM-1 S-protein S-protein 0.9556277990341187
expression O O 0.9998764991760254
and O O 0.9999922513961792

( I-protein I-protein 0.8597015142440796
NF I-protein I-protein 0.6054041981697083
) I-protein I-protein 0.8508185148239136
-kappa I-protein I-protein 0.9039716124534607
B E-protein E-protein 0.979536771774292
and O O 0.9848729372024536
NF-kappa B-protein B-protein 0.858676016330719
B-like I-protein I-protein 0.9422244429588318
transcription I-protein I-protein 0.5820346474647522
factors E-protein E-protein 0.9931415915489197
are O O 0.999910831451416
activated O O 0.9989346861839294
after O O 0.9999954700469971
cross-linking O O 0.9451868534088135
CD40 S-protein S-protein 0.9563242793083191
on O O 0.999934196472168
resting O B-cell_type 0.5286644101142883
human B-cell_type I-cell_type 0.4732764959335327
tonsillar I-cell_type I-cell_type 0.5294671058654785
B I-cell_type I-cell_type 0.8053825497627258
cells E-cell_type E-cell_type 0.9183375835418701
and O O 0.9988214373588562
on O O 0.9991740584373474
B B-cell_line B-cell_line 0.43491774797439575
cell I-cell_line I-cell_line 0.4432947337627411

( O O 0.9406563639640808
GCII S-protein S-protein 0.4747404158115387
) O O 0.8868278861045837
. O O 0.9999580383300781
We O O 0.9999721050262451
hypothesized O O 0.9999035596847534
that O O 0.9999974966049194
lymphocyte B-protein B-protein 0.46833235025405884
GCII E-protein E-protein 0.8752586245536804
is O O 0.9994480013847351
altered O O 0.9991486072540283
in O O 0.9999645948410034
adolescent O O 0.7789928913116455
MDD O O 0.3792605698108673
and O O 0.9133462905883789
could O O 0.9989750385284424
serve O O 0.9999727010726929
as O O 0.9999940395355225
a O O 0.9999959468841553
marker O O 0.991358757019043
for O O 0.999930739402771
response O O 0.9874927997589111
to O O 0.9996305704116821

the O O 0.9993783235549927
presence O O 0.9992125034332275
and O O 0.9999662637710571
absence O O 0.9999740123748779
of O O 0.9999966621398926
a O O 0.9999794960021973
500-fold O O 0.9055815935134888
excess O O 0.9788506627082825
of O O 0.9995970129966736
unlabeled O O 0.7459923028945923
ligand O O 0.46296584606170654
and O O 0.9527501463890076

associated O O 0.9138549566268921

lymphoid I-cell_type I-cell_type 0.5340083241462708
cells E-cell_type E-cell_type 0.8787047266960144
, O O 0.7756350040435791
and O O 0.9995156526565552
are O O 0.9999839067459106
viable O O 0.9971484541893005
alternatives O O 0.9984862208366394
to O O 0.9999792575836182
promoters S-DNA S-DNA 0.9487329125404358
commonly O O 0.9985365867614746

the O O 0.9983996748924255
Th2 O O 0.40630263090133667
pathway O O 0.9221858978271484
. O O 0.9997709393501282
IL-12 S-protein S-protein 0.9672635793685913
and O O 0.9936049580574036
type B-protein B-protein 0.6863149404525757
I I-protein I-protein 0.5037802457809448
but I-protein I-protein 0.5965566039085388
not I-protein I-protein 0.8293026089668274
type I-protein I-protein 0.4106910228729248
II I-protein I-protein 0.6961544156074524
interferons E-protein E-protein 0.9959508180618286
induce O O 0.9982800483703613
expression O O 0.9986977577209473
of O O 0.9999886751174927
the O O 0.9999003410339355

increased O O 0.9952164888381958
expression O O 0.9991182684898376
of O O 0.999993085861206
GCRbeta S-protein S-protein 0.9906260967254639
in O O 0.9998575448989868
airway O B-cell_type 0.5683482885360718
T B-cell_type I-cell_type 0.8088403940200806
cells E-cell_type E-cell_type 0.9372026920318604
. O O 0.9999237060546875
Activation O O 0.9995384216308594
of O O 0.9999901056289673
the O O 0.9999876022338867
Janus B-protein B-protein 0.8537649512290955
kinase I-protein I-protein 0.7850762009620667
3 E-protein E-protein 0.9519226551055908
-STAT5a S-protein S-protein 0.5326595902442932
pathway O O 0.994682252407074
after O O 0.9999885559082031
CD40 S-protein S-protein 0.9838399291038513
triggering O O 0.9969498515129089
of O O 0.999983549118042
human B-cell_type B-cell_type 0.43931281566619873

and O O 0.8848080039024353
ATF2 S-protein S-protein 0.82696533203125
but O O 0.9900319576263428
not O O 0.9964630007743835
with O O 0.9998078942298889
ATF4/CREB2 S-protein S-protein 0.7493276596069336
. O O 0.9999468326568604
One O O 0.9998739957809448
ATF/CRE B-DNA B-DNA 0.3810766339302063
motif E-DNA E-DNA 0.8981906175613403
is O O 0.9996589422225952
located O O 0.9999372959136963
in O O 0.9999946355819702
the O O 0.9998338222503662
distal B-DNA B-DNA 0.9058464169502258
promoter E-DNA E-DNA 0.9909321069717407
at O O 0.9997599720954895
the O O 0.9999585151672363
nuclear B-DNA B-DNA 0.3815632462501526
matrix-associated I-DNA I-DNA 0.4911263585090637
Site I-DNA I-DNA 0.5960769653320312
IV E-DNA E-DNA 0.8321732878684998
, O O 0.9357307553291321
and O O 0.9975937008857727
the O O 0.9998880624771118
second O O 0.9172088503837585
motif O O 0.683488130569458
is O O 0.9997958540916443
present O O 0.9999154806137085

TPA S-protein S-protein 0.7620617151260376
-induced O O 0.9968562126159668
HL-60 O O 0.4790005385875702
differentiation O O 0.9863311052322388
but O O 0.9997400641441345
unchanged O O 0.9989367127418518
during O O 0.9998562335968018
granulocyte O O 0.4899681806564331
differentiation O O 0.9970700740814209
. O O 0.9999986886978149
From O O 0.9999971389770508
these O O 0.9999959468841553
data O O 0.9992627501487732
, O O 0.9999977350234985
we O O 0.9999892711639404
conclude O O 0.9999996423721313
that O O 0.9999986886978149
the O O 0.9999958276748657
induction O O 0.9993997812271118
of O O 0.9999890327453613
PO-B S-protein S-protein 0.7983143329620361
DNA O O 0.8162879347801208
binding O O 0.9964655637741089
is O O 0.9999980926513672
a O O 0.9999991655349731
general O O 0.9592524766921997
marker O O 0.965360701084137

T B-cell_line B-cell_type 0.31305915117263794
cells E-cell_line E-cell_type 0.849123477935791
, O O 0.9732702970504761
than O O 0.9999616146087646
previously O O 0.9962083101272583
reported O O 0.9998366832733154
with O O 0.999996542930603
other O O 0.9998458623886108
methods O O 0.9968464970588684
. O O 0.9999949932098389
We O O 0.9999086856842041
also O O 0.999980092048645
found O O 0.9999884366989136
that O O 0.9999973773956299
the O O 0.9999717473983765
deviation O O 0.994720458984375
of O O 0.9999070167541504
methylation O O 0.9623016715049744
in O O 0.9992784857749939
granulocytes S-cell_type S-cell_type 0.9982731342315674
and O O 0.9886916875839233
T B-cell_line B-cell_type 0.9409254193305969
cells E-cell_line E-cell_type 0.9884754419326782
was O O 0.9996993541717529
well O O 0.9975542426109314
correlated O O 0.9992891550064087
. O O 0.9999972581863403
Thus O O 0.9999691247940063
, O O 0.9999878406524658
we O O 0.9999935626983643
conclude O O 0.9999992847442627
that O O 0.9999954700469971
appropriate O O 0.997484564781189
controls O O 0.9994357228279114
from O O 0.9999984502792358
the O O 0.9999926090240479
same O O 0.9999701976776123
individuals O O 0.998386025428772
, O O 0.9999479055404663

marrow I-cell_type I-cell_type 0.5190666317939758
cells E-cell_type E-cell_type 0.8639590740203857
express O O 0.9991974234580994
NF-kappaB S-protein S-protein 0.9870196580886841
that O O 0.9993053674697876
can O O 0.9999327659606934
be O O 0.999862790107727
activated O O 0.9989296793937683
by O O 0.9999961853027344
exposure O O 0.9798193573951721
to O O 0.9995902180671692
phorbol O O 0.7950667142868042
12-myristate O O 0.9036215543746948
13-acetate O O 0.5663137435913086
and O O 0.9951711297035217
a O O 0.9998742341995239
variety O O 0.990717351436615
of O O 0.9998897314071655
cytokines S-protein S-protein 0.9929282069206238
, O O 0.9978463649749756
eg O O 0.49653562903404236
, O O 0.7791504263877869
tumor B-protein B-protein 0.877450704574585
necrosis I-protein I-protein 0.9758391380310059
factor I-protein I-protein 0.5053425431251526
alpha E-protein E-protein 0.9861415028572083
, O O 0.9915596842765808
interleukin-3 S-protein S-protein 0.9754813313484192
, O O 0.990519642829895
and O O 0.9992584586143494
granulocyte-macrophage B-protein B-protein 0.8356606960296631
colony-stimulating I-protein I-protein 0.9405916929244995
factor E-protein E-protein 0.9896087050437927
. O O 0.9994341731071472
In O O 0.9999622106552124
addition O O 0.9999520778656006
, O O 0.9999953508377075
we O O 0.9999457597732544
demonstrate O O 0.9999940395355225
that O O 0.9999922513961792
NF-kappaB S-protein S-protein 0.9977868795394897
may O O 0.9998582601547241
be O O 0.9999849796295166
required O O 0.9999411106109619
for O O 0.9999862909317017
human O B-cell_type 0.5405506491661072

000-fold O O 0.32558131217956543
in O O 0.9965628981590271
monocyte B-cell_line B-cell_line 0.46059516072273254
cell I-cell_line I-cell_line 0.5834271907806396
lines E-cell_line E-cell_line 0.9983300566673279
, O O 0.9977350234985352
peripheral B-cell_type B-cell_type 0.8168902397155762
blood I-cell_type I-cell_type 0.9608038067817688
monocytes E-cell_type E-cell_type 0.9773873686790466
, O O 0.9912399649620056
and O O 0.9968265295028687
unfractionated B-cell_type B-cell_type 0.5661143064498901
peripheral I-cell_type I-cell_type 0.6736719608306885
blood I-cell_type I-cell_type 0.8418219685554504
mononuclear I-cell_type I-cell_type 0.9260464906692505
cells E-cell_type E-cell_type 0.9499019384384155
. O O 0.9998644590377808
1 O B-protein 0.6600331664085388
, O I-protein 0.4971677362918854
25 O I-protein 0.635749340057373
( O I-protein 0.503971517086029
OH O I-protein 0.6139638423919678

the O O 0.9981325268745422
GATA-binding B-protein B-protein 0.6071330904960632
proteins E-protein E-protein 0.9898083806037903
, O O 0.9989331364631653
we O O 0.9999599456787109
hope O O 0.9999959468841553
to O O 0.9999945163726807
learn O O 0.9999986886978149
what O O 0.9999966621398926
proteins O O 0.8201442360877991
GATA-1 S-protein S-protein 0.7310202717781067
binds O O 0.997832715511322
to O O 0.9999909400939941
in O O 0.9998102784156799
the O O 0.9998985528945923
basic O O 0.8850330710411072
transcription O O 0.8446529507637024
machinery O O 0.7348284125328064
or O O 0.9998001456260681

are O O 0.9984322190284729
IL-3 S-protein S-protein 0.9959421753883362
-dependent O O 0.9983199238777161
for O O 0.9998937845230103
growth O O 0.9924867153167725
and O O 0.9998434782028198
they O O 0.999995231628418
differentiate O O 0.999643087387085
into O O 0.9997016787528992
granulocytes O S-cell_type 0.9957133531570435
when O O 0.999671459197998
exposed O O 0.996971845626831
to O O 0.9999591112136841
G-CSF S-protein S-protein 0.9794126749038696
. O O 0.9998942613601685
They O O 0.9999799728393555
are O O 0.9999679327011108
growth-inhibited O O 0.9966273903846741
by O O 0.9999885559082031
TGF-beta1 S-protein S-protein 0.9587942361831665
. O O 0.999894380569458
We O O 0.9999926090240479
show O O 0.9999978542327881
that O O 0.9999986886978149
whereas O O 0.9999936819076538
the O O 0.9999896287918091
expression O O 0.9993613362312317
of O O 0.9999915361404419
MDS1/EVI1 S-DNA S-protein 0.7737793326377869
has O O 0.9997207522392273
no O O 0.999982476234436
effect O O 0.9999715089797974
on O O 0.9999649524688721
granulocytic O O 0.708942174911499
differentiation O O 0.9886136054992676
induced O O 0.9997990727424622

binding O O 0.8711448907852173
of O O 0.9978020787239075
HMG-I B-protein B-protein 0.7612699866294861
( I-protein I-protein 0.6494854688644409
Y I-protein I-protein 0.9686996936798096
) E-protein E-protein 0.9741829037666321
to O O 0.999573290348053
this O O 0.9999439716339111
oligonucleotide O O 0.6114838123321533
causes O O 0.9933578372001648
bending/flexure O O 0.7772967219352722
of O O 0.9974567294120789
the O O 0.9999226331710815
DNA O O 0.7990378141403198
. O O 0.9997127652168274
HMG-I B-protein B-protein 0.8300241827964783
( I-protein I-protein 0.6506624221801758
Y I-protein I-protein 0.972222626209259
) E-protein E-protein 0.9733394384384155
also O O 0.9966002106666565
binds O O 0.9994631409645081
to O O 0.9999762773513794
a O O 0.9999673366546631
second O O 0.9536080956459045
oligonucleotide O O 0.6282265782356262
containing O O 0.9912603497505188
a O O 0.9994640946388245
BP1 B-DNA B-DNA 0.6475570201873779

promonocytic B-cell_type I-cell_line 0.2857261598110199
cells E-cell_type E-cell_line 0.6427518129348755
were O O 0.9997479319572449
examined O O 0.9998505115509033
because O O 0.9999958276748657
they O O 0.9999244213104248
normally O O 0.9999381303787231
express O O 0.9999946355819702
both O O 0.9999685287475586

Using O O 0.9992676377296448
a O O 0.9999406337738037
gel O O 0.887722373008728
mobility O O 0.9713299870491028
shift O O 0.9961854815483093
assay O O 0.9997349381446838
, O O 0.9999929666519165
we O O 0.999968409538269
identified O O 0.999993085861206
a O O 0.9999972581863403
DNA-binding B-protein B-protein 0.6797574758529663
complex E-protein E-protein 0.9926972985267639
in O O 0.9999321699142456
IM-9 O S-protein 0.4565950334072113
nuclear O O 0.7190795540809631
extracts O O 0.9410198926925659
that O O 0.9999903440475464
by O O 0.9999954700469971
several O O 0.9998691082000732
criteria O O 0.9980412721633911
appears O O 0.9999938011169434

factor-alpha E-protein E-protein 0.9845954179763794
( O O 0.9789291024208069
TNF-alpha S-protein S-protein 0.997143566608429
) O O 0.9894981384277344
by O O 0.9999852180480957
the O O 0.999964714050293
leukocytes S-cell_type S-cell_type 0.9951560497283936
when O O 0.9993005990982056
they O O 0.9999443292617798
were O O 0.9999483823776245
stimulated O O 0.9989411234855652
with O O 0.9999821186065674
platelet-activating B-protein B-protein 0.46562841534614563
factor E-protein E-protein 0.9864712357521057
. O O 0.9997087121009827
Increased O O 0.9995943903923035
cytokine O S-protein 0.9860410094261169
secretion O O 0.9982970356941223
was O O 0.9999973773956299
specifically O O 0.9997486472129822
inhibited O O 0.9999767541885376
by O O 0.9999967813491821
G1 S-protein O 0.9026879668235779
, O O 0.9998557567596436
an O O 0.999993085861206
anti-P-selectin B-protein B-protein 0.6672677993774414
mAb E-protein E-protein 0.9929595589637756
that O O 0.999453604221344
prevents O O 0.9999464750289917
P-selectin S-protein S-protein 0.5984027981758118

not O O 0.980776309967041
involve O O 0.9999867677688599
abrogation O O 0.999860405921936
of O O 0.9999977350234985
the O O 0.9999923706054688
ISRE O O 0.2938428223133087
binding O O 0.47647157311439514
of O O 0.9091085195541382
ISGF3gamma O S-protein 0.9047134518623352
. O O 0.9999370574951172
Phorbol O O 0.9362329840660095
ester O O 0.9603002667427063
treatment O O 0.9982678890228271
of O O 0.9999845027923584
monocytes O S-cell_type 0.9914339780807495

nuclear O O 0.5838208198547363

on O O 0.9996538162231445
the O O 0.9999955892562866
first O O 0.9807153940200806
experiences O O 0.9995731711387634
with O O 0.9999967813491821
Urapidil O O 0.8578962087631226
in O O 0.9998353719711304
the O O 0.9999786615371704
treatment O O 0.998433530330658
of O O 0.9999799728393555
hypertension O O 0.9980301260948181
in O O 0.999987006187439
severe O O 0.964004397392273
preeclampsia O O 0.9807277917861938
. O O 0.9999890327453613
The O O 0.9999997615814209
data O O 0.9997013211250305
show O O 0.9999991655349731
that O O 0.999997615814209
hypertension O O 0.9871680736541748

formation O O 0.9318622350692749
. O O 0.9999895095825195
Studies O O 0.9999731779098511
on O O 0.9999405145645142
unicellular B-cell_line B-cell_line 0.3314727544784546
and I-cell_line I-cell_line 0.7703859210014343
paired I-cell_line I-cell_line 0.8149229884147644
daughter I-cell_line I-cell_line 0.6261329054832458
cell I-cell_line I-cell_line 0.4954030215740204
culture E-cell_line E-cell_line 0.9249958395957947
unequivocally O O 0.9988215565681458
indicate O O 0.9999984502792358
that O O 0.9999992847442627
the O O 0.9999939203262329
shift O O 0.9990377426147461
is O O 0.9999924898147583
mediated O O 0.9999368190765381
by O O 0.9999991655349731
modulation O O 0.9980344176292419
of O O 0.999987006187439
the O O 0.9999754428863525
HPC O O 0.8419401049613953
differentiation O O 0.8950687050819397
program O O 0.9946855306625366
to O O 0.9999969005584717
the O O 0.9999947547912598
granulopoietic O O 0.7221358418464661
pathway O O 0.9731200337409973
( O O 0.9978817105293274

between O O 0.9952656030654907
the O O 0.9999598264694214
glucocorticoid B-protein B-protein 0.7397831678390503
receptor E-protein E-protein 0.9814157485961914
and O O 0.9918118715286255
nuclear B-protein B-protein 0.5266708135604858
factor-kappa I-protein I-protein 0.6424055099487305
B I-protein I-protein 0.8127689361572266
factors E-protein E-protein 0.9877653121948242
is O O 0.9998807907104492
at O O 0.999991774559021
least O O 0.9999363422393799
a O O 0.9999954700469971
partial O O 0.996501088142395
explanation O O 0.9999547004699707
for O O 0.9999991655349731
the O O 0.9999996423721313
effects O O 0.9999797344207764
of O O 0.999997615814209
this O O 0.9999963045120239
hormone O O 0.9866238236427307

T B-cell_type B-cell_type 0.2648901641368866
cells E-cell_type E-cell_type 0.7205113768577576
treated O O 0.9994578957557678
with O O 0.9999743700027466
IL-2 S-protein S-protein 0.953720211982727
contained O O 0.9996973276138306
those O O 0.9999810457229614
located O O 0.9983080625534058
in O O 0.9999524354934692
S O O 0.8354764580726624
+ O O 0.9789181351661682
G2/M O O 0.8912063241004944
phases O O 0.9763423204421997
of O O 0.9999535083770752
the O O 0.9999908208847046
cell O O 0.9233079552650452
cycle O O 0.9783185720443726
, O O 0.9999476671218872
whereas O O 0.9999986886978149
the O O 0.9999959468841553
vast O O 0.9977383613586426
majority O O 0.9997883439064026
of O O 0.9999915361404419
T B-cell_type B-cell_type 0.8707098960876465
cells E-cell_type E-cell_type 0.9848836064338684
treated O O 0.9994000196456909
with O O 0.999985933303833
IFN-alpha/beta S-protein S-protein 0.9797152280807495
were O O 0.9999226331710815
located O O 0.9999103546142578
in O O 0.9999758005142212
G0/G1 O O 0.5661855340003967
phase O O 0.6360514760017395
. O O 0.9988478422164917
IFN-alpha/beta S-protein S-protein 0.9123238325119019
specifically O O 0.9957965612411499
induced O O 0.9991838335990906
tyrosine O O 0.8958983421325684

of O O 0.9945059418678284
Ile50 O S-protein 0.9500510692596436
contributes O O 0.9998776912689209
to O O 0.9999905824661255
enhancement O O 0.9982064962387085
of O O 0.9999706745147705
IgE S-protein S-protein 0.9742363095283508
synthesis O O 0.9956938028335571
. O O 0.9999978542327881
A O O 0.9999727010726929
novel O O 0.8283296823501587
growth-factor-dependent B-cell_line B-cell_line 0.49554309248924255
myeloid I-cell_line I-cell_line 0.7184795141220093
cell I-cell_line I-cell_line 0.9217711687088013
line E-cell_line E-cell_line 0.996613085269928
derived O O 0.9976981282234192
from O O 0.9999805688858032
mouse B-cell_type B-cell_type 0.45185157656669617
bone I-cell_type I-cell_type 0.39917218685150146
marrow I-cell_type I-cell_type 0.6480828523635864
cells E-cell_type E-cell_type 0.8781306147575378
contains O O 0.9992148876190186
progenitors O S-cell_type 0.9495645761489868
endowed O O 0.9893312454223633
with O O 0.9999035596847534
high O O 0.9558566212654114
proliferative O O 0.977161169052124
potential O O 0.9991188645362854
. O O 0.9999990463256836
Constitutive O O 0.9666083455085754
expression O O 0.9959147572517395
of O O 0.9999741315841675
human B-protein B-protein 0.4722384810447693
colony-stimulating I-protein I-protein 0.7141703963279724
factor-1 I-protein I-protein 0.5293957591056824
receptor E-protein E-protein 0.9642890691757202
( O O 0.8797439336776733
CSF-1R S-protein S-protein 0.9628546237945557
) O O 0.9282582998275757
confers O O 0.9956085085868835

the O O 0.9978651404380798
IL-2 B-DNA B-DNA 0.6053065657615662
promoter E-DNA E-DNA 0.9950245022773743
in O O 0.9995536208152771
lpr O B-cell_line 0.5080459117889404
CD4-CD8- B-cell_line I-cell_line 0.7833235263824463
T I-cell_line I-cell_line 0.7616199254989624
lymphocytes E-cell_line E-cell_line 0.8751285672187805
results O O 0.9997138381004333
in O O 0.9999935626983643
constitutive O O 0.9662707448005676
expression O O 0.9969035983085632
of O O 0.9999797344207764
a O O 0.9999687671661377
novel B-protein O 0.7762529253959656
nuclear I-protein B-protein 0.33232516050338745
factor I-protein I-protein 0.6290680766105652
of I-protein I-protein 0.48918449878692627
activated I-protein I-protein 0.7169957756996155
T I-protein I-protein 0.759182333946228
cells-binding I-protein I-protein 0.822756826877594
factor E-protein E-protein 0.9837009310722351
. O O 0.9994181394577026
The O O 0.9999898672103882
inert O O 0.5331751704216003
quality O O 0.8050867915153503

-induced O O 0.9222040772438049

have O O 0.9976268410682678
been O O 0.9999426603317261
tested O O 0.9999330043792725
. O O 0.9999988079071045
Relief O O 0.9997089505195618
of O O 0.9999973773956299
cyclin B-protein O 0.30721399188041687
A E-protein O 0.2668446898460388
gene O O 0.7752406001091003
transcriptional O O 0.8291405439376831
inhibition O O 0.9903231859207153
during O O 0.9999568462371826
activation O O 0.9967663288116455
of O O 0.9999567270278931
human B-cell_type B-cell_type 0.5288775563240051
primary I-cell_type I-cell_type 0.6097124814987183
T I-cell_type I-cell_type 0.8079494833946228
lymphocytes E-cell_type E-cell_type 0.9466474056243896
via O O 0.9995798468589783
CD2 S-protein S-protein 0.9270691871643066
and O O 0.9886794686317444
CD28 S-protein S-protein 0.9410011172294617

likely O O 0.9696052670478821
to O O 0.9996792078018188
play O O 0.9999725818634033
a O O 0.9999934434890747
dominant O O 0.9966212511062622
role O O 0.9999480247497559
in O O 0.9999916553497314
TNF-alpha S-protein S-protein 0.9987070560455322
-induced O O 0.9960595369338989
ICAM-1 S-protein S-protein 0.9021687507629395
transcription O O 0.9519447088241577
in O O 0.9999198913574219
monocytic B-cell_type B-cell_type 0.7257370948791504
cells E-cell_type E-cell_type 0.972703218460083
. O O 0.9999299049377441
Competent O O 0.9726473689079285
transcription O O 0.6776344180107117
initiation O O 0.9167537689208984

for O O 0.995010495185852
activation O O 0.9913553595542908
of O O 0.9996953010559082
JAK-1 S-protein S-protein 0.989601194858551
and O O 0.9966444969177246
STAT6 S-protein S-protein 0.9964840412139893
and O O 0.9983922839164734
the O O 0.999976634979248
induction O O 0.9957603812217712
of O O 0.9999576807022095
IL-4 S-protein S-protein 0.9922463893890381
-specific O O 0.9812275767326355
gene O O 0.8893054127693176
expression O O 0.9995869994163513
. O O 0.9999990463256836
The O O 0.9999954700469971
common B-protein B-protein 0.8466350436210632
gamma-chain E-protein I-protein 0.5390650033950806
( O I-protein 0.6991145014762878
gamma B-protein I-protein 0.6053344011306763
( I-protein I-protein 0.9054020643234253
c I-protein I-protein 0.9654212594032288
) E-protein E-protein 0.9810840487480164
) O O 0.8601285815238953
is O O 0.9999730587005615
a O O 0.999996542930603
functional O O 0.968838632106781
component O O 0.8980498313903809
of O O 0.9999208450317383
the O O 0.9998729228973389
IL-4R S-protein S-protein 0.6893362998962402
, O O 0.8887221813201904

differentiate O O 0.9974049925804138
by O O 0.9999960660934448
the O O 0.9999983310699463
addition O O 0.9995747208595276
of O O 0.9999921321868896
human B-protein B-protein 0.4599032700061798
GM-CSF E-protein E-protein 0.9880529642105103
( O O 0.994067907333374
hGM-CSF S-protein S-protein 0.9807019829750061
) O O 0.9953616261482239
. O O 0.9999935626983643
By O O 0.9999735355377197
expressing O O 0.999148964881897
a O O 0.9999852180480957
series O O 0.9714116454124451
of O O 0.9998236298561096
GM-CSFRalpha B-protein B-protein 0.4652635157108307
mutants E-protein E-protein 0.927298367023468
in O O 0.9998397827148438
WT19 B-cell_line B-cell_line 0.8805317878723145
cells E-cell_line E-cell_line 0.9893749952316284
, O O 0.9993414282798767
we O O 0.9999594688415527
have O O 0.999997615814209
determined O O 0.9999890327453613
the O O 0.9999971389770508
amino B-protein B-protein 0.5991052389144897
acid I-protein I-protein 0.7037385106086731
domains E-protein E-protein 0.9829580187797546
of O O 0.9987096786499023
the O O 0.9999411106109619
GM-CSFRalpha S-protein B-protein 0.6169326305389404
cytoplasmic B-protein I-protein 0.7909950017929077
domain E-protein E-protein 0.9738299250602722
that O O 0.998843789100647
regulate O O 0.9993581175804138
cell O O 0.9647755026817322
differentiation O O 0.9985584616661072
, O O 0.9999834299087524

cells E-cell_type E-cell_type 0.5728949904441833
by O O 0.9992727637290955
blocking O O 0.9987673759460449
the O O 0.999991774559021
accumulation O O 0.9991125464439392
of O O 0.9998145699501038
IL2 B-RNA B-RNA 0.9941412806510925
mRNA E-RNA E-RNA 0.9983697533607483
. O O 0.9996626377105713
To O O 0.9999872446060181
determine O O 0.9999970197677612
whether O O 0.9999959468841553
CIF S-protein S-protein 0.9476190209388733
blocks O O 0.9746326804161072
at O O 0.9999988079071045
the O O 0.9999994039535522
level O O 0.9998970031738281
of O O 0.9999920129776001
IL2 S-protein S-protein 0.8471097946166992
transcription O O 0.9276953339576721
, O O 0.9999936819076538
we O O 0.9999592304229736
introduced O O 0.9998971223831177
reporter O B-DNA 0.6479988098144531
plasmids O E-DNA 0.9912406802177429
into O O 0.9999527931213379
the O O 0.9997754693031311
human B-cell_line B-cell_line 0.5168991088867188
T I-cell_line I-cell_line 0.664932370185852
leukemia I-cell_line I-cell_line 0.944807231426239
cell I-cell_line I-cell_line 0.9674375057220459
line I-cell_line I-cell_line 0.9283097386360168
Jurkat E-cell_line E-cell_line 0.9333377480506897
by O O 0.999836802482605
transient O O 0.7655544281005859
transfection O O 0.9619669914245605
. O O 0.999983549118042
These O O 0.9999971389770508
contained O O 0.9999319314956665
the O O 0.9999709129333496
luciferase B-DNA B-DNA 0.7745018005371094
gene E-DNA E-DNA 0.9912120699882507
under O O 0.9998096823692322

to O O 0.999189555644989
the O O 0.9999885559082031
negative-acting B-DNA O 0.7666271924972534
segment E-DNA O 0.8157007098197937
of O O 0.9969494938850403
the O O 0.999923586845398
kappa B-DNA B-DNA 0.5920804142951965
E3 I-DNA I-DNA 0.7627127766609192
' I-DNA I-DNA 0.76303631067276
enhancer E-DNA E-DNA 0.9979497790336609
. O O 0.9999294281005859
This O O 0.9999568462371826
protein O O 0.9640174508094788
also O O 0.9995855689048767
binds O O 0.9997422099113464
to O O 0.9999828338623047
the O O 0.9999123811721802
immunoglobulin B-DNA B-DNA 0.7230468988418579
heavy-chain I-DNA I-DNA 0.7557725310325623
enhancer I-DNA I-DNA 0.813506007194519
mu I-DNA I-DNA 0.5683432817459106
E1 I-DNA I-DNA 0.7511982917785645
site E-DNA E-DNA 0.9951876401901245
. O O 0.9995554089546204
NF-E1 S-protein S-DNA 0.7484816908836365
is O O 0.995102047920227
encoded O O 0.9995513558387756
by O O 0.999992847442627
the O O 0.9999758005142212
same O O 0.9992561936378479
gene O O 0.9553183913230896
as O O 0.9999372959136963
the O O 0.999946117401123
YY-1 B-protein B-protein 0.4508446156978607
protein E-protein E-protein 0.9256722927093506
, O O 0.9701403975486755
which O O 0.9999018907546997
binds O O 0.9997379183769226
to O O 0.9999786615371704
the O O 0.9998847246170044
adeno-associated B-DNA B-DNA 0.40206408500671387
virus I-DNA I-DNA 0.5283907055854797
P5 I-DNA I-DNA 0.8225196599960327
promoter E-DNA E-DNA 0.989589512348175
. O O 0.9985581040382385
NF-E1 S-protein S-protein 0.6468879580497742
is O O 0.9976605176925659
also O O 0.9999668598175049
the O O 0.9999940395355225

by O O 0.9983119964599609
IL-2 S-protein S-protein 0.9983497858047485
in O O 0.9998918771743774
T B-cell_type B-cell_type 0.8459159135818481
cells E-cell_type E-cell_type 0.9892721176147461
, O O 0.9976404905319214
it O O 0.9998549222946167
acts O O 0.999914288520813
to O O 0.9999933242797852
inhibit O O 0.9999493360519409
IL-2 S-protein S-protein 0.9410220980644226
responses O O 0.9950512051582336
in O O 0.9999990463256836
a O O 0.9999967813491821
classical O O 0.8513305187225342
negative O O 0.8577808737754822
feedback O O 0.8404836058616638
loop O O 0.757753849029541
. O O 0.9999841451644897
Human B-cell_type B-cell_type 0.6369079351425171
alveolar I-cell_type I-cell_type 0.7502914071083069
macrophages E-cell_type E-cell_type 0.9932818412780762
are O O 0.999920129776001
markedly O O 0.9976897239685059
deficient O O 0.9999469518661499
in O O 0.9999861717224121
REF-1 S-protein O 0.42433950304985046
and O O 0.9830480813980103
AP-1 S-protein S-protein 0.8764222264289856
DNA O O 0.878589391708374
binding O O 0.98711758852005
activity O O 0.9991169571876526
. O O 0.9999990463256836
Although O O 0.9999964237213135
many O O 0.9999029636383057
functions O O 0.9995624423027039
of O O 0.9999779462814331
human B-cell_type B-cell_type 0.47511470317840576
alveolar I-cell_type I-cell_type 0.7628669142723083
macrophages E-cell_type E-cell_type 0.9918559789657593

NF-kappa B-protein B-protein 0.8590836524963379
B E-protein E-protein 0.9979168772697449
nuclear O O 0.9786402583122253
translocation O O 0.9924324750900269
and O O 0.9999305009841919
the O O 0.9999830722808838
synthesis O O 0.9590447545051575
of O O 0.9995719790458679
a O O 0.9999014139175415
protein O O 0.5329844355583191
( O O 0.8462116718292236
s O O 0.6642402410507202
) O O 0.92225182056427
responsible O O 0.9994223117828369
for O O 0.9999852180480957
terminating O O 0.9526605010032654
NF-kappa B-protein B-protein 0.9129317998886108
B E-protein E-protein 0.9992086291313171
-DNA O O 0.9655161499977112
interaction O O 0.9977458119392395
in O O 0.9999927282333374
the O O 0.9999887943267822
nucleus O O 0.951919436454773
. O O 0.9999793767929077
Antigen O B-protein 0.7278344035148621
receptor O E-protein 0.8713935017585754
signals O O 0.9448253512382507
prolong O O 0.9994797110557556
NF-kappa B-protein B-protein 0.9221333861351013
B E-protein E-protein 0.9664309620857239

and O O 0.9807929992675781
both O O 0.9998513460159302
sites O O 0.9863055944442749
together O O 0.9999860525131226
have O O 0.9999974966049194
strong O O 0.997706413269043
transcriptional O O 0.9352927803993225
activity O O 0.9967634677886963
specifically O O 0.9999568462371826
in O O 0.9999094009399414
T B-cell_type B-cell_type 0.9155262112617493
cells E-cell_type E-cell_type 0.9948847889900208
. O O 0.9998968839645386
Surprisingly O O 0.9999593496322632
, O O 0.9999969005584717
the O O 0.9999970197677612
levels O O 0.9999041557312012
of O O 0.9999935626983643
SRF S-protein S-protein 0.9485800266265869
constitutively O O 0.998432457447052
expressed O O 0.9999358654022217
in O O 0.9998883008956909
T B-cell_type B-cell_type 0.9527970552444458
cells E-cell_type E-cell_type 0.9942547678947449
are O O 0.9997742772102356
consistently O O 0.9993396401405334
higher O O 0.9999096393585205
than O O 0.9999921321868896
in O O 0.999969482421875
other O O 0.9996839761734009

of O O 0.9990205764770508
these O O 0.9999604225158691
T B-cell_type B-cell_type 0.5875170826911926
lymphocyte I-cell_type I-cell_type 0.793074369430542
subsets E-cell_type E-cell_type 0.9840155839920044
has O O 0.9998582601547241
been O O 0.9999935626983643
implicated O O 0.9999668598175049
in O O 0.999992847442627
immunological O O 0.9748033881187439
diseases O O 0.999452531337738
including O O 0.9999902248382568
allergy O O 0.9831917881965637
, O O 0.9988914132118225
inflammation O O 0.9961218237876892
, O O 0.9998561143875122
and O O 0.9998786449432373
autoimmune O O 0.9896060228347778
disease O O 0.9995187520980835
. O O 0.9999957084655762
IL-4 S-protein S-protein 0.984606146812439
may O O 0.9998924732208252
mediate O O 0.9999377727508545
its O O 0.9999915361404419
biological O O 0.994259238243103
effects O O 0.9999555349349976
, O O 0.9999954700469971
at O O 0.9999988079071045
least O O 0.9999854564666748
in O O 0.9999916553497314
part O O 0.9995760321617126
, O O 0.9999899864196777
by O O 0.9999901056289673

results O O 0.9995043277740479
suggest O O 0.9999995231628418
that O O 0.9999979734420776
HIV-TF1 S-protein S-protein 0.9144532680511475
is O O 0.9997884631156921
involved O O 0.9999847412109375
in O O 0.999993085861206
transcriptional O O 0.9799949526786804
regulation O O 0.9995390176773071
of O O 0.9999942779541016
HIV-1 O O 0.9114605188369751
. O O 0.9999587535858154
Severe O O 0.9850993752479553
5-fluorouracil O O 0.7973207831382751
toxicity O O 0.9889737367630005
secondary O O 0.9995303153991699
to O O 0.9999754428863525
dihydropyrimidine B-protein O 0.8539185523986816
dehydrogenase E-protein O 0.8221155405044556
deficiency O O 0.9960163235664368
. O O 0.9999979734420776
A O O 0.9999444484710693
potentially O O 0.9964004755020142
more O O 0.9998573064804077
common O O 0.9883878827095032

-mediated O O 0.9490638375282288
NFAT S-protein S-protein 0.9917289614677429
activation O O 0.9984253644943237
, O O 0.9999833106994629
suggesting O O 0.999993085861206
a O O 0.9999828338623047
functional B-protein O 0.8189539909362793
Ras E-protein S-protein 0.6907340884208679
is O O 0.999394416809082
required O O 0.9999213218688965
for O O 0.9999939203262329
this O O 0.9999688863754272
activation O O 0.9969356060028076
. O O 0.9999932050704956
These O O 0.9999970197677612
results O O 0.9998929500579834
implicate O O 0.9999922513961792
Cbl S-protein S-protein 0.9807904958724976
in O O 0.9996588230133057
Ras S-protein S-protein 0.9982686042785645
-dependent O O 0.9910606741905212
signaling O O 0.9830278158187866
pathways O O 0.9988490343093872
which O O 0.9999959468841553
lead O O 0.9999158382415771
to O O 0.9999513626098633

cell O O 0.5072159171104431
activity O O 0.9816421270370483
in O O 0.9999650716781616
response O O 0.997040331363678
to O O 0.9999297857284546
IL-18 S-protein S-protein 0.9956583976745605
are O O 0.9999339580535889
abrogated O O 0.9981086254119873
. O O 0.9999926090240479
In O O 0.9961410164833069
vivo O O 0.9930602312088013
Th1 O O 0.3029630780220032
response O O 0.8543888330459595
is O O 0.998471200466156
also O O 0.9999349117279053
impaired O O 0.9999088048934937
. O O 0.9999970197677612
Furthermore O O 0.9999866485595703
, O O 0.9999386072158813
IL-18 S-protein S-protein 0.9992501139640808
-induced O O 0.9965896606445312

frequent O O 0.9777718782424927
use O O 0.9993308782577515
of O O 0.9999955892562866
the O O 0.9999674558639526
classical O B-protein 0.6004480123519897
Oct2a S-protein I-protein 0.3417325019836426
and O I-protein 0.7289483547210693
Oct2b S-protein I-protein 0.3971438705921173
isoforms O E-protein 0.9682466387748718
was O O 0.9997628331184387
observed O O 0.9999568462371826
in O O 0.9999924898147583
the O O 0.9999486207962036
lipopolysaccharide-stimulated B-cell_line B-cell_type 0.4569112956523895
B I-cell_line I-cell_type 0.3889900743961334
cells E-cell_line E-cell_type 0.5430536866188049
, O O 0.9924047589302063
while O O 0.9999979734420776
a O O 0.9999815225601196
preference O O 0.9993510842323303
for O O 0.999992847442627
the O O 0.999969482421875
Oct2ab S-protein S-protein 0.8816875219345093
and O O 0.9575371742248535
Oct2ba S-protein B-protein 0.3975604772567749
isoforms O E-protein 0.9785203337669373
was O O 0.9997596144676208
observed O O 0.9999525547027588
in O O 0.9999592304229736
lipopolysaccharide B-cell_line O 0.4111466109752655
plus I-cell_line O 0.8927370309829712
phorbol-di-butyrate-treated I-cell_line B-cell_line 0.38060227036476135
cells E-cell_line E-cell_line 0.6647178530693054
. O O 0.9999088048934937
Positive O O 0.9333176016807556
regulators O O 0.5828133225440979
of O O 0.9972944855690002
the O O 0.9998757839202881
lineage-specific O B-protein 0.5814578533172607
transcription B-protein I-protein 0.5782942771911621
factor E-protein E-protein 0.9002118706703186
GATA-1 S-protein S-protein 0.6481437087059021

have O O 0.9985698461532593

borders O O 0.8958331942558289
of O O 0.9998865127563477
enlarged O O 0.5475444197654724
GCs O O 0.23219750821590424
were O O 0.9996395111083984
ill O O 0.9697741866111755
defined O O 0.9983755350112915
, O O 0.999971866607666
with O O 0.999985933303833
features O O 0.994981586933136
suggestive O O 0.9999473094940186
of O O 0.9999977350234985
an O O 0.9999951124191284
outward O O 0.9886190891265869
migration O O 0.9993116855621338
of O O 0.9999874830245972
GC B-cell_type B-cell_type 0.6099734902381897
cells E-cell_type E-cell_type 0.7907483577728271

region E-DNA O 0.46038517355918884
3 O O 0.5423069000244141
' O O 0.4231325089931488
of O O 0.988375186920166
TCR B-DNA B-DNA 0.4258323609828949
delta I-DNA I-DNA 0.4295445382595062
gene I-DNA I-DNA 0.9062405824661255
segments E-DNA E-DNA 0.9783324599266052
and O O 0.9976928234100342
5 O O 0.6739623546600342
' O O 0.6787014603614807
of O O 0.9961279034614563
TCR B-DNA B-protein 0.4773135483264923
alpha I-DNA E-protein 0.7597718238830566
joining I-DNA O 0.9830586910247803
gene I-DNA O 0.9118300080299377
segments E-DNA O 0.6428713202476501
within O O 0.9999678134918213
this O O 0.9999734163284302
locus O O 0.4296194612979889
. O O 0.9972571730613708
BEAD-1 S-DNA S-protein 0.6797617673873901
blocked O O 0.9985483288764954
the O O 0.999975323677063
ability O O 0.999761164188385
of O O 0.9999954700469971
the O O 0.9999464750289917
TCR B-DNA B-DNA 0.6964433789253235
delta I-DNA I-DNA 0.7583072781562805
enhancer E-DNA E-DNA 0.994329035282135
( O O 0.9940786361694336
Edelta S-DNA S-DNA 0.7567152976989746
) O O 0.9287199378013611
to O O 0.9994459748268127
activate O O 0.9994822144508362

SRE B-DNA B-DNA 0.7394140958786011
sequence E-DNA E-DNA 0.9641693830490112
in O O 0.9998341798782349
lymphocytes S-cell_type S-cell_type 0.9981465339660645
from O O 0.9994161128997803
normal O O 0.8959952592849731
subjects O O 0.9801637530326843
, O O 0.9998273253440857
as O O 0.9999871253967285
well O O 0.999950647354126
as O O 0.9999959468841553
its O O 0.9999785423278809
absence O O 0.9998562335968018
in O O 0.9999325275421143
lymphocytes S-cell_type S-cell_type 0.9984900951385498
from O O 0.9997789263725281
untreated O O 0.9413472414016724
CML O O 0.7752817273139954
patients O O 0.9969896078109741
. O O 0.9999982118606567
However O O 0.9999909400939941
, O O 0.9999977350234985
this O O 0.9999964237213135
factor O O 0.9947815537452698
appeared O O 0.9999935626983643
when O O 0.9999984502792358
these O O 0.99998939037323
CML O O 0.49060559272766113
patients O O 0.9776444435119629
achieved O O 0.9999121427536011
complete O O 0.9902808666229248
haematological O O 0.9804808497428894
remission O O 0.9994643330574036
( O O 0.9999202489852905
CHR O O 0.9036333560943604
) O O 0.9921990036964417

of O O 0.9967607855796814
erythroid O O 0.5160926580429077
differentiation O O 0.9569715857505798
of O O 0.9998610019683838
HEL B-cell_line S-cell_line 0.8916475772857666
, I-cell_line O 0.8838884830474854
KU812 I-cell_line S-cell_line 0.9603098630905151
and I-cell_line O 0.9665927290916443
K562 I-cell_line B-cell_line 0.8199949860572815
cells E-cell_line E-cell_line 0.9982115030288696
, O O 0.9965080618858337
but O O 0.9998382329940796
not O O 0.9994505047798157
the O O 0.9999690055847168
induction O O 0.9979625940322876
of O O 0.9999779462814331
monocytic O O 0.4418398439884186
or O O 0.8858047127723694
granulocytic O O 0.8109027147293091
differentiation O O 0.9876905679702759
of O O 0.9999353885650635
HL-60 B-cell_line S-cell_line 0.9182962775230408
, I-cell_line O 0.8273516893386841
U937 I-cell_line S-cell_line 0.9394564032554626
and I-cell_line O 0.9687203764915466
HEL/S I-cell_line B-cell_line 0.45959073305130005
cells E-cell_line E-cell_line 0.9682283997535706
. O O 0.9999349117279053
The O O 0.9999990463256836
erythroid O O 0.8223239183425903
differentiation O O 0.9931633472442627
of O O 0.9999619722366333
HEL B-cell_line B-cell_line 0.6284816265106201
cells E-cell_line E-cell_line 0.9772805571556091
was O O 0.9998257756233215
inhibited O O 0.9999690055847168

mutant O E-protein 0.8314769268035889
of O O 0.9986361861228943
ZEBRA S-protein S-protein 0.8231871724128723
, O O 0.9853120446205139
Z B-protein B-protein 0.28512367606163025
( I-protein I-protein 0.8322844505310059
S186A I-protein I-protein 0.6038341522216797
) E-protein E-protein 0.8335076570510864
, O O 0.9738412499427795
that O O 0.9998778104782104
was O O 0.9997429251670837
not O O 0.9994950294494629
impaired O O 0.9998219609260559
in O O 0.9999829530715942
its O O 0.99993896484375
ability O O 0.999264657497406
to O O 0.9999319314956665
activate O O 0.9973646998405457
transcription O O 0.8899685740470886
; O O 0.9981881976127625
however O O 0.9999815225601196
, O O 0.9999946355819702
this O O 0.9999451637268066
mutation O O 0.9908930063247681
abolished O O 0.9998894929885864
its O O 0.9999840259552002
ability O O 0.999886155128479
to O O 0.9999773502349854
initiate O O 0.9999167919158936

are O O 0.9987286925315857
implicated O O 0.9999258518218994
in O O 0.9999818801879883
immortalization O O 0.9987200498580933
of O O 0.9999810457229614
common B-cell_type B-cell_type 0.4781084656715393
marmoset I-cell_type I-cell_type 0.6454628109931946
T I-cell_type I-cell_type 0.9376078844070435
lymphocytes E-cell_type E-cell_type 0.9584843516349792
and O O 0.9963945746421814
may O O 0.9994367957115173
also O O 0.9999959468841553
be O O 0.9999916553497314
critical O O 0.9998045563697815
in O O 0.9999943971633911
the O O 0.999994158744812
transformation O O 0.9998071789741516
of O O 0.9999784231185913
human B-cell_type B-cell_type 0.7297613620758057
lymphocytes E-cell_type E-cell_type 0.9927375912666321
and O O 0.9988700747489929

equivalent O O 0.9420560598373413
in O O 0.9998422861099243
patient O O 0.9135594367980957
and O O 0.9728223085403442
controls O O 0.9909313917160034
. O O 0.9999945163726807
These O O 0.9999980926513672
results O O 0.9999767541885376
indicate O O 0.9999986886978149
that O O 0.9999990463256836
an O O 0.9999847412109375
abnormality O O 0.9067931175231934
of/or O O 0.5147820711135864
influencing O O 0.9879443645477295
NF-AT S-protein S-protein 0.9543063640594482
may O O 0.9998949766159058
underlie O O 0.9999936819076538
the O O 0.999998927116394
multiple O O 0.9878069758415222
lymphokine S-protein O 0.4281373918056488
deficiency O O 0.9933967590332031
in O O 0.9999953508377075
this O O 0.999984860420227
patient O O 0.9929099678993225
. O O 0.9999607801437378
FK506 O O 0.8197591304779053
and O O 0.9951536655426025
ciclosporin O O 0.8651681542396545

and O O 0.9407862424850464
uninduced O B-cell_line 0.5561253428459167
THP-1 B-cell_line I-cell_line 0.5429092645645142
cells E-cell_line E-cell_line 0.9784142971038818
. O O 0.999830961227417
However O O 0.9999912977218628
, O O 0.9999960660934448
the O O 0.9999980926513672
intensity O O 0.9989492297172546
of O O 0.9999890327453613
the O O 0.9999964237213135
complex O O 0.8631530404090881
formed O O 0.9961434006690979
appeared O O 0.9998645782470703
to O O 0.9999881982803345
increase O O 0.999995231628418
when O O 0.9999921321868896
nuclear O O 0.9580288529396057
extracts O O 0.9945394396781921
from O O 0.999974250793457
PMA-treated B-cell_line B-cell_line 0.6927514672279358
cells E-cell_line E-cell_line 0.9530838131904602
were O O 0.9997426867485046
used O O 0.999887228012085
. O O 0.9999977350234985
From O O 0.9999963045120239
these O O 0.9999891519546509

case O O 0.8839947581291199
, O O 0.999901533126831
the O O 0.9999985694885254
PTT O O 0.31931331753730774
shift O O 0.5439626574516296
was O O 0.9998953342437744
explained O O 0.9999808073043823
by O O 0.9999973773956299
in-frame O O 0.8700464963912964
splicing O O 0.9626348614692688
out O O 0.9997772574424744
of O O 0.999970555305481
exon B-RNA B-RNA 0.9739379286766052
10 E-RNA E-RNA 0.9946411848068237
, O O 0.9661821722984314
in O O 0.9999853372573853
the O O 0.9999954700469971
presence O O 0.9985597729682922
of O O 0.999982476234436
a O O 0.99996018409729
normal B-DNA O 0.791361391544342

T-cell S-cell_line S-cell_line 0.6584823131561279
, O O 0.8477845191955566
and O O 0.9302798509597778
nonlymphoid B-cell_line B-cell_line 0.5542551875114441
cell I-cell_line I-cell_line 0.7992841601371765
lines E-cell_line E-cell_line 0.9988322854042053
. O O 0.9999303817749023
Expression O O 0.9994612336158752
of O O 0.9999892711639404
recombinant O B-protein 0.5538731813430786
EBF S-protein E-protein 0.8750653266906738
in O O 0.9993512034416199
transfected B-cell_line B-cell_line 0.5360050201416016
nonlymphoid I-cell_line I-cell_line 0.7286415100097656
cells E-cell_line E-cell_line 0.9236380457878113
strongly O O 0.9919398427009583
activated O O 0.9968098998069763
transcription O O 0.906009316444397
from O O 0.9997947812080383
reporter O B-DNA 0.6063186526298523
plasmids O E-DNA 0.9903911352157593
containing O O 0.9987170696258545
functional O O 0.8171143531799316
EBF-binding B-DNA B-DNA 0.7546079158782959
sites E-DNA E-DNA 0.9807491302490234
. O O 0.9999818801879883
Analysis O O 0.9999680519104004
of O O 0.9999972581863403
DNA O O 0.7594984769821167
binding O O 0.9322026968002319
by O O 0.9998307228088379
deletion O B-protein 0.4633238911628723
mutants O E-protein 0.7505483627319336
of O O 0.9957821369171143
EBF S-protein S-protein 0.974622368812561
identified O O 0.9995600581169128
an O O 0.9999725818634033
amino-terminal B-protein B-protein 0.7584819197654724
cysteine-rich I-protein I-protein 0.8634207248687744
DNA-binding I-protein I-protein 0.9655368328094482
domain E-protein E-protein 0.9842303395271301
lacking O O 0.9990742206573486
obvious O O 0.9939777851104736
sequence O O 0.9773651957511902
similarity O O 0.9983863830566406
to O O 0.9999910593032837
known O O 0.9914180040359497
transcription B-protein B-protein 0.7207120060920715
factors E-protein E-protein 0.9947599768638611

found O O 0.9972140192985535
that O O 0.9999927282333374
mRNAs S-RNA S-RNA 0.9785774946212769
encoding O O 0.976958692073822
GATA-1 S-protein S-protein 0.965201199054718
and O O 0.9908786416053772
GATA-2 S-protein S-protein 0.9922631978988647
are O O 0.9998149275779724
expressed O O 0.9999043941497803
in O O 0.9999929666519165
all O O 0.9999814033508301
these O O 0.9999773502349854
cases O O 0.9979503750801086
. O O 0.9999983310699463
These O O 0.9999984502792358
results O O 0.9999762773513794
suggest O O 0.9999991655349731
that O O 0.9999955892562866
M7 B-cell_type B-cell_type 0.5665192008018494
blasts E-cell_type E-cell_type 0.560714066028595
and O O 0.9953113198280334
TMD B-cell_type B-cell_type 0.3490665853023529
blasts E-cell_type E-cell_type 0.5984785556793213
correspond O O 0.9988784193992615
to O O 0.9999959468841553
the O O 0.9999521970748901
erythroid/megakaryocytic B-cell_type B-cell_type 0.5199264287948608
bipotential I-cell_type I-cell_type 0.6018632054328918
progenitor I-cell_type I-cell_type 0.4949371814727783
cells E-cell_type E-cell_type 0.536903440952301
. O O 0.9999147653579712
Expression O O 0.9998016953468323
of O O 0.9999940395355225
Ah B-protein B-protein 0.4063793122768402

active O O 0.8323026895523071
MAPK S-protein S-protein 0.7587707042694092
do O O 0.9997789263725281
not O O 0.9999818801879883
affect O O 0.9999898672103882
IFN-alpha S-protein S-protein 0.9990772008895874
-induced O O 0.9985502362251282
growth O O 0.9700274467468262
arrest O O 0.9996408224105835
or O O 0.9999892711639404
induction O O 0.9992951154708862
of O O 0.9999935626983643
STAT1s1 O S-protein 0.5346919894218445
and O O 0.6923400163650513
-3 O O 0.5459868907928467
DNA O O 0.8496930003166199
binding O O 0.9837265610694885
ability O O 0.9995917677879333
. O O 0.9999994039535522
Copyright O O 0.9848031997680664
1999 O O 0.993740439414978
Academic O O 0.9988691210746765
Press O O 0.9982991814613342
. O O 0.9999951124191284

the O O 0.9985756874084473
tumor B-protein B-protein 0.6767627000808716
necrosis I-protein I-protein 0.9272271990776062
factor I-protein I-protein 0.7222369909286499
receptor-associated I-protein I-protein 0.691948413848877
death I-protein I-protein 0.9266263842582703
domain I-protein I-protein 0.5524100661277771
protein E-protein E-protein 0.9962494969367981
( O O 0.9914224743843079
TRADD S-protein S-protein 0.9971936941146851
) O O 0.9923821091651917
. O O 0.9999831914901733
TRADD S-protein S-protein 0.9343293309211731
was O O 0.9998717308044434
the O O 0.9999971389770508
only O O 0.9993533492088318
protein O O 0.8028481602668762
that O O 0.9977436065673828
interacted O O 0.9980962872505188
with O O 0.9998785257339478
wild-type B-protein B-protein 0.7245252728462219
TES2 E-protein E-protein 0.9165493845939636
and O O 0.9687327742576599
not O O 0.9948844313621521
with O O 0.9995276927947998
isoleucine-mutated B-protein B-protein 0.5564551949501038
TES2 E-protein E-protein 0.8102512359619141
. O O 0.9971551895141602
TRADD S-protein S-protein 0.9561459422111511
associated O O 0.9989099502563477
with O O 0.9999921321868896
wild-type B-protein B-protein 0.47342318296432495
LMP1 E-protein E-protein 0.6860576868057251

of O O 0.995342493057251
c-jun B-RNA B-RNA 0.9902014136314392
mRNA E-RNA E-RNA 0.9960343241691589
does O O 0.9990372657775879
not O O 0.9999550580978394
appear O O 0.9999240636825562
to O O 0.9999589920043945
be O O 0.9999910593032837
mediated O O 0.9998644590377808
at O O 0.9999996423721313
the O O 0.9999997615814209
level O O 0.9996808767318726
of O O 0.9998857975006104
mRNA O S-RNA 0.9407918453216553

and O O 0.9518819451332092
cytochemistry O O 0.9480654001235962
of O O 0.9992413520812988
bone B-cell_type B-cell_type 0.6874764561653137
marrow I-cell_type I-cell_type 0.6142759323120117
progenitors E-cell_type E-cell_type 0.9616926908493042
. O O 0.9999083280563354
X O B-DNA 0.526084303855896
chromosome O E-DNA 0.9831728935241699
inactivation O O 0.9910907745361328
and O O 0.9998452663421631
polymorphism O O 0.9594735503196716
of O O 0.9989412426948547
the O O 0.9999507665634155
human B-DNA B-DNA 0.44212448596954346
androgen I-DNA I-DNA 0.6373478770256042
receptor I-DNA I-DNA 0.5970904231071472
( I-DNA I-DNA 0.7290851473808289
HUMARA I-DNA I-DNA 0.7505329847335815
) I-DNA I-DNA 0.8443863987922668

mRNA S-RNA E-RNA 0.904984176158905
for O O 0.999406099319458
the O O 0.9999663829803467
type O B-protein 0.7557416558265686
I O I-protein 0.9278678297996521
and O I-protein 0.9670478105545044
IV O I-protein 0.9820729494094849
isoforms O E-protein 0.9101161360740662
of O O 0.9778003692626953
17 B-protein O 0.9226285815238953
beta-hydroxysteroid I-protein O 0.9018270969390869
dehydrogenase E-protein O 0.7264242768287659
. O O 0.999901533126831
Conversion O O 0.9961376786231995
of O O 0.9999604225158691
E2 O S-protein 0.7411078214645386
to O O 0.9889541864395142
E1 O S-DNA 0.5521934628486633
was O O 0.9958494901657104
upregulated O O 0.9996066689491272
within O O 0.9999959468841553
24 O O 0.9990622401237488
hours O O 0.9999295473098755
when O O 0.999998927116394
HL60 B-cell_line B-cell_line 0.7355732917785645
cells E-cell_line E-cell_line 0.9977700710296631
were O O 0.9997374415397644
treated O O 0.9999524354934692
with O O 0.9999979734420776
either O O 0.9999102354049683
all-trans O O 0.9618475437164307
retinoic O O 0.927893877029419
acid O O 0.9748620390892029
or O O 0.9996265172958374

which O O 0.9932748079299927
is O O 0.999972939491272
a O O 0.9999969005584717
negative O O 0.914056658744812
regulator O O 0.5646147131919861
of O O 0.998100221157074
cytokine B-protein B-protein 0.3252415060997009
receptor E-protein E-protein 0.9554836750030518
signaling O O 0.9466386437416077
, O O 0.9998040795326233
was O O 0.9999897480010986
lost O O 0.9999747276306152
in O O 0.9999896287918091
most O O 0.9992126226425171
IL-2 B-cell_line B-cell_line 0.32528144121170044
independent I-cell_line I-cell_line 0.5832781195640564
cell I-cell_line I-cell_line 0.8285885453224182
lines E-cell_line E-cell_line 0.9985707998275757
( O O 0.9961822628974915
3/4 O S-cell_line 0.9661743640899658
) O O 0.93394935131073
but O O 0.9995896220207214
not O O 0.9995256662368774
in O O 0.9998276233673096
the O O 0.9997389912605286
leukemic O B-cell_line 0.44100749492645264
ATLL B-cell_type I-cell_line 0.532470703125
cells E-cell_type E-cell_line 0.8302903771400452
( O O 0.9864571690559387
0/3 O S-cell_line 0.8690673112869263
) O O 0.9094451069831848
. O O 0.999976634979248
Finally O O 0.9997033476829529
, O O 0.9999608993530273
the O O 0.9998214840888977
HTLV-I B-cell_line B-cell_line 0.3906135857105255
( I-cell_line I-cell_line 0.44847244024276733
+ I-cell_line I-cell_line 0.5306774973869324
) I-cell_line I-cell_line 0.544869065284729
T-cell I-cell_line I-cell_line 0.49122706055641174
lines E-cell_line E-cell_line 0.9985746145248413
( O O 0.995014488697052

of O O 0.9925521612167358

Smmhc S-protein O 0.44207876920700073
) O O 0.8532622456550598
. O O 0.999883770942688
To O O 0.999995231628418
examine O O 0.9999955892562866
the O O 0.9999974966049194
effect O O 0.9996365308761597
of O O 0.9999887943267822
the O O 0.9999336004257202
inv B-DNA B-DNA 0.47145190834999084
( I-DNA I-DNA 0.7319434285163879
16 I-DNA I-DNA 0.8527931571006775
) I-DNA I-DNA 0.5470325350761414
( I-DNA I-DNA 0.6690422892570496
p13 I-DNA I-DNA 0.9708456993103027
; I-DNA I-DNA 0.9900738000869751
q22 I-DNA I-DNA 0.9785229563713074
) E-DNA E-DNA 0.7667681574821472
on O O 0.987464189529419
myelopoiesis O O 0.9439038038253784
, O O 0.9999085664749146
we O O 0.9999922513961792
used O O 0.9999963045120239
the O O 0.9999860525131226
hMRP8 B-DNA B-DNA 0.8417195081710815
promoter I-DNA E-DNA 0.9852818846702576

BSAP/PAX5 I-protein S-protein 0.45771360397338867
) E-protein O 0.930292546749115
in O O 0.999901533126831
activation O O 0.9967783093452454
of O O 0.9999731779098511
the O O 0.9999383687973022
B B-DNA B-DNA 0.44400444626808167
cell-specific I-DNA I-DNA 0.37104082107543945
BLK I-DNA I-DNA 0.48277100920677185
gene I-DNA I-DNA 0.4978855550289154
promoter E-DNA E-DNA 0.9902229309082031
. O O 0.9994502663612366
AML1 S-protein S-protein 0.8435752987861633
plays O O 0.997698962688446

CD28 S-protein S-protein 0.9198906421661377
response O O 0.8838926553726196
complex O O 0.8014837503433228
. O O 0.9997575879096985
While O O 0.9999990463256836
several O O 0.9999157190322876
lines O O 0.9936102032661438
of O O 0.9999469518661499
investigation O O 0.9997428059577942
have O O 0.9999992847442627

anti-Fas-mediated O O 0.7933720946311951
apoptosis O O 0.990704357624054
even O O 0.9999692440032959
though O O 0.9999979734420776
they O O 0.999994158744812
increased O O 0.9999555349349976
the O O 0.9999932050704956
survival O O 0.9998325109481812
of O O 0.9999923706054688
serum-starved B-cell_type B-cell_type 0.6097220182418823
cells E-cell_type E-cell_type 0.6062425374984741
. O O 0.9998290538787842
Thus O O 0.9999809265136719
, O O 0.9999914169311523
the O O 0.9999977350234985
protective O O 0.9899834394454956
role O O 0.9991236329078674
of O O 0.9999890327453613
BHRF1 S-protein S-protein 0.9790489673614502
against O O 0.9998506307601929
apoptosis O O 0.9882023930549622
resembles O O 0.9998806715011597
that O O 0.9999978542327881
of O O 0.9999661445617676
Bcl-2 S-protein S-protein 0.996768593788147
in O O 0.9998742341995239
being O O 0.9851645231246948
cell O O 0.9682987332344055
type O O 0.9769678115844727
specific O O 0.9979279041290283
and O O 0.9998273849487305
dependent O O 0.9989365935325623
on O O 0.9999738931655884

study O O 0.9947787523269653
. O O 0.9999909400939941
Immunosuppression O O 0.9744057059288025
has O O 0.9998133778572083
been O O 0.999984622001648
often O O 0.9998854398727417
associated O O 0.9998918771743774
with O O 0.9999982118606567
the O O 0.9999984502792358
course O O 0.9996824264526367
of O O 0.9999880790710449

MHC I-DNA I-DNA 0.1905823051929474
) I-DNA I-DNA 0.49695146083831787
class I-DNA I-DNA 0.7557054758071899
II I-DNA I-DNA 0.8026684522628784
genes E-DNA E-DNA 0.9988917708396912
. O O 0.9999709129333496
Here O O 0.9999843835830688
we O O 0.9999765157699585
show O O 0.9999836683273315
, O O 0.9999462366104126
by O O 0.9999889135360718
in O O 0.9988723397254944
vivo O O 0.9954949617385864
DNase B-protein B-protein 0.4512385129928589
I E-protein E-protein 0.9349815845489502
footprinting O O 0.9787067174911499
, O O 0.9999486207962036
that O O 0.9999998807907104
the O O 0.9999750852584839
AIR-1 B-DNA B-DNA 0.746511697769165
locus I-DNA E-DNA 0.7467328310012817
defect E-DNA O 0.8394308686256409
correlates O O 0.9896680116653442
with O O 0.9999966621398926
changes O O 0.9995580315589905
in O O 0.9999961853027344
the O O 0.9999709129333496
DRA B-DNA B-DNA 0.5778198838233948
promoter E-DNA E-DNA 0.9764047861099243
occupancy O O 0.9992867112159729
. O O 0.9999990463256836
Interestingly O O 0.999417781829834

a O O 0.9991875290870667
more O O 0.9986487030982971
proximal B-DNA B-DNA 0.8351030945777893
polyA I-DNA I-DNA 0.4318721294403076
site E-DNA E-DNA 0.8145091533660889
, O O 0.999393105506897
NF-ATc S-protein S-protein 0.8282266855239868
expression O O 0.9617801308631897
switches O O 0.9993958473205566
from O O 0.9999949932098389
the O O 0.9999799728393555
synthesis O O 0.9382482171058655
of O O 0.999363124370575
the O O 0.9999856948852539
two O O 0.9913231134414673
longer O O 0.994234025478363
isoforms O O 0.7801379561424255
in O O 0.9998787641525269
naive B-cell_type B-cell_type 0.656676709651947
T I-cell_type I-cell_type 0.8847322463989258
cells E-cell_type E-cell_type 0.9777920246124268
to O O 0.9998524188995361
that O O 0.9999971389770508
of O O 0.9999773502349854
short O O 0.9087815284729004
isoform B-protein O 0.9358751177787781
A E-protein O 0.9532850384712219

embryos O O 0.6211376190185547
and O O 0.9946144223213196
explants O O 0.9602260589599609
relieves O O 0.9998737573623657
the O O 0.9999902248382568
block O O 0.9844297170639038
to O O 0.9999150037765503
erythroid O O 0.7797389626502991
differentiation O O 0.9809058904647827
imposed O O 0.9998992681503296
by O O 0.999994158744812
PU.1 S-protein S-protein 0.975792407989502
. O O 0.9999574422836304
Our O O 0.999998927116394
results O O 0.9999685287475586
indicate O O 0.9999990463256836
that O O 0.999996542930603
the O O 0.9999686479568481
stoichiometry O O 0.8748725652694702
of O O 0.9945270419120789
directly O O 0.5583066940307617
interacting O O 0.7889167666435242
but O O 0.9815292358398438

inhibit O O 0.9981221556663513
both O O 0.9998934268951416
cell O O 0.9625809192657471
growth O O 0.9946783781051636
and O O 0.9998667240142822
death O O 0.9952869415283203
strongly O O 0.9999687671661377
implies O O 0.9999974966049194
that O O 0.9999978542327881
these O O 0.9999955892562866
two O O 0.9995318651199341
biological O O 0.9834566712379456
processes O O 0.9983738660812378
share O O 0.9999983310699463
a O O 0.9999946355819702
common O O 0.994645357131958
pathway O O 0.9997604489326477
at O O 0.9999995231628418
some O O 0.9999994039535522
point O O 0.9989650249481201

the O O 0.9994244575500488
consequences O O 0.9999306201934814
for O O 0.9999842643737793
T O O 0.7541482448577881
cell O O 0.5944973230361938
activation O O 0.98723304271698
determined O O 0.9998512268066406
. O O 0.999970555305481
p21ras S-protein S-DNA 0.6819895505905151
plays O O 0.9993682503700256
an O O 0.999984622001648
essential O O 0.9989996552467346
role O O 0.9998518228530884
in O O 0.999987006187439
T O O 0.8184060454368591
cell O O 0.6990468502044678
activation O O 0.9939976930618286
. O O 0.9999935626983643

and O O 0.9046544432640076
c-fos S-DNA S-DNA 0.641411542892456
increase O O 0.9763302206993103
were O O 0.9999761581420898
similar O O 0.9999630451202393
, O O 0.9999901056289673
suggesting O O 0.9999955892562866
that O O 0.9999927282333374
cAMP O O 0.9838828444480896
might O O 0.9999909400939941
be O O 0.9999982118606567

by O O 0.999626874923706
classical O O 0.8716468214988708
banding O O 0.9200875163078308
techniques O O 0.9962546825408936
, O O 0.9999985694885254
these O O 0.9999967813491821
data O O 0.9992830157279968
show O O 0.999997615814209
that O O 0.9999982118606567

but O O 0.9914167523384094
instead O O 0.9999791383743286
involves O O 0.9999953508377075
multiple O O 0.9841160178184509
interacting B-DNA B-DNA 0.8588206768035889
elements E-DNA E-DNA 0.8940790295600891
that O O 0.9998637437820435
provide O O 0.999995231628418
both O O 0.9999722242355347
specific O O 0.989950954914093
positive O O 0.9230620861053467
regulation O O 0.986850380897522
in O O 0.9999071359634399
T B-cell_type B-cell_type 0.8158659338951111
cells E-cell_type E-cell_type 0.9921758770942688
and O O 0.9986693859100342
specific O O 0.984428882598877
negative O O 0.8913518786430359
regulation O O 0.9821261763572693
in O O 0.9998810291290283
fibroblasts S-cell_type S-cell_type 0.9946304559707642
. O O 0.9998353719711304
Modulation O O 0.9953658580780029
of O O 0.9998985528945923
the O O 0.9999926090240479
expression O O 0.9956794381141663
of O O 0.9999490976333618
the O O 0.9999439716339111
IFN-gamma B-protein B-protein 0.6194227933883667
receptor I-protein E-protein 0.7114593982696533

. O O 0.999110758304596
The O O 0.9999982118606567
expression O O 0.9994370341300964
of O O 0.999993085861206
STAT1 S-protein S-protein 0.9874581694602966
and O O 0.9939138293266296
STAT5 S-protein S-protein 0.9908863306045532
in O O 0.9999513626098633
a O O 0.9998917579650879
human B-cell_line B-cell_line 0.8174656629562378
T-cell I-cell_line I-cell_line 0.9669830799102783
line E-cell_line E-cell_line 0.9906659722328186
was O O 0.9996949434280396
induced O O 0.9999001026153564
by O O 0.9999929666519165

network E-protein O 0.717315137386322

sites E-DNA E-DNA 0.835193395614624
in O O 0.999927282333374
the O O 0.9998133778572083
5'-UTR S-DNA S-DNA 0.9225496053695679
comprise O O 0.9967156648635864
a O O 0.999934196472168
downstream B-DNA B-DNA 0.6341956853866577
enhancer I-DNA I-DNA 0.350528359413147
domain E-DNA E-DNA 0.8934417963027954
that O O 0.9954102635383606
can O O 0.9999593496322632
function O O 0.9996968507766724

B1 I-DNA I-DNA 0.13120059669017792
gene E-DNA E-DNA 0.9841176271438599
encodes O O 0.986307680606842
a O O 0.9999475479125977
105-kD B-protein B-protein 0.8805598020553589
protein E-protein E-protein 0.9651434421539307
that O O 0.9987982511520386
is O O 0.9999902248382568
the O O 0.9999972581863403
precursor O O 0.9929322004318237
of O O 0.9998756647109985
the O O 0.9999711513519287
p50 B-protein S-protein 0.5613977313041687
component E-protein O 0.6913467645645142

feedback O O 0.9240701198577881
mechanism O O 0.9909900426864624
has O O 0.9999957084655762
been O O 0.9999943971633911
widely O O 0.9967949986457825
recognised O O 0.9999796152114868
in O O 0.99998939037323
initiation O O 0.9816457033157349
as O O 0.9998631477355957
well O O 0.9999374151229858
as O O 0.9999949932098389
progression O O 0.9991419315338135
of O O 0.999975323677063

role O O 0.9773675799369812
in O O 0.9999567270278931
the O O 0.9999973773956299
control O O 0.9917599558830261
of O O 0.9996359348297119
developmental O O 0.98846834897995
expression O O 0.9991939663887024
of O O 0.9999946355819702
the O O 0.9999908208847046
CD4 B-DNA B-DNA 0.490462064743042
gene E-DNA E-DNA 0.9920124411582947
. O O 0.9997491240501404
Erythropoietin S-protein S-protein 0.8982566595077515
stimulates O O 0.9995031356811523
transcription O O 0.9725393652915955
of O O 0.9996868371963501
the O O 0.9999563694000244
TAL1/SCL B-DNA B-DNA 0.6035056114196777
gene E-DNA E-DNA 0.9869458079338074
and O O 0.9976568222045898
phosphorylation O O 0.8350483179092407
of O O 0.9963127970695496
its O O 0.9998455047607422
protein B-protein B-protein 0.5634914636611938
products E-protein E-protein 0.9580587148666382
. O O 0.9997928738594055
Activation O O 0.9827538728713989

cortisol O O 0.8264698386192322
. O O 0.9998506307601929
As O O 0.9999758005142212
glucocorticoids O O 0.8391885161399841
regulate O O 0.9913711547851562
interferon-alpha S-protein S-protein 0.8115729689598083
( O O 0.9772458672523499
IFN B-protein B-protein 0.5244839787483215
alpha E-protein E-protein 0.9649266600608826
) O O 0.9505943059921265
production O O 0.9979861974716187
, O O 0.9999982118606567
we O O 0.9999512434005737
hypothesized O O 0.9992172718048096

of O O 0.9964190721511841
Th1 B-cell_type B-cell_type 0.7987461090087891
cells E-cell_type E-cell_type 0.7778546214103699
, O O 0.9833009243011475
which O O 0.9997556805610657
are O O 0.9999929666519165
a O O 0.9999847412109375
primary O O 0.9724345207214355
source O O 0.9958357810974121
of O O 0.9999649524688721
interferon B-protein B-protein 0.7620194554328918
gamma E-protein E-protein 0.9812005162239075
( O O 0.9718151092529297
IFNgamma S-protein S-protein 0.9935559630393982
) O O 0.9575321674346924
, O O 0.9996985197067261

widely O O 0.9001863598823547
expressed O O 0.9993829727172852
in O O 0.9999837875366211
both O O 0.9974241256713867
tumour B-cell_type B-cell_type 0.6686668992042542
and I-cell_type I-cell_type 0.48494529724121094
non I-cell_type I-cell_type 0.5439214110374451
tumour I-cell_type I-cell_type 0.7984755039215088
cells E-cell_type E-cell_type 0.9813215136528015
of O O 0.9994766116142273
A-T O O 0.5677743554115295
and O O 0.9134501218795776
non-A-T O O 0.7304890155792236
individuals O O 0.942794680595398
. O O 0.9999277591705322
[ O O 0.9996154308319092
Correlation O O 0.9979047775268555
of O O 0.9999666213989258
lymphocytic O O 0.5314738154411316
infiltration O O 0.9719398617744446
of O O 0.9998165965080261
tumor O O 0.6232264637947083
tissue O O 0.42780306935310364
with O O 0.9992324113845825
the O O 0.9999864101409912
hormonal O O 0.8944016098976135
and O O 0.9764427542686462
metabolic O O 0.9432045817375183
state O O 0.9818091988563538
in O O 0.999992847442627
patients O O 0.9989540576934814
with O O 0.9999216794967651
breast O O 0.9796335697174072
cancer O O 0.9911572933197021
] O O 0.9988833069801331
Lymphocyte O O 0.5667127370834351
infiltration O O 0.9967229962348938
of O O 0.9999728202819824

. O O 0.9988213181495667
All O O 0.9994315505027771
mutants O O 0.9361656904220581
, O O 0.9996151924133301
including O O 0.999984860420227
one O O 0.9998180270195007
extensively O O 0.9157184958457947
mutagenized O O 0.9296254515647888
strain O O 0.9475603699684143
entirely O O 0.9995908141136169
missing O O 0.9994617104530334
the O O 0.9999517202377319
NF-kappaB B-DNA S-protein 0.6858441829681396
and I-DNA O 0.900549054145813
four I-DNA O 0.9745060801506042
Spl I-DNA B-DNA 0.3921951651573181
binding I-DNA I-DNA 0.46428442001342773
elements E-DNA E-DNA 0.9774347543716431
, O O 0.9991384744644165
replicated O O 0.9982746839523315
with O O 0.9999353885650635
wild-type O O 0.3440065085887909
kinetics O O 0.3137762248516083
and O O 0.8044727444648743
to O O 0.9846799969673157

or O O 0.9312947988510132

truncated O O 0.9077578186988831
analog O O 0.8913196921348572
433-442A O O 0.5131115913391113
binds O O 0.9465977549552917
very O O 0.999873161315918
poorly O O 0.9998524188995361
at O O 0.9999980926513672
both O O 0.9998371601104736
acidic O O 0.7439055442810059
and O O 0.9614590406417847
neutral O O 0.9532417058944702
pH O O 0.6991525292396545
. O O 0.9999397993087769
Both O O 0.9999977350234985
the O O 0.9999911785125732
wild O O 0.4633985757827759

The O O 0.9994614720344543
measured O O 0.8666256666183472
binding O O 0.9336875081062317
to O O 0.9995713829994202
a O O 0.9999121427536011
TCF-1 B-DNA B-DNA 0.41363948583602905
site E-DNA E-DNA 0.9600526690483093
is O O 0.999798595905304
the O O 0.9999979734420776
same O O 0.9999886751174927
in O O 0.999980092048645
the O O 0.9999912977218628
nuclei O O 0.9026678800582886
of O O 0.9962452054023743
resting B-cell_type B-cell_type 0.8266057968139648
, I-cell_type I-cell_type 0.7396649122238159
activated I-cell_type I-cell_type 0.6170286536216736
, I-cell_type I-cell_type 0.7934507131576538
and I-cell_type I-cell_type 0.7586022615432739
anergized I-cell_type I-cell_type 0.8320035934448242
cells E-cell_type E-cell_type 0.8863264918327332
. O O 0.9997156262397766
The O O 0.9999927282333374
inducible B-protein O 0.7723625898361206

monocytoid B-cell_line B-cell_line 0.5077672004699707
U937 I-cell_line I-cell_line 0.4545471668243408
cells E-cell_line E-cell_line 0.9878789782524109
to O O 0.999488353729248
LPS-treated O B-cell_type 0.3830663561820984
endothelial O I-cell_type 0.4894960820674896
cells O E-cell_type 0.6103760004043579
was O O 0.9995627999305725
reduced O O 0.9995736479759216
concomitantly O O 0.9999253749847412
. O O 0.9999949932098389
Oleate O O 0.5787537693977356
also O O 0.9945327043533325
produced O O 0.9999240636825562
a O O 0.999993085861206
quantitatively O O 0.9785551428794861
similar O O 0.9996452331542969
reduction O O 0.999715268611908
of O O 0.9999614953994751
VCAM-1 B-RNA B-RNA 0.8416686058044434
mRNA E-RNA E-RNA 0.9911171197891235
levels O O 0.9987730383872986
on O O 0.9999902248382568
Northern O O 0.9693521857261658
blot O O 0.9339803457260132
analysis O O 0.9991928935050964
and O O 0.9999911785125732
inhibited O O 0.9949643611907959
nuclear B-protein B-protein 0.8101368546485901
factor-kappaB E-protein E-protein 0.9916360378265381
activation O O 0.9961016178131104
on O O 0.9999879598617554
electrophoretic O B-cell_type 0.5875596404075623

potentiate O O 0.8769632577896118
NF-kappaB S-protein S-protein 0.9968066215515137
-mediated O O 0.994280219078064
transactivation O O 0.9953345656394958
of O O 0.9999802112579346
the O O 0.9999833106994629
HIV-1 B-DNA B-DNA 0.6698086261749268
long I-DNA I-DNA 0.8369719982147217
terminal I-DNA I-DNA 0.9732798933982849
repeat I-DNA I-DNA 0.5974750518798828
promoter E-DNA E-DNA 0.9915277361869812
in O O 0.9997536540031433
TNF-alpha-stimulated B-cell_line B-cell_line 0.8115944862365723
Jurkat I-cell_line I-cell_line 0.8987118601799011
cells E-cell_line E-cell_line 0.9943234920501709
but O O 0.9914729595184326
not O O 0.9844576716423035
in O O 0.9886108040809631
cells O O 0.9388277530670166
stimulated O O 0.9987083673477173
with O O 0.9999845027923584
PMA O O 0.9559246897697449
plus O O 0.9983640313148499
ionomycin O O 0.8040727376937866
. O O 0.9996390342712402
AFR O S-protein 0.9429849982261658
behaves O O 0.9986727237701416
like O O 0.9995842576026917
ascorbate O O 0.6996955871582031
, O O 0.9820113182067871
while O O 0.9999219179153442
DHA O O 0.5507193207740784
and O O 0.991726279258728
ascorbate O O 0.8825709223747253
phosphate O O 0.839965283870697

We O O 0.9855555295944214

in O O 0.9984083771705627
th O O 0.9710544347763062
nucleus O O 0.9796051979064941
. O O 0.9999992847442627
Other O O 0.9998183846473694
I B-protein B-protein 0.8571271300315857
kappa I-protein I-protein 0.9443100094795227
B I-protein I-protein 0.5053434371948242
proteins E-protein E-protein 0.9972386360168457
are O O 0.9998917579650879
rather O O 0.999983549118042
involved O O 0.9999277591705322
in O O 0.9999901056289673
terminating O O 0.9697429537773132
NF-kappa B-protein B-protein 0.8985304832458496

cancer O O 0.9290139675140381

SOCS-1 S-DNA S-protein 0.7832902669906616
in O O 0.9999390840530396
a O O 0.9997028708457947
macrophage B-cell_line B-cell_line 0.6612966060638428
cell I-cell_line I-cell_line 0.8457847237586975
line E-cell_line E-cell_line 0.9920226335525513
, O O 0.9835224747657776
RAW264 S-cell_line S-cell_line 0.9657098650932312
, O O 0.9531292915344238
markedly O O 0.9475904703140259
suppressed O O 0.9888056516647339
trans-activation O O 0.8848037719726562
of O O 0.9995995163917542
an O O 0.9999451637268066
IL-4-inducible B-DNA B-DNA 0.7526463866233826
reporter E-DNA E-DNA 0.7018834948539734
as O O 0.9009453058242798
well O O 0.946902871131897
as O O 0.9988836646080017
IL-6- O B-DNA 0.4263775050640106
and O I-DNA 0.5336343050003052
IFN-gamma-induced O I-DNA 0.6967746615409851
reporter O I-DNA 0.7373581528663635

glycation O O 0.5474354028701782
in O O 0.9997929930686951
pancreatic B-cell_type B-cell_type 0.5610718727111816
beta I-cell_type I-cell_type 0.8647080659866333
cells E-cell_type E-cell_type 0.9717953205108643
, O O 0.984889805316925
which O O 0.9995368719100952
occurs O O 0.9999794960021973
in O O 0.9998999834060669
vivo O O 0.9994076490402222
under O O 0.9999213218688965
chronic O O 0.9331507086753845
hyperglycemia O O 0.9886537194252014
, O O 0.9999542236328125
suppresses O O 0.9998300075531006
insulin O O 0.6466891169548035
gene O O 0.8608109354972839
transcription O O 0.9818174242973328
and O O 0.9999030828475952
thus O O 0.9999253749847412
can O O 0.9999281167984009

was O O 0.990622341632843
present O O 0.9996365308761597
in O O 0.9999938011169434
the O O 0.9999512434005737
LTR S-DNA S-DNA 0.9866037368774414
. O O 0.9995883107185364
For O O 0.9999871253967285
example O O 0.9995532631874084
, O O 0.9999047517776489
in O O 0.9998579025268555
experiments O O 0.9978103041648865
involving O O 0.999971866607666
proviral O B-cell_line 0.5595098733901978
clones O E-cell_line 0.7602261900901794
with O O 0.9994028806686401
LTRs S-DNA S-DNA 0.9956867098808289
containing O O 0.9986271858215332
one O O 0.9903811812400818
or O O 0.9948758482933044
two O O 0.9730133414268494
NF-kappa B-DNA B-DNA 0.8452622890472412
B I-DNA I-DNA 0.8430966734886169
elements E-DNA E-DNA 0.9974586367607117
( O O 0.9983012676239014
and O O 0.9975554347038269
no O O 0.9971426129341125
Sp1 B-DNA B-DNA 0.4808325171470642
binding I-DNA I-DNA 0.8738030195236206
sites E-DNA E-DNA 0.9914064407348633
) O O 0.9972767233848572
, O O 0.9999849796295166
a O O 0.9998372793197632

in O O 0.996081531047821
cell O O 0.9390515089035034
proliferation O O 0.9972710013389587
and O O 0.9998817443847656
cytokine S-protein S-protein 0.9599158763885498
production O O 0.9989137649536133
and O O 0.9999755620956421
to O O 0.999984860420227
increased O O 0.9977161884307861
cell O O 0.9413514733314514
apoptosis O O 0.9967203736305237
in O O 0.999984860420227
response O O 0.9987071752548218
to O O 0.9999909400939941
mitogenic O O 0.8582738637924194
stimuli O O 0.9333099722862244
, O O 0.9994431138038635
but O O 0.9999041557312012
not O O 0.999763548374176
to O O 0.9997795224189758
abnormal O O 0.5101780295372009
thymopoiesis O O 0.6271758675575256
. O O 0.9997685551643372
To O O 0.9999966621398926
understand O O 0.9999959468841553
the O O 0.9999992847442627
role O O 0.9997606873512268
of O O 0.999984622001648
NF-kappa B-protein B-protein 0.9243158102035522
B E-protein I-protein 0.9278362989425659
complexes O E-protein 0.9908480644226074
in O O 0.9998999834060669
T O O 0.5202649235725403
cell O O 0.5531376600265503
development O O 0.9935976266860962

dithiothreitol O O 0.7311738729476929
did O O 0.9992493987083435
not O O 0.9999916553497314
affect O O 0.9999938011169434
results O O 0.999930739402771
suggesting O O 0.9999979734420776
the O O 0.9999996423721313
absence O O 0.9999560117721558
of O O 0.9999957084655762
disulfide B-protein O 0.6550068855285645
bridges E-protein O 0.5428423285484314
in O O 0.9999358654022217
the O O 0.9999971389770508
steroid B-protein B-protein 0.6778263449668884
binding I-protein I-protein 0.5975001454353333
domain E-protein E-protein 0.9312973618507385
of O O 0.9829400777816772
the O O 0.9998364448547363
receptor O O 0.49578657746315
. O O 0.9981429576873779
These O O 0.9999933242797852
data O O 0.9981923699378967
are O O 0.9999891519546509

myelodysplastic O O 0.7641680836677551
syndromes O O 0.9870259165763855
. O O 0.9999970197677612
Peripheral O B-cell_type 0.7156841158866882
blood O I-cell_type 0.5068222880363464
mononuclear O I-cell_type 0.9265955686569214
cells O E-cell_type 0.9965741634368896
from O O 0.9998371601104736
seventeen O O 0.9967472553253174
patients O O 0.9994983673095703
with O O 0.9999861717224121
primary O O 0.9613102674484253
myelodysplastic O O 0.957553505897522
syndromes O O 0.9970666766166687
( O O 0.9999420642852783
MDS O O 0.9859867691993713
) O O 0.9998760223388672
in O O 0.9999806880950928
advanced O O 0.9780656695365906
stage O O 0.9864850044250488
were O O 0.9999426603317261
enriched O O 0.960142970085144
for O O 0.9990942478179932
blasts S-cell_type S-cell_type 0.9436894059181213
and O O 0.9978083968162537
tested O O 0.9712467789649963
for O O 0.9990912675857544
( O O 0.9993925094604492
1 O O 0.9992805123329163
) O O 0.999093770980835
karyotype O O 0.9604372978210449
, O O 0.9995562434196472
( O O 0.9995586276054382
2 O O 0.9987514019012451
) O O 0.9995038509368896
genomic O O 0.9833194613456726
configuration O O 0.9966036081314087
and O O 0.9999843835830688
( O O 0.9990301132202148
3 O O 0.9985578656196594

genes E-DNA E-DNA 0.9011999368667603
encoding O O 0.9965800642967224
for O O 0.9997991919517517
myeloperoxidase S-protein S-protein 0.8757671117782593
, O O 0.9900578856468201
elastase S-protein S-protein 0.9374393820762634
, O O 0.9970356225967407
and O O 0.999842643737793
the O O 0.9998286962509155
colony-stimulating B-protein B-protein 0.48732370138168335
factor I-protein I-protein 0.6292575001716614
receptor E-protein E-protein 0.964543879032135
, O O 0.9940028786659241
highlights O O 0.999971866607666
the O O 0.9999984502792358
relevance O O 0.9998829364776611
of O O 0.9999970197677612
the O O 0.9999954700469971
regulation O O 0.998960018157959
of O O 0.9999940395355225
the O O 0.9999511241912842
CD36 B-DNA B-DNA 0.5434225797653198
gene I-DNA I-DNA 0.6276834607124329
promoter E-DNA E-DNA 0.9902663826942444
in O O 0.9997188448905945
monocytic B-cell_type B-cell_type 0.7221056222915649
cells E-cell_type E-cell_type 0.9697076082229614

symptoms O O 0.937179684638977
of O O 0.9995850920677185
illness O O 0.9994252920150757
compared O O 0.9999945163726807
to O O 0.9999984502792358
the O O 0.9999967813491821
fraction O O 0.9964525699615479
of O O 0.9999793767929077
CD4+ B-cell_line B-cell_type 0.8690064549446106
infected I-cell_line I-cell_type 0.920258104801178
T-lymphoid I-cell_line I-cell_type 0.9526844024658203
cells E-cell_line E-cell_type 0.9403976202011108
. O O 0.9998517036437988
In O O 0.9999878406524658
part O O 0.9995428323745728
, O O 0.9999948740005493
this O O 0.9999933242797852
may O O 0.9999570846557617

Detailed O O 0.9585195183753967
histogenetic O O 0.9043741226196289
characterization O O 0.9968101382255554
of O O 0.9999946355819702
these O O 0.9999867677688599
novel O O 0.7050402760505676
PEL B-cell_line B-cell_line 0.5033044815063477
cell I-cell_line I-cell_line 0.7850252389907837
lines E-cell_line E-cell_line 0.998840868473053
suggests O O 0.9999040365219116
that O O 0.9999922513961792
PEL S-cell_line S-protein 0.6620312333106995
may O O 0.9990690350532532
derive O O 0.9999861717224121
from O O 0.9999932050704956
a O O 0.9999876022338867
post-germinal B-cell_line B-cell_type 0.6430144906044006
centre I-cell_line I-cell_type 0.7171648144721985
B I-cell_line I-cell_type 0.4029861390590668
cell E-cell_line E-cell_type 0.6630492210388184
which O O 0.9749211668968201
has O O 0.9999337196350098
undergone O O 0.9999237060546875

by O O 0.9996503591537476
the O O 0.9999988079071045
use O O 0.9996629953384399
of O O 0.9999898672103882
recombinant B-protein O 0.6126904487609863
full I-protein O 0.8087329864501953
length I-protein O 0.6269784569740295
TF E-protein S-protein 0.5137665271759033
and O O 0.951330304145813
truncated B-protein B-protein 0.6763232350349426
surface I-protein I-protein 0.4962841272354126
domain E-protein E-protein 0.9585177302360535
of O O 0.979718804359436
TF S-protein S-protein 0.9704357981681824
. O O 0.9999037981033325
The O O 0.999991774559021
rules O O 0.9892454147338867
of O O 0.999340832233429
assembly O O 0.9910051822662354
of O O 0.999833345413208
the O O 0.9999648332595825
cognate O O 0.5001813769340515
ligands O O 0.7544000744819641
of O O 0.954142153263092

as O O 0.9985300302505493
components O O 0.9958881735801697
of O O 0.9999585151672363
the O O 0.9999929666519165
DNA-protein O B-protein 0.7205972075462341
complexes O E-protein 0.9976723790168762
by O O 0.9999676942825317
anti-peptide B-protein B-protein 0.6798381805419922
antibodies E-protein E-protein 0.9961150884628296
in O O 0.9998703002929688
gel O O 0.8199107050895691
supershift O O 0.9472693204879761
assays O O 0.998160183429718
. O O 0.9999963045120239
C5a S-protein S-protein 0.8106422424316406
induced O O 0.980736494064331
kappaB S-protein S-protein 0.8778315186500549
binding O O 0.9835749864578247
activity O O 0.9994006156921387
was O O 0.999995231628418
detected O O 0.9999632835388184
15 O O 0.9843644499778748
min O O 0.9827706813812256
after O O 0.9999790191650391

presence O O 0.9791969656944275
of O O 0.9998739957809448
an O O 0.9999374151229858
inducible B-DNA B-DNA 0.8176158666610718
nuclear I-DNA I-DNA 0.6005816459655762
factor-kappaB I-DNA I-DNA 0.6665568947792053
( I-DNA I-DNA 0.5985593199729919
NF-kappaB I-DNA I-DNA 0.6441004276275635
) I-DNA I-DNA 0.729529082775116
( I-DNA I-DNA 0.7088127732276917
Rel I-DNA I-DNA 0.8330790400505066
A I-DNA I-DNA 0.641626238822937
) I-DNA I-DNA 0.8702762722969055
binding I-DNA I-DNA 0.9631226062774658
site E-DNA E-DNA 0.99130779504776
in O O 0.9998307228088379
the O O 0.9999748468399048
IL-8 B-DNA B-DNA 0.6908262372016907
promoter E-DNA E-DNA 0.9958142638206482
. O O 0.9996929168701172
TNFalpha S-protein S-protein 0.9696875810623169
treatment O O 0.9956942796707153
induces O O 0.9999843835830688
a O O 0.9999908208847046
rapid O O 0.9874318838119507
translocation O O 0.9961282014846802
of O O 0.9999531507492065

: O O 0.97906494140625
Arsenic O O 0.9534386992454529
trioxide O O 0.982136070728302
( O O 0.9996834993362427
As2O3 O O 0.9840951561927795
) O O 0.9995744824409485
can O O 0.9999967813491821
induce O O 0.9999949932098389
clinical O O 0.9950679540634155
remission O O 0.9999774694442749
in O O 0.9999982118606567
patients O O 0.9994865655899048
with O O 0.999943733215332
acute O O 0.9718000292778015
promyelocytic O O 0.9735087156295776
leukemia O O 0.9961362481117249
via O O 0.9999829530715942

positive O O 0.603239119052887

shared O O 0.9730342626571655
with O O 0.9996392726898193
IL-7R S-protein S-protein 0.9888896942138672
, O O 0.9895646572113037
IL-9R S-protein S-protein 0.9935990571975708
, O O 0.9791942238807678
and O O 0.9962643980979919
IL-15R S-protein S-protein 0.9945107698440552
. O O 0.9996579885482788
IL-4 S-protein S-protein 0.9688921570777893
induces O O 0.999810516834259
Cepsilon B-RNA B-RNA 0.5405042767524719
germline I-RNA I-RNA 0.940427839756012
transcripts E-RNA E-RNA 0.9617297649383545
and O O 0.9959576725959778
IgE B-protein B-protein 0.5245180726051331
isotype E-protein E-protein 0.9455292820930481
switching O O 0.966245174407959
in O O 0.9997300505638123
B B-cell_type B-cell_type 0.850777268409729
cells E-cell_type E-cell_type 0.9952064156532288
from O O 0.9999474287033081
patients O O 0.9995633959770203
with O O 0.9999809265136719
gammac B-protein O 0.9781404733657837
chain E-protein O 0.9547652006149292
deficiency O O 0.9990423321723938
. O O 0.9999983310699463
Induction O O 0.9874892830848694

was O O 0.9943114519119263
profoundly O O 0.9983670115470886
activated O O 0.998468816280365
upon O O 0.9998083710670471
stimulation O O 0.998089611530304
with O O 0.9999899864196777
12-O-tetradecanoylphorbol-13-acetate O O 0.42576760053634644
. O O 0.9983702301979065
These O O 0.9999980926513672
findings O O 0.9996390342712402
therefore O O 0.9999967813491821
suggest O O 0.9999988079071045
that O O 0.9999984502792358
the O O 0.999969482421875
HTLV-I B-DNA B-DNA 0.31361067295074463
enhancer E-DNA E-DNA 0.9934872388839722
contains O O 0.9998032450675964
multiple B-DNA O 0.5352928638458252
functional I-DNA O 0.6153838634490967

( I-DNA I-DNA 0.864593505859375
15 I-DNA I-DNA 0.5053265690803528
; I-DNA I-DNA 0.8910490274429321
17 I-DNA I-DNA 0.9862420558929443
) E-DNA E-DNA 0.9051005840301514
, O O 0.9128836989402771
and O O 0.9967890977859497
in O O 0.9998574256896973
APL B-cell_type B-cell_type 0.3998687267303467
blasts E-cell_type E-cell_type 0.8510040044784546
from O O 0.9999772310256958
patients O O 0.9988428354263306
; O O 0.9999818801879883
that O O 0.9999992847442627
interferon S-protein S-protein 0.9433557391166687
inhibits O O 0.9997063279151917
growth O O 0.967312753200531
and O O 0.9972569346427917
survival O O 0.9995738863945007
of O O 0.9999943971633911
NB4 O B-cell_line 0.7123411297798157
APL B-cell_type I-cell_line 0.7747421264648438
cells E-cell_type E-cell_line 0.9797605872154236
in O O 0.9997385144233704
cooperation O O 0.9992458820343018
with O O 0.999996542930603
RA O O 0.9904578924179077
; O O 0.9998205304145813
that O O 0.9999978542327881
interferons O S-protein 0.8498276472091675
alone O O 0.9962670207023621
have O O 0.999980092048645
minimal O O 0.9859490394592285
maturation O O 0.9860314130783081
effect O O 0.9999707937240601
on O O 0.999993085861206
NB4 B-cell_line B-cell_line 0.7942680716514587
cells E-cell_line E-cell_line 0.968629002571106

tyrosine I-protein B-protein 0.388283908367157
kinases E-protein E-protein 0.9852222800254822
and O O 0.9898244738578796
phosphatases O S-protein 0.5982753038406372
in O O 0.9988774657249451
Fas S-protein S-protein 0.9539443850517273
signaling O O 0.9948362112045288
, O O 0.9999821186065674
we O O 0.9999898672103882
report O O 0.9999964237213135
here O O 0.9999935626983643
that O O 0.9999974966049194
Fas O S-protein 0.9842214584350586
ligation O O 0.9905071258544922
induces O O 0.9999703168869019
apoptosis O O 0.9947209358215332
in O O 0.9999485015869141
T B-cell_type B-cell_type 0.8459047079086304
cells E-cell_type E-cell_type 0.9941648840904236

, O O 0.9972003698348999
we O O 0.9999735355377197
identified O O 0.9998247027397156
NF-kappa B-protein B-protein 0.9237061738967896
B I-protein I-protein 0.9247549176216125
proteins E-protein E-protein 0.9833645224571228
extracted O O 0.9997989535331726
from O O 0.9999876022338867
human O O 0.5677757859230042
thymocyte O O 0.4025894105434418
nuclei O O 0.3007467985153198
as O O 0.9958115816116333
being O O 0.9993267059326172
p50/p65 B-protein S-protein 0.9432634711265564
and I-protein O 0.9829892516136169
p50/c-Rel I-protein B-protein 0.5764463543891907
complexes E-protein E-protein 0.9952890872955322
. O O 0.9999570846557617
Immunochemical O O 0.9429619908332825
and O O 0.9932199716567993
immunofluorescent O O 0.9606377482414246
staining O O 0.9964325428009033
of O O 0.9999779462814331
thymus O O 0.45583778619766235
sections O O 0.4807318449020386
using O O 0.9998303651809692
specific B-protein B-protein 0.8335420489311218
Abs E-protein E-protein 0.9388273358345032
allowed O O 0.999243974685669
visualization O O 0.983382523059845
of O O 0.9998989105224609
nuclear B-protein B-protein 0.541025698184967
NF-kappa I-protein I-protein 0.7466269135475159
B I-protein I-protein 0.8999273777008057
proteins E-protein E-protein 0.9844865202903748
in O O 0.9999001026153564
both O O 0.997979462146759
thymocytes S-cell_type S-cell_type 0.9974168539047241
and O O 0.9941354990005493
nonthymocyte B-cell_type B-cell_type 0.5249185562133789
cells E-cell_type E-cell_type 0.8909580707550049

the O O 0.9987971782684326
activation O O 0.9962056875228882
of O O 0.9998111128807068
Stat6 S-protein S-protein 0.9974201917648315
. O O 0.9998947381973267
METHODS O O 0.8886350393295288
: O O 0.9966999888420105
PBMCs S-cell_type S-cell_type 0.9973172545433044
and O O 0.9904028177261353
sera O O 0.5635974407196045
from O O 0.9993725419044495
8 O O 0.9951815009117126
patients O O 0.9995197057723999
with O O 0.999992847442627
extrinsic O O 0.993289053440094
asthma O O 0.9985333681106567
( O O 0.9999890327453613
mean O O 0.9998596906661987
IgE S-protein O 0.9533839225769043
, O O 0.9999194145202637
285+/-100 O O 0.9984398484230042
IU/mL O O 0.9978506565093994
) O O 0.9999500513076782
, O O 0.9999947547912598
3 O O 0.9994111061096191
patients O O 0.9999117851257324
with O O 0.9999909400939941
HIE O O 0.9389219880104065
( O O 0.9999520778656006
mean O O 0.9997263550758362
IgE S-protein O 0.8520709872245789
, O O 0.9997487664222717
7050+/-1122 O O 0.9977057576179504
IU/mL O O 0.9911026954650879
) O O 0.9998810291290283
, O O 0.9999879598617554

concentration O O 0.8674129247665405
range O O 0.996228814125061
of O O 0.9999594688415527
0.1 O O 0.5762127041816711
to O O 0.9879926443099976
10 O O 0.9986191987991333
microM O O 0.9809269905090332
stimulated O O 0.9994271993637085
the O O 0.9999738931655884
release O O 0.9899542331695557
of O O 0.9997456669807434
up O O 0.9822324514389038
to O O 0.9992528557777405
approximately O O 0.9998476505279541
8 O O 0.9917729496955872
ng/ml O O 0.9897094368934631
IL-8 S-protein S-protein 0.9201824069023132
. O O 0.9999321699142456
Incubation O O 0.985273540019989

by O O 0.9980384707450867
participating O O 0.9988904595375061
in O O 0.9999839067459106
the O O 0.9999942779541016
activation O O 0.9957147240638733
of O O 0.9998596906661987
tumor O O 0.5414947867393494
cell O O 0.7249663472175598
differentiation O O 0.9860266447067261
. O O 0.9999960660934448
The O O 0.9999949932098389
ML-1 B-cell_line B-cell_line 0.5749533772468567
human I-cell_line I-cell_line 0.8505964875221252
myeloblastic I-cell_line I-cell_line 0.9686856865882874
leukemia I-cell_line I-cell_line 0.9859657287597656
cells E-cell_line E-cell_line 0.98665452003479
used O O 0.9985045194625854
in O O 0.9999912977218628
this O O 0.9999957084655762
study O O 0.9987013339996338
proliferate O O 0.9999662637710571
when O O 0.9999715089797974
treated O O 0.9961265921592712
with O O 0.9999747276306152
insulin-like B-protein B-protein 0.7427754402160645
growth I-protein I-protein 0.5033873915672302
factor I-protein I-protein 0.5971800088882446
I E-protein E-protein 0.8304315209388733
and O O 0.8972440958023071
transferrin S-protein O 0.41847795248031616
but O O 0.9750769138336182
differentiate O O 0.998770534992218
to O O 0.9997034668922424
monocytes S-cell_type S-cell_type 0.9973450303077698
when O O 0.9992770552635193
exposed O O 0.9968722462654114
to O O 0.9999563694000244
tumor B-protein B-protein 0.49343401193618774
necrosis I-protein I-protein 0.7095727324485779
factor I-protein I-protein 0.5003694295883179
alpha E-protein E-protein 0.9925133585929871
or O O 0.9974900484085083
transforming B-protein B-protein 0.47941455245018005
growth I-protein I-protein 0.6699246764183044
factor I-protein I-protein 0.4859444797039032
beta1 E-protein E-protein 0.8767179250717163
, O O 0.9568783640861511
or O O 0.9972894191741943
to O O 0.999852180480957
macrophage-like B-cell_type B-cell_type 0.4923943281173706
cells E-cell_type E-cell_type 0.809914767742157
when O O 0.9995880722999573
treated O O 0.9964487552642822
with O O 0.9999830722808838
both O O 0.9999700784683228
these O O 0.9999271631240845
cytokines S-protein S-protein 0.9922123551368713
. O O 0.9999885559082031
Initiation O O 0.9948768019676208
of O O 0.9994692206382751
proliferation O O 0.9965488314628601
but O O 0.999842643737793
not O O 0.9994912147521973
of O O 0.9999061822891235
differentiation O O 0.9925306439399719
was O O 0.9999898672103882
followed O O 0.9999642372131348
by O O 0.9999960660934448
a O O 0.9999977350234985
20- O O 0.9512213468551636

in O O 0.9988340735435486
Tcf-mediated O O 0.47670412063598633
transcription O O 0.7344391345977783
in O O 0.9984126091003418
T B-cell_type B-cell_type 0.9071771502494812
cells E-cell_type E-cell_type 0.9935779571533203
. O O 0.9997865557670593
That O O 0.9999921321868896
is O O 0.9999922513961792
, O O 0.9999902248382568
a O O 0.9999935626983643
dominant B-protein B-protein 0.6360573172569275
negative I-protein I-protein 0.5092717409133911
GSK-3beta E-protein E-protein 0.8851273655891418
does O O 0.998822033405304
not O O 0.9999865293502808
specifically O O 0.9999796152114868
activate O O 0.9995707869529724
Tcf O S-protein 0.9333691000938416
transcription O O 0.9457261562347412
and O O 0.9984793066978455
stimuli O O 0.8871769905090332
( O O 0.9975045323371887
lithium O O 0.9839453101158142
or O O 0.9996622800827026
phytohemagglutinin S-protein O 0.5478065013885498
) O O 0.9985578656196594
that O O 0.9999991655349731

protein E-protein E-protein 0.8972522616386414
and O O 0.9851760864257812
transcriptional B-protein B-protein 0.6498426795005798
transactivator E-protein E-protein 0.9368271827697754
, O O 0.9843389987945557
can O O 0.9996510744094849
interact O O 0.9999233484268188
synergistically O O 0.9999126195907593
with O O 0.9999773502349854
Z S-protein S-protein 0.7355398535728455
in O O 0.9954501986503601
activating O O 0.9802525043487549
the O O 0.9996784925460815
BMRF1 B-DNA B-DNA 0.6101552844047546
promoter E-DNA E-DNA 0.9949485063552856
in O O 0.9997575879096985
Jurkat B-cell_line B-cell_line 0.8671730756759644
cells E-cell_line E-cell_line 0.9955671429634094
( O O 0.9970446228981018
a O O 0.986467719078064
T-cell B-cell_line B-cell_line 0.8141430616378784
line E-cell_line E-cell_line 0.9900480508804321
) O O 0.9016973972320557
or O O 0.9986233711242676
Raji B-cell_line B-cell_line 0.9089697003364563
cells E-cell_line E-cell_line 0.9993667006492615
( O O 0.9974117875099182
an O O 0.9985978007316589
EBV-positive B-cell_line B-cell_line 0.7252954840660095
B-cell E-cell_line E-cell_line 0.8094319701194763
) O O 0.5543460845947266
, O O 0.9914669990539551
whereas O O 0.9999979734420776
the O O 0.9999862909317017
c-myb B-protein B-protein 0.3307841122150421
gene I-protein I-protein 0.7535120844841003
product E-protein E-protein 0.9372454285621643
by O O 0.9992263317108154
itself O O 0.9942374229431152
has O O 0.9999850988388062
little O O 0.9998565912246704

by O O 0.9992934465408325
dexamethasone O O 0.9722174406051636
of O O 0.9996706247329712
endotoxin S-protein S-protein 0.9601977467536926
-induced O O 0.9981942772865295
inflammation O O 0.9975036978721619
is O O 0.9999972581863403
a O O 0.9999992847442627
specific O O 0.9985858201980591
instance O O 0.9998505115509033
of O O 0.9999984502792358
the O O 0.9999992847442627
general O O 0.964296281337738
biological O O 0.9872193336486816
principle O O 0.9993638396263123
that O O 0.9999998807907104
the O O 0.9999815225601196
glucocorticoid B-protein B-protein 0.8182383179664612
receptor E-protein E-protein 0.9911863207817078
is O O 0.9996113181114197
a O O 0.9999969005584717
hormone-dependent O O 0.7406942248344421
regulator O O 0.7622708678245544
of O O 0.9817199110984802

hematopoietic I-cell_type O 0.40034958720207214
neoplasms E-cell_type O 0.35617682337760925
, O O 0.9518102407455444
and O O 0.9985541701316833
is O O 0.9999666213989258
usually O O 0.9999043941497803
associated O O 0.9998431205749512
with O O 0.9999973773956299

. O O 0.9993971586227417
The O O 0.9999982118606567
levels O O 0.9995414018630981
of O O 0.999948263168335
ICAM-1 B-RNA B-RNA 0.9577552080154419
mRNA E-RNA E-RNA 0.9960229396820068
expression O O 0.9977964162826538

of O O 0.998349666595459
human O O 0.5491147041320801
erythrocyte O O 0.49017781019210815
ghost O O 0.5424317121505737
membrane O O 0.4998760521411896
by O O 0.997552216053009
glucocorticoids O O 0.6997203230857849
and O O 0.9916064739227295
the O O 0.9999533891677856
influence O O 0.9981468915939331
of O O 0.99997878074646
the O O 0.9999582767486572
glucocorticoid O B-protein 0.705508828163147
receptor O E-protein 0.8897631764411926
antagonist O O 0.6747626662254333

DNA-binding O O 0.8845987319946289
activities O O 0.998461127281189
are O O 0.9999982118606567
more O O 0.9999878406524658
sensitive O O 0.9998749494552612
to O O 0.9999934434890747
oxidative O O 0.943035364151001
stress O O 0.9920620918273926
than O O 0.9999972581863403
lipid O O 0.9309388399124146
peroxidation O O 0.9964815378189087
. O O 0.9999778270721436
IL-4 S-protein S-protein 0.9977224469184875
-dependent O O 0.998553454875946
regulation O O 0.9998382329940796
of O O 0.9999974966049194
TGF-alpha O S-protein 0.7493441700935364
and O O 0.965356707572937
TGF-beta1 O S-protein 0.9596558213233948
expression O O 0.9975053668022156
in O O 0.9999316930770874
human B-cell_type B-cell_type 0.6081709861755371
eosinophils E-cell_type E-cell_type 0.9369500875473022
. O O 0.9996881484985352
TGFs S-protein S-protein 0.9270754456520081
play O O 0.9998581409454346
important O O 0.9960488677024841
roles O O 0.9994745850563049
in O O 0.9999819993972778
wound O O 0.9703477621078491
healing O O 0.9881289601325989
and O O 0.9996296167373657
carcinogenesis O O 0.9668048620223999

endothelial I-cell_type B-cell_type 0.3888022005558014
cells E-cell_type E-cell_type 0.89316326379776
( O O 0.9949123859405518
HUVEC S-cell_type S-cell_line 0.6960178017616272
) O O 0.9627644419670105
, O O 0.9999299049377441
CoCl2 O O 0.6936283707618713
at O O 0.9996850490570068
2 O O 0.9619392156600952
mM O O 0.9361240863800049
concentration O O 0.988993227481842
induced O O 0.9999749660491943
the O O 0.9999954700469971
surface O O 0.9780348539352417
expression O O 0.9992995262145996
of O O 0.999993085861206
a O O 0.9999767541885376
subset O O 0.9766864776611328
of O O 0.9997918009757996
CAMs S-protein S-protein 0.7054745554924011
( O O 0.9721196293830872
VCAM-1 S-protein S-protein 0.9477230906486511
) O O 0.9889423847198486
and O O 0.9998810291290283
activation O O 0.9848096966743469
of O O 0.9993699193000793
transcription B-protein B-protein 0.5554071068763733
factor E-protein E-protein 0.8929327726364136
NF-kappaB S-protein S-protein 0.7628709673881531

B E-protein E-protein 0.9573285579681396
, O O 0.9916525483131409
termed O O 0.9973561763763428
I O B-protein 0.9608567357063293
kappa O I-protein 0.9881061315536499
B O E-protein 0.9719517230987549
. O O 0.9968547821044922
In O O 0.9999895095825195
contrast O O 0.9999276399612427
, O O 0.9999662637710571
NF-kappa B-protein B-protein 0.7617897391319275
B I-protein I-protein 0.9570206999778748
p50 E-protein E-protein 0.8731411099433899
alone O O 0.9818561673164368
fails O O 0.9997974038124084
to O O 0.9999638795852661
stimulate O O 0.9997674822807312
kappa O O 0.7449209094047546
B-directed O O 0.7545103430747986
transcription O O 0.8908812999725342
, O O 0.9995772242546082
and O O 0.9999626874923706
based O O 0.9994415640830994
on O O 0.9999815225601196
prior O O 0.9951416254043579
in O O 0.9969996809959412
vitro O O 0.9933207631111145
studies O O 0.9968909621238708
, O O 0.9999839067459106
is O O 0.9999843835830688
not O O 0.9998119473457336
directly O O 0.9962916374206543
regulated O O 0.9998501539230347
by O O 0.9999939203262329

adhesion O O 0.9328622221946716
in O O 0.9997627139091492
endothelial B-cell_type B-cell_type 0.8574368953704834
cells E-cell_type E-cell_type 0.9893508553504944
stimulated O O 0.9980437755584717
by O O 0.9999849796295166
TNF S-protein S-protein 0.9619536399841309
, O O 0.9992496371269226
thereby O O 0.9999775886535645
providing O O 0.9999845027923584
an O O 0.9999945163726807
additional O O 0.9994192123413086
mechanism O O 0.9994441866874695
for O O 0.9999960660934448
therapeutic O O 0.9911558628082275
effects O O 0.9998502731323242
of O O 0.9999892711639404
aspirin O O 0.9804505109786987
. O O 0.9999881982803345

T I-cell_type B-cell_type 0.32381126284599304

P O O 0.8487875461578369
> O O 0.9957618117332458
0.05 O O 0.9966913461685181
) O O 0.9998637437820435
of O O 0.9999910593032837
GR S-protein S-protein 0.8447847962379456
between O O 0.9996719360351562
the O O 0.9999830722808838
PCOS O O 0.8233335614204407
patients O O 0.9710704684257507
and O O 0.9996862411499023
the O O 0.9999880790710449
controls O O 0.9984415173530579
. O O 0.9999943971633911
CONCLUSIONS O O 0.9998065829277039
: O O 0.9999954700469971
These O O 0.9999953508377075
results O O 0.9999701976776123
suggest O O 0.9999985694885254
that O O 0.9999977350234985

Ras-related B-protein O 0.40335240960121155

erythroid B-cell_type B-cell_type 0.3467124402523041
progenitors E-cell_type E-cell_type 0.9478511810302734
correlates O O 0.9974752068519592
with O O 0.9999816417694092
the O O 0.9999886751174927
ability O O 0.9999426603317261
of O O 0.9999949932098389
ErbB S-protein S-protein 0.9951812624931335
to O O 0.9996040463447571
induce O O 0.9999569654464722
sustained O O 0.9225585460662842
cell O O 0.8110160231590271
proliferation O O 0.9987201690673828
. O O 0.9999988079071045
Self O O 0.9784097075462341
renewal O O 0.9984458088874817
of O O 0.9999885559082031
normal O B-cell_type 0.5642247200012207
erythroid B-cell_type I-cell_type 0.7393783330917358
progenitors E-cell_type E-cell_type 0.9768998622894287
is O O 0.999631404876709
induced O O 0.9998682737350464
by O O 0.9999982118606567
the O O 0.9999924898147583
receptor B-protein O 0.9117684364318848

LTR E-DNA S-DNA 0.5033882260322571
to O O 0.9995593428611755
this O O 0.9998154044151306
cytokine S-protein S-protein 0.7415890097618103
. O O 0.999427080154419
At O O 0.9999922513961792
the O O 0.9999977350234985
5 B-DNA B-DNA 0.5387736558914185
' I-DNA I-DNA 0.8270682096481323
end E-DNA E-DNA 0.9644374847412109
, O O 0.9989945292472839
this O O 0.9999849796295166
70-bp B-DNA B-DNA 0.5943174362182617
IFN-gamma I-DNA I-DNA 0.578778862953186
response I-DNA I-DNA 0.931790292263031
element E-DNA E-DNA 0.9914097189903259
contains O O 0.9994256496429443
sequence O O 0.9219803810119629
similarity O O 0.9938285946846008
to O O 0.9999881982803345
the O O 0.9998846054077148
gamma B-DNA B-DNA 0.8237923383712769
activated I-DNA I-DNA 0.8392962217330933
site E-DNA E-DNA 0.9637656211853027
( O O 0.960098922252655
GAS S-DNA S-DNA 0.988035261631012
) O O 0.8823921084403992

negative O O 0.8264292478561401
role O O 0.9904606938362122
in O O 0.9999372959136963
T B-protein B-protein 0.6552276015281677
cell I-protein I-protein 0.5016911029815674
antigen I-protein I-protein 0.35993513464927673
receptor E-protein E-protein 0.9906949996948242
( O O 0.9823242425918579
TCR S-protein S-protein 0.9946034550666809
) O O 0.9867498278617859
signaling O O 0.9934163093566895
. O O 0.9999971389770508
The O O 0.999998927116394
physiological O O 0.9370383620262146
substrates O O 0.7522871494293213
for O O 0.9998098015785217
SHP1 S-protein S-protein 0.9423874020576477
in O O 0.999716579914093
T B-cell_type B-cell_type 0.8634275794029236
lymphocytes E-cell_type E-cell_type 0.9790849685668945
, O O 0.9791624546051025
however O O 0.9997557997703552
, O O 0.9999618530273438
have O O 0.9999918937683105
remained O O 0.9999548196792603
unclear O O 0.9998960494995117
or O O 0.9999347925186157
controversial O O 0.9995453953742981

of O O 0.9978487491607666
the O O 0.9999833106994629
pml/RAR B-protein B-protein 0.512216329574585
alpha E-protein I-protein 0.5580253005027771
hybrid O I-protein 0.7782686352729797
protein O E-protein 0.9922174215316772
induced O O 0.9989884495735168
the O O 0.9999947547912598
proliferation O O 0.9994515776634216
of O O 0.9999932050704956
DE B-cell_line B-cell_line 0.4664979875087738
anti-BCR1/25 I-cell_line I-cell_line 0.7092112898826599
T I-cell_line I-cell_line 0.8031065464019775
cell I-cell_line I-cell_line 0.7559440732002258
clones E-cell_line E-cell_line 0.9994818568229675
. O O 0.9999029636383057
It O O 0.9999815225601196
is O O 0.9999903440475464
concluded O O 0.9999972581863403
that O O 0.9999992847442627
the O O 0.9999619722366333
bcr1 B-protein B-DNA 0.4545651972293854
type-pml/RAR I-protein E-DNA 0.3721488416194916

can O O 0.9963155388832092
use O O 0.999991774559021
the O O 0.9999958276748657
limited O O 0.9854679703712463
expression O O 0.9961028099060059
of O O 0.9999771118164062
lymphoid B-protein B-protein 0.4031136929988861
markers E-protein E-protein 0.9573535919189453
or O O 0.9992857575416565
the O O 0.9999936819076538
limited O O 0.9739848375320435
gene O O 0.9248796701431274
rearrangement O O 0.9946388602256775
to O O 0.9999866485595703
conclude O O 0.9999979734420776
that O O 0.9999940395355225
H-RS B-cell_line B-cell_line 0.5794457197189331
cells E-cell_line E-cell_line 0.9821813106536865
have O O 0.999561607837677
a O O 0.9999270439147949
lymphoid O O 0.36926406621932983
origin O O 0.5019142031669617
, O O 0.995768666267395
because O O 0.9999964237213135
these O O 0.9999885559082031
markers O O 0.987293004989624
may O O 0.999984622001648
be O O 0.9999974966049194
aberrant O O 0.9990922212600708

a O O 0.9979292154312134
calcineurin-nuclear B-protein B-protein 0.5422759652137756
factors E-protein E-protein 0.9630403518676758
of O O 0.9687914252281189
activated O O 0.878169059753418
T O O 0.7574660778045654
cell-dependent O O 0.8327814340591431
pathway O O 0.9953418970108032
. O O 0.9999973773956299
Fas B-protein S-protein 0.42802557349205017

IL-4 S-protein S-protein 0.866450846195221
enhances O O 0.999502420425415
mRNA S-RNA O 0.907278299331665
degradation O O 0.9937248826026917
and O O 0.9998769760131836
does O O 0.9999821186065674
not O O 0.9999768733978271
suppress O O 0.9999197721481323
cytokine O B-DNA 0.3705229163169861
gene O E-DNA 0.977185070514679
transcription O O 0.984356701374054
. O O 0.9999943971633911
These O O 0.999998927116394
data O O 0.9996058344841003
indicate O O 0.9999984502792358
that O O 0.9999974966049194
IL-10 S-protein S-protein 0.9935017228126526
and O O 0.9961207509040833
IL-4 S-protein S-protein 0.9921042919158936
inhibit O O 0.9998677968978882
cytokine S-protein S-protein 0.978861927986145
production O O 0.9997051358222961
by O O 0.9999988079071045
different O O 0.9978864789009094
mechanisms O O 0.9980465173721313
. O O 0.9999901056289673
LMP-1 S-protein S-protein 0.9487820267677307
activates O O 0.993362545967102

. O O 0.9988324046134949
Interestingly O O 0.9998692274093628
, O O 0.9999951124191284
evidence O O 0.9999212026596069
for O O 0.999996542930603
the O O 0.9999961853027344
presence O O 0.9988572597503662
of O O 0.99996018409729
B B-cell_type B-cell_type 0.889625608921051
cells E-cell_type E-cell_type 0.9843649864196777
that O O 0.9976789355278015
have O O 0.9999598264694214
already O O 0.9999332427978516
switched O O 0.99991774559021
to O O 0.9998966455459595
IgE S-protein S-protein 0.9866530299186707
was O O 0.9999030828475952
seen O O 0.9999954700469971
in O O 0.9999171495437622
PBMCs S-cell_type S-cell_type 0.9985619187355042
of O O 0.9995875954627991
several O O 0.9998095631599426
patients O O 0.9990997314453125
with O O 0.9999746084213257
asthma O O 0.9966744184494019
or O O 0.9999792575836182

T I-cell_line B-cell_type 0.27015042304992676
cells E-cell_line E-cell_type 0.7553032636642456
. O O 0.999940037727356
A O O 0.9999659061431885
21.4-kb B-DNA B-DNA 0.44185516238212585
DNA I-DNA I-DNA 0.4628080427646637
clone E-DNA E-DNA 0.9708395600318909
, O O 0.9986171722412109
pZVB70 S-DNA S-DNA 0.8556618690490723
, O O 0.9960280656814575
showed O O 0.9999960660934448
the O O 0.9999301433563232
highest O O 0.9813103675842285
transactivating O O 0.8884983658790588
ability O O 0.9984461665153503
, O O 0.9999815225601196

determine O O 0.9995070695877075
whether O O 0.9999922513961792
human B-cell_type B-cell_type 0.4275136888027191
DC E-cell_type E-cell_type 0.8270359039306641
mediate O O 0.9914132356643677
in O O 0.9991573095321655
vitro O O 0.9824517369270325
sensitization O O 0.9990241527557373
of O O 0.99997878074646
naive B-cell_type B-cell_type 0.6410011053085327
CD4+ I-cell_type I-cell_type 0.7876588702201843
T I-cell_type I-cell_type 0.9665464162826538
cells E-cell_type E-cell_type 0.9369287490844727
to O O 0.9996433258056641
epitopes S-protein O 0.4466877281665802
of O O 0.9994317889213562
the O O 0.9999898672103882
immediate B-protein B-DNA 0.5905000567436218
early I-protein I-DNA 0.715644359588623

. O O 0.9976918697357178
In O O 0.9999343156814575
contrast O O 0.9999792575836182
to O O 0.9999992847442627
the O O 0.9999988079071045
purely O O 0.9624103307723999
enhancer-dependent O O 0.9823538064956665
effect O O 0.9997970461845398
of O O 0.9999942779541016
cytokines S-protein S-protein 0.9766462445259094
such O O 0.9998897314071655
as O O 0.9999724626541138
TNF S-protein S-protein 0.9888054132461548
on O O 0.9998817443847656
the O O 0.9999778270721436
activity O O 0.993699312210083
of O O 0.9999082088470459
the O O 0.999923586845398
HIV B-DNA B-DNA 0.5144954323768616

switching O O 0.9648641347885132
. O O 0.9999387264251709
We O O 0.9999722242355347
investigated O O 0.9999819993972778
whether O O 0.9999948740005493
BSAP S-protein S-protein 0.9770126342773438
plays O O 0.9998860359191895
a O O 0.9999958276748657
role O O 0.9999600648880005
in O O 0.9999985694885254
the O O 0.9999969005584717
transcriptional O O 0.9810092449188232
regulation O O 0.9995371103286743
of O O 0.9999982118606567
the O O 0.9999253749847412
epsilon O B-DNA 0.4964737892150879
germline B-DNA I-DNA 0.583223283290863
promoter E-DNA E-DNA 0.993806004524231
in O O 0.9998224377632141
human B-cell_type B-cell_type 0.5673770308494568
B I-cell_type I-cell_type 0.7119074463844299
cells E-cell_type E-cell_type 0.9706771969795227
. O O 0.9998875856399536
Our O O 0.9999990463256836
results O O 0.9999755620956421
showed O O 0.9999991655349731
that O O 0.9999983310699463
BSAP S-protein S-protein 0.9749919176101685
plays O O 0.9999439716339111
a O O 0.9999986886978149
role O O 0.9999051094055176
in O O 0.9999964237213135
both O O 0.9999258518218994
IL-4 S-protein S-protein 0.9942494630813599
-dependent O O 0.9968975782394409

, O O 0.9600217938423157
such O O 0.9991186261177063
as O O 0.9999723434448242
that O O 0.9999873638153076
provided O O 0.9999536275863647
by O O 0.999981164932251
TGF-beta S-protein S-protein 0.9893622994422913
. O O 0.9998887777328491
Here O O 0.9999806880950928
, O O 0.9999803304672241
we O O 0.9999905824661255
show O O 0.9999963045120239
that O O 0.9999977350234985
the O O 0.999995231628418
presence O O 0.9985648989677429
of O O 0.9999839067459106
either O O 0.999815046787262
wild-type O B-protein 0.4139847159385681
EBV O E-protein 0.7453059554100037
or O O 0.9868643879890442
its O O 0.9999514818191528
transforming B-protein O 0.9705163836479187
latent I-protein O 0.8446699976921082
membrane I-protein O 0.8870501518249512

p38 B-protein B-protein 0.902618408203125
MAPK E-protein E-protein 0.9070793390274048
correlates O O 0.9986705780029297
closely O O 0.9999556541442871
with O O 0.9999983310699463
the O O 0.9999935626983643
stimulation O O 0.99672532081604
of O O 0.999974250793457
T O O 0.564841628074646
cell O O 0.7162799835205078
proliferation O O 0.9862121343612671
. O O 0.9999961853027344
In O O 0.999991774559021
contrast O O 0.9999688863754272
, O O 0.999980092048645
PMA-induced O O 0.8459105491638184
JNK S-protein S-protein 0.9363710284233093
activation O O 0.9996800422668457
is O O 0.9999977350234985
inhibited O O 0.9999798536300659
by O O 0.9999983310699463
Ca2+ O O 0.9738283157348633
ionophore O O 0.981151282787323
. O O 0.9999698400497437
T O O 0.7320257425308228
cell O O 0.468744695186615
proliferation O O 0.9913665652275085
and O O 0.9995977282524109
production O O 0.9984045624732971
of O O 0.9999570846557617
IL-2 S-protein S-protein 0.9482954144477844
, O O 0.9823251962661743
IL-4 S-protein S-protein 0.9854485392570496
, O O 0.9918935298919678
and O O 0.999202311038971
IFN-gamma S-protein S-protein 0.9917490482330322
induced O O 0.9993778467178345
by O O 0.9999934434890747
both O O 0.9998401403427124
CD3 S-protein S-protein 0.9588984847068787
and O O 0.9937494993209839
CD3 S-protein S-protein 0.9880947470664978
/CD28 S-protein S-protein 0.9506233930587769
ligation O O 0.9712833166122437
and O O 0.9999614953994751
the O O 0.9999644756317139
nuclear O B-protein 0.5608246922492981

the O O 0.9962988495826721
IL-2 B-protein B-protein 0.5399110913276672
receptor E-protein E-protein 0.9804403185844421
( O O 0.9747856855392456
IL-2R S-protein S-protein 0.994843602180481
) O O 0.990125298500061
. O O 0.9999958276748657
Analysis O O 0.9999874830245972
of O O 0.9999978542327881
intracellular O O 0.8517622947692871
Ca2+ O O 0.851780891418457
mobilization O O 0.9954653382301331
suggested O O 0.9999916553497314
that O O 0.9999996423721313
the O O 0.9999592304229736
CD3 S-protein S-protein 0.9756801128387451
/ O O 0.9949435591697693
TcR S-protein S-protein 0.9846358299255371
-dependent O O 0.995148241519928
signal O O 0.9878911972045898
transduction O O 0.9965736865997314
was O O 0.99998939037323
impaired O O 0.9999567270278931
in O O 0.9999592304229736
PMA/Bt2cAMP-treated B-cell_line B-cell_line 0.8314796090126038
cells E-cell_line E-cell_line 0.9725193977355957
. O O 0.9998980760574341
Remarkably O O 0.9998971223831177

and O O 0.8933194279670715
fibroblastic B-cell_line B-cell_line 0.44327008724212646
cell I-cell_line I-cell_line 0.6139604449272156
lines E-cell_line E-cell_line 0.9988773465156555
. O O 0.9999765157699585
Genetic O O 0.9912990927696228
mapping O O 0.9918322563171387
studies O O 0.9988104104995728
within O O 0.9999961853027344
the O O 0.9999682903289795
E1A B-DNA B-DNA 0.8368592858314514
gene E-DNA E-DNA 0.9946877956390381
demonstrated O O 0.999883770942688
that O O 0.9999978542327881
expression O O 0.9980134963989258
of O O 0.9999730587005615
only O O 0.999927282333374
the O O 0.9996433258056641
first O O 0.7428427338600159
exon O S-DNA 0.3179387152194977
of O O 0.7032026648521423
E1A S-DNA S-DNA 0.4207562804222107
was O O 0.99244624376297

that O O 0.9961890578269958
can O O 0.9999741315841675
then O O 0.9999984502792358
be O O 0.999997615814209
assayed O O 0.9999760389328003
using O O 0.9999884366989136
less O O 0.9976798892021179
stringent O O 0.987368643283844
systems O O 0.9883596897125244
, O O 0.9999724626541138
such O O 0.9999914169311523
as O O 0.9999929666519165
cell-free O O 0.8328689932823181
extracts O O 0.9099932312965393
for O O 0.9999778270721436
in O O 0.986835241317749
vitro O O 0.9812818765640259
transcription O O 0.986846387386322
. O O 0.9999924898147583
The O O 0.9999995231628418
ideal O O 0.9972066283226013
situation O O 0.9995262622833252
would O O 0.9999991655349731
be O O 0.9999990463256836
analyses O O 0.9980968832969666
conducted O O 0.9999750852584839
in O O 0.9999809265136719
GATA-1 B-cell_line B-cell_line 0.4746879041194916
-erythroid I-cell_line I-cell_line 0.46645617485046387
cells E-cell_line E-cell_line 0.9309412240982056
. O O 0.9998050332069397
However O O 0.9999792575836182
, O O 0.9999699592590332

arteritis O O 0.8381686210632324
to O O 0.9990536570549011
evaluate O O 0.9999723434448242
their O O 0.999987006187439
ability O O 0.9998811483383179
to O O 0.9999624490737915
activate O O 0.9971129894256592
human B-cell_line B-cell_type 0.43106797337532043
umbilical I-cell_line I-cell_type 0.6297963261604309
vein I-cell_line I-cell_type 0.5353216528892517
endothelial I-cell_line I-cell_type 0.6127094626426697
cells E-cell_line E-cell_type 0.5724692940711975
( O O 0.9852076768875122
HUVEC S-cell_line S-cell_line 0.8113696575164795
) O O 0.9572908878326416
, O O 0.9982890486717224
and O O 0.9997572302818298
to O O 0.9999213218688965
characterize O O 0.9998024106025696
the O O 0.9999881982803345
mechanism O O 0.9990478157997131
of O O 0.9999836683273315
EC O S-cell_type 0.9757871627807617
activation O O 0.9957394599914551
. O O 0.999995231628418
METHODS O O 0.8824700117111206
: O O 0.997077465057373
A O O 0.9978432655334473
panel O O 0.9857967495918274
of O O 0.9999526739120483
mAECA S-protein S-protein 0.7789626121520996
was O O 0.9997623562812805
generated O O 0.9998881816864014
from O O 0.9999887943267822
peripheral B-cell_type B-cell_type 0.6188817024230957
blood I-cell_type I-cell_type 0.8727394342422485
lymphocytes E-cell_type E-cell_type 0.9854334592819214
of O O 0.9994920492172241
a O O 0.9999843835830688
patient O O 0.9982901215553284
with O O 0.9999878406524658
Takayasu O O 0.9929261207580566
arteritis O O 0.9989500641822815
, O O 0.9999939203262329
using O O 0.9999243021011353
Epstein-Barr O O 0.8940919041633606
virus O O 0.9488531947135925
transformation O O 0.9969018697738647
. O O 0.9999973773956299
Activity O O 0.9937653541564941
against O O 0.9998817443847656
macrovascular B-cell_line B-cell_type 0.43335670232772827
EC E-cell_line E-cell_type 0.6225529909133911
( O O 0.9824800491333008
HUVEC S-cell_line S-cell_line 0.9265057444572449
) O O 0.9689926505088806
and O O 0.9975435137748718
microvascular B-cell_line B-cell_type 0.6643296480178833
EC E-cell_line E-cell_type 0.7055042386054993
( O O 0.9949733018875122
human B-cell_line B-cell_type 0.5200242400169373
bone I-cell_line I-cell_type 0.5758134722709656
marrow I-cell_line I-cell_type 0.5090411305427551
EC I-cell_line E-cell_type 0.3988816440105438

relatively O O 0.9540268182754517
large O O 0.9874264001846313
protein O B-protein 0.6193872690200806
ligand O E-protein 0.9393306970596313
. O O 0.9996515512466431
Minimal O O 0.9428885579109192
residual O O 0.9418060183525085
disease O O 0.995144248008728
in O O 0.9999772310256958
acute O O 0.8717458248138428
myelogenous O O 0.9405442476272583
leukemia O O 0.9857581853866577
with O O 0.999948263168335
PML/RAR B-RNA B-protein 0.6627235412597656
alpha I-RNA E-protein 0.619814395904541
or I-RNA O 0.9667741060256958
AML1/ETO I-RNA B-RNA 0.8993262648582458
mRNA E-RNA E-RNA 0.9959872364997864
and O O 0.9948542714118958
phenotypic O O 0.6955761313438416

expression O O 0.9903705716133118
related O O 0.9999605417251587
to O O 0.9999556541442871
activator B-protein B-protein 0.5493456721305847
protein-1 E-protein E-protein 0.9907127022743225
( O O 0.9834468364715576
AP-1 S-protein S-protein 0.9866107702255249
) O O 0.9920917749404907
activation O O 0.9960936903953552
with O O 0.9999924898147583
a O O 0.9999803304672241
maximal O O 0.8079392910003662
response O O 0.8492809534072876
identical O O 0.9719390869140625
to O O 0.99913090467453
that O O 0.9998492002487183
obtained O O 0.9978785514831543
with O O 0.9999569654464722
compounds O O 0.8991925716400146
known O O 0.9990299940109253

cells E-cell_line E-cell_line 0.6622945070266724
, O O 0.9974339604377747
a O O 0.9999898672103882
subclone O O 0.8411852717399597
of O O 0.9982238411903381
Jurkat B-cell_line B-cell_line 0.8701263666152954
cells E-cell_line E-cell_line 0.997205913066864
, O O 0.9982396364212036
carrying O O 0.999821126461029
the O O 0.9999812841415405
tax B-DNA B-DNA 0.38260623812675476
sequences E-DNA E-DNA 0.9451868534088135
under O O 0.9999712705612183
the O O 0.9999452829360962
control O O 0.990228533744812
of O O 0.9998255372047424
an O O 0.999658465385437
inducible B-DNA B-DNA 0.59145188331604
promoter E-DNA E-DNA 0.9562111496925354
. O O 0.9997727274894714
Furthermore O O 0.9992932081222534
, O O 0.9998218417167664
deletion O O 0.9902099370956421
and O O 0.9993475079536438
mutation O O 0.9813140630722046

( O O 0.9593743085861206
CMV O O 0.7460938692092896
) O O 0.981393575668335
. O O 0.9999942779541016
Several O O 0.9999977350234985
recent O O 0.9999479055404663
studies O O 0.9998941421508789
have O O 0.9999997615814209
suggested O O 0.9999980926513672
that O O 0.9999990463256836
interleukin O B-protein 0.6906129121780396
( O I-protein 0.8572214841842651
IL O I-protein 0.975540816783905
) O I-protein 0.8916397094726562
-6 O E-protein 0.982815682888031
may O O 0.9996384382247925
be O O 0.9999916553497314
used O O 0.9999128580093384
to O O 0.9999865293502808
detect O O 0.9999749660491943
both O O 0.9998090863227844
infection O O 0.9932953715324402
and O O 0.9998663663864136
rejection O O 0.9994340538978577
after O O 0.9999933242797852
lung O O 0.6372039914131165

will O O 0.9969406127929688
aid O O 0.9999592304229736
in O O 0.9999727010726929
determining O O 0.9999855756759644
the O O 0.9999988079071045
role O O 0.9997738003730774
of O O 0.9999964237213135
this O O 0.9999711513519287
virus-host O B-protein 0.5772587060928345
cell O I-protein 0.4570010006427765
protein O E-protein 0.8456481695175171
interaction O O 0.870769202709198

of O O 0.9957067370414734
c-jun B-RNA B-RNA 0.7072539925575256
transcripts E-RNA E-RNA 0.9451932311058044
. O O 0.9996390342712402
M-CSF S-protein S-protein 0.5046020150184631
treatment O O 0.9631004929542542
was O O 0.9999594688415527
also O O 0.9999865293502808
associated O O 0.9999092817306519
with O O 0.9999990463256836
a O O 0.9999983310699463
rapid O O 0.9923630952835083
induction O O 0.999580442905426
of O O 0.9999966621398926
the O O 0.9999617338180542
jun-B B-DNA B-DNA 0.545619010925293
gene E-DNA E-DNA 0.9960117340087891
, O O 0.9987672567367554
although O O 0.9999932050704956
expression O O 0.998051643371582
of O O 0.9999828338623047
this O O 0.9999244213104248
gene O O 0.8712701201438904
was O O 0.9996606111526489
prolonged O O 0.9986984729766846
compared O O 0.9999759197235107
to O O 0.9999957084655762
that O O 0.9999557733535767

the O O 0.9990673661231995
expression O O 0.9995445609092712
of O O 0.9999953508377075
E2F S-protein S-protein 0.997368335723877
-DNA O O 0.9638840556144714
binding O O 0.9814871549606323
activity O O 0.9978748559951782
and O O 0.9999727010726929
the O O 0.999991774559021
constituent O B-protein 0.7064560055732727
proteins O E-protein 0.9616116881370544
found O O 0.9996011853218079
in O O 0.9999898672103882
the O O 0.9999927282333374
complexes O O 0.948650598526001
in O O 0.999875545501709
human B-cell_type B-cell_type 0.4444839060306549
primary I-cell_type I-cell_type 0.4818597733974457
haemopoietic I-cell_type I-cell_type 0.7317361831665039
cells E-cell_type E-cell_type 0.8839932680130005
of O O 0.9984745383262634
various O O 0.9594332575798035
lineages O O 0.5645816326141357
. O O 0.9999899864196777
We O O 0.9999346733093262
also O O 0.9999752044677734
studied O O 0.9992560744285583
blasts O O 0.8959261178970337
from O O 0.9999399185180664
18 O O 0.9995409250259399
patients O O 0.9998103976249695
with O O 0.9999840259552002
acute O O 0.9849322438240051
myeloid O O 0.9912478923797607
leukaemia O O 0.9984111785888672
( O O 0.9999409914016724
AML O O 0.9938236474990845
) O O 0.9999141693115234
. O O 0.9999988079071045
On O O 0.9999834299087524
electromobility O O 0.9765234589576721
shift O O 0.9968163371086121
assays O O 0.9995930790901184
( O O 0.9999465942382812
EMSA O O 0.9883483052253723
) O O 0.9998668432235718
a O O 0.9999973773956299
single O O 0.9713836908340454
E2F-DNA B-protein B-protein 0.420354962348938
binding I-protein I-protein 0.7863036394119263
complex E-protein E-protein 0.9948539137840271
was O O 0.9998062252998352
detected O O 0.9999545812606812
in O O 0.9998286962509155
T B-cell_type B-cell_type 0.921517014503479
cells E-cell_type E-cell_type 0.9886991381645203
, O O 0.9948722720146179
B B-cell_type B-cell_type 0.9518822431564331
cells E-cell_type E-cell_type 0.9951460957527161
and O O 0.9957637786865234
monocytes S-cell_type S-cell_type 0.9927434921264648

the O O 0.9985206723213196
physiology O O 0.9965633749961853
of O O 0.9998846054077148
T B-cell_type B-cell_type 0.8874675631523132
cells E-cell_type E-cell_type 0.99310302734375
and O O 0.9983982443809509
in O O 0.9999561309814453
the O O 0.9999805688858032
replication O O 0.9952415227890015
of O O 0.9999538660049438
HIV-1 O O 0.9307258725166321
. O O 0.9998121857643127
Calcineurin S-protein S-protein 0.8135154843330383
potentiates O O 0.996995210647583
activation O O 0.997829020023346
of O O 0.9999779462814331
the O O 0.9999529123306274
granulocyte-macrophage B-DNA B-DNA 0.6327316164970398
colony-stimulating I-DNA I-DNA 0.6236984133720398
factor I-DNA I-DNA 0.4151986837387085
gene E-DNA E-DNA 0.9725310206413269
in O O 0.9992983341217041
T B-cell_type B-cell_type 0.9261540770530701
cells E-cell_type E-cell_type 0.9898215532302856
: O O 0.9921512603759766
involvement O O 0.999448835849762
of O O 0.9999940395355225
the O O 0.9999504089355469
conserved B-DNA O 0.706609308719635
lymphokine I-DNA B-DNA 0.516624391078949
element I-DNA I-DNA 0.7618996500968933
0 E-DNA E-DNA 0.9937072396278381
. O O 0.9996069073677063
Granulocyte-macrophage B-protein B-protein 0.6764703392982483
colony-stimulating I-protein I-protein 0.8861708045005798
factor E-protein E-protein 0.9855251908302307
( O O 0.9834416508674622
GM-CSF S-protein S-protein 0.9942288398742676
) O O 0.9881008863449097
and O O 0.9997492432594299
interleukin-2 S-protein S-protein 0.9751970767974854
( O O 0.9913612008094788
IL-2 S-protein S-protein 0.9949722290039062
) O O 0.9956652522087097
are O O 0.9999897480010986
produced O O 0.999921441078186
by O O 0.9999951124191284
stimulation O O 0.9902250170707703
with O O 0.9999833106994629
phorbol-12-myristate O O 0.7387082576751709
acetate O O 0.9235780239105225
( O O 0.9984520673751831
PMA O O 0.9949625730514526
) O O 0.9998345375061035
and O O 0.9999735355377197
calcium O O 0.9467670321464539
ionophore O O 0.9159489870071411
( O O 0.99943608045578
A23187 O O 0.9819143414497375
) O O 0.9997565150260925
in O O 0.9999915361404419
human B-cell_line B-cell_line 0.6310004591941833
T I-cell_line I-cell_line 0.574479341506958
cell I-cell_line I-cell_line 0.5264493227005005
leukemia I-cell_line I-cell_line 0.45298314094543457
Jurkat I-cell_line I-cell_line 0.6776916980743408
cells E-cell_line E-cell_line 0.9895495176315308
. O O 0.9999399185180664
The O O 0.9999991655349731
expression O O 0.9995951056480408
of O O 0.9999963045120239
GM-CSF S-protein S-protein 0.9872232675552368
and O O 0.9957897067070007
IL-2 S-protein S-protein 0.9900587201118469
is O O 0.9998729228973389
inhibited O O 0.9999587535858154
by O O 0.9999971389770508
immunosuppressive O O 0.9356316924095154
drugs O O 0.9590844511985779
such O O 0.9999808073043823
as O O 0.9999921321868896
cyclosporin O O 0.9589780569076538
A O O 0.9906274080276489
( O O 0.9998176693916321
CsA O O 0.9951203465461731
) O O 0.9997974038124084
and O O 0.9999818801879883
FK506 O O 0.9959657192230225
. O O 0.9999980926513672
Earlier O O 0.999963641166687
studies O O 0.9999698400497437
on O O 0.9999972581863403
the O O 0.999980092048645
IL-2 S-protein B-DNA 0.6174098253250122
gene O E-DNA 0.9552839398384094
expression O O 0.9974055886268616
showed O O 0.9999991655349731
that O O 0.9999994039535522
overexpression O O 0.997678816318512
of O O 0.9999755620956421
calcineurin S-protein S-protein 0.9890089631080627
( O O 0.9947361350059509
CN S-protein S-protein 0.9964685440063477
) O O 0.9913570880889893
, O O 0.999951958656311
a O O 0.9998425245285034
Ca2+/calmodulin-dependent B-protein B-protein 0.9092712998390198
protein I-protein I-protein 0.695050835609436
phosphatase E-protein E-protein 0.9938666224479675
, O O 0.9990550875663757
can O O 0.9999892711639404
stimulate O O 0.9998683929443359
transcription O O 0.9551382660865784
from O O 0.9999475479125977
the O O 0.9999343156814575
IL-2 B-DNA B-DNA 0.8232340812683105
promoter E-DNA E-DNA 0.9962588548660278
through O O 0.9998241066932678
the O O 0.9999814033508301
NF-AT-binding B-DNA B-DNA 0.9146038889884949
site E-DNA E-DNA 0.97372967004776
. O O 0.9998352527618408
In O O 0.9999960660934448
this O O 0.9999996423721313
study O O 0.9997804760932922
, O O 0.9999957084655762
we O O 0.9997572302818298
obtained O O 0.9998363256454468
evidence O O 0.9999817609786987
that O O 0.9999995231628418
transfection O O 0.9978454113006592
of O O 0.9999830722808838
the O O 0.9998455047607422
cDNAs S-DNA S-DNA 0.9372689723968506
for O O 0.9974572062492371
CN B-protein B-protein 0.6472868919372559
A I-protein E-protein 0.7107783555984497
( I-protein O 0.848788321018219
catalytic I-protein O 0.4432015120983124
) I-protein O 0.5135284662246704
and I-protein O 0.9497589468955994
CN I-protein B-protein 0.6347155570983887
B I-protein I-protein 0.8743555545806885
( I-protein I-protein 0.8725367188453674
regulatory I-protein I-protein 0.4836500287055969
) I-protein I-protein 0.4725911319255829
subunits E-protein E-protein 0.9067175388336182
also O O 0.9996656179428101
augments O O 0.9994636178016663
transcription O O 0.960098147392273
from O O 0.9999243021011353
the O O 0.9999163150787354
GM-CSF B-DNA B-DNA 0.9522343873977661
promoter E-DNA E-DNA 0.9839510917663574
and O O 0.9850717782974243
recovers O O 0.9998096823692322
the O O 0.9999860525131226
transcription O O 0.8929231762886047
inhibited O O 0.9973450303077698
by O O 0.9999934434890747
CsA O O 0.9633330702781677
. O O 0.99997878074646
The O O 0.9999936819076538
constitutively O O 0.6201540231704712
active O O 0.5670860409736633
type O O 0.39457011222839355

different O O 0.99037104845047
techniques O O 0.9970285296440125
: O O 0.9999836683273315
Western O O 0.9321943521499634
blot O O 0.8867977261543274
, O O 0.9945316314697266
indirect O O 0.9616445302963257
immunofluorescence O O 0.9788098335266113
and O O 0.999903678894043
electron O O 0.8491111993789673
microscopy O O 0.9756424427032471
. O O 0.9999926090240479
Low O O 0.984670877456665
levels O O 0.9986264705657959
of O O 0.9999854564666748
nuclear O B-protein 0.6726177334785461
I B-protein I-protein 0.5062822699546814
( I-protein I-protein 0.7700343728065491
kappa I-protein I-protein 0.9837762713432312
) I-protein I-protein 0.9650073051452637
B I-protein I-protein 0.8815780878067017
( I-protein I-protein 0.6910723447799683
alpha I-protein I-protein 0.8837004899978638
) E-protein E-protein 0.9819299578666687
were O O 0.9996613264083862
detected O O 0.999958872795105
in O O 0.9999728202819824

in O O 0.997896671295166

be O O 0.9976909160614014
associated O O 0.9991638660430908
with O O 0.9999949932098389
life-threatening O O 0.9686708450317383
disease O O 0.993216335773468
progression O O 0.9998793601989746
. O O 0.9999996423721313
The O O 0.9999980926513672
molecular O O 0.9429203867912292
basis O O 0.9978943467140198
of O O 0.9999940395355225
GC O O 0.8046919703483582
insensitivity O O 0.9982948899269104
is O O 0.9999954700469971
unknown O O 0.9999219179153442
. O O 0.9999974966049194
Alternative O O 0.9921655654907227
splicing O O 0.9942639470100403
of O O 0.9999614953994751
the O O 0.9998294115066528
GC B-RNA B-protein 0.5390557646751404
receptor I-RNA I-protein 0.9140520095825195
( I-RNA I-protein 0.8763858675956726
GCR I-RNA I-protein 0.7599906325340271
) I-RNA I-protein 0.6114816069602966
pre-mRNA E-RNA E-protein 0.607144296169281
generates O O 0.9944257736206055
a O O 0.99998939037323
second O O 0.9888050556182861
GCR S-protein S-protein 0.8096452355384827
, O O 0.9954847097396851
termed O O 0.998234748840332
GCRbeta S-protein S-protein 0.9732633233070374
, O O 0.996027946472168
which O O 0.9999604225158691
does O O 0.9999845027923584
not O O 0.9999616146087646
bind O O 0.9993520379066467
GC O O 0.8426223397254944
but O O 0.9996756315231323

its O O 0.996839165687561
antigen B-protein B-protein 0.8041037321090698
receptor E-protein E-protein 0.9458613395690918
or O O 0.9904719591140747
via O O 0.9995911717414856
the O O 0.9999727010726929
CD-40 O S-protein 0.9184191226959229
pathway O O 0.9963920712471008
. O O 0.9999961853027344
In O O 0.9999885559082031
both O O 0.9999871253967285
cases O O 0.999016284942627
, O O 0.9999967813491821
induction O O 0.9986159801483154
of O O 0.9999923706054688
TNF-alpha B-DNA B-DNA 0.6517638564109802
gene E-DNA E-DNA 0.8777797818183899
transcription O O 0.9557675123214722
can O O 0.999945878982544
be O O 0.9999943971633911
blocked O O 0.9999593496322632
by O O 0.9999990463256836
the O O 0.9999864101409912
immunosuppressants O O 0.8535374402999878
cyclosporin O O 0.9507485032081604
A O O 0.8640047311782837
and O O 0.9995676875114441
FK506 O O 0.9625390768051147
, O O 0.9996440410614014
which O O 0.9999955892562866
suggested O O 0.9999877214431763
a O O 0.9999984502792358
role O O 0.9992626309394836
for O O 0.9999834299087524
the O O 0.9998237490653992
NFAT B-protein S-protein 0.501626193523407

cord O O 0.4760942757129669
blood O O 0.5254784226417542
and O O 0.9467974901199341
from O O 0.999413013458252
fetal O O 0.5802170634269714
livers O O 0.5968957543373108
, O O 0.9973588585853577
as O O 0.9999492168426514
well O O 0.9999713897705078
as O O 0.999997615814209
from O O 0.9999483823776245
beta O O 0.5648701190948486
zero-thalassemia O O 0.6211923956871033
patients O O 0.9623768925666809
. O O 0.9999611377716064
RESULTS O O 0.9970308542251587
: O O 0.9999904632568359
The O O 0.9999967813491821
results O O 0.9999641180038452
showed O O 0.9999995231628418
high O O 0.9905775785446167
GATA-1 S-protein S-protein 0.9723044037818909
binding O O 0.992302656173706
activity O O 0.9991337656974792
and O O 0.9999840259552002
very O O 0.998542070388794
low O O 0.9976379871368408
SP1 S-protein S-protein 0.9808045029640198
activity O O 0.9993583559989929
in O O 0.9999970197677612
the O O 0.9999781847000122
fetal B-cell_line O 0.7328648567199707
liver I-cell_line O 0.6420770287513733
cultures E-cell_line O 0.7666608095169067
. O O 0.999936580657959
This O O 0.9999983310699463
pattern O O 0.9991335272789001
was O O 0.9999943971633911
in O O 0.9999849796295166
contrast O O 0.9999669790267944
to O O 0.9999957084655762
cultures O O 0.9814644455909729

mRNA E-RNA E-RNA 0.943244457244873
is O O 0.997701108455658
expressed O O 0.999776303768158
in O O 0.9999849796295166
a O O 0.9999834299087524
highly O O 0.9434810280799866
cell-specific O O 0.9767619967460632
manner O O 0.9986395239830017
, O O 0.9999915361404419
being O O 0.9999706745147705
most O O 0.9995405673980713
abundant O O 0.9956095814704895
in O O 0.9996792078018188
B B-cell_type B-cell_type 0.9138649106025696
cells E-cell_type E-cell_type 0.9903506636619568
and O O 0.9976966977119446
essentially O O 0.9973094463348389

a O O 0.9980744123458862
role O O 0.9997405409812927
in O O 0.9999908208847046
terminal O O 0.7573996186256409
neutrophil S-cell_type O 0.35434815287590027
maturation O O 0.9911261200904846
, O O 0.9999516010284424
including O O 0.9999961853027344
the O O 0.9999958276748657
vitamin O O 0.7324356436729431
A O O 0.4308508634567261
derivative O O 0.6287896633148193
, O O 0.9962809681892395
retinoic O O 0.872714102268219
acid O O 0.9514282941818237
. O O 0.999925971031189
Retinoic O O 0.9285501837730408
acid O O 0.9736199378967285
can O O 0.999863862991333
directly O O 0.999891996383667
modulate O O 0.999506950378418
gene O O 0.973798394203186
expression O O 0.9998764991760254
via O O 0.9999850988388062
binding O O 0.9243662357330322

mediate O O 0.9885554909706116
specific O O 0.9928695559501648
events O O 0.9992879033088684
in O O 0.9999796152114868
DC S-cell_type S-cell_type 0.9360079169273376
lineage O O 0.6852679252624512
commitment O O 0.9971317052841187
. O O 0.9999988079071045
Involvement O O 0.999933123588562
of O O 0.9999960660934448
adenylate B-protein B-protein 0.5279899835586548
cyclase E-protein E-protein 0.963787853717804
and O O 0.9891966581344604
p70 B-protein S-protein 0.8020721077919006

types O O 0.6298821568489075
is O O 0.9997895359992981
similar O O 0.9999895095825195
. O O 0.9999982118606567
Increased O O 0.9995564818382263
expression O O 0.9993991851806641
of O O 0.999992847442627
wild-type O B-protein 0.7288106679916382
NFAT1 S-protein E-protein 0.9928171634674072
substantially O O 0.9996222257614136
increases O O 0.9999388456344604
IL-4 B-DNA B-DNA 0.6608132719993591
promoter E-DNA E-DNA 0.9846326112747192
activity O O 0.9987566471099854
in O O 0.9999914169311523
unprimed O O 0.47292545437812805

Regulation O O 0.9900582432746887
of O O 0.999692440032959
transcription O O 0.8904677033424377
of O O 0.9987291693687439
the O O 0.9999794960021973
human B-DNA B-DNA 0.7246294617652893
erythropoietin I-DNA I-DNA 0.8284111618995667
receptor I-DNA I-DNA 0.8811630606651306
gene E-DNA E-DNA 0.9938066005706787
by O O 0.9999394416809082
proteins O O 0.7530521750450134
binding O O 0.9605057835578918
to O O 0.9987448453903198
GATA-1 B-DNA B-DNA 0.710731565952301
and I-DNA I-DNA 0.8884401321411133
Sp1 I-DNA I-DNA 0.47160330414772034
motifs E-DNA E-DNA 0.9620888829231262
. O O 0.9999074935913086
Erythropoietin S-protein S-protein 0.8307868838310242
( O O 0.9142315983772278

demonstrated O O 0.9935797452926636
for O O 0.9999431371688843
the O O 0.9999949932098389
formation O O 0.9973612427711487
of O O 0.9999713897705078
a O O 0.9999902248382568
tight O O 0.9372392296791077
complex O O 0.5601277947425842
with O O 0.999896764755249
endogenous B-protein B-protein 0.8356238603591919
B I-protein I-protein 0.45959725975990295
subunit E-protein E-protein 0.9742181897163391
in O O 0.9997496008872986
Jurkat B-cell_line B-cell_line 0.7731387615203857
cells E-cell_line E-cell_line 0.9906960725784302
, O O 0.998553454875946
consistent O O 0.9996776580810547
with O O 0.9999942779541016
an O O 0.9999878406524658
inhibitory O O 0.9317983984947205
mechanism O O 0.9909982681274414
that O O 0.9999966621398926
involves O O 0.9999972581863403
the O O 0.9999914169311523
sequestration O O 0.9910159111022949

from O O 0.9975066781044006
cells O O 0.968748927116394
exposed O O 0.9999152421951294
for O O 0.9999902248382568
3 O O 0.9920519590377808
h O O 0.9772114753723145
to O O 0.9992334842681885
radiolabeled O O 0.8305041790008545
hormone O O 0.9244607090950012
-- O O 0.9980599284172058
in O O 0.9999682903289795
contrast O O 0.9999380111694336
to O O 0.9999926090240479
identical O O 0.9727501273155212
experiments O O 0.9962815642356873
with O O 0.9999879598617554
intact O B-cell_type 0.6746770739555359
cells O E-cell_type 0.8419308066368103

extent O O 0.991260826587677
similar O O 0.9999030828475952
to O O 0.9999904632568359
that O O 0.9999940395355225
of O O 0.9999620914459229
wild-type O B-protein 0.888289213180542
pp56 B-protein I-protein 0.8969651460647583
( I-protein I-protein 0.7753551006317139
lck I-protein I-protein 0.9360203742980957
) E-protein E-protein 0.9966981410980225
. O O 0.9998660087585449
We O O 0.9999717473983765
conclude O O 0.9999992847442627
that O O 0.9999988079071045
different O O 0.9963079690933228
domains O O 0.9106627106666565
of O O 0.9961820244789124
the O O 0.9994106292724609
pp56 B-protein B-protein 0.6695277094841003
( I-protein I-protein 0.6568663120269775
lck I-protein I-protein 0.9900861382484436
) E-protein I-protein 0.85724276304245
molecule O E-protein 0.9831542372703552
contribute O O 0.9998703002929688
to O O 0.9999485015869141
regulate O O 0.9996098875999451
distinct O O 0.9926255345344543
biologic O O 0.9155972003936768
functions O O 0.9896622896194458
. O O 0.9999963045120239
In O O 0.9999876022338867
fact O O 0.9998040795326233
, O O 0.9999934434890747
while O O 0.9999958276748657
the O O 0.9998387098312378
NH2 S-protein B-protein 0.8691604137420654
regulatory B-protein I-protein 0.5250906944274902
domain E-protein E-protein 0.9651280045509338
is O O 0.9997615218162537
sufficient O O 0.999962568283081
to O O 0.9999877214431763
mediate O O 0.9987717270851135
CD4 S-protein S-protein 0.9374530911445618
accessory O O 0.9534779191017151
function O O 0.9996612071990967
, O O 0.9999980926513672
we O O 0.9999845027923584
show O O 0.9999971389770508
here O O 0.999993085861206
that O O 0.9999994039535522
the O O 0.9999731779098511
catalytic B-protein B-protein 0.6201509833335876
domain E-protein E-protein 0.9745727777481079
of O O 0.9906207323074341
pp56 B-protein B-protein 0.6737000942230225
( I-protein I-protein 0.666843593120575
lck I-protein I-protein 0.952274739742279
) E-protein E-protein 0.9636752605438232

gene E-DNA E-DNA 0.9755597710609436
was O O 0.9987561702728271
followed O O 0.999993085861206
by O O 0.999998927116394
that O O 0.9999972581863403
for O O 0.9999397993087769
the O O 0.9999563694000244
fos-B B-DNA B-DNA 0.33173343539237976
gene E-DNA E-DNA 0.9958765506744385
. O O 0.9998445510864258
Moreover O O 0.9982873797416687
, O O 0.9997530579566956
M-CSF S-protein S-protein 0.9942646622657776
-induced O O 0.997795820236206
expression O O 0.9989972710609436
of O O 0.9999954700469971
the O O 0.999933123588562
fos-related B-DNA B-DNA 0.7777859568595886
gene E-DNA E-DNA 0.8727384805679321

of O O 0.998435914516449
NF-kappa B-protein B-protein 0.5138696432113647
B E-protein E-protein 0.9750292897224426
and O O 0.9947707056999207
ROI O O 0.4628458619117737
formation O O 0.9237965941429138
, O O 0.9998998641967773
levels O O 0.9999361038208008
similar O O 0.9999675750732422
to O O 0.9999948740005493
those O O 0.99997878074646
of O O 0.9999784231185913
adults O O 0.9375215172767639
were O O 0.9995495676994324
not O O 0.999541163444519
achieved O O 0.9999539852142334
. O O 0.9999964237213135

response O O 0.9568856358528137
. O O 0.9999350309371948
Subsequently O O 0.9968364238739014
binding O O 0.9354695677757263
sites O O 0.48729053139686584
have O O 0.9999771118164062
been O O 0.9999890327453613
demonstrated O O 0.9999816417694092
in O O 0.9999948740005493
the O O 0.9999912977218628
plasma O O 0.6944452524185181
membrane O O 0.7281062602996826
of O O 0.995744526386261
human B-cell_type B-cell_type 0.5001227259635925
lymphocytes E-cell_type E-cell_type 0.982919454574585
which O O 0.9996756315231323
show O O 0.9999858140945435
pharmacological O O 0.9781776666641235
( O O 0.9962732791900635
aldosterone O O 0.916918158531189
specificity O O 0.982785165309906
) O O 0.9993913173675537

cells E-cell_type E-cell_type 0.5092148780822754
involves O O 0.9999406337738037
an O O 0.9999879598617554
inducible O O 0.8842665553092957
, O O 0.964035153388977
T-cell-specific B-protein B-protein 0.48775163292884827
factor E-protein E-protein 0.9920496344566345
and O O 0.9988585710525513
an O O 0.9999624490737915
octamer B-protein B-protein 0.5226500630378723
binding I-protein I-protein 0.8829940557479858
protein E-protein E-protein 0.9938982725143433
. O O 0.9991550445556641
Interleukin-3 S-protein S-protein 0.9634918570518494
( O O 0.9808173179626465
IL-3 S-protein S-protein 0.9906378984451294
) O O 0.9807038307189941
is O O 0.9999881982803345

mutant E-DNA O 0.34732645750045776
was O O 0.9994117021560669
deficient O O 0.9997907280921936
in O O 0.9999794960021973
transactivation O O 0.9978592991828918
of O O 0.999993085861206
both O O 0.9999748468399048
the O O 0.9995918869972229
PTHrP B-DNA B-DNA 0.5023406744003296
and I-DNA I-DNA 0.6470035910606384
IL2R I-DNA I-DNA 0.3148801922798157
alpha I-DNA I-DNA 0.44003865122795105
promoters E-DNA E-DNA 0.992361307144165
but O O 0.9992464780807495
not O O 0.9999315738677979
the O O 0.9999004602432251
HTLV-I B-DNA B-DNA 0.7209952473640442
long I-DNA I-DNA 0.9326459765434265
terminal I-DNA I-DNA 0.9907711744308472
repeat E-DNA E-DNA 0.9976673126220703
( O O 0.9976245760917664
LTR S-DNA S-DNA 0.9990413784980774
) O O 0.9696528911590576
. O O 0.9999505281448364

other O O 0.9938094019889832
inhibitors O O 0.9885656237602234
. O O 0.9999918937683105
This O O 0.9999945163726807
finding O O 0.9996954202651978
indicates O O 0.9999977350234985
that O O 0.9999974966049194
phospholipase B-protein B-protein 0.4074360430240631
A2 E-protein E-protein 0.9034072756767273
and O O 0.9541125297546387
5-lipoxygenase S-protein S-protein 0.5567182898521423
are O O 0.999454915523529
also O O 0.999992847442627

commitment O O 0.966500997543335
. O O 0.9999785423278809
Activation O O 0.9988497495651245
of O O 0.999975323677063
primary B-cell_type B-cell_type 0.7173245549201965
human I-cell_type I-cell_type 0.8616516590118408
T-lymphocytes E-cell_type E-cell_type 0.991560161113739
through O O 0.9996182918548584
CD2 B-protein S-protein 0.979353129863739
plus I-protein O 0.9960881471633911
CD28 I-protein B-protein 0.909065842628479
adhesion I-protein I-protein 0.6662583351135254
molecules E-protein E-protein 0.9871866703033447
induces O O 0.9999288320541382
long-term O O 0.9290085434913635
nuclear O O 0.960393488407135
expression O O 0.9981105327606201
of O O 0.9999783039093018
NF-kappa B-protein B-protein 0.9557545781135559
B E-protein E-protein 0.9980699419975281
. O O 0.9998594522476196
Stimulation O O 0.9952448010444641
of O O 0.9999591112136841
highly B-cell_type B-cell_type 0.45513224601745605
purified I-cell_type I-cell_type 0.582211434841156
human I-cell_type I-cell_type 0.49295318126678467
T-cells E-cell_type E-cell_type 0.9397426247596741
via O O 0.9992231130599976
CD2 B-protein S-protein 0.9384796619415283
and I-protein O 0.9737715125083923
CD28 I-protein B-protein 0.9294096231460571
adhesion I-protein I-protein 0.8658962249755859
molecules E-protein E-protein 0.8802607655525208
induces O O 0.999690055847168

cells E-cell_type E-cell_type 0.5108331441879272
and O O 0.988585889339447
T B-cell_type B-cell_type 0.9304379224777222
cells E-cell_type E-cell_type 0.9931650757789612
during O O 0.9994670748710632
development O O 0.9998807907104492
. O O 0.999996542930603
Spi-B S-protein S-protein 0.9917839765548706
and O O 0.9946075081825256
PU.1 S-protein S-protein 0.9962410926818848
are O O 0.9999334812164307
hematopoietic-specific B-protein B-protein 0.6084864139556885
transcription I-protein I-protein 0.4368602931499481
factors E-protein E-protein 0.987528383731842
that O O 0.9998618364334106
constitute O O 0.9999938011169434
a O O 0.9999959468841553
subfamily O O 0.9265704154968262
of O O 0.9982650876045227
the O O 0.9998714923858643
Ets B-protein B-protein 0.8802716732025146
family E-protein E-protein 0.8519509434700012
of O O 0.9514303207397461
DNA-binding B-protein B-protein 0.8967827558517456
proteins E-protein E-protein 0.9983668923377991
. O O 0.9999682903289795
Here O O 0.999962329864502
we O O 0.9999872446060181
show O O 0.9999980926513672
that O O 0.999998927116394
contrary O O 0.9996188879013062
to O O 0.9999943971633911
previous O O 0.9999793767929077
reports O O 0.9999237060546875
, O O 0.999990701675415

various O O 0.9756568670272827

segregated O O 0.9679391384124756
with O O 0.9999486207962036
Vbeta O S-protein 0.9612037539482117
usage O O 0.9947479367256165
. O O 0.999995231628418
We O O 0.9999573230743408
thus O O 0.9999662637710571
propose O O 0.9999946355819702
that O O 0.9999982118606567
during O O 0.9997509121894836
an O O 0.9999725818634033
in O O 0.9982460737228394
vivo O O 0.9952104687690735
chronic O O 0.9656896591186523
response O O 0.9973543882369995
, O O 0.9999926090240479
a O O 0.9999959468841553
narrow O O 0.9297287464141846
range O O 0.9954314231872559
of O O 0.9998855590820312
avidity O O 0.9576890468597412
of O O 0.9982195496559143
the O O 0.9998961687088013
TCR-CD8 B-protein S-protein 0.590240478515625

these O O 0.9961510896682739
cells O O 0.9594533443450928
. O O 0.9999855756759644
It O O 0.9999619722366333
has O O 0.9999856948852539
been O O 0.9999948740005493
demonstrated O O 0.9999874830245972
that O O 0.9999984502792358
Porphyromonas O O 0.9659342765808105
gingivalis O O 0.9968159794807434
LPS O O 0.9952876567840576
( O O 0.9998304843902588
P-LPS O O 0.9210125207901001
) O O 0.9995118379592896
also O O 0.9999804496765137
is O O 0.9999924898147583
able O O 0.9999788999557495
to O O 0.9999884366989136
induce O O 0.9999788999557495

in O O 0.9982275366783142
promonocytic B-cell_line B-cell_line 0.4806370139122009
leukemia I-cell_line I-cell_line 0.7276144027709961
cells I-cell_line E-cell_line 0.8447795510292053
U937 E-cell_line S-cell_line 0.8526802062988281
and O O 0.9736929535865784
HL-60 S-cell_line S-cell_line 0.9823200106620789
, O O 0.9817583560943604
and O O 0.9986692667007446
emphasize O O 0.9999487400054932
the O O 0.9999970197677612
importance O O 0.9999412298202515
of O O 0.9999912977218628
studying O O 0.9956692457199097
cytokine S-protein S-protein 0.9020205736160278
regulation O O 0.9989259839057922
of O O 0.9999918937683105
HIV-1 O O 0.7994599938392639
in O O 0.9992430210113525
normal B-cell_type B-cell_type 0.6213775873184204
monocytes E-cell_type E-cell_type 0.5119967460632324
. O O 0.999881386756897
A O O 0.9999275207519531
mechanism O O 0.9986653327941895
for O O 0.9999978542327881
the O O 0.999997615814209
antiinflammatory O O 0.9201732873916626
effects O O 0.9994736313819885
of O O 0.9999895095825195
corticosteroids O O 0.9819361567497253
: O O 0.9994327425956726

. O O 0.9991208910942078
These O O 0.9999991655349731
findings O O 0.9999784231185913
suggest O O 0.9999996423721313
the O O 0.9999994039535522
involvement O O 0.9999504089355469
of O O 0.999994158744812
HB9 S-DNA S-protein 0.45006245374679565
in O O 0.9988705515861511
regulating O O 0.9783602952957153
gene O O 0.9226226806640625
transcription O O 0.9967817068099976
in O O 0.9999473094940186
lymphoid O O 0.5577787756919861
and O O 0.6322468519210815
pancreatic O O 0.4941823482513428
tissues O O 0.915147066116333

specific O O 0.9742854833602905

( I-protein I-protein 0.7618284821510315
lck I-protein I-protein 0.8736269474029541
) E-protein E-protein 0.9895500540733337
was O O 0.999565064907074
able O O 0.999785840511322
to O O 0.999946117401123
induce O O 0.9999767541885376
NF-AT S-protein S-protein 0.8488779664039612
region O O 0.771111786365509
transactivation O O 0.9874732494354248
on O O 0.9999611377716064
its O O 0.999846339225769
own O O 0.9766521453857422
and O O 0.9987816214561462

due O O 0.9992745518684387
to O O 0.9999918937683105
cell O O 0.9762647747993469
lysis O O 0.9964460730552673
or O O 0.9999290704727173
apoptosis O O 0.9990373849868774
. O O 0.999998927116394
The O O 0.9999982118606567
binding O O 0.9760113954544067
of O O 0.9997498393058777
androgen O O 0.6454616189002991
to O O 0.9414734244346619
androgen B-protein B-protein 0.5886037945747375
receptor E-protein E-protein 0.9729894399642944
on O O 0.9993177652359009
these O O 0.9997156262397766
cells O O 0.9778467416763306
showed O O 0.9999959468841553
approximately O O 0.9998944997787476
50 O O 0.970174252986908
% O O 0.9961656332015991
reduction O O 0.9996519088745117
, O O 0.9999943971633911
underlining O O 0.9999707937240601
a O O 0.9999963045120239
proliferation O O 0.9769263863563538
reduction O O 0.9945387244224548
mechanism O O 0.9992982149124146
. O O 0.9999984502792358

more O O 0.9956890940666199
rarely O O 0.9985988736152649
involved O O 0.9999808073043823
. O O 0.9999979734420776
The O O 0.9999995231628418
results O O 0.999950647354126
define O O 0.9999955892562866
the O O 0.9999902248382568
rhombotin S-DNA B-DNA 0.5170496106147766
gene O I-DNA 0.8748536705970764
family O E-DNA 0.6977440714836121
as O O 0.999935507774353
a O O 0.999996542930603
class O O 0.8978881239891052
of O O 0.9980583786964417
T-cell B-DNA B-DNA 0.29675063490867615
oncogenes E-DNA E-DNA 0.6757388114929199
with O O 0.9995854496955872
duplicated O O 0.8248673677444458
cysteine-rich B-DNA B-protein 0.38268911838531494
LIM I-DNA I-protein 0.7029227018356323
domains E-DNA E-protein 0.9602527022361755
. O O 0.9999490976333618
NF-kappa B-protein B-protein 0.9180796146392822
B E-protein E-protein 0.9992278814315796
activation O O 0.9989320635795593
by O O 0.999993085861206
tumor B-protein B-protein 0.777287483215332
necrosis I-protein I-protein 0.9312762022018433
factor I-protein I-protein 0.5228936672210693
alpha E-protein E-protein 0.9875097274780273
in O O 0.9997591376304626
the O O 0.9997542500495911
Jurkat B-cell_line B-cell_line 0.9053330421447754
T I-cell_line I-cell_line 0.9401459097862244
cell I-cell_line I-cell_line 0.7989620566368103

kinase I-protein I-protein 0.9091097116470337
kinase-3 E-protein E-protein 0.9855985045433044
( O O 0.9765790700912476
MKK3 S-protein S-protein 0.9993917942047119
) O O 0.9815713763237
, O O 0.9999165534973145
a O O 0.9999344348907471
known O O 0.9894969463348389
activator O O 0.5602030158042908
of O O 0.8882356882095337
p38 B-protein B-protein 0.6126204133033752
MAPk E-protein E-protein 0.9972610473632812
. O O 0.9999146461486816
Both O O 0.9999443292617798
MAP B-protein B-protein 0.6573344469070435
ERK I-protein I-protein 0.5655360221862793
kinase I-protein I-protein 0.5699378252029419
kinase-1 E-protein E-protein 0.9893306493759155
( O O 0.961360514163971
MEKK1 S-protein S-protein 0.9990406632423401
) O O 0.9544661045074463
and O O 0.9991645812988281
Raf S-protein S-protein 0.9997575879096985
are O O 0.999901533126831
activated O O 0.996775209903717
strongly O O 0.9999884366989136
by O O 0.9999955892562866
FMLP S-protein S-protein 0.6409546732902527
, O O 0.992871105670929

nonconsensus B-DNA B-DNA 0.6309524178504944
binding I-DNA I-DNA 0.5150710940361023
sites E-DNA E-DNA 0.9917207956314087
at O O 0.9999613761901855
the O O 0.9999840259552002
core B-DNA B-DNA 0.7209721803665161
promoter I-DNA I-DNA 0.5526291131973267
region E-DNA E-DNA 0.9989768266677856
. O O 0.9999775886535645
Moderate O O 0.9767135381698608
ubiquitous O O 0.9199057817459106
activation O O 0.9906296133995056
is O O 0.999955415725708
further O O 0.9999833106994629
induced O O 0.9999946355819702
by O O 0.9999969005584717
CREB/ATF B-protein S-protein 0.9708465337753296
and I-protein O 0.993614137172699
Sp1 I-protein B-protein 0.9046851396560669
factors E-protein E-protein 0.9750514030456543
through O O 0.9998750686645508
proximal B-DNA B-DNA 0.7508714199066162
upstream I-DNA I-DNA 0.49189338088035583

the O O 0.99882572889328
immunosuppressant O O 0.7792947292327881
cyclosporin O O 0.7236279249191284
A O O 0.5081731677055359
. O O 0.9991238713264465
It O O 0.9999697208404541
is O O 0.9999845027923584
also O O 0.9999850988388062
shown O O 0.9999985694885254
in O O 0.9999990463256836
this O O 0.9999991655349731
report O O 0.9999375343322754
that O O 0.9999923706054688
, O O 0.9997833371162415
in O O 0.999956488609314
response O O 0.999594509601593
to O O 0.999984860420227
PMA/anti-CD28 B-protein B-protein 0.6101681590080261
mAb E-protein E-protein 0.9952642917633057
or O O 0.9959860444068909
anti-CD3/anti-CD28 B-protein B-protein 0.7180354595184326
mAb E-protein E-protein 0.9921280145645142
, O O 0.9894809722900391
c-Rel S-protein S-protein 0.9944338202476501
, O O 0.9759607315063477
p50 S-protein S-protein 0.9947178959846497
, O O 0.9769219756126404
and O O 0.9943273663520813
p65 S-protein S-protein 0.9901857376098633
are O O 0.9997805953025818

repeat E-DNA E-DNA 0.9478089809417725
showed O O 0.999985933303833
a O O 0.9999971389770508
dose-dependent O O 0.985908567905426
inhibition O O 0.9987871050834656
of O O 0.9999936819076538
NF-kappa B-protein B-protein 0.7152724862098694
B E-protein E-protein 0.9957828521728516
controlled O O 0.9769848585128784
gene O O 0.8902966976165771
expression O O 0.9997000694274902
by O O 0.9999984502792358
selenium O O 0.9430794715881348
. O O 0.9999551773071289
The O O 0.999998927116394
effects O O 0.9998917579650879
of O O 0.9999914169311523
selenium O O 0.9921995997428894
were O O 0.9999902248382568
specific O O 0.9998121857643127
for O O 0.9999711513519287
NF-kappa B-protein B-protein 0.9545499682426453
B E-protein E-protein 0.9953268766403198
, O O 0.9976403713226318
since O O 0.9999856948852539
the O O 0.9999967813491821
activity O O 0.998577356338501
of O O 0.9999651908874512

bound O O 0.9432325959205627
in O O 0.9927940964698792
vitro O O 0.849956750869751
translated O O 0.9038876295089722
PU.1 S-protein S-protein 0.49797943234443665
, O O 0.9966815114021301
providing O O 0.9999048709869385
biochemical O O 0.9884774088859558
evidence O O 0.9998902082443237
for O O 0.9999986886978149
a O O 0.9999935626983643
direct O O 0.9770503044128418
EBNA-2 S-protein S-protein 0.9315120577812195
-PU.1 S-protein S-protein 0.5988281965255737
interaction O O 0.9923726320266724
. O O 0.9999979734420776
Thus O O 0.999521017074585
, O O 0.9999040365219116
EBNA-2 S-protein S-protein 0.9008173942565918

NF-kappaB S-protein S-protein 0.939651608467102
in O O 0.9999523162841797
ex O O 0.8639614582061768
vivo O O 0.9075050950050354
isolated B-cell_type O 0.8353326916694641
peripheral I-cell_type B-cell_type 0.5398143529891968
blood I-cell_type I-cell_type 0.6649438142776489
mononuclear I-cell_type I-cell_type 0.964801013469696
cells E-cell_type E-cell_type 0.9941338896751404
of O O 0.9995310306549072
patients O O 0.9985672235488892
with O O 0.9999576807022095
diabetes O O 0.9895776510238647
mellitus O O 0.9934773445129395
correlates O O 0.9998935461044312
with O O 0.9999915361404419
the O O 0.9999983310699463
degree O O 0.999891996383667
of O O 0.9999886751174927
diabetic O O 0.917320191860199
nephropathy O O 0.9865049719810486
. O O 0.9999884366989136
NF-kappaB S-protein S-protein 0.9970446228981018
activation O O 0.9994173049926758
is O O 0.9999926090240479
at O O 0.9999734163284302
least O O 0.9998962879180908
in O O 0.9999608993530273
part O O 0.9993600249290466
dependent O O 0.9999611377716064
on O O 0.9999871253967285
oxidative O O 0.9568042159080505
stress O O 0.9985970854759216
since O O 0.9999992847442627

of O O 0.9950403571128845
T B-cell_type B-cell_type 0.7510579228401184
lymphocytes E-cell_type E-cell_type 0.994113028049469
induces O O 0.9997479319572449
transcription O O 0.9309681057929993
of O O 0.9991264939308167
genes S-DNA O 0.4934364855289459
encoding O O 0.9937458038330078
for O O 0.9997773766517639
lymphokines S-protein S-cell_type 0.8677887916564941
. O O 0.9989810585975647
Interleukin-2 B-DNA B-DNA 0.828231930732727
( I-DNA I-DNA 0.8718511462211609
IL-2 I-DNA I-DNA 0.8340654373168945
) I-DNA I-DNA 0.6195356845855713
gene E-DNA E-DNA 0.8904195427894592
expression O O 0.9966521859169006
is O O 0.9999902248382568
controlled O O 0.9994961023330688
transcriptionally O O 0.9999569654464722
by O O 0.9999991655349731
the O O 0.9999926090240479
cooperative O O 0.9307126402854919
activity O O 0.9937441945075989
of O O 0.9998879432678223
specific O O 0.8158067464828491

lymphocytes S-cell_type E-cell_type 0.7284519672393799
in O O 0.9998383522033691
response O O 0.9975301623344421
to O O 0.9999675750732422
self O B-protein 0.6771852970123291
and O I-protein 0.9065110683441162
not-self O I-protein 0.7073602080345154
antigens O E-protein 0.9871999025344849
. O O 0.9990185499191284
c-Rel B-protein S-protein 0.9798924922943115
and I-protein O 0.9777069091796875
p65 I-protein B-protein 0.8448244333267212
subunits E-protein E-protein 0.9743565917015076
bind O O 0.9973863959312439
to O O 0.9999856948852539
an O O 0.9999107122421265
upstream B-DNA B-DNA 0.6383341550827026
NF-kappaB I-DNA I-DNA 0.4106157124042511
site E-DNA E-DNA 0.9834620952606201
in O O 0.999902606010437
human B-DNA B-DNA 0.6772608160972595
granulocyte I-DNA I-DNA 0.6081426739692688
macrophage-colony I-DNA I-DNA 0.40962836146354675
stimulating I-DNA I-DNA 0.6690160632133484
factor I-DNA I-DNA 0.8626323342323303
promoter E-DNA E-DNA 0.9721493721008301
involved O O 0.9972381591796875
in O O 0.9999651908874512
phorbol O O 0.8978548049926758
ester O O 0.9585050344467163
response O O 0.9926759600639343
in O O 0.9999667406082153
5637 B-cell_line B-cell_line 0.8524205684661865
cells E-cell_line E-cell_line 0.9966614246368408
. O O 0.9999063014984131
To O O 0.9999984502792358
further O O 0.9999940395355225
clarify O O 0.9999960660934448
the O O 0.9999984502792358
complex O O 0.9877408146858215
transcriptional O O 0.9755955934524536
regulation O O 0.9994339346885681
of O O 0.999996542930603
the O O 0.999974250793457
human B-DNA B-DNA 0.764263927936554
GM-CSF I-DNA I-DNA 0.9156694412231445
gene E-DNA E-DNA 0.9488362073898315

interleukin-1beta E-protein S-protein 0.4468075931072235
was O O 0.9991850256919861
severely O O 0.9997639060020447
inhibited O O 0.9999911785125732
by O O 0.999998927116394
dissociated O O 0.9095789194107056
glucocorticoids O O 0.8613809943199158
in O O 0.9999547004699707
human B-cell_line B-cell_line 0.4463777244091034
monocytic I-cell_line I-cell_line 0.36088505387306213
THP I-cell_line I-cell_line 0.7157042622566223
1 I-cell_line I-cell_line 0.743765115737915
cells E-cell_line E-cell_line 0.9728964567184448
. O O 0.9998795986175537
Moreover O O 0.9995734095573425
, O O 0.9999566078186035
in O O 0.9999691247940063
two O O 0.9992318153381348
in O O 0.9981189370155334
vivo O O 0.9960391521453857
models O O 0.9967652559280396

of O O 0.9972000122070312
viral O O 0.7089495062828064
gene O O 0.7414423823356628
expression O O 0.9885528087615967
and O O 0.9997290968894958
replication O O 0.991441547870636
. O O 0.9999864101409912
Cellular O O 0.9636598825454712
and O O 0.9940620064735413
molecular O O 0.973924458026886
mechanisms O O 0.9980302453041077
of O O 0.9999927282333374
IL-5 S-protein S-protein 0.8889994621276855
synthesis O O 0.9885849356651306
in O O 0.9999785423278809
atopic O O 0.8700005412101746
diseases O O 0.9827221632003784
: O O 0.9998168349266052
a O O 0.9999929666519165
study O O 0.9994198083877563
with O O 0.9999885559082031
allergen-specific B-cell_line B-cell_type 0.5882529616355896
human I-cell_line I-cell_type 0.43053096532821655
helper I-cell_line I-cell_type 0.4505921006202698
T I-cell_line I-cell_type 0.5985757112503052
cells E-cell_line E-cell_type 0.7277241349220276
. O O 0.9998569488525391
BACKGROUND O O 0.968169093132019
: O O 0.9989470839500427
Cytokines S-protein O 0.4576887786388397
produced O O 0.9988275170326233
by O O 0.999972939491272
helper B-cell_type B-cell_type 0.4996591806411743
T I-cell_type I-cell_type 0.8086134195327759
cells E-cell_type E-cell_type 0.9469071626663208
are O O 0.9998486042022705
intimately O O 0.9989966750144958
involved O O 0.9999942779541016
in O O 0.9999938011169434
chronic O O 0.9679117202758789
allergic O O 0.9926484227180481
diseases O O 0.9997771382331848
associated O O 0.9998579025268555
with O O 0.9999901056289673
eosinophilic O O 0.8401873707771301
inflammation O O 0.9965590834617615
. O O 0.9999949932098389
OBJECTIVE O O 0.8982011079788208
: O O 0.9970391988754272
We O O 0.9997501969337463
investigated O O 0.9999830722808838
the O O 0.999996542930603
production O O 0.9997368454933167
of O O 0.9999904632568359
IL-5 S-protein S-protein 0.9881681799888611
, O O 0.9994491934776306
a O O 0.9999610185623169
potent O B-protein 0.8548615574836731
growth O I-protein 0.5679855942726135
factor O E-protein 0.9661155343055725
and O O 0.9886366724967957
chemotactic O B-protein 0.5054953098297119
factor O E-protein 0.9276825189590454
for O O 0.9812120795249939
eosinophils S-cell_type S-cell_type 0.9972987771034241
, O O 0.9982085227966309
by O O 0.9999649524688721
CD4+ B-cell_type B-cell_type 0.8196368217468262

of O O 0.9925521612167358

the O O 0.9987571239471436
endogenous O B-DNA 0.5221028327941895
GATA-1 B-DNA I-DNA 0.3891896605491638
gene E-DNA E-DNA 0.9940150380134583
, O O 0.9887429475784302
we O O 0.9997684359550476
are O O 0.9999603033065796
in O O 0.9998669624328613
a O O 0.9999858140945435
position O O 0.997880220413208
to O O 0.9999781847000122
introduce O O 0.9999940395355225
a O O 0.999947190284729
variety O O 0.9911677837371826
of O O 0.9997337460517883
constructs O O 0.8561739325523376
that O O 0.9998952150344849
harbor O O 0.9997546076774597
subtle O O 0.9190769195556641
modifications O O 0.9954740405082703
in O O 0.9999785423278809
flanking O B-DNA 0.5096138119697571
or O I-DNA 0.8650437593460083
protein-coding B-DNA I-DNA 0.3904789984226227
sequences E-DNA E-DNA 0.9719752669334412
. O O 0.9999597072601318
We O O 0.9999743700027466
can O O 0.9999771118164062
now O O 0.9999923706054688
study O O 0.9998891353607178
regulatory O B-DNA 0.818037748336792
regions O E-DNA 0.7190771102905273
and O O 0.9986196756362915
functional O O 0.8664150238037109
domains O O 0.39972302317619324
of O O 0.9974664449691772
the O O 0.9999009370803833
protein O B-protein 0.6466361880302429

female O O 0.8266662359237671
monozygotic O O 0.6782729029655457
( O O 0.8955860733985901
MZ O O 0.508328378200531
) O O 0.5692276954650879
twins O O 0.672967255115509
heterozygous O O 0.9365656971931458
for O O 0.9997292160987854
Fabry O O 0.9700971841812134
disease O O 0.9992755055427551
, O O 0.9999971389770508
an O O 0.9999841451644897
X O O 0.5886958241462708
linked O O 0.8451329469680786
disorder O O 0.983173131942749
resulting O O 0.9999978542327881
from O O 0.9999996423721313
the O O 0.9999961853027344
deficient O O 0.9856825470924377
activity O O 0.9989435076713562
of O O 0.999991774559021
alpha-galactosidase B-protein B-protein 0.3585258424282074
A E-protein E-protein 0.9349626898765564
. O O 0.9988337159156799
While O O 0.9999899864196777

with O O 0.9994389414787292
the O O 0.9999974966049194
observations O O 0.9957149624824524
made O O 0.9999889135360718
in O O 0.9999910593032837
primary B-cell_type B-cell_type 0.4908796548843384
monocytes E-cell_type E-cell_type 0.9049189686775208
. O O 0.9999330043792725
( O O 0.9995899796485901
ABSTRACT O O 0.9849022030830383
TRUNCATED O O 0.9947848916053772
AT O O 0.9998806715011597
250 O O 0.9986842274665833
WORDS O O 0.9976034760475159
) O O 0.9999786615371704
Involvement O O 0.9997970461845398
of O O 0.9999918937683105
transcription B-protein B-protein 0.678212583065033
factor E-protein E-protein 0.9224244356155396
YB-1 S-protein S-protein 0.6470781564712524
in O O 0.9998897314071655
human O O 0.7548988461494446
T-cell O O 0.7959384918212891
lymphotropic O O 0.8603591322898865
virus O O 0.9127009510993958
type O O 0.9462058544158936
I O O 0.9015015363693237
basal O O 0.8065478801727295
gene O O 0.8017051219940186
expression O O 0.9735302925109863
. O O 0.9999465942382812
Sequences O O 0.990665078163147
which O O 0.9999810457229614
control O O 0.9972758889198303
basal O O 0.7676352262496948
human O O 0.7872658371925354
T-cell O O 0.6931508779525757
lymphotropic O O 0.62466961145401
virus O O 0.5623864531517029
type O O 0.6280680894851685

two-hybrid O O 0.353892058134079
system O O 0.7242693305015564
. O O 0.9999654293060303
Furthermore O O 0.9999830722808838
, O O 0.9999916553497314
we O O 0.9999078512191772
observed O O 0.999975323677063
the O O 0.9999973773956299
association O O 0.9941031336784363
of O O 0.9999285936355591
p47phox O S-protein 0.6330538988113403
with O O 0.9921127557754517
the O O 0.9997531771659851
hIL-4R B-protein B-protein 0.8227788209915161
alpha E-protein E-protein 0.974202573299408
in O O 0.9984272718429565
B B-cell_type B-cell_type 0.870084822177887
cells E-cell_type E-cell_type 0.9885080456733704
derived O O 0.9989027976989746
from O O 0.9999901056289673
a O O 0.9998501539230347
normal O O 0.9134345054626465
donor O O 0.8928398489952087
. O O 0.9998964071273804
These O O 0.9999982118606567
results O O 0.9999821186065674
suggest O O 0.9999990463256836
that O O 0.9999974966049194
p47phox O S-protein 0.649847686290741
is O O 0.9982643723487854
involved O O 0.9999834299087524
in O O 0.9999977350234985
the O O 0.9999978542327881
signal O O 0.9800786972045898
transduction O O 0.9963579773902893
of O O 0.9999691247940063
IL-4 S-protein S-protein 0.9897072315216064
in O O 0.999832272529602
B B-cell_type B-cell_type 0.7891838550567627
cells E-cell_type E-cell_type 0.9864444136619568

group O O 0.4415214955806732
of O O 0.9976850748062134
cytokines S-protein S-protein 0.9834718704223633
and O O 0.9962701797485352
intracellular O B-protein 0.6502739787101746
transcriptional O I-protein 0.5269566774368286
factors O E-protein 0.9787043333053589
may O O 0.9997778534889221
all O O 0.9999916553497314
contribute O O 0.9999983310699463
to O O 0.9999899864196777
B-lymphocyte O S-cell_type 0.8966240882873535
differentiation O O 0.9904749989509583
control O O 0.9992307424545288
. O O 0.9999977350234985
Transcription B-protein B-DNA 0.6088783740997314
factor E-protein I-DNA 0.9084465503692627
binding O I-DNA 0.5415621399879456
sites O E-DNA 0.9117704033851624
downstream O O 0.9937382936477661
of O O 0.9999972581863403
the O O 0.9999791383743286
human B-DNA B-DNA 0.6209114193916321
immunodeficiency I-DNA I-DNA 0.7757731676101685
virus I-DNA I-DNA 0.8963992595672607
type I-DNA I-DNA 0.945858359336853

direct O O 0.9694087505340576
transcription O O 0.9778258800506592
from O O 0.9999512434005737
NFAT B-DNA B-DNA 0.7292330861091614
sites E-DNA E-DNA 0.9341657757759094
in O O 0.9999295473098755
non- O O 0.6752079129219055
T B-cell_type B-cell_type 0.341898649930954
cells E-cell_type E-cell_type 0.8576761484146118
. O O 0.9998812675476074
These O O 0.999998927116394
results O O 0.9999589920043945
reveal O O 0.9999995231628418
a O O 0.9999985694885254
central O O 0.9856843948364258
role O O 0.9989412426948547
for O O 0.999984622001648
CaMKIV/Gr S-protein S-protein 0.9694257974624634
as O O 0.9999850988388062
a O O 0.9999756813049316
Ca O B-protein 0.8289868235588074
( O I-protein 0.49658918380737305
2+ O I-protein 0.7788472175598145

hepatic B-protein O 0.6395530700683594
PCD/DCoH I-protein S-protein 0.4747970998287201
protein E-protein O 0.7130699753761292
level O O 0.9975335597991943
was O O 0.9999781847000122
20-fold O O 0.9994416832923889
higher O O 0.9999690055847168
than O O 0.9999933242797852
that O O 0.9999136924743652
in O O 0.9997147917747498
normal B-cell_type B-cell_type 0.5292202234268188
human I-cell_type I-cell_type 0.45898231863975525
epidermal I-cell_type I-cell_type 0.8655775189399719
keratinocytes E-cell_type E-cell_type 0.9719766974449158
and O O 0.9995638728141785

of O O 0.9978286623954773
adenovirus B-DNA B-DNA 0.38234156370162964
E1a I-DNA I-DNA 0.6338335275650024
sequences E-DNA E-DNA 0.9666749238967896
relevant O O 0.9996181726455688
to O O 0.9999934434890747
the O O 0.9999951124191284
use O O 0.9997462630271912
of O O 0.9999947547912598
E1a- O O 0.6090052127838135
adenovirus O O 0.28066855669021606
vectors O O 0.5076258778572083
for O O 0.9994853734970093
gene O O 0.9789292216300964
therapy O O 0.9988960027694702
for O O 0.9999955892562866
the O O 0.9999895095825195
respiratory O O 0.9246567487716675
manifestations O O 0.9934385418891907
of O O 0.9999879598617554
cystic O O 0.9658839106559753
fibrosis O O 0.9978446960449219
. O O 0.9999980926513672
Lung O O 0.7572399377822876
disease O O 0.9768292307853699
associated O O 0.9978098273277283

stimulus- O O 0.7203029990196228
and O O 0.8933808207511902
cell-specific O O 0.7596446871757507
. O O 0.9998125433921814
We O O 0.999981164932251
here O O 0.9999810457229614
describe O O 0.9999983310699463
the O O 0.9999963045120239
genomic O O 0.6718952059745789
organisation O O 0.7759361863136292
( O O 0.9988320469856262
3 O O 0.9601829648017883
exons S-DNA O 0.5389949679374695
of O O 0.9688194990158081
132 O O 0.5960155725479126
, O O 0.9611143469810486
112 O O 0.5636157989501953
and O O 0.9537288546562195
542 O O 0.9119059443473816
bp O O 0.6559963822364807
and O O 0.9976782202720642
2 O O 0.8593079447746277
introns S-DNA O 0.8289840221405029
of O O 0.9840916991233826
1211 O S-DNA 0.576644778251648
and O O 0.9514947533607483
378 O O 0.9506504535675049
bp O O 0.501769483089447
) O O 0.9911269545555115
and O O 0.9998942613601685

similar O O 0.9836971163749695

biochemically O O 0.8938071727752686
and O O 0.9907124638557434
functionally O O 0.9984622001647949
characterized O O 0.9998601675033569
a O O 0.9999903440475464
new O O 0.9796222448348999
transcription B-protein B-protein 0.4484516382217407
factor E-protein E-protein 0.9913457632064819
, O O 0.9974960684776306
NP-TCII S-protein S-protein 0.9561625123023987
, O O 0.9840251803398132
which O O 0.9996215105056763
is O O 0.9999390840530396
present O O 0.9999191761016846
in O O 0.9999569654464722
nuclei O O 0.4268266260623932
from O O 0.9923558235168457
unstimulated B-cell_line B-cell_type 0.6132642030715942
T I-cell_line I-cell_type 0.5486494302749634
and I-cell_line I-cell_type 0.8418575525283813
B I-cell_line I-cell_type 0.8904932141304016
lymphocytes E-cell_line E-cell_type 0.9534333348274231
but O O 0.9995042085647583

Involvement O O 0.9953364729881287

under O O 0.9984607696533203

activities O O 0.9844638705253601
. O O 0.9999924898147583
In O O 0.9999682903289795
order O O 0.9998786449432373
to O O 0.9999958276748657
apprehend O O 0.9999881982803345
the O O 0.9999964237213135
role O O 0.9991807341575623
of O O 0.9999951124191284
the O O 0.999976634979248
HIV1 B-DNA B-DNA 0.49474456906318665
tat I-DNA I-DNA 0.5615501403808594
gene E-DNA E-DNA 0.9796170592308044
in O O 0.9998018145561218
inducing O O 0.9808449745178223
the O O 0.9997512698173523
differentiation O O 0.9981417655944824
of O O 0.9999905824661255
HIV1-infected B-cell_line B-cell_line 0.6902636885643005
U937 I-cell_line I-cell_line 0.6272892355918884
cells E-cell_line E-cell_line 0.9949237704277039
, O O 0.9996681213378906
we O O 0.9999576807022095
have O O 0.9999951124191284
successfully O O 0.9991616010665894
introduced O O 0.9999558925628662
this O O 0.9998370409011841
gene O O 0.9678255915641785
into O O 0.9999217987060547
U937 B-cell_line B-cell_line 0.9666382074356079
cells E-cell_line E-cell_line 0.9989217519760132
by O O 0.9997199177742004
infecting O O 0.98911452293396
them O O 0.9988284707069397

the O O 0.9990196228027344
patient O O 0.97249436378479
relative O O 0.9986194372177124
to O O 0.9999154806137085
controls O O 0.9814046025276184
. O O 0.9999904632568359
In O O 0.9999830722808838
contrast O O 0.9999805688858032
, O O 0.9999793767929077
CAT B-DNA S-protein 0.9446837902069092
gene E-DNA O 0.6361754536628723
expression O O 0.9989319443702698
directed O O 0.9999493360519409
by O O 0.9999992847442627
a O O 0.9999593496322632
multimer O O 0.42926424741744995
of O O 0.96200031042099
the O O 0.9982636570930481
OCT-1 B-DNA B-DNA 0.5747888088226318
proximal I-DNA I-DNA 0.8462310433387756
( I-DNA I-DNA 0.9174724221229553
OCT-1p I-DNA I-DNA 0.9580626487731934
) I-DNA I-DNA 0.9530689716339111
-binding I-DNA I-DNA 0.9672650694847107
site E-DNA E-DNA 0.994408369064331
was O O 0.9999417066574097

of O O 0.9991268515586853
the O O 0.9999961853027344
G0 O O 0.7433440685272217
and O O 0.9665660262107849
G1 O O 0.8257994055747986
phases O O 0.9122723340988159
of O O 0.9998804330825806
the O O 0.9999954700469971
cell O O 0.8876111507415771
cycle O O 0.9738168120384216
and O O 0.9986500144004822
regulation O O 0.9994340538978577
of O O 0.9999822378158569
apoptosis O O 0.9967926144599915
. O O 0.9999977350234985
In O O 0.9999215602874756
EBV O O 0.9554979801177979
infection O O 0.9993414282798767
most O O 0.999995231628418
of O O 0.9999977350234985
the O O 0.9999974966049194
changes O O 0.9989309906959534
, O O 0.9999945163726807
including O O 0.9999929666519165
the O O 0.9999958276748657
early O O 0.9884726405143738
induction O O 0.9997838139533997
of O O 0.9999945163726807
cyclin B-protein B-protein 0.41550108790397644
D2 E-protein E-protein 0.7728825211524963
, O O 0.9890244603157043
are O O 0.9999793767929077
dependent O O 0.9999724626541138
on O O 0.9999945163726807
expression O O 0.999005138874054
of O O 0.9999873638153076
EBV B-DNA B-DNA 0.5728133916854858
genes E-DNA E-DNA 0.9920187592506409
, O O 0.9995421171188354
but O O 0.9999899864196777
an O O 0.999995231628418
alteration O O 0.9950822591781616
in O O 0.9999456405639648

B E-protein E-protein 0.9751471877098083
activation O O 0.9964016675949097
is O O 0.9999971389770508
a O O 0.9999992847442627
mechanism O O 0.9993324875831604
that O O 0.9999982118606567
favors O O 0.9999632835388184
continuous O O 0.9903427362442017
viral O O 0.9556211829185486
replication O O 0.9963430762290955
in O O 0.9999728202819824
macrophages S-cell_type S-cell_type 0.9972530007362366
remains O O 0.9987506866455078

apparent O O 0.9497101902961731
affinity O O 0.9974295496940613
than O O 0.99997878074646
does O O 0.9999268054962158
PtdIns O S-protein 0.40305930376052856
. O O 0.9991102814674377
LPS-binding B-protein B-protein 0.7080007195472717
protein E-protein E-protein 0.9925892353057861
, O O 0.9957745671272278
a O O 0.9998894929885864
lipid O B-protein 0.5109567642211914
transfer O I-protein 0.5861819386482239
protein O E-protein 0.9716121554374695
found O O 0.9988253712654114
in O O 0.9999434947967529
serum O O 0.40394890308380127
, O O 0.9279812574386597
facilitates O O 0.9990307092666626
both O O 0.999962568283081
PS O O 0.41404402256011963
-and O O 0.9928896427154541
PtdIns- O O 0.9512696862220764
mCD14 S-protein S-protein 0.8485550284385681
binding O O 0.9771958589553833
. O O 0.9999707937240601
PtdIns O O 0.5402183532714844
binding O O 0.8817626237869263
to O O 0.9955649971961975
mCD14 S-protein S-protein 0.8393927812576294
can O O 0.9996993541717529
be O O 0.9999372959136963
blocked O O 0.999808132648468
by O O 0.9999912977218628

[ O O 0.9498925805091858
Ca2+ O O 0.7088481783866882
] O O 0.9228017926216125
i O O 0.988387405872345
. O O 0.9999639987945557
Deltorphin O O 0.800393283367157
also O O 0.9992521405220032
increased O O 0.9999685287475586
accumulation O O 0.999484658241272
of O O 0.9999896287918091
AP-1 B-protein B-protein 0.8150967359542847
transcription I-protein I-protein 0.6311464309692383
factor I-protein I-protein 0.6505188941955566
complexes E-protein E-protein 0.9917296767234802
, O O 0.9996826648712158
suggesting O O 0.9999932050704956
that O O 0.9999983310699463
DOR1 S-protein S-protein 0.9073007702827454
augments O O 0.9992133378982544
IL-2 S-protein S-protein 0.9259442687034607
secretion O O 0.9761890172958374

addition O O 0.9965953230857849
, O O 0.9999833106994629
DNA O O 0.856683075428009
methylation O O 0.9782500863075256
was O O 0.9999852180480957
revealed O O 0.9999957084655762
as O O 0.9999966621398926
one O O 0.9999961853027344
of O O 0.9999994039535522
the O O 0.9999992847442627
possible O O 0.9926618337631226
factors O O 0.9290392994880676
in O O 0.9999752044677734
establishing O O 0.9988635778427124
MNDA S-protein S-protein 0.6808794736862183
expression O O 0.9977274537086487
. O O 0.9999988079071045
The O O 0.9999839067459106
5 B-DNA B-DNA 0.7291136980056763
' I-DNA I-DNA 0.8983884453773499
flanking I-DNA I-DNA 0.9565173983573914
sequence E-DNA E-DNA 0.9991915822029114
has O O 0.9999226331710815
promoter O O 0.7676876783370972
activity O O 0.9937441945075989
which O O 0.9999938011169434
is O O 0.9999927282333374
elevated O O 0.99951171875
by O O 0.9999942779541016

importance O O 0.9978525638580322
of O O 0.9999951124191284
these O O 0.9999918937683105
sites O O 0.9770148992538452
was O O 0.9999901056289673
confirmed O O 0.9999961853027344
by O O 0.9999996423721313
in O O 0.999699592590332
vivo O O 0.9958856701850891
studies O O 0.9984663724899292
in O O 0.9999868869781494
gene-targeted O O 0.7257364988327026
mice O O 0.8310879468917847
deficient O O 0.9659675359725952
of O O 0.999288022518158
either O O 0.9997597336769104
Oct-2 S-protein S-protein 0.9764324426651001
, O O 0.9913047552108765
Bob1 S-protein S-protein 0.9747578501701355
, O O 0.9896697402000427
or O O 0.9986082911491394
both O O 0.9974385499954224
NF-kappaB S-protein B-protein 0.8896374702453613
subunits O E-protein 0.8765451312065125
p50 O S-protein 0.9554072022438049
and O O 0.982477605342865
p52 O S-protein 0.9560545682907104
. O O 0.9990967512130737
In O O 0.9999608993530273
all O O 0.9999517202377319
of O O 0.9999958276748657
these O O 0.9999717473983765
animals O O 0.9608078598976135
, O O 0.9999561309814453
the O O 0.9999929666519165
expression O O 0.9991094470024109
of O O 0.9999839067459106
BLR1 S-protein S-protein 0.7985053062438965
was O O 0.9995974898338318
reduced O O 0.9995478987693787
or O O 0.9998219609260559
absent O O 0.9992978572845459
. O O 0.9999951124191284
In O O 0.9998685121536255
mice O O 0.9067993760108948
deficient O O 0.9639524221420288
only O O 0.9977274537086487
of O O 0.9998606443405151
p52/NF-kappaB S-protein S-protein 0.9326497316360474

one O O 0.9979038238525391
of O O 0.9999605417251587
which O O 0.9999818801879883
is O O 0.9999798536300659
the O O 0.9999853372573853
erythroid B-protein B-protein 0.6044853925704956
transcription I-protein I-protein 0.8634153604507446
factor E-protein E-protein 0.9747644066810608
GATA-1 S-protein S-protein 0.7066681385040283
. O O 0.9999650716781616
These O O 0.9999970197677612
results O O 0.9998067021369934

if O O 0.9949668049812317
not O O 0.9851903319358826
qualitative O O 0.9878880381584167
, O O 0.9999629259109497
differences O O 0.999674916267395
between O O 0.9998310804367065
signaling O O 0.9849056601524353
initiated O O 0.9995552897453308
by O O 0.9999986886978149
these O O 0.9999948740005493
two O O 0.9990817308425903
ligands O O 0.985295295715332
for O O 0.9998776912689209
CD28 S-protein S-protein 0.9534353017807007
may O O 0.9998595714569092
contribute O O 0.999998927116394
to O O 0.9999974966049194
functional O O 0.9971572160720825
differences O O 0.9999135732650757
( O O 0.9999904632568359
e.g. O O 0.9999632835388184
Th1 O O 0.9566792845726013
or O O 0.9993317723274231
Th2 O O 0.9566593170166016
differentiation O O 0.9970396161079407
) O O 0.9999275207519531
in O O 0.999954342842102
T O O 0.41554224491119385
cell O O 0.30679237842559814
responses O O 0.8456653356552124
. O O 0.999971866607666
Binding O O 0.9761733412742615
of O O 0.99962317943573
HMG-I B-protein B-protein 0.6916877627372742
( I-protein I-protein 0.8280318975448608
Y I-protein I-protein 0.9576385021209717

regardless O O 0.9989137649536133
of O O 0.9999842643737793
whether O O 0.9999979734420776
the O O 0.9999706745147705
fetal O O 0.5818566679954529
or O O 0.8453688621520996
the O O 0.9775407910346985
adult B-DNA B-DNA 0.839745044708252
globin I-DNA I-DNA 0.4873814582824707
genes E-DNA E-DNA 0.9865351319313049
are O O 0.9996843338012695
expressed O O 0.9999091625213623
. O O 0.9999972581863403

transcription B-protein B-protein 0.45671823620796204
factors E-protein E-protein 0.9962303042411804
are O O 0.9999563694000244
found O O 0.9999904632568359
in O O 0.9999918937683105
this O O 0.999993085861206
region O O 0.9889512658119202
: O O 0.9999281167984009
two O O 0.9926470518112183
adjacent O B-DNA 0.8017184734344482
sites O E-DNA 0.9150283336639404
at O O 0.9994339346885681
positions O B-DNA 0.48776641488075256
-50 B-DNA I-DNA 0.7150191068649292
and I-DNA I-DNA 0.5488844513893127
-54 I-DNA I-DNA 0.45900848507881165
bp E-DNA E-DNA 0.9650671482086182
and O O 0.9657195806503296
a O O 0.9960075616836548
more O O 0.9585947394371033
5 B-DNA B-DNA 0.5053054094314575
' I-DNA I-DNA 0.5734313726425171
site E-DNA E-DNA 0.9932268261909485
at O O 0.99970942735672
position O B-DNA 0.7842965722084045
-67 B-DNA I-DNA 0.5447824597358704
bp E-DNA E-DNA 0.9795602560043335
. O O 0.9987175464630127
Using O O 0.9999644756317139
a O O 0.9999550580978394
series O O 0.9353166222572327
of O O 0.9951654672622681
constructs O O 0.4837627708911896
containing O O 0.9941605925559998
deletions O O 0.5874567627906799
and O O 0.9584366083145142
mutations O O 0.7862042188644409

interfere O O 0.9860979318618774
with O O 0.9999221563339233
the O O 0.9999663829803467
viral O O 0.9042114019393921
response O O 0.9913896918296814
to O O 0.9999024868011475
cell O O 0.8889961838722229
activation O O 0.954674243927002
signals O O 0.9975995421409607
, O O 0.9999293088912964
decrease O O 0.9991136193275452
LTR S-DNA S-DNA 0.9685793519020081
transcription O O 0.9574057459831238
, O O 0.9996069073677063
and O O 0.9999393224716187
inhibit O O 0.9997667670249939
viral O O 0.953375518321991
replication O O 0.993367612361908
. O O 0.9999951124191284
The O O 0.999967098236084
5'-UTR S-DNA S-DNA 0.8097852468490601
also O O 0.9852738976478577
interacts O O 0.999386191368103
with O O 0.9999865293502808
a O O 0.9999496936798096
specific O O 0.925769567489624
nucleosome S-protein O 0.537298321723938
that O O 0.9978984594345093
is O O 0.9999337196350098
rapidly O O 0.9983882904052734
displaced O O 0.9999421834945679
during O O 0.9999889135360718
transcriptional O O 0.9653334617614746
activation O O 0.9979336261749268
of O O 0.9999881982803345
the O O 0.9999663829803467
latent O O 0.5662810206413269
provirus O O 0.48269930481910706
. O O 0.9998505115509033
We O O 0.9999877214431763
propose O O 0.9999979734420776
that O O 0.999998927116394
the O O 0.9999580383300781
inducible B-DNA O 0.7547605037689209
transcription I-DNA B-protein 0.33994510769844055
factor I-DNA E-protein 0.9556335806846619

1.3 O O 0.6869562268257141
, O O 0.970048725605011
respectively O O 0.9989239573478699
) O O 0.9992874264717102
, O O 0.9999922513961792
indicating O O 0.9999969005584717
an O O 0.9999995231628418
increased O O 0.9992460012435913
rate O O 0.9994561076164246
of O O 0.9999884366989136
apoptosis O O 0.995535135269165
in O O 0.9999966621398926
80.5 O O 0.8920385837554932
% O O 0.997843861579895

deficient O O 0.9415958523750305
in O O 0.9996582269668579
transactivation O O 0.9857021570205688
of O O 0.9997401833534241
genes O O 0.7050322890281677
by O O 0.99998939037323
the O O 0.999975323677063
nuclear B-protein B-protein 0.7523893713951111
factor I-protein I-protein 0.45098674297332764
( I-protein I-protein 0.6458731889724731
NF I-protein I-protein 0.6664444208145142
) I-protein I-protein 0.5911694169044495
-kappaB E-protein E-protein 0.9745073318481445
pathway O O 0.9711000323295593
was O O 0.9999861717224121
unable O O 0.9998725652694702
to O O 0.9999861717224121
induce O O 0.999990701675415
transcriptional O O 0.953055202960968
activity O O 0.9981532692909241
of O O 0.9999915361404419
IL-1alpha B-DNA B-DNA 0.3989100158214569
promoter-CAT I-DNA I-DNA 0.28597649931907654
constructs E-DNA E-DNA 0.9359458088874817
, O O 0.9992941617965698
but O O 0.9999668598175049
was O O 0.9999549388885498
rescued O O 0.9999258518218994
by O O 0.9999978542327881
exogenous O O 0.9425218105316162
provision O O 0.9969902038574219
of O O 0.999964714050293
p65/p50 S-protein S-protein 0.6788204312324524

detectable O O 0.6916100978851318
MNDA S-protein S-protein 0.40079426765441895
. O O 0.9979355335235596
Although O O 0.9999921321868896
, O O 0.9999759197235107
the O O 0.9999972581863403
level O O 0.9983964562416077
of O O 0.9992284774780273
MNDA B-RNA B-RNA 0.983953058719635
mRNA E-RNA E-RNA 0.9978557229042053
in O O 0.999530553817749
primary B-cell_type B-cell_type 0.6982737183570862
monocytes E-cell_type E-cell_type 0.9085164070129395
is O O 0.9998469352722168
very O O 0.9999744892120361
low O O 0.9999873638153076
it O O 0.9999867677688599
was O O 0.9999949932098389
up-regulated O O 0.9999624490737915
at O O 0.9999990463256836
6 O O 0.9980649352073669
h O O 0.9948602318763733
following O O 0.999988317489624
the O O 0.9999978542327881

are O O 0.9979169964790344
described O O 0.9999243021011353
. O O 0.9999817609786987
Photoaffinity O O 0.8324419260025024
labeling O O 0.9733023643493652
of O O 0.9998630285263062
plasma B-protein B-protein 0.5229630470275879
membrane I-protein I-protein 0.6064904928207397
receptors E-protein E-protein 0.9870445132255554
for O O 0.9988915324211121
aldosterone O O 0.5493325591087341
from O O 0.998239278793335
human B-cell_type B-cell_type 0.5593850612640381
mononuclear I-cell_type I-cell_type 0.8992022275924683
leukocytes E-cell_type E-cell_type 0.9940021634101868
. O O 0.9999672174453735
Non-genomic O O 0.9016795754432678
effects O O 0.9991791844367981
of O O 0.9999935626983643
aldosterone O O 0.9428711533546448
on O O 0.9998660087585449
the O O 0.9999622106552124
sodium-proton-antiport S-protein S-protein 0.6492640972137451
have O O 0.993543267250061
been O O 0.9998154044151306
shown O O 0.9999819993972778
in O O 0.9999662637710571
human B-cell_type B-cell_type 0.5660139918327332
mononuclear I-cell_type I-cell_type 0.898938000202179
leukocytes E-cell_type E-cell_type 0.9872310757637024
which O O 0.9993237257003784
could O O 0.9999908208847046
be O O 0.999987006187439
related O O 0.9998782873153687
to O O 0.9999951124191284
a O O 0.9999885559082031
new O O 0.9854959845542908
aldosterone B-protein B-protein 0.5098206996917725
membrane I-protein I-protein 0.559046745300293
receptor E-protein E-protein 0.981650710105896
. O O 0.9998687505722046
In O O 0.9999861717224121
the O O 0.9999967813491821
present O O 0.9980190992355347
paper O O 0.9771488904953003
plasma O O 0.9407675862312317
membranes O O 0.7568398118019104
from O O 0.999977707862854
human B-cell_type B-cell_type 0.5347167253494263
mononuclear I-cell_type I-cell_type 0.8815909624099731
leukocytes E-cell_type E-cell_type 0.9946579337120056
were O O 0.9999163150787354
covalently O O 0.8899292349815369
photolabeled O O 0.9701921343803406
with O O 0.9998250603675842
a O O 0.9997645020484924
[ O O 0.9867847561836243

undertaken O O 0.9952594637870789
to O O 0.9999698400497437
investigate O O 0.9999924898147583
the O O 0.9999932050704956
immunotoxicity O O 0.9875566959381104
of O O 0.9998421669006348
one O O 0.9998611211776733
member O O 0.9795414805412292
of O O 0.9997192025184631
this O O 0.9999918937683105
family O O 0.9471926689147949
, O O 0.9990742206573486
dimethyldithiocarbamate O O 0.8977835774421692
( O O 0.994830310344696
DMDTC O O 0.9169155359268188
) O O 0.9965364933013916
. O O 0.9999977350234985
We O O 0.9999955892562866
demonstrate O O 0.9999991655349731
that O O 0.9999990463256836
0.1-0.5 O O 0.9671239852905273
microM O O 0.9871928691864014
DMDTC O O 0.6408114433288574
inhibits O O 0.999915361404419
TNF-alpha S-protein S-protein 0.9992781281471252
-induced O O 0.9985241293907166
activation O O 0.99863201379776
of O O 0.9999805688858032
NF-kappaB S-protein S-protein 0.9916150569915771
in O O 0.9999129772186279
primary B-cell_type B-cell_type 0.9061601161956787

elucidate O O 0.9875797629356384
further O O 0.9997909665107727
the O O 0.9999986886978149
mechanism O O 0.9994484782218933
by O O 0.9999983310699463
which O O 0.9999979734420776
ZAP-70 S-protein S-protein 0.9897125959396362
regulates O O 0.999734103679657
these O O 0.9999804496765137
initial O O 0.9801570177078247
events O O 0.9979972243309021
, O O 0.9999943971633911
we O O 0.9999853372573853
used O O 0.9999842643737793
a O O 0.9999785423278809
dominant-negative O O 0.7526232004165649
mutant O O 0.6830511689186096
approach O O 0.9968094229698181
. O O 0.9999977350234985
We O O 0.9999911785125732
overexpressed O O 0.9998927116394043
in O O 0.9999940395355225
the O O 0.9998828172683716
Jurkat B-cell_line B-cell_line 0.8238618969917297
T-cell I-cell_line I-cell_line 0.6773967742919922

myeloma O O 0.6012271046638489
cell O O 0.5981358289718628
growth O O 0.9763997793197632
via O O 0.9997001886367798
phosphorylation O O 0.9780426025390625
of O O 0.9996522665023804
retinoblastoma B-protein B-protein 0.7487894892692566
protein E-protein E-protein 0.9862108826637268
. O O 0.9983521699905396
Interleukin-6 S-protein S-protein 0.9837099313735962
( O O 0.9909597635269165
IL-6 S-protein S-protein 0.9964969754219055
) O O 0.9819846749305725
mediates O O 0.999220609664917
autocrine O O 0.7986404895782471
and O O 0.9875840544700623
paracrine O O 0.9127412438392639
growth O O 0.987128496170044
of O O 0.9999185800552368
multiple B-cell_line B-cell_line 0.8004041314125061
myeloma I-cell_line I-cell_line 0.5678192973136902
( I-cell_line I-cell_line 0.9185313582420349
MM I-cell_line I-cell_line 0.5565145611763
) I-cell_line I-cell_line 0.5983560085296631
cells E-cell_line E-cell_line 0.642900288105011

suggest O O 0.9989967942237854
that O O 0.9999982118606567
proposed O O 0.9894523620605469
strategies O O 0.9981189370155334
involving O O 0.9999967813491821
inhibition O O 0.9981703758239746
of O O 0.9999754428863525
NF-kappaB S-protein S-protein 0.995307981967926
activation O O 0.999308705329895
as O O 0.9999990463256836
an O O 0.999976396560669
adjunct O O 0.9932505488395691
to O O 0.9998437166213989
cancer O O 0.9721517562866211
chemotherapy O O 0.9957025647163391
should O O 0.9999923706054688
be O O 0.9999972581863403
approached O O 0.9999610185623169
with O O 0.9999933242797852
caution O O 0.9993317723274231
. O O 0.9999988079071045
High O O 0.922882616519928
molecular O O 0.9447576403617859
weight O O 0.9828313589096069
dextran O O 0.9549638628959656
sulfate O O 0.9928514957427979

macrophages S-cell_type S-cell_type 0.8695040345191956
, O O 0.9889666438102722
and O O 0.9999706745147705
its O O 0.9999532699584961
expression O O 0.9996633529663086
is O O 0.9999922513961792
markedly O O 0.9997943043708801
increased O O 0.9999866485595703
during O O 0.9999961853027344
the O O 0.9999986886978149
process O O 0.999963641166687
of O O 0.999988317489624
monocyte S-cell_type O 0.7116804122924805
differentiation O O 0.9972248077392578
. O O 0.9999978542327881

suppresses O O 0.9961888194084167
apoptosis O O 0.9961153268814087
in O O 0.9999179840087891
B B-cell_type B-cell_type 0.7978038787841797
cells E-cell_type E-cell_type 0.9918879866600037
and O O 0.9982399940490723
suggests O O 0.9999901056289673
a O O 0.9999960660934448
novel O O 0.9715816974639893
activity O O 0.9977454543113708
for O O 0.9999864101409912
TIMP-1 S-protein S-protein 0.9881309270858765
in O O 0.999953031539917
tissue O O 0.9170425534248352
homeostasis O O 0.9759884476661682
. O O 0.9999264478683472
Spi-1/PU.1 S-DNA B-DNA 0.7852650284767151
proto-oncogene S-DNA E-DNA 0.9231513738632202
induces O O 0.9998212456703186
opposite O O 0.9791598320007324
effects O O 0.9998667240142822
on O O 0.9999828338623047
monocytic O O 0.5563952326774597
and O O 0.9486396312713623
erythroid O O 0.9084770083427429
differentiation O O 0.996636152267456
of O O 0.9999778270721436
K562 B-cell_line B-cell_line 0.6852059960365295

adhesion I-protein B-protein 0.4788466989994049
molecule I-protein I-protein 0.7138568758964539
1 E-protein E-protein 0.9972591400146484
( O O 0.9931719303131104
VCAM-1 S-protein S-protein 0.9967001080513
) O O 0.9919155240058899
by O O 0.9999873638153076
interleukin-4 S-protein S-protein 0.9896119236946106
( O O 0.9912007451057434
IL-4 S-protein S-protein 0.9967527985572815
) O O 0.9923266768455505
on O O 0.9999116659164429
endothelial B-cell_type B-cell_type 0.8838260769844055
cells E-cell_type E-cell_type 0.995693564414978
. O O 0.9999401569366455
We O O 0.9989451766014099

trancriptional O O 0.7379326820373535
roles O O 0.9658390879631042
of O O 0.9999454021453857
STAT5 S-protein S-protein 0.9565646648406982
and O O 0.9839733242988586
functional O O 0.9323629140853882
roles O O 0.9618693590164185
of O O 0.999935507774353
ERK S-protein S-protein 0.922944962978363
and/or O O 0.7283686995506287
p38 S-protein S-protein 0.5860483050346375
in O O 0.9995154142379761
normal B-cell_type B-cell_type 0.5990315079689026
human I-cell_type I-cell_type 0.6125584244728088
monocytes E-cell_type E-cell_type 0.9721335172653198
stimulated O O 0.9972549080848694
by O O 0.9999865293502808
physiological O O 0.9604304432868958
receptor-mediated O O 0.9552333354949951
agonists O O 0.9783148765563965
GM-CSF S-protein S-protein 0.9557016491889954
and O O 0.9989641904830933
FMLP O O 0.4975653886795044
. O O 0.9999139308929443

wild-type O O 0.5926713347434998
E. O O 0.9120616912841797
coli O O 0.9347130060195923
endotoxin O O 0.5630761384963989
and O O 0.9977793097496033
markedly O O 0.9957566857337952
stimulated O O 0.998871386051178
the O O 0.9999816417694092
activation O O 0.9973713159561157
of O O 0.9999784231185913
human B-protein B-protein 0.40038496255874634
monocyte I-protein I-protein 0.34683957695961
nuclear I-protein I-protein 0.5676571726799011
factor-kappaB E-protein E-protein 0.9949439167976379
and O O 0.9983164072036743
the O O 0.9999885559082031
induction O O 0.9974508881568909
of O O 0.9999740123748779
Mn B-RNA B-RNA 0.9189605116844177
SOD I-RNA I-RNA 0.8315824866294861
mRNA E-RNA E-RNA 0.9926498532295227
and O O 0.9948191046714783
enzyme O O 0.5565306544303894
activity O O 0.974816620349884
. O O 0.9999704360961914
However O O 0.9999650716781616
, O O 0.9999697208404541
in O O 0.9999703168869019
contrast O O 0.9999767541885376
to O O 0.9999969005584717
the O O 0.9999934434890747

in O O 0.9941272735595703
B B-cell_type B-cell_type 0.8262810707092285
cells E-cell_type E-cell_type 0.9889037013053894
and O O 0.997187077999115
interacts O O 0.9975743889808655
with O O 0.9999879598617554
the O O 0.9999500513076782
Oct1 O S-protein 0.9572700262069702
and O O 0.9566055536270142
Oct2 O S-protein 0.9783233404159546
transcription B-protein B-protein 0.4951860308647156
factors E-protein E-protein 0.994320273399353
. O O 0.9999418258666992
Upon O O 0.9997860789299011
activation O O 0.9993094205856323
of O O 0.9999877214431763
Jurkat B-cell_line B-cell_line 0.7167021632194519
T I-cell_line I-cell_line 0.8193271160125732
cells E-cell_line E-cell_line 0.9702995419502258
and O O 0.9950880408287048
primary B-cell_type B-cell_type 0.6927796006202698
murine I-cell_type I-cell_type 0.8977606296539307
thymocytes E-cell_type E-cell_type 0.9946488738059998
with O O 0.9999126195907593
phorbol O O 0.9543270468711853
esters O O 0.9824503660202026
and O O 0.9999221563339233
ionomycin O O 0.933769702911377
, O O 0.9994472861289978
BOB.1/OBF.1 S-protein S-protein 0.9362401962280273
expression O O 0.9989728927612305
and O O 0.9999547004699707
transactivation O O 0.9825465679168701
function O O 0.9997920393943787
were O O 0.9999960660934448
induced O O 0.9999088048934937
. O O 0.9999897480010986
BOB.1/OBF.1 S-protein S-protein 0.885706901550293
was O O 0.9996042847633362
phosphorylated O O 0.9932460188865662
at O O 0.9999793767929077
Ser184 O O 0.5301566123962402
both O O 0.9994394183158875
in O O 0.9998687505722046
vivo O O 0.9965240359306335
and O O 0.9998868703842163
in O O 0.9992285966873169
vitro O O 0.9940642714500427
, O O 0.999727189540863
and O O 0.9999439716339111
this O O 0.9999805688858032
modification O O 0.999779999256134
was O O 0.9999929666519165
required O O 0.9999608993530273
for O O 0.9999938011169434

the O O 0.9987865090370178
binding O O 0.9221767783164978
and O O 0.9855474233627319
transcriptional O O 0.9671350121498108
activity O O 0.9986478686332703
of O O 0.9999922513961792
the O O 0.9999825954437256

cells E-cell_line E-cell_type 0.5205049514770508

the O O 0.9988642930984497
interleukin B-DNA B-DNA 0.42448878288269043
( I-DNA I-DNA 0.5979624390602112
IL I-DNA I-DNA 0.7408031821250916
) I-DNA I-DNA 0.7990992069244385
-2 I-DNA I-DNA 0.7749990224838257
homology I-DNA I-DNA 0.3655141294002533
NFAT-1 I-DNA I-DNA 0.3148742914199829
region E-DNA E-DNA 0.7328512072563171
was O O 0.9998564720153809
mutated O O 0.9984434247016907
resulted O O 0.9999951124191284
in O O 0.9999971389770508
almost O O 0.9997655749320984
complete O O 0.9982978701591492
elimination O O 0.9999029636383057
of O O 0.9999877214431763
suppression O O 0.9941104054450989
by O O 0.9999905824661255
CD8+ B-cell_type B-cell_type 0.8955870866775513
T I-cell_type I-cell_type 0.9633156061172485
cells E-cell_type E-cell_type 0.9513046145439148

T-helper B-cell_type B-protein 0.4458332359790802
lymphocyte I-cell_type I-protein 0.31390172243118286
2 I-cell_type I-protein 0.3961440920829773
( I-cell_type I-protein 0.5373515486717224
Th2 I-cell_type I-protein 0.4254857301712036
) I-cell_type I-protein 0.43331435322761536
phenotype E-cell_type E-protein 0.28108611702919006
. O O 0.9900776147842407
Part O O 0.9955586194992065
of O O 0.9999945163726807
this O O 0.9999949932098389
process O O 0.9995326995849609
involves O O 0.9999986886978149
the O O 0.9999964237213135
prevention O O 0.9999197721481323
of O O 0.999997615814209
the O O 0.999995231628418
development O O 0.9972129464149475

efficacious O O 0.9243597388267517

PKC S-protein S-protein 0.9852352142333984
activation O O 0.9991827607154846
by O O 0.9999967813491821
12-O-tetradecanoyl O O 0.8023874759674072
phorbol O O 0.890845775604248
13-acetate O O 0.7630535364151001
, O O 0.9968279004096985
which O O 0.999983549118042
bypasses O O 0.999568521976471
early O O 0.9032970666885376
receptor-triggered O O 0.9166507124900818
biochemical O O 0.9258501529693604
events O O 0.9956564903259277
, O O 0.9999896287918091

antiatherogenic O O 0.8236058950424194
mechanism O O 0.9918364882469177
of O O 0.9999802112579346
a O O 0.9999889135360718
nutritional O O 0.8816776871681213
component O O 0.681480884552002
in O O 0.9999722242355347
the O O 0.9999966621398926
mediterranean O O 0.8571690917015076
diet O O 0.9449238777160645
. O O 0.9999749660491943
Because O O 0.999997615814209
oleic O O 0.7908602952957153
acid O O 0.9149078726768494
is O O 0.999672532081604
implicated O O 0.9999698400497437
in O O 0.9999982118606567
the O O 0.9999969005584717
antiatherogenic O O 0.867743194103241
effects O O 0.9981960654258728
attributed O O 0.9999932050704956
to O O 0.9999980926513672
the O O 0.9999954700469971
Mediterranean O O 0.7802714109420776
diet O O 0.9369334578514099
, O O 0.9999529123306274
we O O 0.9999691247940063
investigated O O 0.9999901056289673
whether O O 0.9999991655349731
this O O 0.9999246597290039
fatty O O 0.9405518770217896
acid O O 0.9836454391479492
can O O 0.9999674558639526
modulate O O 0.9996121525764465
endothelial O O 0.8980146646499634
activation O O 0.9926620721817017

mRNA E-RNA E-RNA 0.9429434537887573
were O O 0.9995299577713013
detected O O 0.9999029636383057
in O O 0.9999496936798096
human O O 0.49383819103240967
spleen O O 0.3448537290096283
and O O 0.868760883808136
peripheral B-cell_type B-cell_type 0.4430888295173645
blood I-cell_type I-cell_type 0.8569890260696411
leukocytes E-cell_type E-cell_type 0.9278071522712708
, O O 0.9925963878631592
but O O 0.9997984766960144
not O O 0.9997851252555847
other O O 0.9994909763336182
human O O 0.6977096796035767
tissues O O 0.8221346139907837
. O O 0.9999879598617554
The O O 0.9999988079071045
level O O 0.998547375202179
of O O 0.999713122844696
SP140 B-RNA B-RNA 0.9944953322410583
mRNA E-RNA E-RNA 0.9973140358924866
in O O 0.9994964599609375
myeloid B-cell_line B-cell_line 0.3664796054363251
precursor I-cell_line I-cell_line 0.5406809449195862
cell I-cell_line I-cell_line 0.8345470428466797
lines E-cell_line E-cell_line 0.9948462247848511
HL60 S-cell_line S-cell_line 0.7208535075187683
and O O 0.9953058362007141
NB4 S-cell_line S-cell_line 0.9007750153541565
markedly O O 0.9851016998291016
increased O O 0.9998984336853027
in O O 0.9998977184295654

distinct O O 0.976628839969635
biological O O 0.9795640110969543
roles O O 0.9990405440330505
in O O 0.9999955892562866
the O O 0.9999951124191284
control O O 0.9949489831924438
of O O 0.9998902082443237
cell O O 0.9546944499015808
proliferation O O 0.9987823367118835
for O O 0.9999945163726807
the O O 0.9999877214431763
respective O O 0.9881746768951416
proteins O O 0.5611464977264404
. O O 0.9997579455375671
v-erbA S-protein S-protein 0.7478407025337219
overexpression O O 0.9902313351631165
is O O 0.9999691247940063
required O O 0.9999698400497437
to O O 0.9999943971633911
extinguish O O 0.99991774559021
c-erbA S-protein S-protein 0.7040996551513672
function O O 0.9978194236755371
in O O 0.999972939491272
erythroid B-cell_type O 0.5398999452590942
cell E-cell_type O 0.798707902431488
differentiation O O 0.9793286323547363
and O O 0.9995831847190857
regulation O O 0.9996346235275269
of O O 0.9999936819076538
the O O 0.99996018409729
erbA B-DNA B-DNA 0.5060721635818481
target I-DNA I-DNA 0.6108952164649963
gene E-DNA E-DNA 0.9395871758460999
CAII S-DNA S-DNA 0.7174469828605652
. O O 0.999875545501709
The O O 0.9999710321426392
v-erbA B-protein B-protein 0.5009645819664001
oncoprotein E-protein E-protein 0.9793745875358582
represents O O 0.9997653365135193
a O O 0.9999970197677612
retrovirus-transduced O O 0.5533724427223206
oncogenic O O 0.4610421359539032
version O O 0.4832504391670227
of O O 0.9987567663192749
the O O 0.9999254941940308
thyroid B-protein O 0.4845239222049713
hormone I-protein O 0.38499727845191956
( I-protein O 0.8360525965690613
T3/T4 I-protein O 0.49061110615730286
) I-protein O 0.4924846291542053

2 O O 0.4299454092979431
) O O 0.8729793429374695
this O O 0.999261200428009
erythropoietic O O 0.8012338876724243
wave O O 0.8978453874588013
is O O 0.9998650550842285
characterized O O 0.9997462630271912
by O O 0.9999954700469971
less O O 0.999855637550354
than O O 0.9999622106552124
4 O O 0.9416794776916504
% O O 0.9956318140029907
apoptotic O B-cell_type 0.5601281523704529
cells O E-cell_type 0.9294507503509521
; O O 0.9991845488548279
( O O 0.9996115565299988
3 O O 0.9983036518096924
) O O 0.998828113079071
asymmetric O O 0.9208927154541016
divisions O O 0.9638249278068542
are O O 0.9999960660934448
virtually O O 0.9998583793640137
absent O O 0.9999967813491821

and O O 0.9320893883705139
CLC S-protein O 0.458839476108551
) O O 0.9776231646537781
, O O 0.9997072815895081
were O O 0.9999964237213135
isolated O O 0.9986552000045776
. O O 0.9999970197677612
However O O 0.9999958276748657
, O O 0.9999974966049194
the O O 0.9999983310699463
molecular O O 0.9558746814727783
basis O O 0.997188150882721
for O O 0.9999912977218628
the O O 0.9999964237213135
commitment O O 0.9988722205162048
of O O 0.9999884366989136
progenitors O O 0.7681896090507507
to O O 0.9985743761062622
the O O 0.9998990297317505
eosinophil B-cell_type B-cell_type 0.45332059264183044
lineage E-cell_type E-cell_type 0.9826470017433167
has O O 0.9997900128364563
not O O 0.9999831914901733
been O O 0.9999949932098389
determined O O 0.9999898672103882

Both O O 0.9989864230155945
iNO O S-protein 0.679669976234436
production O O 0.9953317046165466
and O O 0.9998995065689087
endothelial O O 0.8380925059318542
VCAM-1 S-protein S-protein 0.5923779010772705
expression O O 0.9984495639801025
were O O 0.9999959468841553
induced O O 0.9999520778656006
simultaneously O O 0.9999920129776001
with O O 0.9999957084655762
bacterial O O 0.8801692724227905
LPS O O 0.7637802958488464
and O O 0.997157096862793
murine-specific B-protein B-protein 0.765424370765686
IFN-gamma E-protein E-protein 0.8545224070549011
. O O 0.9997398257255554
Inhibition O O 0.9985753297805786
of O O 0.9999806880950928
iNO B-protein B-protein 0.3190307319164276
synthase E-protein E-protein 0.8584089875221252

in O O 0.9983276724815369
EBV-infected B-cell_type B-cell_line 0.5954828858375549
lymphoblastoid I-cell_type I-cell_line 0.632800281047821
cells E-cell_type E-cell_line 0.7246584892272949
. O O 0.9998186230659485
In O O 0.9999902248382568
order O O 0.9999548196792603
to O O 0.9999959468841553
understand O O 0.9999940395355225
the O O 0.9999988079071045
role O O 0.9997722506523132
of O O 0.9999884366989136
NF-kappaB S-protein S-protein 0.98843914270401
in O O 0.9999467134475708
EBV O O 0.9257702827453613
transformation O O 0.9976171851158142
we O O 0.9999872446060181
have O O 0.9999967813491821
established O O 0.9988433122634888
stably O O 0.885677695274353
transfected O O 0.8905688524246216
IkappaBalpha S-protein S-protein 0.9476918578147888
into O O 0.9998056292533875
lymphoblastoid B-cell_type B-cell_type 0.7748290300369263
cells E-cell_type E-cell_type 0.8901605010032654
. O O 0.999870777130127
Two O O 0.9996950626373291
clones O O 0.9597423672676086
were O O 0.9999825954437256
obtained O O 0.9999605417251587
in O O 0.9999909400939941
which O O 0.9999974966049194
the O O 0.9999942779541016
loss O O 0.9992328882217407
of O O 0.9999761581420898
NF-kappaB S-protein S-protein 0.897337794303894
binding O O 0.7846029996871948

tal-1 S-DNA S-DNA 0.8132633566856384
transcription O O 0.84281325340271
within O O 0.999731719493866
exon B-DNA B-DNA 0.5832933783531189
4 E-DNA E-DNA 0.8293700814247131
. O O 0.9990262985229492
These O O 0.9999920129776001
results O O 0.9999630451202393
suggest O O 0.9999988079071045
that O O 0.9999970197677612
distinct O O 0.9951537847518921
regulatory B-DNA B-DNA 0.6727209091186523
elements E-DNA E-DNA 0.9860084652900696
are O O 0.9999561309814453
associated O O 0.9981974959373474

( O O 0.9784610867500305
ADT O O 0.6332882046699524
, O O 0.9808369278907776
5- O O 0.9879727363586426
[ O O 0.9981622099876404
p-methoxyphenyl O O 0.865869402885437
] O O 0.960419237613678
-3H-1 O O 0.9470388889312744
, O O 0.9989383816719055
2-dithiol-3-thione O O 0.9799284338951111
) O O 0.9995777010917664
is O O 0.9999985694885254
an O O 0.9999988079071045
antioxidant O O 0.8900059461593628

specific O O 0.933968722820282
binding O O 0.9613529443740845
. O O 0.9999395608901978
Binding O O 0.9688720703125
of O O 0.9982814788818359
AP-2 S-protein S-protein 0.9811475872993469
prevented O O 0.9998313188552856
the O O 0.9999954700469971
subsequent O O 0.9985058307647705
binding O O 0.9955507516860962
of O O 0.9999386072158813
members O O 0.9118775725364685
of O O 0.9983265995979309
the O O 0.9997366070747375
CREB/ATF B-protein B-protein 0.5696302652359009
family E-protein E-protein 0.8900780081748962
to O O 0.9995930790901184
an O O 0.999883770942688
adjacent B-DNA B-DNA 0.7618647217750549
regulatory I-DNA I-DNA 0.4430568516254425
motif E-DNA E-DNA 0.9829505085945129
in O O 0.9999374151229858
the O O 0.9999914169311523
21 B-DNA B-DNA 0.7487266659736633
bp I-DNA I-DNA 0.9067350029945374
repeat E-DNA E-DNA 0.9983206391334534
. O O 0.9998935461044312
Transfection O O 0.9899296164512634
of O O 0.999961256980896
an O O 0.9999712705612183
AP-2 B-DNA B-DNA 0.7137101888656616
expression I-DNA I-DNA 0.8905967473983765
construct E-DNA E-DNA 0.9935787916183472
into O O 0.9998760223388672
T-lymphocytes S-cell_type S-cell_type 0.9712952375411987
activated O O 0.9702028632164001
gene O O 0.8820611834526062
expression O O 0.999470055103302
from O O 0.9999986886978149
the O O 0.9999740123748779
HTLV-I B-DNA B-DNA 0.7551791071891785
LTR E-DNA E-DNA 0.9983231425285339
. O O 0.9997506737709045

II I-protein I-protein 0.5128740072250366
antigens E-protein E-protein 0.9736594557762146
expression O O 0.9981050491333008
also O O 0.9999922513961792
inhibits O O 0.9999656677246094
HLA B-protein B-protein 0.444268137216568
class I-protein I-protein 0.660206139087677
II E-protein E-protein 0.9447529911994934
constitutive O O 0.680333137512207
expression O O 0.991992712020874
in O O 0.9999960660934448
the O O 0.9999542236328125
human B-cell_line B-cell_line 0.7983067631721497
Raji I-cell_line I-cell_line 0.9011831879615784
B I-cell_line I-cell_line 0.9866456985473633
cell I-cell_line I-cell_line 0.8597495555877686

in O O 0.9987697005271912
IL-1 S-protein S-protein 0.9837024211883545
signal O O 0.9919845461845398
transduction O O 0.9987819790840149
. O O 0.9999970197677612
We O O 0.9998419284820557
generated O O 0.9995588660240173
permanent O O 0.901125431060791
clones O O 0.8264486789703369
of O O 0.9996156692504883
the O O 0.9999496936798096
murine B-cell_line B-cell_line 0.3296920955181122
T I-cell_line I-cell_line 0.5092993378639221
cell I-cell_line I-cell_line 0.7729195356369019
line I-cell_line E-cell_line 0.946405827999115
EL4 I-cell_line B-cell_line 0.6700006723403931
6.1 E-cell_line E-cell_line 0.9992632269859314
overexpressing O O 0.8528225421905518
human B-protein O 0.49034383893013
( I-protein O 0.6487066745758057
h I-protein O 0.5457031726837158
) I-protein O 0.6159546971321106
IRAK E-protein S-protein 0.3009778559207916
to O O 0.9398387670516968
evaluate O O 0.9998089671134949
the O O 0.9999818801879883
role O O 0.9988147020339966

fetal B-protein O 0.5103570222854614

differentiation-associated O O 0.8977769613265991
pattern O O 0.9850032925605774
of O O 0.9998620748519897
BZLF1 S-protein S-protein 0.7932272553443909
expression O O 0.9957848191261292
was O O 0.9999926090240479
observed O O 0.9998303651809692
, O O 0.9999579191207886
BZ1 S-protein S-protein 0.5912052392959595
reacting O O 0.9899886250495911
with O O 0.9999459981918335
nuclei O O 0.9140110611915588
of O O 0.9991461038589478
the O O 0.9999892711639404
upper O O 0.6377884149551392
spinous O O 0.7074681520462036
layer O O 0.6728538870811462
of O O 0.9930821061134338
the O O 0.9999023675918579
lesion O O 0.9865710139274597
. O O 0.9999963045120239
This O O 0.9999977350234985
finding O O 0.9997867941856384
suggests O O 0.9999980926513672
that O O 0.999997615814209
the O O 0.9999572038650513
BZLF1 B-DNA B-DNA 0.47932612895965576
promoter E-DNA E-DNA 0.9944379329681396
may O O 0.9998903274536133
be O O 0.9999911785125732
regulated O O 0.9999639987945557
by O O 0.9999988079071045
the O O 0.9999973773956299
degree O O 0.9991325736045837
of O O 0.9999755620956421
squamous O O 0.9651999473571777
differentiation O O 0.9993281364440918
. O O 0.9999988079071045
A O O 0.9996166229248047

the O O 0.9981504082679749
synthesis O O 0.9687466621398926
of O O 0.9995055198669434
heat B-protein B-protein 0.6434416770935059
shock I-protein I-protein 0.5648437738418579
( I-protein I-protein 0.6799740195274353
HS I-protein I-protein 0.9239436388015747
) I-protein I-protein 0.9244694709777832
/stress I-protein I-protein 0.7946034073829651
proteins E-protein E-protein 0.9988607168197632
( O O 0.9976907968521118
HSP S-protein S-protein 0.9247459173202515
) O O 0.9953189492225647
, O O 0.9998315572738647
and O O 0.999929666519165
, O O 0.9997169375419617
in O O 0.9999033212661743
particular O O 0.999786913394928
, O O 0.9999123811721802
of O O 0.9998817443847656
Hsp70 S-protein S-protein 0.9874067902565002
. O O 0.9999040365219116
We O O 0.999931812286377
determined O O 0.9999933242797852
whether O O 0.9999988079071045
Hsp70 S-protein S-protein 0.942073404788971
induction O O 0.9996620416641235
by O O 0.999998927116394
TS O O 0.7850058078765869
was O O 0.9996894598007202
mediated O O 0.9999053478240967

inducible O O 0.9313247799873352

cells O E-cell_type 0.6001586318016052
were O O 0.999763548374176
kept O O 0.9999501705169678
for O O 0.9999897480010986
3 O O 0.9985830783843994
d O O 0.9995996356010437
in O O 0.9999905824661255
the O O 0.9999892711639404
presence O O 0.9972947239875793
of O O 0.9999690055847168
40 O O 0.8729363679885864
and O O 0.9963526725769043
60 O O 0.9946692585945129
mM O O 0.9946562051773071
D-ribose O O 0.9886433482170105
, O O 0.9999557733535767
respectively O O 0.9999904632568359
. O O 0.9999963045120239
In O O 0.9999520778656006
agreement O O 0.9994578957557678
with O O 0.9999985694885254
this O O 0.9999978542327881
, O O 0.9999539852142334
decrease O O 0.999894380569458
in O O 0.9999948740005493
the O O 0.999975323677063
insulin B-RNA B-RNA 0.6593706607818604
mRNA E-RNA E-RNA 0.9757591485977173
and O O 0.995032787322998
insulin O O 0.5037550926208496
content O O 0.8396120667457581
was O O 0.999971866607666

Garcia-Cozar O O 0.9646480083465576
, O O 0.9998798370361328
F. O O 0.9995672106742859
J. O O 0.9999673366546631
, O O 0.9999912977218628
Raghavan O O 0.9999421834945679
, O O 0.9999926090240479
A. O O 0.9999847412109375
, O O 0.9999903440475464
Okamura O O 0.9999674558639526
, O O 0.9999938011169434
H. O O 0.9999750852584839
, O O 0.9999891519546509
Rao O O 0.9998685121536255
, O O 0.9999895095825195
A. O O 0.9999557733535767
, O O 0.999976396560669
and O O 0.999982476234436
Hogan O O 0.9998443126678467
, O O 0.9999934434890747
P. O O 0.9998807907104492
G. O O 0.9998821020126343
( O O 0.999937891960144
1998 O O 0.9991051554679871
) O O 0.9999192953109741
Mol. O O 0.9996613264083862
Cell O O 0.9911965131759644
1 O O 0.9866074323654175

days O O 0.8679397106170654
) O O 0.9786050319671631
post-stimulation O O 0.9946777820587158
. O O 0.9999978542327881
A O O 0.9999959468841553
better O O 0.9999098777770996
understanding O O 0.9998997449874878
of O O 0.9999945163726807
transcriptional O O 0.9581130146980286
regulation O O 0.9996398687362671
at O O 0.9999998807907104
this O O 0.9999977350234985
important O O 0.9991497993469238
stage O O 0.9997674822807312
of O O 0.9999926090240479
T-cell O O 0.6815020442008972
maturation O O 0.9950984120368958
may O O 0.9999957084655762
yield O O 0.9999973773956299
new O O 0.9997867941856384
insights O O 0.999506950378418
into O O 0.9999974966049194
T-cell O O 0.47207438945770264
development O O 0.9876478910446167
and O O 0.9999136924743652
new O O 0.992738664150238
immunotherapeutic O O 0.9214950203895569
targets O O 0.8363989591598511
. O O 0.9999967813491821
Involvement O O 0.9999210834503174
of O O 0.9999973773956299
different O O 0.9979671835899353
transduction O O 0.7527768611907959

CTL O O 0.37414050102233887
) O O 0.7756900191307068
response O O 0.9971868395805359
to O O 0.9999951124191284
the O O 0.9999911785125732
HLA-B8-restricted O O 0.7429900169372559
peptide O O 0.8637905120849609
, O O 0.9995224475860596
RAKFKQLL O S-protein 0.684529185295105
, O O 0.9946990013122559
located O O 0.9999432563781738
in O O 0.9999897480010986
the O O 0.9998892545700073
Epstein-Barr B-protein B-protein 0.6089316010475159
virus I-protein I-protein 0.6013857126235962
immediate-early I-protein I-protein 0.47967761754989624
antigen E-protein E-protein 0.9706417322158813
, O O 0.9958005547523499
BZLF1 S-protein S-protein 0.9443029761314392
, O O 0.9964865446090698
is O O 0.9999513626098633
characterized O O 0.9998862743377686
by O O 0.9999960660934448
a O O 0.9999827146530151
diverse O O 0.9378818869590759
T B-protein B-protein 0.629743754863739
cell I-protein I-protein 0.4976496696472168
receptor I-protein E-protein 0.956523060798645
( I-protein O 0.9614676237106323
TCR I-protein S-protein 0.9263495206832886
) I-protein O 0.9094209671020508
repertoire E-protein O 0.8731646537780762
. O O 0.9999915361404419
Here O O 0.9999445676803589
, O O 0.9999880790710449
we O O 0.999991774559021
show O O 0.9999978542327881
that O O 0.9999967813491821
this O O 0.9999563694000244
diversity O O 0.9993927478790283
can O O 0.9999971389770508
be O O 0.9999905824661255
partitioned O O 0.9998307228088379
on O O 0.9999945163726807
the O O 0.9999805688858032

mononuclear B-cell_type B-cell_type 0.368808776140213
phagocytes E-cell_type E-cell_type 0.9788302183151245
upon O O 0.9995651841163635
stimulation O O 0.9955303072929382
by O O 0.9999877214431763
mycobacterial O B-protein 0.5771673917770386
proteins O E-protein 0.986770749092102
. O O 0.9999250173568726
In O O 0.9999619722366333
this O O 0.9999983310699463
regard O O 0.9999549388885498
, O O 0.9999970197677612
the O O 0.9999786615371704
cytokine S-protein B-protein 0.46060702204704285
interleukin B-protein I-protein 0.5574508905410767
6 E-protein E-protein 0.9800666570663452
( O O 0.9703839421272278
IL-6 S-protein S-protein 0.9915059208869934
) O O 0.9809322357177734
may O O 0.999991774559021
play O O 0.9999948740005493
a O O 0.9999951124191284

were O O 0.9990142583847046
accumulated O O 0.9991274476051331

domain E-protein E-protein 0.855146050453186
of O O 0.9979199767112732
the O O 0.9999629259109497
calcineurin B-protein B-protein 0.7583809494972229
A I-protein I-protein 0.6539217233657837
chain E-protein E-protein 0.9713202118873596
and O O 0.9879433512687683
on O O 0.9997829794883728
an O O 0.9998939037322998
86-amino B-protein B-protein 0.7657501697540283
acid I-protein I-protein 0.9398695230484009
fragment E-protein E-protein 0.9827486872673035
of O O 0.9974601864814758
the O O 0.9998443126678467
NFAT B-protein B-DNA 0.5942445993423462

Here O O 0.9994279742240906
, O O 0.9999957084655762
we O O 0.9999943971633911
show O O 0.9999986886978149
that O O 0.9999982118606567
overexpression O O 0.9971565008163452
of O O 0.9999479055404663
p95vav S-protein S-protein 0.5439050197601318
alone O O 0.9682791233062744
in O O 0.9999691247940063
Jurkat O B-cell_line 0.7781054973602295
T B-cell_type I-cell_line 0.8740429282188416

C/EBP B-protein B-protein 0.5874196887016296
beta E-protein E-protein 0.9300105571746826
in O O 0.998645007610321
chronic O O 0.891392707824707
inflammation O O 0.9965115189552307
. O O 0.9999977350234985
The O O 0.9999991655349731
regulation O O 0.999528169631958
of O O 0.999995231628418
the O O 0.9999774694442749
production O O 0.9719459414482117
or O O 0.9992252588272095
activity O O 0.9936617612838745
of O O 0.9999364614486694
C/EBP B-protein B-protein 0.8006177544593811
beta E-protein E-protein 0.9528794884681702
, O O 0.9820031523704529
to O O 0.9996665716171265
inhibit O O 0.9998210072517395
inflammatory O B-protein 0.8006128668785095
mediator O E-protein 0.8785362243652344
expression O O 0.9987322688102722
by O O 0.9999953508377075
synovial B-cell_type B-cell_type 0.5039142966270447
macrophages E-cell_type E-cell_type 0.8437365293502808
and O O 0.9936834573745728
fibroblasts S-cell_type S-cell_type 0.9790899753570557
, O O 0.998325765132904
offers O O 0.9999953508377075
a O O 0.999996542930603
novel O O 0.9621877670288086

pulsed O O 0.8457068204879761
with O O 0.9991776347160339
BCR1/25 O S-DNA 0.6716856360435486
. O O 0.9997110962867737
The O O 0.9999958276748657
autologous B-cell_line B-DNA 0.5904967784881592
DE I-cell_line I-DNA 0.41933566331863403
LCL E-cell_line E-DNA 0.9305768013000488
containing O O 0.9972176551818848
a O O 0.9999457597732544
transduced O O 0.8215286731719971
pml/RAR B-DNA B-DNA 0.43737268447875977
alpha I-DNA I-DNA 0.6222078204154968
fusion I-DNA I-DNA 0.816361129283905
gene E-DNA E-DNA 0.9950346946716309
and O O 0.9996059536933899
expressing O O 0.9989227652549744
a O O 0.9999233484268188
bcr1 O B-DNA 0.5482174158096313
type O I-DNA 0.6129263043403625

of O O 0.9925521612167358

Recent O O 0.9982839226722717
reports O O 0.999896764755249
have O O 0.9999996423721313
demonstrated O O 0.9999866485595703
that O O 0.9999985694885254
differential O O 0.9938856959342957
expression O O 0.9996218681335449
of O O 0.999994158744812
cell O B-protein 0.6778942942619324
surface O I-protein 0.5143861174583435
molecules O E-protein 0.9902206659317017
, O O 0.9989830851554871
such O O 0.9999785423278809
as O O 0.9999709129333496
adhesion B-protein B-protein 0.7898576259613037
molecule E-protein E-protein 0.9886464476585388
and O O 0.9937937259674072
chemokine B-protein B-protein 0.6582046151161194
receptor E-protein E-protein 0.9807418584823608
, O O 0.9930566549301147
is O O 0.9999817609786987
involved O O 0.999981164932251
in O O 0.9999921321868896
their O O 0.9999905824661255
recruitment O O 0.9997852444648743
into O O 0.999993085861206
target O O 0.8948007225990295
tissues O O 0.9785820841789246

position O O 0.8186062574386597
but O O 0.9994885921478271
that O O 0.9999992847442627
this O O 0.9999725818634033
stimulation O O 0.9987506866455078
is O O 0.9999933242797852
restricted O O 0.9996684789657593
to O O 0.9999581575393677
B B-cell_type B-cell_type 0.85548996925354
cells E-cell_type E-cell_type 0.9873759746551514
. O O 0.999869704246521
This O O 0.9999974966049194
result O O 0.999972939491272
indicates O O 0.9999986886978149
the O O 0.9999992847442627
involvement O O 0.9999812841415405
of O O 0.9999963045120239

GM-CSF S-protein S-protein 0.9007982611656189
+ O O 0.9970197081565857
RA O O 0.9457076787948608
: O O 0.9959904551506042
27 O O 0.9995214939117432
% O O 0.9995111227035522
) O O 0.9997771382331848
. O O 0.9999966621398926
Moreover O O 0.999652624130249
, O O 0.9999299049377441
RA O O 0.9185133576393127
induced O O 0.9978455305099487
apoptosis O O 0.9961645603179932
of O O 0.9999377727508545
CD34+ B-cell_type B-cell_type 0.8196960687637329
cells E-cell_type E-cell_type 0.6258150339126587
and O O 0.9943317174911499
CD34+CD71+ B-cell_type B-cell_type 0.8545044660568237
cells E-cell_type E-cell_type 0.5322003960609436
stimulated O O 0.997393012046814
with O O 0.9999765157699585
erythropoietin S-protein S-protein 0.9900168776512146
. O O 0.9999798536300659
To O O 0.9999895095825195
explore O O 0.9999735355377197
the O O 0.9999909400939941
receptor O O 0.8965780138969421

been O O 0.9962073564529419
well O O 0.9826374650001526
defined O O 0.9989437460899353
. O O 0.9999957084655762
We O O 0.9999880790710449
demonstrate O O 0.9999936819076538
that O O 0.999997615814209
, O O 0.9998666048049927
in O O 0.999650239944458
primary B-cell_type B-cell_type 0.5316574573516846
NK I-cell_type I-cell_type 0.8921889066696167
cells E-cell_type E-cell_type 0.971213161945343
, O O 0.9991648197174072
IL-13 S-protein S-protein 0.9721827507019043
, O O 0.9941638112068176
but O O 0.9994136095046997
not O O 0.9984397292137146
IL-4 S-protein S-protein 0.9932895302772522
, O O 0.9991432428359985
may O O 0.9999921321868896
induce O O 0.9999918937683105
low O O 0.993897020816803
levels O O 0.9998595714569092
of O O 0.9999822378158569
IFN-gamma S-protein S-protein 0.8601779937744141

solution O O 0.8290780186653137
hybridization O O 0.966308057308197
assay O O 0.9993380904197693
. O O 0.9999977350234985
Serum O O 0.8690113425254822
cortisol O O 0.9218947291374207
, O O 0.9974772334098816
osteocalcin O O 0.9066873788833618
and O O 0.9979523420333862
urinary O O 0.9494654536247253
cortisol O O 0.9861538410186768
levels O O 0.9999333620071411

augmented O O 0.9722540378570557
adherence O O 0.9972051978111267
of O O 0.9999715089797974
sickle B-cell_type B-cell_type 0.5695125460624695
red I-cell_type I-cell_type 0.3879533112049103
blood I-cell_type I-cell_type 0.817514181137085
cells E-cell_type E-cell_type 0.9693009853363037
and O O 0.9981008172035217
transendothelial O O 0.6459912657737732
migration O O 0.9408840537071228
of O O 0.9995504021644592
monocyte-like B-cell_line B-cell_line 0.4116204082965851
HL-60 I-cell_line I-cell_line 0.5662493109703064
cells E-cell_line E-cell_line 0.9575358629226685
is O O 0.9997532963752747
blocked O O 0.9997528195381165
by O O 0.9999959468841553
PAF-receptor O O 0.7105052471160889
antagonist O O 0.6363933682441711
. O O 0.9998199343681335
In O O 0.9999289512634277
response O O 0.9978312849998474
to O O 0.9999294281005859

, O O 0.9965924620628357
the O O 0.9999744892120361
C-terminal B-protein B-protein 0.923136293888092
region E-protein E-protein 0.9762328863143921
of O O 0.9989103078842163
Ku S-protein S-protein 0.41706588864326477
was O O 0.9919623732566833
able O O 0.9996053576469421
to O O 0.999954342842102
activate O O 0.9998953342437744
transcription O O 0.5376874804496765
via O O 0.9469178318977356
TRE-1 S-DNA S-DNA 0.7205756902694702
but O O 0.9881492853164673
this O O 0.9999560117721558

receptor I-RNA E-protein 0.7977043390274048

events O O 0.9797571301460266
that O O 0.9999864101409912
are O O 0.9999902248382568
rapidly O O 0.9992250204086304
expressed O O 0.999956488609314
( O O 0.9999324083328247
seconds O O 0.9922704696655273
) O O 0.9993556141853333
are O O 0.9999940395355225
due O O 0.9999945163726807
to O O 0.9999988079071045
a O O 0.999998927116394
possible O O 0.9976682066917419
interaction O O 0.9983978867530823

prove O O 0.9991733431816101
that O O 0.9999985694885254
Th2 B-protein B-protein 0.5265385508537292
type I-protein I-protein 0.4356582760810852
cytokines E-protein E-protein 0.979009211063385
had O O 0.9998492002487183
a O O 0.9999955892562866
protective O O 0.9955571293830872
effect O O 0.9999783039093018
on O O 0.9999909400939941
hepatocytes S-cell_type S-cell_type 0.9825006127357483
. O O 0.9997956156730652
Upon O O 0.999895453453064
HBxAg S-protein S-protein 0.7862390279769897
stimulation O O 0.9982194304466248
, O O 0.9999977350234985
there O O 0.9999966621398926
was O O 0.9999980926513672

NF-kappaB-like B-DNA B-DNA 0.5719649791717529
element E-DNA E-DNA 0.9928037524223328
was O O 0.9997079968452454
able O O 0.999836802482605
to O O 0.9999798536300659
form O O 0.9999579191207886
a O O 0.9999867677688599
complex O O 0.8819512724876404
with O O 0.9990636706352234
NF-kappaB B-protein B-protein 0.5066890716552734
family I-protein I-protein 0.6306712627410889
proteins E-protein E-protein 0.9932667016983032
in O O 0.9997809529304504
vitro O O 0.9902728199958801
. O O 0.9999923706054688
Furthermore O O 0.9999713897705078
, O O 0.9999790191650391
Tax S-protein S-protein 0.9999192953109741
-induced O O 0.9982097148895264
transactivation O O 0.998754620552063
of O O 0.9999938011169434
the O O 0.9999020099639893
bcl-x B-DNA B-DNA 0.8382843732833862
promoter E-DNA E-DNA 0.9967837333679199
was O O 0.9997897744178772
also O O 0.999992847442627
diminished O O 0.9999897480010986
by O O 0.9999995231628418
the O O 0.9999959468841553
mutant B-protein B-protein 0.5292943716049194
IkappaBalpha E-protein E-protein 0.8938679099082947
, O O 0.9879905581474304
which O O 0.9999353885650635
specifically O O 0.9999634027481079
inhibits O O 0.9999426603317261
NF-kappaB S-protein S-protein 0.9986312985420227
activity O O 0.9996874332427979
. O O 0.9999992847442627
Our O O 0.9999997615814209
findings O O 0.9999653100967407
suggest O O 0.9999995231628418
that O O 0.9999988079071045
constitutive O O 0.9226396083831787
expression O O 0.995110809803009
of O O 0.9999697208404541
Bcl-x B-protein B-protein 0.5376497507095337
( I-protein I-protein 0.5176607966423035
L I-protein I-protein 0.8475903272628784
) E-protein E-protein 0.9478532075881958
induced O O 0.994494616985321
by O O 0.9999686479568481
Tax S-protein S-protein 0.9987181425094604
through O O 0.9999533891677856
the O O 0.9999855756759644
NF-kappaB S-protein S-protein 0.9497422575950623
pathway O O 0.9901949763298035

of O O 0.9975937008857727
acute O O 0.9108714461326599
leukemia O O 0.9827037453651428
and O O 0.9996933937072754
may O O 0.9998656511306763
be O O 0.9999938011169434
associated O O 0.999626874923706
with O O 0.999997615814209
a O O 0.9999948740005493
poor O O 0.989463210105896
prognosis O O 0.9988111257553101
. O O 0.9999994039535522
The O O 0.9999991655349731
role O O 0.99480801820755

IL-5 S-protein S-protein 0.9595308303833008
production O O 0.9992196559906006
by O O 0.9999922513961792
CD4+ B-cell_type B-cell_type 0.957381010055542
T I-cell_type I-cell_type 0.9867695569992065
cells E-cell_type E-cell_type 0.9852017760276794
from O O 0.9998233914375305
both O O 0.9999653100967407
atopic O O 0.8532964587211609
and O O 0.9783867597579956
nonatopic O O 0.9230136871337891
subjects O O 0.9725154638290405
with O O 0.9999772310256958
asthma O O 0.9816914200782776
was O O 0.9999325275421143
significantly O O 0.9999054670333862
enhanced O O 0.999889612197876
compared O O 0.9999611377716064
with O O 0.9999947547912598
that O O 0.9999356269836426
by O O 0.9999090433120728
cells O O 0.9730748534202576
from O O 0.9999624490737915
healthy O O 0.8789870738983154
controls O O 0.9824762344360352
. O O 0.9999974966049194
Peripheral B-cell_type B-cell_type 0.5339807271957397
blood I-cell_type I-cell_type 0.6997030377388
mononuclear I-cell_type I-cell_type 0.9062066078186035

sequences E-DNA O 0.8338580131530762
shows O O 0.9999867677688599
high O O 0.9759334921836853
conservation O O 0.9940817952156067
in O O 0.9999667406082153
the O O 0.9998843669891357
5 B-DNA B-DNA 0.6128448843955994
' I-DNA I-DNA 0.8387415409088135
flank E-DNA E-DNA 0.9698946475982666
and O O 0.9273579120635986
exons S-DNA S-DNA 0.9346250295639038
. O O 0.9994737505912781
A O O 0.9999361038208008
CpG O B-DNA 0.7520028352737427
island O E-DNA 0.9740052819252014
suggests O O 0.9995328187942505
expression O O 0.99944669008255
in O O 0.9999957084655762
the O O 0.9999940395355225
germ O B-cell_line 0.49081170558929443
line O E-cell_line 0.9600870609283447
. O O 0.9996567964553833

adhesion B-protein B-protein 0.4324902296066284
protein I-protein E-protein 0.9821258783340454
Mac-1 E-protein S-protein 0.5756653547286987
and O O 0.9992094039916992
the O O 0.9999107122421265
NADPH-oxidase B-protein S-protein 0.7919789552688599
component I-protein O 0.46875160932540894
cytochrome E-protein B-protein 0.3929721713066101
b558 S-protein E-protein 0.9142082929611206
is O O 0.9985595345497131
localized O O 0.9992719292640686
in O O 0.9999442100524902
gelatinase S-protein O 0.5918785929679871
granules O O 0.5918928384780884
. O O 0.9998762607574463
Although O O 0.9999958276748657
no O O 0.9998286962509155
qualitative O O 0.987570583820343
difference O O 0.9998654127120972
was O O 0.9999970197677612
observed O O 0.99956876039505
between O O 0.9990795850753784
specific O O 0.9778825640678406
granules O O 0.8648508787155151
and O O 0.9995600581169128
gelatinase S-protein O 0.7880125045776367
granules O O 0.8465076684951782
with O O 0.9999580383300781
respect O O 0.9995467066764832
to O O 0.9999927282333374
cytochrome B-protein B-protein 0.5210443139076233
b558 E-protein E-protein 0.7927985191345215
and O O 0.9664539694786072
Mac-1 S-protein O 0.39930689334869385
, O O 0.9978930354118347

tissues O O 0.8291764259338379
in O O 0.9999862909317017
patients O O 0.999329686164856
with O O 0.9999682903289795
sepsis O O 0.9970721006393433
or O O 0.9999421834945679
septic O O 0.9003627896308899
shock O O 0.9513814449310303
. O O 0.9998946189880371
DESIGN O O 0.9944487810134888
: O O 0.9999434947967529
The O O 0.9999936819076538
effects O O 0.9998518228530884
of O O 0.9999881982803345
hypercortisolaemia O O 0.9756397604942322

of O O 0.9988777041435242
common O O 0.8549413681030273
downstream O O 0.9113520383834839
signaling O O 0.9686282277107239
events O O 0.9986383318901062
, O O 0.9999867677688599
including O O 0.9999885559082031
the O O 0.9999959468841553
activation O O 0.9932518601417542
of O O 0.9999321699142456
protein B-protein B-protein 0.756916344165802
tyrosine I-protein I-protein 0.9441462159156799
kinase E-protein E-protein 0.9654341340065002
and O O 0.9903289079666138
of O O 0.9999479055404663
mitogen-activated B-protein B-protein 0.8186755180358887
protein I-protein I-protein 0.4824490547180176
kinase E-protein E-protein 0.9235961437225342
cascades O O 0.6450663805007935
. O O 0.9998688697814941
By O O 0.9998447895050049
using O O 0.9999006986618042
PD-98059 O O 0.9295545816421509
and O O 0.9984388947486877
SB203580 O O 0.9457293748855591
, O O 0.9998621940612793
two O O 0.9978358149528503
potent O O 0.9778320789337158
and O O 0.9957501888275146
selective O O 0.9633422493934631
inhibitors O O 0.8786271214485168
of O O 0.9998971223831177
MEK1 S-protein S-protein 0.9791364073753357
( O O 0.9983658194541931
a O O 0.9957690238952637
kinase S-protein O 0.34281983971595764
upstream O O 0.5567429661750793
of O O 0.9861688613891602
ERK1/2 S-protein S-protein 0.9493699073791504
) O O 0.9880929589271545
and O O 0.9994625449180603
p38 S-protein S-protein 0.9172489047050476
, O O 0.9894858598709106
respectively O O 0.999920129776001

. O O 0.9954484105110168

the O O 0.9989528656005859
same O O 0.9994768500328064
DNA O B-DNA 0.6108612418174744
element O E-DNA 0.995945155620575
but O O 0.9989610910415649
activate O O 0.9996716976165771
distinct O O 0.98277747631073
sets O O 0.7810545563697815
of O O 0.9973087310791016
genes O O 0.6610696315765381
. O O 0.9997443556785583
We O O 0.9999669790267944
expressed O O 0.9999779462814331
these O O 0.999981164932251
factors O O 0.9723178148269653
in O O 0.9999192953109741
S. O O 0.7614584565162659
cerevisiae O O 0.8434831500053406
and O O 0.9952229857444763
observed O O 0.9968125224113464
greater O O 0.9985812902450562
than O O 0.9998798370361328
5-fold O O 0.6858439445495605
stimulation O O 0.9729595184326172
of O O 0.9999411106109619
a O O 0.9996380805969238
lacZ B-DNA B-DNA 0.8909041285514832
reporter I-DNA I-DNA 0.6697104573249817
gene E-DNA E-DNA 0.9891397356987
only O O 0.9991129040718079
with O O 0.9999611377716064
Oct-2 S-protein S-protein 0.9849992394447327
. O O 0.9999698400497437
Transfer O O 0.9664658904075623
of O O 0.9990630745887756
the O O 0.9999276399612427
Oct-2 B-protein B-protein 0.5350634455680847
C-terminal I-protein I-protein 0.791032612323761
domain E-protein E-protein 0.9136760830879211
onto O O 0.9997712969779968
either O O 0.9987766146659851
Oct-1 S-protein S-protein 0.7732336521148682
( O O 0.8725492358207703
Oct1.2 S-protein S-protein 0.8289139270782471
) O O 0.5700891017913818
or O O 0.99899822473526
a O O 0.9998718500137329
nonactivating B-protein B-protein 0.5731490254402161
DNA-binding I-protein I-protein 0.8549907207489014
domain E-protein E-protein 0.9699660539627075
from O O 0.9995031356811523
GAL4 S-protein S-protein 0.9100518822669983
created O O 0.9945908784866333
activators O O 0.8294528126716614

endowed O O 0.9588305354118347
with O O 0.9999053478240967
high O O 0.9217569828033447
proliferative O O 0.9368494153022766
potential O O 0.9773725867271423
( O O 0.999503493309021
HPP-47.10 B-cell_line B-cell_line 0.468398779630661
cells E-cell_line E-cell_line 0.9653781652450562
) O O 0.9945539236068726
. O O 0.9999939203262329
In O O 0.9999200105667114
conclusion O O 0.9999136924743652
, O O 0.9999977350234985
we O O 0.9999537467956543
have O O 0.999996542930603
characterized O O 0.9998385906219482
a O O 0.9999816417694092
novel O B-cell_line 0.7758222222328186
continuous B-cell_line I-cell_line 0.7098763585090637
myeloid I-cell_line I-cell_line 0.4512462317943573
cell I-cell_line I-cell_line 0.8559065461158752
line E-cell_line E-cell_line 0.9900243282318115
presenting O O 0.9974996447563171
a O O 0.9999909400939941
hierarchical O O 0.8910899758338928
structure O O 0.9773953557014465
similar O O 0.9999492168426514
to O O 0.9999940395355225
that O O 0.9999948740005493
of O O 0.999985933303833
the O O 0.9999344348907471
bone B-cell_line B-cell_line 0.47661158442497253
marrow I-cell_line I-cell_line 0.39930838346481323
progenitor I-cell_line I-cell_line 0.49224984645843506
cell I-cell_line I-cell_line 0.448132187128067
compartment E-cell_line E-cell_line 0.9018280506134033
. O O 0.9997493624687195
Regulation O O 0.9991206526756287
of O O 0.9999697208404541

proteins E-protein E-protein 0.9678233861923218
is O O 0.9998681545257568
required O O 0.9999790191650391
. O O 0.9999980926513672
Peripheral B-cell_type B-cell_type 0.6231747269630432
blood I-cell_type I-cell_type 0.5877670645713806
mononuclear I-cell_type I-cell_type 0.9540205001831055
cells E-cell_type E-cell_type 0.9958482980728149
isolated O O 0.9964084029197693
from O O 0.9999918937683105
patients O O 0.9992223978042603
with O O 0.9999643564224243
diabetic O O 0.9730720520019531
nephropathy O O 0.9908099174499512
show O O 0.9999986886978149
increased O O 0.9998540878295898
activation O O 0.9994372725486755
of O O 0.9999902248382568
the O O 0.9999661445617676
oxidative-stress B-protein B-protein 0.48044395446777344
sensitive I-protein I-protein 0.6319065093994141
transcription I-protein I-protein 0.7521790266036987
factor E-protein E-protein 0.9254493713378906

. O O 0.9954484105110168

response O O 0.9511776566505432
that O O 0.9996620416641235
is O O 0.9998939037322998
delayed O O 0.9995421171188354
relative O O 0.9999680519104004
to O O 0.9999723434448242
NF-kappa B-protein B-protein 0.8663276433944702
B E-protein E-protein 0.9985396862030029
activation O O 0.9949743747711182
and O O 0.9999622106552124
to O O 0.9999641180038452
induction O O 0.9947787523269653
of O O 0.9998950958251953
cell B-protein O 0.7812679409980774
surface I-protein O 0.8740924000740051

using O O 0.9949343800544739
Ig B-DNA B-DNA 0.6609660983085632
enhancer I-DNA E-DNA 0.9873895645141602
and I-DNA O 0.9868175983428955
promoter E-DNA S-DNA 0.7907689809799194
, O O 0.9886302947998047
which O O 0.9999827146530151
direct O O 0.9937143921852112
transgene O S-DNA 0.7677793502807617
expression O O 0.9780173301696777
in O O 0.9997311234474182
cells O O 0.9745304584503174
committed O O 0.999828577041626
to O O 0.9999889135360718
the O O 0.9999257326126099
lymphoid O B-cell_type 0.6637401580810547
lineage O E-cell_type 0.9943479895591736
. O O 0.9999499320983887
The O O 0.9999974966049194
transgenic O O 0.8933112621307373
mice O O 0.9905774593353271
exhibited O O 0.9999573230743408
abnormal O O 0.9884260892868042
development O O 0.9997212290763855
in O O 0.9999971389770508
the O O 0.9999493360519409
thymus O O 0.7055409550666809
and O O 0.9642418622970581
spleen O O 0.8203189373016357
and O O 0.9949106574058533
were O O 0.9999748468399048
susceptible O O 0.997601330280304
to O O 0.9998855590820312

issue O O 0.9445639252662659
by O O 0.9999889135360718
using O O 0.9998705387115479
two O O 0.9995394945144653
different O O 0.9988540410995483
experimental O O 0.9433841705322266
approaches O O 0.9930114150047302
that O O 0.9999963045120239
allowed O O 0.9998911619186401
LMP1 S-protein S-protein 0.9994845390319824
-induced O O 0.9938313961029053
effects O O 0.9990411400794983
to O O 0.9999661445617676
be O O 0.9999659061431885
monitored O O 0.9996046423912048
immediately O O 0.9999092817306519
following O O 0.9999868869781494
expression O O 0.999799907207489
of O O 0.9999970197677612
the O O 0.9999486207962036
viral O B-protein 0.7914050817489624
protein O E-protein 0.9499663710594177
and O O 0.9800344705581665
in O O 0.9998835325241089
the O O 0.9999923706054688
absence O O 0.9997811913490295

leads O O 0.9987637996673584
to O O 0.9999934434890747
the O O 0.9999933242797852
nuclear O O 0.8395490050315857
association O O 0.9298526644706726
of O O 0.9982680082321167
the O O 0.9999550580978394
cytosolic B-protein B-protein 0.6633627414703369
component E-protein E-protein 0.9135860204696655
of O O 0.9530985355377197
NF-ATc S-protein S-protein 0.9715393781661987
. O O 0.9999477863311768
The O O 0.9999927282333374
activation O O 0.9814890027046204
of O O 0.9994922876358032
calcineurin S-protein S-protein 0.9945651292800903
and O O 0.998084545135498
the O O 0.999832034111023
nuclear O O 0.5432671904563904
import O O 0.6252068877220154
of O O 0.9608004093170166
NF-ATc S-protein S-protein 0.9842723608016968
can O O 0.9998810291290283
both O O 0.9999946355819702

of O O 0.9900282025337219
p65 S-protein S-protein 0.9702999591827393
. O O 0.9975001215934753
We O O 0.9999639987945557
demonstrate O O 0.9999898672103882
in O O 0.9994519352912903
vitro O O 0.9860671162605286
cleavage O O 0.9890115261077881
of O O 0.9998968839645386
p65 S-protein S-protein 0.962691068649292
by O O 0.9996974468231201
purified O B-protein 0.8533668518066406
elastase S-protein E-protein 0.751183271408081
and O O 0.9933116436004639
cathepsin B-protein B-protein 0.5170923471450806
G E-protein E-protein 0.9942405223846436
. O O 0.9982981085777283
It O O 0.9999681711196899
is O O 0.9999972581863403
possible O O 0.9999924898147583
that O O 0.9999984502792358
particular O O 0.9962104558944702
serine B-protein B-protein 0.7368484735488892
proteases E-protein E-protein 0.9045827388763428
may O O 0.9998425245285034
have O O 0.9999971389770508
inhibiting O O 0.992085874080658
effects O O 0.9999475479125977
on O O 0.999996542930603
the O O 0.999975323677063
replication O O 0.9956119060516357
of O O 0.9999464750289917

transcription O O 0.8362898826599121
of O O 0.9993106126785278
both O O 0.9999862909317017
the O O 0.9998838901519775
endogenous O B-DNA 0.8047317266464233
and O I-DNA 0.6696876287460327
the O I-DNA 0.867759644985199
transfected O I-DNA 0.6982848048210144
gene O E-DNA 0.9299797415733337
was O O 0.9996747970581055
inducible O O 0.9999501705169678
by O O 0.999998927116394
PMA O O 0.9661475419998169
treatment O O 0.999509334564209
. O O 0.9999986886978149
Tax S-protein S-protein 0.9837855100631714
expression O O 0.9998465776443481
in O O 0.9999924898147583
Jurkat B-cell_line B-cell_line 0.7093230485916138
T I-cell_line I-cell_line 0.7957863211631775

rat O O 0.3352377116680145
and O O 0.8788173794746399
mouse O O 0.8216232061386108
tissues O O 0.9784265160560608
have O O 0.9999909400939941
detected O O 0.9999291896820068
ubiquitously O O 0.7878206372261047
expressed O O 0.9544550180435181
Pan O B-RNA 0.5021612048149109
transcripts O E-RNA 0.9715800881385803
, O O 0.9977878332138062
but O O 0.9999898672103882
the O O 0.999996542930603
abundance O O 0.9926375150680542
, O O 0.9985707998275757
distribution O O 0.982846200466156
, O O 0.9979569911956787
and O O 0.9993035793304443
form O O 0.9653109312057495
of O O 0.9997513890266418
Pan B-protein B-protein 0.4767153859138489
proteins E-protein E-protein 0.9789126515388489
have O O 0.9996651411056519
not O O 0.9999203681945801
been O O 0.9999874830245972
clearly O O 0.9982677698135376
defined O O 0.9998908042907715
. O O 0.9999974966049194
Studies O O 0.9999246597290039
of O O 0.999987006187439
cell B-cell_line B-cell_line 0.49150174856185913
lines E-cell_line E-cell_line 0.9893102645874023

posttranslational O O 0.8684934377670288
levels O O 0.9985809326171875
in O O 0.999964714050293
T B-cell_type B-cell_type 0.696596622467041
lymphocytes E-cell_type E-cell_type 0.9927524328231812
. O O 0.9999608993530273
Tuberculosis O O 0.9866811037063599
and O O 0.9997304081916809
chronic O O 0.9888168573379517
hepatitis O O 0.991778552532196
B O O 0.9955052137374878
virus O O 0.9982534050941467
infection O O 0.9997127652168274
in O O 0.9999880790710449
Africans O O 0.9616206288337708
and O O 0.9990973472595215
variation O O 0.9964976906776428
in O O 0.9999957084655762
the O O 0.9999864101409912
vitamin B-DNA B-DNA 0.6407580971717834
D I-DNA I-DNA 0.48692479729652405
receptor I-DNA I-DNA 0.7757472991943359
gene E-DNA E-DNA 0.9978620409965515
. O O 0.9999531507492065
The O O 0.9999921321868896

with O O 0.9990009665489197
APL O O 0.6244368553161621
in O O 0.9990780353546143
whom O O 0.9999803304672241
the O O 0.9999884366989136
leukaemic O O 0.585880696773529
clone O O 0.5874118804931641
was O O 0.9988401532173157
characterized O O 0.9998313188552856
by O O 0.9999983310699463
a O O 0.9999918937683105
true O O 0.9822944402694702
variant O O 0.9694727063179016
of O O 0.9999717473983765
the O O 0.9998216032981873
classical B-DNA B-DNA 0.5635518431663513
t I-DNA I-DNA 0.34957432746887207
( I-DNA I-DNA 0.509787380695343
15 I-DNA I-DNA 0.870765209197998
; I-DNA I-DNA 0.9715821146965027
17 I-DNA I-DNA 0.9925716519355774
) E-DNA E-DNA 0.586800754070282
. O O 0.9902166128158569
The O O 0.9999943971633911
patient O O 0.9914076924324036
whose O O 0.9999210834503174
disease O O 0.9970861077308655
had O O 0.999977707862854
numerous O O 0.9979053735733032
atypical O O 0.9508652091026306
clinical O O 0.9184580445289612
features O O 0.9368345737457275
, O O 0.9997732043266296
had O O 0.9931788444519043
t B-DNA B-DNA 0.6134895086288452
( I-DNA I-DNA 0.516343891620636
11 I-DNA I-DNA 0.8862543106079102
; I-DNA I-DNA 0.9687920808792114
17 I-DNA I-DNA 0.9957072734832764
) I-DNA I-DNA 0.5557624697685242
( I-DNA I-DNA 0.6040953993797302
q13 I-DNA I-DNA 0.9730133414268494
; I-DNA I-DNA 0.987342357635498
121 I-DNA I-DNA 0.8963677287101746
) E-DNA E-DNA 0.8025373220443726
. O O 0.9944043159484863
The O O 0.9999912977218628
chromosome B-DNA B-DNA 0.7055105566978455
17 I-DNA E-DNA 0.9792618751525879
breakpoint E-DNA O 0.5799534320831299
was O O 0.9994381070137024
localized O O 0.9988462924957275
to O O 0.9999434947967529
intron B-DNA S-DNA 0.7675072550773621

of O O 0.9925521612167358

whether O O 0.999018669128418
this O O 0.999980092048645
may O O 0.999963641166687
be O O 0.9999955892562866
partly O O 0.9999552965164185
explained O O 0.9999923706054688
by O O 0.9999996423721313
changes O O 0.9996078610420227
in O O 0.9999914169311523
expression O O 0.999396562576294
of O O 0.9999932050704956
NF-kappaB S-protein S-protein 0.9838189482688904
with O O 0.9997499585151672
monocyte O O 0.6011905670166016
differentiation O O 0.9909533262252808
. O O 0.9999936819076538
We O O 0.9999872446060181
demonstrated O O 0.9999878406524658
that O O 0.9999988079071045
constitutive O O 0.9599143266677856
expression O O 0.9982913136482239
of O O 0.9999862909317017
NF-kappaB S-protein S-protein 0.7945243716239929

line E-cell_line E-cell_line 0.9966418743133545
and O O 0.9940833449363708
the O O 0.9991481304168701
hybrids S-cell_line O 0.5091916918754578
. O O 0.9999275207519531
These O O 0.9999954700469971
results O O 0.9998956918716431
confirm O O 0.9999909400939941
and O O 0.9999387264251709
extend O O 0.9999920129776001
the O O 0.9999955892562866
notion O O 0.9994986057281494
of O O 0.9999973773956299
the O O 0.9999929666519165
functional O O 0.9808986783027649
conservation O O 0.9959456324577332
of O O 0.999972939491272
the O O 0.999962568283081
AIR-1 B-protein B-DNA 0.7972015738487244
gene I-protein E-DNA 0.943109393119812

differentiation O O 0.9297026991844177
switch O O 0.9720054268836975
during O O 0.9999314546585083
myelopoiesis O O 0.8973450660705566
in O O 0.9996258020401001
human B-cell_type B-cell_type 0.5671494603157043
cells E-cell_type E-cell_type 0.9848462343215942
. O O 0.9998152852058411
By O O 0.9999772310256958
using O O 0.9999556541442871
a O O 0.9999746084213257
reverse O O 0.767227053642273
transcription-PCR-based O O 0.7935432195663452
approach O O 0.9934084415435791
and O O 0.9999409914016724
a O O 0.9999934434890747
set O O 0.9992583394050598
of O O 0.9999690055847168
primers O O 0.8054388761520386

3B I-protein S-protein 0.3419812321662903
, I-protein O 0.8149451017379761
3C I-protein S-protein 0.44082292914390564
, I-protein O 0.6883663535118103
-LP E-protein S-protein 0.38607409596443176
) O O 0.5987576842308044
, O O 0.9976009726524353
three O O 0.9494368433952332
latent B-protein B-protein 0.4651241898536682
membrane I-protein I-protein 0.7932153940200806
proteins E-protein E-protein 0.9993627667427063
( O O 0.9892131686210632
LMP1 S-protein S-protein 0.9880053400993347
, O O 0.9822872281074524
2A S-protein S-protein 0.9708648324012756
, O O 0.9789799451828003
2B S-protein S-protein 0.9877920746803284
) O O 0.9887652397155762
, O O 0.9997281432151794
and O O 0.9988667964935303
two O O 0.9213842153549194
nuclear B-RNA B-protein 0.5391628742218018
RNAs E-RNA E-protein 0.42747634649276733
( O O 0.9458761811256409
EBERs S-RNA S-protein 0.9138128161430359
) O O 0.9578295350074768
are O O 0.9999290704727173
expressed O O 0.9999127388000488
. O O 0.9999985694885254
This O O 0.999988317489624
form O O 0.9726456999778748
of O O 0.9991550445556641
latency O O 0.8880622982978821
, O O 0.9990050196647644
termed O O 0.9976850748062134
latency O O 0.9306610226631165
III O O 0.6299532055854797

autocrine O O 0.6174756288528442

agent O O 0.943070650100708
. O O 0.9999910593032837
The O O 0.9999994039535522
present O O 0.9982591271400452
study O O 0.9999632835388184
examined O O 0.999995231628418
the O O 0.9999995231628418
effect O O 0.9999754428863525
of O O 0.9999945163726807
ADT O O 0.8157245516777039
pretreatment O O 0.9991723299026489
on O O 0.999988317489624
NF-kappa B-protein B-protein 0.8165218830108643
B E-protein E-protein 0.9985092282295227
activation O O 0.9975354671478271
in O O 0.9999756813049316
response O O 0.9606318473815918
to O O 0.9985172152519226

mobility O O 0.9406228065490723
shift O O 0.9863043427467346
assays O O 0.9983792304992676
( O O 0.9999631643295288
EMSA O O 0.9881604909896851
) O O 0.9999010562896729
. O O 0.9999985694885254
Transfection O O 0.997002899646759
of O O 0.9999837875366211
EL-4 B-cell_line B-cell_line 0.830828845500946
cells E-cell_line E-cell_line 0.9936535358428955
with O O 0.9998939037322998
the O O 0.9999797344207764
IL-4 B-DNA B-DNA 0.702336847782135
promoter-reporter I-DNA I-DNA 0.6193662881851196
constructs E-DNA E-DNA 0.9981282353401184
carrying O O 0.9991346001625061
mutated B-DNA O 0.7522971034049988
P-like I-DNA B-DNA 0.6327921748161316
elements E-DNA E-DNA 0.9943760633468628
showed O O 0.9999793767929077
that O O 0.9999996423721313
four O O 0.981960654258728
P-like B-DNA B-DNA 0.6488552689552307
elements E-DNA E-DNA 0.9944256544113159
, O O 0.9986006617546082
CLE0 S-DNA S-DNA 0.9654667973518372
, O O 0.9518890380859375
P S-DNA S-DNA 0.9597143530845642
, O O 0.8376854658126831

min O O 0.7887480854988098
and O O 0.9927324652671814
by O O 0.9998975992202759
C5b-7 S-protein O 0.4618104100227356
at O O 0.9988862872123718
10 O O 0.9971447587013245
min O O 0.9993311166763306
, O O 0.9999847412109375
over O O 0.9999492168426514
the O O 0.999983549118042
C5b6 S-protein S-protein 0.8941510915756226
level O O 0.9978159666061401
. O O 0.9999979734420776
The O O 0.9999996423721313
role O O 0.9941880702972412
of O O 0.9999659061431885
mitogen-activated B-protein B-protein 0.43419376015663147
protein I-protein I-protein 0.41157516837120056
kinase E-protein E-protein 0.9464315176010132
( O O 0.9167255163192749
MAPK S-protein S-protein 0.9497905373573303
) O O 0.8902065753936768
pathway O O 0.9976149797439575
on O O 0.9999654293060303
TCC S-protein S-protein 0.4390498697757721
-inducible O O 0.9929910898208618
mitotic O O 0.8792966604232788
signaling O O 0.9835923910140991
was O O 0.9999775886535645
evaluated O O 0.9999771118164062
by O O 0.9999972581863403
assessing O O 0.9991188645362854
DNA O O 0.9283446669578552
synthesis O O 0.9921849370002747
and O O 0.9997134804725647
activator B-protein B-protein 0.7995783686637878
protein I-protein I-protein 0.41436469554901123
1 E-protein E-protein 0.982142984867096
( O O 0.978959858417511
AP-1 S-protein S-protein 0.9736850261688232
) O O 0.9851245880126953
DNA-binding O O 0.9226083755493164
activity O O 0.9991722106933594
. O O 0.9999994039535522
The O O 0.9999983310699463
MAPK/ERK-specific O O 0.5364893674850464
inhibitor O O 0.6637265086174011
PD O O 0.6524990797042847

T O O 0.4722138047218323
cell-mediated O O 0.8529224395751953
immune O O 0.9538677930831909
response O O 0.9982596039772034
as O O 0.9999922513961792
well O O 0.9999500513076782
as O O 0.999997615814209
an O O 0.9999902248382568
endotoxic O O 0.9360796809196472
challenge O O 0.9975019097328186
during O O 0.9999885559082031

protein E-protein E-protein 0.976466178894043
( O O 0.9882538318634033
CREB S-protein S-protein 0.9956977367401123
) O O 0.9817783832550049
or O O 0.9998427629470825
CREB S-protein S-protein 0.8906390070915222
fused O O 0.951410174369812
to O O 0.999441921710968
the O O 0.999913215637207
GAL4 B-protein B-protein 0.5140666365623474
activation I-protein I-protein 0.7229306697845459
domain E-protein E-protein 0.9025452136993408
( O O 0.9728867411613464
GAD S-protein S-protein 0.9782688021659851
) O O 0.9928449988365173
in O O 0.9999955892562866
this O O 0.999985933303833
strain O O 0.9841461777687073
did O O 0.9999556541442871
not O O 0.9999895095825195
modify O O 0.9999308586120605
the O O 0.999990701675415
expression O O 0.9997454285621643
of O O 0.9999973773956299
the O O 0.9999895095825195
reporter B-DNA B-DNA 0.6059497594833374
gene E-DNA E-DNA 0.9894481897354126
. O O 0.9996984004974365
Tax S-protein S-protein 0.978268027305603
alone O O 0.9983476400375366
was O O 0.9999555349349976
also O O 0.9999737739562988
inactive O O 0.9998182654380798
. O O 0.9999978542327881
However O O 0.9999901056289673
, O O 0.9999817609786987
expression O O 0.9985554814338684

the O O 0.9978005290031433

IP-10 S-protein S-protein 0.9107485413551331
, O O 0.9892891645431519
ISG54 S-protein S-protein 0.9511047601699829
, O O 0.9934760928153992
and O O 0.9994263648986816
intercellular B-protein B-protein 0.6956084370613098
adhesion I-protein I-protein 0.8743492364883423
molecule-1 E-protein E-protein 0.9972782731056213
. O O 0.9997057318687439
The O O 0.999996542930603
reduction O O 0.9979165196418762
in O O 0.9999483823776245
gene O O 0.9728952050209045
expression O O 0.9996188879013062
resulted O O 0.9999978542327881
from O O 0.9999988079071045
the O O 0.9999973773956299
ability O O 0.9999692440032959
of O O 0.9999924898147583
IL-10 S-protein S-protein 0.9835298657417297
to O O 0.9995881915092468
suppress O O 0.999854564666748
IFN S-protein S-protein 0.9984245300292969
-induced O O 0.9947556257247925
assembly O O 0.9970967769622803
of O O 0.9999082088470459
signal B-protein B-protein 0.5144258141517639
transducer I-protein I-protein 0.4901109039783478

role O O 0.9543783664703369
of O O 0.9992735981941223
kappaB-responsive B-DNA B-DNA 0.5378190875053406
elements E-DNA E-DNA 0.9934746623039246
of O O 0.9991291165351868
the O O 0.9999703168869019
human B-DNA B-DNA 0.6450904607772827
immunodeficiency I-DNA I-DNA 0.795029878616333
virus I-DNA I-DNA 0.9001336097717285
type I-DNA I-DNA 0.953083336353302
1 I-DNA I-DNA 0.9606742858886719
( I-DNA I-DNA 0.9575046300888062
HIV-1 I-DNA I-DNA 0.9871808886528015
) I-DNA I-DNA 0.9860002398490906
enhancer E-DNA E-DNA 0.9867041110992432
not O O 0.9954772591590881
only O O 0.9999521970748901
in O O 0.9998741149902344
early O O 0.7241765260696411
initiation O O 0.9397809505462646
but O O 0.9974448680877686
also O O 0.9999634027481079
in O O 0.9998903274536133
long-term O O 0.932795524597168
maintenance O O 0.9987390637397766
of O O 0.9999850988388062

a O O 0.9995064735412598
persistent O O 0.9697473049163818
nuclear O O 0.9438195824623108
accumulation O O 0.9910497665405273
of O O 0.9998745918273926
RelB S-protein S-protein 0.992287278175354
. O O 0.9999279975891113
In O O 0.999991774559021
this O O 0.9999995231628418
study O O 0.9999339580535889
we O O 0.9999971389770508
analyzed O O 0.9999867677688599
the O O 0.999998927116394
effect O O 0.9999730587005615
of O O 0.9999908208847046
CD40 S-protein S-protein 0.9761210680007935
stimulation O O 0.9985829591751099
on O O 0.9999957084655762
the O O 0.9999940395355225
activity O O 0.9991955161094666

epithelial I-cell_type I-cell_type 0.4375991225242615
cells E-cell_type E-cell_type 0.9275882244110107
in O O 0.9997137188911438
vitro O O 0.9912699460983276
also O O 0.9999067783355713
showed O O 0.9999983310699463
consistent O O 0.9962105751037598
patterns O O 0.9989570379257202
of O O 0.9999738931655884
variation O O 0.996410071849823
in O O 0.9999864101409912
expression O O 0.9991784691810608
among O O 0.9999945163726807
breast O O 0.7160477638244629
tumor O O 0.6302137970924377
samples O O 0.8517737984657288
. O O 0.9997498393058777
By O O 0.9999603033065796
using O O 0.9996101260185242
immunohistochemistry O O 0.9452936053276062
with O O 0.9999192953109741
antibodies O S-protein 0.8196821808815002
against O O 0.9931424856185913
proteins O O 0.7719686627388
encoded O O 0.9989049434661865
by O O 0.9999924898147583
a O O 0.9999345541000366
particular O O 0.9807664155960083
gene O O 0.9276500940322876

adhesion O O 0.9634249806404114
, O O 0.9999154806137085
the O O 0.9999969005584717
level O O 0.9984188079833984
of O O 0.9999794960021973
the O O 0.9999128580093384
I B-protein B-protein 0.9106963276863098
kappa I-protein I-protein 0.9608439803123474
B I-protein I-protein 0.7475177049636841
alpha I-protein I-protein 0.8100485801696777
protein E-protein E-protein 0.9925393462181091
is O O 0.9998061060905457
markedly O O 0.9982247948646545
diminished O O 0.9994150400161743
but O O 0.9999426603317261
is O O 0.9999644756317139
rapidly O O 0.9997739195823669
replaced O O 0.9999574422836304
in O O 0.9999947547912598
a O O 0.999981164932251
cycloheximide-sensitive O O 0.4813400208950043
manner O O 0.9085208177566528
within O O 0.9998307228088379
20 O O 0.998955488204956
min O O 0.9984593391418457
. O O 0.9999964237213135
Accompanying O O 0.9999308586120605
the O O 0.999995231628418
rapid O O 0.982376217842102
turnover O O 0.9983733892440796
of O O 0.999993085861206
the O O 0.9999264478683472
I B-protein B-protein 0.8711315989494324
kappa I-protein I-protein 0.9407714605331421
B I-protein I-protein 0.8446109294891357
alpha I-protein I-protein 0.6766751408576965
protein E-protein E-protein 0.9931063055992126
is O O 0.9999581575393677
simultaneous O O 0.9944908618927002
translocation O O 0.9363323450088501

hAEC I-cell_line S-protein 0.47664472460746765
) I-cell_line O 0.5303213000297546
system E-cell_line O 0.5584765076637268
to O O 0.9998877048492432
investigate O O 0.9999935626983643
these O O 0.9999891519546509
effects O O 0.9999170303344727
at O O 0.9999996423721313
the O O 0.9999988079071045
late B-cell_type O 0.9838703870773315
erythroblast I-cell_type O 0.9547106623649597
stage E-cell_type O 0.997087299823761
. O O 0.9999994039535522
Restoration O O 0.9992272853851318
of O O 0.9999939203262329
the O O 0.9999889135360718
CCAAT B-DNA B-DNA 0.7771759033203125
box E-DNA E-DNA 0.9930832386016846
at O O 0.9998656511306763
-70 B-DNA B-DNA 0.7882673740386963
bp E-DNA E-DNA 0.8808407783508301
, O O 0.9218264818191528
or O O 0.9909430146217346
insertion O O 0.9831966161727905
of O O 0.9999094009399414
an O O 0.9999392032623291
EKLF B-DNA B-DNA 0.779268205165863
binding I-DNA I-DNA 0.9234620332717896
site E-DNA E-DNA 0.9934121966362
at O O 0.9998596906661987
-85 B-DNA O 0.770517110824585
bp E-DNA O 0.5877653360366821
or O O 0.8144358396530151
-95 B-DNA B-DNA 0.556620717048645
bp E-DNA E-DNA 0.9126571416854858
in O O 0.9993619322776794
the O O 0.9998239874839783
promoter S-DNA O 0.5503649711608887
significantly O O 0.9989187717437744
increased O O 0.9999387264251709
delta O B-DNA 0.4344947338104248
globin O I-DNA 0.3006213903427124
gene O E-DNA 0.9503973126411438
expression O O 0.9930300116539001
in O O 0.9999873638153076
hAEC O S-cell_line 0.9304473400115967
. O O 0.9998700618743896
Our O O 0.9999984502792358
results O O 0.9999639987945557
demonstrate O O 0.9999991655349731
that O O 0.9999992847442627
the O O 0.9999951124191284
altered O O 0.9429901838302612
CCAAT B-DNA B-DNA 0.39729613065719604
box E-DNA E-DNA 0.9656058549880981
( O O 0.9979522228240967
CCAAC O S-DNA 0.6222377419471741

I B-protein B-protein 0.9032601118087769
kappa I-protein I-protein 0.918921172618866
B I-protein I-protein 0.7192592620849609
alpha E-protein E-protein 0.996479332447052
, O O 0.9976550340652466
I B-protein B-protein 0.9623128175735474
kappa I-protein I-protein 0.9526007771492004
B I-protein I-protein 0.7279055118560791
beta E-protein E-protein 0.9946604371070862
is O O 0.9993969202041626
constitutively O O 0.9729148745536804
phosphorylated O O 0.891626238822937
and O O 0.9953938722610474
resynthesized O O 0.9787375926971436
as O O 0.9999681711196899
a O O 0.999991774559021
hypophosphorylated B-protein B-protein 0.6393538117408752
form E-protein E-protein 0.8266879916191101
. O O 0.9998719692230225
The O O 0.9999991655349731
absence O O 0.9998832941055298
of O O 0.9999935626983643
slow O O 0.7940154671669006
migrating O O 0.9194945693016052
forms O O 0.9306800365447998
of O O 0.9999687671661377
I B-protein B-protein 0.7693979144096375
kappa I-protein I-protein 0.701693058013916
B I-protein I-protein 0.5671618580818176
beta E-protein E-protein 0.9865222573280334
following O O 0.9980936646461487
stimulation O O 0.9993323683738708
suggests O O 0.9999986886978149

the O O 0.9982537627220154
transcription B-protein B-protein 0.5532037615776062
factor I-protein E-protein 0.9661869406700134
GATA-3 E-protein S-protein 0.8869060277938843
is O O 0.9997419714927673
expressed O O 0.9998028874397278
in O O 0.9999244213104248
Th2 B-cell_line B-cell_type 0.6016314625740051
but I-cell_line I-cell_type 0.4099131226539612
not I-cell_line I-cell_type 0.4465651214122772
Th1 I-cell_line I-cell_type 0.6053290963172913
cells E-cell_line E-cell_type 0.7011367082595825
and O O 0.9904614090919495
is O O 0.9999483823776245
crucial O O 0.9999186992645264
for O O 0.9999908208847046
activation O O 0.999516487121582
of O O 0.9999910593032837
the O O 0.9999732971191406

and O O 0.9816635847091675
Western O O 0.9757028222084045
blot O O 0.981473982334137
analysis O O 0.9999344348907471
demonstrated O O 0.9999980926513672
that O O 0.9999996423721313
10 O O 0.9859493374824524
microM O O 0.9564056396484375
of O O 0.9995408058166504
C-JUN O O 0.45786574482917786
AS O O 0.7766164541244507
oligonucleotides O O 0.8793790936470032

which O O 0.9875433444976807
, O O 0.9993576407432556
when O O 0.9999427795410156
released O O 0.9995150566101074
at O O 0.9999903440475464
sites O O 0.9648064374923706
of O O 0.9996242523193359
vascular O O 0.8392313122749329
injury O O 0.9846816062927246
, O O 0.9999691247940063
affect O O 0.9999891519546509
vascular O O 0.8300387859344482
remodeling O O 0.9618304371833801
. O O 0.9999641180038452
Although O O 0.999996542930603
estrogens O O 0.8594483733177185
initiate O O 0.9997090697288513
vascular O O 0.9067007899284363
responses O O 0.9963220357894897
, O O 0.9999955892562866
genomic O O 0.9430232048034668
sex O O 0.9970876574516296
may O O 0.9999972581863403
influence O O 0.9999815225601196
and/or O O 0.9523828625679016

the O O 0.9978005290031433

i O O 0.8395798206329346
rise O O 0.9971252083778381
in O O 0.9999434947967529
Jurkat B-cell_line B-cell_line 0.578097403049469
T I-cell_line I-cell_line 0.6056117415428162
cells E-cell_line E-cell_line 0.9762054085731506
. O O 0.9999545812606812
A O O 0.999936580657959
synthetic O O 0.9479044079780579
thrombin B-protein O 0.5687484741210938
receptor E-protein O 0.8052135705947876
agonist O O 0.9418008327484131
peptide O O 0.9692204594612122
( O O 0.9985172152519226
TRP O O 0.9748559594154358
) O O 0.9982661604881287
of O O 0.9999250173568726
7 O O 0.9924556016921997
residues O O 0.9945628046989441
( O O 0.9999514818191528
SFLLRNP O O 0.9398459196090698
) O O 0.9994957447052002
was O O 0.9999942779541016
found O O 0.9999947547912598
to O O 0.9999955892562866
be O O 0.9999970197677612
as O O 0.9999957084655762
effective O O 0.9998584985733032
as O O 0.9999971389770508
thrombin S-protein S-protein 0.9568809866905212
for O O 0.9996814727783203
[ O O 0.9965404868125916
Ca2+ O O 0.9784374237060547
] O O 0.99854975938797

could O O 0.9988740086555481
involve O O 0.9999984502792358
the O O 0.9999972581863403
activation O O 0.998528242111206
of O O 0.999963641166687
PKC O S-protein 0.965836763381958
. O O 0.9999756813049316
An O O 0.9999856948852539
11-base-pair O B-DNA 0.6423395872116089
DNA O I-DNA 0.44802650809288025
sequence O I-DNA 0.5299747586250305
motif O E-DNA 0.8558720946311951

receptor E-protein E-protein 0.9541962146759033
, O O 0.9966386556625366
suggesting O O 0.9999817609786987
a O O 0.9999982118606567
physical O O 0.978065550327301
association O O 0.9939258694648743
of O O 0.999931812286377
the O O 0.9999812841415405
kinase S-protein S-protein 0.45142000913619995
with O O 0.9663993120193481
the O O 0.9981383085250854
receptor O O 0.5058352947235107
. O O 0.9979673027992249
The O O 0.9999371767044067
nuclear B-protein B-protein 0.7505442500114441

correlated O O 0.8998374938964844

the O O 0.9971101880073547
TCR S-protein S-protein 0.6668612360954285
, O O 0.9783363342285156
supported O O 0.9998389482498169
higher O O 0.997308611869812
levels O O 0.9994809031486511
of O O 0.9999885559082031
viral O O 0.7931744456291199
replication O O 0.9385467767715454
and O O 0.9983323216438293
gene O O 0.9617688059806824
expression O O 0.9983500242233276
. O O 0.9999960660934448
This O O 0.9999902248382568
was O O 0.9999686479568481
due O O 0.9999963045120239
to O O 0.9999988079071045
the O O 0.9999988079071045
presence O O 0.9998584985733032
of O O 0.9999920129776001
active O O 0.8517966270446777
NF-kappa B-protein B-protein 0.8820980787277222
B I-protein I-protein 0.7477778792381287
complexes E-protein E-protein 0.9931042790412903
in O O 0.9999706745147705
the O O 0.999992847442627
nucleus O O 0.9292519092559814
of O O 0.9994022846221924
CD45 S-protein S-protein 0.4834432005882263

regulatory I-DNA I-DNA 0.4480513036251068
elements E-DNA E-DNA 0.9960773587226868
of O O 0.9997337460517883
the O O 0.9999040365219116
human B-DNA B-DNA 0.867539644241333
IL-4 I-DNA I-DNA 0.9072584509849548
promoter E-DNA E-DNA 0.9979752898216248
. O O 0.999943733215332
A O O 0.9999778270721436
novel B-DNA O 0.9456682801246643
T I-DNA B-DNA 0.47381022572517395
cell-specific I-DNA I-DNA 0.45005184412002563
negative I-DNA I-DNA 0.7710460424423218
regulatory I-DNA I-DNA 0.9466075301170349
element E-DNA E-DNA 0.9979233741760254
( O O 0.9959760308265686
NRE S-DNA S-DNA 0.9994683861732483
) O O 0.9625060558319092
composed O O 0.9996875524520874
of O O 0.9999926090240479
two O O 0.9934240579605103
protein-binding O B-DNA 0.6367236375808716
sites O E-DNA 0.9610974788665771
were O O 0.9997937083244324
mapped O O 0.9989745616912842

of O O 0.9962600469589233
a O O 0.999950647354126
reporter B-DNA B-DNA 0.7469460368156433
gene E-DNA E-DNA 0.9635677337646484
. O O 0.9998527765274048
To O O 0.999974250793457
characterize O O 0.9984567165374756
regulatory O O 0.7781027555465698
sequences O O 0.8253788948059082
important O O 0.9993377327919006
for O O 0.9999113082885742
promoter O O 0.7335337996482849
activity O O 0.9760848879814148
, O O 0.9999895095825195
we O O 0.9999717473983765
performed O O 0.999914288520813
linker O O 0.9754191040992737
scanning O O 0.9976614713668823
analysis O O 0.9999231100082397
of O O 0.999997615814209
the O O 0.9999011754989624
92-bp B-DNA B-DNA 0.909020185470581
CD11b I-DNA I-DNA 0.7491954565048218
promoter E-DNA E-DNA 0.9895645380020142
and O O 0.9962930083274841
demonstrate O O 0.9999698400497437
that O O 0.9999980926513672
a O O 0.9999406337738037
sequence O O 0.7872013449668884
at O O 0.9980134963989258
bp O B-DNA 0.5872641801834106
-60 O E-DNA 0.8653133511543274
is O O 0.9959477782249451
essential O O 0.9999247789382935
for O O 0.9999674558639526
CD11b B-DNA S-protein 0.5215179324150085

binds O O 0.8456832766532898
Oct-1 S-protein S-protein 0.9778492450714111
and O O 0.9933386445045471
Oct-2 S-protein S-protein 0.9905780553817749
in O O 0.9996374845504761
vitro O O 0.9906152486801147
with O O 0.9999746084213257
5-fold O O 0.8644621968269348
lower O O 0.9890609979629517
affinity O O 0.9880345463752747
than O O 0.9999886751174927
the O O 0.9999936819076538
consensus B-DNA B-DNA 0.5273624658584595
octamer I-DNA I-DNA 0.5988450050354004
motif E-DNA E-DNA 0.9845476746559143
, O O 0.9969923496246338
mutation O O 0.9489409923553467
of O O 0.9996182918548584
the O O 0.999976634979248
variant O B-DNA 0.46373477578163147
octamer B-DNA I-DNA 0.5619741082191467
motif E-DNA E-DNA 0.9530473947525024
to O O 0.999701201915741
either O O 0.9999467134475708
a O O 0.9985631108283997
consensus B-DNA B-DNA 0.8975800275802612
octamer E-DNA I-DNA 0.7583944201469421
or O I-DNA 0.5913312435150146

24 O O 0.361140638589859

regulation O O 0.990575909614563

four-fold O O 0.9064438939094543
compared O O 0.9995601773262024
to O O 0.9999940395355225
the O O 0.9999922513961792
levels O O 0.9974976181983948
obtained O O 0.9999470710754395
in O O 0.9999946355819702
the O O 0.9999991655349731
absence O O 0.9998185038566589
of O O 0.9999946355819702
DM O O 0.8458482623100281
. O O 0.9999141693115234
Further O O 0.9999279975891113
, O O 0.9999898672103882
the O O 0.9999978542327881
level O O 0.999652624130249
of O O 0.9999799728393555
nuclear B-protein B-protein 0.4850006401538849
proteins E-protein E-protein 0.971760630607605
capable O O 0.9971300959587097
of O O 0.999886155128479
binding O O 0.9237421751022339
to O O 0.9948790073394775

in O O 0.999549925327301
high O O 0.9625695943832397
levels O O 0.9993751645088196
of O O 0.9999920129776001
HLA-DRA B-DNA B-DNA 0.3572901487350464
gene E-DNA E-DNA 0.9381043910980225
expression O O 0.993682861328125
, O O 0.9999785423278809
and O O 0.9999715089797974
in O O 0.9994957447052002
vitro O O 0.9835783243179321
DNA-binding O O 0.9708008766174316
studies O O 0.9994982481002808
reveal O O 0.9999992847442627
that O O 0.9999973773956299
HMG O B-protein 0.4792540669441223
I/Y S-protein E-protein 0.9330036640167236
stimulates O O 0.9995970129966736
Oct-2A S-protein S-protein 0.727357029914856
binding O O 0.5237928628921509

BCL-6 B-RNA B-RNA 0.8778447508811951
mRNA E-RNA E-RNA 0.9992927312850952
. O O 0.9996346235275269
Stimulation O O 0.9992507100105286
of O O 0.9999866485595703
mouse B-cell_type B-cell_type 0.4711192548274994
B I-cell_type I-cell_type 0.5016745328903198
cells E-cell_type E-cell_type 0.6157798171043396
with O O 0.9998225569725037
anti-IgM B-protein S-protein 0.9142234325408936
or I-protein O 0.9870093464851379
IgD I-protein B-protein 0.46538233757019043
antibodies E-protein E-protein 0.9898486733436584
, O O 0.998950719833374
bacterial O O 0.516057014465332
lipopolysaccharide O O 0.3894212245941162
, O O 0.9842779040336609
phorbol O O 0.8479143977165222
12-myristate O O 0.9420487880706787
13-acetate O O 0.889680802822113
plus O O 0.9923353791236877
ionomycin O O 0.6747531294822693
, O O 0.9990381002426147
or O O 0.99985671043396
CD40 B-protein B-protein 0.8277292251586914
ligand E-protein E-protein 0.9190194010734558
led O O 0.9997325539588928
to O O 0.9999771118164062
a O O 0.9999942779541016
five-fold O O 0.9611404538154602
to O O 0.9914981722831726

estrogen B-RNA B-protein 0.3130086064338684
receptor I-RNA I-protein 0.6139868497848511
alpha I-RNA E-protein 0.733319878578186
( I-RNA O 0.8656086325645447
ER-alpha I-RNA S-protein 0.9767950177192688
) I-RNA O 0.9489520192146301
, I-RNA O 0.9874981045722961
ER-beta I-RNA S-protein 0.9715408086776733
, I-RNA O 0.9593307971954346
and I-RNA O 0.9889582395553589
progesterone I-RNA B-RNA 0.6519927978515625
receptor I-RNA I-RNA 0.8631990551948547
( I-RNA I-RNA 0.6707885265350342
PR I-RNA I-RNA 0.8995726704597473
) I-RNA I-RNA 0.9800507426261902
mRNAs E-RNA E-RNA 0.959364116191864
; O O 0.9982665777206421
the O O 0.9999854564666748
ER-alpha S-protein S-protein 0.8293888568878174
protein O O 0.6242396235466003
expression O O 0.9780780673027039
was O O 0.9999552965164185
confirmed O O 0.9999852180480957
by O O 0.9999946355819702
immunocytochemical O O 0.8406242728233337

corresponding B-protein O 0.9461106657981873

inhibitors O O 0.7027966976165771
of O O 0.9999305009841919
NF-kappa B-protein B-protein 0.8451374769210815
B E-protein E-protein 0.9990046620368958
activation O O 0.9990047812461853
might O O 0.999997615814209
prove O O 0.9999974966049194
beneficial O O 0.9999202489852905
for O O 0.9999935626983643
the O O 0.9999920129776001
treatment O O 0.9996339082717896
of O O 0.9999972581863403
cytokine-mediated O O 0.893753170967102
inflammatory O O 0.9165451526641846
diseases O O 0.9975535273551941

DC S-cell_type S-cell_type 0.6967540979385376
can O O 0.9997982382774353
be O O 0.9999825954437256
derived O O 0.9998278617858887
from O O 0.9999945163726807
a O O 0.9998966455459595
single O O 0.9861102104187012
type O O 0.9721698760986328
of O O 0.9993768334388733
GM-CSF-responsive B-cell_type B-cell_type 0.652587890625
progenitor I-cell_type I-cell_type 0.6809954047203064
cell E-cell_type E-cell_type 0.611110508441925
. O O 0.9984675049781799
We O O 0.999991774559021
have O O 0.9999953508377075
used O O 0.9999842643737793
this O O 0.9999793767929077
MTHC B-cell_line O 0.3455621302127838
system E-cell_line O 0.6176714897155762
to O O 0.9999717473983765
analyze O O 0.9999828338623047
differences O O 0.9996111989021301
in O O 0.9999908208847046

be O O 0.9978047013282776
detected O O 0.9999476671218872
in O O 0.999967098236084
T B-cell_type B-cell_type 0.6327658891677856
rosetting I-cell_type I-cell_type 0.4761533737182617
CD4+ I-cell_type I-cell_type 0.5139341354370117
and I-cell_type I-cell_type 0.7349458336830139
CD8+ I-cell_type I-cell_type 0.8730456233024597

PML O B-RNA 0.44044914841651917
transcript O E-RNA 0.9776291847229004
and O O 0.9941897392272949
protein O O 0.70549476146698
expression O O 0.9853412508964539
in O O 0.999969482421875
a O O 0.9999901056289673
time O O 0.987993597984314
and O O 0.9987303614616394
dose-dependent O O 0.9834542274475098
manner O O 0.9985849857330322
. O O 0.9999984502792358
In O O 0.9997833371162415
situ O O 0.9772103428840637

are O O 0.9987949132919312
treated O O 0.9997387528419495
homogeneously O O 0.9995562434196472
despite O O 0.9999995231628418
the O O 0.9999998807907104
fact O O 0.9999933242797852
that O O 0.9999995231628418
only O O 0.9999592304229736
50 O O 0.9951820969581604
% O O 0.9999178647994995
of O O 0.9999979734420776
patients O O 0.9979946613311768
experience O O 0.9999940395355225
long-term O O 0.9920965433120728
disease-free O O 0.9944016337394714
survival O O 0.9998517036437988
( O O 0.9999338388442993

the O O 0.9993681311607361
reduced O O 0.9893503785133362
glutathione O O 0.8328506350517273
( O O 0.9853624105453491
GSH O O 0.7222179770469666
) O O 0.929635226726532
levels O O 0.9994699358940125
in O O 0.9999624490737915
EC S-cell_type S-cell_type 0.9714730978012085
. O O 0.9998741149902344
In O O 0.9967482089996338
vitro O O 0.9940587282180786
studies O O 0.9991353154182434
demonstrated O O 0.9999896287918091
that O O 0.9999984502792358
whereas O O 0.9999929666519165
the O O 0.9999696016311646
binding O O 0.9358804225921631
affinity O O 0.9925133585929871
of O O 0.9999585151672363
NF-kappa B-protein B-protein 0.9685471057891846
B E-protein E-protein 0.9986096620559692
to O O 0.9997840523719788
the O O 0.999890923500061
VCAM-NF-kappa B-DNA B-protein 0.5051552653312683
B I-DNA I-protein 0.40148791670799255
oligomer E-DNA E-protein 0.4622577428817749
peaked O O 0.9717960953712463
at O O 0.9999693632125854

cells O E-cell_type 0.5205050706863403

i.e O O 0.8479546308517456
. O O 0.9995142221450806
beta-casein S-protein S-protein 0.9064789414405823
, O O 0.9957577586174011
a O O 0.9997764229774475
cytokine-inducible B-protein B-protein 0.7063130140304565
SH2-containing I-protein I-protein 0.9360034465789795
protein E-protein E-protein 0.9915374517440796
( O O 0.9937276840209961
CIS S-protein S-protein 0.9837214350700378
) O O 0.9867969751358032
, O O 0.9998856782913208
and O O 0.9997819066047668
oncostatin B-protein B-protein 0.45250624418258667
M E-protein E-protein 0.9721003770828247
( O O 0.9869530200958252
OSM S-protein S-protein 0.886707603931427
) O O 0.9646856188774109
, O O 0.9999226331710815
suggesting O O 0.9999897480010986
that O O 0.9999974966049194
STAT6 O S-protein 0.9949808716773987
activated O O 0.9968324303627014
by O O 0.9999498128890991
IL-4 S-protein S-protein 0.907722532749176
substitutes O O 0.8474164009094238
for O O 0.9998113512992859
the O O 0.99998939037323
function O O 0.9991601705551147
of O O 0.9999821186065674
STAT5 S-protein S-protein 0.9949017763137817
in O O 0.9997548460960388
T B-cell_type B-cell_type 0.923874020576477
cells E-cell_type E-cell_type 0.9934791326522827
. O O 0.9995847344398499
IL-2 S-protein S-protein 0.9948902130126953
-induced O O 0.9935709238052368
beta-casein S-protein S-protein 0.7219894528388977

antisense O O 0.5627463459968567
orientation O O 0.5451010465621948
( O O 0.9913626313209534
tat/AS S-DNA S-protein 0.4386676549911499
) O O 0.9041067361831665
, O O 0.999064028263092
tat S-DNA S-protein 0.39349424839019775
carrying O O 0.9803324937820435
a O O 0.9996127486228943
mutation O O 0.9566057920455933
in O O 0.9999163150787354
the O O 0.9999091625213623
aminoacid B-protein B-protein 0.3748944401741028
cys22-gly22 E-protein E-protein 0.5650163292884827
( O O 0.8510332107543945
tat B-DNA B-protein 0.6089985370635986
22/S E-DNA E-protein 0.554690420627594
) O O 0.6079912185668945
or O O 0.8506522178649902
with O O 0.9983439445495605
the O O 0.9998683929443359
backbone B-DNA B-DNA 0.4336584806442261
vector I-DNA E-DNA 0.7562841176986694
alone E-DNA O 0.7955229878425598
( O O 0.9919484853744507
pRPneo-SL3 S-DNA S-DNA 0.7603572010993958
) O O 0.9562594294548035
did O O 0.9999072551727295
not O O 0.9999918937683105
show O O 0.999997615814209
any O O 0.9999979734420776
significant O O 0.9998192191123962
difference O O 0.999987006187439

) O O 0.7676184177398682
, O O 0.9868914484977722
peptides O O 0.7622671127319336
, O O 0.999660849571228
use O O 0.9992368221282959
of O O 0.9999799728393555
stabilizers O O 0.9110370874404907
like O O 0.9974238872528076
beta B-protein B-protein 0.5185526013374329
2-m E-protein E-protein 0.9900874495506287
are O O 0.9993840456008911
still O O 0.9999268054962158
needed O O 0.9999697208404541
. O O 0.9999939203262329
OCA-B S-protein S-protein 0.9768220782279968
is O O 0.999900221824646
a O O 0.9999946355819702
functional O O 0.9819539785385132
analog O O 0.9008914232254028
of O O 0.9991673231124878
VP16 S-protein S-protein 0.8729414939880371
but O O 0.9982609152793884
targets O O 0.9998737573623657
a O O 0.9999959468841553
separate O O 0.9732015132904053
surface O O 0.9709106683731079
of O O 0.999613344669342
the O O 0.99996018409729
Oct-1 B-protein B-protein 0.6209586262702942
POU I-protein I-protein 0.7225727438926697
domain E-protein E-protein 0.8791763782501221
[ O O 0.9905187487602234
published O O 0.9809911251068115
erratum O O 0.7744147777557373
appears O O 0.9993964433670044
in O O 0.9999845027923584
Mol O O 0.8348265886306763
Cell O O 0.9432010054588318
Biol O O 0.9939242005348206
1998 O O 0.9991313815116882
Apr O O 0.9981441497802734
; O O 0.9998753070831299
18 O O 0.9977467656135559
( O O 0.9997934699058533
4 O O 0.9954984188079834
) O O 0.9988466501235962

highest O O 0.907850444316864
activity O O 0.996250569820404
. O O 0.9999967813491821
These O O 0.9999978542327881
results O O 0.9999699592590332
demonstrate O O 0.9999990463256836
the O O 0.9999994039535522
selective O O 0.996166467666626
role O O 0.9994361996650696
of O O 0.9999798536300659
GATA-4 S-protein S-protein 0.9804361462593079
in O O 0.9999533891677856
the O O 0.9999769926071167
transcriptional O O 0.9398254156112671
regulation O O 0.9982245564460754
of O O 0.9999798536300659

( O O 0.9760091304779053
n O O 0.9277241826057434
= O O 0.9964723587036133
7 O O 0.9934431314468384
) O O 0.999383807182312
. O O 0.9999967813491821
Postoperatively O O 0.988084614276886
, O O 0.9997995495796204
blood O O 0.868809163570404
was O O 0.9981306195259094
taken O O 0.9999758005142212
as O O 0.9999855756759644
well O O 0.9996839761734009
in O O 0.9999918937683105
order O O 0.9995167255401611
to O O 0.9999964237213135
compare O O 0.9999769926071167
pre- O O 0.9710810780525208
and O O 0.988994300365448
postoperative O O 0.989693820476532
values O O 0.9989439845085144
. O O 0.9999974966049194
Eicosanoids O S-cell_type 0.8748044371604919
were O O 0.9997009038925171
measured O O 0.9996147155761719
in O O 0.9998989105224609
peripheral B-cell_type B-cell_type 0.5734208822250366
blood I-cell_type I-cell_type 0.8550329804420471
monocytes E-cell_type E-cell_type 0.9865244626998901
and O O 0.998884379863739
mammary O O 0.670326292514801
tissue O O 0.9383870959281921

in O O 0.9989437460899353
nuclear O O 0.9724818468093872
extracts O O 0.9959211349487305
from O O 0.9999971389770508
hypoxic B-cell_type O 0.7544957995414734
ECs E-cell_type S-cell_type 0.6855933666229248
for O O 0.9990780353546143
the O O 0.9999819993972778
NF-kB O B-DNA 0.6758224964141846
site O E-DNA 0.9791568517684937
. O O 0.9999483823776245
Studies O O 0.999955415725708
with O O 0.9999940395355225
human O O 0.6800693273544312
umbilical O O 0.6274932026863098
vein O O 0.32658353447914124
segments O O 0.530602753162384
exposed O O 0.9992566704750061
to O O 0.9999556541442871
hypoxia O O 0.9836169481277466
also O O 0.9999063014984131
demonstrated O O 0.999967098236084

stabilization O O 0.9938992261886597
of O O 0.9999799728393555
the O O 0.9999924898147583
DNA-bound B-protein B-protein 0.6516868472099304
multi-protein I-protein I-protein 0.8364976644515991
complexes E-protein E-protein 0.9987402558326721
. O O 0.9999520778656006
We O O 0.9999784231185913
show O O 0.999996542930603
, O O 0.9999867677688599
however O O 0.9999896287918091
, O O 0.9999969005584717
that O O 0.9999986886978149
the O O 0.9999964237213135
presence O O 0.9995267391204834
of O O 0.9999771118164062
CIITA S-protein S-protein 0.8830476999282837
does O O 0.999841570854187
not O O 0.9999899864196777
affect O O 0.9999986886978149
the O O 0.9999951124191284
stability O O 0.9999266862869263
of O O 0.9999951124191284

. O O 0.9983533620834351
To O O 0.9999816417694092
identify O O 0.9999852180480957
such O O 0.9994743466377258
target B-DNA B-DNA 0.62623131275177
genes E-DNA E-DNA 0.9646695256233215
, O O 0.9997366070747375
we O O 0.9999743700027466
established O O 0.9992290735244751
Egr-1-overexpressing B-cell_line B-cell_line 0.6119722127914429
transfectants E-cell_line E-cell_line 0.9509318470954895
from O O 0.9997591376304626
the O O 0.9999673366546631
murine B-cell_line B-cell_line 0.5502013564109802
B I-cell_line I-cell_line 0.7254841923713684
cell I-cell_line I-cell_line 0.9122507572174072
line I-cell_line I-cell_line 0.8142537474632263
K46 E-cell_line E-cell_line 0.9608073234558105
and O O 0.9959487915039062
from O O 0.9998138546943665
human B-cell_line B-cell_line 0.3917296230792999
Ramos I-cell_line I-cell_line 0.6672521829605103
B I-cell_line I-cell_line 0.765433132648468
cells E-cell_line E-cell_line 0.8678125143051147
. O O 0.999881386756897
All O O 0.9994460940361023
clones O O 0.8909251093864441
derived O O 0.9999268054962158
from O O 0.9999861717224121
K46 B-cell_line B-cell_line 0.7036839723587036
B I-cell_line I-cell_line 0.7219896912574768
cells E-cell_line E-cell_line 0.8950860500335693
showed O O 0.9999754428863525
increased O O 0.9997444748878479
expression O O 0.9995966553688049
of O O 0.9999852180480957
CD44 S-protein S-protein 0.8736628293991089
. O O 0.9998072981834412
Most O O 0.999882698059082
interestingly O O 0.9839941263198853
, O O 0.9997076392173767
expression O O 0.9996436834335327
of O O 0.9999823570251465

to O O 0.9929365515708923

containing O O 0.993073582649231
the O O 0.999778687953949
Y292 O B-DNA 0.4825288653373718
, O I-DNA 0.48692405223846436
Y315 O I-DNA 0.6829676628112793
, O I-DNA 0.819774329662323
and O I-DNA 0.743120551109314
Y319 O I-DNA 0.8527176380157471
sites O E-DNA 0.9885420799255371
, O O 0.9986101388931274
did O O 0.9999781847000122
not O O 0.9999876022338867
eliminate O O 0.9999842643737793
the O O 0.9999908208847046
ability O O 0.9998914003372192
of O O 0.9999902248382568
ZAP-70 S-protein S-protein 0.937751054763794
to O O 0.9996974468231201
induce O O 0.9999961853027344
multiple B-DNA O 0.9173430800437927
gene I-DNA O 0.8706299066543579
reporters E-DNA O 0.4881763756275177
in O O 0.9999274015426636
Syk-deficient B-cell_line B-cell_line 0.862690806388855
DT-40 I-cell_line I-cell_line 0.889744758605957
B I-cell_line I-cell_line 0.9535262584686279
cells E-cell_line E-cell_line 0.9933956265449524
and O O 0.9961517453193665
ZAP-70/Syk-deficient B-cell_line B-cell_line 0.857928454875946
Jurkat I-cell_line I-cell_line 0.8672000169754028
cells E-cell_line E-cell_line 0.9944597482681274
. O O 0.999832272529602

acute O O 0.8487904667854309
promyelocytic O O 0.8603425025939941
leukaemia O O 0.9635701775550842
treated O O 0.9998168349266052
with O O 0.999993085861206
all-trans O O 0.9571162462234497
retinoic O O 0.9320786595344543
acid O O 0.979404091835022
: O O 0.9995638728141785
molecular O O 0.9762638807296753
analysis O O 0.9995423555374146
of O O 0.9999954700469971
the O O 0.9999576807022095
cell O O 0.8866175413131714
origin O O 0.9182184934616089
of O O 0.9997480511665344
the O O 0.9999591112136841
basophils S-cell_type S-cell_type 0.9823180437088013
. O O 0.9998635053634644
We O O 0.9999854564666748
report O O 0.9999980926513672
a O O 0.9999985694885254
patient O O 0.9917784333229065
with O O 0.9999289512634277
acute O O 0.9343904256820679
promyelocytic O O 0.9415319561958313
leukaemia O O 0.9782297611236572
who O O 0.9998482465744019
developed O O 0.9996626377105713
marked O O 0.9908972382545471
basophilia O O 0.9199777245521545
during O O 0.9999865293502808
all-trans O O 0.9736497402191162
retinoic O O 0.9549881219863892
acid O O 0.9747690558433533
treatment O O 0.9994739890098572

p65 E-protein S-protein 0.8773894309997559
disrupts O O 0.9996053576469421
its O O 0.9999877214431763
ability O O 0.9998877048492432
to O O 0.9999780654907227
engage O O 0.9988975524902344
I B-protein B-protein 0.9127429723739624
kappa I-protein I-protein 0.907941997051239
B/MAD-3 E-protein E-protein 0.9232128262519836
, O O 0.9313275814056396
and O O 0.990281343460083
4 O O 0.9692632555961609
) O O 0.9979002475738525
the O O 0.9999767541885376
unique O O 0.8321553468704224
C-terminus S-protein S-protein 0.48900243639945984
of O O 0.9890031218528748
NF-kappa B-protein B-protein 0.7819306254386902
B I-protein I-protein 0.897489070892334
p65 E-protein E-protein 0.958341658115387
attenuates O O 0.9984959363937378
its O O 0.9999232292175293
own O O 0.9900319576263428
nuclear O O 0.7423145771026611
localization O O 0.811296284198761
and O O 0.9849350452423096
contains O O 0.9994767308235168
sequences O O 0.9668643474578857
that O O 0.9999508857727051
are O O 0.9999860525131226
required O O 0.9999111890792847
for O O 0.9999825954437256
I B-protein B-protein 0.8325151205062866
kappa I-protein I-protein 0.8679432272911072
B E-protein E-protein 0.9991394281387329
-mediated O O 0.9948045611381531
inhibition O O 0.9987903237342834
of O O 0.9999920129776001
NF-kappa B-protein B-protein 0.606867253780365
B I-protein I-protein 0.920950174331665
p65 E-protein E-protein 0.5427330136299133
DNA O O 0.3629506230354309
binding O O 0.46338802576065063

the O O 0.9979648590087891
IL-2 B-DNA B-DNA 0.5864267945289612
promoter E-DNA E-DNA 0.9945991039276123
. O O 0.9998132586479187
We O O 0.9999902248382568
report O O 0.9999985694885254
that O O 0.9999990463256836
a O O 0.9999853372573853
constitutively O O 0.781295657157898
active O O 0.8542028665542603
form O O 0.810883641242981
of O O 0.9979358911514282
calcineurin S-protein S-protein 0.9794433116912842
partially O O 0.9949144124984741
substitutes O O 0.9994751811027527
for O O 0.9999799728393555
the O O 0.9999823570251465
Ca2+ O O 0.7433597445487976
co-stimulus O O 0.6401922702789307
required O O 0.994906485080719

, O O 0.995219886302948
the O O 0.9999868869781494
fragment O O 0.7706966996192932
spanning O O 0.9967411160469055
nucleotides B-DNA B-DNA 0.8024342656135559
-158 I-DNA I-DNA 0.70685213804245
to I-DNA I-DNA 0.8014439344406128
-90 E-DNA E-DNA 0.9464814066886902
was O O 0.999283492565155
required O O 0.9999902248382568
for O O 0.9999955892562866
optimal O O 0.9349306225776672
transcription O O 0.9703837037086487
in O O 0.999941349029541
monocytic B-cell_type B-cell_type 0.6271263957023621

by O O 0.9990444779396057
which O O 0.9999864101409912
IL-10 S-protein S-protein 0.9964499473571777
downregulates O O 0.9995088577270508
expression O O 0.9928855299949646
of O O 0.9999455213546753
intercellular B-protein B-protein 0.5012486577033997
adhesion I-protein I-protein 0.7234578728675842
molecule-1 E-protein E-protein 0.9974161386489868
( O O 0.9862334728240967
ICAM-1 S-protein S-protein 0.9947604537010193
) O O 0.9925529360771179
on O O 0.999982476234436
the O O 0.9999880790710449
cell O O 0.8333621025085449
surface O O 0.943647563457489
of O O 0.9996172189712524
normal B-cell_type B-cell_type 0.48915132880210876
human I-cell_type I-cell_type 0.7343392372131348
monocytes E-cell_type E-cell_type 0.9748532176017761
activated O O 0.9905619025230408
with O O 0.99991774559021
interferon-gamma S-protein S-protein 0.9664889574050903
( O O 0.9773502349853516
IFN-gamma S-protein S-protein 0.9901633858680725
) O O 0.9671288728713989

are O O 0.9992904663085938
subject O O 0.9992523789405823
to O O 0.9999858140945435
direct O O 0.9927419424057007
CTL O O 0.5947754979133606
control O O 0.9879934787750244
in O O 0.9999396800994873
vivo O O 0.997268557548523
and O O 0.9998949766159058
that O O 0.9999974966049194
immediate B-protein B-protein 0.8775433301925659
early I-protein I-protein 0.7572336792945862
and I-protein I-protein 0.8878791928291321
early I-protein I-protein 0.580021858215332
proteins E-protein E-protein 0.9907446503639221
are O O 0.999942421913147
frequently O O 0.9998645782470703
the O O 0.9999936819076538
immunodominant O O 0.680807888507843
targets O O 0.5741182565689087
. O O 0.999955415725708
This O O 0.9999903440475464
contrasts O O 0.999950647354126
with O O 0.9999990463256836
findings O O 0.9997512698173523
in O O 0.9999896287918091
alpha- O O 0.849789023399353
and O O 0.9654364585876465
beta- O O 0.958257257938385
herpesvirus O O 0.877302348613739
systems O O 0.9272730350494385
( O O 0.9998806715011597
herpes O O 0.9014667868614197
simplex O O 0.8486441969871521
, O O 0.99856036901474
cytomegalovirus O O 0.7343729734420776
) O O 0.9937942028045654
where O O 0.9999645948410034
viral O O 0.9545643925666809
interference O O 0.9969918727874756
with O O 0.999996542930603
the O O 0.9999918937683105
antigen-processing O O 0.8640737533569336
pathway O O 0.9982374906539917
during O O 0.999982476234436
lytic O O 0.9443832635879517
infection O O 0.9912562370300293
renders O O 0.9997888207435608

than O O 0.9946388602256775
0.05 O O 0.9315158128738403
, O O 0.999133288860321
P O O 0.9123678207397461
less O O 0.999679684638977
than O O 0.9999719858169556
0.01 O O 0.9739131331443787
and O O 0.9997550845146179
P O O 0.8739582896232605
less O O 0.9991936087608337
than O O 0.9999746084213257
0.01 O O 0.9746493101119995
compared O O 0.9998397827148438
with O O 0.999956488609314
control O O 0.9841921329498291
) O O 0.999595582485199
. O O 0.9999969005584717
Thus O O 0.999997615814209
the O O 0.9999988079071045
inhibitory O O 0.9639860987663269
effect O O 0.9998711347579956
of O O 0.9999963045120239
insulin S-protein O 0.7434210181236267
on O O 0.9998810291290283
the O O 0.9999610185623169
GR S-protein S-protein 0.7918482422828674
binding O O 0.9098663330078125
power O O 0.9801208972930908
is O O 0.9999746084213257
both O O 0.9999979734420776
dose- O O 0.9675307869911194
and O O 0.9871709942817688
time-dependent O O 0.9881369471549988
, O O 0.9998921155929565
which O O 0.9999836683273315
strongly O O 0.9997952580451965
suggests O O 0.999992847442627
that O O 0.9999955892562866
GR S-protein S-protein 0.9883558750152588
is O O 0.9998515844345093
tonically O O 0.985173225402832
controlled O O 0.9996160268783569
by O O 0.9999988079071045
insulin S-protein O 0.4233635365962982

tissues O O 0.8751509189605713
, O O 0.9995157718658447
where O O 0.9999485015869141
B O B-cell_type 0.7113487720489502
cells O E-cell_type 0.9843187928199768
are O O 0.9996227025985718
activated O O 0.9553854465484619
, O O 0.9964097142219543
differentiated O O 0.9163383841514587
, O O 0.9948699474334717
and O O 0.9991829991340637
proliferated O O 0.72234708070755
, O O 0.9759712815284729
or O O 0.9974212646484375
if O O 0.9999535083770752
the O O 0.9997852444648743
lymphocytes O S-cell_type 0.9929896593093872
are O O 0.998843789100647
merely O O 0.9993599057197571
infiltrated O O 0.9995263814926147
after O O 0.9999945163726807
recruitment O O 0.9992440938949585
from O O 0.9999990463256836
the O O 0.9999767541885376
secondary O O 0.9592642784118652
lymphoid O O 0.8391452431678772
organs O O 0.8836737275123596
. O O 0.9999765157699585
To O O 0.9999871253967285
ascertain O O 0.9999337196350098

expression O O 0.9724651575088501
was O O 0.9999434947967529
blocked O O 0.9999639987945557
at O O 0.9999990463256836
the O O 0.9999994039535522
transcriptional O O 0.9392227530479431
level O O 0.9986756443977356
by O O 0.9999979734420776
okadaic O O 0.9897052645683289
acid O O 0.9984484910964966
. O O 0.9999979734420776
The O O 0.9999957084655762
transcription B-protein B-protein 0.5167486667633057
factors E-protein E-protein 0.9959575533866882
active O O 0.9972625970840454
at O O 0.999995231628418
the O O 0.9999935626983643
IL-2 B-DNA B-DNA 0.5821324586868286
promoter E-DNA E-DNA 0.9944431185722351
were O O 0.9997897744178772
differentially O O 0.9957846999168396
influenced O O 0.9998369216918945
: O O 0.9999659061431885
upon O O 0.9984769225120544
down-modulation O O 0.9877600073814392

in O O 0.997896671295166

necrosis I-protein I-protein 0.5830532908439636
factor-alpha E-protein E-protein 0.9914108514785767
( O O 0.9864610433578491
TNF-alpha S-protein S-protein 0.996956467628479
) O O 0.9928181171417236
induces O O 0.9999749660491943
NF B-protein B-protein 0.7835626006126404
kappaB E-protein E-protein 0.9972370862960815
activation O O 0.9965648055076599
that O O 0.999990701675415
is O O 0.9999836683273315
inhibited O O 0.999901533126831
by O O 0.9999974966049194
PDTC O O 0.9735637903213501
. O O 0.9999954700469971
Contrary O O 0.9999690055847168
to O O 0.9999967813491821
the O O 0.9999979734420776
results O O 0.9998186230659485
in O O 0.9999698400497437
Jurkat B-cell_line B-cell_line 0.8257994055747986
cells E-cell_line E-cell_line 0.9948857426643372
, O O 0.9996696710586548
PDTC O O 0.49270349740982056
did O O 0.9987843632698059
not O O 0.999970555305481
inhibit O O 0.9998857975006104
tumor B-protein B-protein 0.4502585232257843
necrosis I-protein I-protein 0.8431695699691772
factor-alpha E-protein E-protein 0.9951422214508057
-induced O O 0.9920161962509155

protein O E-protein 0.9336634874343872
( O O 0.9739307761192322
s O O 0.9410240054130554
) O O 0.9725608825683594
. O O 0.9999744892120361
Bacterially O O 0.5443382859230042
expressed O O 0.7118051648139954
RP1 B-protein B-protein 0.5844870805740356
protein E-protein E-protein 0.9875764846801758
revealed O O 0.999573290348053
specific O O 0.9767845273017883
binding O O 0.9177595973014832
to O O 0.9967681169509888
wild-type S-protein O 0.3620443344116211
but O O 0.49747639894485474
not O O 0.6235978007316589
to O O 0.9397115111351013
mutated B-protein O 0.7700571417808533
APC I-protein B-protein 0.3304232656955719
protein E-protein E-protein 0.9902419447898865
. O O 0.9998868703842163
The O O 0.9999990463256836
rapid O O 0.9671568870544434
up-regulation O O 0.9973018169403076
of O O 0.9999371767044067
RP1 B-RNA B-RNA 0.9879981279373169
mRNA E-RNA E-RNA 0.9983080625534058
in O O 0.9995245933532715
properly O B-cell_type 0.6169756054878235
activated B-cell_type I-cell_type 0.5892856121063232
T I-cell_type I-cell_type 0.4707017242908478
cells E-cell_type E-cell_type 0.8923496603965759
suggests O O 0.9998286962509155
that O O 0.9999986886978149
this O O 0.9999710321426392
gene O O 0.9701358079910278

We O O 0.997859537601471
have O O 0.9999843835830688
therefore O O 0.9999645948410034
investigated O O 0.9999948740005493
the O O 0.9999955892562866
transcriptional O O 0.9034608602523804
activity O O 0.9927870631217957
of O O 0.9999606609344482
A-MYB S-protein S-protein 0.8765917420387268
and O O 0.9963401556015015
its O O 0.9998218417167664
regulation O O 0.9981433153152466
in O O 0.9999954700469971
several O O 0.999065101146698
human B-cell_line B-cell_line 0.5762244462966919
lymphoid I-cell_line I-cell_line 0.7642329931259155
cell I-cell_line I-cell_line 0.8900725245475769
lines E-cell_line E-cell_line 0.998591959476471
using O O 0.999707043170929
co-transfection O O 0.8733567595481873
assays O O 0.9780781865119934
and O O 0.9998995065689087
show O O 0.9999908208847046
that O O 0.9999979734420776
A-MYB S-protein S-protein 0.8259698748588562
is O O 0.9997808337211609
transcriptionally O O 0.9797075986862183
active O O 0.9981671571731567
in O O 0.9999895095825195
all O O 0.9999736547470093
the O O 0.9997971653938293
B B-cell_line B-cell_line 0.741825520992279
cell I-cell_line I-cell_line 0.8502453565597534
lines E-cell_line E-cell_line 0.9972503781318665
studied O O 0.9996333122253418

grouped O O 0.9512785077095032

kinases O E-protein 0.9617756009101868
that O O 0.9942100048065186
are O O 0.9999840259552002
activated O O 0.9979945421218872
by O O 0.999994158744812
the O O 0.9996662139892578
IL-3/IL-5/GM-CSF B-protein B-protein 0.4860144853591919
receptor I-protein I-protein 0.48231184482574463
beta-subunit E-protein E-protein 0.9726042747497559
in O O 0.9974104762077332
eosinophils S-cell_type S-cell_type 0.9989814162254333
. O O 0.9998278617858887
This O O 0.999992847442627
review O O 0.9986979961395264
will O O 0.9999939203262329
concentrate O O 0.9999866485595703
on O O 0.9999867677688599
this O O 0.9999954700469971
topic O O 0.9989534616470337
and O O 0.9999769926071167
on O O 0.999970555305481
its O O 0.9999934434890747
role O O 0.9995532631874084

to O O 0.9966243505477905
TFIIIB S-protein S-protein 0.6373257040977478
is O O 0.9992030262947083
required O O 0.9998037219047546
for O O 0.9999912977218628
the O O 0.9999817609786987
transcription O O 0.951192319393158
of O O 0.9996707439422607
class B-DNA B-DNA 0.4347659945487976
III I-DNA I-DNA 0.7448238730430603
snRNA I-DNA I-DNA 0.9162279367446899
genes E-DNA E-DNA 0.9935511350631714
, O O 0.9984900951385498
and O O 0.999942421913147
acts O O 0.9979326725006104
through O O 0.9999769926071167
weak O O 0.9792376756668091
interaction O O 0.9982489347457886
with O O 0.9999949932098389
the O O 0.9998879432678223
four-subunit B-protein O 0.46175920963287354
PTF E-protein S-protein 0.4235534369945526
. O O 0.9953346848487854
Attenuated O O 0.9312363862991333
function O O 0.9909782409667969
of O O 0.9997792840003967
a O O 0.9999526739120483
variant O O 0.9038974046707153

, O O 0.9312350153923035
13-dihydrohelenalin O O 0.5118785500526428
, O O 0.9869855046272278
chamissonolid O O 0.8291733264923096
and O O 0.9962700605392456
their O O 0.9998279809951782
ester O O 0.8379338979721069
derivatives O O 0.9621132612228394
. O O 0.9999715089797974
While O O 0.9999990463256836
these O O 0.9999725818634033
compounds O O 0.9906306862831116
affect O O 0.9999955892562866
various O O 0.997787594795227
cellular O O 0.912415623664856
processes O O 0.9870060682296753
, O O 0.9999954700469971
current O O 0.9941051006317139
data O O 0.996877908706665
do O O 0.9999958276748657
not O O 0.9999896287918091
fully O O 0.9999505281448364
explain O O 0.9999947547912598
how O O 0.9999939203262329
sesquiterpene O O 0.6658890843391418
lactones O O 0.3713000416755676
exert O O 0.9993641972541809

apoptosis O O 0.9791602492332458
by O O 0.9999778270721436
obligatory O O 0.900420069694519
heterodimerization O O 0.9504357576370239
with O O 0.9998024106025696
Max S-protein S-protein 0.9380602240562439
, O O 0.9925596714019775
and O O 0.9990527033805847
therefore O O 0.9998432397842407
, O O 0.9999240636825562
by O O 0.9999717473983765
regulating O O 0.9850085973739624
gene O O 0.8812568187713623
transcription O O 0.9781451225280762
. O O 0.9998944997787476
Epstein-Barr B-protein B-protein 0.7829536199569702
virus I-protein I-protein 0.6461824774742126
SM I-protein I-protein 0.8030653595924377
protein E-protein E-protein 0.9066579341888428

We O O 0.998863935470581
investigated O O 0.9999911785125732
the O O 0.999998927116394
hypothesis O O 0.998223602771759
that O O 0.9999959468841553
polymorphic O O 0.7656359672546387
nucleotides O O 0.5777737498283386
within O O 0.9999380111694336
the O O 0.9999688863754272
IL-10 B-DNA B-DNA 0.5127483606338501
and I-DNA I-DNA 0.586194634437561
TGF-beta I-DNA I-DNA 0.7980633974075317
gene I-DNA I-DNA 0.5265442132949829
promoters E-DNA E-DNA 0.9983160495758057
would O O 0.99993896484375
link O O 0.9999332427978516
to O O 0.9999929666519165
the O O 0.9999706745147705
expression O O 0.9981375932693481
of O O 0.9999746084213257
allergies O O 0.9603129029273987
and O O 0.9984116554260254
asthma O O 0.9939258694648743
. O O 0.9999794960021973
DNA O O 0.9681552052497864
taken O O 0.9999325275421143
from O O 0.9999874830245972
families O O 0.9819677472114563
with O O 0.9999488592147827
an O O 0.999948263168335
asthmatic O O 0.851165771484375
proband O O 0.3722915053367615
was O O 0.9991769194602966
examined O O 0.9999619722366333
for O O 0.9999957084655762
base O O 0.947226881980896
exchanges O O 0.9881721138954163
by O O 0.9999994039535522
single-stranded O O 0.8411036729812622
conformational O O 0.8340103030204773
polymorphism O O 0.8915524482727051
( O O 0.9976475834846497
SSCP O O 0.9845907688140869
) O O 0.9998268485069275
. O O 0.999998927116394
We O O 0.9999933242797852
demonstrated O O 0.999990701675415
the O O 0.999998927116394
presence O O 0.9998927116394043
of O O 0.9999960660934448
a O O 0.9999821186065674
polymorphism O O 0.9034252762794495
in O O 0.9998750686645508
the O O 0.999974250793457
promoter B-DNA O 0.7749126553535461

. O O 0.9954484105110168

. O O 0.998528242111206
Control O O 0.9935702085494995
of O O 0.9999034404754639
cell O O 0.8484565615653992
cycle O O 0.891252338886261
entry O O 0.9425309896469116
and O O 0.9995734095573425
apoptosis O O 0.980911374092102
in O O 0.9998041987419128
B B-cell_type B-cell_type 0.7224999070167542
lymphocytes E-cell_type E-cell_type 0.989730954170227
infected O O 0.9975428581237793
by O O 0.9999938011169434
Epstein-Barr O O 0.9313674569129944
virus O O 0.9653325080871582
. O O 0.9999639987945557
Infection O O 0.9941413998603821
of O O 0.9999158382415771
human B-cell_type B-cell_type 0.5729540586471558
B I-cell_type I-cell_type 0.8190462589263916

to O O 0.9987090826034546
activate O O 0.9980831146240234
Tcf-dependent O O 0.31772056221961975
transcription O O 0.5290996432304382
in O O 0.9958261847496033
T B-cell_type B-cell_type 0.7063660621643066
lymphocytes E-cell_type E-cell_type 0.9869957566261292
. O O 0.9998894929885864
In O O 0.9999781847000122
contrast O O 0.9999234676361084
, O O 0.9999819993972778
in O O 0.9997554421424866
C57MG B-cell_line B-cell_line 0.5515647530555725
fibroblast I-cell_line I-cell_line 0.5622783899307251
cells E-cell_line E-cell_line 0.8877753615379333
, O O 0.999606192111969
lithium O O 0.9283774495124817
inactivates O O 0.9970377683639526
GSK-3beta S-protein S-protein 0.9140664339065552
and O O 0.9923882484436035
induces O O 0.9996961355209351
Tcf-controlled O O 0.665515661239624
transcription O O 0.8500756621360779
. O O 0.9997304081916809
This O O 0.9999953508377075
is O O 0.9999908208847046
the O O 0.9999991655349731
first O O 0.9998390674591064
demonstration O O 0.9996213912963867
that O O 0.999998927116394
lithium O O 0.9474523067474365
can O O 0.999727189540863
alter O O 0.9995410442352295
gene O O 0.9741814136505127
expression O O 0.998939573764801
of O O 0.9999886751174927
Tcf-responsive B-DNA B-DNA 0.7122166752815247
genes E-DNA E-DNA 0.9911342859268188
, O O 0.9970638155937195
and O O 0.9998992681503296
points O O 0.9993466734886169
to O O 0.9999939203262329
a O O 0.9999933242797852
difference O O 0.9999165534973145
in O O 0.9999773502349854
regulation O O 0.999459445476532
of O O 0.9999889135360718
Wnt O S-protein 0.39711993932724
signaling O O 0.7003197073936462
between O O 0.9890618920326233
fibroblasts S-cell_type S-cell_type 0.9941131472587585
and O O 0.9954643845558167

; O O 0.9708940386772156
and O O 0.9985930323600769
at O O 0.9999889135360718
48 O O 0.9905791878700256
hours O O 0.999695897102356
, O O 0.9999804496765137
levels O O 0.999914288520813
were O O 0.9999972581863403
increased O O 0.9998993873596191
by O O 0.9999949932098389
5.1-fold O O 0.9998489618301392
. O O 0.9999904632568359

for O O 0.9967376589775085
the O O 0.9999779462814331
activation O O 0.995832622051239
of O O 0.9999353885650635
proIL-1beta B-DNA B-DNA 0.2975640892982483
gene E-DNA E-DNA 0.9444552659988403
transcription O O 0.9459646940231323
. O O 0.9999785423278809
Copyright O O 0.9869393110275269
1999 O O 0.9902770519256592
Academic O O 0.9967299699783325
Press O O 0.9969698786735535
. O O 0.9999922513961792
N-acetyl-L-cysteine O O 0.6188071370124817
inhibits O O 0.9979769587516785
primary O O 0.5980425477027893
human O O 0.5726087689399719
T O O 0.6644613742828369
cell O O 0.5181367993354797
responses O O 0.7761715650558472
at O O 0.9999755620956421
the O O 0.999997615814209
dendritic O O 0.5200501680374146
cell O O 0.3561899960041046
level O O 0.9683375954627991
: O O 0.999717652797699

population O O 0.6410952806472778
of O O 0.9987701773643494
immature B-cell_type B-cell_type 0.6320885419845581
thymocytes E-cell_type E-cell_type 0.8832210898399353
, O O 0.9978760480880737
T B-cell_line B-cell_line 0.4681117832660675
lymphoblastoid I-cell_line I-cell_line 0.7014746069908142
cell I-cell_line I-cell_line 0.9220622777938843
lines E-cell_line E-cell_line 0.9961124062538147
, O O 0.9948145747184753
and O O 0.9996713399887085
childhood B-cell_type B-cell_type 0.45032063126564026
acute I-cell_type I-cell_type 0.3764001429080963
T I-cell_type I-cell_type 0.3812488317489624
lymphoblastic I-cell_type I-cell_type 0.5923659801483154
leukemia I-cell_type I-cell_type 0.7133438587188721
cells E-cell_type E-cell_type 0.5690703392028809
suggested O O 0.9998559951782227
that O O 0.9999985694885254
EBV-receptor O O 0.7100247144699097
interactions O O 0.9858742952346802
on O O 0.9999799728393555
T B-cell_type B-cell_type 0.8382862210273743

for O O 0.9948549270629883

alpha I-DNA I-DNA 0.312578409910202
enhancer E-DNA E-DNA 0.997835099697113
. O O 0.9999765157699585
The O O 0.9999902248382568
human B-protein B-protein 0.42998573184013367
T I-protein I-protein 0.31519004702568054
cell-specific I-protein I-protein 0.5872999429702759
transcription I-protein I-protein 0.6887791156768799
factor E-protein E-protein 0.9367209672927856
TCF-1 B-protein B-protein 0.7102264165878296
alpha E-protein E-protein 0.9944992065429688
plays O O 0.999573290348053
a O O 0.9999775886535645
key O O 0.9973994493484497
role O O 0.9999338388442993
in O O 0.9999979734420776
the O O 0.9999954700469971
tissue-specific O O 0.9417304396629333
activation O O 0.9871413707733154
of O O 0.9998393058776855
the O O 0.9999170303344727
T B-protein B-protein 0.41327065229415894
cell I-protein I-protein 0.6097479462623596
receptor E-protein E-protein 0.8800167441368103
( O O 0.82780522108078
TCR S-protein S-protein 0.7204023599624634

, O O 0.9736445546150208
and O O 0.9993537068367004
this O O 0.9999889135360718
effect O O 0.999828577041626
closely O O 0.9993785619735718
correlated O O 0.9999500513076782
with O O 0.9999971389770508
inhibition O O 0.997366726398468
of O O 0.9999767541885376
IL-1 B-protein B-protein 0.2939181625843048
beta E-protein E-protein 0.8764734268188477
release O O 0.9298854470252991
and O O 0.9978081583976746
, O O 0.9998120665550232
in O O 0.9999716281890869
particular O O 0.9999043941497803
, O O 0.9999525547027588
with O O 0.9999815225601196
up-regulation O O 0.9986345171928406
of O O 0.9999809265136719
endogenous O O 0.4823985695838928

preoperatively O O 0.9783358573913574
was O O 0.9999092817306519
significantly O O 0.999921441078186
decreased O O 0.9999406337738037
when O O 0.9999961853027344
compared O O 0.9999368190765381
with O O 0.9999977350234985
data O O 0.9853936433792114
obtained O O 0.9999343156814575
in O O 0.9999665021896362
healthy O O 0.9101133942604065
control O O 0.9871847033500671
individuals O O 0.9995025396347046
( O O 0.9999775886535645
P O O 0.9980995059013367
< O O 0.9999353885650635
0.001 O O 0.999651312828064
) O O 0.999915361404419
, O O 0.9999982118606567
the O O 0.9999992847442627
degree O O 0.9999451637268066
of O O 0.9999970197677612
the O O 0.999997615814209
defect O O 0.9970941543579102

cascades O O 0.5737639665603638
. O O 0.9999288320541382
Here O O 0.9999867677688599
we O O 0.9999948740005493
report O O 0.9999953508377075
the O O 0.9999984502792358
characterization O O 0.9994699358940125
of O O 0.9999947547912598
a O O 0.99997878074646
nuclear B-protein B-protein 0.6566682457923889
complex E-protein E-protein 0.9669217467308044
from O O 0.9998152852058411
human O B-cell_type 0.4486599266529083
monocytic B-cell_type I-cell_type 0.7997241616249084
cells E-cell_type E-cell_type 0.938795804977417
that O O 0.99970942735672
bound O O 0.9998562335968018
to O O 0.9999594688415527
a O O 0.9988044500350952
kappa B-DNA B-DNA 0.9059247970581055
B-like I-DNA I-DNA 0.9659724235534668
site E-DNA E-DNA 0.9949287176132202
, O O 0.9964861869812012
5'-CGGAGTTTCC-3 B-DNA B-DNA 0.70662522315979
' E-DNA E-DNA 0.6449956297874451
, O O 0.5905885100364685
in O O 0.9992338418960571
the O O 0.9999254941940308
5'-flanking B-DNA B-DNA 0.8763296604156494
region E-DNA E-DNA 0.9923948049545288

) I-protein I-protein 0.469620943069458
receptor E-protein E-protein 0.9619166851043701
was O O 0.9995067119598389
largely O O 0.9999120235443115
absent O O 0.9999948740005493
at O O 0.9999996423721313
this O O 0.9999997615814209
stage O O 0.9998472929000854
and O O 0.9999910593032837
in O O 0.9999877214431763
the O O 0.9999743700027466
CD34+Thy-1-CD45RA- B-cell_line B-cell_type 0.4033075273036957
subsets E-cell_line E-cell_type 0.646558403968811
. O O 0.9999004602432251
The O O 0.9999924898147583
M-CSF B-protein B-protein 0.3952571749687195
receptor E-protein E-protein 0.977329432964325
was O O 0.9994279742240906
first O O 0.9991017580032349
detectable O O 0.9994643330574036
in O O 0.9999914169311523
the O O 0.9999444484710693
myeloid-committed B-cell_line B-cell_line 0.4068479835987091
CD34+Thy-l-CD45RA+ I-cell_line I-cell_line 0.5253115892410278
subset E-cell_line E-cell_line 0.9485662579536438
. O O 0.999862790107727
All O O 0.999985933303833
other O O 0.99994957447052
molecules O O 0.9841306805610657
studied O O 0.9997625946998596
were O O 0.9999927282333374
found O O 0.9999250173568726
to O O 0.9999841451644897
be O O 0.9999778270721436
expressed O O 0.9997444748878479
at O O 0.9999988079071045
this O O 0.9999966621398926
stage O O 0.9999557733535767
of O O 0.9999773502349854
differentiation O O 0.9995490908622742
. O O 0.9999991655349731
Different O O 0.9989078044891357
cocktails O O 0.9418197870254517
of O O 0.9999752044677734
the O O 0.9999786615371704
identified O O 0.9431155323982239
ligands O O 0.9003720283508301
were O O 0.9999680519104004
added O O 0.9998630285263062
to O O 0.999975323677063
sorted B-cell_line O 0.7549727559089661
CD34+Thy-1+ I-cell_line B-cell_type 0.4314049184322357
single I-cell_line I-cell_type 0.7139803171157837
cells E-cell_line E-cell_type 0.5499505996704102
. O O 0.9999313354492188
Low O O 0.9868619441986084
proliferative O O 0.9880071878433228
capacity O O 0.9998114705085754
was O O 0.9999971389770508
observed O O 0.9999725818634033
after O O 0.9999985694885254
1 O O 0.9933292865753174
week O O 0.9992576241493225
in O O 0.9999724626541138
culture O O 0.9665653705596924
in O O 0.9999687671661377
the O O 0.999994158744812
presence O O 0.9993284940719604
of O O 0.9999814033508301
stem B-protein B-protein 0.5859576463699341
cell I-protein I-protein 0.3934161365032196
factor E-protein E-protein 0.8188061714172363

( I-protein I-protein 0.7454456090927124
c I-protein I-protein 0.8158895373344421
) I-protein I-protein 0.8220337629318237
chain E-protein E-protein 0.9903411865234375
in O O 0.9998631477355957
these O O 0.9999622106552124
receptors O O 0.646066427230835
are O O 0.9991851449012756
proposed O O 0.9998030066490173
to O O 0.9999806880950928
cause O O 0.9999916553497314
the O O 0.9999973773956299
severe O O 0.9930096864700317
phenotype O O 0.9703670740127563
of O O 0.9998840093612671
X-SCID O O 0.7480241656303406
patients O O 0.9498730301856995
. O O 0.9999934434890747
Interestingly O O 0.9964166879653931
, O O 0.9998855590820312
gene O O 0.9862576127052307
disruption O O 0.9994878768920898
of O O 0.9999946355819702
either O O 0.9997182488441467
IL-7 S-protein S-protein 0.9582669734954834
or O O 0.9960241317749023
the O O 0.9993740916252136
IL-7 B-protein B-protein 0.5434085130691528
receptor I-protein E-protein 0.9077115654945374
( I-protein O 0.7543545961380005
IL-7R I-protein S-protein 0.8669323921203613
) I-protein O 0.8151302337646484

nucleus O O 0.9186855554580688

data O O 0.972077488899231
indicate O O 0.9999901056289673
that O O 0.9999992847442627
the O O 0.9999908208847046
defect O O 0.9842284917831421
induced O O 0.9998679161071777
by O O 0.9999840259552002
HCMV O O 0.9589012265205383
resides O O 0.9994809031486511
in O O 0.9999918937683105
the O O 0.9999921321868896
activation O O 0.9946743249893188
of O O 0.9999172687530518
the O O 0.999798595905304
IFN-gamma-responsive B-DNA B-DNA 0.7361629605293274
promoter E-DNA E-DNA 0.9584825038909912
of O O 0.9839420914649963
CIITA S-DNA S-protein 0.6839987635612488
. O O 0.9998968839645386
This O O 0.9999816417694092
is O O 0.9999828338623047
the O O 0.9999983310699463
first O O 0.9997890591621399
demonstration O O 0.9998108744621277
of O O 0.9999967813491821
a O O 0.9999885559082031
viral O O 0.7576178312301636
inhibition O O 0.9510055780410767
of O O 0.9993996620178223
CIITA S-DNA S-protein 0.5939838290214539
expression O O 0.9917579293251038
. O O 0.9999918937683105
3-deazaadenosine O O 0.7982857823371887
, O O 0.9968619346618652
a O O 0.999890923500061
S-adenosylhomocysteine B-protein O 0.749732494354248
hydrolase E-protein O 0.5780708193778992
inhibitor O O 0.6411313414573669
, O O 0.9994696974754333
has O O 0.9999886751174927
dual O O 0.9742512106895447
effects O O 0.999599039554596
on O O 0.9999972581863403

HAECs S-cell_type S-cell_line 0.8025370240211487
) O O 0.9266499280929565
activated O O 0.9932724237442017
by O O 0.9999816417694092
phorbol O O 0.9124751091003418
12-myristate O O 0.9839140176773071
13-acetate O O 0.9846404790878296
( O O 0.9995554089546204
PMA O O 0.9899999499320984
) O O 0.9995779395103455
or O O 0.9999665021896362
lipopolysaccharide O O 0.9838613867759705
. O O 0.9999940395355225
The O O 0.999997615814209
`` O O 0.767047643661499
natural O O 0.7786228656768799
'' O O 0.7308009266853333
PPAR O S-protein 0.5672098398208618
activator O O 0.47262048721313477

production O O 0.9877645373344421

fatty O O 0.8542943000793457
acid O O 0.9485352039337158
metabolites O O 0.8859216570854187
, O O 0.9998266100883484
peroxisome O O 0.4690299332141876
proliferators O O 0.48435139656066895
, O O 0.9743396043777466
and O O 0.9964375495910645
thiazolidinediones O S-protein 0.6574510931968689
and O O 0.9883804321289062
are O O 0.9997598528862
now O O 0.9999585151672363
recognized O O 0.9999368190765381
as O O 0.9999759197235107
important O O 0.9998530149459839

express O O 0.9982327222824097
a O O 0.9999500513076782
novel O O 0.7989858984947205
IL-10-stimulated B-protein B-protein 0.7941969037055969
STAT I-protein I-protein 0.7451454401016235
protein E-protein E-protein 0.9929989576339722
with O O 0.9998784065246582
an O O 0.9995245933532715
M O O 0.5411898493766785
( O O 0.5014054775238037
r O O 0.8444381356239319
) O O 0.44568052887916565
of O O 0.9237102270126343
70 B-protein B-protein 0.5897744297981262
kDa E-protein E-protein 0.8819966912269592
that O O 0.9964421391487122
is O O 0.9998800754547119
recognized O O 0.9996927976608276
by O O 0.9999977350234985
the O O 0.9999486207962036
anti-STAT3 B-protein B-protein 0.9499465227127075
Ab E-protein E-protein 0.9963788390159607
but O O 0.9968805313110352
is O O 0.9998990297317505
not O O 0.9993942975997925
observed O O 0.9993894100189209
in O O 0.9998032450675964
T B-cell_type B-cell_type 0.9480382204055786
cells E-cell_type E-cell_type 0.9937936067581177
. O O 0.9997652173042297
IL-10 S-protein S-protein 0.8830681443214417
treatment O O 0.9923081398010254
of O O 0.9999748468399048
both O O 0.9993645548820496
T B-cell_type B-cell_type 0.8823143243789673
cells E-cell_type E-cell_type 0.9866192936897278
and O O 0.9947237968444824
monocytes S-cell_type S-cell_type 0.9910248517990112
results O O 0.9996864795684814
in O O 0.9999972581863403
the O O 0.9999920129776001
ligand-induced O O 0.9373944401741028
tyrosine O O 0.8539769649505615
phosphorylation O O 0.949653685092926
of O O 0.9995409250259399
tyk2 S-protein S-protein 0.9256480932235718
and O O 0.9881626963615417
Jak1 S-protein S-protein 0.9892213344573975
, O O 0.9961813688278198
but O O 0.999883770942688

constitutive O O 0.9043217301368713
phosphorylation O O 0.943412184715271
of O O 0.9989439845085144
the O O 0.9996458292007446
Jak3 S-protein S-protein 0.9003915786743164
, O O 0.8671124577522278
STAT3 S-protein S-protein 0.9679360389709473
, O O 0.9477689266204834
and O O 0.9792831540107727
STAT5 S-protein B-protein 0.7728791832923889
proteins O E-protein 0.965651273727417
; O O 0.9990301132202148
( O O 0.9986139535903931
2 O O 0.9958270192146301
) O O 0.9987228512763977
malignant O O 0.9234411716461182
transformation O O 0.9943891167640686
in O O 0.9999932050704956

findings O O 0.9938595294952393
suggest O O 0.9999990463256836
the O O 0.9999977350234985
presence O O 0.9994397759437561
in O O 0.9999833106994629
vaginal O O 0.8890091776847839
fluid O O 0.9530916810035706
of O O 0.9986099004745483
agent O O 0.9497348666191101
( O O 0.9955832362174988
s O O 0.9895414710044861

immunofluorescence O O 0.8822181224822998
with O O 0.9998255372047424
beta- B-protein B-protein 0.6561605930328369
and I-protein I-protein 0.6932211518287659
gamma-specific I-protein I-protein 0.8780551552772522
antibodies E-protein E-protein 0.9965742826461792
. O O 0.9999709129333496
The O O 0.9999978542327881
number O O 0.9993209838867188
of O O 0.9999822378158569
gamma-positive B-cell_line B-cell_type 0.4474950432777405
cells E-cell_line E-cell_type 0.5794156193733215
and O O 0.9966807961463928
their O O 0.9999268054962158
fluorescence O O 0.9683512449264526

. O O 0.9989466071128845
Thus O O 0.99992835521698
, O O 0.9999676942825317
erythroid O O 0.874507486820221
development O O 0.9981158971786499
of O O 0.9999897480010986
M-TAT B-cell_line B-cell_line 0.6286911964416504
cells E-cell_line E-cell_line 0.9731948971748352
is O O 0.9997819066047668
promoted O O 0.9998762607574463
by O O 0.999995231628418
EPO S-protein S-protein 0.9809421300888062
and O O 0.9992426633834839
suppressed O O 0.9938417673110962
by O O 0.9999796152114868
GM-CSF S-protein S-protein 0.9613760709762573
. O O 0.9999681711196899
These O O 0.9999924898147583

proteins O E-protein 0.8701483011245728
that O O 0.9992861151695251
are O O 0.9999816417694092
controlled O O 0.998441755771637
by O O 0.9999727010726929
calcineurin S-protein S-protein 0.9973999261856079
carry O O 0.9998754262924194
out O O 0.9998605251312256
the O O 0.9999904632568359
nuclear O O 0.6653088331222534
import O O 0.7203237414360046
of O O 0.970035970211029
NF-ATc S-protein S-protein 0.9749983549118042
. O O 0.9998669624328613
Although O O 0.9999274015426636
NF-ATp S-protein S-protein 0.9809519648551941
copurifies O O 0.9893897175788879
with O O 0.999984860420227

mutant O O 0.5011395215988159
studied O O 0.9970530271530151
here O O 0.9998581409454346
could O O 0.9999979734420776
be O O 0.9999939203262329
phosphorylated O O 0.9833327531814575
on O O 0.9999278783798218
tyrosine O O 0.927485466003418
when O O 0.9999650716781616
associated O O 0.997721254825592
to O O 0.9999889135360718
the O O 0.9999719858169556
TCR B-protein B-protein 0.4460892677307129
zeta I-protein I-protein 0.5959674715995789
chain E-protein E-protein 0.9848339557647705
and O O 0.9986995458602905
was O O 0.999901533126831
able O O 0.9996246099472046
to O O 0.9999312162399292
bind O O 0.9994332194328308
p56 B-protein B-protein 0.8865430951118469
( I-protein I-protein 0.9499152898788452
lck I-protein I-protein 0.981033205986023
) E-protein E-protein 0.9959182143211365
. O O 0.9998161196708679
This O O 0.9999972581863403
result O O 0.999963641166687
demonstrates O O 0.9999988079071045
that O O 0.999998927116394
Tyr-492 O O 0.5247126221656799
and O O 0.9901127815246582
Tyr-493 O O 0.4764823019504547
are O O 0.9994413256645203
not O O 0.9998742341995239
responsible O O 0.999980092048645
for O O 0.9999961853027344
the O O 0.9999892711639404
Src O B-protein 0.539818525314331
homology O I-protein 0.7460412979125977
domain O E-protein 0.5993805527687073
2-mediated O O 0.6706205010414124
association O O 0.6536568403244019
of O O 0.8819607496261597
p56 B-protein B-protein 0.44229045510292053
( I-protein I-protein 0.7719131112098694

because O O 0.9990215301513672
mouse O B-protein 0.37104830145835876
CSF-1 S-protein E-protein 0.749427318572998
can O O 0.9987260699272156
not O O 0.9999719858169556
activate O O 0.9994663596153259
human O B-protein 0.5466494560241699
CSF-1R S-protein E-protein 0.9355472922325134
. O O 0.9998123049736023
Then O O 0.9999274015426636
bone B-cell_type B-cell_type 0.8912208080291748
marrow I-cell_type I-cell_type 0.6357318162918091
cells E-cell_type E-cell_type 0.9529669880867004
from O O 0.9998574256896973
transgenic O O 0.8835517168045044
mice O O 0.9915314316749573
were O O 0.9999942779541016
plated O O 0.9947944283485413
onto O O 0.9998219609260559
MS-5 O B-cell_line 0.8052375912666321
stromal O I-cell_line 0.8040298223495483
cells O E-cell_line 0.9386861324310303
expressing O O 0.9985696077346802
the O O 0.9999924898147583
membrane B-protein O 0.6583340764045715
form E-protein O 0.4599286913871765
of O O 0.9990723133087158
human B-protein B-cell_line 0.4556520879268646
CSF-1 E-protein I-cell_line 0.8576338291168213
( O I-cell_line 0.9197871685028076
2M-1 B-cell_line I-cell_line 0.22448311746120453
cells E-cell_line E-cell_line 0.8467164635658264
) O O 0.9824712872505188
in O O 0.9999486207962036
order O O 0.9990779161453247
to O O 0.9999873638153076
combine O O 0.999935507774353
the O O 0.9999754428863525
hematopoietic O O 0.7624709606170654
supporting O O 0.9123473763465881
properties O O 0.953174352645874
of O O 0.9999673366546631
stromal B-cell_type B-cell_type 0.665280282497406
cells E-cell_type E-cell_type 0.9827365875244141
and O O 0.9994613528251648
the O O 0.9999963045120239
proliferative O O 0.9871991276741028
effects O O 0.9998806715011597
of O O 0.9999872446060181
CSF-1 S-protein S-protein 0.9598672389984131
. O O 0.9999451637268066
Thus O O 0.9999380111694336
, O O 0.9999669790267944
we O O 0.9999860525131226
were O O 0.9999961853027344
able O O 0.9997971653938293
to O O 0.999908447265625

. O O 0.9954484105110168

to O O 0.9991337656974792
be O O 0.9999856948852539
an O O 0.9999970197677612
important O O 0.9992535710334778
component O O 0.9992606043815613
of O O 0.9999880790710449
the O O 0.9999982118606567
mechanism O O 0.9973219037055969
of O O 0.999762237071991
transactivation O O 0.9971551895141602
. O O 0.9999977350234985
In O O 0.9999966621398926
this O O 0.9999997615814209
report O O 0.9996137022972107
we O O 0.9999803304672241
demonstrate O O 0.9999929666519165
that O O 0.9999958276748657
in O O 0.9998206496238708
certain O O 0.997340738773346
CNS-derived B-cell_line B-cell_line 0.8144486546516418
cells E-cell_line E-cell_line 0.9324840903282166
Tat S-protein S-protein 0.5703214406967163
is O O 0.999674916267395
capable O O 0.9994449019432068
of O O 0.9998843669891357
activating O O 0.965268075466156
HIV-1 O O 0.5120567679405212
through O O 0.9993594288825989
a O O 0.9999518394470215
TAR S-DNA S-DNA 0.6824625134468079
-independent O O 0.9431038498878479
pathway O O 0.9983420372009277

) O O 0.7966629266738892
. O O 0.9998052716255188
Stimulation O O 0.9994221925735474
with O O 0.9999960660934448
different O O 0.999756395816803
GC O O 0.6686438322067261
at O O 0.9997053742408752
therapeutic O O 0.8865254521369934
concentrations O O 0.9830572009086609
resulted O O 0.9999939203262329
in O O 0.9999960660934448
monocyte O O 0.8272594213485718
apoptosis O O 0.9970598816871643
in O O 0.9999948740005493
a O O 0.9999948740005493
time- O O 0.9507361054420471
and O O 0.9880043864250183

HIV O O 0.43463414907455444
) O O 0.6571036577224731
-induced O O 0.9808745384216309
apoptosis O O 0.99861741065979
( O O 0.9999865293502808
J.Corbeil O O 0.9965502023696899
, O O 0.9999744892120361
M.Tremblay O O 0.9989338517189026
, O O 0.9999805688858032
and O O 0.9999862909317017
D.D.Richman O O 0.9990721940994263
, O O 0.9999903440475464
J.Exp.Med.183 O O 0.9992521405220032
: O O 0.9999195337295532
39-48 O O 0.9996412992477417
, O O 0.9999686479568481
1996 O O 0.9994854927062988
) O O 0.9999704360961914
. O O 0.9999982118606567
We O O 0.9999921321868896
have O O 0.9999978542327881
pursued O O 0.9999765157699585
our O O 0.9999972581863403
investigation O O 0.9999884366989136
of O O 0.9999990463256836
the O O 0.9999991655349731
role O O 0.9994828701019287
of O O 0.9999942779541016
the O O 0.9999749660491943
CD4 S-protein S-protein 0.7165914177894592
transduction O O 0.7385857105255127
pathway O O 0.9805923700332642

E1A S-protein S-protein 0.23343855142593384

Jun S-protein S-protein 0.9195218086242676
could O O 0.9998310804367065
contribute O O 0.9999978542327881
to O O 0.9999983310699463
the O O 0.9999994039535522
increase O O 0.9999680519104004
in O O 0.9999861717224121
illness O O 0.9928787350654602
due O O 0.9999850988388062
to O O 0.9999971389770508
influenza O O 0.8464887738227844
virus O O 0.8854881525039673
in O O 0.9997043013572693
the O O 0.9998646974563599
elderly O O 0.986140251159668
. O O 0.9999903440475464
The O O 0.9999994039535522
regulation O O 0.9998998641967773
of O O 0.9999958276748657
HIV O O 0.9405691623687744
by O O 0.9999512434005737
retinoic O O 0.7554202079772949
acid O O 0.8484245538711548

the O O 0.9993053674697876
activity O O 0.9978929162025452
of O O 0.9999768733978271
nuclear B-protein B-protein 0.5245568156242371
proteins E-protein E-protein 0.9778684377670288
that O O 0.9993894100189209
bind O O 0.9997051358222961
to O O 0.999909520149231
the O O 0.9998362064361572
IL-2 O B-DNA 0.6487590670585632
promoter O E-DNA 0.9967495203018188
. O O 0.9998070597648621
Nuclear O O 0.9663118124008179
extracts O O 0.9957297444343567
from O O 0.9999868869781494
primary B-cell_type B-cell_type 0.5088668465614319
human I-cell_type I-cell_type 0.6048736572265625
T I-cell_type I-cell_type 0.9378034472465515
lymphocytes E-cell_type E-cell_type 0.9773882627487183
were O O 0.9998109936714172
analyzed O O 0.9998748302459717
by O O 0.9999977350234985
electrophoretic O O 0.9014686942100525
DNA O O 0.9294213652610779
mobility O O 0.9953746199607849
shift O O 0.9986333250999451
assays O O 0.9997808337211609
. O O 0.9999995231628418
Both O O 0.9999871253967285
Dex O O 0.8331052660942078
and O O 0.9952630996704102
CsA O O 0.9482802152633667
inhibited O O 0.9998059868812561
the O O 0.9999922513961792
binding O O 0.9919877052307129
of O O 0.999806821346283
transcription O B-protein 0.6421881318092346
factors O E-protein 0.9956691265106201
AP-1 S-protein S-protein 0.9832571148872375
and O O 0.9931746125221252
NF-AT S-protein S-protein 0.9983280301094055
, O O 0.9927065968513489
but O O 0.9995291233062744
not O O 0.9994099140167236
of O O 0.9997944235801697
NF-kB S-protein S-protein 0.9880003333091736
and O O 0.9908366203308105
OCT-1/OAF S-protein S-protein 0.9829539060592651
, O O 0.993353009223938

RXR B-protein B-protein 0.3833008408546448
alpha E-protein E-protein 0.9926643967628479
levels O O 0.9992411136627197
. O O 0.9999980926513672
Combinations O O 0.999619722366333
of O O 0.999997615814209
all-trans O O 0.8995242714881897
retinoic O O 0.9270684123039246
acid O O 0.9770128726959229
( O O 0.9989877343177795
RA O O 0.9975727200508118
) O O 0.999853253364563
and O O 0.9999657869338989
VD O O 0.9817845821380615
, O O 0.999799907207489
in O O 0.9999924898147583
some O O 0.9999954700469971
cases O O 0.998740017414093
, O O 0.9999881982803345
increased O O 0.999972939491272
this O O 0.9999933242797852
effect O O 0.9999938011169434
. O O 0.999998927116394
This O O 0.9999961853027344
response O O 0.9998140931129456
suggests O O 0.9999986886978149
the O O 0.9999992847442627
involvement O O 0.9999841451644897
of O O 0.9999974966049194
RXR B-protein B-protein 0.7145713567733765
alpha E-protein E-protein 0.9948535561561584
in O O 0.9997101426124573
monocytic O O 0.5171374678611755
differentiation O O 0.9642523527145386
upon O O 0.9998446702957153
VD O O 0.8317275047302246
treatment O O 0.9997075200080872

induced O O 0.8935953974723816
C/EBP B-RNA B-RNA 0.8792092204093933
epsilon I-RNA I-RNA 0.9509544372558594
mRNA E-RNA E-RNA 0.9933291673660278
accumulation O O 0.9929325580596924
in O O 0.99998939037323
the O O 0.9999982118606567
absence O O 0.9999135732650757
of O O 0.999997615814209
new O O 0.9759055376052856
protein O O 0.700186550617218
synthesis O O 0.9435510039329529
. O O 0.9999221563339233
ATRA O O 0.8615556359291077
also O O 0.9993559718132019
induced O O 0.9998952150344849
expression O O 0.9990326166152954
of O O 0.9999889135360718
C/EBP B-protein B-protein 0.7748960852622986
epsilon I-protein I-protein 0.8269760608673096
protein E-protein E-protein 0.9875662326812744
in O O 0.9994041919708252
NB4 B-cell_line B-cell_line 0.7209039330482483
cells E-cell_line E-cell_line 0.9642521739006042
, O O 0.9948467016220093
as O O 0.9999740123748779
shown O O 0.999991774559021
by O O 0.9999971389770508
Western O O 0.9174128770828247
blotting O O 0.9394814968109131
. O O 0.9999508857727051
In O O 0.9999170303344727
contrast O O 0.9999681711196899
to O O 0.9999985694885254
the O O 0.9999990463256836
increase O O 0.9999688863754272
of O O 0.9999895095825195
C/EBP O B-protein 0.38524144887924194
epsilon O E-protein 0.7884872555732727
in O O 0.9989148378372192

vascular I-protein B-protein 0.4513252377510071
ICAM-1 E-protein E-protein 0.9073963761329651
. O O 0.9984455704689026
It O O 0.9999784231185913
is O O 0.9999982118606567
interesting O O 0.9999991655349731
that O O 0.9999992847442627
IL-11 S-protein S-protein 0.9744797348976135
did O O 0.9999053478240967
not O O 0.9999958276748657
affect O O 0.9999924898147583
BAL O O 0.571419358253479
fluid O O 0.8159238696098328
content O O 0.9705523252487183
of O O 0.999929666519165
the O O 0.9999872446060181
CXC B-protein B-protein 0.5181118845939636
chemokines E-protein E-protein 0.9613547921180725
, O O 0.997422456741333
macrophage B-protein B-protein 0.8595104813575745
inflammatory I-protein I-protein 0.9565787315368652
protein-2 E-protein E-protein 0.9878203272819519
( O O 0.9764873385429382
MIP-2 S-protein S-protein 0.8842414021492004

lymphokine I-DNA B-DNA 0.3063766658306122
element I-DNA I-DNA 0.9070284366607666
0 E-DNA E-DNA 0.9736449122428894
( O O 0.9962728023529053
CLE0 S-DNA S-DNA 0.9873380661010742
) O O 0.9482983350753784
, O O 0.9992116689682007
located O O 0.9977551102638245
at O O 0.9978864789009094
positions O O 0.7684672474861145
between O O 0.9638097882270813
-54 O B-DNA 0.6380503177642822
and O I-DNA 0.5779245495796204

cells E-cell_type E-cell_type 0.5711331367492676
isolated O O 0.997122585773468
from O O 0.9999886751174927
synovial O O 0.7184996008872986
fluid O O 0.7294779419898987
and O O 0.9624704718589783
peripheral O O 0.7020896673202515
blood O O 0.6769050359725952
of O O 0.9975975155830383
patients O O 0.9988229870796204
with O O 0.9999710321426392
rheumatoid O O 0.9445890188217163
arthritis O O 0.9973390698432922
. O O 0.9999988079071045
The O O 0.999998927116394
complexes S-protein O 0.9615597724914551
consisted O O 0.9999572038650513
of O O 0.999991774559021
p50/p50 B-protein B-protein 0.7618364095687866
homodimers E-protein E-protein 0.9882837533950806
and O O 0.9929409027099609
p50/p65 O B-protein 0.6599555611610413
heterodimers O E-protein 0.9955365657806396
. O O 0.9999548196792603
Increased O O 0.9994106292724609
NF-kappa B-protein B-protein 0.8962224125862122
B E-protein E-protein 0.9982168078422546
binding O O 0.9942688941955566
to O O 0.9999744892120361
DNA O O 0.6314132809638977

AP-1 S-protein S-protein 0.899012565612793
and O O 0.9865049719810486
observed O O 0.9970616698265076
that O O 0.9999849796295166
it O O 0.9997990727424622
was O O 0.9999589920043945
indeed O O 0.9999302625656128
up-regulated O O 0.9987505674362183
in O O 0.9998248219490051
infected B-cell_type B-cell_type 0.4997197687625885
cells E-cell_type E-cell_type 0.9611974954605103
. O O 0.9996615648269653
Since O O 0.9999576807022095
AP-1 S-protein S-protein 0.9903150200843811
is O O 0.9998335838317871
implicated O O 0.999937891960144
in O O 0.9999939203262329
the O O 0.9999982118606567
control O O 0.9993044137954712
of O O 0.9999932050704956
the O O 0.9999489784240723

in O O 0.9992720484733582
the O O 0.9999969005584717
early O O 0.9756790995597839
generation O O 0.9869173765182495
of O O 0.9997246861457825
NFAT B-protein B-protein 0.48932260274887085
complexes E-protein E-protein 0.9982128143310547
rather O O 0.9995026588439941
than O O 0.9999704360961914
the O O 0.9999772310256958
binding O O 0.9699468016624451
of O O 0.9988875985145569
preformed O O 0.8044536113739014
NF-AT B-protein B-protein 0.5509960055351257
complexes E-protein E-protein 0.9981300234794617
. O O 0.999971866607666
These O O 0.9999988079071045
results O O 0.9999855756759644
suggest O O 0.9999992847442627
that O O 0.9999980926513672
oxidative O O 0.9686141014099121
signals O O 0.9965535402297974
can O O 0.9999939203262329

To O O 0.9990215301513672
characterize O O 0.9999512434005737
the O O 0.9999986886978149
role O O 0.999785840511322
of O O 0.9999940395355225
these O O 0.9999701976776123
P-like B-DNA B-DNA 0.5614970922470093
elements E-DNA E-DNA 0.9809212684631348
and O O 0.9983999133110046
their O O 0.9999663829803467
binding B-protein O 0.848859965801239
factors E-protein O 0.8197079300880432
in O O 0.9996699094772339
the O O 0.9999648332595825
native B-DNA B-DNA 0.7255551218986511
promoter E-DNA E-DNA 0.9824752807617188
, O O 0.998488187789917
we O O 0.9999723434448242
did O O 0.999983549118042
transient O O 0.9373945593833923
transfection O O 0.970374584197998
and O O 0.9997660517692566
electrophoretic O O 0.6724900007247925

1 I-DNA I-DNA 0.46021735668182373
gene E-DNA E-DNA 0.9206165075302124
transcription O O 0.7330945134162903
and O O 0.9778127670288086
pp90rsk S-protein S-protein 0.6143545508384705
during O O 0.9989781379699707
induction O O 0.9988290667533875
of O O 0.9999669790267944
monocytic O O 0.7269778847694397
differentiation O O 0.9928901195526123
. O O 0.999997615814209
The O O 0.9999994039535522
present O O 0.9952777624130249
work O O 0.9994551539421082
has O O 0.9999957084655762
studied O O 0.9997283816337585
mechanisms O O 0.9987736344337463
responsible O O 0.9999746084213257
for O O 0.9999948740005493
induction O O 0.9987378716468811
of O O 0.999987006187439
early B-DNA B-DNA 0.6161019206047058
growth I-DNA I-DNA 0.4101719260215759
response I-DNA I-DNA 0.5107714533805847
1 I-DNA I-DNA 0.5417845845222473

) I-protein I-protein 0.6619694232940674
type I-protein I-protein 0.44196030497550964
II E-protein E-protein 0.9581114649772644
, O O 0.9966558218002319
an O O 0.999946117401123
enzyme S-protein O 0.44711610674858093
catalyzing O O 0.962889552116394
the O O 0.9996228218078613
rate-limiting O O 0.49425578117370605
step O O 0.5590651631355286
in O O 0.9995775818824768
the O O 0.999993085861206
generation O O 0.98455411195755
of O O 0.9998881816864014
guanine O O 0.7659249305725098
nucleotides O O 0.6692175269126892
, O O 0.9946092367172241
is O O 0.9999781847000122
increased O O 0.999955415725708
more O O 0.9999837875366211
than O O 0.9999912977218628
10-fold O O 0.9885691404342651
in O O 0.999893069267273
activated B-cell_type B-cell_type 0.4881950616836548
peripheral I-cell_type I-cell_type 0.5384839773178101
blood I-cell_type I-cell_type 0.9269537329673767
T I-cell_type I-cell_type 0.9860818386077881
lymphocytes E-cell_type E-cell_type 0.9945026636123657
and O O 0.9974631071090698
is O O 0.9999659061431885

1 E-protein E-protein 0.43787747621536255
, O O 0.9536446928977966
transiently O O 0.969657301902771
expressed O O 0.9996511936187744
in O O 0.9999669790267944
R7-57 B-cell_line B-cell_line 0.8019113540649414
reporter I-cell_line I-cell_line 0.7962383031845093
cells E-cell_line E-cell_line 0.9829809665679932
, O O 0.9915533661842346
was O O 0.999985933303833
the O O 0.999997615814209
only O O 0.9996906518936157
EBV B-protein B-protein 0.4882622957229614
trans-activator E-protein E-protein 0.5459323525428772
found O O 0.9728455543518066
, O O 0.9998987913131714
sufficient O O 0.9998217225074768
in O O 0.9999756813049316
inducing O O 0.9992318153381348
the O O 0.9999892711639404
viral O O 0.931351363658905
lytic O O 0.9579815864562988
cycle O O 0.9888073205947876
. O O 0.9999957084655762
Basing O O 0.9966512322425842
on O O 0.9999843835830688
these O O 0.9999810457229614
experiments O O 0.9920682907104492
, O O 0.9999802112579346
trans-cellular O O 0.9288427233695984
activation O O 0.9930873513221741
of O O 0.9998998641967773
EBV O O 0.5740041732788086
was O O 0.9994620680809021

analysed O O 0.9788733720779419
. O O 0.9999761581420898
Our O O 0.9999985694885254
findings O O 0.9999279975891113
demonstrate O O 0.9999983310699463
that O O 0.9999979734420776
truncated B-RNA B-RNA 0.7238199710845947
TSG101 I-RNA I-RNA 0.26679784059524536
and I-RNA I-RNA 0.703589916229248
FHIT I-RNA I-RNA 0.6292136907577515
transcripts E-RNA E-RNA 0.9611954092979431
are O O 0.9996392726898193
commonly O O 0.994888961315155
detected O O 0.9999629259109497
in O O 0.9999834299087524
both O O 0.9997301697731018
normal O O 0.6856349110603333
and O O 0.9378396272659302
malignant O O 0.8885437250137329
tissues O O 0.9810321927070618
and O O 0.9999762773513794
that O O 0.9999984502792358
a O O 0.9999946355819702
significant O O 0.9994582533836365
fraction O O 0.9997521042823792
of O O 0.9999966621398926
these O O 0.9999786615371704
are O O 0.9999761581420898

the O O 0.9997891783714294
effect O O 0.9999892711639404
on O O 0.9999984502792358
the O O 0.9999313354492188
Na B-protein O 0.4973021447658539
( I-protein O 0.9454441070556641
+ I-protein O 0.9608493447303772
) I-protein O 0.9648500680923462
-H I-protein O 0.9760101437568665
( I-protein O 0.9956403970718384
+ I-protein O 0.9832075834274292
) I-protein O 0.9863155484199524
-antiport E-protein O 0.9397519826889038
, O O 0.9998985528945923
a O O 0.9999856948852539
high O O 0.9880030155181885
turnover O O 0.9907674193382263
rate O O 0.9996416568756104
, O O 0.9999793767929077
and O O 0.9999656677246094

for O O 0.9932401180267334
HLA-DRA S-DNA S-DNA 0.747381329536438
, O O 0.9933831095695496
the O O 0.9999290704727173
prototype B-DNA B-DNA 0.5214418172836304
class I-DNA I-DNA 0.4918566942214966
II I-DNA I-DNA 0.3393888473510742
gene E-DNA E-DNA 0.9950088262557983
. O O 0.9993249177932739
Oct-1 S-protein S-protein 0.9823347330093384
, O O 0.9985450506210327
a O O 0.9999529123306274
POU B-protein B-protein 0.38734620809555054
domain I-protein I-protein 0.35166624188423157
transcription I-protein I-protein 0.7548164129257202
factor E-protein E-protein 0.9875200986862183
, O O 0.9937745332717896
was O O 0.9999377727508545
identified O O 0.9999756813049316
as O O 0.9999897480010986
a O O 0.9999890327453613
repressor O O 0.8834769129753113
of O O 0.9979721903800964
HLA-DRA S-DNA B-DNA 0.5833289623260498
promoter O E-DNA 0.9825178980827332
activity O O 0.9851846694946289
in O O 0.999990701675415
the O O 0.9999878406524658

lung O B-protein 0.34586256742477417

growth-transforming O O 0.939738929271698
infection O O 0.9979296922683716
may O O 0.9999876022338867
have O O 0.9999970197677612
rendered O O 0.9998944997787476
these O O 0.9999803304672241
agents O O 0.9979432225227356
less O O 0.9999806880950928
dependent O O 0.9999817609786987
upon O O 0.999977707862854
viral O O 0.9551377296447754
replication O O 0.9978446960449219
as O O 0.9999985694885254
a O O 0.9999942779541016
means O O 0.9990246295928955
of O O 0.9999618530273438
successfully O O 0.9970064759254456
colonizing O O 0.9985566735267639
their O O 0.9999667406082153
hosts O O 0.979706346988678
. O O 0.9999963045120239
Triggering O O 0.9997585415840149
of O O 0.9999895095825195
HLA-DR B-protein B-protein 0.4297027587890625
antigens E-protein E-protein 0.9976574182510376
differentially O O 0.9993914365768433
modulates O O 0.9980424642562866
tumor B-protein B-protein 0.5866050124168396
necrosis I-protein I-protein 0.8647863864898682
factor I-protein I-protein 0.5820315480232239
alpha E-protein E-protein 0.9533662796020508

T B-cell_line B-cell_line 0.3139791190624237
cell I-cell_line I-cell_line 0.7410033345222473
lines E-cell_line E-cell_line 0.9988380074501038
could O O 0.9998216032981873
be O O 0.999996542930603
anergized O O 0.9997336268424988
by O O 0.9999995231628418
the O O 0.9999926090240479
autopresentation O O 0.9876065850257874
of O O 0.9999544620513916
native O O 0.6943103671073914
peptide O O 0.8051530122756958
since O O 0.9992666840553284
anergy O O 0.934694230556488
was O O 0.9992270469665527
induced O O 0.9999377727508545
in O O 0.9999761581420898
cultures O O 0.9100282788276672
lacking O O 0.9998189806938171
fresh O O 0.7814843058586121
antigen-presenting B-cell_type B-cell_type 0.47639045119285583
cells E-cell_type E-cell_type 0.9075772762298584
. O O 0.9998216032981873

the O O 0.9983035326004028
glucocorticoid B-protein B-protein 0.6865867972373962
receptor E-protein E-protein 0.9647949934005737
, O O 0.984534502029419
i.e. O O 0.9981297850608826
, O O 0.9998887777328491
it O O 0.9997697472572327
was O O 0.9999748468399048
abolished O O 0.9999703168869019
by O O 0.9999992847442627
the O O 0.9999518394470215
glucocorticoid B-protein B-protein 0.652887225151062
receptor E-protein E-protein 0.9551135897636414
antagonist O O 0.9436188340187073
RU38486 O O 0.9358727335929871
. O O 0.9999754428863525
This O O 0.9999948740005493
is O O 0.9999927282333374
the O O 0.9999988079071045
first O O 0.99946528673172
description O O 0.9994909763336182
of O O 0.999994158744812
an O O 0.9995885491371155

also O O 0.9931991696357727
prevented O O 0.9993720650672913
nuclear B-protein B-protein 0.9061602354049683
factor-kappa I-protein I-protein 0.8213028311729431
B E-protein E-protein 0.986176073551178
( O O 0.9950815439224243
NF-kappa B-protein B-protein 0.8135411143302917
B E-protein E-protein 0.9954119324684143
) O O 0.9791282415390015
activation O O 0.9927253723144531
, O O 0.9999598264694214
and O O 0.9999885559082031
a O O 0.9999940395355225
good O O 0.9985877275466919
correlation O O 0.9992161989212036
between O O 0.9998797178268433
this O O 0.999810516834259
inhibition O O 0.9949796795845032
and O O 0.9998204112052917
inhibition O O 0.9955600500106812
of O O 0.9999459981918335
HIV O O 0.6245865225791931
replication O O 0.9302137494087219
was O O 0.9999489784240723
observed O O 0.9997105002403259
. O O 0.9999957084655762
Moreover O O 0.9993988275527954
, O O 0.9999629259109497
supplementing O O 0.9956865906715393

) O O 0.6661299467086792
2D3 O O 0.33024802803993225
action O O 0.9684565663337708
in O O 0.9999076128005981
immune B-cell_type B-cell_type 0.6487037539482117
cells E-cell_type E-cell_type 0.9861019849777222
. O O 0.9999253749847412
Molecular O O 0.9643365144729614
cloning O O 0.9899113774299622
and O O 0.9996253252029419
characterization O O 0.9986750483512878
of O O 0.999984622001648
a O O 0.9999526739120483
cDNA S-DNA S-DNA 0.7455033659934998
, O O 0.954438328742981
CHEMR1 S-DNA S-DNA 0.9049391150474548
, O O 0.9849231243133545
encoding O O 0.9951863884925842
a O O 0.9993534684181213
chemokine B-protein B-protein 0.6819902062416077
receptor E-protein E-protein 0.9580945372581482
with O O 0.9986463189125061
a O O 0.9999105930328369
homology O O 0.8195961713790894
to O O 0.9973748922348022
the O O 0.9998264908790588

that O O 0.9953239560127258
may O O 0.9999840259552002
allow O O 0.9999984502792358
for O O 0.999988317489624
other O O 0.9998964071273804
adaptors O O 0.584237813949585
( O O 0.9971585273742676
in O O 0.9997727274894714
addition O O 0.999763548374176
to O O 0.9998779296875
p300/CBP S-protein S-protein 0.9460586905479431
) O O 0.9969780445098877
to O O 0.9999814033508301
link O O 0.9982227683067322
Stat1 S-protein S-protein 0.9954007267951965
to O O 0.9998179078102112
the O O 0.999975323677063
basal B-protein B-protein 0.7828199863433838
transcription I-protein I-protein 0.6608375906944275
complex E-protein E-protein 0.9783070087432861
. O O 0.9998682737350464

precursor O O 0.664696455001831
polypeptide O O 0.5392006635665894
of O O 0.9941635727882385
p50-NF-kappa B-protein B-protein 0.7747239470481873
B E-protein E-protein 0.9979238510131836
. O O 0.9997648596763611
Like O O 0.9999799728393555
the O O 0.9999617338180542
105-kDa O B-protein 0.7119442224502563
precursor O E-protein 0.9425496459007263
, O O 0.9978917241096497
it O O 0.9999405145645142
contains O O 0.9999754428863525
an O O 0.9999209642410278
amino-terminal B-protein B-protein 0.8408992290496826
Rel-related I-protein I-protein 0.9690766930580139
domain E-protein E-protein 0.9451853632926941
of O O 0.9849167466163635
about O O 0.9982574582099915
300 O O 0.799698531627655
amino O O 0.5012165307998657
acids O O 0.7860279083251953
and O O 0.9897651672363281
a O O 0.9998924732208252
carboxy-terminal B-protein B-protein 0.9358519315719604
domain E-protein E-protein 0.9789958000183105
containing O O 0.9915577173233032
six O O 0.936201810836792
full B-protein O 0.9131693243980408
cell I-protein O 0.8267698884010315
cycle E-protein O 0.7327038049697876
or O O 0.9669986367225647

T B-cell_type B-cell_type 0.25451353192329407
lymphocytes E-cell_type E-cell_type 0.9388535022735596
for O O 0.9995868802070618
production O O 0.999542236328125
of O O 0.9999827146530151
IL-3 S-protein S-protein 0.9837506413459778
and O O 0.9977966547012329
GM-CSF S-protein S-protein 0.9931071400642395
. O O 0.9999208450317383
Nuclear O O 0.8896439075469971
appearance O O 0.981351912021637
of O O 0.9997833371162415
a O O 0.9999836683273315
factor O O 0.9707071781158447
that O O 0.999922513961792
binds O O 0.999923825263977
the O O 0.9999696016311646
CD28 B-DNA B-DNA 0.35624608397483826
response I-DNA I-DNA 0.4706907868385315
element E-DNA E-DNA 0.9537304639816284
within O O 0.9992571473121643
the O O 0.9999512434005737
interleukin-2 B-DNA B-DNA 0.8934811949729919
enhancer E-DNA E-DNA 0.9929730892181396
correlates O O 0.9860032200813293
with O O 0.9999839067459106
interleukin-2 S-protein S-protein 0.9343097805976868
production O O 0.9959671497344971
. O O 0.9999973773956299
Activation O O 0.9989722967147827
of O O 0.9999608993530273
T B-cell_type B-cell_type 0.7873533964157104
lymphocytes E-cell_type E-cell_type 0.9882752895355225
requires O O 0.9999270439147949
the O O 0.9999990463256836
combined O O 0.9933708906173706
signaling O O 0.9958068132400513
of O O 0.9999779462814331
the O O 0.999976396560669
T B-protein B-protein 0.33952081203460693
cell I-protein I-protein 0.3768676519393921

expression O O 0.9764560461044312
in O O 0.9998096823692322
B B-cell_type B-cell_type 0.9125288128852844
cells E-cell_type E-cell_type 0.9865128993988037
, O O 0.979712724685669
and O O 0.9999412298202515
the O O 0.9999912977218628
clustering O O 0.9903711676597595
of O O 0.9999167919158936
lesions O O 0.9765406250953674
disrupting O O 0.9998308420181274
its O O 0.9999854564666748

macrophage-like O B-cell_line 0.4588388204574585
PMA-differentiated B-cell_line I-cell_line 0.44680488109588623
U937 I-cell_line I-cell_line 0.7746777534484863
cells E-cell_line E-cell_line 0.9967281818389893
, O O 0.9843122363090515
as O O 0.9999938011169434
assessed O O 0.9966975450515747
by O O 0.9999912977218628
trypan O O 0.8736003041267395
blue O O 0.8514323830604553
exclusion O O 0.923374593257904
cell O O 0.8047568798065186
counting O O 0.986943244934082
, O O 0.9999701976776123
thymidine O O 0.6887537240982056

Northern O O 0.9244428277015686
blots O O 0.9214192032814026
. O O 0.9999933242797852
In O O 0.9999716281890869
PMA-treated B-cell_line B-cell_line 0.7804127335548401
THP-1 I-cell_line I-cell_line 0.8891635537147522
cells E-cell_line E-cell_line 0.9976075887680054
we O O 0.9984198808670044
could O O 0.9999986886978149
detect O O 0.9999980926513672
three O O 0.9987244009971619
major O O 0.9400485754013062
transcription B-DNA B-DNA 0.5958908200263977
initiation I-DNA I-DNA 0.564939558506012
sites E-DNA E-DNA 0.6172081232070923
as O O 0.9999690055847168
revealed O O 0.9998915195465088
by O O 0.9999973773956299
Nuclease O O 0.7773149609565735

IFN S-protein S-protein 0.9511732459068298
-MCP O O 0.46705320477485657
was O O 0.9997732043266296
blocked O O 0.9999592304229736
in O O 0.9999922513961792
Ad5 O B-cell_line 0.5798963904380798
E1A-transfected B-cell_line I-cell_line 0.5097560882568359

transcription B-protein B-protein 0.3841174840927124
factor I-protein E-protein 0.9609803557395935
AP-1 E-protein S-protein 0.6274974346160889
in O O 0.9998595714569092
human B-cell_line B-cell_line 0.5132161974906921
T I-cell_line I-cell_line 0.46018239855766296
lymphoid I-cell_line I-cell_line 0.5173177123069763
Jurkat I-cell_line I-cell_line 0.5114332437515259
cells E-cell_line E-cell_line 0.8551040291786194
. O O 0.9999274015426636
The O O 0.9999974966049194
induction O O 0.9988570213317871
of O O 0.9999916553497314
the O O 0.999945878982544
AP-1 S-protein S-protein 0.9016176462173462
transcription B-protein B-protein 0.583177387714386
factor E-protein E-protein 0.9692915678024292
has O O 0.9994603991508484
been O O 0.9999698400497437
ascribed O O 0.999931812286377
to O O 0.9999967813491821
the O O 0.9999955892562866
early O O 0.9259478449821472
events O O 0.9990173578262329
leading O O 0.9999879598617554
to O O 0.9999749660491943
T O O 0.6866143345832825
lymphocyte O O 0.8074662089347839
activation O O 0.990704357624054
. O O 0.999992847442627
We O O 0.9999889135360718
have O O 0.9999978542327881
examined O O 0.9999853372573853
the O O 0.999998927116394
possibility O O 0.9998985528945923
that O O 0.9999961853027344
stimulation O O 0.9926789999008179

nonlymphoid B-cell_type I-cell_type 0.2602875828742981
cells E-cell_type E-cell_type 0.6541815400123596
trans-activated B-DNA O 0.9002243876457214
reporter I-DNA B-DNA 0.6011936068534851
plasmids E-DNA E-DNA 0.9803506731987
that O O 0.9999046325683594
contained O O 0.999981164932251
the O O 0.9999368190765381
minimal O B-DNA 0.6710052490234375
mu B-DNA I-DNA 0.8322063684463501
enhancer E-DNA E-DNA 0.9925488233566284
. O O 0.9999330043792725
These O O 0.9999982118606567
results O O 0.999935507774353
implicate O O 0.9999986886978149
two O O 0.9997788071632385
members O O 0.9881064891815186
of O O 0.9998890161514282
the O O 0.9997792840003967
Ets B-protein B-protein 0.7637577652931213
family E-protein E-protein 0.8293723464012146
in O O 0.9983866214752197
the O O 0.9999878406524658
activation O O 0.9778424501419067
of O O 0.9993444085121155
IgH B-DNA B-DNA 0.7479892373085022
gene E-DNA E-DNA 0.9797956943511963
expression O O 0.9937772750854492
. O O 0.9999892711639404
1 O O 0.8966130614280701

to O O 0.9952427744865417
CD14 S-protein S-protein 0.9690186977386475
, O O 0.9996460676193237
a O O 0.9999816417694092
surface B-protein O 0.8968045711517334
receptor E-protein O 0.8458195328712463
that O O 0.9993570446968079
mediates O O 0.9998173117637634
many O O 0.9995754361152649
LPS O O 0.6791473031044006
responses O O 0.9385865330696106
, O O 0.9997313618659973
was O O 0.9999579191207886
found O O 0.9999707937240601
to O O 0.9999918937683105
be O O 0.9999910593032837
crucial O O 0.9997201561927795
, O O 0.9999802112579346
as O O 0.9999980926513672
pretreatment O O 0.9844469428062439
of O O 0.9998874664306641
THP-1 B-cell_line B-cell_line 0.7316428422927856
cells E-cell_line E-cell_line 0.964836597442627
with O O 0.9998775720596313
the O O 0.9999798536300659
monoclonal B-protein B-protein 0.5397005081176758
antibody I-protein I-protein 0.42694970965385437
60b E-protein E-protein 0.9143747091293335
, O O 0.9858501553535461
which O O 0.9999122619628906
blocks O O 0.9998681545257568
this O O 0.9999494552612305
binding O O 0.9869001507759094
, O O 0.999724805355072
inhibited O O 0.9980766773223877
JNK S-protein S-protein 0.9948339462280273
activation O O 0.9995986819267273
. O O 0.9999990463256836
These O O 0.9999986886978149
results O O 0.9999904632568359
suggest O O 0.9999994039535522
that O O 0.9999992847442627
LPS O O 0.9625141024589539
activation O O 0.9972937703132629
of O O 0.9999715089797974
JNK S-protein S-protein 0.983449399471283
in O O 0.9998583793640137
monocyte/macrophage B-cell_type B-cell_type 0.7927679419517517
cells E-cell_type E-cell_type 0.9477121829986572
is O O 0.9998620748519897

430-444 O O 0.6935948133468628
, O O 0.9967924952507019
442A O O 0.7817794680595398
has O O 0.9999184608459473
an O O 0.999977707862854
Asp O O 0.5428686141967773
to O O 0.9286584258079529
Ala O O 0.27904418110847473
substitution O O 0.8652047514915466
at O O 0.9999101161956787
position O B-DNA 0.37089598178863525
442 O E-DNA 0.5517931580543518
and O O 0.9129512906074524
binds O O 0.9760352373123169
to O O 0.9991974234580994
DQ0302 O O 0.6534634232521057
with O O 0.9999516010284424
a O O 0.9995002746582031
Kd O O 0.6008514761924744
similar O O 0.8704327940940857
to O O 0.9085238575935364
433-442 O O 0.8031175136566162
. O O 0.9990725517272949
The O O 0.9999954700469971
short O O 0.5042516589164734

activation O O 0.9799625873565674
of O O 0.9998513460159302
HIV-1 B-DNA B-DNA 0.41850224137306213
LTR E-DNA E-DNA 0.9988248944282532
in O O 0.9998282194137573
transiently O O 0.4318132996559143
or O O 0.8182015419006348
stably O B-cell_line 0.6893768906593323
transfected O I-cell_line 0.6357282400131226
cell B-cell_line I-cell_line 0.5402270555496216
lines E-cell_line E-cell_line 0.9975919723510742
is O O 0.9997830986976624
inhibited O O 0.9999613761901855
by O O 0.9999991655349731
a O O 0.9999948740005493
potent O O 0.9843832850456238
antioxidant O O 0.9009423851966858
drug O O 0.9465811848640442
, O O 0.9997208714485168
pyrrolidine O O 0.8869383335113525
dithiocarbamate O O 0.925387978553772
and O O 0.9987348914146423
by O O 0.9999896287918091
another O O 0.9999948740005493
drug O O 0.9945558309555054
, O O 0.9998615980148315

human O O 0.583096981048584
immunodeficiency O O 0.73835289478302
virus O O 0.7781575918197632
( O O 0.993506669998169
HIV O O 0.9929003715515137
) O O 0.9994291663169861
differs O O 0.9999793767929077
in O O 0.999942421913147
T B-cell_type B-cell_type 0.8192322254180908
lymphocytes E-cell_type E-cell_type 0.9846712946891785
and O O 0.9969992637634277
macrophages S-cell_type S-cell_type 0.9982555508613586
. O O 0.9998568296432495
In O O 0.9991931319236755
T B-cell_type B-cell_type 0.836662232875824
cells E-cell_type E-cell_type 0.9921843409538269
, O O 0.9994763731956482
HIV O O 0.723040759563446
transcription O O 0.9449215531349182
is O O 0.9999130964279175
poorly O O 0.9953716397285461
detected O O 0.999847412109375
in O O 0.9999086856842041
vivo O O 0.9948378205299377
. O O 0.9999876022338867
Cloned O O 0.5184307098388672
, O O 0.8157652020454407
normal O B-cell_type 0.4406146705150604
T B-cell_type I-cell_type 0.7842722535133362
lymphocytes E-cell_type E-cell_type 0.9438786506652832
show O O 0.9999486207962036
very O O 0.9995760321617126
little O O 0.9999231100082397
, O O 0.9999381303787231
if O O 0.9999915361404419
any O O 0.9999831914901733
, O O 0.9999029636383057
basal O O 0.7323550581932068

P O O 0.7921147346496582
< O O 0.9977236390113831
0.005 O O 0.9991243481636047
, O O 0.9999710321426392
n O O 0.9867510795593262
= O O 0.9996892213821411
4-6 O O 0.9957576394081116
) O O 0.9997608065605164
. O O 0.9999959468841553
As O O 0.999843955039978
in O O 0.9999772310256958
the O O 0.9999951124191284
adhesion O O 0.9528890252113342
studies O O 0.9916635751724243
, O O 0.9999855756759644
cortisol O O 0.7351521253585815
but O O 0.9808566570281982
not O O 0.9949193596839905
tetrahydrocortisol O O 0.8475562930107117
inhibited O O 0.9838778972625732
expression O O 0.9965246319770813
of O O 0.9999610185623169
ELAM-1 S-protein S-protein 0.9019492864608765
and O O 0.9910160303115845
ICAM-1 S-protein S-protein 0.9803712964057922
( O O 0.9924951791763306
both O O 0.9992734789848328

proliferative O O 0.9334200024604797
responses O O 0.9986769556999207
to O O 0.9999943971633911
recombinant B-protein B-protein 0.776953935623169
truncated I-protein I-protein 0.8516879081726074
glycoprotein I-protein I-protein 0.7289965152740479
B E-protein I-protein 0.8141905665397644
( O I-protein 0.8980059027671814
gB S-protein I-protein 0.6111499667167664
) O I-protein 0.6234185695648193
or O I-protein 0.8526222705841064
gD S-protein E-protein 0.6857250928878784
of O O 0.9829148054122925
HSV-2 O O 0.37920594215393066
or O O 0.993256688117981
purified O O 0.849871814250946
natural O O 0.9024597406387329
gC O O 0.31954941153526306
of O O 0.9642113447189331
HSV-2 O O 0.32403114438056946
comprised O O 0.9959903359413147
a O O 0.9999734163284302
minority O O 0.9976379871368408
of O O 0.9999954700469971
the O O 0.999996542930603
total O O 0.9951985478401184
number O O 0.9988940358161926
of O O 0.9999788999557495
HSV-specific B-cell_line B-cell_line 0.6826587319374084
clones E-cell_line E-cell_line 0.9931942224502563
isolated O O 0.9954633116722107
from O O 0.9999865293502808
lesions O O 0.9773545861244202
. O O 0.9999923706054688
The O O 0.9999938011169434

and O O 0.9376595616340637

identified O O 0.9765728116035461
homologues O O 0.8905389308929443
of O O 0.9983928799629211
STAT5 S-protein S-protein 0.9926638603210449
, O O 0.9915949702262878
STAT5A S-protein S-protein 0.9965483546257019
, O O 0.9901790618896484
and O O 0.9984110593795776
STAT5B S-protein S-protein 0.9957278966903687
, O O 0.9969636797904968
as O O 0.9999382495880127
well O O 0.9997697472572327
as O O 0.9999940395355225
lower O O 0.9899865984916687
molecular O O 0.9092336893081665
weight O O 0.8250532746315002
variants O O 0.5826066732406616
of O O 0.9993946552276611
STAT5 S-protein S-protein 0.9719067811965942
. O O 0.9999209642410278
To O O 0.9999905824661255
define O O 0.9999544620513916
the O O 0.9999885559082031
activation O O 0.9979566335678101
of O O 0.9999707937240601
the O O 0.9999639987945557
STAT5 B-protein B-protein 0.48296207189559937
homologues E-protein E-protein 0.770204484462738

which O O 0.994442880153656
was O O 0.9998939037322998
blocked O O 0.9999393224716187
by O O 0.9999985694885254
coincubation O O 0.9758342504501343
with O O 0.9999305009841919
spironolactone O O 0.9071370959281921
. O O 0.9998776912689209
In O O 0.9999716281890869
addition O O 0.9999839067459106
, O O 0.9999953508377075
the O O 0.9999901056289673
expression O O 0.997965931892395
of O O 0.9999783039093018
mineralocorticoid B-RNA B-RNA 0.9255815744400024
receptor I-RNA I-RNA 0.9653294682502747
mRNA E-RNA E-RNA 0.9802976846694946
in O O 0.9991727471351624
human O B-cell_type 0.6948307752609253
monocytes S-cell_type E-cell_type 0.9697780013084412
was O O 0.9997418522834778
observed O O 0.9999130964279175
by O O 0.9999983310699463
PCR O O 0.663006067276001
of O O 0.9955378770828247
reversed B-RNA O 0.8575689196586609
transcribed I-RNA O 0.8712985515594482
RNA E-RNA O 0.5993400812149048
. O O 0.9998179078102112
Our O O 0.9999988079071045
results O O 0.9999736547470093
further O O 0.9999984502792358
indicate O O 0.999998927116394
that O O 0.9999961853027344

neutrophils S-cell_type S-cell_type 0.6437854170799255
and O O 0.9993740916252136
the O O 0.9999959468841553
lung O O 0.6685015559196472
vascular O O 0.6612417697906494
leak O O 0.73538738489151
of O O 0.9981142282485962
albumin S-protein O 0.7478270530700684
. O O 0.9999133348464966
These O O 0.9999979734420776
in O O 0.9992844462394714
vivo O O 0.9944074153900146
anti-inflammatory O O 0.8530163764953613
effects O O 0.9968138337135315
of O O 0.9999791383743286
IL-11 S-protein S-protein 0.9832497239112854
were O O 0.999953031539917
associated O O 0.9998059868812561
with O O 0.9999969005584717
reduced O O 0.9904195666313171

demonstrate O O 0.9991503953933716
that O O 0.9999923706054688
Tax S-protein S-protein 0.9999139308929443
-stimulated O O 0.9980812072753906
nuclear O O 0.9741914868354797
expression O O 0.998921275138855
of O O 0.9999948740005493
NF-kappa B-protein B-protein 0.9321994185447693
B E-protein E-protein 0.9994556307792664
in O O 0.9999098777770996
both O O 0.9982976317405701
HTLV-I-infected B-cell_line B-cell_line 0.4644169807434082
and I-cell_line I-cell_line 0.44431072473526
Tax-transfected I-cell_line I-cell_line 0.35887327790260315
human I-cell_line I-cell_line 0.7077888250350952
T I-cell_line I-cell_line 0.7086189389228821
cells E-cell_line E-cell_line 0.6979713439941406
is O O 0.999222993850708
associated O O 0.9999098777770996
with O O 0.9999985694885254
the O O 0.9999957084655762
phosphorylation O O 0.9770153760910034
and O O 0.9995142221450806
rapid O O 0.9733846187591553
proteolytic O O 0.9621788263320923
degradation O O 0.9983534812927246
of O O 0.9999924898147583
I B-protein B-protein 0.901229202747345
kappa I-protein I-protein 0.9164862632751465
B I-protein I-protein 0.6030988097190857
alpha E-protein E-protein 0.9978317618370056
. O O 0.9998563528060913
In O O 0.9998136162757874
contrast O O 0.9997864365577698
to O O 0.9999845027923584
prior O O 0.9905726313591003
in O O 0.99973064661026

resistant O O 0.6626049280166626
. O O 0.9997550845146179
Gel O O 0.8317071795463562
shift O O 0.9823840856552124
analyses O O 0.9993237257003784
demonstrate O O 0.9999988079071045
that O O 0.9999991655349731
NF-kappa B-protein B-protein 0.829828679561615
B E-protein E-protein 0.9964855909347534
nuclear O O 0.970827043056488
translocation O O 0.9963956475257874
is O O 0.9999879598617554
stimulated O O 0.9995062351226807
primarily O O 0.9999762773513794
by O O 0.9999951124191284

: O O 0.8840867877006531

] O O 0.9710531830787659
of O O 0.9999343156814575
the O O 0.9999986886978149
body O O 0.9262985587120056
burden O O 0.9867842793464661
reference O O 0.9909884333610535
values O O 0.994864284992218
of O O 0.9999908208847046
a O O 0.9999679327011108
not O O 0.9991268515586853
particularly O O 0.988434910774231
exposed O O 0.9607387781143188
population O O 0.7745944857597351
show O O 0.9999891519546509
detectable O O 0.9938241243362427
deviations O O 0.9947174191474915
in O O 0.9999958276748657
these O O 0.9999885559082031
immunological O O 0.9258821606636047
variables O O 0.9807477593421936
, O O 0.9999915361404419
when O O 0.9999954700469971
compared O O 0.9998419284820557
with O O 0.9999978542327881
persons O O 0.9981433153152466
at O O 0.9999991655349731
the O O 0.9999985694885254
lower O O 0.9940958023071289

RAR B-DNA B-protein 0.20927099883556366
alpha E-DNA E-protein 0.8274834752082825
) O O 0.934452474117279
in O O 0.9999626874923706
the O O 0.9999878406524658
acute O O 0.84562748670578
promyelocytic O O 0.916450023651123
leukemia O O 0.9477569460868835
( O O 0.9962201714515686
APL O O 0.9894071221351624
) O O 0.9980564713478088
15 O O 0.9978131055831909
; O O 0.9995330572128296
17 O O 0.9946631193161011
translocation O O 0.9942460656166077
. O O 0.9999874830245972
PML S-protein S-protein 0.4567398428916931
is O O 0.9988849759101868
expressed O O 0.9998261332511902
in O O 0.9999773502349854
diverse O O 0.8951232433319092
tissues O O 0.9439411759376526
and O O 0.9985753297805786
cell O B-cell_line 0.8308602571487427
lines O E-cell_line 0.9501822590827942
and O O 0.9970362186431885
localized O O 0.5923236012458801

) O O 0.6286272406578064

) O O 0.7349106073379517
or O O 0.9929360747337341
PP2B S-protein S-protein 0.9415509700775146
( O O 0.997393012046814
cyclosporine O B-protein 0.48712781071662903
A O E-protein 0.7647000551223755
) O O 0.7997112274169922
. O O 0.999942421913147
Pretreatment O O 0.9815234541893005
with O O 0.999955415725708
the O O 0.9999806880950928
broad O O 0.9053939580917358
serine/threonine O O 0.7244431972503662
kinase O O 0.6998881697654724
inhibitor O O 0.6109443306922913
staurosporine O O 0.9119953513145447

DNA-binding B-protein B-protein 0.4152974784374237
domain E-protein E-protein 0.8997629880905151
of O O 0.9798840284347534
ZEBRA S-protein S-protein 0.9855625629425049
abolished O O 0.9989929795265198
this O O 0.9999686479568481
additional O O 0.995954155921936
function O O 0.9994612336158752
and O O 0.9999614953994751
uncovered O O 0.9999419450759888
a O O 0.9999961853027344
new O O 0.9990831613540649
role O O 0.9984460473060608
for O O 0.9999852180480957
the O O 0.9999197721481323
ZEBRA B-protein B-protein 0.6084824204444885
protein E-protein E-protein 0.9490862488746643
in O O 0.9984269142150879
disruption O O 0.9971364736557007
of O O 0.9999727010726929
EBV O O 0.8949877023696899
latency O O 0.9949197173118591
. O O 0.9999967813491821

binding O O 0.8555004596710205
to O O 0.9979627132415771
this O O 0.9999618530273438
sequence O O 0.9860864877700806
, O O 0.9999780654907227
only O O 0.9999902248382568
one O O 0.9999450445175171
of O O 0.9999938011169434
these O O 0.999953031539917
complexes O O 0.9259052276611328
is O O 0.9997056126594543
specific O O 0.9996055960655212
for O O 0.9999874830245972
both O O 0.9999881982803345
the O O 0.9998722076416016
CD28RE S-DNA S-protein 0.5688002705574036
and O O 0.9650718569755554
the O O 0.9927253723144531

also O O 0.987981379032135
induces O O 0.999842643737793
an O O 0.9999771118164062
array O O 0.9955717325210571
of O O 0.999963641166687
cellular B-DNA B-DNA 0.4311058223247528
genes E-DNA E-DNA 0.9888420104980469
. O O 0.9998257756233215
Tax S-protein S-protein 0.9994543194770813
-mediated O O 0.997385561466217
transformation O O 0.9995170831680298
of O O 0.9999809265136719
T B-cell_type B-cell_type 0.9164968132972717
cells E-cell_type E-cell_type 0.9894396662712097
likely O O 0.9994078874588013
involves O O 0.9999979734420776
the O O 0.9999978542327881
deregulated O O 0.8999096155166626
expression O O 0.9942530989646912
of O O 0.9999746084213257
various O O 0.9783796072006226
cellular B-DNA B-DNA 0.42204543948173523
genes E-DNA E-DNA 0.9547986388206482
that O O 0.9983437061309814
normally O O 0.9998133778572083
regulate O O 0.9998289346694946
lymphocyte S-cell_type O 0.46547040343284607
growth O O 0.6514374017715454
produced O O 0.9874963760375977

for O O 0.9977695941925049
EBNA B-DNA B-DNA 0.7259032726287842
gene E-DNA I-DNA 0.8975859880447388
promoter O E-DNA 0.9787896275520325
activity O O 0.9693050384521484
in O O 0.999963641166687
Epstein-Barr B-cell_line B-cell_line 0.8630856275558472
virus-immortalized I-cell_line I-cell_line 0.9269142150878906
lymphoblastoid I-cell_line I-cell_line 0.9797359704971313
cell I-cell_line I-cell_line 0.9657695889472961
lines E-cell_line E-cell_line 0.9994956254959106
. O O 0.9999678134918213
During O O 0.9999754428863525
Epstein-Barr O O 0.7566739916801453
virus O O 0.9128096103668213
latent O O 0.9408919811248779
infection O O 0.997231662273407
of O O 0.9999699592590332
B B-cell_type B-cell_type 0.7825921177864075
lymphocytes E-cell_type E-cell_type 0.9982407093048096
in O O 0.9998049139976501
vitro O O 0.9972457885742188
, O O 0.9999755620956421
six O O 0.9942964911460876
viral B-protein B-protein 0.8418380618095398
nuclear I-protein I-protein 0.5578204989433289
antigens E-protein E-protein 0.9946958422660828
( O O 0.9921356439590454
EBNAs S-protein S-protein 0.9866481423377991
) O O 0.9964545965194702
are O O 0.9999878406524658
expressed O O 0.9998974800109863
from O O 0.9999939203262329

an O O 0.9984033703804016
Ad5 O B-DNA 0.5301878452301025
E1A S-DNA I-DNA 0.5892183184623718
deletion O I-DNA 0.4909009635448456
mutant O E-DNA 0.845291256904602
, O O 0.9765452742576599
dl343 O O 0.24526533484458923
, O O 0.9757247567176819
or O O 0.9984361529350281
transfected O O 0.9143396019935608
with O O 0.9996503591537476
the O O 0.9999722242355347
Ad5 B-DNA B-DNA 0.4913696050643921
E1A I-DNA I-DNA 0.6470916867256165
gene E-DNA E-DNA 0.9935382008552551
. O O 0.9995031356811523
IFN S-protein S-protein 0.9792287349700928
-MCP O O 0.4988972544670105
was O O 0.9997857213020325
not O O 0.99981290102005
inhibited O O 0.9999752044677734
by O O 0.9999980926513672
infection O O 0.997164785861969
with O O 0.9999825954437256
dl343 O O 0.507340133190155
, O O 0.9978907704353333
despite O O 0.9999971389770508
the O O 0.9999978542327881
production O O 0.999891996383667
of O O 0.9999967813491821
large O O 0.853833019733429
amounts O O 0.997276246547699
of O O 0.9999817609786987
both O O 0.9999030828475952

lymphoma I-cell_line O 0.5298558473587036
or I-cell_line O 0.9947168231010437
human I-cell_line B-cell_line 0.7012909054756165
embryonic I-cell_line I-cell_line 0.5458489656448364
kidney I-cell_line I-cell_line 0.3914305865764618
293 I-cell_line I-cell_line 0.6075526475906372
cells E-cell_line E-cell_line 0.9416998028755188
. O O 0.9999240636825562
These O O 0.9999995231628418
results O O 0.9999570846557617
add O O 0.9999988079071045
a O O 0.9999983310699463
different O O 0.9999628067016602

long I-DNA I-DNA 0.42430031299591064
terminal I-DNA I-DNA 0.7922934889793396
repeats E-DNA E-DNA 0.9940164089202881
, O O 0.9998723268508911
reflecting O O 0.9999427795410156
p100 S-protein S-protein 0.990753173828125
-mediated O O 0.997477114200592
cytoplasmic O O 0.9288526177406311
sequestration O O 0.9753608703613281
of O O 0.9997435212135315
the O O 0.9999804496765137
normally O B-protein 0.6584850549697876
nuclearly O I-protein 0.5881890058517456
expressed O I-protein 0.6084024310112
Tax B-protein I-protein 0.560701847076416
protein E-protein E-protein 0.9955801367759705
. O O 0.9998169541358948
In O O 0.9999117851257324
contrast O O 0.9998581409454346
, O O 0.9999781847000122
a O O 0.999982476234436
mutant O O 0.5626046657562256
of O O 0.780152440071106
Tax S-protein S-protein 0.7503119111061096
that O O 0.9994945526123047
selectively O O 0.9799664616584778
fails O O 0.9987001419067383
to O O 0.9998006224632263
activate O O 0.9992184638977051
nuclear O B-protein 0.6862883567810059
NF-kappa B-protein I-protein 0.8334618210792542
B E-protein E-protein 0.953673243522644

promoter E-DNA E-DNA 0.9655675888061523
. O O 0.9998762607574463
Furthermore O O 0.9999600648880005
, O O 0.9999638795852661
as O O 0.999984860420227
a O O 0.9999935626983643
consequence O O 0.9999462366104126
of O O 0.9999991655349731
the O O 0.9999996423721313
increased O O 0.9982688426971436
HB24 B-RNA B-RNA 0.8199112415313721
mRNA E-RNA E-RNA 0.9920146465301514
levels O O 0.9966129660606384
, O O 0.999996542930603
the O O 0.9999750852584839
Jurkat B-cell_line B-cell_line 0.8967289328575134
HB24 I-cell_line I-cell_line 0.7166260480880737
transfectants E-cell_line E-cell_line 0.9868908524513245
proliferated O O 0.9935293793678284
more O O 0.999830961227417
rapidly O O 0.9993999004364014
than O O 0.9999852180480957
control B-cell_line B-cell_line 0.8391862511634827
cell I-cell_line I-cell_line 0.7313871383666992
lines E-cell_line E-cell_line 0.9928638935089111
. O O 0.9999421834945679
Thus O O 0.9979583024978638

the O O 0.9985550045967102
variant B-DNA B-DNA 0.7508093118667603
allele E-DNA E-DNA 0.8975735902786255
can O O 0.9993007183074951
serve O O 0.9999864101409912
as O O 0.9999936819076538
a O O 0.9999892711639404
primary O O 0.951295793056488
tool O O 0.9956379532814026
for O O 0.9999707937240601

this O O 0.999160647392273
variant O O 0.8861434459686279
octamer B-DNA B-DNA 0.32297495007514954
motif E-DNA E-DNA 0.9475744962692261
in O O 0.9999147653579712
the O O 0.9999645948410034

lamin I-RNA I-RNA 0.5926761031150818
C I-RNA I-RNA 0.7133618593215942
, I-RNA I-RNA 0.7812090516090393
and I-RNA I-RNA 0.5792775750160217
vimentin I-RNA I-RNA 0.956762433052063
transcripts E-RNA E-RNA 0.9938675761222839
. O O 0.9999130964279175
Other O O 0.9999983310699463
studies O O 0.9998433589935303
have O O 0.9999995231628418
demonstrated O O 0.9999908208847046
that O O 0.9999979734420776
TPA-induced O O 0.8025224804878235
monocytic O O 0.883920431137085
differentiation O O 0.9984961748123169
and O O 0.9999868869781494
expression O O 0.9993707537651062
of O O 0.9999949932098389
the O O 0.9999425411224365
c-jun S-DNA B-DNA 0.803179144859314
and O I-DNA 0.5878400206565857
c-fos B-DNA I-DNA 0.6548665165901184
genes E-DNA E-DNA 0.992238461971283
in O O 0.9997566342353821
myeloid B-cell_type B-cell_type 0.49095630645751953
leukemia I-cell_type I-cell_type 0.7351022362709045
cells E-cell_type E-cell_type 0.9075387120246887
are O O 0.9998997449874878
regulated O O 0.9996219873428345

) O O 0.7876173257827759
in O O 0.9967750906944275
B B-cell_type B-cell_type 0.7417617440223694
cells E-cell_type E-cell_type 0.9729301929473877
transfected O O 0.993099570274353
with O O 0.9999873638153076
epitope-tagged B-DNA B-DNA 0.6411264538764954
nucleolin I-DNA I-DNA 0.23254835605621338
expression I-DNA I-DNA 0.6546723246574402
constructs E-DNA E-DNA 0.9899601936340332
, O O 0.9999653100967407
the O O 0.9999943971633911
LR1-DNA B-protein B-protein 0.5975342392921448
complex E-protein E-protein 0.9931221604347229
was O O 0.9997550845146179
recognized O O 0.9999758005142212
by O O 0.9999990463256836
the O O 0.9999593496322632
anti-tag B-protein B-protein 0.7832940220832825
antibody E-protein E-protein 0.9860289692878723
. O O 0.9988484382629395
Nucleolin S-protein S-protein 0.871466338634491
is O O 0.9997476935386658
an O O 0.9999872446060181
abundant B-protein O 0.978597104549408
nucleolar I-protein O 0.7136660218238831

on O O 0.9990641474723816
SIVmac O O 0.5223267078399658
replication O O 0.9099432229995728
in O O 0.9999423027038574
primary B-cell_line B-cell_line 0.503810703754425
macrophage I-cell_line I-cell_line 0.6740210652351379
cultures E-cell_line E-cell_line 0.8984760046005249
. O O 0.9999644756317139
Analysis O O 0.9999877214431763
of O O 0.9999971389770508
long B-DNA B-DNA 0.4595337212085724
terminal I-DNA I-DNA 0.7849797606468201
repeat E-DNA E-DNA 0.9958782196044922
-driven O O 0.9813118577003479

closely O O 0.9310778379440308

uncover O O 0.9982450008392334
the O O 0.9999960660934448
influence O O 0.9990724325180054
of O O 0.9999794960021973
platelet-activating B-protein B-protein 0.575078010559082
factor E-protein E-protein 0.9645833373069763
on O O 0.9957196116447449
B B-cell_type B-cell_type 0.5523638129234314
lymphocytes E-cell_type E-cell_type 0.9780088663101196
. O O 0.9999494552612305
Employing O O 0.9999788999557495
the O O 0.999975323677063
EBV-transformed B-cell_line B-cell_line 0.8007326126098633
human I-cell_line I-cell_line 0.9058322310447693
B I-cell_line I-cell_line 0.9659621119499207
cell I-cell_line I-cell_line 0.9650694727897644
line E-cell_line I-cell_line 0.9193133115768433
SKW6.4 S-cell_line E-cell_line 0.9601613283157349
, O O 0.9980657696723938
we O O 0.9999501705169678
demonstrate O O 0.9999972581863403
that O O 0.9999969005584717
platelet-activating B-protein B-protein 0.6443651914596558
factor E-protein E-protein 0.9898508787155151
significantly O O 0.999294638633728
alters O O 0.9996287822723389
membrane O O 0.8161669373512268
phospholipid O O 0.8372854590415955
metabolism O O 0.9866112470626831
indicated O O 0.9999494552612305
by O O 0.9999988079071045
the O O 0.9999752044677734
incorporation O O 0.984331488609314
of O O 0.9996917247772217
32P O O 0.27825435996055603
into O O 0.9894363880157471
phosphatidylcholine O O 0.37314242124557495
, O O 0.9018968939781189
phosphatidylinositol O O 0.664239764213562
, O O 0.9602713584899902
and O O 0.995729386806488
phosphatidic O O 0.9391173124313354
acid O O 0.9786020517349243

on O O 0.9996547698974609
the O O 0.9999988079071045
intracellular O O 0.9045438766479492
concentrations O O 0.993374764919281
of O O 0.9999916553497314
sodium O O 0.9176463484764099
, O O 0.9974269270896912
potassium O O 0.976482093334198
and O O 0.9993619322776794
calcium O O 0.9796085953712463
, O O 0.9997809529304504
cell O O 0.9578331708908081
volume O O 0.9927265644073486
and O O 0.999932050704956
the O O 0.9999872446060181
sodium-proton-antiport S-protein S-protein 0.8489697575569153
have O O 0.9992260932922363
been O O 0.9999650716781616
described O O 0.9999594688415527
in O O 0.9999680519104004
intact O B-cell_type 0.4669414460659027
human B-cell_type I-cell_type 0.43675747513771057
mononuclear I-cell_type I-cell_type 0.9430635571479797
leukocytes E-cell_type E-cell_type 0.9979315996170044
( O O 0.9976565837860107
HML S-cell_type S-cell_type 0.9934250116348267
) O O 0.981074869632721
. O O 0.9999921321868896
In O O 0.9999665021896362
the O O 0.9999903440475464

monocytic B-cell_line I-cell_line 0.4683075547218323
cell I-cell_line I-cell_line 0.7105484008789062
line E-cell_line E-cell_line 0.9930499792098999
( O O 0.9990310668945312
Singh O O 0.7828898429870605
and O O 0.9951580166816711
Aggarwal O O 0.6904251575469971
, O O 0.9994655251502991
J. O O 0.9959198236465454
Biol. O O 0.9999561309814453
Chem. O O 0.9970111846923828
1995 O O 0.9996321201324463
: O O 0.9999879598617554
270 O O 0.9998125433921814
: O O 0.9999697208404541
10631 O O 0.9990167617797852
) O O 0.9999344348907471
. O O 0.9999982118606567
Since O O 0.9999920129776001
TNF S-protein S-protein 0.9649345278739929
is O O 0.9995778203010559

IKK S-protein B-protein 0.9215295314788818
kinase O E-protein 0.8579500913619995
activity O O 0.9742951393127441
, O O 0.9996393918991089
and O O 0.9999796152114868
prevent O O 0.9999200105667114
the O O 0.9999959468841553
degradation O O 0.9991931319236755
of O O 0.9999891519546509
IkappaBalpha S-protein S-protein 0.9940692186355591
and O O 0.9982178807258606
IkappaBbeta S-protein S-protein 0.9960607886314392
in O O 0.9998185038566589
activated O B-cell_type 0.6276570558547974
endothelial O I-cell_type 0.6579470634460449
cells O E-cell_type 0.9421340227127075
. O O 0.9998918771743774
Furthermore O O 0.9999973773956299
, O O 0.9999914169311523
myricetin O O 0.5753726363182068
was O O 0.9993599057197571
also O O 0.9999810457229614
found O O 0.9999909400939941

and O O 0.9843787550926208
alpha O O 0.8636813759803772
THF/THF O O 0.8033885955810547
( O O 0.9973102807998657
0.35 O O 0.9933761954307556
; O O 0.999734103679657
N O O 0.9986187219619751
: O O 0.999790608882904
0.92+/-0.42 O O 0.9994311928749084
) O O 0.9997500777244568
ratios O O 0.9995065927505493
. O O 0.9999995231628418
The O O 0.999998927116394
number O O 0.9994490742683411
of O O 0.9999916553497314
mineralocorticoid B-protein B-protein 0.7962644100189209
receptors E-protein E-protein 0.9984418749809265
in O O 0.9997689127922058
mononuclear B-cell_type B-cell_type 0.8909993171691895
leukocytes E-cell_type E-cell_type 0.9913705587387085
was O O 0.9998770952224731
in O O 0.9999772310256958
the O O 0.9999980926513672
lower O O 0.9974884986877441
normal O O 0.9536053538322449
range O O 0.9989896416664124
for O O 0.999994158744812
age O O 0.9972112774848938
, O O 0.9999730587005615
while O O 0.9999974966049194
the O O 0.9999982118606567
number O O 0.9991016387939453
of O O 0.9999829530715942
glucocorticoid B-protein B-protein 0.8345767259597778

cells E-cell_type E-cell_type 0.5244508385658264
. O O 0.9997615218162537
Unlike O O 0.9999748468399048
IL-12 S-protein S-protein 0.9860849380493164
, O O 0.998609185218811
which O O 0.999804675579071
acts O O 0.9997115731239319
only O O 0.9999784231185913
on O O 0.9997703433036804
Th1 B-cell_type B-cell_type 0.6156138777732849
cells E-cell_type E-cell_type 0.8475752472877502
, O O 0.9990079998970032
IFN-alpha/beta S-protein S-protein 0.9957529306411743
can O O 0.9999282360076904
activate O O 0.9999696016311646
Stat4 S-protein S-protein 0.9827644228935242

10 O O 0.8733519315719604
( O O 0.9965612292289734
-7 O O 0.9984723925590515
) O O 0.9996156692504883
mol/L O O 0.9884980320930481
1 O O 0.9768314957618713
, O O 0.999686598777771
25 O O 0.9985560774803162
( O O 0.9999542236328125
OH O O 0.9975837469100952
) O O 0.999660849571228
2D3 O O 0.9991313815116882
for O O 0.9999872446060181
24 O O 0.9983445405960083
to O O 0.9998781681060791
72 O O 0.9996660947799683
hours O O 0.9995964169502258
, O O 0.9999767541885376
and O O 0.999964714050293
levels O O 0.9995726943016052
of O O 0.9999667406082153
expression O O 0.9986594915390015

nervosa O O 0.7969838976860046
as O O 0.9977428913116455
well O O 0.9998202919960022
as O O 0.9999969005584717
in O O 0.9998328685760498
Cushing O O 0.7824411392211914
's O O 0.9880837798118591
patients O O 0.9984257221221924
compared O O 0.9999691247940063
to O O 0.9999841451644897
control O O 0.969218909740448
subjects O O 0.9341281652450562
( O O 0.9998536109924316
dissociation O O 0.9017748236656189
constant O O 0.9657121896743774

of O O 0.9925521612167358

mechanisms O O 0.9460081458091736
controlling O O 0.99996018409729
the O O 0.9999967813491821
pattern O O 0.9967489242553711
of O O 0.9999377727508545
alpha B-protein B-protein 0.3675287961959839
4 E-protein E-protein 0.95451420545578
expression O O 0.9963001608848572
. O O 0.9999982118606567
The O O 0.9999988079071045
activity O O 0.9964602589607239
of O O 0.9999381303787231
constructs O O 0.8556811213493347
containing O O 0.9973927736282349
5 B-DNA O 0.3816309869289398

between O O 0.9971523284912109
the O O 0.999980092048645
enhancer O O 0.6766951680183411
core O O 0.44254255294799805
of O O 0.9794259667396545
SL3 O S-DNA 0.6866081953048706
and O O 0.9774180054664612
the O O 0.9989880919456482
core O O 0.42786353826522827
of O O 0.9617162942886353
the O O 0.9990553259849548
nonleukemogenic O O 0.7641237378120422
virus O O 0.6876335144042969
, O O 0.998370349407196
Akv O O 0.9194965958595276
. O O 0.9999285936355591
This O O 0.9999847412109375
difference O O 0.9998334646224976
strongly O O 0.9999537467956543
affects O O 0.9999860525131226
transcription O O 0.9614807367324829
in O O 0.9994696974754333
T O B-cell_type 0.9085498452186584
cells O E-cell_type 0.992168128490448
and O O 0.996141254901886
leukemogenicity O O 0.8927539587020874
of O O 0.9985060691833496
SL3 S-DNA S-protein 0.4382951855659485
. O O 0.999119222164154
However O O 0.9999728202819824
, O O 0.9999728202819824
no O O 0.9997736811637878

and O O 0.9361099004745483
VCAM-1 B-RNA B-RNA 0.7273455262184143
mRNA E-RNA E-RNA 0.9972056746482849
expression O O 0.9967514276504517
. O O 0.9999979734420776
This O O 0.9999834299087524
may O O 0.999974250793457
have O O 0.9999957084655762
implications O O 0.9999873638153076
for O O 0.9999939203262329
pathophysiological O O 0.975837230682373
conditions O O 0.9986792206764221
that O O 0.9999982118606567
involve O O 0.9999990463256836
the O O 0.9999972581863403
upregulation O O 0.9990556836128235
of O O 0.9999963045120239
these O O 0.9999740123748779
molecules O O 0.8577057123184204
( O O 0.995063841342926
e.g. O O 0.9927911758422852

next O O 0.977405846118927
6 O O 0.9919785261154175
hr O O 0.97055983543396
. O O 0.9999676942825317
In O O 0.9999604225158691
freshly O O 0.6275762915611267
isolated O O 0.7099975347518921
cells O O 0.652546226978302
, O O 0.9991506338119507
both O O 0.9999829530715942
FOS B-RNA O 0.30264535546302795
and I-RNA O 0.9695735573768616
FOSB I-RNA S-DNA 0.5028282999992371

pertussis O O 0.7806065082550049
toxin O O 0.784088134765625
inhibited O O 0.9995713829994202
these O O 0.9999902248382568
functions O O 0.9991704225540161
of O O 0.9999885559082031
PAF S-protein S-protein 0.9652284979820251
, O O 0.9990745782852173
whereas O O 0.9999946355819702
cholera O B-protein 0.5309213399887085
toxin O E-protein 0.8887777328491211
had O O 0.9993379712104797
no O O 0.9999748468399048
inhibitory O O 0.9569244384765625
effect O O 0.9995359182357788
. O O 0.9999970197677612
Pyrrolidine O O 0.9175320863723755
dithiocarbamate O O 0.9688328504562378
, O O 0.9995964169502258
an O O 0.9999728202819824
inhibitor O O 0.9876403212547302
for O O 0.9998108744621277
NF-kappa B-protein B-protein 0.8303825855255127
B E-protein E-protein 0.9984108209609985
activation O O 0.9962279796600342
, O O 0.9999685287475586
markedly O O 0.9989799857139587
reduced O O 0.9997394680976868
PAF S-protein S-protein 0.9977516531944275
-stimulated O O 0.9963091015815735
kappa O B-protein 0.8713069558143616
B O E-protein 0.8529571890830994
binding O O 0.9303075075149536
activity O O 0.9982095956802368
as O O 0.9999923706054688
well O O 0.9999221563339233
as O O 0.9999979734420776
up-regulation O O 0.9892470240592957
of O O 0.9997612833976746
HB-EGF B-RNA B-RNA 0.988965630531311
mRNA E-RNA E-RNA 0.9983148574829102
. O O 0.9998682737350464
These O O 0.9999983310699463
results O O 0.9998902082443237

expressed O O 0.9570366144180298
c-myb B-RNA B-RNA 0.9855807423591614
mRNA E-RNA E-RNA 0.9944948554039001
, O O 0.9827405214309692
and O O 0.9999308586120605
50 O O 0.9197434186935425
% O O 0.9953632354736328
of O O 0.9999892711639404
them O O 0.9997976422309875
began O O 0.9993174076080322
to O O 0.9998642206192017
synthesize O O 0.9985641837120056
hemoglobin S-protein S-protein 0.8619291186332703

patients O O 0.9846411347389221
whose O O 0.9999821186065674
infiltration O O 0.998578667640686
of O O 0.9999816417694092
c-fos-positive B-protein B-cell_type 0.296110600233078
lymphocytes E-protein E-cell_type 0.7930459976196289
into O O 0.9998224377632141
tumor O O 0.5225816965103149
tissues O O 0.7876653075218201
were O O 0.9998942613601685
moderate O O 0.993144154548645
or O O 0.9993927478790283
remarkable O O 0.9992029070854187
at O O 0.9999986886978149
4 O O 0.9984983205795288
Gy O O 0.9948999285697937
of O O 0.9999285936355591
radiotherapy O O 0.9749793410301208
, O O 0.9999619722366333
the O O 0.9999958276748657
tumors O O 0.9645208716392517
responded O O 0.9997974038124084
significantly O O 0.9999946355819702
well O O 0.9999920129776001
to O O 0.9999955892562866
radiation O O 0.9850034117698669
therapy O O 0.998771607875824
( O O 0.999861478805542
P O O 0.9704290628433228
< O O 0.9955396056175232

gene O O 0.8100554943084717
expression O O 0.9910936951637268
from O O 0.9999967813491821
a O O 0.9999556541442871
CAT B-DNA B-DNA 0.946765124797821
reporter I-DNA I-DNA 0.6637318134307861
construct E-DNA E-DNA 0.9971035122871399
by O O 0.9998555183410645
increasing O O 0.9999321699142456
the O O 0.9999938011169434
amount O O 0.9998551607131958
of O O 0.9999680519104004
cytoplasmic B-RNA B-RNA 0.9038431644439697
CAT I-RNA I-RNA 0.9484913945198059
mRNA E-RNA E-RNA 0.9971823692321777
. O O 0.9998168349266052
Mutagenesis O O 0.9879379868507385
of O O 0.9999197721481323
the O O 0.9999394416809082
CKII S-protein B-DNA 0.8182308077812195
site O E-DNA 0.9931867122650146
in O O 0.9998656511306763
SM S-protein O 0.20659348368644714
made O O 0.9749178886413574
no O O 0.9999127388000488
difference O O 0.9999966621398926
to O O 0.9999985694885254
the O O 0.9999809265136719

Jun S-protein S-protein 0.8749260306358337
at O O 0.9992781281471252
each O O 0.9999395608901978
data O O 0.8135114312171936
point O O 0.503155529499054
compared O O 0.9996911287307739
with O O 0.9999672174453735
cells O O 0.9593633413314819
from O O 0.999975323677063
young O O 0.9793537855148315
donors O O 0.9849092364311218
. O O 0.9999961853027344
Flow O O 0.878288745880127
cytometric O O 0.9775136709213257
analysis O O 0.9996911287307739
also O O 0.9999929666519165
showed O O 0.9999986886978149
that O O 0.9999985694885254
at O O 0.9999899864196777
72 O O 0.9506123065948486
h O O 0.9885045886039734
of O O 0.9998810291290283
virus O O 0.9902903437614441
exposure O O 0.9995061159133911
fewer O O 0.9996912479400635
T B-cell_type B-cell_type 0.880014955997467
cells E-cell_type E-cell_type 0.9967020153999329
from O O 0.9997687935829163
the O O 0.9999920129776001

these O O 0.9965234398841858
cells O O 0.9594330191612244
. O O 0.999983549118042
IL-2 S-protein S-protein 0.7137756943702698
binding O O 0.8676892518997192
analysis O O 0.9986093044281006
demonstrated O O 0.9999963045120239
that O O 0.9999984502792358
IL-2 S-protein S-protein 0.9576844573020935
markedly O O 0.9992031455039978
increased O O 0.9999769926071167
the O O 0.9999971389770508
number O O 0.9997467398643494
of O O 0.999993085861206
low O B-protein 0.7440943121910095
affinity O I-protein 0.5906044840812683
IL-2Rs S-protein E-protein 0.7956278324127197
on O O 0.9997937083244324
the O O 0.9998692274093628
leukemia B-cell_type B-cell_type 0.6623378396034241
cells E-cell_type E-cell_type 0.9728073477745056
, O O 0.9970124959945679
without O O 0.9999878406524658
an O O 0.9999974966049194
effect O O 0.9999970197677612
on O O 0.9999995231628418
the O O 0.999997615814209
number O O 0.9991915822029114
of O O 0.99998939037323
high-affinity B-protein O 0.4817691147327423

not O O 0.9789824485778809
result O O 0.9997650980949402
in O O 0.9999949932098389
appearance O O 0.9987776875495911
of O O 0.9999799728393555
NF-MATp35 S-protein S-protein 0.9646969437599182
. O O 0.9998687505722046
These O O 0.9999969005584717
results O O 0.9999305009841919
indicate O O 0.9999991655349731
that O O 0.9999977350234985
mitogenic O O 0.7758051156997681
combinations O O 0.8919886946678162
of O O 0.9999475479125977
T O O 0.6879563927650452
cell O O 0.6079404950141907
activation O O 0.9443178772926331
signals O O 0.996250569820404
are O O 0.9999973773956299
integrated O O 0.9984851479530334
at O O 0.9999969005584717
the O O 0.9999985694885254
level O O 0.9993164539337158

in O O 0.9989314675331116
heat B-protein B-protein 0.6215757131576538
shock I-protein I-protein 0.6700984835624695
proteins E-protein E-protein 0.938914954662323
, O O 0.9998601675033569
we O O 0.9998767375946045
obtained O O 0.9998712539672852
saturable O O 0.9049907326698303
binding O O 0.9292541742324829
of O O 0.9986461997032166
[ O O 0.9809562563896179
3H O O 0.8415729999542236
] O O 0.9445421099662781
aldosterone O O 0.9656649827957153
. O O 0.9999818801879883
The O O 0.9999948740005493

find O O 0.9989284873008728
that O O 0.9999942779541016
LMP1 S-protein S-protein 0.9683032035827637
signaling O O 0.9976592063903809
through O O 0.9999755620956421
TRADD S-protein S-protein 0.9004231095314026
differs O O 0.9997449517250061
from O O 0.999988317489624
TNFR1 S-protein S-protein 0.9051287174224854
signaling O O 0.9969929456710815
through O O 0.9999827146530151
TRADD S-protein S-protein 0.9347421526908875
. O O 0.9997335076332092
LMP1 S-protein S-protein 0.9564206600189209
needs O O 0.9997574687004089
only O O 0.999962568283081
11 O O 0.8894847631454468
amino O O 0.8637052178382874
acids O O 0.8396540880203247
to O O 0.9992603659629822
activate O O 0.9985979199409485
NF-kappaB S-protein S-protein 0.9910007119178772
or O O 0.9960365891456604
synergize O O 0.9288892149925232

binding I-protein O 0.7511973977088928
domain E-protein O 0.4901025593280792
and O O 0.9501758813858032
p65 B-protein B-protein 0.874761700630188
activation I-protein I-protein 0.8262509107589722
domain E-protein E-protein 0.8044800758361816
) O O 0.8854180574417114
expression O O 0.8842722773551941
vectors O O 0.6847718358039856
, O O 0.9994838237762451
respectively O O 0.9996175765991211
, O O 0.9997772574424744
and O O 0.9998000264167786
neither O O 0.9994138479232788

agents O O 0.9690179228782654
that O O 0.9999779462814331
increase O O 0.9999805688858032
cAMP O O 0.8958126306533813
concentrations O O 0.9893198013305664
such O O 0.9999954700469971
as O O 0.999994158744812
dibutyryl O O 0.8826287984848022
cAMP O O 0.9513826370239258
, O O 0.9997043013572693
forskolin O O 0.9291490912437439
and O O 0.9992249011993408
prostaglandin O O 0.9863459467887878
E2 O O 0.968509316444397
. O O 0.9999916553497314
These O O 0.9999980926513672
stable O O 0.9089611768722534
Jurkat B-cell_line B-cell_line 0.7731230854988098
cell I-cell_line I-cell_line 0.503551185131073
clones E-cell_line E-cell_line 0.9988632202148438
provide O O 0.9999195337295532
a O O 0.9999967813491821
convenient O O 0.9932361245155334
and O O 0.9990142583847046
sensitive O O 0.9937443137168884
tool O O 0.9972423315048218
to O O 0.9999914169311523
study O O 0.9999709129333496
NFAT S-protein S-protein 0.9916757345199585
regulation O O 0.9997977614402771
. O O 0.9999982118606567

male O O 0.9289100766181946
patient O O 0.9795612692832947
presented O O 0.999541163444519
with O O 0.9999706745147705
mild O O 0.9565773010253906
hypertension O O 0.9987863898277283
. O O 0.9999980926513672
Hydrochlorothiazide O O 0.8784223198890686
therapy O O 0.9983555674552917
resulted O O 0.9999969005584717
in O O 0.9999959468841553
life-threatening O O 0.9457300901412964
hypokalemia O O 0.977569043636322
. O O 0.999990701675415
The O O 0.999995231628418

, O O 0.9373978972434998

signaling O O 0.9540445804595947
pathways O O 0.9988139867782593
requires O O 0.9999909400939941
SLP-76 S-protein S-protein 0.9872205853462219
. O O 0.9999392032623291
A O O 0.9999127388000488
novel O O 0.9719257950782776
function O O 0.9972262978553772
of O O 0.9999356269836426
Stat1 S-protein S-protein 0.9765830039978027
and O O 0.9870038628578186
Stat3 S-protein B-protein 0.8720472455024719
proteins O E-protein 0.9530245661735535
in O O 0.9997885823249817
erythropoietin S-protein S-protein 0.975145161151886
-induced O O 0.9964686632156372
erythroid O O 0.8529151082038879
differentiation O O 0.9938241243362427
of O O 0.999976396560669
a O O 0.9999440908432007
human B-cell_line B-cell_line 0.6864668130874634
leukemia I-cell_line I-cell_line 0.9594805836677551
cell I-cell_line I-cell_line 0.9826929569244385
line E-cell_line E-cell_line 0.9944000840187073
. O O 0.99992835521698
We O O 0.9999758005142212
recently O O 0.9999854564666748
determined O O 0.9999983310699463
that O O 0.9999988079071045
erythropoietin S-protein S-protein 0.9888845682144165
( O O 0.9952788352966309
EPO S-protein S-protein 0.9831923842430115
) O O 0.9835468530654907
activates O O 0.9996451139450073
3 O O 0.8009675741195679
members O O 0.767137885093689
of O O 0.9957610964775085
the O O 0.9992563128471375
signal O B-protein 0.6006261706352234
transducer O I-protein 0.6312311887741089
and O I-protein 0.8302310705184937
activator O I-protein 0.8954364657402039
of O I-protein 0.9949092268943787
transcription O I-protein 0.7567591667175293
( O I-protein 0.6425991058349609
STAT O I-protein 0.9087896347045898
) O I-protein 0.89023357629776
family O E-protein 0.9789162874221802
, O O 0.9846475124359131
Stat1alpha S-protein S-protein 0.9809839725494385
, O O 0.9896194338798523
Stat3 S-protein S-protein 0.9940690994262695
, O O 0.9901995062828064
and O O 0.9981101751327515
Stat5 S-protein S-protein 0.9947150349617004
, O O 0.9977177381515503
in O O 0.9999915361404419
the O O 0.9999494552612305
human B-cell_line B-cell_line 0.7068259119987488
EPO-dependent I-cell_line I-cell_line 0.8987582921981812
cell I-cell_line I-cell_line 0.957673192024231
lines E-cell_line E-cell_line 0.9992412328720093
, O O 0.994579553604126
UT-7 S-cell_line S-cell_line 0.9977510571479797
and O O 0.991450846195221
UT-7/EPO S-cell_line S-cell_line 0.9793699383735657

to O O 0.99695885181427
transactivation O O 0.9844979643821716
by O O 0.9999005794525146
Tat S-protein S-protein 0.975899875164032
. O O 0.9996265172958374
In O O 0.999942421913147
addition O O 0.9999732971191406
, O O 0.9999972581863403
the O O 0.999992847442627
SIV B-DNA B-DNA 0.5159508585929871
TATA I-DNA I-DNA 0.5180245041847229
box E-DNA E-DNA 0.9954494833946228
was O O 0.9996455907821655
shown O O 0.9999434947967529
to O O 0.9999905824661255
be O O 0.9999922513961792
stronger O O 0.9999368190765381
than O O 0.9999960660934448
that O O 0.9999961853027344
of O O 0.9999700784683228

initiates O O 0.9947082996368408
murine O O 0.6740030646324158
acute O O 0.9015306234359741
promyelocytic O O 0.9292775392532349
leukemia O O 0.9883579611778259
. O O 0.9999964237213135
The O O 0.9999973773956299
malignant B-cell_type B-cell_type 0.513759970664978
cells E-cell_type E-cell_type 0.6323943138122559
of O O 0.9990247488021851
acute O O 0.9216958284378052
promyelocytic O O 0.9618575572967529
leukemia O O 0.993172824382782
( O O 0.9997408986091614
APL O O 0.995930016040802
) O O 0.9999029636383057
contain O O 0.9999978542327881
a O O 0.9999918937683105
reciprocal O O 0.8296038508415222
chromosomal O O 0.5718424916267395

inflammatory O O 0.8595314025878906
diseases O O 0.9964630007743835
including O O 0.9999878406524658
asthma O O 0.9849415421485901
and O O 0.9993724226951599
rhinitis O O 0.9959301352500916
which O O 0.9999574422836304
are O O 0.9999909400939941
frequently O O 0.9995498061180115
treated O O 0.9999697208404541
with O O 0.999993085861206
glucocorticoids O O 0.9692924618721008
. O O 0.999981164932251
We O O 0.9999898672103882
observed O O 0.9999678134918213
that O O 0.9999974966049194
dexamethasone O O 0.9345375299453735
dramatically O O 0.9969124794006348
inhibited O O 0.9987564086914062
RANTES B-RNA B-RNA 0.5749318599700928
mRNA E-RNA E-RNA 0.9921919703483582
expression O O 0.9919230341911316
dose O O 0.9985490441322327

impart O O 0.9976396560668945
their O O 0.999987006187439
efficacy O O 0.9982004165649414
have O O 0.9999880790710449
not O O 0.9999257326126099
been O O 0.9999889135360718
defined O O 0.9996811151504517
. O O 0.9999972581863403
The O O 0.9999964237213135
endothelium O O 0.738980233669281
plays O O 0.9987450838088989
a O O 0.9999973773956299
critical O O 0.9993494153022766
role O O 0.9999822378158569
in O O 0.999992847442627
inflammation O O 0.9989719390869141
by O O 0.9999915361404419
directing O O 0.9655215740203857
circulating B-cell_type B-cell_type 0.625933825969696
leukocytes E-cell_type E-cell_type 0.9592421650886536
into O O 0.9998818635940552
extravascular O O 0.5161850452423096
tissues O O 0.7762129902839661
by O O 0.9999344348907471

by O O 0.9990653395652771
stimulation O O 0.9987183809280396
of O O 0.9999940395355225
the O O 0.9999762773513794
COS B-cell_line B-cell_line 0.5803025364875793
cells E-cell_line E-cell_line 0.9555755853652954
with O O 0.9998206496238708
ionomycin O O 0.6713905930519104
and O O 0.9935125708580017
phorbol O O 0.9580188989639282
12-myristate O O 0.9822559356689453
13-acetate O O 0.9434484839439392
. O O 0.9999704360961914
Recombinant O O 0.756988525390625
NFAT1 S-protein S-protein 0.749727189540863
can O O 0.9997283816337585
mediate O O 0.997789740562439
transcription O O 0.9855117201805115
of O O 0.9997991919517517
the O O 0.9998621940612793
interleukin-2 S-protein S-protein 0.7267524003982544
, O O 0.9315393567085266
interleukin-4 O S-protein 0.968579888343811
, O O 0.9952338337898254
tumor B-protein B-protein 0.8949097394943237
necrosis I-protein I-protein 0.959962785243988
factor I-protein I-protein 0.5417298078536987
alpha E-protein E-protein 0.9780096411705017
, O O 0.989589273929596
and O O 0.999480664730072
granulocyte-macrophage B-DNA B-DNA 0.6337397694587708
colony-stimulating I-DNA I-DNA 0.7165051102638245
factor I-DNA I-DNA 0.7694177627563477
promoters E-DNA E-DNA 0.9231958389282227

binding O O 0.9015644192695618
to O O 0.9945135116577148
15-LO B-DNA B-DNA 0.3612227141857147
promoter I-DNA I-DNA 0.907974362373352
DNA E-DNA E-DNA 0.9438472986221313
which O O 0.9971386194229126
are O O 0.9999749660491943
distinct O O 0.9998728036880493
from O O 0.9999799728393555
those O O 0.9999302625656128
derived O O 0.9992094039916992
from O O 0.9999849796295166
IL-13-treated B-cell_line O 0.2579919397830963
human I-cell_line O 0.30187875032424927
peripheral I-cell_line O 0.36892348527908325
monocyte E-cell_line O 0.26457932591438293
nuclear O O 0.5231953859329224
extracts O O 0.8483993411064148
. O O 0.9999653100967407
In O O 0.9999409914016724
addition O O 0.9998619556427002
, O O 0.9999295473098755
fluorescent O O 0.8820139765739441
in O O 0.9989787340164185
situ O O 0.866356611251831
hybridization O O 0.9877411723136902
( O O 0.998759388923645

A O O 0.9776666760444641
1.2-kb B-DNA B-DNA 0.43773239850997925
cDNA E-DNA E-DNA 0.9105042815208435
encoding O O 0.8637401461601257
full-length O B-protein 0.8366600275039673
human B-DNA I-protein 0.6507918834686279
C/EBP-epsilon E-DNA E-protein 0.5206552147865295
was O O 0.9971434473991394
cloned O O 0.9995896220207214
from O O 0.9999942779541016
a O O 0.9998713731765747
promyelocyte-late B-DNA O 0.6165421605110168
myeloblast-derived I-DNA O 0.8011540770530701
lambda I-DNA O 0.7890545725822449
gt11 I-DNA O 0.4773525595664978
library E-DNA O 0.7940751910209656
. O O 0.9993176460266113
Molecular O O 0.9488144516944885

binding I-DNA I-DNA 0.46617814898490906
site E-DNA E-DNA 0.9826902151107788
( O O 0.9979265928268433
-152 B-DNA B-DNA 0.8767035603523254
to I-DNA I-DNA 0.9332689642906189
-147 E-DNA E-DNA 0.9694162607192993
) O O 0.8472558259963989
is O O 0.9998760223388672
required O O 0.999924898147583
to O O 0.9999909400939941
mediate O O 0.9999645948410034
the O O 0.9999979734420776
effect O O 0.9999722242355347
. O O 0.9999920129776001

lines E-cell_line E-cell_line 0.988243818283081
keeping O O 0.9988396763801575
strictly O O 0.9263719320297241
erythroid-specific O O 0.6933649778366089
properties O O 0.7147044539451599
in O O 0.999961256980896
vitro O O 0.9947813153266907
through O O 0.9999902248382568
the O O 0.9999876022338867
targeted O O 0.9316415786743164
and O O 0.9877647757530212
conditional O O 0.9819180965423584
immortalization O O 0.9953566193580627
of O O 0.999951958656311
erythrocytic B-cell_type O 0.3270738124847412

possessed O O 0.9863713383674622
a O O 0.9999220371246338
more O O 0.9973166584968567
monocytic O O 0.6474968194961548
phenotype O O 0.6222749352455139
than O O 0.9994426369667053
the O O 0.9999679327011108
parental B-cell_type B-cell_type 0.5426135659217834
myeloblasts E-cell_type E-cell_type 0.6184969544410706
, O O 0.9956595301628113
as O O 0.9999691247940063
determined O O 0.999739944934845
by O O 0.9999936819076538
differential O O 0.9671986699104309
staining O O 0.9824821949005127
, O O 0.9998258948326111
increased O O 0.9996508359909058
expression O O 0.9991374015808105
of O O 0.9999954700469971
the O O 0.9999808073043823
myeloid-specific B-protein B-protein 0.5154892802238464
surface I-protein I-protein 0.7808766961097717
markers E-protein E-protein 0.9773263335227966
, O O 0.9972593784332275
and O O 0.9998080134391785
transcription O O 0.7995739579200745
of O O 0.9958003163337708
the O O 0.9998407363891602
c-fms B-DNA B-DNA 0.8226889371871948
proto-oncogene E-DNA E-DNA 0.9905804991722107
. O O 0.9987181425094604

ER S-protein S-protein 0.5275117754936218
to O O 0.9975407123565674
diminish O O 0.9999920129776001
the O O 0.9999974966049194
DNA-binding O O 0.8794302344322205
activity O O 0.9941304326057434
of O O 0.9999465942382812
GATA-1 S-protein S-protein 0.983248233795166
. O O 0.9999605417251587
These O O 0.9999959468841553
results O O 0.999966025352478
suggest O O 0.9999991655349731
that O O 0.9999966621398926
additional O O 0.9934561848640442
factor O O 0.7166183590888977
( O O 0.9970484375953674
s O O 0.9906813502311707
) O O 0.9993007183074951
are O O 0.9999969005584717
necessary O O 0.9999873638153076
for O O 0.9999970197677612
full O O 0.9930378794670105
ER S-protein S-protein 0.969519317150116
function O O 0.9995554089546204
. O O 0.9999972581863403

stimulated O O 0.9256337881088257

staphylococcal B-protein O 0.9534229636192322
enterotoxin I-protein O 0.9220361113548279
A E-protein O 0.6773320436477661
( O O 0.9977037310600281
SEA S-protein S-protein 0.936781644821167
) O O 0.9915992021560669
to O O 0.9999613761901855
investigate O O 0.99996018409729
molecular O O 0.9106528162956238
mechanisms O O 0.9844879508018494
of O O 0.9999685287475586
T-lymphocyte O O 0.6726022958755493
anergy O O 0.743866503238678
in O O 0.9989610910415649
vivo O O 0.9981245398521423
. O O 0.999996542930603
Injection O O 0.9897740483283997
of O O 0.9998704195022583
SEA S-protein S-protein 0.6838549375534058
to O O 0.9974365830421448
adult O O 0.8974476456642151
mice O O 0.9833689332008362
activates O O 0.9985994696617126
CD4+ B-cell_type B-cell_type 0.8070170283317566
T I-cell_type I-cell_type 0.9483480453491211
cells E-cell_type E-cell_type 0.9410141706466675
expressing O O 0.9977982044219971
certain O O 0.998881995677948
T-cell B-protein B-protein 0.623017430305481
receptor I-protein I-protein 0.9098721146583557
( I-protein I-protein 0.7587594985961914
TCR I-protein I-protein 0.5766693353652954
) I-protein I-protein 0.7861818671226501
variable I-protein I-protein 0.7849465012550354
region I-protein I-protein 0.4605255424976349
beta-chain I-protein I-protein 0.751314103603363
families E-protein E-protein 0.9668107628822327
and O O 0.9972917437553406
induces O O 0.9998722076416016
strong O O 0.9875771999359131
and O O 0.9985283613204956
rapid O O 0.9984676241874695
production O O 0.9999262094497681
of O O 0.9999960660934448
interleukin O B-protein 0.8248359560966492
2 O E-protein 0.9975690245628357
( O O 0.9933143258094788
IL-2 S-protein S-protein 0.9957681894302368
) O O 0.9958622455596924
. O O 0.9999960660934448
In O O 0.9999886751174927
contrast O O 0.9999637603759766
, O O 0.9999901056289673
repeated O O 0.9816117882728577
injections O O 0.9963101744651794
of O O 0.9999867677688599
SEA S-protein O 0.6162587404251099
cause O O 0.9989870190620422
CD4+ B-cell_type S-protein 0.40015164017677307
T-cell E-cell_type O 0.4777231812477112
deletion O O 0.6372418403625488
and O O 0.9821408987045288
anergy O O 0.9018927216529846
in O O 0.9996553659439087
the O O 0.9999145269393921
remaining O O 0.9774184823036194
CD4+ O B-cell_type 0.8277203440666199
T B-cell_type I-cell_type 0.9593740105628967
cells E-cell_type E-cell_type 0.9378165006637573
, O O 0.9927317500114441
characterized O O 0.9976430535316467
by O O 0.9999911785125732
reduced O O 0.9979159235954285
expression O O 0.9991095662117004
of O O 0.9999911785125732
IL-2 S-protein S-protein 0.9187979698181152
at O O 0.9999433755874634
mRNA O S-RNA 0.9558643102645874
and O O 0.9318661689758301
protein O O 0.7734124064445496
levels O O 0.9952257871627808
. O O 0.9999960660934448
We O O 0.9999845027923584
analyzed O O 0.9992363452911377
expression O O 0.9996638298034668
of O O 0.999988317489624

dependently O O 0.9925110340118408

. O O 0.9989302754402161
Both O O 0.9996891021728516
CHO-CD80 S-protein S-protein 0.9495771527290344
and O O 0.9956781268119812
CHO-CD86 S-protein S-protein 0.9038854241371155
, O O 0.9960067868232727
in O O 0.9999892711639404
the O O 0.9999955892562866
presence O O 0.9993653893470764
of O O 0.9999908208847046
anti-CD3 B-protein B-protein 0.6908843517303467
mAb E-protein E-protein 0.9969791173934937
, O O 0.9976428151130676
costimulated O O 0.8848726749420166
NFAT S-protein S-protein 0.9614564776420593
-dependent O O 0.9971108436584473
transcriptional O O 0.9706554412841797
activation O O 0.9978556036949158
. O O 0.9999980926513672
Several O O 0.9998863935470581
intracellular O B-protein 0.7523300051689148
signaling B-protein I-protein 0.5872828364372253
proteins E-protein E-protein 0.9804686307907104
, O O 0.9974616765975952
such O O 0.9999657869338989
as O O 0.999966025352478
CBL S-protein S-protein 0.8826584815979004
and O O 0.9918680787086487
VAV S-protein S-protein 0.9607879519462585
, O O 0.9961821436882019
were O O 0.9999806880950928
phosphorylated O O 0.9722475409507751
on O O 0.9998694658279419
tyrosine O O 0.8894907832145691
in O O 0.9998077750205994
response O O 0.994780957698822
to O O 0.9999016523361206
CD80 S-protein S-protein 0.9329536557197571
, O O 0.995966911315918

( O O 0.9904690384864807
Kd O O 0.9865401387214661
8.98 O O 0.9995529055595398
+/- O O 0.9999867677688599
1.07 O O 0.9997536540031433
nM O O 0.9998832941055298
, O O 0.9999772310256958
Bmax O O 0.995435893535614
183 O O 0.9997618794441223
+/- O O 0.9999680519104004
29.8 O O 0.9988055229187012
fmol/mg O O 0.9986577033996582
) O O 0.9998258948326111
and O O 0.999985933303833
controls O O 0.9963380098342896
( O O 0.9999566078186035
Kd O O 0.9979013204574585
9.36 O O 0.9997010827064514
+/- O O 0.9999760389328003
1.17 O O 0.9995200634002686
nM O O 0.999656081199646
, O O 0.99996018409729
Bmax O O 0.9940939545631409
158 O O 0.9991543292999268
+/- O O 0.9999357461929321
16 O O 0.9991958737373352
fmol/mg O O 0.9936090707778931
) O O 0.9999092817306519

was O O 0.9908639788627625
expressed O O 0.9997355341911316
in O O 0.9999915361404419
Escherichia O O 0.813099205493927
coli O O 0.8689648509025574
and O O 0.9974892139434814
in O O 0.9996477365493774
insect B-cell_type B-cell_type 0.7935001850128174
cells E-cell_type E-cell_type 0.9158771634101868
as O O 0.9994531273841858

by O O 0.9996387958526611
opposite O O 0.9695612192153931
glucocorticoid B-protein B-protein 0.7282809615135193
receptor E-protein E-protein 0.9670051336288452
changes O O 0.9715797901153564
, O O 0.999981164932251
respectively O O 0.9998251795768738
opposing O O 0.9960965514183044
and O O 0.9995118379592896
favoring O O 0.9988546371459961
glucocorticoid O O 0.8167104125022888
actions O O 0.9927405714988708
. O O 0.9999991655349731
This O O 0.9999992847442627
study O O 0.9999759197235107
suggests O O 0.9999967813491821
that O O 0.9999983310699463
the O O 0.999976634979248

, O O 0.961262583732605
reversible O O 0.9927707314491272
, O O 0.9998588562011719
and O O 0.9999697208404541
according O O 0.9999918937683105
to O O 0.9999613761901855
serum O O 0.7317336201667786
and O O 0.9560160636901855
urinary O O 0.9222396612167358
cortisol O O 0.9692882299423218
levels O O 0.9998094439506531
and O O 0.9999915361404419

NF-kappa B-protein B-protein 0.8168487548828125
B E-protein E-protein 0.9967033267021179
activation O O 0.9958848357200623
was O O 0.9999899864196777
independent O O 0.9999595880508423
of O O 0.9999984502792358
the O O 0.9999935626983643
transmembrane B-protein B-protein 0.6978543400764465
domain E-protein E-protein 0.9523833990097046
of O O 0.9908919930458069
CD40 S-protein S-protein 0.9796794056892395

level O O 0.9712292551994324
of O O 0.9993461966514587
virus O O 0.9798846244812012
, O O 0.9993188381195068
presumably O O 0.9999618530273438
because O O 0.9999961853027344
they O O 0.9999338388442993
are O O 0.9999889135360718
unresponsive O O 0.999843955039978
to O O 0.9999910593032837
TNF S-protein S-protein 0.991772472858429
and O O 0.9975757002830505
IL-7 S-protein S-protein 0.9954268932342529
. O O 0.99991774559021
Together O O 0.9999734163284302
, O O 0.9999897480010986
these O O 0.9999948740005493
data O O 0.9995529055595398
suggest O O 0.9999985694885254

. O O 0.998892605304718
Secretion O O 0.9925892353057861
of O O 0.9997320771217346
ILs S-protein S-protein 0.7388832569122314
was O O 0.9991849064826965
blocked O O 0.9996211528778076
with O O 0.9999740123748779
monensine O O 0.8544296026229858
. O O 0.999901294708252
Intracellular O O 0.898931086063385
ILs S-protein S-protein 0.4460277557373047
were O O 0.9995688796043396

primary O O 0.44675448536872864
translocation O O 0.8665347099304199
alone O O 0.9991501569747925
. O O 0.9999983310699463
Some O O 0.9999722242355347
expression O O 0.9988294243812561
of O O 0.9999845027923584
TCL1 S-protein S-protein 0.9300323128700256
could O O 0.9998513460159302
also O O 0.9999954700469971
be O O 0.9999909400939941
detected O O 0.9999464750289917
in O O 0.9999834299087524
randomly O O 0.5135176181793213
selected O O 0.9102948904037476
A-T O O 0.2716149687767029

PMA O O 0.8395851850509644

. O O 0.9978370070457458
Lipopolysaccharide O O 0.9048589468002319
( O O 0.9912390112876892
LPS O O 0.9292401671409607
) O O 0.9867680668830872
stimulation O O 0.9987998008728027
of O O 0.9999879598617554
human B-cell_type B-cell_type 0.5630307793617249
neutrophils E-cell_type E-cell_type 0.9857401251792908
is O O 0.9998483657836914
known O O 0.9999648332595825
to O O 0.9999880790710449
result O O 0.999998927116394
in O O 0.9999966621398926
activation O O 0.9979137778282166
of O O 0.9999117851257324
p38 B-protein S-protein 0.49196502566337585

depending O O 0.9968998432159424
on O O 0.9999845027923584
its O O 0.9999822378158569
intracellular O O 0.947729229927063
localization O O 0.9948399662971497
. O O 0.9999903440475464
Nef S-protein S-protein 0.946715235710144
of O O 0.9993937015533447
primate O O 0.6854829788208008
lentiviruses O O 0.4792317748069763
is O O 0.9993221759796143
required O O 0.9999697208404541
for O O 0.9999865293502808
viremia O O 0.9509741067886353
and O O 0.999177873134613
progression O O 0.9978675842285156
to O O 0.9999879598617554
AIDS O O 0.9866858720779419
in O O 0.9999380111694336
monkeys O O 0.5686205625534058
. O O 0.9996780157089233
Negative O O 0.8237842917442322
, O O 0.9502705335617065
positive O O 0.9112311601638794
, O O 0.9918009638786316
and O O 0.9991337656974792
no O O 0.9998806715011597
effects O O 0.9998534917831421
of O O 0.9999761581420898

bearing O O 0.973730206489563
clustered O O 0.7936156392097473
point O O 0.7530573010444641
mutations O O 0.6660754084587097
in O O 0.9999761581420898
the O O 0.9999804496765137
X2 B-DNA B-DNA 0.7699369788169861
box E-DNA E-DNA 0.9942920207977295
. O O 0.99953293800354
Since O O 0.9999958276748657
the O O 0.9999940395355225
co-expression O O 0.8621755838394165
with O O 0.9996466636657715
a O O 0.9996401071548462
dominant O O 0.4083261489868164
negative O O 0.49059349298477173
c-Fos S-protein S-protein 0.41753509640693665
abolished O O 0.9902563095092773
the O O 0.999962568283081
responsiveness O O 0.9954363703727722
to O O 0.9999699592590332
TPA O O 0.7326221466064453
, O O 0.9993399977684021
we O O 0.9999715089797974
conclude O O 0.9999988079071045
that O O 0.9999977350234985
activated O O 0.9693946242332458
transcription O O 0.9811344146728516
of O O 0.99985671043396
the O O 0.9999808073043823
DRA B-DNA B-DNA 0.826370358467102
gene E-DNA E-DNA 0.9925481677055359
depends O O 0.999935507774353
on O O 0.9999854564666748
interactions O O 0.9963634610176086
between O O 0.9999239444732666
the O O 0.9996927976608276
X2 B-DNA B-DNA 0.703129231929779
box E-DNA E-DNA 0.9866569638252258
and O O 0.9953552484512329
NF-X2 S-DNA S-DNA 0.9041042923927307
, O O 0.967495858669281
which O O 0.9997747540473938
contains O O 0.999617338180542
c-Fos S-protein S-protein 0.6754927635192871
. O O 0.9974601864814758
Thymocytes O S-cell_type 0.9688981771469116
control O O 0.9980795383453369
the O O 0.9999514818191528
CD4 B-DNA B-DNA 0.7656705975532532
gene E-DNA E-DNA 0.979955792427063
differently O O 0.9995226860046387

the O O 0.9991829991340637
activity O O 0.9992941617965698
of O O 0.9999936819076538
the O O 0.9999589920043945
IL-2 B-DNA B-DNA 0.4870951175689697
promoter E-DNA E-DNA 0.9940381050109863
in O O 0.999681830406189
EBV-transformed B-cell_line B-cell_type 0.4571436643600464
B I-cell_line I-cell_type 0.4394186735153198
cells E-cell_line E-cell_type 0.500236451625824
, O O 0.9811788201332092
whereas O O 0.9999945163726807
other O O 0.9998090863227844
transcription B-protein B-protein 0.5737904906272888
factors E-protein E-protein 0.9934275150299072
appear O O 0.9997913241386414
to O O 0.9999951124191284
be O O 0.9999979734420776
less O O 0.9999837875366211
important O O 0.9999759197235107
for O O 0.9999834299087524
IL-2 S-protein S-protein 0.9781752824783325
expression O O 0.9985479712486267
in O O 0.99998939037323
these O O 0.9997945427894592
cells O O 0.9746844172477722
. O O 0.9999949932098389
Latent B-protein B-protein 0.6509283185005188
membrane I-protein I-protein 0.5058376789093018
protein-1 E-protein E-protein 0.9951797723770142
induces O O 0.999494194984436
cyclin B-protein B-protein 0.4206850528717041
D2 E-protein E-protein 0.669283390045166
expression O O 0.929081380367279

the O O 0.9994240999221802
differential O O 0.9893224835395813
expression O O 0.9990758895874023
of O O 0.9999959468841553
PKC B-protein B-protein 0.6267911791801453
isoforms E-protein E-protein 0.9888513684272766
in O O 0.9998310804367065
alveolar B-cell_type B-cell_type 0.7554857134819031
macrophages E-cell_type E-cell_type 0.9750829339027405
and O O 0.9980109333992004
blood B-cell_type B-cell_type 0.5198687314987183
monocytes E-cell_type E-cell_type 0.9026237726211548
is O O 0.9995039701461792
associated O O 0.9999074935913086
with O O 0.9999988079071045
important O O 0.9977512955665588
functional O O 0.9855288863182068
alterations O O 0.99094158411026
in O O 0.9999864101409912
the O O 0.9999194145202637
cells O O 0.9713299870491028
. O O 0.9999947547912598
Expression O O 0.9993842840194702
of O O 0.9999881982803345
gamma-IFN B-DNA B-DNA 0.5491963624954224
responsive I-DNA I-DNA 0.6132611036300659
genes E-DNA E-DNA 0.9948365688323975

. O O 0.9992161989212036
The O O 0.9999955892562866
induction O O 0.9982045888900757
of O O 0.9999884366989136
these O O 0.9999523162841797
genes O O 0.5385525226593018
is O O 0.999800980091095
associated O O 0.9998816251754761
with O O 0.9999969005584717
interleukin-2 S-protein S-protein 0.9728119373321533
( O O 0.9969667792320251
IL-2 S-protein S-protein 0.9613001346588135
) O O 0.9915359020233154
-induced O O 0.9856135249137878
T-cell O O 0.4576893746852875
proliferation O O 0.9962666630744934
. O O 0.9999963045120239
Treatment O O 0.9977765679359436
of O O 0.9999550580978394
T B-cell_type B-cell_type 0.789991021156311
lymphocytes E-cell_type E-cell_type 0.990031361579895
with O O 0.9997710585594177
IFN-alpha S-protein S-protein 0.9474075436592102
, O O 0.990826427936554
IL-2 S-protein S-protein 0.9825435280799866
, O O 0.9955360889434814
IL-12 S-protein S-protein 0.9885286688804626
, O O 0.9945545196533203
and O O 0.99947589635849
IL-15 S-protein S-protein 0.9768620133399963
upregulated O O 0.9840779304504395
IL-2Ralpha S-protein S-protein 0.8924857974052429
, O O 0.9877865314483643
c-myc S-DNA S-DNA 0.6610647439956665
, O O 0.9385473728179932
and O O 0.9918138980865479
pim-1 B-DNA B-DNA 0.46930649876594543
gene E-DNA E-DNA 0.8879054188728333

PGE2 S-protein O 0.29975879192352295
production O O 0.9911208748817444
. O O 0.9999943971633911
As O O 0.9999507665634155
evidenced O O 0.9998917579650879
by O O 0.9999958276748657
electro O O 0.7906933426856995
mobility O O 0.9505814909934998
shift O O 0.992320716381073
assay O O 0.9993597865104675
( O O 0.999931812286377
EMSA O O 0.992968738079071
) O O 0.9997852444648743
and O O 0.999974250793457
the O O 0.9999969005584717
use O O 0.9999469518661499
of O O 0.9999977350234985
a O O 0.9999818801879883
NF-kappa B-DNA B-protein 0.5964745283126831
B I-DNA E-protein 0.8796027898788452
prototypic I-DNA O 0.49802225828170776
probe E-DNA O 0.8246896862983704
, O O 0.9999525547027588
these O O 0.9999849796295166
drugs O O 0.9979773163795471
probably O O 0.9999865293502808
exert O O 0.9999932050704956
their O O 0.9997784495353699

only O O 0.9972586631774902
one O O 0.9998955726623535
of O O 0.9999943971633911
its O O 0.9999825954437256
two O O 0.9956296682357788
alleles S-DNA S-DNA 0.792984127998352
in O O 0.9990973472595215
early B-cell_type B-cell_type 0.48077520728111267
B-lymphoid I-cell_type I-cell_type 0.7382160425186157
progenitors E-cell_type E-cell_type 0.9398155212402344
and O O 0.9972766041755676
mature B-cell_type B-cell_type 0.5788208246231079
B I-cell_type I-cell_type 0.8266911506652832
cells E-cell_type E-cell_type 0.9447511434555054
, O O 0.9798306226730347
while O O 0.9999754428863525
it O O 0.9974374771118164
transiently O O 0.9980711340904236
switches O O 0.9998583793640137
to O O 0.9999896287918091
a O O 0.9999629259109497
biallelic O O 0.6345267295837402
mode O O 0.7939097881317139
of O O 0.9805995225906372
transcription O O 0.9204168915748596
in O O 0.999800980091095
pre-B B-cell_type B-cell_type 0.5393924117088318
and I-cell_type I-cell_type 0.6663911938667297
immature I-cell_type I-cell_type 0.6502441167831421
B I-cell_type I-cell_type 0.7482022047042847
cells E-cell_type E-cell_type 0.654516875743866
. O O 0.9995371103286743
As O O 0.9999934434890747
a O O 0.9999963045120239
consequence O O 0.9999548196792603
, O O 0.9999908208847046

by O O 0.9995517134666443
the O O 0.9999939203262329
kappa B-DNA B-DNA 0.8680810928344727
intron I-DNA I-DNA 0.6719411611557007
enhancer E-DNA E-DNA 0.9861692190170288
. O O 0.9999630451202393
Together O O 0.999993085861206
these O O 0.9999959468841553
data O O 0.9970846772193909
demonstrate O O 0.9999904632568359
that O O 0.9999990463256836
the O O 0.999908447265625
v-abl B-protein B-protein 0.45633018016815186
protein E-protein E-protein 0.9821463227272034
specifically O O 0.9989805817604065
interferes O O 0.9999494552612305
with O O 0.9999790191650391
light-chain B-DNA O 0.47141504287719727
gene E-DNA O 0.6669518351554871
rearrangement O O 0.8882306814193726
by O O 0.9999552965164185
suppressing O O 0.9945986270904541
at O O 0.9999407529830933
least O O 0.9997320771217346
two O O 0.9999046325683594
pathways O O 0.9934893846511841
essential O O 0.9996318817138672
for O O 0.9999916553497314
this O O 0.999993085861206
stage O O 0.9989678859710693
of O O 0.9999608993530273
B-cell S-cell_type O 0.7103067636489868
differentiation O O 0.993069052696228
and O O 0.9999450445175171
suggest O O 0.999995231628418
that O O 0.9999978542327881
tyrosine O O 0.8151754140853882
phosphorylation O O 0.9647528529167175
is O O 0.9999291896820068

oxidant-induced O O 0.8702846169471741
NF-kappaB S-protein S-protein 0.9826416373252869
activation O O 0.9992313385009766
. O O 0.9999974966049194
Transactivation O O 0.9887861013412476
of O O 0.9999176263809204
the O O 0.9999072551727295
interleukin-1alpha B-DNA B-DNA 0.8385337591171265
promoter E-DNA E-DNA 0.9968359470367432
by O O 0.9999216794967651
human B-protein B-protein 0.6615235209465027
T-cell I-protein I-protein 0.5271285176277161
leukemia I-protein I-protein 0.4868203103542328
virus I-protein I-protein 0.6067888140678406
type I-protein I-protein 0.8220037817955017
I I-protein I-protein 0.9197463393211365
and I-protein I-protein 0.8867787718772888
type I-protein I-protein 0.9735864996910095
II I-protein I-protein 0.9884763956069946
Tax I-protein I-protein 0.6655951738357544
proteins E-protein E-protein 0.9991911053657532
. O O 0.9999748468399048
Human B-cell_line O 0.8385099768638611
T-cell I-cell_line O 0.7331534624099731
leukemia I-cell_line O 0.899592399597168

these O O 0.999041736125946
alterations O O 0.9972285628318787
to O O 0.9999847412109375
the O O 0.9999959468841553
induction O O 0.9994113445281982
of O O 0.9999924898147583
primary O O 0.5857158899307251
erythroblast O O 0.35198527574539185
transformation O O 0.9684396982192993
. O O 0.9999858140945435
Avian B-cell_type B-cell_line 0.4882303476333618
erythroblasts E-cell_type E-cell_line 0.7829603552818298
expressing O O 0.9964718818664551
the O O 0.9999831914901733
activated B-protein B-protein 0.8561338186264038
mouse I-protein I-protein 0.327688992023468
EpoR I-protein E-protein 0.8569391369819641
( I-protein O 0.7970784306526184
R129C I-protein S-protein 0.40046554803848267
) E-protein O 0.39240866899490356
differentiated O O 0.981170117855072
into O O 0.9997735619544983
erythrocytes S-cell_type S-cell_type 0.9937853813171387
in O O 0.9995085000991821
response O O 0.9974716901779175
to O O 0.9999600648880005
hEpo S-protein S-protein 0.9844651818275452
. O O 0.9999407529830933
Expression O O 0.9986072182655334
of O O 0.9999678134918213
Spi-1 S-protein S-protein 0.9578881859779358
in O O 0.9999078512191772
these O O 0.9995380640029907
cells O O 0.9679459929466248

, O O 0.9901352524757385
that O O 0.999977707862854
PI B-protein B-protein 0.6897457242012024
3-kinase E-protein E-protein 0.99643874168396
profoundly O O 0.9980383515357971
influenced O O 0.9999523162841797
the O O 0.9999887943267822
transactivation O O 0.9568820595741272
capacity O O 0.9921187162399292
of O O 0.9998921155929565
' O O 0.9805616736412048
nuclear B-protein B-protein 0.5614060759544373
factor I-protein I-protein 0.6314836144447327
of I-protein I-protein 0.6046413779258728
activated I-protein I-protein 0.7924641370773315

associated O O 0.9678346514701843
with O O 0.9999129772186279
HIV O O 0.927727222442627
replication O O 0.9931463003158569
, O O 0.9999427795410156
and O O 0.9998500347137451
is O O 0.9999662637710571
thus O O 0.9999570846557617
likely O O 0.9999793767929077
to O O 0.9999958276748657
explain O O 0.999984622001648

CD4 B-protein S-protein 0.6550277471542358

5 B-DNA I-DNA 0.6824058890342712
' I-DNA I-DNA 0.5235404372215271
palindromic I-DNA I-DNA 0.475827157497406
octamer I-DNA I-DNA 0.641640305519104
sequence E-DNA E-DNA 0.9978396892547607
. O O 0.999920129776001
Expression O O 0.9993544220924377
of O O 0.9999963045120239
the O O 0.9999843835830688
gene O O 0.6643975973129272
encoding O O 0.9122433662414551
human B-protein B-protein 0.5316842198371887
inosine- I-protein I-protein 0.5158214569091797
5'-monophosphate I-protein I-protein 0.714461624622345
dehydrogenase I-protein E-protein 0.9937971830368042
( I-protein O 0.9867472648620605
IMPDH I-protein S-protein 0.9728145599365234

T B-cell_type B-cell_type 0.279103547334671
cells E-cell_type E-cell_type 0.8521194458007812
that O O 0.9993896484375
exhibited O O 0.9999146461486816
all O O 0.9999489784240723
5 O O 0.8550043106079102
defects O O 0.8764218091964722
. O O 0.9999957084655762
Our O O 0.9999991655349731
data O O 0.9985276460647583
have O O 0.9999969005584717
implications O O 0.9999909400939941
for O O 0.9999978542327881
the O O 0.9999964237213135
detection O O 0.9997771382331848
of O O 0.9999920129776001
potentially O O 0.790600061416626
dysfunctional O B-cell_type 0.6697087287902832
T B-cell_type I-cell_type 0.3786155879497528
cells E-cell_type E-cell_type 0.8344762325286865

lytic O O 0.7215958833694458
cascade O O 0.9230347275733948
by O O 0.9999440908432007
activating O O 0.9602950811386108
viral O O 0.5909732580184937
gene O O 0.788098931312561
expression O O 0.9804702401161194
. O O 0.999953031539917
ZEBRA S-protein S-protein 0.6549969911575317
is O O 0.9992936849594116
also O O 0.9999587535858154
indispensable O O 0.9988358616828918
for O O 0.999943733215332
viral O O 0.8804267048835754
replication O O 0.9600399136543274
and O O 0.9992756247520447
binds O O 0.9985709190368652
directly O O 0.9997144341468811
to O O 0.9999947547912598
the O O 0.999971866607666
EBV O O 0.45722678303718567
lytic O O 0.44089052081108093
origin O O 0.3526156544685364
of O O 0.8701288104057312
replication O O 0.8247948884963989
. O O 0.9997226595878601

( O O 0.964004397392273
120 O O 0.9936140179634094
% O O 0.9970914125442505
) O O 0.9987573623657227
, O O 0.9999233484268188
without O O 0.9999784231185913
affecting O O 0.9999780654907227
the O O 0.9999978542327881
activities O O 0.9993520379066467
of O O 0.9999927282333374
NFkappaB S-protein S-protein 0.992760181427002
and O O 0.9969567060470581
CD28RC S-protein S-protein 0.9413409233093262
, O O 0.9949861764907837
which O O 0.9999614953994751
was O O 0.9999712705612183
confirmed O O 0.9999878406524658
by O O 0.9999964237213135
transfection O O 0.9295663833618164
assays O O 0.9925684928894043
. O O 0.9999964237213135
We O O 0.999970555305481
also O O 0.9999864101409912

were O O 0.9988536834716797
induced O O 0.9971250891685486
to O O 0.9999212026596069
differentiate O O 0.9997604489326477
, O O 0.9999070167541504
as O O 0.9999808073043823
indicated O O 0.9988215565681458
, O O 0.9999247789382935
for O O 0.9999728202819824
example O O 0.9994046688079834
, O O 0.9999663829803467
by O O 0.999995231628418
increased O O 0.9982189536094666
expression O O 0.9985052347183228
of O O 0.9999847412109375
adhesion B-protein B-protein 0.8189176917076111
molecules E-protein E-protein 0.9992528557777405
. O O 0.9999750852584839
One O O 0.9947896003723145

B E-protein E-protein 0.8810587525367737
, O O 0.9183608889579773
which O O 0.997992992401123
is O O 0.9997671246528625
rapidly O O 0.9994145631790161
taken O O 0.999992847442627
up O O 0.9999966621398926
into O O 0.9999077320098877
nuclei O O 0.6984378695487976
, O O 0.9964578747749329

Kd O O 0.6807684302330017
value O O 0.9552057385444641
for O O 0.9997578263282776
aldosterone O O 0.8628191947937012
was O O 0.9999727010726929
0.3 O O 0.9988799691200256
nM O O 0.9990924596786499
and O O 0.9999885559082031
the O O 0.9999959468841553
Bmax O O 0.8623175621032715
= O O 0.9971578121185303
32 O O 0.9903871417045593
pmol/mg O O 0.9766258001327515
. O O 0.9999871253967285
Hormone O O 0.9604160785675049
binding O O 0.9507585167884827
specificity O O 0.9965794682502747

( O O 0.7729172110557556

assayed O O 0.9792914986610413
by O O 0.999983549118042
direct O O 0.9820619225502014
immunoprecipitation O O 0.9971103072166443
and O O 0.9999746084213257
by O O 0.9999961853027344
evaluation O O 0.9997273087501526
of O O 0.9999897480010986
bound O O 0.9320006370544434
STATs S-protein S-protein 0.8383539319038391
to O O 0.9975963234901428
immobilized O O 0.8989514708518982
GRR S-DNA S-DNA 0.9007143974304199
. O O 0.9998015761375427
Selective O O 0.980005145072937

with O O 0.9992625117301941
the O O 0.999923586845398
CD2 B-protein B-protein 0.4620842933654785
antigen E-protein E-protein 0.9797669649124146
results O O 0.9992926120758057
in O O 0.9999876022338867
the O O 0.9999802112579346
proliferation O O 0.994499921798706
of O O 0.9999690055847168
normal B-cell_type B-cell_type 0.5168331265449524
human I-cell_type I-cell_type 0.5414652228355408
T I-cell_type I-cell_type 0.884002685546875
cells E-cell_type E-cell_type 0.9711527824401855
. O O 0.9999150037765503
The O O 0.9999996423721313
effect O O 0.9999649524688721
of O O 0.9999940395355225

controlling O O 0.8847878575325012
CD19 S-protein B-DNA 0.8409739136695862
gene O E-DNA 0.9013927578926086
expression O O 0.9981281161308289
, O O 0.9999959468841553
we O O 0.999906063079834
isolated O O 0.9972375631332397
and O O 0.9982385635375977
functionally O O 0.9986666440963745
characterized O O 0.9998759031295776
the O O 0.9999643564224243
CD19 B-DNA B-DNA 0.760708212852478
promoter E-DNA E-DNA 0.9890097975730896
using O O 0.9985787868499756

with O O 0.9990967512130737
similar O O 0.9980084300041199
mutations O O 0.995130181312561
in O O 0.9999966621398926
the O O 0.9999864101409912
NF B-protein B-DNA 0.46952617168426514
kappa I-protein I-DNA 0.7522298097610474
B1 E-protein I-DNA 0.5928622484207153
site O E-DNA 0.9800161719322205
responded O O 0.999944806098938
to O O 0.9999856948852539
cytokine S-protein S-protein 0.6844180226325989

Tax S-protein S-protein 0.9282770752906799
. O O 0.9998759031295776
IL-2 S-protein S-protein 0.9894905686378479
induced O O 0.999901533126831
the O O 0.9999818801879883
DNA O O 0.9034276008605957
binding O O 0.9241763949394226
activity O O 0.9949599504470825
of O O 0.9999635219573975
STAT3 S-protein S-protein 0.9820111989974976
and O O 0.9945476651191711
STAT5 S-protein S-protein 0.9762134552001953
of O O 0.9882856607437134

conclusion O O 0.9926977753639221
, O O 0.999996542930603
elevated O O 0.9783843755722046
IFN B-protein B-protein 0.40339037775993347
alpha E-protein E-protein 0.9974332451820374
levels O O 0.9998018145561218
in O O 0.9999902248382568
AIDS-GR O S-protein 0.8855307698249817
may O O 0.9997163414955139
be O O 0.9999973773956299
due O O 0.999980092048645
to O O 0.9999994039535522
the O O 0.9999996423721313
lack O O 0.9999117851257324
of O O 0.9999969005584717
inhibitory O O 0.9504857659339905
effect O O 0.9997918009757996
of O O 0.999993085861206
cortisol O O 0.9230521321296692
on O O 0.9999066591262817
IFN B-protein B-protein 0.35185959935188293
alpha E-protein E-protein 0.9970742464065552
production O O 0.9990656971931458
due O O 0.9999864101409912
to O O 0.9999969005584717
cortisol O O 0.9512553215026855
resistance O O 0.9957148432731628
in O O 0.9999837875366211
monocytes S-cell_type S-cell_type 0.9826427698135376
JNK S-protein S-protein 0.6480894088745117
( O O 0.9958011507987976
c-Jun B-protein B-protein 0.4176368713378906
NH2-terminal I-protein I-protein 0.9013273119926453
kinase E-protein E-protein 0.8380119204521179

gene S-DNA E-DNA 0.7673718333244324

of O O 0.9845346212387085
conditionally O O 0.9815772175788879
expressed O O 0.9968453049659729
EBNA2 S-protein S-protein 0.9904588460922241
in O O 0.9998823404312134
the O O 0.9999979734420776
context O O 0.9998619556427002
of O O 0.9999969005584717
the O O 0.9999979734420776
IFN S-protein S-protein 0.8042298555374146
response O O 0.9102082848548889
in O O 0.9998047947883606
Burkitt B-cell_line B-cell_line 0.807254433631897
's I-cell_line I-cell_line 0.7990744113922119
lymphoma I-cell_line I-cell_line 0.9182255864143372
cell I-cell_line I-cell_line 0.9210554361343384
lines E-cell_line E-cell_line 0.9995463490486145
. O O 0.9999432563781738
Expression O O 0.9995285272598267
of O O 0.9999874830245972
EBNA2 S-protein S-protein 0.974398136138916
led O O 0.9998106360435486
to O O 0.9999841451644897
the O O 0.9999945163726807
transcriptional O O 0.8571139574050903
activation O O 0.9632217884063721
of O O 0.9981107711791992
both O O 0.9995715022087097
endogenous O O 0.5077358484268188
or O O 0.8234900236129761
transfected O O 0.6721649169921875

is O O 0.997297465801239
essential O O 0.9999289512634277
for O O 0.9999841451644897
thymus-dependent O O 0.7920353412628174
humoral O O 0.8298373818397522
immune O O 0.9235485196113586
responses O O 0.9924375414848328
and O O 0.999913215637207
rescuing O O 0.9844522476196289
B B-cell_type B-cell_type 0.6791702508926392
cells E-cell_type E-cell_type 0.9891297817230225
from O O 0.9999269247055054
apoptosis O O 0.9985113739967346
. O O 0.9999982118606567
Many O O 0.999995231628418
of O O 0.9999994039535522
the O O 0.9999984502792358
effects O O 0.9997163414955139
of O O 0.9999772310256958
CD40 S-protein S-protein 0.9658470749855042
are O O 0.999808132648468
believed O O 0.9999592304229736
to O O 0.9999791383743286
be O O 0.9999762773513794
achieved O O 0.9999268054962158
through O O 0.999994158744812
altered O O 0.9613661766052246
gene O O 0.869308590888977
expression O O 0.999760091304779

, O O 0.9154564142227173
Stat3 S-protein S-protein 0.9859277009963989
, O O 0.9892116785049438
and O O 0.9986342787742615
Stat5 S-protein S-protein 0.9993323683738708
in O O 0.9999063014984131
human O O 0.6021298766136169
platelet O O 0.47224560379981995
lysates O O 0.5894972085952759
. O O 0.9998465776443481
Thrombopoietin S-protein S-protein 0.9393424391746521
induced O O 0.9961950778961182
tyrosine O O 0.7745605111122131
phosphorylation O O 0.8957128524780273
of O O 0.9979478716850281
Stat3 S-protein S-protein 0.9915196299552917
and O O 0.9978542923927307

activation O O 0.9683382511138916
. O O 0.999818742275238
Sp1 S-protein S-protein 0.9428958892822266
and O O 0.9898155927658081
NF-kappaB S-protein S-protein 0.9907711744308472
transcription O O 0.9158557653427124
factor O O 0.8337640166282654
binding O O 0.9409698843955994
was O O 0.9998385906219482
shown O O 0.9999850988388062
to O O 0.9999948740005493
be O O 0.9999922513961792
mutually O O 0.9945090413093567
exclusive O O 0.9999351501464844
by O O 0.9999988079071045
EMSA O O 0.7289625406265259
displacement O O 0.9566096067428589
studies O O 0.9962963461875916
with O O 0.9999979734420776
purified O O 0.7053789496421814
recombinant O O 0.6561658382415771
Sp1 S-protein S-protein 0.6490404605865479
and O O 0.9915380477905273
recombinant O B-protein 0.4630468785762787
p50 S-protein E-protein 0.8706250190734863
. O O 0.9983649849891663
The O O 0.9999980926513672
functional O O 0.9656789898872375
contribution O O 0.9975929856300354

based O O 0.9863937497138977
on O O 0.9999305009841919
the O O 0.9999970197677612
murine B-DNA B-DNA 0.5042961835861206
sequence E-DNA E-DNA 0.9100728034973145
were O O 0.9997877478599548
used O O 0.9999591112136841
to O O 0.9999922513961792
construct O O 0.999962329864502
a O O 0.9999877214431763
quantitative O O 0.9386835098266602
reverse O O 0.9092985987663269
transcription-PCR O O 0.7541465163230896
assay O O 0.9979300498962402
for O O 0.9999837875366211
gene O O 0.9676381349563599
expression O O 0.9992082715034485
. O O 0.999996542930603
B B-cell_type B-cell_type 0.5017344951629639
lymphocyte E-cell_type E-cell_type 0.9031373858451843
stimulation O O 0.9806159138679504
via O O 0.9998843669891357
both O O 0.9999325275421143

enhancing O O 0.9813002347946167
binding O O 0.9774873852729797
activity O O 0.9984802603721619
of O O 0.999984622001648
the O O 0.999934196472168
transcription B-protein B-protein 0.654697060585022
factor I-protein E-protein 0.9534158110618591
NF-kappa I-protein B-protein 0.8228825330734253
B E-protein E-protein 0.9983566403388977
to O O 0.9997645020484924
its O O 0.9996117949485779
consensus O B-DNA 0.7838545441627502
sequence O E-DNA 0.9703221917152405
in O O 0.9995463490486145
the O O 0.9999401569366455
5 O B-DNA 0.642626941204071
' O I-DNA 0.7918121218681335
regulatory O I-DNA 0.8728926777839661

relation O O 0.9882764220237732
to O O 0.9997431635856628
age O O 0.9957725405693054
and O O 0.999893307685852
to O O 0.9999696016311646
sport O O 0.9802013039588928
activity O O 0.9993405938148499
. O O 0.999996542930603
Glucocorticoid B-protein B-protein 0.7271415591239929
receptors E-protein E-protein 0.9981619715690613
( O O 0.9921661615371704
GR S-protein S-protein 0.9937054514884949
) O O 0.9959577918052673
are O O 0.999997615814209

normal O O 0.8660245537757874
epidermis O O 0.8372917175292969
, O O 0.9955714344978333
benign O O 0.8499796390533447
, O O 0.969386875629425
and O O 0.9899874329566956
malignant O O 0.820094108581543
tumors O O 0.8200097680091858
originating O O 0.9980015158653259
from O O 0.9999687671661377
epidermal B-cell_type B-cell_type 0.6899129152297974
cells E-cell_type E-cell_type 0.9590403437614441
, O O 0.9982030391693115
and O O 0.9994791150093079
squamous B-cell_line O 0.6191191077232361
cell I-cell_line O 0.6644802689552307
carcinoma I-cell_line O 0.5718422532081604
( I-cell_line O 0.9106089472770691
SCC I-cell_line O 0.5684597492218018
) I-cell_line O 0.6814033389091492
cell I-cell_line O 0.44168347120285034

surface I-protein I-protein 0.6155292987823486
antigens E-protein E-protein 0.9786992073059082
was O O 0.9998418092727661
investigated O O 0.9999877214431763
in O O 0.9999969005584717
two O O 0.9988793730735779
models O O 0.9749159812927246
of O O 0.9998102784156799
leukemic B-cell_line B-cell_line 0.37210509181022644
cell I-cell_line I-cell_line 0.571682870388031
lines E-cell_line E-cell_line 0.9975758194923401
, O O 0.9996582269668579
CEM B-cell_line B-cell_line 0.8583982586860657
C7 E-cell_line E-cell_line 0.9296184182167053
denoted O O 0.9792082905769348
( O O 0.9982560276985168
r+ O O 0.9556907415390015
, O O 0.9959753155708313
ly+ O S-cell_line 0.8863378167152405
) O O 0.7433449625968933
and O O 0.9974182844161987
CEM B-cell_line B-cell_line 0.8517060875892639
C1 E-cell_line E-cell_line 0.9407212734222412
( O O 0.9671761393547058
r+ O O 0.3462880551815033
, O O 0.780508816242218
ly- O O 0.3407183587551117
) O O 0.43858224153518677
. O O 0.99951171875
The O O 0.9999984502792358
reactivity O O 0.9791354537010193

demonstrate O O 0.9991753697395325
here O O 0.9999897480010986
that O O 0.9999995231628418
the O O 0.9999657869338989
SLP-76 S-protein B-protein 0.7984451055526733
linker O I-protein 0.3204789161682129
protein O E-protein 0.9732600450515747
interacts O O 0.9980881810188293
with O O 0.9999797344207764
both O O 0.9992586970329285
nck S-protein S-protein 0.7809295058250427
, O O 0.991178572177887
an O O 0.9996159076690674
adaptor B-protein B-protein 0.5209362506866455
protein E-protein E-protein 0.9759244322776794
, O O 0.9943159222602844
and O O 0.99943608045578
Vav S-protein S-protein 0.9287114143371582

induction O O 0.9894737601280212
by O O 0.9999921321868896
CsA O O 0.9149855971336365
may O O 0.9998095631599426
contribute O O 0.999998927116394
to O O 0.9999970197677612
its O O 0.9999938011169434
successful O O 0.9995810389518738
use O O 0.9999270439147949
in O O 0.9999784231185913
cardiac O O 0.8989874124526978
transplant O O 0.9696738719940186
medicine O O 0.9981308579444885
and O O 0.9999521970748901
might O O 0.9999845027923584
be O O 0.9999983310699463
useful O O 0.9999203681945801
in O O 0.9999816417694092
managing O O 0.999110758304596

acid I-protein I-protein 0.49572253227233887
receptors E-protein E-protein 0.9971651434898376
( O O 0.9937317967414856
RAR S-protein S-protein 0.9952855706214905
) O O 0.9905728697776794
, O O 0.9998376369476318
termed O O 0.9565330147743225
RAR B-protein B-protein 0.782322347164154
alpha E-protein E-protein 0.9800277352333069
, O O 0.9903579354286194
RAR B-protein B-protein 0.864949107170105
beta E-protein E-protein 0.9736444354057312
, O O 0.979514479637146
and O O 0.9980478286743164
RAR B-protein B-protein 0.876241147518158
gamma E-protein E-protein 0.9181804656982422
, O O 0.9603760242462158
have O O 0.9998860359191895
been O O 0.9999558925628662
described O O 0.9999852180480957
. O O 0.9999934434890747
They O O 0.999976396560669
are O O 0.9999653100967407
composed O O 0.9996383190155029
of O O 0.9999905824661255
different O O 0.9872419834136963
structural B-protein B-protein 0.7742865681648254
domains E-protein E-protein 0.8534062504768372
, O O 0.9982796907424927
including O O 0.9998961687088013

the O O 0.9978005290031433

) O O 0.7844197750091553
and O O 0.9908922910690308
other O O 0.999452531337738
cytokines S-protein S-protein 0.9980504512786865
. O O 0.9999740123748779
Human B-RNA B-protein 0.46497875452041626
monocyte I-RNA I-protein 0.4554639160633087
IL-1 I-RNA I-protein 0.5199522972106934
receptor I-RNA I-protein 0.6745461821556091
antagonist I-RNA E-protein 0.7333022952079773
( I-RNA O 0.8131715655326843
IL-1ra I-RNA S-protein 0.3493753671646118
) I-RNA O 0.3803751766681671
messenger I-RNA O 0.3322482109069824
ribonucleic I-RNA O 0.4545222520828247
acid E-RNA O 0.7220120429992676
( O O 0.9784263968467712

past O O 0.9901297688484192
decade O O 0.9991939663887024
it O O 0.9997825026512146
has O O 0.9999947547912598
become O O 0.9999672174453735
clear O O 0.9999852180480957
that O O 0.9999979734420776
glucocorticosteroid B-protein B-protein 0.5919927954673767
receptors E-protein E-protein 0.9946209192276001
play O O 0.9999085664749146
a O O 0.9999960660934448
significant O O 0.9999250173568726
role O O 0.999991774559021
in O O 0.9999985694885254
the O O 0.9999980926513672
mechanism O O 0.9993996620178223
of O O 0.9999879598617554
glucocorticosteroid O O 0.9758473038673401
action O O 0.999640941619873
. O O 0.9999995231628418
We O O 0.9999634027481079
studied O O 0.9996490478515625
glucocorticosteroid B-protein B-protein 0.6523464918136597
receptor E-protein E-protein 0.9878672361373901
density O O 0.9844486713409424
and O O 0.9998617172241211
affinity O O 0.9549193978309631
on O O 0.9993346333503723
peripheral B-cell_type B-cell_type 0.7602965235710144
blood I-cell_type I-cell_type 0.9328969120979309
mononuclear I-cell_type I-cell_type 0.9917502999305725
cells E-cell_type E-cell_type 0.9963763356208801
by O O 0.9998990297317505

Because O O 0.999723494052887
this O O 0.9998975992202759
segment O O 0.9757267832756042
presumably O O 0.9999428987503052
folds O O 0.9996733665466309
upon O O 0.9998631477355957
specific O O 0.9842299818992615
DNA O O 0.9025253653526306
binding O O 0.9682504534721375
, O O 0.9998366832733154
its O O 0.9999858140945435
flexibility O O 0.9995889067649841
in O O 0.9999808073043823
solution O O 0.9941022992134094
may O O 0.9999904632568359
reduce O O 0.9999822378158569

lymphocyte O O 0.33159253001213074
( O O 0.8202852010726929
CTL O O 0.3869502544403076
) O O 0.3562990427017212
response O O 0.9523757100105286
to O O 0.9998661279678345
latently B-cell_type B-cell_type 0.7423893213272095
infected I-cell_type I-cell_type 0.587398886680603
cells E-cell_type E-cell_type 0.9232177138328552
is O O 0.9987898468971252
well O O 0.9936001300811768
characterized O O 0.9989336133003235
, O O 0.9999806880950928
very O O 0.9999256134033203
little O O 0.9999765157699585
is O O 0.9999890327453613
known O O 0.9999977350234985
about O O 0.999995231628418
T O O 0.6234276294708252
cell O O 0.601759672164917

retention O O 0.9526033401489258
of O O 0.9990346431732178
RelA S-protein S-protein 0.9075376987457275
; O O 0.9782848954200745
and O O 0.9955873489379883
( O O 0.9973956346511841
vi O O 0.9191656112670898
) O O 0.9299370646476746
as O O 0.9999710321426392
observed O O 0.9991707801818848
with O O 0.9999663829803467
I B-protein B-protein 0.8963385224342346
kappa I-protein I-protein 0.8678359389305115
B I-protein I-protein 0.7865031957626343
alpha E-protein E-protein 0.9961040019989014
, O O 0.9993125200271606
nuclear O B-protein 0.530918300151825
RelA S-protein E-protein 0.8632224798202515
stimulates O O 0.9911303520202637
p100 B-RNA B-RNA 0.8802250623703003
mRNA E-RNA E-RNA 0.9950767159461975
and O O 0.9960559606552124
protein O O 0.7959522604942322
expression O O 0.9938488602638245
. O O 0.9999955892562866
These O O 0.9999990463256836
findings O O 0.9997860789299011
thus O O 0.9999935626983643
reveal O O 0.9999992847442627
the O O 0.9999991655349731
presence O O 0.9998596906661987
of O O 0.9999942779541016
a O O 0.9999933242797852
second O O 0.9399778842926025
inducible O O 0.9608799815177917
autoregulated O O 0.8509529829025269
inhibitory O O 0.8209627270698547
pathway O O 0.9976021647453308
that O O 0.999997615814209
helps O O 0.9999885559082031
ensure O O 0.9999700784683228

affected O O 0.9842373728752136
kappaB S-protein S-protein 0.9742414951324463
binding O O 0.98506098985672
activity O O 0.9981532692909241
induced O O 0.9999759197235107
by O O 0.9999816417694092
TNFalpha S-protein S-protein 0.9960005879402161
in O O 0.9999059438705444
the O O 0.9999465942382812
same O O 0.9996041655540466
cells O O 0.9806088805198669
. O O 0.9999916553497314
These O O 0.9999969005584717
results O O 0.9998815059661865
imply O O 0.999997615814209
a O O 0.9999991655349731
potential O O 0.9990087747573853
role O O 0.9997090697288513
of O O 0.999990701675415
the O O 0.9998946189880371
anaphylatoxins S-protein S-protein 0.7894536256790161
C5a S-protein S-protein 0.4084039330482483
and O O 0.8892776966094971
C3a S-protein S-protein 0.8945034742355347
in O O 0.9991322159767151

not O O 0.9663320779800415
all O O 0.9992325305938721
, O O 0.9995447993278503
adenovirus O O 0.6649177670478821
types O O 0.6048180460929871
during O O 0.9999865293502808
many O O 0.9999158382415771
years O O 0.9995176792144775
of O O 0.999956488609314
symbiotic O O 0.9167918562889099
, O O 0.9917826652526855
persistent O O 0.97808837890625
relationship O O 0.9989773035049438
in O O 0.9999966621398926

by O O 0.9990097284317017
zDEVD-fmk O S-protein 0.8910696506500244
, O O 0.9984651803970337
an O O 0.9998916387557983
inhibitor O O 0.9413692355155945
specific O O 0.9897013902664185
for O O 0.9996638298034668
caspase B-protein B-protein 0.5990859866142273
3-like I-protein I-protein 0.7968212962150574
proteases E-protein E-protein 0.9959796667098999
. O O 0.9999639987945557
In-vitro O O 0.6848239898681641
cleavage O O 0.6631816029548645
of O O 0.9953593611717224
recombinant B-protein B-protein 0.5667726397514343
SP1 E-protein E-protein 0.8953859806060791
by O O 0.9998729228973389
recombinant B-protein B-protein 0.6586830019950867
caspase I-protein I-protein 0.8993451595306396
3 E-protein E-protein 0.9796665906906128
( O O 0.9732862114906311
CPP32 S-protein S-protein 0.9529572129249573
) O O 0.910977840423584
or O O 0.9997989535331726
caspase B-protein B-protein 0.5983807444572449
7 E-protein E-protein 0.9926578402519226
( O O 0.9962132573127747
Mch B-protein B-protein 0.5476936101913452
3 E-protein E-protein 0.8539703488349915
) O O 0.9152489304542542
results O O 0.9999688863754272
in O O 0.9999974966049194

CREB S-protein S-protein 0.7053588032722473
were O O 0.9996776580810547
detected O O 0.9997690320014954
, O O 0.9999825954437256
identical O O 0.9992790818214417
to O O 0.9999933242797852
what O O 0.9999958276748657
we O O 0.9997404217720032
observed O O 0.9998912811279297
in O O 0.9999912977218628
mice O O 0.9901978969573975
. O O 0.9999953508377075
Antibodies O O 0.9544715285301208
recognizing O O 0.9993857145309448
double-stranded O B-DNA 0.5322169065475464
DNA O E-DNA 0.9866589307785034
were O O 0.9999008178710938
confined O O 0.9999643564224243
to O O 0.9999909400939941
patients O O 0.9986878037452698
with O O 0.9999792575836182
frequent O O 0.9929089546203613
polyomavirus O O 0.9930534958839417

of O O 0.9986594915390015
the O O 0.9999967813491821
interferon B-protein B-protein 0.463412344455719
gamma E-protein E-protein 0.7782501578330994
induction O O 0.7931989431381226
pathway O O 0.9908246397972107
. O O 0.9999895095825195
Estrogen O B-DNA 0.5528771877288818
binding O I-DNA 0.4222966134548187
sites O E-DNA 0.7939395308494568
in O O 0.9999282360076904
peripheral B-cell_type B-cell_type 0.49519217014312744
blood I-cell_type I-cell_type 0.8578515648841858
monocytes E-cell_type E-cell_type 0.964931845664978
and O O 0.9934980869293213
effects O O 0.9988206028938293
of O O 0.999977707862854
danazol O O 0.9629626870155334
on O O 0.9999254941940308
their O O 0.9999822378158569
sites O O 0.9901941418647766
in O O 0.9999727010726929

and O O 0.9225277900695801
anti-Fos B-protein B-protein 0.47260433435440063
antibodies E-protein E-protein 0.9976389408111572
abolished O O 0.9976345300674438
binding O O 0.9937399625778198
to O O 0.9999628067016602
the O O 0.9999277591705322
NFAT B-DNA B-DNA 0.5513977408409119
motif E-DNA E-DNA 0.9115727543830872
in O O 0.9999344348907471
both O O 0.9995736479759216
T B-cell_type B-cell_type 0.6293887495994568
and I-cell_type I-cell_type 0.8324130177497864
B I-cell_type I-cell_type 0.9530371427536011
cells E-cell_type E-cell_type 0.9792191386222839
, O O 0.983608067035675
indicating O O 0.9999752044677734
that O O 0.9999940395355225
Jun O S-protein 0.9848554730415344
and O O 0.9804876446723938
Fos O S-protein 0.9400635361671448
are O O 0.9999226331710815
critical O O 0.9990968704223633
for O O 0.9999382495880127
NFAT B-protein B-protein 0.524305522441864
complex E-protein E-protein 0.957435131072998
formation O O 0.9679913520812988
in O O 0.9999860525131226
both O O 0.9998470544815063
cell O O 0.9369074106216431
types O O 0.7379100322723389
. O O 0.9999955892562866
Purified O B-protein 0.48625102639198303
recombinant O I-protein 0.6327435970306396
Jun B-protein I-protein 0.5152839422225952
and I-protein I-protein 0.8577771186828613
Fos I-protein I-protein 0.7970468401908875
proteins E-protein E-protein 0.9539192914962769
failed O O 0.9995235204696655
to O O 0.9999841451644897
bind O O 0.9997950196266174
directly O O 0.9999556541442871
to O O 0.9999958276748657
the O O 0.9999024868011475
NFAT B-DNA B-DNA 0.6917954683303833
motif E-DNA E-DNA 0.9017534852027893

in O O 0.9996036887168884
the O O 0.9999972581863403
induction O O 0.9981176853179932
of O O 0.9999728202819824
apoptosis O O 0.9610317945480347
were O O 0.999945878982544
not O O 0.999901533126831
related O O 0.9999797344207764
to O O 0.9999866485595703
levels O O 0.9995265007019043
of O O 0.9999562501907349
p56 B-protein B-protein 0.5737866759300232
( I-protein I-protein 0.6467009782791138
lck I-protein I-protein 0.9455543160438538
) E-protein E-protein 0.9891629219055176
or O O 0.9992120265960693
NF- B-protein B-protein 0.7088034749031067
kappaB E-protein E-protein 0.9463335275650024
activation O O 0.998584508895874
. O O 0.999998927116394
Initial O O 0.9820902347564697

specific O O 0.964531660079956
probes O O 0.50284743309021
for O O 0.9996306896209717
chromosomes O B-DNA 0.8474932909011841
X S-DNA I-DNA 0.9464128613471985
and O I-DNA 0.9476817846298218
17 S-DNA E-DNA 0.9170465469360352
showed O O 0.999776303768158
that O O 0.9999986886978149
the O O 0.9998989105224609
breakpoints O O 0.9697948098182678
on O O 0.9998898506164551
both O O 0.9995824694633484
chromosomes S-DNA O 0.7458935976028442
lie O O 0.9705362915992737
within O O 0.999990701675415
the O O 0.9999833106994629
alphoid O O 0.6280599236488342
arrays O O 0.7766302227973938
, O O 0.9996755123138428
making O O 0.9999345541000366

the O O 0.9989894032478333
activity O O 0.9987441301345825
of O O 0.999982476234436
neutrophils S-cell_type S-cell_type 0.9952101111412048
during O O 0.999774158000946
the O O 0.9999977350234985
normal O O 0.9007925391197205
menstrual O O 0.9512320160865784
cycle O O 0.9889122247695923
, O O 0.9997747540473938
not O O 0.9999098777770996
only O O 0.9999860525131226
during O O 0.9996579885482788
pregnancy O O 0.9993127584457397
, O O 0.9999802112579346
and O O 0.999968409538269
influence O O 0.9994670748710632
inflammation O O 0.9997263550758362
. O O 0.9999988079071045
Identification O O 0.9997724890708923
of O O 0.9999966621398926
the O O 0.9999829530715942
TCL1 B-DNA B-DNA 0.5454346537590027
gene E-DNA E-DNA 0.9899091720581055
involved O O 0.9997618794441223
in O O 0.9999586343765259
T-cell S-cell_type O 0.4242643415927887
malignancies O O 0.7225373983383179
. O O 0.9999843835830688
The O O 0.9999955892562866
TCL1 B-DNA B-DNA 0.5361289381980896
locus E-DNA E-DNA 0.9914793968200684
on O O 0.9992635846138
chromosome B-DNA B-DNA 0.7879195213317871
14q32.1 E-DNA E-DNA 0.9949496984481812
is O O 0.9995959401130676
frequently O O 0.9996893405914307
involved O O 0.9999887943267822
in O O 0.9999778270721436
chromosomal O O 0.4946129620075226

demonstrate O O 0.9994483590126038
that O O 0.9999996423721313
the O O 0.9999746084213257
human B-DNA B-DNA 0.7995219230651855
LOX-1 I-DNA I-DNA 0.790091335773468
gene E-DNA E-DNA 0.9985835552215576
is O O 0.9998225569725037
a O O 0.9999949932098389
new O O 0.9986684322357178
member O O 0.9955698847770691
of O O 0.999972939491272
the O O 0.9999922513961792
natural B-protein B-protein 0.7085539698600769
killer I-protein I-protein 0.49742943048477173
gene I-protein I-protein 0.4244436025619507
complex E-protein E-protein 0.9688482880592346
with O O 0.9998496770858765
a O O 0.9999831914901733
unique O O 0.788906991481781
expression O O 0.7210439443588257
profile O O 0.5408229231834412
. O O 0.9999327659606934
Copyright O O 0.9853919148445129
1998 O O 0.9918387532234192
Academic O O 0.9982147216796875
Press O O 0.9966645836830139
. O O 0.9999977350234985
Transcriptional O O 0.9807661771774292
regulation O O 0.9995613694190979
of O O 0.9999973773956299
the O O 0.9999687671661377
beta-casein B-DNA B-DNA 0.922113835811615
gene E-DNA E-DNA 0.9933225512504578
by O O 0.9995185136795044

site E-DNA O 0.8186613321304321
( O O 0.9840970039367676
GAS S-DNA S-DNA 0.9212551712989807
) O O 0.8330633640289307
probe O O 0.8477892875671387
. O O 0.9999798536300659
We O O 0.9999896287918091
found O O 0.999997615814209
that O O 0.9999910593032837
IL-5 S-protein S-protein 0.9601170420646667
induces O O 0.9986855387687683

of O O 0.9985682964324951
the O O 0.9999897480010986
enhancer B-DNA B-DNA 0.6633451581001282
elements E-DNA E-DNA 0.9857749938964844
of O O 0.999188244342804
human O O 0.7472145557403564
T-cell O O 0.6752421855926514
leukemia O O 0.8624305129051208

signals O O 0.8748463988304138
, O O 0.9994096755981445
such O O 0.999981164932251
as O O 0.9999873638153076
activation O O 0.9893724322319031
of O O 0.9996569156646729
the O O 0.9999589920043945
CD28 B-protein B-protein 0.552696168422699
cell I-protein I-protein 0.8058453798294067
surface I-protein I-protein 0.9314612746238708
molecule E-protein E-protein 0.9934971332550049
on O O 0.9995055198669434
T B-cell_type B-cell_type 0.8953137397766113
cells E-cell_type E-cell_type 0.9904513359069824
, O O 0.9965236783027649
lead O O 0.9999474287033081
to O O 0.9999805688858032
activation O O 0.998837411403656
through O O 0.9999955892562866
a O O 0.9999899864196777
distinct O O 0.9976105690002441
region O O 0.978278398513794

25 O O 0.6069169640541077
( O O 0.9861763119697571
OH O O 0.9542694687843323
) O O 0.9916675686836243
2D3 O O 0.962617814540863
alone O O 0.9995081424713135
. O O 0.9999985694885254
In O O 0.9999779462814331
addition O O 0.999778687953949
, O O 0.9996870756149292
exogenous O O 0.8952993154525757
p27 B-protein S-protein 0.5174819231033325

. O O 0.9989274144172668
A O O 0.9912678599357605
region O B-DNA 0.7756350040435791
between-3134 O I-DNA 0.7075872421264648
and O I-DNA 0.5254258513450623
-2729 O I-DNA 0.851327121257782
bp O I-DNA 0.827305793762207
upstream O E-DNA 0.9958810806274414
from O O 0.9999561309814453
the O O 0.9999176263809204
transcription B-DNA B-DNA 0.6899980902671814
site E-DNA E-DNA 0.9499825239181519
of O O 0.9987592697143555
the O O 0.9999213218688965
human B-DNA B-DNA 0.8010598421096802
pro-interleukin I-DNA I-DNA 0.9066202640533447
1beta I-DNA I-DNA 0.7540071606636047

Hox11 S-protein S-protein 0.7270925045013428
and O O 0.9978094696998596
that O O 0.9999876022338867
abnormal O O 0.9467397332191467
expression O O 0.9932562112808228
of O O 0.9999580383300781
Aldh1 S-protein S-protein 0.8772681355476379
in O O 0.9998108744621277
Hox11 S-protein S-protein 0.47472435235977173
null O O 0.7883132696151733
mice O O 0.9878947138786316
may O O 0.9999967813491821
cause O O 0.9999974966049194
loss O O 0.9999665021896362
of O O 0.9999896287918091
splenic B-cell_type O 0.39464446902275085

. O O 0.9991243481636047
The O O 0.9999936819076538
biochemical O O 0.9391187429428101
modifications O O 0.9918150305747986
responsible O O 0.9999672174453735
for O O 0.9999920129776001
the O O 0.9999892711639404
defect O O 0.9946795105934143
in O O 0.9999594688415527
transduction O O 0.9910234212875366
and O O 0.999661922454834
execution O O 0.9984244108200073
of O O 0.9999825954437256
the O O 0.9999860525131226
proliferative O O 0.8016541600227356
signal O O 0.915862500667572
are O O 0.9998500347137451
analyzed O O 0.9995502829551697
as O O 0.9999949932098389
a O O 0.9999953508377075
function O O 0.9996602535247803
of O O 0.9999635219573975
age O O 0.9992066025733948
. O O 0.9999990463256836
The O O 0.9999994039535522
multiple O O 0.9405583143234253
alterations O O 0.9854108095169067
observed O O 0.9999237060546875
on O O 0.9999881982803345
the O O 0.9999852180480957
various O O 0.9953659772872925
biochemical O O 0.9476473927497864
pathways O O 0.9972084164619446

, O O 0.9954776167869568
the O O 0.9999707937240601
GR S-protein S-protein 0.9867722392082214
in O O 0.9998002648353577
MNL S-cell_type S-cell_type 0.9101125001907349
did O O 0.998802661895752
not O O 0.9999876022338867
demonstrate O O 0.9999674558639526
circadian O O 0.8946332335472107
variation O O 0.990944504737854
, O O 0.9999781847000122
in O O 0.9999895095825195
contrast O O 0.999990701675415
to O O 0.9999963045120239
concentrations O O 0.9981178045272827
of O O 0.9999884366989136
plasma O O 0.8393037915229797
cortisol O O 0.9231707453727722
. O O 0.9997736811637878
Synergism O O 0.9417983293533325
between O O 0.9994262456893921
two O O 0.9928722381591797
distinct O O 0.9914754629135132
elements O O 0.640967845916748
of O O 0.9997273087501526
the O O 0.9998824596405029
HTLV-I B-DNA B-DNA 0.7409456968307495
enhancer E-DNA E-DNA 0.9947590231895447
during O O 0.9990935325622559
activation O O 0.9978540539741516
by O O 0.9999949932098389
the O O 0.9997005462646484
trans-activator S-protein O 0.2706596553325653
of O O 0.8145872950553894
HTLV-I O O 0.32272571325302124
. O O 0.9973579049110413
We O O 0.9999703168869019
have O O 0.9999957084655762
conducted O O 0.9998260140419006
functional O O 0.9926436543464661
studies O O 0.999016523361206

of O O 0.9985284805297852
HIV-1-infected B-cell_type B-cell_line 0.7315046191215515
promonocytic I-cell_type I-cell_line 0.8894602656364441
U1 I-cell_type I-cell_line 0.9198912382125854
cells E-cell_type E-cell_line 0.9962397813796997
with O O 0.999835729598999
r-h-TBP-1 S-protein S-protein 0.8917058706283569
or O O 0.9968971014022827
rhu B-protein B-protein 0.5712746381759644
TNFR I-protein I-protein 0.5185659527778625
: I-protein I-protein 0.5520344376564026
Fc E-protein E-protein 0.822721540927887
reduced O O 0.97350013256073
PMA-induced O O 0.8526296019554138
HIV-1 B-protein O 0.6671685576438904
p24 I-protein B-protein 0.43447041511535645
antigen E-protein E-protein 0.9697703719139099
production O O 0.9958363771438599

of O O 0.9948587417602539
collagenase-1 S-protein S-protein 0.947498619556427
in O O 0.9997797608375549
monocytic B-cell_type B-cell_type 0.7466312646865845
cells E-cell_type E-cell_type 0.9779660105705261
. O O 0.9999393224716187
Our O O 0.9999998807907104
findings O O 0.999974250793457
suggest O O 0.9999995231628418
that O O 0.9999978542327881
distinct O O 0.9782775640487671
regulatory B-DNA B-DNA 0.6755369305610657
elements E-DNA E-DNA 0.9844580292701721
, O O 0.9997720122337341
acting O O 0.9222946166992188
somewhat O O 0.9984281063079834
independently O O 0.9999332427978516
of O O 0.9999933242797852
each O O 0.9999915361404419
other O O 0.9990293979644775
, O O 0.9995881915092468
control O O 0.9985876083374023
expression O O 0.9969442486763
of O O 0.9999496936798096
collagenase-1 S-protein S-protein 0.3046441376209259

A O O 0.5040884017944336
and O O 0.9723632335662842
FK506 O O 0.445231556892395
action O O 0.9964140057563782
because O O 0.9999924898147583
transcription O O 0.9266512989997864
directed O O 0.9976603984832764
by O O 0.9999969005584717
this O O 0.9996585845947266
protein O O 0.8625314235687256
is O O 0.9980668425559998
blocked O O 0.9995014667510986
in O O 0.9999144077301025
T B-cell_type B-cell_type 0.8775386810302734
cells E-cell_type E-cell_type 0.9866379499435425
treated O O 0.9987642765045166
with O O 0.999997615814209
these O O 0.9999388456344604
drugs O O 0.9963920712471008
, O O 0.9999732971191406
with O O 0.9999933242797852
little O O 0.9998643398284912
or O O 0.9999291896820068
no O O 0.9999526739120483
effect O O 0.9999387264251709
on O O 0.999995231628418

produced O O 0.9898518919944763
by O O 0.99996018409729
eTh1 B-cell_type B-cell_type 0.696472704410553
cells E-cell_type E-cell_type 0.8038080930709839
. O O 0.999909520149231
Here O O 0.9999840259552002
we O O 0.9999858140945435
have O O 0.9999963045120239
used O O 0.9996942281723022
reporter O O 0.8252912759780884
transgenic O O 0.9112311601638794
mice O O 0.9880462884902954
to O O 0.9999958276748657
show O O 0.9999986886978149
that O O 0.9999936819076538
DNA O O 0.8596689105033875
binding O O 0.9350937008857727
and O O 0.9969960451126099

purity O O 0.9293749332427979
to O O 0.9995488524436951
allow O O 0.9999958276748657
its O O 0.9999898672103882
usage O O 0.9985194802284241
in O O 0.9999892711639404
signal O O 0.9551635384559631
transduction O O 0.9864223599433899
studies O O 0.9985048770904541
. O O 0.9999990463256836
This O O 0.999997615814209
report O O 0.9997113347053528
sets O O 0.9999867677688599
a O O 0.9999940395355225
basis O O 0.9998131394386292
for O O 0.9999979734420776
further O O 0.9999090433120728
studies O O 0.9999066591262817
on O O 0.9999967813491821

cells E-cell_line E-cell_type 0.584725022315979
do O O 0.9994164705276489
not O O 0.9999570846557617
express O O 0.99822598695755
CIITA-specific B-RNA B-RNA 0.8999952077865601
transcripts E-RNA E-RNA 0.9909446239471436
. O O 0.9998303651809692
Transfection O O 0.9890101552009583
of O O 0.9999485015869141
a O O 0.9998704195022583
cDNA O S-DNA 0.9206987619400024
containing O O 0.9938993453979492
the O O 0.9998457431793213
human B-DNA B-DNA 0.724140465259552
CIITA I-DNA I-DNA 0.876587986946106
coding I-DNA I-DNA 0.9697772264480591
sequence E-DNA E-DNA 0.9913153648376465
under O O 0.9998877048492432

natural B-cell_type B-cell_type 0.8140624165534973
killer I-cell_type I-cell_type 0.6418130993843079
cells E-cell_type E-cell_type 0.9685565233230591
and O O 0.9974766373634338
selective O O 0.9306325316429138
defects O O 0.991063117980957
in O O 0.9999666213989258
gamma B-cell_type B-cell_type 0.44670647382736206
delta I-cell_type I-cell_type 0.5568790435791016
T I-cell_type I-cell_type 0.5755871534347534
cells E-cell_type E-cell_type 0.6243405342102051
and O O 0.9941211342811584
dendritic B-cell_type B-cell_type 0.6864261627197266
antigen-presenting I-cell_type I-cell_type 0.7865960001945496
cells E-cell_type E-cell_type 0.910571277141571
point O O 0.9975156784057617
to O O 0.9999940395355225
Ikaros S-protein S-protein 0.909711480140686
as O O 0.9999699592590332
an O O 0.9999923706054688
essential O O 0.9984380602836609
factor O O 0.9928476810455322
for O O 0.9999850988388062
the O O 0.9999961853027344
establishment O O 0.9995749592781067
of O O 0.9999918937683105
early O O 0.7701438069343567
branchpoints O O 0.6141835451126099
of O O 0.9941368103027344

of O O 0.9947216510772705
IFN-gamma S-protein S-protein 0.9899508357048035
was O O 0.9998225569725037
associated O O 0.9996017813682556
with O O 0.9999954700469971
high O O 0.9735884070396423
levels O O 0.9990419745445251
of O O 0.9999710321426392
serum B-protein B-protein 0.5018656849861145
AST/ALT E-protein E-protein 0.9673255085945129
. O O 0.9992246627807617
However O O 0.999956488609314
, O O 0.9999744892120361
we O O 0.9999390840530396
could O O 0.999996542930603
not O O 0.9999836683273315

patients O O 0.9892962574958801
with O O 0.9999803304672241
SLE O O 0.9753566980361938
( O O 0.9998619556427002
n O O 0.9884937405586243
= O O 0.9995490908622742
6 O O 0.9989373087882996
) O O 0.9998936653137207
and O O 0.9999524354934692
healthy O O 0.9761753678321838
donors O O 0.9910606741905212
( O O 0.9999790191650391
n O O 0.9976377487182617
= O O 0.9998747110366821
8 O O 0.9988835453987122
) O O 0.9998940229415894
. O O 0.999990701675415
T B-cell_type B-cell_type 0.7073169946670532
cells E-cell_type E-cell_type 0.9797288775444031
were O O 0.9999147653579712
separated O O 0.9996529817581177
into O O 0.9999771118164062
CD4 S-cell_type S-protein 0.3815189301967621
and O O 0.8152531981468201
CD8 S-cell_type S-protein 0.46256786584854126
. O O 0.9960334897041321
Some O O 0.999725878238678
monocytes S-cell_type S-cell_type 0.9944861531257629
and O O 0.9895532131195068
T B-cell_type B-cell_type 0.6017324924468994

detected O O 0.9974232912063599
20 O O 0.9973576664924622
days O O 0.9995927214622498
after O O 0.9999957084655762
infection O O 0.99957674741745
in O O 0.9999983310699463
two O O 0.9997113347053528
and O O 0.9998183846473694
47 O O 0.9979820251464844
days O O 0.9997263550758362
after O O 0.9999947547912598

mutants O O 0.45910289883613586
. O O 0.9999732971191406
Direct O O 0.9995760321617126
assays O O 0.9998127818107605
of O O 0.999995231628418
PKC S-protein S-protein 0.9943501353263855
activity O O 0.9993938207626343
were O O 0.9999984502792358
conducted O O 0.9999499320983887
. O O 0.9999959468841553

chain E-protein E-protein 0.9751365184783936
. O O 0.9999374151229858
In O O 0.9999886751174927
this O O 0.9999994039535522
study O O 0.9996722936630249
, O O 0.9999972581863403
two O O 0.99910968542099
regions O O 0.989548921585083
in O O 0.9999822378158569
the O O 0.9999743700027466
cytoplasmic B-protein B-protein 0.7220064401626587
domain E-protein E-protein 0.9596143364906311
of O O 0.9979056119918823
human B-protein B-protein 0.5067033767700195
IL-9Ralpha E-protein E-protein 0.9272136688232422
were O O 0.9989380240440369
found O O 0.9999737739562988
to O O 0.9999964237213135
be O O 0.9999980926513672
important O O 0.9999819993972778
for O O 0.999975323677063
IL-9 S-protein S-protein 0.9990200996398926
-mediated O O 0.9899584650993347
cell O O 0.9782534837722778

levels O O 0.9863877296447754
, O O 0.9998947381973267
was O O 0.9998931884765625
also O O 0.9999747276306152
slightly O O 0.9999454021453857
augmented O O 0.9999687671661377
by O O 0.9999984502792358
LTB4 O O 0.4451015293598175
, O O 0.994766354560852
although O O 0.9999841451644897
to O O 0.9999587535858154
a O O 0.9999943971633911
much O O 0.9991862177848816
lower O O 0.9998360872268677
extent O O 0.999858021736145
than O O 0.9999860525131226
c-fos S-DNA S-DNA 0.7400716543197632
. O O 0.997443437576294

structure O O 0.663693368434906
for O O 0.9991573095321655
human B-cell_type B-cell_type 0.46786871552467346
T-lymphocytes E-cell_type E-cell_type 0.9485713243484497
. O O 0.9998807907104492
Using O O 0.9998817443847656
recombinant B-protein B-protein 0.7235000729560852
HBxAg I-protein I-protein 0.3752366900444031
protein E-protein E-protein 0.9918501377105713
, O O 0.9996318817138672
we O O 0.9999641180038452
found O O 0.9999926090240479
HBxAg S-protein S-protein 0.9984997510910034
-specific O O 0.9944310784339905
stimulation O O 0.9992281198501587
of O O 0.9999903440475464
peripheral B-cell_type B-cell_type 0.6613135933876038
blood I-cell_type I-cell_type 0.9001210331916809
mononuclear I-cell_type I-cell_type 0.9904160499572754
cells E-cell_type E-cell_type 0.9959771037101746
in O O 0.9999184608459473
patients O O 0.9997170567512512
with O O 0.9999876022338867

of O O 0.9964323043823242
ICAM-1 S-protein S-protein 0.9780210852622986
and O O 0.9937669038772583
LFA-3 S-protein S-protein 0.989298939704895
by O O 0.999915361404419
Tax1 S-protein S-protein 0.9886828064918518
of O O 0.9996567964553833
human O O 0.8273919224739075
T-cell O O 0.8806980848312378
leukemia O O 0.9566519260406494
virus O O 0.9855013489723206
type O O 0.978583574295044
1 O O 0.9780394434928894
and O O 0.9977335929870605
mechanism O O 0.9874309301376343
of O O 0.9996799230575562
down-regulation O O 0.9993565678596497
of O O 0.9999861717224121
ICAM-1 S-protein S-protein 0.9763542413711548
or O O 0.9983242154121399
LFA-1 S-protein S-protein 0.9938158988952637
in O O 0.9998013377189636
adult-T-cell-leukemia B-cell_line B-cell_line 0.5537028312683105
cell I-cell_line I-cell_line 0.7723879218101501
lines E-cell_line E-cell_line 0.9987567663192749
. O O 0.9999055862426758

with O O 0.99951171875
10 O O 0.9900700449943542
( O O 0.9997380375862122
-7 O O 0.9996039271354675
) O O 0.9996082186698914
M O O 0.97630774974823
all-trans O O 0.9965858459472656
retinoic O O 0.9788650274276733
acid O O 0.9964641332626343
( O O 0.999954342842102
all-trans O O 0.9993399977684021
RA O O 0.9970383644104004
) O O 0.9998792409896851
induces O O 0.9997650980949402
neutrophil S-cell_type O 0.8754645586013794
differentiation O O 0.9941571950912476
, O O 0.9999700784683228
whereas O O 0.9999918937683105
treatment O O 0.9970388412475586
with O O 0.9999876022338867
10 O O 0.9852988719940186
( O O 0.9995332956314087
-7 O O 0.9989249110221863
) O O 0.9995661377906799
M O O 0.9882087707519531

can O O 0.9951918125152588
have O O 0.9999889135360718
a O O 0.999994158744812
profound O O 0.9982559084892273
impact O O 0.9999886751174927
on O O 0.9999978542327881
the O O 0.9999936819076538
activation O O 0.989599347114563
status O O 0.9996141195297241
of O O 0.9999890327453613
eukaryotic B-cell_type B-cell_type 0.761919379234314
cells E-cell_type E-cell_type 0.9571521878242493
. O O 0.9999531507492065
Novel B-protein B-protein 0.8505613803863525
membrane I-protein I-protein 0.45969197154045105
receptors E-protein E-protein 0.989337682723999
for O O 0.9991984963417053
aldosterone O O 0.6159127354621887
in O O 0.9959841966629028
human B-cell_type B-cell_type 0.6443678140640259
lymphocytes E-cell_type E-cell_type 0.9889906644821167
: O O 0.9955610036849976
a O O 0.999946117401123
50 B-protein B-protein 0.5617598295211792
kDa I-protein I-protein 0.8760915994644165
protein E-protein E-protein 0.9855622053146362
on O O 0.9996724128723145
SDS-PAGE O S-protein 0.610498309135437
. O O 0.9984955787658691
Fast O O 0.9632679224014282
in O O 0.999214768409729
vitro O O 0.9917663931846619
effects O O 0.9998874664306641
of O O 0.999992847442627
aldosterone O O 0.9499676823616028

DQ S-DNA S-protein 0.4637501835823059
and O O 0.9550496339797974
DP S-DNA S-protein 0.601913571357727
, O O 0.9709770679473877
is O O 0.9998600482940674
mediated O O 0.9999336004257202
by O O 0.9999991655349731
its O O 0.9999803304672241
remaining O O 0.9944882988929749
C-terminal B-protein B-protein 0.7563101053237915
residues E-protein E-protein 0.9688730835914612
( O O 0.9977476000785828
amino B-protein B-protein 0.6760580539703369
acids I-protein I-protein 0.7422395944595337
317-1130 E-protein E-protein 0.8991647362709045

as O O 0.9993077516555786
NF B-protein B-protein 0.626484751701355
kappa I-protein I-protein 0.7045720219612122
B E-protein E-protein 0.9909092783927917
and O O 0.9938485026359558
AP-1 S-protein S-protein 0.9772242307662964
, O O 0.9989233613014221
are O O 0.9999871253967285
activated O O 0.9939932227134705
upon O O 0.9997202754020691
stimulation O O 0.9986501336097717
of O O 0.9999836683273315
the O O 0.9999339580535889
cells O O 0.96226966381073
with O O 0.999950647354126
several O O 0.9980902075767517
chemoattractants O O 0.3897067904472351
at O O 0.9998499155044556
physiologically O O 0.8903542757034302
relevant O O 0.9688836336135864
concentrations O O 0.9807724952697754
. O O 0.9999970197677612
Activation O O 0.998029887676239
of O O 0.999967098236084
transcription O B-protein 0.8073834776878357
factors O E-protein 0.9987292885780334
through O O 0.9999535083770752
these O O 0.9999730587005615

using O O 0.996471643447876
water O O 0.912405252456665
soluble O O 0.984664261341095
phorbol O O 0.9570132493972778
esters O O 0.9754346013069153
reveal O O 0.9999942779541016
that O O 0.9999964237213135
differentiation O O 0.9977442026138306
becomes O O 0.9999723434448242
irreversible O O 0.9998273253440857
soon O O 0.9999933242797852
after O O 0.999997615814209
AP-1 S-protein S-protein 0.985558032989502
appears O O 0.9997723698616028
. O O 0.9999984502792358
This O O 0.9999957084655762
tight O O 0.9896801114082336
correlation O O 0.999653697013855
between O O 0.9999880790710449

increase O O 0.9993810653686523
in O O 0.9999833106994629
the O O 0.9999966621398926
rate O O 0.9990384578704834
of O O 0.9999817609786987
transendothelial O O 0.8286283016204834
migration O O 0.9950059056282043
of O O 0.9999866485595703
monocyte-like B-cell_line B-cell_line 0.5400702953338623
HL-60 I-cell_line I-cell_line 0.6838456988334656
cells E-cell_line E-cell_line 0.9798763990402222
and O O 0.9992536902427673
a O O 0.9999957084655762
twentyfold O O 0.9441140294075012
increase O O 0.9997269511222839
in O O 0.9999812841415405
phosphorylation O O 0.9732888340950012
of O O 0.9997727274894714
platelet B-protein B-protein 0.4076707661151886
endothelial I-protein I-protein 0.3945959210395813
cell I-protein I-protein 0.6782751083374023
adhesion I-protein I-protein 0.8959928154945374
molecules E-protein E-protein 0.9989199638366699
( O O 0.993065595626831
PECAM-1 S-protein S-protein 0.8951793909072876
) O O 0.9897485375404358

by O O 0.9975507855415344
CD40 S-protein S-protein 0.993285059928894
and O O 0.998877227306366
surface B-protein B-protein 0.8751591444015503
Ig E-protein E-protein 0.981744110584259
is O O 0.999873161315918
protein B-protein B-protein 0.6836047172546387
kinase I-protein I-protein 0.6191487908363342
C E-protein E-protein 0.9869165420532227
dependent O O 0.9820988178253174
. O O 0.9999959468841553
The O O 0.9999966621398926
murine B-DNA B-DNA 0.6821617484092712
fra-1 I-DNA I-DNA 0.5108453035354614
gene E-DNA E-DNA 0.9964001178741455
, O O 0.9788045883178711
encoding O O 0.9857330322265625
Fos-related B-protein B-protein 0.6341935396194458
Ag I-protein I-protein 0.6643314361572266
1 E-protein E-protein 0.6621429920196533
, O O 0.9792583584785461
was O O 0.9998533725738525
isolated O O 0.9996658563613892

) O O 0.72955721616745
is O O 0.9996497631072998
a O O 0.9999980926513672
recently O O 0.9860255122184753
identified O O 0.9988240599632263
member O O 0.960567057132721
of O O 0.9995236396789551
the O O 0.9999490976333618
tumor B-protein B-protein 0.5837875604629517
necrosis I-protein I-protein 0.83180171251297
factor I-protein I-protein 0.5329152941703796
receptor I-protein I-protein 0.5903040766716003
superfamily E-protein E-protein 0.9480970501899719
and O O 0.9694685935974121
is O O 0.9997610449790955
expressed O O 0.9998831748962402
on O O 0.9998564720153809
activated B-cell_type B-cell_type 0.5948532223701477
T I-cell_type I-cell_type 0.698246955871582

all O O 0.999392032623291
the O O 0.9999942779541016
isoforms S-protein O 0.45127639174461365
are O O 0.9991143345832825
able O O 0.9998838901519775
to O O 0.9999827146530151
activate O O 0.9999892711639404
an O O 0.9999803304672241
octamer S-DNA O 0.61308753490448
containing O O 0.9236779808998108
promoter B-DNA B-DNA 0.5264610052108765
element E-DNA E-DNA 0.9608191251754761
in O O 0.9986571073532104
fibroblasts O S-cell_type 0.9870278835296631
revealing O O 0.9993745684623718
an O O 0.9999716281890869
unexpected O O 0.9868956208229065
functional O O 0.9618143439292908
redundancy O O 0.9977229237556458
. O O 0.9999966621398926

specific O O 0.9825695753097534
to O O 0.9998307228088379
the O O 0.9999772310256958
peptide O O 0.9539523720741272
. O O 0.9999396800994873
We O O 0.9999440908432007
then O O 0.9998335838317871
generated O O 0.9991857409477234
new O O 0.9869938492774963
donor O O 0.8873438239097595
anti-pml/RAR-alpha B-cell_line B-cell_line 0.4486652612686157
CD4 I-cell_line I-cell_line 0.5099091529846191
( I-cell_line I-cell_line 0.5356403589248657
+ I-cell_line I-cell_line 0.8090261816978455
) I-cell_line I-cell_line 0.8915184140205383
T-cell I-cell_line I-cell_line 0.9005765914916992
clones E-cell_line E-cell_line 0.9869385957717896
. O O 0.999911904335022
These O O 0.9999856948852539
clones O O 0.9124830365180969
were O O 0.999969482421875
tested O O 0.9998202919960022
for O O 0.9999958276748657
their O O 0.9999874830245972
recognition O O 0.9988248944282532
of O O 0.999981164932251
BCR1/25 O S-protein 0.4902518391609192
. O O 0.9996240139007568
One O O 0.9978837370872498
clone O O 0.7222509384155273
( O O 0.9931219220161438
C3/5 B-cell_line S-DNA 0.34130051732063293

method O O 0.7919953465461731
render O O 0.9980348944664001
it O O 0.9992662072181702
non-applicable O O 0.9984747767448425
for O O 0.9999644756317139
receptor O O 0.8785141110420227
quantitation O O 0.995718777179718
. O O 0.999998927116394
The O O 0.9999994039535522
results O O 0.9999078512191772
from O O 0.9999945163726807
9 O O 0.990846574306488
healthy O O 0.9857037663459778
volunteers O O 0.9971639513969421

kinase O E-protein 0.9746840000152588
( O O 0.9683200716972351
JNK S-protein S-protein 0.9913731217384338
) O O 0.9004946947097778
cascade O O 0.9815452694892883
, O O 0.9997938275337219
but O O 0.99996018409729
not O O 0.9998499155044556
the O O 0.9999375343322754
extracellular B-protein B-protein 0.6349458694458008

B I-protein E-protein 0.5188798904418945

, O O 0.9699667692184448
within O O 0.9997319579124451
the O O 0.9999916553497314
CD28 B-DNA B-DNA 0.8355724215507507
minimal I-DNA I-DNA 0.6053242683410645
promoter E-DNA E-DNA 0.9788970947265625
. O O 0.999861478805542
Both O O 0.9999691247940063
alpha- O B-protein 0.38234519958496094
and O I-protein 0.4970473349094391
beta-bound O I-protein 0.726401150226593
complexes O E-protein 0.9888606667518616
are O O 0.9997097849845886
found O O 0.9999754428863525
only O O 0.9999942779541016
in O O 0.9998247027397156
lymphoid O O 0.4827745854854584
tissues O O 0.7072188258171082

The O O 0.9996540546417236
primary O O 0.9303467273712158
reservoir O O 0.9708741307258606
of O O 0.9995567202568054
infection O O 0.9962881803512573
consists O O 0.9999911785125732
of O O 0.9999938011169434
latently O B-cell_type 0.5794464945793152
infected O I-cell_type 0.6566699147224426
B B-cell_type I-cell_type 0.6748567223548889
lymphocytes E-cell_type E-cell_type 0.9568923115730286
and O O 0.9989305138587952
possibly O O 0.9772192239761353
other O O 0.9974709749221802
mononuclear B-cell_type B-cell_type 0.7434373497962952
cells E-cell_type E-cell_type 0.992546021938324
. O O 0.9999161958694458
Viral O O 0.9482376575469971
reactivation O O 0.9982724189758301
from O O 0.9999972581863403
latency O O 0.9002107977867126

, O O 0.9929547905921936
Science O O 0.9987812638282776
231 O O 0.9994742274284363
: O O 0.9999822378158569
600-602 O O 0.9995537400245667
, O O 0.9999920129776001
1986 O O 0.9997346997261047
; O O 0.9999871253967285
D.Zagury O O 0.9995415210723877
, O O 0.9999880790710449
J. O O 0.9999113082885742
Bernard O O 0.9999690055847168
, O O 0.9999862909317017
R.Leonard O O 0.9998571872711182
, O O 0.9999767541885376
R.Cheynier O O 0.9998841285705566
, O O 0.9999864101409912
M.Feldman O O 0.9999079704284668
, O O 0.9999898672103882
P.S.Sarin O O 0.9997544884681702
, O O 0.9999817609786987
and O O 0.9999912977218628
R.C. O O 0.9999500513076782
Gallo O O 0.9995540976524353

% O O 0.5948426723480225
) O O 0.8962129354476929
during O O 0.9996170997619629
MPE O O 0.5741884112358093
and O O 0.9993127584457397
to O O 0.9999834299087524
a O O 0.9999936819076538
better O O 0.9997698664665222
tolerance O O 0.9988322854042053
of O O 0.9999709129333496
exercise O O 0.9967820644378662
during O O 0.9999901056289673
PPE O O 0.8449285626411438
. O O 0.9999812841415405
Following O O 0.9999874830245972
PCr O O 0.7134849429130554
administration O O 0.9971113204956055
we O O 0.9999959468841553
observed O O 0.9997946619987488
lower O O 0.9966638684272766
blood O O 0.904610812664032
lactate O O 0.8392117023468018
concentrations O O 0.9873551726341248
and O O 0.9999662637710571
different O O 0.9997966885566711
patterns O O 0.9988933205604553
of O O 0.9999901056289673
some O O 0.9999547004699707
enzyme O O 0.3994661271572113
activities O O 0.9375953078269958
, O O 0.9996820688247681
less O O 0.999790370464325
pronounced O O 0.9969397783279419
changes O O 0.9990808963775635
in O O 0.999985933303833
plasma B-protein O 0.852601170539856
ACTH E-protein O 0.6431636214256287
and O O 0.9952734112739563
cortisol O O 0.9178679585456848
concentrations O O 0.9843770265579224
and O O 0.9999762773513794
in O O 0.999945878982544
glucocorticoid O O 0.6877033710479736
binding O O 0.8061484098434448
in O O 0.9966322779655457
lymphocytes S-cell_type S-cell_type 0.9966307282447815
, O O 0.9924457669258118
but O O 0.9998819828033447
no O O 0.9999537467956543
changes O O 0.9993150234222412
in O O 0.9999589920043945
plasma O O 0.635513424873352
growth O O 0.8267809748649597
hormone O O 0.874336838722229
concentrations O O 0.9801422357559204
compared O O 0.9999755620956421

high O O 0.8963981866836548
density O O 0.9712198972702026
in O O 0.999887228012085
human B-cell_type B-cell_type 0.5309240221977234
gingival I-cell_type I-cell_type 0.8316081166267395
fibroblasts E-cell_type E-cell_type 0.9642688632011414
. O O 0.9999047517776489
P-LPS-induced O O 0.7534717917442322
expression O O 0.9747843146324158
of O O 0.999794065952301
the O O 0.9999338388442993
monocyte B-DNA B-protein 0.6948446035385132
chemoattractant I-DNA I-protein 0.8316750526428223
protein I-DNA E-protein 0.9354381561279297

differentiation O O 0.9016316533088684
program O O 0.9809032678604126
foreign O O 0.9706208109855652
to O O 0.9997267127037048
the O O 0.9999542236328125
HeLa B-cell_line O 0.3043179512023926
phenotype E-cell_line O 0.514355480670929
. O O 0.9982670545578003
Evidence O O 0.9993211030960083
for O O 0.999988317489624
suppressed O O 0.9729121327400208
activity O O 0.9963184595108032
of O O 0.9999405145645142
the O O 0.9999582767486572
transcription B-protein B-protein 0.7093372344970703
factor E-protein E-protein 0.9269133806228638

LPS O O 0.8796268701553345
. O O 0.9998950958251953
The O O 0.9999991655349731
effect O O 0.999956488609314
of O O 0.9999934434890747
GH O O 0.8110141158103943
appears O O 0.9994255304336548
to O O 0.9999885559082031
occur O O 0.9999979734420776
in O O 0.9999825954437256
an O O 0.9999812841415405
autocrine O O 0.8112210631370544
fashion O O 0.9816809296607971
, O O 0.9999144077301025
since O O 0.9999979734420776
the O O 0.999998927116394
inhibitory O O 0.9740719199180603
effect O O 0.9999567270278931
on O O 0.9999966621398926
TNF-alpha S-protein S-protein 0.9859808683395386
secretion O O 0.9989820122718811
by O O 0.9999991655349731
constitutive O O 0.9232060313224792
GH O O 0.6082753539085388
production O O 0.9948909282684326
could O O 0.9999961853027344
be O O 0.9999954700469971
abolished O O 0.9999699592590332
in O O 0.9999983310699463
the O O 0.9999982118606567
presence O O 0.998634397983551

leukemic B-cell_type I-cell_type 0.3442065417766571
cells E-cell_type E-cell_type 0.8512900471687317
of O O 0.999273955821991
ATL O O 0.8355848789215088
patients O O 0.9858507513999939
, O O 0.9998551607131958
possibly O O 0.9999669790267944
due O O 0.9999903440475464
to O O 0.9999948740005493
differential O O 0.9939035773277283
NF-kappaB S-protein S-protein 0.9495513439178467
subunit O O 0.6607726812362671
activation O O 0.9965560436248779
. O O 0.9999912977218628
Interferon-alpha S-protein S-protein 0.8818725347518921
induction O O 0.9982082843780518
of O O 0.9999849796295166
STATs1 B-protein S-protein 0.5245457291603088
, I-protein O 0.7049710154533386
-3 E-protein O 0.41740286350250244
DNA O O 0.7382263541221619
binding O O 0.9679518938064575
and O O 0.9994219541549683
growth O O 0.7881497740745544
arrest O O 0.977653443813324
is O O 0.9999514818191528
independent O O 0.9997316002845764
of O O 0.9999926090240479
Lck S-protein S-protein 0.991613507270813
and O O 0.9966992735862732
active O B-protein 0.7129822373390198
mitogen-activated B-protein I-protein 0.5145594477653503
kinase E-protein E-protein 0.9505078196525574
in O O 0.996491014957428
T B-cell_type B-cell_type 0.9257476925849915
cells E-cell_type E-cell_type 0.9952358603477478
. O O 0.999886155128479
Type O B-protein 0.5170976519584656
I O I-protein 0.8875086307525635
interferons S-protein E-protein 0.9906601309776306

large O O 0.9472838640213013
doses O O 0.9906283020973206
of O O 0.9998865127563477
prednisone O O 0.8159782290458679
. O O 0.9998236298561096
The O O 0.9999977350234985
average O O 0.9945857524871826
values O O 0.9935442209243774
from O O 0.9999866485595703
healthy O O 0.881616473197937

cytokines S-protein S-protein 0.6034649610519409
: O O 0.9951261281967163
cross-talk O O 0.852423906326294
between O O 0.9971535205841064
STAT5 S-protein S-protein 0.992923378944397
and O O 0.9958204030990601
other O O 0.9984234571456909
signaling B-protein B-protein 0.4883115887641907
molecules E-protein E-protein 0.9929995536804199
. O O 0.9999840259552002
The O O 0.9999920129776001
beta-casein B-DNA B-DNA 0.6811461448669434
promoter E-DNA E-DNA 0.9943292737007141
has O O 0.9996981620788574
been O O 0.9999698400497437
widely O O 0.9976084232330322
used O O 0.9999595880508423
to O O 0.9999754428863525
monitor O O 0.999937891960144
the O O 0.999983549118042
activation O O 0.9957980513572693
of O O 0.9999151229858398
STAT B-protein S-protein 0.8588019013404846
( I-protein O 0.9659892320632935
signal I-protein B-protein 0.7188727855682373
transducer I-protein I-protein 0.7449626326560974
and I-protein I-protein 0.9091623425483704
activator I-protein I-protein 0.9231922030448914
of I-protein I-protein 0.9943623542785645
transcription I-protein I-protein 0.7897046208381653
) I-protein I-protein 0.9283754825592041
5 E-protein E-protein 0.9578622579574585
since O O 0.9988667964935303
STAT5 S-protein S-protein 0.9901009798049927
was O O 0.9999158382415771

JAK3 S-protein S-protein 0.9681655168533325
and O O 0.9982138872146606
activates O O 0.9954322576522827
STAT B-protein B-protein 0.8135578632354736
proteins E-protein E-protein 0.9978755712509155
. O O 0.9999490976333618
Latent B-protein B-protein 0.5346757173538208
membrane I-protein I-protein 0.8075646758079529
protein I-protein I-protein 0.6050801873207092
1 E-protein E-protein 0.9971579313278198
( O O 0.9871784448623657
LMP1 S-protein S-protein 0.997784435749054
) O O 0.9692521691322327
acts O O 0.9997418522834778
like O O 0.9999054670333862
a O O 0.9999567270278931
permanently B-protein O 0.7621548771858215
activated I-protein O 0.6040050387382507
receptor E-protein O 0.5726953744888306
of O O 0.5833947062492371

functional B-protein O 0.7879709601402283
domain E-protein O 0.7555841207504272
for O O 0.9941051006317139
both O O 0.9994334578514099
receptor O O 0.579403817653656
coupling O O 0.4863088130950928
and O O 0.9564525485038757
dimerization O O 0.9199231266975403
. O O 0.9999560117721558
Evaluation O O 0.9996302127838135
of O O 0.9999939203262329
the O O 0.9999916553497314
respiratory O O 0.6883962154388428
epithelium O O 0.6073756217956543
of O O 0.9951110482215881
normals O O 0.7135517597198486
and O O 0.9845763444900513
individuals O O 0.995297372341156
with O O 0.9999561309814453
cystic O O 0.972111165523529
fibrosis O O 0.9967526793479919
for O O 0.9999866485595703
the O O 0.9999954700469971
presence O O 0.9992190599441528

transcription O O 0.7389168739318848
from O O 0.9999345541000366
a O O 0.9999585151672363
reporter O O 0.7640215158462524
construct O O 0.830003023147583
containing O O 0.9978296160697937
GAL4 B-DNA B-DNA 0.6880639791488647
sites E-DNA E-DNA 0.9911587834358215
in O O 0.9999653100967407
a O O 0.9999574422836304
cotransfection O O 0.5740330219268799
assay O O 0.8443998694419861
in O O 0.9998776912689209
the O O 0.999967098236084
Raji B-cell_line B-cell_line 0.7796419262886047
human I-cell_line I-cell_line 0.9417772889137268
B I-cell_line I-cell_line 0.9778063893318176
cell I-cell_line I-cell_line 0.9748308062553406
line E-cell_line E-cell_line 0.9960399866104126
. O O 0.9998623132705688
However O O 0.9999932050704956
, O O 0.9999954700469971
these O O 0.9999942779541016
plasmids S-DNA O 0.6361008286476135
produced O O 0.999450147151947
transcriptional O O 0.9355367422103882
activity O O 0.9985080361366272
in O O 0.999997615814209
HeLa B-cell_line B-cell_line 0.7732954025268555

in O O 0.999062716960907
situ O O 0.8683376312255859
hybridization O O 0.969157874584198
with O O 0.9999904632568359
BHLF1/NotI O B-protein 0.2685110569000244
oligoprobes O E-protein 0.6814184188842773
on O O 0.9993613362312317
tumour O O 0.7046827077865601
samples O O 0.5395090579986572
. O O 0.9999818801879883
Results O O 0.9999730587005615
were O O 0.999995231628418
statistically O O 0.9988817572593689
correlated O O 0.9998956918716431
with O O 0.9999967813491821
those O O 0.9999940395355225
of O O 0.99998939037323
CD4+ S-protein O 0.773219645023346
cell O O 0.6657941341400146
counts O O 0.4817708730697632
( O O 0.9933955073356628
17 O O 0.9951327443122864
out O O 0.9999369382858276

transcription I-protein B-protein 0.3646939992904663
factors E-protein E-protein 0.9979408383369446
Ets-1 S-protein S-protein 0.985716700553894
, O O 0.9899601936340332
LEF1 S-protein S-protein 0.9968350529670715
, O O 0.9929017424583435
and O O 0.9986212253570557
AML1 S-protein S-protein 0.9950799942016602
as O O 0.9993583559989929
well O O 0.9996753931045532
as O O 0.9999861717224121
by O O 0.9993997812271118
CREB/ATF-1 S-protein S-protein 0.9749689102172852
, O O 0.9981338381767273
as O O 0.9999700784683228
is O O 0.999208390712738
demonstrated O O 0.9999523162841797
in O O 0.999969482421875
gel O O 0.854117214679718
shift O O 0.9757345914840698
and O O 0.9992368221282959
footprinting O O 0.9278584718704224
experiments O O 0.965837299823761
. O O 0.9999914169311523
With O O 0.9999982118606567
the O O 0.9999973773956299
exception O O 0.9999250173568726
of O O 0.999988317489624
LEF1 S-protein S-protein 0.9294611215591431
, O O 0.999751627445221
these O O 0.9999762773513794

kD O I-protein 0.32195472717285156
protein O E-protein 0.9837546944618225
which O O 0.9989990592002869
is O O 0.9999842643737793
most O O 0.999862551689148
abundant O O 0.9974138140678406
in O O 0.999804675579071
T B-cell_type B-cell_type 0.9406326413154602
cells E-cell_type E-cell_type 0.9940823912620544
and O O 0.9964562058448792
which O O 0.9992910623550415
binds O O 0.9990597367286682
to O O 0.9997252821922302
site B-DNA B-protein 0.6124061346054077
B E-DNA E-protein 0.5581949353218079
as O O 0.9988325238227844
a O O 0.999976396560669
200 B-protein B-protein 0.6204728484153748
kD I-protein I-protein 0.808410108089447
complex E-protein E-protein 0.9945405125617981
. O O 0.9999027252197266
This O O 0.9999788999557495
protein O O 0.9640535712242126
is O O 0.9997920393943787
distinct O O 0.9999785423278809
from O O 0.9999964237213135
other O O 0.9997510313987732
members O O 0.9743675589561462
of O O 0.9993164539337158
the O O 0.9998492002487183
steroid/thyroid B-protein B-protein 0.6918937563896179

child O O 0.5383774638175964
. O O 0.9997546076774597
Our O O 0.9999990463256836
data O O 0.9994534850120544
show O O 0.9999992847442627
that O O 0.9999991655349731
new O O 0.995477020740509
mutations O O 0.99114990234375
may O O 0.9999958276748657
occur O O 0.9999985694885254
in O O 0.9999977350234985
the O O 0.9999890327453613
androgen B-DNA B-DNA 0.5370817184448242
receptor I-DNA I-DNA 0.6496226787567139
gene E-DNA E-DNA 0.9947065711021423
leading O O 0.9999151229858398
to O O 0.9999953508377075
sporadic O O 0.9636192321777344
androgen O O 0.8575333952903748
insensitivity O O 0.9715292453765869
syndrome O O 0.9982749223709106
. O O 0.9999978542327881
Molecular O O 0.9295011758804321
genetic O O 0.963720977306366
characterization O O 0.998480498790741
of O O 0.9999819993972778

after O O 0.9982536435127258
in O O 0.9975572824478149
vitro O O 0.9965953230857849
activation O O 0.9991624355316162
. O O 0.9999985694885254
These O O 0.9999990463256836
studies O O 0.999909520149231
indicate O O 0.9999991655349731
that O O 0.9999955892562866
A-myb S-protein S-protein 0.6211985349655151
plays O O 0.993420422077179

RIIA E-protein S-DNA 0.5165916085243225
cross-linking O O 0.8025646805763245
. O O 0.999029278755188
Glutathione-S-transferase B-protein B-protein 0.34194496273994446
( I-protein I-protein 0.5778977870941162
GST I-protein I-protein 0.9303327202796936
) I-protein I-protein 0.9657803773880005
-Grb2 I-protein I-protein 0.800813615322113
fusion I-protein I-protein 0.9283847808837891
proteins E-protein E-protein 0.9959807395935059
have O O 0.9999004602432251
been O O 0.9999853372573853
used O O 0.9999445676803589
to O O 0.9999831914901733
identify O O 0.9999939203262329
the O O 0.9999974966049194
potential O O 0.9976075887680054
role O O 0.9993613362312317
of O O 0.9999798536300659
Grb2-binding B-protein B-protein 0.8769888281822205
proteins E-protein E-protein 0.9990242719650269
in O O 0.9999241828918457
platelet S-cell_type O 0.6018741726875305
activation O O 0.9931561350822449
by O O 0.9999970197677612
the O O 0.9999715089797974
platelet B-protein B-protein 0.5734522938728333
low-affinity I-protein I-protein 0.8190054893493652
IgG I-protein I-protein 0.7747704982757568
receptor E-protein E-protein 0.9806702136993408
, O O 0.9967073202133179
Fc B-protein B-protein 0.7728649973869324
gamma I-protein I-protein 0.744385838508606
RIIA E-protein E-protein 0.8765537738800049

induced O O 0.9440218210220337

result O O 0.9952318072319031
of O O 0.9998875856399536
translocation O O 0.9928808212280273
into O O 0.9999775886535645
the O O 0.9999430179595947
IgH B-DNA B-DNA 0.9187004566192627
locus E-DNA E-DNA 0.974780261516571
; O O 0.991571307182312
and O O 0.999477207660675
( O O 0.999133288860321
3 O O 0.9953225255012512
) O O 0.9962937235832214
it O O 0.9989221096038818
has O O 0.9999595880508423
been O O 0.9999675750732422
implicated O O 0.9999406337738037
in O O 0.9999967813491821
the O O 0.9999966621398926
mechanisms O O 0.9973107576370239
that O O 0.9999924898147583
control O O 0.9995885491371155
Ig B-DNA B-DNA 0.5451361536979675

0.025 O O 0.5744719505310059
) O O 0.9366748332977295
was O O 0.9997977614402771
observed O O 0.9997937083244324
. O O 0.9999938011169434
A O O 0.9993483424186707
difference O O 0.9997027516365051
( O O 0.9999504089355469
P O O 0.986214816570282
< O O 0.9995067119598389
0.02 O O 0.998336136341095
) O O 0.9998998641967773
in O O 0.999992847442627
the O O 0.9999926090240479
distribution O O 0.999238133430481
of O O 0.9999969005584717
the O O 0.9999911785125732
RFLP S-DNA B-DNA 0.3470863401889801
genotypes O E-DNA 0.4652945399284363

and O O 0.9376595616340637

and O O 0.8771795034408569
TCF-1 S-protein S-protein 0.9314947724342346
, O O 0.9883890151977539
but O O 0.9993758797645569
not O O 0.9989944100379944
LEF-1 S-protein S-protein 0.9909809231758118
and O O 0.9937866926193237
PEBP-2alpha S-protein S-protein 0.9949294328689575
, O O 0.9983502626419067
among O O 0.9999833106994629
T B-protein B-protein 0.44477882981300354
cell-specific I-protein I-protein 0.759534478187561
transcription I-protein I-protein 0.8840476870536804
factors E-protein E-protein 0.9946249127388
that O O 0.9996249675750732
are O O 0.9999794960021973
involved O O 0.9999589920043945
in O O 0.9999908208847046
early O O 0.916299045085907
T O O 0.871059000492096
cell O O 0.9026800990104675
development O O 0.9989627599716187
, O O 0.9999957084655762
indicating O O 0.99998939037323
that O O 0.9999967813491821
GATA-3 S-protein S-protein 0.9893074631690979
and O O 0.9953250885009766
TCF-1 S-protein S-protein 0.9818933010101318
expressed O O 0.9990972280502319
during O O 0.9999004602432251
thymocyte O O 0.47996124625205994
development O O 0.9960911870002747
do O O 0.9999920129776001
not O O 0.999984622001648
necessarily O O 0.999993085861206
determine O O 0.9999964237213135
the O O 0.9999877214431763
cell O O 0.9584997892379761
fate O O 0.9981012940406799

A-F O S-protein 0.24251686036586761
) O O 0.7360463738441467
. O O 0.9998164772987366
Both O O 0.9999872446060181
primers O O 0.9101616740226746
detected O O 0.9999220371246338
a O O 0.9999829530715942
single O O 0.9868375658988953
copy O O 0.9444665908813477
of O O 0.9998193383216858
the O O 0.9999829530715942
adenovirus B-DNA B-DNA 0.6380682587623596
type I-DNA I-DNA 0.7773891687393188
2 I-DNA I-DNA 0.917043924331665
genome E-DNA E-DNA 0.9821459650993347
but O O 0.9986955523490906
were O O 0.9999980926513672
less O O 0.9999926090240479
sensitive O O 0.9997479319572449
for O O 0.9999961853027344
the O O 0.9999891519546509
group O O 0.8997253179550171
B O O 0.884509265422821
type O O 0.9561291933059692
35 O O 0.8953815698623657
. O O 0.9999532699584961
None O O 0.9999896287918091
of O O 0.9999994039535522
33 O O 0.9913426637649536
PBMC B-cell_type S-cell_type 0.9905087947845459
specimens E-cell_type O 0.7606094479560852
from O O 0.9999973773956299
healthy O O 0.9919242262840271
adults O O 0.9994333386421204
and O O 0.999968409538269
only O O 0.9999860525131226
one O O 0.999944806098938
of O O 0.9999953508377075
40 O O 0.9924139380455017
pediatric O O 0.8848041892051697
samples O O 0.9270200133323669
was O O 0.9999842643737793
positive O O 0.9937669038772583
( O O 0.9998283386230469
at O O 0.999998927116394
a O O 0.9999955892562866
low O O 0.9919154047966003
level O O 0.9992213249206543
) O O 0.9998130202293396
for O O 0.9999850988388062
adenovirus O B-DNA 0.4580916464328766
DNA O E-DNA 0.9909993410110474
by O O 0.9999624490737915
nested O O 0.8503613471984863
PCR O O 0.34637653827667236
assay O O 0.9973793029785156
. O O 0.999997615814209
In O O 0.9995527863502502

Electrophoretically O O 0.9367152452468872

is O O 0.9904053807258606
produced O O 0.9995918869972229
mainly O O 0.9999414682388306
by O O 0.9999830722808838
activated O B-cell_type 0.5133020877838135
T B-cell_type I-cell_type 0.7786734700202942
cells E-cell_type E-cell_type 0.9402716159820557
, O O 0.950478196144104
and O O 0.9999532699584961
its O O 0.9999278783798218
expression O O 0.9986299276351929
is O O 0.9999852180480957
regulated O O 0.9998565912246704
at O O 0.9999992847442627
the O O 0.9999992847442627
transcriptional O O 0.9468560814857483
level O O 0.9992101192474365
. O O 0.9999959468841553
OBJECTIVE O O 0.96755051612854
: O O 0.9996756315231323
This O O 0.9999943971633911
study O O 0.9997712969779968
focuses O O 0.9999744892120361
on O O 0.9999878406524658

that O O 0.9995318651199341
FMS O O 0.6416880488395691
patients O O 0.9555460810661316
have O O 0.9999897480010986
a O O 0.9999877214431763
mild O O 0.9552682638168335
hypocortisolemia O O 0.9643834233283997
, O O 0.9998811483383179
increased O O 0.9997442364692688
cortisol O O 0.9546923041343689
feedback O O 0.9897103905677795
resistance O O 0.999671220779419
in O O 0.9999803304672241
combination O O 0.951441764831543
probably O O 0.9971815347671509
with O O 0.9999767541885376
a O O 0.9999555349349976
reduced O O 0.9717162847518921

absence O O 0.9907422661781311

bind O O 0.9260042905807495
hematopoietin B-protein B-protein 0.47478657960891724
receptors E-protein E-protein 0.9918209314346313
and O O 0.9981605410575867
activate O O 0.9593297839164734
JAK B-protein B-protein 0.5864566564559937
kinases E-protein E-protein 0.9907181859016418
. O O 0.9998773336410522
In O O 0.9999960660934448
this O O 0.9999996423721313
report O O 0.9996652603149414
we O O 0.9999926090240479
demonstrate O O 0.9999974966049194
that O O 0.9999982118606567
IL-12 S-protein S-protein 0.9975994229316711
induces O O 0.9999265670776367
tyrosine O O 0.7483598589897156
phosphorylation O O 0.9179949760437012
of O O 0.9993904829025269
a O O 0.9999451637268066
recently O O 0.9485892653465271
identified O O 0.9901431798934937
STAT B-protein B-protein 0.8668400645256042
family I-protein I-protein 0.5129584670066833
member E-protein E-protein 0.9875138401985168
, O O 0.9972823858261108
STAT4 S-protein S-protein 0.9899819493293762
, O O 0.9955103397369385
and O O 0.9997202754020691
show O O 0.9999756813049316
that O O 0.9999967813491821
STAT4 S-protein S-protein 0.9956297874450684
expression O O 0.9996055960655212
is O O 0.9999940395355225
regulated O O 0.9998489618301392
by O O 0.9999974966049194
T-cell O O 0.5995256304740906
activation O O 0.9943528175354004
. O O 0.9999971389770508
Furthermore O O 0.9997757077217102

containing O O 0.9584757089614868

in O O 0.9979946613311768
human B-cell_type B-cell_type 0.49061793088912964
T I-cell_type I-cell_type 0.7563151121139526
cells E-cell_type E-cell_type 0.9888048768043518
inhibits O O 0.9998842477798462
human O O 0.914749026298523
immunodeficiency O O 0.9758244752883911
virus O O 0.9800595641136169
replication O O 0.998026430606842
. O O 0.9999990463256836
The O O 0.9999982118606567
human O B-protein 0.5121224522590637
immunodeficiency O I-protein 0.642218828201294
virus O I-protein 0.8444668650627136
( O I-protein 0.6871551275253296
HIV O I-protein 0.7883179783821106
) O I-protein 0.7009114623069763
Rev B-protein I-protein 0.5052085518836975
protein E-protein E-protein 0.9217600226402283
is O O 0.999774158000946
essential O O 0.9999676942825317
for O O 0.9999834299087524
viral O O 0.9143271446228027

our O O 0.9983842372894287
results O O 0.9999715089797974
indicate O O 0.9999996423721313
that O O 0.9999995231628418
the O O 0.9999704360961914
tal-1 B-DNA B-DNA 0.4252018332481384
1A I-DNA I-DNA 0.6617280840873718
promoter E-DNA E-DNA 0.9875991344451904
, O O 0.9430093765258789
which O O 0.999862551689148
contains O O 0.9998644590377808

intracellular O O 0.8146995902061462
signaling O O 0.9668068885803223
pathways O O 0.9989250302314758
in O O 0.9999551773071289
CD34+ B-cell_type B-cell_type 0.7143725156784058
progenitor E-cell_type E-cell_type 0.41591912508010864
to O O 0.84405916929245
dendritic O O 0.3616478741168976
cell O O 0.5638405084609985
differentiation O O 0.9738154411315918
from O O 0.9999747276306152
a O O 0.9999732971191406
human O B-cell_line 0.729152262210846
cell O I-cell_line 0.8908132910728455
line O E-cell_line 0.8895946741104126

Ro O O 0.9279189109802246
09-2210 O O 0.894260585308075
was O O 0.999953031539917
inhibiting O O 0.9999693632125854
an O O 0.999980092048645
activator O O 0.839647650718689
of O O 0.9925179481506348
AP-1 S-protein S-protein 0.8518049716949463
which O O 0.9992978572845459
was O O 0.9999616146087646
upstream O O 0.9935226440429688
of O O 0.9998384714126587
c-jun S-DNA S-DNA 0.8987501859664917
and O O 0.9736772179603577
downstream O O 0.9855374693870544
of O O 0.9998384714126587
ras S-protein S-protein 0.4345538318157196
signaling O O 0.7733707427978516
. O O 0.9997233748435974
To O O 0.9948562383651733

In O O 0.9997435212135315
the O O 0.9999994039535522
present O O 0.9982978701591492
study O O 0.9998847246170044
, O O 0.9999942779541016
we O O 0.9999203681945801
have O O 0.999997615814209
identified O O 0.999966025352478
a O O 0.9999957084655762
cellular O O 0.842833936214447
context O O 0.6386693120002747
( O O 0.9996175765991211
the O O 0.9999581575393677
interleukin-2 B-cell_line B-cell_line 0.37873655557632446
[ I-cell_line I-cell_line 0.6716094613075256
IL-2 I-cell_line I-cell_line 0.6098489165306091
] I-cell_line I-cell_line 0.7102600336074829
-dependent I-cell_line I-cell_line 0.9220995306968689
HT-2 I-cell_line I-cell_line 0.95656418800354
line E-cell_line E-cell_line 0.9913027286529541
) O O 0.9959295392036438
in O O 0.9999966621398926
which O O 0.9999990463256836
the O O 0.9999926090240479
EPO S-protein S-protein 0.8945726156234741
stimulation O O 0.9838593602180481
of O O 0.9998188614845276

implications O O 0.9971635937690735

response O O 0.9739536046981812
. O O 0.9999754428863525
The O O 0.9999957084655762
putative B-protein O 0.8937602043151855
intracellular I-protein B-protein 0.705956757068634
receptors E-protein E-protein 0.9499898552894592
for O O 0.9985450506210327
FK506 O O 0.4546373188495636
and O O 0.9694921970367432
cyclosporin O S-protein 0.5241608023643494
are O O 0.9998229146003723
cis-trans O B-protein 0.751378059387207
prolyl O I-protein 0.6216471791267395
isomerases O E-protein 0.9555666446685791
. O O 0.9999210834503174
Binding O O 0.9886384606361389
of O O 0.9996936321258545
the O O 0.9999814033508301
drug O O 0.9556227922439575
inhibits O O 0.9995599389076233
isomerase S-protein S-protein 0.9573100209236145
activity O O 0.9988045692443848
, O O 0.9999886751174927
but O O 0.9999890327453613
studies O O 0.9999339580535889
with O O 0.9999986886978149
other O O 0.9999194145202637
prolyl O B-protein 0.49865496158599854
isomerase S-protein E-protein 0.9321244359016418
inhibitors O O 0.7890968918800354
and O O 0.9998204112052917
analysis O O 0.9972901344299316
of O O 0.9999728202819824
cyclosporin-resistant B-cell_line B-protein 0.36793458461761475
mutants E-cell_line E-protein 0.6796932220458984
in O O 0.9991446733474731
yeast O O 0.9756311178207397
suggest O O 0.9998852014541626
that O O 0.9999936819076538
the O O 0.9999842643737793
effects O O 0.9999616146087646
of O O 0.999992847442627
the O O 0.999987006187439
drug O O 0.9867483377456665
result O O 0.999993085861206
from O O 0.9999992847442627
the O O 0.9999967813491821
formation O O 0.999450147151947
of O O 0.9999936819076538
an O O 0.9999603033065796
inhibitory B-protein O 0.7253398299217224

both O O 0.998261034488678
activation O O 0.9976223111152649
of O O 0.9999747276306152
the O O 0.9999866485595703
HIV-1 B-DNA B-DNA 0.7847552299499512
promoter E-DNA E-DNA 0.9951820969581604
and O O 0.9987795948982239
acceleration O O 0.9987176656723022
of O O 0.999994158744812
the O O 0.9999971389770508
cytopathic O O 0.9013518691062927
effects O O 0.9988728165626526
. O O 0.999998927116394
An O O 0.9982757568359375

Both O O 0.9968538880348206
GATA-1 S-protein S-protein 0.9729512929916382
and O O 0.9741683006286621
CACCC-binding B-protein B-protein 0.5544162392616272
proteins E-protein E-protein 0.9954631924629211
are O O 0.9999622106552124
critical O O 0.9998008608818054
for O O 0.9999958276748657
the O O 0.9999926090240479
developmentally O O 0.9674649238586426
regulated O O 0.9923058152198792
expression O O 0.9981410503387451
of O O 0.9999866485595703
erythroid-specific B-DNA B-DNA 0.6845337152481079
genes E-DNA E-DNA 0.9954202771186829
. O O 0.9999637603759766
We O O 0.999992847442627
hypothesize O O 0.9999563694000244
that O O 0.9999974966049194
interference O O 0.997952938079834
in O O 0.9999778270721436
DNA-binding O O 0.725729763507843
activities O O 0.9830793142318726
of O O 0.9999499320983887
GATA-1 S-protein S-protein 0.938058078289032
and O O 0.9960724115371704
CACCC-binding B-protein B-protein 0.6713724732398987

cell O O 0.5327444672584534
cycle O O 0.7037445306777954
, O O 0.9924443364143372
and O O 0.9996428489685059
MMP9 S-protein S-protein 0.9463083148002625
can O O 0.999832272529602
confer O O 0.9999445676803589
metastatic O O 0.8774896264076233
properties O O 0.9755880832672119
, O O 0.999996542930603
these O O 0.999997615814209

We O O 0.9855555295944214

and O O 0.9521801471710205
trans-activation O O 0.9762507081031799
of O O 0.9996907711029053
NF-kappa B-protein B-protein 0.7172539830207825
B E-protein E-protein 0.9988828301429749
-mediated O O 0.9868161082267761
gene O O 0.9316525459289551
expression O O 0.9997351765632629
. O O 0.9999980926513672
Furthermore O O 0.9999961853027344
, O O 0.9999955892562866
the O O 0.9999905824661255
NFKB2 S-protein S-protein 0.8819192051887512
precursor O O 0.524195671081543
is O O 0.9998961687088013
physically O O 0.9920809864997864
associated O O 0.999774158000946
with O O 0.9999963045120239
c-Rel S-protein S-protein 0.9967533946037292
and O O 0.9985686540603638
with O O 0.9999256134033203
Tax S-protein S-protein 0.999431312084198
in O O 0.9999470710754395
HTLV-I B-cell_type B-cell_line 0.4597952663898468

CAT B-DNA B-DNA 0.4526051878929138
reporter I-DNA I-DNA 0.6605210304260254
gene E-DNA E-DNA 0.9897543787956238
with O O 0.9988853335380554
the O O 0.9999474287033081
CD18 B-DNA B-DNA 0.7386590242385864
promoter E-DNA E-DNA 0.9929157495498657
was O O 0.998944103717804
inactive O O 0.999279797077179
in O O 0.9999957084655762
the O O 0.9999974966049194
3 O O 0.8349090814590454
of O O 0.9930372834205627
them O O 0.9992541670799255
, O O 0.9999547004699707
again O O 0.9999805688858032
suggesting O O 0.9999905824661255
lack O O 0.9987213015556335
of O O 0.9999531507492065
( O O 0.9984891414642334
a O O 0.9991436004638672
) O O 0.9974773526191711
transcriptional B-protein B-protein 0.6868520975112915
factor E-protein E-protein 0.9858503937721252
( O O 0.9661580324172974
s O O 0.9390503168106079
) O O 0.9891440272331238

be O O 0.9992895126342773
critical O O 0.999907374382019
for O O 0.9999939203262329
HIV-1 O O 0.9435741305351257
replication O O 0.9983031749725342
. O O 0.9999985694885254
The O O 0.9999995231628418
hypothesis O O 0.9984234571456909
that O O 0.9999983310699463
the O O 0.9999796152114868
nuclear B-protein B-protein 0.7594969868659973
factor I-protein I-protein 0.4881865978240967
of I-protein I-protein 0.5607200860977173
activated I-protein I-protein 0.6486078500747681
T I-protein I-protein 0.8972263336181641
cells E-protein E-protein 0.9904465675354004
( O O 0.9943302869796753
NF-AT S-protein S-protein 0.9987649917602539
) O O 0.993908166885376
may O O 0.999994158744812
influence O O 0.9999744892120361
HIV-1 O O 0.9181124567985535
replication O O 0.9970736503601074
is O O 0.999997615814209
therefore O O 0.9999889135360718
compelling O O 0.9999300241470337
given O O 0.9999984502792358
the O O 0.9999997615814209
tight O O 0.9983042478561401
correlation O O 0.9998345375061035
of O O 0.9999964237213135
HIV-1 O O 0.7719375491142273

of O O 0.9983173608779907
DM O O 0.3282155692577362
on O O 0.9936800003051758
IL-2R B-protein B-protein 0.377549946308136
alpha E-protein E-protein 0.9376983046531677
transcription O O 0.941498339176178
was O O 0.9999417066574097
examined O O 0.9999651908874512
by O O 0.9999977350234985
determining O O 0.9999732971191406
the O O 0.9999852180480957
mRNA O O 0.8084468841552734
levels O O 0.9913939833641052
of O O 0.999962329864502
the O O 0.9999443292617798
p50 O B-protein 0.8001613020896912
subunit O E-protein 0.989932656288147
of O O 0.9990577101707458
nuclear O B-protein 0.4814095199108124
factor O I-protein 0.4834565222263336
kappa O I-protein 0.8677613139152527
B O E-protein 0.9969182014465332
( O O 0.996957540512085
NF-kappa B-protein B-protein 0.9582155346870422
B E-protein E-protein 0.9962802529335022
) O O 0.988509476184845
, O O 0.9999537467956543
a O O 0.9999759197235107
transcription B-protein B-protein 0.687243640422821
factor E-protein E-protein 0.9932994842529297
that O O 0.9997751116752625
stimulates O O 0.999736487865448
IL-2R B-protein B-protein 0.4482920169830322
alpha E-protein E-protein 0.9273191690444946
gene O O 0.7467463612556458
expression O O 0.9985333681106567
. O O 0.999998927116394
The O O 0.9999955892562866

-13 E-protein S-protein 0.31943246722221375
and O O 0.9567453265190125
human B-protein B-protein 0.65691077709198
and I-protein I-protein 0.8955972194671631
mouse I-protein I-protein 0.8042221665382385
granulocyte/macrophage-colony I-protein I-protein 0.7207319140434265
stimulating I-protein I-protein 0.48863089084625244
factor E-protein E-protein 0.9813627004623413
( O O 0.9816727638244629
GM-CSF S-protein S-protein 0.9941924214363098
) O O 0.9840680956840515
] O O 0.999123752117157
. O O 0.9999946355819702
It O O 0.9999637603759766
contains O O 0.9999798536300659

NF-kappa B-protein B-protein 0.8599399924278259
B E-protein E-protein 0.9982811212539673
and O O 0.9983362555503845
a O O 0.9995856881141663
novel O O 0.8289322853088379
TH B-protein B-protein 0.47553303837776184
protein E-protein E-protein 0.995388388633728
. O O 0.9999421834945679
The O O 0.9999967813491821
human B-DNA B-DNA 0.43252068758010864
interferon I-DNA I-DNA 0.6213783025741577
beta I-DNA I-DNA 0.47346848249435425
( I-DNA I-DNA 0.906123161315918
IFN-beta I-DNA I-DNA 0.9457460641860962
) I-DNA I-DNA 0.9756271243095398
regulatory I-DNA I-DNA 0.9823116064071655
element E-DNA E-DNA 0.9977651834487915
consists O O 0.9999212026596069
of O O 0.9999964237213135
multiple O O 0.7913019061088562
enhanson B-DNA B-DNA 0.33958351612091064
domains E-DNA E-DNA 0.7245863676071167

side O O 0.8173319697380066
effects O O 0.9983912110328674
were O O 0.9999943971633911
encountered O O 0.9999717473983765
. O O 0.9999972581863403
Pharmacokinetic O O 0.9528521299362183
studies O O 0.9970498085021973
, O O 0.9999809265136719
which O O 0.9999202489852905
were O O 0.9999901056289673
performed O O 0.9999775886535645
in O O 0.9999948740005493
eight O O 0.9997264742851257
patients O O 0.9995238780975342
, O O 0.999972939491272
showed O O 0.9999979734420776
that O O 0.9999977350234985
after O O 0.9999724626541138
a O O 0.9999934434890747
peak O O 0.9900985360145569
level O O 0.9997984766960144
of O O 0.9998457431793213
5.54 O O 0.7793311476707458
micromol/L O O 0.96251380443573

activate O O 0.9473181366920471
transcription O O 0.9245514869689941
in O O 0.9996422529220581
cultured O B-cell_line 0.6378564834594727
cells O E-cell_line 0.8957166075706482
, O O 0.9958422780036926
presumably O O 0.9999599456787109
through O O 0.9999549388885498
RBP-Jkappa S-protein B-DNA 0.378639280796051
response O I-DNA 0.6327617764472961
elements O E-DNA 0.9869260787963867
within O O 0.9989182949066162
DNA O O 0.8473017811775208
. O O 0.9998809099197388
Both O O 0.9999536275863647
truncated O O 0.598125696182251
forms O O 0.6603858470916748
also O O 0.9990085959434509
bound O O 0.9999488592147827
to O O 0.9999849796295166
the O O 0.9999198913574219
transcription B-protein B-protein 0.6184992790222168
factor I-protein E-protein 0.9508245587348938
RBP-Jkappa E-protein S-protein 0.9670554995536804
in O O 0.9998904466629028
extracts O O 0.9650783538818359
prepared O O 0.9992777705192566
from O O 0.9999728202819824
human B-cell_line B-cell_line 0.5186562538146973
and I-cell_line I-cell_line 0.4949013888835907
murine I-cell_line I-cell_line 0.5573170185089111
T-ALL I-cell_line I-cell_line 0.8260126709938049
cell I-cell_line I-cell_line 0.8876203894615173
lines E-cell_line E-cell_line 0.9997722506523132
. O O 0.9999241828918457

these O O 0.9961125254631042
cells O O 0.9774816632270813
have O O 0.9999845027923584
been O O 0.999964714050293
impossible O O 0.9991509914398193
to O O 0.9999397993087769
generate O O 0.9999551773071289
given O O 0.9999809265136719
the O O 0.999998927116394
requirement O O 0.999897837638855
of O O 0.9999948740005493
GATA-1 S-protein S-protein 0.9914646744728088
for O O 0.9998180270195007
Epo B-protein S-protein 0.9543120265007019
receptor E-protein O 0.8028483390808105
expression O O 0.9973896145820618
and O O 0.9999589920043945
red B-cell_type O 0.5192053914070129
cell E-cell_type O 0.4662204682826996
viability O O 0.977417528629303
( O O 0.9999161958694458
C. O O 0.9955722093582153
Simon O O 0.9958217144012451
and O O 0.9999079704284668

responses O O 0.9881801605224609
. O O 0.999987006187439
SRC-related B-DNA B-protein 0.5125312805175781
proto-oncogenes E-DNA E-protein 0.5879108905792236
and O O 0.8972582221031189
transcription B-protein B-protein 0.512320339679718
factors E-protein E-protein 0.9976674914360046
in O O 0.9998199343681335
primary O B-cell_type 0.6283005475997925
human B-cell_type I-cell_type 0.7031875252723694
T I-cell_type I-cell_type 0.9508543014526367
cells E-cell_type E-cell_type 0.9912262558937073
: O O 0.9897884726524353
modulation O O 0.9905842542648315
by O O 0.999985933303833
cyclosporin O O 0.8613376021385193
A O O 0.7574670910835266
and O O 0.9960876703262329
FK506 O O 0.981355607509613
. O O 0.9999831914901733
Activation O O 0.9971699118614197

in O O 0.9984889030456543
response O O 0.9998354911804199
to O O 0.9999960660934448
a O O 0.999984860420227
variety O O 0.9936571717262268
of O O 0.9999567270278931
signals O O 0.9845278859138489
, O O 0.9997963309288025
including O O 0.9999345541000366
adhesion O O 0.9783685207366943
, O O 0.9991982579231262
lipopolysaccharide O O 0.9223536252975464
, O O 0.9976522326469421
and O O 0.9998310804367065
phorbol O O 0.9620836973190308
myristate O O 0.9824596643447876
acetate O O 0.9985141158103943
. O O 0.9999967813491821
Within O O 0.9999889135360718
5 O O 0.9938702583312988
min O O 0.9930319786071777
of O O 0.9998586177825928
monocyte O O 0.48104923963546753

in O O 0.9992328882217407
patients O O 0.9987120628356934
with O O 0.9999737739562988
sepsis O O 0.9955109357833862
or O O 0.9999285936355591
septic O O 0.8776968717575073
shock O O 0.9573314189910889
as O O 0.9998698234558105
compared O O 0.9999041557312012
to O O 0.9999847412109375
healthy O O 0.8678490519523621
controls O O 0.9867904782295227
. O O 0.9999986886978149
However O O 0.9999780654907227
, O O 0.9999935626983643
a O O 0.9999977350234985
decreased O O 0.9976466298103333
affinity O O 0.9992462396621704
of O O 0.9999886751174927

investigate O O 0.9985393285751343
further O O 0.9999556541442871
, O O 0.9999916553497314
we O O 0.9999929666519165
then O O 0.9999817609786987
purified O O 0.9997773766517639
a O O 0.9999843835830688
number O O 0.9985947012901306
of O O 0.9999880790710449
different O O 0.9879173636436462
kinases O O 0.4583473801612854
, O O 0.9977797865867615
including O O 0.9999371767044067
PKC S-protein S-protein 0.9915692210197449
, O O 0.9987021684646606
PhK S-protein S-protein 0.9388234615325928

an O O 0.9976431727409363
organism O O 0.9705789685249329
. O O 0.999966025352478
One O O 0.999996542930603
of O O 0.999998927116394
the O O 0.9999982118606567
best O O 0.9958673715591431
understood O O 0.9903761744499207
apoptotic O O 0.7422174215316772
pathways O O 0.9652488231658936
occurs O O 0.999951958656311
in O O 0.9999340772628784
T B-cell_type B-cell_type 0.8269139528274536
lymphocytes E-cell_type E-cell_type 0.9933731555938721
and O O 0.9967859983444214
is O O 0.9999428987503052
mediated O O 0.9994364380836487
by O O 0.9999881982803345

Here O O 0.999273955821991

for O O 0.9977165460586548
in O O 0.9982346296310425
vivo O O 0.9880256056785583
HIV-1 O O 0.8278891444206238
replication O O 0.9878755211830139
and O O 0.9998831748962402
potential O O 0.9888970255851746
application O O 0.998189389705658
of O O 0.999985933303833
this O O 0.999984622001648
system O O 0.9943358302116394
to O O 0.9999719858169556
the O O 0.9999953508377075
study O O 0.9993126392364502
of O O 0.999982476234436
alternative O O 0.8498699069023132
Tat S-protein S-protein 0.7685776948928833
function O O 0.9960206151008606
are O O 0.9999916553497314
discussed O O 0.9999858140945435
. O O 0.9999967813491821
Functional O O 0.9768226146697998
roles O O 0.9940716624259949
of O O 0.9999758005142212
the O O 0.9999513626098633

results O O 0.9883468747138977
were O O 0.9999960660934448
obtained O O 0.9999966621398926
in O O 0.9999861717224121
hepatic B-cell_line B-cell_line 0.4189854860305786
HTC I-cell_line I-cell_line 0.5248399972915649
cells E-cell_line E-cell_line 0.9030182361602783
for O O 0.9996045231819153
the O O 0.9999969005584717
transactivation O O 0.9917142987251282
of O O 0.9999470710754395
the O O 0.9999817609786987
endogenous B-DNA B-DNA 0.5643974542617798
tyrosine I-DNA I-DNA 0.46250542998313904
amino I-DNA I-DNA 0.49328362941741943
transferase I-DNA I-DNA 0.8398377895355225
gene E-DNA E-DNA 0.9955489635467529
( O O 0.995662271976471
TAT S-DNA S-DNA 0.8964372873306274
) O O 0.9611837267875671
, O O 0.9992851614952087
which O O 0.9999485015869141
encodes O O 0.9999152421951294
one O O 0.9996417760848999
of O O 0.9999936819076538
the O O 0.9999939203262329
enzymes O O 0.5189774632453918
involved O O 0.9979844093322754
in O O 0.9999849796295166
the O O 0.9999886751174927
glucocorticoid-dependent O O 0.8110626935958862
stimulation O O 0.9659836888313293
of O O 0.9995342493057251

triggers O O 0.6632108092308044

. O O 0.9987291693687439
Octamer O O 0.5011032819747925
independent O O 0.8117122054100037
activation O O 0.9548054933547974
of O O 0.9980496168136597
transcription O O 0.8830360174179077
from O O 0.9998855590820312
the O O 0.9999756813049316
kappa B-DNA B-DNA 0.5203918814659119
immunoglobulin I-DNA I-DNA 0.6278427243232727
germline I-DNA I-DNA 0.8409650921821594
promoter E-DNA E-DNA 0.9937718510627747
. O O 0.9999289512634277
Previous O O 0.9999874830245972
analyses O O 0.9984831213951111
of O O 0.9999833106994629
immunoglobulin B-DNA B-DNA 0.7699516415596008
V I-DNA I-DNA 0.5292724370956421
region I-DNA I-DNA 0.8003984689712524
promoters E-DNA E-DNA 0.9846475124359131
has O O 0.9998687505722046
led O O 0.9999932050704956
to O O 0.9999971389770508
the O O 0.9999984502792358
discovery O O 0.9999102354049683
of O O 0.9999974966049194
a O O 0.9999854564666748
common O O 0.9322022199630737
octamer B-DNA B-DNA 0.3970896601676941
motif E-DNA E-DNA 0.9008427262306213
which O O 0.9996671676635742
is O O 0.9999592304229736
functionally O O 0.9858242273330688
important O O 0.9996299743652344

only O O 0.9949328303337097
early O O 0.9629629254341125
and O O 0.9962621331214905
late O O 0.9893320798873901
, O O 0.9997702240943909
but O O 0.999903678894043
also O O 0.9999796152114868
immediate O O 0.9942020773887634
events O O 0.9998972415924072
; O O 0.9999909400939941
however O O 0.9999922513961792
, O O 0.9999946355819702
addition O O 0.9998809099197388
of O O 0.9999960660934448
TNF-alpha S-protein S-protein 0.9904181361198425
prevented O O 0.9996652603149414
all O O 0.9997822642326355
inhibition O O 0.9935011267662048
. O O 0.9999830722808838
These O O 0.9999979734420776
results O O 0.9999593496322632
indicate O O 0.9999985694885254
that O O 0.9999984502792358
the O O 0.9999911785125732
regulation O O 0.9995115995407104
of O O 0.9999940395355225
NF-kappa B-protein B-protein 0.9413825273513794
B E-protein E-protein 0.999477207660675
activation O O 0.998623251914978
during O O 0.9999349117279053
T O O 0.7028186321258545
cell O O 0.48461779952049255
activation O O 0.9968504309654236
by O O 0.999996542930603
TcR/CD3 S-protein S-protein 0.954055666923523
signals O O 0.9921597838401794
is O O 0.9999932050704956

examine O O 0.9989131689071655
the O O 0.999985933303833
activation O O 0.957524299621582
status O O 0.9961357712745667
of O O 0.9999773502349854
the O O 0.999956488609314
transcription B-protein B-protein 0.6776201128959656
factors E-protein E-protein 0.9852317571640015
nuclear B-protein B-protein 0.5919277667999268
factor I-protein I-protein 0.6199873685836792
kappaB E-protein E-protein 0.9918881058692932
( O O 0.9835813045501709
NF-kappaB S-protein S-protein 0.9988135099411011
) O O 0.9915400147438049
and O O 0.999929666519165
heat B-protein B-protein 0.47185218334198
shock I-protein I-protein 0.592192530632019
factor-1 E-protein E-protein 0.9709124565124512
( O O 0.9649472832679749
HSF-1 S-protein S-protein 0.7881736755371094
) O O 0.9498759508132935
, O O 0.9997599720954895
electrophoretic O O 0.7070777416229248
mobility O O 0.919208824634552
shift O O 0.9967557787895203

a O O 0.9985222220420837
human B-cell_line B-cell_line 0.6086837649345398
B I-cell_line I-cell_line 0.8012800216674805
lymphoma I-cell_line I-cell_line 0.9500331878662109
cell I-cell_line I-cell_line 0.9645386338233948
line E-cell_line E-cell_line 0.9930170774459839
, O O 0.9880008101463318
B104 S-cell_line S-cell_line 0.9978378415107727
, O O 0.9673672318458557
by O O 0.9999853372573853
anti-MHC B-protein B-protein 0.5183393359184265
class I-protein I-protein 0.8858659267425537
II I-protein I-protein 0.6202265620231628
antibodies E-protein E-protein 0.998647153377533
. O O 0.999963641166687
The O O 0.9999988079071045
mechanisms O O 0.9976340532302856
involved O O 0.9999897480010986
in O O 0.9999936819076538
the O O 0.9999809265136719
inhibition O O 0.9982261061668396
of O O 0.9999754428863525
growth O O 0.9216307997703552
of O O 0.99935382604599
a O O 0.9998683929443359
human B-cell_line B-cell_line 0.6378493309020996
B I-cell_line I-cell_line 0.8333126902580261
lymphoma I-cell_line I-cell_line 0.9416835308074951
cell I-cell_line I-cell_line 0.961528480052948
line E-cell_line E-cell_line 0.9894296526908875
, O O 0.9880691170692444
B104 S-cell_line S-cell_line 0.9953195452690125
, O O 0.9741827845573425
by O O 0.9999890327453613
anti-MHC B-protein B-protein 0.5025134682655334
class I-protein I-protein 0.8760706782341003
II I-protein I-protein 0.7973640561103821
antibodies E-protein E-protein 0.9987621307373047
( O O 0.9967556595802307
Ab S-protein S-protein 0.35151800513267517

or O O 0.9489914178848267
without O O 0.9970672726631165
anti-CD18 B-protein B-protein 0.7581268548965454
antibody E-protein E-protein 0.9903552532196045
. O O 0.999935507774353
The O O 0.9999983310699463
culture O O 0.7724696397781372
plate O O 0.7444425821304321
was O O 0.9964091181755066
settled O O 0.9998806715011597
for O O 0.9999853372573853
15 O O 0.9989493489265442
minutes O O 0.9997218251228333
at O O 0.9999991655349731
37 O O 0.9946929812431335

SKW6.4 B-cell_line B-cell_line 0.7864876389503479
cells E-cell_line E-cell_line 0.9972514510154724
were O O 0.9998518228530884
transiently O O 0.9982786178588867
transfected O O 0.9997060894966125
with O O 0.9999973773956299
an O O 0.9999386072158813
IgH-enhancer-luciferase B-DNA B-DNA 0.5495567321777344
construct E-DNA E-DNA 0.9743556976318359
. O O 0.9999568462371826
The O O 0.9999961853027344
transcriptional O O 0.40006279945373535

of O O 0.9977720379829407
the O O 0.9999785423278809
promoter O S-DNA 0.7954903244972229
mediates O O 0.8127217888832092
endothelial O O 0.7058693766593933
ICAM-1 S-protein S-protein 0.6796236038208008
expression O O 0.9966104626655579
and O O 0.9999213218688965
neutrophil S-cell_type O 0.8653576374053955
adhesion O O 0.9920936226844788
. O O 0.9999943971633911
We O O 0.9999935626983643
investigated O O 0.9999934434890747
the O O 0.9999974966049194
mechanisms O O 0.9995627999305725
by O O 0.9999996423721313
which O O 0.999563992023468

by O O 0.9986972212791443
Ags S-protein S-protein 0.7607001066207886
or O O 0.9734030961990356
cytokines S-protein S-protein 0.9051880836486816
results O O 0.9999140501022339
in O O 0.99998939037323
translocation O O 0.9922258853912354
of O O 0.9999274015426636
the O O 0.9999756813049316
transcription B-protein B-protein 0.6705536842346191
factors E-protein E-protein 0.9939369559288025
NF-kappa B-protein B-protein 0.9125137329101562
B E-protein E-protein 0.9958349466323853
, O O 0.9804018139839172
AP-1 S-protein S-protein 0.9909550547599792
, O O 0.9915747046470642
NFAT S-protein S-protein 0.998458981513977
, O O 0.9924789667129517
and O O 0.9988276362419128
STAT S-protein S-protein 0.9831129908561707
from O O 0.9994423985481262
the O O 0.9998565912246704

during O O 0.9991683959960938
HL-60 O O 0.6055014729499817
differentiation O O 0.99257493019104
. O O 0.9999951124191284
Of O O 0.999998927116394
these O O 0.999990701675415
, O O 0.9999668598175049
we O O 0.9999558925628662
observed O O 0.999962568283081
that O O 0.9999986886978149
another O O 0.99994957447052
transcription B-protein B-protein 0.512218177318573
factor E-protein E-protein 0.9928246736526489
( O O 0.9875675439834595
AP-1 S-protein S-protein 0.983994722366333
) O O 0.9952717423439026
is O O 0.9999892711639404
also O O 0.9999861717224121
robustly O O 0.9993975162506104
induced O O 0.9999862909317017
at O O 0.9999996423721313
the O O 0.9999978542327881

and O O 0.9477401375770569
E-selectin S-protein S-protein 0.9827284216880798
upregulation O O 0.9993941783905029
. O O 0.9999990463256836
These O O 0.9999991655349731
effects O O 0.9999376535415649
of O O 0.9999923706054688
aspirin O O 0.9842115044593811
were O O 0.9999707937240601
not O O 0.999910831451416
related O O 0.9999816417694092
to O O 0.999997615814209
the O O 0.9999957084655762
inhibition O O 0.9957892298698425
of O O 0.9999655485153198
cyclooxygenase S-protein S-protein 0.9801021218299866
activity O O 0.9993054866790771
, O O 0.9999927282333374

inhibited O O 0.9613151550292969
TCR S-protein S-protein 0.9969221949577332
-induced O O 0.9980702996253967
activation O O 0.9978725910186768
of O O 0.9999343156814575
nuclear B-protein B-protein 0.5353014469146729
factor I-protein I-protein 0.6507124900817871
of I-protein I-protein 0.9091756939888
activated I-protein I-protein 0.9779210686683655
T I-protein I-protein 0.9861434102058411
cells E-protein E-protein 0.9691688418388367
by O O 0.9995697140693665
interfering O O 0.9945684671401978
with O O 0.9999698400497437
both O O 0.9999067783355713
intracellular O O 0.8897761702537537
calcium O O 0.8329188227653503
increase O O 0.9939562678337097
and O O 0.9997051358222961
Ras S-protein S-protein 0.9980462789535522
-regulated O O 0.9954788684844971
activation O O 0.9961203932762146

through O O 0.9981537461280823
activation O O 0.9972500205039978
of O O 0.9998818635940552
Rel/kappaB S-protein S-protein 0.9983799457550049
, O O 0.9991388320922852
a O O 0.9999500513076782
family O O 0.919817328453064
of O O 0.9956218600273132
transcription B-protein B-protein 0.8433663249015808
factors E-protein E-protein 0.9959606528282166
known O O 0.9997174143791199
to O O 0.9999213218688965
regulate O O 0.999713122844696
IL-2 S-protein S-protein 0.612750768661499

myeloid B-cell_type I-cell_type 0.44244444370269775
cells E-cell_type E-cell_type 0.866637110710144
is O O 0.9997093081474304
mediated O O 0.9998088479042053
through O O 0.999982476234436
retinoic B-protein B-protein 0.7638434171676636
acid I-protein I-protein 0.5558632612228394
receptor-alpha E-protein E-protein 0.9935089349746704
. O O 0.9979113936424255
CD38 S-protein S-protein 0.9675969481468201
is O O 0.9998751878738403
a O O 0.9999904632568359
leukocyte B-protein B-protein 0.5634558796882629
differentiation I-protein I-protein 0.723336935043335
antigen E-protein E-protein 0.9751767516136169
that O O 0.9986572265625
has O O 0.999976634979248
been O O 0.9999594688415527

single O O 0.8295141458511353

SP-A S-protein O 0.2548471987247467
activated O O 0.47144490480422974
NF-kappa B-protein B-protein 0.3274410665035248
B E-protein E-protein 0.9881807565689087
in O O 0.9998624324798584
the O O 0.9999254941940308
THP-1 B-cell_line B-cell_line 0.7028326392173767
cell I-cell_line I-cell_line 0.8035749197006226
line E-cell_line E-cell_line 0.9973490238189697
, O O 0.9962092638015747
a O O 0.9998552799224854
human B-cell_line B-cell_line 0.8866490721702576
monocytic I-cell_line I-cell_line 0.960927426815033
cell I-cell_line I-cell_line 0.975963830947876
line E-cell_line E-cell_line 0.9964348077774048
. O O 0.9999109506607056
Activation O O 0.9988333582878113
of O O 0.9999850988388062
NF-kappa B-protein B-protein 0.907324492931366
B E-protein E-protein 0.9974600672721863
in O O 0.9997896552085876
THP-1 B-cell_line B-cell_line 0.8342943787574768
cells E-cell_line E-cell_line 0.9787277579307556

Possible O O 0.9716942310333252
roles O O 0.9971604347229004
of O O 0.9999722242355347
ERK S-protein S-protein 0.9361839294433594
in O O 0.9992089867591858
proliferation O O 0.996908962726593
of O O 0.9999659061431885
transformed B-cell_line B-cell_line 0.479839950799942
cells E-cell_line E-cell_line 0.7637519240379333
were O O 0.9992021918296814
also O O 0.999968409538269
suggested O O 0.999963641166687
. O O 0.9999903440475464
Aiolos S-protein B-protein 0.36191844940185547
transcription B-protein I-protein 0.5242505073547363
factor E-protein E-protein 0.9699655175209045
controls O O 0.9882148504257202
cell O O 0.9168193340301514
death O O 0.9590542912483215
in O O 0.9995276927947998
T B-cell_type B-cell_type 0.9481522440910339
cells E-cell_type E-cell_type 0.9963164329528809
by O O 0.9997299313545227
regulating O O 0.9873669147491455

CD3-activated I-cell_type B-cell_type 0.334216445684433
T I-cell_type I-cell_type 0.6561273336410522
cells E-cell_type E-cell_type 0.5123796463012695
to O O 0.988849401473999
proliferate O O 0.995395839214325
, O O 0.999344527721405
produce O O 0.9996856451034546
IFN-gamma S-protein S-protein 0.9851321578025818
, O O 0.9971412420272827
and O O 0.9997513890266418
kill O O 0.9792748093605042
tumor B-cell_type B-cell_type 0.44784051179885864
cells E-cell_type E-cell_type 0.9817782640457153
. O O 0.9999527931213379
The O O 0.9999960660934448
magnitude O O 0.9765158295631409

AP-1 S-protein S-protein 0.8490169048309326
. O O 0.9999531507492065
Evidence O O 0.9996795654296875
for O O 0.9999943971633911
a O O 0.9999896287918091
polyclonal O O 0.9055320620536804
etiology O O 0.9845715761184692
of O O 0.9999349117279053
palmar O O 0.6781132817268372
fibromatosis O O 0.9103044867515564
. O O 0.9998703002929688
X B-DNA B-DNA 0.5958925485610962
chromosome E-DNA E-DNA 0.9750150442123413
inactivation O O 0.9713825583457947
patterns O O 0.9957269430160522
at O O 0.9999992847442627
the O O 0.9999973773956299
androgen O B-DNA 0.6821306347846985

NF-E2 S-protein S-protein 0.8675094246864319
transcription B-protein B-protein 0.6452484726905823
factors E-protein E-protein 0.9901722073554993
in O O 0.9999624490737915
the O O 0.9999889135360718
BA-induced O O 0.7423207759857178
erythroid O O 0.5535994172096252
differentiation O O 0.9633364081382751
of O O 0.9999257326126099
human B-cell_line B-cell_line 0.42578428983688354
leukemic I-cell_line I-cell_line 0.6370008587837219
K562 I-cell_line I-cell_line 0.7999087572097778
cells E-cell_line E-cell_line 0.9829742908477783
. O O 0.999925971031189
Time-course O O 0.9956177473068237
experiments O O 0.9998630285263062
showed O O 0.9999996423721313
that O O 0.9999978542327881
nuclear O O 0.8100618720054626
levels O O 0.9849784970283508
of O O 0.9995465874671936
GATA-1 S-protein S-protein 0.8891718983650208
and O O 0.9746243357658386
p45 B-protein S-protein 0.7721163034439087

PCD O O 0.41010603308677673
is O O 0.9983965754508972
not O O 0.9998773336410522
due O O 0.9999895095825195
to O O 0.9999939203262329
metalloproteinase S-protein S-protein 0.8858692646026611
inhibition O O 0.9981666803359985
, O O 0.9999889135360718
as O O 0.9999978542327881
reduction O O 0.9935827851295471
and O O 0.9997087121009827
alkylation O O 0.9925848841667175
of O O 0.9999127388000488
the O O 0.9998579025268555
TIMP-1 S-protein S-protein 0.7877588272094727
did O O 0.9981381893157959
not O O 0.9999752044677734
abolish O O 0.9999841451644897
this O O 0.9999880790710449
activity O O 0.9996988773345947
. O O 0.9999985694885254
Retroviral O O 0.8444070219993591

significant O O 0.9935864806175232
increase O O 0.9999430179595947
of O O 0.9999924898147583
SLP-76-dependent B-DNA B-protein 0.6052658557891846
interleukin I-DNA I-protein 0.42388585209846497
( I-DNA I-protein 0.5725923776626587
IL I-DNA I-protein 0.9638055562973022
) I-DNA I-protein 0.9549627900123596
-2 I-DNA E-protein 0.894497275352478
promoter E-DNA O 0.40232744812965393
and O O 0.9633775353431702
nuclear B-protein B-protein 0.5101842880249023
factor I-protein I-protein 0.5598032474517822
of I-protein I-protein 0.5712055563926697
activated I-protein I-protein 0.7331258654594421
T I-protein I-protein 0.837615430355072
cell E-protein E-protein 0.7383893728256226
( O O 0.7080173492431641
NF-AT S-protein S-protein 0.7912581562995911
) O O 0.6968713998794556
activation O O 0.8469375371932983
upon O O 0.9823682904243469
T B-protein B-protein 0.4431368410587311
cell I-protein I-protein 0.510923445224762
receptor E-protein E-protein 0.959730863571167
( O O 0.9561336636543274
TCR S-protein S-protein 0.9282387495040894

cells E-cell_type E-cell_type 0.6085554361343384
were O O 0.9998013377189636
stimulated O O 0.9993336796760559
with O O 0.9999880790710449
estradiol O O 0.943168044090271
, O O 0.9991451501846313
PMA O O 0.9942692518234253
, O O 0.9999006986618042
and O O 0.9999244213104248
ionomycin O O 0.932235062122345
. O O 0.9998366832733154
Epstein-Barr O B-cell_line 0.5877595543861389
virus-transformed O I-cell_line 0.593370258808136
B B-cell_line I-cell_line 0.8457189202308655
cell I-cell_line I-cell_line 0.9686641097068787
lines E-cell_line E-cell_line 0.999016523361206

World O O 0.9079239368438721
primates O O 0.918179988861084
, O O 0.9999136924743652
we O O 0.9999357461929321
used O O 0.9999701976776123
reverse O O 0.8892127275466919
transcription-PCR O O 0.48937293887138367
to O O 0.9984198808670044
clone O O 0.9880805015563965
the O O 0.9998531341552734
glucocorticoid B-protein B-protein 0.7589531540870667
receptor E-protein E-protein 0.977027177810669
from O O 0.9996962547302246
squirrel O O 0.8464398384094238
monkey O O 0.8120413422584534
liver O O 0.6848542094230652
and O O 0.9941851496696472
have O O 0.9999675750732422
compared O O 0.9999063014984131
the O O 0.9999922513961792
sequence O O 0.9902205467224121
to O O 0.9999107122421265
receptor O O 0.8106857538223267
sequences O O 0.6834975481033325

, O O 0.9039902091026306
and O O 0.9591496586799622
lung O O 0.5972291827201843
of O O 0.9886117577552795
the O O 0.9997662901878357
transgenic O O 0.835107147693634
animals O O 0.9043218493461609
. O O 0.999984622001648
Moreover O O 0.9999632835388184
, O O 0.999993085861206
a O O 0.9999972581863403
strong O O 0.9946572184562683
induction O O 0.9984521865844727
of O O 0.9999856948852539
the O O 0.999976396560669
enzyme O S-protein 0.7321483492851257
was O O 0.996452808380127
observed O O 0.999852180480957
in O O 0.9999488592147827
red B-cell_type B-cell_type 0.7411379218101501
cells E-cell_type E-cell_type 0.9654268026351929
during O O 0.9997596144676208
experimental O O 0.988109290599823
anemia O O 0.9932734966278076
in O O 0.9999822378158569
mice O O 0.9856919646263123
. O O 0.999997615814209
The O O 0.9999995231628418
data O O 0.9959612488746643

such O O 0.9965400695800781
as O O 0.9999663829803467
interleukin B-protein B-protein 0.5597907304763794
( I-protein I-protein 0.5822064876556396
IL I-protein I-protein 0.9686713814735413
) I-protein I-protein 0.8453924655914307
-2 E-protein E-protein 0.970392107963562
, O O 0.9767345786094666
IL-3 S-protein S-protein 0.9823585152626038
, O O 0.9897308349609375
IL-4 S-protein S-protein 0.9918031096458435
, O O 0.991755485534668
IL-10 S-protein S-protein 0.9956887364387512
, O O 0.9931562542915344
and O O 0.9994232654571533
granulocyte-macrophage B-protein B-protein 0.8825554847717285
colony-stimulating I-protein I-protein 0.9705462455749512
factor E-protein E-protein 0.8496189117431641

vitro O O 0.8331000804901123
TCR S-protein S-protein 0.9593465924263
stimulation O O 0.9983149766921997
or O O 0.9999710321426392
in O O 0.9986323714256287
vivo O O 0.9827818274497986
antigen O O 0.8438330888748169
challenge O O 0.9794349670410156
. O O 0.9999922513961792
Thus O O 0.9997972846031189
, O O 0.99994957447052
type O O 0.8120774030685425
2 O O 0.5381508469581604
effector O O 0.7667806148529053
function O O 0.980628490447998
was O O 0.9999265670776367
augmented O O 0.9999406337738037
by O O 0.9999947547912598
IL-4 S-protein S-protein 0.9464677572250366
signals O O 0.9599803686141968
transduced O O 0.999549925327301
through O O 0.9999936819076538
a O O 0.9999877214431763
chimeric B-protein B-protein 0.4478303790092468
receptor E-protein E-protein 0.9554088115692139
expressed O O 0.994432270526886
in O O 0.9999704360961914
a O O 0.9999127388000488
T O O 0.46606650948524475
cell-specific O O 0.47106194496154785
manner O O 0.9249407052993774
. O O 0.9999767541885376
This O O 0.999996542930603
influence O O 0.999170184135437
was O O 0.9999929666519165
sufficient O O 0.999984860420227
for O O 0.9999970197677612
establishment O O 0.9995877146720886
of O O 0.9999948740005493
antigen-induced O O 0.8495601415634155
allergic O O 0.8690459132194519
airway O O 0.9016643166542053
hyperresponsiveness O O 0.9888651371002197

of O O 0.9991328120231628
mitogen-activated B-protein B-protein 0.44918787479400635
protein I-protein I-protein 0.3351471722126007
kinase E-protein E-protein 0.9072880148887634
pathways O O 0.9836607575416565
in O O 0.9999861717224121
interleukin-8 S-protein S-protein 0.9466814994812012
production O O 0.9980505704879761
by O O 0.9999964237213135
human B-cell_type B-cell_type 0.6238357424736023
monocytes E-cell_type E-cell_type 0.9816142916679382
and O O 0.9988688826560974
polymorphonuclear B-cell_type O 0.5588206052780151

be O O 0.9970382452011108
functionally O O 0.9962509274482727
inactivated O O 0.9997020363807678
by O O 0.9999994039535522
a O O 0.9999958276748657
nonmutational O O 0.932880699634552
mechanism O O 0.992911159992218
. O O 0.9999973773956299
Myb-transformed B-cell_type B-cell_type 0.49882152676582336
hematopoietic I-cell_type I-cell_type 0.5331181883811951
cells E-cell_type E-cell_type 0.5680402517318726
as O O 0.9997203946113586
a O O 0.9999945163726807
model O O 0.9943484663963318
for O O 0.9999322891235352
monocyte O O 0.7377304434776306
differentiation O O 0.9974566102027893
into O O 0.9999805688858032
dendritic B-cell_type B-cell_type 0.8059458136558533

genes E-DNA E-DNA 0.9195572733879089
mediated O O 0.9994175434112549
by O O 0.9999983310699463
the O O 0.9999663829803467
transcription B-protein B-protein 0.5329611897468567
factor E-protein E-protein 0.9351131319999695
E2F S-protein S-protein 0.9672816395759583
. O O 0.9999586343765259
Initiation O O 0.9964193105697632
of O O 0.9999217987060547
DNA O O 0.8353671431541443
replication O O 0.9795729517936707
requires O O 0.9999810457229614
the O O 0.9999974966049194
function O O 0.9998133778572083
of O O 0.9999960660934448
MCM B-protein B-protein 0.4554167091846466
gene I-protein I-protein 0.5807424187660217
products E-protein E-protein 0.9791998267173767
, O O 0.9984076619148254
which O O 0.9999504089355469
participate O O 0.9999783039093018
in O O 0.9999167919158936
ensuring O O 0.9999244213104248
that O O 0.9999948740005493
DNA O O 0.8755971789360046
replication O O 0.9852928519248962
occurs O O 0.9999619722366333
only O O 0.9999765157699585
once O O 0.999923586845398
in O O 0.9999219179153442
the O O 0.9999268054962158
cell O O 0.9799613356590271
cycle O O 0.9934855103492737
. O O 0.9999973773956299

IkappaBalpha S-protein S-protein 0.9642539024353027
degradation O O 0.999556839466095
. O O 0.9999970197677612
Productive O O 0.9756980538368225
human O O 0.8979771733283997
immunodeficiency O O 0.9692294001579285
virus O O 0.9874821901321411
type O O 0.9929210543632507
1 O O 0.9946501851081848
( O O 0.9995379447937012
HIV-1 O O 0.9942051768302917
) O O 0.9995373487472534
infection O O 0.9998041987419128
causes O O 0.9999935626983643
sustained O O 0.9940622448921204
NF-kappaB S-protein S-protein 0.997515082359314
DNA-binding O O 0.9732277393341064
activity O O 0.999534010887146
in O O 0.9999797344207764
chronically O B-cell_type 0.3827672302722931
infected O I-cell_type 0.4576846957206726
monocytic O I-cell_type 0.4512328803539276
cells O E-cell_type 0.5026649832725525
. O O 0.9998801946640015
A O O 0.9998950958251953
direct O O 0.9968163371086121
temporal O O 0.9908444285392761
correlation O O 0.9994634985923767
exists O O 0.999998927116394
between O O 0.9992519021034241
HIV O O 0.9484130144119263
infection O O 0.9993662238121033
and O O 0.9999936819076538
the O O 0.9999974966049194
appearance O O 0.99988853931427
of O O 0.9999963045120239
NF-kappaB S-protein S-protein 0.9906794428825378
DNA-binding O O 0.9549170136451721
activity O O 0.9993993043899536
in O O 0.9999891519546509
myelomonoblastic B-cell_line B-cell_line 0.5419755578041077
PLB-985 I-cell_line I-cell_line 0.7719771862030029
cells E-cell_line E-cell_line 0.982928991317749

monocytes S-cell_type S-cell_type 0.5639011263847351
during O O 0.9998592138290405
active O O 0.9530420899391174
tuberculosis O O 0.9800997376441956
and O O 0.9997732043266296
by O O 0.9999918937683105
M. O O 0.9827369451522827
tuberculosis O O 0.9993689656257629
. O O 0.9999986886978149
We O O 0.9999872446060181
found O O 0.9999979734420776
a O O 0.9999990463256836
constitutive O O 0.960369348526001
degradation O O 0.9966889023780823
of O O 0.9999910593032837
I B-protein B-protein 0.9180727601051331
kappa I-protein I-protein 0.9228321313858032
B-alpha E-protein E-protein 0.9920159578323364
, O O 0.9989343285560608
the O O 0.9999697208404541
major O B-protein 0.6004267334938049
cytoplasmic B-protein I-protein 0.7836379408836365

that O O 0.9975073933601379
present O O 0.9998434782028198
in O O 0.9999353885650635
NF-kappa B-protein B-protein 0.6973010897636414
B I-protein I-protein 0.6182866096496582
p65 E-protein E-protein 0.984954833984375
. O O 0.9994150400161743
Characterization O O 0.9987574815750122
of O O 0.9999911785125732
a O O 0.9999933242797852
new O O 0.9723700284957886
tissue-specific O B-protein 0.5110297203063965
transcription B-protein I-protein 0.5995175838470459
factor E-protein E-protein 0.9868177175521851
binding O O 0.9897896647453308
to O O 0.9999732971191406
the O O 0.9999284744262695
simian B-DNA B-DNA 0.4411073923110962
virus I-DNA I-DNA 0.49308955669403076
40 I-DNA I-DNA 0.6402944922447205
enhancer I-DNA I-DNA 0.6792823076248169
TC-II I-DNA I-DNA 0.7728132605552673
( I-DNA I-DNA 0.8436833620071411
NF-kappa I-DNA I-DNA 0.6459826827049255
B I-DNA I-DNA 0.7043269872665405
) I-DNA I-DNA 0.9151083827018738
element E-DNA E-DNA 0.9918224215507507
. O O 0.9997239708900452
We O O 0.9999562501907349
have O O 0.9999822378158569

) O O 0.7418336272239685
is O O 0.9986224174499512
expressed O O 0.9999597072601318
exclusively O O 0.9999595880508423
in O O 0.999870777130127
eosinophils S-cell_type S-cell_type 0.9984889030456543
and O O 0.9877949953079224
basophils S-cell_type S-cell_type 0.9820599555969238
in O O 0.9990019202232361
hematopoietic B-cell_type B-cell_type 0.7648016810417175
cells E-cell_type E-cell_type 0.9811553955078125
. O O 0.9999386072158813
In O O 0.9999934434890747
our O O 0.9999945163726807
previous O O 0.9998107552528381
study O O 0.9998736381530762
, O O 0.9999974966049194
we O O 0.9999034404754639
demonstrated O O 0.9999845027923584
a O O 0.9999908208847046
major O O 0.992580771446228
positive O O 0.9875388145446777
regulatory O O 0.9747093319892883
role O O 0.9988635778427124
for O O 0.999980092048645
GATA-1 S-protein S-protein 0.9884998202323914
and O O 0.9996242523193359
a O O 0.999982476234436
negative O O 0.9445917010307312
regulatory O O 0.8834161758422852
role O O 0.9868517518043518
for O O 0.999836802482605
GATA-2 S-protein S-protein 0.9791272282600403
in O O 0.9999334812164307
MBP S-protein B-DNA 0.24102668464183807
gene O E-DNA 0.962998628616333
transcription O O 0.9774630069732666
. O O 0.9999964237213135
Further O O 0.9999402761459351
analysis O O 0.9999791383743286
of O O 0.9999978542327881
the O O 0.9999904632568359
MBP B-DNA B-DNA 0.7136936783790588
promoter I-DNA I-DNA 0.9115820527076721
region E-DNA E-DNA 0.9873450398445129
identified O O 0.9999148845672607
a O O 0.9999873638153076
C/EBP B-DNA B-DNA 0.5037970542907715
( I-DNA I-DNA 0.634616494178772
CCAAT/enhancer-binding I-DNA I-DNA 0.7829778790473938
protein I-DNA I-DNA 0.7235534191131592
) I-DNA I-DNA 0.9403170347213745
consensus I-DNA I-DNA 0.9527068734169006
binding I-DNA I-DNA 0.9824320673942566
site E-DNA E-DNA 0.988240122795105
6 O B-DNA 0.5114394426345825
bp O I-DNA 0.448576956987381
upstream O E-DNA 0.9688391089439392
of O O 0.9991967082023621
the O O 0.999969482421875
functional O O 0.6704003810882568
GATA-binding B-DNA B-DNA 0.710702657699585
site E-DNA E-DNA 0.9819839596748352
in O O 0.9993804693222046
the O O 0.9999600648880005
MBP B-DNA B-DNA 0.778105616569519
gene E-DNA E-DNA 0.9950844645500183
. O O 0.9997480511665344
In O O 0.9999747276306152
the O O 0.9999604225158691
cell B-cell_line B-cell_line 0.6704403162002563
line I-cell_line I-cell_line 0.45576024055480957
HT93A E-cell_line E-cell_line 0.9669140577316284
, O O 0.9482046365737915
which O O 0.9995985627174377
is O O 0.99989914894104
capable O O 0.999852180480957
of O O 0.9999454021453857

cell-specific O B-protein 0.5200230479240417
and O I-protein 0.9316263794898987
developmental B-protein I-protein 0.9326391816139221
stage-specific I-protein I-protein 0.9496804475784302
nuclear I-protein I-protein 0.8569486141204834
factor-DNA I-protein I-protein 0.46200743317604065
complexes E-protein E-protein 0.9892702102661133
which O O 0.9997685551643372
form O O 0.999131977558136
at O O 0.9999896287918091
the O O 0.9999840259552002
enhancer S-DNA S-DNA 0.9004263877868652
( O O 0.9538183212280273
HS-40 S-DNA S-DNA 0.9784138202667236
) O O 0.9664690494537354
and O O 0.999323844909668
the O O 0.9998206496238708
globin B-DNA B-DNA 0.6538258194923401
promoters E-DNA E-DNA 0.9961257576942444
. O O 0.9999524354934692
Transcriptional O O 0.9661158323287964
regulation O O 0.9992945194244385
of O O 0.9999957084655762
the O O 0.9998562335968018
pyruvate B-DNA B-DNA 0.5180644392967224
kinase I-DNA I-DNA 0.7116784453392029
erythroid-specific I-DNA I-DNA 0.6969415545463562
promoter E-DNA E-DNA 0.9926733374595642
. O O 0.9998507499694824
Mammal B-protein O 0.8467419147491455

in O O 0.9980707764625549
differentiated B-cell_type B-cell_type 0.5474421977996826
macrophages E-cell_type E-cell_type 0.6615222096443176
. O O 0.9999070167541504
We O O 0.9999954700469971
have O O 0.9999966621398926
shown O O 0.9999985694885254
elsewhere O O 0.9999995231628418
that O O 0.9999994039535522
both O O 0.9999879598617554
the O O 0.9999752044677734
major B-DNA B-DNA 0.747337818145752
immediate-early I-DNA I-DNA 0.4459514915943146
gene E-DNA E-DNA 0.9818243384361267
( O O 0.9847858548164368
MIE S-DNA S-DNA 0.989497184753418
) O O 0.9790419936180115
and O O 0.9997993111610413
lytic O O 0.817250669002533
cycle O O 0.8757784366607666
infectious O O 0.9242486357688904
progeny O O 0.940229594707489
virus O O 0.9610921144485474
expression O O 0.9977384805679321
can O O 0.9999938011169434
be O O 0.9999949932098389
induced O O 0.9998564720153809
in O O 0.9999918937683105
otherwise O O 0.9798375964164734
nonpermissive O B-cell_line 0.4931871294975281
monocyte-like B-cell_line I-cell_line 0.5307801961898804
U-937 I-cell_line I-cell_line 0.7386518716812134
cell I-cell_line I-cell_line 0.5655234456062317
cultures E-cell_line E-cell_line 0.999346911907196
infected O O 0.9961897730827332

cancer O O 0.9115552306175232
patients O O 0.9905774593353271
is O O 0.9999836683273315
different O O 0.9999969005584717
from O O 0.9999979734420776
that O O 0.999972939491272
in O O 0.9996839761734009
benign O O 0.4844931960105896
mammary O O 0.5894511938095093
tissue O O 0.7033331990242004
. O O 0.9999493360519409
The O O 0.9999990463256836
implications O O 0.9999643564224243
, O O 0.9999953508377075
in O O 0.9999810457229614
particular O O 0.9999688863754272
, O O 0.9999842643737793
in O O 0.9999721050262451
relation O O 0.999897837638855
to O O 0.9999942779541016
future O O 0.9961383938789368
prognosis O O 0.9992628693580627
of O O 0.9999936819076538
the O O 0.9999685287475586

ML-1 B-cell_line B-cell_line 0.5702379941940308
cells E-cell_line E-cell_line 0.9842974543571472
, O O 0.9857048988342285
as O O 0.9999794960021973
assessed O O 0.9986573457717896
by O O 0.9999980926513672
a O O 0.9999552965164185
number O O 0.995430588722229
of O O 0.9999476671218872
features O O 0.9510825276374817
associated O O 0.9980689883232117
with O O 0.9999839067459106
mononuclear O O 0.8007906675338745
differentiation O O 0.994361400604248
including O O 0.9999812841415405
changes O O 0.9978329539299011
in O O 0.9999486207962036
morphology O O 0.9262967109680176
, O O 0.9996227025985718
nonspecific O O 0.9419358968734741
esterase S-protein S-protein 0.6970167756080627
activity O O 0.9962980151176453
, O O 0.9999477863311768
phagocytic O O 0.8642668724060059
ability O O 0.9989643096923828
, O O 0.9999899864196777
NADPH B-protein B-protein 0.3403037190437317
oxidase E-protein E-protein 0.8422887325286865
activity O O 0.9866820573806763

for O O 0.99050372838974
Fas S-protein S-protein 0.9791799187660217
signaling O O 0.9961839318275452
, O O 0.9999765157699585
JNK S-protein S-protein 0.9872597455978394
activation O O 0.9983311295509338
may O O 0.999991774559021
play O O 0.9999923706054688
an O O 0.9999984502792358
important O O 0.9999170303344727
role O O 0.9999743700027466
transducing O O 0.9995694756507874
distal O O 0.8959879279136658
signals O O 0.9805204272270203
that O O 0.9999927282333374
lead O O 0.999990701675415
to O O 0.9999948740005493
apoptosis O O 0.9973021745681763
after O O 0.9999873638153076
Fas S-protein S-protein 0.9885945320129395
ligation O O 0.9939604997634888

glucocorticoid O O 0.719298243522644
hormone O O 0.8863464593887329
inhibition O O 0.9893866777420044
of O O 0.9999232292175293
neutrophil S-cell_type S-cell_type 0.9920335412025452
-mediated O O 0.9776169061660767
tumor O O 0.771760880947113
cell O O 0.6743310689926147
cytostasis O O 0.9605445265769958
is O O 0.9999575614929199
at O O 0.9999885559082031
least O O 0.9998855590820312
partially O O 0.999948263168335
due O O 0.9999967813491821
to O O 0.9999973773956299
a O O 0.9999985694885254
lowering O O 0.9973722696304321
of O O 0.9999219179153442

feature O O 0.8684335947036743

The O O 0.9950821399688721

was O O 0.9926589131355286
strongly O O 0.9982739686965942
inhibited O O 0.9999642372131348
. O O 0.9999986886978149
In O O 0.9999969005584717
this O O 0.9999996423721313
study O O 0.9999254941940308
we O O 0.9999964237213135
present O O 0.9999969005584717
a O O 0.999998927116394
deletion O O 0.9829828143119812
analysis O O 0.9996438026428223
of O O 0.9999964237213135
the O O 0.9999911785125732
N-terminal B-protein B-protein 0.8795783519744873
region E-protein E-protein 0.9595780372619629
of O O 0.9963546991348267
Oct-2a S-protein S-protein 0.9723580479621887
to O O 0.9990382194519043
determine O O 0.9999895095825195
the O O 0.9999954700469971
minimal B-protein B-protein 0.8733793497085571
repression I-protein I-protein 0.7161694765090942
domain E-protein E-protein 0.8994267582893372
. O O 0.999859094619751
We O O 0.9999488592147827
identified O O 0.9999833106994629
a O O 0.9999978542327881
stretch O O 0.9817257523536682
of O O 0.9994200468063354
23 O O 0.7511353492736816
amino O O 0.5581063628196716
acids O O 0.47173961997032166
, O O 0.9864860773086548
rich O O 0.9781815409660339
in O O 0.9979460835456848
serine O O 0.7763535976409912
and O O 0.983337938785553
threonine O O 0.8506263494491577

steroid O O 0.8907024264335632
action O O 0.9996318817138672
include O O 0.9999995231628418
its O O 0.9999982118606567
rapid O O 0.9953059554100037
time O O 0.9982594847679138
course O O 0.9959319233894348
, O O 0.9999316930770874
10 O O 0.9747280478477478
, O O 0.998021125793457
000-fold O O 0.9832419157028198
selectivity O O 0.9990672469139099
for O O 0.9999932050704956
aldosterone O O 0.9436120986938477
over O O 0.999607503414154
cortisol O O 0.9169257283210754

cells E-cell_type E-cell_type 0.5126485824584961
and O O 0.9975714087486267
, O O 0.9997809529304504
less O O 0.9996167421340942
frequently O O 0.9889265298843384
, O O 0.9996045231819153
CD4+ B-cell_type B-cell_type 0.8985119462013245
T I-cell_type I-cell_type 0.9756314754486084
cells E-cell_type E-cell_type 0.9447657465934753
may O O 0.9995905756950378
completely O O 0.9999562501907349
lose O O 0.9999434947967529
CD28 S-protein S-protein 0.9314798712730408
surface O O 0.9646791815757751
expression O O 0.9998167157173157
during O O 0.9999946355819702
chronic O O 0.9605762958526611
infections O O 0.9980054497718811
and O O 0.9999860525131226
with O O 0.9999891519546509
aging O O 0.9990115165710449
. O O 0.9999983310699463
This O O 0.9999942779541016
correlates O O 0.9996689558029175
with O O 0.9999957084655762

of O O 0.9979203343391418
human O O 0.7570626735687256
cytomegalovirus O O 0.8062335848808289
( O O 0.9943548440933228
CMV O O 0.9866822957992554
) O O 0.9992613196372986
can O O 0.9999803304672241
be O O 0.9999877214431763
expressed O O 0.9997761845588684
in O O 0.9998767375946045
monocytic B-cell_type B-cell_type 0.8716998100280762
cells E-cell_type E-cell_type 0.9771208763122559
and O O 0.9954138994216919
are O O 0.9999438524246216
known O O 0.9998146891593933
to O O 0.9999382495880127
regulate O O 0.99994957447052

delta I-cell_line I-cell_line 0.2594113051891327
cells E-cell_line E-cell_line 0.8530135154724121
in O O 0.999923586845398
a O O 0.999954104423523
fetal B-cell_line O 0.7659269571304321
thymic I-cell_line O 0.7092740535736084
organ I-cell_line O 0.6551426649093628
culture E-cell_line O 0.881541907787323
( O O 0.9987298846244812
FTOC S-cell_line O 0.7062393426895142
) O O 0.999813973903656
. O O 0.9999986886978149
Here O O 0.9999970197677612
we O O 0.9999974966049194
document O O 0.9999853372573853
that O O 0.9999991655349731
overexpression O O 0.9932652711868286
of O O 0.9997732043266296
Id3 S-protein S-protein 0.9683675765991211
, O O 0.996891438961029
in O O 0.9998879432678223
progenitors S-cell_type S-cell_type 0.8557301759719849
that O O 0.9933433532714844
have O O 0.9999768733978271
initiated O O 0.9966945648193359
TCR B-DNA B-DNA 0.38709861040115356
gene I-DNA I-DNA 0.9125914573669434
rearrangements E-DNA E-DNA 0.9779263138771057
( O O 0.9996222257614136
pre-T B-cell_type B-cell_type 0.5230104327201843
cells E-cell_type E-cell_type 0.8046408891677856
) O O 0.938510537147522
, O O 0.9995751976966858
inhibits O O 0.9999731779098511
development O O 0.998715877532959
into O O 0.99998939037323
TCRalpha B-cell_line B-protein 0.5208145976066589
beta E-cell_line E-protein 0.8255650997161865
but O O 0.9116768836975098
not O O 0.9859975576400757
into O O 0.997913658618927
TCRgamma B-cell_line B-cell_line 0.6353267431259155

of O O 0.9977428913116455
TF O S-protein 0.8939531445503235
activity O O 0.9929245710372925
promoted O O 0.9999092817306519
by O O 0.9999955892562866
lysoPC O O 0.6766816973686218
. O O 0.9996738433837891
In O O 0.9999521970748901
conclusion O O 0.9999003410339355
, O O 0.9999940395355225
lysoPC O O 0.4041941463947296
markedly O O 0.983302891254425
decreases O O 0.9998730421066284

necessary O O 0.9906072616577148
for O O 0.9997993111610413
targeting O O 0.9985007047653198
the O O 0.9999161958694458
viral O B-protein 0.5885352492332458
protein O E-protein 0.9505612254142761
to O O 0.9864000082015991
Cp S-DNA S-DNA 0.9950606226921082
. O O 0.9996217489242554
Consistent O O 0.9997085928916931
with O O 0.9999897480010986
this O O 0.9999943971633911
result O O 0.9998661279678345
, O O 0.9999924898147583
mutation O O 0.9979054927825928
of O O 0.9999860525131226
the O O 0.9999806880950928
EBNA2 B-DNA B-DNA 0.6453973054885864
response I-DNA I-DNA 0.9244459867477417
element E-DNA E-DNA 0.9925312399864197
( O O 0.9975538849830627
a O O 0.9992743134498596
CBF1/RBP-Jkappa B-DNA B-DNA 0.794389545917511
binding I-DNA I-DNA 0.9035053253173828
site E-DNA E-DNA 0.9702392220497131
) O O 0.9900882840156555
in O O 0.9999507665634155
Cp S-DNA S-DNA 0.9500458240509033
also O O 0.9982311129570007
prevented O O 0.9998480081558228
significant O O 0.997723400592804
repression O O 0.998849630355835
. O O 0.9999974966049194
In O O 0.9999377727508545
addition O O 0.9998642206192017
, O O 0.9999607801437378
amino B-protein B-protein 0.6973310708999634
acids I-protein I-protein 0.5856176018714905
346 I-protein I-protein 0.5353819131851196
to I-protein I-protein 0.6585869789123535
543 E-protein E-protein 0.961317777633667
, O O 0.9872105121612549
which O O 0.9998652935028076
were O O 0.9999819993972778
previously O O 0.9998866319656372
defined O O 0.9999672174453735
as O O 0.9999836683273315
important O O 0.999862790107727
for O O 0.9999831914901733

stimulate O O 0.9961968660354614
the O O 0.9999860525131226
expression O O 0.9997300505638123
of O O 0.9999974966049194
several O O 0.9915505647659302
inflammatory B-protein B-protein 0.7140357494354248
cytokines E-protein E-protein 0.983672559261322
and O O 0.9892861247062683
chemokines S-protein S-protein 0.973831057548523
, O O 0.9986055493354797
which O O 0.9998824596405029
in O O 0.9999051094055176
turn O O 0.9988760352134705
may O O 0.9999909400939941
activate O O 0.9999699592590332
their O O 0.9999881982803345
respective O O 0.9936994314193726
receptors O O 0.5395253896713257
and O O 0.9995019435882568
initiate O O 0.9999607801437378
an O O 0.9999769926071167
autocrine O O 0.8889312744140625
regulatory O O 0.8240708708763123
mechanism O O 0.9814680218696594

a O O 0.9995145797729492
much O O 0.9990115165710449
higher O O 0.9996150732040405
intracellular O O 0.9464291930198669
activity O O 0.996505618095398
of O O 0.999982476234436
this O O 0.9999681711196899
enzyme S-protein S-protein 0.7164314389228821
, O O 0.9819568395614624
and O O 0.9992031455039978
higher O O 0.9621362090110779
thymidine B-RNA B-RNA 0.6114136576652527
kinase I-RNA I-RNA 0.4905191957950592
mRNA E-RNA E-RNA 0.9532302021980286
expression O O 0.9967787861824036

. O O 0.9954484105110168

RIA O O 0.4290807843208313
. O O 0.999874472618103
Differences O O 0.9999282360076904
in O O 0.9999784231185913
pre- O O 0.9908400177955627
and O O 0.9975181818008423
postoperative O O 0.9930703043937683
values O O 0.9988085031509399
of O O 0.999991774559021
cancer O O 0.9622236490249634
patients O O 0.996961772441864
were O O 0.9999986886978149
seen O O 0.9999985694885254
in O O 0.9999849796295166
plasma O O 0.8054116368293762
RIA O O 0.8208587169647217
values O O 0.9884677529335022
: O O 0.9999722242355347
PGE2 O O 0.39977309107780457
and O O 0.9715561270713806
6-k-PGF1 O B-protein 0.504084587097168
alpha O E-protein 0.9937279224395752
were O O 0.9999419450759888
significantly O O 0.9998817443847656
higher O O 0.999970555305481

of O O 0.9925521612167358

human B-cell_type B-cell_type 0.5240598320960999
umbilical I-cell_type I-cell_type 0.6794581413269043
arterial I-cell_type I-cell_type 0.6943787932395935
endothelial I-cell_type I-cell_type 0.8206698298454285
cells E-cell_type E-cell_type 0.8263310790061951
) O O 0.9932748079299927
and O O 0.9999063014984131
mRNA O S-RNA 0.9477282166481018
expression O O 0.9882014393806458
( O O 0.9998456239700317
by O O 0.9999936819076538
70 O O 0.9995911717414856
% O O 0.9999197721481323
at O O 0.999997615814209
100 O O 0.9739688634872437
mumol/L O O 0.993026614189148
PDTC O O 0.7371983528137207
) O O 0.9998846054077148
in O O 0.9999953508377075

strong O O 0.9750367999076843
association O O 0.9988340735435486
of O O 0.9999935626983643
the O O 0.9999831914901733
disease O O 0.9934365749359131
with O O 0.9999725818634033
an O O 0.9999727010726929
epitope S-protein O 0.8639594316482544
within O O 0.9996650218963623
the O O 0.9999920129776001
HLA-DR B-protein B-protein 0.5626451969146729
chain E-protein E-protein 0.991242527961731
shared O O 0.9991984963417053
between O O 0.9990323781967163
various O O 0.9883729815483093
alleles O O 0.5744787454605103
of O O 0.999446451663971
HLA-DR4 S-protein S-DNA 0.5503670573234558
and O O 0.9523126482963562
DR1 S-protein S-DNA 0.6666423082351685
emphasizes O O 0.9987725615501404
the O O 0.9999969005584717
importance O O 0.9998680353164673
of O O 0.9999921321868896
antigen O O 0.7990255951881409
presentation O O 0.9843662977218628
. O O 0.9999898672103882
This O O 0.999990701675415
immune O O 0.9224671125411987
response O O 0.9957137107849121
predominantly O O 0.9999338388442993
occurs O O 0.9999761581420898
in O O 0.9999866485595703
the O O 0.9999736547470093
synovial O O 0.7960116267204285
tissue O O 0.9546250104904175
and O O 0.9991074204444885
fluid O O 0.9664419889450073
of O O 0.9998288154602051
the O O 0.9999653100967407
joints O O 0.7205753922462463
and O O 0.9963802695274353
autoreactive B-cell_type B-cell_type 0.5295881628990173
T I-cell_type I-cell_type 0.8547486066818237
cells E-cell_type E-cell_type 0.9309258460998535
are O O 0.999424934387207
readily O O 0.996321439743042
demonstrable O O 0.9997321963310242
in O O 0.9999902248382568
both O O 0.9999500513076782
the O O 0.9998037219047546
synovial O O 0.6605480909347534

will O O 0.9972779154777527
differentiate O O 0.9996837377548218
into O O 0.9986826777458191
cells O O 0.9427931904792786
that O O 0.9996956586837769
have O O 0.999991774559021
many O O 0.9999308586120605
of O O 0.9999912977218628
the O O 0.9999921321868896
properties O O 0.9793922305107117
of O O 0.9998563528060913
macrophages S-cell_type S-cell_type 0.9966937303543091
. O O 0.9997544884681702
When O O 0.9999934434890747
the O O 0.9998869895935059
same O O 0.9998031258583069
MTHC B-cell_line B-cell_line 0.7618268728256226
lines E-cell_line E-cell_line 0.9993720650672913
are O O 0.9997299313545227
exposed O O 0.9991187453269958

M-CSF S-protein S-protein 0.640434205532074

fusion O I-protein 0.3385731279850006
protein O E-protein 0.9892863631248474
in O O 0.999817430973053
established B-cell_line B-cell_line 0.6761447787284851
human I-cell_line I-cell_line 0.4686494767665863
B I-cell_line I-cell_line 0.534984290599823
cell I-cell_line I-cell_line 0.7686682939529419
lymphoma I-cell_line I-cell_line 0.9069468379020691
lines E-cell_line E-cell_line 0.9989235997200012
resulted O O 0.9999048709869385
in O O 0.9999858140945435
growth O O 0.9570627212524414
retardation O O 0.9982278943061829

the O O 0.9988434314727783
NF B-protein B-protein 0.5054605603218079
kappa I-protein I-protein 0.5119370222091675
B E-protein E-protein 0.9631389379501343
-dependent O O 0.9278990030288696
gene O O 0.5786665081977844
expression O O 0.9993164539337158
. O O 0.9999978542327881
We O O 0.9999974966049194
demonstrate O O 0.9999982118606567
evidence O O 0.9999935626983643
suggesting O O 0.9999986886978149
that O O 0.9999985694885254
redox O O 0.9725658297538757
regulation O O 0.9996987581253052
of O O 0.9999967813491821
NF B-protein B-protein 0.8465830683708191
kappa I-protein I-protein 0.7894161939620972
B E-protein E-protein 0.9931595325469971
by O O 0.9998028874397278
Trx S-protein S-protein 0.9295179843902588
might O O 0.999835729598999
be O O 0.9999891519546509
exerted O O 0.9999614953994751
at O O 0.9999996423721313

important O O 0.9695335626602173
transcriptional O B-DNA 0.4111872911453247
regulator O I-DNA 0.5744338631629944
of O I-DNA 0.5931690335273743
genes O E-DNA 0.9362861514091492
induced O O 0.9955737590789795
in O O 0.9998127818107605
activated B-cell_type B-cell_type 0.548003613948822
monocytes/macrophages E-cell_type E-cell_type 0.5623771548271179
, O O 0.9814359545707703
and O O 0.9990173578262329
NF-IL6 S-protein S-protein 0.9635668992996216
is O O 0.9997339844703674
the O O 0.9999960660934448
only O O 0.9991994500160217
CCAAT/enhancer-binding B-protein B-protein 0.9185596108436584
protein I-protein E-protein 0.9930504560470581
( I-protein O 0.9681580066680908
C/EBP I-protein S-protein 0.7387599945068359

can O O 0.998008668422699
transactivate O O 0.9996024966239929
the O O 0.9999420642852783
PU.1 B-DNA B-DNA 0.6917566657066345
promoter E-DNA E-DNA 0.995121419429779
in O O 0.9997283816337585
HeLa S-cell_line S-cell_line 0.9426784515380859
and O O 0.9707766175270081
myeloid B-cell_type B-cell_type 0.5326005816459656
cells E-cell_type E-cell_type 0.853867769241333
. O O 0.9998958110809326
This O O 0.9998990297317505
B B-protein O 0.41475769877433777
cell I-protein O 0.3820314109325409
restricted I-protein O 0.7624637484550476
coactivator E-protein O 0.6066202521324158
may O O 0.9990082383155823
be O O 0.9999947547912598
responsible O O 0.9999203681945801
for O O 0.9999948740005493
the O O 0.9999865293502808
B O O 0.6107239127159119
cell O O 0.5693525075912476
specific O O 0.9261449575424194
expression O O 0.9961159229278564
of O O 0.9999737739562988
PU.1 S-protein S-protein 0.8448128700256348
mediated O O 0.9977052807807922
by O O 0.9999959468841553
the O O 0.9999768733978271
octamer B-DNA B-DNA 0.7730753421783447
site E-DNA E-DNA 0.9825620651245117
. O O 0.999907374382019
Inhibition O O 0.9971473813056946
of O O 0.9999521970748901
p105 S-protein S-protein 0.8528633713722229
processing O O 0.9925298094749451
by O O 0.9999852180480957
NF-kappaB B-protein B-protein 0.5530988574028015
proteins E-protein E-protein 0.9871619343757629
in O O 0.9997768998146057
transiently B-cell_line B-cell_type 0.5121266841888428
transfected I-cell_line I-cell_type 0.39307576417922974
cells E-cell_line E-cell_type 0.5194334983825684
. O O 0.9997557997703552
Regulation O O 0.9994139671325684
of O O 0.999992847442627
the O O 0.9999657869338989
transcription O B-protein 0.5623250603675842
factor O E-protein 0.9705049395561218
NF-kappaB S-protein S-protein 0.9403035640716553
involves O O 0.9999748468399048
proteasome-mediated O O 0.9475386738777161
processing O O 0.9855162501335144

are O O 0.9984626770019531
activated O O 0.9805099964141846
in O O 0.9996907711029053
vivo O O 0.9901941418647766
, O O 0.9995298385620117
as O O 0.9999756813049316
evidenced O O 0.9998056292533875
by O O 0.9999986886978149
an O O 0.9999948740005493
increase O O 0.9999313354492188
in O O 0.9999946355819702
the O O 0.9999525547027588

transient O O 0.8850650191307068
expression O O 0.9985503554344177
of O O 0.9999955892562866
these O O 0.9999866485595703
constructs O O 0.8777807950973511
in O O 0.9999375343322754
TPA-treated B-cell_line B-cell_line 0.7976446151733398
U-937 I-cell_line I-cell_line 0.8775747418403625
cells E-cell_line E-cell_line 0.9981967806816101
could O O 0.9998291730880737
be O O 0.9999960660934448
assigned O O 0.9999080896377563

, O O 0.9806768894195557
it O O 0.9997732043266296
is O O 0.9999876022338867
expressed O O 0.9999771118164062
in O O 0.9999959468841553
many O O 0.9997742772102356
cell O O 0.9110654592514038
types O O 0.900409460067749
. O O 0.9999988079071045
The O O 0.9999980926513672
third O O 0.9726867079734802
member O O 0.9677849411964417
of O O 0.9999016523361206
the O O 0.9999878406524658
family S-protein O 0.9294629693031311

. O O 0.9988202452659607
Flow O O 0.8992668986320496
cytometric O O 0.9653605818748474
and O O 0.9976740479469299
morphological O O 0.9820376634597778
analyses O O 0.998217761516571
demonstrated O O 0.9999958276748657
that O O 0.9999984502792358
the O O 0.9999895095825195
addition O O 0.9999096393585205
of O O 0.9999926090240479
CD70 O B-cell_line 0.3707297146320343
transfectants O E-cell_line 0.8204513192176819
to O O 0.9981828331947327
B B-cell_line B-cell_line 0.3657895028591156
cell I-cell_line I-cell_line 0.4554601311683655
cultures E-cell_line E-cell_line 0.9634853005409241
remarkably O O 0.9932504892349243
promoted O O 0.9995037317276001
differentiation O O 0.9992921352386475
into O O 0.9999598264694214
plasma B-cell_type B-cell_type 0.8338332176208496
cells E-cell_type E-cell_type 0.9830077886581421
in O O 0.9999003410339355
the O O 0.9999788999557495

LBR S-protein S-protein 0.7074185013771057
's O O 0.9892072677612305
nucleoplasmic B-protein B-protein 0.7034987807273865
domain E-protein E-protein 0.9229657649993896
is O O 0.9994031190872192
encoded O O 0.9994664788246155
by O O 0.9998812675476074
exons B-DNA B-DNA 0.6149517893791199
1-4 E-DNA E-DNA 0.9627112746238708
, O O 0.9740342497825623
and O O 0.9996978044509888
its O O 0.9998807907104492
hydrophobic B-protein B-protein 0.7078942060470581
domain E-protein E-protein 0.7963041067123413
, O O 0.9926888346672058
with O O 0.9999791383743286
eight O O 0.9733191132545471
putative O O 0.9071378707885742
transmembrane B-protein B-protein 0.5694442391395569
segments E-protein E-protein 0.870569109916687
, O O 0.9993669390678406
is O O 0.9999586343765259
encoded O O 0.9990222454071045
by O O 0.9999115467071533
exons B-DNA B-DNA 0.6787171363830566
5-13 E-DNA E-DNA 0.9754806756973267
. O O 0.9994329810142517
The O O 0.9999940395355225
hydrophobic B-protein B-protein 0.5334741473197937
domain E-protein E-protein 0.9072301387786865
is O O 0.9990542531013489
homologous O O 0.938947856426239

The O O 0.9950821399688721

, I-DNA O 0.9306331276893616
blk E-DNA S-DNA 0.6777294278144836
. O O 0.9962712526321411
Gel O O 0.8465438485145569
mobility O O 0.9769015908241272
shift O O 0.9931371212005615
assays O O 0.9989389777183533
and O O 0.9999639987945557
transient O O 0.8956976532936096
transfection O O 0.9748639464378357
assays O O 0.9994953870773315
demonstrate O O 0.9999984502792358
that O O 0.9999984502792358
AML1 S-protein S-protein 0.9513115286827087
binds O O 0.9981166124343872
specifically O O 0.9999504089355469
to O O 0.9999948740005493
this O O 0.9998983144760132
site O O 0.88816899061203
in O O 0.9998701810836792
the O O 0.9999746084213257
blk B-DNA B-DNA 0.4625433087348938
promoter E-DNA E-DNA 0.9050841927528381

binding O O 0.8289128541946411
of O O 0.9957755208015442
these O O 0.9999547004699707
STATs S-protein S-protein 0.8774081468582153
to O O 0.9996851682662964
an O O 0.9999682903289795
immobilized B-DNA O 0.908345103263855
GAS I-DNA B-DNA 0.4096514582633972
element E-DNA E-DNA 0.992946445941925
. O O 0.9999732971191406
Both O O 0.9999806880950928
IL-2 S-protein S-protein 0.9756993055343628
and O O 0.9956479668617249
IL-7 S-protein S-protein 0.9893311262130737
induced O O 0.9997382760047913
substantial O O 0.9980818033218384
amounts O O 0.999955415725708
of O O 0.9999887943267822
STAT5A S-protein S-protein 0.9834370613098145
/STAT5B S-protein S-protein 0.9957951307296753
heterodimerization O O 0.9959009289741516
. O O 0.9999970197677612
Moreover O O 0.9995896220207214
, O O 0.9999713897705078
we O O 0.9999668598175049
observed O O 0.9998955726623535

protection O O 0.9911221265792847
to O O 0.9999276399612427
T B-cell_line B-cell_line 0.4314388930797577
cell I-cell_line I-cell_line 0.6548737287521362
lines E-cell_line E-cell_line 0.9967017769813538
from O O 0.9998917579650879
TCR S-protein S-protein 0.9583473801612854
-mediated O O 0.9971033930778503
apoptosis O O 0.9993756413459778
. O O 0.9999985694885254
These O O 0.9999973773956299
data O O 0.9990317821502686
demonstrate O O 0.9999980926513672
a O O 0.9999978542327881
new O O 0.9976378679275513
antiapoptotic O O 0.9038258790969849
role O O 0.9860097169876099
for O O 0.9998055100440979
Notch-1 S-protein S-protein 0.9662588238716125
, O O 0.9991579055786133
providing O O 0.999974250793457
evidence O O 0.999984622001648
that O O 0.9999984502792358
, O O 0.9998302459716797
in O O 0.9999755620956421
addition O O 0.9997631907463074
to O O 0.9999297857284546

family E-protein E-protein 0.9234579801559448
. O O 0.999683141708374
Tissue-specific O O 0.7947448492050171
expression O O 0.9870822429656982
of O O 0.9999347925186157
the O O 0.9999862909317017
platelet B-DNA B-DNA 0.6658591032028198
GPIIb I-DNA I-DNA 0.843027651309967
gene E-DNA E-DNA 0.9965268969535828
. O O 0.9998806715011597
One O O 0.9999979734420776
of O O 0.9999992847442627
the O O 0.9999992847442627
major O O 0.9749647974967957
objectives O O 0.9968679547309875
in O O 0.9999982118606567
the O O 0.9999988079071045
study O O 0.9993420243263245
of O O 0.9999829530715942
thrombogenesis O O 0.965761125087738
is O O 0.9997536540031433
to O O 0.9999797344207764
determine O O 0.999997615814209
the O O 0.9999973773956299
mechanisms O O 0.999190628528595
by O O 0.9999986886978149
which O O 0.9999990463256836
a O O 0.9999822378158569
hematopoietic B-cell_type O 0.5212187170982361
progenitor E-cell_type O 0.408810555934906
is O O 0.988358199596405
activated O O 0.9934118390083313

precursor E-protein O 0.4033077657222748

for O O 0.9968423843383789
the O O 0.9999494552612305
GM-kappa B-DNA B-DNA 0.5465028882026672
B/GC-box I-DNA I-DNA 0.455830454826355
region E-DNA E-DNA 0.9210054874420166
, O O 0.9995459914207458
suggesting O O 0.9999955892562866
that O O 0.999998927116394
the O O 0.9998705387115479
GC-motif O S-DNA 0.8921182751655579
can O O 0.996975302696228
function O O 0.9999468326568604
independently O O 0.9999809265136719
of O O 0.9999959468841553
the O O 0.9999438524246216
GM-kappa B-DNA B-DNA 0.5806158781051636
B I-DNA I-DNA 0.631695568561554
motif E-DNA E-DNA 0.951637864112854
. O O 0.999962329864502
The O O 0.9999958276748657
major O B-protein 0.7330542206764221
GC-box S-DNA I-protein 0.25075337290763855
binding O I-protein 0.3345640003681183
activity O I-protein 0.41680556535720825
A1 S-protein E-protein 0.6097949147224426
was O O 0.992141842842102
purified O O 0.9986737966537476
and O O 0.9999439716339111
identified O O 0.9999017715454102
as O O 0.9999973773956299
the O O 0.9999767541885376
transcription B-protein B-protein 0.4948567748069763
factor I-protein E-protein 0.9627180099487305
Sp1 E-protein S-protein 0.8216294050216675
. O O 0.9999188184738159
We O O 0.9967859983444214

T I-cell_type B-cell_type 0.31977301836013794
lymphocytes E-cell_type E-cell_type 0.9675248861312866
in O O 0.999954104423523
patients O O 0.9992615580558777
with O O 0.9999639987945557
asthma O O 0.9975844621658325
. O O 0.9999969005584717
METHODS O O 0.9138121008872986
: O O 0.997864305973053
Allergen-specific B-cell_line B-cell_line 0.7434920072555542
T I-cell_line I-cell_line 0.5822852849960327
cell I-cell_line I-cell_line 0.5827507972717285
clones E-cell_line E-cell_line 0.997141420841217
and O O 0.9925092458724976
T B-cell_line B-cell_line 0.504730224609375
cell I-cell_line I-cell_line 0.4911684989929199
hybridomas E-cell_line E-cell_line 0.9147115349769592
were O O 0.9996265172958374
established O O 0.9999443292617798
from O O 0.9999982118606567
the O O 0.9999830722808838
peripheral B-cell_type B-cell_type 0.645772397518158
blood I-cell_type I-cell_type 0.7668333649635315
lymphocytes E-cell_type E-cell_type 0.9851978421211243
of O O 0.9996330738067627
patients O O 0.9994773268699646
with O O 0.9999741315841675
asthma O O 0.9965044260025024
, O O 0.9999576807022095
and O O 0.9999828338623047
the O O 0.9999948740005493
responses O O 0.9997361302375793
to O O 0.9999964237213135
various O O 0.9977670907974243
stimuli O O 0.9807327389717102
were O O 0.9999791383743286
determined O O 0.9999779462814331
. O O 0.9999885559082031
RESULTS O O 0.9972829818725586
: O O 0.9999823570251465
After O O 0.9999426603317261
nonspecific O O 0.9771355390548706
stimulation O O 0.9988246560096741
, O O 0.9999886751174927

suggesting O O 0.998871386051178
a O O 0.9999959468841553
pivotal O O 0.9947921633720398
role O O 0.9996505975723267
of O O 0.9999926090240479
RXR S-protein S-protein 0.9732639789581299
for O O 0.9994606375694275
erythroid O O 0.591533362865448
cell O O 0.5934969782829285
development O O 0.9853680729866028
. O O 0.999994158744812
Peripheral B-cell_type B-cell_type 0.5418292284011841
T I-cell_type I-cell_type 0.8907460570335388
lymphocytes E-cell_type E-cell_type 0.9949935078620911
from O O 0.9999513626098633
women O O 0.9979007244110107
with O O 0.9999712705612183
breast O O 0.982910692691803
cancer O O 0.9989051818847656
exhibit O O 0.9998645782470703
abnormal O O 0.9415339231491089
protein O O 0.7603615522384644
expression O O 0.9957488775253296
of O O 0.9999840259552002
several B-protein O 0.9967523813247681
signaling I-protein B-protein 0.48242318630218506
molecules E-protein E-protein 0.9872035384178162
. O O 0.999963641166687
We O O 0.9999500513076782
examined O O 0.9999740123748779
signaling O O 0.9763733148574829
molecules O O 0.7586550712585449
of O O 0.9999402761459351
peripheral B-cell_type B-cell_type 0.7229555249214172
blood I-cell_type I-cell_type 0.9211328625679016
T I-cell_type I-cell_type 0.9914109706878662
lymphocytes E-cell_type E-cell_type 0.9927391409873962
obtained O O 0.99951171875
from O O 0.9999979734420776
women O O 0.999092698097229
with O O 0.9999634027481079
breast O O 0.9861104488372803
cancer O O 0.9992610812187195

at O O 0.999448835849762
10 O O 0.9956434965133667
( O O 0.9999158382415771
-8 O O 0.999794065952301
) O O 0.9997625946998596
M O O 0.996468186378479
, O O 0.9999750852584839
reduced O O 0.9999755620956421
the O O 0.9999814033508301
D3 O O 0.40136435627937317
concentration O O 0.853804886341095
required O O 0.9998247027397156
for O O 0.9999936819076538
monocyte S-cell_type O 0.6121953129768372
differentiation O O 0.9953017234802246
to O O 0.9999393224716187
5 O O 0.9866793751716614

( O O 0.9673362970352173
an O O 0.99752277135849
Lck-defective B-cell_line B-cell_line 0.66102534532547
cell I-cell_line I-cell_line 0.8581308126449585
line E-cell_line E-cell_line 0.993302583694458
derived O O 0.9944873452186584
from O O 0.9998531341552734
Jurkat S-cell_line S-cell_line 0.9962044358253479
) O O 0.960622251033783
, O O 0.9993473887443542
and O O 0.9996922016143799
JCam/Lck S-cell_line S-cell_line 0.9509646892547607
( O O 0.9425840973854065
JCam B-cell_line B-cell_line 0.32311171293258667
cells E-cell_line E-cell_line 0.8962126970291138
with O O 0.9994317889213562
Lck S-protein S-protein 0.6287822723388672
restored O O 0.8746013045310974
) O O 0.9964227080345154
. O O 0.999992847442627
The O O 0.9999992847442627
results O O 0.9999897480010986
show O O 0.9999992847442627
that O O 0.9999982118606567
IFN-alpha S-protein S-protein 0.9956707954406738
can O O 0.9999125003814697
induce O O 0.9999673366546631
MAPK S-protein S-protein 0.996008038520813
activity O O 0.9987667798995972
, O O 0.9999772310256958
but O O 0.9999419450759888
only O O 0.9999580383300781
in O O 0.9988456964492798
cells O O 0.9698020219802856

controlled O O 0.9708123803138733
by O O 0.9999396800994873
NF-kappa B-protein B-protein 0.8988860845565796
B E-protein E-protein 0.989683985710144
. O O 0.999349057674408
Since O O 0.9999680519104004
HUVECs S-cell_line S-cell_line 0.5343936681747437
released O O 0.9753170013427734
superoxide O O 0.7690855264663696
anions O O 0.5459858775138855
in O O 0.9999898672103882
response O O 0.9997716546058655
to O O 0.9999935626983643
TNF O S-protein 0.6082526445388794

through O O 0.9992215633392334
the O O 0.9999794960021973
NRE B-DNA B-DNA 0.6939017176628113
gamma I-DNA I-DNA 0.48443785309791565
site E-DNA E-DNA 0.9911581873893738
. O O 0.9999444484710693
The O O 0.9999994039535522
ability O O 0.9999351501464844
of O O 0.9999934434890747
RFX1 S-protein S-protein 0.8899598121643066
to O O 0.9985560774803162
transactivate O O 0.9990704655647278
the O O 0.9998676776885986
core B-DNA B-DNA 0.6044740676879883
promoter E-DNA E-DNA 0.9685454368591309
raises O O 0.9997439980506897
the O O 0.9999926090240479
possibility O O 0.99981290102005
that O O 0.9999957084655762
RFX1 S-protein S-protein 0.7996476292610168
may O O 0.9995937943458557
play O O 0.9999823570251465
a O O 0.9999798536300659
dual O O 0.9904465675354004
role O O 0.9997437596321106
in O O 0.999984622001648
regulating O O 0.9913443326950073

Tumor B-protein B-protein 0.7202744483947754
necrosis I-protein I-protein 0.9335216879844666
factor E-protein E-protein 0.971897542476654
( O O 0.9818488359451294
TNF S-protein S-protein 0.9367896914482117
) O O 0.927114725112915
mediates O O 0.9993565678596497
a O O 0.9999874830245972
wide O O 0.9967235922813416
variety O O 0.9985153079032898
of O O 0.9999878406524658
disease O O 0.9734473824501038
states O O 0.9885070323944092
including O O 0.99998939037323
septic O O 0.9233084321022034
shock O O 0.9753750562667847
, O O 0.9990690350532532
acute O O 0.9523319005966187
and O O 0.9944326281547546
chronic O O 0.9959473013877869
inflammation O O 0.9995958209037781
, O O 0.9999798536300659
and O O 0.9999452829360962
cachexia O O 0.9845548272132874

of O O 0.9979954957962036
a O O 0.9999740123748779
murine B-protein B-protein 0.4339156448841095
transcription I-protein I-protein 0.711922824382782
factor E-protein E-protein 0.9954774975776672
, O O 0.9977149963378906
PEBP2 S-protein S-protein 0.9602632522583008
, O O 0.985528290271759
which O O 0.9997206330299377
is O O 0.9999575614929199
implicated O O 0.999932050704956
as O O 0.999990701675415
a O O 0.9997984766960144

mediated O O 0.9920071363449097
through O O 0.9999538660049438
Nef S-protein S-protein 0.9924606680870056
phosphorylation O O 0.9976277947425842
on O O 0.9999868869781494
Thr-15 O O 0.23995862901210785
or O O 0.9398074746131897
GTP-binding O O 0.4020078182220459
activity O O 0.9413691163063049
because O O 0.9999372959136963
mutations O O 0.9958682060241699
in O O 0.9999861717224121
critical O O 0.9754535555839539
sites O O 0.9321414828300476
did O O 0.9999873638153076
not O O 0.9999957084655762
alter O O 0.9999933242797852
this O O 0.9999815225601196
inhibition O O 0.99619460105896

evidence O O 0.9956921935081482
for O O 0.9999696016311646
gene O O 0.9351323246955872
topography O O 0.960231363773346
independent O O 0.9968730807304382
of O O 0.9998834133148193
cell O O 0.9431617856025696
type O O 0.9549242854118347
and O O 0.9984601736068726

its O O 0.998794436454773
association O O 0.9995676875114441
with O O 0.9999959468841553
p50 S-protein S-protein 0.9171442985534668
in O O 0.9969013929367065
vitro O O 0.9768805503845215
, O O 0.999630331993103
however O O 0.9999889135360718

Nef O B-DNA 0.6943289041519165
expression O I-DNA 0.8003216981887817
vector O E-DNA 0.9657344818115234
. O O 0.9999262094497681
Secretion O O 0.9932199716567993
of O O 0.999847412109375
IL-2 S-protein S-protein 0.9559532999992371
and O O 0.993025541305542
TNF-alpha S-protein S-protein 0.9682208299636841
, O O 0.9969375133514404
surface O O 0.9182975888252258
expression O O 0.9942893981933594
of O O 0.9999213218688965

was O O 0.9953352808952332
essential O O 0.9999157190322876
for O O 0.9999731779098511
DNA O O 0.9594337940216064
binding O O 0.9916103482246399
. O O 0.9999932050704956
The O O 0.9999986886978149
disruption O O 0.9996660947799683
of O O 0.9999923706054688
HIV-TF1-binding B-DNA B-DNA 0.505017101764679
site E-DNA E-DNA 0.9164398908615112
induced O O 0.9998925924301147
a O O 0.9999935626983643
60 O O 0.7426283359527588
% O O 0.9789334535598755
decrease O O 0.9995743632316589
in O O 0.9999972581863403
the O O 0.9999943971633911
level O O 0.9995404481887817
of O O 0.9999669790267944
transcription O O 0.9260289072990417
from O O 0.9999734163284302
the O O 0.999982476234436
HIV B-DNA B-DNA 0.8725607395172119
promoter E-DNA E-DNA 0.9936333894729614
in O O 0.9997046589851379
vivo O O 0.9977733492851257
. O O 0.9999969005584717
These O O 0.9999892711639404

mRNA E-RNA E-RNA 0.8742632865905762
in O O 0.9992479681968689
human B-cell_type B-cell_type 0.550922691822052
peripheral I-cell_type I-cell_type 0.8240345120429993
granurocytes E-cell_type E-cell_type 0.9683683514595032
. O O 0.9999455213546753
Transcription B-protein B-protein 0.6722819805145264
factor I-protein E-protein 0.9799546599388123
NF-E2 E-protein S-protein 0.6395235657691956
is O O 0.9999361038208008
crucial O O 0.9999489784240723
for O O 0.9999843835830688
regulation O O 0.9997096657752991
of O O 0.999994158744812
erythroid-specific O B-DNA 0.5737160444259644
gene O E-DNA 0.8822401165962219
expression O O 0.9869204759597778
. O O 0.999975323677063
p45 B-protein B-protein 0.6357159614562988
subunit E-protein E-protein 0.9953130483627319
of O O 0.9985275268554688
NF-E2 S-protein S-protein 0.9383570551872253
contains O O 0.9999052286148071
a O O 0.9999884366989136
basic-leucine B-protein B-protein 0.7097522616386414

maturation O O 0.982750415802002
into O O 0.9999697208404541
extravascular O O 0.7910923957824707
tissues O O 0.9018965363502502
. O O 0.9999942779541016
The O O 0.9999972581863403
mediator O O 0.6498161554336548
( O O 0.9299062490463257
s O O 0.8217557668685913
) O O 0.9557498693466187
of O O 0.9996147155761719
this O O 0.9999854564666748
maturation O O 0.8084535598754883
process O O 0.9742427468299866
has O O 0.999966025352478
not O O 0.9999542236328125
been O O 0.9999758005142212

stress-induced O O 0.9621160626411438
signaling O O 0.9890017509460449
pathways O O 0.9996647834777832
, O O 0.9999830722808838
as O O 0.9999879598617554
well O O 0.999943733215332
as O O 0.9999923706054688
for O O 0.9998769760131836
testing O O 0.9990153312683105
the O O 0.9999955892562866
effects O O 0.9999409914016724
of O O 0.9999949932098389
novel O O 0.8696376085281372
ventilatory O O 0.9190502166748047
strategies O O 0.9888606667518616
or O O 0.999932050704956
adjunctive O O 0.8456502556800842
substances O O 0.8477401733398438
aimed O O 0.9995293617248535
at O O 0.9999892711639404
modulating O O 0.9535233974456787
cell O O 0.9145421981811523
activation O O 0.9988952875137329
induced O O 0.9999841451644897
by O O 0.9999936819076538
mechanical O O 0.9481364488601685
ventilation O O 0.9980601668357849
. O O 0.9999980926513672
Signaling O O 0.9770373106002808
pathways O O 0.9971983432769775
mediated O O 0.9999622106552124
by O O 0.9999983310699463
the O O 0.9999226331710815

In O O 0.9997536540031433
the O O 0.9999988079071045
present O O 0.9986054301261902
study O O 0.9988025426864624
, O O 0.999915361404419
corticosteroid B-protein B-protein 0.5520319938659668
Type I-protein I-protein 0.6457615494728088
I I-protein I-protein 0.7252750396728516
and I-protein I-protein 0.6062385439872742
Type I-protein I-protein 0.8353762030601501
II I-protein I-protein 0.9597886204719543
receptors E-protein E-protein 0.9980478286743164
in O O 0.9998192191123962
mononuclear B-cell_type B-cell_type 0.883525013923645
leukocytes E-cell_type E-cell_type 0.9941196441650391
were O O 0.9999105930328369
measured O O 0.9997660517692566
in O O 0.9999926090240479
10 O O 0.9997343420982361
elderly O O 0.9921712875366211
subjects O O 0.999134361743927
and O O 0.9999948740005493
in O O 0.9999850988388062
9 O O 0.9983323216438293
young O O 0.9973106384277344
adults O O 0.9993877410888672
, O O 0.9999600648880005
before O O 0.9999834299087524
and O O 0.999956488609314
after O O 0.9999914169311523
overnight O O 0.9974468946456909
DST O O 0.8575078845024109
( O O 0.9998266100883484
1 O O 0.9996298551559448
mg O O 0.9976052045822144
) O O 0.9998356103897095
. O O 0.9999964237213135
Receptors O O 0.6774651408195496
were O O 0.9999094009399414
measured O O 0.9990143775939941
by O O 0.9999840259552002

by O O 0.9980972409248352
acting O O 0.9950651526451111
as O O 0.9999387264251709
cofactors O O 0.8523205518722534
for O O 0.9973897337913513
GATA3 S-protein S-protein 0.9866178631782532
. O O 0.9999489784240723
Previously O O 0.9998251795768738
, O O 0.9999879598617554
we O O 0.9999052286148071
have O O 0.9999963045120239
shown O O 0.9999959468841553
that O O 0.9999971389770508
TAL1 S-protein S-protein 0.8414750695228577
and O O 0.9951175451278687
the O O 0.9994526505470276
LIM-only B-DNA B-DNA 0.48200350999832153
protein I-DNA I-DNA 0.36908605694770813
gene E-DNA E-DNA 0.9790428876876831
( O O 0.9910613894462585
LMO S-DNA S-DNA 0.9186147451400757
) O O 0.9729321002960205
are O O 0.9999775886535645
regularly O O 0.9992297887802124
coactivated O O 0.9994706511497498
in O O 0.999948263168335
T-cell O O 0.2904299795627594
acute O O 0.6379028558731079
lymphoblastic O O 0.7361866235733032
leukemia O O 0.928378164768219
( O O 0.9978669285774231
T-ALL O O 0.991777777671814
) O O 0.9997431635856628
. O O 0.999998927116394
This O O 0.9999983310699463
observation O O 0.9997114539146423
is O O 0.999996542930603
likely O O 0.9999799728393555
to O O 0.9999977350234985
relate O O 0.999990701675415
to O O 0.9999990463256836
the O O 0.9999979734420776
findings O O 0.9997965693473816
that O O 0.9999986886978149

presentation O O 0.9855418801307678
by O O 0.9999860525131226
human B-cell_type B-cell_type 0.46951329708099365
intestinal I-cell_type I-cell_type 0.629041850566864
epithelial I-cell_type I-cell_type 0.8657246828079224
cells E-cell_type E-cell_type 0.9063383936882019
. O O 0.9999752044677734
The O O 0.9999979734420776
high O O 0.9517304301261902
concentration O O 0.9932841062545776
of O O 0.999881386756897

cortisol O O 0.8348535299301147
inhibition O O 0.9975111484527588
to O O 0.9999831914901733
IFN B-protein B-protein 0.36652281880378723
alpha E-protein E-protein 0.9904227256774902
production O O 0.9985221028327942
. O O 0.9999969005584717
Therefore O O 0.9999825954437256
, O O 0.9999959468841553
we O O 0.9999641180038452
examined O O 0.999890923500061
glucocorticoid B-protein B-protein 0.6937841773033142
receptor E-protein E-protein 0.9825069308280945
characteristics O O 0.9786379933357239
on O O 0.9999504089355469
monocytes S-cell_type S-cell_type 0.9982423782348633
by O O 0.9998695850372314
[ O O 0.9970963001251221
3H O O 0.9787318706512451
] O O 0.9944932460784912
dexamethasone O O 0.9827806949615479
binding O O 0.9926217794418335
and O O 0.9999326467514038
measured O O 0.9609599709510803
IFN B-protein B-protein 0.7069144248962402
alpha E-protein E-protein 0.9815007448196411
, O O 0.9948315620422363
cortisol O O 0.6168893575668335
, O O 0.9622176885604858
and O O 0.9976716637611389
ACTH O O 0.7912453413009644
in O O 0.9999692440032959
AIDS O O 0.9249417185783386
patients O O 0.9933304190635681
with O O 0.9998824596405029
( O O 0.9997320771217346
AIDS-GR O O 0.9135575890541077
) O O 0.9988861680030823
or O O 0.9999240636825562
without O O 0.9999308586120605
glucocorticoid O O 0.6237791180610657

CACCC I-DNA B-DNA 0.5130794048309326
sites E-DNA E-DNA 0.9970235228538513
in O O 0.9999719858169556
the O O 0.9998809099197388
H5 B-DNA B-DNA 0.6555740833282471
promoter I-DNA E-DNA 0.9725668430328369
and I-DNA O 0.9674978852272034
enhancer E-DNA O 0.4464832544326782
. O O 0.9997454285621643
In O O 0.9999778270721436
contrast O O 0.9999921321868896
, O O 0.9999953508377075
the O O 0.9999898672103882
binding O O 0.9108133316040039
activities O O 0.9945957064628601
of O O 0.999971866607666
NF1 S-protein S-protein 0.9839556813240051
and O O 0.9940872192382812
Sp1 S-protein S-protein 0.9883636236190796
were O O 0.9998286962509155
not O O 0.9997857213020325
affected O O 0.9999494552612305
by O O 0.9999946355819702
ER S-protein S-protein 0.9479141235351562
. O O 0.9999374151229858
Binding O O 0.9878103733062744
of O O 0.9996851682662964
ER S-protein S-protein 0.9641662836074829
to O O 0.9998923540115356
an O O 0.9999650716781616
estrogen B-DNA B-DNA 0.5404542088508606
response I-DNA I-DNA 0.8314895033836365
element E-DNA E-DNA 0.9810532927513123
was O O 0.9995050430297852
enhanced O O 0.999685525894165
by O O 0.999997615814209
addition O O 0.9996565580368042
of O O 0.9999921321868896
rabbit O O 0.32168012857437134

bisacetamide O O 0.5325046181678772
( O O 0.9886646270751953
HMBA O O 0.7449454069137573
) O O 0.9821569323539734
, O O 0.9995856881141663
but O O 0.9999252557754517
not O O 0.9992741942405701
tumor B-protein B-protein 0.744985818862915
necrosis I-protein I-protein 0.923943817615509
factor I-protein I-protein 0.5888156294822693
alpha E-protein E-protein 0.9978728294372559
( O O 0.9959139227867126
TNF-alpha S-protein S-protein 0.9961907863616943
) O O 0.9920573830604553
, O O 0.9999511241912842
confirming O O 0.9999912977218628
the O O 0.9999990463256836
role O O 0.9996395111083984
of O O 0.9999768733978271
NF-kappa B-protein B-protein 0.9534216523170471
B E-protein E-protein 0.9972827434539795
in O O 0.9998377561569214
mediating O O 0.9598827362060547
TNF-alpha S-protein S-protein 0.9843942523002625
induction O O 0.999092698097229

B S-protein I-protein 0.4158799350261688
, O I-protein 0.44096097350120544
and O I-protein 0.703183114528656
C S-protein E-protein 0.6456282734870911
, O O 0.751039981842041
all O O 0.9236022233963013
of O O 0.9990342855453491
which O O 0.9999637603759766
are O O 0.999992847442627
necessary O O 0.9999810457229614
for O O 0.9999926090240479

transcription O O 0.8908377289772034
of O O 0.9997925162315369
the O O 0.999988317489624
ubiquitously B-DNA O 0.6533531546592712
expressed I-DNA O 0.9392271041870117
histone I-DNA B-DNA 0.3500854969024658
H2B I-DNA I-DNA 0.45546793937683105
promoter E-DNA E-DNA 0.9971309304237366
and O O 0.9987607002258301
the O O 0.9999891519546509
transcription O O 0.8860854506492615
of O O 0.9976842403411865
USF- B-DNA B-DNA 0.5396323800086975
and I-DNA I-DNA 0.6764883995056152
Sp1-regulated I-DNA I-DNA 0.9024615287780762
promoters E-DNA E-DNA 0.992457389831543
. O O 0.9996917247772217
Taken O O 0.9999932050704956
together O O 0.999944806098938
, O O 0.999997615814209
our O O 0.9999946355819702
results O O 0.9999769926071167
suggest O O 0.999998927116394
that O O 0.999997615814209
OCA-B S-protein S-protein 0.9768059253692627
is O O 0.9998863935470581
a O O 0.9999924898147583
tissue- B-protein O 0.5552784204483032

numbers O O 0.9842917919158936
of O O 0.9999803304672241
Type B-protein B-protein 0.9452159404754639
I E-protein E-protein 0.8091127872467041
and O O 0.9211785197257996
of O O 0.7473905086517334
Type B-protein B-protein 0.41495177149772644
II I-protein I-protein 0.9105368256568909
receptors E-protein E-protein 0.996039867401123
are O O 0.999927282333374
lower O O 0.9996013045310974
and O O 0.9998801946640015
plasma O O 0.8243278861045837
cortisol O O 0.9247127771377563
is O O 0.9998288154602051
higher O O 0.9999829530715942
than O O 0.9999959468841553
in O O 0.9998767375946045
adult O O 0.7105898857116699
controls O O 0.910058319568634
, O O 0.9997023940086365
but O O 0.9999918937683105
the O O 0.9999990463256836
increase O O 0.9999426603317261
of O O 0.9999945163726807
plasma O O 0.7108345627784729
cortisol O O 0.8874724507331848
is O O 0.9998801946640015

. O O 0.9991610050201416
A O O 0.9998352527618408
total O O 0.9963156580924988
of O O 0.9999479055404663
27 O O 0.9767264127731323
combinations O O 0.9712320566177368
of O O 0.9999743700027466
different O O 0.9968950748443604
promoters S-DNA S-DNA 0.798179030418396

Egr-1 S-protein S-protein 0.6609907150268555
expression O O 0.9701475501060486
is O O 0.9999096393585205
abrogated O O 0.9994283318519592
in O O 0.9999136924743652
group B-cell_line B-cell_line 0.600507378578186
I I-cell_line I-cell_line 0.6934571266174316
Burkitt I-cell_line I-cell_line 0.8949848413467407
tumor I-cell_line I-cell_line 0.9608966112136841
cells E-cell_line E-cell_line 0.9926972985267639
, O O 0.9979968667030334
irrespective O O 0.9999827146530151
of O O 0.9999977350234985
the O O 0.9999958276748657
EBV B-DNA B-DNA 0.6168509125709534
genome E-DNA E-DNA 0.9340473413467407
carrying O O 0.9799842238426208
status O O 0.9957399368286133
. O O 0.9999978542327881
Activated O O 0.8936192989349365
viral O B-DNA 0.545426607131958
gene O E-DNA 0.8964313268661499
expression O O 0.9895802140235901
associated O O 0.9996609687805176
with O O 0.9999942779541016

murine B-DNA B-DNA 0.7269460558891296
leukemia I-DNA I-DNA 0.6667879223823547
virus I-DNA I-DNA 0.6444668173789978
enhancer I-DNA I-DNA 0.2674388587474823
cores E-DNA E-DNA 0.9579573273658752
. O O 0.9999027252197266
Core B-protein B-protein 0.4693959951400757
binding I-protein I-protein 0.6715991497039795
factor E-protein E-protein 0.9740159511566162
( O O 0.9754934906959534
CBF S-protein S-protein 0.991961658000946
) O O 0.9900569319725037
, O O 0.9997938275337219
also O O 0.9999572038650513
known O O 0.9999889135360718
as O O 0.9999064207077026
polyomavirus B-protein B-DNA 0.615472137928009
enhancer-binding I-protein I-DNA 0.7505224347114563
protein I-protein I-DNA 0.443461149930954
2 E-protein I-DNA 0.9545495510101318
and O I-DNA 0.9318329691886902
SL3 B-protein I-DNA 0.4765590727329254
enhancer I-protein E-DNA 0.7870264649391174

oncoproteins O S-protein 0.68243807554245
, O O 0.9943444728851318
cell O O 0.9708943963050842
transformation O O 0.9978081583976746
, O O 0.9999701976776123
or O O 0.9999051094055176
phorbol O O 0.9491912722587585
ester O O 0.9696028232574463
treatment O O 0.9948064684867859
of O O 0.9998594522476196
cells O O 0.9753789305686951
can O O 0.9999887943267822
inhibit O O 0.9998263716697693
alpha/beta O B-protein 0.6063742637634277
interferon O E-protein 0.8832522630691528
( O O 0.9472155570983887
IFN-alpha/beta O S-protein 0.9404705762863159
) O O 0.8839815258979797
-induced O O 0.9837504029273987
gene O O 0.7669162154197693
expression O O 0.9999290704727173
. O O 0.9999995231628418
The O O 0.9999959468841553

, O O 0.9931714534759521
we O O 0.9999744892120361
have O O 0.9999966621398926
studied O O 0.9999059438705444
their O O 0.9999942779541016
pattern O O 0.9982736110687256
of O O 0.9998871088027954
expression O O 0.9993852376937866
in O O 0.9999868869781494
mouse O O 0.37088796496391296
hematopoietic O O 0.5375244617462158
tissues O O 0.44190701842308044
in O O 0.9998637437820435
the O O 0.9999933242797852
adult O O 0.9085440635681152
and O O 0.9894140958786011
during O O 0.9996916055679321
ontogeny O O 0.9322251081466675
using O O 0.9998383522033691
an O O 0.9999735355377197
anti-runt O O 0.677359402179718
box O O 0.536537230014801
antiserum O O 0.6329265832901001
. O O 0.9990882873535156
In O O 0.999987006187439
the O O 0.9999973773956299
adult O O 0.8938164710998535
bone O O 0.8616119027137756
marrow O O 0.9002741575241089
, O O 0.999738872051239
we O O 0.9999700784683228
found O O 0.999967098236084
expression O O 0.9997947812080383
of O O 0.9999903440475464

as O O 0.9992232322692871
decreased O O 0.9993575215339661
NF-kappaB S-protein S-protein 0.9990493655204773
activity O O 0.9993867874145508
as O O 0.9999982118606567
compared O O 0.9997486472129822
with O O 0.9999881982803345
controls O O 0.9969298243522644
. O O 0.9999977350234985
These O O 0.9999979734420776
results O O 0.9999767541885376
demonstrate O O 0.9999991655349731
that O O 0.9999985694885254
TIMP-1 S-protein S-protein 0.9438942074775696

markedly O O 0.9972038269042969
increased O O 0.9996446371078491
IL-2 S-protein S-protein 0.9826005101203918
production O O 0.9993857145309448
in O O 0.9999923706054688
both O O 0.9996883869171143
cell O O 0.9467713236808777
types O O 0.8118871450424194
, O O 0.9998732805252075
but O O 0.9999085664749146
levels O O 0.9998457431793213
of O O 0.9999876022338867
IL-2 S-protein S-protein 0.9940446019172668
in O O 0.9999146461486816
neonatal B-cell_type B-cell_type 0.8427950739860535
T I-cell_type I-cell_type 0.9573203921318054
cells E-cell_type E-cell_type 0.9823563694953918
remained O O 0.9991270899772644
clearly O O 0.9995539784431458
lower O O 0.9999856948852539
than O O 0.9999886751174927
those O O 0.9999873638153076
of O O 0.9999605417251587
adult B-cell_type B-cell_type 0.6333337426185608
T I-cell_type I-cell_type 0.8737289905548096
cells E-cell_type E-cell_type 0.9874635934829712
( O O 0.9951499104499817
respective O O 0.9973395466804504
mean O O 0.9974883794784546
values O O 0.9973711967468262
: O O 0.999968409538269
385 O O 0.997008740901947
+/- O O 0.9999268054962158

the O O 0.9980031847953796
foundation O O 0.9959789514541626
for O O 0.9998342990875244
determining O O 0.9999066591262817
the O O 0.9999946355819702
regulation O O 0.9998811483383179
of O O 0.9999971389770508
this O O 0.9999295473098755
promoter S-DNA S-DNA 0.8232587575912476
in O O 0.9996790885925293
other O O 0.9989057779312134
leukocyte B-cell_type B-cell_type 0.47953447699546814
lineages E-cell_type E-cell_type 0.9610430002212524
. O O 0.9999384880065918
Regulation O O 0.9980467557907104
of O O 0.9999626874923706
B-cell O O 0.5112109780311584
commitment O O 0.8745419979095459
to O O 0.999208390712738
plasma B-cell_type B-cell_type 0.7694107294082642
cells E-cell_type E-cell_type 0.9897370934486389
or O O 0.9972142577171326
to O O 0.9995532631874084
memory B-cell_type B-cell_type 0.866125226020813
B I-cell_type I-cell_type 0.9585994482040405
cells E-cell_type E-cell_type 0.989173173904419
. O O 0.9998860359191895
During O O 0.9999877214431763
humoral O O 0.9416325688362122
immune O O 0.9791560173034668
responses O O 0.9994000196456909

necrosis I-protein I-protein 0.4865367114543915
factor I-protein I-protein 0.8542130589485168
( I-protein I-protein 0.8512430787086487
TNF I-protein I-protein 0.4526429772377014
) I-protein I-protein 0.7225897312164307
-alpha E-protein E-protein 0.998173713684082
controls O O 0.9975571632385254
T-cell O O 0.5474218130111694
activation O O 0.9742833375930786
and O O 0.999665379524231

Crohn O O 0.8279359340667725
's O O 0.9703839421272278
disease O O 0.9960753321647644
( O O 0.9999278783798218
CD O O 0.9766927361488342
) O O 0.9983976483345032
treated O O 0.9998183846473694
with O O 0.9999940395355225
steroids O O 0.995345413684845
( O O 0.999951958656311
66.6 O O 0.9705225825309753
+/- O O 0.9992190599441528
61.0 O O 0.9951637983322144
dpm O O 0.9987480640411377
mg-1 O O 0.9885590672492981
cytosol B-protein O 0.8842753171920776
protein E-protein O 0.8428595066070557
) O O 0.9966126084327698
were O O 0.9999953508377075
not O O 0.9999784231185913

of O O 0.9972930550575256
the O O 0.9999774694442749
DNase B-protein B-DNA 0.6827252507209778
I E-protein E-DNA 0.8691845536231995
as O O 0.9953126907348633
an O O 0.9998676776885986
in O O 0.9900773763656616
vivo O O 0.9880736470222473
footprinting O O 0.9612417817115784
agent O O 0.9976550340652466
reveals O O 0.9999843835830688
that O O 0.9999967813491821

be O O 0.9982486963272095
specifically O O 0.9994208812713623
induced O O 0.9999711513519287
by O O 0.999993085861206
ligands O O 0.9627884030342102
of O O 0.9996888637542725
the O O 0.9999758005142212
CDR2-loop S-protein S-protein 0.8095034956932068
in O O 0.9929373860359192
domain B-protein O 0.7933404445648193
1 E-protein O 0.7562025785446167
( O O 0.9709655046463013
D1 S-protein O 0.34193122386932373
) O O 0.5960114002227783
of O O 0.997142493724823
CD4 S-protein S-protein 0.8720545172691345
( O O 0.9757634401321411
virus B-protein B-protein 0.44589459896087646
envelope I-protein E-protein 0.599388599395752
and I-protein O 0.8359357714653015
anti-CD4 I-protein B-protein 0.5741166472434998

human B-cell_type B-cell_type 0.5824809670448303
monocytes E-cell_type E-cell_type 0.9891873002052307
. O O 0.9998971223831177
Both O O 0.999991774559021
normal B-cell_type O 0.7772721648216248
and I-cell_type O 0.9516099095344543
malignant I-cell_type B-cell_type 0.48626458644866943
cells E-cell_type E-cell_type 0.8219418525695801
contain O O 0.9997391104698181
gangliosides O O 0.7190629243850708
as O O 0.9998979568481445
important O O 0.9912631511688232
cell O O 0.9545400738716125
membrane O O 0.9325822591781616
constituents O O 0.9377126097679138
that O O 0.9999964237213135
, O O 0.9999604225158691

antibodies E-protein E-protein 0.9006118774414062
and O O 0.998245358467102
in O O 0.9997430443763733
human B-cell_type B-cell_type 0.6124340891838074
T I-cell_type I-cell_type 0.8630744218826294
lymphocytes E-cell_type E-cell_type 0.9748559594154358
stimulated O O 0.9985696077346802
with O O 0.9999690055847168
phytohemagglutinin S-protein S-protein 0.9318483471870422
. O O 0.999919056892395
BCL-6 B-RNA B-RNA 0.905426025390625
mRNA E-RNA E-RNA 0.9964812994003296
levels O O 0.997490406036377
began O O 0.9999508857727051
to O O 0.9999758005142212
decrease O O 0.9999960660934448
8 O O 0.9992607235908508
to O O 0.9999403953552246
16 O O 0.9998841285705566
hours O O 0.9999755620956421
after O O 0.9999836683273315
stimulation O O 0.9986214637756348
, O O 0.9999927282333374
before O O 0.9999580383300781
cells O O 0.9790665507316589
entered O O 0.9998465776443481
S O O 0.9139078259468079
phase O O 0.9735444188117981
. O O 0.9999651908874512

cells E-cell_line E-cell_type 0.6009002327919006
positively O O 0.9921566247940063
stained O O 0.9981521964073181
for O O 0.9998906850814819
hemoglobin S-protein S-protein 0.9312362670898438
( O O 0.9773941040039062
Hb S-protein S-protein 0.7119253873825073
) O O 0.7048850059509277
after O O 0.9999589920043945
a O O 0.9999967813491821
7-day O O 0.9587207436561584
exposure O O 0.9986664056777954
to O O 0.9999874830245972
TPO S-protein S-protein 0.7996450066566467
. O O 0.9999414682388306
More O O 0.9999914169311523
than O O 0.9999927282333374
50 O O 0.9992625117301941
% O O 0.9994046688079834
of O O 0.9999926090240479
TPO-treated B-cell_line B-cell_line 0.8127646446228027
UT-7/GMT I-cell_line I-cell_line 0.7890928983688354
cells E-cell_line E-cell_line 0.997351884841919
positively O O 0.9964272379875183
stained O O 0.9989295601844788
for O O 0.99991774559021
Hb S-protein S-protein 0.8839734792709351
. O O 0.9996228218078613
Using O O 0.9998290538787842
UT-7/GMT B-cell_line B-cell_line 0.795002281665802
cells E-cell_line E-cell_line 0.9780477285385132
, O O 0.9983226656913757

Exogenous O O 0.9287922382354736
provision O O 0.9986323714256287
of O O 0.9999914169311523
NFkB S-protein S-protein 0.892400860786438
rescued O O 0.9933257102966309
IL2R S-protein B-protein 0.3693821430206299
alpha O E-protein 0.9734960794448853
expression O O 0.9967057108879089
but O O 0.9999488592147827
not O O 0.9999121427536011
the O O 0.9999727010726929
PTHrP B-DNA B-DNA 0.6438033580780029
promoter E-DNA E-DNA 0.998569130897522
. O O 0.9998795986175537
Thus O O 0.9993842840194702
, O O 0.9998605251312256
HTLV-I B-protein B-protein 0.4451538026332855
Tax E-protein E-protein 0.9065108299255371
, O O 0.9907220602035522
HTLV-II B-protein B-protein 0.49068450927734375
Tax E-protein E-protein 0.912584662437439
, O O 0.9611165523529053
and O O 0.9988858103752136
c-jun S-protein S-protein 0.5127766132354736
transactivate O O 0.8774620890617371
PTHrP S-protein S-protein 0.8029135465621948
and O O 0.9781944155693054
may O O 0.9995512366294861
contribute O O 0.9999980926513672
to O O 0.9999979734420776
the O O 0.9999957084655762
pathogenesis O O 0.9848191738128662

maturation O O 0.976791262626648
and O O 0.9993496537208557
function O O 0.9997145533561707
of O O 0.9999921321868896
the O O 0.9999898672103882
immune O O 0.84377121925354
system O O 0.9499807953834534
as O O 0.9998179078102112
well O O 0.9998643398284912
as O O 0.9999936819076538
differentiation O O 0.995630145072937
of O O 0.9999241828918457
skeletal O O 0.6835840344429016
muscle O O 0.876491367816925
. O O 0.9999542236328125
Here O O 0.9999910593032837
we O O 0.9999966621398926
examine O O 0.9999645948410034
molecular O O 0.8032797574996948

binding O O 0.8139826655387878
was O O 0.9988263249397278
associated O O 0.999872088432312
with O O 0.9999964237213135
incorporation O O 0.9977230429649353
of O O 0.9999501705169678
FKBP51 S-protein S-protein 0.9589345455169678
into O O 0.9996269941329956
GR B-protein B-protein 0.27028459310531616
heterocomplexes E-protein E-protein 0.9220925569534302
; O O 0.9988184571266174
the O O 0.9999979734420776
effect O O 0.9999334812164307
of O O 0.9999953508377075
SML S-cell_type O 0.4592335522174835
cytosol O O 0.5005735158920288
on O O 0.9982295632362366
GR O S-protein 0.6391340494155884
binding O O 0.870120644569397
was O O 0.999660849571228
reproduced O O 0.9997972846031189
with O O 0.9999897480010986
cytosol O O 0.7930364608764648
from O O 0.9992343187332153
COS B-cell_line B-cell_line 0.5134334564208984
cells E-cell_line E-cell_line 0.9517006278038025
expressing O O 0.9947068095207214
squirrel O O 0.8548069596290588
monkey O O 0.7028908133506775
FKBP51 S-protein S-protein 0.46776503324508667
; O O 0.9553719162940979
and O O 0.997077226638794
both O O 0.9999803304672241
the O O 0.9999969005584717
effect O O 0.9999414682388306
of O O 0.9999935626983643
SML S-cell_type O 0.48994243144989014

inducibility O O 0.9677257537841797
of O O 0.9997103810310364
IL-2 S-protein S-protein 0.9612109661102295
expression O O 0.9989601373672485
. O O 0.999997615814209
Electrophoretic O O 0.962478756904602
mobility O O 0.9930649399757385
shift O O 0.9994533658027649
assays O O 0.9998730421066284
( O O 0.9999752044677734
EMSA O O 0.9957354068756104
) O O 0.9999322891235352
showed O O 0.9999996423721313
that O O 0.9999996423721313
specific O O 0.9817537665367126
NFAT S-protein S-protein 0.9270291328430176
binding O O 0.9640147089958191
activity O O 0.9978556036949158
could O O 0.9999946355819702
also O O 0.9999978542327881
be O O 0.9999924898147583
induced O O 0.9998177886009216
in O O 0.9999605417251587
human B-cell_type B-cell_type 0.5772572159767151
B I-cell_type I-cell_type 0.8211774826049805
cells E-cell_type E-cell_type 0.9822117686271667
. O O 0.9999507665634155
The O O 0.9999889135360718
B B-protein B-cell_line 0.4284960627555847
cell I-protein I-cell_line 0.589606761932373
NFAT I-protein I-cell_line 0.36345866322517395

suggest O O 0.9982328414916992

correlation O O 0.9796965718269348
is O O 0.9999973773956299
inverse O O 0.9995831847190857
between O O 0.9994408488273621
plasma O O 0.9115437269210815
cortisol O O 0.9577460885047913
at O O 0.9999783039093018
8 O O 0.9995800852775574
a.m. O O 0.9999212026596069
and O O 0.9999685287475586
Type B-protein B-protein 0.8122289776802063
II I-protein I-protein 0.47905829548835754
receptors E-protein E-protein 0.9904688000679016

responsible O O 0.9940930008888245
for O O 0.9998503923416138
mediating O O 0.9880077838897705
transcription O O 0.9762440919876099
by O O 0.9999738931655884
a O O 0.9999887943267822
subset O O 0.9796169400215149
of O O 0.9996904134750366
activators O O 0.3616829812526703
in O O 0.9966086149215698
B B-cell_type B-cell_type 0.8222731947898865
cells E-cell_type E-cell_type 0.9917814135551453
. O O 0.9997929930686951
Interstitial O O 0.9010621905326843
deletion O O 0.8513866662979126
constitutes O O 0.9999897480010986
the O O 0.9999973773956299
major O O 0.9489099979400635
mechanism O O 0.9955009818077087
for O O 0.9999725818634033

PMA O O 0.7705122232437134
) O O 0.9905339479446411
and O O 0.999893307685852
cytokine-induced O O 0.9000140428543091
human O O 0.9452874064445496
immunodeficiency O O 0.983775794506073
virus O O 0.9919657707214355
type O O 0.9954957962036133
1 O O 0.9957689046859741
( O O 0.9997475743293762
HIV-1 O O 0.991389811038971
) O O 0.9994159936904907
replication O O 0.9993495345115662
in O O 0.99998939037323
chronically O B-cell_line 0.5228061079978943
infected O I-cell_line 0.49459224939346313
cell O I-cell_line 0.8383046984672546
lines O E-cell_line 0.9986306428909302
. O O 0.9999227523803711
Treatment O O 0.9987013339996338

to O O 0.9973301887512207
control O O 0.9983658194541931
transcription O O 0.9437552094459534
of O O 0.9997116923332214
a O O 0.9999535083770752
number O O 0.9932283759117126
of O O 0.9998385906219482
genes O O 0.5462082028388977
, O O 0.9967489242553711
including O O 0.9998693466186523
human B-DNA B-DNA 0.5521126985549927
immunodeficiency I-DNA I-DNA 0.662553071975708
virus I-DNA I-DNA 0.9199733734130859
( I-DNA I-DNA 0.8345973491668701
HIV I-DNA I-DNA 0.9788234233856201
) I-DNA I-DNA 0.9687283039093018
genes E-DNA E-DNA 0.9977594614028931
. O O 0.9999675750732422
In O O 0.9995664954185486
T B-cell_type B-cell_type 0.8107320666313171
cells E-cell_type E-cell_type 0.9883396625518799
, O O 0.999481737613678
NF-kappa B-protein B-protein 0.8813143372535706
B E-protein E-protein 0.9982925057411194
is O O 0.9996521472930908
activated O O 0.9843264222145081
upon O O 0.9997062087059021
cellular O O 0.8787537813186646

marked O O 0.9771438241004944
activation O O 0.9947355389595032
of O O 0.99989914894104
gamma-promoter S-DNA O 0.33262741565704346
activity O O 0.9523115754127502
was O O 0.9998941421508789
also O O 0.9999902248382568
observed O O 0.9999803304672241
with O O 0.999997615814209
this O O 0.9999836683273315
mutation O O 0.9965144991874695
, O O 0.9999934434890747
suggesting O O 0.9999978542327881
the O O 0.9999985694885254
presence O O 0.9992579817771912
of O O 0.9999856948852539
a O O 0.999980092048645
repressor O O 0.7420447468757629
. O O 0.9998947381973267
Fine O O 0.9341572523117065
mutagenesis O O 0.9649500250816345
dissected O O 0.9998778104782104
these O O 0.9999538660049438
activities O O 0.9958842396736145
to O O 0.9999805688858032
different O O 0.9994801878929138
regions O O 0.9817627668380737
of O O 0.9998055100440979
the O O 0.9993624091148376
5'-UTR S-DNA S-DNA 0.8721091151237488
. O O 0.9996650218963623
The O O 0.9999964237213135
stage O O 0.9055370092391968
selector O O 0.5282896757125854
activity O O 0.9788574576377869
was O O 0.9999860525131226
localized O O 0.9998923540115356
to O O 0.9999963045120239
a O O 0.9999903440475464
region O O 0.9854732155799866
centered O O 0.9999071359634399
on O O 0.9998664855957031
nucleotides B-DNA O 0.7396314740180969
+13 I-DNA O 0.597168505191803

GM3 O S-DNA 0.486558198928833
, O O 0.9440135359764099
was O O 0.9998407363891602
targeted O O 0.999946117401123
to O O 0.9999961853027344
a O O 0.9999465942382812
purine-rich B-DNA B-DNA 0.5813949108123779
region E-DNA E-DNA 0.8523882031440735
in O O 0.9998598098754883
the O O 0.9999728202819824
GM-CSF B-DNA B-DNA 0.8061975240707397
proximal I-DNA I-DNA 0.9475615620613098
promoter E-DNA E-DNA 0.9770150184631348
, O O 0.8069137930870056
which O O 0.9998457431793213
overlaps O O 0.9999163150787354
the O O 0.999937891960144
kappaB B-DNA B-DNA 0.6897279620170593
element E-DNA E-DNA 0.9926320314407349
. O O 0.9997504353523254
Gel O O 0.9291050434112549
mobility O O 0.9882870316505432
shift O O 0.9971219897270203
assays O O 0.9989125728607178
and O O 0.9999735355377197
DNase B-protein B-protein 0.49739280343055725
I E-protein E-protein 0.9222316741943359
footprinting O O 0.9818091988563538
demonstrated O O 0.9999760389328003
that O O 0.9999992847442627
GM3 O O 0.3671691119670868

as O O 0.9979385733604431
human O O 0.6166783571243286
partners O O 0.41316545009613037
, O O 0.9944769740104675
respectively O O 0.9997761845588684
, O O 0.9999456405639648
in O O 0.9999390840530396
three O O 0.9989709854125977
independent O O 0.968244194984436
fusions O O 0.7880797982215881
. O O 0.9999825954437256
Irrespective O O 0.9999741315841675
of O O 0.9999946355819702
the O O 0.9999929666519165
human O O 0.34488463401794434
cell O O 0.39567479491233826
partner O O 0.4149172306060791
used O O 0.8484501242637634
for O O 0.9954671859741211
fusion O O 0.9483240246772766
, O O 0.9999350309371948
a O O 0.9999903440475464
certain O O 0.999853253364563
number O O 0.9991722106933594
of O O 0.9999709129333496
hybrids S-cell_line O 0.6445904970169067

5b E-protein O 0.2681671380996704
, O O 0.7462689280509949
but O O 0.9912172555923462
failed O O 0.9978405237197876
to O O 0.9999003410339355
induce O O 0.9999085664749146
reporter B-DNA O 0.7521525621414185
gene E-DNA O 0.8826848864555359
transcription O O 0.9505670666694641
. O O 0.9999927282333374
These O O 0.9999978542327881
biochemical O O 0.9513232111930847
findings O O 0.9963569045066833
correlate O O 0.9999849796295166
perfectly O O 0.999700665473938
with O O 0.9999988079071045
the O O 0.9999942779541016
selective O O 0.9949896931648254
ability O O 0.9998980760574341
of O O 0.999990701675415
c-ErbB S-protein S-protein 0.9629212617874146
to O O 0.999154806137085
cause O O 0.9999806880950928
sustained O O 0.9959514141082764
self O O 0.9811345338821411
renewal O O 0.9987751841545105
in O O 0.9999693632125854
erythroid B-cell_type B-cell_type 0.8907569050788879
progenitors E-cell_type E-cell_type 0.9969472289085388
. O O 0.9999303817749023
Defective O O 0.9640964269638062
transcription O O 0.9096387028694153
of O O 0.9981499910354614
the O O 0.9998595714569092

found O O 0.9976115226745605
that O O 0.9999935626983643
they O O 0.9998465776443481
acted O O 0.99965500831604
as O O 0.999996542930603
a O O 0.9999819993972778
repressor O O 0.9289703965187073
of O O 0.9977109432220459
basal O O 0.8680292963981628
level O O 0.9789971113204956
expression O O 0.9993754029273987
when O O 0.999998927116394
cloned O O 0.889351487159729
upstream O O 0.5967091917991638
of O O 0.9963790774345398
a O O 0.9999030828475952
heterologous B-DNA B-DNA 0.7403221726417542
promoter E-DNA E-DNA 0.9741948843002319
but O O 0.9951878786087036
were O O 0.9999874830245972
also O O 0.9999923706054688
inducible O O 0.9998397827148438
by O O 0.9999977350234985
PMA O O 0.8807560801506042
/PHA S-protein O 0.43391549587249756
. O O 0.999984860420227
Expression O O 0.9998834133148193
of O O 0.9999983310699463
the O O 0.9999895095825195
Runt B-DNA B-DNA 0.483835369348526
domain-encoding I-DNA I-DNA 0.5387300252914429
PEBP2 I-DNA I-DNA 0.5163671374320984
alpha I-DNA I-DNA 0.5999903082847595
genes E-DNA E-DNA 0.9817320704460144

; O O 0.9685691595077515
P O O 0.9752512574195862
= O O 0.998817503452301
0.00005 O O 0.9988195300102234
) O O 0.9998747110366821
when O O 0.9999967813491821
compared O O 0.999896764755249
with O O 0.9999957084655762
tumors O O 0.9017124176025391
with O O 0.9998942613601685
low O O 0.9958263039588928
Ki-67 S-protein O 0.5961387753486633
values O O 0.9373977184295654
. O O 0.9999969005584717
In O O 0.9999721050262451
addition O O 0.9999703168869019
, O O 0.9999951124191284
this O O 0.9999889135360718
proliferative O O 0.9527482390403748

normal O O 0.9396063089370728
glucocorticoid O O 0.7564277052879333
response O O 0.9765363931655884
in O O 0.9999483823776245
HIV-infected B-cell_type B-cell_type 0.5473846197128296
cells E-cell_type E-cell_type 0.7600159645080566
probably O O 0.996679425239563
due O O 0.9999659061431885
to O O 0.9999953508377075
altered O O 0.992219090461731
interactions O O 0.9992542862892151
between O O 0.9999605417251587
the O O 0.9997751116752625

, O O 0.9848954677581787
rolling O O 0.941475510597229
of O O 0.9992327690124512
monocytes S-cell_type S-cell_type 0.9966212511062622
was O O 0.9995390176773071
increased O O 0.9999783039093018
by O O 0.9999971389770508
IkappaB-alpha S-protein S-protein 0.8231375813484192
transfer O O 0.9233980774879456
and O O 0.9997283816337585
was O O 0.9999384880065918
partly O O 0.9998323917388916
mediated O O 0.9999605417251587
by O O 0.9999958276748657
P-selectin S-protein S-protein 0.5617527961730957
; O O 0.9468995928764343
however O O 0.9995030164718628
, O O 0.9999864101409912
it O O 0.9999303817749023
appeared O O 0.9999749660491943
to O O 0.9999958276748657
be O O 0.9999901056289673

small O O 0.8611749410629272
deletions O O 0.7813283205032349
or O O 0.9998680353164673
mitotic O O 0.855426013469696
recombination O O 0.94143146276474
events O O 0.9984826445579529
, O O 0.9999916553497314
neither O O 0.9999954700469971
of O O 0.9999924898147583
which O O 0.9999314546585083
would O O 0.9999864101409912
be O O 0.9999879598617554
detected O O 0.9999057054519653
by O O 0.999997615814209
conventional O O 0.9662405848503113
cytogenetics O O 0.9793018102645874
. O O 0.9999908208847046
We O O 0.9999927282333374
have O O 0.9999988079071045
studied O O 0.9999778270721436
48 O O 0.9957535266876221
patients O O 0.9994809031486511
with O O 0.9999881982803345
polycythemia O O 0.9671133756637573
vera O O 0.9886809587478638
and O O 0.9998979568481445
four O O 0.9998445510864258
patients O O 0.9997439980506897

Fas S-protein S-protein 0.9494236707687378
/Fas B-protein B-protein 0.7201560735702515
ligand E-protein E-protein 0.9768179655075073
( O O 0.9962639212608337
FasL S-protein S-protein 0.992757260799408
) O O 0.9904416799545288
interaction O O 0.9992401599884033
. O O 0.9999984502792358
During O O 0.9999758005142212
studies O O 0.9996668100357056
of O O 0.9999924898147583
apoptosis O O 0.969215989112854
induced O O 0.999526858329773
by O O 0.9999897480010986
T O O 0.7604334950447083
cell-receptor O O 0.5924654006958008
engagement O O 0.9952723383903503
, O O 0.999997615814209
we O O 0.9999281167984009
identified O O 0.9999039173126221
ALG-4F S-protein S-protein 0.9326369762420654
, O O 0.9957286715507507
a O O 0.9999594688415527
truncated B-protein O 0.7281801104545593
transcript E-protein O 0.5795421004295349
that O O 0.9996117949485779
prevents O O 0.9999135732650757
T O O 0.6175757050514221
cell-receptor-induced O O 0.7615063786506653
FasL S-protein S-protein 0.5995050668716431
upregulation O O 0.9965823292732239
and O O 0.9999227523803711
cell O O 0.9732308983802795
death O O 0.997047483921051
. O O 0.9999983310699463
Overexpression O O 0.9993835687637329
of O O 0.9999892711639404
full-length B-protein O 0.7686597108840942
ALG-4 E-protein S-protein 0.8378295302391052
induced O O 0.9958968162536621
transcription O O 0.921461820602417
of O O 0.9973697662353516
FasL S-protein S-protein 0.94651198387146
and O O 0.9848877191543579
, O O 0.9965782761573792
consequently O O 0.9998103976249695

adhesion O O 0.9499025940895081
to O O 0.9997324347496033
HUVECs S-cell_line S-cell_type 0.5456762313842773
with O O 0.9995071887969971
peak O O 0.8538504242897034
responses O O 0.9826179146766663
observed O O 0.9999246597290039
at O O 0.9999955892562866
15 O O 0.9969421029090881
minutes O O 0.9982098340988159
( O O 0.9999566078186035
phase O O 0.9992812275886536
1 O O 0.9975034594535828
) O O 0.999535083770752
and O O 0.9998288154602051
240 O O 0.9815054535865784
minutes O O 0.9814634323120117
( O O 0.9999639987945557
phase O O 0.9981104135513306
2 O O 0.9954208731651306
) O O 0.9995347261428833
. O O 0.9999880790710449
N-Acetylcysteine O O 0.731203019618988
treatment O O 0.9635246992111206
attenuated O O 0.9695586562156677
neutrophil S-cell_type O 0.8634976744651794
adhesion O O 0.9911383986473083
in O O 0.9999924898147583
both O O 0.9999747276306152
phases O O 0.987987220287323
, O O 0.9998679161071777
which O O 0.999955415725708
indicated O O 0.9999862909317017
a O O 0.9999982118606567
role O O 0.9994545578956604
for O O 0.9999810457229614
GSH O O 0.551608145236969
in O O 0.9998990297317505
the O O 0.9999817609786987
adhesion O O 0.9212461709976196
responses O O 0.9948871731758118
. O O 0.9999982118606567
Interestingly O O 0.9994912147521973
, O O 0.9999901056289673
phase O O 0.9811750650405884
1 O O 0.8961241841316223
adhesion O O 0.9947091341018677
was O O 0.9999872446060181
inversely O O 0.9992438554763794
correlated O O 0.9999662637710571
with O O 0.9999977350234985
GSH O O 0.771195113658905

occurs O O 0.998703122138977
before O O 0.9999939203262329
dephosphorylation O O 0.9906806349754333
of O O 0.9997455477714539
pRb S-protein S-protein 0.9552857875823975
is O O 0.9998478889465332
complete O O 0.9999455213546753
because O O 0.9999995231628418
loss O O 0.9997426867485046
of O O 0.9999841451644897
p130 B-protein B-protein 0.397262305021286
Form I-protein I-protein 0.3076002895832062
3 E-protein E-protein 0.9667460322380066
occurs O O 0.9997947812080383
throughout O O 0.999985933303833
the O O 0.9999938011169434
cell O O 0.9593574404716492
cycle O O 0.9852576851844788
prior O O 0.9997981190681458
to O O 0.9999963045120239
complete O O 0.994297444820404
arrest O O 0.9997671246528625
in O O 0.9999966621398926

contains O O 0.9988933205604553
nuclear B-DNA B-DNA 0.7244091629981995
protein I-DNA I-DNA 0.328576922416687
binding I-DNA I-DNA 0.607506275177002
sites E-DNA E-DNA 0.8045042157173157
for O O 0.9996587038040161
Sp1 S-protein S-protein 0.9739325046539307
, O O 0.9931429624557495
PU.1 S-protein S-protein 0.9934862852096558
, O O 0.991949200630188
and/or O O 0.4129367172718048
Elf-1 S-protein S-protein 0.6715990304946899
, O O 0.9842267632484436
and O O 0.9993226528167725
a O O 0.9990361928939819
novel B-protein B-protein 0.6286909580230713
factor E-protein E-protein 0.767096757888794
. O O 0.9776626825332642

activity O O 0.9903386235237122
of O O 0.9999653100967407
the O O 0.9999840259552002
HIV B-DNA B-DNA 0.8174272775650024
enhancer E-DNA E-DNA 0.9966155886650085
and O O 0.9980044960975647
low O O 0.9193758964538574
nuclear O O 0.8855834603309631
expression O O 0.9835841059684753
of O O 0.9998683929443359
NF-kappa B-protein B-protein 0.858676552772522
B E-protein E-protein 0.9962361454963684
, O O 0.9973132014274597
a O O 0.9999314546585083
potent B-protein O 0.8308535218238831
transcriptional I-protein B-protein 0.48289063572883606
activator E-protein E-protein 0.7557874917984009
of O O 0.9478135704994202
the O O 0.9977351427078247
HIV B-DNA B-DNA 0.8066914677619934
enhancer E-DNA E-DNA 0.9932345747947693
. O O 0.9998891353607178
In O O 0.9999661445617676
contrast O O 0.999843955039978
, O O 0.9998359680175781
fixed O B-cell_type 0.9056652188301086
tissue O I-cell_type 0.7828461527824402
macrophages S-cell_type E-cell_type 0.6411935091018677
express O O 0.9998421669006348
detectable O O 0.9292593598365784
HIV B-protein B-protein 0.5140312314033508
proteins E-protein E-protein 0.9924795627593994

was O O 0.9980393052101135
about O O 0.9999896287918091
50 O O 0.9996949434280396
% O O 0.9999614953994751
of O O 0.999997615814209
that O O 0.999997615814209
of O O 0.9999485015869141
1 O O 0.9425190687179565
alpha O O 0.9135341644287109
, O O 0.9981458187103271
25- O O 0.9967064261436462
( O O 0.9998196959495544
OH O O 0.9946355223655701
) O O 0.9996417760848999
2D3 O O 0.9976917505264282
. O O 0.999998927116394
The O O 0.999997615814209
11 O O 0.890638530254364
beta-methyl O O 0.5859002470970154
analog O O 0.44432833790779114
had O O 0.9992940425872803
a O O 0.9998984336853027
greater O O 0.9990811347961426
than O O 0.9998561143875122
10-fold O O 0.9536448121070862
lower O O 0.9871037602424622
activity O O 0.9975683093070984
. O O 0.9999980926513672
The O O 0.9999988079071045
differentiating O O 0.9184994697570801
effects O O 0.9990962743759155
of O O 0.9999970197677612
the O O 0.9999963045120239
other O O 0.9996998310089111
C-11 O B-protein 0.306901752948761
analogs O E-protein 0.5592201948165894
on O O 0.9992407560348511
human B-cell_line B-cell_type 0.6009466052055359
promyeloid I-cell_line I-cell_type 0.4004034698009491
leukemia I-cell_line I-cell_type 0.5079419016838074
cells E-cell_line E-cell_type 0.5563920736312866
( O O 0.9882872700691223
HL-60 S-cell_line S-cell_line 0.9755648374557495
) O O 0.9707731604576111
agreed O O 0.9988784193992615
well O O 0.9999254941940308
with O O 0.9999951124191284
their O O 0.9999706745147705
bone-resorbing O O 0.7451691627502441
activity O O 0.9698090553283691
and O O 0.998835027217865
receptor O O 0.8659120798110962
affinity O O 0.9679619669914246
, O O 0.9996531009674072
but O O 0.9999769926071167
they O O 0.9999876022338867
demonstrated O O 0.999954342842102

respectively O O 0.9974240064620972
. O O 0.9999834299087524
Succinate O O 0.6794716715812683
alone O O 0.9848912358283997
had O O 0.9999352693557739
no O O 0.9999878406524658
effect O O 0.9999598264694214
. O O 0.9999955892562866
Decreased O O 0.9966176152229309
adhesion B-protein B-protein 0.6007859110832214
molecule E-protein E-protein 0.9720091223716736
expression O O 0.9961842894554138
was O O 0.9999845027923584
associated O O 0.9998892545700073
with O O 0.9999984502792358
a O O 0.9999982118606567
reduction O O 0.9996808767318726
of O O 0.9999898672103882
monocytic O O 0.47901761531829834
cell O O 0.7014778852462769
adhesion O O 0.9826688766479492
. O O 0.9999876022338867
TCP O O 0.3628973066806793
succinate O O 0.5441417694091797
( O O 0.9985049962997437
20 O O 0.992531955242157
microM O O 0.9869648218154907
, O O 0.99972003698349
72 O O 0.9961104989051819
h O O 0.9940535426139832
) O O 0.9994376301765442
, O O 0.9998984336853027
but O O 0.99993896484375

and I-protein I-protein 0.904874861240387
b I-protein I-protein 0.4953583776950836
proteins E-protein E-protein 0.9905837774276733
to O O 0.9999074935913086
the O O 0.9999797344207764
human B-DNA B-DNA 0.7047666907310486
GASd I-DNA I-DNA 0.9158458709716797
element E-DNA E-DNA 0.9875639081001282
. O O 0.9998743534088135
To O O 0.9999953508377075
confirm O O 0.9999980926513672
the O O 0.9999960660934448

core O I-DNA 0.6181600093841553
region O E-DNA 0.9329917430877686
show O O 0.999764621257782
little O O 0.9990538954734802
conservation O O 0.9996860027313232
with O O 0.9999971389770508
consensus B-DNA B-DNA 0.5014824867248535
sites E-DNA E-DNA 0.9806308150291443
. O O 0.9999232292175293
Nonetheless O O 0.9997538924217224
, O O 0.9998868703842163
CREB S-protein S-protein 0.951292872428894
, O O 0.9847102761268616
Ets-1 S-protein S-protein 0.9630053043365479
, O O 0.9852254986763
and O O 0.9958829879760742
AML1 S-protein S-protein 0.980954647064209
bind O O 0.980065643787384
and O O 0.9976280331611633
activate O O 0.9986187219619751
cooperatively O O 0.9955549836158752
and O O 0.9995146989822388
very O O 0.9994720816612244
efficiently O O 0.9996117949485779
through O O 0.9999947547912598
the O O 0.9999819993972778

Jurkat B-cell_line B-cell_line 0.43386778235435486
CD4+ I-cell_line I-cell_line 0.7306921482086182
T I-cell_line I-cell_line 0.8423454761505127
cells E-cell_line E-cell_line 0.9920428395271301
with O O 0.9996992349624634
dl-NF O S-protein 0.8471242189407349
, O O 0.9916159510612488
a O O 0.9999178647994995
mutated O O 0.8194663524627686
strain O O 0.8839157819747925
of O O 0.9971147775650024

expression O O 0.9806890487670898
in O O 0.9999558925628662
human B-cell_type B-cell_type 0.6063365340232849
monocytes E-cell_type E-cell_type 0.9892098307609558
by O O 0.9999200105667114
type B-protein B-protein 0.5996611714363098
I I-protein I-protein 0.7619272470474243
and I-protein I-protein 0.8509059548377991
type I-protein I-protein 0.9538442492485046
II I-protein I-protein 0.9778046011924744
interferons E-protein E-protein 0.9975032210350037
. O O 0.9999679327011108
The O O 0.999735414981842
Th2-type B-protein B-protein 0.8904341459274292
cytokines E-protein E-protein 0.9966408014297485
, O O 0.99122554063797
interleukin-4 S-protein S-protein 0.991306722164154
( O O 0.991085946559906
IL-4 S-protein S-protein 0.9984151124954224
) O O 0.9785899519920349
and O O 0.9996234178543091
interleukin-13 S-protein S-protein 0.9887123107910156
( O O 0.9876282215118408
IL-13 S-protein S-protein 0.9986237287521362
) O O 0.988792359828949
, O O 0.9999502897262573

B E-protein E-protein 0.9906471371650696
-independent O O 0.9889988303184509
suppression O O 0.9995145797729492
of O O 0.9999979734420776
HIV O O 0.8411192297935486
expression O O 0.997861921787262
by O O 0.9999977350234985
ascorbic O O 0.90048748254776
acid O O 0.9754902124404907
. O O 0.9999755620956421
Ascorbic O O 0.9513020515441895
acid O O 0.9835425615310669
( O O 0.9996594190597534
ascorbate O O 0.985985279083252
or O O 0.9996163845062256
vitamin O O 0.9883862137794495
C O O 0.9835835099220276
) O O 0.9991000890731812
has O O 0.9999942779541016
been O O 0.9999839067459106
shown O O 0.9999957084655762
to O O 0.9999934434890747
suppress O O 0.9999964237213135
the O O 0.999992847442627
induction O O 0.9997881054878235
of O O 0.9999954700469971
HIV O O 0.9266430735588074
in O O 0.99997878074646
latently B-cell_type O 0.6457999348640442

( O O 0.9721632599830627
1.2-3.3 O O 0.9906882047653198
) O O 0.9977803826332092
fmol/10 O O 0.9843447804450989
( O O 0.9994957447052002
7 O O 0.9994335770606995
) O O 0.9994244575500488
cells O O 0.9701055288314819
vs. O O 0.9999861717224121
2.3 O O 0.9935367703437805
+/- O O 0.9998278617858887
0.9 O O 0.999261200428009
( O O 0.9999603033065796
1.1-4.4 O O 0.9994148015975952
) O O 0.9995730519294739
fmol/10 O O 0.9736722707748413
( O O 0.9992337226867676
7 O O 0.9994094371795654
) O O 0.9992086291313171
cells O O 0.9427867531776428
in O O 0.9999690055847168
controls O O 0.9790332913398743
) O O 0.9998931884765625
. O O 0.9999972581863403
In O O 0.9999810457229614
three O O 0.9999499320983887
patients O O 0.9994508624076843
with O O 0.9999879598617554
PHP O O 0.8565705418586731
who O O 0.9995488524436951
were O O 0.9999690055847168
subjected O O 0.9995229244232178
to O O 0.99997878074646
parathyroidectomy O O 0.9152147173881531
, O O 0.9999423027038574
the O O 0.9999920129776001
calcitriol O O 0.5285097360610962
number O O 0.5627398490905762
came O O 0.9973604083061218
down O O 0.9999761581420898
to O O 0.9999454021453857
normal O O 0.9285376667976379
. O O 0.9999117851257324
Changes O O 0.9975064396858215
of O O 0.9999626874923706
calcitriol B-protein B-protein 0.5742230415344238
receptors E-protein E-protein 0.9962700605392456
in O O 0.9999083280563354
primary O O 0.5093070864677429
and O O 0.7934466600418091
secondary O O 0.9067777395248413
hyperparathyroidism O O 0.9771446585655212
could O O 0.9999096393585205
magnify O O 0.9999901056289673
the O O 0.9999985694885254
consequences O O 0.9999890327453613
of O O 0.9999977350234985
disturbances O O 0.9977455735206604
in O O 0.9999850988388062
serum O O 0.8170796036720276
concentration O O 0.9532191753387451
of O O 0.999446451663971
calcitriol O O 0.682614266872406
itself O O 0.9639004468917847
and O O 0.9987496137619019
might O O 0.9999136924743652
play O O 0.9999897480010986
an O O 0.9999942779541016
important O O 0.9999504089355469
role O O 0.9999825954437256
in O O 0.9999972581863403
the O O 0.9999958276748657
development O O 0.9998202919960022
of O O 0.9999959468841553
secondary O O 0.9727716445922852
hyperparathyroidism O O 0.9910150170326233
in O O 0.9999666213989258
uremia O O 0.8587109446525574
. O O 0.9999376535415649
The O O 0.9999978542327881
severe O O 0.9749709367752075
phenotype O O 0.9632675647735596
of O O 0.9997982382774353
females O O 0.758263349533081
with O O 0.9998587369918823
tiny B-DNA O 0.9533379077911377
ring I-DNA O 0.9708041548728943
X I-DNA B-DNA 0.6648310422897339
chromosomes E-DNA E-DNA 0.9653838276863098
is O O 0.9999029636383057
associated O O 0.9999110698699951
with O O 0.9999986886978149
inability O O 0.999302864074707
of O O 0.9999945163726807
these O O 0.9999730587005615
chromosomes S-DNA S-DNA 0.925395131111145
to O O 0.998988687992096
undergo O O 0.9995494484901428
X O S-DNA 0.8768229484558105
inactivation O O 0.9943296909332275
. O O 0.9999974966049194
Mental O O 0.9873864054679871
retardation O O 0.999559223651886
and O O 0.999990701675415
a O O 0.9999934434890747
constellation O O 0.9931401610374451
of O O 0.9999523162841797
congenital O O 0.6629414558410645
malformations O O 0.846565842628479
not O O 0.9936723709106445
usually O O 0.9997808337211609
associated O O 0.9998797178268433
with O O 0.9999916553497314
Turner O O 0.8415201902389526
syndrome O O 0.9941727519035339
are O O 0.999995231628418
seen O O 0.9999955892562866
in O O 0.9999935626983643
some O O 0.9999828338623047
females O O 0.9291359186172485
with O O 0.9999644756317139
a O O 0.999968409538269
mosaic O O 0.8806019425392151
45 O O 0.9087464809417725
, O O 0.9978302121162415
X/46 O O 0.9844182729721069
, O O 0.9997857213020325
X O O 0.9833459854125977
, O O 0.9997672438621521
r O O 0.9979689717292786
( O O 0.9997543692588806
X O O 0.9884454011917114
) O O 0.9984549283981323
karyotype O O 0.997788667678833
. O O 0.9999988079071045
Studies O O 0.9999756813049316
of O O 0.9999982118606567
these O O 0.9999920129776001
females O O 0.9749755859375
show O O 0.9999953508377075
that O O 0.9999994039535522
the O O 0.9999556541442871
XIST B-DNA B-DNA 0.5529999136924744
locus E-DNA E-DNA 0.9936072826385498
on O O 0.999922513961792
their O O 0.9999927282333374
tiny B-DNA B-DNA 0.7416577935218811
ring I-DNA I-DNA 0.7008469104766846
X I-DNA I-DNA 0.48633891344070435
chromosomes E-DNA E-DNA 0.9955785870552063
is O O 0.9998133778572083
either O O 0.999976396560669
not O O 0.9993970394134521
present O O 0.999850869178772
or O O 0.9997994303703308
not O O 0.9983006119728088
expressed O O 0.9998533725738525
. O O 0.9999973773956299
As O O 0.9999767541885376
XIST S-DNA S-DNA 0.6754488945007324
transcription O O 0.7739678621292114
is O O 0.9986616373062134
well O O 0.9970728158950806
correlated O O 0.9998231530189514
with O O 0.9999964237213135
inactivation O O 0.9955236911773682
of O O 0.999976396560669
the O O 0.9999443292617798
X B-DNA B-DNA 0.9111661911010742
chromosome E-DNA E-DNA 0.9754539132118225
in O O 0.9996566772460938
female B-cell_type O 0.8064178228378296
somatic I-cell_type O 0.5622096657752991
cells E-cell_type O 0.7621666789054871
and O O 0.9885327816009521
spermatogonia S-cell_type O 0.6419793963432312
, O O 0.9973590970039368
nonexpression O O 0.9964954257011414
of O O 0.999970555305481
the O O 0.999983549118042
locus O O 0.6872185468673706
even O O 0.9966350197792053
when O O 0.999974250793457
it O O 0.9987984895706177
is O O 0.9999793767929077
present O O 0.9998944997787476
suggests O O 0.9999963045120239
that O O 0.9999977350234985
these O O 0.9999046325683594
chromosomes S-DNA S-DNA 0.9909716844558716
are O O 0.999752938747406
transcriptionally O O 0.8847817778587341
active O O 0.9827771186828613
. O O 0.9999803304672241
We O O 0.9999935626983643
examined O O 0.9999935626983643
the O O 0.9999967813491821
transcriptional O O 0.8941313624382019
activity O O 0.994499921798706
of O O 0.9999637603759766
ring O B-DNA 0.3873244524002075
X B-DNA I-DNA 0.54228276014328
chromosomes E-DNA E-DNA 0.9876545071601868
lacking O O 0.9998675584793091

STAT6 S-protein S-protein 0.9794553518295288
, O O 0.9960579872131348
and O O 0.9998025298118591
insulin B-protein B-protein 0.4675367474555969
receptor E-protein I-protein 0.612015426158905
substrates O I-protein 0.7794268727302551
1 O I-protein 0.5482344031333923
and O I-protein 0.8205046057701111
2 O E-protein 0.9796635508537292
did O O 0.9979550838470459
not O O 0.9999191761016846
. O O 0.9999887943267822
However O O 0.9999825954437256
, O O 0.9999122619628906
IL-4 S-protein S-protein 0.9995290040969849
-induced O O 0.9975799322128296
effects O O 0.9998062252998352
were O O 0.9999980926513672
clearly O O 0.9997900128364563
improved O O 0.9999872446060181
following O O 0.999996542930603
JAK3 S-protein S-protein 0.960142970085144

133 O O 0.6767508387565613

) I-protein I-protein 0.36164775490760803
-kappa I-protein I-protein 0.6866353750228882
B E-protein E-protein 0.9971446394920349
is O O 0.9998600482940674
a O O 0.9999905824661255
redox B-protein B-protein 0.5132771134376526
sensitive I-protein I-protein 0.5385691523551941
cytosolic I-protein I-protein 0.6684401035308838
transcription I-protein I-protein 0.8416925668716431
factor E-protein E-protein 0.9966413974761963
. O O 0.9997749924659729
Redox O O 0.5840381979942322

stimulation O O 0.98875892162323
with O O 0.9999839067459106
mAb B-protein B-protein 0.7762545943260193
L243 E-protein E-protein 0.9946306943893433
. O O 0.999626636505127
Secreted O O 0.9693515300750732
TNF-alpha S-protein S-protein 0.9744563102722168
mediated O O 0.9994237422943115
the O O 0.9999929666519165
enhancement O O 0.9968926906585693
of O O 0.9999610185623169
nuclear B-protein B-protein 0.6073521971702576
factor I-protein I-protein 0.5344226360321045
kappa I-protein I-protein 0.9238161444664001
B E-protein E-protein 0.9891812205314636
( O O 0.9909479022026062
NF-kappa B-protein B-protein 0.9315255284309387
B E-protein E-protein 0.9870141744613647
) O O 0.9708743691444397
and O O 0.9995285272598267
activator O B-protein 0.7731696963310242
protein-1 O E-protein 0.9872390627861023
( O O 0.9529750943183899
AP-1 S-protein S-protein 0.9530003070831299

modulated O O 0.9017727971076965
along O O 0.9990416169166565
with O O 0.9999772310256958
induction O O 0.9927781224250793
of O O 0.9997958540916443
terminal O O 0.7532249093055725
differentiation O O 0.9872274398803711
. O O 0.9999878406524658
Activated O B-cell_type 0.5090892910957336
T B-cell_type I-cell_type 0.6987494826316833
cells E-cell_type E-cell_type 0.872066855430603
were O O 0.9996935129165649
demonstrated O O 0.9999551773071289
to O O 0.9999933242797852
be O O 0.9999957084655762
important O O 0.9999432563781738
in O O 0.9999381303787231
providing O O 0.9998223185539246
the O O 0.999984622001648
modulating O O 0.9880344271659851

can O O 0.9849439263343811

. O O 0.9984264373779297
Cotransfection O O 0.9717564582824707
with O O 0.9999583959579468
C/EBPbeta B-DNA B-DNA 0.6169477701187134
and I-DNA I-DNA 0.8973221182823181
GATA-1 I-DNA I-DNA 0.7556424736976624
expression I-DNA I-DNA 0.7152110934257507
vectors E-DNA E-DNA 0.9578207731246948
produced O O 0.9998958110809326
a O O 0.9999701976776123
5-fold O O 0.7244916558265686
increase O O 0.9927608966827393
compared O O 0.9999631643295288

after O O 0.9978148937225342

from O O 0.9995546936988831
their O O 0.999988317489624
cytoplasmic O O 0.7927199006080627
pools O O 0.7280072569847107
. O O 0.9999934434890747
Thus O O 0.9999436140060425
, O O 0.9999189376831055
reduced O O 0.9976692795753479
levels O O 0.9999364614486694
of O O 0.9999817609786987
PKC S-protein S-protein 0.7818607091903687

IkappaBalpha B-cell_line B-cell_line 0.5795472860336304
transfected I-cell_line I-cell_line 0.7981597781181335
cells E-cell_line E-cell_line 0.9084973931312561
were O O 0.9998549222946167
apoptotic O O 0.9727372527122498
after O O 0.9999723434448242
8 O O 0.9988706707954407
h O O 0.9971436858177185
of O O 0.9999865293502808
TNFalpha S-protein S-protein 0.942713737487793
treatment O O 0.9975723624229431
. O O 0.9999982118606567
This O O 0.9999599456787109
correlated O O 0.9824203252792358
with O O 0.9999845027923584
a O O 0.9999959468841553
strong O O 0.997427761554718
reduction O O 0.999873161315918
of O O 0.9999951124191284
BrdU O S-protein 0.515727162361145
incorporation O O 0.9852591753005981
after O O 0.9999905824661255

primary O O 0.38069817423820496
than O O 0.9920408129692078
in O O 0.9997114539146423
secondary O O 0.8294087648391724
hyperparathyroidism O O 0.9731119275093079
. O O 0.9999876022338867
Since O O 0.9999746084213257
specific O O 0.9927541613578796
receptors O O 0.6577712893486023
for O O 0.9988558292388916
calcitriol O O 0.7061383128166199
have O O 0.9984923601150513
been O O 0.9999481439590454
described O O 0.9999386072158813
in O O 0.9999159574508667
peripheral B-cell_type B-cell_type 0.7109299898147583
blood I-cell_type I-cell_type 0.9029107689857483
mononuclear I-cell_type I-cell_type 0.9884769916534424
cells E-cell_type E-cell_type 0.9916300177574158
( O O 0.9945490956306458
PBMC S-cell_type S-cell_type 0.9997275471687317
) O O 0.9875224232673645
, O O 0.9999834299087524
we O O 0.9999494552612305
have O O 0.9999978542327881
investigated O O 0.9999871253967285
the O O 0.9999985694885254
specific O O 0.9940364360809326
uptake O O 0.9967339038848877
of O O 0.9999619722366333
3H-labelled O B-protein 0.46438848972320557
1 O I-protein 0.4509323537349701
, O I-protein 0.619300901889801

, O O 0.9760505557060242
transient O O 0.9735246896743774
transfection O O 0.9984418749809265
of O O 0.9999908208847046
HLA-DRA B-DNA B-DNA 0.636831521987915
and I-DNA I-DNA 0.82286536693573
DQB I-DNA I-DNA 0.35232746601104736
reporter I-DNA I-DNA 0.8182082176208496
constructs E-DNA E-DNA 0.9965342283248901
indicated O O 0.9999475479125977
that O O 0.9999996423721313
the O O 0.9999525547027588
affected O O 0.908327579498291
factor O O 0.4708341956138611
operates O O 0.9933074116706848
via O O 0.9948452711105347
cis-elements S-DNA S-DNA 0.9418432712554932
located O O 0.9978756904602051
between O O 0.9959915280342102
-141 B-DNA B-DNA 0.7605487704277039
base I-DNA I-DNA 0.8556985259056091
pairs E-DNA E-DNA 0.8571892380714417
and O O 0.9725311398506165
the O O 0.9997935891151428
transcription B-DNA O 0.43548643589019775
initiation I-DNA O 0.3575565814971924

show O O 0.9582234621047974

B-cell O O 0.534169614315033
and O O 0.921022355556488
T-cell O O 0.5959439873695374
differentiation O O 0.9961894154548645
. O O 0.9999972581863403
The O O 0.9999992847442627
expression O O 0.9995833039283752
of O O 0.9999969005584717
distinct O O 0.9710686802864075
sets O O 0.7917295098304749
of O O 0.9988734126091003
genes O O 0.6583824157714844
at O O 0.9998120665550232
different O O 0.9991425275802612
stages O O 0.9994993209838867
of O O 0.9999748468399048
B-lymphocyte O O 0.7462794780731201
and O O 0.9370777010917664
T-lymphocyte O O 0.7337746620178223
differentiation O O 0.9929438233375549
is O O 0.9999886751174927
controlled O O 0.9969484210014343

histogenesis O O 0.8513786792755127
and O O 0.998764157295227
correlated O O 0.9988331198692322
their O O 0.9999312162399292
expression O O 0.9961774349212646
status O O 0.9995699524879456
to O O 0.9999985694885254
the O O 0.9999942779541016
virologic O O 0.8073321580886841
features O O 0.8753910660743713
of O O 0.9999502897262573
this O O 0.9999912977218628
disease O O 0.9991047978401184
. O O 0.9999966621398926

eosinophils S-cell_type S-cell_type 0.9297288656234741
and O O 0.9938720464706421
basophils S-cell_type S-cell_type 0.948442280292511
suggests O O 0.9998573064804077
that O O 0.9999984502792358
gene O O 0.9774270057678223
transcription O O 0.9971177577972412
in O O 0.9999902248382568
these O O 0.9997943043708801
lineages O O 0.8500488996505737
may O O 0.9999784231185913
be O O 0.9999929666519165
regulated O O 0.9999186992645264
by O O 0.9999979734420776
GATA-binding B-protein B-protein 0.6644901037216187
proteins E-protein E-protein 0.9984588623046875
. O O 0.9999445676803589
Oxidoreductive O O 0.897577166557312
regulation O O 0.9981270432472229
of O O 0.9999873638153076
nuclear B-protein B-protein 0.6589987874031067
factor I-protein I-protein 0.6340951919555664
kappa I-protein I-protein 0.8573402762413025
B E-protein E-protein 0.8527407050132751

whereas O O 0.9992817044258118
the O O 0.9999971389770508
inhibition O O 0.9969573020935059
of O O 0.9999794960021973
IgE S-protein S-protein 0.9111338257789612
class O O 0.8412027359008789
switching O O 0.990575909614563
by O O 0.9999880790710449
interferon-y S-protein S-protein 0.883528470993042
( O O 0.9611998200416565
IFN-gamma S-protein S-protein 0.9880177974700928
) O O 0.973999559879303
occurs O O 0.9999905824661255
through O O 0.9999943971633911
the O O 0.9999972581863403
activation O O 0.9961531758308411
of O O 0.999924898147583
Statl S-protein S-protein 0.9669821858406067
. O O 0.9987838864326477
OBJECTIVE O O 0.9427472949028015
: O O 0.9973341226577759
We O O 0.9995245933532715
hypothesized O O 0.9994513392448425
that O O 0.9999946355819702

the O O 0.9991732239723206
regulatory B-protein O 0.5344833135604858
and I-protein O 0.8049237132072449
catalytic I-protein O 0.5966537594795227
subunits E-protein O 0.828586757183075
of O O 0.9990676045417786
cAMP-dependent B-protein B-protein 0.5941471457481384
protein I-protein I-protein 0.7255000472068787
kinase E-protein E-protein 0.9824180006980896
( O O 0.9871324300765991
protein B-protein B-protein 0.9405771493911743
kinase I-protein I-protein 0.8676077723503113
A E-protein E-protein 0.9790956974029541
) O O 0.9201587438583374
and O O 0.9844590425491333
1 O O 0.44672057032585144
of O O 0.9913768768310547
its O O 0.9997652173042297
substrates O O 0.5247596502304077
, O O 0.9705207943916321
Rap1 S-protein S-protein 0.9920594692230225
, O O 0.9961762428283691
in O O 0.9998728036880493
platelets S-cell_type S-cell_type 0.9980972409248352
from O O 0.9994670748710632
untreated O O 0.8393223285675049
euthymic O O 0.6934277415275574

the O O 0.9980454444885254
nucleus O O 0.9717932939529419
is O O 0.9998428821563721
not O O 0.9999041557312012
sufficient O O 0.9999713897705078
for O O 0.9999926090240479
activation O O 0.9987291693687439
of O O 0.999975323677063
gene O O 0.9505488872528076
expression O O 0.9992222785949707
. O O 0.9999990463256836
Excess O O 0.9755295515060425
beta-catenin S-protein S-protein 0.7329016923904419
can O O 0.999830961227417
squelch O O 0.9999381303787231
reporter O B-DNA 0.697447657585144
gene O E-DNA 0.9086373448371887
activation O O 0.9967928528785706
by O O 0.9999963045120239
LEF-1-beta-catenin B-protein B-protein 0.5493746399879456
complexes E-protein E-protein 0.9974730610847473
but O O 0.9996365308761597

basal O O 0.8000794053077698
and O O 0.9946486353874207
activation-dependent O O 0.926616370677948
induction O O 0.988098680973053
of O O 0.9992218017578125
transcription O O 0.8308868408203125
in O O 0.9991052746772766
U937 B-cell_line B-cell_line 0.9595587253570557
cells E-cell_line E-cell_line 0.9989838004112244
. O O 0.9999179840087891
This O O 0.999990701675415
region O O 0.9942883253097534
contains O O 0.9999799728393555
binding O B-DNA 0.4700581133365631
sites O E-DNA 0.9586582779884338
for O O 0.999637246131897
the O O 0.9999428987503052
cAMP B-protein B-protein 0.6252495646476746
response I-protein I-protein 0.8183013200759888
element-binding I-protein I-protein 0.9502525329589844
protein/activation I-protein I-protein 0.9418065547943115
transcription I-protein I-protein 0.9471759796142578
factor E-protein E-protein 0.9770367741584778
( O O 0.9598696231842041
CREB/ATF S-protein S-protein 0.9850630760192871
) O O 0.9713202118873596
and O O 0.9990898370742798
Sp1 S-protein S-protein 0.9350262880325317

rich O O 0.886033296585083

DQA1 O S-protein 0.5742946267127991
polymorphism O O 0.6943040490150452
. O O 0.9997478127479553
T B-cell_type B-cell_type 0.6432660818099976
cells E-cell_type E-cell_type 0.9713397026062012
infiltrating O O 0.999336302280426
a O O 0.99997878074646
herpes O O 0.7518796324729919
simplex O O 0.7859933376312256
virus O O 0.6887197494506836
( O O 0.9564128518104553
HSV O O 0.8753734827041626
) O O 0.9732958078384399
lesion O O 0.944456934928894
from O O 0.9999994039535522
a O O 0.9999700784683228
HLA O B-DNA 0.4763116240501404
DQ O I-DNA 0.41289597749710083
2 O E-DNA 0.6647647619247437
, O O 0.9033138751983643
7 O O 0.8703521490097046
individual O O 0.9447706341743469
yielded O O 0.9994596838951111
a O O 0.9999830722808838
virus-specific B-cell_line B-cell_line 0.7184281349182129
CD4+ I-cell_line I-cell_line 0.3975563049316406
clone E-cell_line E-cell_line 0.9635021090507507
restricted O O 0.9896237254142761
by O O 0.9999877214431763
DQ2 S-protein O 0.33212482929229736
. O O 0.9998763799667358
Presentation O O 0.9992929697036743
of O O 0.9999876022338867
viral O O 0.5953763127326965
peptide O O 0.542589008808136
and O O 0.9385212659835815
protein O O 0.6202124357223511
segregated O O 0.8919580578804016
with O O 0.9993720650672913

B O O 0.5215942859649658
lineage O O 0.7576720118522644
leukemia O O 0.9143791794776917
. O O 0.9998712539672852
Detection O O 0.9984910488128662
of O O 0.9999836683273315
adenovirus O B-DNA 0.7554886341094971
DNA O E-DNA 0.9971000552177429
in O O 0.9998972415924072
peripheral B-cell_type B-cell_type 0.7302855253219604
blood I-cell_type I-cell_type 0.9199238419532776
mononuclear I-cell_type I-cell_type 0.9898039102554321
cells E-cell_type E-cell_type 0.996306300163269
by O O 0.9999542236328125
polymerase O O 0.8252025246620178
chain O O 0.776897132396698
reaction O O 0.9834797382354736
assay O O 0.9996277093887329
. O O 0.9999955892562866
Adenovirus O O 0.7306879162788391
can O O 0.9982689619064331

Chinese O O 0.8768676519393921
medicine O O 0.9940610527992249
, O O 0.9998955726623535
chan'su O O 0.9759680032730103
, O O 0.9992755055427551
caused O O 0.9999085664749146
apoptosis O O 0.9981651902198792
in O O 0.9999815225601196
human B-cell_line B-cell_line 0.5496118664741516
leukemia I-cell_line I-cell_line 0.4955802857875824
U937 I-cell_line I-cell_line 0.7481592893600464
cells E-cell_line E-cell_line 0.9939674139022827
by O O 0.9999586343765259
anomalous O O 0.9414581060409546
activation O O 0.9839620590209961
of O O 0.9998819828033447
mitogen-activated B-protein B-protein 0.8390455842018127
protein I-protein I-protein 0.6847543716430664

independent O O 0.9397643208503723
of O O 0.9984865188598633
TNF S-protein S-protein 0.982041597366333
. O O 0.9998700618743896
This O O 0.9999899864196777
mechanism O O 0.9984782338142395
may O O 0.9999960660934448
be O O 0.9999990463256836
important O O 0.9999879598617554
in O O 0.9999966621398926
the O O 0.9999971389770508
activation O O 0.9986114501953125
of O O 0.9999892711639404
HIV O O 0.8834466934204102
expression O O 0.9983711838722229
from O O 0.9999939203262329
latently O O 0.583722710609436
infected O O 0.6858773827552795
CD4+ B-cell_line B-cell_type 0.6067611575126648
T I-cell_line I-cell_type 0.9648159742355347
cells E-cell_line E-cell_type 0.9379053115844727
, O O 0.9966946840286255
especially O O 0.9997925162315369

heterodimer S-protein E-protein 0.8399049639701843
have O O 0.9980239868164062
been O O 0.9999538660049438
cloned O O 0.9963018894195557
, O O 0.999810516834259
and O O 0.9998698234558105
NF90 S-protein S-protein 0.9567719101905823
was O O 0.9993696808815002
found O O 0.9999734163284302
to O O 0.9999858140945435
encode O O 0.999993085861206
a O O 0.999968409538269
protein O O 0.9016435742378235
containing O O 0.9916337728500366
two O O 0.9866217970848083
domains O O 0.9286371469497681

. O O 0.9990279674530029
The O O 0.9999969005584717
initiating O O 0.9650476574897766
event O O 0.9929952025413513
is O O 0.9999852180480957
still O O 0.999984860420227
uncertain O O 0.9999490976333618
, O O 0.9999891519546509
but O O 0.9999805688858032
activation O O 0.9981371164321899
of O O 0.9999605417251587
a O O 0.9999923706054688
recently O O 0.9761120080947876
described O O 0.9977043271064758
receptor-associated B-protein B-protein 0.5911446213722229
protein I-protein I-protein 0.38389599323272705
kinase E-protein E-protein 0.9763914942741394
is O O 0.9992884397506714
one O O 0.9999936819076538
of O O 0.9999961853027344

, O O 0.9952638149261475
the O O 0.9999932050704956
identification O O 0.9992444515228271
of O O 0.9999926090240479
BCL-6 S-protein S-protein 0.9212619662284851
lesions O O 0.9197083115577698
may O O 0.9999940395355225
have O O 0.9999977350234985
relevant O O 0.9988013505935669
clinical O O 0.9939761161804199
implications O O 0.9999295473098755
. O O 0.9999974966049194
DLCL O O 0.3522244095802307
represent O O 0.9998113512992859
a O O 0.9999979734420776
heterogeneous O O 0.8409115076065063
group O O 0.800129234790802
of O O 0.999650239944458
neoplasms O O 0.7189907431602478

promyelocytic I-cell_line O 0.47575411200523376

FK506 O O 0.23352506756782532

phosphorylation O O 0.9032956957817078
and O O 0.9976835250854492
Ca2+ O O 0.9373148679733276
signals O O 0.9952587485313416
similar O O 0.9999443292617798
to O O 0.9999864101409912
those O O 0.9999821186065674
observed O O 0.9991586208343506
following O O 0.9998924732208252
biological O O 0.9859317541122437
stimulation O O 0.999492883682251
. O O 0.9999988079071045
We O O 0.9999735355377197
have O O 0.9999982118606567
examined O O 0.9999840259552002
the O O 0.9999988079071045
role O O 0.9988614320755005
of O O 0.9999738931655884
cell O B-protein 0.6339781880378723
surface O I-protein 0.5540956854820251
molecules O E-protein 0.99068284034729
in O O 0.9999595880508423
these O O 0.9999557733535767
responses O O 0.995441198348999
. O O 0.9999946355819702
Normal O B-cell_type 0.6106944680213928
T B-cell_type I-cell_type 0.7212806344032288
lymphocytes E-cell_type E-cell_type 0.9913609623908997
whose O O 0.9998210072517395
surface O O 0.9756222367286682
expression O O 0.99614417552948
of O O 0.999956488609314
CD3 S-protein S-protein 0.9463065266609192
was O O 0.9989280104637146
depleted O O 0.9989224672317505
showed O O 0.9999966621398926
impaired O O 0.9958295226097107
UV-induced O O 0.889777421951294
tyrosine O O 0.890882670879364
phosphorylation O O 0.9913924932479858
and O O 0.999904990196228
Ca2+ O O 0.9152459502220154
signals O O 0.9909015893936157
. O O 0.9999990463256836
Similarly O O 0.9999713897705078
, O O 0.9999864101409912
Jurkat B-cell_line B-cell_line 0.6060948371887207
T I-cell_line I-cell_line 0.8936271667480469

`` O O 0.9388716816902161
fetal O O 0.9153120517730713
'' O O 0.9002919793128967
patterns O O 0.8842465877532959
. O O 0.9999903440475464
The O O 0.9999961853027344
progenitors O O 0.5497778058052063
derived O O 0.999342143535614
from O O 0.9999934434890747
a O O 0.9998971223831177
beta O O 0.49018922448158264
zero-thalassemia O O 0.48219358921051025
patient O O 0.7747721672058105
with O O 0.9997908473014832
high O O 0.9883363842964172
HbF S-protein S-protein 0.6728225350379944
production O O 0.9915517568588257
showed O O 0.9999991655349731
`` O O 0.9888796806335449
fetal O O 0.9445984959602356
'' O O 0.9436853528022766
pattern O O 0.9692336916923523
. O O 0.9999595880508423

of O O 0.9964781403541565
8e51 B-cell_line B-cell_line 0.7497497200965881
cells E-cell_line E-cell_line 0.9826846718788147
, O O 0.9981366395950317
expressing O O 0.9972057938575745
a O O 0.999976396560669
defective O O 0.9320310950279236
HIV O O 0.6722010374069214
virus O O 0.7549499869346619
. O O 0.9998075366020203
The O O 0.9999978542327881
double B-DNA B-DNA 0.4914517104625702
NF-kappaB I-DNA I-DNA 0.39752396941185
site E-DNA E-DNA 0.960206925868988
identified O O 0.9989609718322754
in O O 0.9999829530715942
the O O 0.999924898147583
LTR S-DNA S-DNA 0.9892570376396179
of O O 0.9985238909721375
the O O 0.9999154806137085
human O B-DNA 0.6140249371528625
immunodeficiency O I-DNA 0.8390629291534424
virus-1 O I-DNA 0.9416835308074951
( O I-DNA 0.9294247627258301

a O O 0.9986300468444824
correlation O O 0.9951395988464355
was O O 0.999987006187439
observed O O 0.9999901056289673
between O O 0.9992430210113525
monoamine B-protein B-protein 0.6674448251724243
oxidase I-protein I-protein 0.4698205292224884
B E-protein I-protein 0.5046769976615906
enzyme O E-protein 0.869550883769989
activity O O 0.9877369403839111
in O O 0.9997842907905579
blood B-cell_type B-cell_type 0.8034969568252563
cells E-cell_type E-cell_type 0.9935737252235413
( O O 0.9914773106575012
platelets S-cell_type S-cell_type 0.9944772124290466
) O O 0.9739920496940613
and O O 0.9997836947441101

of O O 0.997893750667572
the O O 0.9999716281890869
R-PK B-DNA B-DNA 0.6031524538993835
promoter E-DNA E-DNA 0.9976181387901306
in O O 0.9996789693832397
HeLa B-cell_line B-cell_line 0.867518961429596
cells E-cell_line E-cell_line 0.9975023865699768
. O O 0.9998959302902222
Protease O O 0.9508885741233826
treatment O O 0.9978513717651367
of O O 0.9999816417694092
nuclear O O 0.7964245676994324
extracts O O 0.8729602694511414
distinguishes O O 0.9996603727340698
between O O 0.9937293529510498
class B-protein B-DNA 0.5718872547149658
II I-protein I-DNA 0.505804181098938

LPS B-DNA B-DNA 0.4889880120754242
Response I-DNA I-DNA 0.5891901850700378
Element E-DNA E-DNA 0.9879752993583679
, O O 0.9937646389007568
an O O 0.9998492002487183
enhancer O S-DNA 0.8058860301971436
that O O 0.9874603748321533
is O O 0.9999688863754272
engaged O O 0.9998905658721924
by O O 0.9999964237213135
both O O 0.9998084902763367
AP-1 B-protein B-protein 0.4636363685131073
type I-protein I-protein 0.8301588296890259
heterodimeric I-protein I-protein 0.9165507555007935
complexes E-protein E-protein 0.99825519323349
as O O 0.9998737573623657
well O O 0.9995821118354797
as O O 0.9999897480010986
NF B-protein B-protein 0.9379986524581909
kappa I-protein I-protein 0.9606525301933289
B I-protein E-protein 0.967956006526947
like I-protein O 0.9864961504936218

shown O O 0.9965547323226929
to O O 0.9999873638153076
be O O 0.9999792575836182
hormone-inducible B-protein B-protein 0.7823125123977661
trans-activating I-protein I-protein 0.47928938269615173
proteins E-protein E-protein 0.9881718754768372
in O O 0.9999326467514038
transient O O 0.790317952632904
transfection O O 0.8957359790802002
assays O O 0.9938761591911316
. O O 0.9999933242797852
When O O 0.9999643564224243
stably O O 0.7997258305549622
introduced O O 0.9966272115707397
into O O 0.9999544620513916
primary B-cell_type B-cell_type 0.7399181723594666
erythroblasts E-cell_type E-cell_type 0.9104209542274475
or O O 0.9976065158843994
conditionally B-cell_line B-cell_line 0.7173354625701904
transformed I-cell_line I-cell_line 0.7738291025161743
erythroid I-cell_line I-cell_line 0.30204978585243225
progenitors I-cell_line I-cell_line 0.3693004250526428
cells E-cell_line E-cell_line 0.6820645332336426
, O O 0.9990286827087402
exogenous O O 0.796345591545105
GATA-2/ER S-protein S-protein 0.5906211137771606
promoted O O 0.9953368306159973
proliferation O O 0.9972586631774902
and O O 0.9999325275421143
inhibited O O 0.9992210865020752
terminal O O 0.9664075374603271
differentiation O O 0.9993757605552673
in O O 0.9999957084655762
an O O 0.9999806880950928
estrogen-dependent O O 0.792113721370697
manner O O 0.9863741397857666
. O O 0.999995231628418
These O O 0.9999988079071045
phenotypic O O 0.8800244927406311
effects O O 0.9991682767868042
are O O 0.9999986886978149

the O O 0.9978005290031433

Intravenous O O 0.7966842651367188
PCr O O 0.6442567706108093
injection O O 0.9837926626205444
led O O 0.9999690055847168
to O O 0.9999977350234985
smaller O O 0.9995933175086975
changes O O 0.9998103976249695
in O O 0.9999946355819702
ACTH S-protein O 0.8738892674446106
and O O 0.9963241815567017
cortisol O O 0.9453054070472717
concentrations O O 0.9970855116844177
as O O 0.9999954700469971
well O O 0.9999738931655884
as O O 0.9999969005584717
to O O 0.9999895095825195
a O O 0.9999964237213135
lower O O 0.998930037021637
activation O O 0.9935141801834106
of O O 0.9999051094055176
glucocorticoid O O 0.6075566411018372
binding O O 0.5596466660499573
in O O 0.9936512112617493
lymphocytes S-cell_type S-cell_type 0.9987086057662964
. O O 0.9997491240501404
Putative B-protein B-protein 0.8180328607559204
steroid I-protein I-protein 0.6875236630439758
binding I-protein I-protein 0.7569261193275452
domain E-protein E-protein 0.9629608392715454
of O O 0.9873578548431396
the O O 0.999563992023468
human B-protein B-protein 0.5202422738075256
mineralocorticoid I-protein I-protein 0.7803917527198792
receptor E-protein E-protein 0.9733149409294128
, O O 0.9902862906455994
expressed O O 0.9996873140335083
in O O 0.9999473094940186
E. O O 0.4486198127269745
coli O O 0.6778597235679626
in O O 0.9983904361724854
the O O 0.9999845027923584
presence O O 0.998054027557373

. O O 0.9985206723213196
Hepatic B-cell_type O 0.7160337567329407
microsomes E-cell_type O 0.4618340730667114
and O O 0.9941850304603577
isolated B-cell_type B-cell_type 0.52392578125
hepatocytes E-cell_type E-cell_type 0.729261040687561
in O O 0.9999310970306396
short O O 0.918205201625824
term O O 0.9180195331573486
culture O O 0.9156937599182129
desulfate O O 0.9477260112762451
T3 O O 0.3676454722881317

with O O 0.9995321035385132
the O O 0.9999779462814331
phorbol O O 0.750494122505188
ester O O 0.7430202960968018
12-O-tetradecanoylphorbol-13-acetate O O 0.6196682453155518
( O O 0.9771807193756104
TPA O O 0.8645240068435669
) O O 0.9862897992134094
. O O 0.9999862909317017
Two O O 0.9997338652610779
multicopy B-DNA B-DNA 0.877485990524292
basal I-DNA I-DNA 0.8219896554946899
enhancer I-DNA I-DNA 0.6628128886222839
motifs E-DNA E-DNA 0.9452589750289917
within O O 0.9999104738235474
the O O 0.9999666213989258
SCMV O B-DNA 0.8532189130783081
MIE B-DNA I-DNA 0.7656516432762146
enhancer E-DNA E-DNA 0.9948630928993225
, O O 0.9973135590553284
namely O O 0.989448070526123
, O O 0.998331606388092
11 O O 0.7936378121376038
copies O O 0.6167430877685547
of O O 0.9986634254455566
the O O 0.9999353885650635
16-bp O B-DNA 0.6041554808616638
cyclic B-DNA I-DNA 0.622682511806488
AMP I-DNA I-DNA 0.7952179908752441
response I-DNA I-DNA 0.9558765292167664
element E-DNA E-DNA 0.9637179970741272
( O O 0.9403784275054932

, O O 0.9936309456825256
the O O 0.9999778270721436
functional B-protein O 0.9372820854187012
domains E-protein O 0.4766172170639038
responsible O O 0.9998356103897095
for O O 0.9999581575393677
DNA O O 0.8919272422790527
binding O O 0.9436089396476746
, O O 0.9968200922012329
transactivation O O 0.9725732803344727
, O O 0.9991908669471741
and O O 0.9998078942298889
negative O O 0.9434131383895874
regulation O O 0.9952864050865173
, O O 0.9999725818634033
previously O O 0.9991855025291443
characterized O O 0.9996769428253174
in O O 0.9999481439590454
a O O 0.9999675750732422
fibroblast O O 0.5337432622909546
context O O 0.8276344537734985
, O O 0.9997788071632385
were O O 0.9999899864196777
found O O 0.9999747276306152
to O O 0.9999853372573853
have O O 0.9999932050704956
similar O O 0.9992895126342773
activity O O 0.9990758895874023
in O O 0.9999417066574097
B B-cell_type B-cell_type 0.8680657148361206
cells E-cell_type E-cell_type 0.9931464791297913
. O O 0.9998990297317505
The O O 0.9999955892562866
region O O 0.9737119078636169
of O O 0.9993032217025757
A-MYB S-protein S-protein 0.9113054871559143
responsible O O 0.9986538887023926
for O O 0.9999812841415405
the O O 0.9999686479568481
B O O 0.4658792018890381
cell O O 0.4300941526889801
specific O O 0.8384494781494141

receptor O E-protein 0.79770427942276

content O O 0.9620829224586487
of O O 0.9995852112770081
GCR S-protein S-protein 0.9517595767974854
in O O 0.9996310472488403
leukocytes S-cell_type S-cell_type 0.99493008852005
when O O 0.9995866417884827
compared O O 0.9999089241027832
with O O 0.9999916553497314
the O O 0.9999963045120239
normal O O 0.9426824450492859
control O O 0.9919649362564087
( O O 0.9995216131210327
P O O 0.9901025295257568
less O O 0.9996795654296875
than O O 0.9999645948410034
0.05 O O 0.9823871850967407
) O O 0.9997130036354065
; O O 0.9999759197235107
the O O 0.9999972581863403
cases O O 0.998755693435669
of O O 0.9999860525131226

mutant I-DNA B-DNA 0.4340676963329315
genome E-DNA E-DNA 0.9749089479446411
in O O 0.9999485015869141
the O O 0.9999884366989136
infected O B-cell_type 0.6058908700942993
cells O E-cell_type 0.9254329204559326
despite O O 0.9999474287033081
defective O O 0.9819045662879944
onset O O 0.9881274104118347
of O O 0.9999517202377319
the O O 0.9999951124191284
late O O 0.9790537357330322
phase O O 0.9878751635551453
of O O 0.9977611303329468
replication O O 0.9963518381118774
. O O 0.9999982118606567
These O O 0.9999991655349731
results O O 0.999968409538269
imply O O 0.999998927116394
that O O 0.9999974966049194

glucocorticoid O O 0.653704047203064
resistance O O 0.9891026020050049
characterized O O 0.9998581409454346
by O O 0.9999902248382568
low O O 0.9483007788658142
receptor O O 0.8096452951431274
affinity O O 0.9692497253417969
( O O 0.9996364116668701
Kd O O 0.9803466796875
) O O 0.9980683922767639
for O O 0.9999805688858032
glucocorticoids O O 0.9508746862411499
in O O 0.9996620416641235
mononuclear S-cell_type B-cell_type 0.8534699082374573
, O I-cell_type 0.8834931254386902
cells O E-cell_type 0.9537627696990967
and O O 0.9834586381912231
high O O 0.9636836647987366
values O O 0.9870908260345459
of O O 0.9999479055404663
ACTH O O 0.9261778593063354

in O O 0.997896671295166

The O O 0.9988231062889099
eukaryotic B-protein B-protein 0.6581872701644897
transcription I-protein I-protein 0.4572437107563019
factor I-protein E-protein 0.9758133888244629
NF-kappa I-protein B-protein 0.8103023171424866
B E-protein E-protein 0.999137282371521
is O O 0.9998500347137451
involved O O 0.9999845027923584
in O O 0.9999964237213135
the O O 0.9999972581863403
inducible O O 0.9488227367401123
expression O O 0.9976929426193237
of O O 0.9999932050704956
various O O 0.9523720145225525
inflammatory B-DNA B-DNA 0.5161778330802917
genes E-DNA E-DNA 0.969448983669281

replication O O 0.9386565089225769
is O O 0.9999244213104248
controlled O O 0.9997343420982361
by O O 0.9999994039535522
a O O 0.9999946355819702
complex O O 0.9190825819969177
array O O 0.9503661394119263
of O O 0.9998747110366821
virally B-protein B-protein 0.45406651496887207
encoded I-protein I-protein 0.44967350363731384
and I-protein I-protein 0.6558672785758972
cellular I-protein I-protein 0.48886358737945557
proteins E-protein E-protein 0.9921575784683228
. O O 0.9999532699584961
A O O 0.999993085861206
wide O O 0.9938608407974243
spectrum O O 0.9986605644226074
of O O 0.9999886751174927
levels O O 0.9988382458686829
of O O 0.9999758005142212
HIV-1 O O 0.45834773778915405
expression O O 0.9924605488777161
have O O 0.9999911785125732
been O O 0.9999822378158569

-independent O O 0.8421548008918762

H-89 O O 0.16361533105373383
. O O 0.9903916120529175
H-89 O O 0.5983115434646606
substantially O O 0.9966052770614624
suppressed O O 0.998596727848053
LPS-induced O O 0.5356844663619995
TNF B-RNA B-RNA 0.5061678290367126
mRNA E-RNA E-RNA 0.9974437952041626
accumulation O O 0.996229350566864
in O O 0.9999487400054932
unprimed B-cell_line B-cell_type 0.523039698600769
cells E-cell_line E-cell_type 0.6269822716712952
, O O 0.9635655283927917
but O O 0.9998032450675964
had O O 0.9999853372573853
no O O 0.9999268054962158

a O O 0.9988861680030823
combination O O 0.9992972612380981
of O O 0.9999954700469971
phorbol O O 0.9091708660125732
esters O O 0.9708555936813354
( O O 0.9999547004699707
phorbol O O 0.9323775172233582
12-myristate O O 0.9888350367546082
13 O O 0.9950141310691833
acetate O O 0.9985787868499756
, O O 0.9999793767929077
PMA O O 0.9985746145248413
) O O 0.9999517202377319
and O O 0.9999891519546509
calcium O O 0.966020405292511
ionophores O O 0.9103508591651917
( O O 0.9998243451118469
A23187 O O 0.988381564617157
) O O 0.9998248219490051
is O O 0.9999972581863403
required O O 0.9999943971633911
for O O 0.9999980926513672
their O O 0.9993166923522949

SLP-76 S-protein S-protein 0.9922713041305542
-associated O O 0.9899223446846008
proteins O O 0.8872314095497131
also O O 0.9999594688415527
function O O 0.9999445676803589
to O O 0.9999779462814331
regulate O O 0.9998108744621277
signal O O 0.9805797934532166
transduction O O 0.9986985921859741
. O O 0.9999979734420776
Here O O 0.9998960494995117

pro-coagulant O B-protein 0.6631162762641907
protein O I-protein 0.6727356314659119
tissue O I-protein 0.876462459564209
factor O E-protein 0.9917831420898438
( O O 0.9898126721382141
TF O S-protein 0.9950584173202515
) O O 0.9937898516654968
and O O 0.9999366998672485
the O O 0.9998899698257446
pro-inflammatory O B-protein 0.8078909516334534
protein O E-protein 0.8980989456176758
tumor O B-protein 0.6128045916557312
necrosis O I-protein 0.9425432682037354
factor-alpha O E-protein 0.9946621060371399
( O O 0.9855255484580994
TNF-alpha S-protein S-protein 0.9973416924476624
) O O 0.9905450344085693
, O O 0.9997521042823792
as O O 0.9999821186065674
well O O 0.9998432397842407
as O O 0.9999970197677612
the O O 0.9999338388442993
prostaglandin B-protein B-protein 0.5350964665412903
PGE2 E-protein E-protein 0.8768593072891235
in O O 0.9976251721382141

G B-protein B-protein 0.28729358315467834
( I-protein I-protein 0.8529122471809387
S I-protein I-protein 0.6470228433609009
) I-protein I-protein 0.5775807499885559
alpha E-protein E-protein 0.9908520579338074
expression O O 0.9981235861778259
may O O 0.9999922513961792
also O O 0.9999970197677612
differ O O 0.9999955892562866
in O O 0.9999955892562866
the O O 0.9999964237213135
expression O O 0.9998631477355957
of O O 0.9999985694885254
certain O O 0.9984070658683777
cAMP-dependent B-DNA B-DNA 0.5053086876869202
genes E-DNA E-DNA 0.9957844614982605
. O O 0.9999009370803833
Thrombin S-protein S-protein 0.9721231460571289
generation O O 0.9943552017211914
by O O 0.9999911785125732
apoptotic B-cell_type B-cell_type 0.5447741746902466
vascular I-cell_type I-cell_type 0.581576943397522
smooth I-cell_type I-cell_type 0.6548246741294861
muscle I-cell_type I-cell_type 0.8655819296836853
cells E-cell_type E-cell_type 0.8826033473014832
. O O 0.9999064207077026
Thrombin S-protein S-protein 0.9941114783287048
activation O O 0.9994438290596008
requires O O 0.9999916553497314
assembly O O 0.9955845475196838
of O O 0.9999659061431885
a O O 0.9999701976776123
prothrombinase B-protein B-protein 0.7187280058860779
complex E-protein E-protein 0.9549627900123596
of O O 0.992890477180481
activated O B-protein 0.7961312532424927
coagulation B-protein I-protein 0.5680755376815796
factors E-protein E-protein 0.9858852624893188
on O O 0.9999431371688843
an O O 0.9998953342437744
anionic O O 0.6639043688774109
phospholipid O O 0.455219566822052
surface O O 0.44711166620254517
, O O 0.9963650703430176
classically O O 0.7897807955741882
provided O O 0.9919066429138184
by O O 0.9998563528060913
activated B-cell_type B-cell_type 0.5599116683006287
platelets E-cell_type E-cell_type 0.9041377305984497
. O O 0.9999102354049683
We O O 0.9999816417694092
have O O 0.9999943971633911
previously O O 0.9999462366104126
shown O O 0.9999958276748657
that O O 0.9999960660934448
anionic O O 0.6657541990280151
phosphatidylserine O O 0.4072619080543518
is O O 0.9974784255027771
exposed O O 0.9994875192642212

, O O 0.8344919681549072
MCP-1 S-protein S-protein 0.9485253095626831
, O O 0.9729060530662537
and O O 0.9894417524337769
RANTES S-protein S-protein 0.9715525507926941
by O O 0.9997394680976868
PBMCs S-cell_type S-cell_type 0.98614501953125
obtained O O 0.9978334307670593
from O O 0.9999898672103882
healthy O O 0.919491171836853
subjects O O 0.9821968078613281
. O O 0.9999946355819702
METHODS O O 0.9692903757095337
: O O 0.9985783100128174
Protein O O 0.9209567308425903
production O O 0.996906578540802

of O O 0.9955436587333679
CREB/ATF-1 S-protein S-protein 0.9362666010856628
to O O 0.99647456407547
TRE-1 S-DNA S-DNA 0.9603763818740845
in O O 0.9998923540115356
the O O 0.9999762773513794
HTLV-I O B-DNA 0.6178734302520752
promoter O E-DNA 0.9952448010444641
. O O 0.9998924732208252
We O O 0.9999867677688599
demonstrate O O 0.9999977350234985
the O O 0.9999979734420776
utility O O 0.9978195428848267
of O O 0.9999604225158691
using O O 0.9958113431930542
primary O O 0.7095208168029785
lymphocyte O O 0.5653383135795593
models O O 0.658111572265625
to O O 0.9995779395103455
study O O 0.9995476603507996
HTLV-I O O 0.44247952103614807
transcription O O 0.7920624017715454
in O O 0.9993382096290588
the O O 0.9999940395355225
context O O 0.9995622038841248
of O O 0.9999858140945435
cell O O 0.9357947111129761
signaling O O 0.9751059412956238
and O O 0.9991292357444763
suggest O O 0.9999823570251465
that O O 0.9999949932098389

UV O O 0.6935936212539673
irradiation O O 0.9952625036239624
. O O 0.9999960660934448
These O O 0.9999985694885254
results O O 0.999980092048645
suggest O O 0.9999991655349731
that O O 0.9999985694885254
UV-induced O O 0.8571288585662842
signal O O 0.9600147604942322
transduction O O 0.9963688850402832
is O O 0.9999908208847046
mediated O O 0.9998012185096741
via O O 0.9997588992118835
cell B-protein B-protein 0.7757734060287476
surface I-protein I-protein 0.5612374544143677
receptors E-protein E-protein 0.9870080351829529
that O O 0.9995827078819275
normally O O 0.9997568726539612
respond O O 0.9994745850563049
to O O 0.9998894929885864

immortalized I-cell_line I-protein 0.8644360303878784
by I-cell_line I-protein 0.9898896217346191
SV40 E-cell_line I-protein 0.5929731130599976
) O I-protein 0.7519962787628174
antigens O E-protein 0.9749270677566528
was O O 0.9998594522476196
detected O O 0.9999914169311523
by O O 0.9999977350234985
enzyme-linked O O 0.8278436064720154
immunosorbent O O 0.893927276134491
assay O O 0.9975494742393494
. O O 0.9999964237213135
Inhibition O O 0.9775806665420532
studies O O 0.9972242116928101
were O O 0.9999966621398926
used O O 0.9999649524688721
to O O 0.9999872446060181
select O O 0.9999326467514038
the O O 0.9999550580978394
monoclonal B-protein B-protein 0.46781155467033386
antibodies E-protein E-protein 0.9968427419662476
( O O 0.9949851036071777
mAECA S-protein S-protein 0.9887479543685913
) O O 0.9952923059463501
which O O 0.9999818801879883
share O O 0.9999954700469971
the O O 0.9999966621398926
same O O 0.9999808073043823
EC O B-protein 0.7368485927581787
epitope O E-protein 0.6658530831336975
binding O O 0.4972219169139862
specificity O O 0.8822771310806274
as O O 0.9998745918273926
the O O 0.9999951124191284

different O O 0.9935314059257507
from O O 0.999937891960144
those O O 0.9999264478683472
in O O 0.9999042749404907
patients O O 0.9975398778915405
with O O 0.9999697208404541
ulcerative O O 0.9695138335227966
colitis O O 0.9841613173484802
( O O 0.9997500777244568
UC O O 0.9894535541534424
) O O 0.9999014139175415
( O O 0.9999895095825195
56.1 O O 0.9796444177627563
+/- O O 0.999729335308075
51.6 O O 0.9952892065048218
dpm O O 0.9981972575187683
mg-1 O O 0.9757726192474365
cytosol B-protein B-protein 0.7653967142105103
protein E-protein E-protein 0.961776614189148
) O O 0.9974002838134766
. O O 0.9999959468841553
In O O 0.9997144341468811

were O O 0.9984475374221802
found O O 0.9997616410255432
to O O 0.99998939037323
be O O 0.9999912977218628
defective O O 0.997463583946228
in O O 0.9999560117721558
U937 B-cell_line B-cell_line 0.9525779485702515
cells E-cell_line E-cell_line 0.9994854927062988
infected O O 0.9983953833580017
with O O 0.9999911785125732
E1B B-protein B-protein 0.41023173928260803
19K E-protein I-protein 0.2394365519285202
mutants O E-protein 0.4242417812347412
compared O O 0.9996535778045654
with O O 0.9999933242797852
wild-type O O 0.786639928817749
virus O O 0.8644065856933594
. O O 0.999920129776001
Early O O 0.9700637459754944
viral O O 0.936993420124054
RNA O O 0.46257761120796204
splicing O O 0.9881167411804199
patterns O O 0.9992234706878662
also O O 0.9999955892562866
differ O O 0.9999934434890747
between O O 0.9987322688102722
wild-type B-cell_line B-cell_line 0.3813478946685791
and I-cell_line I-cell_line 0.6419417858123779
dl337-infected I-cell_line I-cell_line 0.4607335031032562
cells E-cell_line E-cell_line 0.657213032245636
. O O 0.9998134970664978
Furthermore O O 0.999993085861206
, O O 0.999995231628418
the O O 0.9999967813491821
defect O O 0.9976598024368286
in O O 0.9999678134918213
viral O O 0.9342920780181885
replication O O 0.9964202642440796
could O O 0.999997615814209
be O O 0.9999939203262329
complemented O O 0.9999572038650513
by O O 0.9999972581863403
dl312 O O 0.794609010219574
virus O O 0.8541074991226196
defective O O 0.95803302526474
in O O 0.9995675683021545

Using O O 0.9974491000175476
electrophoretic O O 0.8927837014198303
mobility O O 0.9871030449867249
shift O O 0.9986926913261414
assays O O 0.9995115995407104
, O O 0.9999933242797852
we O O 0.9999732971191406
have O O 0.9999986886978149
studied O O 0.9999655485153198
these O O 0.9999845027923584
transcription B-protein B-protein 0.4895368814468384
factors E-protein E-protein 0.9914141297340393
in O O 0.9998821020126343
primary B-cell_type B-cell_type 0.7554981112480164
T I-cell_type I-cell_type 0.9402033686637878
cells E-cell_type E-cell_type 0.9941912293434143
from O O 0.9997898936271667
human O O 0.6319724321365356
blood O O 0.49881964921951294
to O O 0.9815453886985779
verify O O 0.9998249411582947
their O O 0.9999805688858032
presence O O 0.9995054006576538
in O O 0.9999933242797852
a O O 0.999971866607666
physiologic O O 0.8849039673805237
setting O O 0.9584911465644836
and O O 0.9996227025985718
to O O 0.9999194145202637

be O O 0.9994532465934753
a O O 0.9999959468841553
mouse O O 0.7960116267204285
homologue O O 0.47570452094078064
of O O 0.9993273019790649
human B-protein B-protein 0.4697103500366211
BAF170 E-protein E-protein 0.6626945734024048
. O O 0.9958542585372925
Immunoprecipitation O O 0.9974666833877563
of O O 0.9999504089355469
cell O O 0.9558291435241699
extract O O 0.9951356053352356
with O O 0.9999890327453613
the O O 0.9999843835830688
antiserum O O 0.7680225372314453
against O O 0.9978048205375671
the O O 0.9999074935913086
mouse B-protein B-protein 0.38343095779418945
SRG3 E-protein E-protein 0.755257785320282
also O O 0.9820322394371033
brought O O 0.9999457597732544
down O O 0.9999423027038574
a O O 0.9999414682388306
195-kD B-protein B-protein 0.8751659393310547
protein E-protein E-protein 0.9700291156768799
that O O 0.9987626075744629
could O O 0.9999918937683105
be O O 0.9999755620956421
recognized O O 0.999946117401123
by O O 0.9999988079071045
an O O 0.9999504089355469
antiserum O O 0.5928172469139099
raised O O 0.983325719833374
against O O 0.9998154044151306
human B-protein B-protein 0.5374051928520203
SWI2 I-protein I-protein 0.3381177484989166
protein E-protein E-protein 0.9910949468612671
. O O 0.9998346567153931
The O O 0.9999991655349731
results O O 0.999984622001648
suggest O O 0.9999988079071045

cells E-cell_type E-cell_type 0.5428725481033325
and O O 0.9990181922912598
to O O 0.9999867677688599
a O O 0.9999939203262329
dramatic O O 0.9962284564971924
decrease O O 0.9998766183853149
in O O 0.9999972581863403
the O O 0.9999887943267822
ex O O 0.9253389835357666
vivo O O 0.9647039175033569
proliferative O O 0.9645345211029053
response O O 0.997393012046814
of O O 0.9999860525131226
splenic B-cell_type B-cell_type 0.7431803941726685
T I-cell_type I-cell_type 0.915559709072113
lymphocytes E-cell_type E-cell_type 0.9635069966316223
. O O 0.9999778270721436
Analysis O O 0.9999823570251465
of O O 0.9999966621398926
IL-2 S-protein S-protein 0.8055958151817322
and O O 0.9724370837211609
IL-2R B-protein B-protein 0.3982446491718292
alpha E-protein E-protein 0.9965871572494507
expression O O 0.9993652701377869
demonstrated O O 0.9999853372573853
that O O 0.9999971389770508
the O O 0.9999923706054688
perturbation O O 0.9977843165397644
of O O 0.9999896287918091
the O O 0.9999580383300781
proliferation O O 0.6574220061302185
response O O 0.8817698359489441
was O O 0.9998373985290527

in O O 0.9993414282798767
which O O 0.9999971389770508
HIV-1 B-DNA B-DNA 0.5875920653343201
AP-1 I-DNA I-DNA 0.6146778464317322
DNA I-DNA I-DNA 0.5842993259429932
recognition I-DNA I-DNA 0.6333054900169373
sequences E-DNA E-DNA 0.9971970319747925
were O O 0.9999454021453857
cloned O O 0.9689899682998657
downstream O O 0.9894850850105286
of O O 0.9999737739562988
the O O 0.9999638795852661
chloramphenicol B-protein B-DNA 0.6471421718597412
acetyltransferase E-protein I-DNA 0.7776821255683899
( O I-DNA 0.9732114672660828
CAT S-protein I-DNA 0.9890390634536743
) O I-DNA 0.9708231091499329
gene O E-DNA 0.9974787831306458
. O O 0.9998775720596313
Mitogen-mediated O O 0.8493943810462952
transcriptional O O 0.9154404401779175
activation O O 0.9926685094833374
of O O 0.999954342842102
the O O 0.9999853372573853
CAT B-DNA B-DNA 0.6277661919593811
gene E-DNA E-DNA 0.9776989221572876
in O O 0.9997121691703796
this O O 0.999929666519165
construct O O 0.9659085869789124
was O O 0.9999599456787109
inhibited O O 0.9999535083770752
in O O 0.9999371767044067
Nef-expressing B-cell_line B-cell_line 0.8429548740386963
cells E-cell_line E-cell_line 0.9591391682624817
but O O 0.9880115985870361
not O O 0.9829314351081848
in O O 0.9884482026100159
control O B-cell_type 0.6088401675224304
cells O E-cell_type 0.6449349522590637
. O O 0.9999352693557739
These O O 0.9999922513961792

C. O O 0.49724844098091125
neoformans O O 0.28859394788742065
was O O 0.9977304339408875
enhanced O O 0.9998389482498169
by O O 0.9999938011169434
anti-capsular B-protein B-protein 0.5872008204460144
antibody E-protein E-protein 0.9869827032089233
, O O 0.996845543384552
while O O 0.9999724626541138
induction O O 0.9974498152732849
by O O 0.9999955892562866
both O O 0.9997013211250305
organisms O O 0.9338884353637695
was O O 0.9997696280479431
inhibited O O 0.9999858140945435
by O O 0.9999929666519165
anti-TNF-alpha B-protein B-protein 0.8056519627571106
antibody E-protein E-protein 0.992741584777832
. O O 0.9999204874038696
In O O 0.9998941421508789
THP-1 O B-cell_line 0.9624729156494141
cells O E-cell_line 0.9959818124771118
transfected O O 0.9949125051498413
with O O 0.9999878406524658
HIV B-DNA O 0.8263015151023865

lines O E-cell_line 0.9837121367454529

therapeutic O O 0.9268473386764526
effect O O 0.9994680285453796
in O O 0.9999958276748657
the O O 0.9998753070831299
T B-cell_type B-cell_type 0.5606686472892761
lymphocytes E-cell_type E-cell_type 0.9802666306495667
of O O 0.9992468357086182
acquired O O 0.9543380737304688
immunodeficiency O O 0.9778195023536682
syndrome O O 0.9983776807785034
patients O O 0.999823272228241
. O O 0.9999985694885254
Simple O O 0.9966296553611755
derivation O O 0.9976133108139038
of O O 0.9999920129776001
TFIID-dependent O B-protein 0.3584100604057312
RNA B-protein I-protein 0.31567302346229553
polymerase I-protein I-protein 0.27772313356399536
II E-protein E-protein 0.9425362944602966
transcription O O 0.8278976082801819
systems O O 0.801271378993988
from O O 0.999994158744812
Schizosaccharomyces O O 0.7776817679405212
pombe O O 0.5956407785415649
and O O 0.9481191039085388
other O O 0.9974554181098938
organisms O O 0.9579497575759888
, O O 0.9995555281639099
and O O 0.999921441078186
factors O O 0.9662328958511353
required O O 0.9998418092727661

and O O 0.9709524512290955
induction O O 0.9942644238471985
of O O 0.9999632835388184
vascular B-protein B-protein 0.7567421197891235
cell I-protein I-protein 0.9230597019195557
adhesion I-protein I-protein 0.9678195714950562
molecule-1 E-protein E-protein 0.999580442905426
in O O 0.9994070529937744
endothelial B-cell_type B-cell_type 0.9105161428451538
cells E-cell_type E-cell_type 0.9920265078544617

gene E-DNA E-DNA 0.9619482159614563
, O O 0.9848740696907043
and O O 0.9997981190681458
were O O 0.9999386072158813
heterozygous O O 0.6870008707046509
as O O 0.9931824803352356
well O O 0.9982439279556274
as O O 0.9999549388885498
homozygous O O 0.8793172836303711
for O O 0.9992852807044983
the O O 0.9999797344207764
codon-10-variant B-DNA O 0.6067242622375488
type E-DNA O 0.4265541434288025
. O O 0.999745786190033
These O O 0.9999985694885254
results O O 0.9999661445617676
indicate O O 0.9999985694885254
that O O 0.9999984502792358
the O O 0.9999926090240479
presence O O 0.9993842840194702
of O O 0.9999927282333374
the O O 0.9999529123306274
codon-10-variant B-DNA O 0.3709257245063782
type E-DNA O 0.36488714814186096
is O O 0.9892215728759766
not O O 0.9993858337402344

neither O O 0.9992654919624329
the O O 0.9999442100524902
SNE S-DNA S-DNA 0.8842856884002686
nor O O 0.9423392415046692
the O O 0.9923617839813232
SEE B-DNA B-DNA 0.6188477277755737
motif E-DNA E-DNA 0.9876718521118164
responded O O 0.9998993873596191
to O O 0.9999822378158569
phosphatase O O 0.487676203250885
inhibition O O 0.9922323226928711
by O O 0.9999948740005493
okadaic O O 0.9584938883781433
acid O O 0.9914412498474121
. O O 0.9999865293502808
However O O 0.9999927282333374
, O O 0.9999959468841553
the O O 0.9999971389770508
TPA O O 0.5027086138725281
responsiveness O O 0.9705939888954163
of O O 0.9999105930328369
both O O 0.9999668598175049
CMV B-DNA B-DNA 0.46440720558166504
elements E-DNA E-DNA 0.9848371148109436
proved O O 0.9999125003814697
to O O 0.9999961853027344
involve O O 0.9999984502792358
synergistic O O 0.9913864135742188
interactions O O 0.9994682669639587
between O O 0.9999858140945435
the O O 0.9998955726623535
core O B-DNA 0.4939500093460083
SRF B-DNA I-DNA 0.43625393509864807
binding I-DNA I-DNA 0.8767425417900085
site E-DNA E-DNA 0.9817626476287842

Ramos I-cell_line B-cell_line 0.6126091480255127
cells E-cell_line E-cell_line 0.9855051636695862
showed O O 0.9999549388885498
reduced O O 0.9986981153488159
levels O O 0.9998598098754883
of O O 0.9999842643737793
CD95 S-protein S-protein 0.9337669014930725
expression O O 0.9992374181747437
. O O 0.9999983310699463
Thus O O 0.9999730587005615
, O O 0.9999634027481079
Egr-1 S-protein S-protein 0.9718919992446899
seems O O 0.9996341466903687
to O O 0.9999856948852539
control O O 0.9999929666519165
the O O 0.9999951124191284
expression O O 0.9992726445198059
of O O 0.9999923706054688
downstream B-DNA B-DNA 0.5411719083786011
target I-DNA I-DNA 0.5097792148590088
genes E-DNA E-DNA 0.9541396498680115
not O O 0.9975293278694153
only O O 0.9999643564224243
as O O 0.9999940395355225
a O O 0.9999903440475464
transcriptional O O 0.7230255007743835

transduction O O 0.9448526501655579
activated O O 0.9938249588012695
when O O 0.9999878406524658
the O O 0.9998905658721924
virus O O 0.9323927760124207
binds O O 0.9931215643882751
to O O 0.9999362230300903
its O O 0.9998685121536255
receptor O O 0.715514600276947
, O O 0.9849153757095337
CD21 S-protein S-protein 0.9228724837303162
. O O 0.9993506073951721
By O O 0.9999804496765137
comparing O O 0.9999511241912842
the O O 0.9999934434890747
expression O O 0.9980669617652893
of O O 0.9999817609786987
genes O O 0.5038993954658508
controlling O O 0.9882990121841431
apoptosis O O 0.976150631904602
, O O 0.9997746348381042
including O O 0.9999531507492065
those O O 0.9999701976776123
encoding O O 0.9975897073745728
several O O 0.9973522424697876
members O O 0.9685887098312378
of O O 0.9990167617797852
the O O 0.9996793270111084
BCL-2 B-protein B-protein 0.8088536858558655
family E-protein E-protein 0.8835228085517883
of O O 0.9738374948501587
proteins O O 0.6166439056396484
, O O 0.9993606209754944
the O O 0.9999958276748657
known O O 0.9978649020195007
relative O O 0.9617646932601929
resistance O O 0.9963836669921875
of O O 0.999937891960144

IL-12 S-protein S-protein 0.9776269197463989
signaling O O 0.9911608099937439
are O O 0.9999963045120239
mutually O O 0.9482132196426392
antagonistic O O 0.994282603263855
, O O 0.9999126195907593
which O O 0.9999548196792603
facilitates O O 0.9999581575393677
rapid O O 0.996336817741394
dominance O O 0.9998680353164673
of O O 0.9999955892562866
one O O 0.9998915195465088
pathway O O 0.9978310465812683
during O O 0.9999872446060181
early O O 0.9800845384597778
Th O O 0.9063398838043213
development O O 0.997549831867218
, O O 0.9999942779541016
producing O O 0.9998879432678223
a O O 0.9999896287918091
stable O O 0.9941914677619934
divergence O O 0.9992534518241882
in O O 0.9999947547912598
cytokine S-protein S-protein 0.6958274841308594
profiles O O 0.658044695854187
. O O 0.9999861717224121

Mutation O O 0.9519398212432861
of O O 0.9997554421424866
the O O 0.9999788999557495
C-site S-DNA S-DNA 0.7915077209472656
that O O 0.9841384291648865
prevented O O 0.9996141195297241
AP-1 S-protein S-protein 0.9569455981254578
binding O O 0.9877474308013916
to O O 0.9999617338180542
this O O 0.9999151229858398
site O O 0.956061065196991
was O O 0.999936580657959
sufficient O O 0.9999774694442749
strikingly O O 0.9999452829360962
to O O 0.999994158744812
reduce O O 0.999902606010437
inducible O O 0.92752605676651
promoter O O 0.5135865211486816

menstrual O O 0.690975546836853
cycle O O 0.9395942091941833
, O O 0.9997125267982483
with O O 0.9999966621398926
a O O 0.9999923706054688
significant O O 0.9998173117637634
increase O O 0.9999935626983643
in O O 0.9999983310699463
the O O 0.9999978542327881
immediate O O 0.9740837812423706
preovulatory O O 0.9571536779403687
period O O 0.9992596507072449
. O O 0.9999995231628418
The O O 0.9999996423721313
presence O O 0.9995126724243164
of O O 0.9999918937683105
androgen B-protein B-protein 0.6084480881690979
receptors E-protein E-protein 0.987024188041687

cells E-cell_type E-cell_type 0.7150024771690369
of O O 0.9995438456535339
elderly O O 0.9388831257820129
individuals O O 0.9953376054763794
was O O 0.999983549118042
closely O O 0.998389720916748
associated O O 0.9999393224716187
with O O 0.999996542930603
impairments O O 0.9987034797668457
in O O 0.999995231628418
the O O 0.9999871253967285
activation O O 0.9939790964126587
of O O 0.999913215637207
both O O 0.9998339414596558
AP-1 S-protein S-protein 0.982795774936676
and O O 0.9974716901779175
NF-AT S-protein S-protein 0.9963956475257874
. O O 0.9999425411224365
By O O 0.9999200105667114
contrast O O 0.9998006224632263
, O O 0.9999691247940063
T B-cell_type B-cell_type 0.7970255017280579
cells E-cell_type E-cell_type 0.996723473072052
from O O 0.999914288520813
elderly O O 0.9693249464035034
subjects O O 0.99817955493927
with O O 0.9999949932098389
normal O O 0.9908588528633118
levels O O 0.9998960494995117
of O O 0.9999890327453613
IL-2 S-protein S-protein 0.9236353635787964
production O O 0.9957119226455688
exhibited O O 0.9999505281448364
normal O O 0.976136326789856
activation O O 0.9945201277732849
of O O 0.9999028444290161
AP-1 S-protein S-protein 0.9790886044502258
and O O 0.9943736791610718
NF-AT S-protein S-protein 0.9965922236442566
. O O 0.9999231100082397
In O O 0.9999126195907593
addition O O 0.9998733997344971
, O O 0.9999845027923584
the O O 0.9999680519104004

components O O 0.7242594957351685
of O O 0.9998878240585327
the O O 0.9999938011169434
specific O O 0.966095507144928
and O O 0.9936249256134033
non-specific O O 0.9836792349815369
immunoreaction O O 0.9705289602279663
. O O 0.9996868371963501
MRP14 S-DNA S-protein 0.7229825854301453
( O O 0.97267746925354
Macrophage B-protein B-protein 0.592479944229126
migration I-protein I-protein 0.7353060245513916
inhibitory I-protein I-protein 0.7763950228691101
related I-protein I-protein 0.8334848880767822
protein E-protein E-protein 0.8547816872596741

or O O 0.9627803564071655
by O O 0.999788224697113
any O O 0.9999966621398926
other O O 0.9999669790267944
component O O 0.9909177422523499
of O O 0.9999234676361084
Gram-positive O B-protein 0.47080284357070923
bacteria O E-protein 0.7897055149078369
. O O 0.9985129237174988
Glucocorticoid B-protein B-protein 0.8081612586975098
receptors E-protein E-protein 0.9985049962997437
are O O 0.9999059438705444
down-regulated O O 0.9988852143287659
in O O 0.9999574422836304
inflamed O O 0.8446659445762634
colonic O O 0.7321597337722778
mucosa O O 0.56308513879776
but O O 0.9730827808380127
not O O 0.9739941954612732
in O O 0.9982858300209045
peripheral B-cell_type B-cell_type 0.7657003998756409
blood I-cell_type I-cell_type 0.939635157585144
mononuclear I-cell_type I-cell_type 0.9934467673301697
cells E-cell_type E-cell_type 0.997530996799469
from O O 0.9999653100967407
patients O O 0.999607264995575
with O O 0.9999667406082153
inflammatory O O 0.9684337377548218
bowel O O 0.9852880835533142
disease O O 0.9995212554931641
[ O O 0.9999327659606934

activity O O 0.9920004606246948

to I-DNA I-DNA 0.7755705118179321
-52 E-DNA E-DNA 0.9155016541481018
) O O 0.7686826586723328
, O O 0.9995085000991821
herein O O 0.983977735042572
called O O 0.9997881054878235
purine B-DNA B-DNA 0.5641278028488159
box I-DNA I-DNA 0.5480608344078064
1 E-DNA E-DNA 0.7179051041603088
( O O 0.9879050254821777
PB1 S-DNA S-DNA 0.9299150109291077
) O O 0.9596211314201355
, O O 0.9994155168533325
has O O 0.9999268054962158
been O O 0.9999295473098755
shown O O 0.9999558925628662
to O O 0.9999854564666748
bind O O 0.9998698234558105
a O O 0.999855637550354
T-cell B-protein B-protein 0.6418346166610718
nuclear I-protein I-protein 0.8955973386764526
protein I-protein I-protein 0.6329782605171204
complex E-protein E-protein 0.9966138005256653
and O O 0.999543309211731
to O O 0.9999516010284424
be O O 0.9998748302459717
required O O 0.9998759031295776
for O O 0.9999858140945435
transcriptional O O 0.9551055431365967
induction O O 0.9983047246932983
of O O 0.9999916553497314
the O O 0.9999568462371826
GM-CSF B-DNA B-DNA 0.6855874061584473
gene E-DNA E-DNA 0.9921453595161438
following O O 0.9997172951698303
T-cell O O 0.6686471700668335
activation O O 0.984063982963562
. O O 0.9999892711639404
The O O 0.9999953508377075
PB1 S-DNA B-DNA 0.3793850243091583
sequence O I-DNA 0.5849519968032837
motif O E-DNA 0.9531471729278564
is O O 0.9998939037322998
highly O O 0.9848567247390747
conserved O O 0.9996126294136047
in O O 0.9999970197677612
both O O 0.9998252987861633
human B-DNA O 0.5597922801971436
and I-DNA O 0.9258677363395691
murine I-DNA O 0.7855452299118042
GM-CSF I-DNA O 0.26665133237838745

HePTP S-protein S-protein 0.3986683785915375
) O O 0.9101654291152954
. O O 0.9999364614486694
Activation O O 0.998624324798584
of O O 0.999953031539917
T B-cell_type B-cell_type 0.7779295444488525
lymphocytes E-cell_type E-cell_type 0.9835444092750549
to O O 0.99847811460495
produce O O 0.9998168349266052
cytokines S-protein S-protein 0.9956211447715759
is O O 0.9999287128448486
regulated O O 0.9999161958694458
by O O 0.9999984502792358
the O O 0.9999920129776001
counterbalance O O 0.9766672849655151
of O O 0.9997802376747131
protein-tyrosine B-protein B-protein 0.7443757653236389
kinases E-protein E-protein 0.9918529391288757
and O O 0.9963448643684387
protein-tyrosine O B-protein 0.4860466420650482
phosphatases O E-protein 0.9752544164657593
, O O 0.9993314743041992
many O O 0.9999889135360718
of O O 0.9999984502792358
which O O 0.9998383522033691

or O O 0.9688552021980286
mitogenic O O 0.7825919389724731
stimulation O O 0.9899433851242065
. O O 0.9999946355819702
Yet O O 0.9999798536300659
these O O 0.9999934434890747
same O O 0.9998935461044312
cells O O 0.9825485944747925
do O O 0.9999959468841553
initiate O O 0.9999696016311646
early O O 0.9504221081733704
TCR S-protein S-protein 0.9878222346305847
-mediated O O 0.9954009652137756
signaling O O 0.9831556081771851
events O O 0.9994344115257263
, O O 0.9999896287918091
such O O 0.9999942779541016
as O O 0.9999918937683105
generation O O 0.9724664092063904
of O O 0.9997978806495667
inositol O B-protein 0.6558226943016052
phosphates O E-protein 0.7089414596557617
and O O 0.9994035959243774
increased O O 0.9982426166534424
intracellular O O 0.8627043962478638
calcium O O 0.8992987275123596

have O O 0.9996067881584167
investigated O O 0.9999691247940063
the O O 0.9999951124191284
molecular O O 0.9444423913955688
mechanisms O O 0.996543824672699
by O O 0.9999972581863403
which O O 0.9999510049819946
T B-cell_line B-cell_line 0.4899575412273407
cell I-cell_line I-cell_line 0.6714999675750732
lines E-cell_line E-cell_line 0.9952528476715088
stimulated O O 0.9989657402038574
with O O 0.9999735355377197
phorbol O O 0.9676274061203003
12-myristate O O 0.9966303706169128
13-acetate O O 0.9949801564216614
( O O 0.9999008178710938
PMA O O 0.9972383975982666
) O O 0.999893069267273
and O O 0.9999756813049316
phytohemagglutin S-protein O 0.920766294002533
( O O 0.9986577033996582
PHA S-protein O 0.9547093510627747
) O O 0.9986675977706909
display O O 0.9997708201408386
significantly O O 0.9993917942047119
higher O O 0.9996801614761353
levels O O 0.9998061060905457
of O O 0.9999903440475464
NF-kappa B-protein B-protein 0.4527932405471802
B1 E-protein E-protein 0.9084405303001404
encoding O O 0.8120121955871582
transcripts S-RNA O 0.36864498257637024
than O O 0.9993935823440552
cells O O 0.9667631983757019
stimulated O O 0.9992196559906006
with O O 0.9999762773513794
tumor B-protein B-protein 0.514316976070404
necrosis I-protein I-protein 0.6684926152229309
factor-alpha E-protein E-protein 0.967720091342926
, O O 0.9915478825569153
despite O O 0.9999804496765137
the O O 0.9999994039535522
fact O O 0.9998205304145813

the O O 0.9982926249504089
transcription B-protein B-protein 0.5682793259620667
factor I-protein E-protein 0.9644365310668945
nuclear I-protein B-protein 0.5171892046928406
factor-kappaB E-protein E-protein 0.9961821436882019
( O O 0.983259916305542
NFkappaB S-protein S-protein 0.9984695315361023
) O O 0.9911205172538757
is O O 0.9999754428863525
impaired O O 0.99985671043396
in O O 0.9998898506164551
T B-cell_type B-cell_type 0.9219858646392822
cells E-cell_type E-cell_type 0.9971832633018494
from O O 0.9999432563781738
patients O O 0.9995373487472534
with O O 0.9999792575836182
renal O O 0.9605199694633484
cell O O 0.9665265679359436
carcinomas O O 0.9914554953575134
( O O 0.9997105002403259

the O O 0.9991816878318787
long B-DNA B-DNA 0.6306147575378418
terminal I-DNA I-DNA 0.7625637650489807
repeat E-DNA E-DNA 0.9935737252235413
( O O 0.9908073544502258
LTR O S-DNA 0.9950255751609802
) O O 0.9676542282104492
of O O 0.9998353719711304
HIV-1 O O 0.8052303791046143
increases O O 0.9995298385620117
in O O 0.9999572038650513
response O O 0.9979804158210754
to O O 0.9999845027923584
mitogenic O O 0.8469700217247009
stimuli O O 0.9431414008140564
of O O 0.999484658241272
T B-cell_type B-cell_type 0.903277575969696
cells E-cell_type E-cell_type 0.9942518472671509
. O O 0.9999122619628906
Here O O 0.9999909400939941
we O O 0.9999914169311523
show O O 0.9999990463256836
that O O 0.9999992847442627
the O O 0.999985933303833
response O O 0.998681366443634
of O O 0.9999915361404419
the O O 0.9998704195022583
HIV-1 B-DNA B-DNA 0.76011723279953
LTR E-DNA E-DNA 0.9991324543952942
may O O 0.999887228012085
be O O 0.9999959468841553
governed O O 0.9997593760490417
by O O 0.9999990463256836
two O O 0.9985540509223938
independent O O 0.9595826268196106
sequences O O 0.7534341216087341
located O O 0.999744713306427
5 O O 0.5094718933105469
' O O 0.3987513482570648
to O O 0.5964048504829407

HSP27 S-protein S-protein 0.7203951478004456
in O O 0.9999064207077026
the O O 0.9999951124191284
signal O O 0.9191831350326538
transduction O O 0.9683799743652344
events O O 0.9986714124679565
of O O 0.9999924898147583
platelet S-cell_type O 0.44068893790245056
activation O O 0.9906342029571533
. O O 0.9999921321868896
Isolation O O 0.9988872408866882
of O O 0.99997878074646
a O O 0.999903678894043
candidate O B-protein 0.6227500438690186
repressor/activator O E-protein 0.7815950512886047
, O O 0.9348551034927368
NF-E1 S-protein S-protein 0.821365237236023
( O O 0.9661453366279602
YY-1 S-protein S-protein 0.8022933006286621
, O O 0.8731655478477478
delta S-protein S-protein 0.34996578097343445
) O O 0.34670382738113403

surrounding O O 0.9975904226303101
the O O 0.9999480247497559
globin B-DNA B-DNA 0.6939693093299866
genes E-DNA E-DNA 0.9964032173156738
. O O 0.9999527931213379
Structure-function O O 0.9612000584602356
studies O O 0.9956040382385254
of O O 0.9999703168869019
the O O 0.9999666213989258
GATA-1 S-protein B-protein 0.8114116191864014
protein O E-protein 0.8500338792800903
could O O 0.9995710253715515
be O O 0.9999929666519165
greatly O O 0.9999051094055176
simplified O O 0.9999600648880005
and O O 0.999977707862854
a O O 0.9999686479568481

the O O 0.9978005290031433

delay O O 0.8734499216079712
growth O O 0.9887374639511108
late O O 0.999728262424469
in O O 0.9999871253967285
G1 O O 0.8146970272064209
phase O O 0.9317353367805481
and O O 0.9992315769195557
transiently O O 0.9825435280799866
arrest O O 0.9997428059577942
these O O 0.9996204376220703
cells O O 0.9709413647651672
from O O 0.9999524354934692
progressing O O 0.9915191531181335
into O O 0.9999618530273438
the O O 0.9999325275421143
S O O 0.8455056548118591
phase O O 0.9264914989471436
. O O 0.9999696016311646
This O O 0.9999939203262329
hypothetical O O 0.9500861763954163
model O O 0.9515493512153625
integrates O O 0.9998834133148193
one O O 0.9998921155929565
mechanism O O 0.9886771440505981
of O O 0.9997150301933289
DNA O O 0.9577104449272156
repair O O 0.9968882203102112
with O O 0.9999946355819702

activity O O 0.9897701740264893
of O O 0.9999699592590332
a O O 0.9999774694442749
natural O B-DNA 0.7120006084442139
immunoglobulin B-DNA I-DNA 0.3962183892726898
promoter E-DNA E-DNA 0.9880792498588562
in O O 0.9997753500938416
an O O 0.9999575614929199
octamer B-DNA B-DNA 0.5914267301559448
site E-DNA E-DNA 0.9836432337760925
-dependent O O 0.9756272435188293
manner O O 0.9970982074737549
. O O 0.9999960660934448
Thus O O 0.999799907207489
, O O 0.9997902512550354
OBF-1 S-protein S-protein 0.9663600325584412
has O O 0.9997181296348572
all O O 0.9999830722808838

TCL1 S-protein S-protein 0.8171173334121704
protein O O 0.5191652178764343
expression O O 0.9946985244750977
is O O 0.9999874830245972
restricted O O 0.9996548891067505
to O O 0.9999808073043823
tumor O B-cell_type 0.5994161367416382
cells O E-cell_type 0.9897807836532593
in O O 0.9998941421508789
AIDS O O 0.9379091858863831
IBLP O O 0.9214364290237427
tissue O O 0.9797878861427307
samples O O 0.9863213896751404
analyzed O O 0.9998177886009216
with O O 0.9999681711196899
immunohistochemical O O 0.7843070030212402
staining O O 0.9711328744888306
. O O 0.9999792575836182
Hyperplastic O O 0.8577291369438171
lymph O O 0.8235330581665039
node O O 0.8479386568069458
and O O 0.9816061854362488
tonsil O O 0.9651511311531067
also O O 0.9995577931404114
exhibit O O 0.9999412298202515
strong O O 0.982698380947113
TCL1 S-protein B-protein 0.8076121807098389
protein O E-protein 0.846072793006897
expression O O 0.9948809146881104
in O O 0.9999721050262451
mantle B-cell_type B-cell_type 0.48594027757644653
zone I-cell_type I-cell_type 0.44370636343955994
B I-cell_type I-cell_type 0.48349371552467346
cells E-cell_type E-cell_type 0.5854607224464417
and O O 0.9987248778343201
in O O 0.9999279975891113
rare O O 0.9852386116981506
interfollicular B-cell_type O 0.746084451675415
zone I-cell_type O 0.7180465459823608

subfamily O O 0.4708115756511688
of O O 0.9982051849365234
Pax B-protein B-protein 0.5147925615310669
proteins E-protein E-protein 0.9933493733406067
is O O 0.9998458623886108
determined O O 0.9999877214431763
by O O 0.9999990463256836
a O O 0.9999637603759766
C-terminal B-protein B-protein 0.7650085687637329
regulatory I-protein I-protein 0.8110952973365784
module E-protein E-protein 0.8181552290916443
composed O O 0.9776186347007751
of O O 0.9997801184654236
activating B-DNA B-DNA 0.5987739562988281
and I-DNA I-DNA 0.8134376406669617
inhibitory I-DNA I-DNA 0.41688889265060425
sequences E-DNA E-DNA 0.9619061946868896
. O O 0.9999816417694092
Second O O 0.9715837240219116
messenger O O 0.8756995797157288
up-regulation O O 0.9972639083862305
of O O 0.9999786615371704
androgen B-DNA B-DNA 0.34067222476005554
receptor I-DNA I-DNA 0.8110091090202332
gene E-DNA E-DNA 0.9006337523460388
transcription O O 0.8894185423851013
is O O 0.9998596906661987
absent O O 0.9999850988388062
in O O 0.9999828338623047

A O O 0.988934338092804
specific O O 0.9920145273208618
inhibitor O O 0.9713308811187744
of O O 0.999767005443573
p38 O B-protein 0.5431756973266602
MAP O I-protein 0.6990674734115601
kinase O E-protein 0.9791842699050903
completely O O 0.9985336065292358
inhibits O O 0.9999730587005615
the O O 0.99997878074646
serine O O 0.6252095103263855
phosphorylation O O 0.767210066318512
of O O 0.9950591325759888
STAT1 S-protein S-protein 0.9932447075843811
and O O 0.9964762330055237
STAT3 S-protein S-protein 0.9975538849830627
induced O O 0.999544084072113
by O O 0.9999635219573975
IL-12 S-protein S-protein 0.9909281134605408
and O O 0.9976109266281128

slower B-protein O 0.9454577565193176
migrating I-protein O 0.9552562832832336
forms E-protein O 0.9765552878379822
into O O 0.9999979734420776
the O O 0.9999346733093262

TNF-alpha B-RNA I-RNA 0.3432422876358032
and I-RNA I-RNA 0.6838202476501465
IL-6 I-RNA I-RNA 0.8773313164710999
mRNAs E-RNA E-RNA 0.996491014957428
was O O 0.9985162615776062
also O O 0.9999756813049316
induced O O 0.9999668598175049
. O O 0.9999985694885254
The O O 0.9999980926513672
levels O O 0.9995949864387512
of O O 0.9999874830245972
secreted O O 0.8421413898468018

the O O 0.9980219602584839
insertion O O 0.980295717716217
did O O 0.999872088432312
contribute O O 0.9999988079071045
to O O 0.9999984502792358
the O O 0.9999978542327881
formation O O 0.999570906162262
of O O 0.9999927282333374
caps O O 0.810925304889679
in O O 0.9991942048072815
response O O 0.9974961876869202
to O O 0.9999567270278931
receptor O O 0.8425590395927429
cross-linking O O 0.9592891931533813
, O O 0.9994799494743347
consistent O O 0.9982397556304932
with O O 0.9999916553497314
suggestions O O 0.9997650980949402

that O O 0.9989551305770874
specific O O 0.9870081543922424
DNA-protein B-protein B-protein 0.4127713143825531
complexes E-protein E-protein 0.9926273226737976
can O O 0.9997501969337463
be O O 0.999963641166687
formed O O 0.9997661709785461
with O O 0.9999921321868896
each O O 0.9996777772903442
element O O 0.8093315958976746
, O O 0.9992055296897888
and O O 0.9999326467514038
that O O 0.9999984502792358
there O O 0.9999954700469971
are O O 0.999993085861206
cell-specific O O 0.9318601489067078
differences O O 0.998568058013916
in O O 0.9999812841415405
factors O O 0.9269188046455383
, O O 0.9996761083602905
which O O 0.9999607801437378
bind O O 0.9994780421257019
to O O 0.9999830722808838
the O O 0.9999681711196899
SP-1-like B-DNA B-DNA 0.8535275459289551
element E-DNA E-DNA 0.9612668752670288
between O O 0.9894634485244751
MEL B-cell_line O 0.6389887928962708
and I-cell_line O 0.8705168962478638
NIH3T3 I-cell_line B-cell_line 0.5728701949119568
cells E-cell_line E-cell_line 0.9904718399047852
. O O 0.999902606010437
These O O 0.9999988079071045
results O O 0.999971866607666
provide O O 0.9999992847442627
evidence O O 0.9999877214431763
for O O 0.9999982118606567
differential O O 0.997620165348053
regulation O O 0.9998903274536133
of O O 0.9999973773956299
the O O 0.999889612197876
promoter O O 0.4676324129104614
function O O 0.9591751098632812
of O O 0.9992596507072449

. O O 0.9992222785949707
At O O 0.999998927116394
the O O 0.9999991655349731
end O O 0.9946229457855225
of O O 0.9999418258666992
both O O 0.9998853206634521
treatment O O 0.9947092533111572
periods O O 0.9998633861541748
symptoms O O 0.9990954399108887
were O O 0.999998927116394
scored O O 0.9999645948410034
after O O 0.9999879598617554
allergen O O 0.7839639782905579
provocation O O 0.9919350147247314
( O O 0.9999334812164307
100 O O 0.9750628471374512
, O O 0.998643696308136
1000 O O 0.9918652176856995
, O O 0.9998470544815063
10000 O O 0.9989755153656006
BU/mL O O 0.9928804636001587
) O O 0.9998430013656616

and O O 0.9376595616340637

However O O 0.9990972280502319
, O O 0.9999746084213257
plasma O O 0.8587186932563782
free O O 0.9832947850227356
cortisol O O 0.9719654321670532
concentrations O O 0.9987502098083496
were O O 0.9999991655349731
similar O O 0.9999960660934448
in O O 0.9999967813491821
the O O 0.9999982118606567
three O O 0.9986269474029541
groups O O 0.9958239793777466
. O O 0.9999978542327881
There O O 0.999994158744812
was O O 0.999997615814209
no O O 0.9999994039535522
difference O O 0.9999984502792358
in O O 0.9999982118606567
the O O 0.999997615814209
number O O 0.9990647435188293
of O O 0.9999842643737793
GR S-protein S-protein 0.7842676043510437
per O O 0.968168318271637
cell O O 0.8466616868972778
among O O 0.9999485015869141
the O O 0.9999916553497314
three O O 0.9987860321998596
groups O O 0.9981069564819336
( O O 0.9999381303787231
FMS O O 0.9925087094306946
: O O 0.9998730421066284
6498 O O 0.9989346861839294
+/- O O 0.9999063014984131
252 O O 0.9979593753814697
, O O 0.9999381303787231
LBP O O 0.9831418991088867
: O O 0.9996613264083862
6625 O O 0.9948164820671082

cell I-cell_line O 0.3503861725330353

by O O 0.9993865489959717
multiple O O 0.9043744206428528
phosphorylations O O 0.8476925492286682
. O O 0.9999598264694214
The O O 0.9999960660934448
activation O O 0.9924547672271729
of O O 0.9999179840087891
nuclear B-protein B-protein 0.5320228934288025
factor I-protein I-protein 0.4914838969707489
kappa I-protein I-protein 0.8454205989837646
B E-protein E-protein 0.9959839582443237
( O O 0.9946774244308472
NF-kappa B-protein B-protein 0.9623820781707764
B E-protein E-protein 0.9915376901626587
) O O 0.9844130873680115
in O O 0.9999102354049683
intact O B-cell_type 0.6763182878494263
cells O E-cell_type 0.916979968547821
is O O 0.999098539352417
mechanistically O O 0.9771113991737366
not O O 0.9915006160736084
well O O 0.9956014156341553
understood O O 0.9999215602874756
. O O 0.9999984502792358
Therefore O O 0.999994158744812
we O O 0.9999866485595703
investigated O O 0.9999853372573853
the O O 0.999997615814209
modifications O O 0.9995738863945007
imposed O O 0.9999953508377075
on O O 0.9999693632125854
NF-kappa B-protein B-protein 0.5433844327926636
B/I I-protein I-protein 0.9638373255729675
kappa I-protein I-protein 0.7247416377067566
B I-protein E-protein 0.8262376189231873
components E-protein O 0.5719165802001953
following O O 0.9998182654380798
stimulation O O 0.9990425705909729
and O O 0.9999779462814331
show O O 0.9999798536300659
that O O 0.9999983310699463
the O O 0.9999957084655762
final O O 0.9908716082572937
step O O 0.9987437129020691
of O O 0.9999836683273315
NF-kappa B-protein B-protein 0.7503160238265991
B E-protein E-protein 0.9954438209533691
induction O O 0.9993208646774292
in O O 0.9999867677688599
vivo O O 0.9813092350959778

proliferation O O 0.9851269125938416
was O O 0.9999828338623047
induced O O 0.9999933242797852
by O O 0.9999995231628418
three O O 0.9996106028556824
peptides O O 0.9136635065078735
, O O 0.9995057582855225
P1 O O 0.48660245537757874
, O O 0.9939337372779846
P4 O O 0.7426309585571289
, O O 0.9975451827049255
and O O 0.9996488094329834
P7 O O 0.8994921445846558
, O O 0.9999246597290039
in O O 0.9999967813491821
71-100 O O 0.9808017611503601
% O O 0.9985395669937134
of O O 0.999997615814209
the O O 0.9999895095825195
donors O O 0.9949527978897095

. O O 0.9993178844451904
Analysis O O 0.9999639987945557
of O O 0.9999935626983643
truncated O B-DNA 0.39561253786087036
LTRs S-DNA E-DNA 0.9529910087585449
confirmed O O 0.9997405409812927
that O O 0.9999974966049194
inhibition O O 0.9943143725395203
of O O 0.9998935461044312
LTR S-DNA S-DNA 0.9802795648574829
activation O O 0.9969028830528259
was O O 0.9999948740005493
not O O 0.9999420642852783
mediated O O 0.9998970031738281
through O O 0.9999898672103882
NF-kappa B-protein B-protein 0.8578024506568909
B E-protein E-protein 0.9996945858001709
-binding O O 0.9908387064933777
activity O O 0.9970563650131226
but O O 0.9999722242355347
through O O 0.9999973773956299
the O O 0.9999912977218628

Southwestern O O 0.7660955786705017
blot O O 0.6816825866699219
, O O 0.9922783374786377
and O O 0.9996961355209351
antibody O O 0.8130810856819153
ablation/supershift O O 0.8601791262626648
assays O O 0.9973652958869934
revealed O O 0.9999923706054688
that O O 0.9999994039535522
it O O 0.9998906850814819
is O O 0.9999886751174927
similar O O 0.9999889135360718
to O O 0.999997615814209
a O O 0.9999818801879883
recently O O 0.9562661051750183
reported O O 0.9935185313224792
nuclear B-protein B-protein 0.6006312966346741
factor E-protein E-protein 0.9233543872833252
designated O O 0.934022068977356
SAF S-protein S-protein 0.9402625560760498
. O O 0.9999490976333618
These O O 0.9999954700469971
results O O 0.9999628067016602
demonstrated O O 0.9999973773956299
that O O 0.9999996423721313
LPS-mediated O O 0.8419114947319031
SAA S-protein B-DNA 0.45345762372016907
gene O E-DNA 0.9893546104431152
induction O O 0.998809814453125
in O O 0.9999111890792847
monocyte/macrophage B-cell_type B-cell_type 0.7765488028526306
cells E-cell_type E-cell_type 0.9515156745910645
is O O 0.9997370839118958
primarily O O 0.9994553923606873
due O O 0.9999949932098389
to O O 0.9999977350234985
the O O 0.9999983310699463
induction O O 0.9999284744262695
of O O 0.9999967813491821
SAF S-protein S-protein 0.6456337571144104

Use O O 0.9952893257141113
of O O 0.9999685287475586
new O O 0.9619116187095642
biologic O O 0.7992748618125916
markers O O 0.5248644351959229
in O O 0.9999810457229614
the O O 0.9999953508377075
ovulation O O 0.8952521085739136
induction O O 0.9982566237449646
. O O 0.9999982118606567
Biological O O 0.9684231281280518
markers O O 0.9796661734580994
of O O 0.9996786117553711
ovulation O O 0.9959404468536377
, O O 0.999967098236084
after O O 0.9999908208847046
a O O 0.9999802112579346
great O O 0.9999128580093384
in O O 0.9999881982803345
the O O 0.9999951124191284
past O O 0.9995077848434448
, O O 0.999968409538269
have O O 0.999992847442627
been O O 0.9999830722808838
fallen O O 0.9973238706588745

lineage E-cell_type O 0.5851185917854309
being O O 0.9983764886856079
more O O 0.9995836615562439
severely O O 0.9972990155220032
affected O O 0.9999817609786987
. O O 0.999998927116394
These O O 0.9999992847442627
data O O 0.9996330738067627
provide O O 0.9999980926513672
direct O O 0.9994876384735107
evidence O O 0.9999806880950928
for O O 0.9999986886978149
the O O 0.9999986886978149
involvement O O 0.9999688863754272
of O O 0.9999966621398926
NF-kappaB/Rel B-protein B-protein 0.787508487701416
family I-protein I-protein 0.5522599816322327
proteins E-protein E-protein 0.9979907274246216
in O O 0.9999591112136841
late O O 0.9911168813705444
stages O O 0.99968421459198
of O O 0.9999719858169556
T B-cell_type O 0.6970230937004089
lymphocyte E-cell_type O 0.5550840497016907
development O O 0.9858976602554321
, O O 0.9999690055847168
coincident O O 0.9898382425308228

JAK1 S-protein S-protein 0.9561601281166077
and O O 0.9981125593185425
JAK2 S-protein S-protein 0.9871375560760498
followed O O 0.9999103546142578
by O O 0.9999940395355225
tyrosine O O 0.8399531841278076
phosphorylation O O 0.9438028931617737
of O O 0.999072790145874
STAT1alpha S-protein S-protein 0.9984971284866333
. O O 0.9999419450759888
Selective O O 0.9827590584754944
activation O O 0.9959088563919067
of O O 0.9999576807022095
STAT1alpha S-protein S-protein 0.9973611235618591
at O O 0.9999775886535645
the O O 0.9999369382858276
IFN-gamma B-protein B-protein 0.5356031060218811
receptor E-protein E-protein 0.9703420400619507
is O O 0.9986224174499512
achieved O O 0.9999663829803467
by O O 0.9999983310699463
specific O O 0.993021547794342
interaction O O 0.9969959259033203
between O O 0.9999163150787354
a O O 0.9999053478240967
cytosolic B-protein B-protein 0.5477224588394165
tyrosine I-protein I-protein 0.8766970038414001
motif E-protein E-protein 0.8697174191474915
including O O 0.9952496290206909
Y440 S-protein O 0.3858273923397064
in O O 0.9988763928413391
the O O 0.9999604225158691
IFN-gamma B-protein B-protein 0.33466771245002747
receptor I-protein I-protein 0.4663408398628235
alpha-chain E-protein E-protein 0.6798784136772156

receptor I-protein I-protein 0.32727381587028503
alpha E-protein E-protein 0.7826789617538452
( O O 0.7247588038444519
PPARalpha S-protein S-protein 0.595658004283905
) O O 0.5512672066688538
ligand O O 0.5109030604362488
WY O O 0.5258561968803406
14 O O 0.776421070098877
, O O 0.9794135093688965
643 O O 0.28081899881362915
does O O 0.9948846697807312
not O O 0.9997368454933167
interfere O O 0.9998763799667358
with O O 0.9999715089797974
leukotriene O B-protein 0.7968177199363708
B4 O E-protein 0.8225888609886169
induced O O 0.9840699434280396
adhesion O O 0.9849880933761597
of O O 0.9998182654380798
neutrophils S-cell_type S-cell_type 0.9960079193115234
to O O 0.9988762736320496
endothelial B-cell_type B-cell_type 0.8362817764282227
cells E-cell_type E-cell_type 0.9902052283287048
. O O 0.9999160766601562
Peroxisome B-protein B-protein 0.5362799167633057
proliferator-activated I-protein I-protein 0.8610901236534119
receptors E-protein E-protein 0.9734553098678589
( O O 0.9529703259468079
PPAR S-protein S-protein 0.951512336730957
) O O 0.8999220132827759
control O O 0.9476770758628845
discrete O B-DNA 0.7682748436927795
genes O E-DNA 0.9619070887565613
involved O O 0.9999558925628662
in O O 0.9999445676803589
fatty O O 0.6650943160057068
acid O O 0.8897523283958435
and O O 0.9948883652687073
lipid O O 0.9546360969543457

parasite-induced O O 0.8215104937553406
NF-kappaB S-protein S-protein 0.9769715666770935
activation O O 0.9991625547409058
plays O O 0.9999892711639404
a O O 0.9999934434890747
crucial O O 0.9996919631958008
role O O 0.9999781847000122
in O O 0.9999971389770508
the O O 0.9999929666519165
survival O O 0.9998564720153809
of O O 0.9999946355819702
T. B-cell_type B-cell_type 0.5247413516044617
parva-transformed I-cell_type I-cell_type 0.4255425035953522
T I-cell_type I-cell_type 0.7440885901451111
cells E-cell_type E-cell_type 0.9187309741973877
by O O 0.9996933937072754
conveying O O 0.9984671473503113
protection O O 0.9996305704116821
against O O 0.9999935626983643
an O O 0.9999707937240601
apoptotic O O 0.8903236389160156
signal O O 0.9809765219688416
that O O 0.9999817609786987
accompanies O O 0.9999264478683472
parasite-mediated O O 0.9712539911270142
transformation O O 0.9991118311882019
. O O 0.9999988079071045
Consequently O O 0.9999752044677734
, O O 0.9999891519546509
inhibition O O 0.9970085024833679
of O O 0.9999681711196899
NF-kappaB S-protein S-protein 0.9754331707954407
nuclear O O 0.9572547078132629
translocation O O 0.9896659851074219
and O O 0.9998704195022583
the O O 0.9999970197677612
expression O O 0.9986679553985596
of O O 0.9999872446060181
dominant B-protein B-protein 0.42510879039764404
negative I-protein I-protein 0.5458120107650757
mutant E-protein I-protein 0.6653408408164978
forms O E-protein 0.7330936789512634
of O O 0.9866422414779663
components O O 0.9132159352302551
of O O 0.9980689883232117
the O O 0.999854564666748
NF-kappaB S-protein S-protein 0.6161527633666992

infection O O 0.9822518825531006
of O O 0.999915599822998
human B-cell_type B-cell_type 0.6612119674682617
thymocytes E-cell_type E-cell_type 0.9849550724029541
: O O 0.9971713423728943
simultaneous O O 0.9900325536727905
early O O 0.9624542593955994
expression O O 0.9984161853790283
of O O 0.9999839067459106
BZLF-1 S-protein S-protein 0.9702695608139038
and O O 0.9988572597503662
its O O 0.9999070167541504
repressor O O 0.8253631591796875
RAZ S-protein S-protein 0.5378569960594177
. O O 0.9994428753852844
Epstein-Barr O O 0.8694387078285217
virus O O 0.8496735095977783
( O O 0.9945008754730225
EBV O O 0.9825084209442139
) O O 0.9991511106491089
is O O 0.9999945163726807
known O O 0.9999736547470093
to O O 0.9999779462814331

some O O 0.9991770386695862
environmental O O 0.9615761041641235
estrogens O O 0.8697773218154907
that O O 0.9999524354934692
display O O 0.9987198114395142
agonist O O 0.9465508460998535
activity O O 0.9974773526191711
in O O 0.9999836683273315
reproductive O O 0.871813952922821
tissue O O 0.9787948131561279
also O O 0.9999779462814331
have O O 0.9999988079071045
an O O 0.9999988079071045
effect O O 0.9999949932098389
on O O 0.9999983310699463
IL-1 B-DNA S-protein 0.6978325843811035

that O O 0.9995773434638977
the O O 0.9999892711639404
type B-protein B-protein 0.579396665096283
II I-protein I-protein 0.7802671194076538
IL-1R E-protein E-protein 0.9712640047073364
does O O 0.9989690780639648
not O O 0.9999808073043823
mediate O O 0.9975511431694031
gene O O 0.940192461013794
activation O O 0.9987164735794067
in O O 0.9999750852584839
Jurkat B-cell_line B-cell_line 0.9085736870765686
cells E-cell_line E-cell_line 0.9976467490196228
. O O 0.9998881816864014
However O O 0.9999887943267822
, O O 0.9999856948852539
a O O 0.9999896287918091
hybrid O O 0.5932518839836121

process O O 0.9446261525154114
. O O 0.9999899864196777
The O O 0.9999903440475464
CD34+ B-cell_line B-cell_line 0.4461698830127716
myelomonocytic I-cell_line I-cell_line 0.9042304158210754
cell I-cell_line I-cell_line 0.8887346982955933
line E-cell_line I-cell_line 0.9237944483757019
KG1 S-cell_line E-cell_line 0.7529403567314148
differentiates O O 0.9925210475921631
into O O 0.9994680285453796
dendritic-like O B-cell_type 0.5450635552406311
cells O E-cell_type 0.649393618106842
in O O 0.9995689988136292
response O O 0.9987894892692566
to O O 0.9999843835830688
granulocyte-macrophage B-protein B-protein 0.6935189962387085
CSF E-protein E-protein 0.7659146785736084
plus O O 0.9926257729530334
TNF-alpha S-protein S-protein 0.9479174613952637
, O O 0.9962462782859802
or O O 0.9998437166213989
PMA O O 0.885845422744751
( O O 0.9907825589179993
with O O 0.9995997548103333
or O O 0.9992420673370361
without O O 0.9999639987945557
the O O 0.9999719858169556
calcium O O 0.7007724642753601
ionophore O O 0.6388413310050964
ionomycin O O 0.44114282727241516

DNA-binding O O 0.6201214790344238
specificity O O 0.9198663234710693
of O O 0.9976916313171387
which O O 0.9999381303787231
mimics O O 0.9991668462753296
that O O 0.9999914169311523
of O O 0.9999879598617554
the O O 0.999972939491272
cellular B-protein B-protein 0.5921071171760559
repressor E-protein E-protein 0.7934910655021667
. O O 0.9984215497970581
By O O 0.9999699592590332
employing O O 0.9999672174453735
a O O 0.999976634979248
derivative O O 0.8164395689964294
E B-DNA B-DNA 0.33143025636672974
box E-DNA E-DNA 0.9223266839981079
that O O 0.998988926410675
binds O O 0.9996639490127563
ZEB S-protein S-protein 0.8202120661735535
but O O 0.9832428097724915
not O O 0.9939436316490173
E2A S-protein S-protein 0.9276519417762756
, O O 0.9982306361198425
we O O 0.9999260902404785
have O O 0.9999909400939941
shown O O 0.9999935626983643
that O O 0.9999974966049194
the O O 0.9999047517776489
repressor S-protein S-protein 0.5098348259925842
is O O 0.9843204021453857
active O O 0.9828737378120422
in O O 0.9991564750671387
B B-cell_type B-cell_type 0.8772412538528442
cells E-cell_type E-cell_type 0.990931510925293
and O O 0.9983711838722229

the O O 0.9995684027671814
rapid O O 0.9765968918800354
but O O 0.9983147382736206
transient O O 0.9929393529891968
action O O 0.9990566372871399
of O O 0.9999837875366211
nuclear B-protein B-protein 0.565316379070282
NF-kappa I-protein I-protein 0.6454639434814453
B E-protein E-protein 0.9967333078384399
. O O 0.9998207688331604
Effects O O 0.999823272228241
of O O 0.9999891519546509
CD45 S-protein S-protein 0.9709699153900146
on O O 0.9996944665908813
NF-kappa B-protein B-protein 0.8388427495956421
B E-protein E-protein 0.9967170357704163
. O O 0.9998000264167786
Implications O O 0.9998787641525269
for O O 0.9999947547912598
replication O O 0.9968072175979614
of O O 0.9999651908874512
HIV-1 O O 0.8807501792907715
. O O 0.9999129772186279
Increased O O 0.999901533126831
levels O O 0.9997230172157288
of O O 0.9999816417694092
replication O O 0.991424024105072
of O O 0.9999251365661621
the O O 0.9999845027923584
HIV O O 0.4132900536060333
type O O 0.5062864422798157
1 O O 0.4289425313472748
are O O 0.9315189123153687
observed O O 0.9975634813308716
after O O 0.9999910593032837
the O O 0.9999973773956299
activation O O 0.9968029260635376
of O O 0.999914288520813
infected B-cell_type O 0.49923470616340637

suggest O O 0.9991629123687744
that O O 0.9999980926513672
cortisol O O 0.7887219190597534
binding O O 0.9062486290931702
to O O 0.9979129433631897
glucocorticoid B-protein B-protein 0.8755158185958862
receptor E-protein E-protein 0.9920036196708679
is O O 0.9994491934776306
slightly O O 0.9998297691345215
impaired O O 0.9999639987945557
in O O 0.9999932050704956
patients O O 0.9995483756065369
with O O 0.9999860525131226

contrast O O 0.9576767086982727

, O O 0.8835327625274658
and O O 0.9733524322509766
NF-kappaB-inducing B-protein B-protein 0.6610706448554993
kinase E-protein E-protein 0.9789328575134277
, O O 0.99160236120224
when O O 0.9999139308929443
coexpressed O O 0.962051272392273
with O O 0.9997588992118835
TLR2 S-protein S-protein 0.976780354976654
, O O 0.999396800994873
abrogate O O 0.979353129863739
TLR2 S-protein S-protein 0.982494056224823
-mediated O O 0.9971708655357361
NF-kappaB S-protein S-protein 0.9974513649940491
activation O O 0.9991821646690369
. O O 0.9999982118606567
These O O 0.999998927116394
results O O 0.9999731779098511
reveal O O 0.9999979734420776

expressed O O 0.9791916012763977
ICAM-1 S-protein S-protein 0.973762571811676
and O O 0.9963282942771912
enhanced O O 0.9906362891197205
surface O O 0.9250695109367371
expression O O 0.9937211275100708
of O O 0.9999574422836304
preformed O O 0.5929027199745178
P-selectin S-protein S-protein 0.5500178933143616
. O O 0.9992837309837341
Phase-2 O O 0.7566310167312622
neutrophil O O 0.6557362079620361
adhesion O O 0.9845476746559143
was O O 0.9999743700027466
attenuated O O 0.9997703433036804
by O O 0.9999988079071045
an O O 0.9999545812606812
anti-E-selectin B-protein B-protein 0.7040970325469971
mAb E-protein E-protein 0.9934412240982056
, O O 0.9981493949890137
indicating O O 0.9999922513961792
a O O 0.9999980926513672
dominant O O 0.9775975346565247
role O O 0.9992478489875793
of O O 0.9999922513961792
this O O 0.9999817609786987
adhesion O B-protein 0.7126691937446594
molecule O E-protein 0.9900203943252563
in O O 0.9999475479125977
the O O 0.9999961853027344
late O O 0.9697049260139465
phase O O 0.9388628602027893
response O O 0.9587029814720154
. O O 0.9999165534973145
Pretreatment O O 0.9735722541809082
with O O 0.9998016953468323

regulatory I-protein I-protein 0.4460345208644867
domain E-protein E-protein 0.8603271842002869
. O O 0.9996790885925293
NFAT S-protein S-protein 0.9602482914924622
binding O O 0.9730424880981445
to O O 0.9997736811637878
the O O 0.9996229410171509
calcineurin B-protein B-protein 0.5810231566429138
catalytic I-protein I-protein 0.6903768181800842
domain E-protein E-protein 0.9524481296539307
was O O 0.999371349811554
inhibited O O 0.9999808073043823
by O O 0.9999992847442627
the O O 0.9999822378158569
calcineurin B-protein B-protein 0.758948802947998
autoinhibitory I-protein I-protein 0.54491126537323
domain E-protein E-protein 0.9811858534812927
and O O 0.9987437129020691
the O O 0.9999629259109497
RII O O 0.5301067233085632
substrate O O 0.3882104754447937
peptide O O 0.5230303406715393

to O O 0.9929365515708923

) O O 0.8630079627037048
in O O 0.9998728036880493
the O O 0.999996542930603
intracellular B-protein B-protein 0.5539126396179199
domain E-protein E-protein 0.9737313389778137
of O O 0.9983645081520081
the O O 0.9999380111694336
murine O B-protein 0.8168701529502869
IL-10 S-protein I-protein 0.8719078302383423
receptor O E-protein 0.9588654041290283
were O O 0.9987697005271912
found O O 0.9999648332595825
to O O 0.9999856948852539
be O O 0.9999809265136719
redundantly O O 0.9964588284492493
required O O 0.9999542236328125
for O O 0.999976634979248
receptor O O 0.8200151324272156
function O O 0.9874413013458252
and O O 0.9996227025985718
for O O 0.9999701976776123
activation O O 0.9924780130386353

in O O 0.9993813037872314
the O O 0.9999916553497314
GM-CSF B-DNA B-DNA 0.5307806134223938
promoter E-DNA E-DNA 0.9968894124031067
plays O O 0.9994422793388367
a O O 0.9999929666519165
central O O 0.9984475374221802
role O O 0.9999880790710449
in O O 0.999998927116394
the O O 0.9999974966049194
transcriptional O O 0.9717615246772766
activation O O 0.9968106150627136
of O O 0.9999790191650391
the O O 0.9999891519546509
endogenous O B-DNA 0.639086127281189
GM-CSF B-DNA I-DNA 0.6530594229698181
gene E-DNA E-DNA 0.9975905418395996
. O O 0.9998607635498047
Colinear O O 0.8281972408294678
triplex O O 0.6299570798873901
formation O O 0.9150724411010742
acts O O 0.9993709921836853
as O O 0.9999898672103882
a O O 0.9999815225601196
selective O O 0.8881644010543823
transcriptional O O 0.6982760429382324
repressor O O 0.6605905294418335
of O O 0.966865599155426
the O O 0.9992068409919739
GM-CSF B-DNA B-DNA 0.5573689341545105
gene E-DNA E-DNA 0.978040337562561
and O O 0.9966707825660706
may O O 0.9999550580978394
have O O 0.9999926090240479
potential O O 0.997835099697113

, O O 0.9373978972434998

( O O 0.9350138902664185
also O O 0.9869912266731262
known O O 0.9994753003120422
as O O 0.9996089339256287
LBP-1 S-protein S-protein 0.9722116589546204
, O O 0.9944077730178833
UBP S-protein S-protein 0.9645980000495911
, O O 0.985225260257721
and O O 0.9947934746742249
CP-2 S-protein S-protein 0.9670621156692505
) O O 0.9896299242973328
has O O 0.999975323677063
been O O 0.9999752044677734
shown O O 0.999988317489624
to O O 0.9999947547912598
repress O O 0.9997252821922302
LTR O S-DNA 0.9847840070724487
transcription O O 0.9188134670257568
in O O 0.9999305009841919
vitro O O 0.960780918598175

the O O 0.9994326233863831
regulation O O 0.9995670914649963
of O O 0.9999955892562866
I B-protein B-protein 0.7862138748168945
kappa I-protein I-protein 0.7686499953269958
B I-protein I-protein 0.512256920337677
alpha E-protein E-protein 0.9883455038070679
phosphorylation O O 0.9759277105331421
was O O 0.9999747276306152
investigated O O 0.9999817609786987
. O O 0.9999986886978149
Our O O 0.9999991655349731
studies O O 0.9998550415039062
demonstrate O O 0.9999985694885254
that O O 0.9999960660934448
incubation O O 0.9960578680038452
of O O 0.9999380111694336
human B-cell_type B-cell_type 0.5603853464126587
T I-cell_type I-cell_type 0.8226058483123779
cells E-cell_type E-cell_type 0.9704118967056274
with O O 0.9996857643127441
low O O 0.9770695567131042
concentrations O O 0.9841086268424988
( O O 0.9999294281005859
approximately O O 0.999887228012085
1-5 O O 0.9983115196228027
nM O O 0.9969081282615662
) O O 0.9999387264251709
of O O 0.9999924898147583
calyculin O S-protein 0.7326167225837708

assays O O 0.9756284952163696
showed O O 0.999983549118042
that O O 0.999997615814209
in O O 0.9850067496299744
vitro O O 0.9458465576171875
translated O O 0.9537915587425232
Pax-5a S-protein S-protein 0.5168999433517456
and O O 0.984550416469574
Pax-5d S-protein S-protein 0.9050382971763611
, O O 0.9974737763404846
but O O 0.9998214840888977
not O O 0.9995230436325073
Pax-5b S-protein S-protein 0.9336729645729065
or O O 0.9983648657798767
Pax-5e S-protein S-protein 0.9448812007904053
, O O 0.9961497783660889
could O O 0.9999896287918091
interact O O 0.9999728202819824
with O O 0.9999954700469971
a O O 0.9999098777770996
B-cell-specific B-DNA B-DNA 0.4347600042819977
activator I-DNA I-DNA 0.40366190671920776
protein-binding I-DNA I-DNA 0.5215360522270203
site E-DNA E-DNA 0.7408832907676697
on O O 0.9987776875495911

leading O O 0.9939101934432983
to O O 0.9998737573623657
gene O O 0.9471688866615295
transcription O O 0.9769730567932129
and O O 0.9989069700241089
translation O O 0.980402946472168
in O O 0.9993240833282471
leukocytes S-cell_type S-cell_type 0.9990829229354858
. O O 0.999797523021698
Transcription B-protein B-protein 0.5310950875282288
factors E-protein E-protein 0.9983888864517212
, O O 0.9995898604393005
such O O 0.9999532699584961

product E-protein E-protein 0.8972153067588806
. O O 0.9998526573181152
The O O 0.9999854564666748
NF-kappa B-protein B-protein 0.8675748109817505
B I-protein I-protein 0.8296297788619995
p65 I-protein I-protein 0.4219543933868408
subunit E-protein E-protein 0.9976820945739746
provides O O 0.9999278783798218
the O O 0.9999910593032837
transactivation O O 0.842156171798706
activity O O 0.9866570830345154
in O O 0.9999600648880005
this O O 0.9999622106552124
complex O O 0.8652207255363464
and O O 0.9910364151000977
serves O O 0.9989878535270691
as O O 0.9999903440475464
an O O 0.999963641166687
intracellular O B-protein 0.7858821153640747
receptor O E-protein 0.8553665280342102
for O O 0.9986501336097717
a O O 0.9999809265136719
cytoplasmic O O 0.4991768002510071
inhibitor O O 0.6756311655044556
of O O 0.9691285490989685
NF-kappa B-protein B-protein 0.8657769560813904

, O O 0.9703247547149658
stimulated O O 0.9908334612846375
by O O 0.9999845027923584
PMA O O 0.9850358963012695
and O O 0.9996578693389893
LPS O O 0.9912609457969666
in O O 0.999985933303833
the O O 0.9999932050704956
absence O O 0.9997254014015198
or O O 0.9999905824661255
the O O 0.9999948740005493
presence O O 0.9989352822303772
of O O 0.9999743700027466
IL-4 S-protein S-protein 0.9918264150619507
or O O 0.9987685084342957
IL-10 S-protein S-protein 0.9955333471298218
. O O 0.9999183416366577
Both O O 0.9999803304672241
IL-4 S-protein S-protein 0.9812620282173157
and O O 0.9955044388771057
IL-10 S-protein S-protein 0.9840270280838013
were O O 0.9999428987503052

NF B-protein B-protein 0.719298779964447
kappa I-protein I-protein 0.7037860751152039
B E-protein E-protein 0.9989416003227234
-mediated O O 0.9937974810600281
gene O O 0.978148341178894
expression O O 0.9999302625656128
. O O 0.9999983310699463
These O O 0.9999990463256836
results O O 0.9999325275421143
may O O 0.999995231628418
also O O 0.9999973773956299
provide O O 0.9999961853027344

cells O E-cell_type 0.5063624978065491
. O O 0.9999316930770874
Highly O O 0.9585875272750854
purified O O 0.9402657151222229
monocytes S-cell_type S-cell_type 0.8849933743476868
were O O 0.9997236132621765
incubated O O 0.9998987913131714
with O O 0.999990701675415
IL-10 S-protein S-protein 0.9102866053581238
for O O 0.9996926784515381
60 O O 0.9933708906173706
to O O 0.9993913173675537
90 O O 0.999903678894043
minutes O O 0.9996426105499268
before O O 0.9999995231628418
the O O 0.9999980926513672
addition O O 0.9998301267623901
of O O 0.9999920129776001
IFNgamma S-protein S-protein 0.959195613861084
or O O 0.9992079138755798
IFNalpha S-protein S-protein 0.9743922352790833
. O O 0.9996333122253418
IL-10 S-protein S-protein 0.9107941389083862
preincubation O O 0.9880324602127075
resulted O O 0.9999947547912598
in O O 0.9999978542327881
the O O 0.9999979734420776
inhibition O O 0.9981911778450012
of O O 0.9999829530715942
gene O O 0.9472095370292664
expression O O 0.9986779093742371
for O O 0.9999951124191284
several O O 0.9995549321174622
IFN-induced B-DNA B-DNA 0.544952392578125
genes E-DNA E-DNA 0.9865396618843079
, O O 0.9988942742347717
such O O 0.9999874830245972
as O O 0.999976396560669

whereas O O 0.9988402724266052
recruitment O O 0.9994990825653076
of O O 0.9999933242797852
EKLF S-protein S-protein 0.9442208409309387
to O O 0.9964010715484619
5'HS2 S-DNA S-DNA 0.9757236838340759
occurred O O 0.9997584223747253
in O O 0.9999865293502808
both O O 0.9989880919456482
gamma-globin-expressing B-cell_line B-cell_line 0.8147949576377869
K562 I-cell_line I-cell_line 0.7446544170379639
cells E-cell_line E-cell_line 0.9962073564529419
and O O 0.9966769218444824
murine B-cell_type B-cell_type 0.5711208581924438
erythroid I-cell_type I-cell_type 0.6078633666038513
leukemia I-cell_type I-cell_type 0.6687718033790588
cells E-cell_type E-cell_type 0.7180866003036499
. O O 0.9998898506164551
Unlike O O 0.9999984502792358
EKLF S-protein S-protein 0.9423989653587341
, O O 0.9992520213127136
Sp1 S-protein S-protein 0.9142065048217773

oncogene O E-DNA 0.6585903763771057

( O O 0.9183487296104431
ALD O O 0.42369920015335083
) O O 0.649424135684967
induce O O 0.9968516230583191
AP-1 S-protein S-protein 0.979884147644043
in O O 0.9999388456344604
human B-cell_type B-cell_type 0.5530356168746948
T I-cell_type I-cell_type 0.8771626353263855
lymphocytes E-cell_type E-cell_type 0.9890655279159546
. O O 0.9998383522033691
It O O 0.999983549118042
was O O 0.999969482421875
therefore O O 0.9999858140945435
hypothesized O O 0.9999806880950928
that O O 0.9999984502792358
ALD O O 0.9196252226829529
would O O 0.999981164932251
protect O O 0.9999810457229614
lymphocytes S-cell_type S-cell_type 0.9736915826797485
against O O 0.9992372989654541
BQ O O 0.6147880554199219
toxicity O O 0.9943602681159973
by O O 0.9999959468841553
inducing O O 0.9996339082717896
QR S-protein S-protein 0.9356349110603333

promoter O E-DNA 0.8999484181404114

center O O 0.7625926733016968
of O O 0.9988422989845276
peripheral O O 0.6930732727050781
lymphoid O O 0.5668060779571533
organs O O 0.4518429934978485
and O O 0.9685429930686951
is O O 0.999119222164154
not O O 0.9991856217384338
detected O O 0.9998494386672974
at O O 0.9999961853027344
significant O O 0.996692419052124
levels O O 0.99992835521698
in O O 0.9999974966049194
all O O 0.9998807907104492
other O O 0.999678373336792
mature O O 0.45596152544021606
or O O 0.830848753452301
immature B-cell_type O 0.6130905747413635
haematopoietic I-cell_type O 0.4988820552825928
populations E-cell_type O 0.591041624546051
studied O O 0.9625486731529236
, O O 0.9995847344398499
including O O 0.9999306201934814
bone B-cell_type B-cell_type 0.528393030166626
marrow I-cell_type I-cell_type 0.6939542293548584
cells E-cell_type E-cell_type 0.9495102763175964
, O O 0.9967790246009827
T B-cell_type B-cell_type 0.9602921605110168
lymphocytes E-cell_type E-cell_type 0.9976194500923157
, O O 0.9972521662712097
granulocytes S-cell_type S-cell_type 0.9940553903579712
, O O 0.991936206817627
monocytes S-cell_type S-cell_type 0.9951906204223633
, O O 0.9852231740951538
either O O 0.9995532631874084
at O O 0.9999780654907227
rest O O 0.9996117949485779

50 O O 0.8301122188568115
% O O 0.9911882877349854
of O O 0.9999788999557495
total O O 0.9535520076751709
Rap1 S-protein S-protein 0.8904334306716919
within O O 0.9996249675750732
30 O O 0.9550144076347351
s O O 0.9831915497779846
after O O 0.99994957447052
stimulation O O 0.9991735816001892
. O O 0.9999986886978149
An O O 0.9999949932098389
increase O O 0.9999557733535767
in O O 0.9999978542327881
the O O 0.9999885559082031
intracellular O O 0.9160043001174927
Ca2+ O O 0.8663879632949829
concentration O O 0.9963405728340149
is O O 0.9999961853027344
both O O 0.9999973773956299
necessary O O 0.9999644756317139
and O O 0.999972939491272
sufficient O O 0.999963641166687

mAb E-protein E-protein 0.9806078672409058
activated O O 0.9971152544021606
both O O 0.9998832941055298
PLD S-protein S-protein 0.8530129790306091
and O O 0.9624656438827515
transcription B-protein B-protein 0.5464886426925659
factor I-protein I-protein 0.822323203086853
AP-1 E-protein E-protein 0.9340201616287231
. O O 0.9996894598007202
Wortmannin O O 0.7908519506454468
, O O 0.9992617964744568
an O O 0.9999797344207764
inhibitor O O 0.9421113133430481
of O O 0.9975752234458923
receptor-coupled O O 0.8122615814208984
PLD S-protein S-protein 0.8134610652923584
activation O O 0.9754530191421509
, O O 0.9998428821563721
blocked O O 0.9998249411582947
the O O 0.999985933303833

thymocytes E-cell_type E-cell_type 0.5073540210723877
. O O 0.9999001026153564
Tumor B-protein B-protein 0.6815000176429749
necrosis I-protein I-protein 0.9496362209320068
factor E-protein E-protein 0.9878143072128296
( O O 0.981855034828186
TNF S-protein S-protein 0.9938860535621643
) O O 0.9803344011306763
and O O 0.9995332956314087
interleukin-7 S-protein S-protein 0.9926559925079346
( O O 0.9950064420700073
IL-7 S-protein S-protein 0.9979768395423889
) O O 0.9930043816566467
, O O 0.9999233484268188
secreted O O 0.9911353588104248
during O O 0.9999467134475708
this O O 0.999983549118042
interaction O O 0.9992644190788269
, O O 0.9999929666519165
are O O 0.999995231628418
critical O O 0.9994137287139893

Gribben O O 0.8905156254768372
et O O 0.9785747528076172
al. O O 0.999521017074585
1993 O O 0.9977414608001709
) O O 0.9999269247055054
. O O 0.999997615814209
Pancreatic O O 0.9744977355003357
development O O 0.999408483505249
and O O 0.9999735355377197
maturation O O 0.9988149404525757
of O O 0.9999847412109375
the O O 0.999958872795105
islet B-cell_type B-cell_type 0.4758094847202301
B I-cell_type I-cell_type 0.3519205152988434
cell E-cell_type E-cell_type 0.7200415730476379
. O O 0.9990808963775635
Studies O O 0.9999778270721436
of O O 0.9999935626983643
pluripotent B-cell_line B-cell_line 0.4691266715526581
islet I-cell_line I-cell_line 0.45433908700942993
cultures E-cell_line E-cell_line 0.9859171509742737
. O O 0.9999417066574097
Pancreas O O 0.9402133822441101
organogenesis O O 0.9935067892074585
is O O 0.9999803304672241
a O O 0.9999949932098389
highly O O 0.9386414885520935
regulated O O 0.9797627329826355

these O O 0.9977903366088867
genes O O 0.49549391865730286
in O O 0.9998946189880371
acute O O 0.8744666576385498
leukemias O O 0.9546114206314087
, O O 0.9994912147521973
10 O O 0.9995977282524109
cases O O 0.9998832941055298
( O O 0.9999927282333374
9 O O 0.9999181032180786
AML O O 0.9986176490783691
and O O 0.9999836683273315
1 O O 0.9998959302902222
ALL O O 0.9991994500160217
) O O 0.9999518394470215
with O O 0.9999972581863403
cytogenetically O O 0.9259538650512695
proven O O 0.9937130808830261
t B-DNA B-DNA 0.5376548171043396
( I-DNA I-DNA 0.8635530471801758
10 I-DNA I-DNA 0.5473216772079468
; I-DNA I-DNA 0.6915535926818848
11 I-DNA I-DNA 0.9586468935012817
) I-DNA I-DNA 0.6560618281364441
( I-DNA I-DNA 0.6192749738693237
p12-14 I-DNA I-DNA 0.7826901078224182
; I-DNA I-DNA 0.8601567149162292
q13-21 I-DNA E-DNA 0.6352730393409729
) E-DNA O 0.4947855472564697
and O O 0.9391447305679321
well-characterized O O 0.867455244064331
morphology O O 0.9326580166816711
, O O 0.9999299049377441

LDP O O 0.6414437890052795
not O O 0.9958090782165527
only O O 0.999990701675415
increases O O 0.999941349029541
plasma O O 0.9268403649330139
estradiol O O 0.9341211915016174
levels O O 0.9996832609176636
, O O 0.9999897480010986
but O O 0.9999760389328003
also O O 0.9999834299087524
increases O O 0.9999912977218628
the O O 0.9999895095825195
leucocytic O O 0.9141923785209656
ER S-protein S-protein 0.8898804783821106
levels O O 0.999794065952301
. O O 0.999998927116394
This O O 0.9999955892562866
may O O 0.9999909400939941
be O O 0.9999985694885254
the O O 0.9999995231628418
basis O O 0.9999871253967285
of O O 0.9999992847442627
the O O 0.9999988079071045

activation O O 0.9755070805549622
by O O 0.9999649524688721
BSAP S-protein S-protein 0.9554128646850586
. O O 0.9999409914016724
In O O 0.9832502007484436
vitro O O 0.969244658946991
mutagenesis O O 0.9792137742042542
and O O 0.9995908141136169
transient O O 0.860331654548645
transfection O O 0.9479515552520752
experiments O O 0.9944155216217041
indicate O O 0.9999984502792358
that O O 0.9999996423721313
the O O 0.9999278783798218
C-terminal B-protein B-protein 0.900786817073822
serine/threonine/proline-rich I-protein I-protein 0.965783953666687
region E-protein E-protein 0.9818860292434692
of O O 0.9984048008918762
BSAP S-protein S-protein 0.9441399574279785
contains O O 0.9999322891235352
a O O 0.9999817609786987
potent O O 0.8195095658302307
transactivation B-protein B-protein 0.4274143576622009
domain E-protein E-protein 0.9246716499328613
of O O 0.9904682040214539
55 O O 0.6150429248809814
amino O O 0.511866569519043
acids O O 0.6839626431465149
which O O 0.9982696771621704
is O O 0.9999843835830688
active O O 0.9988541603088379
from O O 0.9999911785125732
promoter B-DNA O 0.6763356924057007

OVTAL S-cell_type S-protein 0.4797948896884918
) O O 0.7780925631523132
, O O 0.9788429737091064
and O O 0.9975785613059998
breast B-cell_type B-cell_type 0.6250180006027222
tumor I-cell_type I-cell_type 0.5050238370895386
associated I-cell_type I-cell_type 0.7073415517807007
lymphocytes E-cell_type E-cell_type 0.9766868352890015
( O O 0.997048556804657
BRTAL S-cell_type S-protein 0.451551616191864

) O O 0.7437933087348938
pathway O O 0.9899494647979736
in O O 0.9999936819076538
the O O 0.9999797344207764
HTLV-I B-cell_line B-cell_type 0.3746229112148285
infected I-cell_line I-cell_type 0.6292541027069092
cells E-cell_line E-cell_type 0.8982215523719788
, O O 0.998601496219635
we O O 0.9999616146087646
examined O O 0.9999295473098755
tyrosine O O 0.8368157148361206
phosphorylation O O 0.9561321139335632
of O O 0.9993820190429688
Jak3 S-protein S-protein 0.9838472008705139
, O O 0.9943529367446899
STAT3 S-protein S-protein 0.9957115650177002
, O O 0.992687463760376
and O O 0.9993032217025757
STAT5 S-protein S-protein 0.9966895580291748
in O O 0.9999632835388184
several O O 0.9984045624732971
HTLV-I B-cell_line B-cell_line 0.4877534806728363
( I-cell_line I-cell_line 0.502217173576355
+ I-cell_line I-cell_line 0.5076860189437866
) I-cell_line I-cell_line 0.4967435598373413
T-cell I-cell_line I-cell_line 0.5711965560913086
lines E-cell_line E-cell_line 0.9987419247627258
and O O 0.9992527365684509
in O O 0.9998925924301147
uncultured B-cell_type B-cell_type 0.49176129698753357
leukemic I-cell_type I-cell_type 0.5963889360427856
T I-cell_type I-cell_type 0.5188886523246765
cells E-cell_type E-cell_type 0.5843837261199951
isolated O O 0.9954417943954468
from O O 0.9999964237213135
patients O O 0.9989941716194153
with O O 0.9999874830245972
adult O O 0.9610331058502197
T-cell O O 0.9430567026138306
lymphoma/leukemia O O 0.9652130603790283
( O O 0.9992030262947083
ATLL O O 0.9086558222770691
) O O 0.999543309211731
. O O 0.9999980926513672
Constitutive O O 0.9644955992698669
basal O O 0.8705836534500122
phosphorylation O O 0.9594582915306091
of O O 0.999474823474884
Jak3 S-protein S-protein 0.8900728225708008

IL-1beta S-protein B-DNA 0.47206956148147583
gene O E-DNA 0.9381342530250549
transcription O O 0.834467351436615
, O O 0.9985252022743225
and O O 0.999958872795105
prevented O O 0.9998708963394165
the O O 0.999996542930603
transcription O O 0.9901447296142578
of O O 0.9998949766159058
the O O 0.9999877214431763
IL-1beta B-DNA B-DNA 0.49072349071502686
gene E-DNA E-DNA 0.9858357906341553
. O O 0.9996280670166016
In O O 0.9999183416366577
contrast O O 0.9997883439064026
, O O 0.9999411106109619
Staurosporine O O 0.8936210870742798
alone O O 0.9968833327293396
induced O O 0.9997703433036804
AP-1 S-protein S-protein 0.9397099018096924
translocation O O 0.9972586631774902
and O O 0.9999462366104126
stimulation O O 0.9977542757987976
of O O 0.9999668598175049
the O O 0.9999793767929077
gene O O 0.9672657251358032
. O O 0.9999711513519287
Overall O O 0.999954342842102
, O O 0.9999858140945435
our O O 0.9999922513961792
data O O 0.9998111128807068
indicate O O 0.9999992847442627
that O O 0.9999961853027344
Calphostin O B-protein 0.508289098739624
C O E-protein 0.8488004803657532
prevents O O 0.9964015483856201

between O O 0.9964820146560669
0.2 O O 0.8616700768470764
and O O 0.9919523596763611
1.7 O O 0.9851207733154297
kb O O 0.9962230920791626
act O O 0.9952824711799622
in O O 0.9999817609786987
concert O O 0.9965168237686157
with O O 0.9999982118606567
the O O 0.99997878074646
proximal O B-DNA 0.5748043060302734
0.2-kb O I-DNA 0.6682217121124268
region O E-DNA 0.9895908236503601
during O O 0.9998964071273804
S O O 0.8552646040916443
phase O O 0.9639918804168701

sense O O 0.9857026934623718

with O O 0.9994955062866211
PMA O O 0.9789608716964722
to O O 0.9998555183410645
induce O O 0.9999369382858276
expression O O 0.9989861845970154
of O O 0.9999830722808838
endogenous O B-protein 0.5498411059379578
GM-CSF S-protein E-protein 0.822156548500061
and O O 0.9742007851600647
IL-2 S-protein S-protein 0.9907627701759338
. O O 0.9999221563339233
By O O 0.9999840259552002
multimerizing O O 0.9981507658958435
the O O 0.9999744892120361
regulatory B-DNA B-DNA 0.600572407245636
elements E-DNA E-DNA 0.9569734334945679
of O O 0.9998120665550232
the O O 0.9998117089271545
GM-CSF B-DNA B-DNA 0.9036000370979309
promoter E-DNA E-DNA 0.9950932264328003
, O O 0.9992178678512573
we O O 0.9997647404670715

tested O O 0.998295247554779
the O O 0.9999991655349731
hypothesis O O 0.9984452128410339
that O O 0.999996542930603
hydrocortisone O O 0.9633955955505371
may O O 0.9998856782913208
stimulate O O 0.9999603033065796
IkappaB S-protein S-protein 0.996708869934082
production O O 0.9997367262840271
thus O O 0.9999958276748657
inhibiting O O 0.9994730353355408
NF-kappaB S-protein S-protein 0.9962134957313538
translocation O O 0.9984387755393982
from O O 0.9999982118606567
the O O 0.9999674558639526
cytosol O O 0.7985312938690186
into O O 0.999366819858551
the O O 0.9999796152114868
nucleus O O 0.9783768653869629
in O O 0.9999575614929199
MNC S-cell_type S-cell_type 0.9701476693153381
, O O 0.9954479336738586
in O O 0.9999203681945801
vivo O O 0.9993643164634705
. O O 0.9999964237213135
One O O 0.9998134970664978
hundred O O 0.9989718198776245
milligram O O 0.970024824142456
of O O 0.9992088675498962
hydrocortisone O O 0.9443129897117615
was O O 0.9997527003288269
injected O O 0.9998847246170044
intravenously O O 0.9999494552612305
into O O 0.9999626874923706
4 O O 0.9292510747909546
normal O O 0.9408806562423706
subjects O O 0.982014536857605
. O O 0.9999964237213135
Blood O O 0.7509227395057678
samples O O 0.617387056350708
were O O 0.9999562501907349
obtained O O 0.9999810457229614
prior O O 0.9999916553497314
to O O 0.9999957084655762
the O O 0.9999983310699463
injection O O 0.9944818019866943

both O O 0.9970077872276306
functionally O O 0.9929353594779968
and O O 0.9987039566040039
structurally O O 0.9988763928413391
to O O 0.9999884366989136
the O O 0.9999459981918335
v-myb B-DNA B-DNA 0.48776012659072876
oncogene E-DNA E-DNA 0.9974960684776306
. O O 0.999947190284729
Following O O 0.9999961853027344
our O O 0.9999949932098389
observations O O 0.9994698166847229
that O O 0.9999988079071045
A-myb S-DNA S-DNA 0.7315970063209534
is O O 0.9986760020256042
expressed O O 0.9998971223831177
in O O 0.9999915361404419
a O O 0.9999815225601196
restricted O O 0.8490596413612366
subset O O 0.8098663687705994
of O O 0.9995144605636597
normal O B-cell_type 0.6039596796035767
mature B-cell_type I-cell_type 0.5711571574211121
human I-cell_type I-cell_type 0.4971507787704468
B I-cell_type I-cell_type 0.8389725685119629
lymphocytes E-cell_type E-cell_type 0.9235978722572327
, O O 0.9966186285018921
with O O 0.9999918937683105
the O O 0.9999901056289673
phenotype O O 0.4931388795375824
CD38+ O O 0.2921088635921478
, O O 0.6322328448295593

( O O 0.7729171514511108

may O O 0.9953572154045105

is O O 0.9974162578582764
associated O O 0.9989686012268066
with O O 0.9999970197677612
the O O 0.9999957084655762
development O O 0.9997560381889343
of O O 0.9999982118606567
an O O 0.999967098236084
acute O O 0.707043468952179
T-cell O O 0.4747808873653412
malignancy O O 0.7000350952148438
termed O O 0.998263418674469
adult O O 0.8943601250648499
T-cell O O 0.8144282102584839
leukemia O O 0.9336631894111633

revealed O O 0.9986975193023682
a O O 0.9999963045120239
transient O O 0.9454489946365356
up-regulation O O 0.9942037463188171
of O O 0.9999616146087646
the O O 0.9998915195465088
IL-4-induced B-RNA B-RNA 0.8972059488296509
CD23 I-RNA I-RNA 0.949306309223175
mRNA E-RNA E-RNA 0.9965974688529968
by O O 0.9998277425765991
IFN-gamma S-protein S-protein 0.8998411297798157
within O O 0.9975082874298096
2 O O 0.9962064027786255
h O O 0.9923506379127502
of O O 0.9999423027038574
IFN-gamma S-protein S-protein 0.9100700616836548
treatment O O 0.9852129817008972
in O O 0.9999908208847046
these O O 0.9998754262924194
tonsillar B-cell_type B-cell_type 0.5105549097061157
cells E-cell_type E-cell_type 0.873095691204071
. O O 0.9999147653579712
The O O 0.9999996423721313
results O O 0.9999903440475464
suggest O O 0.999998927116394
that O O 0.9999985694885254
the O O 0.9999719858169556

is O O 0.9890015125274658
rapidly O O 0.9949339032173157
degraded O O 0.9997066855430603
. O O 0.9999984502792358
Overexpression O O 0.9991180300712585
of O O 0.9999845027923584
p65 S-protein S-protein 0.950614333152771
increases O O 0.9998300075531006
endogenous O O 0.8543995022773743
I B-protein B-protein 0.8863707780838013
kappa I-protein I-protein 0.9275018572807312
B E-protein I-protein 0.8742582201957703
protein O E-protein 0.9878925085067749
in O O 0.9998934268951416
both O O 0.997568666934967
carcinoma B-cell_type B-cell_type 0.4770231246948242
and I-cell_type I-cell_type 0.884606659412384
lymphoid I-cell_type I-cell_type 0.584661602973938
cells E-cell_type E-cell_type 0.9851489067077637
by O O 0.9999699592590332
two O O 0.9991113543510437
mechanisms O O 0.9903033375740051
: O O 0.9998145699501038
protein O O 0.8422999382019043
stabilization O O 0.9855038523674011
and O O 0.9997281432151794

most O O 0.9868412017822266
T B-cell_type B-cell_type 0.6941958069801331
lymphocytic I-cell_type I-cell_type 0.45431309938430786
and I-cell_type I-cell_type 0.7595299482345581
monocytic I-cell_type I-cell_type 0.9307458996772766
cells E-cell_type E-cell_type 0.9402537941932678
, O O 0.849207878112793
is O O 0.999936580657959
demonstrated O O 0.9999487400054932
in O O 0.9999923706054688
the O O 0.9999868869781494
nuclei O O 0.9446993470191956
of O O 0.9994524121284485
U1 B-cell_line B-cell_line 0.6659952998161316

lymphoid B-cell_type I-cell_type 0.5207915306091309
cells E-cell_type E-cell_type 0.7760111689567566
correlates O O 0.9989967942237854
with O O 0.9999933242797852
the O O 0.9999960660934448
presence O O 0.9997714161872864
of O O 0.9999969005584717
the O O 0.9999542236328125
E B-DNA B-DNA 0.40236935019493103
box E-DNA E-DNA 0.9038820266723633
-binding O O 0.934628427028656
activity O O 0.95694899559021
LEF1/BCF1 S-protein S-protein 0.9176514744758606
in O O 0.9999425411224365
these O O 0.9996763467788696
cells O O 0.9809580445289612
; O O 0.999824583530426

of O O 0.9970188140869141
CN S-protein S-protein 0.7771096229553223
and O O 0.9663610458374023
protein B-protein B-protein 0.5268276333808899
kinase I-protein I-protein 0.6181666254997253
C E-protein E-protein 0.9897571802139282
( O O 0.9718374013900757
PKC S-protein S-protein 0.9971942901611328
) O O 0.9875442981719971
synergistically O O 0.985136866569519
activated O O 0.9883365035057068
transcription O O 0.9593385457992554
from O O 0.9999570846557617
the O O 0.9999600648880005
GM-CSF B-DNA B-DNA 0.8933784365653992
promoter E-DNA E-DNA 0.9923503994941711
. O O 0.9998571872711182
These O O 0.9999983310699463
results O O 0.9999740123748779
suggest O O 0.9999991655349731
that O O 0.9999991655349731
cooperation O O 0.9999078512191772
among O O 0.9999938011169434
NF-kappa B-DNA B-DNA 0.5585160851478577
B- I-DNA I-DNA 0.4224737286567688
, I-DNA I-DNA 0.7836447954177856
AP-1- I-DNA I-DNA 0.9368301033973694
and I-DNA I-DNA 0.983031153678894
NF-AT-binding I-DNA I-DNA 0.9953374862670898
sequences E-DNA E-DNA 0.9981648325920105
is O O 0.9999656677246094
required O O 0.9999713897705078
for O O 0.9999980926513672
induction O O 0.9993508458137512
of O O 0.9999964237213135
the O O 0.9999432563781738
GM-CSF B-DNA B-DNA 0.8672842383384705
gene E-DNA E-DNA 0.9944937825202942
through O O 0.9998420476913452
PKC- O O 0.29643696546554565
and O O 0.4477565586566925

slightly O O 0.9921578168869019
evident O O 0.9998849630355835
in O O 0.9999614953994751
nuclei O O 0.7044386863708496
of O O 0.9966579675674438
uninfected B-cell_type B-cell_type 0.6998796463012695
cells E-cell_type E-cell_type 0.9141281247138977
but O O 0.9982556700706482
was O O 0.9999144077301025
readily O O 0.9987485408782959
detectable O O 0.9998834133148193
in O O 0.9999762773513794
nuclei O O 0.7625530362129211
of O O 0.9965529441833496
infected B-cell_type B-cell_type 0.5347217917442322
monocytes E-cell_type E-cell_type 0.5915620923042297
. O O 0.9998830556869507
Its O O 0.9999827146530151
expression O O 0.99920254945755
remained O O 0.9999916553497314
very O O 0.9997414946556091
low O O 0.9998972415924072
in O O 0.9999723434448242
nuclei O O 0.7999804019927979
of O O 0.9984087347984314
HIV1-infected B-cell_type B-cell_type 0.6417227983474731
macrophages E-cell_type E-cell_type 0.953482985496521
. O O 0.999954342842102
In O O 0.9999982118606567
this O O 0.9999982118606567
paper O O 0.9981793165206909
, O O 0.9999971389770508
we O O 0.999829888343811

activity O O 0.9861968159675598
. O O 0.9999915361404419
Reactive O O 0.9445815682411194
oxygen O O 0.8169889450073242
intermediate-dependent O O 0.984693169593811
NF-kappaB S-protein S-protein 0.995203971862793
activation O O 0.9993917942047119
by O O 0.9999967813491821
interleukin-1beta S-protein S-protein 0.755861759185791
requires O O 0.9980738162994385
5-lipoxygenase S-protein O 0.5258415937423706
or O O 0.9963294863700867
NADPH O B-protein 0.4469358026981354
oxidase O E-protein 0.9396524429321289
activity O O 0.9970390796661377
. O O 0.9999985694885254
We O O 0.9999879598617554
previously O O 0.9999895095825195
reported O O 0.9999951124191284
that O O 0.9999977350234985
the O O 0.9999958276748657
role O O 0.9974545836448669
of O O 0.9999626874923706
reactive O O 0.8003034591674805
oxygen O O 0.5980846285820007

proximal O B-DNA 0.5205000638961792
regions O E-DNA 0.8095111846923828
account O O 0.9997976422309875
for O O 0.999998927116394
the O O 0.9999990463256836
induction O O 0.9998353719711304
of O O 0.9999972581863403
IL-2R O B-protein 0.6162548065185547
alpha O E-protein 0.9691882133483887
transcription O O 0.9456080198287964
by O O 0.999962329864502
IL-2 S-protein S-protein 0.9754291772842407
. O O 0.9998823404312134
To O O 0.9999957084655762
find O O 0.9999879598617554
new O O 0.997778594493866
regulatory B-DNA B-DNA 0.6912737488746643
regions E-DNA E-DNA 0.8793128728866577

, O O 0.9849916100502014
provide O O 0.9999929666519165
evidence O O 0.9999845027923584
for O O 0.9999985694885254
an O O 0.9999843835830688
autoregulatory O O 0.8880098462104797
mechanism O O 0.9939145445823669
for O O 0.9999444484710693
transcription O O 0.9790967106819153
. O O 0.9999645948410034
The O O 0.9999662637710571
cell B-protein B-protein 0.6602587103843689
cycle-dependent I-protein I-protein 0.5852093696594238
transcription I-protein I-protein 0.47509047389030457
factor E-protein E-protein 0.9961052536964417
, O O 0.9961826205253601
E2F-1 S-protein S-protein 0.9825901389122009
, O O 0.9979355335235596
regulates O O 0.9999110698699951
the O O 0.999967098236084

the O O 0.9974502921104431
regions O O 0.9220730066299438
of O O 0.9995959401130676
the O O 0.9999626874923706
gene O O 0.9113997220993042
required O O 0.9976469874382019
for O O 0.9999432563781738
transcription O O 0.8794978260993958
activation O O 0.9911523461341858
, O O 0.9999797344207764
we O O 0.9999059438705444
generated O O 0.9999740123748779
a O O 0.9999905824661255
series O O 0.9909062385559082
of O O 0.9999408721923828
reporter O B-DNA 0.689966082572937
constructs O E-DNA 0.9411120414733887
containing O O 0.9995017051696777
different O O 0.9978038668632507
regions O O 0.9603193998336792
of O O 0.9992433786392212
the O O 0.998322069644928
IL-3 B-DNA B-DNA 0.932188093662262
gene I-DNA E-DNA 0.9733858108520508
5 I-DNA O 0.8177683353424072
' I-DNA O 0.6404241323471069
and I-DNA O 0.8483387231826782
3 I-DNA O 0.6750909090042114
' I-DNA O 0.49170416593551636

activated B-protein I-protein 0.8061463236808777
activator I-protein I-protein 0.4775918126106262
protein-1 E-protein E-protein 0.9763473868370056
transcriptional O O 0.9028351306915283
activity O O 0.9958023428916931
; O O 0.999964714050293
however O O 0.9999827146530151
, O O 0.9999902248382568
this O O 0.9999150037765503
activation O O 0.9922054409980774
was O O 0.9999748468399048
decreased O O 0.9999068975448608
to O O 0.999894380569458
40 O O 0.9982841610908508
% O O 0.9998124241828918
in O O 0.9999468326568604
bcl-2 S-protein S-protein 0.5745551586151123
-overexpressed O O 0.9069112539291382
U937 B-cell_line B-cell_line 0.7532098293304443
cells E-cell_line E-cell_line 0.9967566132545471
. O O 0.9999027252197266
These O O 0.9999988079071045
results O O 0.9999867677688599
indicate O O 0.999998927116394
that O O 0.9999969005584717
Bcl-2 S-protein S-protein 0.9899313449859619
acts O O 0.9991328120231628
downstream O O 0.9997721314430237
of O O 0.9999926090240479
MAPK B-protein S-protein 0.6782752871513367

whether O O 0.9978293776512146
or O O 0.9993290901184082
not O O 0.9996659755706787
the O O 0.9997401833534241
cells O O 0.9736297726631165
expressed O O 0.9999613761901855
the O O 0.9999898672103882
nef O B-DNA 0.45750969648361206
gene O E-DNA 0.9649239778518677
. O O 0.9998307228088379
On O O 0.9999858140945435
the O O 0.9999939203262329
other O O 0.9999799728393555
hand O O 0.9950165152549744
, O O 0.9999047517776489
stimulation O O 0.9993504881858826
of O O 0.9999713897705078
T B-cell_type B-cell_type 0.9010204672813416
cells E-cell_type E-cell_type 0.9952611327171326
by O O 0.9999644756317139
mitogens O S-protein 0.6259589791297913
or O O 0.9853526949882507

- I-protein O 0.8693242073059082
RNA I-protein B-protein 0.46236395835876465
complex E-protein E-protein 0.8426716923713684
with O O 0.9998704195022583
cytosolic O O 0.7711725234985352
extracts O O 0.8685745000839233
from O O 0.9999829530715942
human B-cell_line B-cell_line 0.5810362696647644
K562 I-cell_line I-cell_line 0.46690669655799866
cells E-cell_line E-cell_line 0.9567962884902954
and O O 0.9990686774253845
this O O 0.9999698400497437
binding O O 0.9507408738136292
was O O 0.999725878238678
strongly O O 0.9995662569999695
competed O O 0.9998918771743774
with O O 0.9999918937683105
IRE B-RNA B-RNA 0.9290781021118164
transcripts E-RNA E-RNA 0.9948877692222595
from O O 0.9998074173927307
ferritin B-RNA B-RNA 0.5579161643981934
or I-RNA I-RNA 0.8395639061927795
transferrin I-RNA I-RNA 0.5622106790542603
receptor I-RNA I-RNA 0.9798184633255005
mRNAs E-RNA E-RNA 0.9883878827095032
. O O 0.9997901320457458
A O O 0.9999834299087524
transcript O O 0.9483984708786011
of O O 0.9998273253440857

interleukin-10 S-protein S-protein 0.7968435287475586

. O O 0.9985154271125793
Purified O B-protein 0.5069039463996887
human B-protein I-protein 0.5338854193687439
SP1 E-protein E-protein 0.9581470489501953
was O O 0.9973958730697632
shown O O 0.9999637603759766
to O O 0.9999935626983643
have O O 0.9999908208847046
very O O 0.9964067339897156
strong O O 0.9982991814613342
affinity O O 0.9991445541381836
for O O 0.9999934434890747
the O O 0.9999791383743286
12-bp B-DNA B-DNA 0.6545813083648682
insert E-DNA E-DNA 0.9969648718833923
. O O 0.9998774528503418
Functional O O 0.9681090712547302
Myc-Max B-protein S-protein 0.3722538948059082

. O O 0.9953646659851074
c-Myc S-protein S-protein 0.9198587536811829
and O O 0.9941579103469849
E1A S-protein S-protein 0.9355087876319885
induced O O 0.9968710541725159
cellular O O 0.960890531539917
sensitivity O O 0.9989651441574097
to O O 0.9999905824661255
activated B-cell_type O 0.8648689389228821
NK I-cell_type B-cell_type 0.4320964813232422
cells E-cell_type E-cell_type 0.9747333526611328
involves O O 0.9999064207077026
cytotoxic O O 0.7629095911979675
granules O O 0.4798886477947235
as O O 0.9999289512634277
death O O 0.75103759765625
effectors O O 0.8061338067054749
. O O 0.9999767541885376
The O O 0.9999940395355225
contact O O 0.9824366569519043
of O O 0.9998093247413635
natural B-cell_type B-cell_type 0.6306625008583069
killer I-cell_type I-cell_type 0.8120833039283752
( I-cell_type I-cell_type 0.9391319155693054
NK I-cell_type I-cell_type 0.9904618859291077

Immunological O O 0.9565817713737488
studies O O 0.9993322491645813
in O O 0.9999884366989136
human O O 0.8685056567192078
immunodeficiency O O 0.9514191150665283
virus O O 0.9699086546897888
( O O 0.9962218999862671
HIV O O 0.9907804131507874
) O O 0.9982680082321167
-positive O O 0.9986577033996582
patients O O 0.999840259552002
suggest O O 0.9999990463256836
that O O 0.9999994039535522
the O O 0.9999861717224121
disease O O 0.993291974067688
progression O O 0.9998624324798584
is O O 0.9999955892562866
accompanied O O 0.9999731779098511
by O O 0.9999991655349731
a O O 0.999997615814209
defective O O 0.9860880970954895
production O O 0.9985283613204956
of O O 0.99998939037323
type O B-protein 0.6767033934593201
1 B-protein I-protein 0.8742584586143494
cytokines E-protein E-protein 0.9980300068855286
( O O 0.993838369846344
interleukin-2 S-protein S-protein 0.8969033360481262

) O O 0.8084772825241089
is O O 0.9998286962509155
its O O 0.9999973773956299
ability O O 0.9999159574508667
to O O 0.9999821186065674
block O O 0.9999724626541138
the O O 0.9999901056289673
monocytic O O 0.9499040246009827
production O O 0.9984511137008667
of O O 0.9999923706054688
the O O 0.9998761415481567
osteoclastogenic B-protein B-protein 0.5436792373657227
cytokine I-protein E-protein 0.9166935086250305
TNF-alpha E-protein S-protein 0.6506955027580261
( O O 0.9930089712142944
TNF S-protein S-protein 0.9926366806030273
) O O 0.9944753050804138
. O O 0.9999951124191284
However O O 0.9999843835830688
, O O 0.9999904632568359
the O O 0.9999953508377075

of O O 0.9942913055419922
RP1 S-DNA S-protein 0.9425806999206543
had O O 0.999924898147583
a O O 0.9999771118164062
significant O O 0.9907744526863098
homology O O 0.9878052473068237
to O O 0.9999306201934814
members O O 0.9864382743835449
of O O 0.9998891353607178
the O O 0.9999908208847046
recently O O 0.9731324315071106
found O O 0.9982835054397583
adenomatous B-DNA B-DNA 0.7292442321777344
polyposis I-DNA I-DNA 0.6429091691970825
coli I-DNA I-DNA 0.49501264095306396
( I-DNA I-DNA 0.5099592804908752
APC I-DNA I-DNA 0.7544832825660706
) I-DNA I-DNA 0.8260298371315002
protein-binding I-DNA I-DNA 0.8997824788093567
EB1 I-DNA I-DNA 0.9278536438941956
gene I-DNA I-DNA 0.7538440823554993
family E-DNA E-DNA 0.97765052318573
, O O 0.9461275339126587
which O O 0.9996967315673828
codes O O 0.9468377828598022
for O O 0.9988265633583069
yet O O 0.9993646740913391
unknown O O 0.9975676536560059

. O O 0.9979509711265564
Herein O O 0.9999778270721436
we O O 0.9999862909317017
demonstrate O O 0.9999970197677612
that O O 0.9999992847442627
the O O 0.999994158744812
inducible O O 0.923980176448822
nuclear O O 0.9006294012069702
import O O 0.9901037812232971
of O O 0.9999386072158813
NF-kappa B-protein B-protein 0.8395435214042664
B E-protein E-protein 0.9956502318382263
, O O 0.9814551472663879
AP-1 S-protein S-protein 0.9646573066711426
, O O 0.9865705370903015
NFAT S-protein S-protein 0.9948166012763977
, O O 0.9906781911849976
and O O 0.9985163807868958
STAT1 S-protein S-protein 0.9402533769607544

nuclear B-protein B-protein 0.5614394545555115
factor I-protein I-protein 0.4426850974559784
kappa I-protein I-protein 0.9105673432350159
B E-protein E-protein 0.993013322353363
. O O 0.999566376209259
All O O 0.9999957084655762
of O O 0.999998927116394
the O O 0.9999985694885254
radiation-induced O O 0.9134771823883057
signals O O 0.9836126565933228
were O O 0.999991774559021
effectively O O 0.9999312162399292
prevented O O 0.9999587535858154
by O O 0.9999994039535522
the O O 0.9999779462814331
protein-tyrosine B-protein B-protein 0.7577417492866516
kinase I-protein E-protein 0.8016223907470703
inhibitors I-protein O 0.5503852963447571
genistein I-protein O 0.9022195339202881
and I-protein O 0.9986281394958496
herbimycin I-protein O 0.9856398105621338
A E-protein O 0.9914713501930237
. O O 0.9999877214431763
Thus O O 0.9999439716339111
, O O 0.9999390840530396
tyrosine O O 0.9813323020935059

of O O 0.9985456466674805
the O O 0.999985933303833
AP-1 B-protein B-protein 0.3362225592136383
Fos I-protein I-protein 0.39340463280677795
and I-protein I-protein 0.5138154625892639
Jun I-protein I-protein 0.6814331412315369
family I-protein I-protein 0.7540474534034729
members E-protein E-protein 0.9516170620918274
in O O 0.9989224672317505
anergic B-cell_line B-cell_type 0.480304479598999
T I-cell_line I-cell_type 0.7096064686775208
cells E-cell_line E-cell_type 0.783941924571991
. O O 0.9999258518218994
Sequence-specific O O 0.9379091858863831
DNA O O 0.8219859004020691
binding O O 0.9232116937637329
of O O 0.9986061453819275
the O O 0.9999581575393677

that O O 0.9996525049209595
HTLV-I O O 0.48221105337142944
Tax S-protein S-protein 0.5529668927192688
production O O 0.8603329658508301
induces O O 0.9998811483383179
the O O 0.999990701675415
transcription O O 0.8672844767570496
and O O 0.9913141131401062
subsequent O O 0.9957185387611389
synthesis O O 0.9949625730514526
and O O 0.9997169375419617
secretion O O 0.9913496971130371
of O O 0.9997808337211609
galectin-3 S-protein S-protein 0.8224160671234131
, O O 0.987148106098175
which O O 0.999894380569458
in O O 0.9999399185180664
turn O O 0.9991500377655029
may O O 0.9999943971633911
further O O 0.999990701675415
activate O O 0.9999829530715942
these O O 0.9999896287918091

, O O 0.9924975037574768
ZEBRA S-protein S-protein 0.8939308524131775
, O O 0.9976423382759094
by O O 0.9998107552528381
RT-PCR O O 0.6834425330162048
, O O 0.9976696372032166
was O O 0.9999812841415405
observed O O 0.9999691247940063
within O O 0.9999957084655762
8 O O 0.9982665777206421
hr O O 0.995671272277832
of O O 0.9999569654464722
infection O O 0.9917902946472168
. O O 0.9999959468841553
The O O 0.9999992847442627
appearance O O 0.998988926410675
of O O 0.9999890327453613
a O O 0.9999850988388062
novel O B-RNA 0.8137941360473633
fusion B-protein I-RNA 0.6469786167144775
transcript E-protein E-RNA 0.9808613657951355
( O O 0.9799454212188721

antisense B-cell_line I-cell_line 0.6549312472343445
cell I-cell_line I-cell_line 0.45074665546417236
lines E-cell_line E-cell_line 0.9967703819274902
. O O 0.99992835521698
In O O 0.9999794960021973
addition O O 0.9999791383743286
, O O 0.999993085861206
alpha B-protein B-protein 0.5037616491317749
G2S E-protein E-protein 0.9576568007469177
exhibited O O 0.9996554851531982
increased O O 0.9995110034942627
expression O O 0.9992534518241882
of O O 0.9999847412109375
CD11b S-protein S-protein 0.9488855004310608
and O O 0.9851745963096619
CD54 S-protein S-protein 0.9697253108024597
, O O 0.9983519315719604
while O O 0.9999940395355225
alpha B-cell_line B-cell_line 0.5028066039085388
B5A I-cell_line I-cell_line 0.4686039686203003
cells E-cell_line E-cell_line 0.9037883281707764
showed O O 0.9999675750732422
increased O O 0.9998297691345215
expression O O 0.9996839761734009
of O O 0.9999889135360718
CD102 S-protein S-protein 0.8198733329772949
, O O 0.9913293123245239
suggesting O O 0.9999321699142456
that O O 0.9999922513961792
RXR-alpha S-protein S-protein 0.9966416358947754
has O O 0.999760091304779
a O O 0.9999622106552124
role O O 0.999290943145752
in O O 0.9999662637710571
regulating O O 0.9839003086090088
expression O O 0.9961649179458618

retinoic B-protein B-protein 0.616311252117157
acid I-protein I-protein 0.5092994570732117
receptor I-protein I-protein 0.7979718446731567
alpha E-protein E-protein 0.9981221556663513
( O O 0.9942861199378967
RAR-alpha S-protein S-protein 0.9977871179580688
) O O 0.989087700843811
play O O 0.9998899698257446
a O O 0.9999938011169434
role O O 0.9998792409896851
in O O 0.999995231628418
the O O 0.9999951124191284
regulation O O 0.9996261596679688
of O O 0.9999936819076538
normal O O 0.8436241745948792
erythroid O O 0.5535281300544739
differentiation O O 0.9921175837516785
. O O 0.9999964237213135
Retinoic O O 0.7858589887619019
acid O O 0.8036321997642517
( O O 0.9681840538978577

KH1060 O O 0.1801764965057373
was O O 0.9986750483512878
presumed O O 0.9999492168426514
to O O 0.9999672174453735
be O O 0.999990701675415
mediated O O 0.9998125433921814
by O O 0.9999988079071045
the O O 0.9998500347137451
nuclear B-protein B-protein 0.5658003687858582
vitamin I-protein I-protein 0.6564071774482727
D I-protein I-protein 0.8685151934623718
receptor E-protein E-protein 0.9751830101013184
( O O 0.9682797193527222
VDRnuc S-protein S-protein 0.9684395790100098
) O O 0.9624613523483276
. O O 0.999954342842102

its O O 0.9977728724479675
prognostic O O 0.9725514054298401
character O O 0.9871715903282166
in O O 0.999975323677063
the O O 0.9999994039535522
context O O 0.9999299049377441
of O O 0.9999955892562866
spontaneous O O 0.9804345965385437
abortion O O 0.9989439845085144
. O O 0.999995231628418
Cytosols O S-cell_type 0.8871460556983948
were O O 0.9996660947799683
prepared O O 0.9996064305305481
from O O 0.9999879598617554
lymphocytes O S-cell_type 0.9958304762840271
of O O 0.9993290901184082
24 O O 0.9951317310333252
healthy O O 0.9967801570892334
pregnant O O 0.994885265827179
women O O 0.9995062351226807
( O O 0.9998743534088135
11 O O 0.9994944334030151
first O O 0.9944843649864197
, O O 0.999645471572876
10 O O 0.99945467710495
second O O 0.9990886449813843
and O O 0.9999477863311768

the O O 0.9979200959205627
glucocorticoid B-protein B-protein 0.7070125937461853
receptor E-protein E-protein 0.9861369132995605
was O O 0.9991874098777771
observed O O 0.9998583793640137
. O O 0.9999971389770508
There O O 0.9999909400939941
was O O 0.9999967813491821
a O O 0.9999983310699463
weak O O 0.9980536699295044
but O O 0.9995239973068237
significant O O 0.9997170567512512
negative O O 0.993251383304596
correlation O O 0.9994528889656067
between O O 0.9995207786560059
body O O 0.9094957113265991
temperature O O 0.9980127811431885
and O O 0.999988317489624
the O O 0.9999984502792358
number O O 0.9992345571517944
of O O 0.99998939037323
glucocorticoid B-protein B-protein 0.9165319204330444
receptors E-protein E-protein 0.9986118078231812
in O O 0.9999710321426392
the O O 0.9999881982803345
patient O O 0.9587586522102356
group O O 0.9913090467453003

cell B-cell_line I-cell_line 0.38494324684143066
lines E-cell_line E-cell_line 0.9985387325286865
that O O 0.9997244477272034
express O O 0.9987026453018188
alpha B-protein B-cell_line 0.6791447997093201
4 E-protein I-cell_line 0.6000008583068848
and O I-cell_line 0.7399835586547852
cell B-cell_line I-cell_line 0.4263898432254791
lines E-cell_line E-cell_line 0.9926067590713501
that O O 0.9987928867340088
do O O 0.9999827146530151
not O O 0.999936580657959
. O O 0.9999845027923584
The O O 0.9999691247940063
sequence O O 0.8694759011268616
between O O 0.9949772953987122
position O B-DNA 0.4304530918598175
-42 B-DNA I-DNA 0.32476571202278137
and I-DNA I-DNA 0.5634853839874268
-76 I-DNA I-DNA 0.413831502199173
base I-DNA I-DNA 0.6161493062973022
pairs E-DNA E-DNA 0.8579952716827393
( O O 0.8388254642486572
bp O O 0.6074124574661255
) O O 0.37094858288764954

effect O O 0.991543173789978
in O O 0.9999796152114868
P19 B-cell_line B-cell_line 0.7689375877380371
cells E-cell_line E-cell_line 0.9820907711982727
. O O 0.9999217987060547
Transcriptional O O 0.9833553433418274
activation O O 0.9988709092140198
by O O 0.9999970197677612
CBF B-protein B-protein 0.7499544620513916
beta E-protein E-protein 0.9887717366218567
required O O 0.9958339929580688
binding O O 0.981263279914856
to O O 0.9998794794082642
the O O 0.9999420642852783

of O O 0.9953162670135498
c-Myb B-protein B-protein 0.6868079304695129
protein E-protein E-protein 0.995785653591156
. O O 0.9997598528862
During O O 0.9999039173126221
T-cell O O 0.48100659251213074
activation O O 0.963502049446106
, O O 0.9993987083435059
c-myb S-DNA S-DNA 0.9407848715782166
expression O O 0.9989757537841797
is O O 0.9999936819076538
induced O O 0.9998961687088013
and O O 0.9999836683273315
much O O 0.9999949932098389
of O O 0.9999986886978149
the O O 0.99998939037323

the O O 0.9980837106704712
pol B-DNA B-DNA 0.5137820243835449
gene E-DNA E-DNA 0.9829983115196228
( O O 0.9996603727340698
E. O O 0.9886018633842468
Verdin O O 0.9996668100357056
, O O 0.9999947547912598
J. O O 0.9996873140335083
Virol. O O 0.9999674558639526
65 O O 0.9997351765632629
: O O 0.9999545812606812
6790-6799 O O 0.9996457099914551
, O O 0.9999350309371948
1991 O O 0.9967336654663086
) O O 0.9999030828475952
. O O 0.9999983310699463
In O O 0.9999964237213135
the O O 0.9999988079071045
present O O 0.9948622584342957
report O O 0.984717071056366
, O O 0.9997739195823669
high-resolution O O 0.9177443385124207
mapping O O 0.9853230714797974
of O O 0.9998781681060791
this O O 0.9999911785125732
site O O 0.8335516452789307
with O O 0.9990863800048828
DNase B-protein B-DNA 0.487962543964386
I E-protein E-DNA 0.649003267288208
and O O 0.8607401251792908
micrococcal B-protein B-protein 0.5104714035987854
nuclease E-protein E-protein 0.8777597546577454
identified O O 0.9975684285163879
a O O 0.9999905824661255
nucleosome-free B-DNA O 0.5464563369750977
region E-DNA O 0.4522631764411926
centered O O 0.9978546500205994
around O O 0.9998950958251953
nucleotides B-DNA B-DNA 0.3760736286640167
( I-DNA I-DNA 0.7354713678359985
nt I-DNA I-DNA 0.6672691106796265
) I-DNA I-DNA 0.6803106665611267

drugs O O 0.9280326962471008
on O O 0.999927282333374
HIV-1 O O 0.8195565342903137
activation O O 0.9950540065765381
. O O 0.999997615814209
Previously O O 0.999923825263977
, O O 0.9999938011169434
we O O 0.9998039603233337
have O O 0.9999964237213135
reported O O 0.9999938011169434
that O O 0.9999982118606567
DHEA O O 0.3583357632160187
and O O 0.9412645697593689
synthetic O O 0.8687561750411987
analogs O O 0.8371194005012512
of O O 0.9998775720596313
DHEA O O 0.37743374705314636
can O O 0.9996258020401001
be O O 0.9999958276748657
modest O O 0.9893583059310913
inhibitors O O 0.9918768405914307
of O O 0.999994158744812
HIV-1 O O 0.826181948184967
IIIB O O 0.6261810064315796
replication O O 0.9886170029640198
in O O 0.9999798536300659
phytohemagglutinin-stimulated B-cell_line B-cell_line 0.6280975341796875
peripheral I-cell_line I-cell_line 0.7411199808120728
blood I-cell_line I-cell_line 0.6917471885681152
lymphocyte I-cell_line I-cell_line 0.4579277038574219

the O O 0.9985910058021545
interleukin B-DNA B-DNA 0.546248733997345
2 I-DNA I-DNA 0.6370583176612854
promoter E-DNA E-DNA 0.9952164888381958
. O O 0.9998764991760254
Stimulation O O 0.9970718622207642
of O O 0.9999102354049683
T B-cell_type B-cell_type 0.8475547432899475
cells E-cell_type E-cell_type 0.9888854026794434
with O O 0.9997554421424866
antigen O O 0.8318122029304504
results O O 0.9992314577102661
in O O 0.999976634979248
activation O O 0.9919877052307129
of O O 0.9998214840888977
several O O 0.9843097925186157
kinases S-protein S-protein 0.5932392477989197
, O O 0.9907015562057495
including O O 0.999552309513092
protein B-protein B-protein 0.7120835185050964
kinase I-protein I-protein 0.9466835260391235
C E-protein E-protein 0.9932803511619568
( O O 0.9877561330795288
PKC S-protein S-protein 0.9941149353981018

the O O 0.9997667670249939
high O O 0.9832683205604553
incidence O O 0.9995471835136414
of O O 0.9999926090240479
leukemic O O 0.8609920740127563
relapse O O 0.9960867166519165
following O O 0.9999843835830688
autologous O O 0.9289831519126892
PBSCT O O 0.4114021360874176
, O O 0.995110809803009
which O O 0.9999390840530396
may O O 0.9999825954437256
be O O 0.999992847442627
caused O O 0.9999395608901978
by O O 0.9999982118606567
the O O 0.9999974966049194
reinfusion O O 0.9981971383094788
of O O 0.9999850988388062
PBSC S-cell_type S-cell_type 0.9843078255653381
contaminated O O 0.9748494625091553
by O O 0.9998655319213867
leukemic B-cell_type B-cell_type 0.8236334919929504
cells E-cell_type E-cell_type 0.9951634407043457
. O O 0.9999278783798218
Recently O O 0.9999843835830688
, O O 0.9999979734420776
we O O 0.9999288320541382

individuals O O 0.9459301829338074
. O O 0.999995231628418
The O O 0.9999955892562866
allele-specific O O 0.43039798736572266
expression O O 0.9127193093299866

normal O O 0.8865301609039307
parent O O 0.9141098856925964
molecules O O 0.5693351626396179
and O O 0.9993048906326294
recognized O O 0.9782800078392029
by O O 0.9998273849487305
human B-cell_line B-cell_type 0.4698553681373596
CD4+ I-cell_line I-cell_type 0.8758258819580078
lymphocytes E-cell_line E-cell_type 0.9095320701599121
. O O 0.9999537467956543
The O O 0.999991774559021
zinc B-protein B-protein 0.7559673190116882
finger I-protein I-protein 0.5894938111305237
transcription I-protein I-protein 0.9417330026626587
factor E-protein E-protein 0.9693459272384644
Egr-1 S-protein S-protein 0.833577573299408
is O O 0.9999269247055054
essential O O 0.9998372793197632
for O O 0.9999595880508423
and O O 0.9992893934249878
restricts O O 0.9997254014015198
differentiation O O 0.9988582134246826
along O O 0.9999740123748779
the O O 0.9998300075531006
macrophage B-cell_type B-cell_type 0.44168969988822937
lineage E-cell_type E-cell_type 0.9851022958755493
. O O 0.9998958110809326
We O O 0.9999901056289673
have O O 0.9999959468841553
isolated O O 0.9744158983230591
cDNA B-DNA B-DNA 0.5790892839431763
clones E-DNA E-DNA 0.9868177175521851
of O O 0.9997754693031311
myeloid B-DNA B-DNA 0.38602301478385925
differentiation I-DNA I-DNA 0.7053989171981812
primary I-DNA I-DNA 0.5512893199920654
response I-DNA I-DNA 0.48793908953666687
( I-DNA I-DNA 0.765876054763794
MyD I-DNA I-DNA 0.6023431420326233
) I-DNA I-DNA 0.6314442753791809

mutant O O 0.48020505905151367

ehrlichiosis O O 0.6600943207740784
and O O 0.9900702834129333
immune O O 0.9043184518814087
responses O O 0.9884366989135742
to O O 0.9999433755874634
it O O 0.9993984699249268
. O O 0.9999966621398926
The O O 0.9999655485153198
class B-protein B-protein 0.34670424461364746
II I-protein I-protein 0.4130355417728424
trans-activator I-protein E-protein 0.7843805551528931
CIITA E-protein S-protein 0.8151773810386658
interacts O O 0.9951000809669495
with O O 0.999980092048645
the O O 0.999933123588562
TBP-associated B-protein B-protein 0.6401931047439575
factor I-protein E-protein 0.7613502144813538
TAFII32 E-protein S-protein 0.651390552520752
. O O 0.9998779296875
The O O 0.999967098236084
class B-protein B-protein 0.5684323906898499
II I-protein I-protein 0.6387690901756287
trans- I-protein I-protein 0.7549359798431396
activator E-protein E-protein 0.8974422216415405
( O O 0.8822581171989441
CIITA S-protein S-protein 0.8927803635597229
) O O 0.9350634217262268
is O O 0.9998849630355835
the O O 0.9999963045120239
main O O 0.9824777245521545
transcriptional O O 0.8994651436805725
co-activator O O 0.4144226312637329
for O O 0.9968125224113464
the O O 0.9999326467514038
expression O O 0.998097836971283
of O O 0.9999806880950928
MHC B-protein B-protein 0.7876255512237549
class I-protein I-protein 0.9753713607788086
II I-protein I-protein 0.6510966420173645
proteins E-protein E-protein 0.9992886781692505
. O O 0.9999815225601196
Its O O 0.999974250793457
N-terminal B-protein B-protein 0.8262173533439636
125 I-protein I-protein 0.8024026155471802
amino I-protein I-protein 0.981261134147644
acids E-protein E-protein 0.918864905834198
function O O 0.9963411688804626
as O O 0.9999912977218628
an O O 0.9999890327453613
independent B-protein O 0.9006373882293701
transcriptional I-protein O 0.7855956554412842

transcription I-DNA B-DNA 0.525222897529602
start I-DNA I-DNA 0.5662277936935425
site E-DNA E-DNA 0.9934706687927246
are O O 0.9999421834945679
important O O 0.9999029636383057
for O O 0.9999864101409912
virus O O 0.8810532689094543
infectivity O O 0.9877499938011169
. O O 0.9999908208847046
When O O 0.9999873638153076
transcriptionally O O 0.670817494392395
active O O 0.8033139109611511
, O O 0.9981598258018494
the O O 0.9999771118164062
human O B-DNA 0.4818807542324066
immunodeficiency O I-DNA 0.6087021827697754
virus O I-DNA 0.6440485715866089

expression O O 0.9868497848510742
of O O 0.9999524354934692
mRNAs S-RNA B-protein 0.8949416279792786
encoding O I-protein 0.5476338863372803
receptors S-protein E-protein 0.8578201532363892
for O O 0.9774048924446106
D3 O O 0.43613457679748535
( O O 0.8909879326820374
VDR S-protein S-protein 0.5807930827140808
) O O 0.5355619192123413
, O O 0.9836071729660034
RA O O 0.5273419618606567
( O O 0.8623848557472229
RAR B-protein B-protein 0.42541030049324036

of O O 0.9967888593673706
sexual O O 0.9859368205070496
transmission O O 0.9990422129631042
of O O 0.9999964237213135
human O O 0.8240113854408264
immunodeficiency O O 0.8945049047470093
virus O O 0.8959828615188599
( O O 0.9931476712226868
HIV O O 0.9845081567764282
) O O 0.997177243232727
type O O 0.996415376663208
1 O O 0.9957152009010315
, O O 0.999896764755249
and O O 0.99996018409729
Gardnerella O O 0.9778023958206177
vaginalis O O 0.9951575398445129
is O O 0.9999918937683105
frequently O O 0.9997957348823547
isolated O O 0.9999607801437378
from O O 0.9999992847442627
the O O 0.9999881982803345

study O O 0.9978358149528503
investigated O O 0.9997133612632751
PPARalpha S-protein S-protein 0.9938971400260925
expression O O 0.9993441700935364
in O O 0.9999740123748779
human B-cell_type B-cell_type 0.504504382610321
ECs E-cell_type E-cell_type 0.8308184742927551
and O O 0.9990480542182922
their O O 0.9999873638153076
regulation O O 0.9996534585952759
of O O 0.9999922513961792
vascular B-protein B-protein 0.663938581943512
cell I-protein I-protein 0.8447687029838562
adhesion I-protein I-protein 0.9387475848197937
molecule-1 E-protein E-protein 0.9994553923606873
( O O 0.9920291304588318
VCAM-1 S-protein S-protein 0.9919624924659729
) O O 0.9948201179504395
. O O 0.9999861717224121
METHODS O O 0.7996873259544373
AND O O 0.9921606183052063
RESULTS O O 0.9975632429122925
: O O 0.9999079704284668
Immunohistochemistry O O 0.9512446522712708
revealed O O 0.9998742341995239
that O O 0.9999940395355225
human B-cell_type B-cell_type 0.4232577085494995
carotid I-cell_type I-cell_type 0.5012868046760559
artery I-cell_type I-cell_type 0.7522929906845093
ECs E-cell_type E-cell_type 0.9090583920478821
express O O 0.9994953870773315
PPARalpha S-protein S-protein 0.9974156618118286
. O O 0.9999505281448364
Pretreatment O O 0.9480940103530884

be O O 0.9990083575248718
useful O O 0.9998225569725037
as O O 0.9999988079071045
therapeutic O O 0.9680539965629578
agents O O 0.993882417678833
that O O 0.9999871253967285
are O O 0.9999945163726807
less O O 0.9999767541885376
toxic O O 0.9963935017585754
than O O 0.999976396560669
current O O 0.9456930756568909
drugs O O 0.9844663143157959
. O O 0.9999960660934448
9-cis O O 0.9842957258224487
retinoic O O 0.9865070581436157
acid O O 0.9964801669120789
induces O O 0.9999651908874512
monocyte B-protein B-protein 0.7243084907531738
chemoattractant I-protein I-protein 0.41091299057006836
protein-1 E-protein E-protein 0.9784003496170044
secretion O O 0.9769555330276489

better O O 0.9924315214157104
understanding O O 0.9999053478240967
of O O 0.9999988079071045
the O O 0.9999988079071045
transcriptional O O 0.8298423290252686
events O O 0.9856460690498352
that O O 0.9999797344207764
regulate O O 0.9999727010726929
this O O 0.9999357461929321
expression O O 0.9998026490211487
, O O 0.9999982118606567
we O O 0.9999881982803345
took O O 0.9999774694442749
advantage O O 0.9999741315841675
of O O 0.9999973773956299
our O O 0.9999914169311523
previously O O 0.9960169196128845
described O O 0.9991748929023743
mutant B-cell_line B-cell_line 0.4379795789718628
Jurkat I-cell_line I-cell_line 0.5585842132568359
cells E-cell_line E-cell_line 0.9656549692153931
. O O 0.9998489618301392
These O O 0.9999805688858032
cells O O 0.9823868274688721
are O O 0.9999922513961792

cells O E-cell_type 0.5088530778884888
, O O 0.9982490539550781
Stat6 S-protein S-protein 0.9965032339096069
activation O O 0.9972712397575378
led O O 0.9999802112579346

product E-protein O 0.5639049410820007
latent B-protein B-protein 0.7517105340957642
membrane I-protein I-protein 0.5262141227722168
protein I-protein I-protein 0.4852806031703949
1 E-protein E-protein 0.9952409267425537
engages O O 0.9981929659843445
the O O 0.9998990297317505
tumor O B-protein 0.7345943450927734
necrosis O I-protein 0.930395245552063
factor O I-protein 0.6017556190490723
receptor-associated O I-protein 0.730648398399353
death O I-protein 0.9046427011489868
domain O I-protein 0.5656381845474243
protein O E-protein 0.9859591126441956
to O O 0.9987040758132935
mediate O O 0.9786499738693237
B O O 0.4836761951446533
lymphocyte O O 0.6715797781944275
growth O O 0.821433424949646
transformation O O 0.9784212112426758
and O O 0.9997715353965759
activate O O 0.9897255301475525
NF-kappaB O S-protein 0.9758892059326172
. O O 0.9998657703399658
The O O 0.9999902248382568

in O O 0.9994747042655945
similar O O 0.9988143444061279
concentrations O O 0.9974191188812256
of O O 0.999894380569458
1 O O 0.4568529725074768
, O O 0.7158021330833435
25D3 O O 0.6087043285369873
in O O 0.9985400438308716
that O O 0.9997820258140564
they O O 0.9999111890792847
express O O 0.9999955892562866
the O O 0.99997878074646
CD14 B-protein S-protein 0.6129703521728516

result O O 0.9992086291313171
in O O 0.9999979734420776
similar O O 0.9992029070854187
forms O O 0.9928098917007446
of O O 0.9999692440032959
severe O O 0.9815157651901245
combined O O 0.9830586910247803
immunodeficiency O O 0.991181492805481
( O O 0.9997217059135437
SCID O O 0.9865599870681763
) O O 0.999794065952301
. O O 0.9999982118606567
In O O 0.999996542930603
this O O 0.9999994039535522
review O O 0.9998304843902588
we O O 0.9999960660934448
examine O O 0.9999973773956299
the O O 0.9999953508377075
structure O O 0.9981143474578857
and O O 0.9998278617858887
function O O 0.9992157220840454
of O O 0.9999873638153076
cytokine B-protein B-protein 0.6683048009872437
receptors E-protein E-protein 0.9971611499786377
and O O 0.999619722366333
the O O 0.9999954700469971
signaling O O 0.893781840801239
pathways O O 0.9743834137916565
involved O O 0.9998879432678223
in O O 0.9999874830245972
their O O 0.9999922513961792
regulation O O 0.9996069073677063
of O O 0.9999834299087524
gene O O 0.97166508436203
expression O O 0.9998832941055298
. O O 0.9999992847442627
Furthermore O O 0.9999865293502808
, O O 0.9999922513961792
we O O 0.9999622106552124
discuss O O 0.9999964237213135

isolation O O 0.9894089698791504
of O O 0.9999008178710938
nuclei O O 0.9052976965904236
. O O 0.999909520149231
Specific O O 0.9919012188911438
nuclear O O 0.8514395356178284
translocation O O 0.9256736040115356
of O O 0.9985005855560303
[ B-protein B-protein 0.9710438251495361
3H I-protein I-protein 0.5941518545150757
] I-protein I-protein 0.641817569732666
calcitriol/VDR E-protein E-protein 0.9138048887252808
was O O 0.9994432330131531
found O O 0.9999895095825195
to O O 0.9999902248382568
be O O 0.9999901056289673
time O O 0.9943811297416687
dependent O O 0.9998056292533875
reaching O O 0.9998886585235596
a O O 0.9999639987945557
maximum O O 0.9909303784370422

for O O 0.9973594546318054
Val O S-protein 0.6973975300788879
augmented O O 0.9735056757926941
STAT6 S-protein S-protein 0.9941515326499939
activation O O 0.9959020018577576
, O O 0.9998682737350464
proliferation O O 0.990234375
, O O 0.9994032382965088
and O O 0.9998748302459717
transcription O O 0.9141286015510559
activity O O 0.9955440163612366
of O O 0.9999924898147583
the O O 0.9999200105667114
Iepsilon B-DNA B-DNA 0.8532422184944153
promoter E-DNA E-DNA 0.9917477369308472
by O O 0.9995885491371155
IL-4 S-protein S-protein 0.9676387906074524
, O O 0.9991728663444519
whereas O O 0.9999959468841553
that O O 0.9999955892562866
of O O 0.9999759197235107
Arg O S-protein 0.9344337582588196
for O O 0.995853066444397
Gln O S-protein 0.6947076916694641
did O O 0.9910128712654114
not O O 0.9999046325683594
change O O 0.9999865293502808
these O O 0.9999908208847046
IL-4 S-protein S-protein 0.8943855166435242
signals O O 0.9663420915603638
. O O 0.9999905824661255
Arg551 O O 0.3307409882545471
was O O 0.9987432360649109
not O O 0.9998088479042053
associated O O 0.9998883008956909
with O O 0.9999967813491821
atopic O O 0.9843355417251587
asthma O O 0.9983096122741699
in O O 0.9999990463256836
the O O 0.999995231628418
Japanese O O 0.677513837814331
population O O 0.4754938781261444
. O O 0.9999412298202515
CD23 S-protein S-protein 0.7205473184585571

Resolution O O 0.8184598088264465
of O O 0.9997313618659973
the O O 0.9999788999557495
NF-kappa B-protein B-protein 0.7704488635063171
B I-protein I-protein 0.7634391188621521
complex E-protein E-protein 0.9822784662246704
in O O 0.9999164342880249
gel O O 0.7899670600891113
shift O O 0.977875828742981
analysis O O 0.9993840456008911
shows O O 0.999998927116394
that O O 0.9999991655349731
the O O 0.9999110698699951
binding B-protein B-protein 0.46697935461997986
protein E-protein E-protein 0.9714697003364563
, O O 0.9878250956535339
mobilized O O 0.994351863861084
in O O 0.9999587535858154
naive B-cell_line B-cell_line 0.4337555170059204
Mono I-cell_line I-cell_line 0.45132938027381897
Mac I-cell_line I-cell_line 0.9028123021125793
6 I-cell_line I-cell_line 0.8467235565185547
cells E-cell_line E-cell_line 0.9968395233154297
, O O 0.9984997510910034

, O O 0.9597229361534119
including O O 0.9983263611793518
IL-2 S-protein S-protein 0.9854182004928589
, O O 0.9940563440322876
IL-4 S-protein S-protein 0.9932069182395935
, O O 0.9941368103027344
IL-7 S-protein S-protein 0.9963604807853699
, O O 0.995273768901825
IL-9 S-protein S-protein 0.9977977275848389
, O O 0.992043673992157
and O O 0.997142493724823
IL-15 S-protein S-protein 0.9975960850715637
, O O 0.9982289671897888
are O O 0.9999929666519165
important O O 0.999977707862854
for O O 0.9999940395355225
the O O 0.999988317489624

, O O 0.9945605397224426
we O O 0.9999699592590332
have O O 0.9999963045120239
demonstrated O O 0.999992847442627
that O O 0.9999996423721313
both O O 0.9998987913131714
ERK1/2 O S-protein 0.8922811150550842
and O O 0.977033257484436
p38 O S-protein 0.9317796230316162
cascades O O 0.49798476696014404
play O O 0.999962568283081
a O O 0.9999858140945435
key O O 0.999413013458252
role O O 0.9999904632568359
in O O 0.9999991655349731
the O O 0.999997615814209
production O O 0.9997881054878235
of O O 0.9999910593032837
IL-8 S-protein S-protein 0.9861003756523132
by O O 0.9999594688415527
monocytes S-cell_type S-cell_type 0.9953338503837585
and O O 0.992107093334198
PMN S-cell_type S-cell_type 0.9727053642272949

The O O 0.9995854496955872
decrease O O 0.9999123811721802
of O O 0.9999986886978149
the O O 0.9999979734420776
number O O 0.9990766048431396
of O O 0.9999914169311523
GCR S-protein S-protein 0.9859839081764221
in O O 0.9998805522918701
asthmatics O O 0.749017059803009
, O O 0.9983786344528198
we O O 0.9998708963394165
think O O 0.9999910593032837
, O O 0.9999879598617554
is O O 0.9999973773956299
related O O 0.9999696016311646
to O O 0.9999927282333374
heredity O O 0.9623769521713257
and O O 0.9990885257720947
repeated O O 0.9894983768463135
attacks O O 0.9958152174949646
of O O 0.9999672174453735
asthma O O 0.9936656355857849
. O O 0.999994158744812
Novel O B-protein 0.8403979539871216
aldosterone B-protein I-protein 0.3687102198600769
receptors E-protein E-protein 0.9914672374725342
: O O 0.9932481050491333
specificity-conferring O O 0.8091014623641968
mechanism O O 0.9656635522842407
at O O 0.9999886751174927
the O O 0.9999970197677612
level O O 0.9993022680282593
of O O 0.9999842643737793
the O O 0.9999573230743408
cell O O 0.8925092816352844
membrane O O 0.9116336703300476
. O O 0.9999135732650757
Functional O O 0.9874559044837952
studies O O 0.9982957243919373
in O O 0.9999121427536011
extra-renal B-cell_type B-cell_type 0.6203964948654175
, I-cell_type I-cell_type 0.5133518576622009
nonepithelial I-cell_type I-cell_type 0.7100733518600464
cells E-cell_type E-cell_type 0.9339730739593506
such O O 0.9993239641189575
as O O 0.9998443126678467
smooth B-cell_type O 0.6275331974029541

corticotropin-releasing O O 0.49714142084121704

patients O O 0.9765805006027222
did O O 0.9999581575393677
not O O 0.9999721050262451
differ O O 0.9999861717224121
significantly O O 0.9999951124191284
from O O 0.9999970197677612
those O O 0.9999693632125854
in O O 0.999906063079834
control O O 0.9853591918945312
subjects O O 0.9901770949363708
. O O 0.9999985694885254
In O O 0.9999334812164307
patients O O 0.9989984631538391
with O O 0.9999710321426392
connective O O 0.9762144684791565
tissue O O 0.996207594871521

synthesis O O 0.691898763179779
of O O 0.9968243837356567
IFN-gamma B-RNA B-RNA 0.978031575679779
mRNA E-RNA E-RNA 0.9991695880889893
was O O 0.9993112087249756
only O O 0.999984622001648
slightly O O 0.9996782541275024
decreased O O 0.9998854398727417
, O O 0.9999746084213257
and O O 0.9999741315841675
expression O O 0.998915433883667
of O O 0.9999876022338867
TGF-beta1 S-protein S-protein 0.9553408026695251
was O O 0.9998339414596558
unaffected O O 0.9997827410697937
. O O 0.9999966621398926
These O O 0.9999978542327881
findings O O 0.9996116757392883
correlated O O 0.9999567270278931
with O O 0.9999966621398926
activation O O 0.9985467791557312
of O O 0.9999806880950928
the O O 0.9999631643295288
IkappaBalpha B-DNA B-DNA 0.4458599090576172
gene E-DNA E-DNA 0.984900712966919
and O O 0.9984397292137146
blockade O O 0.9766560196876526
of O O 0.9997633099555969
the O O 0.99998939037323
nuclear O O 0.7879540920257568
translocation O O 0.8932299017906189
of O O 0.9988358616828918
NFkappaB S-protein S-protein 0.9974345564842224
in O O 0.9999676942825317
the O O 0.9999713897705078
xenotransplanted O O 0.7601057291030884
tissue O O 0.8531497120857239
. O O 0.9999431371688843
Dose-response O O 0.9440175294876099
experiments O O 0.9977298378944397
suggested O O 0.9999970197677612
that O O 0.9999970197677612
steroid O O 0.7802854180335999
doses O O 0.9048824906349182
currently O O 0.999812662601471
used O O 0.9999648332595825
in O O 0.9999712705612183
clinical O O 0.8386739492416382
medicine O O 0.9887999296188354
are O O 0.9999887943267822

Tax S-protein S-protein 0.8536972999572754
was O O 0.9999107122421265
able O O 0.9999392032623291
to O O 0.9999891519546509
significantly O O 0.9999829530715942
increase O O 0.9999979734420776
the O O 0.9999955892562866
transcriptional O O 0.9815801978111267
activity O O 0.999546468257904
of O O 0.9999983310699463
a O O 0.9999949932098389
template O O 0.9326895475387573
containing O O 0.9996904134750366
the O O 0.9999223947525024
-257 B-DNA B-DNA 0.8858335614204407
to I-DNA I-DNA 0.7878305912017822
+74 I-DNA I-DNA 0.6629973649978638
region E-DNA E-DNA 0.9914689064025879
of O O 0.9990087151527405
the O O 0.999728262424469
c-sis/PDGF-B B-DNA B-DNA 0.8678804636001587
promoter E-DNA E-DNA 0.9985463619232178
. O O 0.9999008178710938
Electrophoretic O O 0.9643529057502747
mobility O O 0.9926971793174744
shift O O 0.999523401260376
assay O O 0.9985641837120056
analysis O O 0.999927282333374
showed O O 0.9999992847442627
that O O 0.9999982118606567
Tax S-protein S-protein 0.9985392093658447
increased O O 0.9999644756317139
the O O 0.9999881982803345
DNA O O 0.8899917006492615
binding O O 0.9508745670318604
activity O O 0.9978506565093994
of O O 0.9999854564666748
both O O 0.9998447895050049

. O O 0.9954484105110168

the O O 0.994316041469574
-1280 B-DNA B-DNA 0.7691519260406494
element E-DNA E-DNA 0.9949895739555359
and O O 0.9966553449630737
the O O 0.9996703863143921
c-fos B-DNA B-DNA 0.4338217079639435
SRE I-DNA I-DNA 0.45882752537727356
cross E-DNA E-DNA 0.9833769798278809
-competed O O 0.9477859735488892
, O O 0.9998229146003723
whereas O O 0.9999955892562866
their O O 0.9999648332595825
functional O O 0.9579685926437378
and O O 0.9785767197608948
binding B-DNA O 0.8957597017288208
mutants E-DNA O 0.33662161231040955
did O O 0.9997480511665344
not O O 0.9999470710754395
. O O 0.9999905824661255
The O O 0.999995231628418
proximal B-DNA B-DNA 0.5648424029350281
element E-DNA E-DNA 0.9842631220817566
contains O O 0.9998216032981873
the O O 0.9998937845230103
sequence O B-DNA 0.4478358328342438
5'-GGCCAATGGG-3 O I-DNA 0.33335307240486145
' O E-DNA 0.48149192333221436
, O O 0.39446941018104553
which O O 0.9944491386413574
closely O O 0.9918386340141296
resembles O O 0.9998151659965515
the O O 0.9999140501022339
consensus O B-DNA 0.7269344925880432

, O O 0.9947826266288757
we O O 0.9999879598617554
show O O 0.9999986886978149
that O O 0.9999995231628418
a O O 0.999995231628418
novel O O 0.9711539149284363
function O O 0.9983955025672913
of O O 0.9999598264694214
iNO O S-protein 0.751409649848938
is O O 0.9979367256164551
to O O 0.9999477863311768
terminate O O 0.9972063899040222
inflammatory O O 0.9520664811134338
processes O O 0.9950693845748901
. O O 0.9999985694885254
We O O 0.9999942779541016
find O O 0.9999982118606567
that O O 0.9999940395355225
iNO O O 0.4736533761024475
produced O O 0.9976139068603516
by O O 0.9999810457229614
murine B-cell_line B-cell_type 0.4253290891647339
macrophage-like I-cell_line I-cell_type 0.683999240398407
cells E-cell_line E-cell_type 0.8416638970375061
, O O 0.9990127086639404
RAW264.7 S-cell_line S-cell_line 0.8817882537841797

and O O 0.9720433950424194
X- B-DNA O 0.9157581925392151
chromosome E-DNA O 0.7888135313987732
inactivation O O 0.9848611354827881
pattern O O 0.9987970590591431
( O O 0.999964714050293
r O O 0.9979028701782227
= O O 0.9996582269668579
0.17 O O 0.9971081614494324
) O O 0.9998897314071655
, O O 0.9999910593032837
even O O 0.9999380111694336
subdividing O O 0.9996076226234436
the O O 0.9999861717224121
subjects O O 0.99790358543396
in O O 0.9999959468841553
different O O 0.9996411800384521
age O O 0.9967807531356812
groups O O 0.9991569519042969
according O O 0.9999964237213135
to O O 0.9999948740005493
the O O 0.9999954700469971

factor I-protein I-protein 0.6714133620262146
of I-protein I-protein 0.5088273286819458
activated I-protein I-protein 0.5942214727401733
T I-protein I-protein 0.8792264461517334
cells E-protein E-protein 0.9454658627510071
) O O 0.9694927930831909
and O O 0.9995200634002686
NFAT S-protein S-protein 0.9989369511604309
-mediated O O 0.994436502456665
transactivation O O 0.9880961179733276
were O O 0.999982476234436
impaired O O 0.9998412132263184
by O O 0.9999935626983643
BCL-2 S-protein S-protein 0.9825856685638428
. O O 0.9999474287033081
Thus O O 0.9999152421951294
, O O 0.9999712705612183
select O O 0.9947783946990967
genetic O O 0.975417971611023
aberrations O O 0.9762802720069885
in O O 0.9999964237213135
the O O 0.9999924898147583
apoptotic O O 0.5589612722396851
pathway O O 0.9197755455970764
reveal O O 0.9999058246612549
a O O 0.9999830722808838
cell O O 0.9083839654922485
autonomous O O 0.9243231415748596
coregulation O O 0.9856892824172974
of O O 0.9995346069335938
activation O O 0.992175281047821
. O O 0.9999896287918091
Interaction O O 0.9980771541595459
of O O 0.9999536275863647
the O O 0.9999020099639893
human B-protein B-DNA 0.5570730566978455

, O O 0.9592258930206299
tandem O O 0.8710679411888123
copies O O 0.7471338510513306
of O O 0.9999539852142334
the O O 0.9999879598617554
E6 B-DNA B-DNA 0.7513858675956726
motif E-DNA E-DNA 0.9389982223510742
stimulated O O 0.9511011838912964
transcription O O 0.9322999119758606
in O O 0.99983811378479
ARH77 S-cell_line S-cell_line 0.9255085587501526
and O O 0.9120612144470215
Raji B-cell_line B-cell_line 0.8917872905731201
cells E-cell_line E-cell_line 0.99920254945755
but O O 0.9964948296546936
not O O 0.998747706413269
in O O 0.9979276657104492
Jurkat S-cell_line S-cell_line 0.9815248250961304
or O O 0.988810658454895
HeLa B-cell_line B-cell_line 0.9240084290504456
cells E-cell_line E-cell_line 0.9994812607765198
. O O 0.9999197721481323
Furthermore O O 0.9999983310699463
, O O 0.9999959468841553
a O O 0.9999945163726807
mutant B-DNA B-DNA 0.6340024471282959
E6 I-DNA I-DNA 0.22349344193935394
motif E-DNA E-DNA 0.7558237910270691
lost O O 0.9993414282798767

promoter O E-DNA 0.9386030435562134
contains O O 0.9997184872627258
a O O 0.99991774559021
sequence O O 0.770107090473175
GGGGACGTCCCC O S-protein 0.30878952145576477
, O O 0.9743775129318237
named O O 0.994556188583374
B2 S-DNA S-protein 0.633953869342804
, O O 0.9722499847412109
which O O 0.9997779726982117
is O O 0.9999732971191406
similar O O 0.9999679327011108
to O O 0.9999921321868896
the O O 0.9999234676361084
kappa B-DNA B-DNA 0.849023699760437
B I-DNA I-DNA 0.8476220965385437
sequence E-DNA E-DNA 0.9846214056015015
GGGGACTTTCC O O 0.5213159322738647
, O O 0.9931344985961914
the O O 0.9999234676361084
binding O O 0.553238570690155
site O O 0.7104440927505493
of O O 0.961976170539856
the O O 0.9992188215255737
transcription B-protein B-protein 0.5076919794082642
factor E-protein I-protein 0.7660507559776306
nuclear B-protein I-protein 0.5184287428855896
factor I-protein I-protein 0.7927462458610535
( I-protein I-protein 0.5671404600143433
NF I-protein I-protein 0.7298282980918884
) I-protein I-protein 0.9021396040916443
-kappa I-protein I-protein 0.9260894656181335
B E-protein E-protein 0.9883831143379211
. O O 0.9996193647384644
Activation O O 0.9970505237579346
of O O 0.9998910427093506
T B-cell_type B-cell_type 0.7367000579833984

eliminate O O 0.9990881681442261
the O O 0.9999806880950928
ambiguities O O 0.9504718780517578
intrinsic O O 0.9968400001525879
to O O 0.999968409538269
molecular O O 0.9459741115570068
studies O O 0.9980886578559875
on O O 0.9999876022338867
heterogeneous O O 0.7629337310791016
populations O O 0.45977169275283813
of O O 0.9992793202400208
hematopoietic B-cell_type B-cell_type 0.6866098642349243
progenitors/precursors E-cell_type E-cell_type 0.9319210648536682

) O O 0.7818370461463928
, O O 0.9979700446128845
a O O 0.9999825954437256
flexible B-protein O 0.7879359722137451
linker E-protein O 0.4128689765930176
, O O 0.9594510197639465
and O O 0.998616099357605
a O O 0.9998010993003845
C-terminal B-protein B-protein 0.757384717464447
POU-specific I-protein I-protein 0.9191918969154358
homeodomain E-protein E-protein 0.9744710326194763
( O O 0.9907373785972595
POUHD S-protein S-protein 0.7151049375534058
) O O 0.9820834398269653
. O O 0.9999918937683105
Here O O 0.999995231628418
we O O 0.9999969005584717
describe O O 0.9999977350234985
the O O 0.9999961853027344
solution O O 0.9584543108940125
structure O O 0.968568742275238
of O O 0.9998840093612671
a O O 0.9999772310256958
POU-specific B-protein B-protein 0.35967427492141724
homeodomain E-protein E-protein 0.6815436482429504
. O O 0.9989057779312134
An O O 0.9999822378158569
NMR O O 0.23786520957946777
model O O 0.317785382270813
is O O 0.9990172386169434
obtained O O 0.9999614953994751
from O O 0.9999886751174927
Oct-2 S-protein S-protein 0.9291190505027771
, O O 0.9982299208641052
a O O 0.9998661279678345

The O O 0.9993333220481873
additional O O 0.9934514760971069
function O O 0.9994332194328308
that O O 0.9999855756759644
is O O 0.9999691247940063
required O O 0.9999498128890991
for O O 0.9999902248382568
initiation O O 0.9969879984855652
of O O 0.9999856948852539
the O O 0.999988317489624
lytic O O 0.6694198846817017
viral O O 0.6841748356819153
life O O 0.6717817783355713
cycle O O 0.8669044375419617
is O O 0.9999197721481323
likely O O 0.9999927282333374
to O O 0.9999972581863403
require O O 0.9999963045120239
phosphorylation O O 0.9943588376045227
of O O 0.9999527931213379
serine O B-protein 0.4534764587879181
186 O E-protein 0.4691636264324188
of O O 0.8897517323493958
the O O 0.9952398538589478
ZEBRA B-protein B-protein 0.5642248392105103
protein E-protein E-protein 0.9603376388549805
, O O 0.9821590781211853
which O O 0.9999414682388306
may O O 0.9999905824661255
influence O O 0.999996542930603
either O O 0.9999557733535767
DNA O O 0.9771489500999451

. O O 0.9993832111358643
High O O 0.9799184799194336
affinity O O 0.9894673228263855
binding O O 0.9978099465370178
of O O 0.9999868869781494
the O O 0.9999878406524658
radioligand O O 0.4204924702644348
with O O 0.994772732257843
an O O 0.9999507665634155
apparent O O 0.9935775995254517
Kd O O 0.9265702962875366
of O O 0.9964097142219543
approximately O O 0.99982088804245
0.1 O O 0.9942797422409058
nM O O 0.9948142766952515
was O O 0.9999860525131226
found O O 0.9999957084655762
. O O 0.999996542930603
Aldosterone O O 0.9462277293205261
displaced O O 0.9991169571876526

lymphoblastic O O 0.7960168123245239
leukemia O O 0.9531688094139099
of O O 0.9995973706245422
childhood O O 0.9781666994094849
. O O 0.9999794960021973
Molecular O O 0.9499204754829407
, O O 0.9887037873268127
cellular O O 0.974770188331604
, O O 0.997088611125946
and O O 0.9986187219619751
clinical O O 0.9887802600860596
considerations O O 0.9995602965354919
. O O 0.9999985694885254
Glucocorticoids O O 0.9369920492172241
have O O 0.9997926354408264
been O O 0.9999734163284302
included O O 0.9999761581420898
in O O 0.9999854564666748
almost O O 0.9998387098312378
all O O 0.9998626708984375
treatment O O 0.9521780014038086
regimens O O 0.9671463966369629
for O O 0.9999878406524658
childhood O O 0.8415980935096741
acute O O 0.9136990308761597
lymphoblastic O O 0.9630236029624939
leukemia O O 0.9933921694755554
for O O 0.9999804496765137
decades O O 0.9999034404754639
. O O 0.9999986886978149
However O O 0.999993085861206
, O O 0.9999842643737793
optimal O O 0.958092451095581
agents O O 0.9966027736663818
, O O 0.9999216794967651

muB I-DNA I-DNA 0.2061081975698471
elements E-DNA E-DNA 0.9945496916770935
is O O 0.9998946189880371
due O O 0.9999921321868896
in O O 0.9999972581863403
part O O 0.9998757839202881
to O O 0.9999992847442627
a O O 0.9999891519546509
directed O O 0.9384856224060059
DNA O B-DNA 0.6852409243583679
bend O E-DNA 0.9096878170967102
induced O O 0.9996296167373657
by O O 0.999990701675415
PU.1 S-protein S-protein 0.9637954831123352
. O O 0.9998315572738647
[ O O 0.9975534081459045
Cortisone-resistant O O 0.935409665107727
bronchial O O 0.9538686275482178
asthma O O 0.9927076697349548
] O O 0.9999730587005615
There O O 0.9999964237213135
is O O 0.9999978542327881
general O O 0.9996906518936157
agreement O O 0.9999536275863647
on O O 0.9999988079071045
the O O 0.9999960660934448
inflammatory O O 0.7632138729095459
pathogenesis O O 0.9673662185668945
of O O 0.9998354911804199
bronchial O O 0.8538440465927124
asthma O O 0.9770843386650085
: O O 0.999863862991333
an O O 0.9999886751174927
accumulation O O 0.9989007711410522
of O O 0.999976396560669
activated B-cell_type B-cell_type 0.47934678196907043
eosinophils E-cell_type E-cell_type 0.7294882535934448
, O O 0.9987319111824036
degranulated B-cell_type B-cell_type 0.4672316014766693
mast I-cell_type I-cell_type 0.5154706835746765
cells E-cell_type E-cell_type 0.5447443127632141
, O O 0.9932386875152588
T B-cell_type B-cell_type 0.9543463587760925
lymphocytes E-cell_type E-cell_type 0.9970269799232483
and O O 0.9989752769470215
in O O 0.9998873472213745
very O O 0.9950887560844421
severe O O 0.9866982698440552
forms O O 0.9950460195541382
, O O 0.999991774559021

not O O 0.9825443625450134
be O O 0.9998223185539246
achieved O O 0.9999010562896729
, O O 0.9999909400939941
as O O 0.9999959468841553
suggested O O 0.9999638795852661
by O O 0.9999995231628418
the O O 0.9999986886978149
higher O O 0.9772600531578064
values O O 0.9873837828636169
of O O 0.9999580383300781
plasma O O 0.7954192161560059
cortisol O O 0.8268337845802307
usually O O 0.9990801811218262
found O O 0.9999903440475464
in O O 0.9999897480010986
aging O O 0.8732845187187195
subjects O O 0.8565364480018616
. O O 0.9999963045120239
Analysis O O 0.9999451637268066
of O O 0.9999982118606567
the O O 0.9999866485595703
ligand-binding B-protein B-protein 0.7053283452987671
domain E-protein E-protein 0.8901582956314087
of O O 0.9963390827178955
human B-protein B-protein 0.5586544871330261
retinoic I-protein I-protein 0.462193101644516
acid I-protein I-protein 0.6653663516044617
receptor I-protein I-protein 0.8101211786270142
alpha E-protein E-protein 0.995859682559967
by O O 0.9997995495796204
site-directed O O 0.6252159476280212
mutagenesis O O 0.7875257730484009
. O O 0.9999668598175049
Three O O 0.9997571110725403
subtypes O O 0.9763749241828918
of O O 0.9997379183769226
retinoic B-protein O 0.4413551688194275

of O O 0.9961185455322266
nuclear B-protein O 0.5249747037887573
c-Rel E-protein S-protein 0.7122284770011902
, O O 0.9317429065704346
p50 S-protein S-protein 0.9963085055351257
, O O 0.9754520654678345
and O O 0.9889946579933167
p65 S-protein S-protein 0.9943183064460754
, O O 0.9914042949676514
and O O 0.9997683167457581
this O O 0.9997768998146057
augmentation O O 0.9860644340515137
can O O 0.9999185800552368
occur O O 0.9999970197677612
in O O 0.9999921321868896
the O O 0.9999935626983643
presence O O 0.9991982579231262
of O O 0.9999752044677734

lytic O O 0.8418408036231995
replication O O 0.9731563925743103
cycle O O 0.9866413474082947
by O O 0.9999961853027344
TPA O O 0.6332001686096191
treatment O O 0.9678283929824829
or O O 0.9997515082359314
by O O 0.9999748468399048
providing O O 0.9999648332595825
the O O 0.9999954700469971
immediate B-protein B-protein 0.9576790928840637
early I-protein I-protein 0.8475404381752014
transactivator E-protein I-protein 0.7768487930297852
BZLF1 S-protein E-protein 0.7632683515548706
in O O 0.9998204112052917
trans O O 0.6063385605812073
resulted O O 0.9951386451721191
in O O 0.9999728202819824
increased O O 0.998680055141449
expression O O 0.9999033212661743
. O O 0.9999988079071045
We O O 0.999964714050293
demonstrated O O 0.9999748468399048
that O O 0.999998927116394
the O O 0.9999735355377197
virus B-protein O 0.9311371445655823

tumor B-cell_type B-cell_type 0.4011126756668091
cells E-cell_type E-cell_type 0.9439333081245422
. O O 0.9999412298202515
In O O 0.9999959468841553
this O O 0.9999990463256836
study O O 0.9999170303344727
, O O 0.999997615814209
we O O 0.9999630451202393
examined O O 0.9999895095825195
the O O 0.9999954700469971
expression O O 0.9997319579124451
of O O 0.9999908208847046

These O O 0.9991625547409058
cytokines S-protein S-protein 0.9890433549880981
are O O 0.9999526739120483
therefore O O 0.9999885559082031
candidate O O 0.9896406531333923
genes O O 0.6691498756408691
which O O 0.9999443292617798
could O O 0.9999964237213135
contribute O O 0.9999984502792358
to O O 0.9999978542327881
the O O 0.9999969005584717
development O O 0.9999263286590576
of O O 0.9999966621398926
asthma O O 0.9846678376197815
or O O 0.9994760155677795
allergies O O 0.9970206618309021
. O O 0.9999935626983643

alpha I-protein I-protein 0.3883707523345947
receptor E-protein E-protein 0.9860300421714783
. O O 0.9998058676719666
Induction O O 0.9910628795623779
of O O 0.99988853931427
CD38 S-protein S-protein 0.9835416674613953
in O O 0.9998390674591064
acute B-cell_type B-cell_line 0.4692934453487396
promyelocytic I-cell_type I-cell_line 0.2890882194042206
and I-cell_type I-cell_line 0.48613300919532776
acute I-cell_type I-cell_line 0.31578242778778076
myeloblastic I-cell_type I-cell_line 0.6639416813850403
leukemia I-cell_type I-cell_line 0.8274388909339905
cells E-cell_type E-cell_line 0.9177848100662231
was O O 0.9996101260185242
independent O O 0.99996018409729
of O O 0.9999982118606567
ATRA-induced O O 0.8822746872901917
cytodifferentiation O O 0.9901836514472961
. O O 0.9999951124191284
Following O O 0.9997804760932922
culture O O 0.9845362305641174
with O O 0.9999908208847046
ATRA O O 0.9783788919448853
, O O 0.9999827146530151
increased O O 0.9993324875831604
CD38 S-protein S-protein 0.9846926927566528
protein O O 0.8015487194061279
levels O O 0.9997734427452087
were O O 0.9999934434890747
also O O 0.9999890327453613
observed O O 0.9999593496322632
in O O 0.9999780654907227
normal B-cell_type O 0.6853801608085632
CD34+ I-cell_type B-cell_type 0.6227110624313354
bone I-cell_type I-cell_type 0.849364697933197
marrow I-cell_type I-cell_type 0.633691668510437

portion E-protein O 0.38533779978752136

effects O O 0.9985430240631104
on O O 0.9999955892562866
the O O 0.9999717473983765
HIV-1 B-DNA B-DNA 0.4573201537132263
and I-DNA I-DNA 0.7981335520744324
interleukin I-DNA I-DNA 0.5064120888710022
2 I-DNA I-DNA 0.6267200708389282
promoters E-DNA E-DNA 0.9966748952865601
. O O 0.9999709129333496
Further O O 0.9999700784683228
evidence O O 0.9999935626983643
suggests O O 0.9999985694885254
that O O 0.999994158744812
Nef S-protein S-protein 0.9980719089508057
inhibits O O 0.9998030066490173
NF-kappa B-protein B-protein 0.881694495677948
B E-protein E-protein 0.9987173080444336
induction O O 0.9995204210281372
by O O 0.999996542930603
interfering O O 0.9919419288635254
with O O 0.9999690055847168
a O O 0.9999877214431763
signal O O 0.9539613127708435
derived O O 0.9970036149024963
from O O 0.9999727010726929
the O O 0.9999173879623413
T-cell B-protein B-protein 0.4282316267490387
receptor I-protein I-protein 0.4723219573497772
complex E-protein E-protein 0.9928521513938904
. O O 0.9999250173568726
Expression O O 0.9994292855262756
of O O 0.9999653100967407

divergent O O 0.8046318292617798

and O O 0.9758801460266113
Candida O O 0.9790711402893066
albicans O O 0.9792869091033936
on O O 0.9998762607574463
HIV O O 0.575840950012207
expression O O 0.9400514960289001
in O O 0.9998633861541748
monocytic B-cell_type B-cell_type 0.7510316371917725
cells E-cell_type E-cell_type 0.9576481580734253
was O O 0.9996135830879211
examined O O 0.9998008608818054
. O O 0.9999971389770508
Stimulation O O 0.9993428587913513
of O O 0.9999927282333374
the O O 0.9999178647994995
latently O B-cell_line 0.6430732607841492
HIV-infected B-cell_line I-cell_line 0.5719299912452698
myelomonocytic I-cell_line I-cell_line 0.615383505821228
cell I-cell_line I-cell_line 0.9366662502288818
line E-cell_line I-cell_line 0.9536293148994446
OM-10.1 O E-cell_line 0.9494649171829224
with O O 0.9992664456367493
C. O O 0.4885692596435547

and O O 0.914932370185852
P8 O O 0.2745438516139984
, O O 0.9344033598899841
induced O O 0.9877241849899292
naive O O 0.591590940952301
T O O 0.5035977363586426
cell O O 0.5883408784866333
proliferation O O 0.9900029897689819
less O O 0.9999852180480957
effectively O O 0.9997316002845764
and O O 0.9999147653579712
were O O 0.9999749660491943
also O O 0.9999743700027466
less O O 0.999971866607666
immunogenic O O 0.9137731194496155
for O O 0.9967260360717773
T B-cell_type B-cell_type 0.9007619023323059
cells E-cell_type E-cell_type 0.9965903759002686
from O O 0.9998631477355957
vaccinated O O 0.8449181914329529
or O O 0.9763504862785339
naturally O O 0.9459496736526489
immune O O 0.9683068990707397
donors O O 0.9797404408454895
. O O 0.9999947547912598
T O O 0.7079369425773621
cell O O 0.6833155751228333
recognition O O 0.994697093963623
of O O 0.9999847412109375
specific O O 0.9678965210914612
peptides O O 0.9532563090324402
was O O 0.9999927282333374
concordant O O 0.9976083040237427
between O O 0.9997238516807556
naive O O 0.5673703551292419
, O O 0.9513533115386963
DC S-cell_type O 0.7206250429153442

It O O 0.9926857948303223
can O O 0.9999656677246094
only O O 0.9999929666519165
be O O 0.9999762773513794
activated O O 0.9997740387916565
in O O 0.999995231628418
a O O 0.9999865293502808
tissue-specific O O 0.8414844870567322
manner O O 0.9962288737297058
by O O 0.9999946355819702
elements O O 0.8184768557548523
that O O 0.9998107552528381
lie O O 0.9997747540473938
downstream O O 0.9992052912712097
of O O 0.9999871253967285
the O O 0.9999808073043823
initiation B-DNA B-DNA 0.6693302989006042
site E-DNA E-DNA 0.9675003290176392
. O O 0.9997867941856384
We O O 0.9999850988388062
have O O 0.9999957084655762
analyzed O O 0.9998980760574341
the O O 0.9999393224716187
functional O O 0.8746599555015564
domains O O 0.3780609369277954
of O O 0.9993540644645691
the O O 0.9998914003372192

second O O 0.9521704316139221
week O O 0.9985652565956116
of O O 0.9999388456344604
treatment O O 0.9994359612464905
and O O 0.999996542930603
at O O 0.9999996423721313
the O O 0.9999995231628418
end O O 0.9877195358276367
of O O 0.9999901056289673
the O O 0.9999991655349731
6-week O O 0.8880115151405334
washout O O 0.9266882538795471
period O O 0.9994044303894043
with O O 0.9999995231628418
no O O 0.9999781847000122
statistically O O 0.9549008011817932
significant O O 0.9992091059684753
change O O 0.9999741315841675
in O O 0.9999881982803345
cortisol O O 0.9040148854255676
response O O 0.9959583878517151
. O O 0.9999938011169434

( I-RNA I-RNA 0.705727756023407
OH I-RNA I-RNA 0.869856595993042
) I-RNA I-RNA 0.9635063409805298
2D3 I-RNA I-RNA 0.9947947859764099
receptor I-RNA I-RNA 0.9941661357879639
RNA E-RNA E-RNA 0.9940879344940186
were O O 0.999525785446167
not O O 0.9998791217803955
affected O O 0.999957799911499
by O O 0.9999969005584717
terminal O O 0.971986711025238
differentiation O O 0.9985029697418213
of O O 0.9999920129776001
HL-60 S-cell_line S-cell_line 0.8693593144416809
toward O O 0.9860727787017822
either O O 0.9936724901199341
granulocytes S-cell_type S-cell_type 0.9886124730110168
or O O 0.9948840737342834
macrophages S-cell_type S-cell_type 0.9983874559402466
. O O 0.9998403787612915
Nondividing O B-cell_type 0.5151570439338684
macrophages S-cell_type E-cell_type 0.8409387469291687
from O O 0.999924898147583
normal O O 0.9504064917564392
individuals O O 0.9943821430206299
also O O 0.9998329877853394
expressed O O 0.9996242523193359
1 B-RNA B-RNA 0.6110756993293762
, I-RNA I-RNA 0.894404947757721
25 I-RNA I-RNA 0.9577560424804688
( I-RNA I-RNA 0.9757742285728455
OH I-RNA I-RNA 0.9890264868736267
) I-RNA I-RNA 0.9958531856536865
2D3 I-RNA I-RNA 0.9983046054840088
receptor I-RNA I-RNA 0.9954448938369751
RNA E-RNA E-RNA 0.9783976078033447
. O O 0.9997416138648987
In O O 0.999983549118042
contrast O O 0.9999327659606934
, O O 0.9999796152114868
nondividing B-cell_type B-cell_type 0.4860014021396637
peripheral I-cell_type I-cell_type 0.6719279289245605
blood I-cell_type I-cell_type 0.9052228927612305
lymphocytes E-cell_type E-cell_type 0.9748464226722717
from O O 0.9999239444732666
normal O O 0.9220331907272339
individuals O O 0.9942023158073425
did O O 0.9999037981033325
not O O 0.9999257326126099
express O O 0.9996685981750488
1 B-RNA O 0.5298244953155518
, I-RNA O 0.5321356058120728
25 I-RNA O 0.5478229522705078
( I-RNA O 0.7298362255096436
OH I-RNA O 0.3480190634727478
) I-RNA O 0.6044082045555115

compete O O 0.9892725944519043
with O O 0.9999947547912598
the O O 0.9999927282333374
wild O B-protein 0.5792651772499084
type O I-protein 0.7001368999481201
motif O E-protein 0.7437566518783569
for O O 0.9816847443580627
NFAT B-protein B-protein 0.5631111264228821
complex E-protein E-protein 0.9328651428222656
formation O O 0.9479050636291504
in O O 0.9999710321426392
both O O 0.9994307160377502
T B-cell_type B-cell_type 0.6241764426231384
and I-cell_type I-cell_type 0.8303501009941101
B I-cell_type I-cell_type 0.9546046257019043
cells E-cell_type E-cell_type 0.9799441695213318
. O O 0.9996979236602783
We O O 0.9999910593032837
therefore O O 0.9999926090240479
propose O O 0.9999984502792358
a O O 0.9999971389770508
model O O 0.9961169958114624
whereby O O 0.9999936819076538
a O O 0.9999918937683105
core O B-protein 0.8488580584526062
NFAT B-protein I-protein 0.3610045611858368
complex E-protein E-protein 0.9734982252120972

stat1 I-protein B-protein 0.35072556138038635
proteins E-protein E-protein 0.9808374047279358
( O O 0.9933839440345764
91 B-protein B-protein 0.4237302839756012
and I-protein I-protein 0.6328446865081787
84 I-protein I-protein 0.4519765079021454
kDa I-protein I-protein 0.49299323558807373
proteins E-protein E-protein 0.9880406260490417
) O O 0.9925883412361145
were O O 0.99998939037323
translocated O O 0.9990523457527161
to O O 0.9999921321868896
the O O 0.9999837875366211
nucleus O O 0.976991593837738
following O O 0.9999076128005981
interferon-gamma S-protein S-protein 0.8462767004966736
treatment O O 0.9985930323600769
of O O 0.9999891519546509
HeLa B-cell_line B-cell_line 0.875874400138855
cells E-cell_line E-cell_line 0.9965158700942993
. O O 0.9998514652252197

homeodomain E-protein E-protein 0.9116519093513489
( O O 0.994415283203125
POU B-protein S-protein 0.706142783164978
[ I-protein O 0.8442184925079346
H I-protein O 0.7534617781639099
] E-protein O 0.5524591207504272
) O O 0.5598828792572021
. O O 0.999923586845398
Here O O 0.9999836683273315
, O O 0.9999802112579346
we O O 0.9999895095825195
show O O 0.9999964237213135
that O O 0.9999974966049194
OCA-B S-protein S-protein 0.9866284132003784
alters O O 0.9997710585594177
the O O 0.9999895095825195
activity O O 0.9967727065086365
of O O 0.9998869895935059
Oct-1 S-protein S-protein 0.9972732663154602
in O O 0.9999269247055054
two O O 0.9995825886726379
ways O O 0.999593198299408
. O O 0.9999934434890747

, O O 0.9373978972434998

comments O O 0.9746593236923218
] O O 0.9999629259109497
The O O 0.9999639987945557
transcription B-protein B-protein 0.5220016837120056
factor E-protein E-protein 0.9708460569381714
nuclear B-protein B-protein 0.528198778629303
factor-kappa I-protein I-protein 0.5446566343307495

The O O 0.9996336698532104
diagnosis O O 0.9997377991676331
of O O 0.999994158744812
GCT O O 0.6115473508834839
should O O 0.99973064661026
be O O 0.9999985694885254
based O O 0.9998642206192017
primarily O O 0.9999961853027344
on O O 0.9999967813491821
the O O 0.9999943971633911
typical O O 0.9715318083763123
morphology O O 0.954537570476532
revealed O O 0.9998878240585327
by O O 0.9999979734420776
conventional O O 0.9170834422111511
stains O O 0.884682297706604
, O O 0.9996893405914307
but O O 0.9999386072158813
additional O O 0.9984623193740845
immunohistochemical O O 0.7478756904602051
staining O O 0.9867637753486633
with O O 0.999983549118042
a O O 0.9999922513961792
small O O 0.9527918100357056
panel O O 0.9444553256034851
of O O 0.9980072379112244

reporter E-DNA O 0.314452588558197
. O O 0.9876435995101929
Cells O O 0.9300564527511597
were O O 0.9999490976333618
subsequently O O 0.9999246597290039
stimulated O O 0.9999128580093384
with O O 0.9999953508377075
1 O O 0.9782377481460571
) O O 0.9977885484695435
PMA O O 0.9932624697685242
for O O 0.999975323677063
24 O O 0.9967674016952515
h O O 0.9938862919807434
, O O 0.9999079704284668
inducing O O 0.9995632767677307
CAT S-protein S-protein 0.930037796497345
activity O O 0.9992007613182068
by O O 0.9999935626983643
2.6-fold O O 0.9790163040161133
, O O 0.9986106157302856
2 O O 0.9983397722244263
) O O 0.9988970756530762
fibrinogen S-protein O 0.7891036868095398
/Mn2+ O O 0.9817143678665161
for O O 0.9999063014984131
2 O O 0.995509147644043
h O O 0.9983859062194824

superior O O 0.9057896733283997
to O O 0.9987233281135559
prednisone O O 0.36327338218688965
in O O 0.9986469149589539
conventional O O 0.916016697883606
equi-effective O O 0.7744370698928833
doses O O 0.8862526416778564
. O O 0.9999194145202637

) O O 0.802509069442749
were O O 0.9993001222610474
also O O 0.999984622001648
induced O O 0.9999566078186035
by O O 0.9999985694885254
PMA O O 0.9975990653038025
. O O 0.9999966621398926
The O O 0.9999982118606567
nuclear O O 0.9390532970428467
extracts O O 0.9941900968551636
from O O 0.9999547004699707
resting O O 0.4299943745136261
and O O 0.7604088187217712
induced B-cell_line O 0.7262336015701294
ML-1 I-cell_line B-cell_line 0.595317006111145
cells E-cell_line E-cell_line 0.9842899441719055
contain O O 0.999778687953949
proteins O O 0.9322843551635742
binding O O 0.9686203002929688
specifically O O 0.9995204210281372

, O O 0.962685227394104
which O O 0.9997429251670837
was O O 0.9999099969863892
extensively O O 0.9987372756004333
investigated O O 0.9999493360519409
in O O 0.999924898147583
activated B-cell_type B-cell_type 0.5524072051048279
T I-cell_type I-cell_type 0.6961228847503662
cells E-cell_type E-cell_type 0.9363192915916443
, O O 0.9938880801200867
we O O 0.9999505281448364
have O O 0.9999969005584717
studied O O 0.9999687671661377
the O O 0.9999970197677612
role O O 0.9997758269309998
of O O 0.9999948740005493
an O O 0.9999426603317261
upstream O B-DNA 0.47980189323425293
NF-kappaB B-DNA I-DNA 0.5522580742835999
like I-DNA I-DNA 0.4979354441165924
site E-DNA E-DNA 0.9574496746063232
in O O 0.9997116923332214
the O O 0.9999821186065674
5637 B-cell_line B-cell_line 0.5726248621940613
non-lymphoid I-cell_line I-cell_line 0.7314789295196533
cell I-cell_line I-cell_line 0.8818532824516296
line E-cell_line E-cell_line 0.9930949807167053
, O O 0.9583656191825867
which O O 0.9998416900634766
derives O O 0.9995928406715393
from O O 0.9999558925628662
a O O 0.9999027252197266
bladder O O 0.8344794511795044

the O O 0.9988992214202881
leucine B-protein B-protein 0.581061601638794
zipper I-protein I-protein 0.7766426801681519
protein I-protein I-protein 0.673109233379364
family E-protein E-protein 0.9828976988792419
suggests O O 0.9994613528251648
c-myb S-DNA S-DNA 0.859599769115448
is O O 0.9982556700706482
likely O O 0.9999357461929321
to O O 0.9999901056289673
engage O O 0.9999856948852539
in O O 0.9999865293502808
similar O O 0.9995847344398499
interactions O O 0.9984140396118164
with O O 0.9999969005584717
cellularly B-protein O 0.7774544358253479
encoded I-protein O 0.8776440620422363
transcription I-protein B-protein 0.6192873120307922
factors E-protein E-protein 0.9966623783111572
. O O 0.9999532699584961
Alpha-lipoic O O 0.9363691210746765
acid O O 0.9730396866798401
is O O 0.9998883008956909
a O O 0.9999958276748657
potent O O 0.9801934361457825
inhibitor O O 0.9542325735092163
of O O 0.9997268319129944
NF-kappa B-protein B-protein 0.9139047861099243

Jurkat B-cell_line B-cell_line 0.35734105110168457
cells E-cell_line E-cell_line 0.9638345837593079
. O O 0.9998334646224976
We O O 0.9999915361404419
propose O O 0.9999991655349731
that O O 0.9999996423721313
the O O 0.9999535083770752
MNP B-protein B-protein 0.5669669508934021
protein E-protein E-protein 0.9311505556106567
( O O 0.9270607233047485
s O O 0.8677147626876831
) O O 0.9616559743881226
binding O O 0.98562091588974
at O O 0.9999946355819702
the O O 0.9999895095825195
MNP B-DNA B-DNA 0.649754524230957
site E-DNA E-DNA 0.972366988658905
constitutes O O 0.9999364614486694
a O O 0.9999967813491821
novel O O 0.8993991613388062
transcription B-protein B-protein 0.3829675018787384
factor E-protein E-protein 0.9909660816192627
( O O 0.9858086109161377
s O O 0.9392896294593811
) O O 0.9951273202896118
expressed O O 0.9997183680534363
in O O 0.9999221563339233
hematopoietic B-cell_type B-cell_type 0.8504161834716797
cells E-cell_type E-cell_type 0.9780267477035522

on O O 0.9991344809532166
human B-cell_type B-cell_type 0.5711948275566101
neutrophils E-cell_type E-cell_type 0.9867136478424072
[ O O 0.9997380375862122
see O O 0.9999263286590576
comments O O 0.9965373277664185
] O O 0.9999233484268188
BACKGROUND O O 0.9993535876274109
: O O 0.9999961853027344
Recent O O 0.9999024868011475
studies O O 0.999908447265625
have O O 0.9999996423721313
raised O O 0.999988317489624
the O O 0.9999967813491821
hypothesis O O 0.9986943602561951
that O O 0.9999954700469971
glucocorticoids O O 0.966381847858429
could O O 0.9999213218688965
diminish O O 0.9999951124191284
the O O 0.9999926090240479
ability O O 0.9999762773513794
of O O 0.9999896287918091
endothelial B-cell_type B-cell_type 0.843527615070343
cells E-cell_type E-cell_type 0.9944607019424438
to O O 0.9995679259300232
direct O O 0.9991655349731445
leukocyte O O 0.6961303353309631
traffic O O 0.9864645004272461
into O O 0.9999788999557495
inflamed O O 0.8906687498092651
tissues O O 0.9726256132125854
by O O 0.9999814033508301
inhibiting O O 0.9981367588043213
expression O O 0.9987609386444092
of O O 0.9999867677688599
the O O 0.9999279975891113
adhesion B-protein B-protein 0.7326175570487976
molecules E-protein E-protein 0.9910510778427124

IL-6 S-protein S-protein 0.9266269207000732
. O O 0.9999399185180664
This O O 0.9999845027923584
regulation O O 0.9991546869277954
could O O 0.999995231628418
not O O 0.9999784231185913
be O O 0.9999922513961792
appreciably O O 0.9998661279678345
modified O O 0.999961256980896
by O O 0.9999990463256836
enhanced O O 0.9943962097167969
expression O O 0.9989590644836426
of O O 0.9999912977218628
STAT B-protein B-protein 0.7764778733253479
proteins E-protein E-protein 0.9979694485664368
. O O 0.9999693632125854
The O O 0.999998927116394
similar O O 0.9993016719818115
actions O O 0.9998472929000854
of O O 0.9999935626983643
IL-10R S-protein S-protein 0.7195026874542236

beta I-RNA I-RNA 0.8763363361358643
mRNA E-RNA E-RNA 0.9886636137962341
in O O 0.9989331364631653
response O O 0.9984641075134277
to O O 0.9999853372573853
LPS O O 0.9939272403717041
. O O 0.9999920129776001
Preincubation O O 0.9916890263557434
of O O 0.9998416900634766
cells O O 0.9726555943489075
with O O 0.9999778270721436
1 O O 0.957913875579834
, O O 0.9956978559494019
25- O O 0.9981703758239746
( O O 0.9997183680534363
OH O O 0.9867470264434814
) O O 0.9973785877227783
2D3 O O 0.993645429611206
augmented O O 0.9988170862197876
IL-1 B-RNA B-protein 0.39127305150032043
beta I-RNA E-protein 0.7025483250617981
mRNA E-RNA O 0.7022016048431396
levels O O 0.9969685673713684
only O O 0.9999555349349976
in O O 0.9994551539421082
U-937 S-cell_line S-cell_line 0.9624382853507996
and O O 0.9538864493370056
HL-60 S-cell_line B-cell_line 0.7535733580589294
cells O E-cell_line 0.9957919120788574
. O O 0.999782145023346
From O O 0.9999489784240723

. O O 0.9991732239723206
Our O O 0.9999978542327881
results O O 0.9999774694442749
suggest O O 0.999998927116394
that O O 0.9999889135360718
Syk S-protein S-protein 0.998156726360321
, O O 0.9989200830459595
in O O 0.9999572038650513
contrast O O 0.9999573230743408
to O O 0.999974250793457
Zap S-protein S-protein 0.9990593791007996
, O O 0.9981852173805237
can O O 0.9999604225158691
transduce O O 0.999782383441925
signals O O 0.9956380724906921
from O O 0.9999891519546509
the O O 0.9998216032981873
T B-protein B-protein 0.4152650535106659
cell I-protein I-protein 0.6283340454101562
antigen I-protein I-protein 0.6195828914642334
receptor E-protein E-protein 0.8925105929374695

clinicians O O 0.8742319345474243
determine O O 0.9999886751174927
which O O 0.9999970197677612
therapies O O 0.9830912947654724
should O O 0.9999451637268066
remain O O 0.9999607801437378
novelties O O 0.8211133480072021
and O O 0.9996405839920044
which O O 0.999943733215332
should O O 0.9999721050262451
become O O 0.99997878074646
an O O 0.999991774559021
accepted O O 0.9934272766113281
part O O 0.9986059069633484
of O O 0.9999856948852539
the O O 0.9999874830245972
armamentarium O O 0.8026347756385803

a O O 0.9987983703613281
constitutively O O 0.7799139022827148
active O O 0.8773454427719116
Cbl B-protein B-protein 0.34237435460090637
mutant E-protein E-protein 0.9790321588516235
in O O 0.9994099140167236
T B-cell_type B-cell_type 0.879630982875824
cells E-cell_type E-cell_type 0.9911722540855408
. O O 0.9998080134391785
T B-protein B-protein 0.6834578514099121
cell I-protein I-protein 0.5277301073074341
receptor E-protein E-protein 0.9697859883308411
( O O 0.9764472842216492
TCR S-protein S-protein 0.982977032661438
) O O 0.9756439328193665
stimulation O O 0.9979693293571472
induces O O 0.9999833106994629
rapid O O 0.9443842172622681
tyrosine O O 0.8515147566795349
phosphorylation O O 0.9653511643409729
of O O 0.9997782111167908
cellular B-protein B-protein 0.5160127878189087
proteins E-protein E-protein 0.987032413482666
, O O 0.9965542554855347
including O O 0.9999136924743652
Cbl S-protein S-protein 0.9849138855934143
, O O 0.9970183372497559
a O O 0.9998213648796082
protooncogene B-protein B-protein 0.7522006630897522
product E-protein E-protein 0.9785481691360474
whose O O 0.9989494681358337

receptors O E-protein 0.7900120615959167
'' O O 0.8559026718139648
to O O 0.9984102249145508
which O O 0.9999946355819702
specific O O 0.9341138601303101
antigens O S-protein 0.4864710867404938
bind O O 0.929806649684906
. O O 0.9998756647109985
Studies O O 0.9987034797668457
in O O 0.9999797344207764
mice O O 0.9750692844390869
have O O 0.9999756813049316

responses O O 0.9945053458213806
to O O 0.9999843835830688
all O O 0.99996018409729
three O O 0.9987925291061401
stimuli O O 0.9123839139938354
, O O 0.9982150793075562
disparate O O 0.9635004997253418
stimulus- O O 0.982188880443573
and O O 0.9980478286743164
response-specific O O 0.9886876344680786
patterns O O 0.998296320438385
of O O 0.999954342842102
deactivation O O 0.9982035160064697
are O O 0.9999978542327881
seen O O 0.9999971389770508
. O O 0.9999960660934448
Inhibition O O 0.9955647587776184
by O O 0.9999867677688599
IL-10 S-protein S-protein 0.9824278950691223
of O O 0.9968634843826294

. O O 0.9993181228637695
The O O 0.9999984502792358
role O O 0.99828040599823
of O O 0.9999794960021973
platelets O S-cell_type 0.9829224348068237
for O O 0.9974505305290222
monocyte B-protein B-protein 0.6124171018600464
chemotactic I-protein I-protein 0.5030584931373596
protein-1 E-protein E-protein 0.9895567297935486
( O O 0.9809690713882446
MCP-1 S-protein S-protein 0.9878755211830139
) O O 0.98884516954422
secretion O O 0.9856494069099426
and O O 0.9997624754905701
surface O O 0.8825458288192749
expression O O 0.9784975647926331
of O O 0.9997995495796204
intercellular B-cell_type B-protein 0.5882676839828491
adhesion I-cell_type I-protein 0.771172821521759
molecule-1 E-cell_type E-protein 0.9978014826774597
( O O 0.9820830821990967
ICAM-1 S-protein S-protein 0.9963085055351257
) O O 0.9921028017997742
on O O 0.9997462630271912
endothelial B-cell_type B-cell_type 0.9188804030418396
cells E-cell_type E-cell_type 0.9938685297966003
has O O 0.9999176263809204

developments O O 0.9578762650489807
, O O 0.9999781847000122
including O O 0.9999973773956299
the O O 0.9999991655349731
identification O O 0.9991481304168701
of O O 0.9999957084655762
novel O O 0.7822443246841431
families O O 0.5002692341804504
of O O 0.9971411228179932
transcription B-DNA B-protein 0.7210079431533813
factors E-DNA E-protein 0.9972735047340393
that O O 0.9999126195907593
regulate O O 0.9999641180038452
multiple O O 0.782547116279602
T-cell B-DNA B-DNA 0.3494419455528259
genes E-DNA E-DNA 0.9889804124832153
during O O 0.9999045133590698
thymocyte O O 0.6670251488685608
ontogeny O O 0.6536657810211182
and O O 0.9840725064277649
T-cell S-cell_type O 0.5784323215484619
activation O O 0.9917482137680054
, O O 0.9999730587005615

The O O 0.9945663213729858
Tat B-protein B-protein 0.8813936114311218
protein E-protein E-protein 0.9953515529632568
of O O 0.9993354678153992
human O O 0.8675046563148499
immunodeficiency O O 0.9643179774284363
virus O O 0.9859821796417236
type O O 0.9928283095359802
1 O O 0.9947050213813782
( O O 0.9997958540916443
HIV-1 O O 0.9940628409385681
) O O 0.9996582269668579
is O O 0.9999943971633911
essential O O 0.9999862909317017
for O O 0.9999871253967285
productive O O 0.9911718964576721
infection O O 0.9996045231819153
and O O 0.9999935626983643
is O O 0.9999958276748657
a O O 0.9999980926513672
potential O O 0.9992867112159729
target O O 0.9993473887443542
for O O 0.9999936819076538
antiviral O O 0.9704005122184753
therapy O O 0.9965445399284363

this O O 0.9994145631790161
patient O O 0.9951351284980774
, O O 0.9999446868896484
it O O 0.999915599822998
is O O 0.9999957084655762
argued O O 0.9999940395355225
that O O 0.9999991655349731
the O O 0.9999963045120239
major O O 0.9570612907409668
likely O O 0.992119312286377
factor O O 0.7804277539253235
is O O 0.9998087286949158

receptor E-protein E-protein 0.7977045178413391

primates O O 0.506435751914978
. O O 0.9999802112579346
This O O 0.999991774559021
paper O O 0.9852638244628906
reports O O 0.9999672174453735
the O O 0.9999979734420776
expression O O 0.9992964267730713
of O O 0.9999839067459106
IL-12R S-protein S-protein 0.9314438104629517
on O O 0.9996665716171265
a O O 0.9999334812164307
human B-cell_line B-cell_line 0.5837875008583069
gamma I-cell_line I-cell_line 0.8409841060638428
delta I-cell_line I-cell_line 0.933397650718689
T I-cell_line I-cell_line 0.9741944074630737
cell I-cell_line I-cell_line 0.9604037404060364
line E-cell_line E-cell_line 0.9956502318382263
that O O 0.9979484677314758
responds O O 0.9999233484268188
to O O 0.9998154044151306
IL-12 S-protein S-protein 0.9541094899177551
with O O 0.9998732805252075
enhanced O O 0.988254189491272
cytolytic O O 0.5689811706542969

RA O O 0.8766611218452454
also O O 0.9998840093612671
exert O O 0.9999668598175049
their O O 0.9999988079071045
effect O O 0.9999983310699463
on O O 0.9999971389770508
the O O 0.9999860525131226
proliferation O O 0.9992514252662659
of O O 0.9999779462814331
primitive B-cell_type B-cell_type 0.6291478872299194
HPCs E-cell_type E-cell_type 0.48910170793533325
( O O 0.9886981248855591
high-proliferative B-cell_line B-cell_type 0.5281252264976501
potential I-cell_line I-cell_type 0.634741485118866
colony-forming I-cell_line I-cell_type 0.5019230842590332
cells E-cell_line E-cell_type 0.5970661640167236
[ O O 0.9855849146842957
HPP-CFCs S-cell_line S-cell_line 0.5862063765525818
] O O 0.9606553912162781

exclusively O O 0.9900700449943542
in O O 0.9996795654296875
myeloid B-cell_type B-cell_type 0.6911653876304626
cells E-cell_type E-cell_type 0.9717811346054077
and O O 0.9964224100112915
vascular B-cell_type B-cell_type 0.5870845317840576
endothelial I-cell_type I-cell_type 0.8947239518165588
cells E-cell_type E-cell_type 0.9844787120819092
in O O 0.9998574256896973
adult O O 0.8710337281227112

was O O 0.9926369190216064
maximal O O 0.9961410164833069
in O O 0.9999507665634155
resting B-cell_type B-cell_line 0.4769984781742096
Go I-cell_type I-cell_line 0.40182632207870483
T-cells E-cell_type E-cell_line 0.6384976506233215
and O O 0.9973347187042236
rapidly O O 0.9618263840675354
declined O O 0.9994433522224426
following O O 0.9999855756759644
anti-CD3 S-protein S-protein 0.9828373193740845
activation O O 0.9994580149650574
. O O 0.9999992847442627
We O O 0.9999955892562866
report O O 0.9999966621398926
here O O 0.999988317489624

p O O 0.8740088939666748
< O O 0.9901254177093506
.001 O O 0.9870461225509644
) O O 0.9989818930625916
less O O 0.9999940395355225
in O O 0.9999580383300781
those O O 0.9999909400939941
with O O 0.9998834133148193
Cushing O O 0.9761002063751221
's O O 0.9992002844810486
disease O O 0.9997276663780212
. O O 0.9999990463256836
In O O 0.9999067783355713
patients O O 0.9993833303451538

in O O 0.9994016885757446
the O O 0.9999953508377075
adhesion O O 0.9969742298126221
of O O 0.9999841451644897
SS B-cell_type B-cell_type 0.6539803147315979
RBC E-cell_type E-cell_type 0.9673150181770325
, O O 0.9982749223709106
PECAM-1 S-protein S-protein 0.9481878280639648
phosphorylation O O 0.9906631708145142
, O O 0.9999006986618042
and O O 0.9999747276306152
the O O 0.9999927282333374
concomitant O O 0.9618890881538391
transendothelial O O 0.9157392382621765
migration O O 0.992752194404602
of O O 0.9999406337738037
monocytes S-cell_type S-cell_type 0.9985345602035522
. O O 0.9998455047607422
Bacterial O O 0.8603973388671875
lipopolysaccharide O O 0.583267092704773
activates O O 0.995599627494812
nuclear B-protein B-protein 0.5526506304740906
factor-kappaB E-protein E-protein 0.9832522869110107
through O O 0.9985260963439941
interleukin-1 B-protein B-protein 0.84754878282547
signaling I-protein I-protein 0.7210918068885803
mediators E-protein E-protein 0.8986309170722961
in O O 0.9995507597923279
cultured B-cell_line B-cell_line 0.6656392216682434
human I-cell_line I-cell_line 0.6978433728218079
dermal I-cell_line I-cell_line 0.888152539730072
endothelial I-cell_line I-cell_line 0.9080044031143188
cells E-cell_line E-cell_line 0.8921024799346924
and O O 0.9871244430541992
mononuclear B-cell_type B-cell_type 0.8449418544769287
phagocytes E-cell_type E-cell_type 0.9882650375366211
. O O 0.9998175501823425

one O O 0.9982988238334656
of O O 0.9999936819076538
the O O 0.999998927116394
twins O O 0.9462541937828064
was O O 0.9992478489875793
clinically O O 0.9782548546791077
affected O O 0.999777615070343
, O O 0.9999978542327881
the O O 0.9999990463256836
other O O 0.999990701675415
was O O 0.9997579455375671
asymptomatic O O 0.9964945912361145
. O O 0.9999936819076538
Enzymatic O O 0.9375318288803101
assay O O 0.9960517287254333
of O O 0.9999743700027466
alpha-galactosidase S-protein S-protein 0.7845296263694763
in O O 0.9975167512893677
blood B-cell_type B-cell_type 0.7979390025138855
leucocytes E-cell_type E-cell_type 0.9890089631080627

The O O 0.9987592697143555
proband O O 0.7530711889266968
had O O 0.9985707998275757
no O O 0.9999796152114868
detectable O O 0.9922242164611816
DPD S-protein S-protein 0.9617205262184143
activity O O 0.9976825714111328
. O O 0.9999984502792358
When O O 0.999993085861206
enzyme O O 0.41648638248443604
levels O O 0.9973104000091553
in O O 0.9999940395355225
the O O 0.999931812286377
proband O O 0.8282923102378845
and O O 0.9872581362724304
relatives O O 0.9913108348846436
were O O 0.9999953508377075
compared O O 0.9999799728393555
with O O 0.9999978542327881

. O O 0.9975849390029907
DNA-binding O O 0.8666340708732605
assays O O 0.996513307094574
with O O 0.9999954700469971
cotranslated O O 0.6233409643173218
wild-type O O 0.39075833559036255
and O O 0.7011535167694092
truncated O O 0.5419849753379822
forms O O 0.5976408123970032
of O O 0.9931695461273193
EBF S-protein S-protein 0.9552346467971802
indicated O O 0.9978340268135071
that O O 0.9999915361404419
the O O 0.9999220371246338
protein O O 0.8257154822349548
interacts O O 0.996016800403595
with O O 0.9999809265136719
its O O 0.9999303817749023

is O O 0.9976691603660583
a O O 0.9999877214431763
cellular O O 0.6892521977424622
organelle O O 0.37887513637542725
that O O 0.9817370176315308
is O O 0.9998977184295654
involved O O 0.9999734163284302
in O O 0.9999945163726807
the O O 0.9999903440475464
pathogenesis O O 0.9832925200462341
of O O 0.9999064207077026
acute O O 0.8529733419418335
promyelocytic O O 0.9491755962371826
leukemia O O 0.9903448224067688
and O O 0.9998489618301392
viral O O 0.979270339012146
infection O O 0.999170184135437
. O O 0.9999994039535522
The O O 0.9999916553497314
NB O S-protein 0.8103522062301636
is O O 0.9942511320114136
also O O 0.9999440908432007
a O O 0.9999935626983643
target O O 0.9947485327720642
of O O 0.9999566078186035
antibodies S-protein O 0.5408840179443359
in O O 0.9991182684898376
the O O 0.9999622106552124
serum O O 0.8695647120475769
of O O 0.998931348323822
patients O O 0.9991914629936218

the O O 0.9985657334327698
zeta-globin B-RNA B-DNA 0.3129154145717621
mRNA I-RNA I-DNA 0.45758792757987976
cap I-RNA I-DNA 0.8905608057975769
site E-RNA E-DNA 0.9912639856338501
were O O 0.9996116757392883
deleted O O 0.9983038902282715
, O O 0.9999016523361206
up O O 0.9982039928436279
to O O 0.9997656941413879
95 O O 0.9945525527000427
% O O 0.9993791580200195
of O O 0.9999982118606567
the O O 0.9999858140945435
zeta-globin B-DNA B-DNA 0.7066853046417236
promoter E-DNA E-DNA 0.9547381401062012
activity O O 0.8798702359199524
was O O 0.9999198913574219
lost O O 0.9999667406082153
in O O 0.9999362230300903
K562 B-cell_line B-cell_line 0.918678343296051
cells E-cell_line E-cell_line 0.9993602633476257
. O O 0.9998651742935181
Reinsertion O O 0.9946842789649963
of O O 0.9999721050262451
these O O 0.9998843669891357
sequences O O 0.9497901201248169
into O O 0.9998718500137329
zeta-luciferase B-DNA B-DNA 0.6225467324256897
constructs E-DNA E-DNA 0.9958803653717041
missing O O 0.996616542339325
the O O 0.9994563460350037
-417 O B-DNA 0.9810708165168762
to O I-DNA 0.9943432807922363
-207 O I-DNA 0.7928428649902344
region O E-DNA 0.991856575012207
showed O O 0.9997974038124084
that O O 0.9999983310699463

lymphocyte O O 0.465322345495224
activation O O 0.9716440439224243
as O O 0.9999321699142456
measured O O 0.9993288516998291
by O O 0.9999898672103882
T B-protein B-protein 0.6435947418212891
cell I-protein I-protein 0.4995872676372528
antigen I-protein I-protein 0.3851366639137268
receptor E-protein E-protein 0.9964367151260376
-induced O O 0.9833548665046692
activation O O 0.992901623249054
of O O 0.9999240636825562
transcription B-protein B-protein 0.7637216448783875
factors E-protein E-protein 0.9941504597663879

HIV O O 0.4520232677459717
) O O 0.9503369331359863
. O O 0.9999872446060181
The O O 0.9999963045120239
long B-DNA B-DNA 0.46535229682922363
terminal I-DNA I-DNA 0.7770935893058777
repeat I-DNA I-DNA 0.93675297498703
( I-DNA I-DNA 0.6485182046890259
LTR I-DNA I-DNA 0.926888644695282
) I-DNA I-DNA 0.5655539035797119
region E-DNA E-DNA 0.9782649278640747
of O O 0.9995608925819397
HIV B-DNA B-DNA 0.8904951810836792
proviral I-DNA I-DNA 0.8444626331329346
DNA E-DNA E-DNA 0.9972889423370361
contains O O 0.9998712539672852
binding O B-DNA 0.4593166708946228
sites O E-DNA 0.9266455173492432
for O O 0.9996232986450195
nuclear B-protein B-protein 0.5829404592514038
factor I-protein I-protein 0.6258890628814697
kappa I-protein I-protein 0.9204469323158264
B E-protein E-protein 0.9938626289367676
( O O 0.9952607750892639
NF-kappa B-protein B-protein 0.9774060845375061
B E-protein E-protein 0.9915245175361633
) O O 0.9737344980239868
, O O 0.9998592138290405
and O O 0.9999747276306152
this O O 0.9997641444206238
transcriptional B-protein B-protein 0.42563384771347046
activator E-protein E-protein 0.9103721976280212
appears O O 0.9958121180534363
to O O 0.9999542236328125
regulate O O 0.999968409538269
HIV O O 0.7849075794219971
activation O O 0.9955590963363647
. O O 0.9999985694885254
Recent O O 0.9999197721481323
findings O O 0.9999521970748901
suggest O O 0.999998927116394
an O O 0.9999902248382568
involvement O O 0.9998235106468201

enhancer E-DNA E-DNA 0.9542344212532043
was O O 0.9995970129966736
abnormal O O 0.9935663342475891
. O O 0.9999922513961792
To O O 0.9999940395355225
ascertain O O 0.9999953508377075
whether O O 0.999998927116394
the O O 0.9999768733978271
abnormal O O 0.8551963567733765
NF-AT S-protein S-protein 0.9503713846206665
binding O O 0.9925609230995178
activity O O 0.9997168183326721
was O O 0.9999974966049194
related O O 0.9999865293502808
to O O 0.999996542930603
an O O 0.9999778270721436
impaired O O 0.9760844111442566
function O O 0.9988002777099609
, O O 0.9999961853027344
we O O 0.9999063014984131
transfected O O 0.9965904951095581
patient O O 0.9174138903617859
and O O 0.9777696132659912
control O O 0.9601971507072449
T B-cell_type B-cell_type 0.45691797137260437
lymphocytes E-cell_type E-cell_type 0.9473409056663513
with O O 0.9998206496238708
constructs O O 0.9688330292701721
containing O O 0.9999302625656128
the O O 0.999927282333374
reporter O B-DNA 0.549056351184845
gene O E-DNA 0.9717410206794739
encoding O O 0.9614076018333435
chloramphenicol B-protein B-protein 0.5424457788467407
acetyl I-protein I-protein 0.6606863141059875
transferase E-protein E-protein 0.9923694133758545
( O O 0.9912992119789124
CAT S-protein S-protein 0.9946175217628479
) O O 0.9947777986526489
under O O 0.9999910593032837

observed O O 0.9729651808738708
for O O 0.9994533658027649
NF-kB2/p52 O S-protein 0.9890578389167786
. O O 0.9999123811721802
Constitutive O O 0.9732436537742615
binding O O 0.9627994894981384
of O O 0.9994387030601501
further O B-protein 0.9644305109977722
factor B-protein I-protein 0.7588757276535034
proteins E-protein E-protein 0.9114007353782654
to O O 0.9990625977516174
DNA O O 0.7804030179977417
, O O 0.9941259622573853
such O O 0.9998974800109863
as O O 0.9999698400497437
JunD S-protein S-protein 0.6907896399497986
, O O 0.9894230961799622
c-Fos S-protein S-protein 0.6878067255020142
and O O 0.9932676553726196
FosB S-protein S-protein 0.9125996828079224
, O O 0.9975377321243286
was O O 0.9999669790267944
detected O O 0.9999580383300781
in O O 0.9999938011169434
several O O 0.9999184608459473
patients O O 0.9989616870880127
whereas O O 0.9999954700469971
the O O 0.9999924898147583
localisation O O 0.9749440550804138
and O O 0.9978529214859009
DNA O O 0.9229416251182556
binding O O 0.9799496531486511
of O O 0.9999233484268188
other O O 0.9976931214332581
factors O O 0.9061357378959656
such O O 0.9995892643928528
as O O 0.9999747276306152
c-Jun S-protein S-protein 0.9357309341430664

Press O O 0.9386608004570007
. O O 0.9998643398284912
TCL1 B-DNA B-DNA 0.2759316563606262
oncogene E-DNA E-DNA 0.9372963905334473
expression O O 0.9964337348937988
in O O 0.9999792575836182
AIDS-related O O 0.848962664604187
lymphomas O O 0.8050417304039001
and O O 0.997965931892395
lymphoid O O 0.7239637970924377
tissues O O 0.9324999451637268
. O O 0.9999896287918091
AIDS-related O O 0.9773131608963013
non-Hodgkin O O 0.9814258813858032
's O O 0.9959477782249451
lymphoma O O 0.9994557499885559
( O O 0.9999537467956543
AIDS O O 0.9968254566192627
NHL O O 0.9883445501327515
) O O 0.9998413324356079
comprises O O 0.9999654293060303

or O O 0.9833354949951172
increased O O 0.9987804293632507
numbers O O 0.9981920123100281
of O O 0.9999812841415405
VDR S-protein S-protein 0.9407351613044739
. O O 0.9999110698699951
In O O 0.9999878406524658
this O O 0.9999996423721313
study O O 0.999760091304779
we O O 0.9999936819076538
have O O 0.999997615814209
analyzed O O 0.9997883439064026
changes O O 0.9987930059432983
in O O 0.9999421834945679
gene O O 0.978365421295166
expression O O 0.9994033575057983
associated O O 0.9998067021369934
with O O 0.9999969005584717
this O O 0.9999856948852539
variable O O 0.9513511061668396
VDR S-protein S-protein 0.9005005955696106
expression O O 0.9995453953742981
. O O 0.9999994039535522
Initial O O 0.9982317090034485
experiments O O 0.9996482133865356
indicated O O 0.9999969005584717
that O O 0.9999995231628418
a O O 0.9999871253967285
50 O O 0.7281631827354431
% O O 0.971509575843811
decrease O O 0.9996583461761475
in O O 0.99997878074646
VDR S-protein S-protein 0.9941723942756653
levels O O 0.999782383441925
was O O 0.9999948740005493
associated O O 0.99977046251297
with O O 0.9999991655349731
a O O 0.9999964237213135
2-fold O O 0.9784104228019714
increase O O 0.9998914003372192
in O O 0.9998910427093506
cell O O 0.9651409983634949
proliferation O O 0.9988922476768494
and O O 0.9999746084213257

we O O 0.9979706406593323
have O O 0.9999903440475464
previously O O 0.9999274015426636
demonstrated O O 0.999983549118042
that O O 0.9999991655349731
its O O 0.9999816417694092
growth O O 0.9978818297386169
depends O O 0.9999971389770508
on O O 0.9999964237213135
the O O 0.9999971389770508
autocrine O O 0.929445207118988
production O O 0.997462272644043
of O O 0.9999909400939941
this O O 0.9998186230659485
T B-protein B-protein 0.4877588152885437
cell I-protein I-protein 0.7085863351821899
growth I-protein I-protein 0.931428074836731
factor E-protein E-protein 0.9913234710693359
and O O 0.9978600144386292
high B-protein B-protein 0.7534425258636475
affinity I-protein I-protein 0.4257434010505676
IL-2R E-protein E-protein 0.9319345951080322
. O O 0.9995844960212708
To O O 0.9999921321868896
dissect O O 0.9998774528503418
the O O 0.9999932050704956
molecular O O 0.9618955254554749
basis O O 0.9975571632385254
for O O 0.9999865293502808

S6 S-protein S-protein 0.25656646490097046
on O O 0.983927309513092
SDS-PAGE O S-DNA 0.5129988789558411
is O O 0.9980316758155823
consistent O O 0.999933123588562
with O O 0.9999990463256836
the O O 0.9999988079071045
estimated O O 0.993958592414856
molecular O O 0.9150238037109375
mass O O 0.947735607624054
for O O 0.9997580647468567
TBP7 S-protein S-protein 0.9389320015907288
, O O 0.9997993111610413
we O O 0.9999698400497437
conclude O O 0.9999991655349731
that O O 0.9999978542327881
subunit B-protein B-protein 0.6491795182228088
6 E-protein E-protein 0.9199749231338501
of O O 0.986270010471344
the O O 0.9994210004806519
26S B-protein B-protein 0.7032912969589233
protease E-protein E-protein 0.9770919680595398
is O O 0.9994621872901917
TBP7 S-protein S-protein 0.979432225227356
. O O 0.9998108744621277
Hypoxia O O 0.9681395888328552
causes O O 0.9998606443405151
the O O 0.9999922513961792
activation O O 0.9980986714363098
of O O 0.9999779462814331
nuclear B-protein B-protein 0.8661359548568726
factor I-protein I-protein 0.8343594074249268
kappa I-protein I-protein 0.899440348148346

residues O O 0.40063247084617615
may O O 0.9994284510612488
form O O 0.9999525547027588
spontaneously O O 0.9987706542015076
during O O 0.999923586845398
storage O O 0.989215075969696
or O O 0.9994819760322571
chemical O O 0.933264434337616
synthesis O O 0.9960950016975403
. O O 0.9999972581863403
A O O 0.9986625909805298
3 O O 0.6871632933616638
' O O 0.44553789496421814
-- O O 0.5661733150482178

protein E-protein E-protein 0.7675349116325378

> I-protein O 0.9595414400100708
R I-protein O 0.7465284466743469
mutant E-protein O 0.7244424819946289
was O O 0.9995176792144775
also O O 0.9999665021896362
defective O O 0.9990794658660889
in O O 0.9999704360961914
Rat-1 O S-protein 0.5614653825759888
fibroblast O O 0.48342493176460266
transformation O O 0.9562954306602478
, O O 0.9995781779289246
and O O 0.9999066591262817
fibroblast O O 0.4916301667690277
cell O O 0.34484484791755676
transformation O O 0.9832192063331604
was O O 0.999983549118042
blocked O O 0.9999592304229736
by O O 0.9999994039535522
a O O 0.9999783039093018
TRAF2 S-protein B-protein 0.664470911026001
dominant-negative O I-protein 0.5180841088294983
mutant O E-protein 0.9147919416427612
. O O 0.997885525226593

with O O 0.9992499947547913
alterations O O 0.992598295211792
in O O 0.9999309778213501
oncogenes S-DNA S-DNA 0.9655218124389648
or O O 0.9952599406242371
tumor-suppressor B-DNA B-DNA 0.5314104557037354
genes E-DNA E-DNA 0.9770810008049011
or O O 0.9986250400543213
infections O O 0.9745030403137207
by O O 0.9999626874923706
oncogenic O O 0.9016808271408081
herpesviruses O O 0.8226994276046753
. O O 0.9999783039093018
However O O 0.9999904632568359
, O O 0.9999942779541016
the O O 0.9999953508377075
clinically O O 0.9215328693389893
significant O O 0.9956662654876709
class O O 0.9567419290542603
of O O 0.9996151924133301
AIDS O O 0.7850488424301147
NHL O O 0.6491556167602539
designated O O 0.9642205834388733
immunoblastic O O 0.7983404994010925
lymphoma O O 0.9093726277351379
plasmacytoid O O 0.9579285383224487
( O O 0.9984911680221558
AIDS O O 0.9921507835388184
IBLP O O 0.988309383392334
) O O 0.9998915195465088
lacks O O 0.9999953508377075

cells E-cell_type E-cell_type 0.46478381752967834
( O O 0.9948288798332214
Bob1/OBF-1/OCA-B S-protein S-protein 0.5705280900001526
) O O 0.9738372564315796
represent O O 0.9999675750732422
two O O 0.9988635778427124
B B-protein B-protein 0.41574206948280334
cell-specific I-protein I-protein 0.6622762680053711
transcriptional I-protein I-protein 0.8649406433105469
coactivators E-protein E-protein 0.9828376770019531
. O O 0.9991620779037476
CIITA S-protein S-protein 0.8092935681343079
and O O 0.9846903681755066
Bob1 S-protein S-protein 0.9548961520195007
interact O O 0.9989650249481201
with O O 0.9999774694442749
proteins O O 0.8556012511253357
that O O 0.9996562004089355
bind O O 0.9997261166572571
to O O 0.9999257326126099
conserved B-DNA O 0.7723532319068909
upstream I-DNA B-DNA 0.4766637980937958
sequences E-DNA E-DNA 0.9767708778381348
in O O 0.9998714923858643
promoters S-DNA S-DNA 0.950401246547699
of O O 0.9989340901374817
class B-DNA B-DNA 0.48165857791900635
II I-DNA I-DNA 0.7470257878303528
major I-DNA I-DNA 0.9153416156768799
histocompatibility I-DNA I-DNA 0.9716269373893738
genes E-DNA E-DNA 0.9958508014678955
and O O 0.9982207417488098
octamer-binding B-protein B-protein 0.6210523247718811
transcription I-protein I-protein 0.8002575635910034
factors E-protein E-protein 0.9926921725273132
Oct-1 S-protein S-protein 0.9856950640678406
and O O 0.9974033236503601
Oct-2 S-protein S-protein 0.9939974546432495

suggesting O O 0.9962527751922607
that O O 0.9999912977218628
an O O 0.9999266862869263
active O O 0.8712800741195679
v-abl B-protein B-protein 0.5044489502906799
protein E-protein E-protein 0.9806458950042725
interferes O O 0.9994235038757324
with O O 0.9999908208847046
this O O 0.9999721050262451
differentiation O O 0.945948600769043
step O O 0.9910396933555603
. O O 0.9999953508377075
To O O 0.9999953508377075
test O O 0.999964714050293
this O O 0.9999693632125854
hypothesis O O 0.9980317950248718
, O O 0.999941349029541
light-chain B-DNA O 0.6242021918296814

The O O 0.9996260404586792
onset O O 0.9988059997558594
of O O 0.9999818801879883
apoptosis O O 0.9978131055831909
in O O 0.9999940395355225
both O O 0.9998306035995483
cell O O 0.9667105674743652
types O O 0.8642094731330872
can O O 0.999993085861206
be O O 0.9999929666519165
delayed O O 0.9998892545700073
by O O 0.9999984502792358
hemopoietins S-protein O 0.48221710324287415
and O O 0.9918362498283386
inflammatory B-protein B-protein 0.7314408421516418
mediators E-protein E-protein 0.9244827628135681
. O O 0.9998509883880615
Although O O 0.9999927282333374
there O O 0.9999963045120239
have O O 0.999997615814209
been O O 0.9999991655349731
a O O 0.9999992847442627
number O O 0.9999022483825684
of O O 0.9999982118606567
reports O O 0.9977201819419861
demonstrating O O 0.9999606609344482
that O O 0.9999904632568359
glucocorticoids O O 0.8954683542251587
( O O 0.9965382814407349
in O O 0.9997978806495667
particular O O 0.9943481087684631
dexamethasone O O 0.954057514667511
) O O 0.9990125894546509
antagonize O O 0.9999315738677979
the O O 0.9999878406524658
eosinophil O O 0.8378602862358093
life-prolonging O O 0.8686397671699524
effects O O 0.9988307356834412
of O O 0.9999924898147583
hemopoietins S-protein O 0.6005817651748657
, O O 0.9998428821563721
direct O O 0.9924787282943726
effects O O 0.9998031258583069
of O O 0.9999946355819702
dexamethasone O O 0.9723140001296997
on O O 0.9999030828475952
eosinophil O S-cell_type 0.9787284135818481
apoptosis O O 0.9903631806373596
have O O 0.9999814033508301
not O O 0.9999572038650513
been O O 0.999988317489624
documented O O 0.9999113082885742
. O O 0.999998927116394
In O O 0.9999945163726807
this O O 0.9999996423721313
study O O 0.9999233484268188
we O O 0.9999969005584717
examined O O 0.9999922513961792
the O O 0.9999985694885254
direct O O 0.9977360963821411
effects O O 0.9999622106552124
of O O 0.9999932050704956
glucocorticoids O O 0.9573113322257996
on O O 0.9998432397842407
eosinophil S-cell_type S-cell_type 0.9116756916046143

the O O 0.9993232488632202
risk O O 0.9998993873596191
of O O 0.9999957084655762
developing O O 0.9974442720413208
prostate O O 0.9666524529457092
cancer O O 0.9990779161453247
in O O 0.9999974966049194
men O O 0.9972809553146362
and O O 0.9999109506607056
osteoporosis O O 0.9978086352348328
in O O 0.9999905824661255
postmenopausal O O 0.9081752896308899
women O O 0.9882556200027466
. O O 0.9999977350234985
Three O O 0.9997451901435852
RFLPs S-DNA S-protein 0.47583889961242676
( O O 0.9931579232215881
TaqI S-DNA S-protein 0.8156194686889648
, O O 0.9975692629814148
ApaI S-DNA S-protein 0.9246345162391663
, O O 0.996117353439331
BsmI S-DNA S-protein 0.8709779381752014
) O O 0.9963896870613098
define O O 0.9999874830245972
two O O 0.9995118379592896
common O O 0.9871810078620911
haplotypes O O 0.7912102937698364
: O O 0.9962466359138489
BAt O S-protein 0.9158369898796082
and O O 0.9886319041252136

loss-of-function O O 0.883258581161499
mutation O O 0.9600194692611694
in O O 0.9999924898147583
one O O 0.9997286200523376
allele S-DNA S-DNA 0.9737069606781006
can O O 0.9995831847190857
be O O 0.9999825954437256
compensated O O 0.9999264478683472
for O O 0.9999942779541016
by O O 0.9999938011169434
the O O 0.9999639987945557
remaining O O 0.9832853674888611
wild-type B-DNA B-DNA 0.6147012114524841
allele E-DNA E-DNA 0.9718037247657776
of O O 0.9927310347557068
the O O 0.9997996687889099
same O O 0.9948744177818298
gene O O 0.8946614861488342
. O O 0.999923825263977
Indeed O O 0.9999690055847168
, O O 0.9999511241912842

interleukin B-DNA B-DNA 0.37250956892967224
2 I-DNA I-DNA 0.4277856647968292
gene E-DNA E-DNA 0.90440833568573
expression O O 0.9370462894439697
in O O 0.9998575448989868
T B-cell_type B-cell_type 0.9250852465629578
cells E-cell_type E-cell_type 0.9950268864631653
. O O 0.9998538494110107
We O O 0.9999887943267822
demonstrate O O 0.9999969005584717
that O O 0.9999984502792358
CaMKIV/Gr S-protein S-protein 0.9157426357269287
reconstitutes O O 0.9995637536048889
the O O 0.9999855756759644
capacity O O 0.9991508722305298
of O O 0.9999938011169434
the O O 0.999984860420227
cytosolic O O 0.45460546016693115
component O O 0.7746320366859436
of O O 0.9964564442634583
NFAT S-protein S-protein 0.868695080280304
to O O 0.9926590323448181

IC50 O S-protein 0.2800893783569336
. O O 0.9993102550506592
Partial O O 0.9825496673583984
cortisol O B-protein 0.7599911093711853
receptor O E-protein 0.9006199240684509
resistance O O 0.9953930377960205
might O O 0.9999943971633911
be O O 0.9999971389770508
less O O 0.9999796152114868
rare O O 0.9997034668922424
than O O 0.9999897480010986
previously O O 0.9981122016906738
thought O O 0.999805748462677
. O O 0.9999992847442627
In O O 0.9999836683273315
the O O 0.999998927116394
six O O 0.9998570680618286
patients O O 0.9976192116737366
presented O O 0.9999048709869385
, O O 0.9999918937683105
at O O 0.999995231628418
least O O 0.9999099969863892
three O O 0.9999372959136963
different O O 0.9993721842765808
forms O O 0.9810414910316467
can O O 0.9999715089797974
be O O 0.9999703168869019
recognized O O 0.9998599290847778
. O O 0.9999970197677612
Therapy O O 0.9977673292160034
with O O 0.9999673366546631
dexamethasone O O 0.92328280210495
was O O 0.9997071623802185
successful O O 0.999968409538269

of O O 0.998480498790741
human O O 0.6566363573074341
fetal O O 0.7385309338569641
globin S-protein O 0.34077319502830505
expression O O 0.8948651552200317
is O O 0.9998666048049927
impaired O O 0.9998979568481445
in O O 0.9999973773956299
the O O 0.9999988079071045
absence O O 0.9999309778213501
of O O 0.9999983310699463
the O O 0.9999703168869019
adult B-protein B-protein 0.5103110074996948
beta-globin I-protein I-protein 0.4282926321029663
gene I-protein I-protein 0.5163004398345947
activator I-protein I-protein 0.5963273048400879
protein E-protein E-protein 0.9419004917144775
EKLF S-protein S-protein 0.931244432926178
. O O 0.9998818635940552
Globin B-DNA B-DNA 0.3894139230251312
genes E-DNA E-DNA 0.9809088706970215
are O O 0.9999697208404541
subject O O 0.9996048808097839
to O O 0.9999878406524658
tissue-specific O O 0.9459385871887207
and O O 0.9952836632728577
developmental O O 0.9950299263000488
stage-specific O O 0.9954572916030884
regulation O O 0.9998024106025696
. O O 0.999998927116394
A O O 0.9996871948242188

Restoration O O 0.9499354362487793

plasmacytomas O O 0.2572442591190338
and O O 0.993523120880127
in O O 0.9999558925628662
some O O 0.9997122883796692
human O B-cell_line 0.44094040989875793
Burkitt O I-cell_line 0.7332439422607422
's O I-cell_line 0.8226976990699768
lymphomas O E-cell_line 0.6507789492607117
it O O 0.9646585583686829
is O O 0.999933123588562
part O O 0.9998469352722168
of O O 0.9999970197677612
a O O 0.9999959468841553
locus B-DNA B-DNA 0.620430588722229
control I-DNA I-DNA 0.5102289915084839
region E-DNA E-DNA 0.9161033630371094
( O O 0.9977468848228455
LCR S-DNA S-DNA 0.9915834069252014
) O O 0.9775876402854919
that O O 0.9999691247940063
is O O 0.9999861717224121
involved O O 0.9999774694442749
in O O 0.9999905824661255
deregulation O O 0.999686598777771
of O O 0.9999939203262329
the O O 0.9998533725738525
c-myc B-DNA B-DNA 0.5202401280403137
oncogene E-DNA E-DNA 0.9939502477645874
as O O 0.9997307658195496
a O O 0.999869704246521

were O O 0.9992818236351013
present O O 0.999721348285675
simultaneously O O 0.9999781847000122
in O O 0.9999905824661255
a O O 0.9999643564224243
ratio O O 0.9979683756828308
of O O 0.9999417066574097
around O O 0.9998548030853271
10 O O 0.9997441172599792
% O O 0.9996364116668701
. O O 0.9999877214431763
DeltaSpi-B S-protein B-protein 0.45429864525794983
product O E-protein 0.948880672454834
was O O 0.9994687438011169
not O O 0.9995825886726379
able O O 0.9999387264251709
to O O 0.9999786615371704
bind O O 0.9997618794441223
DNA O O 0.9214102029800415

of O O 0.9925521612167358

. O O 0.9987947940826416
In O O 0.999984860420227
this O O 0.9999974966049194
work O O 0.9988332390785217
, O O 0.9999954700469971
we O O 0.9999949932098389
report O O 0.9999969005584717
that O O 0.9999972581863403
these O O 0.9998623132705688
anergic B-cell_line B-cell_type 0.5362400412559509
T I-cell_line I-cell_type 0.8314533829689026
cells E-cell_line E-cell_type 0.8942238092422485
are O O 0.9997566342353821
defective O O 0.9972578883171082
in O O 0.9999799728393555
their O O 0.999988317489624
ability O O 0.9998675584793091
to O O 0.9999760389328003
up-regulate O O 0.9993072748184204
protein O O 0.8259600400924683
binding O O 0.922810435295105
and O O 0.9980226755142212
transactivation O O 0.9906752705574036
at O O 0.9999982118606567
two O O 0.9992170333862305
critical O O 0.9855257868766785
IL-2 B-DNA B-DNA 0.5813717842102051
DNA I-DNA I-DNA 0.5998844504356384
enhancer I-DNA I-DNA 0.5036249160766602
elements E-DNA E-DNA 0.997093915939331
: O O 0.9977313876152039
NF-AT S-protein S-protein 0.8151107430458069
( O O 0.972958505153656
nuclear B-protein B-protein 0.7242273688316345
factor I-protein I-protein 0.7534292936325073
of I-protein I-protein 0.8091437816619873
activated I-protein I-protein 0.9272230267524719
T I-protein I-protein 0.9660027027130127
cells E-protein E-protein 0.9611527919769287

because O O 0.9989823698997498
prior O O 0.9924305081367493
modification O O 0.9992367029190063
toward O O 0.9999717473983765
reduction O O 0.9983235001564026
with O O 0.9999938011169434
BHA O S-protein 0.6840222477912903
treatment O O 0.9855259656906128
prevents O O 0.9999406337738037
this O O 0.9999638795852661
activation O O 0.9988642930984497
. O O 0.9999960660934448
It O O 0.999984860420227
appears O O 0.9999961853027344
that O O 0.9999996423721313
a O O 0.9999850988388062
basal O O 0.8187897205352783
redox O O 0.871809184551239
equilibrium O O 0.9440287947654724
tending O O 0.9996649026870728
toward O O 0.9999567270278931
oxidation O O 0.9984908103942871
is O O 0.9999980926513672
a O O 0.9999978542327881
prerequisite O O 0.9997653365135193
for O O 0.9999980926513672
full O O 0.998857855796814
activation O O 0.9996894598007202
of O O 0.999991774559021
transduction O O 0.9035136103630066
pathways O O 0.980137288570404
regulating O O 0.9999438524246216
the O O 0.9999969005584717
activity O O 0.9990955591201782
of O O 0.9999905824661255
NF-kappa B-DNA B-DNA 0.5280405282974243
B-dependent I-DNA I-DNA 0.828096866607666
genes E-DNA E-DNA 0.9970186948776245
. O O 0.9999654293060303
Selection O O 0.9890915155410767

to O O 0.9945353269577026
express O O 0.9892093539237976
Ig O S-protein 0.8725622296333313
, O O 0.998222291469574
all O O 0.9999736547470093
other O O 0.999961256980896
tested O O 0.9397770762443542
B B-DNA B-DNA 0.42635995149612427
lymphocyte-specific I-DNA I-DNA 0.679802656173706
genes E-DNA E-DNA 0.9860281944274902
also O O 0.9996471405029297
remain O O 0.9999747276306152
active O O 0.998878538608551
. O O 0.9999979734420776
The O O 0.9999927282333374

in O O 0.997896671295166

, O O 0.9781710505485535
to O O 0.9999603033065796
a O O 0.9999749660491943
responsive O O 0.8402570486068726
region O O 0.6810145974159241
within O O 0.999444305896759
the O O 0.9999598264694214
TFG-beta B-DNA B-DNA 0.6761532425880432
2 I-DNA I-DNA 0.5169244408607483
promoter E-DNA E-DNA 0.9902620911598206
. O O 0.9996432065963745
Although O O 0.9999903440475464
GLRP S-protein S-protein 0.6743304133415222
shares O O 0.975934624671936
some O O 0.9997662901878357
characteristics O O 0.9981186985969543
with O O 0.9999974966049194
the O O 0.9999910593032837
inducible O O 0.8344923853874207
transcription B-protein B-protein 0.4398209750652313
factor E-protein E-protein 0.9082709550857544
AP-1 S-protein S-protein 0.7084514498710632
, O O 0.9953551292419434
it O O 0.9999412298202515
appears O O 0.99997878074646
to O O 0.9999876022338867
be O O 0.9999957084655762
distinct O O 0.9999631643295288
from O O 0.9999935626983643
known O O 0.9969431757926941
AP-1 B-protein B-protein 0.599439263343811
family I-protein I-protein 0.5133493542671204
members E-protein E-protein 0.9902896285057068
. O O 0.9999423027038574
These O O 0.9999980926513672
data O O 0.9979002475738525
along O O 0.999987006187439
with O O 0.9999972581863403
previous O O 0.999715268611908
observations O O 0.9992074370384216
demonstrating O O 0.9999899864196777

IL-1ra O S-protein 0.9212708473205566
production O O 0.998114824295044
. O O 0.9999961853027344
Thus O O 0.9997727274894714
, O O 0.9999908208847046
the O O 0.9999979734420776
balance O O 0.9994811415672302
between O O 0.9998912811279297
an O O 0.9999449253082275
endogenously B-protein O 0.8169002532958984
produced I-protein O 0.9706620573997498
viral I-protein B-protein 0.5943746566772461
inducer E-protein E-protein 0.5268331170082092
( O O 0.9944403767585754
IL-1 B-protein B-protein 0.5370045304298401
beta E-protein E-protein 0.904704749584198
) O O 0.9676034450531006
and O O 0.9998610019683838
an O O 0.9996461868286133
inhibitor O O 0.9643958210945129
( O O 0.997922956943512
IL-1ra S-protein O 0.5638537406921387
) O O 0.9895339608192444
may O O 0.9999878406524658
represent O O 0.9999985694885254
an O O 0.9999992847442627
important O O 0.9995821118354797
pathway O O 0.9997639060020447
leading O O 0.9999817609786987
to O O 0.9999932050704956
modulation O O 0.9976776242256165
of O O 0.9999840259552002
HIV O O 0.6758474707603455
expression O O 0.9880719184875488
from O O 0.9999843835830688
monocytic B-cell_type B-cell_type 0.8339480757713318
cells E-cell_type E-cell_type 0.9801581501960754
. O O 0.9998834133148193
Herpesvirus B-cell_line B-cell_line 0.7332552075386047
saimiri I-cell_line I-cell_line 0.6512712240219116
immortalized I-cell_line I-cell_line 0.9346880316734314
gamma I-cell_line I-cell_line 0.4839378595352173
delta I-cell_line I-cell_line 0.5125238299369812
T I-cell_line I-cell_line 0.46572205424308777
cell I-cell_line I-cell_line 0.7064090967178345
line E-cell_line E-cell_line 0.9935872554779053
activated O O 0.9655578136444092
by O O 0.999943733215332
IL-12 S-protein S-protein 0.9869340658187866
. O O 0.9996542930603027
IL-12 S-protein S-protein 0.9906884431838989
is O O 0.9999513626098633
a O O 0.9999948740005493
novel O O 0.8720631003379822
heterodimeric B-protein B-protein 0.58428955078125
cytokine E-protein E-protein 0.9888484477996826
important O O 0.9980972409248352
for O O 0.9999867677688599
the O O 0.9999918937683105
regulation O O 0.9864379167556763

between O O 0.9857696294784546
consensus B-DNA B-DNA 0.6052064895629883
binding I-DNA I-DNA 0.6699610948562622
sequences E-DNA E-DNA 0.9937849044799805
for O O 0.9998218417167664
Sp1 S-protein S-protein 0.9525541663169861
and O O 0.9948803186416626
elevated O O 0.8209843635559082
total O O 0.7337237596511841
serum O O 0.8063616156578064
. O O 0.9998316764831543
This O O 0.9999948740005493
polymorphism O O 0.9447553157806396
was O O 0.999811589717865
associated O O 0.9998834133148193
with O O 0.9999971389770508
elevated O O 0.9510001540184021
total B-protein O 0.9496464729309082
serum I-protein O 0.9618504047393799
IgE E-protein S-protein 0.8551817536354065
in O O 0.9999736547470093
subjects O O 0.9456089735031128
heterozygotic O O 0.720211923122406
or O O 0.9271841049194336
homozygotic O O 0.6387059688568115
for O O 0.9923874139785767

Increased O O 0.9899360537528992
activity O O 0.9989983439445496
of O O 0.9999936819076538
various O O 0.9533634781837463
proteases S-protein O 0.5131802558898926
is O O 0.999932050704956
observed O O 0.9998883008956909
in O O 0.9999788999557495
both O O 0.9993112087249756
human O O 0.5611585378646851
and O O 0.8118740320205688
experimental O O 0.8996835350990295
pancreatitis O O 0.9793106913566589
; O O 0.9997286200523376
however O O 0.9999920129776001
, O O 0.9999982118606567
the O O 0.9999942779541016
information O O 0.9996814727783203
on O O 0.9999947547912598
the O O 0.9999934434890747
effects O O 0.9999476671218872
of O O 0.9999958276748657
specific O O 0.9610432386398315
protease O O 0.6674266457557678
inhibitors O O 0.8113265037536621
on O O 0.9999712705612183
the O O 0.9999706745147705
disease O O 0.9992498755455017
is O O 0.9999933242797852
limited O O 0.9999563694000244
. O O 0.9999991655349731
In O O 0.9999964237213135
this O O 0.9999997615814209
study O O 0.9999092817306519
we O O 0.9999971389770508
show O O 0.9999992847442627
that O O 0.9999991655349731
a O O 0.9999816417694092
novel O O 0.9319279789924622
elastase O O 0.4116855263710022
inhibitor O O 0.64107346534729
, O O 0.999403715133667
guamerin-derived O O 0.7876502275466919
synthetic O O 0.9338719248771667
peptide O O 0.981682300567627
( O O 0.9995306730270386
GDSP O O 0.9957677125930786
) O O 0.9998212456703186
, O O 0.9999891519546509
improves O O 0.9999939203262329
the O O 0.9999970197677612
parameters O O 0.9979692101478577
of O O 0.9999933242797852
cerulein-induced O O 0.9210295081138611
acute O O 0.9415012001991272
pancreatitis O O 0.9983556866645813
in O O 0.9999963045120239

class I-DNA I-DNA 0.2713351249694824
II I-DNA I-DNA 0.7786061763763428
genes E-DNA E-DNA 0.9989022016525269
. O O 0.9999475479125977
This O O 0.9999854564666748
was O O 0.9998206496238708
unambiguously O O 0.9964624047279358
demonstrated O O 0.9999732971191406
by O O 0.9999995231628418
the O O 0.9999995231628418
fact O O 0.9998925924301147
that O O 0.999994158744812
plasmacytoma B-cell_line B-cell_line 0.29865139722824097
x I-cell_line I-cell_line 0.37564048171043396
B I-cell_line I-cell_line 0.5477644205093384
cell I-cell_line I-cell_line 0.6662827730178833
hybrids E-cell_line E-cell_line 0.9978116154670715
carrying O O 0.999487042427063
an O O 0.9999898672103882
AIR-1 B-DNA B-DNA 0.7593458294868469
locus E-DNA E-DNA 0.9723642468452454
derived O O 0.9982233643531799
from O O 0.9999843835830688

characterization O O 0.9843207597732544
and O O 0.9994844198226929
pattern O O 0.994631290435791
of O O 0.9999136924743652
tissue O O 0.8997913599014282
expression O O 0.9894211292266846
of O O 0.9998689889907837
the O O 0.9999867677688599
gene O O 0.9029061198234558
for O O 0.9980217218399048
neutrophil B-protein B-protein 0.7371209859848022
gelatinase-associated I-protein I-protein 0.6083512902259827
lipocalin E-protein E-protein 0.9686448574066162
from O O 0.9994797110557556
humans O O 0.9336472749710083
. O O 0.9999399185180664
Neutrophil B-protein B-protein 0.4628715515136719
gelatinase-associated I-protein I-protein 0.6024122834205627
lipocalin E-protein E-protein 0.9738794565200806
( O O 0.9863418936729431
NGAL S-protein S-protein 0.9696187376976013
) O O 0.9821656346321106
is O O 0.9999847412109375
a O O 0.9999934434890747
25-kDa B-protein B-protein 0.6518617868423462
lipocalin E-protein I-protein 0.5795257091522217

the O O 0.9985036849975586
TF B-protein B-protein 0.423086941242218
complex E-protein E-protein 0.9524078369140625
and O O 0.995571494102478
further O O 0.9998457431793213
showed O O 0.9999977350234985
that O O 0.9999946355819702
c-Rel/p65 B-protein B-protein 0.5246888995170593
heterodimers E-protein E-protein 0.9572613835334778
selectively O O 0.9979384541511536
bound O O 0.9999823570251465
to O O 0.9999880790710449
the O O 0.9998892545700073
TF B-DNA B-DNA 0.7161682844161987
kappa I-DNA I-DNA 0.8794724345207214
B-like I-DNA I-DNA 0.9665546417236328
site E-DNA E-DNA 0.9958749413490295
. O O 0.9999645948410034
Functional O O 0.9942681789398193
studies O O 0.9992536902427673
indicated O O 0.9999946355819702
that O O 0.9999988079071045
the O O 0.9999146461486816

Sp1 B-DNA B-DNA 0.6384758353233337
binding I-DNA I-DNA 0.7826457023620605
site E-DNA E-DNA 0.9902091026306152
adjacent O O 0.9855089783668518
to O O 0.9999064207077026
the O O 0.9993320107460022
octamer B-DNA B-DNA 0.8900800347328186
site E-DNA E-DNA 0.9880067110061646
, O O 0.9713426232337952
and O O 0.999213457107544
the O O 0.9997679591178894
PU.1 B-DNA B-DNA 0.7115656733512878
autoregulatory I-DNA I-DNA 0.9577636122703552
site E-DNA E-DNA 0.9908218383789062
. O O 0.9997803568840027
Finally O O 0.9999674558639526
, O O 0.9999939203262329
we O O 0.9999903440475464
show O O 0.9999988079071045
that O O 0.9999996423721313
the O O 0.9999371767044067
B O B-protein 0.45426174998283386
cell O I-protein 0.6586658358573914
coactivator S-protein E-protein 0.5865134000778198
OBF-1/Bob1/OCA-B S-protein S-protein 0.52678382396698
is O O 0.9978454113006592
only O O 0.9998936653137207
expressed O O 0.9996055960655212
in O O 0.9997957348823547
B B-cell_type B-cell_type 0.9447546601295471
cells E-cell_type E-cell_type 0.9779564142227173
and O O 0.9886642098426819
not O O 0.9915274977684021
in O O 0.9969415068626404
myeloid B-cell_type B-cell_type 0.7388240098953247
cells E-cell_type E-cell_type 0.9657884836196899
, O O 0.9898558855056763
and O O 0.9999682903289795
that O O 0.9999953508377075
OBF-1/Bob1/OCA-B S-protein S-protein 0.6168333888053894

demonstrating O O 0.995419979095459
that O O 0.9999880790710449
secreted O O 0.8546383380889893
TIMP-1 S-protein S-protein 0.8931626081466675
is O O 0.9997525811195374
active O O 0.9984539747238159
in O O 0.9999369382858276
blocking O O 0.9839155077934265
apoptosis O O 0.998548686504364
. O O 0.9999985694885254
Furthermore O O 0.9999849796295166
, O O 0.9999703168869019
TIMP-1 S-protein S-protein 0.9734060764312744
upregulation O O 0.9954657554626465
induced O O 0.9995477795600891
expression O O 0.9980258941650391

suggesting O O 0.9963306784629822
that O O 0.9999895095825195
its O O 0.999984622001648
activity O O 0.9989829659461975
also O O 0.9999899864196777
depends O O 0.9999939203262329
on O O 0.9999736547470093
calcineurin S-protein S-protein 0.9892117977142334
. O O 0.99996018409729
To O O 0.9999814033508301
further O O 0.9999363422393799
dissect O O 0.9994039535522461
p95vav S-protein S-protein 0.9540542364120483
involvement O O 0.9996837377548218
in O O 0.9999961853027344
TCR S-protein S-protein 0.9756816029548645
signaling O O 0.9955037236213684
, O O 0.9999939203262329
we O O 0.999976634979248
analyzed O O 0.9999731779098511
various O O 0.9982568621635437

binding O O 0.8548374772071838
activity O O 0.9931681156158447
is O O 0.9999828338623047
followed O O 0.9999924898147583
by O O 0.999997615814209
functional O O 0.9872482419013977
activation O O 0.9984952211380005
in O O 0.9999953508377075
that O O 0.9999758005142212
inducibility O O 0.9966078996658325
of O O 0.9999686479568481
the O O 0.9999688863754272
IL-2 B-protein B-protein 0.4826752841472626
receptor I-protein I-protein 0.3216511011123657
alpha I-protein E-protein 0.6584764719009399

, O O 0.9395063519477844
nuclear B-protein B-protein 0.5363949537277222
factor-kappaB E-protein E-protein 0.9917592406272888
and O O 0.9857860207557678
activator B-protein B-protein 0.6413367390632629
protein-1 E-protein E-protein 0.9948230981826782
. O O 0.999407172203064
The O O 0.999997615814209
inherent O O 0.9803856611251831
resistance O O 0.9988215565681458
of O O 0.9999706745147705
naive B-cell_type B-cell_type 0.6669304370880127
T I-cell_type I-cell_type 0.9129112362861633
cells E-cell_type E-cell_type 0.9858489036560059
to O O 0.9992619156837463

the O O 0.9979239702224731
E-protein B-DNA B-DNA 0.7985690236091614
genes E-DNA E-DNA 0.9973811507225037
and O O 0.9997497200965881
discuss O O 0.9999552965164185
our O O 0.9999957084655762
current O O 0.9992781281471252
understanding O O 0.9998695850372314
of O O 0.999997615814209
the O O 0.9999988079071045
role O O 0.9993385672569275
of O O 0.9999886751174927
these O O 0.9998750686645508
proteins O O 0.8792563080787659
in O O 0.9993768334388733
lymphoid O O 0.6669310927391052
development O O 0.8509281277656555
Epstein-Barr B-protein B-protein 0.6487609148025513
virus-transforming I-protein I-protein 0.7369611263275146
protein E-protein I-protein 0.7146992683410645
latent B-protein I-protein 0.7479327321052551
infection I-protein I-protein 0.8624155521392822
membrane I-protein I-protein 0.7668924927711487
protein I-protein I-protein 0.39804014563560486
1 E-protein E-protein 0.9936163425445557
activates O O 0.9926062822341919
transcription B-protein B-protein 0.7893205285072327
factor I-protein E-protein 0.9235833883285522
NF-kappaB E-protein S-protein 0.8005754351615906
through O O 0.9998759031295776

expression O O 0.9762603640556335
in O O 0.9999271631240845
THP-1 B-cell_line B-cell_line 0.8665238618850708
cells E-cell_line E-cell_line 0.9716128706932068
resulted O O 0.9999316930770874
in O O 0.9999982118606567
a O O 0.9999984502792358
reduction O O 0.99903404712677
of O O 0.9999583959579468
TNF-alpha S-protein B-RNA 0.9362897872924805
transcripts O E-RNA 0.9969793558120728
. O O 0.999818742275238
In O O 0.9999617338180542
addition O O 0.9997649788856506
, O O 0.99994957447052
high O O 0.9715116620063782
level O O 0.9937385320663452
of O O 0.9991877675056458
expression O O 0.9993419051170349
of O O 0.9999829530715942

